data_5jpw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jpw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.291 0.567 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.25 178.57 5.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.83 1.252 . . . . 0.0 112.289 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.5 152.68 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.173 1.389 . . . . 0.0 110.916 171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.62 -43.42 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.731 1.212 . . . . 0.0 111.704 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.67 -29.85 68.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.101 1.36 . . . . 0.0 113.337 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.22 -57.34 4.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.101 0.96 . . . . 0.0 110.502 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.9 t -51.43 -40.45 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.74 1.216 . . . . 0.0 112.512 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -61.36 -19.76 62.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.76 1.624 . . . . 0.0 113.949 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.19 -35.55 10.34 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.731 1.612 . . . . 0.0 113.357 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mt -51.75 -38.88 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.277 1.031 . . . . 0.0 110.809 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.1 -42.36 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.88 62.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.884 1.22 . . . . 0.0 111.299 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -32.47 71.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.3 -43.23 52.19 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.02 -55.41 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.616 1.098 . . . . 0.0 110.374 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.71 -29.77 70.96 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.422 -0.799 . . . . 0.0 113.138 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -61.24 -46.27 91.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.279 1.032 . . . . 0.0 112.236 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.34 93.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.144 0.977 . . . . 0.0 113.331 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.98 -48.0 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.254 1.021 . . . . 0.0 110.565 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.46 19.91 67.2 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.398 0.999 . . . . 0.0 115.01 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.14 20.46 77.4 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.918 1.247 . . . . 0.0 115.401 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.04 179.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 114.43 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.23 144.69 19.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.405 1.482 . . . . 0.0 113.32 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.65 121.04 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.819 1.248 . . . . 0.0 111.032 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.97 157.98 45.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.269 1.828 . . . . 0.0 111.112 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -106.44 -66.01 1.04 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.208 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -60.6 -18.51 53.42 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.943 1.297 . . . . 0.0 114.254 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.72 -38.96 79.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.036 -1.04 . . . . 0.0 113.191 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.08 -35.24 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.363 0.665 . . . . 0.0 111.943 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -62.12 -50.63 71.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.451 . . . . 0.0 111.341 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.95 -25.6 64.63 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -77.85 -54.26 6.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.01 0.823 . . . . 0.0 111.148 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -54.99 -36.08 65.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.678 0.672 . . . . 0.0 111.984 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -73.78 -56.86 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.345 0.975 . . . . 0.0 112.04 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -57.36 -40.27 77.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.98 1.312 . . . . 0.0 113.342 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.17 -63.64 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 C-N-CA 124.479 1.112 . . . . 0.0 110.524 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.76 -28.77 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.709 1.204 . . . . 0.0 110.788 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.87 -42.54 79.97 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.331 1.053 . . . . 0.0 112.667 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -103.41 -36.2 8.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.226 1.41 . . . . 0.0 112.592 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.9 m -62.89 -49.68 73.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.048 2.139 . . . . 0.0 112.355 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -36.7 83.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.709 0.404 . . . . 0.0 111.407 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 t -63.06 -42.86 99.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.486 0.714 . . . . 0.0 112.495 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -66.94 -49.38 65.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.045 1.738 . . . . 0.0 113.27 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.61 -28.03 68.83 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.68 -1.262 . . . . 0.0 113.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -57.59 -28.24 63.43 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.419 1.088 . . . . 0.0 111.151 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -89.75 -28.04 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.392 1.077 . . . . 0.0 113.285 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.85 -21.74 61.63 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.408 1.083 . . . . 0.0 112.463 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -134.72 8.61 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.373 1.94 . . . . 0.0 112.629 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -116.71 155.76 48.57 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 125.644 1.578 . . . . 0.0 112.578 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.38 114.16 3.15 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.856 3.037 . . . . 0.0 111.66 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.45 175.14 12.57 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.084 2.154 . . . . 0.0 110.808 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.74 100.42 7.08 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.231 1.413 . . . . 0.0 110.887 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.5 143.59 28.06 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.036 1.335 . . . . 0.0 109.949 168.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.402 HD13 ' HG ' ' B' ' 228' ' ' CYS . 1.6 tt -133.44 153.4 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.464 1.505 . . . . 0.0 109.528 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.38 150.42 24.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.734 0.814 . . . . 0.0 111.084 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -133.78 136.67 44.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.331 1.453 . . . . 0.0 109.139 171.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 48.3 t -131.28 140.67 49.84 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.068 0.947 . . . . 0.0 111.159 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.49 101.31 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.543 1.537 . . . . 0.0 109.179 -168.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.22 95.88 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.288 1.435 . . . . 0.0 110.033 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.58 166.17 14.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.985 1.714 . . . . 0.0 112.815 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 119.47 22.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.683 1.193 . . . . 0.0 112.374 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -67.24 -11.29 57.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.084 1.354 . . . . 0.0 113.546 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -54.48 -28.61 46.0 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.996 1.719 . . . . 0.0 114.21 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.3 10.48 0.09 OUTLIER Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.05 97.82 4.57 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.107 1.454 . . . . 0.0 112.478 -165.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.31 169.08 25.96 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.197 1.856 . . . . 0.0 112.862 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.07 174.82 13.22 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.088 1.355 . . . . 0.0 113.319 -167.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.16 98.66 9.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.952 0.901 . . . . 0.0 112.08 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.3 m -95.29 139.82 31.07 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.212 -0.93 . . . . 0.0 109.637 172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.06 111.77 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.949 1.7 . . . . 0.0 110.363 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 m -115.43 107.78 15.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 110.594 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -76.95 35.32 0.16 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.707 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.4 ' HG ' HD13 ' B' ' 209' ' ' ILE . 2.1 m -85.32 176.4 8.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.866 1.266 . . . . 0.0 111.412 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -141.17 137.63 32.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.278 1.431 . . . . 0.0 109.929 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -79.59 132.1 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.422 0.689 . . . . 0.0 109.803 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -142.68 149.0 38.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.372 1.469 . . . . 0.0 110.586 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -123.51 -60.47 1.47 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.176 1.39 . . . . 0.0 112.344 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -92.86 -26.79 17.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.017 0.927 . . . . 0.0 112.852 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -52.86 30.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.817 2.047 . . . . 0.0 113.317 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -146.87 173.87 12.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.769 2.427 . . . . 0.0 110.44 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.92 121.26 6.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.114 1.34 . . . . 0.0 113.359 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -146.85 144.84 29.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.456 1.502 . . . . 0.0 110.616 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.7 t -149.55 164.5 34.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.601 1.161 . . . . 0.0 111.184 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -162.96 150.48 13.35 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.178 -1.576 . . . . 0.0 111.143 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.32 127.03 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.893 1.277 . . . . 0.0 110.113 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.76 111.74 17.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.04 1.336 . . . . 0.0 112.515 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -125.45 93.74 3.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.975 1.71 . . . . 0.0 110.678 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 151.83 29.4 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.685 1.194 . . . . 0.0 112.381 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -125.74 -175.22 3.28 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.915 1.686 . . . . 0.0 110.574 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -54.17 -50.22 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.032 1.333 . . . . 0.0 113.908 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -134.4 1.95 3.21 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.935 1.694 . . . . 0.0 113.895 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.26 156.97 32.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.292 2.237 . . . . 0.0 110.958 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -134.75 120.95 20.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.313 1.445 . . . . 0.0 110.815 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.2 m -126.16 98.31 5.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.218 1.007 . . . . 0.0 110.64 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 116.18 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.439 1.096 . . . . 0.0 111.882 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.12 137.38 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.471 1.908 . . . . 0.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -130.09 147.59 51.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.809 1.244 . . . . 0.0 111.349 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.99 140.01 39.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.796 1.639 . . . . 0.0 113.57 -170.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.55 113.61 13.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.549 1.14 . . . . 0.0 109.621 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.84 77.64 0.23 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.531 2.015 . . . . 0.0 110.734 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.06 108.92 2.8 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 111.232 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 126.736 2.014 . . . . 0.0 111.115 -171.003 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.75 176.77 8.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.44 1.896 . . . . 0.0 111.106 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.06 139.66 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.621 1.568 . . . . 0.0 111.142 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -115.7 92.88 4.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.363 1.465 . . . . 0.0 110.787 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -76.27 149.45 37.12 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.872 -1.143 . . . . 0.0 111.218 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.11 108.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.427 2.291 . . . . 0.0 109.636 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -131.89 119.8 21.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.074 1.75 . . . . 0.0 109.645 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 125.572 1.549 . . . . 0.0 109.902 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 CA-C-O 121.22 0.533 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -77.29 177.33 8.01 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.501 1.12 . . . . 0.0 112.361 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.0 152.59 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.26 1.424 . . . . 0.0 110.814 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.33 -43.2 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.0 -29.81 68.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.035 1.334 . . . . 0.0 113.357 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -73.71 -57.8 3.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 110.398 172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.6 -40.47 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.815 1.246 . . . . 0.0 112.505 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 29.3 t -61.22 -19.95 62.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.773 1.629 . . . . 0.0 113.963 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -97.96 -35.76 10.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.339 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.83 -38.69 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 110.866 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.15 -42.3 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -50.82 62.27 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.873 1.215 . . . . 0.0 111.263 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -32.47 71.14 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -43.27 52.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.95 -55.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.59 1.087 . . . . 0.0 110.336 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.64 -29.88 71.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.395 -0.816 . . . . 0.0 113.102 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.8 t -61.22 -46.3 90.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.231 1.013 . . . . 0.0 112.194 168.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.26 93.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.127 0.971 . . . . 0.0 113.319 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.97 -47.99 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.29 1.036 . . . . 0.0 110.529 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.43 19.96 67.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.391 0.996 . . . . 0.0 115.004 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.42 77.5 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.915 1.245 . . . . 0.0 115.407 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.02 179.45 0.91 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.98 1.312 . . . . 0.0 114.393 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.24 144.76 19.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.418 1.487 . . . . 0.0 113.334 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.71 120.98 15.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 110.982 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.92 157.88 45.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.321 1.848 . . . . 0.0 111.178 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -106.32 -65.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.476 1.111 . . . . 0.0 111.251 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -60.55 -18.51 52.89 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.923 1.289 . . . . 0.0 114.225 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.88 -38.86 79.78 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.981 -1.074 . . . . 0.0 113.207 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.12 -35.13 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.395 0.678 . . . . 0.0 111.982 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.16 -50.75 70.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.353 1.461 . . . . 0.0 111.277 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.89 -25.72 64.75 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -77.79 -54.29 6.52 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.012 0.824 . . . . 0.0 111.141 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -55.09 -35.71 64.89 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.64 0.655 . . . . 0.0 112.007 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -73.97 -57.34 4.04 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.372 0.987 . . . . 0.0 112.02 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.77 -40.13 75.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.037 1.335 . . . . 0.0 113.336 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.02 -63.87 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.489 1.116 . . . . 0.0 110.529 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.67 -28.9 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.741 1.217 . . . . 0.0 110.753 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.94 -41.82 78.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 0.0 112.725 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -104.12 -36.41 7.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.221 1.408 . . . . 0.0 112.514 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 35.2 m -62.59 -49.74 74.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.123 2.169 . . . . 0.0 112.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -37.15 84.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.858 0.463 . . . . 0.0 111.474 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.9 t -61.79 -46.43 89.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.438 0.695 . . . . 0.0 112.112 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -64.04 -49.36 72.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.063 1.745 . . . . 0.0 113.5 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.73 -28.21 68.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.734 -1.229 . . . . 0.0 113.595 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 82.1 m -58.3 -31.35 67.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.613 0.765 . . . . 0.0 110.85 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -84.95 -27.81 26.28 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.893 0.877 . . . . 0.0 113.088 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 27.7 mt -71.41 -20.75 62.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.502 1.121 . . . . 0.0 112.443 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.83 -136.26 9.27 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.702 2.096 . . . . 0.0 112.933 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -115.47 156.23 46.19 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.848 1.659 . . . . 0.0 112.427 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.75 110.85 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.879 3.053 . . . . 0.0 111.738 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.59 173.92 12.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.952 2.101 . . . . 0.0 110.892 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -74.31 96.2 2.79 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.074 1.35 . . . . 0.0 111.8 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -81.91 153.77 26.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.251 1.421 . . . . 0.0 111.413 164.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . 0.4 HD13 ' HG ' ' A' ' 85' ' ' CYS . 2.7 tt -149.26 153.72 10.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.939 2.096 . . . . 0.0 108.681 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.64 151.54 22.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.999 0.919 . . . . 0.0 110.912 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.5 p -132.82 137.56 46.79 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.232 1.413 . . . . 0.0 109.229 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 47.7 t -132.26 145.04 51.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.272 1.029 . . . . 0.0 111.124 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.16 106.73 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.625 1.57 . . . . 0.0 108.782 -167.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 mm -101.18 94.7 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.086 1.355 . . . . 0.0 109.688 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 166.27 14.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.014 1.725 . . . . 0.0 112.6 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.25 121.16 24.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.524 1.13 . . . . 0.0 112.571 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -67.95 -11.17 58.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.049 1.34 . . . . 0.0 113.582 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.25 -28.04 50.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 114.212 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.64 11.5 0.1 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.48 98.5 4.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 -166.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -143.27 169.26 25.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.27 1.89 . . . . 0.0 112.874 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.14 174.64 13.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.18 1.392 . . . . 0.0 113.252 -167.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.24 100.41 11.51 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.91 0.884 . . . . 0.0 112.093 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 79.6 m -96.8 139.61 32.59 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.085 -1.009 . . . . 0.0 109.803 172.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.53 110.18 12.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.848 1.659 . . . . 0.0 109.955 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 10.1 m -112.44 108.03 17.03 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.37 1.068 . . . . 0.0 110.292 -172.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.6 t -76.96 35.52 0.16 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.62 1.168 . . . . 0.0 112.673 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . 0.402 ' HG ' HD13 ' A' ' 66' ' ' ILE . 2.5 m -84.88 175.91 8.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 0.0 111.622 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.2 137.21 32.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.326 1.45 . . . . 0.0 109.932 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -78.91 130.6 35.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.373 0.669 . . . . 0.0 109.704 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -139.85 145.44 38.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.61 1.564 . . . . 0.0 110.25 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 47.6 t -120.5 -61.74 1.54 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.097 1.359 . . . . 0.0 112.419 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 9.1 t -93.26 -25.0 17.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.093 0.957 . . . . 0.0 112.797 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -52.84 30.75 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.753 2.021 . . . . 0.0 112.968 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -148.7 174.49 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.744 2.418 . . . . 0.0 110.44 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.68 120.75 6.25 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.012 1.292 . . . . 0.0 113.514 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 52.6 m -146.39 144.51 29.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.418 1.487 . . . . 0.0 110.769 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 6.9 t -149.14 164.7 33.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.695 1.198 . . . . 0.0 111.179 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 2.9 t -163.12 150.61 13.16 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.166 -1.584 . . . . 0.0 111.11 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.38 127.27 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.919 1.288 . . . . 0.0 110.109 -173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.91 111.91 17.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.029 1.332 . . . . 0.0 112.536 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -125.51 94.13 4.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.958 1.703 . . . . 0.0 110.678 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.76 151.87 28.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 112.39 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -125.9 -175.18 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.86 1.664 . . . . 0.0 110.551 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -54.32 -50.02 68.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.112 1.365 . . . . 0.0 113.949 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -134.61 2.02 3.16 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.953 1.701 . . . . 0.0 113.895 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.27 156.97 32.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.232 2.213 . . . . 0.0 110.879 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.82 121.4 20.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.333 1.453 . . . . 0.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 15.9 m -126.28 98.57 5.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.258 1.023 . . . . 0.0 110.551 -175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 117.74 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.255 1.022 . . . . 0.0 111.85 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.0 137.99 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.558 1.943 . . . . 0.0 111.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.2 t -131.32 147.4 52.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.861 1.264 . . . . 0.0 111.382 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.44 38.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.725 1.61 . . . . 0.0 113.543 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.91 110.08 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -105.29 77.94 0.26 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.237 1.875 . . . . 0.0 110.669 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.73 108.69 2.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.402 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 126.792 2.037 . . . . 0.0 111.137 -171.013 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.198 0.523 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.73 177.31 7.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.546 1.939 . . . . 0.0 111.098 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.08 139.33 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.561 1.544 . . . . 0.0 111.259 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.1 m -114.84 90.76 3.42 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.343 1.457 . . . . 0.0 110.562 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.95 149.99 37.57 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.814 -1.178 . . . . 0.0 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.6 p -143.17 108.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.607 1.963 . . . . 0.0 110.407 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -130.02 120.02 24.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.896 2.078 . . . . 0.0 109.142 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.573 1.149 . . . . 0.0 108.536 167.381 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -101.55 172.02 7.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.147 0.979 . . . . 0.0 111.07 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.95 146.21 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.15 1.38 . . . . 0.0 109.763 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.9 t -60.48 -38.52 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.496 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.56 -29.15 68.98 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.86 1.264 . . . . 0.0 113.74 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.36 -58.23 3.45 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.933 0.893 . . . . 0.0 110.426 171.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.3 t -52.03 -44.01 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.319 1.447 . . . . 0.0 112.095 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.26 -12.8 44.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.127 1.771 . . . . 0.0 113.834 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -101.95 -31.98 10.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 113.133 171.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mt -51.59 -43.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.052 0.941 . . . . 0.0 110.451 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.65 -42.56 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -52.48 56.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.037 1.29 . . . . 0.0 110.805 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.18 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.55 -38.5 70.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.074 0.949 . . . . 0.0 113.089 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.2 mt -61.06 -57.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.329 0.968 . . . . 0.0 110.057 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.82 -28.75 70.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 t -59.73 -46.57 88.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.72 1.208 . . . . 0.0 112.386 168.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.16 79.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.92 0.888 . . . . 0.0 113.151 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.6 mt -67.72 -40.18 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.346 1.058 . . . . 0.0 111.728 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.96 12.85 58.43 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.837 1.208 . . . . 0.0 114.992 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.84 15.52 73.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.723 1.154 . . . . 0.0 114.766 -172.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.61 -175.79 0.71 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.203 1.401 . . . . 0.0 112.369 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.16 107.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.402 1.481 . . . . 0.0 112.616 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -70.52 100.01 1.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.534 1.534 . . . . 0.0 111.109 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.5 164.87 11.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.645 1.178 . . . . 0.0 111.738 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -73.42 -55.75 5.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -68.21 -21.05 64.88 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.623 -0.673 . . . . 0.0 112.559 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -58.61 -44.03 89.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 168.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -54.81 -34.61 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.393 0.997 . . . . 0.0 112.048 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.2 -49.92 65.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.086 0.954 . . . . 0.0 111.936 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.01 -26.0 66.57 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.565 -0.709 . . . . 0.0 112.813 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -76.71 -53.62 7.73 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.308 1.043 . . . . 0.0 111.247 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 t -58.27 -26.78 63.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -81.46 -57.38 3.5 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.597 1.09 . . . . 0.0 112.542 169.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -57.83 -38.36 75.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 113.74 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.02 -62.55 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 123.841 0.856 . . . . 0.0 110.343 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.9 t -48.95 -29.67 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.983 1.313 . . . . 0.0 110.82 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.01 -42.99 86.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.534 0.733 . . . . 0.0 112.788 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -103.87 -34.75 8.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.216 1.406 . . . . 0.0 113.149 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -59.17 -53.96 52.43 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.323 1.849 . . . . 0.0 111.487 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -37.78 83.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.961 0.505 . . . . 0.0 111.979 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 p -70.92 -29.93 66.11 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.92 -51.89 19.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.484 2.314 . . . . 0.0 112.968 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.78 -25.6 67.99 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.865 -1.147 . . . . 0.0 113.731 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 m -59.95 -33.58 72.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.143 0.977 . . . . 0.0 110.939 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -82.09 -28.42 32.33 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.39 -16.56 63.53 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.64 -120.67 4.55 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.247 1.88 . . . . 0.0 112.544 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -131.64 152.38 80.3 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 126.376 1.87 . . . . 0.0 111.631 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.31 109.42 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.953 3.102 . . . . 0.0 112.108 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -148.04 161.56 41.14 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.705 1.202 . . . . 0.0 112.57 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -69.17 92.6 0.56 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.193 1.397 . . . . 0.0 110.828 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -70.5 165.02 23.52 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.629 -0.67 . . . . 0.0 112.038 164.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 tt -144.43 159.88 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.696 1.598 . . . . 0.0 110.092 167.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.67 148.11 23.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.3 1.44 . . . . 0.0 110.776 171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 124.62 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.141 1.776 . . . . 0.0 108.642 175.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.09 151.0 49.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.77 100.0 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.028 1.731 . . . . 0.0 109.012 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 mm -97.27 109.69 23.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 8.3 ttm -124.11 154.78 39.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.747 1.219 . . . . 0.0 110.748 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.59 150.53 36.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.889 1.276 . . . . 0.0 111.833 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -90.66 3.45 54.17 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.11 1.364 . . . . 0.0 113.498 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -67.74 -18.53 64.92 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.162 1.785 . . . . 0.0 115.072 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.55 -1.75 2.14 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.201 1.24 . . . . 0.0 116.201 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.6 122.74 12.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.819 1.81 . . . . 0.0 111.79 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.59 112.82 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.023 1.297 . . . . 0.0 113.163 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.38 151.73 45.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.13 2.572 . . . . 0.0 109.597 -172.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -118.4 104.94 11.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.692 1.597 . . . . 0.0 108.713 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -123.75 117.94 26.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.425 0.69 . . . . 0.0 109.629 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.42 118.96 32.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.607 0.763 . . . . 0.0 110.768 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -122.56 111.95 17.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.105 1.362 . . . . 0.0 110.024 -173.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.0 m -73.91 22.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.081 -1.012 . . . . 0.0 113.698 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.403 ' HG ' HD11 ' B' ' 209' ' ' ILE . 11.5 m -66.19 166.5 11.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 112.117 167.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.2 159.78 36.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.787 2.035 . . . . 0.0 109.773 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -87.17 141.66 28.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.803 0.841 . . . . 0.0 110.374 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.37 158.49 43.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.086 1.354 . . . . 0.0 112.475 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.1 t -135.05 -56.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.03 1.332 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -86.43 -28.77 23.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.223 0.919 . . . . 0.0 112.637 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.4 -43.34 73.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.937 1.695 . . . . 0.0 112.684 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -161.42 -164.54 1.15 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.189 1.796 . . . . 0.0 111.552 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.57 124.92 7.77 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.097 1.808 . . . . 0.0 114.734 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -145.97 178.41 8.21 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.998 2.119 . . . . 0.0 111.764 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 32.7 t -166.59 135.39 2.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.399 1.48 . . . . 0.0 109.811 162.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -143.95 147.37 33.85 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.869 -1.769 . . . . 0.0 112.303 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.3 144.66 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 110.249 -169.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -138.6 113.14 8.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.312 1.445 . . . . 0.0 111.802 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -124.36 105.84 9.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.282 1.833 . . . . 0.0 110.472 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.75 165.75 16.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.107 0.963 . . . . 0.0 111.66 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.03 -178.77 5.61 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.772 1.229 . . . . 0.0 111.673 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -50.06 -56.56 10.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 113.776 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.0 t -133.71 -15.58 2.38 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.555 1.542 . . . . 0.0 113.744 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.1 ptp -104.68 178.74 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.989 1.716 . . . . 0.0 111.089 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.35 157.57 43.63 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.295 -0.878 . . . . 0.0 111.399 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.9 m -131.45 125.49 32.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.962 1.305 . . . . 0.0 110.462 -171.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -125.75 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.341 1.056 . . . . 0.0 110.633 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.39 109.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 126.146 1.778 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.7 t -108.77 126.95 53.58 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.185 1.394 . . . . 0.0 110.878 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.44 157.18 34.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.484 1.914 . . . . 0.0 112.705 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -143.06 158.84 43.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.967 1.307 . . . . 0.0 111.822 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.05 89.07 0.08 OUTLIER Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.311 1.434 . . . . 0.0 111.233 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.79 89.17 1.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.486 1.514 . . . . 0.0 111.404 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.07 1.348 . . . . 0.0 112.957 -172.646 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -137.29 177.9 7.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.694 2.797 . . . . 0.0 111.083 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.66 130.89 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.021 1.728 . . . . 0.0 111.075 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.5 m -97.19 90.55 5.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.146 1.378 . . . . 0.0 110.153 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.49 146.6 34.3 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.817 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.71 140.72 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.97 1.708 . . . . 0.0 110.46 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -149.41 143.96 26.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.927 1.291 . . . . 0.0 112.07 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 125.377 1.471 . . . . 0.0 110.078 173.951 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.995 0.426 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -99.83 172.0 7.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.207 1.003 . . . . 0.0 111.143 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.19 146.36 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.142 1.377 . . . . 0.0 109.782 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.4 -38.69 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.261 -0.899 . . . . 0.0 111.501 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.5 -29.11 68.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.884 1.274 . . . . 0.0 113.814 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.38 -58.41 3.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.929 0.891 . . . . 0.0 110.376 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 53.3 t -52.08 -43.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.35 1.46 . . . . 0.0 112.122 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.1 t -64.14 -12.72 42.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 113.9 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -102.16 -31.96 10.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.782 1.633 . . . . 0.0 113.133 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 23.0 mt -51.41 -43.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 110.464 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.72 -42.51 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -52.32 57.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.037 1.289 . . . . 0.0 110.975 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -34.34 76.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.41 -38.47 71.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.159 0.984 . . . . 0.0 113.119 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.0 -58.05 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.242 0.928 . . . . 0.0 109.975 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.68 -28.93 70.27 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.559 -0.713 . . . . 0.0 112.889 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -59.54 -46.67 88.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.769 1.227 . . . . 0.0 112.401 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.16 79.95 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.923 0.889 . . . . 0.0 113.146 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.71 -40.2 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.317 1.047 . . . . 0.0 111.774 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.02 12.73 58.26 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.865 1.221 . . . . 0.0 115.026 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.96 15.51 74.14 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.76 1.171 . . . . 0.0 114.762 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.72 -175.7 0.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.171 1.388 . . . . 0.0 112.34 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 107.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.316 1.446 . . . . 0.0 112.653 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -70.39 99.86 1.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.632 1.573 . . . . 0.0 111.14 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.53 164.85 11.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.623 1.169 . . . . 0.0 111.738 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -73.35 -55.9 5.78 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.4 m -67.92 -21.21 65.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.516 -0.74 . . . . 0.0 112.54 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -58.48 -44.04 89.22 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.91 -34.58 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.36 0.982 . . . . 0.0 112.039 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -65.97 -50.08 65.58 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.073 0.949 . . . . 0.0 111.943 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.04 -26.09 66.59 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.517 -0.739 . . . . 0.0 112.711 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -76.59 -53.51 7.95 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 111.314 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.5 t -58.42 -26.48 63.34 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.6 t -81.57 -57.94 3.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.625 1.102 . . . . 0.0 112.579 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -57.36 -38.19 73.8 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.08 -62.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 123.857 0.863 . . . . 0.0 110.276 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.95 -29.68 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.018 1.327 . . . . 0.0 110.852 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.06 -42.8 86.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.428 0.691 . . . . 0.0 112.826 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.02 -34.76 8.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 113.085 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 18.6 m -59.14 -53.88 53.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.38 1.872 . . . . 0.0 111.452 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -38.19 84.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.039 0.536 . . . . 0.0 111.94 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 37.2 p -70.78 -29.74 66.03 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -72.14 -51.91 19.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.475 2.31 . . . . 0.0 113.045 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.03 -25.8 67.99 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.808 -1.183 . . . . 0.0 113.706 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 60.2 m -59.33 -34.79 72.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.051 0.94 . . . . 0.0 110.676 167.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -81.12 -28.38 35.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.2 -16.58 63.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.33 1.052 . . . . 0.0 113.074 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.9 -117.21 4.22 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.036 1.779 . . . . 0.0 112.558 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -132.96 158.92 74.61 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 126.716 2.006 . . . . 0.0 111.474 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.04 110.09 3.01 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.572 2.848 . . . . 0.0 112.286 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.84 165.18 29.64 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.687 1.595 . . . . 0.0 111.965 173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -72.7 98.04 2.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.632 1.173 . . . . 0.0 110.425 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -74.39 164.56 26.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.268 0.556 . . . . 0.0 111.937 165.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . 0.403 HD11 ' HG ' ' A' ' 85' ' ' CYS . 4.2 tt -145.09 159.31 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.851 1.66 . . . . 0.0 109.991 166.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.18 147.9 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 125.317 1.447 . . . . 0.0 110.695 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 123.26 14.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.054 1.742 . . . . 0.0 108.616 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.1 p -126.46 150.26 48.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.14 103.19 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.153 1.781 . . . . 0.0 109.002 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.45 108.97 24.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.8 ttm -123.91 162.79 22.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.765 1.226 . . . . 0.0 110.951 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.82 44.23 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 112.277 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -90.62 1.81 56.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -67.71 -18.8 65.03 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.012 1.725 . . . . 0.0 115.078 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.04 -1.41 2.22 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.19 125.26 19.89 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.767 1.783 . . . . 0.0 111.563 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -130.32 112.19 1.25 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.944 1.259 . . . . 0.0 112.999 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.17 153.37 47.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.148 2.579 . . . . 0.0 109.591 -172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -119.55 102.18 8.46 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 108.79 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 1.4 m -121.4 123.59 42.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.015 0.926 . . . . 0.0 109.121 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.59 119.89 29.33 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.172 0.589 . . . . 0.0 111.011 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -122.47 112.38 17.98 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.022 1.329 . . . . 0.0 109.988 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 70.5 m -74.11 23.22 0.08 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 20.6 m -67.18 167.03 12.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.639 1.176 . . . . 0.0 112.109 167.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.59 161.73 37.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.126 2.17 . . . . 0.0 109.73 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -88.66 141.64 28.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.92 0.888 . . . . 0.0 110.275 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -146.01 157.56 43.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.088 1.355 . . . . 0.0 112.544 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.0 t -127.14 -61.09 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.2 1.4 . . . . 0.0 112.133 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 82.7 p -95.34 -21.67 18.24 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -40.69 86.69 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.89 1.276 . . . . 0.0 111.608 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -162.04 -163.79 0.99 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 126.636 1.974 . . . . 0.0 111.026 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.27 9.04 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.061 1.791 . . . . 0.0 114.489 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 87.3 p -148.12 178.18 8.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 111.576 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 31.4 t -166.84 134.71 2.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 109.82 162.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -143.36 147.19 34.29 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.9 -1.75 . . . . 0.0 112.362 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.85 144.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.665 1.186 . . . . 0.0 110.175 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -138.73 113.1 8.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.145 1.378 . . . . 0.0 111.823 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -124.9 103.81 8.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.266 1.827 . . . . 0.0 110.346 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.17 165.99 6.61 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.83 0.852 . . . . 0.0 112.588 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -140.36 -177.73 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.301 1.44 . . . . 0.0 111.465 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -49.81 -56.73 9.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.584 . . . . 0.0 113.852 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.6 t -133.51 -16.71 2.34 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.69 1.596 . . . . 0.0 113.552 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.3 ptp -104.05 -179.32 3.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.196 1.798 . . . . 0.0 111.162 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -149.25 161.27 42.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.008 0.923 . . . . 0.0 111.578 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 32.2 m -132.77 124.95 29.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.425 1.49 . . . . 0.0 110.051 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.08 136.55 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.095 0.958 . . . . 0.0 110.539 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.95 108.03 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.972 1.709 . . . . 0.0 111.093 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.5 t -107.06 123.53 48.35 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.107 1.363 . . . . 0.0 110.775 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.33 158.14 25.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.41 1.884 . . . . 0.0 112.368 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -142.18 156.54 45.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.648 1.179 . . . . 0.0 112.034 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -171.3 88.91 0.08 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.722 0.677 . . . . 0.0 113.119 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.69 91.87 2.94 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.612 1.165 . . . . 0.0 110.777 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 125.187 1.395 . . . . 0.0 112.183 -173.526 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -135.68 177.92 7.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.682 2.393 . . . . 0.0 111.111 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.8 mm -53.01 130.24 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.981 1.712 . . . . 0.0 111.106 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 32.0 m -96.26 86.48 4.23 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.098 1.359 . . . . 0.0 110.114 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.14 145.47 27.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.809 0.844 . . . . 0.0 110.883 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.0 136.86 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.121 1.768 . . . . 0.0 110.964 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -143.74 144.69 31.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.497 1.519 . . . . 0.0 112.109 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.23 1.412 . . . . 0.0 110.522 174.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 121.011 0.434 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.92 166.3 11.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.266 1.026 . . . . 0.0 112.289 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.83 158.08 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.289 1.435 . . . . 0.0 110.584 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.3 -36.4 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.47 -32.59 58.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.687 0.795 . . . . 0.0 112.881 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.74 -54.79 5.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.096 0.558 . . . . 0.0 110.236 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.5 t -52.08 -43.8 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.952 1.301 . . . . 0.0 112.661 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -64.04 -9.45 16.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.628 1.971 . . . . 0.0 113.898 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -102.68 -38.06 7.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.551 1.54 . . . . 0.0 112.433 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.9 mt -50.08 -44.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.851 0.86 . . . . 0.0 110.474 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -59.24 -42.36 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -52.06 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.046 1.294 . . . . 0.0 111.086 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -33.41 74.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.87 59.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.192 0.997 . . . . 0.0 112.931 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.7 mt -59.75 -58.87 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.319 0.963 . . . . 0.0 109.626 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.7 -30.01 71.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -59.29 -50.66 73.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.429 1.091 . . . . 0.0 112.061 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.95 73.18 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.47 -35.76 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.478 1.111 . . . . 0.0 111.582 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.55 81.68 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.109 0.861 . . . . 0.0 114.739 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.37 3.04 56.61 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.158 1.361 . . . . 0.0 115.863 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -64.62 165.26 10.48 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 119.235 1.517 . . . . 0.0 111.694 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.77 -178.75 4.98 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.931 -1.106 . . . . 0.0 112.053 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -51.73 141.04 17.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.546 0.738 . . . . 0.0 111.285 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 165.19 24.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.361 1.065 . . . . 0.0 111.594 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -84.09 -88.3 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.824 0.849 . . . . 0.0 111.055 -171.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -78.47 -21.08 49.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.345 -1.472 . . . . 0.0 113.921 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -38.01 71.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.238 1.015 . . . . 0.0 112.445 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.17 -30.37 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -68.06 -45.29 74.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.827 0.851 . . . . 0.0 111.188 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.39 -26.4 66.43 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -76.73 -53.82 7.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.972 0.806 . . . . 0.0 111.322 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -56.0 -32.07 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.618 0.644 . . . . 0.0 112.452 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -77.65 -59.45 2.78 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.357 0.98 . . . . 0.0 112.581 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -57.08 -39.02 74.17 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.389 1.476 . . . . 0.0 113.63 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.3 -63.5 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 C-N-CA 123.976 0.91 . . . . 0.0 109.97 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.88 -30.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.761 1.224 . . . . 0.0 110.621 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.44 -46.4 83.63 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.646 0.779 . . . . 0.0 112.671 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -98.23 -39.45 8.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 0.0 112.705 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -58.28 -53.09 62.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.265 2.226 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -38.07 85.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.64 0.376 . . . . 0.0 111.208 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 t -62.57 -44.58 95.98 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.329 -0.857 . . . . 0.0 112.252 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -61.38 -49.28 77.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.729 2.012 . . . . 0.0 113.048 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.77 -27.12 65.61 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.0 m -59.9 -30.68 69.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 110.918 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -82.16 -28.01 32.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.519 -0.738 . . . . 0.0 112.97 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.35 -28.87 66.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.637 0.775 . . . . 0.0 111.433 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.42 -104.61 2.3 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.771 1.653 . . . . 0.0 113.855 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 154.44 75.5 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.114 1.766 . . . . 0.0 112.642 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.54 110.51 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.86 3.04 . . . . 0.0 111.673 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.37 170.25 18.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 112.587 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -71.37 116.01 11.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.644 0.778 . . . . 0.0 110.563 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -101.59 164.15 11.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.518 1.127 . . . . 0.0 110.74 165.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.42 155.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.602 1.961 . . . . 0.0 108.518 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.53 151.78 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 110.415 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.53 128.74 25.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.939 2.095 . . . . 0.0 108.862 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.4 p -131.81 145.3 51.49 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.253 -0.904 . . . . 0.0 112.66 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.64 110.25 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.468 1.507 . . . . 0.0 108.606 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mm -109.8 95.67 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.31 1.844 . . . . 0.0 107.808 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -134.5 154.15 51.58 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.654 0.782 . . . . 0.0 111.975 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.27 149.33 33.58 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.731 -0.606 . . . . 0.0 112.019 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -7.38 59.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -65.96 -36.88 84.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.473 1.909 . . . . 0.0 114.367 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.8 40.37 1.59 Allowed Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.6 1.095 . . . . 0.0 115.026 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.06 -169.94 0.67 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.173 1.389 . . . . 0.0 112.701 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.0 73.15 1.05 Allowed Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.545 -1.347 . . . . 0.0 113.939 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.12 90.85 2.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.891 2.076 . . . . 0.0 112.065 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -113.65 136.44 52.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.271 1.428 . . . . 0.0 110.181 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -145.27 147.31 32.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.902 1.281 . . . . 0.0 109.779 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.4 147.88 30.73 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.254 -0.904 . . . . 0.0 111.602 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.1 p -148.52 133.47 18.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.039 0.536 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.5 m -80.51 19.19 0.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.687 -0.633 . . . . 0.0 112.564 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.1 m -68.34 165.16 19.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.717 1.207 . . . . 0.0 112.204 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -163.02 140.11 7.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.653 1.581 . . . . 0.0 110.61 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.02 150.79 40.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.13 0.572 . . . . 0.0 110.498 171.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -140.32 152.75 46.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.62 1.568 . . . . 0.0 110.617 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.3 t -109.24 -66.31 1.07 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.197 0.999 . . . . 0.0 111.426 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.5 p -89.78 -26.68 20.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 113.027 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -77.82 -44.87 26.08 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.364 1.866 . . . . 0.0 112.92 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -148.85 -174.24 4.57 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.117 2.567 . . . . 0.0 110.686 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.98 123.24 3.97 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.618 1.58 . . . . 0.0 113.441 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.46 125.08 13.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.411 1.484 . . . . 0.0 111.337 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.43 112.24 18.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.601 1.56 . . . . 0.0 112.175 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 t -125.21 147.97 48.84 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.523 -1.361 . . . . 0.0 112.319 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.69 136.39 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.739 1.615 . . . . 0.0 109.723 -170.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.58 101.4 5.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.461 1.504 . . . . 0.0 112.022 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -110.04 129.2 55.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.23 159.37 16.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.973 0.909 . . . . 0.0 110.934 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.75 -178.4 4.48 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.599 1.56 . . . . 0.0 110.593 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -51.24 60.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.181 2.192 . . . . 0.0 113.025 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -138.48 -3.51 1.7 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.299 1.439 . . . . 0.0 114.115 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.3 ptp -126.18 -173.71 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.608 1.963 . . . . 0.0 110.746 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.29 156.41 43.8 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.341 -0.85 . . . . 0.0 111.033 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 4.9 p -131.33 96.15 3.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.333 1.453 . . . . 0.0 111.019 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.25 138.32 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.244 1.018 . . . . 0.0 111.413 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.41 137.03 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.309 1.844 . . . . 0.0 109.999 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.2 t -128.25 123.21 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.072 1.349 . . . . 0.0 109.853 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.21 150.96 27.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.606 1.162 . . . . 0.0 111.53 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.66 106.91 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.764 1.626 . . . . 0.0 107.915 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.23 88.24 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.962 1.744 . . . . 0.0 110.358 -169.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.42 163.61 12.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.998 1.319 . . . . 0.0 112.218 -173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 124.836 1.254 . . . . 0.0 112.381 -174.06 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -121.7 168.21 12.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.925 1.69 . . . . 0.0 112.051 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mm -71.85 146.49 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.447 1.499 . . . . 0.0 110.704 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.1 m -112.79 92.7 4.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.39 1.476 . . . . 0.0 110.292 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.54 149.34 22.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.863 0.865 . . . . 0.0 111.036 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.9 106.75 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.522 2.329 . . . . 0.0 108.795 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.17 152.13 48.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.1 0.96 . . . . 0.0 111.833 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 123.794 0.837 . . . . 0.0 111.4 174.305 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 121.4 0.619 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -93.67 174.38 7.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.06 0.944 . . . . 0.0 112.022 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.58 159.27 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.278 1.431 . . . . 0.0 110.766 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 89.3 t -61.95 -38.33 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.133 -0.979 . . . . 0.0 112.014 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.63 -30.31 60.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 112.877 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.87 -61.05 1.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.763 0.825 . . . . 0.0 110.75 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.06 -41.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.873 1.269 . . . . 0.0 113.124 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -62.3 -8.74 6.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.772 1.629 . . . . 0.0 113.715 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -106.17 -39.51 5.93 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.846 1.658 . . . . 0.0 112.588 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.7 -43.32 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.282 0.947 . . . . 0.0 110.533 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.34 -42.59 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -51.34 57.59 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.957 1.253 . . . . 0.0 110.98 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -33.57 74.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.0 61.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.974 0.91 . . . . 0.0 113.069 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.83 -58.77 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.393 0.997 . . . . 0.0 109.645 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -63.04 -29.69 71.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 t -59.35 -50.57 73.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.466 1.106 . . . . 0.0 112.067 167.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.02 -31.79 72.89 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.68 -35.46 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.22 13.51 81.81 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.055 0.836 . . . . 0.0 114.777 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.17 3.3 56.75 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.873 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.49 164.93 10.72 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.23 1.515 . . . . 0.0 111.646 169.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.82 -178.56 4.32 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.925 -1.109 . . . . 0.0 111.995 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -51.63 139.07 21.55 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.677 -0.639 . . . . 0.0 110.908 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -179.81 4.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.714 1.206 . . . . 0.0 111.01 -175.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -96.47 -99.15 0.18 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.531 0.732 . . . . 0.0 109.998 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -66.62 -23.15 66.13 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.729 -1.232 . . . . 0.0 114.157 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -38.89 72.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.163 0.985 . . . . 0.0 112.552 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 45.2 t -54.82 -33.47 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.604 1.162 . . . . 0.0 112.512 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -66.74 -45.66 77.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.616 0.766 . . . . 0.0 111.553 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.06 -26.06 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.639 -0.663 . . . . 0.0 112.667 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -77.14 -53.14 8.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.797 0.726 . . . . 0.0 111.322 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.0 t -56.03 -31.95 63.59 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.479 0.581 . . . . 0.0 112.508 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 9.4 t -77.68 -59.81 2.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 119.361 0.982 . . . . 0.0 112.633 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -56.63 -38.59 72.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.305 1.442 . . . . 0.0 113.698 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.54 -63.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 123.854 0.861 . . . . 0.0 109.997 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.82 -30.57 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.741 1.217 . . . . 0.0 110.702 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -57.49 -45.72 84.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.685 0.794 . . . . 0.0 112.727 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -98.77 -39.47 8.62 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.194 1.397 . . . . 0.0 112.766 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 26.9 m -58.48 -52.17 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.294 2.238 . . . . 0.0 112.147 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -38.21 86.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.669 0.388 . . . . 0.0 111.179 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.7 t -63.12 -43.87 97.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.368 -0.832 . . . . 0.0 112.347 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.77 -48.92 78.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.826 2.05 . . . . 0.0 112.939 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.45 -25.63 64.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.9 m -60.73 -30.6 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.934 -0.479 . . . . 0.0 110.599 166.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -81.56 -29.58 33.38 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.554 -0.716 . . . . 0.0 112.505 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.86 -17.73 63.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 112.953 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -109.92 -100.13 2.6 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.867 1.698 . . . . 0.0 113.767 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.65 155.23 63.53 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.837 1.655 . . . . 0.0 112.001 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.63 109.34 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 111.574 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -147.37 169.92 18.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.181 0.993 . . . . 0.0 112.471 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -71.46 120.17 16.67 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.271 0.628 . . . . 0.0 110.388 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -106.67 163.63 12.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.821 1.249 . . . . 0.0 110.647 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.2 tt -147.44 155.26 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.335 1.854 . . . . 0.0 108.708 172.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.05 151.13 21.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.984 0.914 . . . . 0.0 110.314 168.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.08 129.59 27.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.871 2.069 . . . . 0.0 108.921 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.44 148.41 52.4 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.165 -0.96 . . . . 0.0 112.532 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 15.6 t -136.15 115.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.071 1.349 . . . . 0.0 108.93 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 3.0 mm -112.7 94.58 3.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.595 1.958 . . . . 0.0 107.538 -172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 9.1 ptm -132.14 150.27 52.2 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.289 1.436 . . . . 0.0 111.757 -170.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -88.01 140.18 29.76 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.292 0.637 . . . . 0.0 112.312 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -9.23 58.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.98 -30.68 71.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.326 1.851 . . . . 0.0 114.485 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.65 29.97 5.4 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.229 0.918 . . . . 0.0 115.343 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.4 176.24 1.92 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 118.29 1.045 . . . . 0.0 111.941 163.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 59.24 1.28 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.233 1.873 . . . . 0.0 116.253 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.96 99.14 8.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.242 1.817 . . . . 0.0 110.457 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.48 132.01 55.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.262 1.425 . . . . 0.0 110.209 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 28.7 m -140.77 147.21 38.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.713 0.805 . . . . 0.0 110.172 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.67 147.9 33.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.476 0.655 . . . . 0.0 111.538 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 134.78 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.236 0.614 . . . . 0.0 111.529 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 29.8 m -80.9 19.15 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 173.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.24 165.13 19.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.557 1.143 . . . . 0.0 112.172 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -162.84 140.7 8.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.539 1.536 . . . . 0.0 110.568 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 150.22 40.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.329 0.652 . . . . 0.0 110.429 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.99 151.08 45.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.6 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.5 t -108.59 -66.42 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.148 0.979 . . . . 0.0 111.594 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 58.1 p -89.76 -26.46 20.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.815 0.846 . . . . 0.0 112.998 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.9 m -77.59 -45.14 26.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.366 1.866 . . . . 0.0 112.92 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -148.95 -174.17 4.56 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.112 2.565 . . . . 0.0 110.802 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.68 125.58 5.24 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.656 1.598 . . . . 0.0 113.358 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.72 125.82 12.91 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 111.235 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.8 p -122.06 112.26 18.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.409 1.484 . . . . 0.0 112.244 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.8 t -124.67 148.5 47.94 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.401 -1.437 . . . . 0.0 112.32 -173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.59 136.46 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.682 1.593 . . . . 0.0 109.82 -170.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.8 99.22 4.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.381 1.472 . . . . 0.0 112.176 -169.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -108.24 124.44 50.3 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.88 1.272 . . . . 0.0 110.01 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.36 158.86 18.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -129.91 -176.71 4.01 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.744 1.618 . . . . 0.0 110.728 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -51.51 55.9 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.672 1.989 . . . . 0.0 113.394 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.6 t -138.77 -2.89 1.69 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.402 1.481 . . . . 0.0 113.855 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 13.8 ptp -127.87 -175.85 3.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.801 2.04 . . . . 0.0 110.726 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -141.41 158.33 44.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.093 0.957 . . . . 0.0 111.543 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 3.8 p -130.81 93.14 3.35 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.79 1.636 . . . . 0.0 110.452 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.64 136.35 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.224 1.01 . . . . 0.0 111.095 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.75 138.07 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.162 1.785 . . . . 0.0 110.249 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 t -128.68 123.07 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.082 1.353 . . . . 0.0 109.986 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -108.65 150.4 27.58 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.49 1.116 . . . . 0.0 111.423 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -128.19 105.55 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.876 1.67 . . . . 0.0 108.042 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -137.48 94.71 0.22 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.22 1.867 . . . . 0.0 109.838 -171.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.57 163.88 22.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.088 0.955 . . . . 0.0 111.679 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 124.853 1.261 . . . . 0.0 112.099 -174.597 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -121.85 168.33 11.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.93 1.692 . . . . 0.0 112.091 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.61 147.95 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.389 1.475 . . . . 0.0 110.651 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 80.4 m -114.79 91.75 3.72 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.375 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.03 148.78 22.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.147 0.979 . . . . 0.0 110.792 168.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.11 104.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.902 2.081 . . . . 0.0 109.653 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -135.7 153.87 51.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.401 1.48 . . . . 0.0 112.214 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 CA--C 1.551 1.011 0 O-C-N 121.729 -0.607 . . . . 0.0 111.527 175.351 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 121.238 0.542 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -69.96 175.8 4.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.747 0.819 . . . . 0.0 111.899 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.17 146.68 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.8 1.24 . . . . 0.0 110.769 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.54 -39.31 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.154 0.982 . . . . 0.0 111.458 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.83 -28.82 69.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.767 1.227 . . . . 0.0 113.222 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.26 -58.49 3.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.558 1.143 . . . . 0.0 110.837 171.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.26 -41.16 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.485 1.114 . . . . 0.0 112.424 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -62.92 -17.4 61.72 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.255 1.422 . . . . 0.0 113.934 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -97.97 -35.16 10.55 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.767 1.627 . . . . 0.0 113.259 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 mt -50.41 -41.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.203 1.001 . . . . 0.0 110.684 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.59 -40.76 90.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -52.35 56.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.857 1.208 . . . . 0.0 111.058 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -33.01 73.51 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.89 -42.44 57.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.615 0.766 . . . . 0.0 112.984 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.57 -56.95 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.99 0.813 . . . . 0.0 109.828 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.12 -30.89 70.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.3 t -59.84 -49.65 76.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.56 1.144 . . . . 0.0 112.238 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.21 77.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.075 0.95 . . . . 0.0 113.507 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.9 -37.02 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.866 1.266 . . . . 0.0 111.613 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.37 17.59 74.46 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.145 0.878 . . . . 0.0 114.599 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.11 78.58 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.694 1.14 . . . . 0.0 115.576 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.62 156.55 8.22 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 113.138 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -175.63 1.03 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.413 1.485 . . . . 0.0 112.352 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -47.99 146.75 2.37 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -136.74 178.5 7.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.067 1.347 . . . . 0.0 112.24 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -95.37 -118.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.454 1.501 . . . . 0.0 110.45 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.8 p -66.75 0.47 2.36 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.885 2.074 . . . . 0.0 115.91 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -50.52 -44.36 56.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.844 1.202 . . . . 0.0 112.761 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.2 t -55.92 -34.05 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -67.03 -51.61 52.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.451 1.023 . . . . 0.0 112.411 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.73 -25.65 68.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.49 -0.756 . . . . 0.0 112.42 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.64 -56.08 4.93 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.713 1.205 . . . . 0.0 111.629 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -22.59 63.42 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.94 -60.19 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.375 0.989 . . . . 0.0 111.905 166.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.3 -39.26 72.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.01 1.277 . . . . 0.0 113.905 -173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.19 -64.56 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 110.022 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -47.77 -30.17 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.957 1.303 . . . . 0.0 110.993 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.86 -42.83 85.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.955 0.902 . . . . 0.0 112.87 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -101.78 -39.77 7.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.611 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -57.64 -53.17 61.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.425 2.29 . . . . 0.0 112.598 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -37.11 80.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.571 0.623 . . . . 0.0 111.333 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m -65.15 -37.06 86.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -69.21 -52.12 31.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.163 1.785 . . . . 0.0 112.965 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.06 -26.46 68.57 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.858 -1.151 . . . . 0.0 113.7 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.6 m -57.48 -31.96 66.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 167.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -88.81 -25.53 22.17 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.17 -16.79 63.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.065 0.946 . . . . 0.0 113.26 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.02 -112.61 3.36 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.658 1.599 . . . . 0.0 112.77 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -132.67 152.11 79.33 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 125.422 1.489 . . . . 0.0 113.492 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.06 104.14 1.48 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.44 3.426 . . . . 0.0 112.275 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -142.81 177.9 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.297 1.839 . . . . 0.0 112.216 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -100.19 75.91 1.86 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.625 1.57 . . . . 0.0 111.35 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -67.05 147.12 53.59 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 111.009 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.89 156.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.384 1.474 . . . . 0.0 109.756 170.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.69 158.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.491 0.716 . . . . 0.0 109.976 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.53 131.97 32.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.744 1.617 . . . . 0.0 108.973 164.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.5 p -124.92 150.33 46.68 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 167.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.34 117.88 50.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.284 1.034 . . . . 0.0 108.247 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.91 120.95 65.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 107.71 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -144.45 139.74 28.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.61 0.719 . . . . 0.0 111.319 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -145.79 106.73 4.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.463 1.905 . . . . 0.0 109.424 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -146.72 -58.57 0.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.754 0.821 . . . . 0.0 112.567 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -122.52 -9.96 8.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.286 1.434 . . . . 0.0 113.767 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.0 -3.85 55.95 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.315 1.435 . . . . 0.0 114.908 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.38 165.99 21.27 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 156.06 52.33 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.53 0.586 . . . . 0.0 113.966 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.05 178.95 4.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.556 1.942 . . . . 0.0 111.354 169.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.15 92.73 3.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.141 1.377 . . . . 0.0 109.791 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.7 m -108.88 147.24 32.45 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.687 -1.258 . . . . 0.0 108.871 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.63 146.18 32.15 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.232 -0.918 . . . . 0.0 112.194 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -143.16 143.12 31.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 112.883 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t -78.39 12.13 2.1 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.5 m -62.71 173.03 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.093 0.957 . . . . 0.0 112.394 168.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -161.63 157.1 24.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.689 1.995 . . . . 0.0 110.082 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -78.11 146.95 34.87 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.626 172.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.15 158.54 43.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.666 1.586 . . . . 0.0 111.577 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t -134.47 -57.29 0.84 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.202 1.401 . . . . 0.0 112.479 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 m -84.24 -36.81 22.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.946 0.899 . . . . 0.0 112.09 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.4 -46.86 59.17 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.743 1.617 . . . . 0.0 112.719 -172.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.07 -167.97 2.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.768 2.427 . . . . 0.0 109.923 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.43 156.06 15.88 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 124.297 0.951 . . . . 0.0 113.835 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -145.75 169.62 18.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.983 1.713 . . . . 0.0 112.243 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.3 t -166.35 158.17 13.63 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.073 1.749 . . . . 0.0 110.292 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.6 t -150.32 146.78 26.96 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 119.534 -1.979 . . . . 0.0 111.261 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.7 95.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.266 1.426 . . . . 0.0 110.661 -166.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -86.79 116.08 24.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.099 1.76 . . . . 0.0 112.366 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -126.39 113.62 17.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.725 1.61 . . . . 0.0 110.231 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.3 170.56 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.58 1.552 . . . . 0.0 112.599 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.6 -170.92 3.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.888 1.275 . . . . 0.0 112.482 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -42.92 -58.57 2.34 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.301 2.24 . . . . 0.0 114.16 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t -136.05 -29.59 1.0 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 113.099 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.57 149.8 34.81 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.925 0.89 . . . . 0.0 111.586 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -136.36 141.16 43.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.533 1.533 . . . . 0.0 109.585 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.7 p -144.24 71.92 1.33 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.695 -169.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.94 142.04 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.319 -0.863 . . . . 0.0 111.588 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.1 t -121.61 142.91 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.639 1.975 . . . . 0.0 110.335 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -138.78 122.87 17.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.889 1.675 . . . . 0.0 109.553 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.3 142.67 51.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.07 1.748 . . . . 0.0 113.586 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -140.67 125.83 18.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.073 0.949 . . . . 0.0 111.263 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.85 70.33 0.22 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 127.378 2.418 . . . . 0.0 111.394 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.64 128.91 37.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.119 0.968 . . . . 0.0 111.287 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.141 1.776 . . . . 0.0 111.779 -161.119 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.637 0.256 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -129.22 167.11 18.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.805 1.242 . . . . 0.0 111.687 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.4 mm -51.08 132.08 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.239 2.215 . . . . 0.0 111.243 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 m -99.82 95.85 7.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.345 1.458 . . . . 0.0 109.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.64 148.39 30.27 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.377 -0.827 . . . . 0.0 111.141 166.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -131.98 89.1 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.803 2.441 . . . . 0.0 109.049 173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -134.63 166.16 23.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.25 1.42 . . . . 0.0 111.714 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.547 0.864 0 C-N-CA 125.273 1.429 . . . . 0.0 111.048 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.175 0.512 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.33 173.41 10.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.577 0.751 . . . . 0.0 112.116 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 94.5 t -123.97 142.49 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.63 1.572 . . . . 0.0 109.726 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.11 -41.79 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.86 0.864 . . . . 0.0 111.552 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.06 -35.29 66.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.7 1.6 . . . . 0.0 113.348 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -72.6 -58.92 3.0 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.788 1.235 . . . . 0.0 110.746 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 80.8 t -52.19 -40.77 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.502 1.121 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -63.63 -17.82 63.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 113.982 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.37 -35.24 11.26 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.491 1.517 . . . . 0.0 113.192 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.4 mt -50.66 -41.35 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.104 0.961 . . . . 0.0 110.712 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 121.322 -0.861 . . . . 0.0 113.322 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -52.33 57.29 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.831 1.196 . . . . 0.0 110.982 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -33.0 73.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.84 -42.23 58.38 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.61 -56.89 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.106 0.866 . . . . 0.0 109.786 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.2 -30.89 70.69 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.0 t -59.75 -49.75 76.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.631 1.172 . . . . 0.0 112.24 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.25 77.49 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.88 -36.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.879 1.272 . . . . 0.0 111.55 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 70.43 17.57 74.57 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.111 0.862 . . . . 0.0 114.588 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.0 78.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.705 1.145 . . . . 0.0 115.595 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -57.63 156.66 8.07 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.914 1.357 . . . . 0.0 113.101 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.5 -175.52 1.05 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.43 1.492 . . . . 0.0 112.256 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -48.1 146.97 2.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.584 1.553 . . . . 0.0 113.395 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -136.95 178.39 7.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.084 1.353 . . . . 0.0 112.276 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -95.46 -117.66 0.11 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.403 1.481 . . . . 0.0 110.492 169.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 58.5 p -66.76 0.39 2.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.855 2.062 . . . . 0.0 115.957 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -50.86 -44.58 59.63 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.793 1.179 . . . . 0.0 112.779 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.35 -34.02 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -66.7 -51.55 54.71 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.453 1.024 . . . . 0.0 112.403 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.86 -25.63 67.98 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.517 -0.739 . . . . 0.0 112.507 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -76.88 -55.91 5.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.612 1.165 . . . . 0.0 111.547 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 t -60.26 -22.1 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -82.55 -60.41 2.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.233 0.924 . . . . 0.0 111.909 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -55.92 -39.09 71.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.974 1.261 . . . . 0.0 113.905 -173.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.33 -64.51 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.52 -30.49 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.999 1.319 . . . . 0.0 111.004 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.88 -42.22 84.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.072 0.949 . . . . 0.0 112.778 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -102.95 -38.68 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.215 1.406 . . . . 0.0 112.781 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.9 m -58.97 -52.85 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.33 2.252 . . . . 0.0 112.624 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -36.04 79.8 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.553 0.615 . . . . 0.0 111.561 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.1 m -60.34 -49.77 76.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 0.0 112.327 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -60.14 -51.73 68.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.91 1.684 . . . . 0.0 113.56 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.04 -26.08 68.11 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.1 m -58.89 -34.2 71.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.615 0.766 . . . . 0.0 110.952 167.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -84.75 -24.69 28.7 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.72 -15.45 63.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.657 1.183 . . . . 0.0 113.302 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -113.05 -113.17 3.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.666 1.603 . . . . 0.0 112.762 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -130.76 153.17 81.53 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 125.774 1.63 . . . . 0.0 112.959 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.89 98.79 0.92 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.198 3.266 . . . . 0.0 112.193 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -140.01 165.84 26.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.225 1.41 . . . . 0.0 112.91 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -84.75 78.54 9.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.912 1.685 . . . . 0.0 111.644 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -59.5 156.32 13.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 112.365 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.13 155.96 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.185 1.794 . . . . 0.0 108.949 165.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.91 160.16 29.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.596 162.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.3 141.5 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 109.766 164.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.74 148.71 47.43 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.103 0.961 . . . . 0.0 111.41 171.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.87 104.83 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.899 1.28 . . . . 0.0 108.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 3.7 mm -101.38 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.543 1.537 . . . . 0.0 108.266 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 4.5 tpt -134.57 136.79 43.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.926 0.87 . . . . 0.0 112.322 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -143.17 100.26 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.986 2.114 . . . . 0.0 109.347 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -143.03 -63.92 0.41 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.521 0.728 . . . . 0.0 111.981 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -109.5 -22.48 11.98 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 113.439 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.9 -9.59 76.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.651 1.596 . . . . 0.0 115.03 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -143.98 81.88 1.7 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.027 1.731 . . . . 0.0 110.762 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 176.9 88.61 0.07 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.016 0.817 . . . . 0.0 112.797 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.68 124.84 7.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.755 1.622 . . . . 0.0 109.489 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.44 88.21 2.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.755 1.622 . . . . 0.0 109.101 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 88.5 m -106.34 144.43 33.04 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.541 -1.35 . . . . 0.0 108.144 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.33 133.42 27.78 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.37 -0.831 . . . . 0.0 112.177 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.0 p -134.03 144.58 48.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.021 0.928 . . . . 0.0 113.015 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 15.6 t -78.91 12.3 2.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 19.1 m -63.22 172.74 1.74 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.952 . . . . 0.0 112.518 168.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -162.42 158.15 23.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.725 2.01 . . . . 0.0 110.128 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -76.36 139.8 41.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.5 -0.75 . . . . 0.0 110.506 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -145.22 153.36 41.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.391 1.476 . . . . 0.0 111.859 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 25.8 t -128.74 -59.75 1.12 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.745 1.618 . . . . 0.0 112.499 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.0 m -83.37 -37.24 23.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.872 0.869 . . . . 0.0 111.867 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -51.72 43.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.856 1.662 . . . . 0.0 112.023 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.01 -171.13 3.75 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.732 2.413 . . . . 0.0 109.791 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.54 154.4 16.53 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.308 0.956 . . . . 0.0 114.176 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 85.7 p -144.75 168.45 20.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.24 1.816 . . . . 0.0 112.068 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.6 t -166.23 157.62 13.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.043 1.737 . . . . 0.0 110.185 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.1 t -150.05 146.53 27.01 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.368 -2.082 . . . . 0.0 111.37 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.41 92.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.205 1.402 . . . . 0.0 110.611 -166.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -84.73 115.02 22.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.107 1.763 . . . . 0.0 112.32 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -124.63 117.26 23.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.474 1.51 . . . . 0.0 110.006 172.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -103.05 170.73 7.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.719 1.607 . . . . 0.0 112.425 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.75 -173.66 4.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.896 1.278 . . . . 0.0 112.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -40.16 -58.36 1.49 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 127.422 2.289 . . . . 0.0 114.031 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.2 t -136.39 -20.95 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.816 1.647 . . . . 0.0 113.341 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 21.9 ptm -90.18 132.93 35.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.871 1.268 . . . . 0.0 111.699 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.22 131.9 55.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.124 1.37 . . . . 0.0 109.873 172.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.6 p -137.95 68.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.593 1.557 . . . . 0.0 111.941 -172.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pp -85.36 138.27 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.122 0.969 . . . . 0.0 111.949 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.95 144.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.822 2.049 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 t -139.32 122.61 17.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.001 1.72 . . . . 0.0 109.781 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -125.62 143.07 51.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.974 1.71 . . . . 0.0 113.625 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -140.48 126.3 19.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.993 0.917 . . . . 0.0 111.103 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.62 70.06 0.22 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.915 2.198 . . . . 0.0 110.881 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.45 130.46 43.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.104 0.962 . . . . 0.0 111.227 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 126.251 1.82 . . . . 0.0 111.512 -162.056 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -130.26 167.26 18.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.831 1.252 . . . . 0.0 111.883 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -50.2 133.64 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.402 2.281 . . . . 0.0 111.354 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 55.3 m -101.74 91.0 4.21 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.395 1.478 . . . . 0.0 109.697 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.76 148.14 34.98 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.739 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 4.0 p -137.68 92.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 108.816 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -134.55 165.54 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.441 1.896 . . . . 0.0 111.548 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 125.02 1.328 . . . . 0.0 111.509 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -66.89 171.56 5.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.662 1.585 . . . . 0.0 112.78 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.81 147.97 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.638 1.575 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.9 -40.2 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.26 1.024 . . . . 0.0 111.877 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.4 -32.54 70.27 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.855 1.262 . . . . 0.0 113.12 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.65 -55.92 6.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.411 1.084 . . . . 0.0 110.294 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.15 -43.85 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.834 1.254 . . . . 0.0 112.794 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -63.92 -6.32 5.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.305 1.442 . . . . 0.0 114.167 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -113.17 -34.28 5.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.152 2.181 . . . . 0.0 112.313 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -43.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.041 1.337 . . . . 0.0 110.586 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.82 -43.16 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.45 -0.781 . . . . 0.0 112.883 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -52.04 50.88 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.363 0.983 . . . . 0.0 111.675 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -31.85 72.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.43 63.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.2 mt -58.05 -55.44 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.244 0.929 . . . . 0.0 109.972 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.07 -30.84 70.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 t -61.21 -43.23 99.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.892 0.877 . . . . 0.0 112.396 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.34 -36.37 79.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.272 1.029 . . . . 0.0 113.479 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.61 -42.05 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.385 1.074 . . . . 0.0 110.996 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.11 57.96 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.837 1.208 . . . . 0.0 115.218 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.3 22.93 71.42 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.658 1.123 . . . . 0.0 114.656 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.24 -177.55 0.54 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.005 1.322 . . . . 0.0 112.434 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.25 141.43 8.54 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.836 1.254 . . . . 0.0 112.714 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -66.57 104.9 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.774 1.229 . . . . 0.0 110.929 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -124.15 114.94 20.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.019 1.727 . . . . 0.0 110.797 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -77.47 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.862 0.865 . . . . 0.0 112.603 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -57.57 -25.13 59.53 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.373 -1.455 . . . . 0.0 114.06 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -57.99 -30.57 66.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.6 t -52.85 -34.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.359 0.981 . . . . 0.0 111.851 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -64.34 -50.99 65.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.641 1.176 . . . . 0.0 112.641 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -66.81 -28.06 68.06 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.272 -0.893 . . . . 0.0 112.721 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.95 -54.56 6.69 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.673 0.789 . . . . 0.0 111.214 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -58.43 -26.1 62.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.579 0.751 . . . . 0.0 112.76 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 t -83.56 -54.23 5.09 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.217 0.917 . . . . 0.0 112.961 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -58.76 -38.73 79.1 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.916 1.235 . . . . 0.0 113.344 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.8 t -68.66 -63.71 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 124.035 0.934 . . . . 0.0 109.833 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.39 -29.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.895 1.278 . . . . 0.0 111.175 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.42 -46.51 86.33 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -95.31 -41.15 9.17 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.835 1.254 . . . . 0.0 112.541 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 m -52.92 -55.97 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.552 2.341 . . . . 0.0 112.463 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -37.32 84.91 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.161 0.437 . . . . 0.0 110.984 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -60.82 -46.53 90.17 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 112.515 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.18 -49.92 75.73 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.653 1.981 . . . . 0.0 113.015 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.57 -28.33 66.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 m -58.95 -27.54 65.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.884 0.874 . . . . 0.0 111.72 165.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -87.87 -23.31 24.01 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.55 -15.19 63.22 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.07 -99.86 0.21 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.678 0.656 . . . . 0.0 113.795 172.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -94.31 109.47 42.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.663 1.185 . . . . 0.0 112.87 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.77 103.12 1.7 Allowed 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.968 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -141.78 163.41 32.97 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.796 1.638 . . . . 0.0 113.733 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -68.61 101.9 1.38 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.068 1.747 . . . . 0.0 112.204 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -81.43 173.52 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.689 1.596 . . . . 0.0 112.107 164.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 tt -142.39 154.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.375 1.87 . . . . 0.0 109.464 162.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.4 m -143.49 145.31 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.997 1.719 . . . . 0.0 109.658 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -142.75 155.9 44.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.472 1.109 . . . . 0.0 110.192 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.4 p -148.29 156.43 42.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.041 0.937 . . . . 0.0 112.938 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.86 132.15 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.223 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.51 111.33 35.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 127.324 2.25 . . . . 0.0 107.532 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.1 ttt -117.05 154.12 31.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.13 0.972 . . . . 0.0 111.392 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.52 153.08 20.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.823 1.249 . . . . 0.0 111.964 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -60.77 -16.35 39.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.775 1.63 . . . . 0.0 114.546 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -58.37 -26.99 63.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.043 1.337 . . . . 0.0 112.788 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.52 27.1 72.95 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.146 0.879 . . . . 0.0 114.598 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.66 151.68 10.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.569 1.147 . . . . 0.0 113.527 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.8 102.95 1.04 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.522 1.058 . . . . 0.0 114.173 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 pp -143.6 147.61 34.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.11 2.564 . . . . 0.0 109.549 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -134.65 132.28 38.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.4 m -133.28 139.15 46.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.243 1.017 . . . . 0.0 109.886 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.75 124.05 12.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.537 0.735 . . . . 0.0 110.933 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.9 p -130.51 137.98 50.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.792 0.806 . . . . 0.0 111.649 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.4 m -81.41 13.64 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.454 -0.779 . . . . 0.0 112.69 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.2 m -60.07 161.46 6.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.006 0.908 . . . . 0.0 111.92 169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -157.53 136.57 11.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.717 1.607 . . . . 0.0 109.539 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 163.87 27.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.718 0.407 . . . . 0.0 111.098 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -140.02 155.31 47.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.423 1.089 . . . . 0.0 111.508 168.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -118.28 -63.34 1.43 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.889 2.076 . . . . 0.0 111.753 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -109.63 -28.94 8.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.315 1.446 . . . . 0.0 112.173 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -42.73 85.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.708 2.403 . . . . 0.0 112.994 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.93 -175.59 5.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.864 1.665 . . . . 0.0 112.185 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.73 153.26 20.86 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.628 1.109 . . . . 0.0 114.185 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 t -163.27 163.17 25.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.424 1.89 . . . . 0.0 110.554 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 8.1 p -167.91 149.79 5.47 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.984 1.714 . . . . 0.0 111.327 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -145.33 144.46 30.73 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.116 -1.615 . . . . 0.0 111.679 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -143.29 126.31 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.112 1.365 . . . . 0.0 110.604 -161.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -127.83 122.44 32.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 -170.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -133.49 104.41 6.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.786 1.634 . . . . 0.0 110.293 -174.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.59 168.05 9.94 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.1 . . . . 0.0 112.394 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -145.29 -176.18 5.0 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.781 0.832 . . . . 0.0 112.548 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -49.84 -51.89 36.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.944 1.698 . . . . 0.0 113.874 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.4 t -132.95 -47.27 0.86 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.7 ptp -67.08 170.83 6.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.587 0.755 . . . . 0.0 112.411 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -146.11 147.46 31.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.5 1.52 . . . . 0.0 109.557 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 28.9 p -128.26 143.6 51.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.244 1.021 . . . . 0.0 112.606 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.37 119.85 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.584 1.554 . . . . 0.0 110.102 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 t -104.99 136.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.828 1.651 . . . . 0.0 109.571 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.9 t -131.26 123.58 28.69 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 110.601 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.68 149.56 29.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.858 1.663 . . . . 0.0 111.791 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -141.31 152.32 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.832 1.253 . . . . 0.0 110.657 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.09 85.41 0.23 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.837 1.208 . . . . 0.0 112.074 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.29 121.4 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.353 1.461 . . . . 0.0 111.675 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 124.546 1.138 . . . . 0.0 113.174 -169.148 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -130.81 177.6 7.29 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.448 1.499 . . . . 0.0 112.007 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.4 mm -51.6 138.13 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.908 2.083 . . . . 0.0 111.313 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.6 m -107.42 91.93 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.579 1.552 . . . . 0.0 110.818 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -93.19 148.82 21.69 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.326 -0.859 . . . . 0.0 111.294 171.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.31 115.47 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.022 2.129 . . . . 0.0 109.833 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -140.86 133.72 29.04 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.48 1.512 . . . . 0.0 111.157 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 126.172 1.789 . . . . 0.0 109.698 175.089 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 121.252 0.548 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.01 161.17 26.81 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.46 144.29 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.101 1.361 . . . . 0.0 112.897 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.32 -41.47 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.881 1.672 . . . . 0.0 112.232 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.37 -31.84 69.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.589 1.156 . . . . 0.0 113.178 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.87 -55.66 5.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.274 174.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 58.2 t -44.72 -46.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.158 1.783 . . . . 0.0 112.842 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -63.95 -7.03 7.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.732 1.613 . . . . 0.0 114.429 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -111.03 -33.66 6.43 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.569 2.348 . . . . 0.0 112.196 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 30.2 mt -50.14 -42.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.043 1.337 . . . . 0.0 110.644 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.45 -43.79 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.343 -0.848 . . . . 0.0 112.929 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -52.36 50.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.358 0.981 . . . . 0.0 111.519 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.76 72.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.71 62.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.124 0.97 . . . . 0.0 113.313 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 56.4 mt -57.49 -55.33 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.158 0.89 . . . . 0.0 109.88 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.08 -31.08 70.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 18.0 t -61.17 -42.95 99.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.858 0.863 . . . . 0.0 112.354 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.31 77.5 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.264 1.025 . . . . 0.0 113.586 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.25 -42.43 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.38 1.072 . . . . 0.0 110.88 173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.91 58.21 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.982 1.277 . . . . 0.0 115.173 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.74 23.39 70.71 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.585 1.088 . . . . 0.0 114.598 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.12 -177.18 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.043 1.337 . . . . 0.0 112.488 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -48.76 141.75 7.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.722 1.209 . . . . 0.0 112.571 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.93 101.47 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.566 1.146 . . . . 0.0 110.862 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -117.8 114.44 23.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.081 1.753 . . . . 0.0 110.542 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -74.15 -64.37 1.03 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.372 1.069 . . . . 0.0 112.546 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.9 m -56.63 -23.74 43.32 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -55.24 -28.79 55.75 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.7 -31.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.479 1.036 . . . . 0.0 112.89 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -65.34 -50.34 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.828 1.251 . . . . 0.0 112.207 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.91 -26.85 67.06 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.401 -0.812 . . . . 0.0 112.661 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.39 -53.95 7.04 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.818 0.847 . . . . 0.0 111.592 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.1 t -56.72 -28.49 61.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.588 0.631 . . . . 0.0 112.592 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.8 t -82.43 -55.81 4.27 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.341 0.973 . . . . 0.0 112.816 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -59.53 -39.27 83.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.078 1.308 . . . . 0.0 113.281 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 79.2 t -68.36 -63.91 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 C-N-CA 123.706 0.803 . . . . 0.0 109.625 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 96.2 t -49.9 -29.62 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -58.89 -46.94 86.67 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.599 0.636 . . . . 0.0 112.43 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -93.87 -40.2 10.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.756 1.222 . . . . 0.0 112.771 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 5.4 m -54.71 -56.03 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.746 2.418 . . . . 0.0 112.42 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -37.07 79.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.112 0.414 . . . . 0.0 110.602 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.6 t -62.41 -47.71 82.94 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.217 -0.927 . . . . 0.0 112.557 169.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -56.81 -47.35 80.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.871 1.668 . . . . 0.0 113.001 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.24 -18.93 59.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 89.1 m -61.69 -40.31 94.55 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.613 -0.679 . . . . 0.0 110.26 157.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -75.25 -19.58 59.65 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.874 -1.142 . . . . 0.0 113.896 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 10.5 mt -59.07 -20.23 51.43 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . 168.21 -54.07 0.22 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.724 1.147 . . . . 0.0 115.554 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -57.96 156.5 19.2 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 127.367 2.267 . . . . 0.0 113.735 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.18 160.17 42.9 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.985 2.457 . . . . 0.0 113.278 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.28 93.71 3.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.955 0.902 . . . . 0.0 113.003 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -165.41 85.26 0.37 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.024 1.33 . . . . 0.0 114.217 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.3 158.78 43.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.782 1.233 . . . . 0.0 112.194 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 tt -138.57 156.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.112 2.165 . . . . 0.0 109.356 171.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.05 147.75 21.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.432 1.893 . . . . 0.0 110.054 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 14.6 t -143.02 154.55 44.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.72 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.73 157.46 43.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.35 1.06 . . . . 0.0 112.504 171.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 26.3 t -134.18 136.06 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.172 1.389 . . . . 0.0 109.141 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mm -108.95 108.82 26.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 127.365 2.266 . . . . 0.0 106.9 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 62.0 mtt -107.82 158.95 16.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.603 1.161 . . . . 0.0 110.848 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -119.14 150.87 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.882 1.273 . . . . 0.0 110.933 -174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -59.61 -17.11 30.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.694 1.598 . . . . 0.0 114.882 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -59.58 -30.0 68.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.376 1.471 . . . . 0.0 112.955 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.42 42.54 93.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.25 1.405 . . . . 0.0 114.405 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.33 175.63 0.42 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.528 1.531 . . . . 0.0 114.258 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.35 91.26 0.3 Allowed Glycine 0 CA--C 1.539 1.582 0 O-C-N 120.571 -1.331 . . . . 0.0 114.424 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.81 118.35 13.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.149 1.78 . . . . 0.0 113.122 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.12 133.04 55.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.694 0.798 . . . . 0.0 110.076 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 50.5 m -135.47 141.89 45.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.876 0.87 . . . . 0.0 110.283 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.13 128.62 18.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.5 p -132.6 139.43 47.78 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.669 0.747 . . . . 0.0 111.509 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -82.46 12.5 4.47 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.562 -0.711 . . . . 0.0 112.605 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.3 m -60.7 161.65 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.988 0.899 . . . . 0.0 111.895 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -158.73 139.36 12.64 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.481 1.513 . . . . 0.0 109.582 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . 0.403 ' CZ2' ' HB2' ' B' ' 232' ' ' SER . 0.0 OUTLIER -72.41 161.63 30.57 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.834 171.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -137.98 149.74 46.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.722 1.209 . . . . 0.0 110.319 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' SER . . . . . 0.403 ' HB2' ' CZ2' ' B' ' 230' ' ' TRP . 1.8 t -112.05 -63.27 1.45 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.785 2.034 . . . . 0.0 112.125 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 8.5 t -109.82 -26.18 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.442 1.497 . . . . 0.0 112.237 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -41.41 75.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.627 2.771 . . . . 0.0 113.193 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.54 -173.89 4.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.912 2.085 . . . . 0.0 110.589 -172.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -98.86 158.57 20.2 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.437 1.017 . . . . 0.0 114.078 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.3 t -166.44 163.21 17.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.114 1.766 . . . . 0.0 110.621 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.57 141.45 2.38 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.2 1.8 . . . . 0.0 111.091 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -142.59 146.75 34.89 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 119.955 -1.716 . . . . 0.0 111.949 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -141.3 146.43 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.884 1.273 . . . . 0.0 110.353 -168.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -137.79 126.77 24.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 112.544 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -135.86 102.38 5.04 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.753 1.621 . . . . 0.0 109.984 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.51 164.84 13.23 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.983 -1.073 . . . . 0.0 112.242 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -141.71 -177.62 5.27 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.407 1.083 . . . . 0.0 111.691 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -47.81 -51.43 22.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.295 1.838 . . . . 0.0 114.088 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.1 t -132.05 -48.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.532 1.533 . . . . 0.0 111.996 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.74 173.96 3.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.076 0.95 . . . . 0.0 112.655 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.62 146.32 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.381 1.472 . . . . 0.0 109.829 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.5 p -127.49 143.04 51.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.055 0.931 . . . . 0.0 112.424 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.08 127.88 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.628 1.571 . . . . 0.0 109.56 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.24 123.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.378 1.471 . . . . 0.0 110.16 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.2 t -119.53 115.6 24.36 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.149 0.979 . . . . 0.0 110.116 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -97.38 153.78 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.795 1.238 . . . . 0.0 111.826 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -142.05 149.77 40.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.345 1.458 . . . . 0.0 110.091 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -135.08 80.55 0.31 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 124.972 1.272 . . . . 0.0 113.003 -171.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.21 108.09 20.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.635 1.174 . . . . 0.0 112.087 -167.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 C-N-CA 126.56 1.944 . . . . 0.0 113.172 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.14 177.94 7.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.427 1.491 . . . . 0.0 112.087 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.1 mm -51.69 140.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 126.991 2.116 . . . . 0.0 111.354 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 71.6 m -110.93 91.84 3.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.589 1.555 . . . . 0.0 110.702 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -94.77 149.38 21.31 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.428 -0.795 . . . . 0.0 111.323 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.9 p -149.32 118.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.04 1.736 . . . . 0.0 110.907 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.87 138.14 30.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.764 1.625 . . . . 0.0 110.663 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 126.145 1.778 . . . . 0.0 109.373 175.502 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 121.342 0.592 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -69.16 166.07 19.08 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.463 0.705 . . . . 0.0 112.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -135.53 159.57 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.714 1.206 . . . . 0.0 111.729 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.08 -38.33 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.439 1.096 . . . . 0.0 112.608 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.91 -27.97 68.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.859 1.264 . . . . 0.0 113.042 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -76.34 -56.41 4.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.711 0.804 . . . . 0.0 110.801 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.3 t -52.49 -39.59 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.157 1.383 . . . . 0.0 112.615 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.18 -15.06 12.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.612 1.565 . . . . 0.0 114.276 174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -108.58 -35.49 6.44 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.327 1.851 . . . . 0.0 112.786 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.32 -42.9 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.459 1.027 . . . . 0.0 110.581 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.84 -43.41 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.598 -0.689 . . . . 0.0 112.53 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -54.02 31.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.605 1.093 . . . . 0.0 111.405 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.68 75.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.23 62.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.667 0.787 . . . . 0.0 112.811 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.23 -57.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.113 0.869 . . . . 0.0 109.885 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.74 -31.75 71.06 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -58.84 -50.4 74.13 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.441 1.096 . . . . 0.0 112.182 168.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.63 -33.22 75.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.15 -37.72 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.836 1.254 . . . . 0.0 111.337 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.86 16.96 78.16 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.071 0.843 . . . . 0.0 114.54 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.9 8.49 72.67 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.172 1.368 . . . . 0.0 116.001 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.78 150.74 15.56 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 118.934 1.367 . . . . 0.0 113.747 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -175.77 3.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.168 1.787 . . . . 0.0 112.197 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -37.39 136.1 0.5 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 129.046 2.939 . . . . 0.0 114.995 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -134.94 174.5 10.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.519 1.528 . . . . 0.0 112.968 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.06 -93.06 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.4 1.48 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 p -98.99 4.9 47.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.332 2.253 . . . . 0.0 113.398 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -50.76 -43.76 58.45 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.019 -1.051 . . . . 0.0 112.689 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.21 -35.17 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.392 1.077 . . . . 0.0 112.687 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -67.81 -49.64 61.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 112.532 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.14 -26.78 67.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.092 -1.005 . . . . 0.0 112.576 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -75.23 -55.75 5.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.814 1.246 . . . . 0.0 111.182 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t -58.38 -23.5 57.2 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.549 -0.739 . . . . 0.0 112.99 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -85.1 -54.98 4.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.793 1.179 . . . . 0.0 112.368 169.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -57.78 -35.63 71.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.922 1.237 . . . . 0.0 113.782 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.15 -67.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 124.318 1.047 . . . . 0.0 109.688 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.13 -28.42 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.695 1.198 . . . . 0.0 111.226 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -52.22 -57.86 8.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.698 0.799 . . . . 0.0 112.908 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -90.61 -39.81 12.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.545 1.138 . . . . 0.0 112.396 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.7 m -57.2 -53.93 52.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.122 2.169 . . . . 0.0 112.514 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.99 -37.99 84.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.71 0.686 . . . . 0.0 111.722 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -63.24 -40.28 96.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 0.0 112.379 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.95 -50.77 61.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.528 1.931 . . . . 0.0 113.189 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.46 -24.1 65.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 53.5 m -59.2 -30.42 68.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.218 1.007 . . . . 0.0 111.262 165.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -90.6 -22.71 21.1 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.51 -15.22 60.5 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.42 -126.51 1.57 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.713 1.149 . . . . 0.0 112.442 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 5.3 mmpt? -55.78 112.09 3.89 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.957 1.703 . . . . 0.0 112.957 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.53 108.98 2.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.441 2.761 . . . . 0.0 111.748 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -144.56 179.81 7.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.446 1.898 . . . . 0.0 111.005 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -90.88 128.14 36.64 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 166.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -113.88 145.43 41.48 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.907 1.683 . . . . 0.0 108.847 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 tt -122.75 153.65 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.232 1.013 . . . . 0.0 110.045 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.51 151.79 28.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.49 1.916 . . . . 0.0 109.032 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.63 138.69 47.44 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.051 1.74 . . . . 0.0 108.46 166.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.88 138.45 37.44 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.02 126.79 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.342 1.457 . . . . 0.0 108.911 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.0 mm -117.64 94.66 3.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 127.358 2.263 . . . . 0.0 107.442 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.61 107.84 12.44 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.728 1.611 . . . . 0.0 110.642 -168.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -66.65 135.2 53.73 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.318 -0.864 . . . . 0.0 112.198 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -8.4 2.94 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.093 1.757 . . . . 0.0 115.498 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -16.8 49.69 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.079 2.152 . . . . 0.0 113.773 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.68 -3.04 5.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.068 1.318 . . . . 0.0 115.761 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 45.71 0.28 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.824 1.65 . . . . 0.0 113.974 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 161.6 33.52 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.914 1.245 . . . . 0.0 113.394 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -151.82 -171.66 4.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.595 1.558 . . . . 0.0 112.085 -172.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.96 138.11 41.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.401 0.546 . . . . 0.0 111.149 168.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.7 m -142.76 144.68 32.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.336 1.454 . . . . 0.0 110.12 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.34 144.19 31.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.8 p -145.88 140.7 27.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.015 0.912 . . . . 0.0 112.264 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 t -78.87 23.33 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.28 1.032 . . . . 0.0 112.584 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.9 m -67.07 171.19 5.82 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.304 -0.873 . . . . 0.0 111.648 165.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -163.44 149.74 11.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.741 2.416 . . . . 0.0 108.557 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -81.26 134.96 35.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.07 0.85 . . . . 0.0 109.594 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.38 127.23 5.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.229 . . . . 0.0 111.564 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -113.8 -31.96 6.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.597 1.559 . . . . 0.0 112.161 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -80.1 -38.46 31.6 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.803 1.641 . . . . 0.0 112.556 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -53.75 5.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.068 1.347 . . . . 0.0 112.405 -171.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -139.99 -161.27 1.17 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.927 2.491 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.82 153.5 16.93 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.831 -1.168 . . . . 0.0 113.754 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 p -155.62 154.83 32.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.729 1.612 . . . . 0.0 111.259 170.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 34.1 t -153.58 97.54 2.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.707 1.203 . . . . 0.0 111.797 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t -90.04 146.19 24.53 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.03 -1.044 . . . . 0.0 112.268 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.68 131.68 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.037 1.735 . . . . 0.0 109.265 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -119.79 128.7 53.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.525 1.53 . . . . 0.0 110.736 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -131.81 159.76 37.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.205 1.402 . . . . 0.0 110.089 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.5 144.68 42.32 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.201 -0.937 . . . . 0.0 111.0 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -117.31 -173.01 2.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.75 1.22 . . . . 0.0 109.318 -165.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -48.6 70.14 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 120.953 -1.092 . . . . 0.0 113.667 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 t -140.73 -17.82 0.86 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.908 2.083 . . . . 0.0 113.129 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.0 mtm -91.28 170.37 10.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.669 1.587 . . . . 0.0 111.09 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -138.02 161.17 37.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.874 0.869 . . . . 0.0 110.73 163.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.0 p -141.62 136.44 30.98 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.049 0.94 . . . . 0.0 111.301 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.2 119.45 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.869 1.268 . . . . 0.0 109.982 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.19 129.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.924 1.289 . . . . 0.0 110.661 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -121.47 106.86 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.274 0.63 . . . . 0.0 111.745 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.81 138.84 33.04 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -129.15 126.06 38.43 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.844 1.658 . . . . 0.0 110.335 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -126.17 73.65 0.43 Allowed Glycine 0 CA--C 1.524 0.61 0 C-N-CA 126.782 2.134 . . . . 0.0 111.671 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.42 123.11 17.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.964 1.306 . . . . 0.0 110.081 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.894 1.677 . . . . 0.0 111.54 -162.805 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -130.95 174.8 9.64 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.07 1.348 . . . . 0.0 111.833 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 136.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 111.418 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.0 m -94.74 96.42 9.37 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.288 1.435 . . . . 0.0 110.411 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -95.52 145.93 24.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.944 -1.097 . . . . 0.0 111.015 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.65 118.37 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.207 2.203 . . . . 0.0 109.349 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -137.75 150.37 47.2 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.306 -0.871 . . . . 0.0 112.053 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 125.203 1.401 . . . . 0.0 110.96 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 121.205 0.526 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.05 155.73 40.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.3 p -131.07 158.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.174 1.39 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.22 -35.94 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.779 2.032 . . . . 0.0 111.784 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.29 -31.96 66.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.439 1.096 . . . . 0.0 113.122 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -82.52 -51.12 8.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.499 -0.751 . . . . 0.0 110.491 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 90.2 t -51.0 -39.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.733 1.213 . . . . 0.0 112.511 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -61.15 -16.4 44.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.236 1.814 . . . . 0.0 114.493 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -104.18 -34.63 8.31 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.224 1.809 . . . . 0.0 112.526 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 36.1 mt -51.51 -43.59 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.133 0.878 . . . . 0.0 110.804 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.96 -43.16 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.702 -0.624 . . . . 0.0 112.318 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -54.66 24.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.601 1.091 . . . . 0.0 111.453 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -34.38 75.29 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.75 60.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 112.899 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.1 mt -59.84 -56.81 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.113 0.87 . . . . 0.0 109.61 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.41 -32.35 71.25 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 40.5 t -58.56 -50.4 73.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.515 1.126 . . . . 0.0 112.17 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.29 75.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 92.7 mt -61.94 -37.95 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.873 1.269 . . . . 0.0 111.22 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.06 17.04 78.45 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.045 0.831 . . . . 0.0 114.448 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.89 8.6 72.5 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.132 1.349 . . . . 0.0 115.967 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.85 151.22 14.87 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.947 1.373 . . . . 0.0 113.652 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.34 -173.17 2.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 112.23 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -39.79 137.71 0.87 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.732 2.813 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -136.84 174.09 11.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.516 1.526 . . . . 0.0 112.831 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -87.77 -92.44 0.11 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.416 1.486 . . . . 0.0 112.224 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 19.1 p -99.84 5.15 45.49 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.345 2.258 . . . . 0.0 113.248 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -50.76 -43.7 58.44 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.05 -1.031 . . . . 0.0 112.674 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.02 -35.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.331 1.052 . . . . 0.0 112.711 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.71 -49.81 60.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.475 1.11 . . . . 0.0 112.489 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.91 -26.91 67.82 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.621 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -75.09 -55.74 5.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.807 1.243 . . . . 0.0 111.215 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.1 t -58.95 -21.63 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 4.8 t -86.51 -55.6 3.81 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.824 1.193 . . . . 0.0 112.412 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -57.48 -35.95 70.85 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.045 1.293 . . . . 0.0 113.82 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.79 -67.16 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.382 1.073 . . . . 0.0 109.543 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.63 -29.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.797 1.239 . . . . 0.0 111.049 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.59 -55.27 23.46 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.29 -37.89 11.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.772 1.229 . . . . 0.0 112.571 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -60.07 -53.04 62.51 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.006 2.122 . . . . 0.0 112.731 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.02 -35.8 81.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.696 0.68 . . . . 0.0 112.043 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t -60.65 -50.42 73.56 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.726 0.81 . . . . 0.0 111.308 169.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -58.37 -51.17 70.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.522 1.929 . . . . 0.0 113.586 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.2 -23.03 63.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -61.17 -41.01 96.02 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -74.57 -24.08 58.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.42 -11.33 9.98 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -159.81 -73.65 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.942 1.246 . . . . 0.0 114.807 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -65.99 168.45 9.1 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 126.756 2.022 . . . . 0.0 113.318 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.38 173.54 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.223 2.615 . . . . 0.0 112.05 171.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.82 94.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.404 1.482 . . . . 0.0 113.04 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -158.13 107.06 2.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.596 1.959 . . . . 0.0 111.916 168.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -154.68 165.34 36.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.977 1.711 . . . . 0.0 111.031 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.8 tt -147.72 156.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 126.174 1.79 . . . . 0.0 108.864 160.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.13 152.46 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.289 1.836 . . . . 0.0 109.657 162.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.6 p -132.85 138.94 47.21 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.104 1.762 . . . . 0.0 108.518 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.75 145.7 38.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.879 0.847 . . . . 0.0 112.745 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.35 131.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.983 1.313 . . . . 0.0 109.224 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -118.71 93.45 2.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 127.215 2.206 . . . . 0.0 107.358 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.6 90.85 3.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 109.888 -172.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.53 153.22 13.34 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.457 -1.402 . . . . 0.0 113.533 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -7.79 53.7 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -16.91 56.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.441 1.896 . . . . 0.0 114.108 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 -3.18 6.38 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.176 1.231 . . . . 0.0 116.176 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -74.1 51.99 0.43 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.427 1.491 . . . . 0.0 113.287 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.05 30.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.652 1.596 . . . . 0.0 112.842 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.69 -173.8 4.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.32 1.848 . . . . 0.0 110.804 -174.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.41 139.26 40.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.842 0.747 . . . . 0.0 111.002 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 53.4 m -142.74 145.12 33.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.803 1.241 . . . . 0.0 110.142 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.71 38.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.433 1.093 . . . . 0.0 110.729 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 69.4 p -145.88 142.2 28.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.892 0.853 . . . . 0.0 112.07 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 9.5 t -80.79 25.81 0.43 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.975 0.91 . . . . 0.0 112.496 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 58.9 m -67.51 171.35 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.334 -0.854 . . . . 0.0 111.599 164.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -166.44 154.33 10.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.921 2.489 . . . . 0.0 108.83 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -81.61 132.09 35.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.428 -0.795 . . . . 0.0 110.014 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -152.78 116.46 4.77 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.046 1.338 . . . . 0.0 112.512 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.3 t -107.02 -34.05 7.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.397 1.479 . . . . 0.0 112.393 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 12.2 p -80.01 -36.09 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.986 1.314 . . . . 0.0 112.32 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -56.6 3.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.242 1.417 . . . . 0.0 111.802 -174.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -155.57 0.65 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.581 2.352 . . . . 0.0 109.341 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.59 153.5 16.79 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 120.728 -1.233 . . . . 0.0 113.556 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 25.8 p -156.79 147.18 21.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.211 1.404 . . . . 0.0 112.315 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.981 1.312 . . . . 0.0 111.838 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 14.2 t -86.57 146.4 26.37 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.034 -1.041 . . . . 0.0 112.205 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 t -139.39 135.96 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 109.267 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.34 129.79 51.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.538 1.535 . . . . 0.0 110.848 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -132.63 159.03 40.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.225 1.41 . . . . 0.0 110.035 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -136.64 144.16 43.87 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.026 -1.046 . . . . 0.0 111.028 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.9 -173.5 2.4 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.61 1.164 . . . . 0.0 109.454 -165.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -50.97 65.44 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.996 -1.065 . . . . 0.0 113.654 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.6 t -140.17 -10.94 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.064 1.746 . . . . 0.0 113.43 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.0 mtm -94.25 169.27 10.36 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 110.542 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -139.56 157.87 45.08 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 111.262 165.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.1 p -141.27 138.57 33.31 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.933 . . . . 0.0 111.876 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.66 126.83 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.877 1.271 . . . . 0.0 109.937 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.54 129.3 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.443 1.497 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -121.8 106.55 11.38 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.401 0.68 . . . . 0.0 111.9 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.99 140.93 29.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -131.57 115.54 16.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.142 1.777 . . . . 0.0 109.701 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.85 76.23 0.22 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.573 2.035 . . . . 0.0 111.028 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.08 123.38 20.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.838 0.855 . . . . 0.0 112.263 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 126.112 1.765 . . . . 0.0 112.058 -165.529 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -131.71 175.1 9.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 111.929 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 mm -52.86 140.5 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.662 1.985 . . . . 0.0 111.64 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 90.4 m -99.06 93.95 6.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.372 1.469 . . . . 0.0 110.332 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -94.26 146.82 23.75 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.036 -1.04 . . . . 0.0 110.778 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.6 120.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.384 1.874 . . . . 0.0 110.015 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.09 152.15 48.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.033 0.933 . . . . 0.0 112.075 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 125.223 1.409 . . . . 0.0 111.114 -179.624 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.151 0.5 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.49 158.66 31.36 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.399 -0.813 . . . . 0.0 112.534 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.55 141.49 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.774 0.83 . . . . 0.0 111.852 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.12 -42.89 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.858 1.663 . . . . 0.0 111.327 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.95 -31.48 60.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 113.311 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -86.64 -53.34 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.044 0.937 . . . . 0.0 111.701 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -44.14 -48.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.836 1.255 . . . . 0.0 112.605 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -65.31 -3.18 3.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.396 1.478 . . . . 0.0 113.919 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.54 -31.67 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.236 1.815 . . . . 0.0 112.274 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -50.87 -44.71 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.369 0.986 . . . . 0.0 110.437 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.81 -41.85 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -51.93 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.747 1.158 . . . . 0.0 111.585 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -33.32 75.27 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.05 69.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.396 1.079 . . . . 0.0 113.091 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.5 mt -59.86 -56.64 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.258 0.936 . . . . 0.0 110.274 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -60.45 -31.59 70.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.1 t -59.19 -46.68 87.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.32 1.048 . . . . 0.0 112.499 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.94 81.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.401 1.08 . . . . 0.0 113.815 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.95 -43.43 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 110.713 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.35 14.02 61.29 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.59 1.091 . . . . 0.0 115.066 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.78 85.87 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.139 1.352 . . . . 0.0 115.105 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -63.84 168.15 5.35 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 118.735 1.267 . . . . 0.0 112.55 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.63 102.03 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.203 1.801 . . . . 0.0 111.657 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.84 139.07 46.93 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.64 1.976 . . . . 0.0 112.499 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.23 156.98 43.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -57.89 -53.49 57.66 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.7 m -69.92 -26.36 64.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -58.7 -45.7 88.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.042 0.537 . . . . 0.0 112.182 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -56.91 -35.13 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.842 0.746 . . . . 0.0 112.424 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.89 -47.52 80.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.989 0.915 . . . . 0.0 111.621 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -67.81 -24.06 65.25 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -78.93 -52.57 8.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.132 0.878 . . . . 0.0 111.555 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -55.01 -35.23 64.18 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.665 0.666 . . . . 0.0 112.135 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -75.89 -55.76 5.32 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.205 0.911 . . . . 0.0 112.593 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.92 -38.03 75.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.911 1.284 . . . . 0.0 113.532 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.22 -62.32 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 C-N-CA 123.92 0.888 . . . . 0.0 110.384 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.61 -29.84 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.632 1.173 . . . . 0.0 110.75 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.53 -30.61 69.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.753 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -112.53 -42.24 3.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.995 1.718 . . . . 0.0 112.257 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -51.85 -55.58 19.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.5 2.32 . . . . 0.0 112.577 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -37.99 87.38 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.412 0.625 . . . . 0.0 110.989 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.6 m -67.15 -28.36 68.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.22 -52.38 10.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.555 2.342 . . . . 0.0 112.249 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.74 -25.53 67.32 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -55.38 -37.03 67.02 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.367 1.067 . . . . 0.0 110.913 166.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -81.79 -34.13 30.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.494 0.718 . . . . 0.0 112.712 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -69.74 -28.91 66.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.366 0.666 . . . . 0.0 111.013 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.67 -118.79 4.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.045 1.783 . . . . 0.0 113.256 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -133.89 151.98 77.82 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.696 1.598 . . . . 0.0 113.606 -171.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 113.77 3.86 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.929 3.086 . . . . 0.0 112.214 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -147.62 171.7 15.19 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.299 1.839 . . . . 0.0 110.663 171.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.9 135.86 48.24 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.741 0.781 . . . . 0.0 110.84 162.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -131.13 157.49 42.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 128.014 2.526 . . . . 0.0 108.208 170.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -138.56 155.18 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.178 1.391 . . . . 0.0 109.144 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.23 148.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 124.751 1.221 . . . . 0.0 110.374 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -145.83 154.05 41.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.304 1.042 . . . . 0.0 110.53 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.5 p -146.07 149.51 34.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.275 1.03 . . . . 0.0 112.854 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.73 111.33 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.841 1.656 . . . . 0.0 109.402 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mm -107.33 96.47 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.523 1.529 . . . . 0.0 107.481 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.64 89.4 2.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.885 1.274 . . . . 0.0 111.247 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -166.15 120.43 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.473 1.909 . . . . 0.0 107.966 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -152.59 -64.56 0.16 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.757 1.223 . . . . 0.0 111.304 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.2 -15.61 13.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.638 1.575 . . . . 0.0 113.507 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.44 -11.66 33.27 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.273 1.892 . . . . 0.0 114.533 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.52 117.44 9.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.219 1.408 . . . . 0.0 111.938 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.3 174.49 19.62 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.64 1.59 . . . . 0.0 114.095 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.92 -172.54 2.18 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.49 1.916 . . . . 0.0 111.599 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.78 108.56 20.41 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.527 -0.733 . . . . 0.0 110.241 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.3 m -120.41 137.72 54.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.831 0.852 . . . . 0.0 109.868 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.32 134.61 29.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.298 0.639 . . . . 0.0 111.683 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB2' ' HG ' ' A' ' 85' ' ' CYS . 56.3 p -132.28 134.99 45.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.972 0.892 . . . . 0.0 111.229 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -83.36 24.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.515 -0.74 . . . . 0.0 111.599 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.445 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 64.8 m -62.79 163.54 9.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.63 0.729 . . . . 0.0 111.288 164.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.05 136.84 5.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 108.986 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 149.79 48.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.412 0.685 . . . . 0.0 110.296 173.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -134.07 152.2 51.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.073 1.349 . . . . 0.0 110.794 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t -120.13 -65.42 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.4 1.08 . . . . 0.0 112.465 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.8 t -82.18 -35.75 28.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.043 0.838 . . . . 0.0 112.607 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -67.37 -36.5 81.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.227 1.411 . . . . 0.0 113.352 -171.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.17 179.14 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.36 2.264 . . . . 0.0 111.121 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 134.52 11.98 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.946 1.26 . . . . 0.0 113.14 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -150.5 139.53 21.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.768 1.627 . . . . 0.0 110.458 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 5.5 p -151.48 120.27 6.58 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.913 0.779 . . . . 0.0 111.902 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -132.29 151.71 51.71 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 112.078 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.5 139.76 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.605 1.562 . . . . 0.0 109.943 -170.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.05 131.98 50.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.983 1.313 . . . . 0.0 112.13 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -139.46 106.54 5.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.802 1.241 . . . . 0.0 110.926 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -86.38 148.81 25.41 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.986 0.914 . . . . 0.0 112.066 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -123.66 -176.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.755 1.622 . . . . 0.0 110.694 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -67.71 0.24 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.597 1.559 . . . . 0.0 113.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.5 t -117.32 8.19 13.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.405 1.882 . . . . 0.0 112.488 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.0 mtt -134.58 173.98 11.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.43 1.892 . . . . 0.0 111.069 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -151.45 161.99 41.72 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 109.794 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 10.3 p -132.27 151.21 51.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 110.406 171.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.49 137.8 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 109.257 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.24 140.13 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.939 1.296 . . . . 0.0 109.678 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -131.9 145.13 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.998 0.919 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.24 145.1 51.71 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.262 1.425 . . . . 0.0 111.934 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.1 151.63 51.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.772 1.629 . . . . 0.0 111.08 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.81 86.72 0.15 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.175 1.369 . . . . 0.0 111.353 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -78.14 122.39 25.58 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.993 1.317 . . . . 0.0 111.568 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.654 1.581 . . . . 0.0 112.302 -168.198 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.13 169.08 15.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.911 1.284 . . . . 0.0 111.836 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.2 mm -60.34 151.06 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.373 1.869 . . . . 0.0 111.275 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.2 m -124.59 95.23 4.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.971 1.708 . . . . 0.0 110.885 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -97.64 149.96 21.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.933 -1.104 . . . . 0.0 111.434 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.98 102.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.488 2.315 . . . . 0.0 109.045 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -142.45 115.84 9.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.614 1.166 . . . . 0.0 111.724 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 125.102 1.361 . . . . 0.0 110.91 -179.377 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -65.75 167.02 9.92 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.275 -0.89 . . . . 0.0 111.575 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.39 145.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.411 1.084 . . . . 0.0 111.315 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.38 -39.65 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.618 1.167 . . . . 0.0 111.925 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.36 -31.12 68.92 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.667 1.587 . . . . 0.0 113.312 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -74.0 -60.05 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.939 0.895 . . . . 0.0 110.172 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 40.3 t -54.23 -42.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.752 1.221 . . . . 0.0 113.143 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -64.74 -3.31 3.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.058 1.343 . . . . 0.0 113.747 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.37 -33.35 5.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.438 1.895 . . . . 0.0 112.432 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 39.1 mt -51.8 -43.14 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.497 1.044 . . . . 0.0 110.352 169.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.97 -41.93 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.74 56.93 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.772 1.169 . . . . 0.0 111.52 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -33.74 76.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.0 71.71 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.228 1.011 . . . . 0.0 113.036 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.88 -56.97 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.241 0.928 . . . . 0.0 110.312 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -60.28 -31.67 70.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -59.27 -46.7 87.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.34 1.056 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.11 81.62 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.402 1.081 . . . . 0.0 113.797 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.82 -43.43 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.277 1.031 . . . . 0.0 110.734 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.86 13.77 62.06 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.493 1.044 . . . . 0.0 115.0 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.78 10.82 85.85 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.188 1.375 . . . . 0.0 115.027 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -63.79 168.25 5.19 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.694 1.247 . . . . 0.0 112.501 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.62 102.55 0.07 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.076 1.75 . . . . 0.0 111.598 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.95 138.65 48.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.573 1.949 . . . . 0.0 112.526 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.8 156.63 43.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.697 1.199 . . . . 0.0 111.422 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -57.98 -53.53 57.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -69.42 -26.88 64.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -58.59 -45.47 89.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 0.0 112.22 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 4.2 t -56.49 -35.66 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.832 0.742 . . . . 0.0 112.444 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -63.8 -47.46 80.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.87 0.868 . . . . 0.0 111.585 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -67.92 -23.93 65.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -78.84 -52.9 7.68 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.172 0.896 . . . . 0.0 111.406 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.8 t -54.96 -34.79 63.6 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.736 0.698 . . . . 0.0 112.185 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.4 t -75.79 -56.75 4.38 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.178 0.899 . . . . 0.0 112.636 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -57.23 -38.44 73.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.952 1.301 . . . . 0.0 113.646 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.9 -64.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 83.1 t -51.65 -29.28 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 110.677 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.88 -34.48 73.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.171 0.988 . . . . 0.0 113.548 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -110.69 -38.6 5.11 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.693 1.597 . . . . 0.0 112.355 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 22.1 m -55.29 -53.52 55.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.419 2.288 . . . . 0.0 111.753 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 7.6 tp -60.12 -36.01 76.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.259 0.481 . . . . 0.0 112.054 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 68.4 m -70.6 -30.73 67.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.964 0.906 . . . . 0.0 113.355 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -71.34 -52.12 20.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.903 2.081 . . . . 0.0 112.453 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.93 -26.43 68.31 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 53.9 m -58.32 -30.46 66.71 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.941 0.896 . . . . 0.0 110.984 168.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -85.88 -36.28 20.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.817 0.847 . . . . 0.0 112.717 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.82 -23.8 66.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.968 0.907 . . . . 0.0 112.699 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.55 -112.68 3.71 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.153 1.359 . . . . 0.0 112.734 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -137.63 154.53 75.03 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.711 1.604 . . . . 0.0 113.237 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.48 115.32 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.682 2.921 . . . . 0.0 112.2 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.35 172.68 15.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.413 1.885 . . . . 0.0 110.686 171.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -71.81 132.16 44.06 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.568 -0.708 . . . . 0.0 110.907 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -129.31 147.68 51.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.736 1.614 . . . . 0.0 109.198 168.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.2 tt -128.38 154.81 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.397 1.479 . . . . 0.0 109.253 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.69 150.76 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.134 1.374 . . . . 0.0 111.055 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 18.6 p -137.83 151.95 48.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.601 1.561 . . . . 0.0 110.279 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.3 p -146.43 152.33 38.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.162 0.982 . . . . 0.0 113.003 168.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.51 114.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 108.974 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 3.1 mm -107.28 91.26 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.446 1.898 . . . . 0.0 107.648 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 2.2 ttt -98.73 135.94 39.5 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.374 1.47 . . . . 0.0 109.506 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -81.72 145.65 30.39 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.492 -0.755 . . . . 0.0 112.37 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -76.1 -0.16 20.94 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.289 1.435 . . . . 0.0 114.045 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.18 -21.31 13.1 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.424 1.89 . . . . 0.0 113.996 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.03 -12.27 62.23 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.703 1.621 . . . . 0.0 114.36 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.75 89.71 1.37 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.272 1.429 . . . . 0.0 111.55 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.55 -169.01 27.73 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.97 1.272 . . . . 0.0 113.672 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.2 -176.03 4.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.665 2.386 . . . . 0.0 111.379 -173.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.01 104.24 13.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.216 1.007 . . . . 0.0 110.278 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 135.24 54.1 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.837 0.855 . . . . 0.0 110.56 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.78 12.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.286 0.234 . . . . 0.0 111.038 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.402 ' HB2' ' HG ' ' B' ' 228' ' ' CYS . 15.0 p -120.65 138.15 54.08 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.954 0.883 . . . . 0.0 110.966 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 69.8 m -84.2 21.36 1.4 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.41 -0.806 . . . . 0.0 111.899 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . 0.402 ' HG ' ' HB2' ' B' ' 226' ' ' SER . 39.2 m -64.82 162.6 15.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.509 0.724 . . . . 0.0 111.65 168.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.725 1.61 . . . . 0.0 110.388 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -69.78 151.8 45.35 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.426 -0.796 . . . . 0.0 110.483 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -137.03 151.04 48.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.396 1.478 . . . . 0.0 110.351 167.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 2.4 t -119.78 -64.76 1.23 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.425 1.09 . . . . 0.0 112.523 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 46.6 t -82.44 -35.74 27.27 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.258 -0.901 . . . . 0.0 112.647 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -36.7 80.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.3 1.44 . . . . 0.0 113.406 -170.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.27 178.7 7.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.478 2.311 . . . . 0.0 110.744 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -96.95 134.33 11.73 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.871 1.224 . . . . 0.0 112.955 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 56.0 m -150.52 148.63 28.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.924 1.689 . . . . 0.0 110.152 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 3.2 p -152.57 121.41 6.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.726 1.211 . . . . 0.0 111.331 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.0 t -132.71 151.02 52.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.239 1.416 . . . . 0.0 112.271 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.6 139.98 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.517 1.527 . . . . 0.0 110.014 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.81 130.88 49.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.861 1.264 . . . . 0.0 112.236 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -138.77 104.29 5.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.0 1.32 . . . . 0.0 110.639 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.58 149.87 27.22 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.217 -0.927 . . . . 0.0 111.679 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -124.38 -177.79 3.9 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.361 1.465 . . . . 0.0 110.868 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -67.91 0.23 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.513 1.525 . . . . 0.0 113.35 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -119.15 15.13 13.18 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.486 1.914 . . . . 0.0 112.952 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 43.0 mtt -142.47 175.11 10.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.493 1.917 . . . . 0.0 109.9 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -151.54 158.7 43.92 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.869 0.868 . . . . 0.0 109.972 161.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 12.6 p -134.09 144.06 48.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.437 1.113 . . . . 0.0 110.99 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.19 132.64 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.427 1.491 . . . . 0.0 109.299 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.1 142.01 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.205 1.402 . . . . 0.0 110.027 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.1 t -135.79 144.52 45.8 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.785 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -130.21 144.36 51.32 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.479 1.511 . . . . 0.0 111.728 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -132.63 148.45 52.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.181 1.792 . . . . 0.0 110.571 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -147.61 87.3 0.16 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.581 1.562 . . . . 0.0 112.32 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.01 118.46 21.76 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 111.604 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.753 1.621 . . . . 0.0 112.347 -168.153 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -129.86 169.53 15.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.16 150.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.443 1.897 . . . . 0.0 111.366 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.6 m -123.67 88.41 2.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.739 1.616 . . . . 0.0 110.878 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -93.61 150.74 20.18 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.378 -0.826 . . . . 0.0 111.369 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.15 108.51 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.624 1.97 . . . . 0.0 110.043 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -141.65 113.32 7.77 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.742 1.617 . . . . 0.0 111.294 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 125.043 1.337 . . . . 0.0 110.875 -178.894 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 121.781 0.8 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -140.16 167.96 20.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.628 1.571 . . . . 0.0 110.959 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.99 152.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.92 1.288 . . . . 0.0 110.148 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.75 -35.84 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.263 -0.898 . . . . 0.0 111.517 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.61 -25.02 67.08 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.142 0.977 . . . . 0.0 113.48 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -78.62 -57.67 3.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.246 1.018 . . . . 0.0 110.535 169.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.8 t -50.49 -44.92 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.475 1.51 . . . . 0.0 112.535 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -67.68 -9.06 40.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.266 1.827 . . . . 0.0 113.628 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -102.33 -31.37 10.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.581 1.552 . . . . 0.0 112.844 170.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mt -49.27 -44.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.359 1.064 . . . . 0.0 110.467 170.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.97 -43.68 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -49.96 65.35 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.257 1.39 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -33.35 75.38 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.113 0.965 . . . . 0.0 113.091 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.9 mt -57.59 -56.17 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.225 0.92 . . . . 0.0 110.315 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.07 -32.01 70.54 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -60.86 -45.47 94.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.331 1.052 . . . . 0.0 112.449 170.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.95 71.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.24 -44.03 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.999 . . . . 0.0 110.938 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.03 71.92 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.61 26.84 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.348 1.451 . . . . 0.0 116.257 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.27 -179.17 1.52 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.024 1.412 . . . . 0.0 112.689 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -156.92 0.57 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.986 1.314 . . . . 0.0 111.803 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.9 158.04 0.74 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.028 1.331 . . . . 0.0 112.42 162.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.49 -176.4 5.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.715 1.206 . . . . 0.0 111.75 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.58 -100.76 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.882 1.273 . . . . 0.0 109.655 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -67.83 -24.33 65.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.96 1.304 . . . . 0.0 113.992 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -41.63 78.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.055 -1.028 . . . . 0.0 112.669 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.2 -29.18 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.615 0.766 . . . . 0.0 112.57 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.12 -48.43 78.53 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.695 1.198 . . . . 0.0 111.385 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.55 -26.36 67.09 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.349 -0.844 . . . . 0.0 112.986 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -77.13 -54.24 6.76 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.498 -0.752 . . . . 0.0 111.186 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 t -56.5 -29.83 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.783 0.719 . . . . 0.0 112.739 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -79.73 -52.68 7.63 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.477 1.035 . . . . 0.0 112.505 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -58.5 -38.0 76.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.578 1.151 . . . . 0.0 113.323 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.02 -65.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 124.667 1.187 . . . . 0.0 109.807 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.7 -29.09 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.873 1.269 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.67 -47.19 80.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 0.0 112.705 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.57 -38.29 9.21 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.023 1.329 . . . . 0.0 112.885 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -56.39 -53.64 54.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.538 1.935 . . . . 0.0 112.135 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -40.16 91.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.688 0.676 . . . . 0.0 111.307 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 p -69.68 -27.96 65.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -75.2 -52.15 11.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.677 2.391 . . . . 0.0 113.04 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.65 -28.27 69.79 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.626 -1.296 . . . . 0.0 113.308 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.9 m -56.25 -32.99 65.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.754 1.222 . . . . 0.0 111.056 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -85.59 -28.34 24.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.211 1.004 . . . . 0.0 113.233 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.73 -25.34 62.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.95 0.9 . . . . 0.0 112.312 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.47 -141.14 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.253 1.883 . . . . 0.0 112.035 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -112.84 155.08 44.6 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.397 1.479 . . . . 0.0 112.813 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.44 111.91 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.882 3.054 . . . . 0.0 111.238 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.2 174.86 10.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 0.0 111.387 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE3' ' CE2' ' B' ' 254' ' ' PHE . 0.5 OUTLIER -66.21 124.17 21.92 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.943 0.897 . . . . 0.0 110.072 163.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -124.56 165.36 17.97 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.999 2.12 . . . . 0.0 109.811 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.8 tp -152.06 154.24 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.63 1.572 . . . . 0.0 109.52 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.84 148.18 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 111.359 167.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.96 127.31 13.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 110.191 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.9 p -127.58 155.53 43.7 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.897 0.879 . . . . 0.0 112.301 173.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.19 122.72 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.948 1.299 . . . . 0.0 108.723 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mm -120.78 116.35 49.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 127.937 2.495 . . . . 0.0 107.474 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -135.92 151.93 50.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.184 0.992 . . . . 0.0 112.279 -171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -105.15 110.6 23.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.884 1.673 . . . . 0.0 112.263 -168.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.99 -6.17 11.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.186 2.194 . . . . 0.0 113.225 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -25.75 6.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.819 2.448 . . . . 0.0 114.336 162.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.31 7.05 0.59 Allowed Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 130.26 45.46 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.594 1.697 . . . . 0.0 112.338 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.6 112.9 2.16 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.85 171.56 15.01 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.41 1.884 . . . . 0.0 112.324 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -121.73 130.93 53.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 110.621 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.5 m -142.23 147.42 36.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.268 1.427 . . . . 0.0 109.059 177.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 153.2 40.77 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.822 -1.174 . . . . 0.0 111.904 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -155.58 165.03 37.8 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.3 t -116.43 9.89 14.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 112.643 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.45 106.26 5.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.995 1.318 . . . . 0.0 113.189 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -127.03 151.4 48.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.74 1.216 . . . . 0.0 111.429 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 145.83 52.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.195 0.998 . . . . 0.0 110.218 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -140.84 151.85 44.66 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.612 1.565 . . . . 0.0 109.351 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 t -117.02 -63.75 1.4 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.365 1.466 . . . . 0.0 112.143 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t -87.9 -28.76 21.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.201 1.001 . . . . 0.0 112.885 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -52.79 8.64 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.327 1.451 . . . . 0.0 111.948 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -151.54 -174.21 4.76 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.129 2.972 . . . . 0.0 109.608 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.63 6.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.297 1.427 . . . . 0.0 113.342 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.47 165.75 30.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.195 1.398 . . . . 0.0 111.126 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.94 126.93 10.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.984 0.914 . . . . 0.0 110.789 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 t -134.64 144.68 47.99 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.497 -1.377 . . . . 0.0 111.901 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.24 139.36 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.837 1.255 . . . . 0.0 110.11 -168.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.01 123.98 20.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.781 1.633 . . . . 0.0 112.255 -170.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -135.03 103.07 5.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.259 1.824 . . . . 0.0 110.531 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.95 149.59 44.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.165 0.986 . . . . 0.0 112.552 171.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -127.46 -179.37 4.87 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.509 . . . . 0.0 110.469 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.23 -48.61 72.7 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 13.74 5.35 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.447 1.899 . . . . 0.0 112.388 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.0 mtt -143.17 176.87 8.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.815 2.046 . . . . 0.0 109.695 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.0 156.1 35.37 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.276 1.03 . . . . 0.0 110.105 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 24.0 p -133.94 136.21 44.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.927 . . . . 0.0 111.647 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.19 129.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.34 1.456 . . . . 0.0 110.168 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.76 111.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.2 1.8 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -107.38 121.39 44.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.189 0.996 . . . . 0.0 110.151 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.63 160.51 22.36 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.294 1.438 . . . . 0.0 112.467 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.93 156.52 48.63 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.996 1.318 . . . . 0.0 109.874 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -179.95 91.99 0.08 OUTLIER Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.14 174.02 2.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.094 0.95 . . . . 0.0 112.155 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 124.784 1.234 . . . . 0.0 111.96 -179.565 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.176 0.036 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.08 -177.88 4.31 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.182 1.793 . . . . 0.0 111.152 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.26 140.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.006 0.922 . . . . 0.0 110.762 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.6 m -121.69 119.89 33.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.878 1.671 . . . . 0.0 110.606 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 117.27 33.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.59 1.156 . . . . 0.0 110.891 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.48 105.02 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 128.987 2.915 . . . . 0.0 109.31 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -133.33 156.52 47.46 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.164 -0.96 . . . . 0.0 112.262 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.03 1.332 . . . . 0.0 109.704 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.805 0 CA-C-O 121.736 0.779 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -139.63 167.4 22.19 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.573 1.549 . . . . 0.0 110.898 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.14 152.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.018 1.327 . . . . 0.0 110.172 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.41 -36.49 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.212 -0.93 . . . . 0.0 111.581 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.15 -24.2 66.11 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -79.19 -58.34 3.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.44 1.096 . . . . 0.0 110.62 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 24.7 t -50.38 -44.56 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 112.602 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -68.12 -8.76 41.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 113.651 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -102.8 -30.91 10.57 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.55 1.54 . . . . 0.0 112.787 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.1 mt -49.34 -44.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.408 1.083 . . . . 0.0 110.344 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.56 -43.65 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -50.01 65.04 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.157 1.344 . . . . 0.0 111.384 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -33.44 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.12 -40.47 71.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.207 1.003 . . . . 0.0 112.97 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 44.3 mt -57.56 -56.39 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.215 0.916 . . . . 0.0 110.277 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.88 -32.15 70.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -60.81 -45.5 94.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.344 1.057 . . . . 0.0 112.452 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.86 71.37 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.27 -44.16 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.161 0.984 . . . . 0.0 110.916 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.08 71.27 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.103 0.859 . . . . 0.0 115.071 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.33 -4.6 26.68 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.396 1.474 . . . . 0.0 116.229 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.35 -179.26 1.58 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.077 1.439 . . . . 0.0 112.558 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.48 -156.86 0.57 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.917 1.287 . . . . 0.0 111.759 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.92 158.03 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.105 1.362 . . . . 0.0 112.458 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.55 -176.23 5.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.718 1.207 . . . . 0.0 111.779 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.9 -100.92 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.87 1.268 . . . . 0.0 109.632 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 22.4 m -67.61 -24.31 65.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.937 1.295 . . . . 0.0 114.018 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -41.62 78.6 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.035 -1.041 . . . . 0.0 112.593 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.07 -29.23 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.545 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -63.17 -48.63 77.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.637 1.175 . . . . 0.0 111.391 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.41 -26.4 67.21 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.332 -0.855 . . . . 0.0 112.922 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -76.94 -54.44 6.57 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.505 -0.747 . . . . 0.0 111.23 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.3 t -56.56 -29.27 61.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.2 t -80.16 -53.08 7.01 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.497 1.044 . . . . 0.0 112.557 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -58.04 -37.86 75.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.649 1.18 . . . . 0.0 113.276 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 74.0 t -66.66 -66.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 124.844 1.257 . . . . 0.0 109.711 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.66 -29.25 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.71 1.204 . . . . 0.0 111.06 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.45 -47.35 79.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.499 0.72 . . . . 0.0 112.752 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.73 -38.17 9.19 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.053 1.341 . . . . 0.0 113.004 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 20.6 m -56.45 -53.38 58.11 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.559 1.943 . . . . 0.0 112.116 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -40.66 93.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.786 0.721 . . . . 0.0 111.303 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 35.3 p -69.14 -29.09 67.05 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.325 -0.86 . . . . 0.0 113.257 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -73.93 -51.73 15.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.662 2.385 . . . . 0.0 113.073 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.4 -28.22 69.54 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.61 -1.306 . . . . 0.0 113.292 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 96.2 m -58.17 -27.49 63.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.611 1.164 . . . . 0.0 111.117 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -90.76 -28.43 18.26 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.443 1.097 . . . . 0.0 113.607 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.13 -27.06 63.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.689 0.796 . . . . 0.0 111.821 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -137.01 9.58 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.127 1.822 . . . . 0.0 111.949 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -119.76 160.55 41.97 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 125.463 1.505 . . . . 0.0 113.571 -173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 115.93 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.629 2.886 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.8 175.55 11.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.317 1.447 . . . . 0.0 111.7 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.26 109.05 5.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.78 1.232 . . . . 0.0 109.719 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.83 159.47 15.77 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.86 1.264 . . . . 0.0 109.948 167.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.9 tt -146.8 157.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 109.863 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.87 147.27 25.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.894 1.678 . . . . 0.0 110.722 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.01 126.97 11.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.94 1.696 . . . . 0.0 109.628 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.41 158.42 42.04 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.635 0.774 . . . . 0.0 112.931 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.05 124.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.758 1.223 . . . . 0.0 109.703 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.2 mm -123.92 113.02 35.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.766 2.426 . . . . 0.0 107.845 -172.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -134.64 153.12 52.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.255 1.026 . . . . 0.0 112.41 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -103.44 114.15 28.2 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.984 1.714 . . . . 0.0 112.512 -168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -66.95 -5.51 12.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.002 2.121 . . . . 0.0 113.336 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.78 -24.8 6.44 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.627 2.371 . . . . 0.0 114.332 161.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 7.97 1.49 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.2 88.13 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.199 1.5 . . . . 0.0 113.529 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 142.21 33.27 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.157 -0.964 . . . . 0.0 113.918 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.97 172.02 17.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.209 2.204 . . . . 0.0 111.186 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -125.18 122.53 37.32 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.803 1.241 . . . . 0.0 109.981 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 93.8 m -132.51 145.92 51.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 108.427 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -140.62 143.3 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.502 -0.749 . . . . 0.0 110.819 173.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 83.2 p -140.67 158.18 44.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.696 0.76 . . . . 0.0 111.546 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 34.5 t -103.83 5.4 35.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.087 0.955 . . . . 0.0 111.991 170.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 73.1 m -67.4 151.89 46.65 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.452 1.12 . . . . 0.0 113.73 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.97 162.07 23.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.672 2.389 . . . . 0.0 109.695 -171.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.9 144.63 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.382 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -136.37 151.15 49.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.317 1.847 . . . . 0.0 110.587 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 22.3 t -117.55 -68.19 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.695 1.198 . . . . 0.0 111.929 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 4.6 t -83.87 -32.0 25.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.436 0.694 . . . . 0.0 112.345 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.18 42.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.859 1.664 . . . . 0.0 112.522 -173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -154.62 -172.9 4.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 128.804 2.842 . . . . 0.0 110.053 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -120.02 131.39 8.86 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.605 1.574 . . . . 0.0 113.776 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 p -155.08 159.91 40.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.174 2.19 . . . . 0.0 111.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.7 t -149.66 110.36 4.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.762 1.225 . . . . 0.0 110.698 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.3 t -118.71 146.46 44.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.637 1.175 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.91 141.31 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.717 1.207 . . . . 0.0 110.241 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.67 124.65 20.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.922 1.689 . . . . 0.0 112.355 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -135.29 105.65 6.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.213 1.805 . . . . 0.0 110.599 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 150.11 40.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.204 1.002 . . . . 0.0 112.395 172.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -127.87 -179.89 5.2 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.434 1.494 . . . . 0.0 110.529 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -48.45 75.09 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.0 t -131.6 14.68 4.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.492 1.917 . . . . 0.0 112.478 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 26.5 mtt -143.4 176.49 9.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.796 2.039 . . . . 0.0 109.82 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -154.11 155.91 36.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.325 1.05 . . . . 0.0 110.043 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 21.7 p -135.22 135.4 40.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.947 0.899 . . . . 0.0 111.734 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -134.56 131.36 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.319 1.448 . . . . 0.0 110.394 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.13 107.68 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.126 1.77 . . . . 0.0 110.75 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.7 t -96.31 129.39 43.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.547 0.739 . . . . 0.0 110.139 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -126.62 147.76 49.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 112.272 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.531 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 1.1 m-85 -117.22 149.47 40.35 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.966 1.706 . . . . 0.0 111.264 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -172.02 89.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.407 -170.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.47 165.22 14.81 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.883 0.849 . . . . 0.0 111.952 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 124.568 1.147 . . . . 0.0 111.631 175.434 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.466 0.174 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.78 -173.3 2.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.2 mm -57.8 141.89 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 110.649 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 88.7 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.561 1.944 . . . . 0.0 110.011 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.77 136.19 33.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.728 0.811 . . . . 0.0 110.81 171.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 5.4 p -131.77 103.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 128.199 2.6 . . . . 0.0 109.656 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -129.78 157.95 40.78 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 0.0 111.562 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 124.836 1.254 . . . . 0.0 109.37 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -61.87 164.96 5.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.457 0.703 . . . . 0.0 111.935 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.51 156.83 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.804 0.842 . . . . 0.0 111.398 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 t -57.39 -34.76 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.097 1.759 . . . . 0.0 111.523 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.39 -27.6 67.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.645 1.178 . . . . 0.0 113.256 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -78.12 -59.23 2.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.991 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 t -49.74 -45.91 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.502 1.521 . . . . 0.0 112.87 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 t -60.73 -25.26 66.32 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.302 1.441 . . . . 0.0 112.894 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.52 -37.75 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.51 -1.369 . . . . 0.0 113.155 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mt -52.1 -43.6 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.515 1.126 . . . . 0.0 110.84 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.1 -42.15 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.47 -0.776 . . . . 0.0 113.032 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -52.9 54.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.174 1.352 . . . . 0.0 112.082 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.11 74.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.54 -45.68 65.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.004 0.922 . . . . 0.0 112.882 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mt -54.72 -57.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 119.204 0.911 . . . . 0.0 110.415 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.97 -29.92 68.76 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.8 p -66.68 -33.7 76.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.23 52.09 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.043 1.337 . . . . 0.0 112.438 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.69 -41.51 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.869 1.268 . . . . 0.0 110.926 171.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.15 81.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.251 0.929 . . . . 0.0 114.272 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 10.02 75.54 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.334 1.445 . . . . 0.0 115.903 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -61.22 155.58 20.56 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.072 1.436 . . . . 0.0 113.056 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.78 -171.53 1.62 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.167 1.787 . . . . 0.0 112.286 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -41.41 139.29 1.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.743 2.817 . . . . 0.0 114.737 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -135.88 174.75 10.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.485 1.514 . . . . 0.0 113.163 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -90.42 -97.45 0.11 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.541 1.537 . . . . 0.0 111.138 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.8 p -89.37 -1.65 58.13 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.681 1.992 . . . . 0.0 114.326 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.31 -42.77 61.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.433 1.493 . . . . 0.0 113.566 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.08 -32.15 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.55 -48.77 71.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 112.176 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -68.54 -25.99 65.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -76.63 -55.45 5.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.918 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -54.29 -35.3 62.44 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.953 0.797 . . . . 0.0 112.186 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -75.68 -54.55 6.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.129 0.877 . . . . 0.0 112.761 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.91 -36.85 73.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.668 1.187 . . . . 0.0 113.33 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.64 -63.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 C-N-CA 124.177 0.991 . . . . 0.0 110.015 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.8 t -49.15 -30.75 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.057 0.943 . . . . 0.0 110.715 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -59.91 -35.84 75.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -107.02 -42.54 4.87 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.36 1.464 . . . . 0.0 112.659 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 m -54.18 -54.84 34.25 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.339 2.256 . . . . 0.0 112.254 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -39.07 86.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.517 0.598 . . . . 0.0 111.218 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -57.48 -52.61 64.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.203 0.601 . . . . 0.0 111.425 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -59.77 -51.13 71.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.565 1.946 . . . . 0.0 114.489 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.06 -28.64 69.61 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.574 -1.329 . . . . 0.0 113.734 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 m -59.46 -33.91 71.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.47 0.708 . . . . 0.0 111.071 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -80.66 -24.9 38.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.26 -16.01 62.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.2 -111.3 3.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 112.693 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -133.91 150.92 75.83 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.369 1.868 . . . . 0.0 112.222 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 102.58 1.42 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.98 3.12 . . . . 0.0 112.404 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -143.05 161.67 37.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.471 1.509 . . . . 0.0 112.109 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -65.5 100.07 0.47 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.96 1.704 . . . . 0.0 110.991 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -75.02 166.14 24.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.467 1.107 . . . . 0.0 111.9 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.99 156.07 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.443 2.297 . . . . 0.0 108.186 164.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.69 155.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.782 -0.574 . . . . 0.0 109.455 160.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -134.68 137.47 43.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.519 1.128 . . . . 0.0 109.991 165.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -128.88 144.76 51.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.795 0.838 . . . . 0.0 111.916 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -131.82 99.5 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.298 1.839 . . . . 0.0 108.841 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.75 99.96 10.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.89 96.18 2.76 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.124 1.369 . . . . 0.0 111.292 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -149.35 159.06 44.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.305 1.442 . . . . 0.0 110.458 154.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -153.48 -80.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.07 1.748 . . . . 0.0 110.059 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -84.0 -18.85 35.78 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.895 1.278 . . . . 0.0 113.775 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.68 -2.26 3.71 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.784 1.659 . . . . 0.0 115.093 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.05 179.08 2.45 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.967 1.707 . . . . 0.0 114.167 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.1 -172.29 28.23 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.812 2.149 . . . . 0.0 112.356 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 179.64 6.36 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 111.986 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -106.87 111.21 23.62 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.469 -0.77 . . . . 0.0 111.1 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.6 m -116.93 140.71 49.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.474 1.11 . . . . 0.0 109.972 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.02 138.95 34.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.733 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -139.56 120.81 14.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 110.429 -166.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 t -79.97 66.23 5.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.319 1.057 . . . . 0.0 110.093 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -114.04 171.18 7.76 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 0.0 110.787 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -144.07 129.58 19.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.986 1.314 . . . . 0.0 109.86 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -76.98 125.98 30.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.434 1.094 . . . . 0.0 109.846 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -146.01 90.06 1.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.488 1.115 . . . . 0.0 111.336 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -68.1 -60.57 2.39 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.173 1.389 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.7 t -88.08 -33.67 18.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.476 1.11 . . . . 0.0 112.304 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 m -74.75 -38.24 62.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -165.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.76 -134.47 0.14 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.335 1.854 . . . . 0.0 109.422 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.96 150.59 20.66 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.316 1.436 . . . . 0.0 113.464 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 p -162.63 157.3 21.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.6 t -165.25 157.99 15.95 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.302 1.841 . . . . 0.0 109.378 165.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 t -143.24 139.14 30.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.28 -1.512 . . . . 0.0 111.13 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.1 138.31 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 109.658 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.25 119.08 11.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.733 1.613 . . . . 0.0 111.023 -166.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -135.83 141.74 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.868 1.267 . . . . 0.0 112.149 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 165.7 24.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.49 -174.12 4.59 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.17 -62.41 0.95 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.294 1.837 . . . . 0.0 113.536 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -139.18 -6.59 1.39 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.987 1.715 . . . . 0.0 113.124 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.9 ptm -129.17 78.81 1.88 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.642 1.577 . . . . 0.0 112.111 -165.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -51.27 133.5 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.165 1.386 . . . . 0.0 111.306 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 14.3 p -113.63 136.33 52.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 111.767 -176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.1 126.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.81 1.644 . . . . 0.0 110.994 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.78 122.98 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.221 1.808 . . . . 0.0 110.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -115.64 118.42 33.05 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.788 1.235 . . . . 0.0 110.675 -178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.98 140.8 37.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.262 1.825 . . . . 0.0 112.15 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -133.41 148.51 51.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.339 1.456 . . . . 0.0 109.67 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.1 127.44 3.85 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 125.591 1.567 . . . . 0.0 109.344 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.95 133.43 49.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.63 0.772 . . . . 0.0 111.419 -168.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 124.959 1.304 . . . . 0.0 112.305 -169.623 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.354 0.597 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -132.54 174.46 10.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.364 1.866 . . . . 0.0 111.083 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.15 134.34 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.17 1.788 . . . . 0.0 111.399 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 m -98.32 92.32 5.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.206 1.402 . . . . 0.0 110.242 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -92.55 149.83 21.12 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.701 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.39 97.79 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.569 2.347 . . . . 0.0 108.686 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -144.72 166.26 25.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.048 1.339 . . . . 0.0 112.539 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 125.367 1.467 . . . . 0.0 109.622 174.643 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.172 0.51 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.39 166.9 2.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.196 0.999 . . . . 0.0 112.788 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.52 156.99 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.415 1.086 . . . . 0.0 111.546 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.99 -38.91 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.618 1.167 . . . . 0.0 111.469 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.27 -26.47 67.79 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.565 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -76.86 -60.71 2.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.883 0.873 . . . . 0.0 110.421 171.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 51.1 t -49.23 -45.95 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.001 1.72 . . . . 0.0 112.194 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 21.7 t -59.74 -25.15 64.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.272 1.429 . . . . 0.0 112.98 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -86.93 -37.72 17.34 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.604 -1.31 . . . . 0.0 113.05 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.4 mt -51.95 -44.12 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.975 0.91 . . . . 0.0 110.979 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -52.53 49.96 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.917 1.235 . . . . 0.0 111.959 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.66 72.56 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -45.78 56.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 112.868 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 51.6 mt -54.43 -57.37 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.275 0.943 . . . . 0.0 110.327 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.75 -30.09 68.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 9.7 p -66.7 -33.51 75.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 172.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.15 -33.55 50.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.057 1.343 . . . . 0.0 112.535 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.77 -40.4 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.844 1.258 . . . . 0.0 110.969 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.27 15.04 80.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.208 0.908 . . . . 0.0 114.327 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.44 78.17 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.315 1.436 . . . . 0.0 115.797 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -61.19 155.34 21.04 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.119 1.46 . . . . 0.0 113.103 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.89 -171.44 1.63 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.198 1.799 . . . . 0.0 112.242 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -41.35 139.44 1.04 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.739 2.816 . . . . 0.0 114.808 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -135.93 174.3 10.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.495 1.518 . . . . 0.0 113.19 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.21 -96.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.658 1.583 . . . . 0.0 111.292 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.7 p -90.67 -1.71 57.86 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.803 2.041 . . . . 0.0 114.354 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.6 -42.48 61.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.422 1.489 . . . . 0.0 113.7 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.98 -31.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.05 -49.08 68.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.794 1.238 . . . . 0.0 112.139 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -68.33 -26.19 65.48 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -76.48 -55.57 5.41 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 110.941 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.6 t -55.36 -32.45 62.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.928 0.786 . . . . 0.0 112.399 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.3 t -77.54 -55.7 5.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.281 0.946 . . . . 0.0 112.756 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.65 -36.19 71.55 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.884 1.22 . . . . 0.0 113.405 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.74 -63.4 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 109.964 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.77 -31.14 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.302 1.041 . . . . 0.0 110.722 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.82 -35.36 74.56 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -107.62 -42.41 4.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.42 1.488 . . . . 0.0 112.663 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.8 m -54.62 -54.18 44.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.417 2.287 . . . . 0.0 112.379 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -38.94 87.63 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 0.0 111.187 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 23.8 t -58.05 -51.98 67.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.307 0.643 . . . . 0.0 111.522 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.58 -51.54 69.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.576 1.95 . . . . 0.0 114.273 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.0 pp -65.48 -28.59 69.32 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.622 -1.299 . . . . 0.0 113.881 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 4.6 m -58.99 -32.46 69.71 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.397 0.679 . . . . 0.0 111.059 168.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -81.09 -27.27 35.7 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.692 -0.63 . . . . 0.0 112.58 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.4 -21.21 62.87 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.32 -111.72 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.013 1.292 . . . . 0.0 112.364 171.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -133.51 152.22 78.74 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.926 1.69 . . . . 0.0 112.37 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.42 99.96 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.891 3.061 . . . . 0.0 112.107 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -142.4 162.96 34.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.544 1.537 . . . . 0.0 112.196 174.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -66.39 101.95 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.191 1.796 . . . . 0.0 111.085 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -80.04 165.07 22.92 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.86 1.264 . . . . 0.0 111.908 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.7 tt -149.14 157.6 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 127.781 2.432 . . . . 0.0 108.236 164.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.72 155.67 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 161.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 134.25 40.0 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.672 1.189 . . . . 0.0 109.59 166.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 8.3 p -128.02 148.57 50.54 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.902 0.881 . . . . 0.0 112.505 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -133.27 104.24 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.195 1.798 . . . . 0.0 109.061 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -99.12 109.22 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 107.837 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 159.1 35.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.284 1.433 . . . . 0.0 111.445 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.23 130.06 41.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.525 1.53 . . . . 0.0 112.712 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -80.88 -4.13 53.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.171 2.189 . . . . 0.0 114.116 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -58.45 -20.38 44.58 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.436 1.894 . . . . 0.0 114.639 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.67 5.03 3.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.756 1.645 . . . . 0.0 114.614 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.4 6.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 113.114 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -175.1 -177.53 44.26 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.43 1.966 . . . . 0.0 111.76 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 179.85 7.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.487 1.515 . . . . 0.0 112.315 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -109.96 109.96 20.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.59 0.632 . . . . 0.0 111.411 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 35.7 m -113.85 138.49 50.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.829 0.852 . . . . 0.0 110.393 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.04 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.551 . . . . 0.0 111.293 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 3.2 m -136.07 119.6 17.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.793 0.837 . . . . 0.0 110.114 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.1 t -79.88 64.88 4.86 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.413 1.101 . . . . 0.0 109.975 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 170.83 7.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 110.641 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.79 132.07 21.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 109.899 -170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -76.83 124.6 27.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.459 1.104 . . . . 0.0 109.618 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -142.74 84.23 1.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.843 1.257 . . . . 0.0 110.976 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.5 t -65.11 -62.08 1.76 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.274 1.429 . . . . 0.0 112.474 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 35.8 t -88.48 -28.65 20.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.287 1.035 . . . . 0.0 112.535 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.1 m -77.08 -38.23 52.88 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.655 -0.653 . . . . 0.0 112.63 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 -134.75 0.14 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.211 1.804 . . . . 0.0 109.689 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.81 150.92 20.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.381 1.467 . . . . 0.0 113.272 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 31.3 p -162.6 156.74 21.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.159 1.384 . . . . 0.0 111.915 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.6 162.59 16.63 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.342 1.857 . . . . 0.0 109.644 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.2 t -146.49 141.14 26.77 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.392 -1.442 . . . . 0.0 110.78 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.5 136.52 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.973 1.309 . . . . 0.0 109.509 -171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 121.81 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.45 1.5 . . . . 0.0 111.394 -171.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -130.43 169.89 14.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.621 1.569 . . . . 0.0 110.912 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.65 164.83 14.38 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.043 1.337 . . . . 0.0 111.89 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -177.15 5.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.382 1.473 . . . . 0.0 109.458 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.55 -71.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.212 2.205 . . . . 0.0 114.055 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.0 t -138.32 16.41 2.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.489 1.516 . . . . 0.0 113.167 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.78 121.83 13.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.598 1.559 . . . . 0.0 110.987 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -79.08 152.2 30.97 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.558 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 23.1 p -133.46 115.7 15.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.388 0.675 . . . . 0.0 112.501 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.91 129.62 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.432 1.493 . . . . 0.0 111.565 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.25 121.3 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.485 1.914 . . . . 0.0 111.044 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.5 t -112.95 121.9 46.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.774 1.23 . . . . 0.0 110.627 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -108.4 141.44 40.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.289 1.836 . . . . 0.0 112.392 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.44 147.95 50.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.404 1.482 . . . . 0.0 109.697 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -138.09 125.18 3.15 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 125.698 1.618 . . . . 0.0 109.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.66 132.14 48.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.626 0.77 . . . . 0.0 111.783 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 125.041 1.337 . . . . 0.0 112.483 -169.409 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.277 0.56 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -132.29 175.12 9.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.421 1.888 . . . . 0.0 111.135 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.1 132.67 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.016 1.727 . . . . 0.0 111.385 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 57.1 m -95.72 88.62 5.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.086 1.354 . . . . 0.0 110.004 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -92.12 150.04 21.16 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.277 -0.89 . . . . 0.0 111.42 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.63 102.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.747 2.019 . . . . 0.0 109.444 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -143.89 167.12 23.07 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.839 1.655 . . . . 0.0 111.794 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.993 1.317 . . . . 0.0 109.755 174.202 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.464 0.65 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -125.11 165.3 18.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.854 1.261 . . . . 0.0 110.496 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.87 142.51 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.762 1.225 . . . . 0.0 110.138 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.61 -41.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.808 1.643 . . . . 0.0 113.813 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.35 -29.8 67.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.291 1.036 . . . . 0.0 112.93 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -76.36 -56.11 4.94 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.41 1.084 . . . . 0.0 110.736 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 t -48.25 -44.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.538 1.135 . . . . 0.0 112.277 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -68.23 -6.84 25.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.474 1.51 . . . . 0.0 114.12 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -107.11 -32.73 7.7 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.538 1.935 . . . . 0.0 112.662 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 mt -50.29 -42.76 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.277 0.944 . . . . 0.0 110.133 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -59.85 -43.85 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.463 -0.773 . . . . 0.0 113.085 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -51.77 56.15 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.923 1.238 . . . . 0.0 111.132 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -34.01 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.3 -37.46 63.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.706 0.803 . . . . 0.0 112.839 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.2 mt -59.43 -59.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.337 0.971 . . . . 0.0 109.544 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.57 -31.6 70.72 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.0 t -58.71 -50.5 73.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 112.209 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.96 -31.98 72.08 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.43 -44.43 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.384 1.073 . . . . 0.0 110.973 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.19 12.0 74.56 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.11 -1.93 26.94 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 171.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.23 170.06 6.35 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 119.347 1.574 . . . . 0.0 112.004 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.75 -147.24 0.34 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -68.23 103.07 1.49 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.037 2.135 . . . . 0.0 111.28 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -92.95 173.06 7.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.291 1.437 . . . . 0.0 112.645 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -84.2 -112.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.469 1.108 . . . . 0.0 110.367 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.7 m -61.95 -20.32 63.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.576 1.55 . . . . 0.0 114.659 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.05 -41.84 75.66 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.138 -0.976 . . . . 0.0 112.501 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.0 t -54.77 -36.1 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.526 1.131 . . . . 0.0 112.675 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -66.11 -47.85 72.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.785 0.721 . . . . 0.0 112.42 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -65.17 -24.06 67.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.029 0.831 . . . . 0.0 112.466 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.66 -53.63 6.96 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -56.2 -30.55 62.44 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.816 0.734 . . . . 0.0 112.588 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -78.85 -58.43 3.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 170.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -58.21 -39.21 78.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.048 1.295 . . . . 0.0 113.538 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.26 -62.42 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 123.89 0.876 . . . . 0.0 109.956 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -50.04 -29.55 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.46 1.104 . . . . 0.0 110.855 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.27 -52.01 66.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.609 0.763 . . . . 0.0 112.01 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -92.35 -38.62 11.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.5 m -61.27 -53.16 60.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.402 2.281 . . . . 0.0 112.431 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -37.86 84.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.28 0.562 . . . . 0.0 111.003 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m -65.96 -29.63 70.06 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.86 -50.28 12.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.421 2.289 . . . . 0.0 112.592 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.18 -25.74 67.85 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.856 -1.152 . . . . 0.0 113.786 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -57.53 -32.82 67.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.564 1.146 . . . . 0.0 110.848 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -84.27 -30.55 25.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.56 -31.92 70.4 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.588 0.355 . . . . 0.0 111.105 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.04 -137.79 4.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.013 1.292 . . . . 0.0 111.976 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.75 158.76 39.61 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.154 1.382 . . . . 0.0 112.791 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.44 109.46 2.45 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.514 2.809 . . . . 0.0 111.161 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.96 173.81 12.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.763 1.225 . . . . 0.0 112.123 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.23 112.08 10.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.28 . . . . 0.0 110.537 168.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.88 134.85 54.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.967 1.307 . . . . 0.0 109.34 170.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -118.06 152.36 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.369 1.868 . . . . 0.0 109.158 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.98 154.53 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.331 1.052 . . . . 0.0 110.218 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 153.38 40.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.775 168.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -147.18 156.33 42.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.076 0.95 . . . . 0.0 112.737 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.28 121.27 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.442 1.497 . . . . 0.0 108.993 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.64 118.21 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 126.876 2.07 . . . . 0.0 107.507 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.95 161.78 35.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.52 1.528 . . . . 0.0 110.751 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -130.1 157.48 42.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.745 -1.222 . . . . 0.0 113.99 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -76.44 -7.92 56.07 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.286 1.435 . . . . 0.0 114.368 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.39 -16.29 45.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.536 1.934 . . . . 0.0 114.263 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.04 30.57 0.79 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.101 1.334 . . . . 0.0 115.301 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.26 73.69 0.49 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.977 1.311 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 95.24 0.23 Allowed Glycine 0 N--CA 1.468 0.776 0 C-N-CA 126.192 1.853 . . . . 0.0 115.049 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.55 162.32 25.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.773 1.629 . . . . 0.0 111.892 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.05 97.73 5.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.815 1.246 . . . . 0.0 108.622 170.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.2 m -105.69 136.39 45.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.821 0.848 . . . . 0.0 109.13 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 119.57 12.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.84 0.856 . . . . 0.0 110.542 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 p -125.08 139.7 53.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.929 0.871 . . . . 0.0 111.378 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.2 m -87.19 16.17 5.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.664 0.785 . . . . 0.0 112.277 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.7 m -70.7 166.22 21.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.345 1.058 . . . . 0.0 112.163 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.3 151.44 26.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.868 1.667 . . . . 0.0 110.769 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -78.92 127.98 32.71 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.474 -0.767 . . . . 0.0 110.005 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.78 139.4 38.26 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.245 1.018 . . . . 0.0 112.144 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -134.44 -38.13 0.84 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.607 1.563 . . . . 0.0 113.219 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 t -89.68 -43.22 10.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.35 1.46 . . . . 0.0 111.299 173.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -43.35 87.55 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.965 1.706 . . . . 0.0 112.416 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.68 -161.67 0.94 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.463 1.905 . . . . 0.0 111.377 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.41 114.66 4.49 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.873 1.702 . . . . 0.0 115.944 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 m -139.45 176.21 8.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.125 2.17 . . . . 0.0 111.602 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.84 131.49 6.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.002 2.121 . . . . 0.0 109.208 166.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.9 t -139.11 146.02 40.18 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.825 -1.797 . . . . 0.0 112.436 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 137.85 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.951 1.3 . . . . 0.0 110.259 -167.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 114.91 16.63 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.279 1.432 . . . . 0.0 111.695 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -121.5 97.7 5.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.741 1.616 . . . . 0.0 109.557 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -63.75 168.83 4.56 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.356 -0.84 . . . . 0.0 112.337 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.89 -177.83 5.16 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.857 1.663 . . . . 0.0 112.93 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.8 t -135.29 -30.12 1.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.251 1.42 . . . . 0.0 113.679 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptp -87.25 176.81 7.38 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.962 -1.086 . . . . 0.0 112.506 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.55 150.54 30.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.663 1.185 . . . . 0.0 111.639 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.2 p -136.59 142.86 43.35 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.262 1.029 . . . . 0.0 112.346 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.39 135.13 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.701 1.6 . . . . 0.0 109.978 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.65 131.5 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.903 1.681 . . . . 0.0 110.255 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.2 p -125.07 147.51 48.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.56 136.47 47.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.068 2.147 . . . . 0.0 110.967 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -135.42 157.99 45.5 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.792 1.637 . . . . 0.0 108.982 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.24 85.17 0.05 OUTLIER Glycine 0 N--CA 1.464 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 111.442 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.02 153.9 42.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.035 0.934 . . . . 0.0 110.085 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.474 0.764 0 C-N-CA 123.455 0.702 . . . . 0.0 111.608 -171.21 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -130.6 -179.92 5.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.761 1.224 . . . . 0.0 111.559 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.3 134.2 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.105 1.362 . . . . 0.0 110.93 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.6 m -115.84 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 110.245 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -90.98 147.48 23.06 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.447 -0.783 . . . . 0.0 111.384 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.89 103.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 128.019 2.527 . . . . 0.0 108.708 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.58 130.6 21.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.059 1.344 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 125.453 1.501 . . . . 0.0 109.911 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.98 162.32 15.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 111.643 175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.79 135.9 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.656 1.582 . . . . 0.0 109.968 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.62 -42.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.094 2.158 . . . . 0.0 113.451 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.29 -31.33 65.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.647 1.179 . . . . 0.0 112.92 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -87.61 -49.21 7.32 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.965 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 21.6 t -45.7 -41.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 120.114 1.325 . . . . 0.0 112.263 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -70.89 -8.28 51.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.113 1.765 . . . . 0.0 115.036 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -103.34 -31.44 10.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.762 2.425 . . . . 0.0 112.581 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.8 mt -50.56 -42.65 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.226 1.01 . . . . 0.0 110.296 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.39 -42.89 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -51.9 56.13 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.859 1.208 . . . . 0.0 111.058 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -33.64 76.33 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.17 -36.56 61.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.626 0.77 . . . . 0.0 112.976 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 55.1 mt -59.75 -59.43 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.291 0.95 . . . . 0.0 109.558 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.32 -31.72 70.56 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.0 t -58.57 -50.3 74.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.372 1.069 . . . . 0.0 112.16 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.15 72.16 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.72 -44.28 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.327 1.051 . . . . 0.0 110.867 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.17 75.08 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 -1.96 26.83 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -66.35 170.53 5.86 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 119.319 1.559 . . . . 0.0 112.025 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.57 -146.31 0.34 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.853 1.661 . . . . 0.0 112.09 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -70.03 97.76 1.21 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.022 2.129 . . . . 0.0 111.365 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.57 173.95 10.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.267 1.427 . . . . 0.0 112.8 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -85.77 -106.66 0.05 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.461 1.105 . . . . 0.0 110.557 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 30.0 m -66.1 -20.73 66.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -55.6 -38.75 69.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.054 0.942 . . . . 0.0 112.612 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -35.24 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.939 0.896 . . . . 0.0 113.304 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -69.08 -46.37 67.96 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.8 0.84 . . . . 0.0 111.992 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -65.68 -24.92 67.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.501 0.591 . . . . 0.0 112.496 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -78.14 -54.77 5.88 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.667 0.787 . . . . 0.0 111.656 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.9 t -56.05 -30.17 61.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.759 0.708 . . . . 0.0 112.617 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -78.78 -59.95 2.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.21 0.914 . . . . 0.0 112.627 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -57.2 -39.38 75.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.094 1.315 . . . . 0.0 113.594 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 91.4 t -67.8 -62.95 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 C-N-CA 123.895 0.878 . . . . 0.0 109.839 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.2 t -50.11 -29.81 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 110.76 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.55 -52.29 65.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.75 0.82 . . . . 0.0 111.839 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -91.62 -38.64 12.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.795 1.238 . . . . 0.0 112.694 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 42.1 m -62.74 -52.77 61.94 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.768 2.427 . . . . 0.0 112.532 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.75 86.74 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.54 0.686 . . . . 0.0 111.09 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 52.9 m -64.7 -31.42 72.63 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -77.08 -49.51 15.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.461 2.305 . . . . 0.0 112.652 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.65 -27.98 69.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.879 -1.138 . . . . 0.0 113.661 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -58.55 -32.48 68.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.833 0.853 . . . . 0.0 110.807 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -81.7 -31.46 32.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.01 -30.29 55.81 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.706 0.23 . . . . 0.0 110.964 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.83 -134.6 2.61 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.507 1.527 . . . . 0.0 111.682 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 153.18 49.86 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.535 1.134 . . . . 0.0 113.849 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 107.16 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.057 3.171 . . . . 0.0 111.687 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.1 171.08 17.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 111.759 175.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.2 98.16 1.32 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.799 1.24 . . . . 0.0 111.366 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -83.3 155.64 23.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.845 0.858 . . . . 0.0 110.671 163.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.1 tt -141.03 153.33 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.825 2.05 . . . . 0.0 108.759 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 23.4 m -141.42 154.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.284 1.034 . . . . 0.0 110.297 169.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 15.0 t -146.65 153.79 40.72 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.892 0.877 . . . . 0.0 109.827 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 22.7 p -148.45 160.49 43.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.157 0.983 . . . . 0.0 112.667 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.49 136.37 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 110.467 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 5.4 mm -119.15 120.41 63.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 127.791 2.436 . . . . 0.0 107.164 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 22.3 ttt -140.27 156.6 46.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.193 1.397 . . . . 0.0 111.171 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.99 140.71 52.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.715 1.206 . . . . 0.0 112.286 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -62.22 -7.88 4.85 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.203 1.801 . . . . 0.0 115.071 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.62 -16.95 43.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.396 2.278 . . . . 0.0 114.212 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 126.91 29.12 0.89 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.961 1.267 . . . . 0.0 115.127 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.88 72.52 0.25 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.311 1.444 . . . . 0.0 112.846 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.25 96.69 0.24 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.353 1.93 . . . . 0.0 114.983 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 pp -126.92 161.18 28.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 111.651 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.78 97.91 4.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.868 1.267 . . . . 0.0 108.591 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 38.8 m -110.17 132.29 54.3 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.262 0.625 . . . . 0.0 109.506 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -135.33 118.02 16.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.202 1.001 . . . . 0.0 110.276 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 24.2 p -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.987 0.899 . . . . 0.0 111.075 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 72.4 m -86.08 16.11 4.53 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.369 -0.832 . . . . 0.0 112.147 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 20.7 m -70.26 165.82 21.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.121 0.968 . . . . 0.0 112.055 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -155.81 150.77 26.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -76.49 130.95 38.69 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.26 141.86 37.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.172 0.989 . . . . 0.0 111.385 166.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 11.0 t -134.01 -50.0 0.82 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.647 1.579 . . . . 0.0 112.033 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 34.2 t -78.48 -34.26 47.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.778 0.831 . . . . 0.0 111.618 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -47.58 28.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.474 1.509 . . . . 0.0 113.065 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.32 -162.74 1.25 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.884 1.673 . . . . 0.0 111.825 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -102.19 112.14 4.24 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.823 1.678 . . . . 0.0 116.138 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 68.7 m -140.03 175.76 9.31 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.071 2.148 . . . . 0.0 111.971 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 40.3 t -160.04 127.02 4.44 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.066 2.147 . . . . 0.0 109.398 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.7 t -136.04 146.1 46.75 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 119.755 -1.841 . . . . 0.0 112.536 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.25 139.43 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.003 1.321 . . . . 0.0 110.289 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 117.73 19.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.988 1.315 . . . . 0.0 111.948 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -124.63 96.15 4.79 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.69 1.596 . . . . 0.0 109.566 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.21 169.38 4.57 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.53 -0.731 . . . . 0.0 112.456 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -142.39 -177.2 5.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 111.981 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -44.43 81.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.263 1.825 . . . . 0.0 112.802 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.4 t -133.93 -34.92 0.98 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.623 1.569 . . . . 0.0 113.469 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 18.6 ptp -86.6 177.39 7.39 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.956 -1.09 . . . . 0.0 112.71 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -151.43 157.89 42.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.01 1.324 . . . . 0.0 111.22 165.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 25.8 p -137.0 141.65 42.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.079 0.952 . . . . 0.0 111.621 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.07 134.18 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.059 1.343 . . . . 0.0 110.108 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.62 130.74 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 126.007 1.723 . . . . 0.0 110.211 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 45.7 p -124.63 144.97 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.497 0.719 . . . . 0.0 111.181 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -128.41 137.55 51.91 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.865 2.066 . . . . 0.0 110.733 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -135.71 163.51 30.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.985 1.714 . . . . 0.0 108.834 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 153.65 86.54 0.06 OUTLIER Glycine 0 N--CA 1.464 0.504 0 O-C-N 121.382 -0.824 . . . . 0.0 111.183 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.65 156.67 36.32 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.968 0.907 . . . . 0.0 110.231 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 121.825 0.822 . . . . 0.0 111.248 -172.115 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -131.01 179.87 5.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.858 1.263 . . . . 0.0 111.524 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.28 134.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.044 1.338 . . . . 0.0 110.838 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 74.0 m -116.24 90.62 3.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.916 1.686 . . . . 0.0 110.091 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -91.16 148.72 22.17 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.615 0.722 . . . . 0.0 111.371 170.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.34 112.8 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 127.222 2.209 . . . . 0.0 109.932 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.12 130.6 18.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.976 1.31 . . . . 0.0 111.655 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 125.495 1.518 . . . . 0.0 109.91 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.726 0.774 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -110.3 168.18 9.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.355 1.462 . . . . 0.0 110.475 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.83 159.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.754 0.788 . . . . 0.0 111.146 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.03 -34.73 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.763 2.025 . . . . 0.0 111.702 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -59.69 -28.6 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.922 0.889 . . . . 0.0 113.099 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -82.27 -54.19 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.687 0.795 . . . . 0.0 110.706 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -49.97 -42.37 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.088 1.355 . . . . 0.0 112.422 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 t -59.58 -19.44 48.78 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.006 1.723 . . . . 0.0 113.747 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -97.48 -43.21 7.36 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.877 1.671 . . . . 0.0 112.111 172.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.0 mt -50.41 -41.97 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.02 -44.63 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.82 58.92 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.22 1.373 . . . . 0.0 111.518 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -34.56 76.2 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.35 -43.51 66.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.681 0.792 . . . . 0.0 112.972 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.61 -58.92 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 118.983 0.811 . . . . 0.0 109.773 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.53 -31.67 72.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.6 t -61.01 -48.15 83.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.998 0.919 . . . . 0.0 112.035 169.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.38 76.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.586 1.155 . . . . 0.0 114.002 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.39 -49.96 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 0.0 110.532 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.7 11.61 59.01 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.271 0.938 . . . . 0.0 115.289 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.66 -3.99 23.04 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.32 169.76 8.34 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 119.254 1.527 . . . . 0.0 111.8 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 -148.77 0.36 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.377 1.471 . . . . 0.0 111.676 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -60.5 131.33 50.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.178 1.791 . . . . 0.0 110.918 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.01 -177.31 3.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.293 1.437 . . . . 0.0 112.235 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -98.04 -96.6 0.22 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.913 1.285 . . . . 0.0 110.078 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -73.85 -22.62 59.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.965 1.306 . . . . 0.0 113.91 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.54 -44.03 84.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.207 -0.933 . . . . 0.0 112.393 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.57 -36.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.895 0.878 . . . . 0.0 113.009 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -61.12 -53.97 50.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.53 1.132 . . . . 0.0 111.176 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.68 -54.93 5.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 112.224 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -58.7 -22.72 58.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -85.53 -57.64 2.98 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.269 0.941 . . . . 0.0 112.25 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -59.75 -40.89 89.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.09 1.314 . . . . 0.0 113.752 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.62 -62.91 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 C-N-CA 124.075 0.95 . . . . 0.0 109.86 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -49.92 -28.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.682 1.193 . . . . 0.0 110.952 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -57.72 11.02 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.796 0.725 . . . . 0.0 111.858 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -86.28 -36.64 19.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.169 0.988 . . . . 0.0 113.217 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 m -60.91 -51.82 67.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.777 2.031 . . . . 0.0 112.172 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tp -61.48 -32.25 72.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.354 0.662 . . . . 0.0 112.287 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 t -61.98 -58.51 7.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.549 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.88 -49.55 49.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -62.64 -44.44 96.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 119.028 -0.511 . . . . 0.0 109.768 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -64.88 -25.16 67.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.307 0.958 . . . . 0.0 113.356 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.21 -2.88 14.52 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 171.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.27 -98.7 0.18 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 124.865 1.221 . . . . 0.0 114.64 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -67.83 168.88 11.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 125.431 1.492 . . . . 0.0 114.392 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.11 167.74 21.02 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.541 2.161 . . . . 0.0 112.668 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -55.49 97.55 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.357 2.263 . . . . 0.0 114.45 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 96.06 0.65 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.921 2.088 . . . . 0.0 111.212 174.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.37 150.32 28.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.183 1.393 . . . . 0.0 110.012 170.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.42 146.61 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 171.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.98 148.18 25.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.644 1.578 . . . . 0.0 110.392 165.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -135.74 155.96 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.671 1.188 . . . . 0.0 109.791 166.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.0 t -151.41 144.41 24.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.247 1.419 . . . . 0.0 110.834 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.85 140.54 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.067 1.347 . . . . 0.0 109.876 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 mm -126.34 110.87 24.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 127.334 2.253 . . . . 0.0 108.374 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.14 168.71 18.35 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.023 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -110.99 124.81 52.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.312 1.445 . . . . 0.0 111.261 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -84.26 -0.71 53.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.981 1.712 . . . . 0.0 114.033 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.38 -19.7 64.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.102 1.761 . . . . 0.0 114.166 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.09 34.75 0.36 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.306 1.432 . . . . 0.0 114.617 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.11 173.14 3.96 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 118.905 1.353 . . . . 0.0 112.794 171.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.2 103.98 0.33 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.186 1.374 . . . . 0.0 113.195 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 164.09 31.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.821 1.248 . . . . 0.0 113.609 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -127.53 131.66 50.04 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.308 1.043 . . . . 0.0 110.395 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.9 m -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.957 1.303 . . . . 0.0 109.039 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.09 121.27 12.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.436 1.094 . . . . 0.0 110.787 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.2 p -129.69 131.04 46.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.347 0.594 . . . . 0.0 111.447 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -90.67 18.34 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.268 -0.895 . . . . 0.0 111.978 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.8 m -61.2 162.93 6.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.286 1.435 . . . . 0.0 112.408 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -158.23 134.36 9.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.228 1.011 . . . . 0.0 111.602 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.72 148.0 30.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 110.913 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -134.68 149.57 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.841 1.656 . . . . 0.0 110.644 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.8 t -97.3 -66.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.831 1.252 . . . . 0.0 112.304 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 t -91.24 -26.47 18.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.974 . . . . 0.0 112.535 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -30.76 52.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.905 1.682 . . . . 0.0 113.091 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 -167.02 1.05 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.961 2.104 . . . . 0.0 111.135 -172.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.87 146.15 15.28 Favored Glycine 0 CA--C 1.539 1.571 0 O-C-N 120.909 -1.119 . . . . 0.0 114.641 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 134.99 13.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.193 1.397 . . . . 0.0 111.784 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 24.0 t -127.99 97.26 4.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.661 1.184 . . . . 0.0 113.077 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -88.14 150.02 23.58 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.028 -1.045 . . . . 0.0 112.715 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.27 138.68 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.332 1.853 . . . . 0.0 109.407 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -125.23 119.48 28.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.709 1.604 . . . . 0.0 111.956 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -128.52 102.54 6.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 110.127 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -77.52 151.3 34.62 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.177 -0.952 . . . . 0.0 112.039 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.15 -178.42 3.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.32 1.448 . . . . 0.0 109.952 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -60.46 -45.02 95.23 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -129.92 -21.12 3.06 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.818 1.647 . . . . 0.0 113.919 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.9 mtt -100.84 173.12 6.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 170.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -147.84 147.43 29.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.083 1.353 . . . . 0.0 109.936 167.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 9.0 p -133.35 134.01 43.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.894 1.277 . . . . 0.0 110.641 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.97 110.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.041 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.36 138.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 110.8 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.5 p -134.16 114.74 13.43 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.282 -0.886 . . . . 0.0 112.576 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.08 136.12 40.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.84 1.256 . . . . 0.0 112.043 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -134.34 112.86 11.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.426 1.491 . . . . 0.0 111.183 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -103.07 61.94 0.46 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.743 -1.223 . . . . 0.0 113.878 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -52.43 109.5 0.4 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 113.298 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 127.098 2.159 . . . . 0.0 111.934 -171.316 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 120.331 0.11 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -128.89 168.73 15.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.912 1.285 . . . . 0.0 111.375 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -62.5 135.78 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.317 1.447 . . . . 0.0 110.842 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.3 m -106.37 88.95 2.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.864 1.666 . . . . 0.0 110.147 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -89.96 149.83 22.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.154 172.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.27 104.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.988 2.115 . . . . 0.0 109.356 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.8 119.96 18.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 110.826 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 125.429 1.491 . . . . 0.0 108.851 174.442 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 121.416 0.627 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -105.27 173.63 6.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.841 1.256 . . . . 0.0 111.195 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.32 161.44 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.585 1.154 . . . . 0.0 111.584 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.03 -40.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.513 1.125 . . . . 0.0 112.126 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.76 -25.15 67.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.592 1.157 . . . . 0.0 113.018 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -79.46 -58.29 3.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 110.986 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 85.9 t -52.38 -40.94 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.915 1.286 . . . . 0.0 112.607 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 19.5 t -58.94 -18.62 35.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.572 1.549 . . . . 0.0 113.408 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.3 -43.86 6.44 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.135 1.374 . . . . 0.0 112.031 171.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 38.7 mt -50.58 -42.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.201 1.0 . . . . 0.0 111.262 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.26 -43.54 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.487 -0.758 . . . . 0.0 112.887 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -51.76 53.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.943 1.247 . . . . 0.0 111.399 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.23 75.57 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.28 -43.43 64.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.801 0.84 . . . . 0.0 113.037 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.38 -58.76 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 119.124 0.874 . . . . 0.0 109.702 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -62.45 -31.74 72.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 37.5 t -60.9 -48.18 83.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.988 0.915 . . . . 0.0 112.108 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.19 76.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.29 -49.9 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.512 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 92.73 11.55 59.03 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.235 0.922 . . . . 0.0 115.266 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.5 -4.0 23.29 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -67.12 169.61 8.24 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.299 1.549 . . . . 0.0 111.862 170.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.13 -148.49 0.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.362 1.465 . . . . 0.0 111.615 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.44 132.31 53.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.155 1.782 . . . . 0.0 110.999 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -177.34 4.1 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.288 1.435 . . . . 0.0 112.157 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -98.06 -96.71 0.22 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 0.0 110.143 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.2 m -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.014 1.326 . . . . 0.0 113.929 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.9 -44.0 86.49 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.09 -1.006 . . . . 0.0 112.377 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.77 -36.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.943 0.897 . . . . 0.0 112.988 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.75 -54.44 45.16 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.626 1.17 . . . . 0.0 111.075 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -64.33 -22.83 67.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 113.049 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.35 -54.9 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.188 0.903 . . . . 0.0 112.301 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.3 t -58.86 -21.04 56.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.2 t -87.02 -58.75 2.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.212 0.915 . . . . 0.0 112.332 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -58.88 -40.7 85.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.142 1.337 . . . . 0.0 113.793 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.52 -63.27 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 124.182 0.993 . . . . 0.0 109.817 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 77.1 t -48.6 -29.74 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.234 1.413 . . . . 0.0 111.167 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -55.45 33.5 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.628 0.771 . . . . 0.0 111.711 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -88.87 -35.08 16.75 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.369 1.068 . . . . 0.0 113.367 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.2 m -63.43 -52.62 60.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.0 2.12 . . . . 0.0 112.605 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -32.57 73.92 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.609 0.364 . . . . 0.0 111.023 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t -60.52 -57.81 11.14 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.387 -0.821 . . . . 0.0 111.469 165.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -50.37 -49.14 55.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.711 1.604 . . . . 0.0 113.433 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.74 -27.87 64.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 1.5 m -60.89 -44.96 96.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 163.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -64.58 -25.76 68.11 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.227 0.921 . . . . 0.0 113.415 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.16 -4.6 18.14 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.99 -101.89 0.26 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 119.984 1.265 . . . . 0.0 114.658 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.28 167.81 11.45 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.82 1.648 . . . . 0.0 114.008 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.08 166.03 24.42 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.178 1.919 . . . . 0.0 112.236 168.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -50.97 115.87 1.73 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.964 1.705 . . . . 0.0 112.269 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 171.08 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 130.222 3.409 . . . . 0.0 111.193 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -145.6 171.06 15.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.572 1.949 . . . . 0.0 109.743 167.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.77 151.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.0 143.18 27.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.339 1.456 . . . . 0.0 109.092 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 155.04 51.34 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.876 0.87 . . . . 0.0 110.144 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.11 148.67 28.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.183 1.393 . . . . 0.0 111.288 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.75 141.06 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 110.445 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.2 mm -126.65 110.38 23.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 127.847 2.459 . . . . 0.0 108.171 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 167.51 20.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.919 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -111.55 126.96 55.54 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.253 1.421 . . . . 0.0 111.214 -168.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -85.69 0.35 52.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.913 1.685 . . . . 0.0 113.956 -168.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.1 -19.92 64.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.073 1.749 . . . . 0.0 114.152 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 37.41 0.39 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.329 1.442 . . . . 0.0 114.375 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.12 172.68 6.46 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 118.758 1.279 . . . . 0.0 112.285 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -142.27 78.88 0.27 Allowed Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.553 1.073 . . . . 0.0 114.396 -173.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.36 156.03 28.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 111.393 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.32 134.3 52.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 110.892 173.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 99.6 m -138.54 143.85 39.65 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 109.063 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.28 13.75 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.594 1.157 . . . . 0.0 110.84 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.4 p -128.46 136.59 51.04 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.813 -0.555 . . . . 0.0 111.761 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.5 m -94.22 18.79 10.29 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.662 -0.648 . . . . 0.0 111.776 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.3 m -61.68 162.59 8.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.065 1.346 . . . . 0.0 112.347 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -158.63 134.93 9.25 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.514 1.126 . . . . 0.0 111.466 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 147.16 27.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.167 0.987 . . . . 0.0 110.791 171.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -131.87 144.58 50.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.127 1.771 . . . . 0.0 110.14 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.0 t -89.45 -68.19 0.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 112.238 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 6.9 t -92.74 -25.49 18.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.265 1.026 . . . . 0.0 112.533 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -29.34 55.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.933 1.693 . . . . 0.0 112.911 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -164.38 0.9 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.04 1.736 . . . . 0.0 111.644 -171.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -151.19 144.51 11.82 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.935 -1.103 . . . . 0.0 114.455 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.45 151.28 33.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.734 1.614 . . . . 0.0 110.633 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 12.4 t -142.43 104.54 4.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.507 1.123 . . . . 0.0 112.565 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.3 t -97.36 147.58 24.03 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.43 1.092 . . . . 0.0 112.418 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.13 136.28 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.862 1.665 . . . . 0.0 109.626 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -125.1 119.06 27.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.491 1.516 . . . . 0.0 111.829 -173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -128.07 102.51 6.76 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.329 1.452 . . . . 0.0 109.956 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.59 151.0 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.15 -0.969 . . . . 0.0 111.881 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.82 -178.24 3.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.301 1.44 . . . . 0.0 109.937 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.62 -44.77 95.96 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -129.89 -21.61 3.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.744 1.617 . . . . 0.0 113.894 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.8 mtt -100.64 173.33 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.995 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -147.6 148.07 30.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.037 1.335 . . . . 0.0 110.002 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 9.8 p -132.73 135.41 45.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.821 1.248 . . . . 0.0 111.014 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.85 111.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.97 1.308 . . . . 0.0 111.172 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.7 143.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.046 1.339 . . . . 0.0 111.161 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 66.8 p -139.02 110.66 7.09 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.16 139.94 30.15 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.519 1.128 . . . . 0.0 113.05 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -137.29 102.65 4.87 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.769 1.627 . . . . 0.0 110.204 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -95.12 61.13 1.59 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 113.507 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.02 109.47 0.26 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 0.0 113.528 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 126.509 1.924 . . . . 0.0 112.419 -171.3 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.3 0.095 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -128.85 169.9 14.03 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.965 1.306 . . . . 0.0 111.313 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.73 138.45 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.173 1.389 . . . . 0.0 110.944 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 66.7 m -109.59 86.0 2.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.874 1.669 . . . . 0.0 109.853 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.96 150.94 23.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.603 0.761 . . . . 0.0 111.133 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 2.3 p -149.94 105.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.364 1.866 . . . . 0.0 109.934 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.47 121.73 21.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.383 . . . . 0.0 110.687 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 125.236 1.415 . . . . 0.0 108.727 174.443 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 121.436 0.636 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.27 171.82 2.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.782 1.633 . . . . 0.0 113.434 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.09 147.06 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.446 1.098 . . . . 0.0 112.173 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.24 -40.48 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.087 1.355 . . . . 0.0 112.075 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.1 -33.4 69.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.623 1.569 . . . . 0.0 112.631 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -77.2 -52.23 9.6 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.905 1.282 . . . . 0.0 111.177 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 t -48.51 -42.34 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.485 1.114 . . . . 0.0 112.222 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -56.98 -24.75 55.65 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.194 1.398 . . . . 0.0 113.603 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.97 -35.58 11.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.329 1.452 . . . . 0.0 113.292 172.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.89 -43.1 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 119.615 1.098 . . . . 0.0 110.445 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.29 -43.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -52.58 45.95 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.864 1.211 . . . . 0.0 111.45 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -30.71 70.57 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.45 -43.84 31.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.6 mt -55.78 -56.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.564 1.075 . . . . 0.0 109.88 175.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -59.61 -28.25 67.02 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -67.37 -35.47 79.42 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.12 -29.89 43.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.972 1.309 . . . . 0.0 113.147 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.69 -37.03 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.58 1.152 . . . . 0.0 111.458 172.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.81 11.45 84.61 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.103 0.858 . . . . 0.0 114.832 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.06 -0.97 35.46 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.575 1.56 . . . . 0.0 116.382 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.85 168.82 4.68 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.128 1.464 . . . . 0.0 112.931 167.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.61 -154.55 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.771 1.628 . . . . 0.0 111.901 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.1 160.03 0.39 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.337 1.455 . . . . 0.0 112.992 163.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -151.1 175.07 12.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.342 1.057 . . . . 0.0 113.295 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -97.37 -101.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.541 1.537 . . . . 0.0 110.02 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -67.99 -22.09 65.02 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -58.82 -43.75 90.72 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.97 -1.081 . . . . 0.0 112.99 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.63 -38.57 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.209 1.003 . . . . 0.0 112.782 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -63.13 -54.72 33.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.932 1.293 . . . . 0.0 111.696 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.75 -26.23 68.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.254 -0.904 . . . . 0.0 112.634 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -75.48 -53.89 7.92 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.112 0.965 . . . . 0.0 111.182 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -59.2 -22.23 60.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -86.55 -56.74 3.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.681 1.128 . . . . 0.0 112.457 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -58.22 -37.11 74.21 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.786 1.234 . . . . 0.0 113.676 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.3 t -69.49 -64.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 123.897 0.879 . . . . 0.0 109.559 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.01 -31.68 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.866 1.266 . . . . 0.0 111.103 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -43.56 90.6 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.635 0.652 . . . . 0.0 112.602 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -96.81 -44.26 7.15 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.985 1.314 . . . . 0.0 112.391 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.2 m -55.82 -51.88 65.95 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.522 2.329 . . . . 0.0 112.871 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.23 -38.98 88.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.166 0.439 . . . . 0.0 110.94 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 p -64.43 -30.67 71.7 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.22 -0.925 . . . . 0.0 113.334 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.03 -48.61 20.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.194 2.198 . . . . 0.0 113.075 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.63 -27.8 69.18 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.728 -1.232 . . . . 0.0 114.135 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.7 m -58.16 -34.73 70.63 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.444 1.098 . . . . 0.0 110.925 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -78.94 -36.31 41.9 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.773 -0.579 . . . . 0.0 112.262 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.75 -24.56 66.23 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -105.39 2.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 113.257 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -138.28 152.58 71.79 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.577 1.551 . . . . 0.0 112.12 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.88 111.31 3.0 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.611 2.874 . . . . 0.0 111.375 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.12 179.86 7.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.331 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -93.57 95.37 9.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.472 1.509 . . . . 0.0 111.678 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -83.71 151.6 25.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.887 1.675 . . . . 0.0 109.933 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.3 tp -125.67 149.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.709 1.604 . . . . 0.0 108.667 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.9 146.29 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.529 0.732 . . . . 0.0 111.285 164.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.86 117.71 13.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.397 2.279 . . . . 0.0 109.732 174.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.3 p -123.79 136.6 54.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.404 0.682 . . . . 0.0 112.448 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.56 109.3 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.347 1.459 . . . . 0.0 109.29 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 mm -103.15 111.13 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.68 105.4 3.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.895 1.278 . . . . 0.0 109.905 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.09 10.64 1.74 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -69.83 -77.66 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.922 1.289 . . . . 0.0 112.998 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.63 -20.8 5.86 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.85 7.24 5.19 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.641 -1.089 . . . . 0.0 115.708 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.9 93.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.509 1.924 . . . . 0.0 114.812 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.39 78.1 1.0 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.694 1.616 . . . . 0.0 113.429 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 pp -54.48 150.92 8.41 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.629 1.572 . . . . 0.0 112.475 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -123.06 83.31 2.11 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.487 1.515 . . . . 0.0 109.363 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.5 m -97.17 139.09 33.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.673 -0.642 . . . . 0.0 109.465 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.54 128.03 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 110.422 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -127.76 117.41 21.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.921 0.889 . . . . 0.0 109.622 -170.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -79.9 41.56 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.425 1.107 . . . . 0.0 111.177 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.76 179.6 7.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.98 1.312 . . . . 0.0 110.577 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -145.55 154.05 41.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.724 1.609 . . . . 0.0 109.621 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -97.45 132.48 43.11 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.006 0.922 . . . . 0.0 109.89 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -144.05 141.53 30.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.228 1.411 . . . . 0.0 110.435 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -114.17 -56.52 2.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.426 1.491 . . . . 0.0 111.718 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.96 -40.25 10.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.172 0.989 . . . . 0.0 112.097 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -32.39 73.18 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.644 2.378 . . . . 0.0 114.223 -169.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.22 -177.5 6.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.591 1.957 . . . . 0.0 110.85 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.09 116.93 3.86 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.969 1.747 . . . . 0.0 114.027 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 t -140.93 172.55 12.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.398 1.879 . . . . 0.0 110.505 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -168.14 140.34 2.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.543 1.537 . . . . 0.0 110.639 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -148.98 144.64 26.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.959 -1.713 . . . . 0.0 111.602 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -139.02 120.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.472 1.109 . . . . 0.0 109.489 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 93.83 4.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.297 1.039 . . . . 0.0 113.024 -171.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -99.43 105.73 17.7 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.96 1.304 . . . . 0.0 110.362 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -109.49 165.77 11.39 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.558 1.543 . . . . 0.0 110.71 169.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -139.13 179.78 6.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.67 1.188 . . . . 0.0 110.031 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -45.1 -40.28 6.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.921 1.688 . . . . 0.0 115.011 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.7 t -133.7 22.9 3.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.302 1.841 . . . . 0.0 113.083 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 mtt -135.79 158.76 43.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -148.99 116.56 6.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.114 1.765 . . . . 0.0 110.704 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.09 68.16 1.3 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.162 1.785 . . . . 0.0 111.481 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pp -97.18 153.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.635 -1.291 . . . . 0.0 113.175 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -132.84 116.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.805 2.042 . . . . 0.0 111.889 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.5 t -97.91 136.17 38.59 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.558 1.143 . . . . 0.0 110.084 171.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.3 166.59 22.78 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.901 1.68 . . . . 0.0 112.262 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.21 161.07 43.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.009 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.32 83.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -137.92 158.24 44.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.938 1.695 . . . . 0.0 112.682 -169.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 125.05 1.34 . . . . 0.0 112.505 -175.239 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 111.628 0.232 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -129.31 166.94 18.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.357 1.463 . . . . 0.0 111.447 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.4 149.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.768 1.627 . . . . 0.0 111.324 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.2 m -121.61 91.29 3.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 110.861 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -77.5 148.06 35.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.886 166.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.67 97.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 127.864 2.466 . . . . 0.0 109.089 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.93 151.92 48.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.283 1.033 . . . . 0.0 111.631 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 CA--C 1.546 0.798 0 C-N-CA 124.794 1.238 . . . . 0.0 111.457 -179.248 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 120.56 0.219 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.26 170.49 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.515 -0.741 . . . . 0.0 112.811 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.18 141.94 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.957 1.303 . . . . 0.0 112.006 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 16.1 t -59.27 -34.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.561 1.144 . . . . 0.0 111.604 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -60.63 -15.38 27.82 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.167 1.387 . . . . 0.0 113.671 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -109.3 -47.56 3.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 110.13 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 4.3 m -51.31 -32.4 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t -60.75 -20.99 62.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.433 1.493 . . . . 0.0 114.267 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -103.45 -31.8 9.81 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.166 1.786 . . . . 0.0 112.971 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 41.0 mt -49.81 -41.15 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.413 1.006 . . . . 0.0 110.689 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.85 -43.43 97.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -51.99 48.27 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.724 1.147 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -31.46 71.03 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.53 -42.6 42.52 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 56.8 mt -55.77 -55.99 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.533 1.06 . . . . 0.0 109.886 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -59.15 -29.18 67.23 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 6.5 p -66.63 -34.37 77.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.1 -29.79 34.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.347 . . . . 0.0 113.199 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.25 -37.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 111.276 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.51 84.13 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.121 0.867 . . . . 0.0 114.817 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.13 35.45 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.471 1.51 . . . . 0.0 116.319 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -63.68 168.49 4.81 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.152 1.476 . . . . 0.0 112.958 167.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -85.16 -155.04 0.2 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.7 1.6 . . . . 0.0 111.718 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.14 159.39 0.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 0.0 113.06 164.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -151.15 172.06 16.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.351 1.46 . . . . 0.0 112.24 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -93.44 -100.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.4 1.08 . . . . 0.0 109.44 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 70.6 m -65.57 -22.22 66.67 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -59.64 -42.37 92.61 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.757 -1.214 . . . . 0.0 112.764 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.19 -38.08 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.292 1.037 . . . . 0.0 112.762 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -62.27 -55.68 25.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.452 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -63.62 -26.45 68.69 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.484 -0.76 . . . . 0.0 112.654 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -75.3 -54.21 7.46 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.172 0.989 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.5 t -58.02 -25.07 60.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 13.8 t -84.43 -56.81 3.43 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.668 1.122 . . . . 0.0 112.201 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -57.7 -37.01 72.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.893 1.224 . . . . 0.0 113.684 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.24 -65.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.165 0.986 . . . . 0.0 109.622 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.08 -31.99 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.668 1.187 . . . . 0.0 111.154 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -43.1 90.4 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.478 0.581 . . . . 0.0 112.566 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -96.5 -44.37 7.2 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.02 1.328 . . . . 0.0 112.511 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -59.43 -48.68 80.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.113 2.565 . . . . 0.0 113.495 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -40.62 97.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.959 0.345 . . . . 0.0 110.396 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 1.4 p -62.05 -30.87 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 112.996 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -76.2 -48.31 20.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.017 2.127 . . . . 0.0 112.918 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.37 -30.42 71.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.937 1.244 . . . . 0.0 113.463 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 31.0 m -58.34 -30.59 66.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.218 1.007 . . . . 0.0 111.05 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -81.47 -36.04 29.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.7 mt -78.36 -19.49 53.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -95.52 -101.7 1.87 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.709 1.623 . . . . 0.0 112.445 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -141.38 151.34 60.89 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 113.012 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.76 110.52 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.832 3.022 . . . . 0.0 111.446 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.88 178.85 8.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 0.0 112.152 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -88.05 93.47 9.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.308 1.443 . . . . 0.0 111.538 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.73 139.41 30.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.235 1.414 . . . . 0.0 109.952 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 3.0 tt -119.76 153.58 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.11 1.764 . . . . 0.0 109.644 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 22.1 m -142.02 146.63 22.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.36 1.064 . . . . 0.0 110.718 170.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.16 119.92 17.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.064 2.146 . . . . 0.0 109.1 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.3 p -123.03 144.35 49.34 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.543 -0.723 . . . . 0.0 112.215 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 64.9 t -124.31 101.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.038 1.735 . . . . 0.0 108.254 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.32 113.63 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.918 0.887 . . . . 0.0 108.837 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.8 ptp -134.98 146.51 49.15 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.848 0.859 . . . . 0.0 110.529 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -90.14 143.86 26.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.348 -0.845 . . . . 0.0 110.9 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -70.0 4.06 2.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.363 1.465 . . . . 0.0 114.347 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -50.45 -35.23 27.86 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.498 1.519 . . . . 0.0 112.416 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.69 20.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.902 1.239 . . . . 0.0 115.334 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.27 61.09 1.15 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.2 1.4 . . . . 0.0 113.849 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -74.91 63.72 2.37 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.647 1.594 . . . . 0.0 112.959 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.04 159.26 11.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.097 1.759 . . . . 0.0 111.826 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -125.97 89.32 3.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 110.178 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 53.3 m -97.09 139.04 33.68 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.438 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.71 127.16 44.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.093 1.357 . . . . 0.0 110.122 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m -126.16 116.86 22.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.147 0.979 . . . . 0.0 109.605 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.9 t -80.04 44.61 0.67 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.504 1.145 . . . . 0.0 111.152 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 3.8 m -86.73 179.39 6.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.112 1.365 . . . . 0.0 110.507 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -147.03 148.13 31.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.45 1.5 . . . . 0.0 109.864 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -91.12 132.49 36.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -142.41 139.14 31.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 110.469 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 45.7 t -112.18 -58.64 2.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.465 1.506 . . . . 0.0 111.817 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.8 -38.68 12.22 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.172 0.989 . . . . 0.0 112.155 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -32.38 72.69 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.443 2.297 . . . . 0.0 114.088 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.77 -175.87 5.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.609 1.964 . . . . 0.0 110.803 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -113.62 123.59 6.19 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.563 1.554 . . . . 0.0 114.165 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 22.7 t -146.35 170.92 15.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.208 2.203 . . . . 0.0 110.575 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.2 p -168.78 126.07 1.01 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 0.0 111.896 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.7 t -141.47 141.84 33.64 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 119.597 -1.939 . . . . 0.0 112.575 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.61 123.46 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.652 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 99.02 6.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.308 1.043 . . . . 0.0 113.163 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.07 88.84 2.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.255 1.422 . . . . 0.0 110.884 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -83.48 163.69 20.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.829 0.852 . . . . 0.0 111.37 164.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -141.63 179.93 6.54 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -49.45 -41.23 39.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.451 1.5 . . . . 0.0 113.937 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 21.59 2.85 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 29.2 mtt -139.32 160.33 40.07 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.479 -1.388 . . . . 0.0 113.653 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -135.99 109.87 8.17 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.688 1.995 . . . . 0.0 110.956 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 70.9 m -130.6 78.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.355 1.462 . . . . 0.0 110.697 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.48 145.81 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.266 1.026 . . . . 0.0 112.339 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.55 129.58 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.199 1.8 . . . . 0.0 112.126 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.2 t -114.29 130.24 56.65 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.641 1.577 . . . . 0.0 109.606 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -128.42 151.98 48.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.037 1.735 . . . . 0.0 111.764 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -141.02 143.67 34.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.451 1.1 . . . . 0.0 110.94 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -168.47 82.15 0.1 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.257 0.932 . . . . 0.0 111.523 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.2 160.07 38.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.405 1.882 . . . . 0.0 112.121 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 124.852 1.261 . . . . 0.0 112.515 -175.723 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -129.62 166.68 19.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.347 1.459 . . . . 0.0 111.432 171.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.44 149.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 111.394 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 28.2 m -121.47 91.16 3.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.162 1.385 . . . . 0.0 110.876 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -78.36 149.33 33.42 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.904 -1.123 . . . . 0.0 110.862 166.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.7 97.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.742 2.417 . . . . 0.0 109.245 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -133.7 157.67 45.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.307 1.443 . . . . 0.0 110.87 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.308 1.043 . . . . 0.0 111.361 177.769 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 121.893 0.854 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -139.18 165.86 26.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.163 1.385 . . . . 0.0 110.117 173.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.62 152.31 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.278 1.031 . . . . 0.0 110.929 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -57.25 -41.17 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.727 1.211 . . . . 0.0 111.323 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.16 66.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -62.54 1.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.766 0.827 . . . . 0.0 110.263 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.6 t -45.44 -47.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.436 1.894 . . . . 0.0 112.565 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 t -65.87 -13.63 59.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.163 1.785 . . . . 0.0 113.745 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -31.86 11.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.945 1.698 . . . . 0.0 112.255 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.37 -42.33 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.509 0.724 . . . . 0.0 110.272 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.42 -42.12 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -52.24 54.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.175 1.352 . . . . 0.0 111.174 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -30.99 72.03 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.75 -38.7 58.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.432 1.093 . . . . 0.0 113.203 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mt -56.89 -56.99 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.166 0.894 . . . . 0.0 109.691 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -59.64 -27.89 66.75 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -47.74 78.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.092 0.957 . . . . 0.0 112.024 169.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.5 -27.16 63.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.775 1.23 . . . . 0.0 114.047 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.58 -35.41 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.564 1.146 . . . . 0.0 111.153 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.48 15.91 70.06 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.1 0.857 . . . . 0.0 114.299 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.9 2.44 78.29 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.087 1.327 . . . . 0.0 115.631 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -65.73 174.34 2.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.841 1.321 . . . . 0.0 112.243 168.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -155.01 0.21 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.119 1.368 . . . . 0.0 111.78 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -51.18 159.45 0.64 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.176 0.991 . . . . 0.0 112.28 158.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -151.6 177.39 10.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.38 1.472 . . . . 0.0 110.631 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -92.14 -114.22 0.09 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.32 1.048 . . . . 0.0 110.931 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -57.47 -22.41 43.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.383 1.873 . . . . 0.0 114.655 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -51.35 -38.97 55.97 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.376 1.471 . . . . 0.0 112.901 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.51 -32.42 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 112.915 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -68.24 -45.15 74.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.227 0.922 . . . . 0.0 112.168 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -22.86 65.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.75 0.704 . . . . 0.0 112.724 174.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.5 -55.1 5.29 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.716 0.806 . . . . 0.0 111.501 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -56.19 -28.99 60.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.916 0.78 . . . . 0.0 113.045 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -79.98 -57.57 3.58 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.338 0.972 . . . . 0.0 112.179 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -57.42 -38.21 73.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.94 1.245 . . . . 0.0 113.484 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.75 -65.55 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 123.874 0.869 . . . . 0.0 109.491 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.8 t -47.9 -32.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.355 1.062 . . . . 0.0 110.939 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -58.42 -40.54 82.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.8 -40.99 5.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.479 1.512 . . . . 0.0 112.681 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 m -57.68 -53.37 58.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.702 2.401 . . . . 0.0 112.404 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -40.52 92.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.798 0.727 . . . . 0.0 110.693 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -60.9 -40.92 94.91 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.663 -0.648 . . . . 0.0 112.72 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -66.07 -51.29 59.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.924 2.089 . . . . 0.0 113.382 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.02 -26.24 67.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -58.93 -32.72 69.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.13 0.972 . . . . 0.0 111.466 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -85.58 -23.99 27.38 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -67.79 -26.28 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.12 0.968 . . . . 0.0 112.3 170.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.74 -119.4 4.14 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.965 1.745 . . . . 0.0 112.535 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -129.73 156.29 79.08 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.445 1.498 . . . . 0.0 113.156 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.77 113.39 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.93 3.087 . . . . 0.0 112.212 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.11 166.12 31.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.517 1.127 . . . . 0.0 112.196 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -73.3 98.78 2.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.657 0.783 . . . . 0.0 110.956 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -73.34 158.02 35.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.828 0.851 . . . . 0.0 111.179 161.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 tt -132.44 151.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.337 1.455 . . . . 0.0 108.955 164.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.0 m -142.0 149.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.859 1.263 . . . . 0.0 110.309 169.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 p -135.8 139.37 43.45 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.654 1.582 . . . . 0.0 109.903 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -136.1 150.32 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.648 -0.657 . . . . 0.0 112.056 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.87 104.64 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.888 1.675 . . . . 0.0 108.661 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mm -101.2 120.63 51.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.811 1.644 . . . . 0.0 108.926 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.81 166.17 26.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.883 0.849 . . . . 0.0 112.211 174.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -85.96 157.07 20.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.734 1.614 . . . . 0.0 111.245 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.33 11.07 1.04 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.604 1.962 . . . . 0.0 114.954 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -5.48 5.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 114.942 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.81 -3.38 45.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.965 1.745 . . . . 0.0 114.711 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.47 87.53 0.88 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.233 1.413 . . . . 0.0 111.652 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.31 89.3 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.002 1.763 . . . . 0.0 111.031 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.58 160.16 20.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.738 1.215 . . . . 0.0 111.658 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -87.94 96.85 10.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.444 -0.785 . . . . 0.0 109.99 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -117.14 132.16 56.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.783 0.833 . . . . 0.0 109.862 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.57 32.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.323 0.649 . . . . 0.0 111.74 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.9 m -134.09 121.35 21.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.723 1.209 . . . . 0.0 110.569 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -74.35 17.62 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.071 -1.018 . . . . 0.0 113.02 175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.4 m -62.8 167.94 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.833 -1.167 . . . . 0.0 112.22 167.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.18 154.79 21.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.667 1.587 . . . . 0.0 110.636 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -84.22 150.54 25.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.585 1.154 . . . . 0.0 110.241 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -146.93 164.62 32.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.589 1.956 . . . . 0.0 110.303 171.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -128.87 -56.28 1.2 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.498 1.119 . . . . 0.0 113.216 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -78.32 -46.98 18.75 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.389 1.076 . . . . 0.0 112.197 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -48.34 61.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.571 1.949 . . . . 0.0 112.525 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -149.29 -159.71 1.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.411 3.084 . . . . 0.0 108.79 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.56 -173.7 18.02 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.975 1.274 . . . . 0.0 112.923 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.6 p -155.27 173.45 16.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.359 2.263 . . . . 0.0 109.635 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 36.1 t -147.0 122.01 10.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.171 -0.956 . . . . 0.0 109.658 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 t -133.18 149.27 52.05 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.663 -1.273 . . . . 0.0 112.204 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.7 116.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.655 1.582 . . . . 0.0 108.266 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -113.77 95.21 5.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.905 1.282 . . . . 0.0 110.285 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -104.57 118.42 36.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.527 1.131 . . . . 0.0 110.208 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -104.42 162.93 12.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.818 1.647 . . . . 0.0 111.302 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -151.29 -177.41 6.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.209 1.004 . . . . 0.0 111.506 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.73 -67.57 0.2 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.827 2.451 . . . . 0.0 113.847 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.5 t -133.97 24.72 3.93 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.184 1.394 . . . . 0.0 113.306 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.54 162.83 34.12 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.163 -1.586 . . . . 0.0 111.218 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -140.02 137.22 34.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.73 1.212 . . . . 0.0 110.34 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 11.2 p -139.97 85.88 2.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.874 1.321 . . . . 0.0 111.845 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.09 133.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.024 1.329 . . . . 0.0 111.104 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.81 126.44 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.605 1.562 . . . . 0.0 110.867 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 t -117.13 127.9 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.481 1.912 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.73 149.12 43.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.061 1.744 . . . . 0.0 112.582 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -142.2 94.0 2.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.358 1.463 . . . . 0.0 108.663 174.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.01 95.06 0.16 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 120.571 -1.331 . . . . 0.0 110.743 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.68 75.27 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.468 1.907 . . . . 0.0 112.142 -174.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.47 0.571 0 O-C-N 121.466 -0.771 . . . . 0.0 112.075 -178.472 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.41 148.9 49.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.054 1.741 . . . . 0.0 112.308 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -60.21 150.71 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.47 1.908 . . . . 0.0 111.471 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 m -115.95 89.59 3.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.229 1.412 . . . . 0.0 110.886 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -98.57 146.45 25.8 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.022 -1.049 . . . . 0.0 111.139 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.52 94.08 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 128.032 2.533 . . . . 0.0 108.006 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.17 162.54 35.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.935 1.294 . . . . 0.0 111.559 176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 124.968 1.307 . . . . 0.0 108.392 174.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 121.987 0.899 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -139.76 166.62 24.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.286 1.435 . . . . 0.0 110.028 173.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.68 152.45 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.263 1.025 . . . . 0.0 110.992 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.15 -41.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.79 1.236 . . . . 0.0 111.347 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 113.564 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.65 -62.68 1.5 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.788 0.835 . . . . 0.0 110.172 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 96.1 t -45.15 -47.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 126.462 1.905 . . . . 0.0 112.607 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t -65.7 -13.8 59.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.111 1.764 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.16 -31.94 11.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.98 1.712 . . . . 0.0 112.203 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 8.6 mt -55.64 -42.18 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.449 0.7 . . . . 0.0 110.26 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.54 -41.71 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.35 53.36 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.145 1.339 . . . . 0.0 111.172 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -30.86 71.91 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.82 -38.88 57.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.421 1.088 . . . . 0.0 113.177 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.78 -56.97 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.222 0.919 . . . . 0.0 109.663 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.57 -27.97 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -47.67 78.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.157 0.983 . . . . 0.0 111.968 170.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.57 -27.41 64.11 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 114.086 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 58.5 mt -61.5 -35.33 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.609 1.164 . . . . 0.0 111.141 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 82.91 16.18 70.75 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.136 0.874 . . . . 0.0 114.259 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.74 2.32 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.128 1.347 . . . . 0.0 115.58 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -65.16 170.99 4.01 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 118.766 1.283 . . . . 0.0 112.33 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.0 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.26 1.424 . . . . 0.0 112.293 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -53.06 154.18 3.12 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.453 -0.78 . . . . 0.0 111.632 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -145.17 171.02 15.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.142 1.377 . . . . 0.0 110.737 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -84.77 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.213 1.005 . . . . 0.0 110.755 175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 15.6 m -59.73 -20.5 56.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.499 1.52 . . . . 0.0 114.727 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.73 -38.42 55.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.501 1.52 . . . . 0.0 112.888 175.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -55.91 -30.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.73 -45.25 71.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.855 0.862 . . . . 0.0 111.693 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -24.08 65.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -78.19 -54.41 6.26 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.734 0.814 . . . . 0.0 111.54 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.9 t -57.02 -27.53 61.69 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.1 t -81.32 -58.22 3.14 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.434 1.015 . . . . 0.0 112.429 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -56.48 -38.21 71.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.988 1.267 . . . . 0.0 113.584 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.68 -65.72 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 123.822 0.849 . . . . 0.0 109.489 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.9 t -47.74 -32.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 110.968 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -58.55 -40.52 83.25 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -104.92 -40.95 5.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.494 1.518 . . . . 0.0 112.616 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 39.3 m -57.47 -53.67 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.705 2.402 . . . . 0.0 112.438 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -40.9 93.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.749 0.704 . . . . 0.0 110.568 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -60.66 -39.6 88.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -67.42 -51.21 54.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.894 2.078 . . . . 0.0 113.396 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.27 -26.06 67.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.4 m -58.68 -32.54 69.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.094 0.958 . . . . 0.0 111.522 165.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -86.21 -23.89 26.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.78 -26.73 66.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.987 0.915 . . . . 0.0 112.194 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -97.56 -121.49 4.25 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.098 1.809 . . . . 0.0 112.562 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -128.0 156.34 76.34 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 125.448 1.499 . . . . 0.0 113.172 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.29 112.5 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.005 3.137 . . . . 0.0 112.21 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.15 166.0 32.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.564 1.146 . . . . 0.0 112.314 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -72.6 100.47 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.714 0.806 . . . . 0.0 110.998 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -75.31 157.26 34.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 111.053 160.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 tt -132.26 151.42 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.576 1.55 . . . . 0.0 108.95 164.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 19.3 m -142.74 149.75 18.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.882 1.273 . . . . 0.0 110.344 170.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 6.7 p -136.89 140.97 42.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.532 1.533 . . . . 0.0 110.145 170.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.8 p -138.48 155.34 48.53 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.617 -0.677 . . . . 0.0 112.176 169.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.96 114.66 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.76 1.624 . . . . 0.0 108.493 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.7 mm -106.93 116.56 50.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 125.863 1.665 . . . . 0.0 108.727 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' MET . . . . . 0.47 ' HE1' ' H ' ' B' ' 219' ' ' GLY . 1.1 tmt? -134.86 119.57 18.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.401 1.48 . . . . 0.0 110.64 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 81.71 0.88 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.278 1.831 . . . . 0.0 111.0 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.11 -74.38 0.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.073 1.349 . . . . 0.0 110.968 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -19.55 2.12 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . 0.47 ' H ' ' HE1' ' B' ' 215' ' ' MET . . . 127.94 -2.48 6.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.058 1.79 . . . . 0.0 115.98 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.99 101.17 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.527 1.531 . . . . 0.0 114.173 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.06 102.18 1.54 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.574 1.083 . . . . 0.0 112.218 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.17 151.81 0.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.363 1.465 . . . . 0.0 113.297 166.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.35 93.27 9.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.334 -0.853 . . . . 0.0 109.462 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 50.3 m -116.01 132.79 56.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.243 0.617 . . . . 0.0 110.428 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.56 129.11 38.6 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.218 0.607 . . . . 0.0 111.321 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -131.56 120.57 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.779 1.232 . . . . 0.0 110.211 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 5.0 t -74.02 16.58 0.22 Allowed 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.194 -0.942 . . . . 0.0 113.045 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.6 m -62.44 167.49 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.88 -1.138 . . . . 0.0 112.26 167.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.22 154.27 21.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.739 1.616 . . . . 0.0 110.523 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -81.38 151.42 27.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.251 1.021 . . . . 0.0 110.122 168.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -145.93 163.2 35.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.619 1.968 . . . . 0.0 109.979 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 14.6 t -126.07 -58.82 1.36 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.447 1.099 . . . . 0.0 112.864 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 17.3 p -79.0 -46.59 17.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.384 1.073 . . . . 0.0 112.333 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -48.41 66.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.434 1.893 . . . . 0.0 112.324 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -150.35 -159.13 0.99 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 129.327 3.051 . . . . 0.0 108.718 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.62 -174.03 18.38 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.951 1.263 . . . . 0.0 113.286 169.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 94.9 p -155.1 173.69 16.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.392 2.277 . . . . 0.0 109.634 170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.18 123.73 11.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 166.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 12.8 t -134.01 149.16 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.528 -1.358 . . . . 0.0 112.118 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.65 114.25 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.453 1.501 . . . . 0.0 108.066 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -111.34 96.97 6.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.9 1.28 . . . . 0.0 109.851 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -107.87 124.78 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 109.931 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 168.78 9.85 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 110.643 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -148.11 -158.04 0.87 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.992 0.917 . . . . 0.0 110.807 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.73 -65.97 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.267 2.227 . . . . 0.0 113.649 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 t -139.39 1.62 1.98 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.9 ptp -98.17 154.37 17.81 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.598 -1.314 . . . . 0.0 112.279 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.9 120.01 25.42 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.867 1.667 . . . . 0.0 108.979 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 20.3 p -126.98 79.01 1.85 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.801 1.286 . . . . 0.0 111.139 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.09 136.13 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.005 1.322 . . . . 0.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.05 126.55 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.547 1.539 . . . . 0.0 110.944 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 32.0 t -113.82 132.15 55.98 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.44 1.896 . . . . 0.0 110.407 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -125.38 149.2 48.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.089 1.756 . . . . 0.0 112.555 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -142.67 98.18 3.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.607 1.563 . . . . 0.0 108.346 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -155.24 94.15 0.14 Allowed Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.655 -1.278 . . . . 0.0 110.64 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.37 76.66 1.37 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.504 1.921 . . . . 0.0 112.256 -173.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.471 0.584 0 O-C-N 121.519 -0.738 . . . . 0.0 112.115 -177.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.28 148.76 49.64 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.987 1.715 . . . . 0.0 112.276 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.91 150.58 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.585 1.954 . . . . 0.0 111.438 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.8 m -116.6 88.55 2.92 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.256 1.422 . . . . 0.0 110.787 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -99.1 147.63 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.3 p -138.26 98.16 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 127.3 2.24 . . . . 0.0 108.794 175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.84 159.52 42.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.587 1.555 . . . . 0.0 111.612 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 124.649 1.18 . . . . 0.0 108.527 171.415 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 CA-C-O 121.661 0.743 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.17 171.49 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.76 1.624 . . . . 0.0 111.425 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.75 161.05 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.544 1.137 . . . . 0.0 111.274 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.39 -44.66 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.591 1.556 . . . . 0.0 111.872 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.61 -25.85 66.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 113.194 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.81 -57.89 3.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.84 0.856 . . . . 0.0 110.85 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.28 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.181 1.392 . . . . 0.0 112.768 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -63.16 -8.29 7.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.617 1.567 . . . . 0.0 114.293 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -109.92 -36.8 5.79 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.877 1.671 . . . . 0.0 112.453 169.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.6 mt -49.34 -44.46 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.086 0.857 . . . . 0.0 110.591 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -59.41 -41.46 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.522 -0.736 . . . . 0.0 112.956 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -51.06 52.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.286 0.948 . . . . 0.0 111.01 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.13 72.2 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.9 -47.68 36.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.035 0.934 . . . . 0.0 112.179 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -59.53 -58.43 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.183 0.901 . . . . 0.0 110.366 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.16 -27.87 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -65.15 -50.61 65.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.699 0.799 . . . . 0.0 111.795 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.84 -30.81 71.09 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 113.883 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -62.89 -31.6 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.81 1.644 . . . . 0.0 112.578 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.76 7.71 0.43 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 119.052 2.381 . . . . 0.0 119.052 -161.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.37 95.67 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 120.237 2.019 . . . . 0.0 114.731 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -146.85 -173.3 4.19 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.426 1.613 . . . . 0.0 114.098 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.62 -178.1 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.481 1.912 . . . . 0.0 112.537 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -48.94 154.63 0.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -134.84 171.56 14.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.914 1.286 . . . . 0.0 112.349 -170.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -91.49 -113.75 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.111 1.365 . . . . 0.0 110.865 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.7 p -74.57 4.62 5.82 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.179 1.792 . . . . 0.0 115.318 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -47.95 -33.44 7.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.321 1.848 . . . . 0.0 114.559 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 p -48.63 -32.17 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.544 1.137 . . . . 0.0 113.55 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.18 -52.02 57.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.155 1.382 . . . . 0.0 112.284 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.18 -26.33 67.36 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.106 -0.996 . . . . 0.0 112.775 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.81 -53.62 7.68 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.269 1.028 . . . . 0.0 111.557 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.54 -24.24 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.566 0.746 . . . . 0.0 112.72 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -80.67 -63.66 1.36 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.102 0.865 . . . . 0.0 112.197 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -55.15 -41.46 71.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.29 1.436 . . . . 0.0 114.289 -171.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.69 -62.55 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 124.219 1.008 . . . . 0.0 110.248 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.6 t -49.04 -31.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.991 1.317 . . . . 0.0 110.766 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -62.61 -31.19 71.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -108.68 -41.48 4.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.225 1.41 . . . . 0.0 112.165 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.9 m -59.15 -51.47 69.86 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.932 2.493 . . . . 0.0 112.583 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -38.41 91.07 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.287 0.565 . . . . 0.0 111.336 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -61.88 -46.0 91.32 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -60.0 -49.14 78.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.709 2.004 . . . . 0.0 112.809 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.75 -24.8 63.58 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.571 -1.331 . . . . 0.0 114.399 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.0 m -60.36 -28.16 67.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.928 0.491 . . . . 0.0 111.024 165.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -87.19 -29.35 21.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.951 0.901 . . . . 0.0 112.695 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.92 -20.82 62.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.626 1.17 . . . . 0.0 112.385 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.61 -110.56 3.51 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.434 1.969 . . . . 0.0 112.81 172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -137.78 148.67 61.77 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.379 1.872 . . . . 0.0 111.13 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.34 120.32 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.048 3.165 . . . . 0.0 112.439 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.79 166.77 32.43 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 112.392 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.09 92.61 0.75 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.663 1.185 . . . . 0.0 110.36 166.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -68.6 162.63 25.46 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.664 0.745 . . . . 0.0 110.797 157.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.3 tt -141.84 153.62 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.742 1.617 . . . . 0.0 109.045 166.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.7 m -144.67 152.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.956 1.302 . . . . 0.0 110.566 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -144.34 158.64 43.63 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.421 1.089 . . . . 0.0 110.256 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.2 p -151.62 152.72 33.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.078 1.351 . . . . 0.0 111.88 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -133.61 123.49 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.917 1.287 . . . . 0.0 109.317 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mm -111.16 108.36 25.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 127.431 2.293 . . . . 0.0 109.121 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -135.91 153.47 51.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.438 2.295 . . . . 0.0 110.733 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -143.98 147.81 34.43 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 112.495 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -80.04 -14.38 58.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.62 -7.75 55.87 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.12 25.51 0.02 OUTLIER Glycine 0 N--CA 1.477 1.375 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.25 126.77 21.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.893 1.277 . . . . 0.0 112.472 -168.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.25 101.4 0.16 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.927 0.775 . . . . 0.0 114.111 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.99 -174.56 2.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.688 2.395 . . . . 0.0 110.358 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.15 130.64 55.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.382 0.673 . . . . 0.0 110.317 170.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.2 m -137.78 142.85 40.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.284 1.433 . . . . 0.0 109.749 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.72 138.29 39.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.675 1.19 . . . . 0.0 110.551 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.2 p -141.43 120.05 12.5 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.583 1.153 . . . . 0.0 110.993 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.8 m -75.91 13.2 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.839 -1.163 . . . . 0.0 113.406 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.2 m -60.43 164.49 4.36 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.899 167.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.95 158.21 30.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.445 1.898 . . . . 0.0 110.053 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -80.72 139.42 36.13 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.247 0.546 . . . . 0.0 109.651 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -154.35 162.66 41.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.164 1.786 . . . . 0.0 111.178 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.6 t -132.98 -59.32 0.89 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.232 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 -39.09 51.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.369 1.068 . . . . 0.0 111.513 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -53.68 53.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.78 1.632 . . . . 0.0 111.641 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -150.09 -69.76 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.982 1.313 . . . . 0.0 112.404 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.29 151.95 6.36 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 127.238 2.352 . . . . 0.0 113.38 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 p -165.35 141.48 5.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.689 1.995 . . . . 0.0 110.557 173.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . 0.53 ' HG ' ' HB1' ' A' ' 110' ' ' ALA . 1.7 p -126.72 63.85 1.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.869 1.268 . . . . 0.0 112.35 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -76.41 150.59 36.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.338 1.855 . . . . 0.0 113.591 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.12 135.21 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.463 1.505 . . . . 0.0 110.457 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -115.19 120.15 38.77 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.48 1.112 . . . . 0.0 112.012 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -133.2 98.54 4.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.695 1.598 . . . . 0.0 110.261 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 173.48 8.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.79 1.236 . . . . 0.0 111.949 166.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -143.43 -176.39 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.764 1.626 . . . . 0.0 111.203 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -51.56 -43.31 62.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.172 1.389 . . . . 0.0 114.246 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 t -137.71 8.52 2.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.271 1.428 . . . . 0.0 114.101 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.14 165.38 16.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.184 1.393 . . . . 0.0 112.819 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -145.28 118.76 9.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.161 1.784 . . . . 0.0 109.941 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.9 p -143.62 74.44 1.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 111.938 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.0 pt -74.71 158.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.457 -0.777 . . . . 0.0 111.421 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.07 141.15 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.486 1.914 . . . . 0.0 109.949 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -135.38 125.18 25.51 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.257 -0.902 . . . . 0.0 111.54 -174.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.53 ' HB1' ' HG ' ' A' ' 95' ' ' CYS . . . -121.62 144.17 48.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.299 1.44 . . . . 0.0 112.823 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -146.18 -176.67 5.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 126.607 1.963 . . . . 0.0 110.125 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.53 84.41 1.11 Allowed Glycine 0 CA--C 1.539 1.552 0 O-C-N 120.87 -1.144 . . . . 0.0 112.892 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 46.22 1.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.174 2.19 . . . . 0.0 113.031 -167.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 122.193 0.997 . . . . 0.0 112.268 -170.669 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -136.23 169.44 17.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.85 2.06 . . . . 0.0 111.443 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 mm -63.71 146.02 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 110.588 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.6 m -106.07 111.74 24.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.279 1.432 . . . . 0.0 110.067 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.99 145.37 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.782 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.86 104.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -139.63 150.36 44.86 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.737 0.815 . . . . 0.0 112.465 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.548 0.901 0 C-N-CA 125.574 1.55 . . . . 0.0 111.557 -175.367 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 121.239 0.542 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.59 162.63 27.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.402 1.081 . . . . 0.0 110.721 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 p -138.61 158.96 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.736 1.215 . . . . 0.0 111.166 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.83 -38.55 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.74 2.416 . . . . 0.0 112.67 -174.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.86 -28.34 68.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 113.072 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.49 -47.8 7.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.47 0.708 . . . . 0.0 110.708 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 70.2 t -48.58 -42.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.338 1.455 . . . . 0.0 112.187 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t -64.25 -8.23 11.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.622 1.569 . . . . 0.0 114.874 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.54 -35.09 6.84 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.308 1.843 . . . . 0.0 112.446 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.9 mt -49.79 -42.13 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.143 0.977 . . . . 0.0 110.583 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.29 -43.57 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.52 63.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.455 1.025 . . . . 0.0 111.053 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -33.73 76.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.57 63.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.647 0.779 . . . . 0.0 112.206 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.5 -59.18 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.109 0.868 . . . . 0.0 109.986 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -61.86 -29.48 70.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 32.9 t -63.6 -51.93 63.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.983 0.913 . . . . 0.0 111.912 167.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.29 -30.71 71.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.071 1.348 . . . . 0.0 113.989 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.78 -34.81 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.249 1.419 . . . . 0.0 111.005 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.33 80.81 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.897 1.237 . . . . 0.0 114.916 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.48 68.82 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.104 1.335 . . . . 0.0 115.487 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -70.57 -176.14 1.2 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.811 1.306 . . . . 0.0 112.301 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.89 154.25 5.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.721 -1.237 . . . . 0.0 111.424 170.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -48.92 150.0 1.66 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.021 1.328 . . . . 0.0 113.1 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -127.85 166.64 17.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.577 1.151 . . . . 0.0 111.483 -173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -89.0 -113.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.519 1.128 . . . . 0.0 110.553 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 61.0 p -74.37 5.91 4.16 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -48.59 -33.97 10.72 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.085 1.754 . . . . 0.0 114.475 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 65.6 t -50.11 -33.02 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.567 1.147 . . . . 0.0 112.665 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.94 -52.99 57.23 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.309 1.443 . . . . 0.0 112.367 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.79 -26.3 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.045 -1.035 . . . . 0.0 112.742 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.96 -53.19 8.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.264 1.026 . . . . 0.0 111.519 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.59 -24.38 63.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.385 0.674 . . . . 0.0 112.79 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.6 t -80.51 -64.01 1.28 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.121 0.873 . . . . 0.0 112.138 165.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -55.25 -39.74 70.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.312 1.445 . . . . 0.0 114.345 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.21 -62.37 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 C-N-CA 124.139 0.976 . . . . 0.0 110.208 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.18 -31.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.922 1.289 . . . . 0.0 110.721 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -62.03 -31.78 72.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.932 0.893 . . . . 0.0 113.376 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -108.22 -41.61 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.162 1.385 . . . . 0.0 112.163 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 46.2 m -59.71 -51.36 70.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.074 2.55 . . . . 0.0 112.617 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -38.32 90.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 111.262 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.5 t -61.32 -46.64 89.44 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.624 -0.673 . . . . 0.0 111.626 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.69 -50.5 73.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.789 2.035 . . . . 0.0 112.941 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.99 -27.65 67.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.081 1.309 . . . . 0.0 114.027 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 93.7 m -59.57 -29.09 67.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.116 0.566 . . . . 0.0 111.283 167.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.72 -28.83 22.84 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 89.8 mt -78.92 -19.4 51.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.181 0.992 . . . . 0.0 111.895 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -102.19 -104.25 2.79 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.429 1.966 . . . . 0.0 112.087 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -141.43 145.81 39.49 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.084 1.754 . . . . 0.0 111.505 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 122.23 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.053 3.168 . . . . 0.0 112.522 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -158.51 167.58 29.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.25 1.42 . . . . 0.0 112.106 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.15 92.13 0.54 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.651 1.18 . . . . 0.0 110.305 166.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -68.06 161.85 25.85 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.603 0.716 . . . . 0.0 110.582 157.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 7.1 tt -141.16 153.54 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.774 1.629 . . . . 0.0 108.94 166.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 25.7 m -144.15 151.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.808 1.243 . . . . 0.0 110.44 173.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.2 t -142.67 157.46 44.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.473 1.109 . . . . 0.0 110.06 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 46.4 t -152.85 147.8 26.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.39 1.476 . . . . 0.0 111.313 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.37 127.57 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.4 mm -113.34 111.17 34.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 127.429 2.292 . . . . 0.0 109.462 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -135.76 153.65 51.48 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.652 2.381 . . . . 0.0 110.945 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -144.32 144.15 31.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.378 1.471 . . . . 0.0 112.636 -172.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -75.97 -15.64 60.13 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -75.8 -7.88 55.52 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.48 23.75 0.02 OUTLIER Glycine 0 CA--C 1.536 1.363 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -138.61 123.33 18.67 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.745 1.272 . . . . 0.0 112.591 -168.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.63 103.06 0.19 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.048 0.832 . . . . 0.0 114.292 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 8.5 mp -114.64 -174.31 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.895 2.478 . . . . 0.0 110.444 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.56 129.96 55.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.58 0.752 . . . . 0.0 110.587 170.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 22.9 m -135.66 145.36 46.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.102 1.361 . . . . 0.0 109.964 172.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.55 41.74 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 110.997 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.8 p -142.88 122.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.462 1.105 . . . . 0.0 110.755 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.7 m -77.03 13.25 1.12 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.946 -1.096 . . . . 0.0 113.168 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 5.2 m -59.83 164.52 3.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.836 167.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.44 159.57 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.832 . . . . 0.0 110.247 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -80.42 135.72 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.222 0.535 . . . . 0.0 109.567 169.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -152.11 162.84 40.49 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.753 1.621 . . . . 0.0 111.47 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 32.1 t -137.1 -58.98 0.71 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.872 1.269 . . . . 0.0 112.173 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -74.48 -40.78 61.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.102 0.961 . . . . 0.0 111.368 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -54.26 46.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.947 1.699 . . . . 0.0 111.621 -174.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.14 -70.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.876 1.27 . . . . 0.0 112.703 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 137.11 152.69 6.22 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 127.509 2.48 . . . . 0.0 113.484 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 44.9 p -171.49 127.29 0.65 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.558 1.543 . . . . 0.0 112.459 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.56 65.04 0.67 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.972 1.709 . . . . 0.0 112.431 -171.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.9 t -76.94 146.75 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.16 1.384 . . . . 0.0 113.637 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.32 114.94 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.694 1.198 . . . . 0.0 110.906 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -94.14 119.02 32.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.72 1.208 . . . . 0.0 111.859 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -130.08 106.81 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.437 1.495 . . . . 0.0 110.323 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 169.91 9.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.365 1.466 . . . . 0.0 111.667 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -140.83 -177.33 5.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.637 1.575 . . . . 0.0 110.968 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -51.75 -42.25 62.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.888 1.275 . . . . 0.0 114.406 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 7.6 t -138.1 8.21 2.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.252 1.421 . . . . 0.0 114.324 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.35 159.4 27.55 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.45 119.04 15.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.647 1.979 . . . . 0.0 110.33 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.68 73.88 1.43 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.887 1.275 . . . . 0.0 112.031 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.32 125.57 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.37 1.468 . . . . 0.0 111.765 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.22 147.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.412 1.485 . . . . 0.0 110.614 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -139.75 129.76 24.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.93 0.892 . . . . 0.0 111.981 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -123.6 145.2 49.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.367 1.467 . . . . 0.0 113.05 -174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -147.5 -176.5 5.27 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.709 2.004 . . . . 0.0 109.972 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 86.47 84.89 1.09 Allowed Glycine 0 CA--C 1.538 1.523 0 O-C-N 120.794 -1.191 . . . . 0.0 112.922 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.93 1.03 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.066 2.146 . . . . 0.0 113.038 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 122.096 0.951 . . . . 0.0 112.111 -171.104 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 111.46 0.171 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -136.24 169.61 17.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.807 2.043 . . . . 0.0 111.418 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.79 146.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.084 1.354 . . . . 0.0 110.607 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 85.1 m -107.79 103.7 13.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.455 1.502 . . . . 0.0 110.26 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -104.45 147.41 27.6 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.876 -1.14 . . . . 0.0 110.74 171.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.15 107.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.736 2.014 . . . . 0.0 109.916 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -139.0 151.68 47.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.728 0.811 . . . . 0.0 112.564 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 CA--C 1.547 0.865 0 C-N-CA 125.559 1.544 . . . . 0.0 111.499 -176.3 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -123.39 164.76 18.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.433 1.493 . . . . 0.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.66 161.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 110.939 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.33 -36.92 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.767 1.627 . . . . 0.0 112.047 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.83 -26.14 67.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.64 1.176 . . . . 0.0 112.274 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.96 -58.96 2.75 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.297 0.639 . . . . 0.0 110.099 171.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -47.59 -43.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.763 1.625 . . . . 0.0 113.325 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 t -59.3 -21.39 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.605 1.562 . . . . 0.0 113.574 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -99.63 -34.23 10.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.384 1.474 . . . . 0.0 113.114 172.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 mt -51.42 -42.96 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.251 1.02 . . . . 0.0 110.633 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.55 -44.1 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 121.408 -0.807 . . . . 0.0 113.102 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -51.36 65.43 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.945 1.248 . . . . 0.0 111.697 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -35.44 79.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.15 64.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.28 -56.58 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.155 0.889 . . . . 0.0 109.001 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.25 -32.31 73.68 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.7 p -69.81 -36.99 76.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.18 -0.95 . . . . 0.0 112.699 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -28.04 62.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.669 1.188 . . . . 0.0 113.899 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.59 -34.22 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.975 1.31 . . . . 0.0 110.809 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.19 81.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.797 1.189 . . . . 0.0 114.729 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.98 17.69 65.77 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.287 1.422 . . . . 0.0 115.543 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.28 -173.29 1.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.696 1.248 . . . . 0.0 111.733 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 115.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 111.297 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -64.77 126.08 26.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.384 1.074 . . . . 0.0 111.394 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -127.41 127.67 44.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.253 1.021 . . . . 0.0 112.583 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -64.15 -42.49 96.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.265 1.026 . . . . 0.0 112.954 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 t -62.64 -28.78 70.15 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.994 -1.066 . . . . 0.0 112.712 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -72.8 -26.56 61.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.58 -34.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.078 1.308 . . . . 0.0 112.401 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.3 -49.2 72.72 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.953 1.301 . . . . 0.0 112.593 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.88 -25.89 66.61 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.152 -0.967 . . . . 0.0 112.909 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -78.08 -53.07 7.8 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.717 0.807 . . . . 0.0 111.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.61 -22.81 62.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -82.83 -60.22 2.24 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.508 1.049 . . . . 0.0 112.189 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -57.66 -38.98 76.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.113 1.324 . . . . 0.0 114.32 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.2 t -68.52 -64.53 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 C-N-CA 124.644 1.177 . . . . 0.0 109.895 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.6 t -47.53 -30.99 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 110.863 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.61 -38.5 72.14 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.136 0.975 . . . . 0.0 113.314 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -112.21 -34.6 5.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.998 1.719 . . . . 0.0 112.648 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -62.21 -52.67 62.83 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.031 2.132 . . . . 0.0 112.572 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -33.85 75.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.371 0.532 . . . . 0.0 111.123 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 m -60.69 -54.76 41.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.548 0.739 . . . . 0.0 111.853 166.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -53.47 -50.82 64.52 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.435 1.894 . . . . 0.0 112.751 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.95 -27.19 65.51 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.2 m -59.65 -43.4 93.93 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -71.44 -23.11 61.79 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.0 5.77 3.97 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.215 1.406 . . . . 0.0 113.386 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.11 -97.86 0.14 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.594 1.088 . . . . 0.0 114.981 164.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -66.87 170.66 5.67 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 125.163 1.385 . . . . 0.0 114.598 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.12 168.27 14.39 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.166 1.911 . . . . 0.0 112.131 166.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -56.8 113.82 1.82 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.571 1.548 . . . . 0.0 112.651 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.33 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.377 3.071 . . . . 0.0 110.273 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.93 172.28 13.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.833 2.453 . . . . 0.0 108.915 169.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 tt -134.74 153.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.519 1.527 . . . . 0.0 108.403 162.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.08 141.61 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.858 0.863 . . . . 0.0 110.255 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.06 141.55 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.511 1.525 . . . . 0.0 108.932 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 146.93 41.27 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.496 -0.752 . . . . 0.0 112.964 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.24 125.38 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.465 1.506 . . . . 0.0 109.144 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mm -124.63 104.68 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.026 2.13 . . . . 0.0 108.076 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.57 166.96 20.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 112.286 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.09 109.49 12.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.639 1.175 . . . . 0.0 111.861 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -61.38 -20.09 62.63 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.89 -16.69 61.1 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.28 18.09 0.02 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.895 1.918 . . . . 0.0 117.895 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.5 65.84 1.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.367 1.583 . . . . 0.0 111.971 -171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.33 159.42 40.98 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.623 1.106 . . . . 0.0 113.145 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.97 174.88 13.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.43 1.892 . . . . 0.0 112.06 -174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -120.86 133.24 55.31 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.553 1.141 . . . . 0.0 111.112 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.3 m -141.0 144.61 35.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.587 1.555 . . . . 0.0 109.77 174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.8 126.29 20.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.663 1.185 . . . . 0.0 109.991 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.4 p -128.57 113.3 15.27 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.849 0.86 . . . . 0.0 110.755 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -77.45 11.26 2.07 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.557 1.143 . . . . 0.0 112.844 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.6 m -58.76 163.01 3.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.931 1.692 . . . . 0.0 112.714 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -159.16 137.82 10.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.918 1.287 . . . . 0.0 110.353 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -73.7 148.91 42.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.478 0.711 . . . . 0.0 110.195 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -136.16 151.69 50.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 110.913 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.0 t -106.35 -63.24 1.29 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.492 1.117 . . . . 0.0 112.158 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.5 p -84.87 -32.01 23.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.804 0.842 . . . . 0.0 113.159 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -49.86 47.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.24 1.416 . . . . 0.0 111.943 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -149.82 -174.43 4.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.668 2.387 . . . . 0.0 110.3 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.73 149.06 18.65 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.709 1.147 . . . . 0.0 112.256 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -155.56 131.9 10.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.692 1.197 . . . . 0.0 110.418 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 11.0 t -123.31 136.49 54.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -128.19 141.35 51.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.383 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.4 113.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 126.468 1.907 . . . . 0.0 108.949 -168.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.0 114.26 24.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.729 1.612 . . . . 0.0 111.378 -174.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -124.82 105.35 9.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.158 1.783 . . . . 0.0 109.569 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 167.1 7.48 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.475 -0.766 . . . . 0.0 112.253 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -144.83 -179.21 6.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.976 0.911 . . . . 0.0 111.518 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -52.11 55.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.793 1.637 . . . . 0.0 113.74 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.3 t -127.67 -30.11 2.57 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.89 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.2 ptp -96.59 179.44 4.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.49 1.516 . . . . 0.0 111.835 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.1 152.51 37.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.643 1.577 . . . . 0.0 109.38 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.0 p -129.66 137.38 50.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.108 0.963 . . . . 0.0 110.995 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.1 125.38 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.921 1.289 . . . . 0.0 110.271 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.12 128.03 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.895 2.078 . . . . 0.0 108.994 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -126.74 110.14 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.154 1.381 . . . . 0.0 111.291 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.27 143.38 27.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.449 1.9 . . . . 0.0 112.383 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -134.02 126.27 29.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.983 1.313 . . . . 0.0 110.001 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.59 73.99 0.3 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.554 2.026 . . . . 0.0 111.206 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.97 123.22 16.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.006 1.322 . . . . 0.0 110.92 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 125.49 1.516 . . . . 0.0 112.62 -169.142 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.637 0.256 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -127.06 165.43 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.309 1.044 . . . . 0.0 112.373 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.2 mm -64.56 148.38 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.503 1.521 . . . . 0.0 110.872 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.5 m -126.04 100.43 6.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.89 1.276 . . . . 0.0 110.595 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -92.04 149.46 21.51 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.95 168.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.34 103.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.082 2.153 . . . . 0.0 109.22 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -139.1 157.73 45.44 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.095 -1.003 . . . . 0.0 112.507 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 121.047 0.451 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -118.75 167.81 11.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.277 1.431 . . . . 0.0 110.663 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.44 160.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.494 1.118 . . . . 0.0 111.066 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.94 -37.34 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.631 1.173 . . . . 0.0 111.946 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -28.06 66.19 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.093 0.957 . . . . 0.0 112.882 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -77.3 -59.6 2.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.975 1.31 . . . . 0.0 110.767 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 84.0 t -48.67 -42.5 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 125.055 1.342 . . . . 0.0 113.292 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.8 t -58.95 -19.33 41.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.281 1.432 . . . . 0.0 113.454 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -101.92 -34.26 9.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.803 1.241 . . . . 0.0 113.161 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 24.1 mt -51.04 -44.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.496 1.044 . . . . 0.0 110.608 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.29 -43.31 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.453 -0.779 . . . . 0.0 112.874 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -51.02 62.88 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.733 1.151 . . . . 0.0 111.592 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -34.48 76.69 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.11 59.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.946 0.898 . . . . 0.0 113.34 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.18 -57.22 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.206 0.912 . . . . 0.0 109.064 174.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.29 -31.29 72.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.5 p -69.98 -37.57 75.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.19 -0.944 . . . . 0.0 112.681 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.16 -31.22 68.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.388 1.075 . . . . 0.0 113.462 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.8 -35.75 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.364 1.465 . . . . 0.0 112.636 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -58.74 -1.05 0.73 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -159.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.41 -32.68 81.91 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.904 1.852 . . . . 0.0 115.285 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -166.67 2.31 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.848 1.324 . . . . 0.0 112.511 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.07 161.92 3.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.383 1.473 . . . . 0.0 112.703 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.65 130.19 39.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.314 1.446 . . . . 0.0 111.132 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -132.89 133.97 43.97 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.776 1.23 . . . . 0.0 112.156 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -73.57 -43.17 60.47 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.25 1.02 . . . . 0.0 113.101 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 7.2 t -62.23 -27.68 69.16 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.066 -1.021 . . . . 0.0 112.502 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -73.25 -26.19 61.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -53.81 -34.03 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.261 1.391 . . . . 0.0 112.571 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.58 -49.62 72.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.1 1.36 . . . . 0.0 112.567 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.06 -25.42 66.24 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.198 -0.939 . . . . 0.0 112.932 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -78.39 -52.72 8.17 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.611 0.764 . . . . 0.0 111.756 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.75 -22.73 62.5 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.8 t -82.83 -60.6 2.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.492 1.042 . . . . 0.0 112.205 165.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -56.83 -41.31 77.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.302 1.41 . . . . 0.0 114.294 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.35 -64.67 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 110.036 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 87.6 t -47.7 -30.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.958 1.303 . . . . 0.0 110.973 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.08 -38.15 72.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.009 0.924 . . . . 0.0 113.162 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.6 -35.41 5.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 112.596 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 44.7 m -61.48 -52.66 63.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.157 2.183 . . . . 0.0 112.634 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -34.23 76.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.487 0.585 . . . . 0.0 111.192 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 66.5 m -61.06 -53.6 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.511 0.725 . . . . 0.0 111.887 167.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -54.42 -50.88 66.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.594 1.958 . . . . 0.0 112.648 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.38 -26.55 64.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 66.7 m -59.27 -43.48 92.49 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -71.87 -23.25 61.48 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.38 4.96 4.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.28 1.432 . . . . 0.0 113.464 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -155.93 -97.28 0.13 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.517 1.053 . . . . 0.0 114.941 164.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -67.67 171.22 5.52 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 125.156 1.382 . . . . 0.0 114.666 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.62 169.7 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.019 1.812 . . . . 0.0 111.889 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -56.26 114.19 1.87 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.591 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.8 97.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 129.342 3.057 . . . . 0.0 110.169 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -149.8 171.88 16.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.687 2.395 . . . . 0.0 109.044 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -135.24 153.53 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.903 1.681 . . . . 0.0 108.217 162.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.02 141.88 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.863 0.865 . . . . 0.0 110.124 166.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.257 1.423 . . . . 0.0 108.895 169.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.2 p -135.79 150.21 49.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.12 0.962 . . . . 0.0 113.078 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 12.9 t -132.27 125.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.894 1.677 . . . . 0.0 108.184 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mm -122.49 104.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.997 2.119 . . . . 0.0 107.418 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 162.97 29.28 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 112.753 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.1 137.34 52.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.265 1.426 . . . . 0.0 111.134 -174.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -89.1 -14.18 36.88 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -77.85 -17.06 57.8 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 173.59 21.37 0.02 OUTLIER Glycine 0 CA--C 1.538 1.517 0 N-CA-C 117.703 1.841 . . . . 0.0 117.703 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.73 73.25 1.42 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.773 1.786 . . . . 0.0 112.767 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.5 160.16 32.73 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.682 1.134 . . . . 0.0 113.518 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.02 176.68 10.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.797 2.039 . . . . 0.0 111.941 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.19 131.2 53.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.677 1.591 . . . . 0.0 110.957 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 90.6 m -139.05 143.38 38.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.449 1.1 . . . . 0.0 109.916 174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.8 128.73 27.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 110.23 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.9 p -130.81 114.69 15.63 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.845 0.858 . . . . 0.0 110.912 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 t -78.16 11.21 2.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.447 1.099 . . . . 0.0 112.712 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.2 m -58.42 162.51 3.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.803 1.641 . . . . 0.0 112.774 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -158.96 138.55 11.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.846 1.258 . . . . 0.0 110.537 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.73 145.0 47.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.391 0.677 . . . . 0.0 109.927 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -130.13 151.81 50.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.614 1.566 . . . . 0.0 110.23 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 29.7 t -106.75 -64.28 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.927 1.291 . . . . 0.0 112.211 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 70.8 p -83.65 -31.64 26.06 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.868 0.867 . . . . 0.0 113.262 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -48.81 58.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 111.928 -173.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.07 -175.12 5.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.881 2.472 . . . . 0.0 110.754 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.99 146.74 16.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.784 1.183 . . . . 0.0 112.252 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 1.4 m -152.73 126.69 9.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.098 1.359 . . . . 0.0 110.679 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 16.8 t -121.33 130.08 53.43 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.59 1.156 . . . . 0.0 111.416 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.5 t -125.53 143.73 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.166 0.986 . . . . 0.0 111.338 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.42 131.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.506 1.523 . . . . 0.0 109.183 -172.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 114.47 17.8 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.434 1.493 . . . . 0.0 111.346 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.77 102.67 7.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.456 1.903 . . . . 0.0 109.408 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 165.95 7.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.492 -0.755 . . . . 0.0 112.093 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -144.1 -178.74 6.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.998 0.919 . . . . 0.0 111.581 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -51.08 59.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.858 1.663 . . . . 0.0 113.751 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -129.4 -29.28 2.23 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.519 1.528 . . . . 0.0 113.992 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -97.14 179.17 5.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.529 1.532 . . . . 0.0 111.828 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.57 151.72 36.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.369 1.468 . . . . 0.0 109.539 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 29.9 p -129.53 137.52 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.072 0.949 . . . . 0.0 111.148 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.0 130.02 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.992 1.317 . . . . 0.0 109.975 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.5 125.72 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.695 1.598 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.8 m -121.87 109.05 14.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.876 1.671 . . . . 0.0 110.916 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.52 143.83 26.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 112.579 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -134.76 122.46 22.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.347 1.459 . . . . 0.0 109.737 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.43 74.08 0.27 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.419 1.961 . . . . 0.0 111.331 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.92 121.82 13.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.016 1.326 . . . . 0.0 110.919 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 125.994 1.718 . . . . 0.0 112.406 -169.043 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -127.92 166.51 18.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.031 0.933 . . . . 0.0 111.993 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.38 149.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.53 1.532 . . . . 0.0 111.274 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 86.4 m -126.96 99.89 5.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.005 1.322 . . . . 0.0 110.725 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -93.94 150.03 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.163 -0.961 . . . . 0.0 110.858 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.28 104.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.534 1.934 . . . . 0.0 110.062 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.61 159.18 42.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.031 1.332 . . . . 0.0 112.373 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 125.844 1.658 . . . . 0.0 111.94 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 121.176 0.512 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.27 170.16 8.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.262 1.425 . . . . 0.0 111.764 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -149.57 157.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.72 1.208 . . . . 0.0 111.366 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -53.45 -41.27 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.834 1.653 . . . . 0.0 112.063 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.91 -25.85 67.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.74 1.216 . . . . 0.0 113.544 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -79.96 -56.22 4.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.022 0.929 . . . . 0.0 110.632 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.0 t -47.34 -43.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.432 1.893 . . . . 0.0 112.381 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -63.79 -9.66 15.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.292 1.837 . . . . 0.0 114.362 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -111.17 -32.67 6.69 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.524 1.93 . . . . 0.0 112.475 172.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.3 mt -50.74 -43.37 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.014 0.825 . . . . 0.0 110.317 168.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.15 -44.04 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.495 -0.753 . . . . 0.0 112.957 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -52.36 51.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.756 1.162 . . . . 0.0 111.318 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -34.75 77.26 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.41 -41.42 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.78 0.832 . . . . 0.0 112.984 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.2 mt -58.25 -59.56 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.297 0.953 . . . . 0.0 109.522 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -62.97 -29.95 71.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.29 -49.93 75.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.27 1.028 . . . . 0.0 112.104 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.46 72.04 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.48 -40.67 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.799 1.24 . . . . 0.0 111.506 173.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.11 74.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.163 0.887 . . . . 0.0 115.139 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.71 -0.31 36.56 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.392 1.472 . . . . 0.0 116.256 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.47 162.03 8.64 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 118.879 1.34 . . . . 0.0 112.008 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.31 -166.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.599 1.56 . . . . 0.0 111.57 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -43.92 121.67 2.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.392 2.277 . . . . 0.0 112.425 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -115.81 170.17 8.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.631 1.172 . . . . 0.0 113.085 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 -95.86 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.703 1.201 . . . . 0.0 109.317 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -76.81 -21.01 55.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.637 1.175 . . . . 0.0 113.988 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -41.81 76.9 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.998 0.919 . . . . 0.0 112.367 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.16 -33.42 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.02 -46.73 80.1 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.362 0.983 . . . . 0.0 112.204 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -65.79 -24.84 67.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.692 0.678 . . . . 0.0 112.532 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.75 -51.86 9.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.034 0.833 . . . . 0.0 111.887 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -56.52 -29.59 62.06 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.847 0.749 . . . . 0.0 112.521 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -79.35 -60.77 2.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.389 0.995 . . . . 0.0 112.409 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.84 -38.6 75.96 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.334 1.453 . . . . 0.0 114.284 -172.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 81.7 t -68.21 -64.44 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 123.9 0.88 . . . . 0.0 109.469 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.9 t -50.42 -28.44 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.469 1.507 . . . . 0.0 110.835 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.11 28.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.579 1.151 . . . . 0.0 112.115 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -93.27 -35.56 13.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.041 1.336 . . . . 0.0 112.734 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -59.75 -54.38 47.03 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.944 2.097 . . . . 0.0 112.285 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -37.44 83.15 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.122 0.487 . . . . 0.0 111.236 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.0 t -62.18 -40.45 96.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.151 -0.968 . . . . 0.0 113.102 170.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.1 -49.85 63.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.721 1.608 . . . . 0.0 112.422 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.74 -24.8 65.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.9 m -55.89 -34.76 65.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.674 0.789 . . . . 0.0 110.919 163.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -84.88 -31.46 23.72 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.13 -30.47 70.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.472 0.709 . . . . 0.0 111.578 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.38 -100.81 2.61 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.147 1.832 . . . . 0.0 112.724 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -136.63 141.76 36.6 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.867 1.267 . . . . 0.0 113.677 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.44 104.18 1.66 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.448 3.432 . . . . 0.0 112.605 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -142.84 179.89 6.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.078 1.751 . . . . 0.0 112.166 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.5 89.25 3.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.464 1.506 . . . . 0.0 111.706 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.13 147.42 25.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.033 1.333 . . . . 0.0 110.747 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.3 152.96 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 126.117 1.767 . . . . 0.0 109.292 174.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.5 m -138.39 146.68 26.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.604 1.161 . . . . 0.0 110.823 172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 126.98 20.02 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.422 1.889 . . . . 0.0 108.921 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 p -129.7 138.09 50.95 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 112.552 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.1 98.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.139 1.376 . . . . 0.0 109.5 -167.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.7 91.32 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.359 1.864 . . . . 0.0 107.928 -171.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -147.37 93.83 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.057 1.743 . . . . 0.0 110.763 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.54 133.37 8.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 109.649 170.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -52.05 0.14 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.274 1.43 . . . . 0.0 112.123 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.68 -23.95 8.98 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.875 1.27 . . . . 0.0 113.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.0 -1.34 38.35 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.538 1.542 . . . . 0.0 115.056 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.29 68.58 1.43 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.402 1.881 . . . . 0.0 111.237 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.9 15.93 0.09 OUTLIER Glycine 0 CA--C 1.537 1.429 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 -170.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.41 104.46 4.59 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.656 1.983 . . . . 0.0 110.005 -159.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 132.7 51.66 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.836 -1.165 . . . . 0.0 108.835 173.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 m -154.15 140.63 18.79 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.257 -1.527 . . . . 0.0 109.603 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.06 24.36 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.544 -0.722 . . . . 0.0 112.811 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -142.03 129.63 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.619 0.768 . . . . 0.0 110.51 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -79.75 8.83 5.96 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.292 -0.88 . . . . 0.0 112.482 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.65 162.94 17.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.636 1.174 . . . . 0.0 112.675 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.17 151.84 28.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.423 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 169.07 18.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.942 0.497 . . . . 0.0 111.484 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -139.41 148.61 43.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.213 1.005 . . . . 0.0 111.427 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -112.49 -68.94 0.9 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.461 1.504 . . . . 0.0 111.634 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.3 t -84.3 -38.82 19.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.698 0.799 . . . . 0.0 112.108 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -67.51 -45.96 74.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.672 1.189 . . . . 0.0 112.689 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.6 -169.8 3.47 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.56 2.344 . . . . 0.0 110.408 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.43 174.13 15.14 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.266 1.412 . . . . 0.0 114.518 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.7 t -154.88 163.1 40.78 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.385 1.874 . . . . 0.0 111.151 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 20.9 t -164.88 115.13 1.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.002 1.321 . . . . 0.0 112.164 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.694 -1.254 . . . . 0.0 112.01 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.62 151.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 110.184 -172.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -138.94 121.68 16.43 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.501 1.52 . . . . 0.0 111.02 -168.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -135.52 103.1 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.9 1.68 . . . . 0.0 111.018 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.47 142.49 58.37 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.027 -1.046 . . . . 0.0 112.254 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.35 -167.8 1.79 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.842 1.257 . . . . 0.0 109.932 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.03 -52.01 9.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.842 2.057 . . . . 0.0 114.585 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -140.59 -35.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.162 1.785 . . . . 0.0 111.402 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.4 ptp -79.03 112.95 16.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.478 1.511 . . . . 0.0 111.795 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.78 116.48 19.97 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.269 -1.519 . . . . 0.0 109.889 170.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 134.42 35.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.114 173.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.26 132.26 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.778 1.631 . . . . 0.0 109.846 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.77 127.88 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.615 1.566 . . . . 0.0 110.728 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 t -119.14 111.89 18.83 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.124 0.97 . . . . 0.0 110.802 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.47 139.62 30.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.913 0.885 . . . . 0.0 111.193 167.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -124.12 126.71 46.65 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 109.313 168.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.56 78.35 0.24 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 125.531 1.538 . . . . 0.0 112.35 -170.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.66 123.26 24.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.654 1.581 . . . . 0.0 111.764 -173.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 127.174 2.19 . . . . 0.0 112.807 -164.187 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -117.39 178.24 4.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 111.417 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -109.31 145.31 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.802 1.641 . . . . 0.0 109.926 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -117.4 90.71 3.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.047 1.339 . . . . 0.0 110.078 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -104.52 138.53 40.76 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.427 1.091 . . . . 0.0 110.816 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.45 98.98 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.214 2.606 . . . . 0.0 108.586 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.0 p30 -135.31 168.19 19.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.06 0.944 . . . . 0.0 111.82 168.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 124.437 1.095 . . . . 0.0 109.386 166.585 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.72 159.11 15.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.085 0.954 . . . . 0.0 112.255 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.49 156.35 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.149 1.78 . . . . 0.0 110.767 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 44.3 t -51.21 -40.09 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.294 2.638 . . . . 0.0 112.415 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.97 -28.32 62.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 113.175 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.47 -46.96 7.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.045 0.938 . . . . 0.0 110.854 175.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -48.65 -42.27 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.502 1.121 . . . . 0.0 112.067 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 12.1 t -63.55 -9.13 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.545 1.938 . . . . 0.0 114.692 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -109.98 -32.09 7.16 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.688 1.995 . . . . 0.0 112.552 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.9 mt -51.46 -41.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.822 0.849 . . . . 0.0 110.517 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.22 -44.17 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 121.447 -0.783 . . . . 0.0 112.939 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.63 53.8 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.736 1.153 . . . . 0.0 111.345 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.6 77.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.64 65.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.529 0.731 . . . . 0.0 112.924 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.37 -59.9 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 119.127 0.876 . . . . 0.0 109.388 174.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.51 -30.15 71.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.1 t -61.3 -50.04 74.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 112.105 168.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.35 71.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.4 -40.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.822 1.249 . . . . 0.0 111.523 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.05 12.13 74.69 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.192 0.901 . . . . 0.0 115.036 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.56 -0.39 36.96 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.339 1.447 . . . . 0.0 116.266 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.61 162.49 8.3 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 118.852 1.326 . . . . 0.0 111.972 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -93.38 -166.16 1.47 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 111.505 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -43.82 125.58 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.482 2.313 . . . . 0.0 112.597 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -120.4 163.87 17.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.44 1.096 . . . . 0.0 113.749 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -71.91 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.055 1.342 . . . . 0.0 110.982 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m -107.31 -18.81 13.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.258 1.423 . . . . 0.0 113.694 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.42 -42.22 66.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.504 1.122 . . . . 0.0 111.991 174.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.43 -32.38 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.442 1.497 . . . . 0.0 114.5 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.94 -46.4 71.57 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.313 0.96 . . . . 0.0 112.11 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -65.58 -25.36 67.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.664 0.665 . . . . 0.0 112.327 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -77.64 -53.42 7.59 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.973 0.909 . . . . 0.0 111.823 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 15.1 t -56.35 -28.92 60.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.994 0.815 . . . . 0.0 112.671 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . 0.25 10.6 t -79.87 -61.91 1.85 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.425 1.011 . . . . 0.0 112.284 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.76 -38.45 72.48 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.592 1.557 . . . . 0.0 114.037 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.91 -64.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 99.5 t -50.55 -28.37 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.46 1.504 . . . . 0.0 110.939 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -55.4 28.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.762 1.225 . . . . 0.0 112.037 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.73 -34.91 13.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.088 1.355 . . . . 0.0 112.817 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 38.2 m -60.7 -55.21 35.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.997 2.119 . . . . 0.0 112.343 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -36.45 82.19 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.515 0.598 . . . . 0.0 111.556 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 25.2 t -58.17 -51.08 71.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.635 0.774 . . . . 0.0 112.036 167.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.96 -50.91 71.89 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.808 1.643 . . . . 0.0 112.806 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.34 -27.73 67.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 63.9 m -57.33 -36.23 70.89 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.099 0.56 . . . . 0.0 110.598 165.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -79.15 -31.48 44.02 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.071 -1.018 . . . . 0.0 113.192 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.19 -28.95 61.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.178 0.591 . . . . 0.0 110.888 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.27 -94.95 1.99 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.355 1.931 . . . . 0.0 112.791 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -140.17 143.16 32.69 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.401 1.481 . . . . 0.0 113.061 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 114.12 3.75 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.732 2.955 . . . . 0.0 112.081 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.76 175.11 12.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.687 1.595 . . . . 0.0 112.673 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -94.54 87.65 5.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.744 1.218 . . . . 0.0 111.566 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -72.85 153.14 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.288 1.035 . . . . 0.0 112.253 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.5 tt -143.24 153.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.694 1.998 . . . . 0.0 108.72 166.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.75 144.79 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.296 1.038 . . . . 0.0 110.171 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.17 123.51 19.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.798 1.639 . . . . 0.0 108.681 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 11.8 p -124.5 142.13 51.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.186 0.994 . . . . 0.0 112.096 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 t -133.78 111.65 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.122 1.369 . . . . 0.0 107.622 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.2 mm -111.83 90.38 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.788 1.635 . . . . 0.0 107.73 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 162.69 13.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.478 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -75.23 137.98 41.61 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.405 0.622 . . . . 0.0 112.209 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -2.63 20.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.869 2.067 . . . . 0.0 114.185 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -55.06 -29.55 57.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.244 1.818 . . . . 0.0 113.901 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.47 75.89 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.797 1.189 . . . . 0.0 115.438 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.58 60.84 1.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.882 1.673 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.25 62.25 0.07 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-O 121.805 0.669 . . . . 0.0 114.225 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.85 96.25 1.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.698 1.999 . . . . 0.0 109.205 -171.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.18 101.39 6.74 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.199 -1.563 . . . . 0.0 108.63 173.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 22.8 m -130.98 139.09 49.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.398 -1.439 . . . . 0.0 109.765 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.97 138.36 31.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 m -141.46 135.73 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.79 0.836 . . . . 0.0 110.759 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 8.3 t -82.76 9.62 9.35 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.362 -0.836 . . . . 0.0 112.368 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.66 162.57 18.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.177 0.991 . . . . 0.0 112.685 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -154.97 149.9 26.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.207 1.803 . . . . 0.0 110.25 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.15 167.87 21.03 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.176 0.512 . . . . 0.0 111.225 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -139.38 148.65 43.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.451 1.1 . . . . 0.0 110.981 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -109.94 -68.31 0.93 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.536 1.535 . . . . 0.0 111.645 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 11.8 t -84.09 -39.46 19.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.871 0.868 . . . . 0.0 112.036 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -66.6 -46.48 75.75 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.026 1.331 . . . . 0.0 113.038 -172.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.68 -170.51 3.68 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 127.798 2.439 . . . . 0.0 110.19 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -116.08 173.75 14.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.21 1.386 . . . . 0.0 114.571 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 21.3 t -153.41 163.59 39.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.573 1.949 . . . . 0.0 111.062 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 23.1 t -164.85 111.66 1.0 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.023 1.329 . . . . 0.0 112.235 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.8 t -113.93 147.33 38.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.545 -1.347 . . . . 0.0 112.373 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.3 t -139.79 153.27 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.326 1.85 . . . . 0.0 110.394 -173.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -135.13 130.32 35.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.922 1.689 . . . . 0.0 111.621 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -138.68 101.94 4.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.414 1.886 . . . . 0.0 110.368 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.1 146.2 53.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.802 -1.186 . . . . 0.0 112.073 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.32 -175.34 3.84 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.011 1.325 . . . . 0.0 110.226 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.63 -66.74 0.33 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.111 1.764 . . . . 0.0 114.527 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -133.51 17.37 3.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.089 1.756 . . . . 0.0 111.88 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 12.8 ptp -137.92 158.45 44.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.741 2.016 . . . . 0.0 109.095 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -126.1 123.9 39.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.917 0.887 . . . . 0.0 109.894 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.36 130.72 39.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.828 0.851 . . . . 0.0 110.965 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.3 pt -128.72 129.68 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 109.188 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.79 126.03 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.634 1.574 . . . . 0.0 110.45 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 13.6 t -118.64 110.47 17.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.185 0.994 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.91 141.22 29.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.987 0.915 . . . . 0.0 111.316 167.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -125.07 125.6 44.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.258 1.423 . . . . 0.0 109.164 167.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.31 77.26 0.23 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.897 1.713 . . . . 0.0 111.67 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 123.53 25.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.276 1.431 . . . . 0.0 111.95 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 127.321 2.248 . . . . 0.0 112.479 -165.046 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -118.29 176.53 5.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.041 1.737 . . . . 0.0 111.51 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.51 146.42 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.753 1.621 . . . . 0.0 109.859 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 27.1 m -119.73 90.8 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.867 1.267 . . . . 0.0 110.027 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -109.11 140.4 42.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 0.0 110.958 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.14 94.23 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 127.906 2.482 . . . . 0.0 109.68 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.3 167.69 18.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.683 1.193 . . . . 0.0 113.032 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 28.5 p90 . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 124.07 0.948 . . . . 0.0 110.303 166.895 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 120.883 0.373 . . . . 0.0 111.752 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -104.75 176.0 5.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.9 1.28 . . . . 0.0 111.313 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.89 154.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.516 1.127 . . . . 0.0 112.065 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -57.98 -44.52 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.579 1.552 . . . . 0.0 112.214 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.31 -26.39 68.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.921 0.888 . . . . 0.0 113.045 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -77.23 -60.41 2.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.146 1.379 . . . . 0.0 109.837 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.5 t -48.97 -42.6 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.789 1.636 . . . . 0.0 112.518 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -66.91 -9.55 39.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.703 1.601 . . . . 0.0 114.247 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -107.56 -32.46 7.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.275 1.83 . . . . 0.0 112.613 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -50.24 -44.52 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.248 1.019 . . . . 0.0 110.09 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.51 -45.41 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -50.34 62.53 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.458 1.027 . . . . 0.0 111.575 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -33.53 75.83 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.37 68.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.788 0.835 . . . . 0.0 112.406 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.7 mt -58.86 -57.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.889 0.768 . . . . 0.0 110.179 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -63.94 -25.14 68.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -66.71 -50.21 63.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.571 -0.706 . . . . 0.0 111.611 166.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.01 65.66 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.567 1.547 . . . . 0.0 114.217 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.13 -30.28 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 127.389 2.276 . . . . 0.0 112.059 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.69 -14.69 0.01 OUTLIER Glycine 0 C--O 1.279 2.967 0 N-CA-C 120.662 3.025 . . . . 0.0 120.662 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.24 -42.3 49.01 Favored Glycine 0 N--CA 1.482 1.702 0 C-N-CA 127.761 2.6 . . . . 0.0 115.772 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.47 -168.76 3.14 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.224 2.012 . . . . 0.0 111.896 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.79 -170.46 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.955 2.502 . . . . 0.0 112.798 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -74.28 103.82 4.82 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 119.978 -1.701 . . . . 0.0 111.192 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -122.99 88.52 2.94 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.021 1.328 . . . . 0.0 113.514 -174.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -64.96 -16.06 62.92 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.7 p -79.4 -31.56 42.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.988 1.715 . . . . 0.0 115.408 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -61.89 -15.39 42.32 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.159 1.784 . . . . 0.0 114.366 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.1 t -49.62 -31.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.754 1.622 . . . . 0.0 113.262 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -60.51 -53.36 58.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.947 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -67.94 -26.56 66.02 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.362 -0.837 . . . . 0.0 112.317 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -76.86 -52.66 9.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 111.223 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 t -59.0 -28.62 66.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 112.692 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -79.06 -59.36 2.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.156 0.889 . . . . 0.0 112.337 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.07 -38.02 78.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.781 1.173 . . . . 0.0 114.016 -172.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.82 -59.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 C-N-CA 123.691 0.796 . . . . 0.0 110.574 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.61 -30.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.12 0.968 . . . . 0.0 110.835 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.22 -28.41 70.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.01 -42.86 3.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.063 1.745 . . . . 0.0 112.385 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 m -54.97 -54.18 46.11 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.552 2.341 . . . . 0.0 113.016 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -39.06 93.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.125 0.42 . . . . 0.0 110.675 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -58.22 -52.02 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.308 0.643 . . . . 0.0 111.456 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.47 -47.62 83.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.391 2.276 . . . . 0.0 113.598 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.3 -25.51 63.36 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.667 -1.271 . . . . 0.0 114.403 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.1 m -61.76 -24.44 66.82 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.645 -0.659 . . . . 0.0 111.299 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -91.03 -19.89 22.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.76 -22.2 59.94 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.598 0.759 . . . . 0.0 112.729 162.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.89 -154.65 28.8 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.227 1.87 . . . . 0.0 112.143 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -90.8 161.57 35.59 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.847 1.659 . . . . 0.0 112.317 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.35 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.813 3.009 . . . . 0.0 112.384 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.45 165.26 32.65 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.543 1.537 . . . . 0.0 112.123 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -75.36 93.61 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.584 1.554 . . . . 0.0 111.241 170.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -68.52 162.77 24.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.619 -0.676 . . . . 0.0 111.378 163.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.3 150.72 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.618 1.567 . . . . 0.0 108.905 163.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.8 148.13 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.219 1.008 . . . . 0.0 111.117 164.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -140.24 156.3 46.54 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.13 1.372 . . . . 0.0 110.161 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.6 p -143.88 146.38 32.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.759 1.623 . . . . 0.0 111.968 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 124.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.997 1.319 . . . . 0.0 108.006 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.2 112.31 37.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 127.937 2.495 . . . . 0.0 107.332 -169.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.2 tpt -140.53 146.96 38.81 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.35 1.46 . . . . 0.0 111.169 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -95.3 130.11 42.18 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.628 1.171 . . . . 0.0 112.727 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -69.45 -10.11 56.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.324 1.85 . . . . 0.0 114.454 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.74 -20.61 35.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.744 2.017 . . . . 0.0 114.294 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.3 -1.5 3.03 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.124 1.345 . . . . 0.0 114.913 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 155.55 27.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.902 1.351 . . . . 0.0 111.626 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.82 160.32 31.83 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.084 0.85 . . . . 0.0 113.289 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 168.68 22.0 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.082 1.753 . . . . 0.0 112.586 -173.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -121.76 132.46 54.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 110.695 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 m -139.08 146.08 40.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.361 1.464 . . . . 0.0 109.729 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.95 146.38 30.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.39 0.676 . . . . 0.0 111.377 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.4 p -148.18 151.14 35.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 t -79.24 11.08 3.07 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.8 m -63.86 173.2 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.384 -0.823 . . . . 0.0 112.648 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -162.94 154.88 18.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.876 2.071 . . . . 0.0 109.931 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -76.83 147.62 37.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.207 1.003 . . . . 0.0 110.474 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.2 81.29 0.69 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -62.56 1.54 Allowed 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.522 -1.361 . . . . 0.0 113.315 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 p -97.07 -11.04 24.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.918 1.687 . . . . 0.0 113.117 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -47.8 21.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.251 1.42 . . . . 0.0 112.726 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -154.46 -47.63 0.09 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.02 111.36 1.4 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-N 120.35 1.432 . . . . 0.0 115.145 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -146.37 163.85 34.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.49 1.516 . . . . 0.0 112.352 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.1 t -156.46 149.37 23.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.203 1.801 . . . . 0.0 110.608 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 t -142.67 142.79 32.11 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.73 -1.856 . . . . 0.0 111.138 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.4 107.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.137 0.975 . . . . 0.0 109.995 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -92.17 124.01 35.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.106 0.962 . . . . 0.0 112.437 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -131.21 136.95 48.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.101 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.98 164.36 12.56 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 111.795 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -138.23 -178.73 5.41 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.871 1.668 . . . . 0.0 110.018 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.25 -49.59 60.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.061 2.545 . . . . 0.0 114.193 -175.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.5 t -136.45 0.77 2.55 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.173 1.389 . . . . 0.0 113.282 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.4 ptp -132.84 176.88 8.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.86 1.664 . . . . 0.0 111.958 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -136.09 147.47 47.84 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.98 1.312 . . . . 0.0 110.694 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.21 69.66 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.964 1.306 . . . . 0.0 110.786 -163.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.53 138.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.323 1.049 . . . . 0.0 111.325 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.09 145.15 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.688 1.595 . . . . 0.0 111.613 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.26 120.98 16.35 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.912 1.285 . . . . 0.0 110.469 -166.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.93 136.74 52.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.132 1.773 . . . . 0.0 112.711 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.23 117.27 17.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.165 1.386 . . . . 0.0 108.372 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.04 73.15 0.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.113 1.34 . . . . 0.0 112.945 -163.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.02 119.76 18.68 Favored 'General case' 0 C--O 1.273 2.331 0 C-N-CA 125.243 1.417 . . . . 0.0 111.544 -165.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.301 -1.536 0 CA-C-O 123.372 1.558 . . . . 0.0 114.042 -165.097 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -129.36 164.2 24.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.277 1.031 . . . . 0.0 112.334 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.5 mm -49.02 137.49 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 128.408 2.683 . . . . 0.0 112.053 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 93.7 m -100.49 92.01 4.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.981 1.312 . . . . 0.0 110.598 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -89.12 150.54 22.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.213 167.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.29 103.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.46 2.304 . . . . 0.0 109.007 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.51 130.2 40.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 111.153 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.548 1.539 . . . . 0.0 108.487 176.966 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 121.624 0.726 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -84.96 179.23 7.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.517 1.127 . . . . 0.0 112.024 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.25 156.7 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.343 -0.848 . . . . 0.0 113.049 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.9 -44.49 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.559 1.944 . . . . 0.0 111.969 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.08 -25.83 68.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.595 0.758 . . . . 0.0 113.035 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -78.57 -59.5 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.259 1.423 . . . . 0.0 110.048 172.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -49.29 -43.58 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 126.359 1.864 . . . . 0.0 112.173 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -66.95 -9.29 36.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.469 1.508 . . . . 0.0 114.152 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -106.88 -32.44 7.91 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.21 1.804 . . . . 0.0 112.715 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 28.6 mt -50.37 -44.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.341 1.056 . . . . 0.0 110.057 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.44 -45.29 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -50.44 61.42 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.469 1.031 . . . . 0.0 111.574 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.12 74.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.32 66.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.745 0.818 . . . . 0.0 112.411 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.99 -57.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.932 0.787 . . . . 0.0 110.101 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.75 -25.32 68.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -66.79 -50.05 63.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.693 -0.629 . . . . 0.0 111.553 166.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.71 -24.87 65.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.544 1.538 . . . . 0.0 114.235 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 mt -56.12 -30.3 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 127.415 2.286 . . . . 0.0 111.916 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -41.31 -13.61 0.01 OUTLIER Glycine 0 C--O 1.28 3.012 0 N-CA-C 120.656 3.023 . . . . 0.0 120.656 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.14 -42.01 54.46 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 127.724 2.583 . . . . 0.0 115.574 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.34 -168.82 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.35 2.075 . . . . 0.0 111.966 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.57 -170.63 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.929 2.492 . . . . 0.0 112.832 165.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.2 102.59 4.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.032 -1.668 . . . . 0.0 111.245 -172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -122.94 88.36 2.92 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.098 1.359 . . . . 0.0 113.202 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.32 -21.24 65.11 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.0 p -77.67 -27.81 50.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.375 1.87 . . . . 0.0 115.175 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -64.34 -15.64 60.74 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.389 1.475 . . . . 0.0 114.111 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.55 -29.45 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.742 1.617 . . . . 0.0 114.538 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -60.64 -52.69 64.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.522 1.055 . . . . 0.0 112.434 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -68.12 -26.56 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.499 -0.751 . . . . 0.0 112.248 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -77.04 -52.93 8.48 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.866 0.866 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -58.92 -28.26 66.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.997 0.919 . . . . 0.0 112.755 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 5.9 t -79.22 -60.19 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.148 0.885 . . . . 0.0 112.355 167.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -58.55 -37.47 75.77 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.89 1.223 . . . . 0.0 114.033 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 89.0 t -71.01 -59.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 123.682 0.793 . . . . 0.0 110.42 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 92.4 t -48.65 -31.1 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.095 0.958 . . . . 0.0 110.819 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.18 -27.73 69.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.72 -43.02 3.51 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.043 1.737 . . . . 0.0 112.331 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.2 m -55.01 -54.18 46.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.64 2.376 . . . . 0.0 113.064 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.94 93.19 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.204 0.456 . . . . 0.0 110.66 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 11.3 t -58.49 -51.71 68.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.31 0.644 . . . . 0.0 111.52 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.57 -48.15 81.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.441 2.297 . . . . 0.0 113.505 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.66 -25.31 63.85 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.662 -1.273 . . . . 0.0 114.37 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.9 m -62.19 -24.82 67.43 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.708 -0.62 . . . . 0.0 111.278 166.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -89.99 -21.33 22.46 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.74 -22.19 60.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.841 0.856 . . . . 0.0 113.011 162.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -153.53 26.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.274 1.892 . . . . 0.0 112.212 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -93.66 157.21 38.7 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.532 1.533 . . . . 0.0 112.281 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 112.75 3.3 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.934 3.089 . . . . 0.0 112.104 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -147.4 159.33 43.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.712 1.205 . . . . 0.0 112.217 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -68.8 79.67 0.3 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.326 2.251 . . . . 0.0 111.661 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -60.95 159.02 12.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.979 0.895 . . . . 0.0 111.087 163.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 3.0 tt -137.25 153.22 28.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 125.952 1.701 . . . . 0.0 108.831 166.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 19.2 m -141.49 147.12 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.703 1.201 . . . . 0.0 109.869 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -138.42 157.71 45.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.792 1.237 . . . . 0.0 109.405 168.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 32.0 p -145.82 152.66 39.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 112.124 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.7 128.75 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.961 1.304 . . . . 0.0 108.247 -176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.9 mm -119.87 114.08 42.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 128.093 2.557 . . . . 0.0 106.809 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 36.2 tpp -140.19 148.37 41.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.499 1.52 . . . . 0.0 111.161 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -97.65 128.15 44.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.014 1.326 . . . . 0.0 112.36 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.78 -9.07 48.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.449 1.9 . . . . 0.0 114.452 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -57.27 -21.36 33.89 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.104 2.161 . . . . 0.0 114.412 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 -2.76 3.35 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.963 1.268 . . . . 0.0 115.102 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.9 164.46 14.94 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.81 1.305 . . . . 0.0 111.93 169.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -173.81 162.65 33.49 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.025 0.821 . . . . 0.0 113.425 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.21 171.84 16.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.998 1.719 . . . . 0.0 113.063 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -120.69 133.4 55.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.403 0.681 . . . . 0.0 111.055 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 19.2 m -138.22 147.01 43.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.426 1.09 . . . . 0.0 110.296 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -143.98 146.5 32.95 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.719 -0.613 . . . . 0.0 111.359 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 95.6 p -147.98 151.21 35.4 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 11.53 2.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.7 m -63.72 173.5 1.72 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.869 0.843 . . . . 0.0 112.342 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.08 156.78 22.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.835 2.054 . . . . 0.0 109.793 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.21 138.15 45.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 0.0 109.617 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -145.6 104.82 3.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.895 1.278 . . . . 0.0 111.472 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 39.2 t -78.5 -75.7 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.019 -1.051 . . . . 0.0 111.033 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 64.8 p -85.81 -19.17 31.07 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.209 1.403 . . . . 0.0 113.068 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -41.99 80.3 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.096 1.759 . . . . 0.0 112.94 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -153.07 -77.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.62 1.168 . . . . 0.0 113.124 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 161.07 105.46 0.2 Allowed Glycine 0 CA--C 1.538 1.527 0 O-C-N 120.659 -1.276 . . . . 0.0 114.566 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 77.3 p -137.72 162.15 34.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.8 1.24 . . . . 0.0 112.775 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.3 t -157.12 155.17 30.59 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.987 1.715 . . . . 0.0 110.221 171.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.0 t -148.36 145.07 27.93 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 119.803 -1.811 . . . . 0.0 111.003 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.62 118.9 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -106.17 123.29 47.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.565 1.146 . . . . 0.0 112.256 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -130.63 140.01 50.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.603 1.561 . . . . 0.0 110.974 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.5 159.74 15.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.77 . . . . 0.0 111.624 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -133.68 178.42 6.95 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.437 1.895 . . . . 0.0 110.251 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -48.57 57.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.466 2.706 . . . . 0.0 113.837 -176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.8 t -137.28 0.67 2.34 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.11 1.364 . . . . 0.0 113.288 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.6 ptp -131.62 178.94 6.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.807 1.643 . . . . 0.0 111.994 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.106 1.362 . . . . 0.0 110.458 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 8.3 p -141.02 71.77 1.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 0.0 111.014 -164.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.99 140.59 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.112 0.965 . . . . 0.0 111.683 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.88 139.25 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.271 1.829 . . . . 0.0 110.935 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 36.1 p -130.93 139.09 50.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.43 1.092 . . . . 0.0 112.173 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -127.19 138.86 53.22 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.044 1.738 . . . . 0.0 112.783 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -132.96 109.01 9.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.094 1.357 . . . . 0.0 109.042 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.06 66.24 0.58 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.579 2.038 . . . . 0.0 110.438 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.37 142.52 57.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 111.184 -169.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -128.94 163.71 24.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 112.24 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.3 mm -49.49 135.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 128.053 2.541 . . . . 0.0 111.921 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.5 m -97.55 88.02 4.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.921 1.288 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -85.58 150.46 24.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.626 -0.671 . . . . 0.0 110.777 164.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.95 107.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.578 1.951 . . . . 0.0 109.687 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.69 133.48 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.506 1.123 . . . . 0.0 111.027 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 125.448 1.499 . . . . 0.0 108.361 176.614 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.434 0.635 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.42 164.37 12.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.784 0.833 . . . . 0.0 112.122 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.14 158.07 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.809 0.844 . . . . 0.0 112.358 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.76 -39.86 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.835 2.054 . . . . 0.0 112.92 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.22 -22.99 63.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.003 0.921 . . . . 0.0 113.097 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -96.86 -51.17 4.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.038 0.935 . . . . 0.0 111.972 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.1 t -48.59 -38.06 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.008 1.323 . . . . 0.0 112.464 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 t -63.9 -13.68 47.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.045 1.738 . . . . 0.0 114.298 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -101.8 -38.14 7.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.899 2.08 . . . . 0.0 111.976 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -51.71 -42.44 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.067 0.849 . . . . 0.0 110.866 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.92 -42.41 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.6 -0.688 . . . . 0.0 112.804 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.86 49.52 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 111.121 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -30.71 70.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.04 -44.66 38.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.541 0.736 . . . . 0.0 112.966 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 -58.01 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.061 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.27 -29.56 70.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.64 -46.81 86.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.834 0.854 . . . . 0.0 112.181 168.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.01 -35.57 80.91 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.32 -48.23 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.918 1.287 . . . . 0.0 109.907 172.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.43 12.79 74.93 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.389 0.995 . . . . 0.0 114.662 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 3.39 38.61 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.684 1.434 . . . . 0.0 116.684 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.98 146.25 43.22 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.696 1.748 . . . . 0.0 111.085 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.62 -160.39 0.15 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.914 1.286 . . . . 0.0 111.876 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -47.73 136.64 10.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.297 1.039 . . . . 0.0 111.617 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -136.7 179.16 6.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.775 1.63 . . . . 0.0 111.375 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.97 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.335 1.054 . . . . 0.0 112.226 165.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.9 p -47.31 -0.54 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.179 2.591 . . . . 0.0 117.821 168.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.22 -39.5 2.98 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.666 2.386 . . . . 0.0 113.31 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.77 -29.52 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.368 1.467 . . . . 0.0 113.193 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.95 -49.36 75.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.668 1.187 . . . . 0.0 112.312 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.56 -25.41 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.471 -0.768 . . . . 0.0 112.638 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.09 -54.1 7.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.893 0.769 . . . . 0.0 111.393 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.06 -24.27 62.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.771 0.829 . . . . 0.0 112.651 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.3 t -83.32 -59.71 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.407 1.003 . . . . 0.0 113.033 166.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -58.44 -38.78 78.18 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.987 1.315 . . . . 0.0 113.896 -172.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.65 -62.87 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 C-N-CA 124.309 1.044 . . . . 0.0 109.623 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -48.92 -30.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.414 1.486 . . . . 0.0 111.051 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -59.33 -34.35 72.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -112.71 -36.34 5.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.632 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.8 m -59.92 -51.74 68.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.757 2.023 . . . . 0.0 111.816 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -43.38 98.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 111.057 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -66.79 -26.2 66.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -75.31 -51.98 11.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.262 2.225 . . . . 0.0 113.271 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.59 -25.89 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -59.61 -33.93 72.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.144 0.577 . . . . 0.0 110.493 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -79.59 -28.6 41.05 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mt -61.95 -32.3 72.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.58 -99.62 2.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.711 1.148 . . . . 0.0 113.269 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -135.95 146.31 56.24 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.86 1.664 . . . . 0.0 113.092 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.53 99.11 1.01 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.296 3.33 . . . . 0.0 112.32 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -140.62 167.89 21.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.615 1.566 . . . . 0.0 111.823 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -61.52 129.27 40.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.77 1.228 . . . . 0.0 110.543 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -115.09 152.16 33.02 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.09 1.756 . . . . 0.0 110.167 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -151.98 157.3 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.514 1.526 . . . . 0.0 109.283 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.28 152.14 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.236 1.814 . . . . 0.0 109.055 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -128.86 144.41 51.17 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.079 1.352 . . . . 0.0 108.315 161.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.2 p -137.57 154.22 49.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.724 0.773 . . . . 0.0 111.688 167.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.41 114.47 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.779 1.231 . . . . 0.0 109.605 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.26 97.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 126.165 1.786 . . . . 0.0 106.596 -177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -154.63 90.07 1.29 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 112.592 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -151.6 142.57 23.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.832 2.053 . . . . 0.0 108.698 160.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -158.03 -62.61 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.38 1.472 . . . . 0.0 111.242 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -115.04 -9.51 12.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.764 1.626 . . . . 0.0 114.303 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.67 2.31 57.46 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.28 1.419 . . . . 0.0 115.254 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -177.34 2.24 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.118 1.459 . . . . 0.0 112.261 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.16 -173.12 41.54 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.444 1.021 . . . . 0.0 114.13 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.87 174.02 10.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.079 2.552 . . . . 0.0 110.543 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -98.42 100.82 12.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.281 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -111.94 142.65 44.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 108.744 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 145.44 32.49 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 111.193 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.411 ' CB ' ' HG ' ' A' ' 85' ' ' CYS . 30.7 p -139.96 143.69 36.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 122.086 0.946 . . . . 0.0 112.097 175.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -81.72 16.2 1.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.102 0.961 . . . . 0.0 112.056 170.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 25.0 m -64.3 161.5 16.61 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.198 -0.939 . . . . 0.0 112.044 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -160.01 138.25 10.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.149 1.38 . . . . 0.0 111.995 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -70.12 146.69 50.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.16 0.584 . . . . 0.0 110.503 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -140.45 160.3 40.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.183 1.393 . . . . 0.0 110.925 168.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -117.52 -64.4 1.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.055 1.342 . . . . 0.0 112.223 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 t -86.5 -39.77 15.94 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.788 0.835 . . . . 0.0 112.163 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -53.87 52.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.134 1.774 . . . . 0.0 111.589 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -142.44 176.3 9.12 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.503 2.721 . . . . 0.0 109.542 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.33 140.57 15.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.989 0.804 . . . . 0.0 112.117 172.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -143.42 149.44 37.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.42 . . . . 0.0 110.282 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.26 108.97 4.02 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.09 0.956 . . . . 0.0 111.48 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 t -100.97 143.25 31.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.895 0.878 . . . . 0.0 111.729 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.39 128.87 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.441 1.896 . . . . 0.0 109.245 -168.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -121.64 122.18 39.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.937 1.695 . . . . 0.0 112.063 -170.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -133.49 117.49 17.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.688 1.595 . . . . 0.0 110.767 -175.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.77 167.5 21.28 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.348 -0.845 . . . . 0.0 112.946 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -151.39 -175.16 5.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.079 1.352 . . . . 0.0 111.375 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.83 -59.21 2.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.601 1.96 . . . . 0.0 113.347 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.2 t -138.13 -35.58 0.62 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.807 1.643 . . . . 0.0 112.846 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.9 ptp -100.33 89.85 4.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.932 1.293 . . . . 0.0 112.797 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.29 155.87 8.35 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.53 -0.731 . . . . 0.0 111.661 173.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 2.8 p -127.51 135.76 50.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.936 1.294 . . . . 0.0 111.066 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.65 122.43 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.491 1.517 . . . . 0.0 110.258 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.92 138.13 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.292 1.837 . . . . 0.0 108.756 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -127.52 107.48 9.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.416 1.086 . . . . 0.0 110.431 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.56 147.74 25.19 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.242 1.017 . . . . 0.0 112.388 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 8.0 m-85 -136.78 118.58 15.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.217 2.207 . . . . 0.0 108.959 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.42 100.74 0.93 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.719 2.104 . . . . 0.0 110.423 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.04 145.41 36.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.646 1.178 . . . . 0.0 111.882 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.851 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.94 161.33 29.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.277 1.831 . . . . 0.0 111.7 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.98 153.04 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.939 1.695 . . . . 0.0 110.259 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 100.0 m -121.86 94.32 4.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.313 1.445 . . . . 0.0 110.844 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -88.15 149.79 23.69 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.241 -0.912 . . . . 0.0 111.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.26 94.44 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 127.69 2.396 . . . . 0.0 108.521 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.98 165.56 27.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.11 1.364 . . . . 0.0 112.378 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 125.214 1.405 . . . . 0.0 109.944 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.346 0.594 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.75 159.07 15.23 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 0.0 111.935 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.66 158.9 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.551 1.141 . . . . 0.0 111.267 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.81 -35.54 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.82 2.048 . . . . 0.0 113.383 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.33 -23.05 66.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.864 0.866 . . . . 0.0 113.039 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -86.49 -54.52 4.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.901 1.28 . . . . 0.0 110.643 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 39.8 t -53.91 -38.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.087 1.355 . . . . 0.0 112.577 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.1 t -61.19 -11.36 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.286 1.834 . . . . 0.0 114.258 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -107.4 -36.9 6.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.879 1.671 . . . . 0.0 112.317 168.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.8 mt -51.11 -40.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.508 1.049 . . . . 0.0 111.25 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.81 -41.18 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.462 -0.774 . . . . 0.0 113.058 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -49.28 51.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.901 1.228 . . . . 0.0 111.646 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -29.62 70.11 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.29 -44.67 28.88 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.06 -58.73 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.221 0.918 . . . . 0.0 110.052 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.14 -29.49 70.38 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -62.89 -46.38 88.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.789 0.836 . . . . 0.0 112.059 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.24 79.8 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.3 -47.96 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.936 1.294 . . . . 0.0 109.946 172.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.14 12.89 75.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.395 0.998 . . . . 0.0 114.685 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.48 40.3 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -60.12 146.43 43.22 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 119.671 1.735 . . . . 0.0 111.115 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.68 -160.29 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.982 1.313 . . . . 0.0 111.789 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -47.93 137.48 9.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.269 1.028 . . . . 0.0 111.748 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -137.09 179.44 6.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.732 1.613 . . . . 0.0 111.426 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -63.48 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.508 1.123 . . . . 0.0 112.185 164.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 42.0 p -47.16 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.284 2.634 . . . . 0.0 117.925 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.76 -39.56 3.81 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.815 2.446 . . . . 0.0 113.442 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.18 -28.79 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.199 1.4 . . . . 0.0 113.169 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.63 -49.55 74.73 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.71 1.204 . . . . 0.0 112.354 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.58 -25.76 65.94 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.516 -0.74 . . . . 0.0 112.666 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -75.63 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.887 0.767 . . . . 0.0 111.452 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.0 t -59.65 -22.95 62.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.769 0.828 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -84.24 -59.64 2.33 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.477 1.035 . . . . 0.0 113.19 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -58.32 -38.62 77.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.99 1.316 . . . . 0.0 114.03 -172.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.45 -62.65 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 124.393 1.077 . . . . 0.0 109.591 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.96 -30.4 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.473 1.509 . . . . 0.0 110.953 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.21 -33.07 70.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -114.62 -35.48 4.86 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.654 1.581 . . . . 0.0 112.824 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 54.2 m -61.58 -48.3 81.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.984 2.114 . . . . 0.0 112.079 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.79 -45.16 93.95 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.455 0.645 . . . . 0.0 110.642 176.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 83.0 p -66.18 -25.26 66.86 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.137 -0.977 . . . . 0.0 113.375 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -75.79 -54.53 6.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.438 2.295 . . . . 0.0 113.155 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -26.28 68.28 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.744 1.156 . . . . 0.0 113.433 -172.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -56.99 -40.57 76.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.325 0.65 . . . . 0.0 110.835 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -73.87 -29.07 61.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.784 0.834 . . . . 0.0 112.637 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 5.2 mt -62.49 -31.98 72.81 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -97.9 2.1 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.767 1.175 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -136.78 146.74 56.48 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.776 1.631 . . . . 0.0 112.98 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.23 97.27 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.202 3.268 . . . . 0.0 112.203 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.15 167.67 21.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.506 1.522 . . . . 0.0 111.838 172.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -61.77 131.35 49.6 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.887 1.275 . . . . 0.0 110.754 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -116.96 152.33 34.79 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.259 1.824 . . . . 0.0 110.296 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.7 tt -152.81 157.41 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.38 152.56 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.451 1.9 . . . . 0.0 109.225 165.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 2.1 p -127.27 144.05 51.12 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.025 1.33 . . . . 0.0 108.353 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 20.1 p -138.12 155.83 48.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.959 0.885 . . . . 0.0 112.01 168.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.46 125.21 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.374 1.07 . . . . 0.0 109.877 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.2 mm -115.82 98.32 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.027 2.131 . . . . 0.0 107.18 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -116.26 152.66 33.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.444 1.497 . . . . 0.0 110.48 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.97 147.6 32.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.813 0.816 . . . . 0.0 112.483 -175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -75.9 1.23 15.68 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.937 1.695 . . . . 0.0 114.292 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -64.97 -13.17 56.78 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.52 5.26 61.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.965 1.269 . . . . 0.0 115.348 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.2 -169.89 0.69 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.566 1.183 . . . . 0.0 112.185 169.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.85 -170.54 42.86 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.071 -1.018 . . . . 0.0 114.152 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.69 -171.44 2.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.341 2.256 . . . . 0.0 111.449 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -114.36 94.79 4.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.462 0.705 . . . . 0.0 110.232 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 23.3 m -106.67 142.35 36.46 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.891 173.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.88 141.21 38.58 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.425 0.69 . . . . 0.0 110.638 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' SER . . . . . 0.425 ' CB ' ' HG ' ' B' ' 228' ' ' CYS . 25.0 p -135.98 140.27 43.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.119 0.962 . . . . 0.0 111.714 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.9 t -80.44 14.99 1.77 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.828 0.851 . . . . 0.0 111.993 171.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . 0.425 ' HG ' ' CB ' ' B' ' 226' ' ' SER . 13.2 m -64.66 161.77 17.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.214 -0.929 . . . . 0.0 112.017 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.09 139.02 10.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.85 146.59 51.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.725 -0.61 . . . . 0.0 110.343 174.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -139.88 159.32 42.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.247 1.419 . . . . 0.0 110.726 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 43.3 t -117.1 -64.58 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.09 1.356 . . . . 0.0 112.228 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.5 t -86.78 -39.64 15.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.796 0.839 . . . . 0.0 112.095 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -54.29 47.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 111.614 -174.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -142.11 176.55 8.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.465 2.706 . . . . 0.0 109.631 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.03 140.57 15.2 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.046 0.831 . . . . 0.0 112.229 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 150.05 39.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.289 1.436 . . . . 0.0 110.276 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.4 t -148.44 107.59 3.89 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.143 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.7 t -98.8 142.69 30.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.861 0.864 . . . . 0.0 111.527 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 123.41 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 109.075 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -115.14 119.16 35.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.853 1.661 . . . . 0.0 111.339 -172.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.7 148.55 49.0 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.14 1.376 . . . . 0.0 110.514 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.12 165.49 11.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.816 1.246 . . . . 0.0 111.355 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.72 -176.06 5.46 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.78 1.232 . . . . 0.0 110.521 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.27 -67.09 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.127 1.771 . . . . 0.0 113.017 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -139.53 4.97 2.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.072 1.749 . . . . 0.0 113.405 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 23.9 ptp -133.99 82.01 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 111.992 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -58.15 147.23 30.76 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.361 -0.837 . . . . 0.0 111.379 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 4.4 p -134.47 116.54 15.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.275 1.03 . . . . 0.0 111.991 -171.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.8 pt -117.14 130.16 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.615 1.166 . . . . 0.0 111.188 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.59 139.05 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.721 2.008 . . . . 0.0 108.691 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.3 t -129.83 109.82 11.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.344 1.058 . . . . 0.0 110.655 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.11 148.0 23.91 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.185 0.994 . . . . 0.0 112.243 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' B' ' 228' ' ' CYS . 8.7 m-85 -136.3 119.13 16.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.122 2.169 . . . . 0.0 108.952 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.03 100.09 0.91 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.662 2.077 . . . . 0.0 110.304 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.24 145.69 36.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.624 1.17 . . . . 0.0 111.734 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 178.315 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.69 161.24 29.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.342 1.857 . . . . 0.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.19 152.34 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.833 1.653 . . . . 0.0 110.269 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 98.3 m -120.92 91.57 3.56 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.475 1.51 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -86.47 150.74 24.06 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.08 100.11 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.754 2.022 . . . . 0.0 109.344 174.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.38 166.97 23.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.724 1.61 . . . . 0.0 111.69 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 124.901 1.28 . . . . 0.0 109.588 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.0 152.45 48.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.318 1.047 . . . . 0.0 113.419 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.46 161.56 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.423 1.889 . . . . 0.0 111.421 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.466 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 63.7 t -61.03 -35.55 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.642 1.977 . . . . 0.0 111.56 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.35 4.83 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.98 1.312 . . . . 0.0 114.008 172.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -109.23 -59.79 1.85 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.8 -1.187 . . . . 0.0 107.888 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 16' ' ' VAL . 2.1 p -44.39 -42.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.192 1.797 . . . . 0.0 112.971 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 t -60.04 -11.65 6.38 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -115.57 -33.93 5.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.654 1.982 . . . . 0.0 112.308 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -41.84 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.144 0.977 . . . . 0.0 110.731 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.5 p -59.05 -42.85 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.413 -0.804 . . . . 0.0 112.7 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -53.14 33.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.158 0.89 . . . . 0.0 110.728 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -31.86 71.99 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.14 -42.3 38.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.535 0.734 . . . . 0.0 112.964 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.0 mt -59.47 -56.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.284 0.947 . . . . 0.0 109.522 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.03 -28.88 70.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.5 t -62.52 -47.52 83.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.365 1.066 . . . . 0.0 112.299 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.78 76.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -32.1 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.887 1.275 . . . . 0.0 111.3 170.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.19 17.37 55.73 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.657 1.122 . . . . 0.0 114.709 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.22 21.53 77.76 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.659 1.123 . . . . 0.0 115.265 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -55.36 156.86 4.05 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 119.485 1.643 . . . . 0.0 112.569 171.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 -179.45 1.07 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.468 1.507 . . . . 0.0 112.391 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -47.56 141.71 4.95 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.606 1.562 . . . . 0.0 113.251 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -132.71 171.83 13.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.811 1.244 . . . . 0.0 112.586 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -91.65 -114.63 0.08 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 109.843 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -70.64 -1.01 9.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 114.985 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.4 -41.27 39.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.152 1.381 . . . . 0.0 113.629 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.5 -30.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 118.402 -0.809 . . . . 0.0 113.001 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.29 -55.03 32.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.787 1.176 . . . . 0.0 111.632 170.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.93 -25.35 67.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.86 -0.525 . . . . 0.0 112.405 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.39 -56.35 4.71 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.2 1.0 . . . . 0.0 111.45 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 t -57.41 -26.66 61.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.823 0.738 . . . . 0.0 112.76 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -81.29 -57.38 3.52 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.304 0.956 . . . . 0.0 112.811 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -60.24 -34.79 74.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.466 -1.397 . . . . 0.0 114.073 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.6 t -70.33 -64.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.214 1.005 . . . . 0.0 109.368 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.17 -30.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.055 1.342 . . . . 0.0 111.002 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.5 -32.56 71.55 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -114.0 -35.46 5.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.496 1.519 . . . . 0.0 112.75 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.7 m -62.03 -51.36 68.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.073 2.149 . . . . 0.0 112.108 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -42.93 98.67 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.91 0.323 . . . . 0.0 110.691 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 p -66.51 -27.01 67.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -74.29 -50.49 18.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.532 2.333 . . . . 0.0 113.309 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.41 -29.81 70.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.2 1.364 . . . . 0.0 114.045 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.2 m -57.12 -27.96 62.27 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.162 0.985 . . . . 0.0 111.444 167.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.78 -28.17 19.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.78 -33.62 74.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.062 0.545 . . . . 0.0 109.852 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.1 -98.67 2.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.635 1.588 . . . . 0.0 112.403 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -134.27 121.06 15.23 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.661 1.185 . . . . 0.0 112.788 -173.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.72 107.1 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.006 3.138 . . . . 0.0 112.977 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -146.17 170.94 15.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.351 1.861 . . . . 0.0 112.13 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -76.5 81.16 3.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.521 1.529 . . . . 0.0 111.957 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.71 138.17 46.42 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.622 1.569 . . . . 0.0 110.162 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 154.46 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.405 1.482 . . . . 0.0 109.879 171.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.84 159.19 33.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 124.613 1.165 . . . . 0.0 110.826 162.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 p -136.04 146.76 47.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.249 1.019 . . . . 0.0 110.793 157.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.4 p -136.63 143.43 43.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.313 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.05 95.78 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.877 1.271 . . . . 0.0 108.345 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mm -91.34 114.13 28.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 tpt -137.61 161.54 36.19 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.34 1.456 . . . . 0.0 110.736 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -67.47 151.98 46.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.494 -0.754 . . . . 0.0 111.37 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 1.87 1.35 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.152 2.181 . . . . 0.0 115.002 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -56.24 -21.86 26.14 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.773 1.629 . . . . 0.0 114.299 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.99 34.15 70.6 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.955 0.788 . . . . 0.0 113.897 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -177.38 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.069 1.748 . . . . 0.0 113.779 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.83 47.47 3.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.086 1.327 . . . . 0.0 114.327 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.38 125.55 24.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.909 1.354 . . . . 0.0 109.463 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -120.22 92.58 3.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.199 1.0 . . . . 0.0 109.537 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.1 m -109.98 142.89 40.73 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.028 -1.045 . . . . 0.0 109.329 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.8 140.39 34.7 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.637 -0.665 . . . . 0.0 111.945 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -139.38 127.56 22.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 p -75.07 13.09 0.74 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.899 -1.126 . . . . 0.0 113.967 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.4 m -58.29 164.48 2.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.585 1.554 . . . . 0.0 112.694 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -167.14 138.52 3.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.954 1.702 . . . . 0.0 110.331 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -83.03 149.19 27.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.752 0.821 . . . . 0.0 110.872 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -142.09 159.0 43.11 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.364 1.865 . . . . 0.0 111.123 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.9 t -114.66 -64.12 1.36 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.716 1.206 . . . . 0.0 111.201 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -87.26 -18.04 31.16 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -41.46 12.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.753 1.621 . . . . 0.0 112.738 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -164.27 -171.68 2.48 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.458 1.903 . . . . 0.0 111.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.83 140.42 14.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.883 1.706 . . . . 0.0 114.83 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.9 p -155.87 158.04 37.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.462 1.905 . . . . 0.0 111.912 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 17.8 t -146.39 160.4 42.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.506 1.522 . . . . 0.0 111.026 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -148.83 144.82 27.2 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.145 -1.597 . . . . 0.0 111.24 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -134.89 102.64 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.809 1.244 . . . . 0.0 109.427 -170.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.28 104.52 16.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.823 1.249 . . . . 0.0 112.356 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -103.86 143.82 32.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.333 1.063 . . . . 0.0 110.725 170.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.03 147.8 33.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.365 1.866 . . . . 0.0 110.996 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -141.4 -172.3 3.48 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 112.195 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -58.51 2.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.865 2.466 . . . . 0.0 114.576 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.9 t -141.45 21.71 2.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.967 1.307 . . . . 0.0 113.438 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.1 150.21 45.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.384 1.474 . . . . 0.0 111.32 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.16 128.92 49.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.298 1.839 . . . . 0.0 109.645 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.8 p -137.72 82.55 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.208 1.004 . . . . 0.0 112.773 -172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -109.8 133.45 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.027 0.931 . . . . 0.0 112.077 -173.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.54 146.33 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.226 1.81 . . . . 0.0 111.408 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -133.9 129.2 36.02 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.139 1.376 . . . . 0.0 110.067 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.82 135.92 53.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.67 1.988 . . . . 0.0 112.434 -169.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -132.29 115.22 15.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.5 58.52 0.39 Allowed Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.862 1.696 . . . . 0.0 112.801 -167.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.72 124.27 19.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 112.888 -168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 126.03 1.732 . . . . 0.0 111.739 -169.957 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 111.298 0.11 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -128.96 173.11 10.71 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.51 142.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.365 1.466 . . . . 0.0 111.26 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.4 m -101.3 88.86 3.58 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.225 1.41 . . . . 0.0 110.295 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -79.96 147.9 31.42 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.26 -0.9 . . . . 0.0 110.788 164.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.76 95.2 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.831 2.452 . . . . 0.0 108.743 175.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -139.35 169.49 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.556 1.142 . . . . 0.0 112.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 125.059 1.344 . . . . 0.0 110.127 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -127.5 154.76 44.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 113.308 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.43 158.6 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.295 1.838 . . . . 0.0 111.154 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.56 -37.52 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.157 1.783 . . . . 0.0 111.923 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.02 -22.87 66.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.366 1.066 . . . . 0.0 113.615 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -75.86 -59.16 2.88 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 169.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.16 -43.17 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.96 2.104 . . . . 0.0 112.588 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -60.38 -10.9 5.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.207 1.803 . . . . 0.0 114.695 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -114.25 -33.91 5.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.591 1.957 . . . . 0.0 112.244 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.0 mt -50.19 -42.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.843 0.857 . . . . 0.0 110.723 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.6 p -59.04 -42.65 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.389 -0.82 . . . . 0.0 112.736 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -52.73 37.11 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.222 0.919 . . . . 0.0 110.768 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -31.8 71.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.06 -42.41 38.43 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.613 0.765 . . . . 0.0 112.946 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.74 -57.02 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 119.4 1.0 . . . . 0.0 109.636 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.99 -28.53 70.16 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 t -62.64 -47.76 82.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.436 1.094 . . . . 0.0 112.281 168.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.37 -33.79 76.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -32.08 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.918 1.287 . . . . 0.0 111.392 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 62.08 17.3 55.18 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.665 1.126 . . . . 0.0 114.733 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 22.02 77.58 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.689 1.138 . . . . 0.0 115.314 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.29 157.25 3.73 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 119.386 1.593 . . . . 0.0 112.672 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.4 -179.69 1.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.384 1.474 . . . . 0.0 112.378 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -47.55 141.45 5.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.469 1.507 . . . . 0.0 113.256 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -132.33 171.75 13.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 112.444 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.57 -113.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 109.721 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 3.6 m -71.58 -1.03 12.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.242 1.817 . . . . 0.0 114.958 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -49.6 -40.92 40.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 113.626 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.9 -30.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.687 0.795 . . . . 0.0 112.868 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -62.57 -55.53 26.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.766 1.166 . . . . 0.0 111.87 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.3 -25.3 67.57 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.8 -0.562 . . . . 0.0 112.248 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -76.5 -56.17 4.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.342 1.057 . . . . 0.0 111.463 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.7 t -57.28 -26.62 61.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.936 0.789 . . . . 0.0 112.78 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.2 t -81.72 -57.78 3.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.171 0.896 . . . . 0.0 112.86 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.83 -34.78 73.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.279 1.4 . . . . 0.0 114.007 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.29 -64.12 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.105 0.962 . . . . 0.0 109.375 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -49.2 -30.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.135 1.374 . . . . 0.0 110.964 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -60.66 -32.63 71.81 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -113.59 -35.56 5.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.402 1.481 . . . . 0.0 112.797 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 48.3 m -61.63 -52.11 65.71 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.985 2.114 . . . . 0.0 111.919 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -42.48 99.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.008 0.367 . . . . 0.0 110.749 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 60.2 p -67.0 -27.17 67.21 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.84 -50.99 17.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.55 2.34 . . . . 0.0 113.247 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.96 -29.98 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.646 -1.284 . . . . 0.0 114.098 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 87.8 m -57.0 -28.31 62.33 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.154 0.982 . . . . 0.0 111.36 167.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -89.41 -28.11 19.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.95 -33.51 73.82 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.081 0.553 . . . . 0.0 109.897 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.96 -98.96 2.15 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.763 1.649 . . . . 0.0 112.398 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -134.12 121.07 15.41 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.729 1.212 . . . . 0.0 112.798 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.48 106.96 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.988 3.125 . . . . 0.0 112.709 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -146.97 172.17 14.11 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.369 1.868 . . . . 0.0 111.962 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -77.8 83.93 4.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.392 1.477 . . . . 0.0 111.854 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -74.53 142.12 44.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.306 1.443 . . . . 0.0 109.946 166.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.1 156.56 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.381 1.472 . . . . 0.0 110.129 170.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.34 159.3 28.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 110.379 165.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 19.1 p -136.93 151.23 48.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.111 157.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 18.3 p -141.12 150.4 42.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.92 1.288 . . . . 0.0 111.771 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.12 103.08 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.225 1.41 . . . . 0.0 108.341 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mm -99.73 117.52 45.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.136 1.374 . . . . 0.0 107.989 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.0 tpt -142.2 147.74 37.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.654 0.781 . . . . 0.0 111.745 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -152.29 91.49 1.6 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.732 2.013 . . . . 0.0 109.646 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -59.44 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 175.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.99 -46.11 0.43 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.305 1.042 . . . . 0.0 113.665 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.51 -8.94 26.29 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.122 1.344 . . . . 0.0 115.412 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -140.01 79.02 1.69 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -171.67 21.1 0.07 OUTLIER Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 134.01 54.95 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.828 2.051 . . . . 0.0 111.572 -174.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -128.43 88.15 2.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.468 1.107 . . . . 0.0 109.3 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 55.5 m -107.09 142.32 36.94 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.699 -1.251 . . . . 0.0 109.579 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.25 138.03 39.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.27 0.628 . . . . 0.0 111.676 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 2.4 m -136.38 127.72 28.33 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -170.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 78.9 p -74.46 10.12 1.45 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 36.0 m -60.68 166.46 3.25 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 0.0 112.961 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -166.0 147.1 6.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.213 1.805 . . . . 0.0 110.42 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -86.44 151.53 23.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.718 0.807 . . . . 0.0 111.077 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.53 159.76 41.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.389 1.875 . . . . 0.0 112.916 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.6 t -125.18 -53.9 1.61 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.541 1.937 . . . . 0.0 112.223 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 79.2 p -104.22 -6.29 21.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.832 1.653 . . . . 0.0 113.635 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -42.74 9.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.675 1.59 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.16 -164.71 0.8 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.224 2.209 . . . . 0.0 110.611 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.82 142.5 13.96 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.373 1.463 . . . . 0.0 114.987 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 24.5 p -153.74 157.56 39.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.633 1.973 . . . . 0.0 111.997 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 19.3 t -145.22 160.27 41.73 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.786 1.634 . . . . 0.0 111.124 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 145.54 26.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.173 -1.579 . . . . 0.0 111.286 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.9 t -135.73 104.57 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.627 1.171 . . . . 0.0 109.333 -171.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.75 104.53 16.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.543 1.137 . . . . 0.0 112.126 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -98.64 140.09 33.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.227 1.013 . . . . 0.0 110.648 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.83 149.21 43.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.321 1.848 . . . . 0.0 111.018 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -143.24 -166.24 2.27 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.579 1.151 . . . . 0.0 111.398 -170.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -42.32 -61.05 1.28 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.778 2.431 . . . . 0.0 114.21 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.0 t -145.41 -6.13 0.64 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.135 1.374 . . . . 0.0 113.845 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 16.0 ptm -94.16 149.41 21.26 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.19 1.396 . . . . 0.0 110.118 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -131.83 134.49 45.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.67 1.588 . . . . 0.0 109.054 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 10.1 p -140.48 84.27 1.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.184 0.992 . . . . 0.0 112.07 -170.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.76 136.94 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.43 -0.793 . . . . 0.0 111.281 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.49 143.45 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.918 1.687 . . . . 0.0 110.508 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 t -131.39 127.16 36.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.694 1.198 . . . . 0.0 110.191 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -123.06 136.66 54.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.803 2.041 . . . . 0.0 112.548 -168.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.54 116.29 15.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.712 1.205 . . . . 0.0 109.146 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.98 60.8 0.34 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.68 1.61 . . . . 0.0 112.959 -166.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -61.73 126.95 29.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.932 1.293 . . . . 0.0 113.09 -166.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 126.153 1.781 . . . . 0.0 111.714 -169.354 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 111.297 0.11 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -129.28 173.37 10.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.697 1.599 . . . . 0.0 111.063 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 11.0 mm -56.79 144.13 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.429 1.492 . . . . 0.0 111.318 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 89.9 m -105.81 90.2 3.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.211 1.404 . . . . 0.0 110.255 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -82.76 149.82 27.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.451 -0.781 . . . . 0.0 111.021 164.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.29 94.69 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 127.819 2.448 . . . . 0.0 109.285 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.51 169.21 18.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.554 1.542 . . . . 0.0 112.144 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.741 1.217 . . . . 0.0 110.099 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.96 155.49 30.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.79 0.836 . . . . 0.0 110.482 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.96 156.69 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.793 1.237 . . . . 0.0 110.49 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.1 t -57.88 -43.4 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.575 1.55 . . . . 0.0 110.824 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 7.11 0.32 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.11 1.764 . . . . 0.0 114.058 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -122.2 -54.41 1.9 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 p -45.55 -44.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.706 0.802 . . . . 0.0 112.808 166.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -62.73 -11.01 14.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -106.77 -38.24 6.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.874 2.07 . . . . 0.0 112.352 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mt -49.6 -41.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.135 1.374 . . . . 0.0 110.901 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.65 -41.78 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.4 -0.812 . . . . 0.0 112.903 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -51.23 57.86 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.571 1.078 . . . . 0.0 111.087 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -30.12 71.31 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.38 -40.72 29.45 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.094 0.957 . . . . 0.0 113.39 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.04 -55.75 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.275 0.943 . . . . 0.0 109.65 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.08 -31.44 70.01 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -58.64 -50.39 74.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.892 1.277 . . . . 0.0 112.149 167.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.32 -31.7 72.16 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.57 -37.08 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.529 1.132 . . . . 0.0 110.777 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 16.98 78.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.023 0.821 . . . . 0.0 114.165 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.86 79.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.052 1.311 . . . . 0.0 115.48 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.34 168.74 5.32 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.005 1.402 . . . . 0.0 113.635 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.74 -167.61 0.49 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.732 1.613 . . . . 0.0 113.387 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -52.35 149.66 5.41 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.848 1.659 . . . . 0.0 112.864 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -144.42 172.8 12.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.828 1.251 . . . . 0.0 112.463 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.68 -92.84 0.12 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.788 1.635 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -98.17 4.02 48.99 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.961 2.504 . . . . 0.0 113.881 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -49.38 -43.89 44.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.249 1.02 . . . . 0.0 112.641 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -52.07 -36.83 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.63 1.172 . . . . 0.0 113.19 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.2 -52.96 42.99 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.467 1.107 . . . . 0.0 112.201 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.59 -23.56 67.31 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.082 -1.011 . . . . 0.0 112.904 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -77.06 -55.67 5.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.951 1.301 . . . . 0.0 111.525 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 t -57.12 -29.16 63.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.619 0.645 . . . . 0.0 112.628 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -78.34 -58.8 3.06 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.247 0.93 . . . . 0.0 112.241 170.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -59.1 -41.28 87.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 113.972 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.44 -63.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.0 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.4 -29.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.628 1.171 . . . . 0.0 110.591 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.87 -38.9 76.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -107.33 -39.87 5.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.676 1.59 . . . . 0.0 112.155 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -60.49 -50.66 72.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.271 2.228 . . . . 0.0 112.542 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -35.84 81.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.232 0.539 . . . . 0.0 111.44 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.6 t -63.06 -40.56 98.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.469 -0.769 . . . . 0.0 112.215 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -66.22 -49.15 68.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.891 2.076 . . . . 0.0 113.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.85 -25.8 67.36 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.717 -1.239 . . . . 0.0 114.089 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.0 m -62.87 -23.51 67.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.452 1.101 . . . . 0.0 111.469 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -91.92 -24.52 19.26 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.155 0.982 . . . . 0.0 113.257 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.92 -22.32 66.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.928 1.291 . . . . 0.0 114.381 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.67 -130.42 3.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.29 1.424 . . . . 0.0 112.444 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -64.61 120.2 63.74 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.616 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.21 120.72 5.44 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.954 3.103 . . . . 0.0 112.385 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -163.91 -171.03 2.32 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.118 1.767 . . . . 0.0 112.277 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.95 123.79 36.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.062 1.345 . . . . 0.0 111.525 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 126.9 55.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.394 1.878 . . . . 0.0 109.353 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.18 148.25 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.124 0.97 . . . . 0.0 110.203 174.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.36 155.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.233 1.013 . . . . 0.0 111.256 167.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -140.41 155.27 46.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.997 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 p -146.21 149.49 34.04 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.469 1.128 . . . . 0.0 112.32 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.22 123.55 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.17 1.388 . . . . 0.0 109.082 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.5 98.67 7.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.565 1.946 . . . . 0.0 107.387 -174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 ttt -110.27 157.13 19.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 0.0 110.474 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.53 133.56 53.98 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.86 1.264 . . . . 0.0 110.988 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -64.81 -9.2 18.87 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.53 -19.16 23.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.241 1.816 . . . . 0.0 114.422 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.86 42.69 0.56 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.908 1.242 . . . . 0.0 113.905 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.4 74.25 1.57 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.254 1.021 . . . . 0.0 112.27 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.66 161.58 20.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.089 1.328 . . . . 0.0 115.113 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.0 -177.78 5.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.119 1.367 . . . . 0.0 113.52 -165.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -104.99 111.91 24.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.902 0.881 . . . . 0.0 110.161 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.2 m -112.18 144.87 40.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.108 1.363 . . . . 0.0 109.425 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.02 33.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.185 0.993 . . . . 0.0 112.004 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.0 p -142.62 138.76 30.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.081 0.943 . . . . 0.0 112.347 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -81.88 17.73 1.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.797 0.839 . . . . 0.0 112.034 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 39.8 m -61.78 173.9 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.762 1.268 . . . . 0.0 111.676 165.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.03 149.86 14.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.854 2.062 . . . . 0.0 109.289 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -83.56 134.66 34.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.722 0.809 . . . . 0.0 109.193 170.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -138.14 119.26 14.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 109.646 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.93 -47.0 4.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.058 1.743 . . . . 0.0 113.826 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 t -106.39 -22.36 12.83 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.806 1.242 . . . . 0.0 112.979 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -30.52 30.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.007 1.723 . . . . 0.0 112.999 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.44 -165.99 1.15 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.124 2.17 . . . . 0.0 110.103 -178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.06 147.06 16.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.425 1.012 . . . . 0.0 113.073 170.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 p -162.79 150.98 14.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.923 1.289 . . . . 0.0 111.42 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 29.7 p -156.47 172.2 18.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.749 1.22 . . . . 0.0 112.246 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -154.4 150.75 28.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.358 1.063 . . . . 0.0 111.41 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.66 134.5 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.2 1.4 . . . . 0.0 109.562 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -123.61 125.74 45.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.06 1.344 . . . . 0.0 111.621 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -135.29 120.0 18.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.783 1.633 . . . . 0.0 109.938 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -82.16 153.28 26.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.335 -0.853 . . . . 0.0 111.803 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -120.74 -170.51 2.01 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 109.047 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -51.66 -54.14 31.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.0 t -138.14 -22.0 1.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.038 1.335 . . . . 0.0 114.319 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.1 ptp -92.29 177.63 6.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.807 1.243 . . . . 0.0 111.483 168.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -142.29 145.95 34.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 109.828 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 24.6 p -128.17 130.44 48.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.402 1.081 . . . . 0.0 110.869 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.05 133.39 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.157 0.983 . . . . 0.0 109.664 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.28 129.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 126.006 1.723 . . . . 0.0 109.665 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 p -126.49 148.79 49.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.34 131.92 37.0 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.5 1.52 . . . . 0.0 110.973 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -130.7 114.35 15.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.072 0.939 . . . . 0.0 110.031 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.05 84.05 0.49 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.638 1.59 . . . . 0.0 110.613 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.98 126.91 36.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.359 1.064 . . . . 0.0 112.737 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 125.032 1.333 . . . . 0.0 112.632 -174.569 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.446 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -118.96 170.78 8.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.541 0.736 . . . . 0.0 112.106 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.95 127.8 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.139 1.776 . . . . 0.0 111.493 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.3 m -97.62 101.54 13.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.914 1.686 . . . . 0.0 110.619 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -92.8 147.37 22.91 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.733 -1.229 . . . . 0.0 111.203 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.92 113.42 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.771 2.428 . . . . 0.0 109.505 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.08 141.77 42.37 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.317 -0.864 . . . . 0.0 112.15 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.099 178.567 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.34 0.591 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -65.56 164.81 13.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.311 0.577 . . . . 0.0 111.272 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.46 155.5 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.861 1.265 . . . . 0.0 110.633 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.02 -41.78 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.16 0.984 . . . . 0.0 111.61 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -25.57 68.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.92 1.288 . . . . 0.0 113.406 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -56.51 4.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.361 1.465 . . . . 0.0 110.635 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -50.81 -44.3 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.874 1.27 . . . . 0.0 112.198 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -62.06 -13.45 26.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.741 1.217 . . . . 0.0 113.621 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -100.64 -39.67 7.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.743 2.017 . . . . 0.0 112.353 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -50.85 -42.55 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.98 1.312 . . . . 0.0 110.905 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.24 -41.78 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.433 -0.792 . . . . 0.0 112.857 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -51.32 58.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.69 1.132 . . . . 0.0 111.249 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -30.29 71.44 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.54 -39.9 30.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.986 0.914 . . . . 0.0 113.448 175.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.57 -55.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.302 0.956 . . . . 0.0 109.572 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.0 -31.56 70.03 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 3.0 t -58.33 -50.45 73.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.779 1.232 . . . . 0.0 112.211 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.6 72.1 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.61 -37.22 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.504 1.121 . . . . 0.0 110.871 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.988 0.804 . . . . 0.0 114.303 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.48 17.48 77.65 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.063 1.316 . . . . 0.0 115.621 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -65.24 172.98 2.74 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 118.934 1.367 . . . . 0.0 113.625 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.25 -160.54 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.377 1.471 . . . . 0.0 112.511 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -48.26 151.42 1.03 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.851 1.66 . . . . 0.0 113.083 165.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -147.8 172.3 14.34 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.983 1.313 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.51 -92.78 0.12 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.81 1.644 . . . . 0.0 111.383 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 2.0 p -98.26 3.99 48.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.981 2.512 . . . . 0.0 113.948 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.64 -43.87 47.12 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.075 -1.015 . . . . 0.0 112.619 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.9 -37.02 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.68 1.192 . . . . 0.0 113.132 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.17 -53.29 39.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.491 1.116 . . . . 0.0 112.177 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -64.26 -23.66 67.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.072 -1.018 . . . . 0.0 112.985 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.86 -55.93 5.05 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.978 1.311 . . . . 0.0 111.541 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 8.5 t -57.14 -27.89 62.26 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.603 0.638 . . . . 0.0 112.719 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.9 t -79.45 -60.03 2.52 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.388 0.995 . . . . 0.0 112.3 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -58.13 -41.24 83.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.28 1.4 . . . . 0.0 113.975 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.81 -63.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 124.874 1.269 . . . . 0.0 109.734 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.06 -29.31 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.047 1.339 . . . . 0.0 110.907 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -59.23 -37.25 77.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -109.1 -39.03 5.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.793 1.637 . . . . 0.0 112.118 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 52.4 m -61.7 -51.73 67.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.655 2.382 . . . . 0.0 112.4 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -36.51 83.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 117.953 0.342 . . . . 0.0 110.823 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.1 t -59.3 -43.67 92.6 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.546 -0.721 . . . . 0.0 112.203 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.46 -51.62 62.18 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.366 2.267 . . . . 0.0 113.292 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.07 -27.24 67.92 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 22.9 m -59.13 -37.01 76.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.132 0.573 . . . . 0.0 109.995 168.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -77.25 -25.18 51.24 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . 0.297 0.0 OUTLIER -56.01 -26.2 47.71 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.967 1.707 . . . . 0.0 114.112 178.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -139.69 -82.77 0.09 OUTLIER Glycine 0 CA--C 1.535 1.295 0 CA-C-N 119.62 1.1 . . . . 0.0 114.425 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.15 172.62 3.4 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 125.97 1.708 . . . . 0.0 113.64 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.0 170.85 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 166.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -56.75 112.39 1.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.329 1.452 . . . . 0.0 112.899 172.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -177.75 100.97 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.255 2.622 . . . . 0.0 111.057 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -151.67 169.26 22.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.614 1.566 . . . . 0.0 110.497 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.2 tt -133.58 155.57 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 108.92 157.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.17 152.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 123.861 0.865 . . . . 0.0 111.105 165.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 39.7 p -133.69 158.83 42.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.84 1.256 . . . . 0.0 110.266 170.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.87 156.75 42.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.336 1.065 . . . . 0.0 112.656 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.66 127.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.408 -0.808 . . . . 0.0 110.752 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.4 mm -119.22 98.29 6.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 127.094 2.158 . . . . 0.0 107.356 -169.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.7 ttt -105.61 156.22 18.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.456 1.102 . . . . 0.0 110.401 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -122.42 132.04 54.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.801 1.24 . . . . 0.0 110.8 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -64.45 -9.11 16.31 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -57.31 -20.72 30.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.432 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 123.72 40.86 0.44 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.688 1.137 . . . . 0.0 114.232 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.45 70.33 1.25 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.317 1.047 . . . . 0.0 112.575 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.31 155.32 16.38 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.468 1.509 . . . . 0.0 115.597 -173.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 178.35 9.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.937 1.695 . . . . 0.0 112.624 -166.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -108.79 110.61 22.02 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.386 1.075 . . . . 0.0 111.216 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 55.7 m -105.67 145.2 31.37 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.266 1.026 . . . . 0.0 109.207 173.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.88 33.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 111.044 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 94.1 p -137.55 143.71 41.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.203 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.4 t -84.55 15.77 3.56 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.782 0.833 . . . . 0.0 111.885 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 31.8 m -61.23 167.7 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.169 0.988 . . . . 0.0 111.636 166.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.6 147.29 21.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.693 1.997 . . . . 0.0 109.779 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -82.64 128.55 34.44 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 0.0 108.7 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -133.04 116.42 16.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.794 1.638 . . . . 0.0 109.302 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 -47.11 5.16 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.9 1.68 . . . . 0.0 114.41 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 16.7 t -106.43 -21.02 13.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.74 1.216 . . . . 0.0 112.977 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -29.81 29.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.45 1.9 . . . . 0.0 113.356 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.1 -167.65 1.54 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.0 2.52 . . . . 0.0 109.294 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.58 146.35 16.92 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.419 1.009 . . . . 0.0 112.906 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 29.7 p -160.64 147.28 15.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.976 1.31 . . . . 0.0 111.783 170.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 11.6 p -152.35 169.28 22.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.789 1.236 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 9.6 t -155.65 151.74 27.83 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.693 -1.254 . . . . 0.0 111.645 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.67 138.86 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.24 1.416 . . . . 0.0 109.817 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -127.3 127.56 44.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.057 1.343 . . . . 0.0 111.782 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -136.5 119.63 16.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 110.04 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -81.95 153.11 26.43 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.936 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -120.93 -170.67 2.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.52 1.528 . . . . 0.0 109.079 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -51.67 -54.85 23.64 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t -137.46 -21.57 1.16 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.958 1.303 . . . . 0.0 114.245 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 20.1 ptp -93.03 178.06 5.87 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.386 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -142.43 145.97 34.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.075 1.35 . . . . 0.0 109.63 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 25.0 p -128.22 132.8 48.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.314 1.046 . . . . 0.0 110.888 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.61 138.26 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.124 0.969 . . . . 0.0 109.925 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.3 p -127.53 128.88 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.119 1.768 . . . . 0.0 110.07 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.5 p -123.23 148.93 45.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.672 1.189 . . . . 0.0 111.453 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -136.55 139.22 42.05 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.327 1.451 . . . . 0.0 112.698 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.2 121.72 15.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.631 1.172 . . . . 0.0 109.572 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -111.69 82.03 0.3 Allowed Glycine 0 N--CA 1.469 0.859 0 C-N-CA 126.316 1.913 . . . . 0.0 111.863 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.87 105.34 17.27 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.706 1.202 . . . . 0.0 113.575 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 125.092 1.357 . . . . 0.0 112.532 -169.71 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.415 0.15 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 274' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 274' ' ' LYS 0.327 0.0 OUTLIER -127.34 177.04 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.209 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.17 129.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.176 0.99 . . . . 0.0 110.174 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 63.0 m -102.1 93.53 5.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.722 1.609 . . . . 0.0 109.953 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.89 149.59 24.7 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.329 -0.857 . . . . 0.0 111.081 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.2 118.13 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.723 2.009 . . . . 0.0 109.974 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -138.64 143.97 39.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.561 1.144 . . . . 0.0 111.569 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 125.819 1.647 . . . . 0.0 108.799 178.348 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -97.23 46.37 1.03 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.121 1.369 . . . . 0.0 112.228 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -58.2 -25.49 61.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.932 -1.105 . . . . 0.0 113.505 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.25 -14.67 61.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.294 1.438 . . . . 0.0 114.302 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.86 -31.6 72.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.57 1.148 . . . . 0.0 112.912 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -115.85 178.29 4.37 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.099 1.76 . . . . 0.0 111.758 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.36 179.19 8.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.861 1.264 . . . . 0.0 110.692 174.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -127.12 150.89 49.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.706 1.602 . . . . 0.0 111.069 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.91 125.23 35.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.235 1.414 . . . . 0.0 111.807 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.43 -20.44 60.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.082 -1.011 . . . . 0.0 112.958 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.17 -25.62 63.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 t -93.98 -19.05 21.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.466 1.106 . . . . 0.0 112.771 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 132.02 48.35 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.0 -1.062 . . . . 0.0 111.824 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.25 178.57 5.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.83 1.252 . . . . 0.0 112.289 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.5 152.68 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.173 1.389 . . . . 0.0 110.916 171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.62 -43.42 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.731 1.212 . . . . 0.0 111.704 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.67 -29.85 68.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.101 1.36 . . . . 0.0 113.337 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.22 -57.34 4.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.101 0.96 . . . . 0.0 110.502 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.9 t -51.43 -40.45 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.74 1.216 . . . . 0.0 112.512 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -61.36 -19.76 62.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.76 1.624 . . . . 0.0 113.949 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.19 -35.55 10.34 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.731 1.612 . . . . 0.0 113.357 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mt -51.75 -38.88 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.277 1.031 . . . . 0.0 110.809 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.9 p -64.1 -42.36 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.88 62.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.884 1.22 . . . . 0.0 111.299 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -32.47 71.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.3 -43.23 52.19 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.02 -55.41 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.616 1.098 . . . . 0.0 110.374 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.71 -29.77 70.96 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.422 -0.799 . . . . 0.0 113.138 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -61.24 -46.27 91.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.279 1.032 . . . . 0.0 112.236 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.34 93.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.144 0.977 . . . . 0.0 113.331 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.98 -48.0 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.254 1.021 . . . . 0.0 110.565 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.46 19.91 67.2 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.398 0.999 . . . . 0.0 115.01 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.14 20.46 77.4 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.918 1.247 . . . . 0.0 115.401 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.04 179.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 114.43 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.23 144.69 19.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.405 1.482 . . . . 0.0 113.32 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.65 121.04 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.819 1.248 . . . . 0.0 111.032 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.97 157.98 45.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.269 1.828 . . . . 0.0 111.112 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -106.44 -66.01 1.04 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.208 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -60.6 -18.51 53.42 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.943 1.297 . . . . 0.0 114.254 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.72 -38.96 79.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.036 -1.04 . . . . 0.0 113.191 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.08 -35.24 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.363 0.665 . . . . 0.0 111.943 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -62.12 -50.63 71.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.451 . . . . 0.0 111.341 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.95 -25.6 64.63 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -77.85 -54.26 6.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.01 0.823 . . . . 0.0 111.148 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -54.99 -36.08 65.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.678 0.672 . . . . 0.0 111.984 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -73.78 -56.86 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.345 0.975 . . . . 0.0 112.04 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -57.36 -40.27 77.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.98 1.312 . . . . 0.0 113.342 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.17 -63.64 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 C-N-CA 124.479 1.112 . . . . 0.0 110.524 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.76 -28.77 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.709 1.204 . . . . 0.0 110.788 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.87 -42.54 79.97 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.331 1.053 . . . . 0.0 112.667 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -103.41 -36.2 8.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.226 1.41 . . . . 0.0 112.592 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.9 m -62.89 -49.68 73.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.048 2.139 . . . . 0.0 112.355 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -36.7 83.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.709 0.404 . . . . 0.0 111.407 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 t -63.06 -42.86 99.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.486 0.714 . . . . 0.0 112.495 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -66.94 -49.38 65.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.045 1.738 . . . . 0.0 113.27 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.61 -28.03 68.83 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.68 -1.262 . . . . 0.0 113.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -57.59 -28.24 63.43 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.419 1.088 . . . . 0.0 111.151 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -89.75 -28.04 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.392 1.077 . . . . 0.0 113.285 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.85 -21.74 61.63 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.408 1.083 . . . . 0.0 112.463 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -134.72 8.61 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.373 1.94 . . . . 0.0 112.629 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -116.71 155.76 48.57 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 125.644 1.578 . . . . 0.0 112.578 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.38 114.16 3.15 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.856 3.037 . . . . 0.0 111.66 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.45 175.14 12.57 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.084 2.154 . . . . 0.0 110.808 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.74 100.42 7.08 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.231 1.413 . . . . 0.0 110.887 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.5 143.59 28.06 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.036 1.335 . . . . 0.0 109.949 168.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.402 HD13 ' HG ' ' B' ' 228' ' ' CYS . 1.6 tt -133.44 153.4 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.464 1.505 . . . . 0.0 109.528 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.38 150.42 24.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.734 0.814 . . . . 0.0 111.084 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -133.78 136.67 44.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.331 1.453 . . . . 0.0 109.139 171.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 48.3 t -131.28 140.67 49.84 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.068 0.947 . . . . 0.0 111.159 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.49 101.31 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.543 1.537 . . . . 0.0 109.179 -168.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.22 95.88 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.288 1.435 . . . . 0.0 110.033 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.58 166.17 14.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.985 1.714 . . . . 0.0 112.815 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 119.47 22.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.683 1.193 . . . . 0.0 112.374 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -67.24 -11.29 57.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.084 1.354 . . . . 0.0 113.546 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -54.48 -28.61 46.0 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.996 1.719 . . . . 0.0 114.21 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.3 10.48 0.09 OUTLIER Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.05 97.82 4.57 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.107 1.454 . . . . 0.0 112.478 -165.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.31 169.08 25.96 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.197 1.856 . . . . 0.0 112.862 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.07 174.82 13.22 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.088 1.355 . . . . 0.0 113.319 -167.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.16 98.66 9.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.952 0.901 . . . . 0.0 112.08 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.3 m -95.29 139.82 31.07 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.212 -0.93 . . . . 0.0 109.637 172.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.06 111.77 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.949 1.7 . . . . 0.0 110.363 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 m -115.43 107.78 15.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 110.594 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -76.95 35.32 0.16 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.707 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.4 ' HG ' HD13 ' B' ' 209' ' ' ILE . 2.1 m -85.32 176.4 8.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.866 1.266 . . . . 0.0 111.412 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -141.17 137.63 32.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.278 1.431 . . . . 0.0 109.929 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -79.59 132.1 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.422 0.689 . . . . 0.0 109.803 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -142.68 149.0 38.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.372 1.469 . . . . 0.0 110.586 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -123.51 -60.47 1.47 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.176 1.39 . . . . 0.0 112.344 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -92.86 -26.79 17.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.017 0.927 . . . . 0.0 112.852 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -52.86 30.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.817 2.047 . . . . 0.0 113.317 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -146.87 173.87 12.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.769 2.427 . . . . 0.0 110.44 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.92 121.26 6.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.114 1.34 . . . . 0.0 113.359 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -146.85 144.84 29.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.456 1.502 . . . . 0.0 110.616 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.7 t -149.55 164.5 34.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.601 1.161 . . . . 0.0 111.184 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -162.96 150.48 13.35 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.178 -1.576 . . . . 0.0 111.143 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.32 127.03 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.893 1.277 . . . . 0.0 110.113 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.76 111.74 17.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.04 1.336 . . . . 0.0 112.515 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -125.45 93.74 3.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.975 1.71 . . . . 0.0 110.678 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 151.83 29.4 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.685 1.194 . . . . 0.0 112.381 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -125.74 -175.22 3.28 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.915 1.686 . . . . 0.0 110.574 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -54.17 -50.22 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.032 1.333 . . . . 0.0 113.908 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -134.4 1.95 3.21 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.935 1.694 . . . . 0.0 113.895 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.26 156.97 32.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.292 2.237 . . . . 0.0 110.958 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -134.75 120.95 20.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.313 1.445 . . . . 0.0 110.815 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.2 m -126.16 98.31 5.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.218 1.007 . . . . 0.0 110.64 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 116.18 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.439 1.096 . . . . 0.0 111.882 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.12 137.38 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.471 1.908 . . . . 0.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -130.09 147.59 51.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.809 1.244 . . . . 0.0 111.349 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.99 140.01 39.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.796 1.639 . . . . 0.0 113.57 -170.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.55 113.61 13.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.549 1.14 . . . . 0.0 109.621 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.84 77.64 0.23 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.531 2.015 . . . . 0.0 110.734 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.06 108.92 2.8 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 111.232 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 m -135.52 111.47 9.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.736 2.014 . . . . 0.0 111.115 -171.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.76 1.35 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.947 1.299 . . . . 0.0 114.273 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.11 2.15 77.08 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.332 1.444 . . . . 0.0 116.177 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.61 16.11 60.65 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.996 1.398 . . . . 0.0 115.54 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.51 90.0 0.06 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.055 1.788 . . . . 0.0 113.398 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.1 p -139.03 -170.28 2.83 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.178 2.191 . . . . 0.0 111.685 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.08 23.13 7.53 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.444 1.021 . . . . 0.0 114.698 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.44 152.63 11.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.129 1.372 . . . . 0.0 114.62 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.8 t -72.29 -36.15 68.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.001 1.321 . . . . 0.0 113.161 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -74.16 165.17 54.79 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 123.975 0.797 . . . . 0.0 113.73 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 152.58 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.22 2.613 . . . . 0.0 111.94 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.55 146.39 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.319 1.048 . . . . 0.0 111.142 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 115.07 14.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.056 1.343 . . . . 0.0 110.779 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.1 tp -80.23 146.37 31.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.121 0.968 . . . . 0.0 110.523 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.17 -165.73 38.44 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.875 1.702 . . . . 0.0 111.443 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -127.16 164.14 22.29 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.612 1.165 . . . . 0.0 111.598 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.58 153.34 42.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.02 1.328 . . . . 0.0 111.328 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.75 176.77 8.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.44 1.896 . . . . 0.0 111.106 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.06 139.66 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.621 1.568 . . . . 0.0 111.142 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -115.7 92.88 4.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.363 1.465 . . . . 0.0 110.787 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -76.27 149.45 37.12 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.872 -1.143 . . . . 0.0 111.218 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.11 108.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.427 2.291 . . . . 0.0 109.636 174.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -131.89 119.8 21.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.074 1.75 . . . . 0.0 109.645 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.09 88.55 3.15 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.572 1.549 . . . . 0.0 109.902 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.5 117.69 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 110.867 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.29 -18.34 18.19 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.677 2.251 . . . . 0.0 113.279 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.01 171.28 16.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.618 2.367 . . . . 0.0 110.503 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -117.84 160.48 21.32 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.9 1.28 . . . . 0.0 111.44 166.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 mt -67.43 125.66 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.593 1.957 . . . . 0.0 110.416 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.713 1.605 . . . . 0.0 111.596 177.844 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -84.29 49.79 1.73 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.123 1.369 . . . . 0.0 113.496 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -60.01 -25.34 65.21 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.707 -1.246 . . . . 0.0 113.403 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.85 -14.43 61.43 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.275 1.43 . . . . 0.0 114.334 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.9 -31.71 72.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.556 1.142 . . . . 0.0 112.888 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -115.74 178.36 4.34 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.134 1.774 . . . . 0.0 111.871 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.2 179.18 8.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.707 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.98 151.2 48.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.72 1.608 . . . . 0.0 111.101 171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -90.34 125.07 35.41 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.272 1.429 . . . . 0.0 111.817 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.23 -20.59 60.12 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.104 -0.997 . . . . 0.0 112.994 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.11 -25.1 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.8 t -94.9 -18.97 20.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.547 1.139 . . . . 0.0 112.829 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.69 133.22 51.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.001 -1.062 . . . . 0.0 111.828 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -77.29 177.33 8.01 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.501 1.12 . . . . 0.0 112.361 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.0 152.59 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.26 1.424 . . . . 0.0 110.814 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.33 -43.2 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.0 -29.81 68.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.035 1.334 . . . . 0.0 113.357 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -73.71 -57.8 3.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 110.398 172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.6 -40.47 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.815 1.246 . . . . 0.0 112.505 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 29.3 t -61.22 -19.95 62.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.773 1.629 . . . . 0.0 113.963 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -97.96 -35.76 10.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.339 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.83 -38.69 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 110.866 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.15 -42.3 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -50.82 62.27 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.873 1.215 . . . . 0.0 111.263 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -32.47 71.14 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -43.27 52.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.95 -55.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.59 1.087 . . . . 0.0 110.336 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.64 -29.88 71.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.395 -0.816 . . . . 0.0 113.102 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.8 t -61.22 -46.3 90.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.231 1.013 . . . . 0.0 112.194 168.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.26 93.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.127 0.971 . . . . 0.0 113.319 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.97 -47.99 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.29 1.036 . . . . 0.0 110.529 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.43 19.96 67.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.391 0.996 . . . . 0.0 115.004 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.42 77.5 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.915 1.245 . . . . 0.0 115.407 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.02 179.45 0.91 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.98 1.312 . . . . 0.0 114.393 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.24 144.76 19.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.418 1.487 . . . . 0.0 113.334 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.71 120.98 15.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 110.982 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.92 157.88 45.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.321 1.848 . . . . 0.0 111.178 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -106.32 -65.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.476 1.111 . . . . 0.0 111.251 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -60.55 -18.51 52.89 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.923 1.289 . . . . 0.0 114.225 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.88 -38.86 79.78 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.981 -1.074 . . . . 0.0 113.207 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.12 -35.13 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.395 0.678 . . . . 0.0 111.982 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.16 -50.75 70.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.353 1.461 . . . . 0.0 111.277 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.89 -25.72 64.75 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -77.79 -54.29 6.52 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.012 0.824 . . . . 0.0 111.141 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -55.09 -35.71 64.89 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.64 0.655 . . . . 0.0 112.007 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -73.97 -57.34 4.04 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.372 0.987 . . . . 0.0 112.02 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.77 -40.13 75.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.037 1.335 . . . . 0.0 113.336 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.02 -63.87 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.489 1.116 . . . . 0.0 110.529 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.67 -28.9 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.741 1.217 . . . . 0.0 110.753 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.94 -41.82 78.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 0.0 112.725 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -104.12 -36.41 7.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.221 1.408 . . . . 0.0 112.514 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 35.2 m -62.59 -49.74 74.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.123 2.169 . . . . 0.0 112.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -37.15 84.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.858 0.463 . . . . 0.0 111.474 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.9 t -61.79 -46.43 89.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.438 0.695 . . . . 0.0 112.112 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -64.04 -49.36 72.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.063 1.745 . . . . 0.0 113.5 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.73 -28.21 68.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.734 -1.229 . . . . 0.0 113.595 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 82.1 m -58.3 -31.35 67.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.613 0.765 . . . . 0.0 110.85 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -84.95 -27.81 26.28 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.893 0.877 . . . . 0.0 113.088 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 27.7 mt -71.41 -20.75 62.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.502 1.121 . . . . 0.0 112.443 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.83 -136.26 9.27 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.702 2.096 . . . . 0.0 112.933 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -115.47 156.23 46.19 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.848 1.659 . . . . 0.0 112.427 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.75 110.85 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.879 3.053 . . . . 0.0 111.738 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.59 173.92 12.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.952 2.101 . . . . 0.0 110.892 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -74.31 96.2 2.79 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.074 1.35 . . . . 0.0 111.8 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -81.91 153.77 26.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.251 1.421 . . . . 0.0 111.413 164.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . 0.4 HD13 ' HG ' ' A' ' 85' ' ' CYS . 2.7 tt -149.26 153.72 10.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.939 2.096 . . . . 0.0 108.681 167.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.64 151.54 22.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.999 0.919 . . . . 0.0 110.912 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.5 p -132.82 137.56 46.79 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.232 1.413 . . . . 0.0 109.229 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 47.7 t -132.26 145.04 51.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.272 1.029 . . . . 0.0 111.124 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.16 106.73 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.625 1.57 . . . . 0.0 108.782 -167.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 mm -101.18 94.7 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.086 1.355 . . . . 0.0 109.688 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 166.27 14.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.014 1.725 . . . . 0.0 112.6 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.25 121.16 24.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.524 1.13 . . . . 0.0 112.571 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -67.95 -11.17 58.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.049 1.34 . . . . 0.0 113.582 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.25 -28.04 50.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 114.212 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.64 11.5 0.1 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.48 98.5 4.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 -166.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -143.27 169.26 25.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.27 1.89 . . . . 0.0 112.874 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.14 174.64 13.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.18 1.392 . . . . 0.0 113.252 -167.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.24 100.41 11.51 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.91 0.884 . . . . 0.0 112.093 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 79.6 m -96.8 139.61 32.59 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.085 -1.009 . . . . 0.0 109.803 172.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.53 110.18 12.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.848 1.659 . . . . 0.0 109.955 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 10.1 m -112.44 108.03 17.03 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.37 1.068 . . . . 0.0 110.292 -172.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.6 t -76.96 35.52 0.16 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.62 1.168 . . . . 0.0 112.673 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . 0.402 ' HG ' HD13 ' A' ' 66' ' ' ILE . 2.5 m -84.88 175.91 8.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 0.0 111.622 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.2 137.21 32.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.326 1.45 . . . . 0.0 109.932 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -78.91 130.6 35.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.373 0.669 . . . . 0.0 109.704 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -139.85 145.44 38.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.61 1.564 . . . . 0.0 110.25 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 47.6 t -120.5 -61.74 1.54 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.097 1.359 . . . . 0.0 112.419 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 9.1 t -93.26 -25.0 17.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.093 0.957 . . . . 0.0 112.797 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -52.84 30.75 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.753 2.021 . . . . 0.0 112.968 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -148.7 174.49 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.744 2.418 . . . . 0.0 110.44 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.68 120.75 6.25 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.012 1.292 . . . . 0.0 113.514 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 52.6 m -146.39 144.51 29.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.418 1.487 . . . . 0.0 110.769 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 6.9 t -149.14 164.7 33.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.695 1.198 . . . . 0.0 111.179 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 2.9 t -163.12 150.61 13.16 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.166 -1.584 . . . . 0.0 111.11 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.38 127.27 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.919 1.288 . . . . 0.0 110.109 -173.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.91 111.91 17.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.029 1.332 . . . . 0.0 112.536 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -125.51 94.13 4.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.958 1.703 . . . . 0.0 110.678 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.76 151.87 28.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 112.39 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -125.9 -175.18 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.86 1.664 . . . . 0.0 110.551 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -54.32 -50.02 68.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.112 1.365 . . . . 0.0 113.949 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -134.61 2.02 3.16 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.953 1.701 . . . . 0.0 113.895 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.27 156.97 32.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.232 2.213 . . . . 0.0 110.879 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.82 121.4 20.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.333 1.453 . . . . 0.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 15.9 m -126.28 98.57 5.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.258 1.023 . . . . 0.0 110.551 -175.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 117.74 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.255 1.022 . . . . 0.0 111.85 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.0 137.99 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.558 1.943 . . . . 0.0 111.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.2 t -131.32 147.4 52.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.861 1.264 . . . . 0.0 111.382 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.44 38.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.725 1.61 . . . . 0.0 113.543 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.91 110.08 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -105.29 77.94 0.26 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.237 1.875 . . . . 0.0 110.669 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.73 108.69 2.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.402 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 33.6 m -135.5 112.56 10.36 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.792 2.037 . . . . 0.0 111.137 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.4 pp -104.71 1.38 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.884 1.274 . . . . 0.0 114.193 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.83 2.31 74.81 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.325 1.441 . . . . 0.0 116.21 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.18 60.65 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 118.995 1.397 . . . . 0.0 115.466 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -62.61 90.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.022 1.772 . . . . 0.0 113.432 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 90.4 p -138.94 -170.2 2.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.211 2.204 . . . . 0.0 111.722 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.01 7.58 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.479 1.037 . . . . 0.0 114.712 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.52 152.64 11.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.087 1.355 . . . . 0.0 114.608 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 t -72.35 -36.12 68.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.971 1.309 . . . . 0.0 113.161 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -74.22 165.22 54.78 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 123.992 0.805 . . . . 0.0 113.683 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.49 152.74 65.72 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.949 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.8 146.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.33 1.052 . . . . 0.0 111.12 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 115.13 14.84 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.07 1.348 . . . . 0.0 110.824 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 57.9 tp -80.24 146.5 31.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.134 0.974 . . . . 0.0 110.546 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.02 -165.76 38.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.901 1.715 . . . . 0.0 111.431 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -127.48 164.48 21.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.608 1.163 . . . . 0.0 111.611 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -125.21 152.96 43.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.04 1.336 . . . . 0.0 111.315 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.73 177.31 7.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.546 1.939 . . . . 0.0 111.098 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.08 139.33 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.561 1.544 . . . . 0.0 111.259 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.1 m -114.84 90.76 3.42 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.343 1.457 . . . . 0.0 110.562 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.95 149.99 37.57 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.814 -1.178 . . . . 0.0 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.6 p -143.17 108.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.607 1.963 . . . . 0.0 110.407 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -130.02 120.02 24.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.896 2.078 . . . . 0.0 109.142 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -99.55 98.92 7.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.573 1.149 . . . . 0.0 108.536 167.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.45 116.51 4.74 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.82 2.347 . . . . 0.0 110.533 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.54 -18.5 19.92 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.512 2.141 . . . . 0.0 113.325 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 171.81 15.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.616 2.367 . . . . 0.0 110.658 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -118.27 160.54 21.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.92 1.288 . . . . 0.0 111.604 166.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.68 126.03 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.661 1.984 . . . . 0.0 110.437 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 125.706 1.602 . . . . 0.0 111.612 177.621 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -87.62 5.45 39.48 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -170.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.1 mmm -62.98 -53.75 49.03 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.676 -1.265 . . . . 0.0 112.419 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -69.02 -16.58 63.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.75 -20.95 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.853 0.861 . . . . 0.0 112.464 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -99.09 143.97 28.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.613 1.165 . . . . 0.0 111.492 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -153.02 -177.34 6.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.913 1.685 . . . . 0.0 109.916 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.05 164.51 27.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 0.0 112.867 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.06 124.33 21.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.201 1.401 . . . . 0.0 112.201 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.26 -16.99 44.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.834 1.654 . . . . 0.0 114.06 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -82.6 -37.9 24.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.853 -1.154 . . . . 0.0 112.342 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 t -73.12 -13.9 61.28 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.463 1.905 . . . . 0.0 112.829 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 139.63 58.79 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.769 -1.207 . . . . 0.0 111.217 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -101.55 172.02 7.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.147 0.979 . . . . 0.0 111.07 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.95 146.21 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.15 1.38 . . . . 0.0 109.763 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.9 t -60.48 -38.52 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.496 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.56 -29.15 68.98 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.86 1.264 . . . . 0.0 113.74 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.36 -58.23 3.45 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.933 0.893 . . . . 0.0 110.426 171.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.3 t -52.03 -44.01 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.319 1.447 . . . . 0.0 112.095 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.26 -12.8 44.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.127 1.771 . . . . 0.0 113.834 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -101.95 -31.98 10.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 113.133 171.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mt -51.59 -43.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.052 0.941 . . . . 0.0 110.451 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.65 -42.56 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -52.48 56.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.037 1.29 . . . . 0.0 110.805 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.18 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.55 -38.5 70.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.074 0.949 . . . . 0.0 113.089 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 50.2 mt -61.06 -57.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.329 0.968 . . . . 0.0 110.057 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.82 -28.75 70.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 t -59.73 -46.57 88.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.72 1.208 . . . . 0.0 112.386 168.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.16 79.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.92 0.888 . . . . 0.0 113.151 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.6 mt -67.72 -40.18 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.346 1.058 . . . . 0.0 111.728 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.96 12.85 58.43 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.837 1.208 . . . . 0.0 114.992 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.84 15.52 73.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.723 1.154 . . . . 0.0 114.766 -172.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.61 -175.79 0.71 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.203 1.401 . . . . 0.0 112.369 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.16 107.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.402 1.481 . . . . 0.0 112.616 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -70.52 100.01 1.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.534 1.534 . . . . 0.0 111.109 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.5 164.87 11.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.645 1.178 . . . . 0.0 111.738 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -73.42 -55.75 5.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -68.21 -21.05 64.88 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.623 -0.673 . . . . 0.0 112.559 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -58.61 -44.03 89.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 168.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -54.81 -34.61 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.393 0.997 . . . . 0.0 112.048 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.2 -49.92 65.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.086 0.954 . . . . 0.0 111.936 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.01 -26.0 66.57 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.565 -0.709 . . . . 0.0 112.813 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -76.71 -53.62 7.73 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.308 1.043 . . . . 0.0 111.247 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 t -58.27 -26.78 63.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -81.46 -57.38 3.5 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.597 1.09 . . . . 0.0 112.542 169.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -57.83 -38.36 75.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 113.74 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.0 t -68.02 -62.55 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 123.841 0.856 . . . . 0.0 110.343 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.9 t -48.95 -29.67 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.983 1.313 . . . . 0.0 110.82 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.01 -42.99 86.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.534 0.733 . . . . 0.0 112.788 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -103.87 -34.75 8.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.216 1.406 . . . . 0.0 113.149 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -59.17 -53.96 52.43 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.323 1.849 . . . . 0.0 111.487 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -37.78 83.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.961 0.505 . . . . 0.0 111.979 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 p -70.92 -29.93 66.11 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.92 -51.89 19.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.484 2.314 . . . . 0.0 112.968 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.78 -25.6 67.99 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.865 -1.147 . . . . 0.0 113.731 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 m -59.95 -33.58 72.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.143 0.977 . . . . 0.0 110.939 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -82.09 -28.42 32.33 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.39 -16.56 63.53 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.64 -120.67 4.55 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.247 1.88 . . . . 0.0 112.544 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -131.64 152.38 80.3 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 126.376 1.87 . . . . 0.0 111.631 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.31 109.42 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.953 3.102 . . . . 0.0 112.108 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -148.04 161.56 41.14 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.705 1.202 . . . . 0.0 112.57 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -69.17 92.6 0.56 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.193 1.397 . . . . 0.0 110.828 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -70.5 165.02 23.52 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.629 -0.67 . . . . 0.0 112.038 164.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.5 tt -144.43 159.88 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.696 1.598 . . . . 0.0 110.092 167.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.9 m -139.67 148.11 23.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.3 1.44 . . . . 0.0 110.776 171.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 124.62 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.141 1.776 . . . . 0.0 108.642 175.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.09 151.0 49.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.77 100.0 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.028 1.731 . . . . 0.0 109.012 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 mm -97.27 109.69 23.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 8.3 ttm -124.11 154.78 39.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.747 1.219 . . . . 0.0 110.748 -177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.59 150.53 36.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.889 1.276 . . . . 0.0 111.833 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -90.66 3.45 54.17 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.11 1.364 . . . . 0.0 113.498 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -67.74 -18.53 64.92 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.162 1.785 . . . . 0.0 115.072 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.55 -1.75 2.14 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.201 1.24 . . . . 0.0 116.201 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.6 122.74 12.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.819 1.81 . . . . 0.0 111.79 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.59 112.82 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.023 1.297 . . . . 0.0 113.163 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.38 151.73 45.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.13 2.572 . . . . 0.0 109.597 -172.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -118.4 104.94 11.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.692 1.597 . . . . 0.0 108.713 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 m -123.75 117.94 26.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.425 0.69 . . . . 0.0 109.629 -174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.42 118.96 32.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.607 0.763 . . . . 0.0 110.768 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -122.56 111.95 17.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.105 1.362 . . . . 0.0 110.024 -173.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.0 m -73.91 22.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.081 -1.012 . . . . 0.0 113.698 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.403 ' HG ' HD11 ' B' ' 209' ' ' ILE . 11.5 m -66.19 166.5 11.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 112.117 167.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.2 159.78 36.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.787 2.035 . . . . 0.0 109.773 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -87.17 141.66 28.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.803 0.841 . . . . 0.0 110.374 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.37 158.49 43.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.086 1.354 . . . . 0.0 112.475 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.1 t -135.05 -56.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.03 1.332 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -86.43 -28.77 23.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.223 0.919 . . . . 0.0 112.637 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.4 -43.34 73.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.937 1.695 . . . . 0.0 112.684 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -161.42 -164.54 1.15 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.189 1.796 . . . . 0.0 111.552 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.57 124.92 7.77 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.097 1.808 . . . . 0.0 114.734 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -145.97 178.41 8.21 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.998 2.119 . . . . 0.0 111.764 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 32.7 t -166.59 135.39 2.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.399 1.48 . . . . 0.0 109.811 162.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -143.95 147.37 33.85 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.869 -1.769 . . . . 0.0 112.303 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.3 144.66 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 110.249 -169.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -138.6 113.14 8.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.312 1.445 . . . . 0.0 111.802 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -124.36 105.84 9.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.282 1.833 . . . . 0.0 110.472 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.75 165.75 16.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.107 0.963 . . . . 0.0 111.66 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.03 -178.77 5.61 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.772 1.229 . . . . 0.0 111.673 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -50.06 -56.56 10.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 113.776 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.0 t -133.71 -15.58 2.38 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.555 1.542 . . . . 0.0 113.744 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.1 ptp -104.68 178.74 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.989 1.716 . . . . 0.0 111.089 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.35 157.57 43.63 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.295 -0.878 . . . . 0.0 111.399 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.9 m -131.45 125.49 32.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.962 1.305 . . . . 0.0 110.462 -171.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -125.75 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.341 1.056 . . . . 0.0 110.633 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.39 109.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 126.146 1.778 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.7 t -108.77 126.95 53.58 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.185 1.394 . . . . 0.0 110.878 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -123.44 157.18 34.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.484 1.914 . . . . 0.0 112.705 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -143.06 158.84 43.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.967 1.307 . . . . 0.0 111.822 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.05 89.07 0.08 OUTLIER Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.311 1.434 . . . . 0.0 111.233 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.79 89.17 1.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.486 1.514 . . . . 0.0 111.404 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 t -75.58 98.89 4.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.07 1.348 . . . . 0.0 112.957 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.8 -4.66 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.025 1.33 . . . . 0.0 114.518 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.03 2.41 26.67 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.09 33.03 7.13 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.198 1.499 . . . . 0.0 114.211 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.5 97.01 0.16 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.491 1.52 . . . . 0.0 112.905 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -124.67 -163.91 1.22 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.616 1.966 . . . . 0.0 111.828 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.12 -0.2 33.46 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.716 1.627 . . . . 0.0 115.431 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -172.51 0.61 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.728 1.211 . . . . 0.0 112.511 169.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.6 t -56.4 -24.45 44.89 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 114.017 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.34 0.44 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.132 1.825 . . . . 0.0 112.257 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.91 159.45 52.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.359 2.706 . . . . 0.0 112.61 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.6 97.79 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 125.782 1.633 . . . . 0.0 112.376 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 107.23 9.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.803 1.641 . . . . 0.0 114.284 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -151.23 173.01 14.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.237 2.615 . . . . 0.0 111.883 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.45 73.05 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.779 1.181 . . . . 0.0 113.437 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.15 72.9 1.41 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.853 1.661 . . . . 0.0 111.962 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.75 159.46 24.22 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.045 1.338 . . . . 0.0 112.463 166.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -137.29 177.9 7.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.694 2.797 . . . . 0.0 111.083 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.66 130.89 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.021 1.728 . . . . 0.0 111.075 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.5 m -97.19 90.55 5.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.146 1.378 . . . . 0.0 110.153 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.49 146.6 34.3 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.817 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -129.71 140.72 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.97 1.708 . . . . 0.0 110.46 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -149.41 143.96 26.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.927 1.291 . . . . 0.0 112.07 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -134.42 96.57 15.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.377 1.471 . . . . 0.0 110.078 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.61 164.43 35.74 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.15 2.567 . . . . 0.0 112.006 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.5 -48.33 1.67 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.099 2.533 . . . . 0.0 113.162 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -160.98 -57.05 0.05 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.962 1.705 . . . . 0.0 111.373 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 172.61 13.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.58 1.952 . . . . 0.0 112.129 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.07 168.06 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.396 1.478 . . . . 0.0 112.172 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.408 1.883 . . . . 0.0 112.115 -179.206 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 49.7 m -89.64 5.69 44.61 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.233 1.413 . . . . 0.0 114.432 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 84.7 mmm -63.65 -53.53 50.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.851 -1.155 . . . . 0.0 112.313 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.78 -16.68 63.87 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.68 -21.13 62.62 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.853 0.861 . . . . 0.0 112.444 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -99.04 143.9 28.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.59 1.156 . . . . 0.0 111.496 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -153.03 -177.28 6.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.927 1.691 . . . . 0.0 109.94 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.15 164.69 27.11 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.928 1.291 . . . . 0.0 112.874 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.03 124.15 20.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.16 -17.04 44.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 113.937 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.34 -38.23 24.55 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.866 -1.146 . . . . 0.0 112.325 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.1 t -72.92 -14.33 61.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.391 1.877 . . . . 0.0 112.674 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.95 138.14 58.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.771 -1.206 . . . . 0.0 111.254 174.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -99.83 172.0 7.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.207 1.003 . . . . 0.0 111.143 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.19 146.36 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.142 1.377 . . . . 0.0 109.782 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.4 -38.69 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.261 -0.899 . . . . 0.0 111.501 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.5 -29.11 68.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.884 1.274 . . . . 0.0 113.814 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.38 -58.41 3.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.929 0.891 . . . . 0.0 110.376 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 53.3 t -52.08 -43.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.35 1.46 . . . . 0.0 112.122 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.1 t -64.14 -12.72 42.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 113.9 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -102.16 -31.96 10.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.782 1.633 . . . . 0.0 113.133 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 23.0 mt -51.41 -43.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 110.464 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.72 -42.51 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -52.32 57.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.037 1.289 . . . . 0.0 110.975 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -34.34 76.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.41 -38.47 71.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.159 0.984 . . . . 0.0 113.119 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.0 -58.05 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.242 0.928 . . . . 0.0 109.975 172.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.68 -28.93 70.27 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.559 -0.713 . . . . 0.0 112.889 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -59.54 -46.67 88.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.769 1.227 . . . . 0.0 112.401 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.16 79.95 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.923 0.889 . . . . 0.0 113.146 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.71 -40.2 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.317 1.047 . . . . 0.0 111.774 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.02 12.73 58.26 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.865 1.221 . . . . 0.0 115.026 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.96 15.51 74.14 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.76 1.171 . . . . 0.0 114.762 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.72 -175.7 0.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.171 1.388 . . . . 0.0 112.34 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 107.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.316 1.446 . . . . 0.0 112.653 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -70.39 99.86 1.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.632 1.573 . . . . 0.0 111.14 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.53 164.85 11.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.623 1.169 . . . . 0.0 111.738 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -73.35 -55.9 5.78 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.4 m -67.92 -21.21 65.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.516 -0.74 . . . . 0.0 112.54 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -58.48 -44.04 89.22 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.91 -34.58 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.36 0.982 . . . . 0.0 112.039 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -65.97 -50.08 65.58 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.073 0.949 . . . . 0.0 111.943 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.04 -26.09 66.59 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.517 -0.739 . . . . 0.0 112.711 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -76.59 -53.51 7.95 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 111.314 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.5 t -58.42 -26.48 63.34 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.6 t -81.57 -57.94 3.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.625 1.102 . . . . 0.0 112.579 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -57.36 -38.19 73.8 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 87.8 t -68.08 -62.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 123.857 0.863 . . . . 0.0 110.276 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.95 -29.68 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.018 1.327 . . . . 0.0 110.852 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.06 -42.8 86.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.428 0.691 . . . . 0.0 112.826 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.02 -34.76 8.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 113.085 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 18.6 m -59.14 -53.88 53.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.38 1.872 . . . . 0.0 111.452 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -38.19 84.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.039 0.536 . . . . 0.0 111.94 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 37.2 p -70.78 -29.74 66.03 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -72.14 -51.91 19.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.475 2.31 . . . . 0.0 113.045 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.03 -25.8 67.99 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.808 -1.183 . . . . 0.0 113.706 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 60.2 m -59.33 -34.79 72.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.051 0.94 . . . . 0.0 110.676 167.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -81.12 -28.38 35.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.2 -16.58 63.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.33 1.052 . . . . 0.0 113.074 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.9 -117.21 4.22 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.036 1.779 . . . . 0.0 112.558 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -132.96 158.92 74.61 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 126.716 2.006 . . . . 0.0 111.474 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.04 110.09 3.01 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.572 2.848 . . . . 0.0 112.286 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.84 165.18 29.64 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.687 1.595 . . . . 0.0 111.965 173.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -72.7 98.04 2.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.632 1.173 . . . . 0.0 110.425 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -74.39 164.56 26.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.268 0.556 . . . . 0.0 111.937 165.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . 0.403 HD11 ' HG ' ' A' ' 85' ' ' CYS . 4.2 tt -145.09 159.31 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.851 1.66 . . . . 0.0 109.991 166.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 35.1 m -140.18 147.9 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 125.317 1.447 . . . . 0.0 110.695 171.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 123.26 14.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.054 1.742 . . . . 0.0 108.616 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.1 p -126.46 150.26 48.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.14 103.19 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.153 1.781 . . . . 0.0 109.002 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.45 108.97 24.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.8 ttm -123.91 162.79 22.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.765 1.226 . . . . 0.0 110.951 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.82 44.23 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 112.277 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -90.62 1.81 56.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -67.71 -18.8 65.03 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.012 1.725 . . . . 0.0 115.078 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.04 -1.41 2.22 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.19 125.26 19.89 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.767 1.783 . . . . 0.0 111.563 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -130.32 112.19 1.25 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.944 1.259 . . . . 0.0 112.999 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.17 153.37 47.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.148 2.579 . . . . 0.0 109.591 -172.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -119.55 102.18 8.46 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 108.79 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 1.4 m -121.4 123.59 42.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.015 0.926 . . . . 0.0 109.121 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.59 119.89 29.33 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.172 0.589 . . . . 0.0 111.011 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -122.47 112.38 17.98 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.022 1.329 . . . . 0.0 109.988 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 70.5 m -74.11 23.22 0.08 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 20.6 m -67.18 167.03 12.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.639 1.176 . . . . 0.0 112.109 167.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.59 161.73 37.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.126 2.17 . . . . 0.0 109.73 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -88.66 141.64 28.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.92 0.888 . . . . 0.0 110.275 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -146.01 157.56 43.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.088 1.355 . . . . 0.0 112.544 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.0 t -127.14 -61.09 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.2 1.4 . . . . 0.0 112.133 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 82.7 p -95.34 -21.67 18.24 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -40.69 86.69 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.89 1.276 . . . . 0.0 111.608 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -162.04 -163.79 0.99 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 126.636 1.974 . . . . 0.0 111.026 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.27 9.04 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.061 1.791 . . . . 0.0 114.489 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 87.3 p -148.12 178.18 8.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 111.576 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 31.4 t -166.84 134.71 2.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 109.82 162.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -143.36 147.19 34.29 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.9 -1.75 . . . . 0.0 112.362 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.85 144.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.665 1.186 . . . . 0.0 110.175 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -138.73 113.1 8.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.145 1.378 . . . . 0.0 111.823 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -124.9 103.81 8.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.266 1.827 . . . . 0.0 110.346 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.17 165.99 6.61 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.83 0.852 . . . . 0.0 112.588 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -140.36 -177.73 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.301 1.44 . . . . 0.0 111.465 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -49.81 -56.73 9.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.584 . . . . 0.0 113.852 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.6 t -133.51 -16.71 2.34 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.69 1.596 . . . . 0.0 113.552 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.3 ptp -104.05 -179.32 3.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.196 1.798 . . . . 0.0 111.162 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -149.25 161.27 42.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.008 0.923 . . . . 0.0 111.578 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 32.2 m -132.77 124.95 29.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.425 1.49 . . . . 0.0 110.051 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.08 136.55 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.095 0.958 . . . . 0.0 110.539 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.95 108.03 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.972 1.709 . . . . 0.0 111.093 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.5 t -107.06 123.53 48.35 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.107 1.363 . . . . 0.0 110.775 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -118.33 158.14 25.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.41 1.884 . . . . 0.0 112.368 -177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -142.18 156.54 45.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.648 1.179 . . . . 0.0 112.034 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -171.3 88.91 0.08 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.722 0.677 . . . . 0.0 113.119 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.69 91.87 2.94 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.612 1.165 . . . . 0.0 110.777 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.3 t -84.96 98.72 10.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.187 1.395 . . . . 0.0 112.183 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -3.83 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -175.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -74.03 3.64 36.27 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.741 1.162 . . . . 0.0 115.898 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.64 33.45 7.09 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.377 1.589 . . . . 0.0 114.359 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -62.47 97.6 0.18 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.394 1.473 . . . . 0.0 112.985 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 9.6 t -125.62 -164.35 1.29 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.628 1.971 . . . . 0.0 111.95 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 109.55 -0.65 30.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.759 1.647 . . . . 0.0 115.309 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -171.32 0.65 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.767 1.227 . . . . 0.0 112.525 170.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 8.7 t -55.65 -27.21 48.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.501 1.52 . . . . 0.0 114.24 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 129.96 -72.31 0.48 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.798 1.666 . . . . 0.0 112.519 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 153.54 67.37 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.069 2.513 . . . . 0.0 112.053 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.72 158.58 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.34 1.056 . . . . 0.0 111.272 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 168.24 9.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.036 1.335 . . . . 0.0 112.048 167.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.3 mt -72.51 169.42 16.5 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.45 1.1 . . . . 0.0 112.17 170.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.78 165.62 20.75 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.548 1.547 . . . . 0.0 112.986 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.08 88.15 2.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.717 2.007 . . . . 0.0 109.76 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -151.78 157.3 41.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.096 1.358 . . . . 0.0 111.703 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -135.68 177.92 7.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.682 2.393 . . . . 0.0 111.111 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.8 mm -53.01 130.24 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.981 1.712 . . . . 0.0 111.106 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 32.0 m -96.26 86.48 4.23 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.098 1.359 . . . . 0.0 110.114 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.14 145.47 27.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.809 0.844 . . . . 0.0 110.883 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.0 136.86 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.121 1.768 . . . . 0.0 110.964 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -143.74 144.69 31.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.497 1.519 . . . . 0.0 112.109 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.5 97.43 15.99 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.23 1.412 . . . . 0.0 110.522 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.05 164.5 35.47 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.18 2.587 . . . . 0.0 112.076 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.93 -49.28 1.09 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.198 2.599 . . . . 0.0 113.252 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -160.49 -57.45 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.009 1.724 . . . . 0.0 111.495 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.36 172.61 13.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.599 1.96 . . . . 0.0 112.167 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.69 168.08 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 0.0 112.203 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.346 1.858 . . . . 0.0 112.031 -179.041 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p -152.61 103.38 2.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 112.3 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.01 -35.07 77.46 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.282 1.433 . . . . 0.0 113.132 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.45 -17.06 64.25 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.99 -16.97 57.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.946 . . . . 0.0 113.254 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.62 140.08 58.83 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.288 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.08 176.76 8.56 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.999 1.719 . . . . 0.0 110.706 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.28 30.23 7.45 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.813 1.645 . . . . 0.0 112.933 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.71 19.33 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.716 2.406 . . . . 0.0 116.048 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.45 -28.16 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.472 1.509 . . . . 0.0 113.014 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -73.66 -29.27 62.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -90.82 -23.75 20.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 147.21 46.06 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.33 -0.856 . . . . 0.0 112.009 170.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.92 166.3 11.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.266 1.026 . . . . 0.0 112.289 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.83 158.08 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.289 1.435 . . . . 0.0 110.584 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.3 -36.4 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.47 -32.59 58.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.687 0.795 . . . . 0.0 112.881 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.74 -54.79 5.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.096 0.558 . . . . 0.0 110.236 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 77.5 t -52.08 -43.8 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.952 1.301 . . . . 0.0 112.661 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -64.04 -9.45 16.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.628 1.971 . . . . 0.0 113.898 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -102.68 -38.06 7.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.551 1.54 . . . . 0.0 112.433 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.9 mt -50.08 -44.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.851 0.86 . . . . 0.0 110.474 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -59.24 -42.36 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -52.06 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.046 1.294 . . . . 0.0 111.086 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -33.41 74.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.87 59.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.192 0.997 . . . . 0.0 112.931 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 59.7 mt -59.75 -58.87 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.319 0.963 . . . . 0.0 109.626 173.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.7 -30.01 71.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -59.29 -50.66 73.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.429 1.091 . . . . 0.0 112.061 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.95 73.18 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.47 -35.76 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.478 1.111 . . . . 0.0 111.582 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.55 81.68 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.109 0.861 . . . . 0.0 114.739 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.37 3.04 56.61 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.158 1.361 . . . . 0.0 115.863 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -64.62 165.26 10.48 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 119.235 1.517 . . . . 0.0 111.694 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.77 -178.75 4.98 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.931 -1.106 . . . . 0.0 112.053 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -51.73 141.04 17.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.546 0.738 . . . . 0.0 111.285 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 165.19 24.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.361 1.065 . . . . 0.0 111.594 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -84.09 -88.3 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.824 0.849 . . . . 0.0 111.055 -171.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -78.47 -21.08 49.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.345 -1.472 . . . . 0.0 113.921 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -38.01 71.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.238 1.015 . . . . 0.0 112.445 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.17 -30.37 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -68.06 -45.29 74.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.827 0.851 . . . . 0.0 111.188 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.39 -26.4 66.43 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -76.73 -53.82 7.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.972 0.806 . . . . 0.0 111.322 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -56.0 -32.07 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.618 0.644 . . . . 0.0 112.452 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -77.65 -59.45 2.78 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.357 0.98 . . . . 0.0 112.581 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -57.08 -39.02 74.17 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.389 1.476 . . . . 0.0 113.63 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.3 t -68.3 -63.5 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 C-N-CA 123.976 0.91 . . . . 0.0 109.97 -177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.88 -30.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.761 1.224 . . . . 0.0 110.621 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.44 -46.4 83.63 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.646 0.779 . . . . 0.0 112.671 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -98.23 -39.45 8.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 0.0 112.705 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -58.28 -53.09 62.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.265 2.226 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -38.07 85.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.64 0.376 . . . . 0.0 111.208 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 t -62.57 -44.58 95.98 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.329 -0.857 . . . . 0.0 112.252 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -61.38 -49.28 77.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.729 2.012 . . . . 0.0 113.048 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -68.77 -27.12 65.61 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.0 m -59.9 -30.68 69.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 110.918 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -82.16 -28.01 32.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.519 -0.738 . . . . 0.0 112.97 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.35 -28.87 66.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.637 0.775 . . . . 0.0 111.433 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.42 -104.61 2.3 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.771 1.653 . . . . 0.0 113.855 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 154.44 75.5 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.114 1.766 . . . . 0.0 112.642 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.54 110.51 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.86 3.04 . . . . 0.0 111.673 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.37 170.25 18.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 112.587 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -71.37 116.01 11.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.644 0.778 . . . . 0.0 110.563 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -101.59 164.15 11.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.518 1.127 . . . . 0.0 110.74 165.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -147.42 155.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.602 1.961 . . . . 0.0 108.518 171.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.53 151.78 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 110.415 167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.53 128.74 25.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.939 2.095 . . . . 0.0 108.862 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.4 p -131.81 145.3 51.49 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.253 -0.904 . . . . 0.0 112.66 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.64 110.25 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.468 1.507 . . . . 0.0 108.606 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mm -109.8 95.67 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.31 1.844 . . . . 0.0 107.808 -174.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -134.5 154.15 51.58 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.654 0.782 . . . . 0.0 111.975 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.27 149.33 33.58 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.731 -0.606 . . . . 0.0 112.019 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -7.38 59.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -65.96 -36.88 84.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.473 1.909 . . . . 0.0 114.367 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.8 40.37 1.59 Allowed Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.6 1.095 . . . . 0.0 115.026 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.06 -169.94 0.67 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.173 1.389 . . . . 0.0 112.701 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.0 73.15 1.05 Allowed Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.545 -1.347 . . . . 0.0 113.939 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.12 90.85 2.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.891 2.076 . . . . 0.0 112.065 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -113.65 136.44 52.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.271 1.428 . . . . 0.0 110.181 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -145.27 147.31 32.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.902 1.281 . . . . 0.0 109.779 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.4 147.88 30.73 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.254 -0.904 . . . . 0.0 111.602 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.1 p -148.52 133.47 18.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.039 0.536 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.5 m -80.51 19.19 0.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.687 -0.633 . . . . 0.0 112.564 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 56.1 m -68.34 165.16 19.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.717 1.207 . . . . 0.0 112.204 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -163.02 140.11 7.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.653 1.581 . . . . 0.0 110.61 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.02 150.79 40.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.13 0.572 . . . . 0.0 110.498 171.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -140.32 152.75 46.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.62 1.568 . . . . 0.0 110.617 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.3 t -109.24 -66.31 1.07 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.197 0.999 . . . . 0.0 111.426 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.5 p -89.78 -26.68 20.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 113.027 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -77.82 -44.87 26.08 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.364 1.866 . . . . 0.0 112.92 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -148.85 -174.24 4.57 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.117 2.567 . . . . 0.0 110.686 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.98 123.24 3.97 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.618 1.58 . . . . 0.0 113.441 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.46 125.08 13.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.411 1.484 . . . . 0.0 111.337 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.43 112.24 18.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.601 1.56 . . . . 0.0 112.175 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 t -125.21 147.97 48.84 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.523 -1.361 . . . . 0.0 112.319 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.69 136.39 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.739 1.615 . . . . 0.0 109.723 -170.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.58 101.4 5.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.461 1.504 . . . . 0.0 112.022 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -110.04 129.2 55.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.23 159.37 16.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.973 0.909 . . . . 0.0 110.934 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.75 -178.4 4.48 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.599 1.56 . . . . 0.0 110.593 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -51.24 60.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.181 2.192 . . . . 0.0 113.025 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -138.48 -3.51 1.7 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.299 1.439 . . . . 0.0 114.115 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.3 ptp -126.18 -173.71 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.608 1.963 . . . . 0.0 110.746 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.29 156.41 43.8 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.341 -0.85 . . . . 0.0 111.033 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 4.9 p -131.33 96.15 3.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.333 1.453 . . . . 0.0 111.019 -175.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.25 138.32 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.244 1.018 . . . . 0.0 111.413 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.41 137.03 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.309 1.844 . . . . 0.0 109.999 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.2 t -128.25 123.21 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.072 1.349 . . . . 0.0 109.853 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -110.21 150.96 27.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.606 1.162 . . . . 0.0 111.53 174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.66 106.91 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.764 1.626 . . . . 0.0 107.915 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.23 88.24 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.962 1.744 . . . . 0.0 110.358 -169.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -64.42 163.61 12.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.998 1.319 . . . . 0.0 112.218 -173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.8 t -124.68 130.31 52.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.836 1.254 . . . . 0.0 112.381 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.56 -57.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.06 1.744 . . . . 0.0 109.549 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.97 -26.74 73.4 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.64 -0.533 . . . . 0.0 112.957 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.5 25.32 68.58 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.203 1.001 . . . . 0.0 114.16 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.0 149.16 31.05 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.898 1.237 . . . . 0.0 113.713 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -69.22 177.83 2.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.979 1.312 . . . . 0.0 113.419 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.85 20.58 5.65 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.91 1.243 . . . . 0.0 113.982 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -58.13 177.64 0.12 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.563 1.545 . . . . 0.0 112.352 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -18.95 14.74 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.93 -73.39 0.4 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.097 1.808 . . . . 0.0 111.97 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.23 157.06 62.84 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.109 2.539 . . . . 0.0 112.384 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.7 pt -110.77 148.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.861 1.664 . . . . 0.0 110.636 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 138.62 48.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.757 1.223 . . . . 0.0 110.791 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.7 mt -135.26 121.76 20.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.94 1.696 . . . . 0.0 109.49 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.75 -174.95 28.23 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.009 1.29 . . . . 0.0 113.639 -173.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.9 ttm -81.38 -178.08 6.77 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.049 1.34 . . . . 0.0 112.416 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -132.49 174.98 9.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.079 1.752 . . . . 0.0 112.421 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -121.7 168.21 12.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.925 1.69 . . . . 0.0 112.051 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mm -71.85 146.49 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.447 1.499 . . . . 0.0 110.704 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.1 m -112.79 92.7 4.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.39 1.476 . . . . 0.0 110.292 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.54 149.34 22.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.863 0.865 . . . . 0.0 111.036 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.9 106.75 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.522 2.329 . . . . 0.0 108.795 175.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.17 152.13 48.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.1 0.96 . . . . 0.0 111.833 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -75.47 152.23 85.48 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.794 0.837 . . . . 0.0 111.4 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.97 159.01 53.86 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.975 2.45 . . . . 0.0 112.26 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.51 -48.2 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.172 2.582 . . . . 0.0 113.232 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -159.1 -53.99 0.06 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.806 1.642 . . . . 0.0 111.938 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 170.86 11.31 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.132 1.373 . . . . 0.0 112.258 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.77 168.31 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.854 1.662 . . . . 0.0 111.884 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.054 1.742 . . . . 0.0 110.981 177.122 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.637 0 CA-C-O 119.503 -0.61 . . . . 0.0 112.342 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.8 p -152.73 101.8 2.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.648 1.179 . . . . 0.0 112.398 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -61.36 -34.95 76.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.33 1.452 . . . . 0.0 113.074 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -65.65 -16.91 64.19 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.0 -17.01 57.62 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.046 0.938 . . . . 0.0 113.245 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.73 140.27 58.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.762 0.825 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.04 176.77 8.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.963 1.705 . . . . 0.0 110.702 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -114.32 30.2 7.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.779 1.631 . . . . 0.0 112.979 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.5 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 127.772 2.429 . . . . 0.0 116.068 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -63.48 -28.04 69.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.483 1.513 . . . . 0.0 113.059 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -73.64 -30.21 62.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.9 t -90.15 -23.84 21.22 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.92 147.78 41.98 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.403 -0.811 . . . . 0.0 112.1 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -93.67 174.38 7.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.06 0.944 . . . . 0.0 112.022 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.58 159.27 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.278 1.431 . . . . 0.0 110.766 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 89.3 t -61.95 -38.33 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.133 -0.979 . . . . 0.0 112.014 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.63 -30.31 60.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 112.877 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.87 -61.05 1.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.763 0.825 . . . . 0.0 110.75 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 77.9 t -54.06 -41.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.873 1.269 . . . . 0.0 113.124 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -62.3 -8.74 6.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.772 1.629 . . . . 0.0 113.715 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -106.17 -39.51 5.93 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.846 1.658 . . . . 0.0 112.588 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.7 -43.32 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.282 0.947 . . . . 0.0 110.533 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.34 -42.59 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -51.34 57.59 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.957 1.253 . . . . 0.0 110.98 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -33.57 74.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.0 61.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.974 0.91 . . . . 0.0 113.069 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 60.5 mt -59.83 -58.77 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.393 0.997 . . . . 0.0 109.645 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -63.04 -29.69 71.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 t -59.35 -50.57 73.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.466 1.106 . . . . 0.0 112.067 167.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.02 -31.79 72.89 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.68 -35.46 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.22 13.51 81.81 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.055 0.836 . . . . 0.0 114.777 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.17 3.3 56.75 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.873 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.49 164.93 10.72 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.23 1.515 . . . . 0.0 111.646 169.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.82 -178.56 4.32 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.925 -1.109 . . . . 0.0 111.995 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -51.63 139.07 21.55 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.677 -0.639 . . . . 0.0 110.908 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -179.81 4.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.714 1.206 . . . . 0.0 111.01 -175.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -96.47 -99.15 0.18 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.531 0.732 . . . . 0.0 109.998 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -66.62 -23.15 66.13 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.729 -1.232 . . . . 0.0 114.157 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -38.89 72.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.163 0.985 . . . . 0.0 112.552 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 45.2 t -54.82 -33.47 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.604 1.162 . . . . 0.0 112.512 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -66.74 -45.66 77.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.616 0.766 . . . . 0.0 111.553 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.06 -26.06 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.639 -0.663 . . . . 0.0 112.667 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -77.14 -53.14 8.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.797 0.726 . . . . 0.0 111.322 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.0 t -56.03 -31.95 63.59 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.479 0.581 . . . . 0.0 112.508 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 9.4 t -77.68 -59.81 2.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 119.361 0.982 . . . . 0.0 112.633 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -56.63 -38.59 72.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.305 1.442 . . . . 0.0 113.698 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.54 -63.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 123.854 0.861 . . . . 0.0 109.997 -177.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.82 -30.57 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.741 1.217 . . . . 0.0 110.702 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -57.49 -45.72 84.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.685 0.794 . . . . 0.0 112.727 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -98.77 -39.47 8.62 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.194 1.397 . . . . 0.0 112.766 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 26.9 m -58.48 -52.17 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.294 2.238 . . . . 0.0 112.147 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -38.21 86.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.669 0.388 . . . . 0.0 111.179 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.7 t -63.12 -43.87 97.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.368 -0.832 . . . . 0.0 112.347 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.77 -48.92 78.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.826 2.05 . . . . 0.0 112.939 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -69.45 -25.63 64.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.9 m -60.73 -30.6 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.934 -0.479 . . . . 0.0 110.599 166.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -81.56 -29.58 33.38 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.554 -0.716 . . . . 0.0 112.505 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.86 -17.73 63.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 112.953 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -109.92 -100.13 2.6 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.867 1.698 . . . . 0.0 113.767 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.65 155.23 63.53 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.837 1.655 . . . . 0.0 112.001 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.63 109.34 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 111.574 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -147.37 169.92 18.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.181 0.993 . . . . 0.0 112.471 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -71.46 120.17 16.67 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.271 0.628 . . . . 0.0 110.388 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -106.67 163.63 12.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.821 1.249 . . . . 0.0 110.647 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.2 tt -147.44 155.26 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.335 1.854 . . . . 0.0 108.708 172.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.2 m -140.05 151.13 21.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.984 0.914 . . . . 0.0 110.314 168.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.08 129.59 27.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.871 2.069 . . . . 0.0 108.921 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.44 148.41 52.4 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.165 -0.96 . . . . 0.0 112.532 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 15.6 t -136.15 115.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.071 1.349 . . . . 0.0 108.93 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 3.0 mm -112.7 94.58 3.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.595 1.958 . . . . 0.0 107.538 -172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 9.1 ptm -132.14 150.27 52.2 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.289 1.436 . . . . 0.0 111.757 -170.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -88.01 140.18 29.76 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.292 0.637 . . . . 0.0 112.312 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -9.23 58.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.98 -30.68 71.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.326 1.851 . . . . 0.0 114.485 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.65 29.97 5.4 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.229 0.918 . . . . 0.0 115.343 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.4 176.24 1.92 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 118.29 1.045 . . . . 0.0 111.941 163.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 59.24 1.28 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.233 1.873 . . . . 0.0 116.253 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.96 99.14 8.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.242 1.817 . . . . 0.0 110.457 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.48 132.01 55.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.262 1.425 . . . . 0.0 110.209 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 28.7 m -140.77 147.21 38.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.713 0.805 . . . . 0.0 110.172 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.67 147.9 33.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.476 0.655 . . . . 0.0 111.538 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 134.78 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.236 0.614 . . . . 0.0 111.529 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 29.8 m -80.9 19.15 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 173.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 56.6 m -68.24 165.13 19.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.557 1.143 . . . . 0.0 112.172 172.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -162.84 140.7 8.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.539 1.536 . . . . 0.0 110.568 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 150.22 40.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.329 0.652 . . . . 0.0 110.429 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.99 151.08 45.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.6 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.5 t -108.59 -66.42 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.148 0.979 . . . . 0.0 111.594 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 58.1 p -89.76 -26.46 20.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.815 0.846 . . . . 0.0 112.998 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.9 m -77.59 -45.14 26.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.366 1.866 . . . . 0.0 112.92 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -148.95 -174.17 4.56 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.112 2.565 . . . . 0.0 110.802 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.68 125.58 5.24 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.656 1.598 . . . . 0.0 113.358 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.72 125.82 12.91 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 111.235 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.8 p -122.06 112.26 18.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.409 1.484 . . . . 0.0 112.244 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.8 t -124.67 148.5 47.94 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.401 -1.437 . . . . 0.0 112.32 -173.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.59 136.46 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.682 1.593 . . . . 0.0 109.82 -170.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.8 99.22 4.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.381 1.472 . . . . 0.0 112.176 -169.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -108.24 124.44 50.3 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.88 1.272 . . . . 0.0 110.01 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.36 158.86 18.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -129.91 -176.71 4.01 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.744 1.618 . . . . 0.0 110.728 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -51.51 55.9 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.672 1.989 . . . . 0.0 113.394 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.6 t -138.77 -2.89 1.69 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.402 1.481 . . . . 0.0 113.855 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 13.8 ptp -127.87 -175.85 3.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.801 2.04 . . . . 0.0 110.726 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -141.41 158.33 44.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.093 0.957 . . . . 0.0 111.543 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 3.8 p -130.81 93.14 3.35 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.79 1.636 . . . . 0.0 110.452 -178.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.64 136.35 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.224 1.01 . . . . 0.0 111.095 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.75 138.07 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.162 1.785 . . . . 0.0 110.249 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 t -128.68 123.07 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.082 1.353 . . . . 0.0 109.986 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -108.65 150.4 27.58 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.49 1.116 . . . . 0.0 111.423 173.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -128.19 105.55 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.876 1.67 . . . . 0.0 108.042 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -137.48 94.71 0.22 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.22 1.867 . . . . 0.0 109.838 -171.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -68.57 163.88 22.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.088 0.955 . . . . 0.0 111.679 -175.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t -125.86 129.81 50.11 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.853 1.261 . . . . 0.0 112.099 -174.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.67 -57.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.134 1.774 . . . . 0.0 109.632 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.33 -25.82 74.67 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.976 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.34 25.46 68.49 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 118.284 1.042 . . . . 0.0 114.267 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -57.14 149.97 29.97 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.785 1.183 . . . . 0.0 113.754 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 88.2 p -69.31 177.51 2.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.877 1.271 . . . . 0.0 113.447 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 116.65 19.3 5.39 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.897 1.237 . . . . 0.0 114.147 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -58.56 177.74 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.53 1.532 . . . . 0.0 112.263 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.04 -18.72 15.27 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 139.62 -73.13 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.18 1.847 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.33 156.93 63.04 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.026 2.484 . . . . 0.0 112.416 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 24.8 pt -110.46 148.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.853 1.661 . . . . 0.0 110.657 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 138.82 48.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.757 1.223 . . . . 0.0 110.844 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 54.4 mt -135.24 121.62 20.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 109.497 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.93 -175.03 28.37 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.034 1.302 . . . . 0.0 113.581 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 8.0 ttm -81.53 -177.71 6.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.095 1.358 . . . . 0.0 112.437 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.94 175.21 9.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.1 1.76 . . . . 0.0 112.414 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -121.85 168.33 11.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.93 1.692 . . . . 0.0 112.091 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.61 147.95 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.389 1.475 . . . . 0.0 110.651 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 80.4 m -114.79 91.75 3.72 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.375 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.03 148.78 22.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.147 0.979 . . . . 0.0 110.792 168.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 1.4 p -142.11 104.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.902 2.081 . . . . 0.0 109.653 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -135.7 153.87 51.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.401 1.48 . . . . 0.0 112.214 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -74.92 150.14 85.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.729 -0.607 . . . . 0.0 111.527 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 159.37 50.92 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.273 2.649 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.23 -49.22 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.195 2.597 . . . . 0.0 113.334 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -159.4 -53.97 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.743 1.617 . . . . 0.0 111.919 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.96 171.09 11.4 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.176 1.39 . . . . 0.0 112.27 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 168.54 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.835 1.654 . . . . 0.0 111.802 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.15 0 C-N-CA 126.033 1.733 . . . . 0.0 110.921 177.112 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -61.14 115.4 3.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.851 1.66 . . . . 0.0 112.445 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ttt -66.9 -40.8 87.83 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.513 -0.742 . . . . 0.0 112.093 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -15.82 63.82 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -23.29 67.22 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.471 1.109 . . . . 0.0 113.111 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -129.86 168.52 16.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.7 2.0 . . . . 0.0 111.39 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -155.87 166.9 32.09 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.245 -0.909 . . . . 0.0 112.72 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.81 51.07 1.05 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.847 1.659 . . . . 0.0 112.571 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.14 0.37 4.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.407 1.483 . . . . 0.0 114.969 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.31 -24.33 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.081 2.152 . . . . 0.0 115.124 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -18.02 18.32 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.72 1.608 . . . . 0.0 114.818 172.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 t -61.68 -32.85 73.06 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.632 1.173 . . . . 0.0 112.712 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.09 140.24 37.91 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.356 -0.84 . . . . 0.0 111.127 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -69.96 175.8 4.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.747 0.819 . . . . 0.0 111.899 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.17 146.68 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.8 1.24 . . . . 0.0 110.769 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.54 -39.31 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.154 0.982 . . . . 0.0 111.458 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.83 -28.82 69.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.767 1.227 . . . . 0.0 113.222 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.26 -58.49 3.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.558 1.143 . . . . 0.0 110.837 171.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.26 -41.16 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.485 1.114 . . . . 0.0 112.424 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -62.92 -17.4 61.72 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.255 1.422 . . . . 0.0 113.934 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -97.97 -35.16 10.55 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.767 1.627 . . . . 0.0 113.259 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 mt -50.41 -41.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.203 1.001 . . . . 0.0 110.684 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.59 -40.76 90.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -52.35 56.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.857 1.208 . . . . 0.0 111.058 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -33.01 73.51 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.89 -42.44 57.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.615 0.766 . . . . 0.0 112.984 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.57 -56.95 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.99 0.813 . . . . 0.0 109.828 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.12 -30.89 70.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.3 t -59.84 -49.65 76.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.56 1.144 . . . . 0.0 112.238 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.21 77.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.075 0.95 . . . . 0.0 113.507 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.9 -37.02 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.866 1.266 . . . . 0.0 111.613 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.37 17.59 74.46 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.145 0.878 . . . . 0.0 114.599 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.11 78.58 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.694 1.14 . . . . 0.0 115.576 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.62 156.55 8.22 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 113.138 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -175.63 1.03 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.413 1.485 . . . . 0.0 112.352 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -47.99 146.75 2.37 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -136.74 178.5 7.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.067 1.347 . . . . 0.0 112.24 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -95.37 -118.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.454 1.501 . . . . 0.0 110.45 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.8 p -66.75 0.47 2.36 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.885 2.074 . . . . 0.0 115.91 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -50.52 -44.36 56.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.844 1.202 . . . . 0.0 112.761 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.2 t -55.92 -34.05 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -67.03 -51.61 52.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.451 1.023 . . . . 0.0 112.411 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.73 -25.65 68.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.49 -0.756 . . . . 0.0 112.42 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.64 -56.08 4.93 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.713 1.205 . . . . 0.0 111.629 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -22.59 63.42 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.94 -60.19 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.375 0.989 . . . . 0.0 111.905 166.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.3 -39.26 72.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.01 1.277 . . . . 0.0 113.905 -173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.19 -64.56 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 110.022 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -47.77 -30.17 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.957 1.303 . . . . 0.0 110.993 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.86 -42.83 85.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.955 0.902 . . . . 0.0 112.87 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -101.78 -39.77 7.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.611 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -57.64 -53.17 61.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.425 2.29 . . . . 0.0 112.598 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -37.11 80.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.571 0.623 . . . . 0.0 111.333 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m -65.15 -37.06 86.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -69.21 -52.12 31.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.163 1.785 . . . . 0.0 112.965 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.06 -26.46 68.57 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.858 -1.151 . . . . 0.0 113.7 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.6 m -57.48 -31.96 66.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 167.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -88.81 -25.53 22.17 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.17 -16.79 63.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.065 0.946 . . . . 0.0 113.26 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.02 -112.61 3.36 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.658 1.599 . . . . 0.0 112.77 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -132.67 152.11 79.33 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 125.422 1.489 . . . . 0.0 113.492 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.06 104.14 1.48 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.44 3.426 . . . . 0.0 112.275 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -142.81 177.9 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.297 1.839 . . . . 0.0 112.216 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -100.19 75.91 1.86 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.625 1.57 . . . . 0.0 111.35 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -67.05 147.12 53.59 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 111.009 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.89 156.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.384 1.474 . . . . 0.0 109.756 170.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.69 158.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.491 0.716 . . . . 0.0 109.976 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.53 131.97 32.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.744 1.617 . . . . 0.0 108.973 164.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.5 p -124.92 150.33 46.68 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 167.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.34 117.88 50.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.284 1.034 . . . . 0.0 108.247 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.6 mm -114.91 120.95 65.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 107.71 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -144.45 139.74 28.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.61 0.719 . . . . 0.0 111.319 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -145.79 106.73 4.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.463 1.905 . . . . 0.0 109.424 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -146.72 -58.57 0.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.754 0.821 . . . . 0.0 112.567 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -122.52 -9.96 8.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.286 1.434 . . . . 0.0 113.767 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.0 -3.85 55.95 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.315 1.435 . . . . 0.0 114.908 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.38 165.99 21.27 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 156.06 52.33 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.53 0.586 . . . . 0.0 113.966 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.05 178.95 4.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.556 1.942 . . . . 0.0 111.354 169.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.15 92.73 3.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.141 1.377 . . . . 0.0 109.791 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.7 m -108.88 147.24 32.45 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.687 -1.258 . . . . 0.0 108.871 176.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.63 146.18 32.15 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.232 -0.918 . . . . 0.0 112.194 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -143.16 143.12 31.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 112.883 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t -78.39 12.13 2.1 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 12.5 m -62.71 173.03 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.093 0.957 . . . . 0.0 112.394 168.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -161.63 157.1 24.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.689 1.995 . . . . 0.0 110.082 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -78.11 146.95 34.87 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.626 172.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.15 158.54 43.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.666 1.586 . . . . 0.0 111.577 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t -134.47 -57.29 0.84 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.202 1.401 . . . . 0.0 112.479 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 m -84.24 -36.81 22.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.946 0.899 . . . . 0.0 112.09 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.4 -46.86 59.17 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.743 1.617 . . . . 0.0 112.719 -172.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.07 -167.97 2.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.768 2.427 . . . . 0.0 109.923 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.43 156.06 15.88 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 124.297 0.951 . . . . 0.0 113.835 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -145.75 169.62 18.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.983 1.713 . . . . 0.0 112.243 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.3 t -166.35 158.17 13.63 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.073 1.749 . . . . 0.0 110.292 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.6 t -150.32 146.78 26.96 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 119.534 -1.979 . . . . 0.0 111.261 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.7 95.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.266 1.426 . . . . 0.0 110.661 -166.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -86.79 116.08 24.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.099 1.76 . . . . 0.0 112.366 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -126.39 113.62 17.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.725 1.61 . . . . 0.0 110.231 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.3 170.56 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.58 1.552 . . . . 0.0 112.599 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.6 -170.92 3.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.888 1.275 . . . . 0.0 112.482 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -42.92 -58.57 2.34 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.301 2.24 . . . . 0.0 114.16 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t -136.05 -29.59 1.0 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 113.099 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.57 149.8 34.81 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.925 0.89 . . . . 0.0 111.586 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -136.36 141.16 43.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.533 1.533 . . . . 0.0 109.585 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 1.7 p -144.24 71.92 1.33 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.695 -169.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.94 142.04 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.319 -0.863 . . . . 0.0 111.588 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.1 t -121.61 142.91 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.639 1.975 . . . . 0.0 110.335 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -138.78 122.87 17.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.889 1.675 . . . . 0.0 109.553 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.3 142.67 51.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.07 1.748 . . . . 0.0 113.586 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -140.67 125.83 18.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.073 0.949 . . . . 0.0 111.263 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.85 70.33 0.22 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 127.378 2.418 . . . . 0.0 111.394 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.64 128.91 37.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.119 0.968 . . . . 0.0 111.287 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.7 m -141.52 92.63 2.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.141 1.776 . . . . 0.0 111.779 -161.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.507 HD13 ' H ' ' A' ' 115' ' ' ILE . 0.2 OUTLIER -87.95 1.62 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.887 1.675 . . . . 0.0 114.97 -174.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.47 -5.24 77.22 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.1 1.28 61.29 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 118.833 1.317 . . . . 0.0 116.254 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -147.99 91.06 0.14 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.267 1.413 . . . . 0.0 112.791 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.8 m -118.04 103.5 9.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 110.689 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.32 -15.77 0.76 Allowed Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.776 1.655 . . . . 0.0 115.861 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -133.98 169.15 17.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.103 2.561 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 t -116.41 -14.56 10.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.939 1.696 . . . . 0.0 113.637 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.57 -175.59 27.46 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.47 151.31 86.02 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.022 2.481 . . . . 0.0 111.893 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.7 pt -123.01 147.27 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.129 1.372 . . . . 0.0 110.993 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.5 164.57 37.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.676 1.59 . . . . 0.0 112.077 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.3 mt -76.59 118.63 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.589 1.556 . . . . 0.0 109.83 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.4 -159.18 29.99 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.108 1.813 . . . . 0.0 113.055 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.82 93.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.844 0.858 . . . . 0.0 111.062 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.93 98.14 5.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.606 1.963 . . . . 0.0 110.764 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -129.22 167.11 18.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.805 1.242 . . . . 0.0 111.687 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.4 mm -51.08 132.08 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.239 2.215 . . . . 0.0 111.243 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 m -99.82 95.85 7.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.345 1.458 . . . . 0.0 109.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.64 148.39 30.27 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.377 -0.827 . . . . 0.0 111.141 166.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -131.98 89.1 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.803 2.441 . . . . 0.0 109.049 173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -134.63 166.16 23.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.25 1.42 . . . . 0.0 111.714 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.33 156.08 73.12 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.273 1.429 . . . . 0.0 111.048 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.13 161.88 44.04 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.257 2.638 . . . . 0.0 112.69 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.55 -53.18 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.357 2.704 . . . . 0.0 112.854 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -160.19 -61.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.399 1.48 . . . . 0.0 111.514 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -100.88 176.19 5.37 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.91 141.17 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.319 -0.863 . . . . 0.0 111.881 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.475 1.91 . . . . 0.0 112.306 -178.174 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 3.1 p -60.26 115.54 3.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.935 1.694 . . . . 0.0 112.488 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.7 ttt -66.98 -40.6 87.47 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.505 -0.747 . . . . 0.0 112.136 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -15.78 63.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -23.39 67.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.518 1.127 . . . . 0.0 113.118 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -129.78 168.52 16.42 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.596 1.958 . . . . 0.0 111.381 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -155.9 166.79 32.43 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.21 -0.931 . . . . 0.0 112.713 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.6 51.14 1.06 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 112.531 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.21 0.33 5.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.439 1.496 . . . . 0.0 114.945 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.44 -24.16 7.39 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.007 2.123 . . . . 0.0 115.201 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -17.77 16.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.722 1.609 . . . . 0.0 114.838 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 6.0 t -61.81 -32.34 72.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.722 1.209 . . . . 0.0 112.93 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.76 144.3 33.73 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.242 -0.911 . . . . 0.0 111.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.33 173.41 10.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.577 0.751 . . . . 0.0 112.116 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 94.5 t -123.97 142.49 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.63 1.572 . . . . 0.0 109.726 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.11 -41.79 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.86 0.864 . . . . 0.0 111.552 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.06 -35.29 66.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.7 1.6 . . . . 0.0 113.348 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -72.6 -58.92 3.0 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.788 1.235 . . . . 0.0 110.746 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 80.8 t -52.19 -40.77 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.502 1.121 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -63.63 -17.82 63.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 113.982 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.37 -35.24 11.26 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.491 1.517 . . . . 0.0 113.192 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.4 mt -50.66 -41.35 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.104 0.961 . . . . 0.0 110.712 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 121.322 -0.861 . . . . 0.0 113.322 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -52.33 57.29 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.831 1.196 . . . . 0.0 110.982 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -33.0 73.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.84 -42.23 58.38 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 66.1 mt -60.61 -56.89 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.106 0.866 . . . . 0.0 109.786 173.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.2 -30.89 70.69 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.0 t -59.75 -49.75 76.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.631 1.172 . . . . 0.0 112.24 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.25 77.49 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.88 -36.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.879 1.272 . . . . 0.0 111.55 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 70.43 17.57 74.57 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.111 0.862 . . . . 0.0 114.588 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.0 78.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.705 1.145 . . . . 0.0 115.595 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -57.63 156.66 8.07 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.914 1.357 . . . . 0.0 113.101 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.5 -175.52 1.05 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.43 1.492 . . . . 0.0 112.256 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -48.1 146.97 2.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.584 1.553 . . . . 0.0 113.395 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -136.95 178.39 7.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.084 1.353 . . . . 0.0 112.276 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -95.46 -117.66 0.11 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.403 1.481 . . . . 0.0 110.492 169.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 58.5 p -66.76 0.39 2.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.855 2.062 . . . . 0.0 115.957 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -50.86 -44.58 59.63 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.793 1.179 . . . . 0.0 112.779 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.35 -34.02 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -66.7 -51.55 54.71 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.453 1.024 . . . . 0.0 112.403 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.86 -25.63 67.98 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.517 -0.739 . . . . 0.0 112.507 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -76.88 -55.91 5.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.612 1.165 . . . . 0.0 111.547 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 t -60.26 -22.1 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -82.55 -60.41 2.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.233 0.924 . . . . 0.0 111.909 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -55.92 -39.09 71.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.974 1.261 . . . . 0.0 113.905 -173.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 97.2 t -68.33 -64.51 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.52 -30.49 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.999 1.319 . . . . 0.0 111.004 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.88 -42.22 84.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.072 0.949 . . . . 0.0 112.778 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -102.95 -38.68 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.215 1.406 . . . . 0.0 112.781 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.9 m -58.97 -52.85 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.33 2.252 . . . . 0.0 112.624 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -36.04 79.8 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.553 0.615 . . . . 0.0 111.561 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.1 m -60.34 -49.77 76.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 0.0 112.327 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -60.14 -51.73 68.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.91 1.684 . . . . 0.0 113.56 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.04 -26.08 68.11 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.1 m -58.89 -34.2 71.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.615 0.766 . . . . 0.0 110.952 167.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -84.75 -24.69 28.7 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.72 -15.45 63.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.657 1.183 . . . . 0.0 113.302 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -113.05 -113.17 3.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.666 1.603 . . . . 0.0 112.762 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -130.76 153.17 81.53 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 125.774 1.63 . . . . 0.0 112.959 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.89 98.79 0.92 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.198 3.266 . . . . 0.0 112.193 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -140.01 165.84 26.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.225 1.41 . . . . 0.0 112.91 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -84.75 78.54 9.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.912 1.685 . . . . 0.0 111.644 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -59.5 156.32 13.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 112.365 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -144.13 155.96 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.185 1.794 . . . . 0.0 108.949 165.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.91 160.16 29.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.596 162.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.3 141.5 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 109.766 164.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.74 148.71 47.43 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.103 0.961 . . . . 0.0 111.41 171.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.87 104.83 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.899 1.28 . . . . 0.0 108.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 3.7 mm -101.38 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.543 1.537 . . . . 0.0 108.266 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 4.5 tpt -134.57 136.79 43.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.926 0.87 . . . . 0.0 112.322 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -143.17 100.26 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.986 2.114 . . . . 0.0 109.347 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -143.03 -63.92 0.41 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.521 0.728 . . . . 0.0 111.981 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -109.5 -22.48 11.98 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 113.439 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.9 -9.59 76.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.651 1.596 . . . . 0.0 115.03 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -143.98 81.88 1.7 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.027 1.731 . . . . 0.0 110.762 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 176.9 88.61 0.07 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.016 0.817 . . . . 0.0 112.797 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.68 124.84 7.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.755 1.622 . . . . 0.0 109.489 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.44 88.21 2.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.755 1.622 . . . . 0.0 109.101 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 88.5 m -106.34 144.43 33.04 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.541 -1.35 . . . . 0.0 108.144 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.33 133.42 27.78 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.37 -0.831 . . . . 0.0 112.177 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.0 p -134.03 144.58 48.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.021 0.928 . . . . 0.0 113.015 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 15.6 t -78.91 12.3 2.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 19.1 m -63.22 172.74 1.74 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.952 . . . . 0.0 112.518 168.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -162.42 158.15 23.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.725 2.01 . . . . 0.0 110.128 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -76.36 139.8 41.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.5 -0.75 . . . . 0.0 110.506 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -145.22 153.36 41.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.391 1.476 . . . . 0.0 111.859 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 25.8 t -128.74 -59.75 1.12 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.745 1.618 . . . . 0.0 112.499 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.0 m -83.37 -37.24 23.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.872 0.869 . . . . 0.0 111.867 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -51.72 43.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.856 1.662 . . . . 0.0 112.023 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.01 -171.13 3.75 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.732 2.413 . . . . 0.0 109.791 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.54 154.4 16.53 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.308 0.956 . . . . 0.0 114.176 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 85.7 p -144.75 168.45 20.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.24 1.816 . . . . 0.0 112.068 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.6 t -166.23 157.62 13.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.043 1.737 . . . . 0.0 110.185 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.1 t -150.05 146.53 27.01 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.368 -2.082 . . . . 0.0 111.37 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.41 92.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.205 1.402 . . . . 0.0 110.611 -166.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -84.73 115.02 22.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.107 1.763 . . . . 0.0 112.32 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -124.63 117.26 23.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.474 1.51 . . . . 0.0 110.006 172.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -103.05 170.73 7.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.719 1.607 . . . . 0.0 112.425 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.75 -173.66 4.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.896 1.278 . . . . 0.0 112.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -40.16 -58.36 1.49 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 127.422 2.289 . . . . 0.0 114.031 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.2 t -136.39 -20.95 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.816 1.647 . . . . 0.0 113.341 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 21.9 ptm -90.18 132.93 35.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.871 1.268 . . . . 0.0 111.699 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.22 131.9 55.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.124 1.37 . . . . 0.0 109.873 172.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.6 p -137.95 68.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.593 1.557 . . . . 0.0 111.941 -172.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pp -85.36 138.27 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.122 0.969 . . . . 0.0 111.949 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.95 144.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.822 2.049 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 t -139.32 122.61 17.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.001 1.72 . . . . 0.0 109.781 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -125.62 143.07 51.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.974 1.71 . . . . 0.0 113.625 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -140.48 126.3 19.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.993 0.917 . . . . 0.0 111.103 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.62 70.06 0.22 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.915 2.198 . . . . 0.0 110.881 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.45 130.46 43.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.104 0.962 . . . . 0.0 111.227 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.0 m -142.39 100.51 3.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.251 1.82 . . . . 0.0 111.512 -162.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . 0.481 HD13 ' H ' ' B' ' 258' ' ' ILE . 0.2 OUTLIER -96.25 2.18 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.881 1.672 . . . . 0.0 114.551 -174.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -76.0 -5.28 79.89 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.82 60.21 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.796 1.298 . . . . 0.0 116.293 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -148.35 91.86 0.15 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.215 1.388 . . . . 0.0 112.794 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.1 m -119.46 103.21 9.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.316 1.447 . . . . 0.0 110.804 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 69.49 -15.93 0.79 Allowed Glycine 0 CA--C 1.541 1.714 0 C-N-CA 125.726 1.631 . . . . 0.0 115.755 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -134.05 168.66 18.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.164 2.586 . . . . 0.0 110.981 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 10.1 t -114.24 -14.43 12.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.922 1.689 . . . . 0.0 113.563 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -74.6 -177.27 38.06 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 125.657 1.599 . . . . 0.0 114.26 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.04 139.85 52.37 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.535 2.823 . . . . 0.0 112.568 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 43.5 pt -108.05 147.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.794 1.238 . . . . 0.0 111.263 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.85 169.44 19.8 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.67 1.588 . . . . 0.0 111.97 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 33.5 mt -83.97 110.36 18.36 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.336 1.455 . . . . 0.0 109.909 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -89.62 -160.37 36.42 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.262 1.887 . . . . 0.0 113.152 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 97.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.962 0.905 . . . . 0.0 111.097 170.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.29 97.68 4.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.295 1.838 . . . . 0.0 111.126 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -130.26 167.26 18.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.831 1.252 . . . . 0.0 111.883 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -50.2 133.64 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.402 2.281 . . . . 0.0 111.354 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 55.3 m -101.74 91.0 4.21 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.395 1.478 . . . . 0.0 109.697 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.76 148.14 34.98 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.739 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 4.0 p -137.68 92.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 108.816 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -134.55 165.54 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.441 1.896 . . . . 0.0 111.548 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.79 155.69 57.02 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.02 1.328 . . . . 0.0 111.509 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.0 162.13 42.98 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.399 2.733 . . . . 0.0 112.447 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.45 -52.56 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.254 2.636 . . . . 0.0 112.834 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -160.89 -60.41 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.378 1.471 . . . . 0.0 111.462 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -102.48 174.37 5.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.931 2.092 . . . . 0.0 111.19 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.03 134.33 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.073 1.349 . . . . 0.0 110.388 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.339 1.856 . . . . 0.0 112.492 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m -72.89 8.22 1.64 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.057 1.743 . . . . 0.0 115.327 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -0.74 2.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.441 1.897 . . . . 0.0 114.339 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.59 -33.92 56.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.774 2.029 . . . . 0.0 114.915 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -90.09 -18.91 25.01 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.566 1.146 . . . . 0.0 113.148 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -93.57 -172.36 2.88 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.631 1.972 . . . . 0.0 111.593 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 -172.19 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.475 1.91 . . . . 0.0 110.112 175.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.58 118.16 3.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.959 0.904 . . . . 0.0 111.605 167.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.67 55.53 0.85 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.798 1.639 . . . . 0.0 112.879 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -28.29 64.2 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.827 -1.171 . . . . 0.0 113.589 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.99 -25.77 67.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.934 1.694 . . . . 0.0 115.389 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -103.13 -25.39 13.41 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.008 0.923 . . . . 0.0 112.199 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.58 124.44 19.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.439 1.096 . . . . 0.0 112.808 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -66.89 171.56 5.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.662 1.585 . . . . 0.0 112.78 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.81 147.97 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.638 1.575 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.9 -40.2 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.26 1.024 . . . . 0.0 111.877 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.4 -32.54 70.27 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.855 1.262 . . . . 0.0 113.12 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.65 -55.92 6.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.411 1.084 . . . . 0.0 110.294 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.15 -43.85 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.834 1.254 . . . . 0.0 112.794 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -63.92 -6.32 5.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.305 1.442 . . . . 0.0 114.167 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -113.17 -34.28 5.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.152 2.181 . . . . 0.0 112.313 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -43.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.041 1.337 . . . . 0.0 110.586 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.82 -43.16 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.45 -0.781 . . . . 0.0 112.883 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -52.04 50.88 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.363 0.983 . . . . 0.0 111.675 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -31.85 72.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.43 63.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.2 mt -58.05 -55.44 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.244 0.929 . . . . 0.0 109.972 173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.07 -30.84 70.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 t -61.21 -43.23 99.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.892 0.877 . . . . 0.0 112.396 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.34 -36.37 79.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.272 1.029 . . . . 0.0 113.479 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.61 -42.05 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.385 1.074 . . . . 0.0 110.996 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.11 57.96 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.837 1.208 . . . . 0.0 115.218 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.3 22.93 71.42 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.658 1.123 . . . . 0.0 114.656 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.24 -177.55 0.54 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.005 1.322 . . . . 0.0 112.434 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.25 141.43 8.54 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.836 1.254 . . . . 0.0 112.714 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -66.57 104.9 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.774 1.229 . . . . 0.0 110.929 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -124.15 114.94 20.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.019 1.727 . . . . 0.0 110.797 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -77.47 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.862 0.865 . . . . 0.0 112.603 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -57.57 -25.13 59.53 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.373 -1.455 . . . . 0.0 114.06 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -57.99 -30.57 66.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.6 t -52.85 -34.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.359 0.981 . . . . 0.0 111.851 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -64.34 -50.99 65.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.641 1.176 . . . . 0.0 112.641 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -66.81 -28.06 68.06 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.272 -0.893 . . . . 0.0 112.721 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.95 -54.56 6.69 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.673 0.789 . . . . 0.0 111.214 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -58.43 -26.1 62.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.579 0.751 . . . . 0.0 112.76 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 t -83.56 -54.23 5.09 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.217 0.917 . . . . 0.0 112.961 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -58.76 -38.73 79.1 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.916 1.235 . . . . 0.0 113.344 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.8 t -68.66 -63.71 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 124.035 0.934 . . . . 0.0 109.833 -177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.39 -29.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.895 1.278 . . . . 0.0 111.175 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.42 -46.51 86.33 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -95.31 -41.15 9.17 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.835 1.254 . . . . 0.0 112.541 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 m -52.92 -55.97 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.552 2.341 . . . . 0.0 112.463 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.23 -37.32 84.91 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.161 0.437 . . . . 0.0 110.984 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -60.82 -46.53 90.17 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 112.515 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.18 -49.92 75.73 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.653 1.981 . . . . 0.0 113.015 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.57 -28.33 66.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 m -58.95 -27.54 65.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.884 0.874 . . . . 0.0 111.72 165.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -87.87 -23.31 24.01 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.55 -15.19 63.22 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.07 -99.86 0.21 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.678 0.656 . . . . 0.0 113.795 172.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -94.31 109.47 42.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.663 1.185 . . . . 0.0 112.87 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.77 103.12 1.7 Allowed 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.968 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -141.78 163.41 32.97 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.796 1.638 . . . . 0.0 113.733 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -68.61 101.9 1.38 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.068 1.747 . . . . 0.0 112.204 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -81.43 173.52 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.689 1.596 . . . . 0.0 112.107 164.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.6 tt -142.39 154.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.375 1.87 . . . . 0.0 109.464 162.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.4 m -143.49 145.31 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.997 1.719 . . . . 0.0 109.658 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -142.75 155.9 44.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.472 1.109 . . . . 0.0 110.192 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.4 p -148.29 156.43 42.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.041 0.937 . . . . 0.0 112.938 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.86 132.15 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.223 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.51 111.33 35.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 127.324 2.25 . . . . 0.0 107.532 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.1 ttt -117.05 154.12 31.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.13 0.972 . . . . 0.0 111.392 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.52 153.08 20.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.823 1.249 . . . . 0.0 111.964 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -60.77 -16.35 39.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.775 1.63 . . . . 0.0 114.546 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -58.37 -26.99 63.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.043 1.337 . . . . 0.0 112.788 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.52 27.1 72.95 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.146 0.879 . . . . 0.0 114.598 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.66 151.68 10.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.569 1.147 . . . . 0.0 113.527 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.8 102.95 1.04 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.522 1.058 . . . . 0.0 114.173 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 pp -143.6 147.61 34.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.11 2.564 . . . . 0.0 109.549 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -134.65 132.28 38.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 48.4 m -133.28 139.15 46.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.243 1.017 . . . . 0.0 109.886 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.75 124.05 12.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.537 0.735 . . . . 0.0 110.933 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.9 p -130.51 137.98 50.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.792 0.806 . . . . 0.0 111.649 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.4 m -81.41 13.64 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.454 -0.779 . . . . 0.0 112.69 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.2 m -60.07 161.46 6.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.006 0.908 . . . . 0.0 111.92 169.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -157.53 136.57 11.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.717 1.607 . . . . 0.0 109.539 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 163.87 27.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.718 0.407 . . . . 0.0 111.098 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -140.02 155.31 47.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.423 1.089 . . . . 0.0 111.508 168.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -118.28 -63.34 1.43 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.889 2.076 . . . . 0.0 111.753 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -109.63 -28.94 8.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.315 1.446 . . . . 0.0 112.173 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -42.73 85.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.708 2.403 . . . . 0.0 112.994 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.93 -175.59 5.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.864 1.665 . . . . 0.0 112.185 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.73 153.26 20.86 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.628 1.109 . . . . 0.0 114.185 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 t -163.27 163.17 25.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.424 1.89 . . . . 0.0 110.554 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 8.1 p -167.91 149.79 5.47 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.984 1.714 . . . . 0.0 111.327 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -145.33 144.46 30.73 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.116 -1.615 . . . . 0.0 111.679 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -143.29 126.31 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.112 1.365 . . . . 0.0 110.604 -161.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -127.83 122.44 32.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 -170.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -133.49 104.41 6.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.786 1.634 . . . . 0.0 110.293 -174.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.59 168.05 9.94 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.1 . . . . 0.0 112.394 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -145.29 -176.18 5.0 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.781 0.832 . . . . 0.0 112.548 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -49.84 -51.89 36.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.944 1.698 . . . . 0.0 113.874 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.4 t -132.95 -47.27 0.86 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.7 ptp -67.08 170.83 6.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.587 0.755 . . . . 0.0 112.411 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -146.11 147.46 31.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.5 1.52 . . . . 0.0 109.557 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 28.9 p -128.26 143.6 51.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.244 1.021 . . . . 0.0 112.606 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.37 119.85 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.584 1.554 . . . . 0.0 110.102 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 t -104.99 136.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.828 1.651 . . . . 0.0 109.571 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.9 t -131.26 123.58 28.69 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 110.601 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -109.68 149.56 29.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.858 1.663 . . . . 0.0 111.791 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -141.31 152.32 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.832 1.253 . . . . 0.0 110.657 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.09 85.41 0.23 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.837 1.208 . . . . 0.0 112.074 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.29 121.4 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.353 1.461 . . . . 0.0 111.675 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 m -148.73 117.84 6.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.546 1.138 . . . . 0.0 113.174 -169.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -22.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.945 2.098 . . . . 0.0 115.623 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.86 -16.47 78.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.334 0.968 . . . . 0.0 114.604 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.95 13.26 56.9 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.687 1.136 . . . . 0.0 115.262 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.57 66.58 3.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.756 1.646 . . . . 0.0 113.37 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -133.98 176.17 8.81 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.185 2.194 . . . . 0.0 111.733 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.57 28.75 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.891 1.234 . . . . 0.0 115.214 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -68.06 47.59 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.021 2.128 . . . . 0.0 113.62 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.2 p -149.48 -15.23 0.28 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.23 -167.04 23.1 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.33 1.443 . . . . 0.0 112.405 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.25 174.67 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.413 2.742 . . . . 0.0 112.159 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.79 96.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.76 1.624 . . . . 0.0 113.027 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 166.16 11.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.014 0.926 . . . . 0.0 112.723 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.8 mt -66.06 126.42 28.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.515 1.126 . . . . 0.0 110.96 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 157.44 92.77 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.022 0.82 . . . . 0.0 113.056 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.3 ttm -64.04 159.73 19.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.725 1.21 . . . . 0.0 112.48 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -117.29 91.83 3.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.501 1.52 . . . . 0.0 112.042 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -130.81 177.6 7.29 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.448 1.499 . . . . 0.0 112.007 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.4 mm -51.6 138.13 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.908 2.083 . . . . 0.0 111.313 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.6 m -107.42 91.93 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.579 1.552 . . . . 0.0 110.818 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -93.19 148.82 21.69 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.326 -0.859 . . . . 0.0 111.294 171.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.31 115.47 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.022 2.129 . . . . 0.0 109.833 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -140.86 133.72 29.04 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.48 1.512 . . . . 0.0 111.157 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.26 97.87 14.48 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.172 1.789 . . . . 0.0 109.698 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.12 162.69 38.31 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 123.123 2.548 . . . . 0.0 111.894 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -50.22 2.82 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.433 2.755 . . . . 0.0 113.111 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.56 -69.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.292 1.837 . . . . 0.0 109.766 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.54 167.8 8.35 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.85 2.06 . . . . 0.0 112.28 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.21 160.48 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.95 1.3 . . . . 0.0 112.247 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.252 1.231 0 C-N-CA 127.003 2.121 . . . . 0.0 110.65 -179.476 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 20.0 m -72.96 9.54 1.14 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.471 1.909 . . . . 0.0 115.521 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.15 -0.61 2.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.239 1.816 . . . . 0.0 114.39 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.61 -34.11 57.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.903 2.081 . . . . 0.0 114.763 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -89.88 -19.14 24.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.528 1.131 . . . . 0.0 113.144 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -93.12 -172.27 2.92 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.567 1.947 . . . . 0.0 111.628 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 -172.03 3.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 110.092 175.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -51.5 117.4 2.62 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.942 0.897 . . . . 0.0 111.53 167.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.79 55.35 0.87 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.757 1.623 . . . . 0.0 112.822 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -29.2 62.83 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.873 -1.142 . . . . 0.0 113.535 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.03 -21.66 63.82 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.086 1.754 . . . . 0.0 115.601 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.4 t -112.9 -20.62 11.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.872 1.269 . . . . 0.0 112.639 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.51 118.76 8.0 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.114 -0.991 . . . . 0.0 112.302 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.01 161.17 26.81 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.46 144.29 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.101 1.361 . . . . 0.0 112.897 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.32 -41.47 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.881 1.672 . . . . 0.0 112.232 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.37 -31.84 69.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.589 1.156 . . . . 0.0 113.178 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.87 -55.66 5.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.274 174.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 58.2 t -44.72 -46.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.158 1.783 . . . . 0.0 112.842 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -63.95 -7.03 7.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.732 1.613 . . . . 0.0 114.429 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -111.03 -33.66 6.43 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.569 2.348 . . . . 0.0 112.196 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 30.2 mt -50.14 -42.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.043 1.337 . . . . 0.0 110.644 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.45 -43.79 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.343 -0.848 . . . . 0.0 112.929 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -52.36 50.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.358 0.981 . . . . 0.0 111.519 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.76 72.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.71 62.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.124 0.97 . . . . 0.0 113.313 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 56.4 mt -57.49 -55.33 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.158 0.89 . . . . 0.0 109.88 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.08 -31.08 70.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 18.0 t -61.17 -42.95 99.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.858 0.863 . . . . 0.0 112.354 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.31 77.5 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.264 1.025 . . . . 0.0 113.586 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.25 -42.43 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.38 1.072 . . . . 0.0 110.88 173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.91 58.21 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.982 1.277 . . . . 0.0 115.173 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.74 23.39 70.71 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.585 1.088 . . . . 0.0 114.598 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.12 -177.18 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.043 1.337 . . . . 0.0 112.488 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -48.76 141.75 7.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.722 1.209 . . . . 0.0 112.571 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.93 101.47 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.566 1.146 . . . . 0.0 110.862 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -117.8 114.44 23.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.081 1.753 . . . . 0.0 110.542 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -74.15 -64.37 1.03 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.372 1.069 . . . . 0.0 112.546 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.9 m -56.63 -23.74 43.32 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -55.24 -28.79 55.75 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.7 -31.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.479 1.036 . . . . 0.0 112.89 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -65.34 -50.34 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.828 1.251 . . . . 0.0 112.207 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.91 -26.85 67.06 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.401 -0.812 . . . . 0.0 112.661 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.39 -53.95 7.04 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.818 0.847 . . . . 0.0 111.592 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.1 t -56.72 -28.49 61.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.588 0.631 . . . . 0.0 112.592 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.8 t -82.43 -55.81 4.27 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.341 0.973 . . . . 0.0 112.816 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -59.53 -39.27 83.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.078 1.308 . . . . 0.0 113.281 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 79.2 t -68.36 -63.91 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 C-N-CA 123.706 0.803 . . . . 0.0 109.625 -177.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 96.2 t -49.9 -29.62 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -58.89 -46.94 86.67 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.599 0.636 . . . . 0.0 112.43 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -93.87 -40.2 10.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.756 1.222 . . . . 0.0 112.771 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 5.4 m -54.71 -56.03 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.746 2.418 . . . . 0.0 112.42 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -37.07 79.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.112 0.414 . . . . 0.0 110.602 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.6 t -62.41 -47.71 82.94 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.217 -0.927 . . . . 0.0 112.557 169.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -56.81 -47.35 80.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.871 1.668 . . . . 0.0 113.001 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.24 -18.93 59.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 89.1 m -61.69 -40.31 94.55 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.613 -0.679 . . . . 0.0 110.26 157.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -75.25 -19.58 59.65 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.874 -1.142 . . . . 0.0 113.896 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 10.5 mt -59.07 -20.23 51.43 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . 168.21 -54.07 0.22 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.724 1.147 . . . . 0.0 115.554 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -57.96 156.5 19.2 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 127.367 2.267 . . . . 0.0 113.735 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.18 160.17 42.9 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.985 2.457 . . . . 0.0 113.278 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.28 93.71 3.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.955 0.902 . . . . 0.0 113.003 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -165.41 85.26 0.37 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.024 1.33 . . . . 0.0 114.217 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.3 158.78 43.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.782 1.233 . . . . 0.0 112.194 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.3 tt -138.57 156.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.112 2.165 . . . . 0.0 109.356 171.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.05 147.75 21.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.432 1.893 . . . . 0.0 110.054 173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 14.6 t -143.02 154.55 44.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.72 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.73 157.46 43.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.35 1.06 . . . . 0.0 112.504 171.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 26.3 t -134.18 136.06 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.172 1.389 . . . . 0.0 109.141 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mm -108.95 108.82 26.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 127.365 2.266 . . . . 0.0 106.9 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 62.0 mtt -107.82 158.95 16.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.603 1.161 . . . . 0.0 110.848 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -119.14 150.87 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.882 1.273 . . . . 0.0 110.933 -174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -59.61 -17.11 30.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.694 1.598 . . . . 0.0 114.882 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -59.58 -30.0 68.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.376 1.471 . . . . 0.0 112.955 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.42 42.54 93.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.25 1.405 . . . . 0.0 114.405 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.33 175.63 0.42 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.528 1.531 . . . . 0.0 114.258 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.35 91.26 0.3 Allowed Glycine 0 CA--C 1.539 1.582 0 O-C-N 120.571 -1.331 . . . . 0.0 114.424 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.81 118.35 13.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.149 1.78 . . . . 0.0 113.122 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.12 133.04 55.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.694 0.798 . . . . 0.0 110.076 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 50.5 m -135.47 141.89 45.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.876 0.87 . . . . 0.0 110.283 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.13 128.62 18.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.5 p -132.6 139.43 47.78 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.669 0.747 . . . . 0.0 111.509 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -82.46 12.5 4.47 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.562 -0.711 . . . . 0.0 112.605 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.3 m -60.7 161.65 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.988 0.899 . . . . 0.0 111.895 170.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -158.73 139.36 12.64 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.481 1.513 . . . . 0.0 109.582 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . 0.403 ' CZ2' ' HB2' ' B' ' 232' ' ' SER . 0.0 OUTLIER -72.41 161.63 30.57 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.834 171.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -137.98 149.74 46.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.722 1.209 . . . . 0.0 110.319 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' SER . . . . . 0.403 ' HB2' ' CZ2' ' B' ' 230' ' ' TRP . 1.8 t -112.05 -63.27 1.45 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.785 2.034 . . . . 0.0 112.125 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 8.5 t -109.82 -26.18 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.442 1.497 . . . . 0.0 112.237 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -41.41 75.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.627 2.771 . . . . 0.0 113.193 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.54 -173.89 4.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.912 2.085 . . . . 0.0 110.589 -172.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -98.86 158.57 20.2 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.437 1.017 . . . . 0.0 114.078 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.3 t -166.44 163.21 17.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.114 1.766 . . . . 0.0 110.621 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.57 141.45 2.38 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.2 1.8 . . . . 0.0 111.091 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -142.59 146.75 34.89 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 119.955 -1.716 . . . . 0.0 111.949 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -141.3 146.43 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.884 1.273 . . . . 0.0 110.353 -168.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -137.79 126.77 24.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 112.544 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -135.86 102.38 5.04 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.753 1.621 . . . . 0.0 109.984 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.51 164.84 13.23 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.983 -1.073 . . . . 0.0 112.242 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -141.71 -177.62 5.27 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.407 1.083 . . . . 0.0 111.691 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -47.81 -51.43 22.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.295 1.838 . . . . 0.0 114.088 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.1 t -132.05 -48.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.532 1.533 . . . . 0.0 111.996 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.74 173.96 3.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.076 0.95 . . . . 0.0 112.655 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.62 146.32 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.381 1.472 . . . . 0.0 109.829 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.5 p -127.49 143.04 51.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.055 0.931 . . . . 0.0 112.424 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.08 127.88 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.628 1.571 . . . . 0.0 109.56 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.24 123.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.378 1.471 . . . . 0.0 110.16 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.2 t -119.53 115.6 24.36 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.149 0.979 . . . . 0.0 110.116 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -97.38 153.78 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.795 1.238 . . . . 0.0 111.826 173.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -142.05 149.77 40.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.345 1.458 . . . . 0.0 110.091 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -135.08 80.55 0.31 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 124.972 1.272 . . . . 0.0 113.003 -171.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.21 108.09 20.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.635 1.174 . . . . 0.0 112.087 -167.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.46 120.38 21.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.56 1.944 . . . . 0.0 113.172 -170.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -21.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 115.517 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.98 81.13 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.273 0.94 . . . . 0.0 114.762 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.01 13.09 56.88 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.711 1.148 . . . . 0.0 115.324 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -80.4 61.33 4.44 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.77 1.653 . . . . 0.0 113.88 -171.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.75 -179.83 5.62 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.067 1.747 . . . . 0.0 112.475 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 110.07 5.16 29.01 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.037 1.303 . . . . 0.0 115.275 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.32 34.6 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.997 2.519 . . . . 0.0 114.932 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 18.7 p -139.0 -13.69 1.2 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 131.21 -167.09 22.57 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.077 1.322 . . . . 0.0 112.842 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.5 174.4 9.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.539 2.826 . . . . 0.0 112.312 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.15 96.35 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.718 1.607 . . . . 0.0 113.057 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 166.57 11.43 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.251 -0.906 . . . . 0.0 112.753 171.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 44.4 mt -66.06 126.68 29.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.641 1.176 . . . . 0.0 110.897 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.36 92.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.01 0.814 . . . . 0.0 113.199 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 4.5 ttm -63.43 160.89 15.3 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.763 1.225 . . . . 0.0 112.595 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -118.52 91.37 3.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.799 1.639 . . . . 0.0 112.092 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.14 177.94 7.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.427 1.491 . . . . 0.0 112.087 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.1 mm -51.69 140.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 126.991 2.116 . . . . 0.0 111.354 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 71.6 m -110.93 91.84 3.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.589 1.555 . . . . 0.0 110.702 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -94.77 149.38 21.31 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.428 -0.795 . . . . 0.0 111.323 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.9 p -149.32 118.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.04 1.736 . . . . 0.0 110.907 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.87 138.14 30.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.764 1.625 . . . . 0.0 110.663 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -130.91 94.57 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.145 1.778 . . . . 0.0 109.373 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.16 160.01 48.37 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 122.574 2.182 . . . . 0.0 112.015 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.24 -51.43 3.55 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.786 2.991 . . . . 0.0 113.344 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -68.92 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.215 1.806 . . . . 0.0 109.46 174.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.53 168.19 7.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.879 2.072 . . . . 0.0 112.339 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.51 160.46 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 C--O 1.253 1.285 0 C-N-CA 127.089 2.156 . . . . 0.0 110.745 -179.57 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 121.286 0.381 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m -81.51 37.23 0.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.726 2.01 . . . . 0.0 115.387 -165.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.7 mtt -59.1 -24.63 63.12 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.619 -1.301 . . . . 0.0 114.125 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.16 -13.73 30.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.08 -27.36 63.56 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.307 -0.871 . . . . 0.0 112.931 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -82.86 158.85 22.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.613 1.165 . . . . 0.0 112.05 168.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -148.27 161.73 40.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.966 1.306 . . . . 0.0 111.459 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.34 165.65 12.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.894 1.678 . . . . 0.0 112.141 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.74 79.61 2.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.714 1.205 . . . . 0.0 112.383 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.68 -22.04 64.97 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.734 -1.229 . . . . 0.0 113.496 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.02 -24.39 63.27 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -98.81 -24.04 15.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.334 1.054 . . . . 0.0 113.014 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.57 159.07 30.56 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.243 -0.91 . . . . 0.0 112.071 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -69.16 166.07 19.08 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.463 0.705 . . . . 0.0 112.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -135.53 159.57 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.714 1.206 . . . . 0.0 111.729 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.08 -38.33 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.439 1.096 . . . . 0.0 112.608 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.91 -27.97 68.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.859 1.264 . . . . 0.0 113.042 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -76.34 -56.41 4.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.711 0.804 . . . . 0.0 110.801 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.3 t -52.49 -39.59 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.157 1.383 . . . . 0.0 112.615 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.18 -15.06 12.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.612 1.565 . . . . 0.0 114.276 174.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -108.58 -35.49 6.44 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.327 1.851 . . . . 0.0 112.786 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.32 -42.9 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.459 1.027 . . . . 0.0 110.581 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.84 -43.41 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.598 -0.689 . . . . 0.0 112.53 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -54.02 31.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.605 1.093 . . . . 0.0 111.405 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.68 75.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.23 62.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.667 0.787 . . . . 0.0 112.811 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.0 mt -60.23 -57.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.113 0.869 . . . . 0.0 109.885 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.74 -31.75 71.06 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -58.84 -50.4 74.13 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.441 1.096 . . . . 0.0 112.182 168.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.63 -33.22 75.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.15 -37.72 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.836 1.254 . . . . 0.0 111.337 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.86 16.96 78.16 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.071 0.843 . . . . 0.0 114.54 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.9 8.49 72.67 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.172 1.368 . . . . 0.0 116.001 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.78 150.74 15.56 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 118.934 1.367 . . . . 0.0 113.747 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -175.77 3.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.168 1.787 . . . . 0.0 112.197 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -37.39 136.1 0.5 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 129.046 2.939 . . . . 0.0 114.995 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -134.94 174.5 10.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.519 1.528 . . . . 0.0 112.968 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.06 -93.06 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.4 1.48 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 p -98.99 4.9 47.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.332 2.253 . . . . 0.0 113.398 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -50.76 -43.76 58.45 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.019 -1.051 . . . . 0.0 112.689 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.21 -35.17 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.392 1.077 . . . . 0.0 112.687 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -67.81 -49.64 61.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 112.532 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.14 -26.78 67.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.092 -1.005 . . . . 0.0 112.576 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -75.23 -55.75 5.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.814 1.246 . . . . 0.0 111.182 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t -58.38 -23.5 57.2 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.549 -0.739 . . . . 0.0 112.99 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -85.1 -54.98 4.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.793 1.179 . . . . 0.0 112.368 169.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -57.78 -35.63 71.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.922 1.237 . . . . 0.0 113.782 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.1 t -75.15 -67.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 124.318 1.047 . . . . 0.0 109.688 -178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.13 -28.42 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.695 1.198 . . . . 0.0 111.226 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -52.22 -57.86 8.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.698 0.799 . . . . 0.0 112.908 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -90.61 -39.81 12.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.545 1.138 . . . . 0.0 112.396 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.7 m -57.2 -53.93 52.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.122 2.169 . . . . 0.0 112.514 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.99 -37.99 84.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.71 0.686 . . . . 0.0 111.722 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -63.24 -40.28 96.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 0.0 112.379 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.95 -50.77 61.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.528 1.931 . . . . 0.0 113.189 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.46 -24.1 65.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 53.5 m -59.2 -30.42 68.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.218 1.007 . . . . 0.0 111.262 165.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -90.6 -22.71 21.1 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.51 -15.22 60.5 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.42 -126.51 1.57 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.713 1.149 . . . . 0.0 112.442 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 5.3 mmpt? -55.78 112.09 3.89 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.957 1.703 . . . . 0.0 112.957 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.53 108.98 2.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.441 2.761 . . . . 0.0 111.748 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -144.56 179.81 7.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.446 1.898 . . . . 0.0 111.005 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -90.88 128.14 36.64 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 166.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -113.88 145.43 41.48 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.907 1.683 . . . . 0.0 108.847 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 tt -122.75 153.65 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.232 1.013 . . . . 0.0 110.045 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.51 151.79 28.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.49 1.916 . . . . 0.0 109.032 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.63 138.69 47.44 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.051 1.74 . . . . 0.0 108.46 166.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.88 138.45 37.44 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.02 126.79 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.342 1.457 . . . . 0.0 108.911 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.0 mm -117.64 94.66 3.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 127.358 2.263 . . . . 0.0 107.442 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.61 107.84 12.44 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.728 1.611 . . . . 0.0 110.642 -168.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -66.65 135.2 53.73 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.318 -0.864 . . . . 0.0 112.198 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -8.4 2.94 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.093 1.757 . . . . 0.0 115.498 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -16.8 49.69 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.079 2.152 . . . . 0.0 113.773 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.68 -3.04 5.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.068 1.318 . . . . 0.0 115.761 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 45.71 0.28 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.824 1.65 . . . . 0.0 113.974 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 161.6 33.52 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.914 1.245 . . . . 0.0 113.394 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -151.82 -171.66 4.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.595 1.558 . . . . 0.0 112.085 -172.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.96 138.11 41.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.401 0.546 . . . . 0.0 111.149 168.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.7 m -142.76 144.68 32.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.336 1.454 . . . . 0.0 110.12 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.34 144.19 31.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.8 p -145.88 140.7 27.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.015 0.912 . . . . 0.0 112.264 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 t -78.87 23.33 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.28 1.032 . . . . 0.0 112.584 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.9 m -67.07 171.19 5.82 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.304 -0.873 . . . . 0.0 111.648 165.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -163.44 149.74 11.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.741 2.416 . . . . 0.0 108.557 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -81.26 134.96 35.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.07 0.85 . . . . 0.0 109.594 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.38 127.23 5.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.229 . . . . 0.0 111.564 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -113.8 -31.96 6.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.597 1.559 . . . . 0.0 112.161 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -80.1 -38.46 31.6 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.803 1.641 . . . . 0.0 112.556 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -53.75 5.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.068 1.347 . . . . 0.0 112.405 -171.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -139.99 -161.27 1.17 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.927 2.491 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.82 153.5 16.93 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.831 -1.168 . . . . 0.0 113.754 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 p -155.62 154.83 32.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.729 1.612 . . . . 0.0 111.259 170.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 34.1 t -153.58 97.54 2.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.707 1.203 . . . . 0.0 111.797 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t -90.04 146.19 24.53 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.03 -1.044 . . . . 0.0 112.268 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.68 131.68 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.037 1.735 . . . . 0.0 109.265 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -119.79 128.7 53.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.525 1.53 . . . . 0.0 110.736 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -131.81 159.76 37.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.205 1.402 . . . . 0.0 110.089 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.5 144.68 42.32 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.201 -0.937 . . . . 0.0 111.0 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -117.31 -173.01 2.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.75 1.22 . . . . 0.0 109.318 -165.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -48.6 70.14 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 120.953 -1.092 . . . . 0.0 113.667 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 t -140.73 -17.82 0.86 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.908 2.083 . . . . 0.0 113.129 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.0 mtm -91.28 170.37 10.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.669 1.587 . . . . 0.0 111.09 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -138.02 161.17 37.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.874 0.869 . . . . 0.0 110.73 163.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.0 p -141.62 136.44 30.98 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.049 0.94 . . . . 0.0 111.301 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.2 119.45 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.869 1.268 . . . . 0.0 109.982 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.19 129.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.924 1.289 . . . . 0.0 110.661 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -121.47 106.86 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.274 0.63 . . . . 0.0 111.745 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.81 138.84 33.04 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -129.15 126.06 38.43 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.844 1.658 . . . . 0.0 110.335 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -126.17 73.65 0.43 Allowed Glycine 0 CA--C 1.524 0.61 0 C-N-CA 126.782 2.134 . . . . 0.0 111.671 -171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.42 123.11 17.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.964 1.306 . . . . 0.0 110.081 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t -146.81 83.58 1.59 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.894 1.677 . . . . 0.0 111.54 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -78.09 -2.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.23 2.73 88.04 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.397 1.475 . . . . 0.0 116.325 -174.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.11 20.39 72.88 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 119.173 1.486 . . . . 0.0 115.049 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.18 -176.88 35.86 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.342 1.449 . . . . 0.0 114.579 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.2 t -76.19 -172.65 2.13 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.554 1.142 . . . . 0.0 113.474 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.56 6.46 6.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.8 2.143 . . . . 0.0 113.89 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -123.28 172.08 8.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.456 1.902 . . . . 0.0 113.741 -168.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -118.78 2.28 11.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 113.872 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.27 -169.49 41.05 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.905 1.717 . . . . 0.0 112.285 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.62 169.66 13.97 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.442 2.761 . . . . 0.0 112.351 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -59.1 125.71 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.839 . . . . 0.0 111.631 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.39 155.92 39.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.719 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.24 149.57 37.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.32 1.048 . . . . 0.0 110.957 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.59 176.65 42.22 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.427 -0.796 . . . . 0.0 115.021 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mtt -86.8 145.7 26.52 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 112.928 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.7 93.78 1.71 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.021 1.728 . . . . 0.0 111.257 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -130.95 174.8 9.64 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.07 1.348 . . . . 0.0 111.833 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 136.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 111.418 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.0 m -94.74 96.42 9.37 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.288 1.435 . . . . 0.0 110.411 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -95.52 145.93 24.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.944 -1.097 . . . . 0.0 111.015 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.65 118.37 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.207 2.203 . . . . 0.0 109.349 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -137.75 150.37 47.2 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.306 -0.871 . . . . 0.0 112.053 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.81 154.43 77.89 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.203 1.401 . . . . 0.0 110.96 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.78 121.4 8.92 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.018 2.479 . . . . 0.0 111.164 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.67 176.23 9.13 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.9 2.4 . . . . 0.0 111.606 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.25 162.63 19.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.94 1.696 . . . . 0.0 110.764 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -144.75 176.64 9.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.065 1.346 . . . . 0.0 110.861 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 178.42 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 126.933 2.093 . . . . 0.0 110.801 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.848 1.659 . . . . 0.0 114.147 177.517 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 26.3 m -81.04 37.29 0.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.751 2.02 . . . . 0.0 115.38 -165.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 42.5 mtt -59.23 -24.67 63.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.68 -1.263 . . . . 0.0 114.116 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.29 -13.54 29.62 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.0 -27.19 63.51 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.222 -0.924 . . . . 0.0 112.91 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -82.87 159.44 22.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.533 1.133 . . . . 0.0 112.105 169.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -148.19 163.59 36.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.068 1.347 . . . . 0.0 111.464 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.57 165.49 13.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.887 1.675 . . . . 0.0 112.14 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.94 80.12 2.82 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.769 1.227 . . . . 0.0 112.372 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.15 -21.27 64.91 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.715 -1.241 . . . . 0.0 113.473 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.86 -23.57 63.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 14.2 t -99.43 -25.15 14.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.514 1.126 . . . . 0.0 113.038 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.65 153.55 43.27 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.277 -0.889 . . . . 0.0 111.976 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.05 155.73 40.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.3 p -131.07 158.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.174 1.39 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.22 -35.94 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.779 2.032 . . . . 0.0 111.784 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.29 -31.96 66.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.439 1.096 . . . . 0.0 113.122 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -82.52 -51.12 8.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.499 -0.751 . . . . 0.0 110.491 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 90.2 t -51.0 -39.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.733 1.213 . . . . 0.0 112.511 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -61.15 -16.4 44.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.236 1.814 . . . . 0.0 114.493 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -104.18 -34.63 8.31 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.224 1.809 . . . . 0.0 112.526 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 36.1 mt -51.51 -43.59 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.133 0.878 . . . . 0.0 110.804 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.96 -43.16 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.702 -0.624 . . . . 0.0 112.318 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -54.66 24.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.601 1.091 . . . . 0.0 111.453 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -34.38 75.29 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.75 60.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 112.899 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.1 mt -59.84 -56.81 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.113 0.87 . . . . 0.0 109.61 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.41 -32.35 71.25 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 40.5 t -58.56 -50.4 73.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.515 1.126 . . . . 0.0 112.17 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.29 75.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 92.7 mt -61.94 -37.95 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.873 1.269 . . . . 0.0 111.22 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.06 17.04 78.45 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.045 0.831 . . . . 0.0 114.448 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.89 8.6 72.5 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.132 1.349 . . . . 0.0 115.967 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.85 151.22 14.87 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.947 1.373 . . . . 0.0 113.652 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.34 -173.17 2.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 112.23 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -39.79 137.71 0.87 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.732 2.813 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -136.84 174.09 11.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.516 1.526 . . . . 0.0 112.831 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -87.77 -92.44 0.11 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.416 1.486 . . . . 0.0 112.224 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 19.1 p -99.84 5.15 45.49 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.345 2.258 . . . . 0.0 113.248 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -50.76 -43.7 58.44 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.05 -1.031 . . . . 0.0 112.674 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.02 -35.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.331 1.052 . . . . 0.0 112.711 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.71 -49.81 60.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.475 1.11 . . . . 0.0 112.489 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.91 -26.91 67.82 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.621 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -75.09 -55.74 5.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.807 1.243 . . . . 0.0 111.215 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.1 t -58.95 -21.63 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 4.8 t -86.51 -55.6 3.81 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.824 1.193 . . . . 0.0 112.412 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -57.48 -35.95 70.85 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.045 1.293 . . . . 0.0 113.82 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.79 -67.16 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.382 1.073 . . . . 0.0 109.543 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.63 -29.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.797 1.239 . . . . 0.0 111.049 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.59 -55.27 23.46 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.29 -37.89 11.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.772 1.229 . . . . 0.0 112.571 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -60.07 -53.04 62.51 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.006 2.122 . . . . 0.0 112.731 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.02 -35.8 81.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.696 0.68 . . . . 0.0 112.043 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t -60.65 -50.42 73.56 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.726 0.81 . . . . 0.0 111.308 169.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -58.37 -51.17 70.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.522 1.929 . . . . 0.0 113.586 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.2 -23.03 63.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -61.17 -41.01 96.02 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -74.57 -24.08 58.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.42 -11.33 9.98 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -159.81 -73.65 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.942 1.246 . . . . 0.0 114.807 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -65.99 168.45 9.1 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 126.756 2.022 . . . . 0.0 113.318 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.38 173.54 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.223 2.615 . . . . 0.0 112.05 171.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.82 94.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.404 1.482 . . . . 0.0 113.04 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -158.13 107.06 2.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.596 1.959 . . . . 0.0 111.916 168.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -154.68 165.34 36.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.977 1.711 . . . . 0.0 111.031 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.8 tt -147.72 156.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 126.174 1.79 . . . . 0.0 108.864 160.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.13 152.46 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.289 1.836 . . . . 0.0 109.657 162.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.6 p -132.85 138.94 47.21 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.104 1.762 . . . . 0.0 108.518 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.75 145.7 38.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.879 0.847 . . . . 0.0 112.745 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.35 131.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.983 1.313 . . . . 0.0 109.224 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -118.71 93.45 2.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 127.215 2.206 . . . . 0.0 107.358 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.6 90.85 3.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 109.888 -172.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.53 153.22 13.34 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.457 -1.402 . . . . 0.0 113.533 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -7.79 53.7 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -16.91 56.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.441 1.896 . . . . 0.0 114.108 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 -3.18 6.38 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.176 1.231 . . . . 0.0 116.176 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -74.1 51.99 0.43 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.427 1.491 . . . . 0.0 113.287 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.05 30.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.652 1.596 . . . . 0.0 112.842 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.69 -173.8 4.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.32 1.848 . . . . 0.0 110.804 -174.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.41 139.26 40.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.842 0.747 . . . . 0.0 111.002 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 53.4 m -142.74 145.12 33.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.803 1.241 . . . . 0.0 110.142 175.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.71 38.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.433 1.093 . . . . 0.0 110.729 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 69.4 p -145.88 142.2 28.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.892 0.853 . . . . 0.0 112.07 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 9.5 t -80.79 25.81 0.43 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.975 0.91 . . . . 0.0 112.496 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 58.9 m -67.51 171.35 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.334 -0.854 . . . . 0.0 111.599 164.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -166.44 154.33 10.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.921 2.489 . . . . 0.0 108.83 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -81.61 132.09 35.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.428 -0.795 . . . . 0.0 110.014 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -152.78 116.46 4.77 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.046 1.338 . . . . 0.0 112.512 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.3 t -107.02 -34.05 7.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.397 1.479 . . . . 0.0 112.393 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 12.2 p -80.01 -36.09 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.986 1.314 . . . . 0.0 112.32 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -56.6 3.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.242 1.417 . . . . 0.0 111.802 -174.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -155.57 0.65 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.581 2.352 . . . . 0.0 109.341 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.59 153.5 16.79 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 120.728 -1.233 . . . . 0.0 113.556 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 25.8 p -156.79 147.18 21.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.211 1.404 . . . . 0.0 112.315 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.981 1.312 . . . . 0.0 111.838 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 14.2 t -86.57 146.4 26.37 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.034 -1.041 . . . . 0.0 112.205 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 t -139.39 135.96 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 109.267 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.34 129.79 51.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.538 1.535 . . . . 0.0 110.848 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -132.63 159.03 40.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.225 1.41 . . . . 0.0 110.035 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -136.64 144.16 43.87 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.026 -1.046 . . . . 0.0 111.028 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.9 -173.5 2.4 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.61 1.164 . . . . 0.0 109.454 -165.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -50.97 65.44 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.996 -1.065 . . . . 0.0 113.654 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.6 t -140.17 -10.94 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.064 1.746 . . . . 0.0 113.43 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.0 mtm -94.25 169.27 10.36 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 110.542 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -139.56 157.87 45.08 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 111.262 165.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.1 p -141.27 138.57 33.31 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.933 . . . . 0.0 111.876 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.66 126.83 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.877 1.271 . . . . 0.0 109.937 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.54 129.3 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.443 1.497 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -121.8 106.55 11.38 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.401 0.68 . . . . 0.0 111.9 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.99 140.93 29.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -131.57 115.54 16.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.142 1.777 . . . . 0.0 109.701 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.85 76.23 0.22 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.573 2.035 . . . . 0.0 111.028 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.08 123.38 20.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.838 0.855 . . . . 0.0 112.263 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 10.4 t -142.66 119.6 11.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.112 1.765 . . . . 0.0 112.058 -165.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.29 -0.26 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 114.095 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.57 2.72 74.07 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.34 1.447 . . . . 0.0 115.721 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.32 24.73 62.79 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 118.784 1.292 . . . . 0.0 115.11 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.41 -175.59 45.65 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.102 1.334 . . . . 0.0 114.248 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t -74.63 -175.77 2.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.399 1.08 . . . . 0.0 113.546 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 124.26 9.17 5.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.703 2.097 . . . . 0.0 114.068 -170.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 170.66 11.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.237 1.815 . . . . 0.0 113.645 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.3 t -120.08 4.5 10.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.662 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 167.31 -168.03 40.23 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.94 1.733 . . . . 0.0 112.389 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.89 -179.33 2.05 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.993 3.129 . . . . 0.0 112.843 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.0 85.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.695 1.198 . . . . 0.0 113.793 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' B' ' 269' ' ' LYS . 16.7 mmmt -70.3 159.92 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.437 1.095 . . . . 0.0 112.323 175.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.37 138.44 31.43 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.115 1.366 . . . . 0.0 110.101 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -171.38 171.71 44.13 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.758 0.694 . . . . 0.0 114.458 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.54 147.92 27.5 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.921 1.289 . . . . 0.0 112.547 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -154.08 93.1 1.6 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.614 1.565 . . . . 0.0 111.884 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -131.71 175.1 9.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 111.929 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 mm -52.86 140.5 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.662 1.985 . . . . 0.0 111.64 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 90.4 m -99.06 93.95 6.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.372 1.469 . . . . 0.0 110.332 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -94.26 146.82 23.75 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.036 -1.04 . . . . 0.0 110.778 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.6 120.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.384 1.874 . . . . 0.0 110.015 -178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.09 152.15 48.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.033 0.933 . . . . 0.0 112.075 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -135.0 154.4 79.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.223 1.409 . . . . 0.0 111.114 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.51 122.12 9.92 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.11 2.54 . . . . 0.0 111.336 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.09 174.96 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.983 2.455 . . . . 0.0 111.908 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.95 162.01 19.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.866 1.666 . . . . 0.0 110.646 168.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -144.43 176.36 9.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.906 1.282 . . . . 0.0 110.854 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 177.88 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.859 2.063 . . . . 0.0 110.817 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.824 1.649 . . . . 0.0 114.212 177.51 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -66.8 1.69 1.73 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.4 mtt -52.95 -36.58 60.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.92 -15.25 29.01 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 -19.73 65.78 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -135.97 131.71 35.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.36 1.464 . . . . 0.0 111.436 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -143.12 131.3 21.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.482 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.1 177.15 4.56 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.71 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 101.05 0.12 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 112.219 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.11 -15.27 59.62 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.968 -1.082 . . . . 0.0 112.528 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.24 -27.4 69.32 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 t -82.43 -26.28 32.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.462 1.105 . . . . 0.0 112.57 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.67 118.22 17.39 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.626 -1.296 . . . . 0.0 111.63 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.49 158.66 31.36 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.399 -0.813 . . . . 0.0 112.534 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.55 141.49 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.774 0.83 . . . . 0.0 111.852 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.12 -42.89 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.858 1.663 . . . . 0.0 111.327 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.95 -31.48 60.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 113.311 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -86.64 -53.34 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.044 0.937 . . . . 0.0 111.701 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.3 t -44.14 -48.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.836 1.255 . . . . 0.0 112.605 169.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -65.31 -3.18 3.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.396 1.478 . . . . 0.0 113.919 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.54 -31.67 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.236 1.815 . . . . 0.0 112.274 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -50.87 -44.71 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.369 0.986 . . . . 0.0 110.437 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.81 -41.85 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -51.93 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.747 1.158 . . . . 0.0 111.585 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -33.32 75.27 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.05 69.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.396 1.079 . . . . 0.0 113.091 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.5 mt -59.86 -56.64 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.258 0.936 . . . . 0.0 110.274 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -60.45 -31.59 70.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.1 t -59.19 -46.68 87.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.32 1.048 . . . . 0.0 112.499 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.94 81.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.401 1.08 . . . . 0.0 113.815 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.95 -43.43 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 110.713 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.35 14.02 61.29 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.59 1.091 . . . . 0.0 115.066 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.78 85.87 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.139 1.352 . . . . 0.0 115.105 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -63.84 168.15 5.35 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 118.735 1.267 . . . . 0.0 112.55 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.63 102.03 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.203 1.801 . . . . 0.0 111.657 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.84 139.07 46.93 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.64 1.976 . . . . 0.0 112.499 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.23 156.98 43.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -57.89 -53.49 57.66 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.7 m -69.92 -26.36 64.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -58.7 -45.7 88.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.042 0.537 . . . . 0.0 112.182 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -56.91 -35.13 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.842 0.746 . . . . 0.0 112.424 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.89 -47.52 80.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.989 0.915 . . . . 0.0 111.621 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -67.81 -24.06 65.25 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -78.93 -52.57 8.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.132 0.878 . . . . 0.0 111.555 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -55.01 -35.23 64.18 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.665 0.666 . . . . 0.0 112.135 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -75.89 -55.76 5.32 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.205 0.911 . . . . 0.0 112.593 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.92 -38.03 75.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.911 1.284 . . . . 0.0 113.532 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.22 -62.32 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 C-N-CA 123.92 0.888 . . . . 0.0 110.384 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.61 -29.84 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.632 1.173 . . . . 0.0 110.75 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.53 -30.61 69.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.753 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -112.53 -42.24 3.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.995 1.718 . . . . 0.0 112.257 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -51.85 -55.58 19.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.5 2.32 . . . . 0.0 112.577 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -37.99 87.38 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.412 0.625 . . . . 0.0 110.989 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.6 m -67.15 -28.36 68.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.22 -52.38 10.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.555 2.342 . . . . 0.0 112.249 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.74 -25.53 67.32 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -55.38 -37.03 67.02 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.367 1.067 . . . . 0.0 110.913 166.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -81.79 -34.13 30.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.494 0.718 . . . . 0.0 112.712 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -69.74 -28.91 66.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.366 0.666 . . . . 0.0 111.013 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.67 -118.79 4.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.045 1.783 . . . . 0.0 113.256 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -133.89 151.98 77.82 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.696 1.598 . . . . 0.0 113.606 -171.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 113.77 3.86 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.929 3.086 . . . . 0.0 112.214 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -147.62 171.7 15.19 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.299 1.839 . . . . 0.0 110.663 171.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.9 135.86 48.24 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.741 0.781 . . . . 0.0 110.84 162.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -131.13 157.49 42.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 128.014 2.526 . . . . 0.0 108.208 170.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -138.56 155.18 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.178 1.391 . . . . 0.0 109.144 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.0 m -139.23 148.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 124.751 1.221 . . . . 0.0 110.374 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -145.83 154.05 41.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.304 1.042 . . . . 0.0 110.53 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.5 p -146.07 149.51 34.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.275 1.03 . . . . 0.0 112.854 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.73 111.33 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.841 1.656 . . . . 0.0 109.402 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.3 mm -107.33 96.47 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.523 1.529 . . . . 0.0 107.481 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.64 89.4 2.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.885 1.274 . . . . 0.0 111.247 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -166.15 120.43 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.473 1.909 . . . . 0.0 107.966 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -152.59 -64.56 0.16 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.757 1.223 . . . . 0.0 111.304 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.2 -15.61 13.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.638 1.575 . . . . 0.0 113.507 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.44 -11.66 33.27 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.273 1.892 . . . . 0.0 114.533 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.52 117.44 9.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.219 1.408 . . . . 0.0 111.938 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.3 174.49 19.62 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.64 1.59 . . . . 0.0 114.095 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.92 -172.54 2.18 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.49 1.916 . . . . 0.0 111.599 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.78 108.56 20.41 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.527 -0.733 . . . . 0.0 110.241 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.3 m -120.41 137.72 54.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.831 0.852 . . . . 0.0 109.868 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.32 134.61 29.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.298 0.639 . . . . 0.0 111.683 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB2' ' HG ' ' A' ' 85' ' ' CYS . 56.3 p -132.28 134.99 45.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.972 0.892 . . . . 0.0 111.229 174.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -83.36 24.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.515 -0.74 . . . . 0.0 111.599 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.445 ' HG ' ' HB2' ' A' ' 83' ' ' SER . 64.8 m -62.79 163.54 9.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.63 0.729 . . . . 0.0 111.288 164.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.05 136.84 5.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 108.986 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 149.79 48.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.412 0.685 . . . . 0.0 110.296 173.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -134.07 152.2 51.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.073 1.349 . . . . 0.0 110.794 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t -120.13 -65.42 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.4 1.08 . . . . 0.0 112.465 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.8 t -82.18 -35.75 28.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.043 0.838 . . . . 0.0 112.607 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -67.37 -36.5 81.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.227 1.411 . . . . 0.0 113.352 -171.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.17 179.14 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.36 2.264 . . . . 0.0 111.121 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 134.52 11.98 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.946 1.26 . . . . 0.0 113.14 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -150.5 139.53 21.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.768 1.627 . . . . 0.0 110.458 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 5.5 p -151.48 120.27 6.58 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.913 0.779 . . . . 0.0 111.902 -178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -132.29 151.71 51.71 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 112.078 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.5 139.76 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.605 1.562 . . . . 0.0 109.943 -170.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.05 131.98 50.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.983 1.313 . . . . 0.0 112.13 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -139.46 106.54 5.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.802 1.241 . . . . 0.0 110.926 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -86.38 148.81 25.41 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.986 0.914 . . . . 0.0 112.066 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -123.66 -176.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.755 1.622 . . . . 0.0 110.694 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -67.71 0.24 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.597 1.559 . . . . 0.0 113.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.5 t -117.32 8.19 13.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.405 1.882 . . . . 0.0 112.488 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.0 mtt -134.58 173.98 11.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.43 1.892 . . . . 0.0 111.069 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -151.45 161.99 41.72 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 109.794 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 10.3 p -132.27 151.21 51.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 110.406 171.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.49 137.8 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 109.257 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.24 140.13 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.939 1.296 . . . . 0.0 109.678 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -131.9 145.13 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.998 0.919 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -130.24 145.1 51.71 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.262 1.425 . . . . 0.0 111.934 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.1 151.63 51.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.772 1.629 . . . . 0.0 111.08 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.81 86.72 0.15 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.175 1.369 . . . . 0.0 111.353 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -78.14 122.39 25.58 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.993 1.317 . . . . 0.0 111.568 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 m -142.18 121.59 13.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.654 1.581 . . . . 0.0 112.302 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.39 8.23 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.15 -2.07 30.23 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.656 1.598 . . . . 0.0 117.053 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.87 1.5 73.26 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.208 1.504 . . . . 0.0 115.711 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.39 73.34 0.2 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.325 1.917 . . . . 0.0 111.552 177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.1 t -151.3 171.19 17.84 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.306 1.443 . . . . 0.0 111.439 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.92 2.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.178 1.847 . . . . 0.0 114.978 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.72 169.72 14.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.409 1.883 . . . . 0.0 112.11 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.5 t -122.43 -19.23 6.47 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.679 1.592 . . . . 0.0 114.333 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -175.1 -72.27 0.05 OUTLIER Glycine 0 CA--C 1.537 1.453 0 O-C-N 121.114 -0.991 . . . . 0.0 113.524 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.18 163.27 39.73 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.874 2.382 . . . . 0.0 111.8 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.2 pt -127.57 139.08 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 111.501 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.78 158.07 45.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.903 1.681 . . . . 0.0 113.02 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.7 170.03 17.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.184 0.994 . . . . 0.0 111.605 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.3 158.12 30.88 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.099 1.333 . . . . 0.0 112.743 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtt -77.03 157.08 31.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.899 0.879 . . . . 0.0 112.312 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -145.98 96.16 2.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.633 1.573 . . . . 0.0 111.404 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.13 169.08 15.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.911 1.284 . . . . 0.0 111.836 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.2 mm -60.34 151.06 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.373 1.869 . . . . 0.0 111.275 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.2 m -124.59 95.23 4.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.971 1.708 . . . . 0.0 110.885 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -97.64 149.96 21.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.933 -1.104 . . . . 0.0 111.434 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.98 102.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.488 2.315 . . . . 0.0 109.045 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -142.45 115.84 9.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.614 1.166 . . . . 0.0 111.724 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -134.71 82.84 43.43 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.102 1.361 . . . . 0.0 110.91 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.53 165.34 23.1 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.92 2.413 . . . . 0.0 112.802 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.95 -23.09 41.17 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.339 2.693 . . . . 0.0 114.337 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -118.09 -178.84 3.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.433 2.293 . . . . 0.0 110.858 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -61.3 171.56 1.35 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.039 1.336 . . . . 0.0 113.113 171.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.92 168.41 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 0.0 112.348 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.194 1.798 . . . . 0.0 111.032 177.438 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 17.0 m -66.79 1.46 1.83 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 51.5 mtt -52.17 -37.1 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.999 1.32 . . . . 0.0 113.331 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.76 -15.41 29.26 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.21 -19.81 65.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.052 -1.03 . . . . 0.0 113.65 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.08 130.71 33.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.345 1.458 . . . . 0.0 111.543 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -142.22 131.09 22.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.626 0.771 . . . . 0.0 111.503 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.28 177.55 3.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.494 1.117 . . . . 0.0 112.646 177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.12 98.38 0.08 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.323 1.449 . . . . 0.0 112.259 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.72 -16.98 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.861 -1.149 . . . . 0.0 112.512 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.21 -27.14 69.15 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.8 t -83.76 -24.82 30.96 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.216 1.007 . . . . 0.0 112.675 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.34 127.27 32.18 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.361 -1.462 . . . . 0.0 111.051 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -65.75 167.02 9.92 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.275 -0.89 . . . . 0.0 111.575 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.39 145.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.411 1.084 . . . . 0.0 111.315 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.38 -39.65 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.618 1.167 . . . . 0.0 111.925 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.36 -31.12 68.92 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.667 1.587 . . . . 0.0 113.312 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -74.0 -60.05 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.939 0.895 . . . . 0.0 110.172 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 40.3 t -54.23 -42.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.752 1.221 . . . . 0.0 113.143 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -64.74 -3.31 3.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.058 1.343 . . . . 0.0 113.747 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.37 -33.35 5.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.438 1.895 . . . . 0.0 112.432 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 39.1 mt -51.8 -43.14 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.497 1.044 . . . . 0.0 110.352 169.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.97 -41.93 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.74 56.93 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.772 1.169 . . . . 0.0 111.52 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -33.74 76.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.0 71.71 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.228 1.011 . . . . 0.0 113.036 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.88 -56.97 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.241 0.928 . . . . 0.0 110.312 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -60.28 -31.67 70.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -59.27 -46.7 87.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.34 1.056 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.11 81.62 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.402 1.081 . . . . 0.0 113.797 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.82 -43.43 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.277 1.031 . . . . 0.0 110.734 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.86 13.77 62.06 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.493 1.044 . . . . 0.0 115.0 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.78 10.82 85.85 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.188 1.375 . . . . 0.0 115.027 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -63.79 168.25 5.19 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.694 1.247 . . . . 0.0 112.501 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.62 102.55 0.07 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.076 1.75 . . . . 0.0 111.598 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.95 138.65 48.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.573 1.949 . . . . 0.0 112.526 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.8 156.63 43.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.697 1.199 . . . . 0.0 111.422 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -57.98 -53.53 57.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -69.42 -26.88 64.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -58.59 -45.47 89.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 0.0 112.22 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 4.2 t -56.49 -35.66 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.832 0.742 . . . . 0.0 112.444 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -63.8 -47.46 80.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.87 0.868 . . . . 0.0 111.585 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -67.92 -23.93 65.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -78.84 -52.9 7.68 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.172 0.896 . . . . 0.0 111.406 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.8 t -54.96 -34.79 63.6 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.736 0.698 . . . . 0.0 112.185 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.4 t -75.79 -56.75 4.38 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.178 0.899 . . . . 0.0 112.636 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -57.23 -38.44 73.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.952 1.301 . . . . 0.0 113.646 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.9 -64.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 83.1 t -51.65 -29.28 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 110.677 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.88 -34.48 73.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.171 0.988 . . . . 0.0 113.548 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -110.69 -38.6 5.11 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.693 1.597 . . . . 0.0 112.355 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 22.1 m -55.29 -53.52 55.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.419 2.288 . . . . 0.0 111.753 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 7.6 tp -60.12 -36.01 76.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.259 0.481 . . . . 0.0 112.054 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 68.4 m -70.6 -30.73 67.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.964 0.906 . . . . 0.0 113.355 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -71.34 -52.12 20.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.903 2.081 . . . . 0.0 112.453 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 2.8 pp -64.93 -26.43 68.31 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 53.9 m -58.32 -30.46 66.71 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.941 0.896 . . . . 0.0 110.984 168.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -85.88 -36.28 20.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.817 0.847 . . . . 0.0 112.717 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.82 -23.8 66.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.968 0.907 . . . . 0.0 112.699 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.55 -112.68 3.71 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.153 1.359 . . . . 0.0 112.734 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -137.63 154.53 75.03 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.711 1.604 . . . . 0.0 113.237 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.48 115.32 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.682 2.921 . . . . 0.0 112.2 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.35 172.68 15.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.413 1.885 . . . . 0.0 110.686 171.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -71.81 132.16 44.06 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.568 -0.708 . . . . 0.0 110.907 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -129.31 147.68 51.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.736 1.614 . . . . 0.0 109.198 168.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.2 tt -128.38 154.81 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.397 1.479 . . . . 0.0 109.253 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.69 150.76 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.134 1.374 . . . . 0.0 111.055 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 18.6 p -137.83 151.95 48.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.601 1.561 . . . . 0.0 110.279 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.3 p -146.43 152.33 38.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.162 0.982 . . . . 0.0 113.003 168.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.51 114.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 108.974 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 3.1 mm -107.28 91.26 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.446 1.898 . . . . 0.0 107.648 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 2.2 ttt -98.73 135.94 39.5 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.374 1.47 . . . . 0.0 109.506 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -81.72 145.65 30.39 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.492 -0.755 . . . . 0.0 112.37 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -76.1 -0.16 20.94 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.289 1.435 . . . . 0.0 114.045 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.18 -21.31 13.1 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.424 1.89 . . . . 0.0 113.996 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.03 -12.27 62.23 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.703 1.621 . . . . 0.0 114.36 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.75 89.71 1.37 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.272 1.429 . . . . 0.0 111.55 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.55 -169.01 27.73 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.97 1.272 . . . . 0.0 113.672 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.2 -176.03 4.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.665 2.386 . . . . 0.0 111.379 -173.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.01 104.24 13.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.216 1.007 . . . . 0.0 110.278 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 135.24 54.1 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.837 0.855 . . . . 0.0 110.56 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.78 12.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.286 0.234 . . . . 0.0 111.038 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.402 ' HB2' ' HG ' ' B' ' 228' ' ' CYS . 15.0 p -120.65 138.15 54.08 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.954 0.883 . . . . 0.0 110.966 174.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 69.8 m -84.2 21.36 1.4 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.41 -0.806 . . . . 0.0 111.899 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . 0.402 ' HG ' ' HB2' ' B' ' 226' ' ' SER . 39.2 m -64.82 162.6 15.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.509 0.724 . . . . 0.0 111.65 168.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.725 1.61 . . . . 0.0 110.388 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -69.78 151.8 45.35 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.426 -0.796 . . . . 0.0 110.483 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -137.03 151.04 48.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.396 1.478 . . . . 0.0 110.351 167.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 2.4 t -119.78 -64.76 1.23 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.425 1.09 . . . . 0.0 112.523 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 46.6 t -82.44 -35.74 27.27 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.258 -0.901 . . . . 0.0 112.647 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -36.7 80.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.3 1.44 . . . . 0.0 113.406 -170.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.27 178.7 7.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.478 2.311 . . . . 0.0 110.744 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -96.95 134.33 11.73 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.871 1.224 . . . . 0.0 112.955 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 56.0 m -150.52 148.63 28.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.924 1.689 . . . . 0.0 110.152 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 3.2 p -152.57 121.41 6.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.726 1.211 . . . . 0.0 111.331 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.0 t -132.71 151.02 52.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.239 1.416 . . . . 0.0 112.271 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.6 139.98 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.517 1.527 . . . . 0.0 110.014 -169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.81 130.88 49.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.861 1.264 . . . . 0.0 112.236 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -138.77 104.29 5.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.0 1.32 . . . . 0.0 110.639 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.58 149.87 27.22 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.217 -0.927 . . . . 0.0 111.679 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -124.38 -177.79 3.9 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.361 1.465 . . . . 0.0 110.868 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -67.91 0.23 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.513 1.525 . . . . 0.0 113.35 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -119.15 15.13 13.18 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.486 1.914 . . . . 0.0 112.952 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 43.0 mtt -142.47 175.11 10.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.493 1.917 . . . . 0.0 109.9 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -151.54 158.7 43.92 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.869 0.868 . . . . 0.0 109.972 161.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 12.6 p -134.09 144.06 48.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.437 1.113 . . . . 0.0 110.99 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.19 132.64 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.427 1.491 . . . . 0.0 109.299 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.1 142.01 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.205 1.402 . . . . 0.0 110.027 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.1 t -135.79 144.52 45.8 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.785 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -130.21 144.36 51.32 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.479 1.511 . . . . 0.0 111.728 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -132.63 148.45 52.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.181 1.792 . . . . 0.0 110.571 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -147.61 87.3 0.16 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.581 1.562 . . . . 0.0 112.32 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.01 118.46 21.76 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 111.604 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 75.6 m -141.36 119.11 11.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.753 1.621 . . . . 0.0 112.347 -168.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.1 pp -111.13 8.19 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -68.88 -2.32 29.51 Favored Glycine 0 CA--C 1.542 1.746 0 N-CA-C 117.092 1.597 . . . . 0.0 117.092 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.96 71.35 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 119.275 1.537 . . . . 0.0 115.783 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -162.48 74.97 0.18 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.543 2.021 . . . . 0.0 111.206 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.3 t -152.82 171.0 18.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.474 1.51 . . . . 0.0 111.35 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 80.5 -28.64 2.68 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 126.261 1.886 . . . . 0.0 114.908 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.11 168.97 15.33 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.439 1.896 . . . . 0.0 112.208 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 37.2 t -121.33 -19.17 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.681 1.592 . . . . 0.0 114.363 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -175.33 -72.55 0.05 OUTLIER Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.224 -0.922 . . . . 0.0 113.522 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.87 162.75 41.57 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.789 2.326 . . . . 0.0 111.794 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.123 1.369 . . . . 0.0 111.452 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.24 158.15 45.07 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.867 1.667 . . . . 0.0 113.027 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.87 170.05 17.28 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.119 0.967 . . . . 0.0 111.615 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -167.24 158.13 30.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.137 1.351 . . . . 0.0 112.672 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 3.6 mtt -76.95 157.28 31.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.806 0.843 . . . . 0.0 112.254 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -145.88 96.32 2.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 111.348 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -129.86 169.53 15.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.16 150.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.443 1.897 . . . . 0.0 111.366 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.6 m -123.67 88.41 2.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.739 1.616 . . . . 0.0 110.878 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -93.61 150.74 20.18 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.378 -0.826 . . . . 0.0 111.369 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.15 108.51 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.624 1.97 . . . . 0.0 110.043 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -141.65 113.32 7.77 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.742 1.617 . . . . 0.0 111.294 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -130.12 83.54 62.95 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.043 1.337 . . . . 0.0 110.875 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.5 165.46 25.01 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.954 2.436 . . . . 0.0 112.57 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.24 -20.02 33.08 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.277 2.651 . . . . 0.0 114.339 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -118.8 -179.04 3.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.461 2.304 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -61.34 171.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.083 1.353 . . . . 0.0 113.145 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 168.73 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.693 1.597 . . . . 0.0 112.338 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.227 1.811 . . . . 0.0 111.036 177.78 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.1 p -65.14 67.15 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.837 2.055 . . . . 0.0 115.749 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.2 mmt -71.25 -75.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.134 1.774 . . . . 0.0 111.991 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 20.1 pt-20 -102.59 -65.06 1.02 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.164 0.986 . . . . 0.0 113.405 -172.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 16.3 m-20 -130.99 1.33 4.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.657 2.383 . . . . 0.0 111.367 178.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.07 170.88 9.11 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.175 1.39 . . . . 0.0 112.315 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -128.44 160.14 33.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.305 1.442 . . . . 0.0 111.749 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.0 83.14 1.78 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.266 1.826 . . . . 0.0 110.67 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 152.11 42.63 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.555 0.742 . . . . 0.0 112.01 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.38 -23.17 23.43 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.149 -0.969 . . . . 0.0 113.371 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.24 -24.07 62.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 t -91.41 -14.12 31.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.843 2.057 . . . . 0.0 112.761 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.72 160.26 28.47 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.933 -1.105 . . . . 0.0 111.368 169.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -140.16 167.96 20.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.628 1.571 . . . . 0.0 110.959 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.99 152.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.92 1.288 . . . . 0.0 110.148 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.75 -35.84 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.263 -0.898 . . . . 0.0 111.517 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.61 -25.02 67.08 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.142 0.977 . . . . 0.0 113.48 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -78.62 -57.67 3.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.246 1.018 . . . . 0.0 110.535 169.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.8 t -50.49 -44.92 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.475 1.51 . . . . 0.0 112.535 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -67.68 -9.06 40.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.266 1.827 . . . . 0.0 113.628 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -102.33 -31.37 10.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.581 1.552 . . . . 0.0 112.844 170.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mt -49.27 -44.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.359 1.064 . . . . 0.0 110.467 170.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.97 -43.68 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -49.96 65.35 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.257 1.39 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -33.35 75.38 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.113 0.965 . . . . 0.0 113.091 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 44.9 mt -57.59 -56.17 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.225 0.92 . . . . 0.0 110.315 173.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.07 -32.01 70.54 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -60.86 -45.47 94.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.331 1.052 . . . . 0.0 112.449 170.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.95 71.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.24 -44.03 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.999 . . . . 0.0 110.938 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.03 71.92 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.61 26.84 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.348 1.451 . . . . 0.0 116.257 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.27 -179.17 1.52 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.024 1.412 . . . . 0.0 112.689 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -156.92 0.57 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.986 1.314 . . . . 0.0 111.803 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.9 158.04 0.74 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.028 1.331 . . . . 0.0 112.42 162.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.49 -176.4 5.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.715 1.206 . . . . 0.0 111.75 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.58 -100.76 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.882 1.273 . . . . 0.0 109.655 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -67.83 -24.33 65.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.96 1.304 . . . . 0.0 113.992 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -41.63 78.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.055 -1.028 . . . . 0.0 112.669 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.2 -29.18 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.615 0.766 . . . . 0.0 112.57 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.12 -48.43 78.53 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.695 1.198 . . . . 0.0 111.385 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.55 -26.36 67.09 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.349 -0.844 . . . . 0.0 112.986 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -77.13 -54.24 6.76 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.498 -0.752 . . . . 0.0 111.186 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 t -56.5 -29.83 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.783 0.719 . . . . 0.0 112.739 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -79.73 -52.68 7.63 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.477 1.035 . . . . 0.0 112.505 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -58.5 -38.0 76.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.578 1.151 . . . . 0.0 113.323 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.02 -65.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 124.667 1.187 . . . . 0.0 109.807 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.7 -29.09 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.873 1.269 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.67 -47.19 80.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 0.0 112.705 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.57 -38.29 9.21 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.023 1.329 . . . . 0.0 112.885 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -56.39 -53.64 54.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.538 1.935 . . . . 0.0 112.135 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -40.16 91.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.688 0.676 . . . . 0.0 111.307 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 p -69.68 -27.96 65.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -75.2 -52.15 11.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.677 2.391 . . . . 0.0 113.04 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.65 -28.27 69.79 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.626 -1.296 . . . . 0.0 113.308 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.9 m -56.25 -32.99 65.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.754 1.222 . . . . 0.0 111.056 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -85.59 -28.34 24.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.211 1.004 . . . . 0.0 113.233 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.73 -25.34 62.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.95 0.9 . . . . 0.0 112.312 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.47 -141.14 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.253 1.883 . . . . 0.0 112.035 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -112.84 155.08 44.6 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.397 1.479 . . . . 0.0 112.813 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.44 111.91 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.882 3.054 . . . . 0.0 111.238 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.2 174.86 10.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 0.0 111.387 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.531 ' HE3' ' CE2' ' B' ' 254' ' ' PHE . 0.5 OUTLIER -66.21 124.17 21.92 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.943 0.897 . . . . 0.0 110.072 163.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -124.56 165.36 17.97 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.999 2.12 . . . . 0.0 109.811 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.8 tp -152.06 154.24 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.63 1.572 . . . . 0.0 109.52 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.84 148.18 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 111.359 167.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.96 127.31 13.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 110.191 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 7.9 p -127.58 155.53 43.7 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.897 0.879 . . . . 0.0 112.301 173.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -140.19 122.72 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.948 1.299 . . . . 0.0 108.723 175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.9 mm -120.78 116.35 49.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 127.937 2.495 . . . . 0.0 107.474 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 14.5 tmm? -135.92 151.93 50.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.184 0.992 . . . . 0.0 112.279 -171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -105.15 110.6 23.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.884 1.673 . . . . 0.0 112.263 -168.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.99 -6.17 11.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.186 2.194 . . . . 0.0 113.225 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -25.75 6.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.819 2.448 . . . . 0.0 114.336 162.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.31 7.05 0.59 Allowed Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 130.26 45.46 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.594 1.697 . . . . 0.0 112.338 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.6 112.9 2.16 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.85 171.56 15.01 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.41 1.884 . . . . 0.0 112.324 -176.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -121.73 130.93 53.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 110.621 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 51.5 m -142.23 147.42 36.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.268 1.427 . . . . 0.0 109.059 177.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 153.2 40.77 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.822 -1.174 . . . . 0.0 111.904 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -155.58 165.03 37.8 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.3 t -116.43 9.89 14.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 112.643 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.45 106.26 5.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.995 1.318 . . . . 0.0 113.189 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -127.03 151.4 48.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.74 1.216 . . . . 0.0 111.429 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 145.83 52.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.195 0.998 . . . . 0.0 110.218 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -140.84 151.85 44.66 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.612 1.565 . . . . 0.0 109.351 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 t -117.02 -63.75 1.4 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.365 1.466 . . . . 0.0 112.143 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t -87.9 -28.76 21.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.201 1.001 . . . . 0.0 112.885 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -52.79 8.64 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.327 1.451 . . . . 0.0 111.948 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -151.54 -174.21 4.76 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.129 2.972 . . . . 0.0 109.608 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.63 6.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.297 1.427 . . . . 0.0 113.342 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.47 165.75 30.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.195 1.398 . . . . 0.0 111.126 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.94 126.93 10.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.984 0.914 . . . . 0.0 110.789 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 t -134.64 144.68 47.99 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.497 -1.377 . . . . 0.0 111.901 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.24 139.36 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.837 1.255 . . . . 0.0 110.11 -168.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.01 123.98 20.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.781 1.633 . . . . 0.0 112.255 -170.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -135.03 103.07 5.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.259 1.824 . . . . 0.0 110.531 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.95 149.59 44.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.165 0.986 . . . . 0.0 112.552 171.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -127.46 -179.37 4.87 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.509 . . . . 0.0 110.469 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.23 -48.61 72.7 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 13.74 5.35 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.447 1.899 . . . . 0.0 112.388 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.0 mtt -143.17 176.87 8.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.815 2.046 . . . . 0.0 109.695 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.0 156.1 35.37 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.276 1.03 . . . . 0.0 110.105 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 24.0 p -133.94 136.21 44.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.927 . . . . 0.0 111.647 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.19 129.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.34 1.456 . . . . 0.0 110.168 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.76 111.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.2 1.8 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -107.38 121.39 44.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.189 0.996 . . . . 0.0 110.151 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -119.63 160.51 22.36 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.294 1.438 . . . . 0.0 112.467 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.93 156.52 48.63 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.996 1.318 . . . . 0.0 109.874 175.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -179.95 91.99 0.08 OUTLIER Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.14 174.02 2.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.094 0.95 . . . . 0.0 112.155 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -120.28 159.22 25.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.784 1.234 . . . . 0.0 111.96 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.2 pt -56.83 -50.75 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.652 2.381 . . . . 0.0 113.271 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -125.14 -26.69 1.31 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.683 1.135 . . . . 0.0 114.388 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.04 10.02 44.26 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 124.834 1.207 . . . . 0.0 115.652 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.94 33.01 2.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.12 1.819 . . . . 0.0 114.367 -170.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.0 p -126.96 83.82 2.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.557 1.943 . . . . 0.0 110.698 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.47 69.49 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.732 0.682 . . . . 0.0 113.848 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.59 166.46 1.8 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.961 1.304 . . . . 0.0 112.747 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.9 m -46.79 -39.45 11.84 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.361 1.864 . . . . 0.0 114.861 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.32 -83.21 0.35 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.274 2.368 . . . . 0.0 111.137 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.67 163.66 36.78 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.608 2.872 . . . . 0.0 112.827 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -82.21 156.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.875 169.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 173.18 1.84 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.797 1.639 . . . . 0.0 112.506 168.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.42 146.64 49.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.777 1.231 . . . . 0.0 111.791 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.26 159.15 27.22 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 126.073 1.797 . . . . 0.0 113.799 -171.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -73.33 167.95 20.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.713 1.205 . . . . 0.0 112.707 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.56 114.17 14.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.412 1.885 . . . . 0.0 111.071 172.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.08 -177.88 4.31 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.182 1.793 . . . . 0.0 111.152 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.26 140.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.006 0.922 . . . . 0.0 110.762 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.6 m -121.69 119.89 33.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.878 1.671 . . . . 0.0 110.606 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 117.27 33.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.59 1.156 . . . . 0.0 110.891 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.48 105.02 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 128.987 2.915 . . . . 0.0 109.31 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -133.33 156.52 47.46 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.164 -0.96 . . . . 0.0 112.262 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.56 94.31 47.76 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.03 1.332 . . . . 0.0 109.704 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.78 164.93 33.8 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.003 2.469 . . . . 0.0 111.952 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.43 -23.57 20.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.956 2.437 . . . . 0.0 113.819 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -67.98 141.15 56.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.702 0.801 . . . . 0.0 111.759 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.1 178.53 6.94 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.406 1.482 . . . . 0.0 112.304 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.8 160.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.188 1.795 . . . . 0.0 111.214 173.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.251 1.18 0 C-N-CA 127.024 2.13 . . . . 0.0 112.567 -177.225 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -65.43 67.09 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.545 2.338 . . . . 0.0 115.782 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 9.3 mmt -70.19 -74.78 0.13 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.829 1.652 . . . . 0.0 112.011 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' B' ' 148' ' ' ASP . 20.2 pt-20 -102.99 -64.96 1.03 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -172.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . 0.4 ' H ' ' HG3' ' B' ' 147' ' ' GLU . 16.1 m-20 -131.02 1.36 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.599 2.359 . . . . 0.0 111.274 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.01 170.96 8.86 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.167 1.387 . . . . 0.0 112.341 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -128.51 160.25 32.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.347 1.459 . . . . 0.0 111.75 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.93 83.2 1.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.345 1.858 . . . . 0.0 110.688 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.72 151.38 45.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.554 0.741 . . . . 0.0 112.055 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -23.77 23.8 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.214 -0.929 . . . . 0.0 113.312 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -70.75 -24.31 62.59 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -92.47 -13.75 29.49 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.678 1.991 . . . . 0.0 112.826 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.37 160.51 27.15 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.944 -1.098 . . . . 0.0 111.291 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -139.63 167.4 22.19 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.573 1.549 . . . . 0.0 110.898 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.14 152.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.018 1.327 . . . . 0.0 110.172 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.41 -36.49 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.212 -0.93 . . . . 0.0 111.581 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.15 -24.2 66.11 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -79.19 -58.34 3.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.44 1.096 . . . . 0.0 110.62 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 24.7 t -50.38 -44.56 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 112.602 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -68.12 -8.76 41.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 113.651 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -102.8 -30.91 10.57 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.55 1.54 . . . . 0.0 112.787 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.1 mt -49.34 -44.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.408 1.083 . . . . 0.0 110.344 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.56 -43.65 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -50.01 65.04 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.157 1.344 . . . . 0.0 111.384 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -33.44 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.12 -40.47 71.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.207 1.003 . . . . 0.0 112.97 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 44.3 mt -57.56 -56.39 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.215 0.916 . . . . 0.0 110.277 173.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.88 -32.15 70.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -60.81 -45.5 94.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.344 1.057 . . . . 0.0 112.452 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.86 71.37 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.27 -44.16 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.161 0.984 . . . . 0.0 110.916 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.08 71.27 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.103 0.859 . . . . 0.0 115.071 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.33 -4.6 26.68 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.396 1.474 . . . . 0.0 116.229 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.35 -179.26 1.58 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.077 1.439 . . . . 0.0 112.558 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.48 -156.86 0.57 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.917 1.287 . . . . 0.0 111.759 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.92 158.03 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.105 1.362 . . . . 0.0 112.458 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.55 -176.23 5.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.718 1.207 . . . . 0.0 111.779 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.9 -100.92 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.87 1.268 . . . . 0.0 109.632 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 22.4 m -67.61 -24.31 65.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.937 1.295 . . . . 0.0 114.018 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -41.62 78.6 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.035 -1.041 . . . . 0.0 112.593 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.07 -29.23 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.545 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -63.17 -48.63 77.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.637 1.175 . . . . 0.0 111.391 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.41 -26.4 67.21 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.332 -0.855 . . . . 0.0 112.922 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -76.94 -54.44 6.57 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.505 -0.747 . . . . 0.0 111.23 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.3 t -56.56 -29.27 61.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.2 t -80.16 -53.08 7.01 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.497 1.044 . . . . 0.0 112.557 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -58.04 -37.86 75.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.649 1.18 . . . . 0.0 113.276 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 74.0 t -66.66 -66.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 124.844 1.257 . . . . 0.0 109.711 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.66 -29.25 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.71 1.204 . . . . 0.0 111.06 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.45 -47.35 79.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.499 0.72 . . . . 0.0 112.752 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.73 -38.17 9.19 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.053 1.341 . . . . 0.0 113.004 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 20.6 m -56.45 -53.38 58.11 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.559 1.943 . . . . 0.0 112.116 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -40.66 93.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.786 0.721 . . . . 0.0 111.303 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 35.3 p -69.14 -29.09 67.05 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.325 -0.86 . . . . 0.0 113.257 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -73.93 -51.73 15.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.662 2.385 . . . . 0.0 113.073 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.4 -28.22 69.54 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.61 -1.306 . . . . 0.0 113.292 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 96.2 m -58.17 -27.49 63.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.611 1.164 . . . . 0.0 111.117 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -90.76 -28.43 18.26 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.443 1.097 . . . . 0.0 113.607 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.13 -27.06 63.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.689 0.796 . . . . 0.0 111.821 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -137.01 9.58 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.127 1.822 . . . . 0.0 111.949 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -119.76 160.55 41.97 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 125.463 1.505 . . . . 0.0 113.571 -173.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 115.93 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.629 2.886 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.8 175.55 11.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.317 1.447 . . . . 0.0 111.7 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.26 109.05 5.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.78 1.232 . . . . 0.0 109.719 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.83 159.47 15.77 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.86 1.264 . . . . 0.0 109.948 167.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.9 tt -146.8 157.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 109.863 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 33.7 m -138.87 147.27 25.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.894 1.678 . . . . 0.0 110.722 174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.01 126.97 11.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.94 1.696 . . . . 0.0 109.628 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.41 158.42 42.04 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.635 0.774 . . . . 0.0 112.931 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.05 124.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.758 1.223 . . . . 0.0 109.703 177.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.2 mm -123.92 113.02 35.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.766 2.426 . . . . 0.0 107.845 -172.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -134.64 153.12 52.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.255 1.026 . . . . 0.0 112.41 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -103.44 114.15 28.2 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.984 1.714 . . . . 0.0 112.512 -168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -66.95 -5.51 12.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.002 2.121 . . . . 0.0 113.336 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.78 -24.8 6.44 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.627 2.371 . . . . 0.0 114.332 161.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 7.97 1.49 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.2 88.13 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.199 1.5 . . . . 0.0 113.529 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 142.21 33.27 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.157 -0.964 . . . . 0.0 113.918 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.97 172.02 17.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.209 2.204 . . . . 0.0 111.186 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -125.18 122.53 37.32 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.803 1.241 . . . . 0.0 109.981 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 93.8 m -132.51 145.92 51.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 108.427 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -140.62 143.3 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.502 -0.749 . . . . 0.0 110.819 173.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 83.2 p -140.67 158.18 44.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.696 0.76 . . . . 0.0 111.546 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 34.5 t -103.83 5.4 35.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.087 0.955 . . . . 0.0 111.991 170.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 73.1 m -67.4 151.89 46.65 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.452 1.12 . . . . 0.0 113.73 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.97 162.07 23.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.672 2.389 . . . . 0.0 109.695 -171.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.9 144.63 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.382 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -136.37 151.15 49.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.317 1.847 . . . . 0.0 110.587 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 22.3 t -117.55 -68.19 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.695 1.198 . . . . 0.0 111.929 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 4.6 t -83.87 -32.0 25.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.436 0.694 . . . . 0.0 112.345 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.18 42.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.859 1.664 . . . . 0.0 112.522 -173.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -154.62 -172.9 4.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 128.804 2.842 . . . . 0.0 110.053 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -120.02 131.39 8.86 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.605 1.574 . . . . 0.0 113.776 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 p -155.08 159.91 40.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.174 2.19 . . . . 0.0 111.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.7 t -149.66 110.36 4.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.762 1.225 . . . . 0.0 110.698 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.3 t -118.71 146.46 44.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.637 1.175 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.91 141.31 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.717 1.207 . . . . 0.0 110.241 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.67 124.65 20.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.922 1.689 . . . . 0.0 112.355 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -135.29 105.65 6.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.213 1.805 . . . . 0.0 110.599 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 150.11 40.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.204 1.002 . . . . 0.0 112.395 172.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -127.87 -179.89 5.2 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.434 1.494 . . . . 0.0 110.529 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -48.45 75.09 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.0 t -131.6 14.68 4.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.492 1.917 . . . . 0.0 112.478 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 26.5 mtt -143.4 176.49 9.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.796 2.039 . . . . 0.0 109.82 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -154.11 155.91 36.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.325 1.05 . . . . 0.0 110.043 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 21.7 p -135.22 135.4 40.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.947 0.899 . . . . 0.0 111.734 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -134.56 131.36 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.319 1.448 . . . . 0.0 110.394 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.13 107.68 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.126 1.77 . . . . 0.0 110.75 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.7 t -96.31 129.39 43.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.547 0.739 . . . . 0.0 110.139 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -126.62 147.76 49.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 112.272 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.531 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 1.1 m-85 -117.22 149.47 40.35 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.966 1.706 . . . . 0.0 111.264 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -172.02 89.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.407 -170.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.47 165.22 14.81 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.883 0.849 . . . . 0.0 111.952 -178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.4 t -102.21 160.11 14.81 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.568 1.147 . . . . 0.0 111.631 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -58.16 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.074 2.15 . . . . 0.0 112.63 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -113.82 -26.22 3.94 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.541 1.067 . . . . 0.0 114.591 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 60.25 23.75 60.3 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.42 1.11 . . . . 0.0 114.88 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.4 -164.57 25.66 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.171 1.843 . . . . 0.0 114.641 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 74.5 p -59.47 162.28 5.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.521 1.129 . . . . 0.0 113.031 174.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.78 81.61 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.432 1.015 . . . . 0.0 114.392 -170.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -67.82 -173.42 0.35 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.814 1.246 . . . . 0.0 111.923 165.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 18.3 m -47.58 -39.04 15.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.077 1.751 . . . . 0.0 114.785 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 124.16 -74.82 0.39 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.334 1.921 . . . . 0.0 112.27 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.07 173.67 14.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.654 2.903 . . . . 0.0 112.943 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.1 154.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.65 1.98 . . . . 0.0 111.403 163.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 168.26 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.017 1.327 . . . . 0.0 112.543 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 92.6 mt -117.46 156.92 27.15 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.367 1.467 . . . . 0.0 111.997 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.97 159.83 10.43 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.842 1.687 . . . . 0.0 114.063 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.43 165.71 24.56 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.577 -0.955 . . . . 0.0 112.033 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -131.98 116.58 17.3 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.924 1.689 . . . . 0.0 110.701 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.78 -173.3 2.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.2 mm -57.8 141.89 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 110.649 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 88.7 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.561 1.944 . . . . 0.0 110.011 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.77 136.19 33.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.728 0.811 . . . . 0.0 110.81 171.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 5.4 p -131.77 103.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 128.199 2.6 . . . . 0.0 109.656 -175.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -129.78 157.95 40.78 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 0.0 111.562 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.44 94.54 48.81 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.836 1.254 . . . . 0.0 109.37 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.1 164.66 34.05 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.053 2.502 . . . . 0.0 111.979 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.5 -22.18 21.58 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.97 2.446 . . . . 0.0 113.765 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.65 140.59 55.48 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.777 0.831 . . . . 0.0 111.531 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.45 1.5 . . . . 0.0 112.794 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 159.31 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.412 1.885 . . . . 0.0 111.654 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.207 2.203 . . . . 0.0 112.741 -177.58 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -81.42 164.55 21.99 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.141 0.976 . . . . 0.0 113.433 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 mtm -69.97 -44.83 68.66 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.291 1.836 . . . . 0.0 112.206 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.67 -13.37 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.44 -27.73 60.74 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.396 1.078 . . . . 0.0 112.859 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -77.58 161.69 27.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.18 1.392 . . . . 0.0 111.354 172.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -135.48 154.08 51.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.506 1.122 . . . . 0.0 111.869 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 -9.7 44.99 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.07 -10.14 13.19 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.17 1.788 . . . . 0.0 115.002 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -53.03 -27.8 21.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.899 1.679 . . . . 0.0 113.831 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.59 -16.72 6.63 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 t -60.87 -27.61 68.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.321 1.448 . . . . 0.0 113.421 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 116.14 7.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 110.829 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -61.87 164.96 5.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.457 0.703 . . . . 0.0 111.935 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.51 156.83 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.804 0.842 . . . . 0.0 111.398 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 t -57.39 -34.76 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.097 1.759 . . . . 0.0 111.523 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.39 -27.6 67.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.645 1.178 . . . . 0.0 113.256 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -78.12 -59.23 2.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.991 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 t -49.74 -45.91 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.502 1.521 . . . . 0.0 112.87 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 t -60.73 -25.26 66.32 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.302 1.441 . . . . 0.0 112.894 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.52 -37.75 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.51 -1.369 . . . . 0.0 113.155 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mt -52.1 -43.6 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.515 1.126 . . . . 0.0 110.84 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.1 -42.15 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.47 -0.776 . . . . 0.0 113.032 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -52.9 54.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.174 1.352 . . . . 0.0 112.082 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.11 74.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.54 -45.68 65.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.004 0.922 . . . . 0.0 112.882 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mt -54.72 -57.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 119.204 0.911 . . . . 0.0 110.415 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.97 -29.92 68.76 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.8 p -66.68 -33.7 76.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.23 52.09 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.043 1.337 . . . . 0.0 112.438 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.69 -41.51 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.869 1.268 . . . . 0.0 110.926 171.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.15 81.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.251 0.929 . . . . 0.0 114.272 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 10.02 75.54 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.334 1.445 . . . . 0.0 115.903 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -61.22 155.58 20.56 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.072 1.436 . . . . 0.0 113.056 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.78 -171.53 1.62 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.167 1.787 . . . . 0.0 112.286 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -41.41 139.29 1.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.743 2.817 . . . . 0.0 114.737 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -135.88 174.75 10.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.485 1.514 . . . . 0.0 113.163 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -90.42 -97.45 0.11 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.541 1.537 . . . . 0.0 111.138 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.8 p -89.37 -1.65 58.13 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.681 1.992 . . . . 0.0 114.326 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.31 -42.77 61.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.433 1.493 . . . . 0.0 113.566 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.08 -32.15 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.55 -48.77 71.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 112.176 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -68.54 -25.99 65.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -76.63 -55.45 5.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.918 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -54.29 -35.3 62.44 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.953 0.797 . . . . 0.0 112.186 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -75.68 -54.55 6.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.129 0.877 . . . . 0.0 112.761 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.91 -36.85 73.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.668 1.187 . . . . 0.0 113.33 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.64 -63.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 C-N-CA 124.177 0.991 . . . . 0.0 110.015 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.8 t -49.15 -30.75 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.057 0.943 . . . . 0.0 110.715 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -59.91 -35.84 75.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -107.02 -42.54 4.87 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.36 1.464 . . . . 0.0 112.659 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 m -54.18 -54.84 34.25 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.339 2.256 . . . . 0.0 112.254 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -39.07 86.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.517 0.598 . . . . 0.0 111.218 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -57.48 -52.61 64.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.203 0.601 . . . . 0.0 111.425 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -59.77 -51.13 71.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.565 1.946 . . . . 0.0 114.489 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.06 -28.64 69.61 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.574 -1.329 . . . . 0.0 113.734 -177.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 m -59.46 -33.91 71.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.47 0.708 . . . . 0.0 111.071 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -80.66 -24.9 38.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.26 -16.01 62.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.2 -111.3 3.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 112.693 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -133.91 150.92 75.83 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.369 1.868 . . . . 0.0 112.222 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 102.58 1.42 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.98 3.12 . . . . 0.0 112.404 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -143.05 161.67 37.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.471 1.509 . . . . 0.0 112.109 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -65.5 100.07 0.47 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.96 1.704 . . . . 0.0 110.991 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -75.02 166.14 24.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.467 1.107 . . . . 0.0 111.9 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.99 156.07 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.443 2.297 . . . . 0.0 108.186 164.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.69 155.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.782 -0.574 . . . . 0.0 109.455 160.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -134.68 137.47 43.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.519 1.128 . . . . 0.0 109.991 165.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -128.88 144.76 51.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.795 0.838 . . . . 0.0 111.916 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -131.82 99.5 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.298 1.839 . . . . 0.0 108.841 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.75 99.96 10.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.89 96.18 2.76 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.124 1.369 . . . . 0.0 111.292 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -149.35 159.06 44.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.305 1.442 . . . . 0.0 110.458 154.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -153.48 -80.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.07 1.748 . . . . 0.0 110.059 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -84.0 -18.85 35.78 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.895 1.278 . . . . 0.0 113.775 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.68 -2.26 3.71 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.784 1.659 . . . . 0.0 115.093 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.05 179.08 2.45 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.967 1.707 . . . . 0.0 114.167 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.1 -172.29 28.23 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.812 2.149 . . . . 0.0 112.356 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 179.64 6.36 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 111.986 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -106.87 111.21 23.62 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.469 -0.77 . . . . 0.0 111.1 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.6 m -116.93 140.71 49.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.474 1.11 . . . . 0.0 109.972 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.02 138.95 34.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.733 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -139.56 120.81 14.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 110.429 -166.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 t -79.97 66.23 5.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.319 1.057 . . . . 0.0 110.093 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -114.04 171.18 7.76 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 0.0 110.787 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -144.07 129.58 19.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.986 1.314 . . . . 0.0 109.86 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -76.98 125.98 30.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.434 1.094 . . . . 0.0 109.846 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -146.01 90.06 1.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.488 1.115 . . . . 0.0 111.336 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -68.1 -60.57 2.39 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.173 1.389 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.7 t -88.08 -33.67 18.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.476 1.11 . . . . 0.0 112.304 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 m -74.75 -38.24 62.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -165.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.76 -134.47 0.14 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.335 1.854 . . . . 0.0 109.422 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.96 150.59 20.66 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.316 1.436 . . . . 0.0 113.464 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 p -162.63 157.3 21.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.6 t -165.25 157.99 15.95 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.302 1.841 . . . . 0.0 109.378 165.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 t -143.24 139.14 30.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.28 -1.512 . . . . 0.0 111.13 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.1 138.31 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 109.658 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.25 119.08 11.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.733 1.613 . . . . 0.0 111.023 -166.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -135.83 141.74 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.868 1.267 . . . . 0.0 112.149 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 165.7 24.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.49 -174.12 4.59 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.17 -62.41 0.95 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.294 1.837 . . . . 0.0 113.536 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -139.18 -6.59 1.39 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.987 1.715 . . . . 0.0 113.124 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.9 ptm -129.17 78.81 1.88 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.642 1.577 . . . . 0.0 112.111 -165.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -51.27 133.5 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.165 1.386 . . . . 0.0 111.306 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 14.3 p -113.63 136.33 52.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 111.767 -176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.1 126.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.81 1.644 . . . . 0.0 110.994 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.78 122.98 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.221 1.808 . . . . 0.0 110.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -115.64 118.42 33.05 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.788 1.235 . . . . 0.0 110.675 -178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.98 140.8 37.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.262 1.825 . . . . 0.0 112.15 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -133.41 148.51 51.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.339 1.456 . . . . 0.0 109.67 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.1 127.44 3.85 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 125.591 1.567 . . . . 0.0 109.344 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.95 133.43 49.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.63 0.772 . . . . 0.0 111.419 -168.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -134.65 132.83 39.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.959 1.304 . . . . 0.0 112.305 -169.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.3 -1.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.28 -2.19 64.11 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.936 1.255 . . . . 0.0 115.702 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.32 77.56 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 118.775 1.288 . . . . 0.0 115.139 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -54.16 114.8 4.49 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.877 1.703 . . . . 0.0 112.811 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.2 t -135.01 172.51 12.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.861 1.665 . . . . 0.0 111.993 -173.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 135.87 36.65 0.2 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.092 1.805 . . . . 0.0 114.907 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -54.35 166.53 0.41 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.088 1.755 . . . . 0.0 113.842 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.3 t -56.2 -43.78 78.84 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.711 1.605 . . . . 0.0 113.264 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.11 176.85 24.87 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.121 1.344 . . . . 0.0 113.393 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -66.05 145.75 80.18 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.826 2.35 . . . . 0.0 111.101 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.66 154.82 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.097 0.475 . . . . 0.0 111.463 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 166.66 25.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.56 1.144 . . . . 0.0 112.674 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.96 126.66 28.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.187 1.395 . . . . 0.0 109.786 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -157.07 162.78 31.99 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.909 1.242 . . . . 0.0 112.573 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.9 170.55 16.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.478 1.511 . . . . 0.0 110.961 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.1 164.4 29.22 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.36 1.464 . . . . 0.0 112.289 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -132.54 174.46 10.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.364 1.866 . . . . 0.0 111.083 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.15 134.34 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.17 1.788 . . . . 0.0 111.399 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 m -98.32 92.32 5.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.206 1.402 . . . . 0.0 110.242 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -92.55 149.83 21.12 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.701 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -143.39 97.79 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.569 2.347 . . . . 0.0 108.686 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -144.72 166.26 25.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.048 1.339 . . . . 0.0 112.539 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -120.34 89.09 43.21 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.367 1.467 . . . . 0.0 109.622 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.87 167.35 27.26 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.426 2.751 . . . . 0.0 112.196 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.97 -32.52 17.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.73 2.287 . . . . 0.0 113.881 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.96 -62.92 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.012 1.325 . . . . 0.0 112.467 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -97.04 178.01 5.41 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.575 1.95 . . . . 0.0 112.039 -172.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.79 172.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.41 1.484 . . . . 0.0 112.754 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.452 2.301 . . . . 0.0 112.244 179.851 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -87.31 162.84 17.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.807 0.843 . . . . 0.0 112.649 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 7.1 mtm -70.65 -44.64 66.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 112.32 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.94 -12.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -74.31 -27.58 60.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.433 1.093 . . . . 0.0 112.944 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -77.48 162.48 27.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 111.473 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -136.44 153.92 50.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.482 1.113 . . . . 0.0 111.965 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.82 47.34 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.36 -9.95 14.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.065 1.746 . . . . 0.0 114.998 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.37 -27.54 24.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 113.834 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -56.91 -16.68 7.29 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 3.4 t -60.17 -27.13 66.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.347 1.459 . . . . 0.0 113.274 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.32 114.67 6.98 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.006 0.922 . . . . 0.0 111.206 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.39 166.9 2.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.196 0.999 . . . . 0.0 112.788 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.52 156.99 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.415 1.086 . . . . 0.0 111.546 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.99 -38.91 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.618 1.167 . . . . 0.0 111.469 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.27 -26.47 67.79 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.565 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -76.86 -60.71 2.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.883 0.873 . . . . 0.0 110.421 171.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 51.1 t -49.23 -45.95 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.001 1.72 . . . . 0.0 112.194 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 21.7 t -59.74 -25.15 64.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.272 1.429 . . . . 0.0 112.98 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -86.93 -37.72 17.34 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.604 -1.31 . . . . 0.0 113.05 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.4 mt -51.95 -44.12 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.975 0.91 . . . . 0.0 110.979 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -52.53 49.96 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.917 1.235 . . . . 0.0 111.959 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.66 72.56 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -45.78 56.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 112.868 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 51.6 mt -54.43 -57.37 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.275 0.943 . . . . 0.0 110.327 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.75 -30.09 68.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 9.7 p -66.7 -33.51 75.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 172.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.15 -33.55 50.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.057 1.343 . . . . 0.0 112.535 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.77 -40.4 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.844 1.258 . . . . 0.0 110.969 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.27 15.04 80.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.208 0.908 . . . . 0.0 114.327 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.44 78.17 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.315 1.436 . . . . 0.0 115.797 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -61.19 155.34 21.04 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.119 1.46 . . . . 0.0 113.103 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.89 -171.44 1.63 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.198 1.799 . . . . 0.0 112.242 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -41.35 139.44 1.04 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.739 2.816 . . . . 0.0 114.808 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -135.93 174.3 10.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.495 1.518 . . . . 0.0 113.19 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.21 -96.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.658 1.583 . . . . 0.0 111.292 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.7 p -90.67 -1.71 57.86 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.803 2.041 . . . . 0.0 114.354 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.6 -42.48 61.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.422 1.489 . . . . 0.0 113.7 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.98 -31.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.05 -49.08 68.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.794 1.238 . . . . 0.0 112.139 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -68.33 -26.19 65.48 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -76.48 -55.57 5.41 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 110.941 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.6 t -55.36 -32.45 62.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.928 0.786 . . . . 0.0 112.399 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.3 t -77.54 -55.7 5.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.281 0.946 . . . . 0.0 112.756 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.65 -36.19 71.55 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.884 1.22 . . . . 0.0 113.405 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 69.6 t -67.74 -63.4 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 109.964 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.77 -31.14 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.302 1.041 . . . . 0.0 110.722 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.82 -35.36 74.56 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -107.62 -42.41 4.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.42 1.488 . . . . 0.0 112.663 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.8 m -54.62 -54.18 44.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.417 2.287 . . . . 0.0 112.379 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -38.94 87.63 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 0.0 111.187 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 23.8 t -58.05 -51.98 67.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.307 0.643 . . . . 0.0 111.522 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.58 -51.54 69.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.576 1.95 . . . . 0.0 114.273 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.0 pp -65.48 -28.59 69.32 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.622 -1.299 . . . . 0.0 113.881 -177.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 4.6 m -58.99 -32.46 69.71 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.397 0.679 . . . . 0.0 111.059 168.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -81.09 -27.27 35.7 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.692 -0.63 . . . . 0.0 112.58 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.4 -21.21 62.87 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.32 -111.72 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.013 1.292 . . . . 0.0 112.364 171.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -133.51 152.22 78.74 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.926 1.69 . . . . 0.0 112.37 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.42 99.96 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.891 3.061 . . . . 0.0 112.107 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -142.4 162.96 34.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.544 1.537 . . . . 0.0 112.196 174.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -66.39 101.95 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.191 1.796 . . . . 0.0 111.085 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -80.04 165.07 22.92 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.86 1.264 . . . . 0.0 111.908 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.7 tt -149.14 157.6 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 127.781 2.432 . . . . 0.0 108.236 164.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.72 155.67 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 161.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 134.25 40.0 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.672 1.189 . . . . 0.0 109.59 166.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 8.3 p -128.02 148.57 50.54 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.902 0.881 . . . . 0.0 112.505 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -133.27 104.24 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.195 1.798 . . . . 0.0 109.061 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -99.12 109.22 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 107.837 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 159.1 35.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.284 1.433 . . . . 0.0 111.445 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.23 130.06 41.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.525 1.53 . . . . 0.0 112.712 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -80.88 -4.13 53.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.171 2.189 . . . . 0.0 114.116 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -58.45 -20.38 44.58 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.436 1.894 . . . . 0.0 114.639 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.67 5.03 3.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.756 1.645 . . . . 0.0 114.614 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.4 6.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 113.114 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -175.1 -177.53 44.26 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.43 1.966 . . . . 0.0 111.76 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 179.85 7.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.487 1.515 . . . . 0.0 112.315 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -109.96 109.96 20.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.59 0.632 . . . . 0.0 111.411 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 35.7 m -113.85 138.49 50.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.829 0.852 . . . . 0.0 110.393 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.04 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.551 . . . . 0.0 111.293 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 3.2 m -136.07 119.6 17.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.793 0.837 . . . . 0.0 110.114 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.1 t -79.88 64.88 4.86 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.413 1.101 . . . . 0.0 109.975 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 170.83 7.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 110.641 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.79 132.07 21.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 109.899 -170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -76.83 124.6 27.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.459 1.104 . . . . 0.0 109.618 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -142.74 84.23 1.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.843 1.257 . . . . 0.0 110.976 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.5 t -65.11 -62.08 1.76 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.274 1.429 . . . . 0.0 112.474 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 35.8 t -88.48 -28.65 20.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.287 1.035 . . . . 0.0 112.535 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.1 m -77.08 -38.23 52.88 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.655 -0.653 . . . . 0.0 112.63 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 -134.75 0.14 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.211 1.804 . . . . 0.0 109.689 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.81 150.92 20.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.381 1.467 . . . . 0.0 113.272 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 31.3 p -162.6 156.74 21.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.159 1.384 . . . . 0.0 111.915 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.6 162.59 16.63 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.342 1.857 . . . . 0.0 109.644 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.2 t -146.49 141.14 26.77 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.392 -1.442 . . . . 0.0 110.78 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.5 136.52 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.973 1.309 . . . . 0.0 109.509 -171.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 121.81 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.45 1.5 . . . . 0.0 111.394 -171.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -130.43 169.89 14.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.621 1.569 . . . . 0.0 110.912 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.65 164.83 14.38 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.043 1.337 . . . . 0.0 111.89 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -177.15 5.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.382 1.473 . . . . 0.0 109.458 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.55 -71.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.212 2.205 . . . . 0.0 114.055 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.0 t -138.32 16.41 2.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.489 1.516 . . . . 0.0 113.167 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.78 121.83 13.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.598 1.559 . . . . 0.0 110.987 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -79.08 152.2 30.97 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.558 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 23.1 p -133.46 115.7 15.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.388 0.675 . . . . 0.0 112.501 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.91 129.62 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.432 1.493 . . . . 0.0 111.565 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.25 121.3 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.485 1.914 . . . . 0.0 111.044 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.5 t -112.95 121.9 46.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.774 1.23 . . . . 0.0 110.627 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -108.4 141.44 40.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.289 1.836 . . . . 0.0 112.392 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.44 147.95 50.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.404 1.482 . . . . 0.0 109.697 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -138.09 125.18 3.15 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 125.698 1.618 . . . . 0.0 109.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.66 132.14 48.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.626 0.77 . . . . 0.0 111.783 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 52.1 m -134.33 132.21 39.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.041 1.337 . . . . 0.0 112.483 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.3 pp -117.91 -1.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.18 -2.17 64.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.86 1.219 . . . . 0.0 115.717 -175.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.61 15.35 77.65 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 118.777 1.288 . . . . 0.0 115.214 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.48 113.58 3.56 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.91 1.719 . . . . 0.0 113.003 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -131.09 173.48 10.97 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.182 1.793 . . . . 0.0 112.025 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 135.62 34.81 0.24 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.225 1.869 . . . . 0.0 114.996 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.2 167.16 0.47 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.044 1.738 . . . . 0.0 113.856 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 23.0 t -58.6 -41.72 86.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.993 1.317 . . . . 0.0 113.281 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -105.28 177.83 23.22 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.327 1.441 . . . . 0.0 113.119 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.07 149.95 85.55 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.856 2.371 . . . . 0.0 111.669 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.05 157.7 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 122.897 0.479 . . . . 0.0 111.578 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.45 167.44 26.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.373 1.069 . . . . 0.0 112.868 174.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.21 120.49 13.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.145 1.378 . . . . 0.0 109.978 171.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -151.4 161.38 29.15 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.114 1.34 . . . . 0.0 112.746 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.59 170.41 16.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.618 1.567 . . . . 0.0 110.885 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.34 164.69 28.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.389 1.476 . . . . 0.0 112.296 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -132.29 175.12 9.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.421 1.888 . . . . 0.0 111.135 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.1 132.67 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.016 1.727 . . . . 0.0 111.385 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 57.1 m -95.72 88.62 5.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.086 1.354 . . . . 0.0 110.004 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -92.12 150.04 21.16 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.277 -0.89 . . . . 0.0 111.42 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.4 p -148.63 102.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.747 2.019 . . . . 0.0 109.444 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -143.89 167.12 23.07 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.839 1.655 . . . . 0.0 111.794 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -116.59 89.05 26.56 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.993 1.317 . . . . 0.0 109.755 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.55 167.19 27.68 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.357 2.705 . . . . 0.0 112.238 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.02 -32.87 16.69 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.837 2.358 . . . . 0.0 113.833 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -62.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.935 1.294 . . . . 0.0 112.468 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.43 178.02 5.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.61 1.964 . . . . 0.0 111.97 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.82 172.09 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.3 1.44 . . . . 0.0 112.802 -174.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.253 1.262 0 C-N-CA 127.462 2.305 . . . . 0.0 112.299 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -70.51 -171.19 0.46 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.344 1.858 . . . . 0.0 113.148 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt -46.14 -57.03 4.86 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.609 1.963 . . . . 0.0 113.814 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 5' ' ' ASP 0.286 11.0 pt-20 -112.27 -77.25 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.577 0.751 . . . . 0.0 112.959 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.503 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 20.3 t70 -125.37 -14.02 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.829 1.652 . . . . 0.0 111.645 166.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -163.57 175.09 11.01 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.863 2.065 . . . . 0.0 113.292 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.96 178.72 1.69 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.9 2.08 . . . . 0.0 112.853 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.29 46.3 1.92 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.258 1.823 . . . . 0.0 112.781 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.84 4.67 2.39 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.42 -26.25 12.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.036 1.735 . . . . 0.0 114.644 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.25 -17.58 20.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 t -61.53 -26.25 67.82 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.975 1.71 . . . . 0.0 113.812 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.87 155.6 17.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.658 1.183 . . . . 0.0 110.882 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -125.11 165.3 18.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.854 1.261 . . . . 0.0 110.496 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.87 142.51 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.762 1.225 . . . . 0.0 110.138 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.61 -41.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.808 1.643 . . . . 0.0 113.813 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.35 -29.8 67.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.291 1.036 . . . . 0.0 112.93 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -76.36 -56.11 4.94 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.41 1.084 . . . . 0.0 110.736 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 t -48.25 -44.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.538 1.135 . . . . 0.0 112.277 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -68.23 -6.84 25.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.474 1.51 . . . . 0.0 114.12 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -107.11 -32.73 7.7 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.538 1.935 . . . . 0.0 112.662 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 mt -50.29 -42.76 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.277 0.944 . . . . 0.0 110.133 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -59.85 -43.85 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.463 -0.773 . . . . 0.0 113.085 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -51.77 56.15 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.923 1.238 . . . . 0.0 111.132 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -34.01 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.3 -37.46 63.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.706 0.803 . . . . 0.0 112.839 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.2 mt -59.43 -59.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.337 0.971 . . . . 0.0 109.544 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.57 -31.6 70.72 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.0 t -58.71 -50.5 73.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 112.209 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.96 -31.98 72.08 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.43 -44.43 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.384 1.073 . . . . 0.0 110.973 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.19 12.0 74.56 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.11 -1.93 26.94 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 171.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.23 170.06 6.35 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 119.347 1.574 . . . . 0.0 112.004 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.75 -147.24 0.34 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -68.23 103.07 1.49 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.037 2.135 . . . . 0.0 111.28 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -92.95 173.06 7.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.291 1.437 . . . . 0.0 112.645 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -84.2 -112.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.469 1.108 . . . . 0.0 110.367 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.7 m -61.95 -20.32 63.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.576 1.55 . . . . 0.0 114.659 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.05 -41.84 75.66 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.138 -0.976 . . . . 0.0 112.501 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.0 t -54.77 -36.1 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.526 1.131 . . . . 0.0 112.675 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -66.11 -47.85 72.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.785 0.721 . . . . 0.0 112.42 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -65.17 -24.06 67.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.029 0.831 . . . . 0.0 112.466 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.66 -53.63 6.96 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -56.2 -30.55 62.44 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.816 0.734 . . . . 0.0 112.588 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -78.85 -58.43 3.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 170.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -58.21 -39.21 78.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.048 1.295 . . . . 0.0 113.538 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.26 -62.42 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 123.89 0.876 . . . . 0.0 109.956 -177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -50.04 -29.55 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.46 1.104 . . . . 0.0 110.855 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.27 -52.01 66.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.609 0.763 . . . . 0.0 112.01 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -92.35 -38.62 11.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.5 m -61.27 -53.16 60.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.402 2.281 . . . . 0.0 112.431 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -37.86 84.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.28 0.562 . . . . 0.0 111.003 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m -65.96 -29.63 70.06 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.86 -50.28 12.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.421 2.289 . . . . 0.0 112.592 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.18 -25.74 67.85 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.856 -1.152 . . . . 0.0 113.786 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -57.53 -32.82 67.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.564 1.146 . . . . 0.0 110.848 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -84.27 -30.55 25.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.56 -31.92 70.4 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.588 0.355 . . . . 0.0 111.105 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.04 -137.79 4.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.013 1.292 . . . . 0.0 111.976 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.75 158.76 39.61 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.154 1.382 . . . . 0.0 112.791 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.44 109.46 2.45 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.514 2.809 . . . . 0.0 111.161 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.96 173.81 12.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.763 1.225 . . . . 0.0 112.123 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.23 112.08 10.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.28 . . . . 0.0 110.537 168.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.88 134.85 54.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.967 1.307 . . . . 0.0 109.34 170.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -118.06 152.36 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.369 1.868 . . . . 0.0 109.158 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.98 154.53 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.331 1.052 . . . . 0.0 110.218 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 153.38 40.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.775 168.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -147.18 156.33 42.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.076 0.95 . . . . 0.0 112.737 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.28 121.27 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.442 1.497 . . . . 0.0 108.993 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.64 118.21 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 126.876 2.07 . . . . 0.0 107.507 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.95 161.78 35.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.52 1.528 . . . . 0.0 110.751 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -130.1 157.48 42.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.745 -1.222 . . . . 0.0 113.99 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -76.44 -7.92 56.07 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.286 1.435 . . . . 0.0 114.368 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.39 -16.29 45.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.536 1.934 . . . . 0.0 114.263 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.04 30.57 0.79 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.101 1.334 . . . . 0.0 115.301 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.26 73.69 0.49 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.977 1.311 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 95.24 0.23 Allowed Glycine 0 N--CA 1.468 0.776 0 C-N-CA 126.192 1.853 . . . . 0.0 115.049 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.55 162.32 25.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.773 1.629 . . . . 0.0 111.892 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.05 97.73 5.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.815 1.246 . . . . 0.0 108.622 170.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.2 m -105.69 136.39 45.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.821 0.848 . . . . 0.0 109.13 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 119.57 12.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.84 0.856 . . . . 0.0 110.542 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 p -125.08 139.7 53.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.929 0.871 . . . . 0.0 111.378 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.2 m -87.19 16.17 5.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.664 0.785 . . . . 0.0 112.277 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.7 m -70.7 166.22 21.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.345 1.058 . . . . 0.0 112.163 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.3 151.44 26.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.868 1.667 . . . . 0.0 110.769 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -78.92 127.98 32.71 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.474 -0.767 . . . . 0.0 110.005 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.78 139.4 38.26 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.245 1.018 . . . . 0.0 112.144 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -134.44 -38.13 0.84 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.607 1.563 . . . . 0.0 113.219 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 t -89.68 -43.22 10.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.35 1.46 . . . . 0.0 111.299 173.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -43.35 87.55 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.965 1.706 . . . . 0.0 112.416 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.68 -161.67 0.94 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.463 1.905 . . . . 0.0 111.377 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.41 114.66 4.49 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.873 1.702 . . . . 0.0 115.944 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 m -139.45 176.21 8.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.125 2.17 . . . . 0.0 111.602 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.84 131.49 6.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.002 2.121 . . . . 0.0 109.208 166.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.9 t -139.11 146.02 40.18 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.825 -1.797 . . . . 0.0 112.436 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 137.85 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.951 1.3 . . . . 0.0 110.259 -167.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 114.91 16.63 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.279 1.432 . . . . 0.0 111.695 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -121.5 97.7 5.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.741 1.616 . . . . 0.0 109.557 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -63.75 168.83 4.56 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.356 -0.84 . . . . 0.0 112.337 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.89 -177.83 5.16 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.857 1.663 . . . . 0.0 112.93 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.8 t -135.29 -30.12 1.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.251 1.42 . . . . 0.0 113.679 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptp -87.25 176.81 7.38 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.962 -1.086 . . . . 0.0 112.506 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.55 150.54 30.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.663 1.185 . . . . 0.0 111.639 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.2 p -136.59 142.86 43.35 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.262 1.029 . . . . 0.0 112.346 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.39 135.13 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.701 1.6 . . . . 0.0 109.978 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.65 131.5 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.903 1.681 . . . . 0.0 110.255 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.2 p -125.07 147.51 48.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.56 136.47 47.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.068 2.147 . . . . 0.0 110.967 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -135.42 157.99 45.5 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.792 1.637 . . . . 0.0 108.982 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.24 85.17 0.05 OUTLIER Glycine 0 N--CA 1.464 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 111.442 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.02 153.9 42.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.035 0.934 . . . . 0.0 110.085 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 m -154.58 82.06 1.1 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.455 0.702 . . . . 0.0 111.608 -171.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -14.66 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -92.31 8.38 77.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.327 1.918 . . . . 0.0 115.733 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.66 30.4 0.33 Allowed Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.058 1.429 . . . . 0.0 115.771 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.93 -162.0 6.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.963 1.744 . . . . 0.0 115.149 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 t -57.55 159.35 5.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.796 0.838 . . . . 0.0 112.156 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.38 19.03 9.66 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.466 1.031 . . . . 0.0 113.987 -165.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -61.63 173.18 1.02 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.934 1.294 . . . . 0.0 112.383 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.3 m -67.52 23.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.145 2.178 . . . . 0.0 115.188 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.05 -172.51 33.74 Favored Glycine 0 CA--C 1.543 1.792 0 C-N-CA 126.84 2.162 . . . . 0.0 113.878 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.7 146.15 65.81 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.27 2.647 . . . . 0.0 112.172 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.6 pt -81.32 164.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.232 1.015 . . . . 0.0 111.7 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 162.76 34.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.125 2.17 . . . . 0.0 110.795 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.0 mt -135.07 120.39 19.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.961 1.304 . . . . 0.0 109.498 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -161.65 153.86 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.997 1.284 . . . . 0.0 112.32 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttm -75.83 160.72 29.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.536 0.734 . . . . 0.0 112.213 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.27 83.49 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.16 1.384 . . . . 0.0 112.016 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -130.6 -179.92 5.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.761 1.224 . . . . 0.0 111.559 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.3 134.2 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.105 1.362 . . . . 0.0 110.93 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.6 m -115.84 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 110.245 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -90.98 147.48 23.06 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.447 -0.783 . . . . 0.0 111.384 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.89 103.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 128.019 2.527 . . . . 0.0 108.708 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.58 130.6 21.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.059 1.344 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -144.0 91.44 6.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.453 1.501 . . . . 0.0 109.911 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.33 167.55 21.93 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.259 2.639 . . . . 0.0 112.8 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.41 -14.6 31.03 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.754 . . . . 0.0 113.442 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -56.95 129.99 44.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.376 1.07 . . . . 0.0 110.882 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.39 171.4 16.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.017 2.127 . . . . 0.0 110.316 -175.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.2 161.75 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.655 1.582 . . . . 0.0 111.659 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.61 1.964 . . . . 0.0 110.604 -177.648 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 23.0 m -138.7 -47.14 0.5 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.286 1.034 . . . . 0.0 113.724 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 14.6 tpt -66.38 -43.3 86.27 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.145 0.978 . . . . 0.0 113.031 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -109.47 -25.01 10.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 114.055 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.99 -20.33 29.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.558 1.143 . . . . 0.0 113.353 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.75 162.72 17.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.837 2.055 . . . . 0.0 110.618 168.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.19 165.49 22.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.524 1.53 . . . . 0.0 110.994 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.54 39.39 0.83 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.262 1.425 . . . . 0.0 113.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.88 -2.71 5.51 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.44 -25.61 16.73 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.252 1.821 . . . . 0.0 114.547 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -59.22 -19.16 43.15 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 3.8 t -58.86 -22.44 59.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.533 1.933 . . . . 0.0 114.555 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.26 139.98 46.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.226 1.41 . . . . 0.0 109.944 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -111.98 162.32 15.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 111.643 175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.79 135.9 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.656 1.582 . . . . 0.0 109.968 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.62 -42.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.094 2.158 . . . . 0.0 113.451 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.29 -31.33 65.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.647 1.179 . . . . 0.0 112.92 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -87.61 -49.21 7.32 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.965 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 21.6 t -45.7 -41.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 120.114 1.325 . . . . 0.0 112.263 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -70.89 -8.28 51.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.113 1.765 . . . . 0.0 115.036 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -103.34 -31.44 10.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.762 2.425 . . . . 0.0 112.581 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.8 mt -50.56 -42.65 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.226 1.01 . . . . 0.0 110.296 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.39 -42.89 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -51.9 56.13 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.859 1.208 . . . . 0.0 111.058 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -33.64 76.33 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.17 -36.56 61.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.626 0.77 . . . . 0.0 112.976 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 55.1 mt -59.75 -59.43 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.291 0.95 . . . . 0.0 109.558 173.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.32 -31.72 70.56 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.0 t -58.57 -50.3 74.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.372 1.069 . . . . 0.0 112.16 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.15 72.16 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.72 -44.28 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.327 1.051 . . . . 0.0 110.867 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.17 75.08 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 -1.96 26.83 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -66.35 170.53 5.86 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 119.319 1.559 . . . . 0.0 112.025 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.57 -146.31 0.34 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.853 1.661 . . . . 0.0 112.09 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -70.03 97.76 1.21 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.022 2.129 . . . . 0.0 111.365 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.57 173.95 10.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.267 1.427 . . . . 0.0 112.8 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -85.77 -106.66 0.05 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.461 1.105 . . . . 0.0 110.557 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 30.0 m -66.1 -20.73 66.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -55.6 -38.75 69.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.054 0.942 . . . . 0.0 112.612 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -35.24 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.939 0.896 . . . . 0.0 113.304 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -69.08 -46.37 67.96 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.8 0.84 . . . . 0.0 111.992 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -65.68 -24.92 67.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.501 0.591 . . . . 0.0 112.496 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -78.14 -54.77 5.88 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.667 0.787 . . . . 0.0 111.656 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.9 t -56.05 -30.17 61.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.759 0.708 . . . . 0.0 112.617 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -78.78 -59.95 2.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.21 0.914 . . . . 0.0 112.627 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -57.2 -39.38 75.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.094 1.315 . . . . 0.0 113.594 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 91.4 t -67.8 -62.95 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 C-N-CA 123.895 0.878 . . . . 0.0 109.839 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.2 t -50.11 -29.81 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 110.76 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.55 -52.29 65.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.75 0.82 . . . . 0.0 111.839 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -91.62 -38.64 12.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.795 1.238 . . . . 0.0 112.694 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 42.1 m -62.74 -52.77 61.94 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.768 2.427 . . . . 0.0 112.532 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.75 86.74 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.54 0.686 . . . . 0.0 111.09 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 52.9 m -64.7 -31.42 72.63 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -77.08 -49.51 15.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.461 2.305 . . . . 0.0 112.652 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.65 -27.98 69.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.879 -1.138 . . . . 0.0 113.661 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -58.55 -32.48 68.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.833 0.853 . . . . 0.0 110.807 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -81.7 -31.46 32.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.01 -30.29 55.81 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.706 0.23 . . . . 0.0 110.964 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.83 -134.6 2.61 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.507 1.527 . . . . 0.0 111.682 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 153.18 49.86 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.535 1.134 . . . . 0.0 113.849 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 107.16 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.057 3.171 . . . . 0.0 111.687 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.1 171.08 17.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 111.759 175.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.2 98.16 1.32 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.799 1.24 . . . . 0.0 111.366 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -83.3 155.64 23.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.845 0.858 . . . . 0.0 110.671 163.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.1 tt -141.03 153.33 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.825 2.05 . . . . 0.0 108.759 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 23.4 m -141.42 154.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.284 1.034 . . . . 0.0 110.297 169.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 15.0 t -146.65 153.79 40.72 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.892 0.877 . . . . 0.0 109.827 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 22.7 p -148.45 160.49 43.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.157 0.983 . . . . 0.0 112.667 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.49 136.37 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 110.467 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 5.4 mm -119.15 120.41 63.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 127.791 2.436 . . . . 0.0 107.164 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 22.3 ttt -140.27 156.6 46.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.193 1.397 . . . . 0.0 111.171 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.99 140.71 52.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.715 1.206 . . . . 0.0 112.286 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -62.22 -7.88 4.85 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.203 1.801 . . . . 0.0 115.071 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.62 -16.95 43.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.396 2.278 . . . . 0.0 114.212 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 126.91 29.12 0.89 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.961 1.267 . . . . 0.0 115.127 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.88 72.52 0.25 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.311 1.444 . . . . 0.0 112.846 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.25 96.69 0.24 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.353 1.93 . . . . 0.0 114.983 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 pp -126.92 161.18 28.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 111.651 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.78 97.91 4.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.868 1.267 . . . . 0.0 108.591 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 38.8 m -110.17 132.29 54.3 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.262 0.625 . . . . 0.0 109.506 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -135.33 118.02 16.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.202 1.001 . . . . 0.0 110.276 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 24.2 p -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.987 0.899 . . . . 0.0 111.075 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 72.4 m -86.08 16.11 4.53 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.369 -0.832 . . . . 0.0 112.147 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 20.7 m -70.26 165.82 21.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.121 0.968 . . . . 0.0 112.055 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -155.81 150.77 26.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -76.49 130.95 38.69 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.26 141.86 37.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.172 0.989 . . . . 0.0 111.385 166.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 11.0 t -134.01 -50.0 0.82 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.647 1.579 . . . . 0.0 112.033 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 34.2 t -78.48 -34.26 47.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.778 0.831 . . . . 0.0 111.618 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -47.58 28.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.474 1.509 . . . . 0.0 113.065 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.32 -162.74 1.25 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.884 1.673 . . . . 0.0 111.825 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -102.19 112.14 4.24 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.823 1.678 . . . . 0.0 116.138 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 68.7 m -140.03 175.76 9.31 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.071 2.148 . . . . 0.0 111.971 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 40.3 t -160.04 127.02 4.44 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.066 2.147 . . . . 0.0 109.398 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.7 t -136.04 146.1 46.75 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 119.755 -1.841 . . . . 0.0 112.536 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.25 139.43 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.003 1.321 . . . . 0.0 110.289 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 117.73 19.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.988 1.315 . . . . 0.0 111.948 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -124.63 96.15 4.79 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.69 1.596 . . . . 0.0 109.566 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.21 169.38 4.57 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.53 -0.731 . . . . 0.0 112.456 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -142.39 -177.2 5.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 111.981 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -44.43 81.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.263 1.825 . . . . 0.0 112.802 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.4 t -133.93 -34.92 0.98 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.623 1.569 . . . . 0.0 113.469 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 18.6 ptp -86.6 177.39 7.39 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.956 -1.09 . . . . 0.0 112.71 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -151.43 157.89 42.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.01 1.324 . . . . 0.0 111.22 165.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 25.8 p -137.0 141.65 42.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.079 0.952 . . . . 0.0 111.621 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.07 134.18 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.059 1.343 . . . . 0.0 110.108 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.62 130.74 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 126.007 1.723 . . . . 0.0 110.211 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 45.7 p -124.63 144.97 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.497 0.719 . . . . 0.0 111.181 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -128.41 137.55 51.91 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.865 2.066 . . . . 0.0 110.733 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -135.71 163.51 30.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.985 1.714 . . . . 0.0 108.834 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 153.65 86.54 0.06 OUTLIER Glycine 0 N--CA 1.464 0.504 0 O-C-N 121.382 -0.824 . . . . 0.0 111.183 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.65 156.67 36.32 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.968 0.907 . . . . 0.0 110.231 -178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.1 m -155.78 79.83 1.01 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.825 0.822 . . . . 0.0 111.248 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . 0.42 ' H ' HD13 ' B' ' 258' ' ' ILE . 2.0 mp -62.26 -24.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 0.0 111.913 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.67 6.55 57.99 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.725 1.631 . . . . 0.0 116.362 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 135.17 32.14 0.31 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 119.26 1.53 . . . . 0.0 115.656 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.41 -158.17 8.09 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.378 1.942 . . . . 0.0 115.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 6.1 t -58.01 160.75 4.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.083 0.953 . . . . 0.0 112.359 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.82 20.9 9.49 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.512 1.053 . . . . 0.0 113.901 -166.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -61.99 173.3 1.11 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.867 1.267 . . . . 0.0 112.037 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 20.9 m -67.91 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.098 2.159 . . . . 0.0 115.264 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.54 -170.48 42.25 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 127.223 2.344 . . . . 0.0 114.124 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.23 156.77 63.74 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.606 2.87 . . . . 0.0 113.334 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.85 96.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.672 1.589 . . . . 0.0 112.387 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -72.78 149.61 43.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.459 1.104 . . . . 0.0 111.676 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 29.7 mt -127.19 119.24 25.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.554 . . . . 0.0 109.839 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -160.12 159.16 30.49 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.901 1.239 . . . . 0.0 112.822 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 7.8 ttm -77.32 161.87 27.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.589 0.756 . . . . 0.0 111.927 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.98 84.65 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.017 1.327 . . . . 0.0 112.197 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -131.01 179.87 5.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.858 1.263 . . . . 0.0 111.524 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.28 134.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.044 1.338 . . . . 0.0 110.838 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 74.0 m -116.24 90.62 3.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.916 1.686 . . . . 0.0 110.091 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -91.16 148.72 22.17 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.615 0.722 . . . . 0.0 111.371 170.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.34 112.8 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 127.222 2.209 . . . . 0.0 109.932 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.12 130.6 18.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.976 1.31 . . . . 0.0 111.655 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -143.38 91.66 6.86 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.495 1.518 . . . . 0.0 109.91 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.0 167.67 21.02 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.097 2.532 . . . . 0.0 112.623 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.55 -14.47 33.63 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.375 2.717 . . . . 0.0 113.537 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.99 130.56 46.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.345 1.058 . . . . 0.0 110.989 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.6 171.38 16.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.106 2.162 . . . . 0.0 110.323 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.26 161.93 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.633 1.573 . . . . 0.0 111.756 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.605 1.962 . . . . 0.0 110.603 -177.835 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -64.5 -40.11 95.05 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -66.61 -38.99 88.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -78.5 2.14 20.03 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.359 1.463 . . . . 0.0 114.142 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -123.44 11.74 9.31 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.681 1.992 . . . . 0.0 112.637 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -23.73 124.52 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.55 2.74 . . . . 0.0 115.26 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -73.06 171.33 13.09 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.81 0.844 . . . . 0.0 111.966 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.24 51.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.84 1.656 . . . . 0.0 111.452 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.07 74.78 5.6 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.034 1.334 . . . . 0.0 112.434 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.79 -20.01 46.08 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.885 -1.134 . . . . 0.0 113.919 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.58 -28.08 65.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.67 . . . . 0.0 114.741 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 t -104.34 -17.51 14.79 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.352 1.061 . . . . 0.0 112.5 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.63 156.29 23.79 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.726 0.774 . . . . 0.0 111.316 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -110.3 168.18 9.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.355 1.462 . . . . 0.0 110.475 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.83 159.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.754 0.788 . . . . 0.0 111.146 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.03 -34.73 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.763 2.025 . . . . 0.0 111.702 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -59.69 -28.6 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.922 0.889 . . . . 0.0 113.099 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -82.27 -54.19 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.687 0.795 . . . . 0.0 110.706 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 97.4 t -49.97 -42.37 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.088 1.355 . . . . 0.0 112.422 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 t -59.58 -19.44 48.78 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.006 1.723 . . . . 0.0 113.747 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -97.48 -43.21 7.36 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.877 1.671 . . . . 0.0 112.111 172.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.0 mt -50.41 -41.97 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.02 -44.63 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.82 58.92 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.22 1.373 . . . . 0.0 111.518 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -34.56 76.2 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.35 -43.51 66.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.681 0.792 . . . . 0.0 112.972 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.61 -58.92 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 118.983 0.811 . . . . 0.0 109.773 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.53 -31.67 72.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.6 t -61.01 -48.15 83.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.998 0.919 . . . . 0.0 112.035 169.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.38 76.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.586 1.155 . . . . 0.0 114.002 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.39 -49.96 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 0.0 110.532 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.7 11.61 59.01 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.271 0.938 . . . . 0.0 115.289 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.66 -3.99 23.04 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.32 169.76 8.34 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 119.254 1.527 . . . . 0.0 111.8 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 -148.77 0.36 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.377 1.471 . . . . 0.0 111.676 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -60.5 131.33 50.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.178 1.791 . . . . 0.0 110.918 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.01 -177.31 3.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.293 1.437 . . . . 0.0 112.235 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -98.04 -96.6 0.22 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.913 1.285 . . . . 0.0 110.078 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -73.85 -22.62 59.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.965 1.306 . . . . 0.0 113.91 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.54 -44.03 84.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.207 -0.933 . . . . 0.0 112.393 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.57 -36.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.895 0.878 . . . . 0.0 113.009 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -61.12 -53.97 50.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.53 1.132 . . . . 0.0 111.176 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.68 -54.93 5.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 112.224 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -58.7 -22.72 58.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -85.53 -57.64 2.98 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.269 0.941 . . . . 0.0 112.25 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -59.75 -40.89 89.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.09 1.314 . . . . 0.0 113.752 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.62 -62.91 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 C-N-CA 124.075 0.95 . . . . 0.0 109.86 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -49.92 -28.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.682 1.193 . . . . 0.0 110.952 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -57.72 11.02 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.796 0.725 . . . . 0.0 111.858 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -86.28 -36.64 19.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.169 0.988 . . . . 0.0 113.217 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 m -60.91 -51.82 67.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.777 2.031 . . . . 0.0 112.172 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tp -61.48 -32.25 72.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.354 0.662 . . . . 0.0 112.287 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 t -61.98 -58.51 7.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.549 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.88 -49.55 49.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -62.64 -44.44 96.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 119.028 -0.511 . . . . 0.0 109.768 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -64.88 -25.16 67.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.307 0.958 . . . . 0.0 113.356 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.21 -2.88 14.52 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 171.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.27 -98.7 0.18 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 124.865 1.221 . . . . 0.0 114.64 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -67.83 168.88 11.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 125.431 1.492 . . . . 0.0 114.392 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.11 167.74 21.02 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.541 2.161 . . . . 0.0 112.668 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -55.49 97.55 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.357 2.263 . . . . 0.0 114.45 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 96.06 0.65 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.921 2.088 . . . . 0.0 111.212 174.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.37 150.32 28.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.183 1.393 . . . . 0.0 110.012 170.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.42 146.61 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 171.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.6 m -137.98 148.18 25.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.644 1.578 . . . . 0.0 110.392 165.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -135.74 155.96 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.671 1.188 . . . . 0.0 109.791 166.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.0 t -151.41 144.41 24.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.247 1.419 . . . . 0.0 110.834 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.85 140.54 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.067 1.347 . . . . 0.0 109.876 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.4 mm -126.34 110.87 24.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 127.334 2.253 . . . . 0.0 108.374 -175.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.14 168.71 18.35 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.023 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -110.99 124.81 52.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.312 1.445 . . . . 0.0 111.261 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -84.26 -0.71 53.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.981 1.712 . . . . 0.0 114.033 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.38 -19.7 64.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.102 1.761 . . . . 0.0 114.166 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.09 34.75 0.36 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.306 1.432 . . . . 0.0 114.617 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.11 173.14 3.96 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 118.905 1.353 . . . . 0.0 112.794 171.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.2 103.98 0.33 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.186 1.374 . . . . 0.0 113.195 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 164.09 31.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.821 1.248 . . . . 0.0 113.609 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -127.53 131.66 50.04 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.308 1.043 . . . . 0.0 110.395 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 47.9 m -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.957 1.303 . . . . 0.0 109.039 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.09 121.27 12.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.436 1.094 . . . . 0.0 110.787 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.2 p -129.69 131.04 46.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.347 0.594 . . . . 0.0 111.447 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -90.67 18.34 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.268 -0.895 . . . . 0.0 111.978 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.8 m -61.2 162.93 6.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.286 1.435 . . . . 0.0 112.408 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -158.23 134.36 9.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.228 1.011 . . . . 0.0 111.602 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.72 148.0 30.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 110.913 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -134.68 149.57 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.841 1.656 . . . . 0.0 110.644 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.8 t -97.3 -66.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.831 1.252 . . . . 0.0 112.304 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 t -91.24 -26.47 18.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.974 . . . . 0.0 112.535 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -30.76 52.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.905 1.682 . . . . 0.0 113.091 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 -167.02 1.05 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.961 2.104 . . . . 0.0 111.135 -172.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.87 146.15 15.28 Favored Glycine 0 CA--C 1.539 1.571 0 O-C-N 120.909 -1.119 . . . . 0.0 114.641 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 134.99 13.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.193 1.397 . . . . 0.0 111.784 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 24.0 t -127.99 97.26 4.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.661 1.184 . . . . 0.0 113.077 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -88.14 150.02 23.58 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.028 -1.045 . . . . 0.0 112.715 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.27 138.68 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.332 1.853 . . . . 0.0 109.407 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -125.23 119.48 28.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.709 1.604 . . . . 0.0 111.956 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -128.52 102.54 6.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 110.127 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -77.52 151.3 34.62 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.177 -0.952 . . . . 0.0 112.039 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.15 -178.42 3.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.32 1.448 . . . . 0.0 109.952 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -60.46 -45.02 95.23 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -129.92 -21.12 3.06 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.818 1.647 . . . . 0.0 113.919 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.9 mtt -100.84 173.12 6.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 170.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -147.84 147.43 29.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.083 1.353 . . . . 0.0 109.936 167.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 9.0 p -133.35 134.01 43.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.894 1.277 . . . . 0.0 110.641 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.97 110.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.041 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.36 138.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 110.8 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.5 p -134.16 114.74 13.43 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.282 -0.886 . . . . 0.0 112.576 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.08 136.12 40.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.84 1.256 . . . . 0.0 112.043 -176.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -134.34 112.86 11.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.426 1.491 . . . . 0.0 111.183 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -103.07 61.94 0.46 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.743 -1.223 . . . . 0.0 113.878 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -52.43 109.5 0.4 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 113.298 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 m -155.03 106.79 2.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.098 2.159 . . . . 0.0 111.934 -171.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -8.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.455 1.902 . . . . 0.0 115.852 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.45 -5.87 45.73 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.603 1.573 . . . . 0.0 116.158 -165.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.79 44.72 97.06 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 118.476 1.138 . . . . 0.0 112.912 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.21 61.99 1.79 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.876 1.703 . . . . 0.0 113.148 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -66.28 -178.14 0.62 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.402 2.281 . . . . 0.0 112.821 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.65 33.23 3.91 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.208 0.908 . . . . 0.0 114.069 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -59.69 165.81 2.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.235 1.017 . . . . 0.0 112.666 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.8 t -61.46 -24.49 66.59 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.103 1.361 . . . . 0.0 113.757 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.63 177.72 17.88 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.121 1.82 . . . . 0.0 113.18 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.31 174.1 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.672 2.914 . . . . 0.0 112.286 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.05 141.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.759 0.824 . . . . 0.0 111.568 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 163.22 22.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 112.219 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.72 112.7 25.8 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.216 1.406 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -124.59 115.08 2.39 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.179 1.847 . . . . 0.0 111.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.8 mtm -64.75 99.87 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.866 0.833 . . . . 0.0 111.022 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.58 109.83 4.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.435 1.494 . . . . 0.0 110.943 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -128.89 168.73 15.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.912 1.285 . . . . 0.0 111.375 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -62.5 135.78 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.317 1.447 . . . . 0.0 110.842 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.3 m -106.37 88.95 2.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.864 1.666 . . . . 0.0 110.147 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -89.96 149.83 22.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.154 172.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -145.27 104.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.988 2.115 . . . . 0.0 109.356 -177.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.8 119.96 18.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 110.826 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.45 95.44 43.04 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.429 1.491 . . . . 0.0 108.851 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.84 164.78 33.81 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.443 2.762 . . . . 0.0 111.74 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.68 -52.8 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.023 2.482 . . . . 0.0 112.754 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 -69.9 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.885 2.074 . . . . 0.0 109.836 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.48 173.73 3.9 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.267 1.827 . . . . 0.0 112.117 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.4 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 111.962 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.714 2.005 . . . . 0.0 110.544 179.406 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -60.45 -35.54 76.1 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.736 1.268 . . . . 0.0 113.749 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -70.0 -24.33 63.28 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.01 5.2 51.72 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.346 1.458 . . . . 0.0 113.199 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -124.47 10.72 8.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.589 1.956 . . . . 0.0 112.921 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -29.8 127.26 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.849 2.86 . . . . 0.0 113.245 164.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.64 172.31 12.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 111.673 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -124.98 144.63 50.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.756 1.622 . . . . 0.0 111.337 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.86 75.71 4.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.0 1.32 . . . . 0.0 112.348 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -58.7 -20.12 45.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.971 -1.081 . . . . 0.0 113.793 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.24 -27.24 65.28 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.838 1.655 . . . . 0.0 114.763 174.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 5.3 t -104.73 -17.96 14.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.256 1.023 . . . . 0.0 112.522 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.21 154.28 31.84 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.566 -0.709 . . . . 0.0 111.569 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -105.27 173.63 6.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.841 1.256 . . . . 0.0 111.195 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.32 161.44 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.585 1.154 . . . . 0.0 111.584 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.03 -40.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.513 1.125 . . . . 0.0 112.126 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.76 -25.15 67.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.592 1.157 . . . . 0.0 113.018 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -79.46 -58.29 3.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 110.986 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 85.9 t -52.38 -40.94 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.915 1.286 . . . . 0.0 112.607 178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 19.5 t -58.94 -18.62 35.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.572 1.549 . . . . 0.0 113.408 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.3 -43.86 6.44 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.135 1.374 . . . . 0.0 112.031 171.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 38.7 mt -50.58 -42.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.201 1.0 . . . . 0.0 111.262 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.26 -43.54 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.487 -0.758 . . . . 0.0 112.887 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -51.76 53.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.943 1.247 . . . . 0.0 111.399 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.23 75.57 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.28 -43.43 64.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.801 0.84 . . . . 0.0 113.037 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.38 -58.76 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 119.124 0.874 . . . . 0.0 109.702 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -62.45 -31.74 72.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 37.5 t -60.9 -48.18 83.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.988 0.915 . . . . 0.0 112.108 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.19 76.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.29 -49.9 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.512 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 92.73 11.55 59.03 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.235 0.922 . . . . 0.0 115.266 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.5 -4.0 23.29 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -67.12 169.61 8.24 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.299 1.549 . . . . 0.0 111.862 170.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.13 -148.49 0.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.362 1.465 . . . . 0.0 111.615 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.44 132.31 53.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.155 1.782 . . . . 0.0 110.999 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -177.34 4.1 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.288 1.435 . . . . 0.0 112.157 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -98.06 -96.71 0.22 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 0.0 110.143 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.2 m -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.014 1.326 . . . . 0.0 113.929 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.9 -44.0 86.49 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.09 -1.006 . . . . 0.0 112.377 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.77 -36.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.943 0.897 . . . . 0.0 112.988 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.75 -54.44 45.16 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.626 1.17 . . . . 0.0 111.075 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -64.33 -22.83 67.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 113.049 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.35 -54.9 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.188 0.903 . . . . 0.0 112.301 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.3 t -58.86 -21.04 56.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.2 t -87.02 -58.75 2.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.212 0.915 . . . . 0.0 112.332 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -58.88 -40.7 85.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.142 1.337 . . . . 0.0 113.793 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.52 -63.27 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 124.182 0.993 . . . . 0.0 109.817 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 77.1 t -48.6 -29.74 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.234 1.413 . . . . 0.0 111.167 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -55.45 33.5 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.628 0.771 . . . . 0.0 111.711 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -88.87 -35.08 16.75 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.369 1.068 . . . . 0.0 113.367 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.2 m -63.43 -52.62 60.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.0 2.12 . . . . 0.0 112.605 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -32.57 73.92 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.609 0.364 . . . . 0.0 111.023 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t -60.52 -57.81 11.14 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.387 -0.821 . . . . 0.0 111.469 165.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -50.37 -49.14 55.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.711 1.604 . . . . 0.0 113.433 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.0 pp -70.74 -27.87 64.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 1.5 m -60.89 -44.96 96.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 163.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -64.58 -25.76 68.11 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.227 0.921 . . . . 0.0 113.415 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.16 -4.6 18.14 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.99 -101.89 0.26 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 119.984 1.265 . . . . 0.0 114.658 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.28 167.81 11.45 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.82 1.648 . . . . 0.0 114.008 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.08 166.03 24.42 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.178 1.919 . . . . 0.0 112.236 168.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -50.97 115.87 1.73 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.964 1.705 . . . . 0.0 112.269 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 171.08 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 130.222 3.409 . . . . 0.0 111.193 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -145.6 171.06 15.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.572 1.949 . . . . 0.0 109.743 167.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.77 151.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.0 143.18 27.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.339 1.456 . . . . 0.0 109.092 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 155.04 51.34 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.876 0.87 . . . . 0.0 110.144 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.11 148.67 28.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.183 1.393 . . . . 0.0 111.288 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.75 141.06 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 110.445 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.2 mm -126.65 110.38 23.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 127.847 2.459 . . . . 0.0 108.171 -172.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 167.51 20.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.919 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -111.55 126.96 55.54 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.253 1.421 . . . . 0.0 111.214 -168.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -85.69 0.35 52.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.913 1.685 . . . . 0.0 113.956 -168.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.1 -19.92 64.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.073 1.749 . . . . 0.0 114.152 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 37.41 0.39 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.329 1.442 . . . . 0.0 114.375 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.12 172.68 6.46 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 118.758 1.279 . . . . 0.0 112.285 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -142.27 78.88 0.27 Allowed Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.553 1.073 . . . . 0.0 114.396 -173.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.36 156.03 28.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 111.393 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.32 134.3 52.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 110.892 173.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 99.6 m -138.54 143.85 39.65 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 109.063 175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.28 13.75 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.594 1.157 . . . . 0.0 110.84 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.4 p -128.46 136.59 51.04 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.813 -0.555 . . . . 0.0 111.761 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.5 m -94.22 18.79 10.29 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.662 -0.648 . . . . 0.0 111.776 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.3 m -61.68 162.59 8.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.065 1.346 . . . . 0.0 112.347 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -158.63 134.93 9.25 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.514 1.126 . . . . 0.0 111.466 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 147.16 27.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.167 0.987 . . . . 0.0 110.791 171.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -131.87 144.58 50.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.127 1.771 . . . . 0.0 110.14 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.0 t -89.45 -68.19 0.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 112.238 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 6.9 t -92.74 -25.49 18.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.265 1.026 . . . . 0.0 112.533 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -29.34 55.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.933 1.693 . . . . 0.0 112.911 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -164.38 0.9 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.04 1.736 . . . . 0.0 111.644 -171.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -151.19 144.51 11.82 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.935 -1.103 . . . . 0.0 114.455 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.45 151.28 33.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.734 1.614 . . . . 0.0 110.633 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 12.4 t -142.43 104.54 4.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.507 1.123 . . . . 0.0 112.565 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.3 t -97.36 147.58 24.03 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.43 1.092 . . . . 0.0 112.418 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.13 136.28 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.862 1.665 . . . . 0.0 109.626 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -125.1 119.06 27.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.491 1.516 . . . . 0.0 111.829 -173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -128.07 102.51 6.76 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.329 1.452 . . . . 0.0 109.956 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.59 151.0 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.15 -0.969 . . . . 0.0 111.881 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.82 -178.24 3.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.301 1.44 . . . . 0.0 109.937 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.62 -44.77 95.96 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -129.89 -21.61 3.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.744 1.617 . . . . 0.0 113.894 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.8 mtt -100.64 173.33 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.995 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -147.6 148.07 30.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.037 1.335 . . . . 0.0 110.002 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 9.8 p -132.73 135.41 45.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.821 1.248 . . . . 0.0 111.014 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.85 111.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.97 1.308 . . . . 0.0 111.172 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.7 143.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.046 1.339 . . . . 0.0 111.161 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 66.8 p -139.02 110.66 7.09 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.16 139.94 30.15 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.519 1.128 . . . . 0.0 113.05 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -137.29 102.65 4.87 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.769 1.627 . . . . 0.0 110.204 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -95.12 61.13 1.59 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 113.507 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.02 109.47 0.26 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 0.0 113.528 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.8 m -152.94 105.97 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.509 1.924 . . . . 0.0 112.419 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.93 -5.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.384 1.874 . . . . 0.0 115.955 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -67.69 -6.73 44.62 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.066 1.317 . . . . 0.0 115.865 -169.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.28 42.04 99.38 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.514 1.157 . . . . 0.0 112.929 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -73.72 63.7 1.9 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.01 1.767 . . . . 0.0 113.258 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -66.37 -177.89 0.6 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.333 2.253 . . . . 0.0 112.88 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 106.51 32.52 3.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.395 0.998 . . . . 0.0 114.188 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.01 165.17 3.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.321 1.061 . . . . 0.0 112.815 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 20.7 t -61.34 -24.91 66.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.303 1.441 . . . . 0.0 113.703 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -129.1 177.69 17.76 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 126.143 1.83 . . . . 0.0 113.049 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.33 174.1 10.5 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.646 2.897 . . . . 0.0 112.213 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.79 141.32 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.753 0.821 . . . . 0.0 111.579 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.86 22.74 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.177 1.391 . . . . 0.0 112.292 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 43.7 mt -106.54 112.51 25.54 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.197 1.399 . . . . 0.0 110.128 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -124.28 115.09 2.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.143 1.83 . . . . 0.0 111.161 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 18.3 mtm -65.09 99.1 0.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.884 0.842 . . . . 0.0 111.026 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -69.63 109.53 4.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.569 1.548 . . . . 0.0 110.922 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -128.85 169.9 14.03 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.965 1.306 . . . . 0.0 111.313 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.73 138.45 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.173 1.389 . . . . 0.0 110.944 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 66.7 m -109.59 86.0 2.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.874 1.669 . . . . 0.0 109.853 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.96 150.94 23.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.603 0.761 . . . . 0.0 111.133 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 2.3 p -149.94 105.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.364 1.866 . . . . 0.0 109.934 -177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.47 121.73 21.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.383 . . . . 0.0 110.687 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.7 95.21 39.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.236 1.415 . . . . 0.0 108.727 174.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.88 164.85 34.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.552 2.835 . . . . 0.0 111.776 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.7 -52.05 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.862 2.374 . . . . 0.0 112.576 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.12 -69.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.37 173.57 3.91 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.344 1.858 . . . . 0.0 112.17 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.85 157.34 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.541 1.536 . . . . 0.0 111.979 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.808 2.043 . . . . 0.0 110.596 179.439 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.97 97.56 5.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.015 1.326 . . . . 0.0 111.417 -174.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -60.86 -27.63 68.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.11 -17.17 60.97 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -77.03 -31.19 56.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.649 0.78 . . . . 0.0 112.571 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -72.66 147.75 45.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.782 0.833 . . . . 0.0 111.518 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 158.14 45.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.847 1.259 . . . . 0.0 111.538 -177.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.65 64.96 3.79 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.183 1.393 . . . . 0.0 113.081 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.53 -0.56 6.84 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.456 1.503 . . . . 0.0 114.622 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -59.67 -18.66 43.88 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.34 -29.94 47.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -90.58 -29.88 17.56 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.622 0.769 . . . . 0.0 111.431 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.65 131.12 45.56 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.207 -0.933 . . . . 0.0 111.423 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.27 171.82 2.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.782 1.633 . . . . 0.0 113.434 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.09 147.06 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.446 1.098 . . . . 0.0 112.173 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.24 -40.48 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.087 1.355 . . . . 0.0 112.075 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.1 -33.4 69.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.623 1.569 . . . . 0.0 112.631 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -77.2 -52.23 9.6 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.905 1.282 . . . . 0.0 111.177 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 16.1 t -48.51 -42.34 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.485 1.114 . . . . 0.0 112.222 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -56.98 -24.75 55.65 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.194 1.398 . . . . 0.0 113.603 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.97 -35.58 11.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.329 1.452 . . . . 0.0 113.292 172.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.89 -43.1 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 119.615 1.098 . . . . 0.0 110.445 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.29 -43.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -52.58 45.95 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.864 1.211 . . . . 0.0 111.45 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -30.71 70.57 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.45 -43.84 31.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.6 mt -55.78 -56.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.564 1.075 . . . . 0.0 109.88 175.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -59.61 -28.25 67.02 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -67.37 -35.47 79.42 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.12 -29.89 43.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.972 1.309 . . . . 0.0 113.147 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.69 -37.03 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.58 1.152 . . . . 0.0 111.458 172.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.81 11.45 84.61 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.103 0.858 . . . . 0.0 114.832 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.06 -0.97 35.46 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.575 1.56 . . . . 0.0 116.382 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.85 168.82 4.68 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.128 1.464 . . . . 0.0 112.931 167.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.61 -154.55 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.771 1.628 . . . . 0.0 111.901 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.1 160.03 0.39 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.337 1.455 . . . . 0.0 112.992 163.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -151.1 175.07 12.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.342 1.057 . . . . 0.0 113.295 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -97.37 -101.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.541 1.537 . . . . 0.0 110.02 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -67.99 -22.09 65.02 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -58.82 -43.75 90.72 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.97 -1.081 . . . . 0.0 112.99 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.63 -38.57 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.209 1.003 . . . . 0.0 112.782 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -63.13 -54.72 33.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.932 1.293 . . . . 0.0 111.696 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.75 -26.23 68.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.254 -0.904 . . . . 0.0 112.634 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -75.48 -53.89 7.92 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.112 0.965 . . . . 0.0 111.182 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -59.2 -22.23 60.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -86.55 -56.74 3.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.681 1.128 . . . . 0.0 112.457 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -58.22 -37.11 74.21 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.786 1.234 . . . . 0.0 113.676 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 94.3 t -69.49 -64.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 123.897 0.879 . . . . 0.0 109.559 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.01 -31.68 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.866 1.266 . . . . 0.0 111.103 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -43.56 90.6 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.635 0.652 . . . . 0.0 112.602 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -96.81 -44.26 7.15 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.985 1.314 . . . . 0.0 112.391 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.2 m -55.82 -51.88 65.95 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.522 2.329 . . . . 0.0 112.871 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.23 -38.98 88.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.166 0.439 . . . . 0.0 110.94 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 p -64.43 -30.67 71.7 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.22 -0.925 . . . . 0.0 113.334 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.03 -48.61 20.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.194 2.198 . . . . 0.0 113.075 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 pp -64.63 -27.8 69.18 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.728 -1.232 . . . . 0.0 114.135 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.7 m -58.16 -34.73 70.63 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.444 1.098 . . . . 0.0 110.925 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -78.94 -36.31 41.9 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.773 -0.579 . . . . 0.0 112.262 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.75 -24.56 66.23 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -105.39 2.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 113.257 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -138.28 152.58 71.79 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.577 1.551 . . . . 0.0 112.12 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.88 111.31 3.0 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.611 2.874 . . . . 0.0 111.375 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.12 179.86 7.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.331 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -93.57 95.37 9.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.472 1.509 . . . . 0.0 111.678 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -83.71 151.6 25.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.887 1.675 . . . . 0.0 109.933 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.3 tp -125.67 149.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.709 1.604 . . . . 0.0 108.667 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.9 146.29 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.529 0.732 . . . . 0.0 111.285 164.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.86 117.71 13.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.397 2.279 . . . . 0.0 109.732 174.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.3 p -123.79 136.6 54.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.404 0.682 . . . . 0.0 112.448 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.56 109.3 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.347 1.459 . . . . 0.0 109.29 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 mm -103.15 111.13 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.68 105.4 3.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.895 1.278 . . . . 0.0 109.905 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.09 10.64 1.74 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -69.83 -77.66 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.922 1.289 . . . . 0.0 112.998 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.63 -20.8 5.86 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.85 7.24 5.19 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.641 -1.089 . . . . 0.0 115.708 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.9 93.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.509 1.924 . . . . 0.0 114.812 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.39 78.1 1.0 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.694 1.616 . . . . 0.0 113.429 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 pp -54.48 150.92 8.41 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.629 1.572 . . . . 0.0 112.475 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -123.06 83.31 2.11 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.487 1.515 . . . . 0.0 109.363 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.5 m -97.17 139.09 33.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.673 -0.642 . . . . 0.0 109.465 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.54 128.03 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 110.422 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -127.76 117.41 21.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.921 0.889 . . . . 0.0 109.622 -170.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -79.9 41.56 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.425 1.107 . . . . 0.0 111.177 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.76 179.6 7.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.98 1.312 . . . . 0.0 110.577 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -145.55 154.05 41.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.724 1.609 . . . . 0.0 109.621 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -97.45 132.48 43.11 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.006 0.922 . . . . 0.0 109.89 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -144.05 141.53 30.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.228 1.411 . . . . 0.0 110.435 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -114.17 -56.52 2.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.426 1.491 . . . . 0.0 111.718 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.96 -40.25 10.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.172 0.989 . . . . 0.0 112.097 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -32.39 73.18 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.644 2.378 . . . . 0.0 114.223 -169.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.22 -177.5 6.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.591 1.957 . . . . 0.0 110.85 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.09 116.93 3.86 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.969 1.747 . . . . 0.0 114.027 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 t -140.93 172.55 12.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.398 1.879 . . . . 0.0 110.505 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -168.14 140.34 2.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.543 1.537 . . . . 0.0 110.639 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -148.98 144.64 26.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.959 -1.713 . . . . 0.0 111.602 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -139.02 120.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.472 1.109 . . . . 0.0 109.489 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 93.83 4.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.297 1.039 . . . . 0.0 113.024 -171.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -99.43 105.73 17.7 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.96 1.304 . . . . 0.0 110.362 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -109.49 165.77 11.39 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.558 1.543 . . . . 0.0 110.71 169.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -139.13 179.78 6.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.67 1.188 . . . . 0.0 110.031 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -45.1 -40.28 6.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.921 1.688 . . . . 0.0 115.011 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.7 t -133.7 22.9 3.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.302 1.841 . . . . 0.0 113.083 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 mtt -135.79 158.76 43.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -148.99 116.56 6.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.114 1.765 . . . . 0.0 110.704 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.09 68.16 1.3 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.162 1.785 . . . . 0.0 111.481 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pp -97.18 153.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.635 -1.291 . . . . 0.0 113.175 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -132.84 116.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.805 2.042 . . . . 0.0 111.889 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.5 t -97.91 136.17 38.59 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.558 1.143 . . . . 0.0 110.084 171.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.3 166.59 22.78 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.901 1.68 . . . . 0.0 112.262 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -150.21 161.07 43.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.009 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.32 83.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.3 pp -137.92 158.24 44.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.938 1.695 . . . . 0.0 112.682 -169.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 t -137.85 129.86 28.76 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.05 1.34 . . . . 0.0 112.505 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.6 -5.31 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.394 1.477 . . . . 0.0 114.019 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -98.15 18.37 57.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.634 1.588 . . . . 0.0 114.624 -172.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.44 19.73 5.32 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.433 1.492 . . . . 0.0 114.299 -172.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.69 102.95 0.08 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.51 2.005 . . . . 0.0 114.219 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -120.91 -165.51 1.22 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.903 2.081 . . . . 0.0 111.186 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.68 5.54 15.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.521 1.058 . . . . 0.0 115.153 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -53.04 157.05 1.88 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.973 1.387 . . . . 0.0 113.172 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -63.81 -17.45 63.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.93 -71.13 0.37 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.575 1.56 . . . . 0.0 112.26 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.51 170.48 18.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.46 2.773 . . . . 0.0 112.78 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.91 91.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.54 1.936 . . . . 0.0 111.625 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 167.4 21.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.035 0.934 . . . . 0.0 112.476 173.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.38 125.83 26.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.774 1.63 . . . . 0.0 111.206 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.24 83.69 0.51 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.67 1.605 . . . . 0.0 113.193 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.67 90.19 0.4 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.682 1.593 . . . . 0.0 112.992 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.46 99.39 12.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.509 1.524 . . . . 0.0 111.628 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -129.31 166.94 18.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.357 1.463 . . . . 0.0 111.447 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.4 149.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.768 1.627 . . . . 0.0 111.324 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.2 m -121.61 91.29 3.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 110.861 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -77.5 148.06 35.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.886 166.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 p -133.67 97.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 127.864 2.466 . . . . 0.0 109.089 173.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.93 151.92 48.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.283 1.033 . . . . 0.0 111.631 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.39 155.84 80.4 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.794 1.238 . . . . 0.0 111.457 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.79 166.77 28.89 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 124.136 3.224 . . . . 0.0 112.786 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.38 -15.95 24.83 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.867 3.045 . . . . 0.0 115.066 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -160.63 -67.92 0.07 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.802 1.641 . . . . 0.0 111.559 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -75.51 115.79 15.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.296 -171.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -93.94 169.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.253 1.821 . . . . 0.0 112.113 176.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 128.604 2.762 . . . . 0.0 113.277 177.87 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.37 96.59 4.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.458 -174.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -60.65 -27.41 67.78 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.33 -17.35 60.85 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.06 -31.61 56.27 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.609 0.763 . . . . 0.0 112.58 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -72.34 146.82 46.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.396 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.37 158.93 43.27 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.951 1.3 . . . . 0.0 111.394 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.13 64.06 3.21 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.178 1.391 . . . . 0.0 113.061 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.31 0.54 4.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.731 1.612 . . . . 0.0 114.669 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -59.64 -19.41 49.06 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.599 -1.313 . . . . 0.0 114.23 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.99 -26.79 43.3 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 12.3 t -91.32 -33.51 15.28 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.601 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.81 144.02 56.55 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.369 -0.832 . . . . 0.0 111.352 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.26 170.49 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.515 -0.741 . . . . 0.0 112.811 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.18 141.94 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.957 1.303 . . . . 0.0 112.006 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 16.1 t -59.27 -34.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.561 1.144 . . . . 0.0 111.604 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -60.63 -15.38 27.82 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.167 1.387 . . . . 0.0 113.671 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -109.3 -47.56 3.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 110.13 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 4.3 m -51.31 -32.4 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t -60.75 -20.99 62.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.433 1.493 . . . . 0.0 114.267 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -103.45 -31.8 9.81 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.166 1.786 . . . . 0.0 112.971 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 41.0 mt -49.81 -41.15 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.413 1.006 . . . . 0.0 110.689 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.85 -43.43 97.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -51.99 48.27 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.724 1.147 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -31.46 71.03 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.53 -42.6 42.52 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 56.8 mt -55.77 -55.99 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.533 1.06 . . . . 0.0 109.886 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -59.15 -29.18 67.23 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 6.5 p -66.63 -34.37 77.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.1 -29.79 34.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.347 . . . . 0.0 113.199 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.25 -37.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 111.276 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.51 84.13 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.121 0.867 . . . . 0.0 114.817 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.13 35.45 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.471 1.51 . . . . 0.0 116.319 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -63.68 168.49 4.81 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.152 1.476 . . . . 0.0 112.958 167.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -85.16 -155.04 0.2 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.7 1.6 . . . . 0.0 111.718 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.14 159.39 0.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 0.0 113.06 164.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -151.15 172.06 16.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.351 1.46 . . . . 0.0 112.24 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -93.44 -100.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.4 1.08 . . . . 0.0 109.44 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 70.6 m -65.57 -22.22 66.67 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -59.64 -42.37 92.61 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.757 -1.214 . . . . 0.0 112.764 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.19 -38.08 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.292 1.037 . . . . 0.0 112.762 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -62.27 -55.68 25.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.452 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -63.62 -26.45 68.69 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.484 -0.76 . . . . 0.0 112.654 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -75.3 -54.21 7.46 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.172 0.989 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.5 t -58.02 -25.07 60.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 13.8 t -84.43 -56.81 3.43 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.668 1.122 . . . . 0.0 112.201 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -57.7 -37.01 72.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.893 1.224 . . . . 0.0 113.684 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.24 -65.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.165 0.986 . . . . 0.0 109.622 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.08 -31.99 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.668 1.187 . . . . 0.0 111.154 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -43.1 90.4 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.478 0.581 . . . . 0.0 112.566 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -96.5 -44.37 7.2 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.02 1.328 . . . . 0.0 112.511 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -59.43 -48.68 80.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.113 2.565 . . . . 0.0 113.495 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -40.62 97.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.959 0.345 . . . . 0.0 110.396 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 1.4 p -62.05 -30.87 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 112.996 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -76.2 -48.31 20.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.017 2.127 . . . . 0.0 112.918 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.37 -30.42 71.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.937 1.244 . . . . 0.0 113.463 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 31.0 m -58.34 -30.59 66.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.218 1.007 . . . . 0.0 111.05 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -81.47 -36.04 29.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.7 mt -78.36 -19.49 53.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -95.52 -101.7 1.87 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.709 1.623 . . . . 0.0 112.445 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -141.38 151.34 60.89 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 113.012 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.76 110.52 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.832 3.022 . . . . 0.0 111.446 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.88 178.85 8.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 0.0 112.152 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -88.05 93.47 9.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.308 1.443 . . . . 0.0 111.538 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.73 139.41 30.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.235 1.414 . . . . 0.0 109.952 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 3.0 tt -119.76 153.58 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.11 1.764 . . . . 0.0 109.644 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 22.1 m -142.02 146.63 22.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.36 1.064 . . . . 0.0 110.718 170.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.16 119.92 17.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.064 2.146 . . . . 0.0 109.1 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.3 p -123.03 144.35 49.34 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.543 -0.723 . . . . 0.0 112.215 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 64.9 t -124.31 101.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.038 1.735 . . . . 0.0 108.254 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.32 113.63 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.918 0.887 . . . . 0.0 108.837 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.8 ptp -134.98 146.51 49.15 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.848 0.859 . . . . 0.0 110.529 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -90.14 143.86 26.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.348 -0.845 . . . . 0.0 110.9 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -70.0 4.06 2.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.363 1.465 . . . . 0.0 114.347 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -50.45 -35.23 27.86 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.498 1.519 . . . . 0.0 112.416 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.69 20.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.902 1.239 . . . . 0.0 115.334 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.27 61.09 1.15 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.2 1.4 . . . . 0.0 113.849 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -74.91 63.72 2.37 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.647 1.594 . . . . 0.0 112.959 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.04 159.26 11.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.097 1.759 . . . . 0.0 111.826 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -125.97 89.32 3.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 110.178 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 53.3 m -97.09 139.04 33.68 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.438 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.71 127.16 44.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.093 1.357 . . . . 0.0 110.122 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m -126.16 116.86 22.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.147 0.979 . . . . 0.0 109.605 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.9 t -80.04 44.61 0.67 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.504 1.145 . . . . 0.0 111.152 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 3.8 m -86.73 179.39 6.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.112 1.365 . . . . 0.0 110.507 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -147.03 148.13 31.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.45 1.5 . . . . 0.0 109.864 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -91.12 132.49 36.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -142.41 139.14 31.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 110.469 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 45.7 t -112.18 -58.64 2.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.465 1.506 . . . . 0.0 111.817 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.8 -38.68 12.22 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.172 0.989 . . . . 0.0 112.155 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -32.38 72.69 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.443 2.297 . . . . 0.0 114.088 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.77 -175.87 5.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.609 1.964 . . . . 0.0 110.803 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -113.62 123.59 6.19 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.563 1.554 . . . . 0.0 114.165 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 22.7 t -146.35 170.92 15.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.208 2.203 . . . . 0.0 110.575 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.2 p -168.78 126.07 1.01 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 0.0 111.896 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.7 t -141.47 141.84 33.64 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 119.597 -1.939 . . . . 0.0 112.575 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.61 123.46 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.652 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 99.02 6.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.308 1.043 . . . . 0.0 113.163 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.07 88.84 2.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.255 1.422 . . . . 0.0 110.884 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -83.48 163.69 20.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.829 0.852 . . . . 0.0 111.37 164.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -141.63 179.93 6.54 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -49.45 -41.23 39.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.451 1.5 . . . . 0.0 113.937 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 21.59 2.85 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 29.2 mtt -139.32 160.33 40.07 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.479 -1.388 . . . . 0.0 113.653 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -135.99 109.87 8.17 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.688 1.995 . . . . 0.0 110.956 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 70.9 m -130.6 78.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.355 1.462 . . . . 0.0 110.697 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.48 145.81 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.266 1.026 . . . . 0.0 112.339 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.55 129.58 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.199 1.8 . . . . 0.0 112.126 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.2 t -114.29 130.24 56.65 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.641 1.577 . . . . 0.0 109.606 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -128.42 151.98 48.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.037 1.735 . . . . 0.0 111.764 -178.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -141.02 143.67 34.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.451 1.1 . . . . 0.0 110.94 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -168.47 82.15 0.1 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.257 0.932 . . . . 0.0 111.523 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.2 160.07 38.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.405 1.882 . . . . 0.0 112.121 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 18.3 t -139.46 132.35 29.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.852 1.261 . . . . 0.0 112.515 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.06 -9.65 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.679 1.592 . . . . 0.0 113.527 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.43 22.86 38.66 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.996 1.76 . . . . 0.0 114.545 -169.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.03 6.94 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.305 1.431 . . . . 0.0 114.162 -172.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -49.39 100.79 0.04 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.678 2.085 . . . . 0.0 114.343 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 81.0 p -120.4 -165.75 1.23 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.944 2.098 . . . . 0.0 111.098 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 116.21 6.77 15.43 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.391 0.996 . . . . 0.0 115.21 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -54.54 158.8 2.35 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.941 1.371 . . . . 0.0 113.275 174.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.6 m -64.44 -18.08 64.41 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 144.25 -71.07 0.38 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.551 1.548 . . . . 0.0 112.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.56 170.41 18.62 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.486 2.791 . . . . 0.0 112.801 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.98 91.01 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.568 1.947 . . . . 0.0 111.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 167.25 22.24 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.118 0.967 . . . . 0.0 112.498 173.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 125.66 25.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.785 1.634 . . . . 0.0 111.233 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -101.18 83.54 0.51 Allowed Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 113.185 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.85 90.33 0.42 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.719 1.607 . . . . 0.0 113.046 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -88.93 99.34 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.581 1.553 . . . . 0.0 111.75 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -129.62 166.68 19.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.347 1.459 . . . . 0.0 111.432 171.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.44 149.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 111.394 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 28.2 m -121.47 91.16 3.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.162 1.385 . . . . 0.0 110.876 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -78.36 149.33 33.42 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.904 -1.123 . . . . 0.0 110.862 166.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.7 97.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.742 2.417 . . . . 0.0 109.245 175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -133.7 157.67 45.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.307 1.443 . . . . 0.0 110.87 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -134.42 155.87 79.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.308 1.043 . . . . 0.0 111.361 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -74.02 167.76 26.44 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.694 2.929 . . . . 0.0 112.734 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.55 -17.27 26.71 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.327 2.685 . . . . 0.0 114.741 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -161.36 -65.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.575 1.55 . . . . 0.0 112.051 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.13 120.34 22.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.559 1.544 . . . . 0.0 112.294 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.73 169.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.566 1.946 . . . . 0.0 112.085 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 128.334 2.654 . . . . 0.0 113.111 -179.674 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -140.21 -72.72 0.36 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.994 1.317 . . . . 0.0 111.199 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -75.55 -27.14 58.51 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.475 -0.766 . . . . 0.0 112.835 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -13.1 61.97 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.73 -19.04 65.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.574 1.15 . . . . 0.0 113.244 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -118.75 172.36 7.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.825 1.65 . . . . 0.0 111.736 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.01 -174.6 4.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 110.864 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.33 109.94 0.35 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.745 1.618 . . . . 0.0 112.885 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.8 15.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.803 1.241 . . . . 0.0 112.645 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -20.7 60.93 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.44 -26.84 66.6 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.7 t -114.62 -18.22 11.48 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.795 1.638 . . . . 0.0 112.629 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.47 172.53 9.36 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.144 -0.973 . . . . 0.0 111.228 166.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -139.18 165.86 26.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.163 1.385 . . . . 0.0 110.117 173.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.62 152.31 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.278 1.031 . . . . 0.0 110.929 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -57.25 -41.17 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.727 1.211 . . . . 0.0 111.323 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.16 66.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -62.54 1.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.766 0.827 . . . . 0.0 110.263 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.6 t -45.44 -47.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.436 1.894 . . . . 0.0 112.565 178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 t -65.87 -13.63 59.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.163 1.785 . . . . 0.0 113.745 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -31.86 11.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.945 1.698 . . . . 0.0 112.255 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.37 -42.33 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.509 0.724 . . . . 0.0 110.272 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.42 -42.12 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -52.24 54.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.175 1.352 . . . . 0.0 111.174 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -30.99 72.03 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.75 -38.7 58.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.432 1.093 . . . . 0.0 113.203 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.4 mt -56.89 -56.99 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.166 0.894 . . . . 0.0 109.691 172.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -59.64 -27.89 66.75 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -47.74 78.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.092 0.957 . . . . 0.0 112.024 169.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.5 -27.16 63.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.775 1.23 . . . . 0.0 114.047 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.58 -35.41 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.564 1.146 . . . . 0.0 111.153 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.48 15.91 70.06 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.1 0.857 . . . . 0.0 114.299 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.9 2.44 78.29 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.087 1.327 . . . . 0.0 115.631 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -65.73 174.34 2.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.841 1.321 . . . . 0.0 112.243 168.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -155.01 0.21 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.119 1.368 . . . . 0.0 111.78 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -51.18 159.45 0.64 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.176 0.991 . . . . 0.0 112.28 158.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -151.6 177.39 10.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.38 1.472 . . . . 0.0 110.631 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -92.14 -114.22 0.09 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.32 1.048 . . . . 0.0 110.931 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -57.47 -22.41 43.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.383 1.873 . . . . 0.0 114.655 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -51.35 -38.97 55.97 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.376 1.471 . . . . 0.0 112.901 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.51 -32.42 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 112.915 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -68.24 -45.15 74.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.227 0.922 . . . . 0.0 112.168 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -22.86 65.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.75 0.704 . . . . 0.0 112.724 174.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.5 -55.1 5.29 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.716 0.806 . . . . 0.0 111.501 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -56.19 -28.99 60.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.916 0.78 . . . . 0.0 113.045 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -79.98 -57.57 3.58 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.338 0.972 . . . . 0.0 112.179 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -57.42 -38.21 73.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.94 1.245 . . . . 0.0 113.484 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.75 -65.55 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 123.874 0.869 . . . . 0.0 109.491 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.8 t -47.9 -32.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.355 1.062 . . . . 0.0 110.939 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -58.42 -40.54 82.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.8 -40.99 5.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.479 1.512 . . . . 0.0 112.681 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 m -57.68 -53.37 58.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.702 2.401 . . . . 0.0 112.404 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -40.52 92.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.798 0.727 . . . . 0.0 110.693 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -60.9 -40.92 94.91 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.663 -0.648 . . . . 0.0 112.72 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -66.07 -51.29 59.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.924 2.089 . . . . 0.0 113.382 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.02 -26.24 67.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -58.93 -32.72 69.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.13 0.972 . . . . 0.0 111.466 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -85.58 -23.99 27.38 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -67.79 -26.28 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.12 0.968 . . . . 0.0 112.3 170.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.74 -119.4 4.14 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.965 1.745 . . . . 0.0 112.535 171.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -129.73 156.29 79.08 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.445 1.498 . . . . 0.0 113.156 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.77 113.39 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.93 3.087 . . . . 0.0 112.212 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.11 166.12 31.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.517 1.127 . . . . 0.0 112.196 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -73.3 98.78 2.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.657 0.783 . . . . 0.0 110.956 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -73.34 158.02 35.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.828 0.851 . . . . 0.0 111.179 161.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 tt -132.44 151.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.337 1.455 . . . . 0.0 108.955 164.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.0 m -142.0 149.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.859 1.263 . . . . 0.0 110.309 169.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 p -135.8 139.37 43.45 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.654 1.582 . . . . 0.0 109.903 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -136.1 150.32 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.648 -0.657 . . . . 0.0 112.056 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.87 104.64 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.888 1.675 . . . . 0.0 108.661 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.6 mm -101.2 120.63 51.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.811 1.644 . . . . 0.0 108.926 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.81 166.17 26.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.883 0.849 . . . . 0.0 112.211 174.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -85.96 157.07 20.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.734 1.614 . . . . 0.0 111.245 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.33 11.07 1.04 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.604 1.962 . . . . 0.0 114.954 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -5.48 5.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 114.942 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.81 -3.38 45.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.965 1.745 . . . . 0.0 114.711 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.47 87.53 0.88 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.233 1.413 . . . . 0.0 111.652 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.31 89.3 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.002 1.763 . . . . 0.0 111.031 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.58 160.16 20.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.738 1.215 . . . . 0.0 111.658 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -87.94 96.85 10.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.444 -0.785 . . . . 0.0 109.99 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -117.14 132.16 56.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.783 0.833 . . . . 0.0 109.862 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.57 32.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.323 0.649 . . . . 0.0 111.74 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.9 m -134.09 121.35 21.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.723 1.209 . . . . 0.0 110.569 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -74.35 17.62 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.071 -1.018 . . . . 0.0 113.02 175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.4 m -62.8 167.94 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.833 -1.167 . . . . 0.0 112.22 167.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.18 154.79 21.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.667 1.587 . . . . 0.0 110.636 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -84.22 150.54 25.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.585 1.154 . . . . 0.0 110.241 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -146.93 164.62 32.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.589 1.956 . . . . 0.0 110.303 171.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -128.87 -56.28 1.2 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.498 1.119 . . . . 0.0 113.216 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -78.32 -46.98 18.75 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.389 1.076 . . . . 0.0 112.197 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -48.34 61.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.571 1.949 . . . . 0.0 112.525 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -149.29 -159.71 1.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.411 3.084 . . . . 0.0 108.79 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.56 -173.7 18.02 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.975 1.274 . . . . 0.0 112.923 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.6 p -155.27 173.45 16.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.359 2.263 . . . . 0.0 109.635 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 36.1 t -147.0 122.01 10.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.171 -0.956 . . . . 0.0 109.658 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 t -133.18 149.27 52.05 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.663 -1.273 . . . . 0.0 112.204 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.7 116.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.655 1.582 . . . . 0.0 108.266 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -113.77 95.21 5.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.905 1.282 . . . . 0.0 110.285 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -104.57 118.42 36.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.527 1.131 . . . . 0.0 110.208 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -104.42 162.93 12.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.818 1.647 . . . . 0.0 111.302 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -151.29 -177.41 6.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.209 1.004 . . . . 0.0 111.506 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.73 -67.57 0.2 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.827 2.451 . . . . 0.0 113.847 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.5 t -133.97 24.72 3.93 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.184 1.394 . . . . 0.0 113.306 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.54 162.83 34.12 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.163 -1.586 . . . . 0.0 111.218 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -140.02 137.22 34.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.73 1.212 . . . . 0.0 110.34 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 11.2 p -139.97 85.88 2.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.874 1.321 . . . . 0.0 111.845 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.09 133.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.024 1.329 . . . . 0.0 111.104 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.81 126.44 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.605 1.562 . . . . 0.0 110.867 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 t -117.13 127.9 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.481 1.912 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -121.73 149.12 43.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.061 1.744 . . . . 0.0 112.582 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -142.2 94.0 2.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.358 1.463 . . . . 0.0 108.663 174.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -150.01 95.06 0.16 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 120.571 -1.331 . . . . 0.0 110.743 172.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.68 75.27 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.468 1.907 . . . . 0.0 112.142 -174.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -145.33 91.26 2.11 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.466 -0.771 . . . . 0.0 112.075 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.36 -13.25 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.78 -8.91 1.37 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.555 1.074 . . . . 0.0 115.079 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.95 1.53 40.66 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.204 1.383 . . . . 0.0 115.405 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -163.43 175.73 39.65 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.329 1.918 . . . . 0.0 113.345 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 m -74.54 174.02 9.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.342 1.457 . . . . 0.0 112.654 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.41 24.13 9.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.572 1.082 . . . . 0.0 114.847 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -62.38 169.0 3.14 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.287 1.835 . . . . 0.0 112.529 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.0 t -65.43 -24.3 67.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.93 74.68 0.43 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.84 1.686 . . . . 0.0 111.975 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.12 142.61 34.53 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.364 2.709 . . . . 0.0 111.44 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.7 pt -134.48 141.03 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.678 1.591 . . . . 0.0 109.944 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.0 120.5 42.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.481 1.912 . . . . 0.0 110.328 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.1 mt -143.08 -174.41 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 128.884 2.874 . . . . 0.0 109.848 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -168.51 94.08 0.11 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.035 -1.041 . . . . 0.0 112.99 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.2 ttt -151.49 130.72 12.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.282 1.433 . . . . 0.0 110.45 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -168.84 112.16 0.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.456 1.502 . . . . 0.0 112.252 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.41 148.9 49.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.054 1.741 . . . . 0.0 112.308 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -60.21 150.71 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.47 1.908 . . . . 0.0 111.471 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 m -115.95 89.59 3.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.229 1.412 . . . . 0.0 110.886 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -98.57 146.45 25.8 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.022 -1.049 . . . . 0.0 111.139 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.52 94.08 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 128.032 2.533 . . . . 0.0 108.006 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.17 162.54 35.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.935 1.294 . . . . 0.0 111.559 176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -112.68 89.33 12.87 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.968 1.307 . . . . 0.0 108.392 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 114.63 3.39 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.123 2.549 . . . . 0.0 110.432 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -37.9 5.33 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.377 2.051 . . . . 0.0 112.21 -174.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -152.16 175.64 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.773 3.229 . . . . 0.0 110.039 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.07 135.87 56.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.071 1.348 . . . . 0.0 111.722 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.61 172.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.148 1.779 . . . . 0.0 111.449 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.555 1.542 . . . . 0.0 111.186 174.456 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -71.95 0.42 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.351 1.46 . . . . 0.0 111.415 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -74.86 -23.71 58.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.521 -0.737 . . . . 0.0 112.952 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -13.35 62.08 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.67 -33.58 71.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.907 1.283 . . . . 0.0 113.18 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -145.39 134.89 23.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.139 1.775 . . . . 0.0 111.934 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -147.51 6.49 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.97 69.4 1.37 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.457 -1.402 . . . . 0.0 112.348 -167.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.07 134.43 48.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.117 1.367 . . . . 0.0 111.546 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.05 -22.47 65.77 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.91 -28.45 67.51 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 14.0 t -108.51 -18.84 13.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.279 1.432 . . . . 0.0 112.694 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.6 171.6 8.69 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.987 0.899 . . . . 0.0 111.468 167.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -139.76 166.62 24.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.286 1.435 . . . . 0.0 110.028 173.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.68 152.45 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.263 1.025 . . . . 0.0 110.992 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.15 -41.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.79 1.236 . . . . 0.0 111.347 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 113.564 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.65 -62.68 1.5 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.788 0.835 . . . . 0.0 110.172 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 96.1 t -45.15 -47.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 126.462 1.905 . . . . 0.0 112.607 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t -65.7 -13.8 59.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.111 1.764 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.16 -31.94 11.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.98 1.712 . . . . 0.0 112.203 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 8.6 mt -55.64 -42.18 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.449 0.7 . . . . 0.0 110.26 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.54 -41.71 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.35 53.36 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.145 1.339 . . . . 0.0 111.172 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -30.86 71.91 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.82 -38.88 57.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.421 1.088 . . . . 0.0 113.177 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 49.8 mt -56.78 -56.97 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.222 0.919 . . . . 0.0 109.663 172.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.57 -27.97 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -47.67 78.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.157 0.983 . . . . 0.0 111.968 170.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.57 -27.41 64.11 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 114.086 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 58.5 mt -61.5 -35.33 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.609 1.164 . . . . 0.0 111.141 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 82.91 16.18 70.75 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.136 0.874 . . . . 0.0 114.259 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.74 2.32 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.128 1.347 . . . . 0.0 115.58 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -65.16 170.99 4.01 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 118.766 1.283 . . . . 0.0 112.33 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.0 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.26 1.424 . . . . 0.0 112.293 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -53.06 154.18 3.12 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.453 -0.78 . . . . 0.0 111.632 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -145.17 171.02 15.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.142 1.377 . . . . 0.0 110.737 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -84.77 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.213 1.005 . . . . 0.0 110.755 175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 15.6 m -59.73 -20.5 56.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.499 1.52 . . . . 0.0 114.727 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.73 -38.42 55.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.501 1.52 . . . . 0.0 112.888 175.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -55.91 -30.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.73 -45.25 71.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.855 0.862 . . . . 0.0 111.693 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -24.08 65.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -78.19 -54.41 6.26 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.734 0.814 . . . . 0.0 111.54 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.9 t -57.02 -27.53 61.69 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.1 t -81.32 -58.22 3.14 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.434 1.015 . . . . 0.0 112.429 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -56.48 -38.21 71.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.988 1.267 . . . . 0.0 113.584 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 86.7 t -66.68 -65.72 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 123.822 0.849 . . . . 0.0 109.489 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.9 t -47.74 -32.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 110.968 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -58.55 -40.52 83.25 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -104.92 -40.95 5.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.494 1.518 . . . . 0.0 112.616 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 39.3 m -57.47 -53.67 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.705 2.402 . . . . 0.0 112.438 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -40.9 93.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.749 0.704 . . . . 0.0 110.568 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -60.66 -39.6 88.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -67.42 -51.21 54.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.894 2.078 . . . . 0.0 113.396 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -66.27 -26.06 67.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.4 m -58.68 -32.54 69.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.094 0.958 . . . . 0.0 111.522 165.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -86.21 -23.89 26.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.78 -26.73 66.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.987 0.915 . . . . 0.0 112.194 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -97.56 -121.49 4.25 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.098 1.809 . . . . 0.0 112.562 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -128.0 156.34 76.34 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 125.448 1.499 . . . . 0.0 113.172 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.29 112.5 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.005 3.137 . . . . 0.0 112.21 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.15 166.0 32.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.564 1.146 . . . . 0.0 112.314 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -72.6 100.47 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.714 0.806 . . . . 0.0 110.998 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -75.31 157.26 34.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 111.053 160.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 tt -132.26 151.42 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.576 1.55 . . . . 0.0 108.95 164.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 19.3 m -142.74 149.75 18.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.882 1.273 . . . . 0.0 110.344 170.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 6.7 p -136.89 140.97 42.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.532 1.533 . . . . 0.0 110.145 170.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.8 p -138.48 155.34 48.53 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.617 -0.677 . . . . 0.0 112.176 169.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.96 114.66 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.76 1.624 . . . . 0.0 108.493 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.7 mm -106.93 116.56 50.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 125.863 1.665 . . . . 0.0 108.727 177.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' MET . . . . . 0.47 ' HE1' ' H ' ' B' ' 219' ' ' GLY . 1.1 tmt? -134.86 119.57 18.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.401 1.48 . . . . 0.0 110.64 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 81.71 0.88 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.278 1.831 . . . . 0.0 111.0 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.11 -74.38 0.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.073 1.349 . . . . 0.0 110.968 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -19.55 2.12 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . 0.47 ' H ' ' HE1' ' B' ' 215' ' ' MET . . . 127.94 -2.48 6.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.058 1.79 . . . . 0.0 115.98 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.99 101.17 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.527 1.531 . . . . 0.0 114.173 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.06 102.18 1.54 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.574 1.083 . . . . 0.0 112.218 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -44.17 151.81 0.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.363 1.465 . . . . 0.0 113.297 166.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.35 93.27 9.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.334 -0.853 . . . . 0.0 109.462 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 50.3 m -116.01 132.79 56.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.243 0.617 . . . . 0.0 110.428 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.56 129.11 38.6 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.218 0.607 . . . . 0.0 111.321 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -131.56 120.57 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.779 1.232 . . . . 0.0 110.211 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 5.0 t -74.02 16.58 0.22 Allowed 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.194 -0.942 . . . . 0.0 113.045 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.6 m -62.44 167.49 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.88 -1.138 . . . . 0.0 112.26 167.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.22 154.27 21.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.739 1.616 . . . . 0.0 110.523 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -81.38 151.42 27.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.251 1.021 . . . . 0.0 110.122 168.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -145.93 163.2 35.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.619 1.968 . . . . 0.0 109.979 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 14.6 t -126.07 -58.82 1.36 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.447 1.099 . . . . 0.0 112.864 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 17.3 p -79.0 -46.59 17.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.384 1.073 . . . . 0.0 112.333 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -48.41 66.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.434 1.893 . . . . 0.0 112.324 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -150.35 -159.13 0.99 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 129.327 3.051 . . . . 0.0 108.718 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.62 -174.03 18.38 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.951 1.263 . . . . 0.0 113.286 169.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 94.9 p -155.1 173.69 16.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.392 2.277 . . . . 0.0 109.634 170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.18 123.73 11.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 166.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 12.8 t -134.01 149.16 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.528 -1.358 . . . . 0.0 112.118 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.65 114.25 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.453 1.501 . . . . 0.0 108.066 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -111.34 96.97 6.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.9 1.28 . . . . 0.0 109.851 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -107.87 124.78 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 109.931 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 168.78 9.85 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 110.643 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -148.11 -158.04 0.87 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.992 0.917 . . . . 0.0 110.807 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.73 -65.97 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.267 2.227 . . . . 0.0 113.649 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 t -139.39 1.62 1.98 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.9 ptp -98.17 154.37 17.81 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.598 -1.314 . . . . 0.0 112.279 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.9 120.01 25.42 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.867 1.667 . . . . 0.0 108.979 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 20.3 p -126.98 79.01 1.85 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.801 1.286 . . . . 0.0 111.139 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.09 136.13 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.005 1.322 . . . . 0.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.05 126.55 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.547 1.539 . . . . 0.0 110.944 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 32.0 t -113.82 132.15 55.98 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.44 1.896 . . . . 0.0 110.407 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -125.38 149.2 48.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.089 1.756 . . . . 0.0 112.555 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -142.67 98.18 3.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.607 1.563 . . . . 0.0 108.346 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -155.24 94.15 0.14 Allowed Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.655 -1.278 . . . . 0.0 110.64 172.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.37 76.66 1.37 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.504 1.921 . . . . 0.0 112.256 -173.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -146.98 93.0 2.2 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.519 -0.738 . . . . 0.0 112.115 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.9 pp -107.41 -13.39 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -136.65 -5.64 1.93 Allowed Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.709 1.147 . . . . 0.0 115.074 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.87 2.2 28.92 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.342 1.448 . . . . 0.0 115.624 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.64 174.14 41.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.425 1.964 . . . . 0.0 113.232 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 38.2 m -72.61 174.22 7.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.519 1.528 . . . . 0.0 112.929 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 100.73 23.93 9.64 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.557 1.075 . . . . 0.0 114.857 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -62.31 169.09 3.04 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.212 1.805 . . . . 0.0 112.548 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 8.1 t -64.71 -23.37 67.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -128.77 74.8 0.43 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.965 1.745 . . . . 0.0 112.179 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.74 143.32 33.47 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.364 2.709 . . . . 0.0 111.545 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 33.8 pt -134.16 154.46 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.369 1.468 . . . . 0.0 111.298 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 113.14 18.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.647 1.579 . . . . 0.0 111.39 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 7.3 mt -140.91 -176.71 4.77 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.571 2.748 . . . . 0.0 110.313 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.39 94.02 0.11 Allowed Glycine 0 N--CA 1.471 0.996 0 O-C-N 121.234 -0.916 . . . . 0.0 112.779 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 6.4 ttt -151.09 129.26 11.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.289 1.436 . . . . 0.0 110.434 -173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -167.33 112.13 0.72 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.29 1.436 . . . . 0.0 112.321 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.28 148.76 49.64 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.987 1.715 . . . . 0.0 112.276 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.91 150.58 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.585 1.954 . . . . 0.0 111.438 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.8 m -116.6 88.55 2.92 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.256 1.422 . . . . 0.0 110.787 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -99.1 147.63 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.3 p -138.26 98.16 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 127.3 2.24 . . . . 0.0 108.794 175.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.84 159.52 42.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.587 1.555 . . . . 0.0 111.612 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.56 92.98 10.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.649 1.18 . . . . 0.0 108.527 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.8 115.26 3.86 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.049 2.499 . . . . 0.0 110.187 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.31 -35.87 7.83 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.405 2.07 . . . . 0.0 112.276 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -152.58 175.01 13.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.624 3.17 . . . . 0.0 109.988 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -65.55 135.16 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.009 1.324 . . . . 0.0 111.638 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.33 172.52 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 126.136 1.774 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.541 1.536 . . . . 0.0 111.199 174.636 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -127.87 -34.58 2.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.005 1.322 . . . . 0.0 114.034 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.2 mtm -60.11 -33.11 71.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.081 0.953 . . . . 0.0 112.494 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.29 -16.68 58.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.396 1.478 . . . . 0.0 114.526 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.36 -31.19 26.89 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.181 0.992 . . . . 0.0 112.518 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.27 147.63 49.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.016 0.926 . . . . 0.0 111.148 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.43 137.54 19.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 0.0 112.376 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.55 95.06 3.26 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.667 1.587 . . . . 0.0 111.549 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.14 87.45 0.58 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.169 1.388 . . . . 0.0 112.178 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.78 -26.05 56.74 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.992 1.317 . . . . 0.0 113.564 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.91 -23.58 63.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.949 1.7 . . . . 0.0 115.103 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.21 -16.44 14.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.912 1.285 . . . . 0.0 112.596 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.21 166.35 9.93 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.887 0.875 . . . . 0.0 112.029 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.17 171.49 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.76 1.624 . . . . 0.0 111.425 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.75 161.05 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.544 1.137 . . . . 0.0 111.274 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.39 -44.66 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.591 1.556 . . . . 0.0 111.872 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.61 -25.85 66.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 113.194 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.81 -57.89 3.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.84 0.856 . . . . 0.0 110.85 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.28 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.181 1.392 . . . . 0.0 112.768 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -63.16 -8.29 7.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.617 1.567 . . . . 0.0 114.293 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -109.92 -36.8 5.79 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.877 1.671 . . . . 0.0 112.453 169.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.6 mt -49.34 -44.46 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.086 0.857 . . . . 0.0 110.591 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.6 p -59.41 -41.46 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.522 -0.736 . . . . 0.0 112.956 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -51.06 52.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.286 0.948 . . . . 0.0 111.01 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.13 72.2 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.9 -47.68 36.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.035 0.934 . . . . 0.0 112.179 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -59.53 -58.43 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.183 0.901 . . . . 0.0 110.366 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.16 -27.87 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -65.15 -50.61 65.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.699 0.799 . . . . 0.0 111.795 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.84 -30.81 71.09 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 113.883 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -62.89 -31.6 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.81 1.644 . . . . 0.0 112.578 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.76 7.71 0.43 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 119.052 2.381 . . . . 0.0 119.052 -161.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.37 95.67 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 120.237 2.019 . . . . 0.0 114.731 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -146.85 -173.3 4.19 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.426 1.613 . . . . 0.0 114.098 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.62 -178.1 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.481 1.912 . . . . 0.0 112.537 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -48.94 154.63 0.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -134.84 171.56 14.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.914 1.286 . . . . 0.0 112.349 -170.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -91.49 -113.75 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.111 1.365 . . . . 0.0 110.865 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.7 p -74.57 4.62 5.82 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.179 1.792 . . . . 0.0 115.318 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -47.95 -33.44 7.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.321 1.848 . . . . 0.0 114.559 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 p -48.63 -32.17 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.544 1.137 . . . . 0.0 113.55 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.18 -52.02 57.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.155 1.382 . . . . 0.0 112.284 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.18 -26.33 67.36 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.106 -0.996 . . . . 0.0 112.775 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.81 -53.62 7.68 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.269 1.028 . . . . 0.0 111.557 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.54 -24.24 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.566 0.746 . . . . 0.0 112.72 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -80.67 -63.66 1.36 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.102 0.865 . . . . 0.0 112.197 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -55.15 -41.46 71.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.29 1.436 . . . . 0.0 114.289 -171.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 85.2 t -66.69 -62.55 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 124.219 1.008 . . . . 0.0 110.248 -179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.6 t -49.04 -31.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.991 1.317 . . . . 0.0 110.766 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -62.61 -31.19 71.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -108.68 -41.48 4.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.225 1.41 . . . . 0.0 112.165 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.9 m -59.15 -51.47 69.86 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.932 2.493 . . . . 0.0 112.583 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -38.41 91.07 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.287 0.565 . . . . 0.0 111.336 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -61.88 -46.0 91.32 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -60.0 -49.14 78.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.709 2.004 . . . . 0.0 112.809 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.75 -24.8 63.58 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.571 -1.331 . . . . 0.0 114.399 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.0 m -60.36 -28.16 67.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.928 0.491 . . . . 0.0 111.024 165.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -87.19 -29.35 21.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.951 0.901 . . . . 0.0 112.695 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.92 -20.82 62.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.626 1.17 . . . . 0.0 112.385 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.61 -110.56 3.51 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.434 1.969 . . . . 0.0 112.81 172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -137.78 148.67 61.77 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.379 1.872 . . . . 0.0 111.13 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.34 120.32 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.048 3.165 . . . . 0.0 112.439 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.79 166.77 32.43 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 112.392 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.09 92.61 0.75 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.663 1.185 . . . . 0.0 110.36 166.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -68.6 162.63 25.46 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.664 0.745 . . . . 0.0 110.797 157.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 7.3 tt -141.84 153.62 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.742 1.617 . . . . 0.0 109.045 166.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.7 m -144.67 152.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.956 1.302 . . . . 0.0 110.566 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -144.34 158.64 43.63 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.421 1.089 . . . . 0.0 110.256 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.2 p -151.62 152.72 33.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.078 1.351 . . . . 0.0 111.88 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -133.61 123.49 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.917 1.287 . . . . 0.0 109.317 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mm -111.16 108.36 25.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 127.431 2.293 . . . . 0.0 109.121 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -135.91 153.47 51.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.438 2.295 . . . . 0.0 110.733 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -143.98 147.81 34.43 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 112.495 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -80.04 -14.38 58.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.62 -7.75 55.87 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.12 25.51 0.02 OUTLIER Glycine 0 N--CA 1.477 1.375 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.25 126.77 21.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.893 1.277 . . . . 0.0 112.472 -168.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.25 101.4 0.16 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.927 0.775 . . . . 0.0 114.111 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.99 -174.56 2.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.688 2.395 . . . . 0.0 110.358 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.15 130.64 55.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.382 0.673 . . . . 0.0 110.317 170.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.2 m -137.78 142.85 40.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.284 1.433 . . . . 0.0 109.749 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.72 138.29 39.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.675 1.19 . . . . 0.0 110.551 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.2 p -141.43 120.05 12.5 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.583 1.153 . . . . 0.0 110.993 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.8 m -75.91 13.2 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.839 -1.163 . . . . 0.0 113.406 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.2 m -60.43 164.49 4.36 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.899 167.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.95 158.21 30.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.445 1.898 . . . . 0.0 110.053 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -80.72 139.42 36.13 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.247 0.546 . . . . 0.0 109.651 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -154.35 162.66 41.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.164 1.786 . . . . 0.0 111.178 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.6 t -132.98 -59.32 0.89 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.232 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 -39.09 51.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.369 1.068 . . . . 0.0 111.513 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -53.68 53.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.78 1.632 . . . . 0.0 111.641 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -150.09 -69.76 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.982 1.313 . . . . 0.0 112.404 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.29 151.95 6.36 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 127.238 2.352 . . . . 0.0 113.38 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 p -165.35 141.48 5.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.689 1.995 . . . . 0.0 110.557 173.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.53 ' HG ' ' HB1' ' A' ' 110' ' ' ALA . 1.7 p -126.72 63.85 1.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.869 1.268 . . . . 0.0 112.35 -174.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -76.41 150.59 36.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.338 1.855 . . . . 0.0 113.591 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.7 t -142.12 135.21 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.463 1.505 . . . . 0.0 110.457 -176.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -115.19 120.15 38.77 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.48 1.112 . . . . 0.0 112.012 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -133.2 98.54 4.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.695 1.598 . . . . 0.0 110.261 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 173.48 8.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.79 1.236 . . . . 0.0 111.949 166.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -143.43 -176.39 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.764 1.626 . . . . 0.0 111.203 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -51.56 -43.31 62.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.172 1.389 . . . . 0.0 114.246 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 t -137.71 8.52 2.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.271 1.428 . . . . 0.0 114.101 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.14 165.38 16.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.184 1.393 . . . . 0.0 112.819 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -145.28 118.76 9.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.161 1.784 . . . . 0.0 109.941 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.9 p -143.62 74.44 1.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 111.938 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.0 pt -74.71 158.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.457 -0.777 . . . . 0.0 111.421 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.07 141.15 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.486 1.914 . . . . 0.0 109.949 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -135.38 125.18 25.51 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.257 -0.902 . . . . 0.0 111.54 -174.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.53 ' HB1' ' HG ' ' A' ' 95' ' ' CYS . . . -121.62 144.17 48.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.299 1.44 . . . . 0.0 112.823 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -146.18 -176.67 5.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 126.607 1.963 . . . . 0.0 110.125 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.53 84.41 1.11 Allowed Glycine 0 CA--C 1.539 1.552 0 O-C-N 120.87 -1.144 . . . . 0.0 112.892 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 46.22 1.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.174 2.19 . . . . 0.0 113.031 -167.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 t -124.86 77.58 1.62 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.193 0.997 . . . . 0.0 112.268 -170.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -10.49 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -168.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.12 -3.93 29.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.127 1.346 . . . . 0.0 115.133 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.4 3.37 57.6 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.962 1.267 . . . . 0.0 115.849 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.29 174.0 34.8 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.548 2.023 . . . . 0.0 113.345 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.0 p -69.78 174.69 4.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.653 1.581 . . . . 0.0 113.477 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.59 8.98 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.528 1.061 . . . . 0.0 114.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.84 165.22 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.409 1.484 . . . . 0.0 113.559 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 t -76.39 12.34 1.26 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.353 1.861 . . . . 0.0 114.635 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.17 162.39 40.37 Favored Glycine 0 CA--C 1.543 1.842 0 O-C-N 120.728 -1.233 . . . . 0.0 114.207 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.97 171.92 15.68 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.007 3.138 . . . . 0.0 113.143 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.57 132.38 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.964 1.706 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.72 161.18 41.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.761 1.624 . . . . 0.0 112.788 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.9 155.99 22.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.389 1.476 . . . . 0.0 112.599 176.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.23 -171.76 32.16 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.889 1.233 . . . . 0.0 113.617 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.6 mtt -136.99 170.64 15.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.307 1.843 . . . . 0.0 112.225 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.57 143.45 47.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.578 1.951 . . . . 0.0 111.455 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -136.23 169.44 17.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.85 2.06 . . . . 0.0 111.443 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 mm -63.71 146.02 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 110.588 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.6 m -106.07 111.74 24.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.279 1.432 . . . . 0.0 110.067 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.99 145.37 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.782 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.86 104.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -139.63 150.36 44.86 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.737 0.815 . . . . 0.0 112.465 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -133.84 157.77 77.03 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.574 1.55 . . . . 0.0 111.557 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 160.53 48.43 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.524 2.816 . . . . 0.0 112.94 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.92 -38.86 15.63 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.317 2.678 . . . . 0.0 113.473 -175.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.34 -177.96 6.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.843 2.057 . . . . 0.0 110.93 174.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -105.92 136.59 45.3 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.203 1.001 . . . . 0.0 111.783 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.56 165.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.708 2.003 . . . . 0.0 111.326 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.254 1.327 0 C-N-CA 125.881 1.672 . . . . 0.0 111.318 173.87 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 CA-C-O 119.669 -0.517 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -132.86 -37.65 1.01 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.501 1.12 . . . . 0.0 113.67 175.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 18.4 mtm -59.16 -33.56 71.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.299 1.04 . . . . 0.0 112.649 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.32 -16.79 58.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 114.592 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.57 -30.96 26.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.14 0.976 . . . . 0.0 112.548 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.79 147.89 49.84 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.976 0.91 . . . . 0.0 111.23 168.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.1 138.05 20.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.778 0.831 . . . . 0.0 112.447 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.22 96.08 4.46 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.594 1.558 . . . . 0.0 111.576 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.33 86.21 0.59 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.008 1.323 . . . . 0.0 112.226 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.43 -25.91 51.94 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.04 1.336 . . . . 0.0 113.522 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.01 -24.34 62.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.711 1.604 . . . . 0.0 115.018 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.81 -19.75 13.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.376 1.07 . . . . 0.0 112.502 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.26 159.69 20.27 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.23 -0.919 . . . . 0.0 111.56 170.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.59 162.63 27.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.402 1.081 . . . . 0.0 110.721 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 p -138.61 158.96 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.736 1.215 . . . . 0.0 111.166 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.83 -38.55 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.74 2.416 . . . . 0.0 112.67 -174.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.86 -28.34 68.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 113.072 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.49 -47.8 7.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.47 0.708 . . . . 0.0 110.708 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 70.2 t -48.58 -42.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.338 1.455 . . . . 0.0 112.187 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t -64.25 -8.23 11.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.622 1.569 . . . . 0.0 114.874 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.54 -35.09 6.84 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.308 1.843 . . . . 0.0 112.446 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.9 mt -49.79 -42.13 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.143 0.977 . . . . 0.0 110.583 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.29 -43.57 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.52 63.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.455 1.025 . . . . 0.0 111.053 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -33.73 76.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.57 63.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.647 0.779 . . . . 0.0 112.206 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 66.5 mt -59.5 -59.18 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.109 0.868 . . . . 0.0 109.986 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -61.86 -29.48 70.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 32.9 t -63.6 -51.93 63.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.983 0.913 . . . . 0.0 111.912 167.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.29 -30.71 71.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.071 1.348 . . . . 0.0 113.989 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.78 -34.81 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.249 1.419 . . . . 0.0 111.005 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.33 80.81 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.897 1.237 . . . . 0.0 114.916 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.48 68.82 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.104 1.335 . . . . 0.0 115.487 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -70.57 -176.14 1.2 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.811 1.306 . . . . 0.0 112.301 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.89 154.25 5.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.721 -1.237 . . . . 0.0 111.424 170.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -48.92 150.0 1.66 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.021 1.328 . . . . 0.0 113.1 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -127.85 166.64 17.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.577 1.151 . . . . 0.0 111.483 -173.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -89.0 -113.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.519 1.128 . . . . 0.0 110.553 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 61.0 p -74.37 5.91 4.16 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -48.59 -33.97 10.72 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.085 1.754 . . . . 0.0 114.475 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 65.6 t -50.11 -33.02 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.567 1.147 . . . . 0.0 112.665 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.94 -52.99 57.23 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.309 1.443 . . . . 0.0 112.367 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.79 -26.3 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.045 -1.035 . . . . 0.0 112.742 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.96 -53.19 8.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.264 1.026 . . . . 0.0 111.519 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.59 -24.38 63.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.385 0.674 . . . . 0.0 112.79 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.6 t -80.51 -64.01 1.28 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.121 0.873 . . . . 0.0 112.138 165.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -55.25 -39.74 70.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.312 1.445 . . . . 0.0 114.345 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.8 t -68.21 -62.37 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 C-N-CA 124.139 0.976 . . . . 0.0 110.208 -178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.18 -31.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.922 1.289 . . . . 0.0 110.721 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -62.03 -31.78 72.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.932 0.893 . . . . 0.0 113.376 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -108.22 -41.61 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.162 1.385 . . . . 0.0 112.163 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 46.2 m -59.71 -51.36 70.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.074 2.55 . . . . 0.0 112.617 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -38.32 90.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 111.262 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.5 t -61.32 -46.64 89.44 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.624 -0.673 . . . . 0.0 111.626 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.69 -50.5 73.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.789 2.035 . . . . 0.0 112.941 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.99 -27.65 67.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.081 1.309 . . . . 0.0 114.027 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 93.7 m -59.57 -29.09 67.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.116 0.566 . . . . 0.0 111.283 167.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.72 -28.83 22.84 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 89.8 mt -78.92 -19.4 51.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.181 0.992 . . . . 0.0 111.895 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -102.19 -104.25 2.79 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.429 1.966 . . . . 0.0 112.087 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -141.43 145.81 39.49 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.084 1.754 . . . . 0.0 111.505 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 122.23 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.053 3.168 . . . . 0.0 112.522 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -158.51 167.58 29.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.25 1.42 . . . . 0.0 112.106 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.15 92.13 0.54 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.651 1.18 . . . . 0.0 110.305 166.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -68.06 161.85 25.85 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.603 0.716 . . . . 0.0 110.582 157.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 7.1 tt -141.16 153.54 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.774 1.629 . . . . 0.0 108.94 166.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 25.7 m -144.15 151.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.808 1.243 . . . . 0.0 110.44 173.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.2 t -142.67 157.46 44.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.473 1.109 . . . . 0.0 110.06 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 46.4 t -152.85 147.8 26.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.39 1.476 . . . . 0.0 111.313 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.37 127.57 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.4 mm -113.34 111.17 34.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 127.429 2.292 . . . . 0.0 109.462 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -135.76 153.65 51.48 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.652 2.381 . . . . 0.0 110.945 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -144.32 144.15 31.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.378 1.471 . . . . 0.0 112.636 -172.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -75.97 -15.64 60.13 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -75.8 -7.88 55.52 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.48 23.75 0.02 OUTLIER Glycine 0 CA--C 1.536 1.363 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -138.61 123.33 18.67 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.745 1.272 . . . . 0.0 112.591 -168.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.63 103.06 0.19 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.048 0.832 . . . . 0.0 114.292 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 8.5 mp -114.64 -174.31 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.895 2.478 . . . . 0.0 110.444 -176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.56 129.96 55.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.58 0.752 . . . . 0.0 110.587 170.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 22.9 m -135.66 145.36 46.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.102 1.361 . . . . 0.0 109.964 172.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.55 41.74 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 110.997 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.8 p -142.88 122.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.462 1.105 . . . . 0.0 110.755 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.7 m -77.03 13.25 1.12 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.946 -1.096 . . . . 0.0 113.168 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 5.2 m -59.83 164.52 3.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.836 167.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.44 159.57 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.832 . . . . 0.0 110.247 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -80.42 135.72 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.222 0.535 . . . . 0.0 109.567 169.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -152.11 162.84 40.49 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.753 1.621 . . . . 0.0 111.47 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 32.1 t -137.1 -58.98 0.71 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.872 1.269 . . . . 0.0 112.173 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -74.48 -40.78 61.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.102 0.961 . . . . 0.0 111.368 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -54.26 46.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.947 1.699 . . . . 0.0 111.621 -174.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.14 -70.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.876 1.27 . . . . 0.0 112.703 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 137.11 152.69 6.22 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 127.509 2.48 . . . . 0.0 113.484 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 44.9 p -171.49 127.29 0.65 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.558 1.543 . . . . 0.0 112.459 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.56 65.04 0.67 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.972 1.709 . . . . 0.0 112.431 -171.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.9 t -76.94 146.75 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.16 1.384 . . . . 0.0 113.637 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.32 114.94 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.694 1.198 . . . . 0.0 110.906 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -94.14 119.02 32.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.72 1.208 . . . . 0.0 111.859 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -130.08 106.81 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.437 1.495 . . . . 0.0 110.323 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 169.91 9.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.365 1.466 . . . . 0.0 111.667 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -140.83 -177.33 5.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.637 1.575 . . . . 0.0 110.968 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -51.75 -42.25 62.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.888 1.275 . . . . 0.0 114.406 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 7.6 t -138.1 8.21 2.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.252 1.421 . . . . 0.0 114.324 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.35 159.4 27.55 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.45 119.04 15.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.647 1.979 . . . . 0.0 110.33 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.68 73.88 1.43 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.887 1.275 . . . . 0.0 112.031 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.32 125.57 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.37 1.468 . . . . 0.0 111.765 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.22 147.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.412 1.485 . . . . 0.0 110.614 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -139.75 129.76 24.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.93 0.892 . . . . 0.0 111.981 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -123.6 145.2 49.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.367 1.467 . . . . 0.0 113.05 -174.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -147.5 -176.5 5.27 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.709 2.004 . . . . 0.0 109.972 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 86.47 84.89 1.09 Allowed Glycine 0 CA--C 1.538 1.523 0 O-C-N 120.794 -1.191 . . . . 0.0 112.922 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.93 1.03 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.066 2.146 . . . . 0.0 113.038 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 t -125.76 78.24 1.73 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.096 0.951 . . . . 0.0 112.111 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.67 -10.75 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -168.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -110.72 -3.82 28.43 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.084 1.326 . . . . 0.0 115.14 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.33 58.61 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.943 1.259 . . . . 0.0 115.776 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.11 35.05 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.48 1.99 . . . . 0.0 113.391 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 71.3 p -69.7 174.84 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.666 1.586 . . . . 0.0 113.553 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.63 26.28 9.3 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.58 1.086 . . . . 0.0 114.877 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -60.06 164.77 3.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.366 1.466 . . . . 0.0 113.595 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 7.7 t -76.24 17.76 0.34 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.688 1.995 . . . . 0.0 114.523 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -90.31 161.52 28.91 Favored Glycine 0 CA--C 1.54 1.65 0 O-C-N 120.649 -1.282 . . . . 0.0 114.296 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.36 167.7 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.924 3.083 . . . . 0.0 113.199 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.51 121.33 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 111.582 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . 0.444 ' H ' ' HE3' ' B' ' 269' ' ' LYS . 0.0 OUTLIER -144.07 155.55 44.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.6 1.56 . . . . 0.0 113.909 176.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.85 163.1 28.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.339 1.056 . . . . 0.0 112.073 173.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.82 -174.11 28.55 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.986 1.279 . . . . 0.0 113.557 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 6.7 mtt -137.8 169.88 17.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.411 1.885 . . . . 0.0 111.881 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -134.17 142.7 47.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.323 1.849 . . . . 0.0 111.46 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -136.24 169.61 17.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.807 2.043 . . . . 0.0 111.418 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.79 146.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.084 1.354 . . . . 0.0 110.607 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 85.1 m -107.79 103.7 13.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.455 1.502 . . . . 0.0 110.26 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -104.45 147.41 27.6 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.876 -1.14 . . . . 0.0 110.74 171.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.15 107.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.736 2.014 . . . . 0.0 109.916 -178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -139.0 151.68 47.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.728 0.811 . . . . 0.0 112.564 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -133.37 157.5 77.96 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.559 1.544 . . . . 0.0 111.499 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.55 160.87 47.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.56 2.84 . . . . 0.0 112.886 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.96 -38.53 16.32 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.223 2.615 . . . . 0.0 113.503 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.56 -177.87 6.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.907 2.083 . . . . 0.0 110.919 174.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.26 137.07 44.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.254 1.022 . . . . 0.0 111.828 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.6 165.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 0.0 111.383 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 35.0 t . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.926 1.69 . . . . 0.0 111.361 173.945 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.271 1.428 . . . . 0.0 112.616 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -56.92 -39.83 75.2 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.64 1.176 . . . . 0.0 114.018 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.75 -12.97 59.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.72 -22.04 37.61 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.322 1.049 . . . . 0.0 112.876 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -66.67 137.69 56.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.463 1.505 . . . . 0.0 110.348 168.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -142.9 157.93 44.11 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.434 1.094 . . . . 0.0 111.861 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.12 68.69 2.6 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.492 1.517 . . . . 0.0 113.091 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.22 -0.16 7.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.311 1.445 . . . . 0.0 114.731 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.77 -30.64 70.15 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.658 -1.276 . . . . 0.0 114.159 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.7 -25.25 16.18 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -75.93 -19.72 58.56 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.075 0.55 . . . . 0.0 111.832 170.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.17 146.79 42.13 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.771 -1.206 . . . . 0.0 112.219 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -123.39 164.76 18.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.433 1.493 . . . . 0.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.66 161.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 110.939 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.33 -36.92 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.767 1.627 . . . . 0.0 112.047 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.83 -26.14 67.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.64 1.176 . . . . 0.0 112.274 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.96 -58.96 2.75 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.297 0.639 . . . . 0.0 110.099 171.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -47.59 -43.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.763 1.625 . . . . 0.0 113.325 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 t -59.3 -21.39 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.605 1.562 . . . . 0.0 113.574 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -99.63 -34.23 10.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.384 1.474 . . . . 0.0 113.114 172.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 mt -51.42 -42.96 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.251 1.02 . . . . 0.0 110.633 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.55 -44.1 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 121.408 -0.807 . . . . 0.0 113.102 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -51.36 65.43 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.945 1.248 . . . . 0.0 111.697 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -35.44 79.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.15 64.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.28 -56.58 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.155 0.889 . . . . 0.0 109.001 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.25 -32.31 73.68 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.7 p -69.81 -36.99 76.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.18 -0.95 . . . . 0.0 112.699 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -28.04 62.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.669 1.188 . . . . 0.0 113.899 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.59 -34.22 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.975 1.31 . . . . 0.0 110.809 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.19 81.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.797 1.189 . . . . 0.0 114.729 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.98 17.69 65.77 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.287 1.422 . . . . 0.0 115.543 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.28 -173.29 1.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.696 1.248 . . . . 0.0 111.733 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 115.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 111.297 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -64.77 126.08 26.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.384 1.074 . . . . 0.0 111.394 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -127.41 127.67 44.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.253 1.021 . . . . 0.0 112.583 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -64.15 -42.49 96.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.265 1.026 . . . . 0.0 112.954 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 t -62.64 -28.78 70.15 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.994 -1.066 . . . . 0.0 112.712 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -72.8 -26.56 61.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.58 -34.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.078 1.308 . . . . 0.0 112.401 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.3 -49.2 72.72 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.953 1.301 . . . . 0.0 112.593 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.88 -25.89 66.61 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.152 -0.967 . . . . 0.0 112.909 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -78.08 -53.07 7.8 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.717 0.807 . . . . 0.0 111.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.61 -22.81 62.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -82.83 -60.22 2.24 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.508 1.049 . . . . 0.0 112.189 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -57.66 -38.98 76.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.113 1.324 . . . . 0.0 114.32 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 88.2 t -68.52 -64.53 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 C-N-CA 124.644 1.177 . . . . 0.0 109.895 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.6 t -47.53 -30.99 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 110.863 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.61 -38.5 72.14 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.136 0.975 . . . . 0.0 113.314 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -112.21 -34.6 5.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.998 1.719 . . . . 0.0 112.648 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -62.21 -52.67 62.83 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.031 2.132 . . . . 0.0 112.572 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -33.85 75.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.371 0.532 . . . . 0.0 111.123 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 m -60.69 -54.76 41.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.548 0.739 . . . . 0.0 111.853 166.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -53.47 -50.82 64.52 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.435 1.894 . . . . 0.0 112.751 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.95 -27.19 65.51 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.2 m -59.65 -43.4 93.93 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -71.44 -23.11 61.79 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.0 5.77 3.97 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.215 1.406 . . . . 0.0 113.386 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.11 -97.86 0.14 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.594 1.088 . . . . 0.0 114.981 164.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -66.87 170.66 5.67 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 125.163 1.385 . . . . 0.0 114.598 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.12 168.27 14.39 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.166 1.911 . . . . 0.0 112.131 166.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -56.8 113.82 1.82 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.571 1.548 . . . . 0.0 112.651 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.33 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.377 3.071 . . . . 0.0 110.273 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.93 172.28 13.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.833 2.453 . . . . 0.0 108.915 169.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 tt -134.74 153.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.519 1.527 . . . . 0.0 108.403 162.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.08 141.61 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.858 0.863 . . . . 0.0 110.255 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.06 141.55 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.511 1.525 . . . . 0.0 108.932 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 146.93 41.27 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.496 -0.752 . . . . 0.0 112.964 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.24 125.38 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.465 1.506 . . . . 0.0 109.144 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mm -124.63 104.68 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.026 2.13 . . . . 0.0 108.076 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.57 166.96 20.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 112.286 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.09 109.49 12.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.639 1.175 . . . . 0.0 111.861 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -61.38 -20.09 62.63 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.89 -16.69 61.1 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.28 18.09 0.02 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.895 1.918 . . . . 0.0 117.895 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.5 65.84 1.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.367 1.583 . . . . 0.0 111.971 -171.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.33 159.42 40.98 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.623 1.106 . . . . 0.0 113.145 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.97 174.88 13.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.43 1.892 . . . . 0.0 112.06 -174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -120.86 133.24 55.31 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.553 1.141 . . . . 0.0 111.112 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.3 m -141.0 144.61 35.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.587 1.555 . . . . 0.0 109.77 174.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.8 126.29 20.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.663 1.185 . . . . 0.0 109.991 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.4 p -128.57 113.3 15.27 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.849 0.86 . . . . 0.0 110.755 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -77.45 11.26 2.07 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.557 1.143 . . . . 0.0 112.844 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.6 m -58.76 163.01 3.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.931 1.692 . . . . 0.0 112.714 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -159.16 137.82 10.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.918 1.287 . . . . 0.0 110.353 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -73.7 148.91 42.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.478 0.711 . . . . 0.0 110.195 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -136.16 151.69 50.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 110.913 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.0 t -106.35 -63.24 1.29 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.492 1.117 . . . . 0.0 112.158 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.5 p -84.87 -32.01 23.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.804 0.842 . . . . 0.0 113.159 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -49.86 47.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.24 1.416 . . . . 0.0 111.943 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -149.82 -174.43 4.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.668 2.387 . . . . 0.0 110.3 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.73 149.06 18.65 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.709 1.147 . . . . 0.0 112.256 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -155.56 131.9 10.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.692 1.197 . . . . 0.0 110.418 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 11.0 t -123.31 136.49 54.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -128.19 141.35 51.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.383 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.4 113.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 126.468 1.907 . . . . 0.0 108.949 -168.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.0 114.26 24.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.729 1.612 . . . . 0.0 111.378 -174.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -124.82 105.35 9.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.158 1.783 . . . . 0.0 109.569 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 167.1 7.48 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.475 -0.766 . . . . 0.0 112.253 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -144.83 -179.21 6.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.976 0.911 . . . . 0.0 111.518 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -52.11 55.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.793 1.637 . . . . 0.0 113.74 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.3 t -127.67 -30.11 2.57 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.89 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.2 ptp -96.59 179.44 4.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.49 1.516 . . . . 0.0 111.835 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.1 152.51 37.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.643 1.577 . . . . 0.0 109.38 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.0 p -129.66 137.38 50.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.108 0.963 . . . . 0.0 110.995 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.1 125.38 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.921 1.289 . . . . 0.0 110.271 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.12 128.03 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.895 2.078 . . . . 0.0 108.994 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -126.74 110.14 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.154 1.381 . . . . 0.0 111.291 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.27 143.38 27.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.449 1.9 . . . . 0.0 112.383 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -134.02 126.27 29.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.983 1.313 . . . . 0.0 110.001 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.59 73.99 0.3 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.554 2.026 . . . . 0.0 111.206 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.97 123.22 16.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.006 1.322 . . . . 0.0 110.92 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -151.51 80.34 1.29 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.49 1.516 . . . . 0.0 112.62 -169.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -113.27 0.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.282 1.433 . . . . 0.0 114.814 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.34 -0.88 55.66 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.321 1.289 . . . . 0.0 116.321 -175.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 2.05 75.11 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.16 1.362 . . . . 0.0 115.664 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.49 -163.56 33.33 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.559 1.552 . . . . 0.0 114.262 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -64.83 -172.69 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.719 1.607 . . . . 0.0 112.705 170.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.16 21.02 14.18 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 125.328 1.442 . . . . 0.0 115.121 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -137.49 159.73 41.13 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.895 1.678 . . . . 0.0 112.065 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.98 -25.56 64.59 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.58 -74.58 0.39 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.1 1.81 . . . . 0.0 112.663 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.26 166.24 30.31 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.559 2.84 . . . . 0.0 112.774 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.3 pt -102.33 133.86 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.962 1.305 . . . . 0.0 111.232 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.41 167.46 21.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.533 1.533 . . . . 0.0 111.19 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.5 mt -86.17 172.23 10.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.371 1.868 . . . . 0.0 112.517 173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.45 158.31 31.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.409 1.481 . . . . 0.0 112.643 171.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -74.82 132.8 41.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 111.404 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.05 85.06 2.14 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.366 1.466 . . . . 0.0 111.277 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -127.06 165.43 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.309 1.044 . . . . 0.0 112.373 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.2 mm -64.56 148.38 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.503 1.521 . . . . 0.0 110.872 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.5 m -126.04 100.43 6.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.89 1.276 . . . . 0.0 110.595 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -92.04 149.46 21.51 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.95 168.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.34 103.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.082 2.153 . . . . 0.0 109.22 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -139.1 157.73 45.44 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.095 -1.003 . . . . 0.0 112.507 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.03 157.2 72.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 165.09 31.31 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.628 2.885 . . . . 0.0 113.189 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.89 168.93 17.39 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.534 2.823 . . . . 0.0 112.439 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.58 169.37 11.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.922 1.689 . . . . 0.0 111.52 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.06 135.67 56.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.892 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.34 161.04 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.947 1.699 . . . . 0.0 110.76 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.806 1.643 . . . . 0.0 112.464 -179.328 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.28 157.96 18.6 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.938 1.695 . . . . 0.0 112.485 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -57.08 -39.55 75.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.526 1.13 . . . . 0.0 113.984 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.15 -12.77 59.62 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.95 -21.95 36.94 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.254 1.021 . . . . 0.0 112.917 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -66.59 137.81 57.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.405 1.482 . . . . 0.0 110.334 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -143.02 157.83 44.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.454 1.102 . . . . 0.0 111.907 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.29 68.9 2.74 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.431 1.492 . . . . 0.0 113.084 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.33 -0.51 8.27 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.51 -30.29 69.63 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.663 -1.273 . . . . 0.0 114.215 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.31 -25.36 15.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.1 t -75.28 -21.17 58.7 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.872 -0.518 . . . . 0.0 111.746 170.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 142.81 50.48 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.822 -1.173 . . . . 0.0 112.061 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -118.75 167.81 11.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.277 1.431 . . . . 0.0 110.663 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.44 160.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.494 1.118 . . . . 0.0 111.066 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.94 -37.34 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.631 1.173 . . . . 0.0 111.946 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -28.06 66.19 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.093 0.957 . . . . 0.0 112.882 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -77.3 -59.6 2.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.975 1.31 . . . . 0.0 110.767 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 84.0 t -48.67 -42.5 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 125.055 1.342 . . . . 0.0 113.292 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.8 t -58.95 -19.33 41.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.281 1.432 . . . . 0.0 113.454 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -101.92 -34.26 9.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.803 1.241 . . . . 0.0 113.161 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 24.1 mt -51.04 -44.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.496 1.044 . . . . 0.0 110.608 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.29 -43.31 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.453 -0.779 . . . . 0.0 112.874 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -51.02 62.88 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.733 1.151 . . . . 0.0 111.592 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -34.48 76.69 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.11 59.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.946 0.898 . . . . 0.0 113.34 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.18 -57.22 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.206 0.912 . . . . 0.0 109.064 174.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.29 -31.29 72.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.5 p -69.98 -37.57 75.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.19 -0.944 . . . . 0.0 112.681 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.16 -31.22 68.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.388 1.075 . . . . 0.0 113.462 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.8 -35.75 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.364 1.465 . . . . 0.0 112.636 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -58.74 -1.05 0.73 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -159.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.41 -32.68 81.91 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.904 1.852 . . . . 0.0 115.285 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -166.67 2.31 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.848 1.324 . . . . 0.0 112.511 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.07 161.92 3.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.383 1.473 . . . . 0.0 112.703 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.65 130.19 39.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.314 1.446 . . . . 0.0 111.132 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -132.89 133.97 43.97 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.776 1.23 . . . . 0.0 112.156 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -73.57 -43.17 60.47 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.25 1.02 . . . . 0.0 113.101 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 7.2 t -62.23 -27.68 69.16 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.066 -1.021 . . . . 0.0 112.502 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -73.25 -26.19 61.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -53.81 -34.03 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.261 1.391 . . . . 0.0 112.571 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.58 -49.62 72.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.1 1.36 . . . . 0.0 112.567 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.06 -25.42 66.24 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.198 -0.939 . . . . 0.0 112.932 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -78.39 -52.72 8.17 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.611 0.764 . . . . 0.0 111.756 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.75 -22.73 62.5 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.8 t -82.83 -60.6 2.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.492 1.042 . . . . 0.0 112.205 165.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -56.83 -41.31 77.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.302 1.41 . . . . 0.0 114.294 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.35 -64.67 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 110.036 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 87.6 t -47.7 -30.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.958 1.303 . . . . 0.0 110.973 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.08 -38.15 72.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.009 0.924 . . . . 0.0 113.162 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.6 -35.41 5.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 112.596 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 44.7 m -61.48 -52.66 63.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.157 2.183 . . . . 0.0 112.634 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -34.23 76.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.487 0.585 . . . . 0.0 111.192 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 66.5 m -61.06 -53.6 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.511 0.725 . . . . 0.0 111.887 167.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -54.42 -50.88 66.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.594 1.958 . . . . 0.0 112.648 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.38 -26.55 64.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 66.7 m -59.27 -43.48 92.49 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -71.87 -23.25 61.48 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.38 4.96 4.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.28 1.432 . . . . 0.0 113.464 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -155.93 -97.28 0.13 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.517 1.053 . . . . 0.0 114.941 164.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -67.67 171.22 5.52 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 125.156 1.382 . . . . 0.0 114.666 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.62 169.7 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.019 1.812 . . . . 0.0 111.889 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -56.26 114.19 1.87 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.591 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.8 97.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 129.342 3.057 . . . . 0.0 110.169 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -149.8 171.88 16.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.687 2.395 . . . . 0.0 109.044 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -135.24 153.53 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.903 1.681 . . . . 0.0 108.217 162.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.02 141.88 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.863 0.865 . . . . 0.0 110.124 166.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.257 1.423 . . . . 0.0 108.895 169.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.2 p -135.79 150.21 49.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.12 0.962 . . . . 0.0 113.078 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 12.9 t -132.27 125.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.894 1.677 . . . . 0.0 108.184 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mm -122.49 104.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.997 2.119 . . . . 0.0 107.418 -174.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 162.97 29.28 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 112.753 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.1 137.34 52.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.265 1.426 . . . . 0.0 111.134 -174.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -89.1 -14.18 36.88 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -77.85 -17.06 57.8 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 173.59 21.37 0.02 OUTLIER Glycine 0 CA--C 1.538 1.517 0 N-CA-C 117.703 1.841 . . . . 0.0 117.703 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.73 73.25 1.42 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.773 1.786 . . . . 0.0 112.767 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.5 160.16 32.73 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.682 1.134 . . . . 0.0 113.518 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.02 176.68 10.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.797 2.039 . . . . 0.0 111.941 -177.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.19 131.2 53.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.677 1.591 . . . . 0.0 110.957 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 90.6 m -139.05 143.38 38.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.449 1.1 . . . . 0.0 109.916 174.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.8 128.73 27.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 110.23 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.9 p -130.81 114.69 15.63 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.845 0.858 . . . . 0.0 110.912 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 t -78.16 11.21 2.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.447 1.099 . . . . 0.0 112.712 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.2 m -58.42 162.51 3.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.803 1.641 . . . . 0.0 112.774 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -158.96 138.55 11.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.846 1.258 . . . . 0.0 110.537 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.73 145.0 47.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.391 0.677 . . . . 0.0 109.927 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -130.13 151.81 50.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.614 1.566 . . . . 0.0 110.23 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 29.7 t -106.75 -64.28 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.927 1.291 . . . . 0.0 112.211 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 70.8 p -83.65 -31.64 26.06 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.868 0.867 . . . . 0.0 113.262 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -48.81 58.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 111.928 -173.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.07 -175.12 5.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.881 2.472 . . . . 0.0 110.754 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.99 146.74 16.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.784 1.183 . . . . 0.0 112.252 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 1.4 m -152.73 126.69 9.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.098 1.359 . . . . 0.0 110.679 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 16.8 t -121.33 130.08 53.43 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.59 1.156 . . . . 0.0 111.416 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.5 t -125.53 143.73 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.166 0.986 . . . . 0.0 111.338 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.42 131.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.506 1.523 . . . . 0.0 109.183 -172.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 114.47 17.8 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.434 1.493 . . . . 0.0 111.346 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.77 102.67 7.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.456 1.903 . . . . 0.0 109.408 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 165.95 7.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.492 -0.755 . . . . 0.0 112.093 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -144.1 -178.74 6.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.998 0.919 . . . . 0.0 111.581 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -51.08 59.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.858 1.663 . . . . 0.0 113.751 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -129.4 -29.28 2.23 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.519 1.528 . . . . 0.0 113.992 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -97.14 179.17 5.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.529 1.532 . . . . 0.0 111.828 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.57 151.72 36.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.369 1.468 . . . . 0.0 109.539 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 29.9 p -129.53 137.52 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.072 0.949 . . . . 0.0 111.148 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.0 130.02 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.992 1.317 . . . . 0.0 109.975 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.5 125.72 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.695 1.598 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.8 m -121.87 109.05 14.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.876 1.671 . . . . 0.0 110.916 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -94.52 143.83 26.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 112.579 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -134.76 122.46 22.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.347 1.459 . . . . 0.0 109.737 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.43 74.08 0.27 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.419 1.961 . . . . 0.0 111.331 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.92 121.82 13.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.016 1.326 . . . . 0.0 110.919 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.9 m -149.77 76.55 1.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.994 1.718 . . . . 0.0 112.406 -169.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.15 -2.1 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.221 1.408 . . . . 0.0 114.698 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.86 0.81 60.9 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.96 1.83 75.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 118.951 1.376 . . . . 0.0 115.732 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.53 -163.94 34.08 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.607 1.575 . . . . 0.0 114.187 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.5 t -65.03 -172.36 0.09 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.732 1.613 . . . . 0.0 112.805 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 99.67 20.78 15.96 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 125.289 1.423 . . . . 0.0 114.953 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -137.37 159.17 42.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.9 1.68 . . . . 0.0 112.226 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.3 t -69.14 -25.85 64.59 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 123.82 -74.06 0.4 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 126.089 1.804 . . . . 0.0 112.844 -177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.18 166.55 29.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.663 2.909 . . . . 0.0 112.845 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 30.3 pt -103.25 134.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.895 1.278 . . . . 0.0 111.241 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.71 167.44 21.42 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.622 1.569 . . . . 0.0 111.236 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 8.3 mt -86.44 172.93 9.99 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.413 1.885 . . . . 0.0 112.616 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.62 159.03 32.02 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.126 1.345 . . . . 0.0 113.177 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -76.63 129.17 36.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.018 0.927 . . . . 0.0 111.456 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.86 83.41 2.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.711 1.604 . . . . 0.0 111.682 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -127.92 166.51 18.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.031 0.933 . . . . 0.0 111.993 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.38 149.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.53 1.532 . . . . 0.0 111.274 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 86.4 m -126.96 99.89 5.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.005 1.322 . . . . 0.0 110.725 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -93.94 150.03 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.163 -0.961 . . . . 0.0 110.858 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.28 104.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.534 1.934 . . . . 0.0 110.062 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.61 159.18 42.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.031 1.332 . . . . 0.0 112.373 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.3 156.61 72.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.844 1.658 . . . . 0.0 111.94 -178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.04 165.23 30.87 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.612 2.875 . . . . 0.0 113.18 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.61 168.85 17.17 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.546 2.831 . . . . 0.0 112.475 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.74 169.26 12.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.034 1.734 . . . . 0.0 111.486 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.84 134.6 55.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.135 0.974 . . . . 0.0 110.918 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.18 152.95 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 110.95 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.696 1.998 . . . . 0.0 110.455 -178.572 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -68.51 84.28 0.28 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.918 2.087 . . . . 0.0 114.074 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -15.24 0.58 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.641 1.976 . . . . 0.0 115.882 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.94 -38.73 79.65 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.5 -3.07 2.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.49 1.516 . . . . 0.0 112.446 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.23 172.68 12.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.492 1.917 . . . . 0.0 111.631 -173.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -150.9 177.44 10.13 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.178 1.391 . . . . 0.0 111.562 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.53 120.51 39.77 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.38 1.472 . . . . 0.0 110.59 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.85 100.9 9.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.468 1.507 . . . . 0.0 111.982 -174.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.81 -18.01 40.46 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -59.38 -12.45 5.93 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 169.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 t -61.21 -18.59 59.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.195 1.398 . . . . 0.0 113.681 168.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.58 148.96 49.75 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.819 -1.175 . . . . 0.0 111.508 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.27 170.16 8.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.262 1.425 . . . . 0.0 111.764 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -149.57 157.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.72 1.208 . . . . 0.0 111.366 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -53.45 -41.27 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.834 1.653 . . . . 0.0 112.063 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.91 -25.85 67.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.74 1.216 . . . . 0.0 113.544 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -79.96 -56.22 4.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.022 0.929 . . . . 0.0 110.632 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.0 t -47.34 -43.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.432 1.893 . . . . 0.0 112.381 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -63.79 -9.66 15.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.292 1.837 . . . . 0.0 114.362 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -111.17 -32.67 6.69 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.524 1.93 . . . . 0.0 112.475 172.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.3 mt -50.74 -43.37 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.014 0.825 . . . . 0.0 110.317 168.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.15 -44.04 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.495 -0.753 . . . . 0.0 112.957 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -52.36 51.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.756 1.162 . . . . 0.0 111.318 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -34.75 77.26 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.41 -41.42 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.78 0.832 . . . . 0.0 112.984 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.2 mt -58.25 -59.56 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.297 0.953 . . . . 0.0 109.522 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -62.97 -29.95 71.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.29 -49.93 75.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.27 1.028 . . . . 0.0 112.104 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.46 72.04 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.48 -40.67 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.799 1.24 . . . . 0.0 111.506 173.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.11 74.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.163 0.887 . . . . 0.0 115.139 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.71 -0.31 36.56 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.392 1.472 . . . . 0.0 116.256 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.47 162.03 8.64 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 118.879 1.34 . . . . 0.0 112.008 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.31 -166.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.599 1.56 . . . . 0.0 111.57 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -43.92 121.67 2.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.392 2.277 . . . . 0.0 112.425 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -115.81 170.17 8.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.631 1.172 . . . . 0.0 113.085 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 -95.86 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.703 1.201 . . . . 0.0 109.317 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -76.81 -21.01 55.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.637 1.175 . . . . 0.0 113.988 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -41.81 76.9 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.998 0.919 . . . . 0.0 112.367 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.16 -33.42 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.02 -46.73 80.1 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.362 0.983 . . . . 0.0 112.204 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -65.79 -24.84 67.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.692 0.678 . . . . 0.0 112.532 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.75 -51.86 9.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.034 0.833 . . . . 0.0 111.887 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -56.52 -29.59 62.06 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.847 0.749 . . . . 0.0 112.521 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -79.35 -60.77 2.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.389 0.995 . . . . 0.0 112.409 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.84 -38.6 75.96 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.334 1.453 . . . . 0.0 114.284 -172.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 81.7 t -68.21 -64.44 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 123.9 0.88 . . . . 0.0 109.469 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.9 t -50.42 -28.44 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.469 1.507 . . . . 0.0 110.835 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.11 28.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.579 1.151 . . . . 0.0 112.115 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -93.27 -35.56 13.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.041 1.336 . . . . 0.0 112.734 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -59.75 -54.38 47.03 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.944 2.097 . . . . 0.0 112.285 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -37.44 83.15 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.122 0.487 . . . . 0.0 111.236 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.0 t -62.18 -40.45 96.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.151 -0.968 . . . . 0.0 113.102 170.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.1 -49.85 63.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.721 1.608 . . . . 0.0 112.422 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.74 -24.8 65.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.9 m -55.89 -34.76 65.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.674 0.789 . . . . 0.0 110.919 163.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -84.88 -31.46 23.72 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.13 -30.47 70.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.472 0.709 . . . . 0.0 111.578 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.38 -100.81 2.61 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.147 1.832 . . . . 0.0 112.724 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -136.63 141.76 36.6 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.867 1.267 . . . . 0.0 113.677 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.44 104.18 1.66 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.448 3.432 . . . . 0.0 112.605 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -142.84 179.89 6.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.078 1.751 . . . . 0.0 112.166 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.5 89.25 3.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.464 1.506 . . . . 0.0 111.706 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.13 147.42 25.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.033 1.333 . . . . 0.0 110.747 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.3 152.96 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 126.117 1.767 . . . . 0.0 109.292 174.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.5 m -138.39 146.68 26.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.604 1.161 . . . . 0.0 110.823 172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 126.98 20.02 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.422 1.889 . . . . 0.0 108.921 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 p -129.7 138.09 50.95 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 112.552 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.1 98.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.139 1.376 . . . . 0.0 109.5 -167.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -106.7 91.32 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.359 1.864 . . . . 0.0 107.928 -171.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -147.37 93.83 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.057 1.743 . . . . 0.0 110.763 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.54 133.37 8.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 109.649 170.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -52.05 0.14 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.274 1.43 . . . . 0.0 112.123 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.68 -23.95 8.98 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.875 1.27 . . . . 0.0 113.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.0 -1.34 38.35 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.538 1.542 . . . . 0.0 115.056 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.29 68.58 1.43 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.402 1.881 . . . . 0.0 111.237 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.9 15.93 0.09 OUTLIER Glycine 0 CA--C 1.537 1.429 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 -170.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.41 104.46 4.59 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.656 1.983 . . . . 0.0 110.005 -159.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 132.7 51.66 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.836 -1.165 . . . . 0.0 108.835 173.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 m -154.15 140.63 18.79 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.257 -1.527 . . . . 0.0 109.603 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.06 24.36 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.544 -0.722 . . . . 0.0 112.811 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -142.03 129.63 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.619 0.768 . . . . 0.0 110.51 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -79.75 8.83 5.96 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.292 -0.88 . . . . 0.0 112.482 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.65 162.94 17.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.636 1.174 . . . . 0.0 112.675 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.17 151.84 28.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.423 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 169.07 18.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.942 0.497 . . . . 0.0 111.484 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -139.41 148.61 43.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.213 1.005 . . . . 0.0 111.427 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -112.49 -68.94 0.9 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.461 1.504 . . . . 0.0 111.634 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.3 t -84.3 -38.82 19.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.698 0.799 . . . . 0.0 112.108 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -67.51 -45.96 74.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.672 1.189 . . . . 0.0 112.689 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.6 -169.8 3.47 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.56 2.344 . . . . 0.0 110.408 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.43 174.13 15.14 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.266 1.412 . . . . 0.0 114.518 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.7 t -154.88 163.1 40.78 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.385 1.874 . . . . 0.0 111.151 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 20.9 t -164.88 115.13 1.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.002 1.321 . . . . 0.0 112.164 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.694 -1.254 . . . . 0.0 112.01 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.62 151.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 110.184 -172.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -138.94 121.68 16.43 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.501 1.52 . . . . 0.0 111.02 -168.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -135.52 103.1 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.9 1.68 . . . . 0.0 111.018 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.47 142.49 58.37 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.027 -1.046 . . . . 0.0 112.254 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.35 -167.8 1.79 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.842 1.257 . . . . 0.0 109.932 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.03 -52.01 9.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.842 2.057 . . . . 0.0 114.585 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -140.59 -35.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.162 1.785 . . . . 0.0 111.402 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.4 ptp -79.03 112.95 16.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.478 1.511 . . . . 0.0 111.795 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.78 116.48 19.97 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.269 -1.519 . . . . 0.0 109.889 170.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 134.42 35.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.114 173.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.26 132.26 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.778 1.631 . . . . 0.0 109.846 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.77 127.88 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.615 1.566 . . . . 0.0 110.728 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 t -119.14 111.89 18.83 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.124 0.97 . . . . 0.0 110.802 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.47 139.62 30.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.913 0.885 . . . . 0.0 111.193 167.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -124.12 126.71 46.65 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 109.313 168.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.56 78.35 0.24 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 125.531 1.538 . . . . 0.0 112.35 -170.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.66 123.26 24.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.654 1.581 . . . . 0.0 111.764 -173.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.4 m -137.64 93.61 2.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.174 2.19 . . . . 0.0 112.807 -164.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.71 -2.2 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.92 63.53 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.441 1.496 . . . . 0.0 115.698 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.88 45.3 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.552 1.176 . . . . 0.0 115.46 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.06 138.9 48.15 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 118.705 1.252 . . . . 0.0 113.048 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.8 m -134.04 -173.75 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.053 1.741 . . . . 0.0 111.849 -175.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.91 12.66 6.39 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 124.816 1.198 . . . . 0.0 115.476 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -56.25 162.67 1.93 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.07 1.748 . . . . 0.0 115.635 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.5 t -103.13 -45.89 4.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.168 1.787 . . . . 0.0 113.061 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.92 -178.3 50.54 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.08 1.324 . . . . 0.0 114.417 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 140.78 56.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.31 2.673 . . . . 0.0 111.256 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 pp -77.32 128.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.784 0.833 . . . . 0.0 111.855 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.81 154.77 49.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.927 1.691 . . . . 0.0 112.059 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -146.14 152.59 39.52 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.251 2.621 . . . . 0.0 109.155 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.1 -149.49 20.27 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.033 1.301 . . . . 0.0 112.533 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.74 175.72 1.06 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.075 0.95 . . . . 0.0 112.466 170.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.05 177.14 8.04 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 112.751 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -117.39 178.24 4.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 111.417 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -109.31 145.31 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.802 1.641 . . . . 0.0 109.926 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -117.4 90.71 3.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.047 1.339 . . . . 0.0 110.078 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -104.52 138.53 40.76 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.427 1.091 . . . . 0.0 110.816 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.45 98.98 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.214 2.606 . . . . 0.0 108.586 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.0 p30 -135.31 168.19 19.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.06 0.944 . . . . 0.0 111.82 168.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -98.84 154.03 37.58 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.437 1.095 . . . . 0.0 109.386 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 115.44 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.267 2.645 . . . . 0.0 111.272 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -53.93 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.656 2.237 . . . . 0.0 112.332 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.67 -176.28 4.21 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.554 2.741 . . . . 0.0 109.944 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -107.81 140.67 40.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.602 1.161 . . . . 0.0 111.328 165.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.51 177.45 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 127.25 2.22 . . . . 0.0 111.405 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.257 9.6 p . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.275 1.83 . . . . 0.0 111.647 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.1 p -69.39 70.32 0.26 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.513 1.925 . . . . 0.0 114.612 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -80.85 0.09 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.241 1.416 . . . . 0.0 111.896 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -92.48 -64.58 1.09 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.24 1.68 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.226 2.211 . . . . 0.0 111.455 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -69.32 162.56 26.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.519 1.128 . . . . 0.0 112.722 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -146.8 173.87 11.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.423 1.489 . . . . 0.0 112.041 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.61 102.92 10.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.421 1.888 . . . . 0.0 110.677 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.78 100.9 12.72 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.45 1.5 . . . . 0.0 112.594 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.29 -19.31 54.46 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.01 -13.02 5.37 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 170.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 4.7 t -57.71 -27.57 63.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.092 1.357 . . . . 0.0 113.423 171.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.59 134.24 49.69 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.739 -1.226 . . . . 0.0 111.634 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.72 159.11 15.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.085 0.954 . . . . 0.0 112.255 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.49 156.35 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.149 1.78 . . . . 0.0 110.767 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 44.3 t -51.21 -40.09 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.294 2.638 . . . . 0.0 112.415 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.97 -28.32 62.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 113.175 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.47 -46.96 7.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.045 0.938 . . . . 0.0 110.854 175.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -48.65 -42.27 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.502 1.121 . . . . 0.0 112.067 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 12.1 t -63.55 -9.13 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.545 1.938 . . . . 0.0 114.692 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -109.98 -32.09 7.16 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.688 1.995 . . . . 0.0 112.552 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.9 mt -51.46 -41.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.822 0.849 . . . . 0.0 110.517 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.22 -44.17 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 121.447 -0.783 . . . . 0.0 112.939 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.63 53.8 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.736 1.153 . . . . 0.0 111.345 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.6 77.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.64 65.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.529 0.731 . . . . 0.0 112.924 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.37 -59.9 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 119.127 0.876 . . . . 0.0 109.388 174.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.51 -30.15 71.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.1 t -61.3 -50.04 74.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 112.105 168.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.35 71.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.4 -40.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.822 1.249 . . . . 0.0 111.523 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.05 12.13 74.69 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.192 0.901 . . . . 0.0 115.036 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.56 -0.39 36.96 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.339 1.447 . . . . 0.0 116.266 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.61 162.49 8.3 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 118.852 1.326 . . . . 0.0 111.972 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -93.38 -166.16 1.47 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 111.505 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -43.82 125.58 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.482 2.313 . . . . 0.0 112.597 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -120.4 163.87 17.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.44 1.096 . . . . 0.0 113.749 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -71.91 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.055 1.342 . . . . 0.0 110.982 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m -107.31 -18.81 13.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.258 1.423 . . . . 0.0 113.694 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.42 -42.22 66.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.504 1.122 . . . . 0.0 111.991 174.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.43 -32.38 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.442 1.497 . . . . 0.0 114.5 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.94 -46.4 71.57 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.313 0.96 . . . . 0.0 112.11 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -65.58 -25.36 67.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.664 0.665 . . . . 0.0 112.327 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -77.64 -53.42 7.59 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.973 0.909 . . . . 0.0 111.823 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 15.1 t -56.35 -28.92 60.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.994 0.815 . . . . 0.0 112.671 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . 0.25 10.6 t -79.87 -61.91 1.85 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.425 1.011 . . . . 0.0 112.284 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.76 -38.45 72.48 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.592 1.557 . . . . 0.0 114.037 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.91 -64.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 99.5 t -50.55 -28.37 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.46 1.504 . . . . 0.0 110.939 178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -55.4 28.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.762 1.225 . . . . 0.0 112.037 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.73 -34.91 13.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.088 1.355 . . . . 0.0 112.817 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 38.2 m -60.7 -55.21 35.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.997 2.119 . . . . 0.0 112.343 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -36.45 82.19 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.515 0.598 . . . . 0.0 111.556 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 25.2 t -58.17 -51.08 71.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.635 0.774 . . . . 0.0 112.036 167.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.96 -50.91 71.89 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.808 1.643 . . . . 0.0 112.806 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.34 -27.73 67.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 63.9 m -57.33 -36.23 70.89 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.099 0.56 . . . . 0.0 110.598 165.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -79.15 -31.48 44.02 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.071 -1.018 . . . . 0.0 113.192 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.19 -28.95 61.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.178 0.591 . . . . 0.0 110.888 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.27 -94.95 1.99 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.355 1.931 . . . . 0.0 112.791 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -140.17 143.16 32.69 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.401 1.481 . . . . 0.0 113.061 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 114.12 3.75 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.732 2.955 . . . . 0.0 112.081 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.76 175.11 12.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.687 1.595 . . . . 0.0 112.673 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -94.54 87.65 5.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.744 1.218 . . . . 0.0 111.566 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -72.85 153.14 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.288 1.035 . . . . 0.0 112.253 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.5 tt -143.24 153.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.694 1.998 . . . . 0.0 108.72 166.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 15.5 m -139.75 144.79 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.296 1.038 . . . . 0.0 110.171 172.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.17 123.51 19.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.798 1.639 . . . . 0.0 108.681 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 11.8 p -124.5 142.13 51.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.186 0.994 . . . . 0.0 112.096 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 t -133.78 111.65 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.122 1.369 . . . . 0.0 107.622 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.2 mm -111.83 90.38 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.788 1.635 . . . . 0.0 107.73 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 162.69 13.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.478 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -75.23 137.98 41.61 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.405 0.622 . . . . 0.0 112.209 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -2.63 20.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.869 2.067 . . . . 0.0 114.185 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -55.06 -29.55 57.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.244 1.818 . . . . 0.0 113.901 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.47 75.89 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.797 1.189 . . . . 0.0 115.438 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.58 60.84 1.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.882 1.673 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.25 62.25 0.07 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-O 121.805 0.669 . . . . 0.0 114.225 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.85 96.25 1.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.698 1.999 . . . . 0.0 109.205 -171.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.18 101.39 6.74 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.199 -1.563 . . . . 0.0 108.63 173.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 22.8 m -130.98 139.09 49.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.398 -1.439 . . . . 0.0 109.765 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.97 138.36 31.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 m -141.46 135.73 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.79 0.836 . . . . 0.0 110.759 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 8.3 t -82.76 9.62 9.35 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.362 -0.836 . . . . 0.0 112.368 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.66 162.57 18.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.177 0.991 . . . . 0.0 112.685 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -154.97 149.9 26.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.207 1.803 . . . . 0.0 110.25 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.15 167.87 21.03 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.176 0.512 . . . . 0.0 111.225 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -139.38 148.65 43.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.451 1.1 . . . . 0.0 110.981 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -109.94 -68.31 0.93 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.536 1.535 . . . . 0.0 111.645 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 11.8 t -84.09 -39.46 19.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.871 0.868 . . . . 0.0 112.036 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -66.6 -46.48 75.75 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.026 1.331 . . . . 0.0 113.038 -172.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.68 -170.51 3.68 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 127.798 2.439 . . . . 0.0 110.19 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -116.08 173.75 14.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.21 1.386 . . . . 0.0 114.571 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 21.3 t -153.41 163.59 39.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.573 1.949 . . . . 0.0 111.062 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 23.1 t -164.85 111.66 1.0 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.023 1.329 . . . . 0.0 112.235 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.8 t -113.93 147.33 38.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.545 -1.347 . . . . 0.0 112.373 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.3 t -139.79 153.27 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.326 1.85 . . . . 0.0 110.394 -173.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -135.13 130.32 35.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.922 1.689 . . . . 0.0 111.621 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -138.68 101.94 4.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.414 1.886 . . . . 0.0 110.368 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.1 146.2 53.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.802 -1.186 . . . . 0.0 112.073 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.32 -175.34 3.84 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.011 1.325 . . . . 0.0 110.226 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.63 -66.74 0.33 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.111 1.764 . . . . 0.0 114.527 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -133.51 17.37 3.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.089 1.756 . . . . 0.0 111.88 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 12.8 ptp -137.92 158.45 44.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.741 2.016 . . . . 0.0 109.095 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -126.1 123.9 39.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.917 0.887 . . . . 0.0 109.894 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.36 130.72 39.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.828 0.851 . . . . 0.0 110.965 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.3 pt -128.72 129.68 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 109.188 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.79 126.03 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.634 1.574 . . . . 0.0 110.45 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 13.6 t -118.64 110.47 17.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.185 0.994 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.91 141.22 29.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.987 0.915 . . . . 0.0 111.316 167.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -125.07 125.6 44.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.258 1.423 . . . . 0.0 109.164 167.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.31 77.26 0.23 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.897 1.713 . . . . 0.0 111.67 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 123.53 25.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.276 1.431 . . . . 0.0 111.95 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m -137.53 99.49 3.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.321 2.248 . . . . 0.0 112.479 -165.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.65 -3.97 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -90.63 2.5 80.41 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.318 1.437 . . . . 0.0 115.724 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 91.83 17.65 47.28 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.738 1.269 . . . . 0.0 115.548 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -57.03 140.37 44.84 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 118.708 1.254 . . . . 0.0 113.352 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.4 m -134.6 -173.59 3.33 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.146 1.779 . . . . 0.0 111.907 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 120.17 11.41 6.87 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.767 1.175 . . . . 0.0 115.389 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -54.78 162.25 1.29 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.163 1.785 . . . . 0.0 115.809 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 32.5 t -102.27 -46.35 4.84 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.211 1.805 . . . . 0.0 113.087 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -78.64 -178.43 50.16 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.069 1.318 . . . . 0.0 114.436 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.68 141.44 60.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.236 2.624 . . . . 0.0 111.261 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.75 128.61 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.803 0.841 . . . . 0.0 111.87 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.81 154.72 49.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.999 1.72 . . . . 0.0 112.113 173.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 45.7 tp -146.38 152.59 39.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.165 2.586 . . . . 0.0 109.123 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 137.59 -149.77 20.5 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.968 1.271 . . . . 0.0 112.548 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 175.22 1.12 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.998 0.919 . . . . 0.0 112.328 169.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -135.31 178.02 7.36 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.07 1.348 . . . . 0.0 112.646 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -118.29 176.53 5.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.041 1.737 . . . . 0.0 111.51 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.51 146.42 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.753 1.621 . . . . 0.0 109.859 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 27.1 m -119.73 90.8 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.867 1.267 . . . . 0.0 110.027 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -109.11 140.4 42.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 0.0 110.958 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 3.0 p -136.14 94.23 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 127.906 2.482 . . . . 0.0 109.68 -175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.3 167.69 18.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.683 1.193 . . . . 0.0 113.032 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -94.23 152.3 40.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.07 0.948 . . . . 0.0 110.303 166.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.28 113.87 3.24 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.377 2.718 . . . . 0.0 110.887 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.74 -52.47 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.506 2.138 . . . . 0.0 112.333 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.17 -176.02 3.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.631 2.772 . . . . 0.0 109.865 177.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.12 140.26 41.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.62 1.168 . . . . 0.0 111.269 165.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.37 177.31 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.227 2.211 . . . . 0.0 111.411 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . 0.26 10.2 p . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.363 1.865 . . . . 0.0 111.713 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.481 0 CA-C-O 119.594 -0.559 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m -123.37 -15.72 7.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.486 1.115 . . . . 0.0 113.928 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.81 -20.51 66.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 112.824 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -63.93 -20.88 66.18 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.802 1.241 . . . . 0.0 114.244 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.56 -23.27 37.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.872 0.869 . . . . 0.0 112.955 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.61 151.77 42.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.114 0.966 . . . . 0.0 111.97 170.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -152.16 168.34 25.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.716 1.606 . . . . 0.0 111.083 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.69 174.28 8.41 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.071 1.748 . . . . 0.0 112.543 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.76 151.95 46.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.902 0.881 . . . . 0.0 113.218 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.56 -23.89 67.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.836 0.855 . . . . 0.0 112.725 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.19 -26.15 42.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -93.79 -21.05 19.54 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.175 0.99 . . . . 0.0 112.424 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.0 128.11 35.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.685 1.194 . . . . 0.0 111.752 168.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -104.75 176.0 5.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.9 1.28 . . . . 0.0 111.313 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -140.89 154.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.516 1.127 . . . . 0.0 112.065 176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -57.98 -44.52 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.579 1.552 . . . . 0.0 112.214 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.31 -26.39 68.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.921 0.888 . . . . 0.0 113.045 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -77.23 -60.41 2.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.146 1.379 . . . . 0.0 109.837 172.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.5 t -48.97 -42.6 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.789 1.636 . . . . 0.0 112.518 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -66.91 -9.55 39.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.703 1.601 . . . . 0.0 114.247 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -107.56 -32.46 7.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.275 1.83 . . . . 0.0 112.613 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -50.24 -44.52 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.248 1.019 . . . . 0.0 110.09 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.51 -45.41 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -50.34 62.53 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.458 1.027 . . . . 0.0 111.575 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -33.53 75.83 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.37 68.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.788 0.835 . . . . 0.0 112.406 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.7 mt -58.86 -57.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.889 0.768 . . . . 0.0 110.179 175.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -63.94 -25.14 68.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -66.71 -50.21 63.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.571 -0.706 . . . . 0.0 111.611 166.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.01 65.66 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.567 1.547 . . . . 0.0 114.217 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.13 -30.28 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 127.389 2.276 . . . . 0.0 112.059 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.69 -14.69 0.01 OUTLIER Glycine 0 C--O 1.279 2.967 0 N-CA-C 120.662 3.025 . . . . 0.0 120.662 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.24 -42.3 49.01 Favored Glycine 0 N--CA 1.482 1.702 0 C-N-CA 127.761 2.6 . . . . 0.0 115.772 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.47 -168.76 3.14 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.224 2.012 . . . . 0.0 111.896 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.79 -170.46 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.955 2.502 . . . . 0.0 112.798 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -74.28 103.82 4.82 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 119.978 -1.701 . . . . 0.0 111.192 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -122.99 88.52 2.94 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.021 1.328 . . . . 0.0 113.514 -174.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -64.96 -16.06 62.92 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.7 p -79.4 -31.56 42.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.988 1.715 . . . . 0.0 115.408 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -61.89 -15.39 42.32 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.159 1.784 . . . . 0.0 114.366 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.1 t -49.62 -31.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.754 1.622 . . . . 0.0 113.262 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -60.51 -53.36 58.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.947 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -67.94 -26.56 66.02 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.362 -0.837 . . . . 0.0 112.317 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -76.86 -52.66 9.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 111.223 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 t -59.0 -28.62 66.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 112.692 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -79.06 -59.36 2.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.156 0.889 . . . . 0.0 112.337 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.07 -38.02 78.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.781 1.173 . . . . 0.0 114.016 -172.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.82 -59.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 C-N-CA 123.691 0.796 . . . . 0.0 110.574 -177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.61 -30.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.12 0.968 . . . . 0.0 110.835 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.22 -28.41 70.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.01 -42.86 3.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.063 1.745 . . . . 0.0 112.385 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 m -54.97 -54.18 46.11 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.552 2.341 . . . . 0.0 113.016 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -39.06 93.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.125 0.42 . . . . 0.0 110.675 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -58.22 -52.02 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.308 0.643 . . . . 0.0 111.456 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.47 -47.62 83.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.391 2.276 . . . . 0.0 113.598 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.3 -25.51 63.36 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.667 -1.271 . . . . 0.0 114.403 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.1 m -61.76 -24.44 66.82 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.645 -0.659 . . . . 0.0 111.299 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -91.03 -19.89 22.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.76 -22.2 59.94 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.598 0.759 . . . . 0.0 112.729 162.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.89 -154.65 28.8 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.227 1.87 . . . . 0.0 112.143 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -90.8 161.57 35.59 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.847 1.659 . . . . 0.0 112.317 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.35 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.813 3.009 . . . . 0.0 112.384 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.45 165.26 32.65 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.543 1.537 . . . . 0.0 112.123 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -75.36 93.61 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.584 1.554 . . . . 0.0 111.241 170.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -68.52 162.77 24.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.619 -0.676 . . . . 0.0 111.378 163.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.3 150.72 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.618 1.567 . . . . 0.0 108.905 163.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.8 148.13 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.219 1.008 . . . . 0.0 111.117 164.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -140.24 156.3 46.54 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.13 1.372 . . . . 0.0 110.161 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.6 p -143.88 146.38 32.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.759 1.623 . . . . 0.0 111.968 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 124.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.997 1.319 . . . . 0.0 108.006 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.2 112.31 37.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 127.937 2.495 . . . . 0.0 107.332 -169.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.2 tpt -140.53 146.96 38.81 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.35 1.46 . . . . 0.0 111.169 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -95.3 130.11 42.18 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.628 1.171 . . . . 0.0 112.727 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -69.45 -10.11 56.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.324 1.85 . . . . 0.0 114.454 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.74 -20.61 35.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.744 2.017 . . . . 0.0 114.294 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.3 -1.5 3.03 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.124 1.345 . . . . 0.0 114.913 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 155.55 27.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.902 1.351 . . . . 0.0 111.626 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.82 160.32 31.83 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.084 0.85 . . . . 0.0 113.289 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 168.68 22.0 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.082 1.753 . . . . 0.0 112.586 -173.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -121.76 132.46 54.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 110.695 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 m -139.08 146.08 40.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.361 1.464 . . . . 0.0 109.729 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.95 146.38 30.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.39 0.676 . . . . 0.0 111.377 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.4 p -148.18 151.14 35.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 t -79.24 11.08 3.07 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.8 m -63.86 173.2 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.384 -0.823 . . . . 0.0 112.648 173.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -162.94 154.88 18.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.876 2.071 . . . . 0.0 109.931 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -76.83 147.62 37.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.207 1.003 . . . . 0.0 110.474 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.2 81.29 0.69 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -62.56 1.54 Allowed 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.522 -1.361 . . . . 0.0 113.315 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 p -97.07 -11.04 24.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.918 1.687 . . . . 0.0 113.117 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -47.8 21.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.251 1.42 . . . . 0.0 112.726 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -154.46 -47.63 0.09 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.02 111.36 1.4 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-N 120.35 1.432 . . . . 0.0 115.145 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -146.37 163.85 34.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.49 1.516 . . . . 0.0 112.352 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.1 t -156.46 149.37 23.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.203 1.801 . . . . 0.0 110.608 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 t -142.67 142.79 32.11 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.73 -1.856 . . . . 0.0 111.138 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.4 107.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.137 0.975 . . . . 0.0 109.995 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -92.17 124.01 35.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.106 0.962 . . . . 0.0 112.437 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -131.21 136.95 48.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.101 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.98 164.36 12.56 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 111.795 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -138.23 -178.73 5.41 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.871 1.668 . . . . 0.0 110.018 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.25 -49.59 60.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.061 2.545 . . . . 0.0 114.193 -175.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.5 t -136.45 0.77 2.55 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.173 1.389 . . . . 0.0 113.282 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.4 ptp -132.84 176.88 8.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.86 1.664 . . . . 0.0 111.958 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -136.09 147.47 47.84 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.98 1.312 . . . . 0.0 110.694 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.21 69.66 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.964 1.306 . . . . 0.0 110.786 -163.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.53 138.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.323 1.049 . . . . 0.0 111.325 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.09 145.15 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.688 1.595 . . . . 0.0 111.613 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.26 120.98 16.35 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.912 1.285 . . . . 0.0 110.469 -166.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.93 136.74 52.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.132 1.773 . . . . 0.0 112.711 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.23 117.27 17.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.165 1.386 . . . . 0.0 108.372 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.04 73.15 0.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.113 1.34 . . . . 0.0 112.945 -163.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.02 119.76 18.68 Favored 'General case' 0 C--O 1.273 2.331 0 C-N-CA 125.243 1.417 . . . . 0.0 111.544 -165.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.3 t -141.13 79.38 1.69 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.372 1.558 . . . . 0.0 114.042 -165.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.3 -12.77 3.41 Favored 'Isoleucine or valine' 0 C--O 1.267 2.025 0 C-N-CA 125.27 1.428 . . . . 0.0 113.993 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.13 0.69 89.61 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 126.882 2.182 . . . . 0.0 115.421 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.66 9.0 2.36 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.95 18.99 10.64 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.754 1.777 . . . . 0.0 115.942 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -117.39 71.73 0.82 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 125.829 1.651 . . . . 0.0 112.105 -163.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.72 1.08 82.8 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.016 1.166 . . . . 0.0 116.016 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -78.93 64.85 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -165.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.2 p -161.44 -11.53 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.46 -169.83 18.94 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.256 2.36 . . . . 0.0 111.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.12 138.05 38.87 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.715 2.277 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.07 166.95 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.652 1.181 . . . . 0.0 111.454 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 172.54 12.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.896 1.678 . . . . 0.0 112.526 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 166.88 9.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.453 1.101 . . . . 0.0 112.449 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.36 -175.62 37.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.734 1.159 . . . . 0.0 112.973 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -138.35 164.0 30.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.453 1.901 . . . . 0.0 111.041 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.13 77.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.342 1.057 . . . . 0.0 112.328 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -129.36 164.2 24.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.277 1.031 . . . . 0.0 112.334 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.5 mm -49.02 137.49 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 128.408 2.683 . . . . 0.0 112.053 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 93.7 m -100.49 92.01 4.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.981 1.312 . . . . 0.0 110.598 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -89.12 150.54 22.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.213 167.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.29 103.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.46 2.304 . . . . 0.0 109.007 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.51 130.2 40.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 111.153 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.76 90.58 47.65 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.548 1.539 . . . . 0.0 108.487 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 166.22 28.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.052 2.501 . . . . 0.0 111.886 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.71 -56.15 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.781 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -165.39 170.2 14.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 129.317 3.047 . . . . 0.0 109.333 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.89 136.22 43.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.098 0.559 . . . . 0.0 110.757 164.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 164.64 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.08 1.752 . . . . 0.0 111.499 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 125.979 1.712 . . . . 0.0 110.907 174.532 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.457 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -121.55 -14.89 8.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.277 1.431 . . . . 0.0 113.69 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.53 -20.69 66.37 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 112.847 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.15 -20.81 66.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.802 1.241 . . . . 0.0 114.26 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.74 -23.33 36.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 112.916 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.52 152.47 42.97 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.127 0.971 . . . . 0.0 111.873 169.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -151.58 169.34 22.35 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.701 1.6 . . . . 0.0 111.074 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.49 174.65 8.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.095 1.758 . . . . 0.0 112.498 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.69 153.16 43.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.01 0.924 . . . . 0.0 112.942 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.99 -27.79 68.4 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.413 -0.804 . . . . 0.0 112.411 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.06 -26.64 59.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 6.0 t -92.17 -19.45 22.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.997 0.919 . . . . 0.0 112.605 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.69 115.47 15.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.796 1.238 . . . . 0.0 112.242 173.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -84.96 179.23 7.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.517 1.127 . . . . 0.0 112.024 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.25 156.7 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.343 -0.848 . . . . 0.0 113.049 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.9 -44.49 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.559 1.944 . . . . 0.0 111.969 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.08 -25.83 68.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.595 0.758 . . . . 0.0 113.035 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -78.57 -59.5 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.259 1.423 . . . . 0.0 110.048 172.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -49.29 -43.58 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 126.359 1.864 . . . . 0.0 112.173 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -66.95 -9.29 36.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.469 1.508 . . . . 0.0 114.152 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -106.88 -32.44 7.91 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.21 1.804 . . . . 0.0 112.715 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 28.6 mt -50.37 -44.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.341 1.056 . . . . 0.0 110.057 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.44 -45.29 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -50.44 61.42 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.469 1.031 . . . . 0.0 111.574 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.12 74.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.32 66.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.745 0.818 . . . . 0.0 112.411 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.6 mt -58.99 -57.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.932 0.787 . . . . 0.0 110.101 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.75 -25.32 68.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -66.79 -50.05 63.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.693 -0.629 . . . . 0.0 111.553 166.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.71 -24.87 65.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.544 1.538 . . . . 0.0 114.235 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 mt -56.12 -30.3 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 127.415 2.286 . . . . 0.0 111.916 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -41.31 -13.61 0.01 OUTLIER Glycine 0 C--O 1.28 3.012 0 N-CA-C 120.656 3.023 . . . . 0.0 120.656 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.14 -42.01 54.46 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 127.724 2.583 . . . . 0.0 115.574 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.34 -168.82 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.35 2.075 . . . . 0.0 111.966 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.57 -170.63 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.929 2.492 . . . . 0.0 112.832 165.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.2 102.59 4.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.032 -1.668 . . . . 0.0 111.245 -172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -122.94 88.36 2.92 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.098 1.359 . . . . 0.0 113.202 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.32 -21.24 65.11 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.0 p -77.67 -27.81 50.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.375 1.87 . . . . 0.0 115.175 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -64.34 -15.64 60.74 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.389 1.475 . . . . 0.0 114.111 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.55 -29.45 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.742 1.617 . . . . 0.0 114.538 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -60.64 -52.69 64.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.522 1.055 . . . . 0.0 112.434 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -68.12 -26.56 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.499 -0.751 . . . . 0.0 112.248 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -77.04 -52.93 8.48 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.866 0.866 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -58.92 -28.26 66.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.997 0.919 . . . . 0.0 112.755 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 5.9 t -79.22 -60.19 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.148 0.885 . . . . 0.0 112.355 167.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -58.55 -37.47 75.77 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.89 1.223 . . . . 0.0 114.033 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 89.0 t -71.01 -59.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 123.682 0.793 . . . . 0.0 110.42 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 92.4 t -48.65 -31.1 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.095 0.958 . . . . 0.0 110.819 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.18 -27.73 69.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.72 -43.02 3.51 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.043 1.737 . . . . 0.0 112.331 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.2 m -55.01 -54.18 46.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.64 2.376 . . . . 0.0 113.064 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.94 93.19 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.204 0.456 . . . . 0.0 110.66 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 11.3 t -58.49 -51.71 68.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.31 0.644 . . . . 0.0 111.52 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.57 -48.15 81.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.441 2.297 . . . . 0.0 113.505 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.66 -25.31 63.85 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.662 -1.273 . . . . 0.0 114.37 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.9 m -62.19 -24.82 67.43 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.708 -0.62 . . . . 0.0 111.278 166.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -89.99 -21.33 22.46 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.74 -22.19 60.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.841 0.856 . . . . 0.0 113.011 162.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -153.53 26.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.274 1.892 . . . . 0.0 112.212 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -93.66 157.21 38.7 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.532 1.533 . . . . 0.0 112.281 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 112.75 3.3 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.934 3.089 . . . . 0.0 112.104 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -147.4 159.33 43.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.712 1.205 . . . . 0.0 112.217 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -68.8 79.67 0.3 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.326 2.251 . . . . 0.0 111.661 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -60.95 159.02 12.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.979 0.895 . . . . 0.0 111.087 163.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 3.0 tt -137.25 153.22 28.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 125.952 1.701 . . . . 0.0 108.831 166.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 19.2 m -141.49 147.12 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.703 1.201 . . . . 0.0 109.869 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -138.42 157.71 45.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.792 1.237 . . . . 0.0 109.405 168.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 32.0 p -145.82 152.66 39.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 112.124 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.7 128.75 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.961 1.304 . . . . 0.0 108.247 -176.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.9 mm -119.87 114.08 42.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 128.093 2.557 . . . . 0.0 106.809 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 36.2 tpp -140.19 148.37 41.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.499 1.52 . . . . 0.0 111.161 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -97.65 128.15 44.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.014 1.326 . . . . 0.0 112.36 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.78 -9.07 48.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.449 1.9 . . . . 0.0 114.452 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -57.27 -21.36 33.89 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.104 2.161 . . . . 0.0 114.412 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 -2.76 3.35 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.963 1.268 . . . . 0.0 115.102 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.9 164.46 14.94 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.81 1.305 . . . . 0.0 111.93 169.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -173.81 162.65 33.49 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.025 0.821 . . . . 0.0 113.425 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.21 171.84 16.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.998 1.719 . . . . 0.0 113.063 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -120.69 133.4 55.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.403 0.681 . . . . 0.0 111.055 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 19.2 m -138.22 147.01 43.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.426 1.09 . . . . 0.0 110.296 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -143.98 146.5 32.95 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.719 -0.613 . . . . 0.0 111.359 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 95.6 p -147.98 151.21 35.4 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 11.53 2.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.7 m -63.72 173.5 1.72 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.869 0.843 . . . . 0.0 112.342 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.08 156.78 22.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.835 2.054 . . . . 0.0 109.793 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.21 138.15 45.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 0.0 109.617 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -145.6 104.82 3.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.895 1.278 . . . . 0.0 111.472 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 39.2 t -78.5 -75.7 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.019 -1.051 . . . . 0.0 111.033 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 64.8 p -85.81 -19.17 31.07 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.209 1.403 . . . . 0.0 113.068 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -41.99 80.3 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.096 1.759 . . . . 0.0 112.94 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -153.07 -77.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.62 1.168 . . . . 0.0 113.124 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 161.07 105.46 0.2 Allowed Glycine 0 CA--C 1.538 1.527 0 O-C-N 120.659 -1.276 . . . . 0.0 114.566 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 77.3 p -137.72 162.15 34.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.8 1.24 . . . . 0.0 112.775 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.3 t -157.12 155.17 30.59 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.987 1.715 . . . . 0.0 110.221 171.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.0 t -148.36 145.07 27.93 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 119.803 -1.811 . . . . 0.0 111.003 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.62 118.9 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -106.17 123.29 47.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.565 1.146 . . . . 0.0 112.256 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -130.63 140.01 50.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.603 1.561 . . . . 0.0 110.974 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.5 159.74 15.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.77 . . . . 0.0 111.624 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -133.68 178.42 6.95 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.437 1.895 . . . . 0.0 110.251 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -48.57 57.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.466 2.706 . . . . 0.0 113.837 -176.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.8 t -137.28 0.67 2.34 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.11 1.364 . . . . 0.0 113.288 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.6 ptp -131.62 178.94 6.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.807 1.643 . . . . 0.0 111.994 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.106 1.362 . . . . 0.0 110.458 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 8.3 p -141.02 71.77 1.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 0.0 111.014 -164.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.99 140.59 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.112 0.965 . . . . 0.0 111.683 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.88 139.25 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.271 1.829 . . . . 0.0 110.935 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 36.1 p -130.93 139.09 50.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.43 1.092 . . . . 0.0 112.173 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -127.19 138.86 53.22 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.044 1.738 . . . . 0.0 112.783 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -132.96 109.01 9.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.094 1.357 . . . . 0.0 109.042 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.06 66.24 0.58 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.579 2.038 . . . . 0.0 110.438 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.37 142.52 57.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 111.184 -169.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.08 130.17 11.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.7 -7.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.46 1.904 . . . . 0.0 113.538 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.93 43.73 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.309 1.909 . . . . 0.0 114.369 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.41 58.29 0.44 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.139 1.352 . . . . 0.0 112.715 -175.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.55 -160.01 29.25 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.405 1.002 . . . . 0.0 112.308 170.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 53.0 m -51.48 148.4 5.16 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.102 0.961 . . . . 0.0 113.321 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.94 3.56 63.86 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.896 1.236 . . . . 0.0 115.149 -172.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -122.8 56.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.107 1.453 . . . . 0.0 113.235 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 57.3 p -161.83 -27.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -144.6 -172.6 15.27 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.486 2.47 . . . . 0.0 111.898 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.3 137.87 44.88 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.936 2.424 . . . . 0.0 112.509 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 48.9 pt -78.2 166.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 111.659 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 172.69 12.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.104 1.762 . . . . 0.0 112.348 173.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.46 166.63 10.01 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.34 1.056 . . . . 0.0 112.443 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -167.83 -175.38 37.57 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.713 1.149 . . . . 0.0 113.124 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 1.4 mtt -138.76 165.35 27.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.471 1.908 . . . . 0.0 111.107 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.9 78.01 1.65 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 0.0 112.095 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -128.94 163.71 24.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 112.24 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.3 mm -49.49 135.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 128.053 2.541 . . . . 0.0 111.921 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.5 m -97.55 88.02 4.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.921 1.288 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -85.58 150.46 24.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.626 -0.671 . . . . 0.0 110.777 164.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.95 107.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.578 1.951 . . . . 0.0 109.687 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.69 133.48 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.506 1.123 . . . . 0.0 111.027 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -127.86 90.31 48.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.448 1.499 . . . . 0.0 108.361 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.04 166.08 29.13 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.238 2.625 . . . . 0.0 111.869 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.85 -55.76 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.244 2.629 . . . . 0.0 112.811 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -165.64 170.25 14.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.261 3.025 . . . . 0.0 109.332 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.7 136.15 43.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.982 0.513 . . . . 0.0 110.829 164.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.66 164.17 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.149 1.78 . . . . 0.0 111.479 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 125.78 1.632 . . . . 0.0 110.944 174.314 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -68.4 162.02 26.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.679 1.191 . . . . 0.0 112.167 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.98 -49.58 62.99 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.937 0.895 . . . . 0.0 112.824 176.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -76.27 -12.01 60.01 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -80.96 -24.73 37.88 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.287 -0.883 . . . . 0.0 112.379 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -63.12 143.15 58.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.488 0.661 . . . . 0.0 111.259 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -135.11 -177.44 4.64 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.905 1.682 . . . . 0.0 110.64 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.24 9.96 21.75 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.623 1.569 . . . . 0.0 113.759 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.31 -1.81 7.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -172.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -59.28 -15.81 17.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.557 1.543 . . . . 0.0 114.355 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -21.94 26.22 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -73.29 -24.55 60.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.601 1.161 . . . . 0.0 113.893 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.04 157.19 31.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.719 0.808 . . . . 0.0 111.466 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.42 164.37 12.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.784 0.833 . . . . 0.0 112.122 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.14 158.07 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.809 0.844 . . . . 0.0 112.358 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.76 -39.86 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.835 2.054 . . . . 0.0 112.92 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.22 -22.99 63.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.003 0.921 . . . . 0.0 113.097 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -96.86 -51.17 4.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.038 0.935 . . . . 0.0 111.972 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.1 t -48.59 -38.06 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.008 1.323 . . . . 0.0 112.464 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 t -63.9 -13.68 47.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.045 1.738 . . . . 0.0 114.298 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -101.8 -38.14 7.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.899 2.08 . . . . 0.0 111.976 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -51.71 -42.44 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.067 0.849 . . . . 0.0 110.866 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.92 -42.41 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.6 -0.688 . . . . 0.0 112.804 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.86 49.52 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 111.121 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -30.71 70.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.04 -44.66 38.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.541 0.736 . . . . 0.0 112.966 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 -58.01 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.061 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.27 -29.56 70.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.64 -46.81 86.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.834 0.854 . . . . 0.0 112.181 168.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.01 -35.57 80.91 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.32 -48.23 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.918 1.287 . . . . 0.0 109.907 172.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.43 12.79 74.93 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.389 0.995 . . . . 0.0 114.662 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 3.39 38.61 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.684 1.434 . . . . 0.0 116.684 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.98 146.25 43.22 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.696 1.748 . . . . 0.0 111.085 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.62 -160.39 0.15 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.914 1.286 . . . . 0.0 111.876 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -47.73 136.64 10.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.297 1.039 . . . . 0.0 111.617 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -136.7 179.16 6.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.775 1.63 . . . . 0.0 111.375 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.97 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.335 1.054 . . . . 0.0 112.226 165.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.9 p -47.31 -0.54 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.179 2.591 . . . . 0.0 117.821 168.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.22 -39.5 2.98 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.666 2.386 . . . . 0.0 113.31 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.77 -29.52 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.368 1.467 . . . . 0.0 113.193 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.95 -49.36 75.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.668 1.187 . . . . 0.0 112.312 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.56 -25.41 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.471 -0.768 . . . . 0.0 112.638 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.09 -54.1 7.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.893 0.769 . . . . 0.0 111.393 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.06 -24.27 62.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.771 0.829 . . . . 0.0 112.651 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.3 t -83.32 -59.71 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.407 1.003 . . . . 0.0 113.033 166.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -58.44 -38.78 78.18 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.987 1.315 . . . . 0.0 113.896 -172.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.65 -62.87 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 C-N-CA 124.309 1.044 . . . . 0.0 109.623 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -48.92 -30.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.414 1.486 . . . . 0.0 111.051 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -59.33 -34.35 72.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -112.71 -36.34 5.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.632 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.8 m -59.92 -51.74 68.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.757 2.023 . . . . 0.0 111.816 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -43.38 98.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 111.057 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -66.79 -26.2 66.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -75.31 -51.98 11.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.262 2.225 . . . . 0.0 113.271 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.59 -25.89 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -59.61 -33.93 72.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.144 0.577 . . . . 0.0 110.493 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -79.59 -28.6 41.05 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mt -61.95 -32.3 72.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.58 -99.62 2.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.711 1.148 . . . . 0.0 113.269 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -135.95 146.31 56.24 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.86 1.664 . . . . 0.0 113.092 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.53 99.11 1.01 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.296 3.33 . . . . 0.0 112.32 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -140.62 167.89 21.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.615 1.566 . . . . 0.0 111.823 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -61.52 129.27 40.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.77 1.228 . . . . 0.0 110.543 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -115.09 152.16 33.02 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.09 1.756 . . . . 0.0 110.167 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -151.98 157.3 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.514 1.526 . . . . 0.0 109.283 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.28 152.14 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.236 1.814 . . . . 0.0 109.055 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -128.86 144.41 51.17 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.079 1.352 . . . . 0.0 108.315 161.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.2 p -137.57 154.22 49.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.724 0.773 . . . . 0.0 111.688 167.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.41 114.47 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.779 1.231 . . . . 0.0 109.605 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.26 97.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 126.165 1.786 . . . . 0.0 106.596 -177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -154.63 90.07 1.29 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 112.592 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -151.6 142.57 23.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.832 2.053 . . . . 0.0 108.698 160.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -158.03 -62.61 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.38 1.472 . . . . 0.0 111.242 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -115.04 -9.51 12.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.764 1.626 . . . . 0.0 114.303 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.67 2.31 57.46 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.28 1.419 . . . . 0.0 115.254 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -177.34 2.24 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.118 1.459 . . . . 0.0 112.261 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.16 -173.12 41.54 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.444 1.021 . . . . 0.0 114.13 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.87 174.02 10.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.079 2.552 . . . . 0.0 110.543 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -98.42 100.82 12.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.281 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -111.94 142.65 44.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 108.744 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 145.44 32.49 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 111.193 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.411 ' CB ' ' HG ' ' A' ' 85' ' ' CYS . 30.7 p -139.96 143.69 36.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 122.086 0.946 . . . . 0.0 112.097 175.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -81.72 16.2 1.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.102 0.961 . . . . 0.0 112.056 170.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 25.0 m -64.3 161.5 16.61 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.198 -0.939 . . . . 0.0 112.044 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -160.01 138.25 10.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.149 1.38 . . . . 0.0 111.995 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -70.12 146.69 50.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.16 0.584 . . . . 0.0 110.503 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -140.45 160.3 40.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.183 1.393 . . . . 0.0 110.925 168.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -117.52 -64.4 1.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.055 1.342 . . . . 0.0 112.223 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 t -86.5 -39.77 15.94 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.788 0.835 . . . . 0.0 112.163 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -53.87 52.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.134 1.774 . . . . 0.0 111.589 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -142.44 176.3 9.12 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.503 2.721 . . . . 0.0 109.542 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.33 140.57 15.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.989 0.804 . . . . 0.0 112.117 172.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -143.42 149.44 37.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.42 . . . . 0.0 110.282 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.26 108.97 4.02 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.09 0.956 . . . . 0.0 111.48 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 t -100.97 143.25 31.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.895 0.878 . . . . 0.0 111.729 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.39 128.87 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.441 1.896 . . . . 0.0 109.245 -168.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -121.64 122.18 39.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.937 1.695 . . . . 0.0 112.063 -170.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -133.49 117.49 17.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.688 1.595 . . . . 0.0 110.767 -175.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.77 167.5 21.28 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.348 -0.845 . . . . 0.0 112.946 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -151.39 -175.16 5.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.079 1.352 . . . . 0.0 111.375 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.83 -59.21 2.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.601 1.96 . . . . 0.0 113.347 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.2 t -138.13 -35.58 0.62 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.807 1.643 . . . . 0.0 112.846 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.9 ptp -100.33 89.85 4.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.932 1.293 . . . . 0.0 112.797 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.29 155.87 8.35 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.53 -0.731 . . . . 0.0 111.661 173.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 2.8 p -127.51 135.76 50.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.936 1.294 . . . . 0.0 111.066 177.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.65 122.43 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.491 1.517 . . . . 0.0 110.258 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.92 138.13 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.292 1.837 . . . . 0.0 108.756 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -127.52 107.48 9.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.416 1.086 . . . . 0.0 110.431 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.56 147.74 25.19 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.242 1.017 . . . . 0.0 112.388 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 8.0 m-85 -136.78 118.58 15.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.217 2.207 . . . . 0.0 108.959 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.42 100.74 0.93 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.719 2.104 . . . . 0.0 110.423 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.04 145.41 36.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.646 1.178 . . . . 0.0 111.882 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 t -151.86 120.63 6.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.8 -47.21 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.466 1.106 . . . . 0.0 109.148 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.89 -23.93 77.31 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.318 0.961 . . . . 0.0 115.219 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.08 92.01 Favored Glycine 0 CA--C 1.539 1.593 0 CA-C-N 118.732 1.266 . . . . 0.0 114.201 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.99 88.02 0.38 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.139 1.828 . . . . 0.0 113.888 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -122.86 177.99 5.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.204 2.602 . . . . 0.0 112.364 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.87 21.3 2.94 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.691 1.139 . . . . 0.0 114.733 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -55.74 -176.76 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 128.783 2.833 . . . . 0.0 114.416 171.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -57.1 -37.64 72.22 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.25 162.04 47.61 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.666 0.65 . . . . 0.0 112.984 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.1 169.76 18.59 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.349 2.699 . . . . 0.0 112.544 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.81 144.76 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.517 1.527 . . . . 0.0 111.386 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 157.07 47.53 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 167.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -139.47 161.81 36.59 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.529 2.732 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.56 -171.21 31.09 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.239 0.924 . . . . 0.0 114.234 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.6 ptp -66.56 176.57 1.86 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.225 1.01 . . . . 0.0 112.908 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.3 170.84 15.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.488 1.515 . . . . 0.0 112.813 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.94 161.33 29.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.277 1.831 . . . . 0.0 111.7 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.98 153.04 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.939 1.695 . . . . 0.0 110.259 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 100.0 m -121.86 94.32 4.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.313 1.445 . . . . 0.0 110.844 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -88.15 149.79 23.69 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.241 -0.912 . . . . 0.0 111.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.26 94.44 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 127.69 2.396 . . . . 0.0 108.521 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.98 165.56 27.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.11 1.364 . . . . 0.0 112.378 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.16 90.23 41.27 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.214 1.405 . . . . 0.0 109.944 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.78 115.94 4.5 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.309 2.673 . . . . 0.0 110.707 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.48 -33.46 6.84 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.5 2.133 . . . . 0.0 112.829 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -155.84 173.3 16.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.301 3.04 . . . . 0.0 109.821 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -70.46 141.93 51.99 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.999 0.52 . . . . 0.0 111.269 166.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.59 172.33 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.412 1.885 . . . . 0.0 111.081 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.617 1.967 . . . . 0.0 110.697 177.341 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 19.6 m -67.22 161.46 24.76 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.486 1.114 . . . . 0.0 112.24 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -52.2 -49.36 64.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.777 0.831 . . . . 0.0 112.879 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -76.28 -11.85 59.98 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -80.99 -24.43 37.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.31 -0.869 . . . . 0.0 112.472 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -63.28 143.52 57.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.579 0.704 . . . . 0.0 111.121 168.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -135.04 -176.73 4.35 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.93 1.692 . . . . 0.0 110.614 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.68 9.84 19.29 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.659 1.584 . . . . 0.0 113.739 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.34 -2.3 8.12 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -58.99 -16.42 18.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.808 1.643 . . . . 0.0 114.228 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -21.72 25.06 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 167.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -72.44 -25.14 61.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.569 1.148 . . . . 0.0 113.74 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.8 155.36 31.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.436 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.75 159.07 15.23 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 0.0 111.935 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.66 158.9 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.551 1.141 . . . . 0.0 111.267 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.81 -35.54 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.82 2.048 . . . . 0.0 113.383 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.33 -23.05 66.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.864 0.866 . . . . 0.0 113.039 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -86.49 -54.52 4.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.901 1.28 . . . . 0.0 110.643 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 39.8 t -53.91 -38.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.087 1.355 . . . . 0.0 112.577 -175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.1 t -61.19 -11.36 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.286 1.834 . . . . 0.0 114.258 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -107.4 -36.9 6.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.879 1.671 . . . . 0.0 112.317 168.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.8 mt -51.11 -40.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.508 1.049 . . . . 0.0 111.25 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.81 -41.18 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.462 -0.774 . . . . 0.0 113.058 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -49.28 51.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.901 1.228 . . . . 0.0 111.646 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -29.62 70.11 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.29 -44.67 28.88 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 71.6 mt -58.06 -58.73 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.221 0.918 . . . . 0.0 110.052 175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.14 -29.49 70.38 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -62.89 -46.38 88.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.789 0.836 . . . . 0.0 112.059 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.24 79.8 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.3 -47.96 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.936 1.294 . . . . 0.0 109.946 172.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.14 12.89 75.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.395 0.998 . . . . 0.0 114.685 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.48 40.3 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -60.12 146.43 43.22 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 119.671 1.735 . . . . 0.0 111.115 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.68 -160.29 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.982 1.313 . . . . 0.0 111.789 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -47.93 137.48 9.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.269 1.028 . . . . 0.0 111.748 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -137.09 179.44 6.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.732 1.613 . . . . 0.0 111.426 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -63.48 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.508 1.123 . . . . 0.0 112.185 164.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 42.0 p -47.16 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.284 2.634 . . . . 0.0 117.925 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.76 -39.56 3.81 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.815 2.446 . . . . 0.0 113.442 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.18 -28.79 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.199 1.4 . . . . 0.0 113.169 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.63 -49.55 74.73 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.71 1.204 . . . . 0.0 112.354 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.58 -25.76 65.94 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.516 -0.74 . . . . 0.0 112.666 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -75.63 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.887 0.767 . . . . 0.0 111.452 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.0 t -59.65 -22.95 62.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.769 0.828 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -84.24 -59.64 2.33 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.477 1.035 . . . . 0.0 113.19 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -58.32 -38.62 77.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.99 1.316 . . . . 0.0 114.03 -172.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.0 t -66.45 -62.65 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 124.393 1.077 . . . . 0.0 109.591 -179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.96 -30.4 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.473 1.509 . . . . 0.0 110.953 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.21 -33.07 70.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -114.62 -35.48 4.86 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.654 1.581 . . . . 0.0 112.824 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 54.2 m -61.58 -48.3 81.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.984 2.114 . . . . 0.0 112.079 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.79 -45.16 93.95 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.455 0.645 . . . . 0.0 110.642 176.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 83.0 p -66.18 -25.26 66.86 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.137 -0.977 . . . . 0.0 113.375 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -75.79 -54.53 6.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.438 2.295 . . . . 0.0 113.155 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.8 -26.28 68.28 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.744 1.156 . . . . 0.0 113.433 -172.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -56.99 -40.57 76.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.325 0.65 . . . . 0.0 110.835 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -73.87 -29.07 61.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.784 0.834 . . . . 0.0 112.637 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 5.2 mt -62.49 -31.98 72.81 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -97.9 2.1 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.767 1.175 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -136.78 146.74 56.48 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.776 1.631 . . . . 0.0 112.98 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.23 97.27 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.202 3.268 . . . . 0.0 112.203 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.15 167.67 21.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.506 1.522 . . . . 0.0 111.838 172.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -61.77 131.35 49.6 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.887 1.275 . . . . 0.0 110.754 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -116.96 152.33 34.79 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.259 1.824 . . . . 0.0 110.296 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.7 tt -152.81 157.41 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.38 152.56 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.451 1.9 . . . . 0.0 109.225 165.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 2.1 p -127.27 144.05 51.12 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.025 1.33 . . . . 0.0 108.353 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 20.1 p -138.12 155.83 48.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.959 0.885 . . . . 0.0 112.01 168.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.46 125.21 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.374 1.07 . . . . 0.0 109.877 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.2 mm -115.82 98.32 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.027 2.131 . . . . 0.0 107.18 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -116.26 152.66 33.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.444 1.497 . . . . 0.0 110.48 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.97 147.6 32.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.813 0.816 . . . . 0.0 112.483 -175.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -75.9 1.23 15.68 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.937 1.695 . . . . 0.0 114.292 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -64.97 -13.17 56.78 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.52 5.26 61.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.965 1.269 . . . . 0.0 115.348 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.2 -169.89 0.69 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.566 1.183 . . . . 0.0 112.185 169.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.85 -170.54 42.86 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.071 -1.018 . . . . 0.0 114.152 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.69 -171.44 2.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.341 2.256 . . . . 0.0 111.449 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -114.36 94.79 4.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.462 0.705 . . . . 0.0 110.232 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 23.3 m -106.67 142.35 36.46 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.891 173.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.88 141.21 38.58 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.425 0.69 . . . . 0.0 110.638 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' SER . . . . . 0.425 ' CB ' ' HG ' ' B' ' 228' ' ' CYS . 25.0 p -135.98 140.27 43.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.119 0.962 . . . . 0.0 111.714 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.9 t -80.44 14.99 1.77 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.828 0.851 . . . . 0.0 111.993 171.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . 0.425 ' HG ' ' CB ' ' B' ' 226' ' ' SER . 13.2 m -64.66 161.77 17.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.214 -0.929 . . . . 0.0 112.017 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.09 139.02 10.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.85 146.59 51.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.725 -0.61 . . . . 0.0 110.343 174.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -139.88 159.32 42.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.247 1.419 . . . . 0.0 110.726 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 43.3 t -117.1 -64.58 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.09 1.356 . . . . 0.0 112.228 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.5 t -86.78 -39.64 15.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.796 0.839 . . . . 0.0 112.095 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -54.29 47.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 111.614 -174.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -142.11 176.55 8.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.465 2.706 . . . . 0.0 109.631 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.03 140.57 15.2 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.046 0.831 . . . . 0.0 112.229 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 150.05 39.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.289 1.436 . . . . 0.0 110.276 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.4 t -148.44 107.59 3.89 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.143 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.7 t -98.8 142.69 30.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.861 0.864 . . . . 0.0 111.527 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 123.41 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 109.075 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -115.14 119.16 35.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.853 1.661 . . . . 0.0 111.339 -172.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.7 148.55 49.0 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.14 1.376 . . . . 0.0 110.514 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.12 165.49 11.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.816 1.246 . . . . 0.0 111.355 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.72 -176.06 5.46 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.78 1.232 . . . . 0.0 110.521 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.27 -67.09 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.127 1.771 . . . . 0.0 113.017 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -139.53 4.97 2.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.072 1.749 . . . . 0.0 113.405 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 23.9 ptp -133.99 82.01 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 111.992 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -58.15 147.23 30.76 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.361 -0.837 . . . . 0.0 111.379 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 4.4 p -134.47 116.54 15.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.275 1.03 . . . . 0.0 111.991 -171.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.8 pt -117.14 130.16 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.615 1.166 . . . . 0.0 111.188 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.59 139.05 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.721 2.008 . . . . 0.0 108.691 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.3 t -129.83 109.82 11.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.344 1.058 . . . . 0.0 110.655 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.11 148.0 23.91 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.185 0.994 . . . . 0.0 112.243 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' B' ' 228' ' ' CYS . 8.7 m-85 -136.3 119.13 16.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.122 2.169 . . . . 0.0 108.952 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.03 100.09 0.91 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.662 2.077 . . . . 0.0 110.304 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.24 145.69 36.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.624 1.17 . . . . 0.0 111.734 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -151.93 122.06 7.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.02 -47.04 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.631 1.172 . . . . 0.0 109.149 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.69 -23.67 77.72 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.3 0.952 . . . . 0.0 115.185 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 58.02 39.57 92.15 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.762 1.281 . . . . 0.0 114.148 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -71.14 87.35 0.39 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.07 1.795 . . . . 0.0 113.882 -175.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 97.8 p -121.98 178.36 4.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.02 2.528 . . . . 0.0 112.358 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 121.56 21.44 3.0 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.724 1.154 . . . . 0.0 114.523 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -55.09 -178.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.849 2.86 . . . . 0.0 114.418 171.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -57.51 -36.61 71.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -79.92 162.75 46.96 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 123.734 0.683 . . . . 0.0 112.99 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.19 169.85 18.49 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.297 2.665 . . . . 0.0 112.512 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.9 pt -119.5 145.07 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.591 1.556 . . . . 0.0 111.352 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 157.31 46.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.606 1.162 . . . . 0.0 112.961 167.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 72.1 mt -139.65 162.01 36.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.589 2.755 . . . . 0.0 109.444 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -171.44 31.03 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.269 0.938 . . . . 0.0 114.23 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 12.7 ptp -66.51 176.52 1.85 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.195 0.998 . . . . 0.0 112.906 171.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.89 15.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.443 1.497 . . . . 0.0 112.711 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.69 161.24 29.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.342 1.857 . . . . 0.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.19 152.34 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.833 1.653 . . . . 0.0 110.269 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 98.3 m -120.92 91.57 3.56 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.475 1.51 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -86.47 150.74 24.06 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.08 100.11 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.754 2.022 . . . . 0.0 109.344 174.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.38 166.97 23.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.724 1.61 . . . . 0.0 111.69 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 88.79 27.24 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.901 1.28 . . . . 0.0 109.588 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 115.52 4.26 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.129 2.552 . . . . 0.0 110.777 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 -34.26 5.99 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.562 2.175 . . . . 0.0 112.739 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -156.58 173.9 16.24 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.554 3.141 . . . . 0.0 109.738 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.94 141.93 52.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.992 0.517 . . . . 0.0 111.197 166.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 172.07 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.456 1.902 . . . . 0.0 111.137 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.575 1.95 . . . . 0.0 110.688 177.294 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -85.26 1.74 46.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.85 1.26 . . . . 0.0 113.814 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -3.43 6.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -16.48 2.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.374 2.27 . . . . 0.0 116.12 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.92 -21.77 66.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.465 1.106 . . . . 0.0 113.628 170.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -137.49 -171.14 2.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.285 2.234 . . . . 0.0 111.157 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -142.71 142.56 32.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.956 0.903 . . . . 0.0 112.144 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.77 -177.99 3.96 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.691 1.996 . . . . 0.0 112.198 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.65 46.37 0.12 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.797 1.639 . . . . 0.0 114.001 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -61.22 -20.09 62.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 119.988 -1.695 . . . . 0.0 112.738 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.3 -24.94 61.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.4 t -103.7 -21.56 13.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.572 1.149 . . . . 0.0 112.962 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 164.75 5.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.191 0.996 . . . . 0.0 113.665 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.0 152.45 48.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.318 1.047 . . . . 0.0 113.419 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.46 161.56 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.423 1.889 . . . . 0.0 111.421 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.466 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 63.7 t -61.03 -35.55 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.642 1.977 . . . . 0.0 111.56 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.35 4.83 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.98 1.312 . . . . 0.0 114.008 172.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -109.23 -59.79 1.85 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.8 -1.187 . . . . 0.0 107.888 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.466 ' CG1' ' HA ' ' A' ' 16' ' ' VAL . 2.1 p -44.39 -42.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.192 1.797 . . . . 0.0 112.971 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 t -60.04 -11.65 6.38 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -115.57 -33.93 5.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.654 1.982 . . . . 0.0 112.308 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -41.84 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.144 0.977 . . . . 0.0 110.731 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.5 p -59.05 -42.85 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.413 -0.804 . . . . 0.0 112.7 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -53.14 33.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.158 0.89 . . . . 0.0 110.728 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -31.86 71.99 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.14 -42.3 38.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.535 0.734 . . . . 0.0 112.964 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.0 mt -59.47 -56.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.284 0.947 . . . . 0.0 109.522 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.03 -28.88 70.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.5 t -62.52 -47.52 83.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.365 1.066 . . . . 0.0 112.299 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.78 76.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -32.1 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.887 1.275 . . . . 0.0 111.3 170.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.19 17.37 55.73 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.657 1.122 . . . . 0.0 114.709 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.22 21.53 77.76 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.659 1.123 . . . . 0.0 115.265 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -55.36 156.86 4.05 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 119.485 1.643 . . . . 0.0 112.569 171.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 -179.45 1.07 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.468 1.507 . . . . 0.0 112.391 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -47.56 141.71 4.95 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.606 1.562 . . . . 0.0 113.251 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -132.71 171.83 13.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.811 1.244 . . . . 0.0 112.586 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -91.65 -114.63 0.08 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 109.843 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -70.64 -1.01 9.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 114.985 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.4 -41.27 39.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.152 1.381 . . . . 0.0 113.629 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.5 -30.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 118.402 -0.809 . . . . 0.0 113.001 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.29 -55.03 32.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.787 1.176 . . . . 0.0 111.632 170.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.93 -25.35 67.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.86 -0.525 . . . . 0.0 112.405 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.39 -56.35 4.71 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.2 1.0 . . . . 0.0 111.45 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 t -57.41 -26.66 61.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.823 0.738 . . . . 0.0 112.76 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -81.29 -57.38 3.52 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.304 0.956 . . . . 0.0 112.811 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -60.24 -34.79 74.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.466 -1.397 . . . . 0.0 114.073 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 83.6 t -70.33 -64.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.214 1.005 . . . . 0.0 109.368 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.17 -30.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.055 1.342 . . . . 0.0 111.002 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.5 -32.56 71.55 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -114.0 -35.46 5.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.496 1.519 . . . . 0.0 112.75 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.7 m -62.03 -51.36 68.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.073 2.149 . . . . 0.0 112.108 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -42.93 98.67 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.91 0.323 . . . . 0.0 110.691 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 p -66.51 -27.01 67.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -74.29 -50.49 18.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.532 2.333 . . . . 0.0 113.309 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.41 -29.81 70.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.2 1.364 . . . . 0.0 114.045 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.2 m -57.12 -27.96 62.27 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.162 0.985 . . . . 0.0 111.444 167.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.78 -28.17 19.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.78 -33.62 74.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.062 0.545 . . . . 0.0 109.852 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.1 -98.67 2.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.635 1.588 . . . . 0.0 112.403 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -134.27 121.06 15.23 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.661 1.185 . . . . 0.0 112.788 -173.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.72 107.1 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.006 3.138 . . . . 0.0 112.977 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -146.17 170.94 15.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.351 1.861 . . . . 0.0 112.13 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -76.5 81.16 3.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.521 1.529 . . . . 0.0 111.957 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.71 138.17 46.42 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.622 1.569 . . . . 0.0 110.162 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 154.46 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.405 1.482 . . . . 0.0 109.879 171.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.84 159.19 33.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 124.613 1.165 . . . . 0.0 110.826 162.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 p -136.04 146.76 47.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.249 1.019 . . . . 0.0 110.793 157.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.4 p -136.63 143.43 43.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.313 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.05 95.78 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.877 1.271 . . . . 0.0 108.345 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mm -91.34 114.13 28.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 tpt -137.61 161.54 36.19 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.34 1.456 . . . . 0.0 110.736 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -67.47 151.98 46.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.494 -0.754 . . . . 0.0 111.37 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 1.87 1.35 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.152 2.181 . . . . 0.0 115.002 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -56.24 -21.86 26.14 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.773 1.629 . . . . 0.0 114.299 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.99 34.15 70.6 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.955 0.788 . . . . 0.0 113.897 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -177.38 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.069 1.748 . . . . 0.0 113.779 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.83 47.47 3.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.086 1.327 . . . . 0.0 114.327 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.38 125.55 24.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.909 1.354 . . . . 0.0 109.463 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -120.22 92.58 3.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.199 1.0 . . . . 0.0 109.537 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.1 m -109.98 142.89 40.73 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.028 -1.045 . . . . 0.0 109.329 -178.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.8 140.39 34.7 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.637 -0.665 . . . . 0.0 111.945 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -139.38 127.56 22.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 p -75.07 13.09 0.74 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.899 -1.126 . . . . 0.0 113.967 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.4 m -58.29 164.48 2.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.585 1.554 . . . . 0.0 112.694 170.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -167.14 138.52 3.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.954 1.702 . . . . 0.0 110.331 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -83.03 149.19 27.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.752 0.821 . . . . 0.0 110.872 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -142.09 159.0 43.11 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.364 1.865 . . . . 0.0 111.123 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.9 t -114.66 -64.12 1.36 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.716 1.206 . . . . 0.0 111.201 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -87.26 -18.04 31.16 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -41.46 12.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.753 1.621 . . . . 0.0 112.738 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -164.27 -171.68 2.48 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.458 1.903 . . . . 0.0 111.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.83 140.42 14.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.883 1.706 . . . . 0.0 114.83 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.9 p -155.87 158.04 37.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.462 1.905 . . . . 0.0 111.912 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 17.8 t -146.39 160.4 42.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.506 1.522 . . . . 0.0 111.026 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -148.83 144.82 27.2 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.145 -1.597 . . . . 0.0 111.24 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -134.89 102.64 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.809 1.244 . . . . 0.0 109.427 -170.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.28 104.52 16.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.823 1.249 . . . . 0.0 112.356 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -103.86 143.82 32.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.333 1.063 . . . . 0.0 110.725 170.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.03 147.8 33.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.365 1.866 . . . . 0.0 110.996 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -141.4 -172.3 3.48 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 112.195 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -58.51 2.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.865 2.466 . . . . 0.0 114.576 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.9 t -141.45 21.71 2.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.967 1.307 . . . . 0.0 113.438 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.1 150.21 45.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.384 1.474 . . . . 0.0 111.32 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.16 128.92 49.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.298 1.839 . . . . 0.0 109.645 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.8 p -137.72 82.55 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.208 1.004 . . . . 0.0 112.773 -172.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -109.8 133.45 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.027 0.931 . . . . 0.0 112.077 -173.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.54 146.33 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.226 1.81 . . . . 0.0 111.408 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -133.9 129.2 36.02 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.139 1.376 . . . . 0.0 110.067 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.82 135.92 53.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.67 1.988 . . . . 0.0 112.434 -169.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -132.29 115.22 15.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.5 58.52 0.39 Allowed Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.862 1.696 . . . . 0.0 112.801 -167.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -58.72 124.27 19.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 112.888 -168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m -133.28 89.4 2.6 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.03 1.732 . . . . 0.0 111.739 -169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.62 -15.85 64.71 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.996 1.284 . . . . 0.0 115.651 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.77 12.73 65.04 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 118.713 1.256 . . . . 0.0 116.122 171.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.17 104.78 0.31 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.316 1.913 . . . . 0.0 114.5 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.8 p -52.06 138.62 24.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.037 2.135 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.15 31.3 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.156 1.36 . . . . 0.0 115.044 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -99.99 23.09 10.31 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.933 1.693 . . . . 0.0 113.555 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.1 t -130.25 -59.38 1.04 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.922 1.689 . . . . 0.0 112.27 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.69 -113.04 3.65 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.242 -1.31 . . . . 0.0 111.244 -173.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.92 138.99 38.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.572 2.181 . . . . 0.0 111.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.9 pp -92.9 131.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.108 1.363 . . . . 0.0 110.617 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.86 129.64 38.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.74 122.46 20.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.595 0.758 . . . . 0.0 110.16 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -160.57 163.89 34.28 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.245 1.402 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 56.9 ttm -119.05 115.78 25.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.789 1.236 . . . . 0.0 110.802 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 120.64 18.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.348 1.459 . . . . 0.0 111.298 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -128.96 173.11 10.71 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.51 142.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.365 1.466 . . . . 0.0 111.26 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.4 m -101.3 88.86 3.58 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.225 1.41 . . . . 0.0 110.295 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -79.96 147.9 31.42 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.26 -0.9 . . . . 0.0 110.788 164.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -137.76 95.2 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.831 2.452 . . . . 0.0 108.743 175.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -139.35 169.49 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.556 1.142 . . . . 0.0 112.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.45 89.79 32.93 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.059 1.344 . . . . 0.0 110.127 174.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.33 165.95 30.63 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.17 2.58 . . . . 0.0 112.47 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.03 -38.32 7.36 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.986 2.457 . . . . 0.0 113.527 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -156.22 -65.98 0.11 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.997 1.319 . . . . 0.0 112.242 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.03 -179.0 6.4 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.161 1.784 . . . . 0.0 112.041 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 163.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.802 1.641 . . . . 0.0 112.097 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.5 t . . . . . 0 C--O 1.252 1.196 0 C-N-CA 127.186 2.194 . . . . 0.0 110.329 -179.724 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -84.31 2.01 42.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.37 1.468 . . . . 0.0 113.946 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -2.04 5.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.765 1.626 . . . . 0.0 115.245 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -54.99 -16.43 2.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.435 2.294 . . . . 0.0 115.939 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.41 -21.66 66.71 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.543 1.137 . . . . 0.0 113.598 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -137.78 -172.31 3.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.136 2.175 . . . . 0.0 111.531 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -140.14 142.55 35.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.598 1.159 . . . . 0.0 111.97 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.8 -179.74 4.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.93 2.092 . . . . 0.0 111.947 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.94 48.77 0.17 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.766 1.627 . . . . 0.0 113.967 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -61.86 -20.93 64.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.012 -1.68 . . . . 0.0 112.817 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -57.43 -21.93 39.92 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -106.7 -21.59 13.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 113.288 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 163.09 7.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.154 0.982 . . . . 0.0 113.509 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -127.5 154.76 44.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 113.308 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.43 158.6 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.295 1.838 . . . . 0.0 111.154 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.56 -37.52 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.157 1.783 . . . . 0.0 111.923 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.02 -22.87 66.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.366 1.066 . . . . 0.0 113.615 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -75.86 -59.16 2.88 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 169.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.16 -43.17 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.96 2.104 . . . . 0.0 112.588 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -60.38 -10.9 5.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.207 1.803 . . . . 0.0 114.695 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -114.25 -33.91 5.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.591 1.957 . . . . 0.0 112.244 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.0 mt -50.19 -42.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.843 0.857 . . . . 0.0 110.723 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.6 p -59.04 -42.65 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.389 -0.82 . . . . 0.0 112.736 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -52.73 37.11 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.222 0.919 . . . . 0.0 110.768 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -31.8 71.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.06 -42.41 38.43 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.613 0.765 . . . . 0.0 112.946 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.74 -57.02 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 119.4 1.0 . . . . 0.0 109.636 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.99 -28.53 70.16 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 t -62.64 -47.76 82.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.436 1.094 . . . . 0.0 112.281 168.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.37 -33.79 76.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -32.08 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.918 1.287 . . . . 0.0 111.392 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 62.08 17.3 55.18 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.665 1.126 . . . . 0.0 114.733 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 22.02 77.58 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.689 1.138 . . . . 0.0 115.314 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.29 157.25 3.73 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 119.386 1.593 . . . . 0.0 112.672 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.4 -179.69 1.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.384 1.474 . . . . 0.0 112.378 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -47.55 141.45 5.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.469 1.507 . . . . 0.0 113.256 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -132.33 171.75 13.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 112.444 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.57 -113.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 109.721 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 3.6 m -71.58 -1.03 12.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.242 1.817 . . . . 0.0 114.958 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -49.6 -40.92 40.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 113.626 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.9 -30.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.687 0.795 . . . . 0.0 112.868 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -62.57 -55.53 26.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.766 1.166 . . . . 0.0 111.87 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.3 -25.3 67.57 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.8 -0.562 . . . . 0.0 112.248 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -76.5 -56.17 4.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.342 1.057 . . . . 0.0 111.463 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.7 t -57.28 -26.62 61.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.936 0.789 . . . . 0.0 112.78 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.2 t -81.72 -57.78 3.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.171 0.896 . . . . 0.0 112.86 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.83 -34.78 73.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.279 1.4 . . . . 0.0 114.007 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 85.8 t -70.29 -64.12 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.105 0.962 . . . . 0.0 109.375 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -49.2 -30.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.135 1.374 . . . . 0.0 110.964 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -60.66 -32.63 71.81 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -113.59 -35.56 5.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.402 1.481 . . . . 0.0 112.797 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 48.3 m -61.63 -52.11 65.71 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.985 2.114 . . . . 0.0 111.919 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -42.48 99.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.008 0.367 . . . . 0.0 110.749 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 60.2 p -67.0 -27.17 67.21 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.84 -50.99 17.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.55 2.34 . . . . 0.0 113.247 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.96 -29.98 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.646 -1.284 . . . . 0.0 114.098 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 87.8 m -57.0 -28.31 62.33 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.154 0.982 . . . . 0.0 111.36 167.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -89.41 -28.11 19.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.95 -33.51 73.82 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.081 0.553 . . . . 0.0 109.897 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.96 -98.96 2.15 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.763 1.649 . . . . 0.0 112.398 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -134.12 121.07 15.41 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.729 1.212 . . . . 0.0 112.798 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.48 106.96 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.988 3.125 . . . . 0.0 112.709 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -146.97 172.17 14.11 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.369 1.868 . . . . 0.0 111.962 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -77.8 83.93 4.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.392 1.477 . . . . 0.0 111.854 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -74.53 142.12 44.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.306 1.443 . . . . 0.0 109.946 166.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.1 156.56 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.381 1.472 . . . . 0.0 110.129 170.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.34 159.3 28.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 110.379 165.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 19.1 p -136.93 151.23 48.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.111 157.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 18.3 p -141.12 150.4 42.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.92 1.288 . . . . 0.0 111.771 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.12 103.08 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.225 1.41 . . . . 0.0 108.341 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mm -99.73 117.52 45.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.136 1.374 . . . . 0.0 107.989 -178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.0 tpt -142.2 147.74 37.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.654 0.781 . . . . 0.0 111.745 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -152.29 91.49 1.6 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.732 2.013 . . . . 0.0 109.646 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -59.44 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 175.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.99 -46.11 0.43 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.305 1.042 . . . . 0.0 113.665 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.51 -8.94 26.29 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.122 1.344 . . . . 0.0 115.412 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -140.01 79.02 1.69 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -171.67 21.1 0.07 OUTLIER Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 134.01 54.95 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.828 2.051 . . . . 0.0 111.572 -174.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -128.43 88.15 2.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.468 1.107 . . . . 0.0 109.3 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 55.5 m -107.09 142.32 36.94 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.699 -1.251 . . . . 0.0 109.579 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.25 138.03 39.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.27 0.628 . . . . 0.0 111.676 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 2.4 m -136.38 127.72 28.33 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -170.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 78.9 p -74.46 10.12 1.45 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 36.0 m -60.68 166.46 3.25 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 0.0 112.961 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -166.0 147.1 6.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.213 1.805 . . . . 0.0 110.42 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -86.44 151.53 23.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.718 0.807 . . . . 0.0 111.077 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.53 159.76 41.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.389 1.875 . . . . 0.0 112.916 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.6 t -125.18 -53.9 1.61 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.541 1.937 . . . . 0.0 112.223 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 79.2 p -104.22 -6.29 21.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.832 1.653 . . . . 0.0 113.635 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -42.74 9.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.675 1.59 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.16 -164.71 0.8 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.224 2.209 . . . . 0.0 110.611 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.82 142.5 13.96 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.373 1.463 . . . . 0.0 114.987 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 24.5 p -153.74 157.56 39.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.633 1.973 . . . . 0.0 111.997 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 19.3 t -145.22 160.27 41.73 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.786 1.634 . . . . 0.0 111.124 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 145.54 26.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.173 -1.579 . . . . 0.0 111.286 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.9 t -135.73 104.57 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.627 1.171 . . . . 0.0 109.333 -171.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.75 104.53 16.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.543 1.137 . . . . 0.0 112.126 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -98.64 140.09 33.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.227 1.013 . . . . 0.0 110.648 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.83 149.21 43.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.321 1.848 . . . . 0.0 111.018 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -143.24 -166.24 2.27 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.579 1.151 . . . . 0.0 111.398 -170.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -42.32 -61.05 1.28 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.778 2.431 . . . . 0.0 114.21 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.0 t -145.41 -6.13 0.64 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.135 1.374 . . . . 0.0 113.845 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 16.0 ptm -94.16 149.41 21.26 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.19 1.396 . . . . 0.0 110.118 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -131.83 134.49 45.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.67 1.588 . . . . 0.0 109.054 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 10.1 p -140.48 84.27 1.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.184 0.992 . . . . 0.0 112.07 -170.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.76 136.94 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.43 -0.793 . . . . 0.0 111.281 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.49 143.45 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.918 1.687 . . . . 0.0 110.508 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 t -131.39 127.16 36.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.694 1.198 . . . . 0.0 110.191 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -123.06 136.66 54.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.803 2.041 . . . . 0.0 112.548 -168.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.54 116.29 15.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.712 1.205 . . . . 0.0 109.146 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.98 60.8 0.34 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.68 1.61 . . . . 0.0 112.959 -166.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -61.73 126.95 29.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.932 1.293 . . . . 0.0 113.09 -166.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 66.6 m -135.32 86.6 2.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.153 1.781 . . . . 0.0 111.714 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -10.11 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -63.45 -17.72 60.15 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.002 1.286 . . . . 0.0 115.316 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.81 9.58 62.83 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -52.16 144.58 18.56 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.062 1.315 . . . . 0.0 114.506 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 82.4 p -61.63 173.42 0.98 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.216 1.406 . . . . 0.0 112.699 171.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 64.47 43.76 96.21 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.501 -0.749 . . . . 0.0 113.154 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -71.06 -149.6 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 126.712 2.005 . . . . 0.0 111.49 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 26.9 t -50.43 -39.86 48.75 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.478 -1.389 . . . . 0.0 112.924 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 121.83 -78.53 0.34 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.833 1.682 . . . . 0.0 112.319 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.73 144.28 59.1 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.04 2.493 . . . . 0.0 111.324 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.9 pp -95.09 128.46 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.837 1.255 . . . . 0.0 110.612 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.69 122.94 28.24 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.321 1.449 . . . . 0.0 110.415 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.96 123.14 19.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.494 0.717 . . . . 0.0 110.174 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.17 160.26 32.38 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.17 1.367 . . . . 0.0 112.157 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 57.0 ttm -116.8 114.95 24.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.9 1.28 . . . . 0.0 110.741 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.71 120.05 17.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.327 1.451 . . . . 0.0 111.297 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -129.28 173.37 10.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.697 1.599 . . . . 0.0 111.063 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 11.0 mm -56.79 144.13 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.429 1.492 . . . . 0.0 111.318 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 89.9 m -105.81 90.2 3.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.211 1.404 . . . . 0.0 110.255 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -82.76 149.82 27.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.451 -0.781 . . . . 0.0 111.021 164.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.5 p -141.29 94.69 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 127.819 2.448 . . . . 0.0 109.285 175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.51 169.21 18.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.554 1.542 . . . . 0.0 112.144 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.87 91.74 31.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.741 1.217 . . . . 0.0 110.099 172.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.82 166.32 29.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.123 2.548 . . . . 0.0 112.474 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -38.62 6.46 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.969 2.446 . . . . 0.0 113.491 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -155.98 -65.99 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.062 1.345 . . . . 0.0 112.158 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.76 -179.33 6.54 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.134 1.774 . . . . 0.0 112.125 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.92 168.39 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.981 1.712 . . . . 0.0 111.971 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.683 1.993 . . . . 0.0 112.225 179.329 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.498 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 156.23 19.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.214 1.406 . . . . 0.0 112.407 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -82.51 -48.81 10.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.949 0.899 . . . . 0.0 112.34 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.23 -12.32 59.75 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -22.3 63.92 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.367 1.467 . . . . 0.0 113.306 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -69.57 132.21 45.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.15 0.886 . . . . 0.0 111.398 171.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -147.57 150.03 33.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.808 1.243 . . . . 0.0 111.597 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 9.01 38.67 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.971 1.708 . . . . 0.0 114.561 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.63 -10.45 8.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.893 1.677 . . . . 0.0 115.519 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -52.11 -22.09 3.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.661 1.984 . . . . 0.0 113.558 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -55.63 -22.7 23.85 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -73.36 -20.32 60.79 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.153 0.981 . . . . 0.0 113.524 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.28 146.43 54.95 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.187 -0.946 . . . . 0.0 111.191 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.96 155.49 30.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.79 0.836 . . . . 0.0 110.482 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.96 156.69 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.793 1.237 . . . . 0.0 110.49 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.1 t -57.88 -43.4 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.575 1.55 . . . . 0.0 110.824 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 7.11 0.32 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.11 1.764 . . . . 0.0 114.058 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -122.2 -54.41 1.9 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.7 p -45.55 -44.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.706 0.802 . . . . 0.0 112.808 166.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -62.73 -11.01 14.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -106.77 -38.24 6.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.874 2.07 . . . . 0.0 112.352 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mt -49.6 -41.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.135 1.374 . . . . 0.0 110.901 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.65 -41.78 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.4 -0.812 . . . . 0.0 112.903 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -51.23 57.86 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.571 1.078 . . . . 0.0 111.087 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -30.12 71.31 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.38 -40.72 29.45 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.094 0.957 . . . . 0.0 113.39 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.04 -55.75 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.275 0.943 . . . . 0.0 109.65 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.08 -31.44 70.01 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -58.64 -50.39 74.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.892 1.277 . . . . 0.0 112.149 167.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.32 -31.7 72.16 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.57 -37.08 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.529 1.132 . . . . 0.0 110.777 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 16.98 78.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.023 0.821 . . . . 0.0 114.165 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.86 79.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.052 1.311 . . . . 0.0 115.48 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.34 168.74 5.32 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.005 1.402 . . . . 0.0 113.635 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.74 -167.61 0.49 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.732 1.613 . . . . 0.0 113.387 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -52.35 149.66 5.41 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.848 1.659 . . . . 0.0 112.864 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -144.42 172.8 12.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.828 1.251 . . . . 0.0 112.463 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.68 -92.84 0.12 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.788 1.635 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -98.17 4.02 48.99 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.961 2.504 . . . . 0.0 113.881 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -49.38 -43.89 44.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.249 1.02 . . . . 0.0 112.641 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -52.07 -36.83 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.63 1.172 . . . . 0.0 113.19 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.2 -52.96 42.99 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.467 1.107 . . . . 0.0 112.201 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.59 -23.56 67.31 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.082 -1.011 . . . . 0.0 112.904 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -77.06 -55.67 5.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.951 1.301 . . . . 0.0 111.525 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 t -57.12 -29.16 63.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.619 0.645 . . . . 0.0 112.628 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -78.34 -58.8 3.06 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.247 0.93 . . . . 0.0 112.241 170.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -59.1 -41.28 87.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 113.972 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.44 -63.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.0 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.4 -29.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.628 1.171 . . . . 0.0 110.591 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.87 -38.9 76.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -107.33 -39.87 5.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.676 1.59 . . . . 0.0 112.155 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -60.49 -50.66 72.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.271 2.228 . . . . 0.0 112.542 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -35.84 81.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.232 0.539 . . . . 0.0 111.44 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.6 t -63.06 -40.56 98.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.469 -0.769 . . . . 0.0 112.215 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -66.22 -49.15 68.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.891 2.076 . . . . 0.0 113.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.85 -25.8 67.36 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.717 -1.239 . . . . 0.0 114.089 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.0 m -62.87 -23.51 67.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.452 1.101 . . . . 0.0 111.469 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -91.92 -24.52 19.26 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.155 0.982 . . . . 0.0 113.257 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.92 -22.32 66.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.928 1.291 . . . . 0.0 114.381 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.67 -130.42 3.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.29 1.424 . . . . 0.0 112.444 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -64.61 120.2 63.74 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.616 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.21 120.72 5.44 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.954 3.103 . . . . 0.0 112.385 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -163.91 -171.03 2.32 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.118 1.767 . . . . 0.0 112.277 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.95 123.79 36.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.062 1.345 . . . . 0.0 111.525 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 126.9 55.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.394 1.878 . . . . 0.0 109.353 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.18 148.25 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.124 0.97 . . . . 0.0 110.203 174.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.36 155.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.233 1.013 . . . . 0.0 111.256 167.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -140.41 155.27 46.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.997 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 p -146.21 149.49 34.04 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.469 1.128 . . . . 0.0 112.32 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.22 123.55 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.17 1.388 . . . . 0.0 109.082 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.5 98.67 7.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.565 1.946 . . . . 0.0 107.387 -174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 ttt -110.27 157.13 19.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 0.0 110.474 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.53 133.56 53.98 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.86 1.264 . . . . 0.0 110.988 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -64.81 -9.2 18.87 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.53 -19.16 23.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.241 1.816 . . . . 0.0 114.422 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.86 42.69 0.56 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.908 1.242 . . . . 0.0 113.905 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.4 74.25 1.57 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.254 1.021 . . . . 0.0 112.27 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.66 161.58 20.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.089 1.328 . . . . 0.0 115.113 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.0 -177.78 5.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.119 1.367 . . . . 0.0 113.52 -165.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -104.99 111.91 24.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.902 0.881 . . . . 0.0 110.161 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.2 m -112.18 144.87 40.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.108 1.363 . . . . 0.0 109.425 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.02 33.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.185 0.993 . . . . 0.0 112.004 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.0 p -142.62 138.76 30.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.081 0.943 . . . . 0.0 112.347 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -81.88 17.73 1.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.797 0.839 . . . . 0.0 112.034 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 39.8 m -61.78 173.9 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.762 1.268 . . . . 0.0 111.676 165.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.03 149.86 14.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.854 2.062 . . . . 0.0 109.289 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -83.56 134.66 34.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.722 0.809 . . . . 0.0 109.193 170.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -138.14 119.26 14.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 109.646 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.93 -47.0 4.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.058 1.743 . . . . 0.0 113.826 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 t -106.39 -22.36 12.83 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.806 1.242 . . . . 0.0 112.979 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -30.52 30.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.007 1.723 . . . . 0.0 112.999 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.44 -165.99 1.15 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.124 2.17 . . . . 0.0 110.103 -178.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.06 147.06 16.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.425 1.012 . . . . 0.0 113.073 170.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 p -162.79 150.98 14.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.923 1.289 . . . . 0.0 111.42 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 29.7 p -156.47 172.2 18.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.749 1.22 . . . . 0.0 112.246 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -154.4 150.75 28.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.358 1.063 . . . . 0.0 111.41 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.66 134.5 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.2 1.4 . . . . 0.0 109.562 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -123.61 125.74 45.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.06 1.344 . . . . 0.0 111.621 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -135.29 120.0 18.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.783 1.633 . . . . 0.0 109.938 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -82.16 153.28 26.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.335 -0.853 . . . . 0.0 111.803 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -120.74 -170.51 2.01 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 109.047 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -51.66 -54.14 31.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.0 t -138.14 -22.0 1.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.038 1.335 . . . . 0.0 114.319 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.1 ptp -92.29 177.63 6.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.807 1.243 . . . . 0.0 111.483 168.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -142.29 145.95 34.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 109.828 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 24.6 p -128.17 130.44 48.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.402 1.081 . . . . 0.0 110.869 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.05 133.39 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.157 0.983 . . . . 0.0 109.664 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.28 129.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 126.006 1.723 . . . . 0.0 109.665 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 p -126.49 148.79 49.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.34 131.92 37.0 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.5 1.52 . . . . 0.0 110.973 -171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -130.7 114.35 15.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.072 0.939 . . . . 0.0 110.031 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.05 84.05 0.49 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.638 1.59 . . . . 0.0 110.613 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.98 126.91 36.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.359 1.064 . . . . 0.0 112.737 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 t -147.26 116.3 6.87 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.032 1.333 . . . . 0.0 112.632 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -16.96 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.89 -15.54 69.31 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.814 1.197 . . . . 0.0 114.759 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.26 20.32 67.21 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 118.638 1.219 . . . . 0.0 115.245 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.61 51.22 3.35 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.135 1.826 . . . . 0.0 114.817 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.5 m -136.97 167.21 21.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.882 2.073 . . . . 0.0 111.899 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.04 18.14 6.96 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.694 1.14 . . . . 0.0 115.713 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -73.03 49.25 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.167 2.187 . . . . 0.0 113.781 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.9 p -144.6 7.18 1.27 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.817 1.647 . . . . 0.0 113.36 -172.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.66 -109.0 2.68 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.756 2.122 . . . . 0.0 111.636 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.85 141.17 64.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.609 2.206 . . . . 0.0 111.895 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.74 124.37 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.361 1.064 . . . . 0.0 111.201 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.32 147.52 40.16 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.705 -1.247 . . . . 0.0 111.55 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.9 mt -84.85 131.79 34.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.622 1.569 . . . . 0.0 110.182 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 158.23 105.87 0.22 Allowed Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.094 0.854 . . . . 0.0 113.188 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 68.8 mtm -67.89 156.73 36.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.372 1.069 . . . . 0.0 112.698 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.87 83.93 1.87 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.93 1.692 . . . . 0.0 111.712 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -118.96 170.78 8.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.541 0.736 . . . . 0.0 112.106 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.95 127.8 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.139 1.776 . . . . 0.0 111.493 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.3 m -97.62 101.54 13.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.914 1.686 . . . . 0.0 110.619 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -92.8 147.37 22.91 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.733 -1.229 . . . . 0.0 111.203 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -137.92 113.42 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.771 2.428 . . . . 0.0 109.505 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.08 141.77 42.37 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.317 -0.864 . . . . 0.0 112.15 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -140.04 94.62 8.81 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.099 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 164.74 33.87 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.6 -59.43 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.652 2.901 . . . . 0.0 112.865 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -158.58 -60.51 0.08 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.205 1.802 . . . . 0.0 110.305 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.409 ' HG2' ' H ' ' A' ' 142' ' ' ILE . 7.2 tt0 -89.2 -176.41 5.1 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.2 1.8 . . . . 0.0 111.952 178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.409 ' H ' ' HG2' ' A' ' 141' ' ' GLU . 0.2 OUTLIER -114.57 161.74 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.636 1.974 . . . . 0.0 111.354 173.34 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 126.513 1.925 . . . . 0.0 110.641 179.315 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.18 157.38 17.17 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 0.0 112.453 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -83.18 -48.87 10.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.144 0.978 . . . . 0.0 112.38 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.17 -12.22 59.45 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 -22.26 64.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.438 1.495 . . . . 0.0 113.34 173.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -69.49 132.33 46.13 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.118 0.872 . . . . 0.0 111.38 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -147.26 151.1 36.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.895 1.278 . . . . 0.0 111.611 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.48 9.36 40.34 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.009 1.724 . . . . 0.0 114.53 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.75 -10.34 8.61 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -52.0 -22.51 4.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.674 1.99 . . . . 0.0 113.587 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -55.2 -22.4 17.45 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -74.65 -20.39 59.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.409 1.084 . . . . 0.0 113.757 174.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.25 150.08 48.84 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.97 -1.082 . . . . 0.0 111.186 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -65.56 164.81 13.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.311 0.577 . . . . 0.0 111.272 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.46 155.5 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.861 1.265 . . . . 0.0 110.633 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.02 -41.78 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.16 0.984 . . . . 0.0 111.61 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -25.57 68.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.92 1.288 . . . . 0.0 113.406 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -56.51 4.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.361 1.465 . . . . 0.0 110.635 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -50.81 -44.3 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.874 1.27 . . . . 0.0 112.198 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -62.06 -13.45 26.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.741 1.217 . . . . 0.0 113.621 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -100.64 -39.67 7.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.743 2.017 . . . . 0.0 112.353 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -50.85 -42.55 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.98 1.312 . . . . 0.0 110.905 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.24 -41.78 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.433 -0.792 . . . . 0.0 112.857 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -51.32 58.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.69 1.132 . . . . 0.0 111.249 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -30.29 71.44 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.54 -39.9 30.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.986 0.914 . . . . 0.0 113.448 175.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.57 -55.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.302 0.956 . . . . 0.0 109.572 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.0 -31.56 70.03 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 3.0 t -58.33 -50.45 73.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.779 1.232 . . . . 0.0 112.211 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.6 72.1 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.61 -37.22 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.504 1.121 . . . . 0.0 110.871 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.988 0.804 . . . . 0.0 114.303 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.48 17.48 77.65 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.063 1.316 . . . . 0.0 115.621 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -65.24 172.98 2.74 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 118.934 1.367 . . . . 0.0 113.625 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.25 -160.54 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.377 1.471 . . . . 0.0 112.511 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -48.26 151.42 1.03 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.851 1.66 . . . . 0.0 113.083 165.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -147.8 172.3 14.34 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.983 1.313 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.51 -92.78 0.12 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.81 1.644 . . . . 0.0 111.383 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 2.0 p -98.26 3.99 48.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.981 2.512 . . . . 0.0 113.948 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.64 -43.87 47.12 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.075 -1.015 . . . . 0.0 112.619 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.9 -37.02 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.68 1.192 . . . . 0.0 113.132 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.17 -53.29 39.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.491 1.116 . . . . 0.0 112.177 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -64.26 -23.66 67.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.072 -1.018 . . . . 0.0 112.985 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.86 -55.93 5.05 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.978 1.311 . . . . 0.0 111.541 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 8.5 t -57.14 -27.89 62.26 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.603 0.638 . . . . 0.0 112.719 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.9 t -79.45 -60.03 2.52 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.388 0.995 . . . . 0.0 112.3 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -58.13 -41.24 83.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.28 1.4 . . . . 0.0 113.975 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.81 -63.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 124.874 1.269 . . . . 0.0 109.734 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.06 -29.31 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.047 1.339 . . . . 0.0 110.907 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -59.23 -37.25 77.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -109.1 -39.03 5.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.793 1.637 . . . . 0.0 112.118 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 52.4 m -61.7 -51.73 67.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.655 2.382 . . . . 0.0 112.4 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -36.51 83.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 117.953 0.342 . . . . 0.0 110.823 177.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.1 t -59.3 -43.67 92.6 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.546 -0.721 . . . . 0.0 112.203 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.46 -51.62 62.18 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.366 2.267 . . . . 0.0 113.292 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.4 pp -66.07 -27.24 67.92 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 22.9 m -59.13 -37.01 76.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.132 0.573 . . . . 0.0 109.995 168.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -77.25 -25.18 51.24 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . 0.297 0.0 OUTLIER -56.01 -26.2 47.71 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.967 1.707 . . . . 0.0 114.112 178.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -139.69 -82.77 0.09 OUTLIER Glycine 0 CA--C 1.535 1.295 0 CA-C-N 119.62 1.1 . . . . 0.0 114.425 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.15 172.62 3.4 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 125.97 1.708 . . . . 0.0 113.64 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.0 170.85 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 166.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -56.75 112.39 1.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.329 1.452 . . . . 0.0 112.899 172.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -177.75 100.97 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.255 2.622 . . . . 0.0 111.057 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -151.67 169.26 22.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.614 1.566 . . . . 0.0 110.497 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.2 tt -133.58 155.57 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 108.92 157.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 35.1 m -136.17 152.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 123.861 0.865 . . . . 0.0 111.105 165.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 39.7 p -133.69 158.83 42.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.84 1.256 . . . . 0.0 110.266 170.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.87 156.75 42.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.336 1.065 . . . . 0.0 112.656 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.66 127.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.408 -0.808 . . . . 0.0 110.752 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.4 mm -119.22 98.29 6.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 127.094 2.158 . . . . 0.0 107.356 -169.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.7 ttt -105.61 156.22 18.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.456 1.102 . . . . 0.0 110.401 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -122.42 132.04 54.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.801 1.24 . . . . 0.0 110.8 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -64.45 -9.11 16.31 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -57.31 -20.72 30.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.432 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 123.72 40.86 0.44 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.688 1.137 . . . . 0.0 114.232 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.45 70.33 1.25 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.317 1.047 . . . . 0.0 112.575 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.31 155.32 16.38 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.468 1.509 . . . . 0.0 115.597 -173.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 178.35 9.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.937 1.695 . . . . 0.0 112.624 -166.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -108.79 110.61 22.02 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.386 1.075 . . . . 0.0 111.216 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 55.7 m -105.67 145.2 31.37 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.266 1.026 . . . . 0.0 109.207 173.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.88 33.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 111.044 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 94.1 p -137.55 143.71 41.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.203 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.4 t -84.55 15.77 3.56 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.782 0.833 . . . . 0.0 111.885 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 31.8 m -61.23 167.7 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.169 0.988 . . . . 0.0 111.636 166.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.6 147.29 21.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.693 1.997 . . . . 0.0 109.779 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -82.64 128.55 34.44 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 0.0 108.7 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -133.04 116.42 16.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.794 1.638 . . . . 0.0 109.302 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 -47.11 5.16 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.9 1.68 . . . . 0.0 114.41 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 16.7 t -106.43 -21.02 13.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.74 1.216 . . . . 0.0 112.977 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -29.81 29.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.45 1.9 . . . . 0.0 113.356 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.1 -167.65 1.54 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.0 2.52 . . . . 0.0 109.294 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.58 146.35 16.92 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.419 1.009 . . . . 0.0 112.906 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 29.7 p -160.64 147.28 15.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.976 1.31 . . . . 0.0 111.783 170.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 11.6 p -152.35 169.28 22.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.789 1.236 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 9.6 t -155.65 151.74 27.83 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.693 -1.254 . . . . 0.0 111.645 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.67 138.86 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.24 1.416 . . . . 0.0 109.817 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -127.3 127.56 44.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.057 1.343 . . . . 0.0 111.782 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -136.5 119.63 16.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 110.04 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -81.95 153.11 26.43 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.936 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -120.93 -170.67 2.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.52 1.528 . . . . 0.0 109.079 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -51.67 -54.85 23.64 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t -137.46 -21.57 1.16 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.958 1.303 . . . . 0.0 114.245 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 20.1 ptp -93.03 178.06 5.87 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.386 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -142.43 145.97 34.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.075 1.35 . . . . 0.0 109.63 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 25.0 p -128.22 132.8 48.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.314 1.046 . . . . 0.0 110.888 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.61 138.26 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.124 0.969 . . . . 0.0 109.925 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.3 p -127.53 128.88 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.119 1.768 . . . . 0.0 110.07 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.5 p -123.23 148.93 45.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.672 1.189 . . . . 0.0 111.453 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -136.55 139.22 42.05 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.327 1.451 . . . . 0.0 112.698 -175.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.2 121.72 15.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.631 1.172 . . . . 0.0 109.572 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -111.69 82.03 0.3 Allowed Glycine 0 N--CA 1.469 0.859 0 C-N-CA 126.316 1.913 . . . . 0.0 111.863 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.87 105.34 17.27 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.706 1.202 . . . . 0.0 113.575 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.5 t -128.53 112.18 14.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.092 1.357 . . . . 0.0 112.532 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -17.99 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 114.681 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -67.35 -16.25 66.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.866 1.222 . . . . 0.0 114.798 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.43 15.86 66.52 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 118.694 1.247 . . . . 0.0 115.499 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.53 59.72 3.7 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.94 1.733 . . . . 0.0 114.153 -174.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 71.3 m -140.59 167.43 22.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.451 2.301 . . . . 0.0 111.325 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.7 19.43 6.52 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 115.761 1.064 . . . . 0.0 115.761 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -73.2 51.26 0.31 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.053 2.141 . . . . 0.0 113.734 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 80.1 p -147.96 6.79 0.8 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.537 1.535 . . . . 0.0 113.504 -170.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 77.13 -109.3 2.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.593 2.044 . . . . 0.0 111.675 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.56 141.81 68.56 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.658 2.239 . . . . 0.0 112.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.34 125.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.363 1.065 . . . . 0.0 111.26 173.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 148.92 43.76 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.246 -0.909 . . . . 0.0 111.826 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 29.4 mt -84.23 130.25 34.83 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.818 1.647 . . . . 0.0 110.028 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 159.6 100.75 0.16 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.969 0.795 . . . . 0.0 113.036 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 69.6 mtm -67.67 157.07 35.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.821 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -107.04 99.01 8.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.191 1.796 . . . . 0.0 111.045 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 274' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' B' ' 274' ' ' LYS 0.327 0.0 OUTLIER -127.34 177.04 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.209 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.17 129.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.176 0.99 . . . . 0.0 110.174 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 63.0 m -102.1 93.53 5.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.722 1.609 . . . . 0.0 109.953 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.89 149.59 24.7 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.329 -0.857 . . . . 0.0 111.081 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.2 118.13 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.723 2.009 . . . . 0.0 109.974 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -138.64 143.97 39.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.561 1.144 . . . . 0.0 111.569 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.05 95.42 9.48 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.819 1.647 . . . . 0.0 108.799 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.23 164.73 33.95 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.818 2.345 . . . . 0.0 112.14 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.52 -59.15 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.514 2.809 . . . . 0.0 112.877 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -158.51 -60.6 0.08 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.16 1.784 . . . . 0.0 110.414 170.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 284' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' B' ' 285' ' ' ILE . 7.1 tt0 -89.36 -176.61 5.13 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.237 1.815 . . . . 0.0 111.887 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 285' ' ' ILE . . . . . 0.401 ' H ' ' HG2' ' B' ' 284' ' ' GLU . 0.2 OUTLIER -114.0 161.66 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.588 1.955 . . . . 0.0 111.363 173.272 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.677 1.991 . . . . 0.0 110.57 179.553 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.291 0.567 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.25 178.57 5.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.83 1.252 . . . . 0.0 112.289 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.5 152.68 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.173 1.389 . . . . 0.0 110.916 171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.62 -43.42 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.731 1.212 . . . . 0.0 111.704 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.67 -29.85 68.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.101 1.36 . . . . 0.0 113.337 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.22 -57.34 4.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.101 0.96 . . . . 0.0 110.502 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.9 t -51.43 -40.45 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.74 1.216 . . . . 0.0 112.512 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -61.36 -19.76 62.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.76 1.624 . . . . 0.0 113.949 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.19 -35.55 10.34 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.731 1.612 . . . . 0.0 113.357 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mt -51.75 -38.88 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.277 1.031 . . . . 0.0 110.809 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 97' ' ' VAL . 9.9 p -64.1 -42.36 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.88 62.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.884 1.22 . . . . 0.0 111.299 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -32.47 71.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.3 -43.23 52.19 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.02 -55.41 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.616 1.098 . . . . 0.0 110.374 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.71 -29.77 70.96 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.422 -0.799 . . . . 0.0 113.138 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -61.24 -46.27 91.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.279 1.032 . . . . 0.0 112.236 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.34 93.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.144 0.977 . . . . 0.0 113.331 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.98 -48.0 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.254 1.021 . . . . 0.0 110.565 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.46 19.91 67.2 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.398 0.999 . . . . 0.0 115.01 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.14 20.46 77.4 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.918 1.247 . . . . 0.0 115.401 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.04 179.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 114.43 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.23 144.69 19.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.405 1.482 . . . . 0.0 113.32 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.65 121.04 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.819 1.248 . . . . 0.0 111.032 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.97 157.98 45.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.269 1.828 . . . . 0.0 111.112 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -106.44 -66.01 1.04 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.208 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -60.6 -18.51 53.42 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.943 1.297 . . . . 0.0 114.254 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.72 -38.96 79.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.036 -1.04 . . . . 0.0 113.191 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.08 -35.24 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.363 0.665 . . . . 0.0 111.943 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -62.12 -50.63 71.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.451 . . . . 0.0 111.341 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.95 -25.6 64.63 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -77.85 -54.26 6.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.01 0.823 . . . . 0.0 111.148 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -54.99 -36.08 65.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.678 0.672 . . . . 0.0 111.984 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -73.78 -56.86 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.345 0.975 . . . . 0.0 112.04 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -57.36 -40.27 77.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.98 1.312 . . . . 0.0 113.342 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.17 -63.64 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 C-N-CA 124.479 1.112 . . . . 0.0 110.524 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.76 -28.77 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.709 1.204 . . . . 0.0 110.788 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.87 -42.54 79.97 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.331 1.053 . . . . 0.0 112.667 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -103.41 -36.2 8.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.226 1.41 . . . . 0.0 112.592 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.9 m -62.89 -49.68 73.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.048 2.139 . . . . 0.0 112.355 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -36.7 83.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.709 0.404 . . . . 0.0 111.407 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 t -63.06 -42.86 99.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.486 0.714 . . . . 0.0 112.495 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -66.94 -49.38 65.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.045 1.738 . . . . 0.0 113.27 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.61 -28.03 68.83 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.68 -1.262 . . . . 0.0 113.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -57.59 -28.24 63.43 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.419 1.088 . . . . 0.0 111.151 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -89.75 -28.04 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.392 1.077 . . . . 0.0 113.285 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.85 -21.74 61.63 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.408 1.083 . . . . 0.0 112.463 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -134.72 8.61 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.373 1.94 . . . . 0.0 112.629 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -116.71 155.76 48.57 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 125.644 1.578 . . . . 0.0 112.578 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.38 114.16 3.15 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.856 3.037 . . . . 0.0 111.66 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.45 175.14 12.57 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.084 2.154 . . . . 0.0 110.808 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.74 100.42 7.08 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.231 1.413 . . . . 0.0 110.887 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.5 143.59 28.06 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.036 1.335 . . . . 0.0 109.949 168.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -133.44 153.4 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.464 1.505 . . . . 0.0 109.528 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.38 150.42 24.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.734 0.814 . . . . 0.0 111.084 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -133.78 136.67 44.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.331 1.453 . . . . 0.0 109.139 171.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 48.3 t -131.28 140.67 49.84 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.068 0.947 . . . . 0.0 111.159 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.49 101.31 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.543 1.537 . . . . 0.0 109.179 -168.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.22 95.88 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.288 1.435 . . . . 0.0 110.033 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.58 166.17 14.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.985 1.714 . . . . 0.0 112.815 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 119.47 22.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.683 1.193 . . . . 0.0 112.374 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -67.24 -11.29 57.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.084 1.354 . . . . 0.0 113.546 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -54.48 -28.61 46.0 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.996 1.719 . . . . 0.0 114.21 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.3 10.48 0.09 OUTLIER Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.05 97.82 4.57 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.107 1.454 . . . . 0.0 112.478 -165.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.31 169.08 25.96 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.197 1.856 . . . . 0.0 112.862 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.07 174.82 13.22 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.088 1.355 . . . . 0.0 113.319 -167.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.16 98.66 9.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.952 0.901 . . . . 0.0 112.08 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.481 ' HB ' HG13 ' A' ' 135' ' ' VAL . 48.3 m -95.29 139.82 31.07 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.212 -0.93 . . . . 0.0 109.637 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.06 111.77 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.949 1.7 . . . . 0.0 110.363 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 m -115.43 107.78 15.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 110.594 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -76.95 35.32 0.16 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.707 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.32 176.4 8.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.866 1.266 . . . . 0.0 111.412 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -141.17 137.63 32.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.278 1.431 . . . . 0.0 109.929 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -79.59 132.1 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.422 0.689 . . . . 0.0 109.803 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -142.68 149.0 38.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.372 1.469 . . . . 0.0 110.586 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -123.51 -60.47 1.47 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.176 1.39 . . . . 0.0 112.344 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -92.86 -26.79 17.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.017 0.927 . . . . 0.0 112.852 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -52.86 30.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.817 2.047 . . . . 0.0 113.317 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -146.87 173.87 12.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.769 2.427 . . . . 0.0 110.44 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.92 121.26 6.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.114 1.34 . . . . 0.0 113.359 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -146.85 144.84 29.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.456 1.502 . . . . 0.0 110.616 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.7 t -149.55 164.5 34.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.601 1.161 . . . . 0.0 111.184 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -162.96 150.48 13.35 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.178 -1.576 . . . . 0.0 111.143 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 23' ' ' VAL . 2.0 t -139.32 127.03 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.893 1.277 . . . . 0.0 110.113 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.76 111.74 17.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.04 1.336 . . . . 0.0 112.515 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -125.45 93.74 3.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.975 1.71 . . . . 0.0 110.678 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 151.83 29.4 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.685 1.194 . . . . 0.0 112.381 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -125.74 -175.22 3.28 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.915 1.686 . . . . 0.0 110.574 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -54.17 -50.22 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.032 1.333 . . . . 0.0 113.908 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -134.4 1.95 3.21 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.935 1.694 . . . . 0.0 113.895 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.26 156.97 32.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.292 2.237 . . . . 0.0 110.958 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -134.75 120.95 20.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.313 1.445 . . . . 0.0 110.815 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.2 m -126.16 98.31 5.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.218 1.007 . . . . 0.0 110.64 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 116.18 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.439 1.096 . . . . 0.0 111.882 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.12 137.38 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.471 1.908 . . . . 0.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -130.09 147.59 51.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.809 1.244 . . . . 0.0 111.349 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.99 140.01 39.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.796 1.639 . . . . 0.0 113.57 -170.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.55 113.61 13.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.549 1.14 . . . . 0.0 109.621 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.84 77.64 0.23 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.531 2.015 . . . . 0.0 110.734 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.06 108.92 2.8 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 111.232 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 126.736 2.014 . . . . 0.0 111.115 -171.003 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.75 176.77 8.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.44 1.896 . . . . 0.0 111.106 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.06 139.66 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.621 1.568 . . . . 0.0 111.142 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -115.7 92.88 4.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.363 1.465 . . . . 0.0 110.787 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -76.27 149.45 37.12 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.872 -1.143 . . . . 0.0 111.218 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -137.11 108.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.427 2.291 . . . . 0.0 109.636 174.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -131.89 119.8 21.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.074 1.75 . . . . 0.0 109.645 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 125.572 1.549 . . . . 0.0 109.902 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 CA-C-O 121.22 0.533 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -77.29 177.33 8.01 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.501 1.12 . . . . 0.0 112.361 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.0 152.59 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.26 1.424 . . . . 0.0 110.814 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.33 -43.2 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.0 -29.81 68.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.035 1.334 . . . . 0.0 113.357 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -73.71 -57.8 3.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 110.398 172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.6 -40.47 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.815 1.246 . . . . 0.0 112.505 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 29.3 t -61.22 -19.95 62.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.773 1.629 . . . . 0.0 113.963 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -97.96 -35.76 10.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.339 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.83 -38.69 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 110.866 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.418 HG21 HG21 ' B' ' 240' ' ' VAL . 10.0 p -64.15 -42.3 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -50.82 62.27 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.873 1.215 . . . . 0.0 111.263 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -32.47 71.14 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -43.27 52.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.95 -55.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.59 1.087 . . . . 0.0 110.336 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.64 -29.88 71.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.395 -0.816 . . . . 0.0 113.102 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.8 t -61.22 -46.3 90.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.231 1.013 . . . . 0.0 112.194 168.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.26 93.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.127 0.971 . . . . 0.0 113.319 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.97 -47.99 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.29 1.036 . . . . 0.0 110.529 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.43 19.96 67.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.391 0.996 . . . . 0.0 115.004 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.42 77.5 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.915 1.245 . . . . 0.0 115.407 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.02 179.45 0.91 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.98 1.312 . . . . 0.0 114.393 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.24 144.76 19.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.418 1.487 . . . . 0.0 113.334 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.71 120.98 15.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 110.982 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.92 157.88 45.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.321 1.848 . . . . 0.0 111.178 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -106.32 -65.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.476 1.111 . . . . 0.0 111.251 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -60.55 -18.51 52.89 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.923 1.289 . . . . 0.0 114.225 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.88 -38.86 79.78 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.981 -1.074 . . . . 0.0 113.207 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.12 -35.13 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.395 0.678 . . . . 0.0 111.982 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.16 -50.75 70.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.353 1.461 . . . . 0.0 111.277 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.89 -25.72 64.75 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -77.79 -54.29 6.52 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.012 0.824 . . . . 0.0 111.141 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -55.09 -35.71 64.89 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.64 0.655 . . . . 0.0 112.007 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -73.97 -57.34 4.04 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.372 0.987 . . . . 0.0 112.02 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.77 -40.13 75.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.037 1.335 . . . . 0.0 113.336 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.02 -63.87 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.489 1.116 . . . . 0.0 110.529 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.67 -28.9 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.741 1.217 . . . . 0.0 110.753 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.94 -41.82 78.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 0.0 112.725 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -104.12 -36.41 7.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.221 1.408 . . . . 0.0 112.514 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 35.2 m -62.59 -49.74 74.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.123 2.169 . . . . 0.0 112.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -37.15 84.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.858 0.463 . . . . 0.0 111.474 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.9 t -61.79 -46.43 89.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.438 0.695 . . . . 0.0 112.112 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -64.04 -49.36 72.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.063 1.745 . . . . 0.0 113.5 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.73 -28.21 68.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.734 -1.229 . . . . 0.0 113.595 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 82.1 m -58.3 -31.35 67.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.613 0.765 . . . . 0.0 110.85 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -84.95 -27.81 26.28 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.893 0.877 . . . . 0.0 113.088 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 27.7 mt -71.41 -20.75 62.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.502 1.121 . . . . 0.0 112.443 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.83 -136.26 9.27 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.702 2.096 . . . . 0.0 112.933 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -115.47 156.23 46.19 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.848 1.659 . . . . 0.0 112.427 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.75 110.85 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.879 3.053 . . . . 0.0 111.738 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.59 173.92 12.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.952 2.101 . . . . 0.0 110.892 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -74.31 96.2 2.79 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.074 1.35 . . . . 0.0 111.8 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -81.91 153.77 26.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.251 1.421 . . . . 0.0 111.413 164.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.26 153.72 10.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.939 2.096 . . . . 0.0 108.681 167.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.64 151.54 22.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.999 0.919 . . . . 0.0 110.912 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.5 p -132.82 137.56 46.79 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.232 1.413 . . . . 0.0 109.229 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 47.7 t -132.26 145.04 51.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.272 1.029 . . . . 0.0 111.124 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.16 106.73 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.625 1.57 . . . . 0.0 108.782 -167.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 mm -101.18 94.7 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.086 1.355 . . . . 0.0 109.688 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 166.27 14.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.014 1.725 . . . . 0.0 112.6 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.25 121.16 24.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.524 1.13 . . . . 0.0 112.571 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -67.95 -11.17 58.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.049 1.34 . . . . 0.0 113.582 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.25 -28.04 50.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 114.212 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.64 11.5 0.1 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.48 98.5 4.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 -166.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -143.27 169.26 25.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.27 1.89 . . . . 0.0 112.874 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.14 174.64 13.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.18 1.392 . . . . 0.0 113.252 -167.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.24 100.41 11.51 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.91 0.884 . . . . 0.0 112.093 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.566 ' HB ' HG13 ' B' ' 278' ' ' VAL . 79.6 m -96.8 139.61 32.59 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.085 -1.009 . . . . 0.0 109.803 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.53 110.18 12.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.848 1.659 . . . . 0.0 109.955 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 10.1 m -112.44 108.03 17.03 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.37 1.068 . . . . 0.0 110.292 -172.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.6 t -76.96 35.52 0.16 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.62 1.168 . . . . 0.0 112.673 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 2.5 m -84.88 175.91 8.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 0.0 111.622 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.2 137.21 32.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.326 1.45 . . . . 0.0 109.932 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -78.91 130.6 35.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.373 0.669 . . . . 0.0 109.704 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -139.85 145.44 38.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.61 1.564 . . . . 0.0 110.25 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 47.6 t -120.5 -61.74 1.54 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.097 1.359 . . . . 0.0 112.419 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 9.1 t -93.26 -25.0 17.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.093 0.957 . . . . 0.0 112.797 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -52.84 30.75 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.753 2.021 . . . . 0.0 112.968 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -148.7 174.49 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.744 2.418 . . . . 0.0 110.44 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.68 120.75 6.25 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.012 1.292 . . . . 0.0 113.514 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 52.6 m -146.39 144.51 29.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.418 1.487 . . . . 0.0 110.769 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 6.9 t -149.14 164.7 33.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.695 1.198 . . . . 0.0 111.179 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 2.9 t -163.12 150.61 13.16 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.166 -1.584 . . . . 0.0 111.11 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.418 HG21 HG21 ' B' ' 166' ' ' VAL . 2.0 t -139.38 127.27 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.919 1.288 . . . . 0.0 110.109 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.91 111.91 17.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.029 1.332 . . . . 0.0 112.536 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -125.51 94.13 4.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.958 1.703 . . . . 0.0 110.678 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.76 151.87 28.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 112.39 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -125.9 -175.18 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.86 1.664 . . . . 0.0 110.551 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -54.32 -50.02 68.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.112 1.365 . . . . 0.0 113.949 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -134.61 2.02 3.16 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.953 1.701 . . . . 0.0 113.895 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.27 156.97 32.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.232 2.213 . . . . 0.0 110.879 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.82 121.4 20.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.333 1.453 . . . . 0.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 15.9 m -126.28 98.57 5.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.258 1.023 . . . . 0.0 110.551 -175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 117.74 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.255 1.022 . . . . 0.0 111.85 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.0 137.99 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.558 1.943 . . . . 0.0 111.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.2 t -131.32 147.4 52.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.861 1.264 . . . . 0.0 111.382 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.44 38.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.725 1.61 . . . . 0.0 113.543 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.91 110.08 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -105.29 77.94 0.26 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.237 1.875 . . . . 0.0 110.669 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.73 108.69 2.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.402 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 126.792 2.037 . . . . 0.0 111.137 -171.013 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.198 0.523 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.73 177.31 7.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.546 1.939 . . . . 0.0 111.098 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.08 139.33 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.561 1.544 . . . . 0.0 111.259 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.1 m -114.84 90.76 3.42 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.343 1.457 . . . . 0.0 110.562 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.95 149.99 37.57 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.814 -1.178 . . . . 0.0 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.6 p -143.17 108.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.607 1.963 . . . . 0.0 110.407 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -130.02 120.02 24.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.896 2.078 . . . . 0.0 109.142 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.573 1.149 . . . . 0.0 108.536 167.381 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -101.55 172.02 7.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.147 0.979 . . . . 0.0 111.07 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.95 146.21 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.15 1.38 . . . . 0.0 109.763 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.9 t -60.48 -38.52 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.496 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.56 -29.15 68.98 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.86 1.264 . . . . 0.0 113.74 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.36 -58.23 3.45 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.933 0.893 . . . . 0.0 110.426 171.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.496 HG13 HD22 ' A' ' 56' ' ' LEU . 52.3 t -52.03 -44.01 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.319 1.447 . . . . 0.0 112.095 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.26 -12.8 44.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.127 1.771 . . . . 0.0 113.834 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -101.95 -31.98 10.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 113.133 171.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mt -51.59 -43.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.052 0.941 . . . . 0.0 110.451 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.65 -42.56 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -52.48 56.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.037 1.29 . . . . 0.0 110.805 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.18 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.55 -38.5 70.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.074 0.949 . . . . 0.0 113.089 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' A' ' 48' ' ' VAL . 50.2 mt -61.06 -57.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.329 0.968 . . . . 0.0 110.057 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.82 -28.75 70.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 t -59.73 -46.57 88.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.72 1.208 . . . . 0.0 112.386 168.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.16 79.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.92 0.888 . . . . 0.0 113.151 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.6 mt -67.72 -40.18 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.346 1.058 . . . . 0.0 111.728 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.96 12.85 58.43 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.837 1.208 . . . . 0.0 114.992 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.84 15.52 73.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.723 1.154 . . . . 0.0 114.766 -172.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.61 -175.79 0.71 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.203 1.401 . . . . 0.0 112.369 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.16 107.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.402 1.481 . . . . 0.0 112.616 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -70.52 100.01 1.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.534 1.534 . . . . 0.0 111.109 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.5 164.87 11.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.645 1.178 . . . . 0.0 111.738 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -73.42 -55.75 5.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -68.21 -21.05 64.88 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.623 -0.673 . . . . 0.0 112.559 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -58.61 -44.03 89.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 168.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -54.81 -34.61 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.393 0.997 . . . . 0.0 112.048 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.2 -49.92 65.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.086 0.954 . . . . 0.0 111.936 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.01 -26.0 66.57 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.565 -0.709 . . . . 0.0 112.813 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -76.71 -53.62 7.73 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.308 1.043 . . . . 0.0 111.247 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 t -58.27 -26.78 63.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -81.46 -57.38 3.5 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.597 1.09 . . . . 0.0 112.542 169.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -57.83 -38.36 75.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 113.74 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 27' ' ' ILE . 88.0 t -68.02 -62.55 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 123.841 0.856 . . . . 0.0 110.343 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.9 t -48.95 -29.67 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.983 1.313 . . . . 0.0 110.82 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.01 -42.99 86.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.534 0.733 . . . . 0.0 112.788 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -103.87 -34.75 8.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.216 1.406 . . . . 0.0 113.149 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -59.17 -53.96 52.43 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.323 1.849 . . . . 0.0 111.487 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -37.78 83.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.961 0.505 . . . . 0.0 111.979 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 p -70.92 -29.93 66.11 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.92 -51.89 19.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.484 2.314 . . . . 0.0 112.968 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.496 HD22 HG13 ' A' ' 19' ' ' VAL . 4.3 pp -64.78 -25.6 67.99 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.865 -1.147 . . . . 0.0 113.731 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 m -59.95 -33.58 72.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.143 0.977 . . . . 0.0 110.939 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -82.09 -28.42 32.33 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.39 -16.56 63.53 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.64 -120.67 4.55 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.247 1.88 . . . . 0.0 112.544 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -131.64 152.38 80.3 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 126.376 1.87 . . . . 0.0 111.631 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.31 109.42 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.953 3.102 . . . . 0.0 112.108 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -148.04 161.56 41.14 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.705 1.202 . . . . 0.0 112.57 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -69.17 92.6 0.56 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.193 1.397 . . . . 0.0 110.828 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -70.5 165.02 23.52 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.629 -0.67 . . . . 0.0 112.038 164.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' B' ' 228' ' ' CYS . 4.5 tt -144.43 159.88 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.696 1.598 . . . . 0.0 110.092 167.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 110' ' ' ALA . 34.9 m -139.67 148.11 23.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.3 1.44 . . . . 0.0 110.776 171.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 124.62 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.141 1.776 . . . . 0.0 108.642 175.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.09 151.0 49.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.77 100.0 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.028 1.731 . . . . 0.0 109.012 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 mm -97.27 109.69 23.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.456 ' HG3' HD21 ' A' ' 79' ' ' LEU . 8.3 ttm -124.11 154.78 39.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.747 1.219 . . . . 0.0 110.748 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.59 150.53 36.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.889 1.276 . . . . 0.0 111.833 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -90.66 3.45 54.17 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.11 1.364 . . . . 0.0 113.498 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -67.74 -18.53 64.92 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.162 1.785 . . . . 0.0 115.072 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.55 -1.75 2.14 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.201 1.24 . . . . 0.0 116.201 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.6 122.74 12.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.819 1.81 . . . . 0.0 111.79 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.59 112.82 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.023 1.297 . . . . 0.0 113.163 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.628 HD22 HD22 ' B' ' 222' ' ' LEU . 0.2 OUTLIER -140.38 151.73 45.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.13 2.572 . . . . 0.0 109.597 -172.207 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -118.4 104.94 11.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.692 1.597 . . . . 0.0 108.713 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 135' ' ' VAL . 1.8 m -123.75 117.94 26.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.425 0.69 . . . . 0.0 109.629 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.42 118.96 32.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.607 0.763 . . . . 0.0 110.768 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -122.56 111.95 17.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.105 1.362 . . . . 0.0 110.024 -173.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.0 m -73.91 22.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.081 -1.012 . . . . 0.0 113.698 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.5 m -66.19 166.5 11.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 112.117 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.2 159.78 36.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.787 2.035 . . . . 0.0 109.773 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -87.17 141.66 28.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.803 0.841 . . . . 0.0 110.374 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.37 158.49 43.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.086 1.354 . . . . 0.0 112.475 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.1 t -135.05 -56.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.03 1.332 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -86.43 -28.77 23.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.223 0.919 . . . . 0.0 112.637 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.4 -43.34 73.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.937 1.695 . . . . 0.0 112.684 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -161.42 -164.54 1.15 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.189 1.796 . . . . 0.0 111.552 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.57 124.92 7.77 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.097 1.808 . . . . 0.0 114.734 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -145.97 178.41 8.21 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.998 2.119 . . . . 0.0 111.764 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 32.7 t -166.59 135.39 2.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.399 1.48 . . . . 0.0 109.811 162.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -143.95 147.37 33.85 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.869 -1.769 . . . . 0.0 112.303 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.3 144.66 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 110.249 -169.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -138.6 113.14 8.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.312 1.445 . . . . 0.0 111.802 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -124.36 105.84 9.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.282 1.833 . . . . 0.0 110.472 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.75 165.75 16.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.107 0.963 . . . . 0.0 111.66 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.03 -178.77 5.61 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.772 1.229 . . . . 0.0 111.673 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -50.06 -56.56 10.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 113.776 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.0 t -133.71 -15.58 2.38 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.555 1.542 . . . . 0.0 113.744 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.1 ptp -104.68 178.74 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.989 1.716 . . . . 0.0 111.089 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.35 157.57 43.63 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.295 -0.878 . . . . 0.0 111.399 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.9 m -131.45 125.49 32.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.962 1.305 . . . . 0.0 110.462 -171.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -125.75 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.341 1.056 . . . . 0.0 110.633 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.39 109.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 126.146 1.778 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.7 t -108.77 126.95 53.58 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.185 1.394 . . . . 0.0 110.878 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -123.44 157.18 34.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.484 1.914 . . . . 0.0 112.705 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -143.06 158.84 43.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.967 1.307 . . . . 0.0 111.822 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.05 89.07 0.08 OUTLIER Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.311 1.434 . . . . 0.0 111.233 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.79 89.17 1.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.486 1.514 . . . . 0.0 111.404 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.07 1.348 . . . . 0.0 112.957 -172.646 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -137.29 177.9 7.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.694 2.797 . . . . 0.0 111.083 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.66 130.89 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.021 1.728 . . . . 0.0 111.075 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.5 m -97.19 90.55 5.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.146 1.378 . . . . 0.0 110.153 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.49 146.6 34.3 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.817 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -129.71 140.72 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.97 1.708 . . . . 0.0 110.46 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -149.41 143.96 26.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.927 1.291 . . . . 0.0 112.07 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 125.377 1.471 . . . . 0.0 110.078 173.951 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.995 0.426 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -99.83 172.0 7.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.207 1.003 . . . . 0.0 111.143 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.19 146.36 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.142 1.377 . . . . 0.0 109.782 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.4 -38.69 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.261 -0.899 . . . . 0.0 111.501 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.5 -29.11 68.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.884 1.274 . . . . 0.0 113.814 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.38 -58.41 3.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.929 0.891 . . . . 0.0 110.376 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.498 HG13 HD22 ' B' ' 199' ' ' LEU . 53.3 t -52.08 -43.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.35 1.46 . . . . 0.0 112.122 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.1 t -64.14 -12.72 42.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 113.9 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -102.16 -31.96 10.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.782 1.633 . . . . 0.0 113.133 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 23.0 mt -51.41 -43.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 110.464 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.72 -42.51 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -52.32 57.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.037 1.289 . . . . 0.0 110.975 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -34.34 76.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.41 -38.47 71.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.159 0.984 . . . . 0.0 113.119 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' B' ' 191' ' ' VAL . 49.8 mt -61.0 -58.05 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.242 0.928 . . . . 0.0 109.975 172.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.68 -28.93 70.27 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.559 -0.713 . . . . 0.0 112.889 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -59.54 -46.67 88.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.769 1.227 . . . . 0.0 112.401 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.16 79.95 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.923 0.889 . . . . 0.0 113.146 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.71 -40.2 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.317 1.047 . . . . 0.0 111.774 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.02 12.73 58.26 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.865 1.221 . . . . 0.0 115.026 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.96 15.51 74.14 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.76 1.171 . . . . 0.0 114.762 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.72 -175.7 0.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.171 1.388 . . . . 0.0 112.34 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 107.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.316 1.446 . . . . 0.0 112.653 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -70.39 99.86 1.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.632 1.573 . . . . 0.0 111.14 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.53 164.85 11.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.623 1.169 . . . . 0.0 111.738 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -73.35 -55.9 5.78 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.4 m -67.92 -21.21 65.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.516 -0.74 . . . . 0.0 112.54 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -58.48 -44.04 89.22 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.91 -34.58 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.36 0.982 . . . . 0.0 112.039 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -65.97 -50.08 65.58 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.073 0.949 . . . . 0.0 111.943 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.04 -26.09 66.59 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.517 -0.739 . . . . 0.0 112.711 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -76.59 -53.51 7.95 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 111.314 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.5 t -58.42 -26.48 63.34 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.6 t -81.57 -57.94 3.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.625 1.102 . . . . 0.0 112.579 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -57.36 -38.19 73.8 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' B' ' 170' ' ' ILE . 87.8 t -68.08 -62.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 123.857 0.863 . . . . 0.0 110.276 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.95 -29.68 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.018 1.327 . . . . 0.0 110.852 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.06 -42.8 86.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.428 0.691 . . . . 0.0 112.826 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.02 -34.76 8.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 113.085 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 18.6 m -59.14 -53.88 53.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.38 1.872 . . . . 0.0 111.452 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -38.19 84.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.039 0.536 . . . . 0.0 111.94 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 37.2 p -70.78 -29.74 66.03 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -72.14 -51.91 19.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.475 2.31 . . . . 0.0 113.045 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.498 HD22 HG13 ' B' ' 162' ' ' VAL . 4.4 pp -65.03 -25.8 67.99 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.808 -1.183 . . . . 0.0 113.706 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 60.2 m -59.33 -34.79 72.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.051 0.94 . . . . 0.0 110.676 167.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -81.12 -28.38 35.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.2 -16.58 63.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.33 1.052 . . . . 0.0 113.074 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.9 -117.21 4.22 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.036 1.779 . . . . 0.0 112.558 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -132.96 158.92 74.61 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 126.716 2.006 . . . . 0.0 111.474 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.04 110.09 3.01 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.572 2.848 . . . . 0.0 112.286 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.84 165.18 29.64 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.687 1.595 . . . . 0.0 111.965 173.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -72.7 98.04 2.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.632 1.173 . . . . 0.0 110.425 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -74.39 164.56 26.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.268 0.556 . . . . 0.0 111.937 165.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 4.2 tt -145.09 159.31 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.851 1.66 . . . . 0.0 109.991 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' B' ' 253' ' ' ALA . 35.1 m -140.18 147.9 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 125.317 1.447 . . . . 0.0 110.695 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 123.26 14.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.054 1.742 . . . . 0.0 108.616 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.1 p -126.46 150.26 48.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.14 103.19 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.153 1.781 . . . . 0.0 109.002 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.45 108.97 24.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.8 ttm -123.91 162.79 22.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.765 1.226 . . . . 0.0 110.951 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.82 44.23 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 112.277 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -90.62 1.81 56.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -67.71 -18.8 65.03 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.012 1.725 . . . . 0.0 115.078 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.04 -1.41 2.22 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.19 125.26 19.89 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.767 1.783 . . . . 0.0 111.563 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -130.32 112.19 1.25 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.944 1.259 . . . . 0.0 112.999 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.628 HD22 HD22 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -139.17 153.37 47.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.148 2.579 . . . . 0.0 109.591 -172.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -119.55 102.18 8.46 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 108.79 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 1.4 m -121.4 123.59 42.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.015 0.926 . . . . 0.0 109.121 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.59 119.89 29.33 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.172 0.589 . . . . 0.0 111.011 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -122.47 112.38 17.98 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.022 1.329 . . . . 0.0 109.988 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 70.5 m -74.11 23.22 0.08 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' CYS . . . . . 0.426 ' SG ' HD11 ' A' ' 66' ' ' ILE . 20.6 m -67.18 167.03 12.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.639 1.176 . . . . 0.0 112.109 167.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.59 161.73 37.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.126 2.17 . . . . 0.0 109.73 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -88.66 141.64 28.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.92 0.888 . . . . 0.0 110.275 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -146.01 157.56 43.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.088 1.355 . . . . 0.0 112.544 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.0 t -127.14 -61.09 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.2 1.4 . . . . 0.0 112.133 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 82.7 p -95.34 -21.67 18.24 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -40.69 86.69 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.89 1.276 . . . . 0.0 111.608 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -162.04 -163.79 0.99 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 126.636 1.974 . . . . 0.0 111.026 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.27 9.04 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.061 1.791 . . . . 0.0 114.489 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 87.3 p -148.12 178.18 8.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 111.576 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 31.4 t -166.84 134.71 2.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 109.82 162.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -143.36 147.19 34.29 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.9 -1.75 . . . . 0.0 112.362 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.85 144.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.665 1.186 . . . . 0.0 110.175 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -138.73 113.1 8.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.145 1.378 . . . . 0.0 111.823 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -124.9 103.81 8.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.266 1.827 . . . . 0.0 110.346 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.17 165.99 6.61 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.83 0.852 . . . . 0.0 112.588 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -140.36 -177.73 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.301 1.44 . . . . 0.0 111.465 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -49.81 -56.73 9.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.584 . . . . 0.0 113.852 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.6 t -133.51 -16.71 2.34 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.69 1.596 . . . . 0.0 113.552 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.3 ptp -104.05 -179.32 3.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.196 1.798 . . . . 0.0 111.162 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -149.25 161.27 42.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.008 0.923 . . . . 0.0 111.578 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 32.2 m -132.77 124.95 29.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.425 1.49 . . . . 0.0 110.051 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.08 136.55 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.095 0.958 . . . . 0.0 110.539 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.95 108.03 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.972 1.709 . . . . 0.0 111.093 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.5 t -107.06 123.53 48.35 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.107 1.363 . . . . 0.0 110.775 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -118.33 158.14 25.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.41 1.884 . . . . 0.0 112.368 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -142.18 156.54 45.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.648 1.179 . . . . 0.0 112.034 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -171.3 88.91 0.08 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.722 0.677 . . . . 0.0 113.119 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.69 91.87 2.94 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.612 1.165 . . . . 0.0 110.777 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 125.187 1.395 . . . . 0.0 112.183 -173.526 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -135.68 177.92 7.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.682 2.393 . . . . 0.0 111.111 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.8 mm -53.01 130.24 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.981 1.712 . . . . 0.0 111.106 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 32.0 m -96.26 86.48 4.23 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.098 1.359 . . . . 0.0 110.114 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.14 145.47 27.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.809 0.844 . . . . 0.0 110.883 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.0 136.86 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.121 1.768 . . . . 0.0 110.964 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -143.74 144.69 31.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.497 1.519 . . . . 0.0 112.109 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.23 1.412 . . . . 0.0 110.522 174.963 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 121.011 0.434 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.92 166.3 11.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.266 1.026 . . . . 0.0 112.289 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.83 158.08 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.289 1.435 . . . . 0.0 110.584 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.3 -36.4 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.47 -32.59 58.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.687 0.795 . . . . 0.0 112.881 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.74 -54.79 5.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.096 0.558 . . . . 0.0 110.236 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 HD22 ' A' ' 56' ' ' LEU . 77.5 t -52.08 -43.8 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.952 1.301 . . . . 0.0 112.661 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -64.04 -9.45 16.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.628 1.971 . . . . 0.0 113.898 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -102.68 -38.06 7.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.551 1.54 . . . . 0.0 112.433 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.9 mt -50.08 -44.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.851 0.86 . . . . 0.0 110.474 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -59.24 -42.36 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -52.06 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.046 1.294 . . . . 0.0 111.086 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -33.41 74.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.87 59.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.192 0.997 . . . . 0.0 112.931 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' HA ' HG21 ' A' ' 48' ' ' VAL . 59.7 mt -59.75 -58.87 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.319 0.963 . . . . 0.0 109.626 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.7 -30.01 71.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -59.29 -50.66 73.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.429 1.091 . . . . 0.0 112.061 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.95 73.18 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.47 -35.76 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.478 1.111 . . . . 0.0 111.582 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.55 81.68 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.109 0.861 . . . . 0.0 114.739 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.37 3.04 56.61 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.158 1.361 . . . . 0.0 115.863 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -64.62 165.26 10.48 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 119.235 1.517 . . . . 0.0 111.694 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.77 -178.75 4.98 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.931 -1.106 . . . . 0.0 112.053 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -51.73 141.04 17.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.546 0.738 . . . . 0.0 111.285 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 165.19 24.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.361 1.065 . . . . 0.0 111.594 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -84.09 -88.3 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.824 0.849 . . . . 0.0 111.055 -171.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -78.47 -21.08 49.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.345 -1.472 . . . . 0.0 113.921 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -38.01 71.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.238 1.015 . . . . 0.0 112.445 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.17 -30.37 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -68.06 -45.29 74.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.827 0.851 . . . . 0.0 111.188 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.39 -26.4 66.43 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -76.73 -53.82 7.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.972 0.806 . . . . 0.0 111.322 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -56.0 -32.07 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.618 0.644 . . . . 0.0 112.452 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -77.65 -59.45 2.78 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.357 0.98 . . . . 0.0 112.581 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -57.08 -39.02 74.17 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.389 1.476 . . . . 0.0 113.63 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 27' ' ' ILE . 86.3 t -68.3 -63.5 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 C-N-CA 123.976 0.91 . . . . 0.0 109.97 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.88 -30.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.761 1.224 . . . . 0.0 110.621 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.44 -46.4 83.63 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.646 0.779 . . . . 0.0 112.671 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -98.23 -39.45 8.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 0.0 112.705 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -58.28 -53.09 62.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.265 2.226 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -38.07 85.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.64 0.376 . . . . 0.0 111.208 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 t -62.57 -44.58 95.98 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.329 -0.857 . . . . 0.0 112.252 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -61.38 -49.28 77.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.729 2.012 . . . . 0.0 113.048 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 19' ' ' VAL . 3.9 pp -68.77 -27.12 65.61 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.0 m -59.9 -30.68 69.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 110.918 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -82.16 -28.01 32.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.519 -0.738 . . . . 0.0 112.97 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.35 -28.87 66.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.637 0.775 . . . . 0.0 111.433 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.42 -104.61 2.3 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.771 1.653 . . . . 0.0 113.855 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 154.44 75.5 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.114 1.766 . . . . 0.0 112.642 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.54 110.51 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.86 3.04 . . . . 0.0 111.673 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.37 170.25 18.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 112.587 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -71.37 116.01 11.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.644 0.778 . . . . 0.0 110.563 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -101.59 164.15 11.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.518 1.127 . . . . 0.0 110.74 165.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.429 HD11 ' SG ' ' B' ' 228' ' ' CYS . 1.0 OUTLIER -147.42 155.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.602 1.961 . . . . 0.0 108.518 171.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 110' ' ' ALA . 3.8 m -139.53 151.78 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 110.415 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.53 128.74 25.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.939 2.095 . . . . 0.0 108.862 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.4 p -131.81 145.3 51.49 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.253 -0.904 . . . . 0.0 112.66 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.64 110.25 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.468 1.507 . . . . 0.0 108.606 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' A' ' 106' ' ' CYS . 3.6 mm -109.8 95.67 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.31 1.844 . . . . 0.0 107.808 -174.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -134.5 154.15 51.58 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.654 0.782 . . . . 0.0 111.975 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.27 149.33 33.58 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.731 -0.606 . . . . 0.0 112.019 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -7.38 59.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -65.96 -36.88 84.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.473 1.909 . . . . 0.0 114.367 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.8 40.37 1.59 Allowed Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.6 1.095 . . . . 0.0 115.026 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.06 -169.94 0.67 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.173 1.389 . . . . 0.0 112.701 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.0 73.15 1.05 Allowed Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.545 -1.347 . . . . 0.0 113.939 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.12 90.85 2.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.891 2.076 . . . . 0.0 112.065 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -113.65 136.44 52.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.271 1.428 . . . . 0.0 110.181 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.441 ' HB ' HG13 ' A' ' 135' ' ' VAL . 27.9 m -145.27 147.31 32.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.902 1.281 . . . . 0.0 109.779 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.4 147.88 30.73 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.254 -0.904 . . . . 0.0 111.602 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.1 p -148.52 133.47 18.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.039 0.536 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.5 m -80.51 19.19 0.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.687 -0.633 . . . . 0.0 112.564 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.482 ' SG ' HD11 ' B' ' 209' ' ' ILE . 56.1 m -68.34 165.16 19.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.717 1.207 . . . . 0.0 112.204 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -163.02 140.11 7.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.653 1.581 . . . . 0.0 110.61 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.02 150.79 40.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.13 0.572 . . . . 0.0 110.498 171.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -140.32 152.75 46.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.62 1.568 . . . . 0.0 110.617 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.3 t -109.24 -66.31 1.07 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.197 0.999 . . . . 0.0 111.426 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.5 p -89.78 -26.68 20.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 113.027 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -77.82 -44.87 26.08 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.364 1.866 . . . . 0.0 112.92 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -148.85 -174.24 4.57 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.117 2.567 . . . . 0.0 110.686 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.98 123.24 3.97 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.618 1.58 . . . . 0.0 113.441 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.46 125.08 13.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.411 1.484 . . . . 0.0 111.337 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.43 112.24 18.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.601 1.56 . . . . 0.0 112.175 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 t -125.21 147.97 48.84 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.523 -1.361 . . . . 0.0 112.319 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.69 136.39 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.739 1.615 . . . . 0.0 109.723 -170.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.58 101.4 5.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.461 1.504 . . . . 0.0 112.022 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -110.04 129.2 55.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.23 159.37 16.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.973 0.909 . . . . 0.0 110.934 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.75 -178.4 4.48 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.599 1.56 . . . . 0.0 110.593 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -51.24 60.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.181 2.192 . . . . 0.0 113.025 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -138.48 -3.51 1.7 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.299 1.439 . . . . 0.0 114.115 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.3 ptp -126.18 -173.71 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.608 1.963 . . . . 0.0 110.746 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.29 156.41 43.8 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.341 -0.85 . . . . 0.0 111.033 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.424 ' CB ' HD12 ' A' ' 71' ' ' ILE . 4.9 p -131.33 96.15 3.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.333 1.453 . . . . 0.0 111.019 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.25 138.32 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.244 1.018 . . . . 0.0 111.413 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.41 137.03 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.309 1.844 . . . . 0.0 109.999 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.2 t -128.25 123.21 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.072 1.349 . . . . 0.0 109.853 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -110.21 150.96 27.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.606 1.162 . . . . 0.0 111.53 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.66 106.91 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.764 1.626 . . . . 0.0 107.915 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.23 88.24 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.962 1.744 . . . . 0.0 110.358 -169.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.532 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.5 mm? -64.42 163.61 12.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.998 1.319 . . . . 0.0 112.218 -173.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 124.836 1.254 . . . . 0.0 112.381 -174.06 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -121.7 168.21 12.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.925 1.69 . . . . 0.0 112.051 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mm -71.85 146.49 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.447 1.499 . . . . 0.0 110.704 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.1 m -112.79 92.7 4.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.39 1.476 . . . . 0.0 110.292 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.54 149.34 22.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.863 0.865 . . . . 0.0 111.036 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.441 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -135.9 106.75 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.522 2.329 . . . . 0.0 108.795 175.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.17 152.13 48.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.1 0.96 . . . . 0.0 111.833 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 123.794 0.837 . . . . 0.0 111.4 174.305 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 121.4 0.619 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -93.67 174.38 7.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.06 0.944 . . . . 0.0 112.022 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.58 159.27 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.278 1.431 . . . . 0.0 110.766 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 89.3 t -61.95 -38.33 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.133 -0.979 . . . . 0.0 112.014 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.63 -30.31 60.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 112.877 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.87 -61.05 1.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.763 0.825 . . . . 0.0 110.75 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.537 HG13 HD22 ' B' ' 199' ' ' LEU . 77.9 t -54.06 -41.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.873 1.269 . . . . 0.0 113.124 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -62.3 -8.74 6.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.772 1.629 . . . . 0.0 113.715 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -106.17 -39.51 5.93 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.846 1.658 . . . . 0.0 112.588 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.7 -43.32 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.282 0.947 . . . . 0.0 110.533 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.34 -42.59 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -51.34 57.59 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.957 1.253 . . . . 0.0 110.98 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -33.57 74.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.0 61.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.974 0.91 . . . . 0.0 113.069 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.459 ' HA ' HG21 ' B' ' 191' ' ' VAL . 60.5 mt -59.83 -58.77 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.393 0.997 . . . . 0.0 109.645 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -63.04 -29.69 71.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 t -59.35 -50.57 73.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.466 1.106 . . . . 0.0 112.067 167.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.02 -31.79 72.89 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.68 -35.46 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.22 13.51 81.81 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.055 0.836 . . . . 0.0 114.777 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.17 3.3 56.75 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.873 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.49 164.93 10.72 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.23 1.515 . . . . 0.0 111.646 169.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.82 -178.56 4.32 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.925 -1.109 . . . . 0.0 111.995 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -51.63 139.07 21.55 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.677 -0.639 . . . . 0.0 110.908 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -179.81 4.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.714 1.206 . . . . 0.0 111.01 -175.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -96.47 -99.15 0.18 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.531 0.732 . . . . 0.0 109.998 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -66.62 -23.15 66.13 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.729 -1.232 . . . . 0.0 114.157 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -38.89 72.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.163 0.985 . . . . 0.0 112.552 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 45.2 t -54.82 -33.47 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.604 1.162 . . . . 0.0 112.512 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -66.74 -45.66 77.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.616 0.766 . . . . 0.0 111.553 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.06 -26.06 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.639 -0.663 . . . . 0.0 112.667 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -77.14 -53.14 8.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.797 0.726 . . . . 0.0 111.322 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.0 t -56.03 -31.95 63.59 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.479 0.581 . . . . 0.0 112.508 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 9.4 t -77.68 -59.81 2.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 119.361 0.982 . . . . 0.0 112.633 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -56.63 -38.59 72.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.305 1.442 . . . . 0.0 113.698 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.459 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.6 t -68.54 -63.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 123.854 0.861 . . . . 0.0 109.997 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.82 -30.57 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.741 1.217 . . . . 0.0 110.702 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -57.49 -45.72 84.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.685 0.794 . . . . 0.0 112.727 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -98.77 -39.47 8.62 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.194 1.397 . . . . 0.0 112.766 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 26.9 m -58.48 -52.17 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.294 2.238 . . . . 0.0 112.147 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -38.21 86.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.669 0.388 . . . . 0.0 111.179 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.7 t -63.12 -43.87 97.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.368 -0.832 . . . . 0.0 112.347 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.77 -48.92 78.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.826 2.05 . . . . 0.0 112.939 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.537 HD22 HG13 ' B' ' 162' ' ' VAL . 4.4 pp -69.45 -25.63 64.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.9 m -60.73 -30.6 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.934 -0.479 . . . . 0.0 110.599 166.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -81.56 -29.58 33.38 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.554 -0.716 . . . . 0.0 112.505 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.86 -17.73 63.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 112.953 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -109.92 -100.13 2.6 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.867 1.698 . . . . 0.0 113.767 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.65 155.23 63.53 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.837 1.655 . . . . 0.0 112.001 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.63 109.34 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 111.574 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -147.37 169.92 18.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.181 0.993 . . . . 0.0 112.471 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -71.46 120.17 16.67 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.271 0.628 . . . . 0.0 110.388 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -106.67 163.63 12.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.821 1.249 . . . . 0.0 110.647 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' ILE . . . . . 0.482 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.2 tt -147.44 155.26 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.335 1.854 . . . . 0.0 108.708 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' B' ' 253' ' ' ALA . 4.2 m -140.05 151.13 21.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.984 0.914 . . . . 0.0 110.314 168.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.08 129.59 27.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.871 2.069 . . . . 0.0 108.921 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.44 148.41 52.4 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.165 -0.96 . . . . 0.0 112.532 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 15.6 t -136.15 115.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.071 1.349 . . . . 0.0 108.93 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' B' ' 249' ' ' CYS . 3.0 mm -112.7 94.58 3.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.595 1.958 . . . . 0.0 107.538 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 9.1 ptm -132.14 150.27 52.2 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.289 1.436 . . . . 0.0 111.757 -170.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -88.01 140.18 29.76 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.292 0.637 . . . . 0.0 112.312 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -9.23 58.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.98 -30.68 71.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.326 1.851 . . . . 0.0 114.485 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.65 29.97 5.4 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.229 0.918 . . . . 0.0 115.343 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.4 176.24 1.92 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 118.29 1.045 . . . . 0.0 111.941 163.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 59.24 1.28 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.233 1.873 . . . . 0.0 116.253 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.96 99.14 8.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.242 1.817 . . . . 0.0 110.457 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.48 132.01 55.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.262 1.425 . . . . 0.0 110.209 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.456 ' HB ' HG13 ' B' ' 278' ' ' VAL . 28.7 m -140.77 147.21 38.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.713 0.805 . . . . 0.0 110.172 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.67 147.9 33.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.476 0.655 . . . . 0.0 111.538 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 134.78 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.236 0.614 . . . . 0.0 111.529 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 29.8 m -80.9 19.15 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 173.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' A' ' 66' ' ' ILE . 56.6 m -68.24 165.13 19.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.557 1.143 . . . . 0.0 112.172 172.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -162.84 140.7 8.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.539 1.536 . . . . 0.0 110.568 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 150.22 40.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.329 0.652 . . . . 0.0 110.429 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.99 151.08 45.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.6 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.5 t -108.59 -66.42 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.148 0.979 . . . . 0.0 111.594 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 58.1 p -89.76 -26.46 20.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.815 0.846 . . . . 0.0 112.998 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.9 m -77.59 -45.14 26.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.366 1.866 . . . . 0.0 112.92 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -148.95 -174.17 4.56 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.112 2.565 . . . . 0.0 110.802 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.68 125.58 5.24 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.656 1.598 . . . . 0.0 113.358 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.72 125.82 12.91 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 111.235 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.8 p -122.06 112.26 18.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.409 1.484 . . . . 0.0 112.244 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.8 t -124.67 148.5 47.94 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.401 -1.437 . . . . 0.0 112.32 -173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.59 136.46 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.682 1.593 . . . . 0.0 109.82 -170.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.8 99.22 4.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.381 1.472 . . . . 0.0 112.176 -169.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -108.24 124.44 50.3 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.88 1.272 . . . . 0.0 110.01 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.36 158.86 18.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -129.91 -176.71 4.01 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.744 1.618 . . . . 0.0 110.728 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -51.51 55.9 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.672 1.989 . . . . 0.0 113.394 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.6 t -138.77 -2.89 1.69 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.402 1.481 . . . . 0.0 113.855 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 13.8 ptp -127.87 -175.85 3.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.801 2.04 . . . . 0.0 110.726 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -141.41 158.33 44.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.093 0.957 . . . . 0.0 111.543 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.427 ' CB ' HD12 ' B' ' 214' ' ' ILE . 3.8 p -130.81 93.14 3.35 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.79 1.636 . . . . 0.0 110.452 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.64 136.35 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.224 1.01 . . . . 0.0 111.095 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.75 138.07 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.162 1.785 . . . . 0.0 110.249 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 t -128.68 123.07 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.082 1.353 . . . . 0.0 109.986 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -108.65 150.4 27.58 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.49 1.116 . . . . 0.0 111.423 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -128.19 105.55 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.876 1.67 . . . . 0.0 108.042 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -137.48 94.71 0.22 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.22 1.867 . . . . 0.0 109.838 -171.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.48 HD22 ' H ' ' B' ' 256' ' ' LEU . 1.6 mm? -68.57 163.88 22.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.088 0.955 . . . . 0.0 111.679 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 124.853 1.261 . . . . 0.0 112.099 -174.597 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -121.85 168.33 11.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.93 1.692 . . . . 0.0 112.091 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.61 147.95 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.389 1.475 . . . . 0.0 110.651 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 80.4 m -114.79 91.75 3.72 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.375 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.03 148.78 22.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.147 0.979 . . . . 0.0 110.792 168.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' B' ' 224' ' ' THR . 1.4 p -142.11 104.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.902 2.081 . . . . 0.0 109.653 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -135.7 153.87 51.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.401 1.48 . . . . 0.0 112.214 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 CA--C 1.551 1.011 0 O-C-N 121.729 -0.607 . . . . 0.0 111.527 175.351 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 121.238 0.542 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -69.96 175.8 4.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.747 0.819 . . . . 0.0 111.899 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.17 146.68 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.8 1.24 . . . . 0.0 110.769 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.54 -39.31 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.154 0.982 . . . . 0.0 111.458 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.83 -28.82 69.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.767 1.227 . . . . 0.0 113.222 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.26 -58.49 3.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.558 1.143 . . . . 0.0 110.837 171.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.26 -41.16 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.485 1.114 . . . . 0.0 112.424 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -62.92 -17.4 61.72 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.255 1.422 . . . . 0.0 113.934 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -97.97 -35.16 10.55 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.767 1.627 . . . . 0.0 113.259 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 mt -50.41 -41.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.203 1.001 . . . . 0.0 110.684 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.59 -40.76 90.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -52.35 56.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.857 1.208 . . . . 0.0 111.058 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -33.01 73.51 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.89 -42.44 57.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.615 0.766 . . . . 0.0 112.984 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.57 -56.95 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.99 0.813 . . . . 0.0 109.828 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.12 -30.89 70.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.3 t -59.84 -49.65 76.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.56 1.144 . . . . 0.0 112.238 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.21 77.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.075 0.95 . . . . 0.0 113.507 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.9 -37.02 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.866 1.266 . . . . 0.0 111.613 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.37 17.59 74.46 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.145 0.878 . . . . 0.0 114.599 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.11 78.58 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.694 1.14 . . . . 0.0 115.576 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.62 156.55 8.22 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 113.138 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -175.63 1.03 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.413 1.485 . . . . 0.0 112.352 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -47.99 146.75 2.37 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -136.74 178.5 7.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.067 1.347 . . . . 0.0 112.24 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -95.37 -118.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.454 1.501 . . . . 0.0 110.45 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.8 p -66.75 0.47 2.36 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.885 2.074 . . . . 0.0 115.91 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -50.52 -44.36 56.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.844 1.202 . . . . 0.0 112.761 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.2 t -55.92 -34.05 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -67.03 -51.61 52.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.451 1.023 . . . . 0.0 112.411 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.73 -25.65 68.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.49 -0.756 . . . . 0.0 112.42 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.64 -56.08 4.93 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.713 1.205 . . . . 0.0 111.629 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -22.59 63.42 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.94 -60.19 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.375 0.989 . . . . 0.0 111.905 166.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.3 -39.26 72.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.01 1.277 . . . . 0.0 113.905 -173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.19 -64.56 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 110.022 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -47.77 -30.17 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.957 1.303 . . . . 0.0 110.993 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.86 -42.83 85.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.955 0.902 . . . . 0.0 112.87 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -101.78 -39.77 7.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.611 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -57.64 -53.17 61.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.425 2.29 . . . . 0.0 112.598 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -37.11 80.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.571 0.623 . . . . 0.0 111.333 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m -65.15 -37.06 86.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -69.21 -52.12 31.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.163 1.785 . . . . 0.0 112.965 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.06 -26.46 68.57 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.858 -1.151 . . . . 0.0 113.7 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.6 m -57.48 -31.96 66.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 167.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -88.81 -25.53 22.17 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.17 -16.79 63.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.065 0.946 . . . . 0.0 113.26 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.02 -112.61 3.36 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.658 1.599 . . . . 0.0 112.77 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -132.67 152.11 79.33 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 125.422 1.489 . . . . 0.0 113.492 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.06 104.14 1.48 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.44 3.426 . . . . 0.0 112.275 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -142.81 177.9 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.297 1.839 . . . . 0.0 112.216 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -100.19 75.91 1.86 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.625 1.57 . . . . 0.0 111.35 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -67.05 147.12 53.59 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 111.009 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.664 HD11 ' SG ' ' B' ' 228' ' ' CYS . 0.7 OUTLIER -130.89 156.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.384 1.474 . . . . 0.0 109.756 170.442 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.69 158.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.491 0.716 . . . . 0.0 109.976 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.53 131.97 32.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.744 1.617 . . . . 0.0 108.973 164.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.5 p -124.92 150.33 46.68 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 167.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.34 117.88 50.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.284 1.034 . . . . 0.0 108.247 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.417 HD12 ' CB ' ' A' ' 106' ' ' CYS . 3.6 mm -114.91 120.95 65.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 107.71 -177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -144.45 139.74 28.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.61 0.719 . . . . 0.0 111.319 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -145.79 106.73 4.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.463 1.905 . . . . 0.0 109.424 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -146.72 -58.57 0.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.754 0.821 . . . . 0.0 112.567 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -122.52 -9.96 8.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.286 1.434 . . . . 0.0 113.767 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.0 -3.85 55.95 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.315 1.435 . . . . 0.0 114.908 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.38 165.99 21.27 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 156.06 52.33 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.53 0.586 . . . . 0.0 113.966 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.05 178.95 4.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.556 1.942 . . . . 0.0 111.354 169.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.15 92.73 3.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.141 1.377 . . . . 0.0 109.791 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.565 ' HB ' HG13 ' A' ' 135' ' ' VAL . 18.7 m -108.88 147.24 32.45 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.687 -1.258 . . . . 0.0 108.871 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.63 146.18 32.15 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.232 -0.918 . . . . 0.0 112.194 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -143.16 143.12 31.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 112.883 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t -78.39 12.13 2.1 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' B' ' 209' ' ' ILE . 12.5 m -62.71 173.03 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.093 0.957 . . . . 0.0 112.394 168.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -161.63 157.1 24.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.689 1.995 . . . . 0.0 110.082 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -78.11 146.95 34.87 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.626 172.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.15 158.54 43.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.666 1.586 . . . . 0.0 111.577 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t -134.47 -57.29 0.84 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.202 1.401 . . . . 0.0 112.479 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 m -84.24 -36.81 22.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.946 0.899 . . . . 0.0 112.09 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.4 -46.86 59.17 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.743 1.617 . . . . 0.0 112.719 -172.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.07 -167.97 2.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.768 2.427 . . . . 0.0 109.923 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.43 156.06 15.88 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 124.297 0.951 . . . . 0.0 113.835 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -145.75 169.62 18.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.983 1.713 . . . . 0.0 112.243 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.3 t -166.35 158.17 13.63 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.073 1.749 . . . . 0.0 110.292 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.6 t -150.32 146.78 26.96 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 119.534 -1.979 . . . . 0.0 111.261 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.7 95.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.266 1.426 . . . . 0.0 110.661 -166.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -86.79 116.08 24.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.099 1.76 . . . . 0.0 112.366 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -126.39 113.62 17.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.725 1.61 . . . . 0.0 110.231 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.3 170.56 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.58 1.552 . . . . 0.0 112.599 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.6 -170.92 3.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.888 1.275 . . . . 0.0 112.482 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -42.92 -58.57 2.34 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.301 2.24 . . . . 0.0 114.16 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t -136.05 -29.59 1.0 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 113.099 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.57 149.8 34.81 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.925 0.89 . . . . 0.0 111.586 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -136.36 141.16 43.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.533 1.533 . . . . 0.0 109.585 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' CB ' HD12 ' A' ' 71' ' ' ILE . 1.7 p -144.24 71.92 1.33 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.695 -169.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.94 142.04 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.319 -0.863 . . . . 0.0 111.588 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.1 t -121.61 142.91 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.639 1.975 . . . . 0.0 110.335 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -138.78 122.87 17.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.889 1.675 . . . . 0.0 109.553 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.3 142.67 51.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.07 1.748 . . . . 0.0 113.586 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -140.67 125.83 18.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.073 0.949 . . . . 0.0 111.263 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.85 70.33 0.22 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 127.378 2.418 . . . . 0.0 111.394 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.64 128.91 37.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.119 0.968 . . . . 0.0 111.287 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.141 1.776 . . . . 0.0 111.779 -161.119 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.637 0.256 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -129.22 167.11 18.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.805 1.242 . . . . 0.0 111.687 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.4 mm -51.08 132.08 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.239 2.215 . . . . 0.0 111.243 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 m -99.82 95.85 7.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.345 1.458 . . . . 0.0 109.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.64 148.39 30.27 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.377 -0.827 . . . . 0.0 111.141 166.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 81' ' ' THR . 1.5 p -131.98 89.1 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.803 2.441 . . . . 0.0 109.049 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -134.63 166.16 23.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.25 1.42 . . . . 0.0 111.714 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.547 0.864 0 C-N-CA 125.273 1.429 . . . . 0.0 111.048 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.175 0.512 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.33 173.41 10.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.577 0.751 . . . . 0.0 112.116 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 94.5 t -123.97 142.49 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.63 1.572 . . . . 0.0 109.726 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.11 -41.79 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.86 0.864 . . . . 0.0 111.552 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.06 -35.29 66.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.7 1.6 . . . . 0.0 113.348 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -72.6 -58.92 3.0 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.788 1.235 . . . . 0.0 110.746 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 80.8 t -52.19 -40.77 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.502 1.121 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -63.63 -17.82 63.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 113.982 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.37 -35.24 11.26 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.491 1.517 . . . . 0.0 113.192 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.4 mt -50.66 -41.35 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.104 0.961 . . . . 0.0 110.712 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 121.322 -0.861 . . . . 0.0 113.322 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -52.33 57.29 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.831 1.196 . . . . 0.0 110.982 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -33.0 73.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.84 -42.23 58.38 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.402 ' HA ' HG21 ' B' ' 191' ' ' VAL . 66.1 mt -60.61 -56.89 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.106 0.866 . . . . 0.0 109.786 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.2 -30.89 70.69 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.0 t -59.75 -49.75 76.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.631 1.172 . . . . 0.0 112.24 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.25 77.49 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.88 -36.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.879 1.272 . . . . 0.0 111.55 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 70.43 17.57 74.57 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.111 0.862 . . . . 0.0 114.588 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.0 78.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.705 1.145 . . . . 0.0 115.595 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -57.63 156.66 8.07 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.914 1.357 . . . . 0.0 113.101 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.5 -175.52 1.05 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.43 1.492 . . . . 0.0 112.256 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -48.1 146.97 2.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.584 1.553 . . . . 0.0 113.395 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -136.95 178.39 7.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.084 1.353 . . . . 0.0 112.276 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -95.46 -117.66 0.11 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.403 1.481 . . . . 0.0 110.492 169.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 58.5 p -66.76 0.39 2.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.855 2.062 . . . . 0.0 115.957 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -50.86 -44.58 59.63 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.793 1.179 . . . . 0.0 112.779 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.35 -34.02 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -66.7 -51.55 54.71 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.453 1.024 . . . . 0.0 112.403 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.86 -25.63 67.98 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.517 -0.739 . . . . 0.0 112.507 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -76.88 -55.91 5.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.612 1.165 . . . . 0.0 111.547 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 t -60.26 -22.1 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -82.55 -60.41 2.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.233 0.924 . . . . 0.0 111.909 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -55.92 -39.09 71.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.974 1.261 . . . . 0.0 113.905 -173.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' B' ' 170' ' ' ILE . 97.2 t -68.33 -64.51 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.52 -30.49 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.999 1.319 . . . . 0.0 111.004 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.88 -42.22 84.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.072 0.949 . . . . 0.0 112.778 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -102.95 -38.68 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.215 1.406 . . . . 0.0 112.781 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.9 m -58.97 -52.85 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.33 2.252 . . . . 0.0 112.624 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -36.04 79.8 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.553 0.615 . . . . 0.0 111.561 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.1 m -60.34 -49.77 76.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 0.0 112.327 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -60.14 -51.73 68.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.91 1.684 . . . . 0.0 113.56 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.04 -26.08 68.11 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.1 m -58.89 -34.2 71.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.615 0.766 . . . . 0.0 110.952 167.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -84.75 -24.69 28.7 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.72 -15.45 63.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.657 1.183 . . . . 0.0 113.302 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -113.05 -113.17 3.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.666 1.603 . . . . 0.0 112.762 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -130.76 153.17 81.53 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 125.774 1.63 . . . . 0.0 112.959 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.89 98.79 0.92 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.198 3.266 . . . . 0.0 112.193 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -140.01 165.84 26.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.225 1.41 . . . . 0.0 112.91 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -84.75 78.54 9.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.912 1.685 . . . . 0.0 111.644 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -59.5 156.32 13.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 112.365 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' ILE . . . . . 0.576 HD11 ' SG ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -144.13 155.96 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.185 1.794 . . . . 0.0 108.949 165.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.91 160.16 29.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.596 162.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.3 141.5 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 109.766 164.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.74 148.71 47.43 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.103 0.961 . . . . 0.0 111.41 171.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.87 104.83 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.899 1.28 . . . . 0.0 108.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' B' ' 249' ' ' CYS . 3.7 mm -101.38 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.543 1.537 . . . . 0.0 108.266 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 4.5 tpt -134.57 136.79 43.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.926 0.87 . . . . 0.0 112.322 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -143.17 100.26 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.986 2.114 . . . . 0.0 109.347 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -143.03 -63.92 0.41 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.521 0.728 . . . . 0.0 111.981 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -109.5 -22.48 11.98 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 113.439 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.9 -9.59 76.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.651 1.596 . . . . 0.0 115.03 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -143.98 81.88 1.7 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.027 1.731 . . . . 0.0 110.762 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 176.9 88.61 0.07 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.016 0.817 . . . . 0.0 112.797 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.68 124.84 7.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.755 1.622 . . . . 0.0 109.489 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.44 88.21 2.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.755 1.622 . . . . 0.0 109.101 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.697 ' HB ' HG13 ' B' ' 278' ' ' VAL . 88.5 m -106.34 144.43 33.04 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.541 -1.35 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.33 133.42 27.78 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.37 -0.831 . . . . 0.0 112.177 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.0 p -134.03 144.58 48.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.021 0.928 . . . . 0.0 113.015 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 15.6 t -78.91 12.3 2.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' CYS . . . . . 0.664 ' SG ' HD11 ' A' ' 66' ' ' ILE . 19.1 m -63.22 172.74 1.74 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.952 . . . . 0.0 112.518 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -162.42 158.15 23.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.725 2.01 . . . . 0.0 110.128 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -76.36 139.8 41.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.5 -0.75 . . . . 0.0 110.506 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -145.22 153.36 41.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.391 1.476 . . . . 0.0 111.859 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 25.8 t -128.74 -59.75 1.12 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.745 1.618 . . . . 0.0 112.499 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.0 m -83.37 -37.24 23.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.872 0.869 . . . . 0.0 111.867 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -51.72 43.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.856 1.662 . . . . 0.0 112.023 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.01 -171.13 3.75 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.732 2.413 . . . . 0.0 109.791 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.54 154.4 16.53 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.308 0.956 . . . . 0.0 114.176 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 85.7 p -144.75 168.45 20.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.24 1.816 . . . . 0.0 112.068 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.6 t -166.23 157.62 13.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.043 1.737 . . . . 0.0 110.185 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.1 t -150.05 146.53 27.01 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.368 -2.082 . . . . 0.0 111.37 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.41 92.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.205 1.402 . . . . 0.0 110.611 -166.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -84.73 115.02 22.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.107 1.763 . . . . 0.0 112.32 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -124.63 117.26 23.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.474 1.51 . . . . 0.0 110.006 172.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -103.05 170.73 7.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.719 1.607 . . . . 0.0 112.425 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.75 -173.66 4.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.896 1.278 . . . . 0.0 112.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -40.16 -58.36 1.49 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 127.422 2.289 . . . . 0.0 114.031 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.2 t -136.39 -20.95 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.816 1.647 . . . . 0.0 113.341 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 21.9 ptm -90.18 132.93 35.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.871 1.268 . . . . 0.0 111.699 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.22 131.9 55.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.124 1.37 . . . . 0.0 109.873 172.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.458 ' HB3' HG23 ' B' ' 214' ' ' ILE . 1.6 p -137.95 68.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.593 1.557 . . . . 0.0 111.941 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pp -85.36 138.27 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.122 0.969 . . . . 0.0 111.949 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.95 144.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.822 2.049 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 t -139.32 122.61 17.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.001 1.72 . . . . 0.0 109.781 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -125.62 143.07 51.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.974 1.71 . . . . 0.0 113.625 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -140.48 126.3 19.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.993 0.917 . . . . 0.0 111.103 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.62 70.06 0.22 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.915 2.198 . . . . 0.0 110.881 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.45 130.46 43.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.104 0.962 . . . . 0.0 111.227 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 126.251 1.82 . . . . 0.0 111.512 -162.056 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -130.26 167.26 18.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.831 1.252 . . . . 0.0 111.883 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -50.2 133.64 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.402 2.281 . . . . 0.0 111.354 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 55.3 m -101.74 91.0 4.21 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.395 1.478 . . . . 0.0 109.697 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.76 148.14 34.98 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.739 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' B' ' 224' ' ' THR . 4.0 p -137.68 92.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 108.816 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -134.55 165.54 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.441 1.896 . . . . 0.0 111.548 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 125.02 1.328 . . . . 0.0 111.509 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -66.89 171.56 5.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.662 1.585 . . . . 0.0 112.78 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.81 147.97 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.638 1.575 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.9 -40.2 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.26 1.024 . . . . 0.0 111.877 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.4 -32.54 70.27 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.855 1.262 . . . . 0.0 113.12 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.65 -55.92 6.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.411 1.084 . . . . 0.0 110.294 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.15 -43.85 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.834 1.254 . . . . 0.0 112.794 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -63.92 -6.32 5.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.305 1.442 . . . . 0.0 114.167 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -113.17 -34.28 5.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.152 2.181 . . . . 0.0 112.313 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -43.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.041 1.337 . . . . 0.0 110.586 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.82 -43.16 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.45 -0.781 . . . . 0.0 112.883 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -52.04 50.88 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.363 0.983 . . . . 0.0 111.675 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -31.85 72.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.43 63.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.45 ' HA ' HG21 ' A' ' 48' ' ' VAL . 58.2 mt -58.05 -55.44 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.244 0.929 . . . . 0.0 109.972 173.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.07 -30.84 70.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 t -61.21 -43.23 99.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.892 0.877 . . . . 0.0 112.396 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.34 -36.37 79.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.272 1.029 . . . . 0.0 113.479 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.61 -42.05 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.385 1.074 . . . . 0.0 110.996 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.11 57.96 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.837 1.208 . . . . 0.0 115.218 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.3 22.93 71.42 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.658 1.123 . . . . 0.0 114.656 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.24 -177.55 0.54 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.005 1.322 . . . . 0.0 112.434 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.25 141.43 8.54 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.836 1.254 . . . . 0.0 112.714 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -66.57 104.9 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.774 1.229 . . . . 0.0 110.929 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -124.15 114.94 20.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.019 1.727 . . . . 0.0 110.797 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -77.47 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.862 0.865 . . . . 0.0 112.603 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -57.57 -25.13 59.53 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.373 -1.455 . . . . 0.0 114.06 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -57.99 -30.57 66.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.6 t -52.85 -34.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.359 0.981 . . . . 0.0 111.851 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -64.34 -50.99 65.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.641 1.176 . . . . 0.0 112.641 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -66.81 -28.06 68.06 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.272 -0.893 . . . . 0.0 112.721 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.95 -54.56 6.69 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.673 0.789 . . . . 0.0 111.214 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -58.43 -26.1 62.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.579 0.751 . . . . 0.0 112.76 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 t -83.56 -54.23 5.09 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.217 0.917 . . . . 0.0 112.961 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -58.76 -38.73 79.1 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.916 1.235 . . . . 0.0 113.344 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 27' ' ' ILE . 71.8 t -68.66 -63.71 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 124.035 0.934 . . . . 0.0 109.833 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.39 -29.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.895 1.278 . . . . 0.0 111.175 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.42 -46.51 86.33 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -95.31 -41.15 9.17 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.835 1.254 . . . . 0.0 112.541 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 m -52.92 -55.97 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.552 2.341 . . . . 0.0 112.463 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' CG ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -62.23 -37.32 84.91 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.161 0.437 . . . . 0.0 110.984 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -60.82 -46.53 90.17 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 112.515 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.18 -49.92 75.73 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.653 1.981 . . . . 0.0 113.015 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.57 -28.33 66.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 m -58.95 -27.54 65.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.884 0.874 . . . . 0.0 111.72 165.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -87.87 -23.31 24.01 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.55 -15.19 63.22 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.07 -99.86 0.21 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.678 0.656 . . . . 0.0 113.795 172.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -94.31 109.47 42.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.663 1.185 . . . . 0.0 112.87 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.77 103.12 1.7 Allowed 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.968 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -141.78 163.41 32.97 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.796 1.638 . . . . 0.0 113.733 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -68.61 101.9 1.38 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.068 1.747 . . . . 0.0 112.204 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.461 ' CG ' HD12 ' A' ' 53' ' ' LEU . 54.4 p90 -81.43 173.52 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.689 1.596 . . . . 0.0 112.107 164.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.459 HD11 ' SG ' ' B' ' 228' ' ' CYS . 2.6 tt -142.39 154.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.375 1.87 . . . . 0.0 109.464 162.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 110' ' ' ALA . 10.4 m -143.49 145.31 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.997 1.719 . . . . 0.0 109.658 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -142.75 155.9 44.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.472 1.109 . . . . 0.0 110.192 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.4 p -148.29 156.43 42.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.041 0.937 . . . . 0.0 112.938 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.86 132.15 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.223 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.51 111.33 35.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 127.324 2.25 . . . . 0.0 107.532 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.1 ttt -117.05 154.12 31.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.13 0.972 . . . . 0.0 111.392 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.52 153.08 20.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.823 1.249 . . . . 0.0 111.964 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -60.77 -16.35 39.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.775 1.63 . . . . 0.0 114.546 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -58.37 -26.99 63.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.043 1.337 . . . . 0.0 112.788 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.52 27.1 72.95 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.146 0.879 . . . . 0.0 114.598 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.66 151.68 10.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.569 1.147 . . . . 0.0 113.527 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.8 102.95 1.04 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.522 1.058 . . . . 0.0 114.173 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 pp -143.6 147.61 34.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.11 2.564 . . . . 0.0 109.549 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -134.65 132.28 38.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.416 ' HB ' HG13 ' A' ' 135' ' ' VAL . 48.4 m -133.28 139.15 46.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.243 1.017 . . . . 0.0 109.886 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.75 124.05 12.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.537 0.735 . . . . 0.0 110.933 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.9 p -130.51 137.98 50.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.792 0.806 . . . . 0.0 111.649 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.4 m -81.41 13.64 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.454 -0.779 . . . . 0.0 112.69 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' B' ' 209' ' ' ILE . 8.2 m -60.07 161.46 6.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.006 0.908 . . . . 0.0 111.92 169.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -157.53 136.57 11.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.717 1.607 . . . . 0.0 109.539 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 163.87 27.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.718 0.407 . . . . 0.0 111.098 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -140.02 155.31 47.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.423 1.089 . . . . 0.0 111.508 168.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -118.28 -63.34 1.43 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.889 2.076 . . . . 0.0 111.753 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -109.63 -28.94 8.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.315 1.446 . . . . 0.0 112.173 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -42.73 85.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.708 2.403 . . . . 0.0 112.994 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.93 -175.59 5.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.864 1.665 . . . . 0.0 112.185 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.73 153.26 20.86 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.628 1.109 . . . . 0.0 114.185 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 t -163.27 163.17 25.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.424 1.89 . . . . 0.0 110.554 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 8.1 p -167.91 149.79 5.47 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.984 1.714 . . . . 0.0 111.327 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -145.33 144.46 30.73 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.116 -1.615 . . . . 0.0 111.679 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -143.29 126.31 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.112 1.365 . . . . 0.0 110.604 -161.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -127.83 122.44 32.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 -170.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -133.49 104.41 6.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.786 1.634 . . . . 0.0 110.293 -174.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.59 168.05 9.94 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.1 . . . . 0.0 112.394 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -145.29 -176.18 5.0 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.781 0.832 . . . . 0.0 112.548 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -49.84 -51.89 36.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.944 1.698 . . . . 0.0 113.874 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.4 t -132.95 -47.27 0.86 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.7 ptp -67.08 170.83 6.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.587 0.755 . . . . 0.0 112.411 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -146.11 147.46 31.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.5 1.52 . . . . 0.0 109.557 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 28.9 p -128.26 143.6 51.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.244 1.021 . . . . 0.0 112.606 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.37 119.85 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.584 1.554 . . . . 0.0 110.102 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 t -104.99 136.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.828 1.651 . . . . 0.0 109.571 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.9 t -131.26 123.58 28.69 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 110.601 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.55 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -109.68 149.56 29.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.858 1.663 . . . . 0.0 111.791 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -141.31 152.32 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.832 1.253 . . . . 0.0 110.657 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.09 85.41 0.23 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.837 1.208 . . . . 0.0 112.074 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.29 121.4 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.353 1.461 . . . . 0.0 111.675 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 124.546 1.138 . . . . 0.0 113.174 -169.148 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -130.81 177.6 7.29 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.448 1.499 . . . . 0.0 112.007 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.4 mm -51.6 138.13 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.908 2.083 . . . . 0.0 111.313 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.6 m -107.42 91.93 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.579 1.552 . . . . 0.0 110.818 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -93.19 148.82 21.69 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.326 -0.859 . . . . 0.0 111.294 171.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.416 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -144.31 115.47 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.022 2.129 . . . . 0.0 109.833 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -140.86 133.72 29.04 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.48 1.512 . . . . 0.0 111.157 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 126.172 1.789 . . . . 0.0 109.698 175.089 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 121.252 0.548 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.01 161.17 26.81 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.46 144.29 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.101 1.361 . . . . 0.0 112.897 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.32 -41.47 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.881 1.672 . . . . 0.0 112.232 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.37 -31.84 69.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.589 1.156 . . . . 0.0 113.178 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.87 -55.66 5.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.274 174.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 58.2 t -44.72 -46.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.158 1.783 . . . . 0.0 112.842 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -63.95 -7.03 7.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.732 1.613 . . . . 0.0 114.429 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -111.03 -33.66 6.43 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.569 2.348 . . . . 0.0 112.196 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 30.2 mt -50.14 -42.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.043 1.337 . . . . 0.0 110.644 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.45 -43.79 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.343 -0.848 . . . . 0.0 112.929 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -52.36 50.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.358 0.981 . . . . 0.0 111.519 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.76 72.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.71 62.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.124 0.97 . . . . 0.0 113.313 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.431 ' HA ' HG21 ' B' ' 191' ' ' VAL . 56.4 mt -57.49 -55.33 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.158 0.89 . . . . 0.0 109.88 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.08 -31.08 70.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 18.0 t -61.17 -42.95 99.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.858 0.863 . . . . 0.0 112.354 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.31 77.5 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.264 1.025 . . . . 0.0 113.586 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.25 -42.43 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.38 1.072 . . . . 0.0 110.88 173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.91 58.21 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.982 1.277 . . . . 0.0 115.173 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.74 23.39 70.71 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.585 1.088 . . . . 0.0 114.598 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.12 -177.18 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.043 1.337 . . . . 0.0 112.488 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -48.76 141.75 7.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.722 1.209 . . . . 0.0 112.571 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.93 101.47 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.566 1.146 . . . . 0.0 110.862 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -117.8 114.44 23.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.081 1.753 . . . . 0.0 110.542 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -74.15 -64.37 1.03 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.372 1.069 . . . . 0.0 112.546 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.9 m -56.63 -23.74 43.32 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -55.24 -28.79 55.75 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.7 -31.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.479 1.036 . . . . 0.0 112.89 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -65.34 -50.34 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.828 1.251 . . . . 0.0 112.207 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.91 -26.85 67.06 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.401 -0.812 . . . . 0.0 112.661 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.39 -53.95 7.04 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.818 0.847 . . . . 0.0 111.592 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.1 t -56.72 -28.49 61.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.588 0.631 . . . . 0.0 112.592 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.8 t -82.43 -55.81 4.27 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.341 0.973 . . . . 0.0 112.816 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -59.53 -39.27 83.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.078 1.308 . . . . 0.0 113.281 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' B' ' 170' ' ' ILE . 79.2 t -68.36 -63.91 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 C-N-CA 123.706 0.803 . . . . 0.0 109.625 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 96.2 t -49.9 -29.62 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -58.89 -46.94 86.67 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.599 0.636 . . . . 0.0 112.43 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -93.87 -40.2 10.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.756 1.222 . . . . 0.0 112.771 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 5.4 m -54.71 -56.03 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.746 2.418 . . . . 0.0 112.42 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -37.07 79.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.112 0.414 . . . . 0.0 110.602 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.6 t -62.41 -47.71 82.94 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.217 -0.927 . . . . 0.0 112.557 169.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -56.81 -47.35 80.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.871 1.668 . . . . 0.0 113.001 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.24 -18.93 59.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 89.1 m -61.69 -40.31 94.55 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.613 -0.679 . . . . 0.0 110.26 157.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -75.25 -19.58 59.65 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.874 -1.142 . . . . 0.0 113.896 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 10.5 mt -59.07 -20.23 51.43 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . 168.21 -54.07 0.22 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.724 1.147 . . . . 0.0 115.554 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -57.96 156.5 19.2 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 127.367 2.267 . . . . 0.0 113.735 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.18 160.17 42.9 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.985 2.457 . . . . 0.0 113.278 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.28 93.71 3.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.955 0.902 . . . . 0.0 113.003 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -165.41 85.26 0.37 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.024 1.33 . . . . 0.0 114.217 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.3 158.78 43.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.782 1.233 . . . . 0.0 112.194 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 85' ' ' CYS . 5.3 tt -138.57 156.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.112 2.165 . . . . 0.0 109.356 171.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' B' ' 253' ' ' ALA . 4.3 m -142.05 147.75 21.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.432 1.893 . . . . 0.0 110.054 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 14.6 t -143.02 154.55 44.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.72 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.73 157.46 43.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.35 1.06 . . . . 0.0 112.504 171.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 26.3 t -134.18 136.06 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.172 1.389 . . . . 0.0 109.141 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mm -108.95 108.82 26.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 127.365 2.266 . . . . 0.0 106.9 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 62.0 mtt -107.82 158.95 16.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.603 1.161 . . . . 0.0 110.848 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -119.14 150.87 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.882 1.273 . . . . 0.0 110.933 -174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -59.61 -17.11 30.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.694 1.598 . . . . 0.0 114.882 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -59.58 -30.0 68.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.376 1.471 . . . . 0.0 112.955 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.42 42.54 93.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.25 1.405 . . . . 0.0 114.405 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.33 175.63 0.42 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.528 1.531 . . . . 0.0 114.258 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.35 91.26 0.3 Allowed Glycine 0 CA--C 1.539 1.582 0 O-C-N 120.571 -1.331 . . . . 0.0 114.424 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.81 118.35 13.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.149 1.78 . . . . 0.0 113.122 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.12 133.04 55.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.694 0.798 . . . . 0.0 110.076 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.472 ' HB ' HG13 ' B' ' 278' ' ' VAL . 50.5 m -135.47 141.89 45.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.876 0.87 . . . . 0.0 110.283 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.13 128.62 18.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.5 p -132.6 139.43 47.78 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.669 0.747 . . . . 0.0 111.509 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -82.46 12.5 4.47 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.562 -0.711 . . . . 0.0 112.605 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' CYS . . . . . 0.459 ' SG ' HD11 ' A' ' 66' ' ' ILE . 4.3 m -60.7 161.65 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.988 0.899 . . . . 0.0 111.895 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -158.73 139.36 12.64 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.481 1.513 . . . . 0.0 109.582 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' TRP . . . . . 0.408 ' CZ2' ' HB2' ' B' ' 232' ' ' SER . 0.0 OUTLIER -72.41 161.63 30.57 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.834 171.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -137.98 149.74 46.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.722 1.209 . . . . 0.0 110.319 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' SER . . . . . 0.408 ' HB2' ' CZ2' ' B' ' 230' ' ' TRP . 1.8 t -112.05 -63.27 1.45 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.785 2.034 . . . . 0.0 112.125 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 8.5 t -109.82 -26.18 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.442 1.497 . . . . 0.0 112.237 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -41.41 75.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.627 2.771 . . . . 0.0 113.193 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.54 -173.89 4.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.912 2.085 . . . . 0.0 110.589 -172.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -98.86 158.57 20.2 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.437 1.017 . . . . 0.0 114.078 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.3 t -166.44 163.21 17.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.114 1.766 . . . . 0.0 110.621 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.57 141.45 2.38 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.2 1.8 . . . . 0.0 111.091 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -142.59 146.75 34.89 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 119.955 -1.716 . . . . 0.0 111.949 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -141.3 146.43 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.884 1.273 . . . . 0.0 110.353 -168.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -137.79 126.77 24.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 112.544 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -135.86 102.38 5.04 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.753 1.621 . . . . 0.0 109.984 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.51 164.84 13.23 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.983 -1.073 . . . . 0.0 112.242 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -141.71 -177.62 5.27 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.407 1.083 . . . . 0.0 111.691 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -47.81 -51.43 22.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.295 1.838 . . . . 0.0 114.088 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.1 t -132.05 -48.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.532 1.533 . . . . 0.0 111.996 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.74 173.96 3.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.076 0.95 . . . . 0.0 112.655 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.62 146.32 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.381 1.472 . . . . 0.0 109.829 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.5 p -127.49 143.04 51.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.055 0.931 . . . . 0.0 112.424 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.08 127.88 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.628 1.571 . . . . 0.0 109.56 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.24 123.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.378 1.471 . . . . 0.0 110.16 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.2 t -119.53 115.6 24.36 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.149 0.979 . . . . 0.0 110.116 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.561 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -97.38 153.78 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.795 1.238 . . . . 0.0 111.826 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -142.05 149.77 40.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.345 1.458 . . . . 0.0 110.091 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -135.08 80.55 0.31 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 124.972 1.272 . . . . 0.0 113.003 -171.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.21 108.09 20.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.635 1.174 . . . . 0.0 112.087 -167.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 C-N-CA 126.56 1.944 . . . . 0.0 113.172 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.14 177.94 7.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.427 1.491 . . . . 0.0 112.087 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.1 mm -51.69 140.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 126.991 2.116 . . . . 0.0 111.354 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 71.6 m -110.93 91.84 3.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.589 1.555 . . . . 0.0 110.702 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -94.77 149.38 21.31 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.428 -0.795 . . . . 0.0 111.323 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.472 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.9 p -149.32 118.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.04 1.736 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.87 138.14 30.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.764 1.625 . . . . 0.0 110.663 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 126.145 1.778 . . . . 0.0 109.373 175.502 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 121.342 0.592 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -69.16 166.07 19.08 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.463 0.705 . . . . 0.0 112.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -135.53 159.57 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.714 1.206 . . . . 0.0 111.729 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.08 -38.33 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.439 1.096 . . . . 0.0 112.608 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.91 -27.97 68.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.859 1.264 . . . . 0.0 113.042 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -76.34 -56.41 4.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.711 0.804 . . . . 0.0 110.801 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.3 t -52.49 -39.59 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.157 1.383 . . . . 0.0 112.615 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.18 -15.06 12.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.612 1.565 . . . . 0.0 114.276 174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -108.58 -35.49 6.44 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.327 1.851 . . . . 0.0 112.786 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.32 -42.9 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.459 1.027 . . . . 0.0 110.581 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.84 -43.41 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.598 -0.689 . . . . 0.0 112.53 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -54.02 31.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.605 1.093 . . . . 0.0 111.405 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.68 75.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.23 62.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.667 0.787 . . . . 0.0 112.811 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' HG21 ' A' ' 48' ' ' VAL . 60.0 mt -60.23 -57.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.113 0.869 . . . . 0.0 109.885 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.74 -31.75 71.06 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -58.84 -50.4 74.13 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.441 1.096 . . . . 0.0 112.182 168.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.63 -33.22 75.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.15 -37.72 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.836 1.254 . . . . 0.0 111.337 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.86 16.96 78.16 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.071 0.843 . . . . 0.0 114.54 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.9 8.49 72.67 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.172 1.368 . . . . 0.0 116.001 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.78 150.74 15.56 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 118.934 1.367 . . . . 0.0 113.747 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -175.77 3.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.168 1.787 . . . . 0.0 112.197 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -37.39 136.1 0.5 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 129.046 2.939 . . . . 0.0 114.995 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -134.94 174.5 10.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.519 1.528 . . . . 0.0 112.968 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.06 -93.06 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.4 1.48 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 p -98.99 4.9 47.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.332 2.253 . . . . 0.0 113.398 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -50.76 -43.76 58.45 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.019 -1.051 . . . . 0.0 112.689 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.21 -35.17 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.392 1.077 . . . . 0.0 112.687 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -67.81 -49.64 61.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 112.532 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.14 -26.78 67.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.092 -1.005 . . . . 0.0 112.576 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -75.23 -55.75 5.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.814 1.246 . . . . 0.0 111.182 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t -58.38 -23.5 57.2 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.549 -0.739 . . . . 0.0 112.99 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -85.1 -54.98 4.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.793 1.179 . . . . 0.0 112.368 169.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -57.78 -35.63 71.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.922 1.237 . . . . 0.0 113.782 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 27' ' ' ILE . 96.1 t -75.15 -67.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 124.318 1.047 . . . . 0.0 109.688 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.13 -28.42 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.695 1.198 . . . . 0.0 111.226 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -52.22 -57.86 8.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.698 0.799 . . . . 0.0 112.908 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -90.61 -39.81 12.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.545 1.138 . . . . 0.0 112.396 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.7 m -57.2 -53.93 52.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.122 2.169 . . . . 0.0 112.514 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.99 -37.99 84.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.71 0.686 . . . . 0.0 111.722 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -63.24 -40.28 96.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 0.0 112.379 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.95 -50.77 61.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.528 1.931 . . . . 0.0 113.189 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.46 -24.1 65.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 53.5 m -59.2 -30.42 68.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.218 1.007 . . . . 0.0 111.262 165.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -90.6 -22.71 21.1 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.51 -15.22 60.5 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.42 -126.51 1.57 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.713 1.149 . . . . 0.0 112.442 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 5.3 mmpt? -55.78 112.09 3.89 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.957 1.703 . . . . 0.0 112.957 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.53 108.98 2.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.441 2.761 . . . . 0.0 111.748 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -144.56 179.81 7.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.446 1.898 . . . . 0.0 111.005 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -90.88 128.14 36.64 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 166.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 112' ' ' GLY . 24.0 m-85 -113.88 145.43 41.48 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.907 1.683 . . . . 0.0 108.847 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 tt -122.75 153.65 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.232 1.013 . . . . 0.0 110.045 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.51 151.79 28.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.49 1.916 . . . . 0.0 109.032 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.63 138.69 47.44 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.051 1.74 . . . . 0.0 108.46 166.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.88 138.45 37.44 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.02 126.79 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.342 1.457 . . . . 0.0 108.911 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.0 mm -117.64 94.66 3.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 127.358 2.263 . . . . 0.0 107.442 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.61 107.84 12.44 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.728 1.611 . . . . 0.0 110.642 -168.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -66.65 135.2 53.73 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.318 -0.864 . . . . 0.0 112.198 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -8.4 2.94 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.093 1.757 . . . . 0.0 115.498 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -16.8 49.69 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.079 2.152 . . . . 0.0 113.773 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.68 -3.04 5.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.068 1.318 . . . . 0.0 115.761 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 45.71 0.28 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.824 1.65 . . . . 0.0 113.974 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 161.6 33.52 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.914 1.245 . . . . 0.0 113.394 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.732 HD13 HD11 ' B' ' 222' ' ' LEU . 1.6 pt? -151.82 -171.66 4.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.595 1.558 . . . . 0.0 112.085 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.96 138.11 41.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.401 0.546 . . . . 0.0 111.149 168.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.7 m -142.76 144.68 32.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.336 1.454 . . . . 0.0 110.12 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.34 144.19 31.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.8 p -145.88 140.7 27.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.015 0.912 . . . . 0.0 112.264 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 t -78.87 23.33 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.28 1.032 . . . . 0.0 112.584 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.9 m -67.07 171.19 5.82 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.304 -0.873 . . . . 0.0 111.648 165.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -163.44 149.74 11.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.741 2.416 . . . . 0.0 108.557 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -81.26 134.96 35.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.07 0.85 . . . . 0.0 109.594 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.38 127.23 5.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.229 . . . . 0.0 111.564 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -113.8 -31.96 6.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.597 1.559 . . . . 0.0 112.161 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -80.1 -38.46 31.6 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.803 1.641 . . . . 0.0 112.556 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -53.75 5.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.068 1.347 . . . . 0.0 112.405 -171.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -139.99 -161.27 1.17 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.927 2.491 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.82 153.5 16.93 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.831 -1.168 . . . . 0.0 113.754 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 p -155.62 154.83 32.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.729 1.612 . . . . 0.0 111.259 170.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 34.1 t -153.58 97.54 2.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.707 1.203 . . . . 0.0 111.797 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t -90.04 146.19 24.53 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.03 -1.044 . . . . 0.0 112.268 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.68 131.68 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.037 1.735 . . . . 0.0 109.265 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -119.79 128.7 53.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.525 1.53 . . . . 0.0 110.736 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -131.81 159.76 37.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.205 1.402 . . . . 0.0 110.089 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.5 144.68 42.32 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.201 -0.937 . . . . 0.0 111.0 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -117.31 -173.01 2.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.75 1.22 . . . . 0.0 109.318 -165.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -48.6 70.14 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 120.953 -1.092 . . . . 0.0 113.667 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 t -140.73 -17.82 0.86 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.908 2.083 . . . . 0.0 113.129 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.0 mtm -91.28 170.37 10.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.669 1.587 . . . . 0.0 111.09 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -138.02 161.17 37.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.874 0.869 . . . . 0.0 110.73 163.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.0 p -141.62 136.44 30.98 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.049 0.94 . . . . 0.0 111.301 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.2 119.45 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.869 1.268 . . . . 0.0 109.982 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.19 129.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.924 1.289 . . . . 0.0 110.661 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -121.47 106.86 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.274 0.63 . . . . 0.0 111.745 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.81 138.84 33.04 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -129.15 126.06 38.43 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.844 1.658 . . . . 0.0 110.335 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 65' ' ' TYR . . . -126.17 73.65 0.43 Allowed Glycine 0 CA--C 1.524 0.61 0 C-N-CA 126.782 2.134 . . . . 0.0 111.671 -171.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.42 123.11 17.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.964 1.306 . . . . 0.0 110.081 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.894 1.677 . . . . 0.0 111.54 -162.805 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -130.95 174.8 9.64 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.07 1.348 . . . . 0.0 111.833 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 136.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 111.418 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.0 m -94.74 96.42 9.37 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.288 1.435 . . . . 0.0 110.411 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -95.52 145.93 24.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.944 -1.097 . . . . 0.0 111.015 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.65 118.37 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.207 2.203 . . . . 0.0 109.349 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -137.75 150.37 47.2 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.306 -0.871 . . . . 0.0 112.053 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 125.203 1.401 . . . . 0.0 110.96 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 121.205 0.526 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.05 155.73 40.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.3 p -131.07 158.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.174 1.39 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.22 -35.94 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.779 2.032 . . . . 0.0 111.784 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.29 -31.96 66.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.439 1.096 . . . . 0.0 113.122 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -82.52 -51.12 8.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.499 -0.751 . . . . 0.0 110.491 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 90.2 t -51.0 -39.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.733 1.213 . . . . 0.0 112.511 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -61.15 -16.4 44.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.236 1.814 . . . . 0.0 114.493 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -104.18 -34.63 8.31 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.224 1.809 . . . . 0.0 112.526 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 36.1 mt -51.51 -43.59 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.133 0.878 . . . . 0.0 110.804 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.96 -43.16 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.702 -0.624 . . . . 0.0 112.318 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -54.66 24.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.601 1.091 . . . . 0.0 111.453 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -34.38 75.29 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.75 60.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 112.899 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.416 ' HA ' HG21 ' B' ' 191' ' ' VAL . 58.1 mt -59.84 -56.81 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.113 0.87 . . . . 0.0 109.61 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.41 -32.35 71.25 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 40.5 t -58.56 -50.4 73.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.515 1.126 . . . . 0.0 112.17 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.29 75.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 92.7 mt -61.94 -37.95 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.873 1.269 . . . . 0.0 111.22 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.06 17.04 78.45 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.045 0.831 . . . . 0.0 114.448 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.89 8.6 72.5 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.132 1.349 . . . . 0.0 115.967 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.85 151.22 14.87 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.947 1.373 . . . . 0.0 113.652 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.34 -173.17 2.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 112.23 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -39.79 137.71 0.87 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.732 2.813 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -136.84 174.09 11.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.516 1.526 . . . . 0.0 112.831 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -87.77 -92.44 0.11 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.416 1.486 . . . . 0.0 112.224 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 19.1 p -99.84 5.15 45.49 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.345 2.258 . . . . 0.0 113.248 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -50.76 -43.7 58.44 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.05 -1.031 . . . . 0.0 112.674 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.02 -35.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.331 1.052 . . . . 0.0 112.711 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.71 -49.81 60.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.475 1.11 . . . . 0.0 112.489 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.91 -26.91 67.82 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.621 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -75.09 -55.74 5.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.807 1.243 . . . . 0.0 111.215 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.1 t -58.95 -21.63 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 4.8 t -86.51 -55.6 3.81 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.824 1.193 . . . . 0.0 112.412 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -57.48 -35.95 70.85 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.045 1.293 . . . . 0.0 113.82 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' B' ' 170' ' ' ILE . 94.9 t -74.79 -67.16 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.382 1.073 . . . . 0.0 109.543 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.63 -29.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.797 1.239 . . . . 0.0 111.049 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.59 -55.27 23.46 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.29 -37.89 11.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.772 1.229 . . . . 0.0 112.571 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -60.07 -53.04 62.51 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.006 2.122 . . . . 0.0 112.731 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.02 -35.8 81.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.696 0.68 . . . . 0.0 112.043 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t -60.65 -50.42 73.56 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.726 0.81 . . . . 0.0 111.308 169.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -58.37 -51.17 70.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.522 1.929 . . . . 0.0 113.586 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.2 -23.03 63.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -61.17 -41.01 96.02 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -74.57 -24.08 58.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.42 -11.33 9.98 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -159.81 -73.65 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.942 1.246 . . . . 0.0 114.807 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -65.99 168.45 9.1 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 126.756 2.022 . . . . 0.0 113.318 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.38 173.54 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.223 2.615 . . . . 0.0 112.05 171.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.82 94.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.404 1.482 . . . . 0.0 113.04 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -158.13 107.06 2.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.596 1.959 . . . . 0.0 111.916 168.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -154.68 165.34 36.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.977 1.711 . . . . 0.0 111.031 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.8 tt -147.72 156.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 126.174 1.79 . . . . 0.0 108.864 160.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.13 152.46 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.289 1.836 . . . . 0.0 109.657 162.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.6 p -132.85 138.94 47.21 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.104 1.762 . . . . 0.0 108.518 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.75 145.7 38.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.879 0.847 . . . . 0.0 112.745 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.35 131.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.983 1.313 . . . . 0.0 109.224 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -118.71 93.45 2.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 127.215 2.206 . . . . 0.0 107.358 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.6 90.85 3.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 109.888 -172.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.53 153.22 13.34 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.457 -1.402 . . . . 0.0 113.533 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -7.79 53.7 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -16.91 56.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.441 1.896 . . . . 0.0 114.108 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 -3.18 6.38 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.176 1.231 . . . . 0.0 116.176 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -74.1 51.99 0.43 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.427 1.491 . . . . 0.0 113.287 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.05 30.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.652 1.596 . . . . 0.0 112.842 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.732 HD11 HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -159.69 -173.8 4.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.32 1.848 . . . . 0.0 110.804 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.41 139.26 40.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.842 0.747 . . . . 0.0 111.002 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.45 ' HB ' HG13 ' B' ' 278' ' ' VAL . 53.4 m -142.74 145.12 33.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.803 1.241 . . . . 0.0 110.142 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.71 38.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.433 1.093 . . . . 0.0 110.729 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 69.4 p -145.88 142.2 28.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.892 0.853 . . . . 0.0 112.07 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 9.5 t -80.79 25.81 0.43 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.975 0.91 . . . . 0.0 112.496 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 58.9 m -67.51 171.35 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.334 -0.854 . . . . 0.0 111.599 164.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -166.44 154.33 10.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.921 2.489 . . . . 0.0 108.83 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -81.61 132.09 35.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.428 -0.795 . . . . 0.0 110.014 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -152.78 116.46 4.77 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.046 1.338 . . . . 0.0 112.512 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.3 t -107.02 -34.05 7.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.397 1.479 . . . . 0.0 112.393 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 12.2 p -80.01 -36.09 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.986 1.314 . . . . 0.0 112.32 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -56.6 3.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.242 1.417 . . . . 0.0 111.802 -174.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -155.57 0.65 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.581 2.352 . . . . 0.0 109.341 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.59 153.5 16.79 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 120.728 -1.233 . . . . 0.0 113.556 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 25.8 p -156.79 147.18 21.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.211 1.404 . . . . 0.0 112.315 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.981 1.312 . . . . 0.0 111.838 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 14.2 t -86.57 146.4 26.37 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.034 -1.041 . . . . 0.0 112.205 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 t -139.39 135.96 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 109.267 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.34 129.79 51.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.538 1.535 . . . . 0.0 110.848 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -132.63 159.03 40.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.225 1.41 . . . . 0.0 110.035 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -136.64 144.16 43.87 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.026 -1.046 . . . . 0.0 111.028 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.9 -173.5 2.4 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.61 1.164 . . . . 0.0 109.454 -165.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -50.97 65.44 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.996 -1.065 . . . . 0.0 113.654 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.6 t -140.17 -10.94 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.064 1.746 . . . . 0.0 113.43 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.0 mtm -94.25 169.27 10.36 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 110.542 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -139.56 157.87 45.08 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 111.262 165.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.1 p -141.27 138.57 33.31 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.933 . . . . 0.0 111.876 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.66 126.83 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.877 1.271 . . . . 0.0 109.937 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.54 129.3 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.443 1.497 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -121.8 106.55 11.38 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.401 0.68 . . . . 0.0 111.9 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.99 140.93 29.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -131.57 115.54 16.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.142 1.777 . . . . 0.0 109.701 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.85 76.23 0.22 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.573 2.035 . . . . 0.0 111.028 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.08 123.38 20.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.838 0.855 . . . . 0.0 112.263 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 126.112 1.765 . . . . 0.0 112.058 -165.529 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -131.71 175.1 9.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 111.929 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 mm -52.86 140.5 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.662 1.985 . . . . 0.0 111.64 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 90.4 m -99.06 93.95 6.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.372 1.469 . . . . 0.0 110.332 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -94.26 146.82 23.75 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.036 -1.04 . . . . 0.0 110.778 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.45 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.9 p -148.6 120.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.384 1.874 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.09 152.15 48.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.033 0.933 . . . . 0.0 112.075 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 125.223 1.409 . . . . 0.0 111.114 -179.624 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.151 0.5 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.49 158.66 31.36 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.399 -0.813 . . . . 0.0 112.534 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.55 141.49 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.774 0.83 . . . . 0.0 111.852 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.12 -42.89 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.858 1.663 . . . . 0.0 111.327 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.95 -31.48 60.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 113.311 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -86.64 -53.34 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.044 0.937 . . . . 0.0 111.701 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.696 HG13 HD22 ' A' ' 56' ' ' LEU . 54.3 t -44.14 -48.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.836 1.255 . . . . 0.0 112.605 169.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -65.31 -3.18 3.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.396 1.478 . . . . 0.0 113.919 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.54 -31.67 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.236 1.815 . . . . 0.0 112.274 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -50.87 -44.71 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.369 0.986 . . . . 0.0 110.437 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 97' ' ' VAL . 9.0 p -59.81 -41.85 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -51.93 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.747 1.158 . . . . 0.0 111.585 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -33.32 75.27 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.05 69.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.396 1.079 . . . . 0.0 113.091 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.5 mt -59.86 -56.64 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.258 0.936 . . . . 0.0 110.274 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -60.45 -31.59 70.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.1 t -59.19 -46.68 87.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.32 1.048 . . . . 0.0 112.499 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.94 81.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.401 1.08 . . . . 0.0 113.815 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.95 -43.43 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 110.713 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.35 14.02 61.29 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.59 1.091 . . . . 0.0 115.066 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.78 85.87 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.139 1.352 . . . . 0.0 115.105 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -63.84 168.15 5.35 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 118.735 1.267 . . . . 0.0 112.55 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.63 102.03 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.203 1.801 . . . . 0.0 111.657 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.84 139.07 46.93 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.64 1.976 . . . . 0.0 112.499 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.23 156.98 43.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -57.89 -53.49 57.66 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.7 m -69.92 -26.36 64.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -58.7 -45.7 88.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.042 0.537 . . . . 0.0 112.182 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -56.91 -35.13 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.842 0.746 . . . . 0.0 112.424 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.89 -47.52 80.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.989 0.915 . . . . 0.0 111.621 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -67.81 -24.06 65.25 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -78.93 -52.57 8.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.132 0.878 . . . . 0.0 111.555 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -55.01 -35.23 64.18 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.665 0.666 . . . . 0.0 112.135 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -75.89 -55.76 5.32 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.205 0.911 . . . . 0.0 112.593 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.92 -38.03 75.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.911 1.284 . . . . 0.0 113.532 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.22 -62.32 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 C-N-CA 123.92 0.888 . . . . 0.0 110.384 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.61 -29.84 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.632 1.173 . . . . 0.0 110.75 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.53 -30.61 69.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.753 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -112.53 -42.24 3.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.995 1.718 . . . . 0.0 112.257 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -51.85 -55.58 19.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.5 2.32 . . . . 0.0 112.577 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -37.99 87.38 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.412 0.625 . . . . 0.0 110.989 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.6 m -67.15 -28.36 68.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.22 -52.38 10.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.555 2.342 . . . . 0.0 112.249 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.696 HD22 HG13 ' A' ' 19' ' ' VAL . 3.7 pp -65.74 -25.53 67.32 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -55.38 -37.03 67.02 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.367 1.067 . . . . 0.0 110.913 166.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -81.79 -34.13 30.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.494 0.718 . . . . 0.0 112.712 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -69.74 -28.91 66.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.366 0.666 . . . . 0.0 111.013 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.67 -118.79 4.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.045 1.783 . . . . 0.0 113.256 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -133.89 151.98 77.82 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.696 1.598 . . . . 0.0 113.606 -171.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 113.77 3.86 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.929 3.086 . . . . 0.0 112.214 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -147.62 171.7 15.19 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.299 1.839 . . . . 0.0 110.663 171.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.9 135.86 48.24 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.741 0.781 . . . . 0.0 110.84 162.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -131.13 157.49 42.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 128.014 2.526 . . . . 0.0 108.208 170.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -138.56 155.18 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.178 1.391 . . . . 0.0 109.144 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 110' ' ' ALA . 13.0 m -139.23 148.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 124.751 1.221 . . . . 0.0 110.374 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -145.83 154.05 41.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.304 1.042 . . . . 0.0 110.53 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.5 p -146.07 149.51 34.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.275 1.03 . . . . 0.0 112.854 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.73 111.33 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.841 1.656 . . . . 0.0 109.402 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.564 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.3 mm -107.33 96.47 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.523 1.529 . . . . 0.0 107.481 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.64 89.4 2.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.885 1.274 . . . . 0.0 111.247 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -166.15 120.43 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.473 1.909 . . . . 0.0 107.966 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -152.59 -64.56 0.16 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.757 1.223 . . . . 0.0 111.304 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.2 -15.61 13.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.638 1.575 . . . . 0.0 113.507 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.44 -11.66 33.27 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.273 1.892 . . . . 0.0 114.533 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.52 117.44 9.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.219 1.408 . . . . 0.0 111.938 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.3 174.49 19.62 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.64 1.59 . . . . 0.0 114.095 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.92 -172.54 2.18 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.49 1.916 . . . . 0.0 111.599 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.78 108.56 20.41 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.527 -0.733 . . . . 0.0 110.241 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.3 m -120.41 137.72 54.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.831 0.852 . . . . 0.0 109.868 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.32 134.61 29.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.298 0.639 . . . . 0.0 111.683 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.3 p -132.28 134.99 45.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.972 0.892 . . . . 0.0 111.229 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -83.36 24.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.515 -0.74 . . . . 0.0 111.599 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.8 m -62.79 163.54 9.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.63 0.729 . . . . 0.0 111.288 164.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.05 136.84 5.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 108.986 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 149.79 48.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.412 0.685 . . . . 0.0 110.296 173.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -134.07 152.2 51.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.073 1.349 . . . . 0.0 110.794 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t -120.13 -65.42 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.4 1.08 . . . . 0.0 112.465 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.8 t -82.18 -35.75 28.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.043 0.838 . . . . 0.0 112.607 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -67.37 -36.5 81.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.227 1.411 . . . . 0.0 113.352 -171.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.17 179.14 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.36 2.264 . . . . 0.0 111.121 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 134.52 11.98 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.946 1.26 . . . . 0.0 113.14 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -150.5 139.53 21.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.768 1.627 . . . . 0.0 110.458 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' CYS . . . . . 0.459 ' SG ' HG11 ' A' ' 19' ' ' VAL . 5.5 p -151.48 120.27 6.58 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.913 0.779 . . . . 0.0 111.902 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -132.29 151.71 51.71 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 112.078 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 23' ' ' VAL . 1.7 t -139.5 139.76 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.605 1.562 . . . . 0.0 109.943 -170.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.05 131.98 50.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.983 1.313 . . . . 0.0 112.13 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -139.46 106.54 5.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.802 1.241 . . . . 0.0 110.926 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -86.38 148.81 25.41 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.986 0.914 . . . . 0.0 112.066 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -123.66 -176.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.755 1.622 . . . . 0.0 110.694 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -67.71 0.24 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.597 1.559 . . . . 0.0 113.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.5 t -117.32 8.19 13.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.405 1.882 . . . . 0.0 112.488 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.0 mtt -134.58 173.98 11.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.43 1.892 . . . . 0.0 111.069 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -151.45 161.99 41.72 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 109.794 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.564 ' CB ' HD12 ' A' ' 71' ' ' ILE . 10.3 p -132.27 151.21 51.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 110.406 171.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.49 137.8 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 109.257 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.24 140.13 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.939 1.296 . . . . 0.0 109.678 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -131.9 145.13 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.998 0.919 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.53 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -130.24 145.1 51.71 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.262 1.425 . . . . 0.0 111.934 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.1 151.63 51.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.772 1.629 . . . . 0.0 111.08 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.81 86.72 0.15 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.175 1.369 . . . . 0.0 111.353 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -78.14 122.39 25.58 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.993 1.317 . . . . 0.0 111.568 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.654 1.581 . . . . 0.0 112.302 -168.198 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.13 169.08 15.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.911 1.284 . . . . 0.0 111.836 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.2 mm -60.34 151.06 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.373 1.869 . . . . 0.0 111.275 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.2 m -124.59 95.23 4.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.971 1.708 . . . . 0.0 110.885 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -97.64 149.96 21.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.933 -1.104 . . . . 0.0 111.434 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.98 102.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.488 2.315 . . . . 0.0 109.045 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -142.45 115.84 9.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.614 1.166 . . . . 0.0 111.724 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 125.102 1.361 . . . . 0.0 110.91 -179.377 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -65.75 167.02 9.92 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.275 -0.89 . . . . 0.0 111.575 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.39 145.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.411 1.084 . . . . 0.0 111.315 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.38 -39.65 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.618 1.167 . . . . 0.0 111.925 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.36 -31.12 68.92 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.667 1.587 . . . . 0.0 113.312 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -74.0 -60.05 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.939 0.895 . . . . 0.0 110.172 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.66 HG13 HD22 ' B' ' 199' ' ' LEU . 40.3 t -54.23 -42.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.752 1.221 . . . . 0.0 113.143 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -64.74 -3.31 3.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.058 1.343 . . . . 0.0 113.747 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.37 -33.35 5.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.438 1.895 . . . . 0.0 112.432 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 39.1 mt -51.8 -43.14 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.497 1.044 . . . . 0.0 110.352 169.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 240' ' ' VAL . 9.0 p -59.97 -41.93 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.74 56.93 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.772 1.169 . . . . 0.0 111.52 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -33.74 76.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.0 71.71 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.228 1.011 . . . . 0.0 113.036 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.88 -56.97 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.241 0.928 . . . . 0.0 110.312 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -60.28 -31.67 70.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -59.27 -46.7 87.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.34 1.056 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.11 81.62 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.402 1.081 . . . . 0.0 113.797 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.82 -43.43 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.277 1.031 . . . . 0.0 110.734 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.86 13.77 62.06 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.493 1.044 . . . . 0.0 115.0 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.78 10.82 85.85 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.188 1.375 . . . . 0.0 115.027 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -63.79 168.25 5.19 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.694 1.247 . . . . 0.0 112.501 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.62 102.55 0.07 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.076 1.75 . . . . 0.0 111.598 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.95 138.65 48.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.573 1.949 . . . . 0.0 112.526 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.8 156.63 43.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.697 1.199 . . . . 0.0 111.422 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -57.98 -53.53 57.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -69.42 -26.88 64.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -58.59 -45.47 89.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 0.0 112.22 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 4.2 t -56.49 -35.66 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.832 0.742 . . . . 0.0 112.444 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -63.8 -47.46 80.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.87 0.868 . . . . 0.0 111.585 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -67.92 -23.93 65.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -78.84 -52.9 7.68 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.172 0.896 . . . . 0.0 111.406 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.8 t -54.96 -34.79 63.6 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.736 0.698 . . . . 0.0 112.185 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.4 t -75.79 -56.75 4.38 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.178 0.899 . . . . 0.0 112.636 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -57.23 -38.44 73.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.952 1.301 . . . . 0.0 113.646 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.9 -64.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 83.1 t -51.65 -29.28 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 110.677 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.88 -34.48 73.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.171 0.988 . . . . 0.0 113.548 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -110.69 -38.6 5.11 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.693 1.597 . . . . 0.0 112.355 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 22.1 m -55.29 -53.52 55.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.419 2.288 . . . . 0.0 111.753 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 7.6 tp -60.12 -36.01 76.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.259 0.481 . . . . 0.0 112.054 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 68.4 m -70.6 -30.73 67.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.964 0.906 . . . . 0.0 113.355 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -71.34 -52.12 20.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.903 2.081 . . . . 0.0 112.453 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.66 HD22 HG13 ' B' ' 162' ' ' VAL . 2.8 pp -64.93 -26.43 68.31 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 53.9 m -58.32 -30.46 66.71 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.941 0.896 . . . . 0.0 110.984 168.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -85.88 -36.28 20.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.817 0.847 . . . . 0.0 112.717 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.82 -23.8 66.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.968 0.907 . . . . 0.0 112.699 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.55 -112.68 3.71 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.153 1.359 . . . . 0.0 112.734 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -137.63 154.53 75.03 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.711 1.604 . . . . 0.0 113.237 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.48 115.32 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.682 2.921 . . . . 0.0 112.2 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.35 172.68 15.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.413 1.885 . . . . 0.0 110.686 171.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -71.81 132.16 44.06 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.568 -0.708 . . . . 0.0 110.907 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -129.31 147.68 51.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.736 1.614 . . . . 0.0 109.198 168.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.2 tt -128.38 154.81 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.397 1.479 . . . . 0.0 109.253 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' B' ' 253' ' ' ALA . 3.5 m -136.69 150.76 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.134 1.374 . . . . 0.0 111.055 172.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 18.6 p -137.83 151.95 48.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.601 1.561 . . . . 0.0 110.279 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.3 p -146.43 152.33 38.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.162 0.982 . . . . 0.0 113.003 168.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.51 114.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 108.974 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' B' ' 249' ' ' CYS . 3.1 mm -107.28 91.26 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.446 1.898 . . . . 0.0 107.648 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 2.2 ttt -98.73 135.94 39.5 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.374 1.47 . . . . 0.0 109.506 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -81.72 145.65 30.39 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.492 -0.755 . . . . 0.0 112.37 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -76.1 -0.16 20.94 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.289 1.435 . . . . 0.0 114.045 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.18 -21.31 13.1 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.424 1.89 . . . . 0.0 113.996 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.03 -12.27 62.23 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.703 1.621 . . . . 0.0 114.36 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.75 89.71 1.37 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.272 1.429 . . . . 0.0 111.55 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.55 -169.01 27.73 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.97 1.272 . . . . 0.0 113.672 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.2 -176.03 4.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.665 2.386 . . . . 0.0 111.379 -173.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.01 104.24 13.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.216 1.007 . . . . 0.0 110.278 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 135.24 54.1 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.837 0.855 . . . . 0.0 110.56 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.78 12.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.286 0.234 . . . . 0.0 111.038 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -120.65 138.15 54.08 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.954 0.883 . . . . 0.0 110.966 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 69.8 m -84.2 21.36 1.4 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.41 -0.806 . . . . 0.0 111.899 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.2 m -64.82 162.6 15.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.509 0.724 . . . . 0.0 111.65 168.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.725 1.61 . . . . 0.0 110.388 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -69.78 151.8 45.35 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.426 -0.796 . . . . 0.0 110.483 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -137.03 151.04 48.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.396 1.478 . . . . 0.0 110.351 167.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 2.4 t -119.78 -64.76 1.23 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.425 1.09 . . . . 0.0 112.523 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 46.6 t -82.44 -35.74 27.27 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.258 -0.901 . . . . 0.0 112.647 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -36.7 80.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.3 1.44 . . . . 0.0 113.406 -170.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.27 178.7 7.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.478 2.311 . . . . 0.0 110.744 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -96.95 134.33 11.73 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.871 1.224 . . . . 0.0 112.955 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 56.0 m -150.52 148.63 28.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.924 1.689 . . . . 0.0 110.152 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 3.2 p -152.57 121.41 6.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.726 1.211 . . . . 0.0 111.331 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.0 t -132.71 151.02 52.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.239 1.416 . . . . 0.0 112.271 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 166' ' ' VAL . 1.7 t -140.6 139.98 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.517 1.527 . . . . 0.0 110.014 -169.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.81 130.88 49.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.861 1.264 . . . . 0.0 112.236 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -138.77 104.29 5.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.0 1.32 . . . . 0.0 110.639 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.58 149.87 27.22 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.217 -0.927 . . . . 0.0 111.679 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -124.38 -177.79 3.9 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.361 1.465 . . . . 0.0 110.868 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -67.91 0.23 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.513 1.525 . . . . 0.0 113.35 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -119.15 15.13 13.18 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.486 1.914 . . . . 0.0 112.952 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 43.0 mtt -142.47 175.11 10.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.493 1.917 . . . . 0.0 109.9 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -151.54 158.7 43.92 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.869 0.868 . . . . 0.0 109.972 161.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.424 ' CB ' HD12 ' B' ' 214' ' ' ILE . 12.6 p -134.09 144.06 48.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.437 1.113 . . . . 0.0 110.99 174.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.19 132.64 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.427 1.491 . . . . 0.0 109.299 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.1 142.01 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.205 1.402 . . . . 0.0 110.027 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.1 t -135.79 144.52 45.8 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.785 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.518 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -130.21 144.36 51.32 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.479 1.511 . . . . 0.0 111.728 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -132.63 148.45 52.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.181 1.792 . . . . 0.0 110.571 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -147.61 87.3 0.16 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.581 1.562 . . . . 0.0 112.32 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.01 118.46 21.76 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 111.604 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.753 1.621 . . . . 0.0 112.347 -168.153 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -129.86 169.53 15.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.16 150.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.443 1.897 . . . . 0.0 111.366 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.6 m -123.67 88.41 2.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.739 1.616 . . . . 0.0 110.878 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -93.61 150.74 20.18 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.378 -0.826 . . . . 0.0 111.369 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.15 108.51 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.624 1.97 . . . . 0.0 110.043 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -141.65 113.32 7.77 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.742 1.617 . . . . 0.0 111.294 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 125.043 1.337 . . . . 0.0 110.875 -178.894 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 121.781 0.8 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -140.16 167.96 20.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.628 1.571 . . . . 0.0 110.959 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.99 152.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.92 1.288 . . . . 0.0 110.148 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.75 -35.84 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.263 -0.898 . . . . 0.0 111.517 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.61 -25.02 67.08 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.142 0.977 . . . . 0.0 113.48 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -78.62 -57.67 3.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.246 1.018 . . . . 0.0 110.535 169.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.8 t -50.49 -44.92 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.475 1.51 . . . . 0.0 112.535 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -67.68 -9.06 40.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.266 1.827 . . . . 0.0 113.628 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -102.33 -31.37 10.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.581 1.552 . . . . 0.0 112.844 170.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mt -49.27 -44.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.359 1.064 . . . . 0.0 110.467 170.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.97 -43.68 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -49.96 65.35 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.257 1.39 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -33.35 75.38 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.113 0.965 . . . . 0.0 113.091 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 48' ' ' VAL . 44.9 mt -57.59 -56.17 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.225 0.92 . . . . 0.0 110.315 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.07 -32.01 70.54 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -60.86 -45.47 94.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.331 1.052 . . . . 0.0 112.449 170.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.95 71.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.24 -44.03 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.999 . . . . 0.0 110.938 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.03 71.92 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.61 26.84 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.348 1.451 . . . . 0.0 116.257 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.27 -179.17 1.52 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.024 1.412 . . . . 0.0 112.689 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -156.92 0.57 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.986 1.314 . . . . 0.0 111.803 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.9 158.04 0.74 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.028 1.331 . . . . 0.0 112.42 162.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.49 -176.4 5.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.715 1.206 . . . . 0.0 111.75 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.58 -100.76 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.882 1.273 . . . . 0.0 109.655 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -67.83 -24.33 65.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.96 1.304 . . . . 0.0 113.992 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -41.63 78.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.055 -1.028 . . . . 0.0 112.669 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.2 -29.18 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.615 0.766 . . . . 0.0 112.57 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.12 -48.43 78.53 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.695 1.198 . . . . 0.0 111.385 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.55 -26.36 67.09 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.349 -0.844 . . . . 0.0 112.986 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -77.13 -54.24 6.76 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.498 -0.752 . . . . 0.0 111.186 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 t -56.5 -29.83 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.783 0.719 . . . . 0.0 112.739 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -79.73 -52.68 7.63 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.477 1.035 . . . . 0.0 112.505 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -58.5 -38.0 76.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.578 1.151 . . . . 0.0 113.323 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 27' ' ' ILE . 75.8 t -67.02 -65.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 124.667 1.187 . . . . 0.0 109.807 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.7 -29.09 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.873 1.269 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.67 -47.19 80.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 0.0 112.705 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.57 -38.29 9.21 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.023 1.329 . . . . 0.0 112.885 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -56.39 -53.64 54.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.538 1.935 . . . . 0.0 112.135 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -40.16 91.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.688 0.676 . . . . 0.0 111.307 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 p -69.68 -27.96 65.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -75.2 -52.15 11.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.677 2.391 . . . . 0.0 113.04 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.65 -28.27 69.79 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.626 -1.296 . . . . 0.0 113.308 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.9 m -56.25 -32.99 65.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.754 1.222 . . . . 0.0 111.056 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -85.59 -28.34 24.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.211 1.004 . . . . 0.0 113.233 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.73 -25.34 62.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.95 0.9 . . . . 0.0 112.312 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.47 -141.14 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.253 1.883 . . . . 0.0 112.035 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -112.84 155.08 44.6 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.397 1.479 . . . . 0.0 112.813 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.44 111.91 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.882 3.054 . . . . 0.0 111.238 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.2 174.86 10.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 0.0 111.387 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HE3' ' CE2' ' B' ' 254' ' ' PHE . 0.5 OUTLIER -66.21 124.17 21.92 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.943 0.897 . . . . 0.0 110.072 163.143 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -124.56 165.36 17.97 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.999 2.12 . . . . 0.0 109.811 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.428 HG22 ' CD2' ' A' ' 111' ' ' PHE . 4.8 tp -152.06 154.24 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.63 1.572 . . . . 0.0 109.52 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 110' ' ' ALA . 33.9 m -136.84 148.18 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 111.359 167.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.96 127.31 13.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 110.191 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' B' ' 225' ' ' ALA . 7.9 p -127.58 155.53 43.7 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.897 0.879 . . . . 0.0 112.301 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.466 ' C ' HD13 ' A' ' 71' ' ' ILE . 10.0 p -140.19 122.72 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.948 1.299 . . . . 0.0 108.723 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 106' ' ' CYS . 1.9 mm -120.78 116.35 49.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 127.937 2.495 . . . . 0.0 107.474 -174.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.465 ' HG3' HD11 ' A' ' 79' ' ' LEU . 14.5 tmm? -135.92 151.93 50.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.184 0.992 . . . . 0.0 112.279 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -105.15 110.6 23.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.884 1.673 . . . . 0.0 112.263 -168.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.99 -6.17 11.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.186 2.194 . . . . 0.0 113.225 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -25.75 6.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.819 2.448 . . . . 0.0 114.336 162.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.31 7.05 0.59 Allowed Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 130.26 45.46 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.594 1.697 . . . . 0.0 112.338 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.6 112.9 2.16 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD11 ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -146.85 171.56 15.01 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.41 1.884 . . . . 0.0 112.324 -176.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -121.73 130.93 53.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 110.621 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 135' ' ' VAL . 51.5 m -142.23 147.42 36.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.268 1.427 . . . . 0.0 109.059 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 153.2 40.77 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.822 -1.174 . . . . 0.0 111.904 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -155.58 165.03 37.8 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.3 t -116.43 9.89 14.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 112.643 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.45 106.26 5.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.995 1.318 . . . . 0.0 113.189 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -127.03 151.4 48.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.74 1.216 . . . . 0.0 111.429 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 145.83 52.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.195 0.998 . . . . 0.0 110.218 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -140.84 151.85 44.66 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.612 1.565 . . . . 0.0 109.351 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 t -117.02 -63.75 1.4 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.365 1.466 . . . . 0.0 112.143 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t -87.9 -28.76 21.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.201 1.001 . . . . 0.0 112.885 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -52.79 8.64 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.327 1.451 . . . . 0.0 111.948 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -151.54 -174.21 4.76 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.129 2.972 . . . . 0.0 109.608 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.63 6.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.297 1.427 . . . . 0.0 113.342 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.47 165.75 30.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.195 1.398 . . . . 0.0 111.126 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.94 126.93 10.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.984 0.914 . . . . 0.0 110.789 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 t -134.64 144.68 47.99 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.497 -1.377 . . . . 0.0 111.901 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.24 139.36 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.837 1.255 . . . . 0.0 110.11 -168.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.01 123.98 20.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.781 1.633 . . . . 0.0 112.255 -170.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -135.03 103.07 5.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.259 1.824 . . . . 0.0 110.531 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.95 149.59 44.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.165 0.986 . . . . 0.0 112.552 171.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -127.46 -179.37 4.87 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.509 . . . . 0.0 110.469 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.23 -48.61 72.7 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 13.74 5.35 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.447 1.899 . . . . 0.0 112.388 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.0 mtt -143.17 176.87 8.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.815 2.046 . . . . 0.0 109.695 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.0 156.1 35.37 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.276 1.03 . . . . 0.0 110.105 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.59 ' HB2' HD12 ' A' ' 71' ' ' ILE . 24.0 p -133.94 136.21 44.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.927 . . . . 0.0 111.647 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.19 129.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.34 1.456 . . . . 0.0 110.168 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.76 111.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.2 1.8 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -107.38 121.39 44.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.189 0.996 . . . . 0.0 110.151 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -119.63 160.51 22.36 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.294 1.438 . . . . 0.0 112.467 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -135.93 156.52 48.63 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.996 1.318 . . . . 0.0 109.874 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -179.95 91.99 0.08 OUTLIER Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.14 174.02 2.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.094 0.95 . . . . 0.0 112.155 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 124.784 1.234 . . . . 0.0 111.96 -179.565 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.176 0.036 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.08 -177.88 4.31 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.182 1.793 . . . . 0.0 111.152 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.26 140.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.006 0.922 . . . . 0.0 110.762 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.6 m -121.69 119.89 33.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.878 1.671 . . . . 0.0 110.606 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 117.27 33.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.59 1.156 . . . . 0.0 110.891 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.426 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -100.48 105.02 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 128.987 2.915 . . . . 0.0 109.31 178.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -133.33 156.52 47.46 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.164 -0.96 . . . . 0.0 112.262 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.03 1.332 . . . . 0.0 109.704 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.805 0 CA-C-O 121.736 0.779 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -139.63 167.4 22.19 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.573 1.549 . . . . 0.0 110.898 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.14 152.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.018 1.327 . . . . 0.0 110.172 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.41 -36.49 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.212 -0.93 . . . . 0.0 111.581 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.15 -24.2 66.11 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -79.19 -58.34 3.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.44 1.096 . . . . 0.0 110.62 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 24.7 t -50.38 -44.56 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 112.602 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -68.12 -8.76 41.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 113.651 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -102.8 -30.91 10.57 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.55 1.54 . . . . 0.0 112.787 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.1 mt -49.34 -44.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.408 1.083 . . . . 0.0 110.344 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.56 -43.65 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -50.01 65.04 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.157 1.344 . . . . 0.0 111.384 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -33.44 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.12 -40.47 71.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.207 1.003 . . . . 0.0 112.97 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' B' ' 191' ' ' VAL . 44.3 mt -57.56 -56.39 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.215 0.916 . . . . 0.0 110.277 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.88 -32.15 70.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -60.81 -45.5 94.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.344 1.057 . . . . 0.0 112.452 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.86 71.37 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.27 -44.16 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.161 0.984 . . . . 0.0 110.916 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.08 71.27 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.103 0.859 . . . . 0.0 115.071 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.33 -4.6 26.68 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.396 1.474 . . . . 0.0 116.229 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.35 -179.26 1.58 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.077 1.439 . . . . 0.0 112.558 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.48 -156.86 0.57 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.917 1.287 . . . . 0.0 111.759 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.92 158.03 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.105 1.362 . . . . 0.0 112.458 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.55 -176.23 5.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.718 1.207 . . . . 0.0 111.779 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.9 -100.92 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.87 1.268 . . . . 0.0 109.632 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 22.4 m -67.61 -24.31 65.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.937 1.295 . . . . 0.0 114.018 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -41.62 78.6 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.035 -1.041 . . . . 0.0 112.593 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.07 -29.23 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.545 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -63.17 -48.63 77.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.637 1.175 . . . . 0.0 111.391 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.41 -26.4 67.21 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.332 -0.855 . . . . 0.0 112.922 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -76.94 -54.44 6.57 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.505 -0.747 . . . . 0.0 111.23 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.3 t -56.56 -29.27 61.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.2 t -80.16 -53.08 7.01 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.497 1.044 . . . . 0.0 112.557 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -58.04 -37.86 75.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.649 1.18 . . . . 0.0 113.276 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' B' ' 170' ' ' ILE . 74.0 t -66.66 -66.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 124.844 1.257 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.66 -29.25 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.71 1.204 . . . . 0.0 111.06 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.45 -47.35 79.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.499 0.72 . . . . 0.0 112.752 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.73 -38.17 9.19 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.053 1.341 . . . . 0.0 113.004 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 20.6 m -56.45 -53.38 58.11 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.559 1.943 . . . . 0.0 112.116 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -40.66 93.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.786 0.721 . . . . 0.0 111.303 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 35.3 p -69.14 -29.09 67.05 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.325 -0.86 . . . . 0.0 113.257 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -73.93 -51.73 15.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.662 2.385 . . . . 0.0 113.073 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.4 -28.22 69.54 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.61 -1.306 . . . . 0.0 113.292 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 96.2 m -58.17 -27.49 63.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.611 1.164 . . . . 0.0 111.117 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -90.76 -28.43 18.26 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.443 1.097 . . . . 0.0 113.607 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.13 -27.06 63.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.689 0.796 . . . . 0.0 111.821 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -137.01 9.58 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.127 1.822 . . . . 0.0 111.949 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -119.76 160.55 41.97 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 125.463 1.505 . . . . 0.0 113.571 -173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 115.93 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.629 2.886 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.8 175.55 11.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.317 1.447 . . . . 0.0 111.7 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.26 109.05 5.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.78 1.232 . . . . 0.0 109.719 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.83 159.47 15.77 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.86 1.264 . . . . 0.0 109.948 167.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.9 tt -146.8 157.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 109.863 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' B' ' 253' ' ' ALA . 33.7 m -138.87 147.27 25.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.894 1.678 . . . . 0.0 110.722 174.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.01 126.97 11.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.94 1.696 . . . . 0.0 109.628 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.41 158.42 42.04 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.635 0.774 . . . . 0.0 112.931 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' VAL . . . . . 0.501 ' C ' HD13 ' B' ' 214' ' ' ILE . 7.6 p -145.05 124.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.758 1.223 . . . . 0.0 109.703 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.2 mm -123.92 113.02 35.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.766 2.426 . . . . 0.0 107.845 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -134.64 153.12 52.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.255 1.026 . . . . 0.0 112.41 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -103.44 114.15 28.2 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.984 1.714 . . . . 0.0 112.512 -168.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -66.95 -5.51 12.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.002 2.121 . . . . 0.0 113.336 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.78 -24.8 6.44 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.627 2.371 . . . . 0.0 114.332 161.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 7.97 1.49 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.2 88.13 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.199 1.5 . . . . 0.0 113.529 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 142.21 33.27 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.157 -0.964 . . . . 0.0 113.918 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.97 172.02 17.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.209 2.204 . . . . 0.0 111.186 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -125.18 122.53 37.32 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.803 1.241 . . . . 0.0 109.981 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.49 ' HB ' HG13 ' B' ' 278' ' ' VAL . 93.8 m -132.51 145.92 51.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 108.427 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' ALA . . . . . 0.42 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . . . -140.62 143.3 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.502 -0.749 . . . . 0.0 110.819 173.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 83.2 p -140.67 158.18 44.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.696 0.76 . . . . 0.0 111.546 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 34.5 t -103.83 5.4 35.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.087 0.955 . . . . 0.0 111.991 170.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 73.1 m -67.4 151.89 46.65 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.452 1.12 . . . . 0.0 113.73 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.97 162.07 23.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.672 2.389 . . . . 0.0 109.695 -171.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.9 144.63 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.382 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -136.37 151.15 49.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.317 1.847 . . . . 0.0 110.587 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 22.3 t -117.55 -68.19 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.695 1.198 . . . . 0.0 111.929 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 4.6 t -83.87 -32.0 25.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.436 0.694 . . . . 0.0 112.345 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.18 42.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.859 1.664 . . . . 0.0 112.522 -173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -154.62 -172.9 4.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 128.804 2.842 . . . . 0.0 110.053 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -120.02 131.39 8.86 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.605 1.574 . . . . 0.0 113.776 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 p -155.08 159.91 40.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.174 2.19 . . . . 0.0 111.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.7 t -149.66 110.36 4.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.762 1.225 . . . . 0.0 110.698 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.3 t -118.71 146.46 44.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.637 1.175 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.91 141.31 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.717 1.207 . . . . 0.0 110.241 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.67 124.65 20.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.922 1.689 . . . . 0.0 112.355 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -135.29 105.65 6.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.213 1.805 . . . . 0.0 110.599 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 150.11 40.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.204 1.002 . . . . 0.0 112.395 172.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -127.87 -179.89 5.2 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.434 1.494 . . . . 0.0 110.529 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -48.45 75.09 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.0 t -131.6 14.68 4.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.492 1.917 . . . . 0.0 112.478 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 26.5 mtt -143.4 176.49 9.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.796 2.039 . . . . 0.0 109.82 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -154.11 155.91 36.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.325 1.05 . . . . 0.0 110.043 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.618 ' HB2' HD12 ' B' ' 214' ' ' ILE . 21.7 p -135.22 135.4 40.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.947 0.899 . . . . 0.0 111.734 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -134.56 131.36 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.319 1.448 . . . . 0.0 110.394 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.13 107.68 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.126 1.77 . . . . 0.0 110.75 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.7 t -96.31 129.39 43.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.547 0.739 . . . . 0.0 110.139 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -126.62 147.76 49.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 112.272 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.558 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 1.1 m-85 -117.22 149.47 40.35 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.966 1.706 . . . . 0.0 111.264 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -172.02 89.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.407 -170.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.428 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.9 OUTLIER -66.47 165.22 14.81 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.883 0.849 . . . . 0.0 111.952 -178.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 124.568 1.147 . . . . 0.0 111.631 175.434 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.466 0.174 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.78 -173.3 2.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.2 mm -57.8 141.89 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 110.649 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 88.7 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.561 1.944 . . . . 0.0 110.011 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.77 136.19 33.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.728 0.811 . . . . 0.0 110.81 171.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.49 HG13 ' HB ' ' B' ' 224' ' ' THR . 5.4 p -131.77 103.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 128.199 2.6 . . . . 0.0 109.656 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -129.78 157.95 40.78 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 0.0 111.562 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 124.836 1.254 . . . . 0.0 109.37 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -61.87 164.96 5.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.457 0.703 . . . . 0.0 111.935 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.51 156.83 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.804 0.842 . . . . 0.0 111.398 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 t -57.39 -34.76 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.097 1.759 . . . . 0.0 111.523 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.39 -27.6 67.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.645 1.178 . . . . 0.0 113.256 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -78.12 -59.23 2.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.991 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.527 HG13 HD22 ' A' ' 56' ' ' LEU . 34.1 t -49.74 -45.91 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.502 1.521 . . . . 0.0 112.87 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 t -60.73 -25.26 66.32 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.302 1.441 . . . . 0.0 112.894 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.52 -37.75 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.51 -1.369 . . . . 0.0 113.155 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mt -52.1 -43.6 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.515 1.126 . . . . 0.0 110.84 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.1 -42.15 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.47 -0.776 . . . . 0.0 113.032 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -52.9 54.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.174 1.352 . . . . 0.0 112.082 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.11 74.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.54 -45.68 65.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.004 0.922 . . . . 0.0 112.882 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mt -54.72 -57.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 119.204 0.911 . . . . 0.0 110.415 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.97 -29.92 68.76 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.8 p -66.68 -33.7 76.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.23 52.09 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.043 1.337 . . . . 0.0 112.438 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.69 -41.51 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.869 1.268 . . . . 0.0 110.926 171.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.15 81.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.251 0.929 . . . . 0.0 114.272 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 10.02 75.54 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.334 1.445 . . . . 0.0 115.903 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -61.22 155.58 20.56 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.072 1.436 . . . . 0.0 113.056 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.78 -171.53 1.62 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.167 1.787 . . . . 0.0 112.286 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -41.41 139.29 1.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.743 2.817 . . . . 0.0 114.737 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -135.88 174.75 10.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.485 1.514 . . . . 0.0 113.163 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -90.42 -97.45 0.11 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.541 1.537 . . . . 0.0 111.138 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.8 p -89.37 -1.65 58.13 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.681 1.992 . . . . 0.0 114.326 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.31 -42.77 61.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.433 1.493 . . . . 0.0 113.566 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.08 -32.15 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.55 -48.77 71.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 112.176 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -68.54 -25.99 65.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -76.63 -55.45 5.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.918 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -54.29 -35.3 62.44 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.953 0.797 . . . . 0.0 112.186 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -75.68 -54.55 6.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.129 0.877 . . . . 0.0 112.761 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.91 -36.85 73.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.668 1.187 . . . . 0.0 113.33 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.64 -63.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 C-N-CA 124.177 0.991 . . . . 0.0 110.015 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.8 t -49.15 -30.75 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.057 0.943 . . . . 0.0 110.715 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -59.91 -35.84 75.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -107.02 -42.54 4.87 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.36 1.464 . . . . 0.0 112.659 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 m -54.18 -54.84 34.25 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.339 2.256 . . . . 0.0 112.254 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -39.07 86.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.517 0.598 . . . . 0.0 111.218 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -57.48 -52.61 64.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.203 0.601 . . . . 0.0 111.425 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -59.77 -51.13 71.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.565 1.946 . . . . 0.0 114.489 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.527 HD22 HG13 ' A' ' 19' ' ' VAL . 3.7 pp -65.06 -28.64 69.61 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.574 -1.329 . . . . 0.0 113.734 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 m -59.46 -33.91 71.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.47 0.708 . . . . 0.0 111.071 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -80.66 -24.9 38.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.26 -16.01 62.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.2 -111.3 3.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 112.693 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -133.91 150.92 75.83 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.369 1.868 . . . . 0.0 112.222 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 102.58 1.42 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.98 3.12 . . . . 0.0 112.404 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -143.05 161.67 37.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.471 1.509 . . . . 0.0 112.109 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -65.5 100.07 0.47 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.96 1.704 . . . . 0.0 110.991 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -75.02 166.14 24.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.467 1.107 . . . . 0.0 111.9 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.99 156.07 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.443 2.297 . . . . 0.0 108.186 164.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.69 155.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.782 -0.574 . . . . 0.0 109.455 160.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -134.68 137.47 43.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.519 1.128 . . . . 0.0 109.991 165.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -128.88 144.76 51.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.795 0.838 . . . . 0.0 111.916 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -131.82 99.5 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.298 1.839 . . . . 0.0 108.841 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.501 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -95.75 99.96 10.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.89 96.18 2.76 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.124 1.369 . . . . 0.0 111.292 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -149.35 159.06 44.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.305 1.442 . . . . 0.0 110.458 154.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -153.48 -80.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.07 1.748 . . . . 0.0 110.059 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -84.0 -18.85 35.78 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.895 1.278 . . . . 0.0 113.775 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.68 -2.26 3.71 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.784 1.659 . . . . 0.0 115.093 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.05 179.08 2.45 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.967 1.707 . . . . 0.0 114.167 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.1 -172.29 28.23 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.812 2.149 . . . . 0.0 112.356 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 179.64 6.36 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 111.986 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -106.87 111.21 23.62 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.469 -0.77 . . . . 0.0 111.1 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.431 ' HB ' HG13 ' A' ' 135' ' ' VAL . 16.6 m -116.93 140.71 49.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.474 1.11 . . . . 0.0 109.972 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.02 138.95 34.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.733 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -139.56 120.81 14.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 110.429 -166.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 t -79.97 66.23 5.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.319 1.057 . . . . 0.0 110.093 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.443 ' SG ' HD11 ' B' ' 209' ' ' ILE . 3.9 m -114.04 171.18 7.76 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 0.0 110.787 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -144.07 129.58 19.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.986 1.314 . . . . 0.0 109.86 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -76.98 125.98 30.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.434 1.094 . . . . 0.0 109.846 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -146.01 90.06 1.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.488 1.115 . . . . 0.0 111.336 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -68.1 -60.57 2.39 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.173 1.389 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.7 t -88.08 -33.67 18.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.476 1.11 . . . . 0.0 112.304 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 m -74.75 -38.24 62.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -165.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.76 -134.47 0.14 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.335 1.854 . . . . 0.0 109.422 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.96 150.59 20.66 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.316 1.436 . . . . 0.0 113.464 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 p -162.63 157.3 21.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.6 t -165.25 157.99 15.95 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.302 1.841 . . . . 0.0 109.378 165.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 t -143.24 139.14 30.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.28 -1.512 . . . . 0.0 111.13 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.1 138.31 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 109.658 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.25 119.08 11.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.733 1.613 . . . . 0.0 111.023 -166.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -135.83 141.74 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.868 1.267 . . . . 0.0 112.149 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 165.7 24.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.49 -174.12 4.59 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.17 -62.41 0.95 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.294 1.837 . . . . 0.0 113.536 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -139.18 -6.59 1.39 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.987 1.715 . . . . 0.0 113.124 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.9 ptm -129.17 78.81 1.88 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.642 1.577 . . . . 0.0 112.111 -165.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -51.27 133.5 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.165 1.386 . . . . 0.0 111.306 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.501 ' CB ' HD12 ' A' ' 71' ' ' ILE . 14.3 p -113.63 136.33 52.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 111.767 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.1 126.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.81 1.644 . . . . 0.0 110.994 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.78 122.98 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.221 1.808 . . . . 0.0 110.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -115.64 118.42 33.05 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.788 1.235 . . . . 0.0 110.675 -178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.98 140.8 37.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.262 1.825 . . . . 0.0 112.15 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -133.41 148.51 51.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.339 1.456 . . . . 0.0 109.67 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.1 127.44 3.85 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 125.591 1.567 . . . . 0.0 109.344 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.95 133.43 49.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.63 0.772 . . . . 0.0 111.419 -168.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 124.959 1.304 . . . . 0.0 112.305 -169.623 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.354 0.597 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -132.54 174.46 10.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.364 1.866 . . . . 0.0 111.083 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.15 134.34 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.17 1.788 . . . . 0.0 111.399 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 m -98.32 92.32 5.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.206 1.402 . . . . 0.0 110.242 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -92.55 149.83 21.12 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.701 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.431 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -143.39 97.79 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.569 2.347 . . . . 0.0 108.686 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -144.72 166.26 25.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.048 1.339 . . . . 0.0 112.539 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 125.367 1.467 . . . . 0.0 109.622 174.643 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.172 0.51 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.39 166.9 2.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.196 0.999 . . . . 0.0 112.788 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.52 156.99 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.415 1.086 . . . . 0.0 111.546 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.99 -38.91 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.618 1.167 . . . . 0.0 111.469 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.27 -26.47 67.79 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.565 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -76.86 -60.71 2.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.883 0.873 . . . . 0.0 110.421 171.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.617 HG13 HD22 ' B' ' 199' ' ' LEU . 51.1 t -49.23 -45.95 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.001 1.72 . . . . 0.0 112.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 21.7 t -59.74 -25.15 64.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.272 1.429 . . . . 0.0 112.98 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -86.93 -37.72 17.34 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.604 -1.31 . . . . 0.0 113.05 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.4 mt -51.95 -44.12 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.975 0.91 . . . . 0.0 110.979 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -52.53 49.96 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.917 1.235 . . . . 0.0 111.959 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.66 72.56 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -45.78 56.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 112.868 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.423 ' HA ' HG21 ' B' ' 191' ' ' VAL . 51.6 mt -54.43 -57.37 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.275 0.943 . . . . 0.0 110.327 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.75 -30.09 68.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 9.7 p -66.7 -33.51 75.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 172.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.15 -33.55 50.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.057 1.343 . . . . 0.0 112.535 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.77 -40.4 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.844 1.258 . . . . 0.0 110.969 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.27 15.04 80.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.208 0.908 . . . . 0.0 114.327 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.44 78.17 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.315 1.436 . . . . 0.0 115.797 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -61.19 155.34 21.04 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.119 1.46 . . . . 0.0 113.103 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.89 -171.44 1.63 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.198 1.799 . . . . 0.0 112.242 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -41.35 139.44 1.04 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.739 2.816 . . . . 0.0 114.808 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -135.93 174.3 10.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.495 1.518 . . . . 0.0 113.19 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.21 -96.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.658 1.583 . . . . 0.0 111.292 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.7 p -90.67 -1.71 57.86 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.803 2.041 . . . . 0.0 114.354 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.6 -42.48 61.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.422 1.489 . . . . 0.0 113.7 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.98 -31.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.05 -49.08 68.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.794 1.238 . . . . 0.0 112.139 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -68.33 -26.19 65.48 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -76.48 -55.57 5.41 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 110.941 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.6 t -55.36 -32.45 62.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.928 0.786 . . . . 0.0 112.399 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.3 t -77.54 -55.7 5.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.281 0.946 . . . . 0.0 112.756 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.65 -36.19 71.55 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.884 1.22 . . . . 0.0 113.405 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' B' ' 170' ' ' ILE . 69.6 t -67.74 -63.4 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 109.964 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.77 -31.14 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.302 1.041 . . . . 0.0 110.722 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.82 -35.36 74.56 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -107.62 -42.41 4.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.42 1.488 . . . . 0.0 112.663 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.8 m -54.62 -54.18 44.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.417 2.287 . . . . 0.0 112.379 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -38.94 87.63 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 0.0 111.187 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 23.8 t -58.05 -51.98 67.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.307 0.643 . . . . 0.0 111.522 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.58 -51.54 69.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.576 1.95 . . . . 0.0 114.273 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.617 HD22 HG13 ' B' ' 162' ' ' VAL . 4.0 pp -65.48 -28.59 69.32 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.622 -1.299 . . . . 0.0 113.881 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 4.6 m -58.99 -32.46 69.71 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.397 0.679 . . . . 0.0 111.059 168.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -81.09 -27.27 35.7 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.692 -0.63 . . . . 0.0 112.58 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.4 -21.21 62.87 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.32 -111.72 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.013 1.292 . . . . 0.0 112.364 171.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -133.51 152.22 78.74 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.926 1.69 . . . . 0.0 112.37 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.42 99.96 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.891 3.061 . . . . 0.0 112.107 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -142.4 162.96 34.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.544 1.537 . . . . 0.0 112.196 174.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -66.39 101.95 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.191 1.796 . . . . 0.0 111.085 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -80.04 165.07 22.92 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.86 1.264 . . . . 0.0 111.908 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' ILE . . . . . 0.443 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.7 tt -149.14 157.6 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 127.781 2.432 . . . . 0.0 108.236 164.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.72 155.67 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 161.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 134.25 40.0 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.672 1.189 . . . . 0.0 109.59 166.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 8.3 p -128.02 148.57 50.54 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.902 0.881 . . . . 0.0 112.505 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -133.27 104.24 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.195 1.798 . . . . 0.0 109.061 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -99.12 109.22 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 107.837 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 159.1 35.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.284 1.433 . . . . 0.0 111.445 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.23 130.06 41.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.525 1.53 . . . . 0.0 112.712 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -80.88 -4.13 53.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.171 2.189 . . . . 0.0 114.116 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -58.45 -20.38 44.58 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.436 1.894 . . . . 0.0 114.639 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.67 5.03 3.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.756 1.645 . . . . 0.0 114.614 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.4 6.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 113.114 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -175.1 -177.53 44.26 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.43 1.966 . . . . 0.0 111.76 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 179.85 7.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.487 1.515 . . . . 0.0 112.315 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -109.96 109.96 20.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.59 0.632 . . . . 0.0 111.411 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.5 ' HB ' HG13 ' B' ' 278' ' ' VAL . 35.7 m -113.85 138.49 50.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.829 0.852 . . . . 0.0 110.393 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.04 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.551 . . . . 0.0 111.293 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 3.2 m -136.07 119.6 17.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.793 0.837 . . . . 0.0 110.114 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.1 t -79.88 64.88 4.86 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.413 1.101 . . . . 0.0 109.975 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 170.83 7.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 110.641 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.79 132.07 21.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 109.899 -170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -76.83 124.6 27.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.459 1.104 . . . . 0.0 109.618 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -142.74 84.23 1.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.843 1.257 . . . . 0.0 110.976 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.5 t -65.11 -62.08 1.76 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.274 1.429 . . . . 0.0 112.474 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 35.8 t -88.48 -28.65 20.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.287 1.035 . . . . 0.0 112.535 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.1 m -77.08 -38.23 52.88 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.655 -0.653 . . . . 0.0 112.63 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 -134.75 0.14 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.211 1.804 . . . . 0.0 109.689 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.81 150.92 20.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.381 1.467 . . . . 0.0 113.272 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 31.3 p -162.6 156.74 21.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.159 1.384 . . . . 0.0 111.915 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.6 162.59 16.63 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.342 1.857 . . . . 0.0 109.644 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.2 t -146.49 141.14 26.77 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.392 -1.442 . . . . 0.0 110.78 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.5 136.52 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.973 1.309 . . . . 0.0 109.509 -171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 121.81 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.45 1.5 . . . . 0.0 111.394 -171.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -130.43 169.89 14.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.621 1.569 . . . . 0.0 110.912 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.65 164.83 14.38 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.043 1.337 . . . . 0.0 111.89 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -177.15 5.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.382 1.473 . . . . 0.0 109.458 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.55 -71.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.212 2.205 . . . . 0.0 114.055 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.0 t -138.32 16.41 2.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.489 1.516 . . . . 0.0 113.167 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.78 121.83 13.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.598 1.559 . . . . 0.0 110.987 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -79.08 152.2 30.97 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.558 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 23.1 p -133.46 115.7 15.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.388 0.675 . . . . 0.0 112.501 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.91 129.62 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.432 1.493 . . . . 0.0 111.565 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.25 121.3 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.485 1.914 . . . . 0.0 111.044 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.5 t -112.95 121.9 46.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.774 1.23 . . . . 0.0 110.627 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -108.4 141.44 40.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.289 1.836 . . . . 0.0 112.392 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.44 147.95 50.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.404 1.482 . . . . 0.0 109.697 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -138.09 125.18 3.15 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 125.698 1.618 . . . . 0.0 109.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.66 132.14 48.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.626 0.77 . . . . 0.0 111.783 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 125.041 1.337 . . . . 0.0 112.483 -169.409 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.277 0.56 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -132.29 175.12 9.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.421 1.888 . . . . 0.0 111.135 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.1 132.67 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.016 1.727 . . . . 0.0 111.385 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 57.1 m -95.72 88.62 5.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.086 1.354 . . . . 0.0 110.004 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -92.12 150.04 21.16 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.277 -0.89 . . . . 0.0 111.42 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.4 p -148.63 102.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.747 2.019 . . . . 0.0 109.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -143.89 167.12 23.07 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.839 1.655 . . . . 0.0 111.794 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.993 1.317 . . . . 0.0 109.755 174.202 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.464 0.65 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -125.11 165.3 18.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.854 1.261 . . . . 0.0 110.496 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.87 142.51 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.762 1.225 . . . . 0.0 110.138 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.61 -41.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.808 1.643 . . . . 0.0 113.813 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.35 -29.8 67.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.291 1.036 . . . . 0.0 112.93 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -76.36 -56.11 4.94 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.41 1.084 . . . . 0.0 110.736 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 56' ' ' LEU . 9.5 t -48.25 -44.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.538 1.135 . . . . 0.0 112.277 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -68.23 -6.84 25.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.474 1.51 . . . . 0.0 114.12 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -107.11 -32.73 7.7 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.538 1.935 . . . . 0.0 112.662 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 mt -50.29 -42.76 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.277 0.944 . . . . 0.0 110.133 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -59.85 -43.85 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.463 -0.773 . . . . 0.0 113.085 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -51.77 56.15 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.923 1.238 . . . . 0.0 111.132 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -34.01 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.3 -37.46 63.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.706 0.803 . . . . 0.0 112.839 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 48' ' ' VAL . 57.2 mt -59.43 -59.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.337 0.971 . . . . 0.0 109.544 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.57 -31.6 70.72 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.0 t -58.71 -50.5 73.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 112.209 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.96 -31.98 72.08 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.43 -44.43 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.384 1.073 . . . . 0.0 110.973 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.19 12.0 74.56 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.11 -1.93 26.94 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 171.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.23 170.06 6.35 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 119.347 1.574 . . . . 0.0 112.004 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.75 -147.24 0.34 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -68.23 103.07 1.49 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.037 2.135 . . . . 0.0 111.28 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -92.95 173.06 7.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.291 1.437 . . . . 0.0 112.645 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -84.2 -112.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.469 1.108 . . . . 0.0 110.367 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.7 m -61.95 -20.32 63.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.576 1.55 . . . . 0.0 114.659 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.05 -41.84 75.66 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.138 -0.976 . . . . 0.0 112.501 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.0 t -54.77 -36.1 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.526 1.131 . . . . 0.0 112.675 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -66.11 -47.85 72.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.785 0.721 . . . . 0.0 112.42 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -65.17 -24.06 67.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.029 0.831 . . . . 0.0 112.466 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.66 -53.63 6.96 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -56.2 -30.55 62.44 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.816 0.734 . . . . 0.0 112.588 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -78.85 -58.43 3.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 170.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -58.21 -39.21 78.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.048 1.295 . . . . 0.0 113.538 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 27' ' ' ILE . 84.6 t -68.26 -62.42 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 123.89 0.876 . . . . 0.0 109.956 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -50.04 -29.55 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.46 1.104 . . . . 0.0 110.855 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.27 -52.01 66.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.609 0.763 . . . . 0.0 112.01 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -92.35 -38.62 11.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.5 m -61.27 -53.16 60.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.402 2.281 . . . . 0.0 112.431 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -37.86 84.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.28 0.562 . . . . 0.0 111.003 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m -65.96 -29.63 70.06 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.86 -50.28 12.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.421 2.289 . . . . 0.0 112.592 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.52 HD22 HG13 ' A' ' 19' ' ' VAL . 4.1 pp -65.18 -25.74 67.85 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.856 -1.152 . . . . 0.0 113.786 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -57.53 -32.82 67.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.564 1.146 . . . . 0.0 110.848 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -84.27 -30.55 25.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.56 -31.92 70.4 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.588 0.355 . . . . 0.0 111.105 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.04 -137.79 4.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.013 1.292 . . . . 0.0 111.976 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.75 158.76 39.61 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.154 1.382 . . . . 0.0 112.791 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.44 109.46 2.45 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.514 2.809 . . . . 0.0 111.161 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.96 173.81 12.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.763 1.225 . . . . 0.0 112.123 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.23 112.08 10.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.28 . . . . 0.0 110.537 168.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.88 134.85 54.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.967 1.307 . . . . 0.0 109.34 170.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -118.06 152.36 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.369 1.868 . . . . 0.0 109.158 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.98 154.53 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.331 1.052 . . . . 0.0 110.218 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 153.38 40.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.775 168.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -147.18 156.33 42.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.076 0.95 . . . . 0.0 112.737 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.28 121.27 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.442 1.497 . . . . 0.0 108.993 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.64 118.21 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 126.876 2.07 . . . . 0.0 107.507 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.95 161.78 35.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.52 1.528 . . . . 0.0 110.751 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -130.1 157.48 42.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.745 -1.222 . . . . 0.0 113.99 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -76.44 -7.92 56.07 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.286 1.435 . . . . 0.0 114.368 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.39 -16.29 45.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.536 1.934 . . . . 0.0 114.263 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.04 30.57 0.79 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.101 1.334 . . . . 0.0 115.301 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.26 73.69 0.49 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.977 1.311 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 95.24 0.23 Allowed Glycine 0 N--CA 1.468 0.776 0 C-N-CA 126.192 1.853 . . . . 0.0 115.049 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.55 162.32 25.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.773 1.629 . . . . 0.0 111.892 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.05 97.73 5.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.815 1.246 . . . . 0.0 108.622 170.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.2 m -105.69 136.39 45.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.821 0.848 . . . . 0.0 109.13 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 119.57 12.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.84 0.856 . . . . 0.0 110.542 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 p -125.08 139.7 53.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.929 0.871 . . . . 0.0 111.378 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.2 m -87.19 16.17 5.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.664 0.785 . . . . 0.0 112.277 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' B' ' 209' ' ' ILE . 24.7 m -70.7 166.22 21.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.345 1.058 . . . . 0.0 112.163 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.3 151.44 26.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.868 1.667 . . . . 0.0 110.769 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -78.92 127.98 32.71 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.474 -0.767 . . . . 0.0 110.005 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.78 139.4 38.26 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.245 1.018 . . . . 0.0 112.144 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -134.44 -38.13 0.84 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.607 1.563 . . . . 0.0 113.219 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 t -89.68 -43.22 10.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.35 1.46 . . . . 0.0 111.299 173.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -43.35 87.55 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.965 1.706 . . . . 0.0 112.416 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.68 -161.67 0.94 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.463 1.905 . . . . 0.0 111.377 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.41 114.66 4.49 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.873 1.702 . . . . 0.0 115.944 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 m -139.45 176.21 8.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.125 2.17 . . . . 0.0 111.602 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.84 131.49 6.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.002 2.121 . . . . 0.0 109.208 166.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.9 t -139.11 146.02 40.18 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.825 -1.797 . . . . 0.0 112.436 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 137.85 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.951 1.3 . . . . 0.0 110.259 -167.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 114.91 16.63 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.279 1.432 . . . . 0.0 111.695 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.403 ' CH2' HG21 ' A' ' 27' ' ' ILE . 8.4 m95 -121.5 97.7 5.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.741 1.616 . . . . 0.0 109.557 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -63.75 168.83 4.56 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.356 -0.84 . . . . 0.0 112.337 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.89 -177.83 5.16 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.857 1.663 . . . . 0.0 112.93 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.8 t -135.29 -30.12 1.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.251 1.42 . . . . 0.0 113.679 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptp -87.25 176.81 7.38 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.962 -1.086 . . . . 0.0 112.506 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.55 150.54 30.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.663 1.185 . . . . 0.0 111.639 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.2 p -136.59 142.86 43.35 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.262 1.029 . . . . 0.0 112.346 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.39 135.13 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.701 1.6 . . . . 0.0 109.978 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.65 131.5 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.903 1.681 . . . . 0.0 110.255 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.2 p -125.07 147.51 48.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.56 136.47 47.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.068 2.147 . . . . 0.0 110.967 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -135.42 157.99 45.5 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.792 1.637 . . . . 0.0 108.982 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.24 85.17 0.05 OUTLIER Glycine 0 N--CA 1.464 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 111.442 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -69.02 153.9 42.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.035 0.934 . . . . 0.0 110.085 -178.19 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.474 0.764 0 C-N-CA 123.455 0.702 . . . . 0.0 111.608 -171.21 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -130.6 -179.92 5.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.761 1.224 . . . . 0.0 111.559 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.3 134.2 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.105 1.362 . . . . 0.0 110.93 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.6 m -115.84 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 110.245 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -90.98 147.48 23.06 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.447 -0.783 . . . . 0.0 111.384 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.89 103.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 128.019 2.527 . . . . 0.0 108.708 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.58 130.6 21.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.059 1.344 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 125.453 1.501 . . . . 0.0 109.911 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.484 ' CZ ' HD11 ' B' ' 165' ' ' ILE . 0.0 OUTLIER -111.98 162.32 15.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 111.643 175.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.79 135.9 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.656 1.582 . . . . 0.0 109.968 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.62 -42.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.094 2.158 . . . . 0.0 113.451 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.29 -31.33 65.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.647 1.179 . . . . 0.0 112.92 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -87.61 -49.21 7.32 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.965 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 21.6 t -45.7 -41.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 120.114 1.325 . . . . 0.0 112.263 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -70.89 -8.28 51.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.113 1.765 . . . . 0.0 115.036 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -103.34 -31.44 10.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.762 2.425 . . . . 0.0 112.581 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' ILE . . . . . 0.484 HD11 ' CZ ' ' B' ' 157' ' ' PHE . 33.8 mt -50.56 -42.65 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.226 1.01 . . . . 0.0 110.296 171.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.39 -42.89 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -51.9 56.13 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.859 1.208 . . . . 0.0 111.058 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -33.64 76.33 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.17 -36.56 61.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.626 0.77 . . . . 0.0 112.976 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' B' ' 191' ' ' VAL . 55.1 mt -59.75 -59.43 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.291 0.95 . . . . 0.0 109.558 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.32 -31.72 70.56 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.0 t -58.57 -50.3 74.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.372 1.069 . . . . 0.0 112.16 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.15 72.16 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.72 -44.28 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.327 1.051 . . . . 0.0 110.867 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.17 75.08 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 -1.96 26.83 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -66.35 170.53 5.86 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 119.319 1.559 . . . . 0.0 112.025 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.57 -146.31 0.34 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.853 1.661 . . . . 0.0 112.09 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -70.03 97.76 1.21 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.022 2.129 . . . . 0.0 111.365 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.57 173.95 10.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.267 1.427 . . . . 0.0 112.8 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -85.77 -106.66 0.05 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.461 1.105 . . . . 0.0 110.557 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 30.0 m -66.1 -20.73 66.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -55.6 -38.75 69.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.054 0.942 . . . . 0.0 112.612 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -35.24 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.939 0.896 . . . . 0.0 113.304 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -69.08 -46.37 67.96 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.8 0.84 . . . . 0.0 111.992 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -65.68 -24.92 67.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.501 0.591 . . . . 0.0 112.496 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -78.14 -54.77 5.88 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.667 0.787 . . . . 0.0 111.656 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.9 t -56.05 -30.17 61.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.759 0.708 . . . . 0.0 112.617 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -78.78 -59.95 2.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.21 0.914 . . . . 0.0 112.627 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -57.2 -39.38 75.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.094 1.315 . . . . 0.0 113.594 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' B' ' 170' ' ' ILE . 91.4 t -67.8 -62.95 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 C-N-CA 123.895 0.878 . . . . 0.0 109.839 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.2 t -50.11 -29.81 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 110.76 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.55 -52.29 65.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.75 0.82 . . . . 0.0 111.839 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -91.62 -38.64 12.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.795 1.238 . . . . 0.0 112.694 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 42.1 m -62.74 -52.77 61.94 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.768 2.427 . . . . 0.0 112.532 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.75 86.74 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.54 0.686 . . . . 0.0 111.09 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 52.9 m -64.7 -31.42 72.63 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -77.08 -49.51 15.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.461 2.305 . . . . 0.0 112.652 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.65 -27.98 69.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.879 -1.138 . . . . 0.0 113.661 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -58.55 -32.48 68.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.833 0.853 . . . . 0.0 110.807 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -81.7 -31.46 32.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.01 -30.29 55.81 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.706 0.23 . . . . 0.0 110.964 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.83 -134.6 2.61 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.507 1.527 . . . . 0.0 111.682 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 153.18 49.86 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.535 1.134 . . . . 0.0 113.849 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 107.16 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.057 3.171 . . . . 0.0 111.687 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.1 171.08 17.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 111.759 175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.2 98.16 1.32 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.799 1.24 . . . . 0.0 111.366 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -83.3 155.64 23.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.845 0.858 . . . . 0.0 110.671 163.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' ILE . . . . . 0.404 HD11 ' SG ' ' A' ' 85' ' ' CYS . 2.1 tt -141.03 153.33 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.825 2.05 . . . . 0.0 108.759 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 253' ' ' ALA . 23.4 m -141.42 154.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.284 1.034 . . . . 0.0 110.297 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 15.0 t -146.65 153.79 40.72 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.892 0.877 . . . . 0.0 109.827 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 22.7 p -148.45 160.49 43.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.157 0.983 . . . . 0.0 112.667 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.49 136.37 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 110.467 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 5.4 mm -119.15 120.41 63.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 127.791 2.436 . . . . 0.0 107.164 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 22.3 ttt -140.27 156.6 46.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.193 1.397 . . . . 0.0 111.171 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.99 140.71 52.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.715 1.206 . . . . 0.0 112.286 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -62.22 -7.88 4.85 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.203 1.801 . . . . 0.0 115.071 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.62 -16.95 43.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.396 2.278 . . . . 0.0 114.212 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 126.91 29.12 0.89 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.961 1.267 . . . . 0.0 115.127 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.88 72.52 0.25 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.311 1.444 . . . . 0.0 112.846 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.25 96.69 0.24 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.353 1.93 . . . . 0.0 114.983 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 pp -126.92 161.18 28.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 111.651 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.78 97.91 4.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.868 1.267 . . . . 0.0 108.591 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 38.8 m -110.17 132.29 54.3 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.262 0.625 . . . . 0.0 109.506 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -135.33 118.02 16.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.202 1.001 . . . . 0.0 110.276 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 24.2 p -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.987 0.899 . . . . 0.0 111.075 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 72.4 m -86.08 16.11 4.53 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.369 -0.832 . . . . 0.0 112.147 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 20.7 m -70.26 165.82 21.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.121 0.968 . . . . 0.0 112.055 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -155.81 150.77 26.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -76.49 130.95 38.69 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.26 141.86 37.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.172 0.989 . . . . 0.0 111.385 166.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 11.0 t -134.01 -50.0 0.82 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.647 1.579 . . . . 0.0 112.033 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 34.2 t -78.48 -34.26 47.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.778 0.831 . . . . 0.0 111.618 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -47.58 28.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.474 1.509 . . . . 0.0 113.065 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.32 -162.74 1.25 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.884 1.673 . . . . 0.0 111.825 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -102.19 112.14 4.24 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.823 1.678 . . . . 0.0 116.138 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 68.7 m -140.03 175.76 9.31 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.071 2.148 . . . . 0.0 111.971 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 40.3 t -160.04 127.02 4.44 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.066 2.147 . . . . 0.0 109.398 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.7 t -136.04 146.1 46.75 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 119.755 -1.841 . . . . 0.0 112.536 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.25 139.43 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.003 1.321 . . . . 0.0 110.289 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 117.73 19.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.988 1.315 . . . . 0.0 111.948 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -124.63 96.15 4.79 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.69 1.596 . . . . 0.0 109.566 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.21 169.38 4.57 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.53 -0.731 . . . . 0.0 112.456 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -142.39 -177.2 5.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 111.981 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -44.43 81.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.263 1.825 . . . . 0.0 112.802 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.4 t -133.93 -34.92 0.98 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.623 1.569 . . . . 0.0 113.469 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 18.6 ptp -86.6 177.39 7.39 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.956 -1.09 . . . . 0.0 112.71 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -151.43 157.89 42.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.01 1.324 . . . . 0.0 111.22 165.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 25.8 p -137.0 141.65 42.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.079 0.952 . . . . 0.0 111.621 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.07 134.18 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.059 1.343 . . . . 0.0 110.108 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.62 130.74 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 126.007 1.723 . . . . 0.0 110.211 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 45.7 p -124.63 144.97 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.497 0.719 . . . . 0.0 111.181 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -128.41 137.55 51.91 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.865 2.066 . . . . 0.0 110.733 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -135.71 163.51 30.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.985 1.714 . . . . 0.0 108.834 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 153.65 86.54 0.06 OUTLIER Glycine 0 N--CA 1.464 0.504 0 O-C-N 121.382 -0.824 . . . . 0.0 111.183 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.478 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.5 OUTLIER -67.65 156.67 36.32 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.968 0.907 . . . . 0.0 110.231 -178.76 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 121.825 0.822 . . . . 0.0 111.248 -172.115 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -131.01 179.87 5.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.858 1.263 . . . . 0.0 111.524 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.28 134.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.044 1.338 . . . . 0.0 110.838 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 74.0 m -116.24 90.62 3.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.916 1.686 . . . . 0.0 110.091 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -91.16 148.72 22.17 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.615 0.722 . . . . 0.0 111.371 170.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.34 112.8 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 127.222 2.209 . . . . 0.0 109.932 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.12 130.6 18.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.976 1.31 . . . . 0.0 111.655 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 125.495 1.518 . . . . 0.0 109.91 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.726 0.774 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -110.3 168.18 9.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.355 1.462 . . . . 0.0 110.475 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.83 159.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.754 0.788 . . . . 0.0 111.146 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.03 -34.73 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.763 2.025 . . . . 0.0 111.702 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -59.69 -28.6 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.922 0.889 . . . . 0.0 113.099 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -82.27 -54.19 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.687 0.795 . . . . 0.0 110.706 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.431 HG13 HD22 ' A' ' 56' ' ' LEU . 97.4 t -49.97 -42.37 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.088 1.355 . . . . 0.0 112.422 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 t -59.58 -19.44 48.78 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.006 1.723 . . . . 0.0 113.747 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -97.48 -43.21 7.36 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.877 1.671 . . . . 0.0 112.111 172.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.0 mt -50.41 -41.97 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.02 -44.63 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.82 58.92 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.22 1.373 . . . . 0.0 111.518 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -34.56 76.2 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.35 -43.51 66.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.681 0.792 . . . . 0.0 112.972 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.61 -58.92 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 118.983 0.811 . . . . 0.0 109.773 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.53 -31.67 72.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.6 t -61.01 -48.15 83.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.998 0.919 . . . . 0.0 112.035 169.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.38 76.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.586 1.155 . . . . 0.0 114.002 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.39 -49.96 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 0.0 110.532 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.7 11.61 59.01 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.271 0.938 . . . . 0.0 115.289 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.66 -3.99 23.04 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.32 169.76 8.34 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 119.254 1.527 . . . . 0.0 111.8 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 -148.77 0.36 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.377 1.471 . . . . 0.0 111.676 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -60.5 131.33 50.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.178 1.791 . . . . 0.0 110.918 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.01 -177.31 3.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.293 1.437 . . . . 0.0 112.235 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -98.04 -96.6 0.22 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.913 1.285 . . . . 0.0 110.078 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -73.85 -22.62 59.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.965 1.306 . . . . 0.0 113.91 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.54 -44.03 84.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.207 -0.933 . . . . 0.0 112.393 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.57 -36.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.895 0.878 . . . . 0.0 113.009 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -61.12 -53.97 50.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.53 1.132 . . . . 0.0 111.176 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.68 -54.93 5.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 112.224 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -58.7 -22.72 58.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -85.53 -57.64 2.98 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.269 0.941 . . . . 0.0 112.25 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -59.75 -40.89 89.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.09 1.314 . . . . 0.0 113.752 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.62 -62.91 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 C-N-CA 124.075 0.95 . . . . 0.0 109.86 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -49.92 -28.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.682 1.193 . . . . 0.0 110.952 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -57.72 11.02 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.796 0.725 . . . . 0.0 111.858 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -86.28 -36.64 19.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.169 0.988 . . . . 0.0 113.217 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 m -60.91 -51.82 67.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.777 2.031 . . . . 0.0 112.172 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tp -61.48 -32.25 72.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.354 0.662 . . . . 0.0 112.287 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 t -61.98 -58.51 7.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.549 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.88 -49.55 49.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.431 HD22 HG13 ' A' ' 19' ' ' VAL . 2.5 pp -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -62.64 -44.44 96.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 119.028 -0.511 . . . . 0.0 109.768 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -64.88 -25.16 67.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.307 0.958 . . . . 0.0 113.356 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.21 -2.88 14.52 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 171.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.27 -98.7 0.18 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 124.865 1.221 . . . . 0.0 114.64 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -67.83 168.88 11.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 125.431 1.492 . . . . 0.0 114.392 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.11 167.74 21.02 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.541 2.161 . . . . 0.0 112.668 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -55.49 97.55 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.357 2.263 . . . . 0.0 114.45 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 96.06 0.65 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.921 2.088 . . . . 0.0 111.212 174.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -153.37 150.32 28.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.183 1.393 . . . . 0.0 110.012 170.386 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.42 146.61 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 171.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 110' ' ' ALA . 4.6 m -137.98 148.18 25.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.644 1.578 . . . . 0.0 110.392 165.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -135.74 155.96 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.671 1.188 . . . . 0.0 109.791 166.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.0 t -151.41 144.41 24.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.247 1.419 . . . . 0.0 110.834 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.85 140.54 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.067 1.347 . . . . 0.0 109.876 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 106' ' ' CYS . 1.4 mm -126.34 110.87 24.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 127.334 2.253 . . . . 0.0 108.374 -175.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.14 168.71 18.35 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.023 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -110.99 124.81 52.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.312 1.445 . . . . 0.0 111.261 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -84.26 -0.71 53.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.981 1.712 . . . . 0.0 114.033 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.38 -19.7 64.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.102 1.761 . . . . 0.0 114.166 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.09 34.75 0.36 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.306 1.432 . . . . 0.0 114.617 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.11 173.14 3.96 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 118.905 1.353 . . . . 0.0 112.794 171.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.2 103.98 0.33 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.186 1.374 . . . . 0.0 113.195 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 164.09 31.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.821 1.248 . . . . 0.0 113.609 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -127.53 131.66 50.04 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.308 1.043 . . . . 0.0 110.395 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.555 ' HB ' HG13 ' A' ' 135' ' ' VAL . 47.9 m -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.957 1.303 . . . . 0.0 109.039 176.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.09 121.27 12.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.436 1.094 . . . . 0.0 110.787 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.2 p -129.69 131.04 46.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.347 0.594 . . . . 0.0 111.447 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -90.67 18.34 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.268 -0.895 . . . . 0.0 111.978 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.8 m -61.2 162.93 6.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.286 1.435 . . . . 0.0 112.408 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -158.23 134.36 9.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.228 1.011 . . . . 0.0 111.602 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.72 148.0 30.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 110.913 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -134.68 149.57 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.841 1.656 . . . . 0.0 110.644 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.8 t -97.3 -66.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.831 1.252 . . . . 0.0 112.304 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 t -91.24 -26.47 18.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.974 . . . . 0.0 112.535 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -30.76 52.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.905 1.682 . . . . 0.0 113.091 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 -167.02 1.05 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.961 2.104 . . . . 0.0 111.135 -172.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.87 146.15 15.28 Favored Glycine 0 CA--C 1.539 1.571 0 O-C-N 120.909 -1.119 . . . . 0.0 114.641 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 134.99 13.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.193 1.397 . . . . 0.0 111.784 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 24.0 t -127.99 97.26 4.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.661 1.184 . . . . 0.0 113.077 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -88.14 150.02 23.58 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.028 -1.045 . . . . 0.0 112.715 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.27 138.68 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.332 1.853 . . . . 0.0 109.407 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -125.23 119.48 28.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.709 1.604 . . . . 0.0 111.956 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -128.52 102.54 6.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 110.127 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -77.52 151.3 34.62 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.177 -0.952 . . . . 0.0 112.039 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.15 -178.42 3.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.32 1.448 . . . . 0.0 109.952 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -60.46 -45.02 95.23 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -129.92 -21.12 3.06 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.818 1.647 . . . . 0.0 113.919 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.9 mtt -100.84 173.12 6.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 170.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -147.84 147.43 29.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.083 1.353 . . . . 0.0 109.936 167.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 71' ' ' ILE . 9.0 p -133.35 134.01 43.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.894 1.277 . . . . 0.0 110.641 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.97 110.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.041 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.36 138.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 110.8 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.5 p -134.16 114.74 13.43 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.282 -0.886 . . . . 0.0 112.576 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -100.08 136.12 40.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.84 1.256 . . . . 0.0 112.043 -176.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -134.34 112.86 11.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.426 1.491 . . . . 0.0 111.183 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -103.07 61.94 0.46 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.743 -1.223 . . . . 0.0 113.878 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -52.43 109.5 0.4 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 113.298 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 127.098 2.159 . . . . 0.0 111.934 -171.316 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 120.331 0.11 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -128.89 168.73 15.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.912 1.285 . . . . 0.0 111.375 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -62.5 135.78 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.317 1.447 . . . . 0.0 110.842 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.3 m -106.37 88.95 2.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.864 1.666 . . . . 0.0 110.147 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -89.96 149.83 22.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.154 172.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -145.27 104.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.988 2.115 . . . . 0.0 109.356 -177.55 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.8 119.96 18.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 110.826 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 125.429 1.491 . . . . 0.0 108.851 174.442 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 121.416 0.627 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -105.27 173.63 6.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.841 1.256 . . . . 0.0 111.195 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.32 161.44 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.585 1.154 . . . . 0.0 111.584 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.03 -40.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.513 1.125 . . . . 0.0 112.126 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.76 -25.15 67.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.592 1.157 . . . . 0.0 113.018 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -79.46 -58.29 3.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 110.986 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.528 HG22 HD13 ' B' ' 199' ' ' LEU . 85.9 t -52.38 -40.94 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.915 1.286 . . . . 0.0 112.607 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 19.5 t -58.94 -18.62 35.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.572 1.549 . . . . 0.0 113.408 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.3 -43.86 6.44 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.135 1.374 . . . . 0.0 112.031 171.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 38.7 mt -50.58 -42.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.201 1.0 . . . . 0.0 111.262 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.26 -43.54 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.487 -0.758 . . . . 0.0 112.887 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -51.76 53.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.943 1.247 . . . . 0.0 111.399 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.23 75.57 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.28 -43.43 64.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.801 0.84 . . . . 0.0 113.037 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.38 -58.76 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 119.124 0.874 . . . . 0.0 109.702 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -62.45 -31.74 72.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 37.5 t -60.9 -48.18 83.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.988 0.915 . . . . 0.0 112.108 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.19 76.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.29 -49.9 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.512 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 92.73 11.55 59.03 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.235 0.922 . . . . 0.0 115.266 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.5 -4.0 23.29 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -67.12 169.61 8.24 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.299 1.549 . . . . 0.0 111.862 170.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.13 -148.49 0.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.362 1.465 . . . . 0.0 111.615 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.44 132.31 53.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.155 1.782 . . . . 0.0 110.999 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -177.34 4.1 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.288 1.435 . . . . 0.0 112.157 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -98.06 -96.71 0.22 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 0.0 110.143 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.2 m -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.014 1.326 . . . . 0.0 113.929 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.9 -44.0 86.49 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.09 -1.006 . . . . 0.0 112.377 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.77 -36.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.943 0.897 . . . . 0.0 112.988 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.75 -54.44 45.16 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.626 1.17 . . . . 0.0 111.075 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -64.33 -22.83 67.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 113.049 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.35 -54.9 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.188 0.903 . . . . 0.0 112.301 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.3 t -58.86 -21.04 56.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.2 t -87.02 -58.75 2.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.212 0.915 . . . . 0.0 112.332 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -58.88 -40.7 85.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.142 1.337 . . . . 0.0 113.793 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.52 -63.27 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 124.182 0.993 . . . . 0.0 109.817 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 77.1 t -48.6 -29.74 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.234 1.413 . . . . 0.0 111.167 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -55.45 33.5 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.628 0.771 . . . . 0.0 111.711 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -88.87 -35.08 16.75 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.369 1.068 . . . . 0.0 113.367 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.2 m -63.43 -52.62 60.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.0 2.12 . . . . 0.0 112.605 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.607 HD13 HD11 ' B' ' 199' ' ' LEU . 0.1 OUTLIER -62.97 -32.57 73.92 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.609 0.364 . . . . 0.0 111.023 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t -60.52 -57.81 11.14 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.387 -0.821 . . . . 0.0 111.469 165.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -50.37 -49.14 55.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.711 1.604 . . . . 0.0 113.433 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.607 HD11 HD13 ' B' ' 196' ' ' LEU . 4.0 pp -70.74 -27.87 64.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 1.5 m -60.89 -44.96 96.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 163.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -64.58 -25.76 68.11 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.227 0.921 . . . . 0.0 113.415 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.16 -4.6 18.14 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.99 -101.89 0.26 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 119.984 1.265 . . . . 0.0 114.658 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.28 167.81 11.45 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.82 1.648 . . . . 0.0 114.008 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.08 166.03 24.42 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.178 1.919 . . . . 0.0 112.236 168.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -50.97 115.87 1.73 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.964 1.705 . . . . 0.0 112.269 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 171.08 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 130.222 3.409 . . . . 0.0 111.193 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 208' ' ' TYR . . . . . 0.405 ' CG ' HD12 ' B' ' 196' ' ' LEU . 54.9 p90 -145.6 171.06 15.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.572 1.949 . . . . 0.0 109.743 167.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.77 151.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.0 143.18 27.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.339 1.456 . . . . 0.0 109.092 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 155.04 51.34 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.876 0.87 . . . . 0.0 110.144 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.11 148.67 28.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.183 1.393 . . . . 0.0 111.288 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.75 141.06 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 110.445 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' B' ' 249' ' ' CYS . 1.2 mm -126.65 110.38 23.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 127.847 2.459 . . . . 0.0 108.171 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 167.51 20.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.919 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -111.55 126.96 55.54 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.253 1.421 . . . . 0.0 111.214 -168.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -85.69 0.35 52.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.913 1.685 . . . . 0.0 113.956 -168.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.1 -19.92 64.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.073 1.749 . . . . 0.0 114.152 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 37.41 0.39 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.329 1.442 . . . . 0.0 114.375 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.12 172.68 6.46 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 118.758 1.279 . . . . 0.0 112.285 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -142.27 78.88 0.27 Allowed Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.553 1.073 . . . . 0.0 114.396 -173.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.36 156.03 28.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 111.393 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.32 134.3 52.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 110.892 173.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.705 ' HB ' HG13 ' B' ' 278' ' ' VAL . 99.6 m -138.54 143.85 39.65 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 109.063 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.28 13.75 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.594 1.157 . . . . 0.0 110.84 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.4 p -128.46 136.59 51.04 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.813 -0.555 . . . . 0.0 111.761 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.5 m -94.22 18.79 10.29 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.662 -0.648 . . . . 0.0 111.776 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.3 m -61.68 162.59 8.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.065 1.346 . . . . 0.0 112.347 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -158.63 134.93 9.25 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.514 1.126 . . . . 0.0 111.466 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 147.16 27.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.167 0.987 . . . . 0.0 110.791 171.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -131.87 144.58 50.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.127 1.771 . . . . 0.0 110.14 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.0 t -89.45 -68.19 0.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 112.238 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 6.9 t -92.74 -25.49 18.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.265 1.026 . . . . 0.0 112.533 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -29.34 55.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.933 1.693 . . . . 0.0 112.911 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -164.38 0.9 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.04 1.736 . . . . 0.0 111.644 -171.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -151.19 144.51 11.82 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.935 -1.103 . . . . 0.0 114.455 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.45 151.28 33.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.734 1.614 . . . . 0.0 110.633 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 12.4 t -142.43 104.54 4.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.507 1.123 . . . . 0.0 112.565 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.3 t -97.36 147.58 24.03 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.43 1.092 . . . . 0.0 112.418 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.13 136.28 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.862 1.665 . . . . 0.0 109.626 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -125.1 119.06 27.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.491 1.516 . . . . 0.0 111.829 -173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -128.07 102.51 6.76 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.329 1.452 . . . . 0.0 109.956 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.59 151.0 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.15 -0.969 . . . . 0.0 111.881 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.82 -178.24 3.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.301 1.44 . . . . 0.0 109.937 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.62 -44.77 95.96 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -129.89 -21.61 3.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.744 1.617 . . . . 0.0 113.894 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.8 mtt -100.64 173.33 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.995 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -147.6 148.07 30.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.037 1.335 . . . . 0.0 110.002 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' B' ' 214' ' ' ILE . 9.8 p -132.73 135.41 45.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.821 1.248 . . . . 0.0 111.014 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.85 111.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.97 1.308 . . . . 0.0 111.172 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.7 143.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.046 1.339 . . . . 0.0 111.161 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 66.8 p -139.02 110.66 7.09 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.16 139.94 30.15 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.519 1.128 . . . . 0.0 113.05 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -137.29 102.65 4.87 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.769 1.627 . . . . 0.0 110.204 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -95.12 61.13 1.59 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 113.507 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.02 109.47 0.26 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 0.0 113.528 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 126.509 1.924 . . . . 0.0 112.419 -171.3 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.3 0.095 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -128.85 169.9 14.03 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.965 1.306 . . . . 0.0 111.313 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.73 138.45 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.173 1.389 . . . . 0.0 110.944 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 66.7 m -109.59 86.0 2.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.874 1.669 . . . . 0.0 109.853 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.96 150.94 23.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.603 0.761 . . . . 0.0 111.133 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.3 p -149.94 105.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.364 1.866 . . . . 0.0 109.934 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.47 121.73 21.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.383 . . . . 0.0 110.687 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 125.236 1.415 . . . . 0.0 108.727 174.443 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 121.436 0.636 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.27 171.82 2.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.782 1.633 . . . . 0.0 113.434 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.09 147.06 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.446 1.098 . . . . 0.0 112.173 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.24 -40.48 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.087 1.355 . . . . 0.0 112.075 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.1 -33.4 69.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.623 1.569 . . . . 0.0 112.631 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -77.2 -52.23 9.6 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.905 1.282 . . . . 0.0 111.177 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 56' ' ' LEU . 16.1 t -48.51 -42.34 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.485 1.114 . . . . 0.0 112.222 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -56.98 -24.75 55.65 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.194 1.398 . . . . 0.0 113.603 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.97 -35.58 11.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.329 1.452 . . . . 0.0 113.292 172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.89 -43.1 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 119.615 1.098 . . . . 0.0 110.445 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.29 -43.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -52.58 45.95 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.864 1.211 . . . . 0.0 111.45 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -30.71 70.57 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.45 -43.84 31.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 48' ' ' VAL . 58.6 mt -55.78 -56.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.564 1.075 . . . . 0.0 109.88 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -59.61 -28.25 67.02 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -67.37 -35.47 79.42 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.12 -29.89 43.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.972 1.309 . . . . 0.0 113.147 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.69 -37.03 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.58 1.152 . . . . 0.0 111.458 172.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.81 11.45 84.61 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.103 0.858 . . . . 0.0 114.832 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.06 -0.97 35.46 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.575 1.56 . . . . 0.0 116.382 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.85 168.82 4.68 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.128 1.464 . . . . 0.0 112.931 167.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.61 -154.55 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.771 1.628 . . . . 0.0 111.901 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.1 160.03 0.39 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.337 1.455 . . . . 0.0 112.992 163.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -151.1 175.07 12.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.342 1.057 . . . . 0.0 113.295 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -97.37 -101.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.541 1.537 . . . . 0.0 110.02 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -67.99 -22.09 65.02 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -58.82 -43.75 90.72 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.97 -1.081 . . . . 0.0 112.99 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.63 -38.57 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.209 1.003 . . . . 0.0 112.782 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -63.13 -54.72 33.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.932 1.293 . . . . 0.0 111.696 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.75 -26.23 68.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.254 -0.904 . . . . 0.0 112.634 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -75.48 -53.89 7.92 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.112 0.965 . . . . 0.0 111.182 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -59.2 -22.23 60.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -86.55 -56.74 3.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.681 1.128 . . . . 0.0 112.457 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -58.22 -37.11 74.21 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.786 1.234 . . . . 0.0 113.676 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 27' ' ' ILE . 94.3 t -69.49 -64.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 123.897 0.879 . . . . 0.0 109.559 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.01 -31.68 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.866 1.266 . . . . 0.0 111.103 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -43.56 90.6 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.635 0.652 . . . . 0.0 112.602 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -96.81 -44.26 7.15 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.985 1.314 . . . . 0.0 112.391 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.2 m -55.82 -51.88 65.95 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.522 2.329 . . . . 0.0 112.871 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.23 -38.98 88.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.166 0.439 . . . . 0.0 110.94 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 p -64.43 -30.67 71.7 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.22 -0.925 . . . . 0.0 113.334 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.03 -48.61 20.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.194 2.198 . . . . 0.0 113.075 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.42 HD22 HG13 ' A' ' 19' ' ' VAL . 3.5 pp -64.63 -27.8 69.18 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.728 -1.232 . . . . 0.0 114.135 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.7 m -58.16 -34.73 70.63 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.444 1.098 . . . . 0.0 110.925 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -78.94 -36.31 41.9 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.773 -0.579 . . . . 0.0 112.262 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.75 -24.56 66.23 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -105.39 2.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 113.257 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -138.28 152.58 71.79 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.577 1.551 . . . . 0.0 112.12 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.88 111.31 3.0 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.611 2.874 . . . . 0.0 111.375 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.12 179.86 7.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.331 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -93.57 95.37 9.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.472 1.509 . . . . 0.0 111.678 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -83.71 151.6 25.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.887 1.675 . . . . 0.0 109.933 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.483 HG22 ' CD2' ' A' ' 111' ' ' PHE . 1.3 tp -125.67 149.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.709 1.604 . . . . 0.0 108.667 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.9 146.29 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.529 0.732 . . . . 0.0 111.285 164.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.86 117.71 13.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.397 2.279 . . . . 0.0 109.732 174.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.3 p -123.79 136.6 54.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.404 0.682 . . . . 0.0 112.448 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.56 109.3 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.347 1.459 . . . . 0.0 109.29 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 mm -103.15 111.13 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.68 105.4 3.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.895 1.278 . . . . 0.0 109.905 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.09 10.64 1.74 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -69.83 -77.66 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.922 1.289 . . . . 0.0 112.998 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.63 -20.8 5.86 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.85 7.24 5.19 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.641 -1.089 . . . . 0.0 115.708 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.9 93.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.509 1.924 . . . . 0.0 114.812 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.39 78.1 1.0 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.694 1.616 . . . . 0.0 113.429 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 pp -54.48 150.92 8.41 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.629 1.572 . . . . 0.0 112.475 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -123.06 83.31 2.11 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.487 1.515 . . . . 0.0 109.363 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.536 ' HB ' HG13 ' A' ' 135' ' ' VAL . 54.5 m -97.17 139.09 33.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.673 -0.642 . . . . 0.0 109.465 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.54 128.03 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 110.422 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -127.76 117.41 21.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.921 0.889 . . . . 0.0 109.622 -170.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -79.9 41.56 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.425 1.107 . . . . 0.0 111.177 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.76 179.6 7.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.98 1.312 . . . . 0.0 110.577 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -145.55 154.05 41.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.724 1.609 . . . . 0.0 109.621 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -97.45 132.48 43.11 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.006 0.922 . . . . 0.0 109.89 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -144.05 141.53 30.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.228 1.411 . . . . 0.0 110.435 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -114.17 -56.52 2.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.426 1.491 . . . . 0.0 111.718 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.96 -40.25 10.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.172 0.989 . . . . 0.0 112.097 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -32.39 73.18 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.644 2.378 . . . . 0.0 114.223 -169.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.22 -177.5 6.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.591 1.957 . . . . 0.0 110.85 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.09 116.93 3.86 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.969 1.747 . . . . 0.0 114.027 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 t -140.93 172.55 12.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.398 1.879 . . . . 0.0 110.505 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -168.14 140.34 2.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.543 1.537 . . . . 0.0 110.639 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -148.98 144.64 26.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.959 -1.713 . . . . 0.0 111.602 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -139.02 120.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.472 1.109 . . . . 0.0 109.489 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 93.83 4.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.297 1.039 . . . . 0.0 113.024 -171.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -99.43 105.73 17.7 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.96 1.304 . . . . 0.0 110.362 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -109.49 165.77 11.39 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.558 1.543 . . . . 0.0 110.71 169.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -139.13 179.78 6.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.67 1.188 . . . . 0.0 110.031 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -45.1 -40.28 6.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.921 1.688 . . . . 0.0 115.011 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.7 t -133.7 22.9 3.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.302 1.841 . . . . 0.0 113.083 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 mtt -135.79 158.76 43.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -148.99 116.56 6.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.114 1.765 . . . . 0.0 110.704 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.09 68.16 1.3 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.162 1.785 . . . . 0.0 111.481 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pp -97.18 153.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.635 -1.291 . . . . 0.0 113.175 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -132.84 116.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.805 2.042 . . . . 0.0 111.889 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.5 t -97.91 136.17 38.59 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.558 1.143 . . . . 0.0 110.084 171.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.3 166.59 22.78 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.901 1.68 . . . . 0.0 112.262 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.483 ' CD2' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -150.21 161.07 43.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.009 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.32 83.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.447 HD11 ' CE1' ' A' ' 111' ' ' PHE . 1.3 pp -137.92 158.24 44.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.938 1.695 . . . . 0.0 112.682 -169.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 125.05 1.34 . . . . 0.0 112.505 -175.239 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 111.628 0.232 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -129.31 166.94 18.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.357 1.463 . . . . 0.0 111.447 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.4 149.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.768 1.627 . . . . 0.0 111.324 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.2 m -121.61 91.29 3.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 110.861 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -77.5 148.06 35.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.886 166.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.536 HG13 ' HB ' ' A' ' 81' ' ' THR . 1.4 p -133.67 97.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 127.864 2.466 . . . . 0.0 109.089 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.93 151.92 48.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.283 1.033 . . . . 0.0 111.631 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 CA--C 1.546 0.798 0 C-N-CA 124.794 1.238 . . . . 0.0 111.457 -179.248 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 120.56 0.219 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.26 170.49 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.515 -0.741 . . . . 0.0 112.811 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.18 141.94 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.957 1.303 . . . . 0.0 112.006 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 159' ' ' VAL . . . . . 0.693 ' HA ' HG22 ' B' ' 162' ' ' VAL . 16.1 t -59.27 -34.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.561 1.144 . . . . 0.0 111.604 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -60.63 -15.38 27.82 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.167 1.387 . . . . 0.0 113.671 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -109.3 -47.56 3.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 110.13 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' B' ' 159' ' ' VAL . 4.3 m -51.31 -32.4 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t -60.75 -20.99 62.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.433 1.493 . . . . 0.0 114.267 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -103.45 -31.8 9.81 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.166 1.786 . . . . 0.0 112.971 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 41.0 mt -49.81 -41.15 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.413 1.006 . . . . 0.0 110.689 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.85 -43.43 97.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -51.99 48.27 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.724 1.147 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -31.46 71.03 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.53 -42.6 42.52 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.46 ' HA ' HG21 ' B' ' 191' ' ' VAL . 56.8 mt -55.77 -55.99 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.533 1.06 . . . . 0.0 109.886 174.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -59.15 -29.18 67.23 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 6.5 p -66.63 -34.37 77.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.1 -29.79 34.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.347 . . . . 0.0 113.199 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.25 -37.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 111.276 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.51 84.13 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.121 0.867 . . . . 0.0 114.817 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.13 35.45 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.471 1.51 . . . . 0.0 116.319 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -63.68 168.49 4.81 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.152 1.476 . . . . 0.0 112.958 167.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -85.16 -155.04 0.2 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.7 1.6 . . . . 0.0 111.718 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.14 159.39 0.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 0.0 113.06 164.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -151.15 172.06 16.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.351 1.46 . . . . 0.0 112.24 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -93.44 -100.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.4 1.08 . . . . 0.0 109.44 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 70.6 m -65.57 -22.22 66.67 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -59.64 -42.37 92.61 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.757 -1.214 . . . . 0.0 112.764 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.19 -38.08 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.292 1.037 . . . . 0.0 112.762 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -62.27 -55.68 25.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.452 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -63.62 -26.45 68.69 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.484 -0.76 . . . . 0.0 112.654 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -75.3 -54.21 7.46 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.172 0.989 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.5 t -58.02 -25.07 60.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 13.8 t -84.43 -56.81 3.43 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.668 1.122 . . . . 0.0 112.201 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -57.7 -37.01 72.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.893 1.224 . . . . 0.0 113.684 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' B' ' 170' ' ' ILE . 98.7 t -70.24 -65.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.165 0.986 . . . . 0.0 109.622 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.08 -31.99 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.668 1.187 . . . . 0.0 111.154 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -43.1 90.4 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.478 0.581 . . . . 0.0 112.566 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -96.5 -44.37 7.2 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.02 1.328 . . . . 0.0 112.511 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -59.43 -48.68 80.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.113 2.565 . . . . 0.0 113.495 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -40.62 97.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.959 0.345 . . . . 0.0 110.396 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 1.4 p -62.05 -30.87 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 112.996 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -76.2 -48.31 20.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.017 2.127 . . . . 0.0 112.918 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.37 -30.42 71.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.937 1.244 . . . . 0.0 113.463 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 31.0 m -58.34 -30.59 66.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.218 1.007 . . . . 0.0 111.05 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -81.47 -36.04 29.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.7 mt -78.36 -19.49 53.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -95.52 -101.7 1.87 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.709 1.623 . . . . 0.0 112.445 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -141.38 151.34 60.89 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 113.012 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.76 110.52 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.832 3.022 . . . . 0.0 111.446 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.88 178.85 8.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 0.0 112.152 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -88.05 93.47 9.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.308 1.443 . . . . 0.0 111.538 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.73 139.41 30.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.235 1.414 . . . . 0.0 109.952 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 3.0 tt -119.76 153.58 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.11 1.764 . . . . 0.0 109.644 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.451 HG12 ' CB ' ' B' ' 253' ' ' ALA . 22.1 m -142.02 146.63 22.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.36 1.064 . . . . 0.0 110.718 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.16 119.92 17.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.064 2.146 . . . . 0.0 109.1 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.3 p -123.03 144.35 49.34 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.543 -0.723 . . . . 0.0 112.215 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 64.9 t -124.31 101.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.038 1.735 . . . . 0.0 108.254 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.32 113.63 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.918 0.887 . . . . 0.0 108.837 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.8 ptp -134.98 146.51 49.15 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.848 0.859 . . . . 0.0 110.529 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -90.14 143.86 26.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.348 -0.845 . . . . 0.0 110.9 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -70.0 4.06 2.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.363 1.465 . . . . 0.0 114.347 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -50.45 -35.23 27.86 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.498 1.519 . . . . 0.0 112.416 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.69 20.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.902 1.239 . . . . 0.0 115.334 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.27 61.09 1.15 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.2 1.4 . . . . 0.0 113.849 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -74.91 63.72 2.37 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.647 1.594 . . . . 0.0 112.959 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.04 159.26 11.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.097 1.759 . . . . 0.0 111.826 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -125.97 89.32 3.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 110.178 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.722 ' HB ' HG13 ' B' ' 278' ' ' VAL . 53.3 m -97.09 139.04 33.68 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.438 177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.71 127.16 44.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.093 1.357 . . . . 0.0 110.122 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m -126.16 116.86 22.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.147 0.979 . . . . 0.0 109.605 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.9 t -80.04 44.61 0.67 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.504 1.145 . . . . 0.0 111.152 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 3.8 m -86.73 179.39 6.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.112 1.365 . . . . 0.0 110.507 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -147.03 148.13 31.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.45 1.5 . . . . 0.0 109.864 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -91.12 132.49 36.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -142.41 139.14 31.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 110.469 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 45.7 t -112.18 -58.64 2.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.465 1.506 . . . . 0.0 111.817 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.8 -38.68 12.22 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.172 0.989 . . . . 0.0 112.155 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -32.38 72.69 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.443 2.297 . . . . 0.0 114.088 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.77 -175.87 5.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.609 1.964 . . . . 0.0 110.803 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -113.62 123.59 6.19 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.563 1.554 . . . . 0.0 114.165 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 22.7 t -146.35 170.92 15.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.208 2.203 . . . . 0.0 110.575 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.2 p -168.78 126.07 1.01 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 0.0 111.896 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.7 t -141.47 141.84 33.64 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 119.597 -1.939 . . . . 0.0 112.575 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.61 123.46 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.652 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 99.02 6.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.308 1.043 . . . . 0.0 113.163 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.07 88.84 2.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.255 1.422 . . . . 0.0 110.884 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -83.48 163.69 20.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.829 0.852 . . . . 0.0 111.37 164.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -141.63 179.93 6.54 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -49.45 -41.23 39.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.451 1.5 . . . . 0.0 113.937 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 21.59 2.85 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 29.2 mtt -139.32 160.33 40.07 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.479 -1.388 . . . . 0.0 113.653 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -135.99 109.87 8.17 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.688 1.995 . . . . 0.0 110.956 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 70.9 m -130.6 78.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.355 1.462 . . . . 0.0 110.697 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.48 145.81 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.266 1.026 . . . . 0.0 112.339 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.55 129.58 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.199 1.8 . . . . 0.0 112.126 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.2 t -114.29 130.24 56.65 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.641 1.577 . . . . 0.0 109.606 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.451 ' CB ' HG12 ' B' ' 210' ' ' VAL . . . -128.42 151.98 48.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.037 1.735 . . . . 0.0 111.764 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -141.02 143.67 34.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.451 1.1 . . . . 0.0 110.94 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -168.47 82.15 0.1 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.257 0.932 . . . . 0.0 111.523 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.2 160.07 38.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.405 1.882 . . . . 0.0 112.121 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 124.852 1.261 . . . . 0.0 112.515 -175.723 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -129.62 166.68 19.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.347 1.459 . . . . 0.0 111.432 171.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.44 149.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 111.394 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 28.2 m -121.47 91.16 3.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.162 1.385 . . . . 0.0 110.876 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -78.36 149.33 33.42 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.904 -1.123 . . . . 0.0 110.862 166.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.722 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.8 p -138.7 97.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.742 2.417 . . . . 0.0 109.245 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -133.7 157.67 45.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.307 1.443 . . . . 0.0 110.87 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.308 1.043 . . . . 0.0 111.361 177.769 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 121.893 0.854 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 14.7 p90 -139.18 165.86 26.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.163 1.385 . . . . 0.0 110.117 173.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.62 152.31 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.278 1.031 . . . . 0.0 110.929 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -57.25 -41.17 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.727 1.211 . . . . 0.0 111.323 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.16 66.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -62.54 1.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.766 0.827 . . . . 0.0 110.263 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 56' ' ' LEU . 96.6 t -45.44 -47.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.436 1.894 . . . . 0.0 112.565 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 t -65.87 -13.63 59.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.163 1.785 . . . . 0.0 113.745 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -31.86 11.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.945 1.698 . . . . 0.0 112.255 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.37 -42.33 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.509 0.724 . . . . 0.0 110.272 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.42 -42.12 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -52.24 54.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.175 1.352 . . . . 0.0 111.174 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -30.99 72.03 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.75 -38.7 58.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.432 1.093 . . . . 0.0 113.203 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.454 ' HA ' HG21 ' A' ' 48' ' ' VAL . 49.4 mt -56.89 -56.99 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.166 0.894 . . . . 0.0 109.691 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -59.64 -27.89 66.75 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -47.74 78.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.092 0.957 . . . . 0.0 112.024 169.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.5 -27.16 63.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.775 1.23 . . . . 0.0 114.047 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.58 -35.41 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.564 1.146 . . . . 0.0 111.153 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.48 15.91 70.06 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.1 0.857 . . . . 0.0 114.299 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.9 2.44 78.29 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.087 1.327 . . . . 0.0 115.631 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -65.73 174.34 2.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.841 1.321 . . . . 0.0 112.243 168.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -155.01 0.21 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.119 1.368 . . . . 0.0 111.78 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -51.18 159.45 0.64 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.176 0.991 . . . . 0.0 112.28 158.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -151.6 177.39 10.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.38 1.472 . . . . 0.0 110.631 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -92.14 -114.22 0.09 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.32 1.048 . . . . 0.0 110.931 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -57.47 -22.41 43.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.383 1.873 . . . . 0.0 114.655 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -51.35 -38.97 55.97 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.376 1.471 . . . . 0.0 112.901 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.51 -32.42 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 112.915 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -68.24 -45.15 74.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.227 0.922 . . . . 0.0 112.168 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -22.86 65.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.75 0.704 . . . . 0.0 112.724 174.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.5 -55.1 5.29 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.716 0.806 . . . . 0.0 111.501 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -56.19 -28.99 60.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.916 0.78 . . . . 0.0 113.045 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -79.98 -57.57 3.58 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.338 0.972 . . . . 0.0 112.179 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -57.42 -38.21 73.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.94 1.245 . . . . 0.0 113.484 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 27' ' ' ILE . 84.3 t -66.75 -65.55 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 123.874 0.869 . . . . 0.0 109.491 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.8 t -47.9 -32.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.355 1.062 . . . . 0.0 110.939 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -58.42 -40.54 82.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.8 -40.99 5.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.479 1.512 . . . . 0.0 112.681 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 m -57.68 -53.37 58.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.702 2.401 . . . . 0.0 112.404 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -40.52 92.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.798 0.727 . . . . 0.0 110.693 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -60.9 -40.92 94.91 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.663 -0.648 . . . . 0.0 112.72 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -66.07 -51.29 59.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.924 2.089 . . . . 0.0 113.382 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.52 HD22 HG13 ' A' ' 19' ' ' VAL . 4.1 pp -66.02 -26.24 67.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -58.93 -32.72 69.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.13 0.972 . . . . 0.0 111.466 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -85.58 -23.99 27.38 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -67.79 -26.28 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.12 0.968 . . . . 0.0 112.3 170.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA3' ' CD2' ' A' ' 14' ' ' PHE . . . -98.74 -119.4 4.14 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.965 1.745 . . . . 0.0 112.535 171.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -129.73 156.29 79.08 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.445 1.498 . . . . 0.0 113.156 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.77 113.39 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.93 3.087 . . . . 0.0 112.212 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.11 166.12 31.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.517 1.127 . . . . 0.0 112.196 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -73.3 98.78 2.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.657 0.783 . . . . 0.0 110.956 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -73.34 158.02 35.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.828 0.851 . . . . 0.0 111.179 161.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 tt -132.44 151.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.337 1.455 . . . . 0.0 108.955 164.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 110' ' ' ALA . 18.0 m -142.0 149.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.859 1.263 . . . . 0.0 110.309 169.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 p -135.8 139.37 43.45 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.654 1.582 . . . . 0.0 109.903 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -136.1 150.32 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.648 -0.657 . . . . 0.0 112.056 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.87 104.64 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.888 1.675 . . . . 0.0 108.661 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.469 HD12 ' HB2' ' A' ' 106' ' ' CYS . 2.6 mm -101.2 120.63 51.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.811 1.644 . . . . 0.0 108.926 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.81 166.17 26.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.883 0.849 . . . . 0.0 112.211 174.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -85.96 157.07 20.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.734 1.614 . . . . 0.0 111.245 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.33 11.07 1.04 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.604 1.962 . . . . 0.0 114.954 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -5.48 5.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 114.942 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.81 -3.38 45.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.965 1.745 . . . . 0.0 114.711 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.47 87.53 0.88 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.233 1.413 . . . . 0.0 111.652 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.31 89.3 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.002 1.763 . . . . 0.0 111.031 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.585 ' H ' HD22 ' A' ' 79' ' ' LEU . 1.3 mm? -64.58 160.16 20.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.738 1.215 . . . . 0.0 111.658 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -87.94 96.85 10.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.444 -0.785 . . . . 0.0 109.99 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -117.14 132.16 56.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.783 0.833 . . . . 0.0 109.862 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.57 32.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.323 0.649 . . . . 0.0 111.74 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.9 m -134.09 121.35 21.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.723 1.209 . . . . 0.0 110.569 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -74.35 17.62 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.071 -1.018 . . . . 0.0 113.02 175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.4 m -62.8 167.94 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.833 -1.167 . . . . 0.0 112.22 167.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.18 154.79 21.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.667 1.587 . . . . 0.0 110.636 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -84.22 150.54 25.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.585 1.154 . . . . 0.0 110.241 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -146.93 164.62 32.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.589 1.956 . . . . 0.0 110.303 171.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -128.87 -56.28 1.2 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.498 1.119 . . . . 0.0 113.216 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -78.32 -46.98 18.75 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.389 1.076 . . . . 0.0 112.197 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -48.34 61.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.571 1.949 . . . . 0.0 112.525 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -149.29 -159.71 1.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.411 3.084 . . . . 0.0 108.79 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.56 -173.7 18.02 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.975 1.274 . . . . 0.0 112.923 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.6 p -155.27 173.45 16.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.359 2.263 . . . . 0.0 109.635 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 36.1 t -147.0 122.01 10.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.171 -0.956 . . . . 0.0 109.658 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 t -133.18 149.27 52.05 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.663 -1.273 . . . . 0.0 112.204 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.7 116.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.655 1.582 . . . . 0.0 108.266 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -113.77 95.21 5.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.905 1.282 . . . . 0.0 110.285 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -104.57 118.42 36.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.527 1.131 . . . . 0.0 110.208 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -104.42 162.93 12.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.818 1.647 . . . . 0.0 111.302 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -151.29 -177.41 6.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.209 1.004 . . . . 0.0 111.506 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.73 -67.57 0.2 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.827 2.451 . . . . 0.0 113.847 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.5 t -133.97 24.72 3.93 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.184 1.394 . . . . 0.0 113.306 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.54 162.83 34.12 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.163 -1.586 . . . . 0.0 111.218 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -140.02 137.22 34.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.73 1.212 . . . . 0.0 110.34 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.469 ' HB2' HD12 ' A' ' 71' ' ' ILE . 11.2 p -139.97 85.88 2.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.874 1.321 . . . . 0.0 111.845 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.09 133.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.024 1.329 . . . . 0.0 111.104 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.81 126.44 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.605 1.562 . . . . 0.0 110.867 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 t -117.13 127.9 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.481 1.912 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.465 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -121.73 149.12 43.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.061 1.744 . . . . 0.0 112.582 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -142.2 94.0 2.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.358 1.463 . . . . 0.0 108.663 174.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 113' ' ' LEU . . . -150.01 95.06 0.16 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 120.571 -1.331 . . . . 0.0 110.743 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.428 HD13 ' C ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -148.68 75.27 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.468 1.907 . . . . 0.0 112.142 -174.256 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.47 0.571 0 O-C-N 121.466 -0.771 . . . . 0.0 112.075 -178.472 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.41 148.9 49.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.054 1.741 . . . . 0.0 112.308 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -60.21 150.71 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.47 1.908 . . . . 0.0 111.471 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 m -115.95 89.59 3.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.229 1.412 . . . . 0.0 110.886 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -98.57 146.45 25.8 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.022 -1.049 . . . . 0.0 111.139 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.52 94.08 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 128.032 2.533 . . . . 0.0 108.006 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.17 162.54 35.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.935 1.294 . . . . 0.0 111.559 176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 124.968 1.307 . . . . 0.0 108.392 174.978 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 121.987 0.899 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 157' ' ' PHE . . . . . 0.436 ' CD2' ' HA3' ' B' ' 203' ' ' GLY . 13.6 p90 -139.76 166.62 24.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.286 1.435 . . . . 0.0 110.028 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.68 152.45 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.263 1.025 . . . . 0.0 110.992 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.15 -41.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.79 1.236 . . . . 0.0 111.347 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 113.564 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.65 -62.68 1.5 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.788 0.835 . . . . 0.0 110.172 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.501 HG13 HD22 ' B' ' 199' ' ' LEU . 96.1 t -45.15 -47.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 126.462 1.905 . . . . 0.0 112.607 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t -65.7 -13.8 59.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.111 1.764 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.16 -31.94 11.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.98 1.712 . . . . 0.0 112.203 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 8.6 mt -55.64 -42.18 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.449 0.7 . . . . 0.0 110.26 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.54 -41.71 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.35 53.36 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.145 1.339 . . . . 0.0 111.172 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -30.86 71.91 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.82 -38.88 57.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.421 1.088 . . . . 0.0 113.177 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' B' ' 191' ' ' VAL . 49.8 mt -56.78 -56.97 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.222 0.919 . . . . 0.0 109.663 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.57 -27.97 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -47.67 78.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.157 0.983 . . . . 0.0 111.968 170.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.57 -27.41 64.11 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 114.086 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 58.5 mt -61.5 -35.33 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.609 1.164 . . . . 0.0 111.141 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 82.91 16.18 70.75 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.136 0.874 . . . . 0.0 114.259 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.74 2.32 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.128 1.347 . . . . 0.0 115.58 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -65.16 170.99 4.01 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 118.766 1.283 . . . . 0.0 112.33 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.0 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.26 1.424 . . . . 0.0 112.293 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -53.06 154.18 3.12 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.453 -0.78 . . . . 0.0 111.632 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -145.17 171.02 15.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.142 1.377 . . . . 0.0 110.737 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -84.77 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.213 1.005 . . . . 0.0 110.755 175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 15.6 m -59.73 -20.5 56.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.499 1.52 . . . . 0.0 114.727 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.73 -38.42 55.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.501 1.52 . . . . 0.0 112.888 175.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -55.91 -30.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.73 -45.25 71.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.855 0.862 . . . . 0.0 111.693 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -24.08 65.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -78.19 -54.41 6.26 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.734 0.814 . . . . 0.0 111.54 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.9 t -57.02 -27.53 61.69 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.1 t -81.32 -58.22 3.14 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.434 1.015 . . . . 0.0 112.429 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -56.48 -38.21 71.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.988 1.267 . . . . 0.0 113.584 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.7 t -66.68 -65.72 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 123.822 0.849 . . . . 0.0 109.489 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.9 t -47.74 -32.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 110.968 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -58.55 -40.52 83.25 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -104.92 -40.95 5.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.494 1.518 . . . . 0.0 112.616 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 39.3 m -57.47 -53.67 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.705 2.402 . . . . 0.0 112.438 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -40.9 93.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.749 0.704 . . . . 0.0 110.568 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -60.66 -39.6 88.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -67.42 -51.21 54.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.894 2.078 . . . . 0.0 113.396 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.501 HD22 HG13 ' B' ' 162' ' ' VAL . 3.9 pp -66.27 -26.06 67.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -175.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.4 m -58.68 -32.54 69.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.094 0.958 . . . . 0.0 111.522 165.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -86.21 -23.89 26.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.78 -26.73 66.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.987 0.915 . . . . 0.0 112.194 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 203' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' B' ' 157' ' ' PHE . . . -97.56 -121.49 4.25 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.098 1.809 . . . . 0.0 112.562 171.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -128.0 156.34 76.34 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 125.448 1.499 . . . . 0.0 113.172 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.29 112.5 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.005 3.137 . . . . 0.0 112.21 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.15 166.0 32.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.564 1.146 . . . . 0.0 112.314 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -72.6 100.47 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.714 0.806 . . . . 0.0 110.998 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -75.31 157.26 34.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 111.053 160.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 tt -132.26 151.42 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.576 1.55 . . . . 0.0 108.95 164.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' B' ' 253' ' ' ALA . 19.3 m -142.74 149.75 18.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.882 1.273 . . . . 0.0 110.344 170.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 6.7 p -136.89 140.97 42.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.532 1.533 . . . . 0.0 110.145 170.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.8 p -138.48 155.34 48.53 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.617 -0.677 . . . . 0.0 112.176 169.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.96 114.66 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.76 1.624 . . . . 0.0 108.493 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.7 mm -106.93 116.56 50.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 125.863 1.665 . . . . 0.0 108.727 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 215' ' ' MET . . . . . 0.417 ' HG2' HD12 ' A' ' 79' ' ' LEU . 1.1 tmt? -134.86 119.57 18.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.401 1.48 . . . . 0.0 110.64 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 81.71 0.88 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.278 1.831 . . . . 0.0 111.0 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.11 -74.38 0.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.073 1.349 . . . . 0.0 110.968 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -19.55 2.12 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.94 -2.48 6.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.058 1.79 . . . . 0.0 115.98 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.99 101.17 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.527 1.531 . . . . 0.0 114.173 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.06 102.18 1.54 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.574 1.083 . . . . 0.0 112.218 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.515 HD23 HD23 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -44.17 151.81 0.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.363 1.465 . . . . 0.0 113.297 166.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.35 93.27 9.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.334 -0.853 . . . . 0.0 109.462 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.496 ' HB ' HG13 ' B' ' 278' ' ' VAL . 50.3 m -116.01 132.79 56.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.243 0.617 . . . . 0.0 110.428 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.56 129.11 38.6 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.218 0.607 . . . . 0.0 111.321 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -131.56 120.57 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.779 1.232 . . . . 0.0 110.211 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 5.0 t -74.02 16.58 0.22 Allowed 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.194 -0.942 . . . . 0.0 113.045 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.6 m -62.44 167.49 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.88 -1.138 . . . . 0.0 112.26 167.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.22 154.27 21.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.739 1.616 . . . . 0.0 110.523 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -81.38 151.42 27.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.251 1.021 . . . . 0.0 110.122 168.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -145.93 163.2 35.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.619 1.968 . . . . 0.0 109.979 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 14.6 t -126.07 -58.82 1.36 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.447 1.099 . . . . 0.0 112.864 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 17.3 p -79.0 -46.59 17.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.384 1.073 . . . . 0.0 112.333 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -48.41 66.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.434 1.893 . . . . 0.0 112.324 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -150.35 -159.13 0.99 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 129.327 3.051 . . . . 0.0 108.718 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.62 -174.03 18.38 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.951 1.263 . . . . 0.0 113.286 169.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 94.9 p -155.1 173.69 16.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.392 2.277 . . . . 0.0 109.634 170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.18 123.73 11.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 166.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 12.8 t -134.01 149.16 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.528 -1.358 . . . . 0.0 112.118 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.65 114.25 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.453 1.501 . . . . 0.0 108.066 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -111.34 96.97 6.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.9 1.28 . . . . 0.0 109.851 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -107.87 124.78 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 109.931 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 168.78 9.85 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 110.643 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -148.11 -158.04 0.87 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.992 0.917 . . . . 0.0 110.807 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.73 -65.97 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.267 2.227 . . . . 0.0 113.649 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 t -139.39 1.62 1.98 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.9 ptp -98.17 154.37 17.81 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.598 -1.314 . . . . 0.0 112.279 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.9 120.01 25.42 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.867 1.667 . . . . 0.0 108.979 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.496 ' HB2' HD12 ' B' ' 214' ' ' ILE . 20.3 p -126.98 79.01 1.85 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.801 1.286 . . . . 0.0 111.139 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.09 136.13 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.005 1.322 . . . . 0.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.05 126.55 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.547 1.539 . . . . 0.0 110.944 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 32.0 t -113.82 132.15 55.98 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.44 1.896 . . . . 0.0 110.407 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -125.38 149.2 48.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.089 1.756 . . . . 0.0 112.555 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -142.67 98.18 3.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.607 1.563 . . . . 0.0 108.346 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 255' ' ' GLY . . . . . 0.45 ' N ' HD13 ' B' ' 256' ' ' LEU . . . -155.24 94.15 0.14 Allowed Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.655 -1.278 . . . . 0.0 110.64 172.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.45 HD13 ' N ' ' B' ' 255' ' ' GLY . 0.0 OUTLIER -148.37 76.66 1.37 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.504 1.921 . . . . 0.0 112.256 -173.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.471 0.584 0 O-C-N 121.519 -0.738 . . . . 0.0 112.115 -177.981 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.28 148.76 49.64 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.987 1.715 . . . . 0.0 112.276 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.91 150.58 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.585 1.954 . . . . 0.0 111.438 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.8 m -116.6 88.55 2.92 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.256 1.422 . . . . 0.0 110.787 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -99.1 147.63 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.3 p -138.26 98.16 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 127.3 2.24 . . . . 0.0 108.794 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.84 159.52 42.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.587 1.555 . . . . 0.0 111.612 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 124.649 1.18 . . . . 0.0 108.527 171.415 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 CA-C-O 121.661 0.743 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.17 171.49 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.76 1.624 . . . . 0.0 111.425 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.75 161.05 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.544 1.137 . . . . 0.0 111.274 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.39 -44.66 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.591 1.556 . . . . 0.0 111.872 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.61 -25.85 66.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 113.194 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.81 -57.89 3.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.84 0.856 . . . . 0.0 110.85 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.28 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.181 1.392 . . . . 0.0 112.768 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -63.16 -8.29 7.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.617 1.567 . . . . 0.0 114.293 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -109.92 -36.8 5.79 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.877 1.671 . . . . 0.0 112.453 169.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.6 mt -49.34 -44.46 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.086 0.857 . . . . 0.0 110.591 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 97' ' ' VAL . 6.6 p -59.41 -41.46 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.522 -0.736 . . . . 0.0 112.956 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -51.06 52.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.286 0.948 . . . . 0.0 111.01 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.13 72.2 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.9 -47.68 36.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.035 0.934 . . . . 0.0 112.179 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.404 HG13 HG11 ' A' ' 48' ' ' VAL . 65.2 mt -59.53 -58.43 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.183 0.901 . . . . 0.0 110.366 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.16 -27.87 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -65.15 -50.61 65.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.699 0.799 . . . . 0.0 111.795 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.84 -30.81 71.09 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 113.883 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -62.89 -31.6 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.81 1.644 . . . . 0.0 112.578 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.76 7.71 0.43 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 119.052 2.381 . . . . 0.0 119.052 -161.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.37 95.67 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 120.237 2.019 . . . . 0.0 114.731 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -146.85 -173.3 4.19 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.426 1.613 . . . . 0.0 114.098 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.62 -178.1 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.481 1.912 . . . . 0.0 112.537 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -48.94 154.63 0.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -134.84 171.56 14.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.914 1.286 . . . . 0.0 112.349 -170.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -91.49 -113.75 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.111 1.365 . . . . 0.0 110.865 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.7 p -74.57 4.62 5.82 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.179 1.792 . . . . 0.0 115.318 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -47.95 -33.44 7.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.321 1.848 . . . . 0.0 114.559 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 p -48.63 -32.17 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.544 1.137 . . . . 0.0 113.55 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.18 -52.02 57.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.155 1.382 . . . . 0.0 112.284 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.18 -26.33 67.36 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.106 -0.996 . . . . 0.0 112.775 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.81 -53.62 7.68 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.269 1.028 . . . . 0.0 111.557 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.54 -24.24 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.566 0.746 . . . . 0.0 112.72 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -80.67 -63.66 1.36 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.102 0.865 . . . . 0.0 112.197 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -55.15 -41.46 71.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.29 1.436 . . . . 0.0 114.289 -171.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.404 HG11 HG13 ' A' ' 27' ' ' ILE . 85.2 t -66.69 -62.55 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 124.219 1.008 . . . . 0.0 110.248 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.6 t -49.04 -31.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.991 1.317 . . . . 0.0 110.766 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -62.61 -31.19 71.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -108.68 -41.48 4.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.225 1.41 . . . . 0.0 112.165 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.9 m -59.15 -51.47 69.86 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.932 2.493 . . . . 0.0 112.583 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -38.41 91.07 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.287 0.565 . . . . 0.0 111.336 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -61.88 -46.0 91.32 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -60.0 -49.14 78.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.709 2.004 . . . . 0.0 112.809 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.75 -24.8 63.58 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.571 -1.331 . . . . 0.0 114.399 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.0 m -60.36 -28.16 67.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.928 0.491 . . . . 0.0 111.024 165.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -87.19 -29.35 21.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.951 0.901 . . . . 0.0 112.695 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.92 -20.82 62.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.626 1.17 . . . . 0.0 112.385 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.61 -110.56 3.51 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.434 1.969 . . . . 0.0 112.81 172.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -137.78 148.67 61.77 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.379 1.872 . . . . 0.0 111.13 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.34 120.32 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.048 3.165 . . . . 0.0 112.439 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.79 166.77 32.43 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 112.392 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.09 92.61 0.75 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.663 1.185 . . . . 0.0 110.36 166.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -68.6 162.63 25.46 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.664 0.745 . . . . 0.0 110.797 157.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.541 HD11 ' SG ' ' B' ' 228' ' ' CYS . 7.3 tt -141.84 153.62 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.742 1.617 . . . . 0.0 109.045 166.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 110' ' ' ALA . 21.7 m -144.67 152.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.956 1.302 . . . . 0.0 110.566 173.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -144.34 158.64 43.63 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.421 1.089 . . . . 0.0 110.256 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.2 p -151.62 152.72 33.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.078 1.351 . . . . 0.0 111.88 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -133.61 123.49 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.917 1.287 . . . . 0.0 109.317 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mm -111.16 108.36 25.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 127.431 2.293 . . . . 0.0 109.121 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -135.91 153.47 51.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.438 2.295 . . . . 0.0 110.733 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -143.98 147.81 34.43 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 112.495 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -80.04 -14.38 58.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.62 -7.75 55.87 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.12 25.51 0.02 OUTLIER Glycine 0 N--CA 1.477 1.375 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.644 ' HB1' HD11 ' B' ' 222' ' ' LEU . . . -139.25 126.77 21.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.893 1.277 . . . . 0.0 112.472 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.25 101.4 0.16 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.927 0.775 . . . . 0.0 114.111 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.721 HD13 HD13 ' B' ' 222' ' ' LEU . 8.8 mp -113.99 -174.56 2.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.688 2.395 . . . . 0.0 110.358 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.15 130.64 55.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.382 0.673 . . . . 0.0 110.317 170.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.2 m -137.78 142.85 40.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.284 1.433 . . . . 0.0 109.749 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.72 138.29 39.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.675 1.19 . . . . 0.0 110.551 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.2 p -141.43 120.05 12.5 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.583 1.153 . . . . 0.0 110.993 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.8 m -75.91 13.2 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.839 -1.163 . . . . 0.0 113.406 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.673 ' SG ' HD11 ' B' ' 209' ' ' ILE . 8.2 m -60.43 164.49 4.36 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.899 167.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.95 158.21 30.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.445 1.898 . . . . 0.0 110.053 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -80.72 139.42 36.13 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.247 0.546 . . . . 0.0 109.651 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -154.35 162.66 41.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.164 1.786 . . . . 0.0 111.178 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.6 t -132.98 -59.32 0.89 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.232 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 -39.09 51.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.369 1.068 . . . . 0.0 111.513 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -53.68 53.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.78 1.632 . . . . 0.0 111.641 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -150.09 -69.76 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.982 1.313 . . . . 0.0 112.404 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.29 151.95 6.36 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 127.238 2.352 . . . . 0.0 113.38 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 p -165.35 141.48 5.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.689 1.995 . . . . 0.0 110.557 173.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.72 63.85 1.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.869 1.268 . . . . 0.0 112.35 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -76.41 150.59 36.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.338 1.855 . . . . 0.0 113.591 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 23' ' ' VAL . 1.7 t -142.12 135.21 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.463 1.505 . . . . 0.0 110.457 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -115.19 120.15 38.77 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.48 1.112 . . . . 0.0 112.012 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -133.2 98.54 4.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.695 1.598 . . . . 0.0 110.261 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 173.48 8.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.79 1.236 . . . . 0.0 111.949 166.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -143.43 -176.39 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.764 1.626 . . . . 0.0 111.203 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -51.56 -43.31 62.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.172 1.389 . . . . 0.0 114.246 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 t -137.71 8.52 2.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.271 1.428 . . . . 0.0 114.101 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.14 165.38 16.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.184 1.393 . . . . 0.0 112.819 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -145.28 118.76 9.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.161 1.784 . . . . 0.0 109.941 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.9 p -143.62 74.44 1.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 111.938 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.0 pt -74.71 158.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.457 -0.777 . . . . 0.0 111.421 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.07 141.15 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.486 1.914 . . . . 0.0 109.949 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -135.38 125.18 25.51 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.257 -0.902 . . . . 0.0 111.54 -174.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -121.62 144.17 48.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.299 1.44 . . . . 0.0 112.823 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -146.18 -176.67 5.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 126.607 1.963 . . . . 0.0 110.125 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.53 84.41 1.11 Allowed Glycine 0 CA--C 1.539 1.552 0 O-C-N 120.87 -1.144 . . . . 0.0 112.892 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 46.22 1.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.174 2.19 . . . . 0.0 113.031 -167.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 122.193 0.997 . . . . 0.0 112.268 -170.669 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -136.23 169.44 17.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.85 2.06 . . . . 0.0 111.443 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 mm -63.71 146.02 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 110.588 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.6 m -106.07 111.74 24.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.279 1.432 . . . . 0.0 110.067 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.99 145.37 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.782 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.86 104.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -139.63 150.36 44.86 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.737 0.815 . . . . 0.0 112.465 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.548 0.901 0 C-N-CA 125.574 1.55 . . . . 0.0 111.557 -175.367 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 121.239 0.542 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.59 162.63 27.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.402 1.081 . . . . 0.0 110.721 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 p -138.61 158.96 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.736 1.215 . . . . 0.0 111.166 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.83 -38.55 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.74 2.416 . . . . 0.0 112.67 -174.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.86 -28.34 68.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 113.072 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.49 -47.8 7.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.47 0.708 . . . . 0.0 110.708 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 70.2 t -48.58 -42.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.338 1.455 . . . . 0.0 112.187 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t -64.25 -8.23 11.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.622 1.569 . . . . 0.0 114.874 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.54 -35.09 6.84 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.308 1.843 . . . . 0.0 112.446 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.9 mt -49.79 -42.13 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.143 0.977 . . . . 0.0 110.583 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.29 -43.57 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.52 63.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.455 1.025 . . . . 0.0 111.053 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -33.73 76.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.57 63.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.647 0.779 . . . . 0.0 112.206 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.4 HG13 HG11 ' B' ' 191' ' ' VAL . 66.5 mt -59.5 -59.18 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.109 0.868 . . . . 0.0 109.986 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -61.86 -29.48 70.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 32.9 t -63.6 -51.93 63.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.983 0.913 . . . . 0.0 111.912 167.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.29 -30.71 71.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.071 1.348 . . . . 0.0 113.989 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.78 -34.81 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.249 1.419 . . . . 0.0 111.005 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.33 80.81 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.897 1.237 . . . . 0.0 114.916 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.48 68.82 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.104 1.335 . . . . 0.0 115.487 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -70.57 -176.14 1.2 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.811 1.306 . . . . 0.0 112.301 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.89 154.25 5.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.721 -1.237 . . . . 0.0 111.424 170.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -48.92 150.0 1.66 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.021 1.328 . . . . 0.0 113.1 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -127.85 166.64 17.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.577 1.151 . . . . 0.0 111.483 -173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -89.0 -113.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.519 1.128 . . . . 0.0 110.553 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 61.0 p -74.37 5.91 4.16 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -48.59 -33.97 10.72 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.085 1.754 . . . . 0.0 114.475 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 65.6 t -50.11 -33.02 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.567 1.147 . . . . 0.0 112.665 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.94 -52.99 57.23 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.309 1.443 . . . . 0.0 112.367 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.79 -26.3 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.045 -1.035 . . . . 0.0 112.742 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.96 -53.19 8.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.264 1.026 . . . . 0.0 111.519 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.59 -24.38 63.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.385 0.674 . . . . 0.0 112.79 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.6 t -80.51 -64.01 1.28 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.121 0.873 . . . . 0.0 112.138 165.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -55.25 -39.74 70.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.312 1.445 . . . . 0.0 114.345 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.4 HG11 HG13 ' B' ' 170' ' ' ILE . 88.8 t -68.21 -62.37 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 C-N-CA 124.139 0.976 . . . . 0.0 110.208 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.18 -31.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.922 1.289 . . . . 0.0 110.721 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -62.03 -31.78 72.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.932 0.893 . . . . 0.0 113.376 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -108.22 -41.61 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.162 1.385 . . . . 0.0 112.163 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 46.2 m -59.71 -51.36 70.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.074 2.55 . . . . 0.0 112.617 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -38.32 90.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 111.262 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.5 t -61.32 -46.64 89.44 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.624 -0.673 . . . . 0.0 111.626 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.69 -50.5 73.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.789 2.035 . . . . 0.0 112.941 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.99 -27.65 67.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.081 1.309 . . . . 0.0 114.027 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 93.7 m -59.57 -29.09 67.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.116 0.566 . . . . 0.0 111.283 167.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.72 -28.83 22.84 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 89.8 mt -78.92 -19.4 51.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.181 0.992 . . . . 0.0 111.895 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -102.19 -104.25 2.79 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.429 1.966 . . . . 0.0 112.087 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -141.43 145.81 39.49 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.084 1.754 . . . . 0.0 111.505 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 122.23 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.053 3.168 . . . . 0.0 112.522 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -158.51 167.58 29.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.25 1.42 . . . . 0.0 112.106 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.15 92.13 0.54 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.651 1.18 . . . . 0.0 110.305 166.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -68.06 161.85 25.85 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.603 0.716 . . . . 0.0 110.582 157.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 209' ' ' ILE . . . . . 0.673 HD11 ' SG ' ' A' ' 85' ' ' CYS . 7.1 tt -141.16 153.54 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.774 1.629 . . . . 0.0 108.94 166.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' B' ' 253' ' ' ALA . 25.7 m -144.15 151.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.808 1.243 . . . . 0.0 110.44 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.2 t -142.67 157.46 44.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.473 1.109 . . . . 0.0 110.06 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 46.4 t -152.85 147.8 26.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.39 1.476 . . . . 0.0 111.313 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.37 127.57 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.4 mm -113.34 111.17 34.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 127.429 2.292 . . . . 0.0 109.462 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -135.76 153.65 51.48 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.652 2.381 . . . . 0.0 110.945 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -144.32 144.15 31.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.378 1.471 . . . . 0.0 112.636 -172.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -75.97 -15.64 60.13 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -75.8 -7.88 55.52 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.48 23.75 0.02 OUTLIER Glycine 0 CA--C 1.536 1.363 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -138.61 123.33 18.67 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.745 1.272 . . . . 0.0 112.591 -168.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.63 103.06 0.19 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.048 0.832 . . . . 0.0 114.292 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.721 HD13 HD13 ' A' ' 79' ' ' LEU . 8.5 mp -114.64 -174.31 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.895 2.478 . . . . 0.0 110.444 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.56 129.96 55.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.58 0.752 . . . . 0.0 110.587 170.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.578 ' HB ' HG13 ' B' ' 278' ' ' VAL . 22.9 m -135.66 145.36 46.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.102 1.361 . . . . 0.0 109.964 172.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.55 41.74 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 110.997 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.8 p -142.88 122.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.462 1.105 . . . . 0.0 110.755 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.7 m -77.03 13.25 1.12 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.946 -1.096 . . . . 0.0 113.168 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' CYS . . . . . 0.541 ' SG ' HD11 ' A' ' 66' ' ' ILE . 5.2 m -59.83 164.52 3.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.836 167.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.44 159.57 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.832 . . . . 0.0 110.247 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -80.42 135.72 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.222 0.535 . . . . 0.0 109.567 169.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -152.11 162.84 40.49 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.753 1.621 . . . . 0.0 111.47 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 32.1 t -137.1 -58.98 0.71 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.872 1.269 . . . . 0.0 112.173 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -74.48 -40.78 61.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.102 0.961 . . . . 0.0 111.368 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -54.26 46.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.947 1.699 . . . . 0.0 111.621 -174.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.14 -70.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.876 1.27 . . . . 0.0 112.703 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 137.11 152.69 6.22 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 127.509 2.48 . . . . 0.0 113.484 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 44.9 p -171.49 127.29 0.65 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.558 1.543 . . . . 0.0 112.459 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.56 65.04 0.67 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.972 1.709 . . . . 0.0 112.431 -171.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.9 t -76.94 146.75 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.16 1.384 . . . . 0.0 113.637 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.32 114.94 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.694 1.198 . . . . 0.0 110.906 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -94.14 119.02 32.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.72 1.208 . . . . 0.0 111.859 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -130.08 106.81 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.437 1.495 . . . . 0.0 110.323 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 169.91 9.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.365 1.466 . . . . 0.0 111.667 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -140.83 -177.33 5.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.637 1.575 . . . . 0.0 110.968 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -51.75 -42.25 62.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.888 1.275 . . . . 0.0 114.406 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 7.6 t -138.1 8.21 2.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.252 1.421 . . . . 0.0 114.324 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.35 159.4 27.55 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.45 119.04 15.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.647 1.979 . . . . 0.0 110.33 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.68 73.88 1.43 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.887 1.275 . . . . 0.0 112.031 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.32 125.57 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.37 1.468 . . . . 0.0 111.765 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.22 147.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.412 1.485 . . . . 0.0 110.614 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -139.75 129.76 24.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.93 0.892 . . . . 0.0 111.981 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -123.6 145.2 49.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.367 1.467 . . . . 0.0 113.05 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -147.5 -176.5 5.27 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.709 2.004 . . . . 0.0 109.972 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 86.47 84.89 1.09 Allowed Glycine 0 CA--C 1.538 1.523 0 O-C-N 120.794 -1.191 . . . . 0.0 112.922 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.93 1.03 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.066 2.146 . . . . 0.0 113.038 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 122.096 0.951 . . . . 0.0 112.111 -171.104 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 111.46 0.171 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -136.24 169.61 17.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.807 2.043 . . . . 0.0 111.418 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.79 146.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.084 1.354 . . . . 0.0 110.607 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 85.1 m -107.79 103.7 13.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.455 1.502 . . . . 0.0 110.26 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -104.45 147.41 27.6 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.876 -1.14 . . . . 0.0 110.74 171.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.4 p -145.15 107.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.736 2.014 . . . . 0.0 109.916 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -139.0 151.68 47.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.728 0.811 . . . . 0.0 112.564 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 CA--C 1.547 0.865 0 C-N-CA 125.559 1.544 . . . . 0.0 111.499 -176.3 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -123.39 164.76 18.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.433 1.493 . . . . 0.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.66 161.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 110.939 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.33 -36.92 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.767 1.627 . . . . 0.0 112.047 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.83 -26.14 67.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.64 1.176 . . . . 0.0 112.274 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.96 -58.96 2.75 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.297 0.639 . . . . 0.0 110.099 171.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 56' ' ' LEU . 96.7 t -47.59 -43.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.763 1.625 . . . . 0.0 113.325 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 t -59.3 -21.39 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.605 1.562 . . . . 0.0 113.574 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -99.63 -34.23 10.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.384 1.474 . . . . 0.0 113.114 172.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 mt -51.42 -42.96 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.251 1.02 . . . . 0.0 110.633 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.55 -44.1 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 121.408 -0.807 . . . . 0.0 113.102 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -51.36 65.43 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.945 1.248 . . . . 0.0 111.697 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -35.44 79.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.15 64.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.4 ' HA ' HG21 ' A' ' 48' ' ' VAL . 61.4 mt -60.28 -56.58 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.155 0.889 . . . . 0.0 109.001 173.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.25 -32.31 73.68 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.7 p -69.81 -36.99 76.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.18 -0.95 . . . . 0.0 112.699 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -28.04 62.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.669 1.188 . . . . 0.0 113.899 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.59 -34.22 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.975 1.31 . . . . 0.0 110.809 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.19 81.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.797 1.189 . . . . 0.0 114.729 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.98 17.69 65.77 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.287 1.422 . . . . 0.0 115.543 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.28 -173.29 1.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.696 1.248 . . . . 0.0 111.733 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 115.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 111.297 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -64.77 126.08 26.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.384 1.074 . . . . 0.0 111.394 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -127.41 127.67 44.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.253 1.021 . . . . 0.0 112.583 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -64.15 -42.49 96.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.265 1.026 . . . . 0.0 112.954 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 t -62.64 -28.78 70.15 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.994 -1.066 . . . . 0.0 112.712 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -72.8 -26.56 61.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.58 -34.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.078 1.308 . . . . 0.0 112.401 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.3 -49.2 72.72 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.953 1.301 . . . . 0.0 112.593 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.88 -25.89 66.61 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.152 -0.967 . . . . 0.0 112.909 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -78.08 -53.07 7.8 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.717 0.807 . . . . 0.0 111.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.61 -22.81 62.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -82.83 -60.22 2.24 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.508 1.049 . . . . 0.0 112.189 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -57.66 -38.98 76.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.113 1.324 . . . . 0.0 114.32 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 27' ' ' ILE . 88.2 t -68.52 -64.53 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 C-N-CA 124.644 1.177 . . . . 0.0 109.895 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.6 t -47.53 -30.99 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 110.863 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.61 -38.5 72.14 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.136 0.975 . . . . 0.0 113.314 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -112.21 -34.6 5.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.998 1.719 . . . . 0.0 112.648 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -62.21 -52.67 62.83 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.031 2.132 . . . . 0.0 112.572 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -33.85 75.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.371 0.532 . . . . 0.0 111.123 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 m -60.69 -54.76 41.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.548 0.739 . . . . 0.0 111.853 166.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -53.47 -50.82 64.52 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.435 1.894 . . . . 0.0 112.751 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.471 HD22 HG13 ' A' ' 19' ' ' VAL . 3.6 pp -68.95 -27.19 65.51 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.2 m -59.65 -43.4 93.93 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -71.44 -23.11 61.79 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.0 5.77 3.97 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.215 1.406 . . . . 0.0 113.386 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.11 -97.86 0.14 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.594 1.088 . . . . 0.0 114.981 164.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -66.87 170.66 5.67 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 125.163 1.385 . . . . 0.0 114.598 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.12 168.27 14.39 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.166 1.911 . . . . 0.0 112.131 166.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -56.8 113.82 1.82 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.571 1.548 . . . . 0.0 112.651 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.33 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.377 3.071 . . . . 0.0 110.273 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.93 172.28 13.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.833 2.453 . . . . 0.0 108.915 169.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 tt -134.74 153.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.519 1.527 . . . . 0.0 108.403 162.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.08 141.61 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.858 0.863 . . . . 0.0 110.255 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.06 141.55 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.511 1.525 . . . . 0.0 108.932 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 146.93 41.27 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.496 -0.752 . . . . 0.0 112.964 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.24 125.38 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.465 1.506 . . . . 0.0 109.144 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mm -124.63 104.68 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.026 2.13 . . . . 0.0 108.076 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.57 166.96 20.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 112.286 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.09 109.49 12.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.639 1.175 . . . . 0.0 111.861 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -61.38 -20.09 62.63 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.89 -16.69 61.1 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.28 18.09 0.02 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.895 1.918 . . . . 0.0 117.895 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.5 65.84 1.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.367 1.583 . . . . 0.0 111.971 -171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.33 159.42 40.98 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.623 1.106 . . . . 0.0 113.145 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.436 ' HB3' HD12 ' B' ' 222' ' ' LEU . 0.0 OUTLIER -160.97 174.88 13.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.43 1.892 . . . . 0.0 112.06 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -120.86 133.24 55.31 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.553 1.141 . . . . 0.0 111.112 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.451 ' HB ' HG13 ' A' ' 135' ' ' VAL . 13.3 m -141.0 144.61 35.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.587 1.555 . . . . 0.0 109.77 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.8 126.29 20.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.663 1.185 . . . . 0.0 109.991 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.4 p -128.57 113.3 15.27 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.849 0.86 . . . . 0.0 110.755 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -77.45 11.26 2.07 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.557 1.143 . . . . 0.0 112.844 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.6 m -58.76 163.01 3.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.931 1.692 . . . . 0.0 112.714 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -159.16 137.82 10.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.918 1.287 . . . . 0.0 110.353 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -73.7 148.91 42.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.478 0.711 . . . . 0.0 110.195 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -136.16 151.69 50.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 110.913 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.0 t -106.35 -63.24 1.29 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.492 1.117 . . . . 0.0 112.158 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.5 p -84.87 -32.01 23.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.804 0.842 . . . . 0.0 113.159 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -49.86 47.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.24 1.416 . . . . 0.0 111.943 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -149.82 -174.43 4.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.668 2.387 . . . . 0.0 110.3 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.73 149.06 18.65 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.709 1.147 . . . . 0.0 112.256 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -155.56 131.9 10.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.692 1.197 . . . . 0.0 110.418 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 11.0 t -123.31 136.49 54.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -128.19 141.35 51.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.383 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.4 113.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 126.468 1.907 . . . . 0.0 108.949 -168.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.0 114.26 24.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.729 1.612 . . . . 0.0 111.378 -174.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -124.82 105.35 9.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.158 1.783 . . . . 0.0 109.569 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 167.1 7.48 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.475 -0.766 . . . . 0.0 112.253 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -144.83 -179.21 6.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.976 0.911 . . . . 0.0 111.518 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -52.11 55.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.793 1.637 . . . . 0.0 113.74 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.3 t -127.67 -30.11 2.57 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.89 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.2 ptp -96.59 179.44 4.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.49 1.516 . . . . 0.0 111.835 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.1 152.51 37.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.643 1.577 . . . . 0.0 109.38 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.0 p -129.66 137.38 50.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.108 0.963 . . . . 0.0 110.995 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.1 125.38 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.921 1.289 . . . . 0.0 110.271 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.12 128.03 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.895 2.078 . . . . 0.0 108.994 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -126.74 110.14 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.154 1.381 . . . . 0.0 111.291 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.27 143.38 27.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.449 1.9 . . . . 0.0 112.383 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -134.02 126.27 29.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.983 1.313 . . . . 0.0 110.001 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.59 73.99 0.3 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.554 2.026 . . . . 0.0 111.206 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.97 123.22 16.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.006 1.322 . . . . 0.0 110.92 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 125.49 1.516 . . . . 0.0 112.62 -169.142 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.637 0.256 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -127.06 165.43 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.309 1.044 . . . . 0.0 112.373 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.2 mm -64.56 148.38 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.503 1.521 . . . . 0.0 110.872 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.5 m -126.04 100.43 6.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.89 1.276 . . . . 0.0 110.595 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -92.04 149.46 21.51 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.95 168.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -146.34 103.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.082 2.153 . . . . 0.0 109.22 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -139.1 157.73 45.44 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.095 -1.003 . . . . 0.0 112.507 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 121.047 0.451 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -118.75 167.81 11.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.277 1.431 . . . . 0.0 110.663 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.44 160.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.494 1.118 . . . . 0.0 111.066 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.94 -37.34 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.631 1.173 . . . . 0.0 111.946 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -28.06 66.19 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.093 0.957 . . . . 0.0 112.882 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -77.3 -59.6 2.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.975 1.31 . . . . 0.0 110.767 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.496 HG13 HD22 ' B' ' 199' ' ' LEU . 84.0 t -48.67 -42.5 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 125.055 1.342 . . . . 0.0 113.292 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.8 t -58.95 -19.33 41.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.281 1.432 . . . . 0.0 113.454 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -101.92 -34.26 9.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.803 1.241 . . . . 0.0 113.161 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 24.1 mt -51.04 -44.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.496 1.044 . . . . 0.0 110.608 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.29 -43.31 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.453 -0.779 . . . . 0.0 112.874 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -51.02 62.88 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.733 1.151 . . . . 0.0 111.592 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -34.48 76.69 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.11 59.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.946 0.898 . . . . 0.0 113.34 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.18 -57.22 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.206 0.912 . . . . 0.0 109.064 174.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.29 -31.29 72.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.5 p -69.98 -37.57 75.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.19 -0.944 . . . . 0.0 112.681 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.16 -31.22 68.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.388 1.075 . . . . 0.0 113.462 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.8 -35.75 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.364 1.465 . . . . 0.0 112.636 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -58.74 -1.05 0.73 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -159.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.41 -32.68 81.91 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.904 1.852 . . . . 0.0 115.285 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -166.67 2.31 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.848 1.324 . . . . 0.0 112.511 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.07 161.92 3.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.383 1.473 . . . . 0.0 112.703 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.65 130.19 39.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.314 1.446 . . . . 0.0 111.132 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -132.89 133.97 43.97 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.776 1.23 . . . . 0.0 112.156 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -73.57 -43.17 60.47 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.25 1.02 . . . . 0.0 113.101 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 7.2 t -62.23 -27.68 69.16 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.066 -1.021 . . . . 0.0 112.502 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -73.25 -26.19 61.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -53.81 -34.03 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.261 1.391 . . . . 0.0 112.571 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.58 -49.62 72.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.1 1.36 . . . . 0.0 112.567 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.06 -25.42 66.24 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.198 -0.939 . . . . 0.0 112.932 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -78.39 -52.72 8.17 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.611 0.764 . . . . 0.0 111.756 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.75 -22.73 62.5 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.8 t -82.83 -60.6 2.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.492 1.042 . . . . 0.0 112.205 165.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -56.83 -41.31 77.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.302 1.41 . . . . 0.0 114.294 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.35 -64.67 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 110.036 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 87.6 t -47.7 -30.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.958 1.303 . . . . 0.0 110.973 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.08 -38.15 72.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.009 0.924 . . . . 0.0 113.162 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.6 -35.41 5.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 112.596 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 44.7 m -61.48 -52.66 63.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.157 2.183 . . . . 0.0 112.634 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -34.23 76.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.487 0.585 . . . . 0.0 111.192 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 66.5 m -61.06 -53.6 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.511 0.725 . . . . 0.0 111.887 167.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -54.42 -50.88 66.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.594 1.958 . . . . 0.0 112.648 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.496 HD22 HG13 ' B' ' 162' ' ' VAL . 3.9 pp -69.38 -26.55 64.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 66.7 m -59.27 -43.48 92.49 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -71.87 -23.25 61.48 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.38 4.96 4.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.28 1.432 . . . . 0.0 113.464 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -155.93 -97.28 0.13 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.517 1.053 . . . . 0.0 114.941 164.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -67.67 171.22 5.52 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 125.156 1.382 . . . . 0.0 114.666 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.62 169.7 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.019 1.812 . . . . 0.0 111.889 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -56.26 114.19 1.87 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.591 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.8 97.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 129.342 3.057 . . . . 0.0 110.169 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -149.8 171.88 16.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.687 2.395 . . . . 0.0 109.044 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -135.24 153.53 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.903 1.681 . . . . 0.0 108.217 162.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 253' ' ' ALA . 27.3 m -139.02 141.88 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.863 0.865 . . . . 0.0 110.124 166.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.257 1.423 . . . . 0.0 108.895 169.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.2 p -135.79 150.21 49.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.12 0.962 . . . . 0.0 113.078 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 12.9 t -132.27 125.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.894 1.677 . . . . 0.0 108.184 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.6 mm -122.49 104.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.997 2.119 . . . . 0.0 107.418 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 162.97 29.28 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 112.753 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.1 137.34 52.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.265 1.426 . . . . 0.0 111.134 -174.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -89.1 -14.18 36.88 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -77.85 -17.06 57.8 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 173.59 21.37 0.02 OUTLIER Glycine 0 CA--C 1.538 1.517 0 N-CA-C 117.703 1.841 . . . . 0.0 117.703 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.73 73.25 1.42 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.773 1.786 . . . . 0.0 112.767 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.5 160.16 32.73 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.682 1.134 . . . . 0.0 113.518 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -162.02 176.68 10.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.797 2.039 . . . . 0.0 111.941 -177.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.19 131.2 53.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.677 1.591 . . . . 0.0 110.957 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.59 ' HB ' HG13 ' B' ' 278' ' ' VAL . 90.6 m -139.05 143.38 38.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.449 1.1 . . . . 0.0 109.916 174.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.8 128.73 27.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 110.23 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.9 p -130.81 114.69 15.63 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.845 0.858 . . . . 0.0 110.912 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 t -78.16 11.21 2.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.447 1.099 . . . . 0.0 112.712 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.2 m -58.42 162.51 3.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.803 1.641 . . . . 0.0 112.774 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -158.96 138.55 11.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.846 1.258 . . . . 0.0 110.537 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.73 145.0 47.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.391 0.677 . . . . 0.0 109.927 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -130.13 151.81 50.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.614 1.566 . . . . 0.0 110.23 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 29.7 t -106.75 -64.28 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.927 1.291 . . . . 0.0 112.211 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 70.8 p -83.65 -31.64 26.06 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.868 0.867 . . . . 0.0 113.262 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -48.81 58.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 111.928 -173.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.07 -175.12 5.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.881 2.472 . . . . 0.0 110.754 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.99 146.74 16.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.784 1.183 . . . . 0.0 112.252 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 1.4 m -152.73 126.69 9.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.098 1.359 . . . . 0.0 110.679 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 16.8 t -121.33 130.08 53.43 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.59 1.156 . . . . 0.0 111.416 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.5 t -125.53 143.73 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.166 0.986 . . . . 0.0 111.338 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.42 131.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.506 1.523 . . . . 0.0 109.183 -172.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 114.47 17.8 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.434 1.493 . . . . 0.0 111.346 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.77 102.67 7.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.456 1.903 . . . . 0.0 109.408 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 165.95 7.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.492 -0.755 . . . . 0.0 112.093 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -144.1 -178.74 6.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.998 0.919 . . . . 0.0 111.581 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -51.08 59.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.858 1.663 . . . . 0.0 113.751 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -129.4 -29.28 2.23 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.519 1.528 . . . . 0.0 113.992 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -97.14 179.17 5.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.529 1.532 . . . . 0.0 111.828 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.57 151.72 36.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.369 1.468 . . . . 0.0 109.539 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.402 ' HB2' HD12 ' B' ' 214' ' ' ILE . 29.9 p -129.53 137.52 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.072 0.949 . . . . 0.0 111.148 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.0 130.02 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.992 1.317 . . . . 0.0 109.975 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.5 125.72 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.695 1.598 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.8 m -121.87 109.05 14.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.876 1.671 . . . . 0.0 110.916 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -94.52 143.83 26.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 112.579 176.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -134.76 122.46 22.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.347 1.459 . . . . 0.0 109.737 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.43 74.08 0.27 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.419 1.961 . . . . 0.0 111.331 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.92 121.82 13.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.016 1.326 . . . . 0.0 110.919 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 125.994 1.718 . . . . 0.0 112.406 -169.043 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -127.92 166.51 18.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.031 0.933 . . . . 0.0 111.993 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.38 149.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.53 1.532 . . . . 0.0 111.274 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 86.4 m -126.96 99.89 5.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.005 1.322 . . . . 0.0 110.725 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -93.94 150.03 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.163 -0.961 . . . . 0.0 110.858 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.59 HG13 ' HB ' ' B' ' 224' ' ' THR . 4.0 p -150.28 104.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.534 1.934 . . . . 0.0 110.062 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.61 159.18 42.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.031 1.332 . . . . 0.0 112.373 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 125.844 1.658 . . . . 0.0 111.94 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 121.176 0.512 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.27 170.16 8.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.262 1.425 . . . . 0.0 111.764 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -149.57 157.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.72 1.208 . . . . 0.0 111.366 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -53.45 -41.27 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.834 1.653 . . . . 0.0 112.063 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.91 -25.85 67.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.74 1.216 . . . . 0.0 113.544 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -79.96 -56.22 4.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.022 0.929 . . . . 0.0 110.632 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.0 t -47.34 -43.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.432 1.893 . . . . 0.0 112.381 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -63.79 -9.66 15.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.292 1.837 . . . . 0.0 114.362 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -111.17 -32.67 6.69 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.524 1.93 . . . . 0.0 112.475 172.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.3 mt -50.74 -43.37 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.014 0.825 . . . . 0.0 110.317 168.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.15 -44.04 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.495 -0.753 . . . . 0.0 112.957 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -52.36 51.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.756 1.162 . . . . 0.0 111.318 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -34.75 77.26 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.41 -41.42 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.78 0.832 . . . . 0.0 112.984 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.463 ' HA ' HG21 ' A' ' 48' ' ' VAL . 56.2 mt -58.25 -59.56 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.297 0.953 . . . . 0.0 109.522 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -62.97 -29.95 71.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.29 -49.93 75.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.27 1.028 . . . . 0.0 112.104 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.46 72.04 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.48 -40.67 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.799 1.24 . . . . 0.0 111.506 173.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.11 74.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.163 0.887 . . . . 0.0 115.139 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.71 -0.31 36.56 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.392 1.472 . . . . 0.0 116.256 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.47 162.03 8.64 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 118.879 1.34 . . . . 0.0 112.008 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.31 -166.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.599 1.56 . . . . 0.0 111.57 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -43.92 121.67 2.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.392 2.277 . . . . 0.0 112.425 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -115.81 170.17 8.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.631 1.172 . . . . 0.0 113.085 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 -95.86 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.703 1.201 . . . . 0.0 109.317 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -76.81 -21.01 55.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.637 1.175 . . . . 0.0 113.988 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -41.81 76.9 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.998 0.919 . . . . 0.0 112.367 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.16 -33.42 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.02 -46.73 80.1 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.362 0.983 . . . . 0.0 112.204 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -65.79 -24.84 67.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.692 0.678 . . . . 0.0 112.532 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.75 -51.86 9.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.034 0.833 . . . . 0.0 111.887 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -56.52 -29.59 62.06 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.847 0.749 . . . . 0.0 112.521 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -79.35 -60.77 2.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.389 0.995 . . . . 0.0 112.409 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.84 -38.6 75.96 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.334 1.453 . . . . 0.0 114.284 -172.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' A' ' 27' ' ' ILE . 81.7 t -68.21 -64.44 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 123.9 0.88 . . . . 0.0 109.469 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.9 t -50.42 -28.44 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.469 1.507 . . . . 0.0 110.835 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.11 28.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.579 1.151 . . . . 0.0 112.115 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -93.27 -35.56 13.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.041 1.336 . . . . 0.0 112.734 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -59.75 -54.38 47.03 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.944 2.097 . . . . 0.0 112.285 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -37.44 83.15 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.122 0.487 . . . . 0.0 111.236 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.0 t -62.18 -40.45 96.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.151 -0.968 . . . . 0.0 113.102 170.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.1 -49.85 63.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.721 1.608 . . . . 0.0 112.422 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.74 -24.8 65.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.9 m -55.89 -34.76 65.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.674 0.789 . . . . 0.0 110.919 163.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -84.88 -31.46 23.72 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.13 -30.47 70.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.472 0.709 . . . . 0.0 111.578 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.38 -100.81 2.61 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.147 1.832 . . . . 0.0 112.724 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -136.63 141.76 36.6 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.867 1.267 . . . . 0.0 113.677 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.44 104.18 1.66 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.448 3.432 . . . . 0.0 112.605 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -142.84 179.89 6.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.078 1.751 . . . . 0.0 112.166 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.5 89.25 3.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.464 1.506 . . . . 0.0 111.706 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.13 147.42 25.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.033 1.333 . . . . 0.0 110.747 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.3 152.96 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 126.117 1.767 . . . . 0.0 109.292 174.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 110' ' ' ALA . 9.5 m -138.39 146.68 26.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.604 1.161 . . . . 0.0 110.823 172.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 126.98 20.02 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.422 1.889 . . . . 0.0 108.921 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 p -129.7 138.09 50.95 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 112.552 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.1 98.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.139 1.376 . . . . 0.0 109.5 -167.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -106.7 91.32 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.359 1.864 . . . . 0.0 107.928 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -147.37 93.83 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.057 1.743 . . . . 0.0 110.763 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.54 133.37 8.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 109.649 170.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -52.05 0.14 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.274 1.43 . . . . 0.0 112.123 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.68 -23.95 8.98 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.875 1.27 . . . . 0.0 113.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.0 -1.34 38.35 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.538 1.542 . . . . 0.0 115.056 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.29 68.58 1.43 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.402 1.881 . . . . 0.0 111.237 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.9 15.93 0.09 OUTLIER Glycine 0 CA--C 1.537 1.429 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 -170.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.41 104.46 4.59 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.656 1.983 . . . . 0.0 110.005 -159.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 132.7 51.66 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.836 -1.165 . . . . 0.0 108.835 173.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 m -154.15 140.63 18.79 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.257 -1.527 . . . . 0.0 109.603 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.06 24.36 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.544 -0.722 . . . . 0.0 112.811 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -142.03 129.63 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.619 0.768 . . . . 0.0 110.51 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -79.75 8.83 5.96 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.292 -0.88 . . . . 0.0 112.482 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.65 162.94 17.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.636 1.174 . . . . 0.0 112.675 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.17 151.84 28.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.423 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 169.07 18.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.942 0.497 . . . . 0.0 111.484 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -139.41 148.61 43.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.213 1.005 . . . . 0.0 111.427 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -112.49 -68.94 0.9 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.461 1.504 . . . . 0.0 111.634 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.3 t -84.3 -38.82 19.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.698 0.799 . . . . 0.0 112.108 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -67.51 -45.96 74.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.672 1.189 . . . . 0.0 112.689 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.6 -169.8 3.47 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.56 2.344 . . . . 0.0 110.408 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.43 174.13 15.14 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.266 1.412 . . . . 0.0 114.518 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.7 t -154.88 163.1 40.78 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.385 1.874 . . . . 0.0 111.151 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 20.9 t -164.88 115.13 1.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.002 1.321 . . . . 0.0 112.164 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.694 -1.254 . . . . 0.0 112.01 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.62 151.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 110.184 -172.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -138.94 121.68 16.43 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.501 1.52 . . . . 0.0 111.02 -168.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -135.52 103.1 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.9 1.68 . . . . 0.0 111.018 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.47 142.49 58.37 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.027 -1.046 . . . . 0.0 112.254 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.35 -167.8 1.79 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.842 1.257 . . . . 0.0 109.932 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.03 -52.01 9.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.842 2.057 . . . . 0.0 114.585 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -140.59 -35.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.162 1.785 . . . . 0.0 111.402 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.4 ptp -79.03 112.95 16.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.478 1.511 . . . . 0.0 111.795 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.78 116.48 19.97 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.269 -1.519 . . . . 0.0 109.889 170.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.469 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -81.38 134.42 35.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.114 173.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.26 132.26 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.778 1.631 . . . . 0.0 109.846 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.77 127.88 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.615 1.566 . . . . 0.0 110.728 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 t -119.14 111.89 18.83 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.124 0.97 . . . . 0.0 110.802 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -87.47 139.62 30.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.913 0.885 . . . . 0.0 111.193 167.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -124.12 126.71 46.65 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 109.313 168.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.56 78.35 0.24 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 125.531 1.538 . . . . 0.0 112.35 -170.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.66 123.26 24.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.654 1.581 . . . . 0.0 111.764 -173.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 127.174 2.19 . . . . 0.0 112.807 -164.187 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -117.39 178.24 4.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 111.417 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -109.31 145.31 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.802 1.641 . . . . 0.0 109.926 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -117.4 90.71 3.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.047 1.339 . . . . 0.0 110.078 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -104.52 138.53 40.76 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.427 1.091 . . . . 0.0 110.816 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.45 98.98 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.214 2.606 . . . . 0.0 108.586 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.0 p30 -135.31 168.19 19.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.06 0.944 . . . . 0.0 111.82 168.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 124.437 1.095 . . . . 0.0 109.386 166.585 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.72 159.11 15.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.085 0.954 . . . . 0.0 112.255 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.49 156.35 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.149 1.78 . . . . 0.0 110.767 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 44.3 t -51.21 -40.09 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.294 2.638 . . . . 0.0 112.415 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.97 -28.32 62.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 113.175 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.47 -46.96 7.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.045 0.938 . . . . 0.0 110.854 175.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -48.65 -42.27 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.502 1.121 . . . . 0.0 112.067 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 12.1 t -63.55 -9.13 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.545 1.938 . . . . 0.0 114.692 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -109.98 -32.09 7.16 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.688 1.995 . . . . 0.0 112.552 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.9 mt -51.46 -41.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.822 0.849 . . . . 0.0 110.517 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.22 -44.17 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 121.447 -0.783 . . . . 0.0 112.939 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.63 53.8 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.736 1.153 . . . . 0.0 111.345 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.6 77.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.64 65.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.529 0.731 . . . . 0.0 112.924 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.462 ' HA ' HG21 ' B' ' 191' ' ' VAL . 58.0 mt -58.37 -59.9 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 119.127 0.876 . . . . 0.0 109.388 174.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.51 -30.15 71.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.1 t -61.3 -50.04 74.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 112.105 168.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.35 71.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.4 -40.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.822 1.249 . . . . 0.0 111.523 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.05 12.13 74.69 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.192 0.901 . . . . 0.0 115.036 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.56 -0.39 36.96 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.339 1.447 . . . . 0.0 116.266 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.61 162.49 8.3 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 118.852 1.326 . . . . 0.0 111.972 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -93.38 -166.16 1.47 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 111.505 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -43.82 125.58 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.482 2.313 . . . . 0.0 112.597 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -120.4 163.87 17.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.44 1.096 . . . . 0.0 113.749 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -71.91 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.055 1.342 . . . . 0.0 110.982 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m -107.31 -18.81 13.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.258 1.423 . . . . 0.0 113.694 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.42 -42.22 66.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.504 1.122 . . . . 0.0 111.991 174.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.43 -32.38 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.442 1.497 . . . . 0.0 114.5 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.94 -46.4 71.57 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.313 0.96 . . . . 0.0 112.11 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -65.58 -25.36 67.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.664 0.665 . . . . 0.0 112.327 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -77.64 -53.42 7.59 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.973 0.909 . . . . 0.0 111.823 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 15.1 t -56.35 -28.92 60.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.994 0.815 . . . . 0.0 112.671 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . 0.25 10.6 t -79.87 -61.91 1.85 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.425 1.011 . . . . 0.0 112.284 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.76 -38.45 72.48 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.592 1.557 . . . . 0.0 114.037 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.2 t -67.91 -64.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 192' ' ' VAL . . . . . 0.47 HG12 HG21 ' B' ' 210' ' ' VAL . 99.5 t -50.55 -28.37 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.46 1.504 . . . . 0.0 110.939 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -55.4 28.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.762 1.225 . . . . 0.0 112.037 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.73 -34.91 13.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.088 1.355 . . . . 0.0 112.817 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 38.2 m -60.7 -55.21 35.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.997 2.119 . . . . 0.0 112.343 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -36.45 82.19 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.515 0.598 . . . . 0.0 111.556 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 25.2 t -58.17 -51.08 71.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.635 0.774 . . . . 0.0 112.036 167.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.96 -50.91 71.89 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.808 1.643 . . . . 0.0 112.806 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.34 -27.73 67.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 63.9 m -57.33 -36.23 70.89 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.099 0.56 . . . . 0.0 110.598 165.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -79.15 -31.48 44.02 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.071 -1.018 . . . . 0.0 113.192 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.19 -28.95 61.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.178 0.591 . . . . 0.0 110.888 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.27 -94.95 1.99 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.355 1.931 . . . . 0.0 112.791 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -140.17 143.16 32.69 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.401 1.481 . . . . 0.0 113.061 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 114.12 3.75 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.732 2.955 . . . . 0.0 112.081 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.76 175.11 12.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.687 1.595 . . . . 0.0 112.673 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -94.54 87.65 5.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.744 1.218 . . . . 0.0 111.566 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -72.85 153.14 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.288 1.035 . . . . 0.0 112.253 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.5 tt -143.24 153.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.694 1.998 . . . . 0.0 108.72 166.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.47 HG21 HG12 ' B' ' 192' ' ' VAL . 15.5 m -139.75 144.79 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.296 1.038 . . . . 0.0 110.171 172.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.17 123.51 19.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.798 1.639 . . . . 0.0 108.681 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 11.8 p -124.5 142.13 51.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.186 0.994 . . . . 0.0 112.096 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 t -133.78 111.65 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.122 1.369 . . . . 0.0 107.622 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.2 mm -111.83 90.38 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.788 1.635 . . . . 0.0 107.73 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 162.69 13.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.478 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -75.23 137.98 41.61 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.405 0.622 . . . . 0.0 112.209 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -2.63 20.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.869 2.067 . . . . 0.0 114.185 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -55.06 -29.55 57.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.244 1.818 . . . . 0.0 113.901 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.47 75.89 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.797 1.189 . . . . 0.0 115.438 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.58 60.84 1.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.882 1.673 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.25 62.25 0.07 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-O 121.805 0.669 . . . . 0.0 114.225 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.85 96.25 1.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.698 1.999 . . . . 0.0 109.205 -171.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.18 101.39 6.74 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.199 -1.563 . . . . 0.0 108.63 173.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.485 ' HB ' HG13 ' B' ' 278' ' ' VAL . 22.8 m -130.98 139.09 49.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.398 -1.439 . . . . 0.0 109.765 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.97 138.36 31.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 m -141.46 135.73 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.79 0.836 . . . . 0.0 110.759 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 8.3 t -82.76 9.62 9.35 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.362 -0.836 . . . . 0.0 112.368 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.66 162.57 18.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.177 0.991 . . . . 0.0 112.685 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -154.97 149.9 26.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.207 1.803 . . . . 0.0 110.25 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.15 167.87 21.03 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.176 0.512 . . . . 0.0 111.225 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -139.38 148.65 43.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.451 1.1 . . . . 0.0 110.981 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -109.94 -68.31 0.93 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.536 1.535 . . . . 0.0 111.645 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 11.8 t -84.09 -39.46 19.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.871 0.868 . . . . 0.0 112.036 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -66.6 -46.48 75.75 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.026 1.331 . . . . 0.0 113.038 -172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.68 -170.51 3.68 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 127.798 2.439 . . . . 0.0 110.19 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -116.08 173.75 14.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.21 1.386 . . . . 0.0 114.571 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 21.3 t -153.41 163.59 39.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.573 1.949 . . . . 0.0 111.062 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 23.1 t -164.85 111.66 1.0 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.023 1.329 . . . . 0.0 112.235 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.8 t -113.93 147.33 38.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.545 -1.347 . . . . 0.0 112.373 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.3 t -139.79 153.27 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.326 1.85 . . . . 0.0 110.394 -173.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -135.13 130.32 35.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.922 1.689 . . . . 0.0 111.621 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -138.68 101.94 4.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.414 1.886 . . . . 0.0 110.368 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.1 146.2 53.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.802 -1.186 . . . . 0.0 112.073 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.32 -175.34 3.84 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.011 1.325 . . . . 0.0 110.226 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.63 -66.74 0.33 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.111 1.764 . . . . 0.0 114.527 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -133.51 17.37 3.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.089 1.756 . . . . 0.0 111.88 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 12.8 ptp -137.92 158.45 44.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.741 2.016 . . . . 0.0 109.095 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -126.1 123.9 39.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.917 0.887 . . . . 0.0 109.894 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.36 130.72 39.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.828 0.851 . . . . 0.0 110.965 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.3 pt -128.72 129.68 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 109.188 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.79 126.03 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.634 1.574 . . . . 0.0 110.45 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 13.6 t -118.64 110.47 17.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.185 0.994 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -85.91 141.22 29.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.987 0.915 . . . . 0.0 111.316 167.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -125.07 125.6 44.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.258 1.423 . . . . 0.0 109.164 167.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.31 77.26 0.23 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.897 1.713 . . . . 0.0 111.67 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 123.53 25.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.276 1.431 . . . . 0.0 111.95 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 127.321 2.248 . . . . 0.0 112.479 -165.046 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -118.29 176.53 5.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.041 1.737 . . . . 0.0 111.51 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.51 146.42 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.753 1.621 . . . . 0.0 109.859 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 27.1 m -119.73 90.8 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.867 1.267 . . . . 0.0 110.027 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -109.11 140.4 42.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 0.0 110.958 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.485 HG13 ' HB ' ' B' ' 224' ' ' THR . 3.0 p -136.14 94.23 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 127.906 2.482 . . . . 0.0 109.68 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.3 167.69 18.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.683 1.193 . . . . 0.0 113.032 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 28.5 p90 . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 124.07 0.948 . . . . 0.0 110.303 166.895 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 120.883 0.373 . . . . 0.0 111.752 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -104.75 176.0 5.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.9 1.28 . . . . 0.0 111.313 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG13 ' H ' ' A' ' 18' ' ' GLU . 14.7 p -140.89 154.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.516 1.127 . . . . 0.0 112.065 176.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -57.98 -44.52 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.579 1.552 . . . . 0.0 112.214 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.31 -26.39 68.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.921 0.888 . . . . 0.0 113.045 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.47 ' H ' HG13 ' A' ' 15' ' ' VAL . 12.1 tt0 -77.23 -60.41 2.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.146 1.379 . . . . 0.0 109.837 172.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.5 t -48.97 -42.6 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.789 1.636 . . . . 0.0 112.518 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -66.91 -9.55 39.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.703 1.601 . . . . 0.0 114.247 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -107.56 -32.46 7.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.275 1.83 . . . . 0.0 112.613 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -50.24 -44.52 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.248 1.019 . . . . 0.0 110.09 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.51 -45.41 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -50.34 62.53 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.458 1.027 . . . . 0.0 111.575 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -33.53 75.83 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.37 68.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.788 0.835 . . . . 0.0 112.406 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 HG11 ' A' ' 48' ' ' VAL . 61.7 mt -58.86 -57.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.889 0.768 . . . . 0.0 110.179 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -63.94 -25.14 68.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -66.71 -50.21 63.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.571 -0.706 . . . . 0.0 111.611 166.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.01 65.66 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.567 1.547 . . . . 0.0 114.217 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.13 -30.28 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 127.389 2.276 . . . . 0.0 112.059 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.69 -14.69 0.01 OUTLIER Glycine 0 C--O 1.279 2.967 0 N-CA-C 120.662 3.025 . . . . 0.0 120.662 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.24 -42.3 49.01 Favored Glycine 0 N--CA 1.482 1.702 0 C-N-CA 127.761 2.6 . . . . 0.0 115.772 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.47 -168.76 3.14 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.224 2.012 . . . . 0.0 111.896 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.79 -170.46 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.955 2.502 . . . . 0.0 112.798 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -74.28 103.82 4.82 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 119.978 -1.701 . . . . 0.0 111.192 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -122.99 88.52 2.94 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.021 1.328 . . . . 0.0 113.514 -174.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -64.96 -16.06 62.92 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.7 p -79.4 -31.56 42.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.988 1.715 . . . . 0.0 115.408 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -61.89 -15.39 42.32 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.159 1.784 . . . . 0.0 114.366 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.1 t -49.62 -31.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.754 1.622 . . . . 0.0 113.262 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -60.51 -53.36 58.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.947 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -67.94 -26.56 66.02 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.362 -0.837 . . . . 0.0 112.317 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -76.86 -52.66 9.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 111.223 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 t -59.0 -28.62 66.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 112.692 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -79.06 -59.36 2.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.156 0.889 . . . . 0.0 112.337 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.07 -38.02 78.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.781 1.173 . . . . 0.0 114.016 -172.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG11 HG13 ' A' ' 27' ' ' ILE . 89.2 t -70.82 -59.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 C-N-CA 123.691 0.796 . . . . 0.0 110.574 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.61 -30.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.12 0.968 . . . . 0.0 110.835 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.22 -28.41 70.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.01 -42.86 3.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.063 1.745 . . . . 0.0 112.385 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 m -54.97 -54.18 46.11 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.552 2.341 . . . . 0.0 113.016 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -39.06 93.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.125 0.42 . . . . 0.0 110.675 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -58.22 -52.02 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.308 0.643 . . . . 0.0 111.456 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.47 -47.62 83.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.391 2.276 . . . . 0.0 113.598 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.3 -25.51 63.36 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.667 -1.271 . . . . 0.0 114.403 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.1 m -61.76 -24.44 66.82 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.645 -0.659 . . . . 0.0 111.299 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -91.03 -19.89 22.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.76 -22.2 59.94 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.598 0.759 . . . . 0.0 112.729 162.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.89 -154.65 28.8 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.227 1.87 . . . . 0.0 112.143 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -90.8 161.57 35.59 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.847 1.659 . . . . 0.0 112.317 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.35 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.813 3.009 . . . . 0.0 112.384 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.45 165.26 32.65 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.543 1.537 . . . . 0.0 112.123 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -75.36 93.61 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.584 1.554 . . . . 0.0 111.241 170.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -68.52 162.77 24.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.619 -0.676 . . . . 0.0 111.378 163.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.3 150.72 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.618 1.567 . . . . 0.0 108.905 163.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.8 148.13 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.219 1.008 . . . . 0.0 111.117 164.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -140.24 156.3 46.54 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.13 1.372 . . . . 0.0 110.161 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.6 p -143.88 146.38 32.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.759 1.623 . . . . 0.0 111.968 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 124.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.997 1.319 . . . . 0.0 108.006 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.2 112.31 37.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 127.937 2.495 . . . . 0.0 107.332 -169.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.2 tpt -140.53 146.96 38.81 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.35 1.46 . . . . 0.0 111.169 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -95.3 130.11 42.18 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.628 1.171 . . . . 0.0 112.727 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -69.45 -10.11 56.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.324 1.85 . . . . 0.0 114.454 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.74 -20.61 35.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.744 2.017 . . . . 0.0 114.294 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.3 -1.5 3.03 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.124 1.345 . . . . 0.0 114.913 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 155.55 27.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.902 1.351 . . . . 0.0 111.626 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.82 160.32 31.83 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.084 0.85 . . . . 0.0 113.289 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 168.68 22.0 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.082 1.753 . . . . 0.0 112.586 -173.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -121.76 132.46 54.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 110.695 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 m -139.08 146.08 40.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.361 1.464 . . . . 0.0 109.729 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.95 146.38 30.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.39 0.676 . . . . 0.0 111.377 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.4 p -148.18 151.14 35.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 t -79.24 11.08 3.07 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' B' ' 209' ' ' ILE . 3.8 m -63.86 173.2 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.384 -0.823 . . . . 0.0 112.648 173.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -162.94 154.88 18.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.876 2.071 . . . . 0.0 109.931 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -76.83 147.62 37.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.207 1.003 . . . . 0.0 110.474 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.2 81.29 0.69 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -62.56 1.54 Allowed 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.522 -1.361 . . . . 0.0 113.315 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 p -97.07 -11.04 24.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.918 1.687 . . . . 0.0 113.117 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -47.8 21.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.251 1.42 . . . . 0.0 112.726 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -154.46 -47.63 0.09 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.02 111.36 1.4 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-N 120.35 1.432 . . . . 0.0 115.145 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -146.37 163.85 34.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.49 1.516 . . . . 0.0 112.352 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.1 t -156.46 149.37 23.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.203 1.801 . . . . 0.0 110.608 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 t -142.67 142.79 32.11 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.73 -1.856 . . . . 0.0 111.138 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.4 107.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.137 0.975 . . . . 0.0 109.995 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -92.17 124.01 35.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.106 0.962 . . . . 0.0 112.437 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -131.21 136.95 48.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.101 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.98 164.36 12.56 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 111.795 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -138.23 -178.73 5.41 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.871 1.668 . . . . 0.0 110.018 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.25 -49.59 60.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.061 2.545 . . . . 0.0 114.193 -175.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.5 t -136.45 0.77 2.55 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.173 1.389 . . . . 0.0 113.282 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.4 ptp -132.84 176.88 8.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.86 1.664 . . . . 0.0 111.958 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -136.09 147.47 47.84 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.98 1.312 . . . . 0.0 110.694 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.21 69.66 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.964 1.306 . . . . 0.0 110.786 -163.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.53 138.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.323 1.049 . . . . 0.0 111.325 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.09 145.15 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.688 1.595 . . . . 0.0 111.613 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.26 120.98 16.35 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.912 1.285 . . . . 0.0 110.469 -166.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.93 136.74 52.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.132 1.773 . . . . 0.0 112.711 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.23 117.27 17.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.165 1.386 . . . . 0.0 108.372 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.04 73.15 0.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.113 1.34 . . . . 0.0 112.945 -163.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.02 119.76 18.68 Favored 'General case' 0 C--O 1.273 2.331 0 C-N-CA 125.243 1.417 . . . . 0.0 111.544 -165.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.301 -1.536 0 CA-C-O 123.372 1.558 . . . . 0.0 114.042 -165.097 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -129.36 164.2 24.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.277 1.031 . . . . 0.0 112.334 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.5 mm -49.02 137.49 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 128.408 2.683 . . . . 0.0 112.053 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 93.7 m -100.49 92.01 4.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.981 1.312 . . . . 0.0 110.598 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -89.12 150.54 22.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.213 167.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.29 103.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.46 2.304 . . . . 0.0 109.007 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.51 130.2 40.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 111.153 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.548 1.539 . . . . 0.0 108.487 176.966 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 121.624 0.726 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -84.96 179.23 7.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.517 1.127 . . . . 0.0 112.024 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.443 HG13 ' H ' ' B' ' 161' ' ' GLU . 8.1 p -144.25 156.7 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.343 -0.848 . . . . 0.0 113.049 169.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.9 -44.49 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.559 1.944 . . . . 0.0 111.969 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.08 -25.83 68.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.595 0.758 . . . . 0.0 113.035 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 161' ' ' GLU . . . . . 0.443 ' H ' HG13 ' B' ' 158' ' ' VAL . 11.4 tt0 -78.57 -59.5 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.259 1.423 . . . . 0.0 110.048 172.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -49.29 -43.58 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 126.359 1.864 . . . . 0.0 112.173 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -66.95 -9.29 36.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.469 1.508 . . . . 0.0 114.152 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -106.88 -32.44 7.91 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.21 1.804 . . . . 0.0 112.715 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 28.6 mt -50.37 -44.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.341 1.056 . . . . 0.0 110.057 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.44 -45.29 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -50.44 61.42 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.469 1.031 . . . . 0.0 111.574 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.12 74.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.32 66.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.745 0.818 . . . . 0.0 112.411 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.423 HG13 HG11 ' B' ' 191' ' ' VAL . 61.6 mt -58.99 -57.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.932 0.787 . . . . 0.0 110.101 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.75 -25.32 68.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -66.79 -50.05 63.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.693 -0.629 . . . . 0.0 111.553 166.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.71 -24.87 65.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.544 1.538 . . . . 0.0 114.235 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 mt -56.12 -30.3 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 127.415 2.286 . . . . 0.0 111.916 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -41.31 -13.61 0.01 OUTLIER Glycine 0 C--O 1.28 3.012 0 N-CA-C 120.656 3.023 . . . . 0.0 120.656 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.14 -42.01 54.46 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 127.724 2.583 . . . . 0.0 115.574 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.34 -168.82 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.35 2.075 . . . . 0.0 111.966 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.57 -170.63 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.929 2.492 . . . . 0.0 112.832 165.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.2 102.59 4.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.032 -1.668 . . . . 0.0 111.245 -172.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -122.94 88.36 2.92 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.098 1.359 . . . . 0.0 113.202 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.32 -21.24 65.11 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.0 p -77.67 -27.81 50.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.375 1.87 . . . . 0.0 115.175 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -64.34 -15.64 60.74 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.389 1.475 . . . . 0.0 114.111 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.55 -29.45 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.742 1.617 . . . . 0.0 114.538 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -60.64 -52.69 64.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.522 1.055 . . . . 0.0 112.434 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -68.12 -26.56 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.499 -0.751 . . . . 0.0 112.248 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -77.04 -52.93 8.48 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.866 0.866 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -58.92 -28.26 66.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.997 0.919 . . . . 0.0 112.755 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 5.9 t -79.22 -60.19 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.148 0.885 . . . . 0.0 112.355 167.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -58.55 -37.47 75.77 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.89 1.223 . . . . 0.0 114.033 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.423 HG11 HG13 ' B' ' 170' ' ' ILE . 89.0 t -71.01 -59.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 123.682 0.793 . . . . 0.0 110.42 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 92.4 t -48.65 -31.1 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.095 0.958 . . . . 0.0 110.819 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.18 -27.73 69.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.72 -43.02 3.51 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.043 1.737 . . . . 0.0 112.331 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.2 m -55.01 -54.18 46.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.64 2.376 . . . . 0.0 113.064 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.94 93.19 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.204 0.456 . . . . 0.0 110.66 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 11.3 t -58.49 -51.71 68.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.31 0.644 . . . . 0.0 111.52 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.57 -48.15 81.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.441 2.297 . . . . 0.0 113.505 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.66 -25.31 63.85 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.662 -1.273 . . . . 0.0 114.37 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.9 m -62.19 -24.82 67.43 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.708 -0.62 . . . . 0.0 111.278 166.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -89.99 -21.33 22.46 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.74 -22.19 60.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.841 0.856 . . . . 0.0 113.011 162.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -153.53 26.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.274 1.892 . . . . 0.0 112.212 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -93.66 157.21 38.7 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.532 1.533 . . . . 0.0 112.281 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 112.75 3.3 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.934 3.089 . . . . 0.0 112.104 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -147.4 159.33 43.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.712 1.205 . . . . 0.0 112.217 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -68.8 79.67 0.3 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.326 2.251 . . . . 0.0 111.661 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -60.95 159.02 12.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.979 0.895 . . . . 0.0 111.087 163.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 209' ' ' ILE . . . . . 0.409 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.0 tt -137.25 153.22 28.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 125.952 1.701 . . . . 0.0 108.831 166.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 19.2 m -141.49 147.12 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.703 1.201 . . . . 0.0 109.869 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -138.42 157.71 45.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.792 1.237 . . . . 0.0 109.405 168.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 32.0 p -145.82 152.66 39.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 112.124 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.7 128.75 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.961 1.304 . . . . 0.0 108.247 -176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.9 mm -119.87 114.08 42.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 128.093 2.557 . . . . 0.0 106.809 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 36.2 tpp -140.19 148.37 41.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.499 1.52 . . . . 0.0 111.161 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -97.65 128.15 44.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.014 1.326 . . . . 0.0 112.36 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.78 -9.07 48.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.449 1.9 . . . . 0.0 114.452 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -57.27 -21.36 33.89 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.104 2.161 . . . . 0.0 114.412 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 -2.76 3.35 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.963 1.268 . . . . 0.0 115.102 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.9 164.46 14.94 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.81 1.305 . . . . 0.0 111.93 169.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -173.81 162.65 33.49 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.025 0.821 . . . . 0.0 113.425 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.21 171.84 16.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.998 1.719 . . . . 0.0 113.063 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -120.69 133.4 55.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.403 0.681 . . . . 0.0 111.055 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 19.2 m -138.22 147.01 43.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.426 1.09 . . . . 0.0 110.296 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -143.98 146.5 32.95 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.719 -0.613 . . . . 0.0 111.359 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 95.6 p -147.98 151.21 35.4 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 11.53 2.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.7 m -63.72 173.5 1.72 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.869 0.843 . . . . 0.0 112.342 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.08 156.78 22.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.835 2.054 . . . . 0.0 109.793 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.21 138.15 45.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 0.0 109.617 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -145.6 104.82 3.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.895 1.278 . . . . 0.0 111.472 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 39.2 t -78.5 -75.7 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.019 -1.051 . . . . 0.0 111.033 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 64.8 p -85.81 -19.17 31.07 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.209 1.403 . . . . 0.0 113.068 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -41.99 80.3 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.096 1.759 . . . . 0.0 112.94 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -153.07 -77.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.62 1.168 . . . . 0.0 113.124 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 161.07 105.46 0.2 Allowed Glycine 0 CA--C 1.538 1.527 0 O-C-N 120.659 -1.276 . . . . 0.0 114.566 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 77.3 p -137.72 162.15 34.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.8 1.24 . . . . 0.0 112.775 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.3 t -157.12 155.17 30.59 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.987 1.715 . . . . 0.0 110.221 171.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.0 t -148.36 145.07 27.93 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 119.803 -1.811 . . . . 0.0 111.003 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.62 118.9 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -106.17 123.29 47.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.565 1.146 . . . . 0.0 112.256 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -130.63 140.01 50.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.603 1.561 . . . . 0.0 110.974 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.5 159.74 15.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.77 . . . . 0.0 111.624 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -133.68 178.42 6.95 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.437 1.895 . . . . 0.0 110.251 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -48.57 57.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.466 2.706 . . . . 0.0 113.837 -176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.8 t -137.28 0.67 2.34 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.11 1.364 . . . . 0.0 113.288 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.6 ptp -131.62 178.94 6.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.807 1.643 . . . . 0.0 111.994 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.106 1.362 . . . . 0.0 110.458 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 8.3 p -141.02 71.77 1.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 0.0 111.014 -164.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.99 140.59 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.112 0.965 . . . . 0.0 111.683 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.88 139.25 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.271 1.829 . . . . 0.0 110.935 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 36.1 p -130.93 139.09 50.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.43 1.092 . . . . 0.0 112.173 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -127.19 138.86 53.22 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.044 1.738 . . . . 0.0 112.783 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -132.96 109.01 9.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.094 1.357 . . . . 0.0 109.042 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.06 66.24 0.58 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.579 2.038 . . . . 0.0 110.438 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.453 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.6 OUTLIER -62.37 142.52 57.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 111.184 -169.299 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -128.94 163.71 24.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 112.24 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.3 mm -49.49 135.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 128.053 2.541 . . . . 0.0 111.921 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.5 m -97.55 88.02 4.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.921 1.288 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -85.58 150.46 24.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.626 -0.671 . . . . 0.0 110.777 164.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.95 107.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.578 1.951 . . . . 0.0 109.687 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.69 133.48 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.506 1.123 . . . . 0.0 111.027 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 125.448 1.499 . . . . 0.0 108.361 176.614 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.434 0.635 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.42 164.37 12.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.784 0.833 . . . . 0.0 112.122 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.14 158.07 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.809 0.844 . . . . 0.0 112.358 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.76 -39.86 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.835 2.054 . . . . 0.0 112.92 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.22 -22.99 63.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.003 0.921 . . . . 0.0 113.097 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -96.86 -51.17 4.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.038 0.935 . . . . 0.0 111.972 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.1 t -48.59 -38.06 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.008 1.323 . . . . 0.0 112.464 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 t -63.9 -13.68 47.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.045 1.738 . . . . 0.0 114.298 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -101.8 -38.14 7.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.899 2.08 . . . . 0.0 111.976 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -51.71 -42.44 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.067 0.849 . . . . 0.0 110.866 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.92 -42.41 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.6 -0.688 . . . . 0.0 112.804 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.86 49.52 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 111.121 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -30.71 70.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.04 -44.66 38.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.541 0.736 . . . . 0.0 112.966 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 -58.01 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.061 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.27 -29.56 70.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.64 -46.81 86.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.834 0.854 . . . . 0.0 112.181 168.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.01 -35.57 80.91 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.32 -48.23 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.918 1.287 . . . . 0.0 109.907 172.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.43 12.79 74.93 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.389 0.995 . . . . 0.0 114.662 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 3.39 38.61 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.684 1.434 . . . . 0.0 116.684 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.98 146.25 43.22 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.696 1.748 . . . . 0.0 111.085 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.62 -160.39 0.15 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.914 1.286 . . . . 0.0 111.876 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -47.73 136.64 10.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.297 1.039 . . . . 0.0 111.617 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -136.7 179.16 6.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.775 1.63 . . . . 0.0 111.375 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.97 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.335 1.054 . . . . 0.0 112.226 165.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.9 p -47.31 -0.54 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.179 2.591 . . . . 0.0 117.821 168.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.22 -39.5 2.98 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.666 2.386 . . . . 0.0 113.31 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.77 -29.52 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.368 1.467 . . . . 0.0 113.193 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.95 -49.36 75.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.668 1.187 . . . . 0.0 112.312 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.56 -25.41 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.471 -0.768 . . . . 0.0 112.638 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.09 -54.1 7.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.893 0.769 . . . . 0.0 111.393 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.06 -24.27 62.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.771 0.829 . . . . 0.0 112.651 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.3 t -83.32 -59.71 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.407 1.003 . . . . 0.0 113.033 166.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -58.44 -38.78 78.18 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.987 1.315 . . . . 0.0 113.896 -172.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.65 -62.87 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 C-N-CA 124.309 1.044 . . . . 0.0 109.623 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -48.92 -30.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.414 1.486 . . . . 0.0 111.051 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -59.33 -34.35 72.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -112.71 -36.34 5.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.632 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.8 m -59.92 -51.74 68.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.757 2.023 . . . . 0.0 111.816 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -43.38 98.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 111.057 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -66.79 -26.2 66.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -75.31 -51.98 11.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.262 2.225 . . . . 0.0 113.271 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.59 -25.89 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -59.61 -33.93 72.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.144 0.577 . . . . 0.0 110.493 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -79.59 -28.6 41.05 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mt -61.95 -32.3 72.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.58 -99.62 2.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.711 1.148 . . . . 0.0 113.269 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -135.95 146.31 56.24 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.86 1.664 . . . . 0.0 113.092 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.53 99.11 1.01 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.296 3.33 . . . . 0.0 112.32 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -140.62 167.89 21.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.615 1.566 . . . . 0.0 111.823 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -61.52 129.27 40.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.77 1.228 . . . . 0.0 110.543 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -115.09 152.16 33.02 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.09 1.756 . . . . 0.0 110.167 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -151.98 157.3 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.514 1.526 . . . . 0.0 109.283 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.28 152.14 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.236 1.814 . . . . 0.0 109.055 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -128.86 144.41 51.17 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.079 1.352 . . . . 0.0 108.315 161.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.2 p -137.57 154.22 49.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.724 0.773 . . . . 0.0 111.688 167.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.41 114.47 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.779 1.231 . . . . 0.0 109.605 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -107.26 97.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 126.165 1.786 . . . . 0.0 106.596 -177.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -154.63 90.07 1.29 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 112.592 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -151.6 142.57 23.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.832 2.053 . . . . 0.0 108.698 160.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -158.03 -62.61 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.38 1.472 . . . . 0.0 111.242 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -115.04 -9.51 12.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.764 1.626 . . . . 0.0 114.303 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.67 2.31 57.46 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.28 1.419 . . . . 0.0 115.254 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -177.34 2.24 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.118 1.459 . . . . 0.0 112.261 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.16 -173.12 41.54 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.444 1.021 . . . . 0.0 114.13 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.87 174.02 10.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.079 2.552 . . . . 0.0 110.543 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -98.42 100.82 12.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.281 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -111.94 142.65 44.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 108.744 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 145.44 32.49 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 111.193 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.7 p -139.96 143.69 36.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 122.086 0.946 . . . . 0.0 112.097 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -81.72 16.2 1.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.102 0.961 . . . . 0.0 112.056 170.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 25.0 m -64.3 161.5 16.61 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.198 -0.939 . . . . 0.0 112.044 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -160.01 138.25 10.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.149 1.38 . . . . 0.0 111.995 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -70.12 146.69 50.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.16 0.584 . . . . 0.0 110.503 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -140.45 160.3 40.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.183 1.393 . . . . 0.0 110.925 168.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -117.52 -64.4 1.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.055 1.342 . . . . 0.0 112.223 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 t -86.5 -39.77 15.94 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.788 0.835 . . . . 0.0 112.163 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -53.87 52.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.134 1.774 . . . . 0.0 111.589 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -142.44 176.3 9.12 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.503 2.721 . . . . 0.0 109.542 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.33 140.57 15.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.989 0.804 . . . . 0.0 112.117 172.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -143.42 149.44 37.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.42 . . . . 0.0 110.282 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.26 108.97 4.02 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.09 0.956 . . . . 0.0 111.48 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 t -100.97 143.25 31.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.895 0.878 . . . . 0.0 111.729 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.39 128.87 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.441 1.896 . . . . 0.0 109.245 -168.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -121.64 122.18 39.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.937 1.695 . . . . 0.0 112.063 -170.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -133.49 117.49 17.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.688 1.595 . . . . 0.0 110.767 -175.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.77 167.5 21.28 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.348 -0.845 . . . . 0.0 112.946 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -151.39 -175.16 5.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.079 1.352 . . . . 0.0 111.375 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.83 -59.21 2.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.601 1.96 . . . . 0.0 113.347 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.2 t -138.13 -35.58 0.62 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.807 1.643 . . . . 0.0 112.846 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.9 ptp -100.33 89.85 4.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.932 1.293 . . . . 0.0 112.797 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.29 155.87 8.35 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.53 -0.731 . . . . 0.0 111.661 173.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.587 ' CB ' HD12 ' A' ' 71' ' ' ILE . 2.8 p -127.51 135.76 50.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.936 1.294 . . . . 0.0 111.066 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.65 122.43 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.491 1.517 . . . . 0.0 110.258 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.92 138.13 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.292 1.837 . . . . 0.0 108.756 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -127.52 107.48 9.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.416 1.086 . . . . 0.0 110.431 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.56 147.74 25.19 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.242 1.017 . . . . 0.0 112.388 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 8.0 m-85 -136.78 118.58 15.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.217 2.207 . . . . 0.0 108.959 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.42 100.74 0.93 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.719 2.104 . . . . 0.0 110.423 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.04 145.41 36.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.646 1.178 . . . . 0.0 111.882 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.851 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.94 161.33 29.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.277 1.831 . . . . 0.0 111.7 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.98 153.04 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.939 1.695 . . . . 0.0 110.259 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 100.0 m -121.86 94.32 4.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.313 1.445 . . . . 0.0 110.844 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -88.15 149.79 23.69 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.241 -0.912 . . . . 0.0 111.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.26 94.44 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 127.69 2.396 . . . . 0.0 108.521 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.98 165.56 27.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.11 1.364 . . . . 0.0 112.378 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 125.214 1.405 . . . . 0.0 109.944 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.346 0.594 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.75 159.07 15.23 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 0.0 111.935 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.66 158.9 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.551 1.141 . . . . 0.0 111.267 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.81 -35.54 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.82 2.048 . . . . 0.0 113.383 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.33 -23.05 66.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.864 0.866 . . . . 0.0 113.039 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -86.49 -54.52 4.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.901 1.28 . . . . 0.0 110.643 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 162' ' ' VAL . . . . . 0.451 HG22 HD23 ' B' ' 199' ' ' LEU . 39.8 t -53.91 -38.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.087 1.355 . . . . 0.0 112.577 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.1 t -61.19 -11.36 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.286 1.834 . . . . 0.0 114.258 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -107.4 -36.9 6.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.879 1.671 . . . . 0.0 112.317 168.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.8 mt -51.11 -40.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.508 1.049 . . . . 0.0 111.25 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.81 -41.18 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.462 -0.774 . . . . 0.0 113.058 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -49.28 51.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.901 1.228 . . . . 0.0 111.646 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -29.62 70.11 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.29 -44.67 28.88 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.407 ' HA ' HG21 ' B' ' 191' ' ' VAL . 71.6 mt -58.06 -58.73 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.221 0.918 . . . . 0.0 110.052 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.14 -29.49 70.38 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -62.89 -46.38 88.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.789 0.836 . . . . 0.0 112.059 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.24 79.8 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.3 -47.96 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.936 1.294 . . . . 0.0 109.946 172.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.14 12.89 75.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.395 0.998 . . . . 0.0 114.685 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.48 40.3 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -60.12 146.43 43.22 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 119.671 1.735 . . . . 0.0 111.115 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.68 -160.29 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.982 1.313 . . . . 0.0 111.789 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -47.93 137.48 9.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.269 1.028 . . . . 0.0 111.748 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -137.09 179.44 6.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.732 1.613 . . . . 0.0 111.426 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -63.48 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.508 1.123 . . . . 0.0 112.185 164.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 42.0 p -47.16 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.284 2.634 . . . . 0.0 117.925 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.76 -39.56 3.81 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.815 2.446 . . . . 0.0 113.442 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.18 -28.79 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.199 1.4 . . . . 0.0 113.169 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.63 -49.55 74.73 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.71 1.204 . . . . 0.0 112.354 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.58 -25.76 65.94 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.516 -0.74 . . . . 0.0 112.666 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -75.63 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.887 0.767 . . . . 0.0 111.452 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.0 t -59.65 -22.95 62.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.769 0.828 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -84.24 -59.64 2.33 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.477 1.035 . . . . 0.0 113.19 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -58.32 -38.62 77.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.99 1.316 . . . . 0.0 114.03 -172.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' B' ' 170' ' ' ILE . 88.0 t -66.45 -62.65 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 124.393 1.077 . . . . 0.0 109.591 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.96 -30.4 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.473 1.509 . . . . 0.0 110.953 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.21 -33.07 70.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -114.62 -35.48 4.86 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.654 1.581 . . . . 0.0 112.824 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 54.2 m -61.58 -48.3 81.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.984 2.114 . . . . 0.0 112.079 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' B' ' 199' ' ' LEU . 0.2 OUTLIER -62.79 -45.16 93.95 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.455 0.645 . . . . 0.0 110.642 176.027 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 83.0 p -66.18 -25.26 66.86 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.137 -0.977 . . . . 0.0 113.375 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -75.79 -54.53 6.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.438 2.295 . . . . 0.0 113.155 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -64.8 -26.28 68.28 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.744 1.156 . . . . 0.0 113.433 -172.869 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -56.99 -40.57 76.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.325 0.65 . . . . 0.0 110.835 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -73.87 -29.07 61.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.784 0.834 . . . . 0.0 112.637 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 5.2 mt -62.49 -31.98 72.81 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -97.9 2.1 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.767 1.175 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -136.78 146.74 56.48 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.776 1.631 . . . . 0.0 112.98 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.23 97.27 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.202 3.268 . . . . 0.0 112.203 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.15 167.67 21.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.506 1.522 . . . . 0.0 111.838 172.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -61.77 131.35 49.6 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.887 1.275 . . . . 0.0 110.754 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -116.96 152.33 34.79 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.259 1.824 . . . . 0.0 110.296 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.7 tt -152.81 157.41 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.38 152.56 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.451 1.9 . . . . 0.0 109.225 165.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 2.1 p -127.27 144.05 51.12 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.025 1.33 . . . . 0.0 108.353 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 20.1 p -138.12 155.83 48.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.959 0.885 . . . . 0.0 112.01 168.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.46 125.21 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.374 1.07 . . . . 0.0 109.877 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' B' ' 249' ' ' CYS . 2.2 mm -115.82 98.32 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.027 2.131 . . . . 0.0 107.18 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -116.26 152.66 33.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.444 1.497 . . . . 0.0 110.48 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.97 147.6 32.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.813 0.816 . . . . 0.0 112.483 -175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -75.9 1.23 15.68 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.937 1.695 . . . . 0.0 114.292 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -64.97 -13.17 56.78 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.52 5.26 61.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.965 1.269 . . . . 0.0 115.348 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.2 -169.89 0.69 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.566 1.183 . . . . 0.0 112.185 169.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.85 -170.54 42.86 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.071 -1.018 . . . . 0.0 114.152 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.69 -171.44 2.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.341 2.256 . . . . 0.0 111.449 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -114.36 94.79 4.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.462 0.705 . . . . 0.0 110.232 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.475 ' HB ' HG13 ' B' ' 278' ' ' VAL . 23.3 m -106.67 142.35 36.46 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.891 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.88 141.21 38.58 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.425 0.69 . . . . 0.0 110.638 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 25.0 p -135.98 140.27 43.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.119 0.962 . . . . 0.0 111.714 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.9 t -80.44 14.99 1.77 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.828 0.851 . . . . 0.0 111.993 171.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 228' ' ' CYS . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 254' ' ' PHE . 13.2 m -64.66 161.77 17.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.214 -0.929 . . . . 0.0 112.017 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.09 139.02 10.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.85 146.59 51.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.725 -0.61 . . . . 0.0 110.343 174.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -139.88 159.32 42.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.247 1.419 . . . . 0.0 110.726 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 43.3 t -117.1 -64.58 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.09 1.356 . . . . 0.0 112.228 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.5 t -86.78 -39.64 15.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.796 0.839 . . . . 0.0 112.095 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -54.29 47.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 111.614 -174.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -142.11 176.55 8.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.465 2.706 . . . . 0.0 109.631 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.03 140.57 15.2 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.046 0.831 . . . . 0.0 112.229 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 150.05 39.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.289 1.436 . . . . 0.0 110.276 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.4 t -148.44 107.59 3.89 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.143 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.7 t -98.8 142.69 30.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.861 0.864 . . . . 0.0 111.527 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 123.41 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 109.075 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -115.14 119.16 35.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.853 1.661 . . . . 0.0 111.339 -172.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.7 148.55 49.0 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.14 1.376 . . . . 0.0 110.514 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.12 165.49 11.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.816 1.246 . . . . 0.0 111.355 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.72 -176.06 5.46 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.78 1.232 . . . . 0.0 110.521 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.27 -67.09 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.127 1.771 . . . . 0.0 113.017 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -139.53 4.97 2.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.072 1.749 . . . . 0.0 113.405 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 23.9 ptp -133.99 82.01 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 111.992 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -58.15 147.23 30.76 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.361 -0.837 . . . . 0.0 111.379 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' B' ' 214' ' ' ILE . 4.4 p -134.47 116.54 15.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.275 1.03 . . . . 0.0 111.991 -171.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.8 pt -117.14 130.16 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.615 1.166 . . . . 0.0 111.188 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.59 139.05 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.721 2.008 . . . . 0.0 108.691 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.3 t -129.83 109.82 11.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.344 1.058 . . . . 0.0 110.655 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.11 148.0 23.91 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.185 0.994 . . . . 0.0 112.243 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 254' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' B' ' 228' ' ' CYS . 8.7 m-85 -136.3 119.13 16.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.122 2.169 . . . . 0.0 108.952 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.03 100.09 0.91 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.662 2.077 . . . . 0.0 110.304 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.24 145.69 36.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.624 1.17 . . . . 0.0 111.734 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 178.315 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.69 161.24 29.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.342 1.857 . . . . 0.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.19 152.34 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.833 1.653 . . . . 0.0 110.269 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 98.3 m -120.92 91.57 3.56 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.475 1.51 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -86.47 150.74 24.06 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.475 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.2 p -141.08 100.11 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.754 2.022 . . . . 0.0 109.344 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.38 166.97 23.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.724 1.61 . . . . 0.0 111.69 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 124.901 1.28 . . . . 0.0 109.588 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.0 152.45 48.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.318 1.047 . . . . 0.0 113.419 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.46 161.56 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.423 1.889 . . . . 0.0 111.421 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.478 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 63.7 t -61.03 -35.55 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.642 1.977 . . . . 0.0 111.56 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.35 4.83 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.98 1.312 . . . . 0.0 114.008 172.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -109.23 -59.79 1.85 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.8 -1.187 . . . . 0.0 107.888 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 16' ' ' VAL . 2.1 p -44.39 -42.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.192 1.797 . . . . 0.0 112.971 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 t -60.04 -11.65 6.38 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -115.57 -33.93 5.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.654 1.982 . . . . 0.0 112.308 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -41.84 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.144 0.977 . . . . 0.0 110.731 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.5 p -59.05 -42.85 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.413 -0.804 . . . . 0.0 112.7 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -53.14 33.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.158 0.89 . . . . 0.0 110.728 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -31.86 71.99 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.14 -42.3 38.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.535 0.734 . . . . 0.0 112.964 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 48' ' ' VAL . 65.0 mt -59.47 -56.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.284 0.947 . . . . 0.0 109.522 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.03 -28.88 70.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.5 t -62.52 -47.52 83.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.365 1.066 . . . . 0.0 112.299 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.78 76.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -32.1 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.887 1.275 . . . . 0.0 111.3 170.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.19 17.37 55.73 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.657 1.122 . . . . 0.0 114.709 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.22 21.53 77.76 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.659 1.123 . . . . 0.0 115.265 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -55.36 156.86 4.05 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 119.485 1.643 . . . . 0.0 112.569 171.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 -179.45 1.07 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.468 1.507 . . . . 0.0 112.391 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -47.56 141.71 4.95 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.606 1.562 . . . . 0.0 113.251 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -132.71 171.83 13.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.811 1.244 . . . . 0.0 112.586 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -91.65 -114.63 0.08 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 109.843 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -70.64 -1.01 9.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 114.985 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.4 -41.27 39.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.152 1.381 . . . . 0.0 113.629 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.5 -30.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 118.402 -0.809 . . . . 0.0 113.001 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.29 -55.03 32.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.787 1.176 . . . . 0.0 111.632 170.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.93 -25.35 67.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.86 -0.525 . . . . 0.0 112.405 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.39 -56.35 4.71 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.2 1.0 . . . . 0.0 111.45 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 t -57.41 -26.66 61.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.823 0.738 . . . . 0.0 112.76 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -81.29 -57.38 3.52 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.304 0.956 . . . . 0.0 112.811 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -60.24 -34.79 74.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.466 -1.397 . . . . 0.0 114.073 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 27' ' ' ILE . 83.6 t -70.33 -64.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.214 1.005 . . . . 0.0 109.368 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.17 -30.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.055 1.342 . . . . 0.0 111.002 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.5 -32.56 71.55 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -114.0 -35.46 5.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.496 1.519 . . . . 0.0 112.75 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.7 m -62.03 -51.36 68.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.073 2.149 . . . . 0.0 112.108 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -42.93 98.67 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.91 0.323 . . . . 0.0 110.691 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 p -66.51 -27.01 67.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -74.29 -50.49 18.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.532 2.333 . . . . 0.0 113.309 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.41 -29.81 70.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.2 1.364 . . . . 0.0 114.045 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.2 m -57.12 -27.96 62.27 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.162 0.985 . . . . 0.0 111.444 167.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.78 -28.17 19.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.78 -33.62 74.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.062 0.545 . . . . 0.0 109.852 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.1 -98.67 2.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.635 1.588 . . . . 0.0 112.403 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -134.27 121.06 15.23 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.661 1.185 . . . . 0.0 112.788 -173.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.72 107.1 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.006 3.138 . . . . 0.0 112.977 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -146.17 170.94 15.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.351 1.861 . . . . 0.0 112.13 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -76.5 81.16 3.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.521 1.529 . . . . 0.0 111.957 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.71 138.17 46.42 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.622 1.569 . . . . 0.0 110.162 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 154.46 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.405 1.482 . . . . 0.0 109.879 171.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.84 159.19 33.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 124.613 1.165 . . . . 0.0 110.826 162.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 p -136.04 146.76 47.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.249 1.019 . . . . 0.0 110.793 157.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.4 p -136.63 143.43 43.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.313 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.05 95.78 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.877 1.271 . . . . 0.0 108.345 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mm -91.34 114.13 28.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 tpt -137.61 161.54 36.19 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.34 1.456 . . . . 0.0 110.736 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -67.47 151.98 46.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.494 -0.754 . . . . 0.0 111.37 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 1.87 1.35 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.152 2.181 . . . . 0.0 115.002 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -56.24 -21.86 26.14 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.773 1.629 . . . . 0.0 114.299 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.99 34.15 70.6 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.955 0.788 . . . . 0.0 113.897 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -177.38 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.069 1.748 . . . . 0.0 113.779 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.83 47.47 3.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.086 1.327 . . . . 0.0 114.327 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.38 125.55 24.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.909 1.354 . . . . 0.0 109.463 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -120.22 92.58 3.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.199 1.0 . . . . 0.0 109.537 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' HG13 ' A' ' 135' ' ' VAL . 31.1 m -109.98 142.89 40.73 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.028 -1.045 . . . . 0.0 109.329 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.8 140.39 34.7 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.637 -0.665 . . . . 0.0 111.945 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -139.38 127.56 22.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 p -75.07 13.09 0.74 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.899 -1.126 . . . . 0.0 113.967 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 57.4 m -58.29 164.48 2.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.585 1.554 . . . . 0.0 112.694 170.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -167.14 138.52 3.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.954 1.702 . . . . 0.0 110.331 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -83.03 149.19 27.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.752 0.821 . . . . 0.0 110.872 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -142.09 159.0 43.11 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.364 1.865 . . . . 0.0 111.123 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.9 t -114.66 -64.12 1.36 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.716 1.206 . . . . 0.0 111.201 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -87.26 -18.04 31.16 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -41.46 12.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.753 1.621 . . . . 0.0 112.738 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -164.27 -171.68 2.48 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.458 1.903 . . . . 0.0 111.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.83 140.42 14.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.883 1.706 . . . . 0.0 114.83 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.9 p -155.87 158.04 37.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.462 1.905 . . . . 0.0 111.912 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 17.8 t -146.39 160.4 42.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.506 1.522 . . . . 0.0 111.026 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -148.83 144.82 27.2 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.145 -1.597 . . . . 0.0 111.24 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -134.89 102.64 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.809 1.244 . . . . 0.0 109.427 -170.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.28 104.52 16.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.823 1.249 . . . . 0.0 112.356 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -103.86 143.82 32.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.333 1.063 . . . . 0.0 110.725 170.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.03 147.8 33.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.365 1.866 . . . . 0.0 110.996 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -141.4 -172.3 3.48 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 112.195 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -58.51 2.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.865 2.466 . . . . 0.0 114.576 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.9 t -141.45 21.71 2.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.967 1.307 . . . . 0.0 113.438 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.1 150.21 45.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.384 1.474 . . . . 0.0 111.32 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.16 128.92 49.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.298 1.839 . . . . 0.0 109.645 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.8 p -137.72 82.55 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.208 1.004 . . . . 0.0 112.773 -172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -109.8 133.45 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.027 0.931 . . . . 0.0 112.077 -173.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.54 146.33 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.226 1.81 . . . . 0.0 111.408 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -133.9 129.2 36.02 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.139 1.376 . . . . 0.0 110.067 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.82 135.92 53.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.67 1.988 . . . . 0.0 112.434 -169.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 90.7 m-85 -132.29 115.22 15.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.5 58.52 0.39 Allowed Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.862 1.696 . . . . 0.0 112.801 -167.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 113' ' ' LEU . 2.4 mm? -58.72 124.27 19.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 112.888 -168.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 126.03 1.732 . . . . 0.0 111.739 -169.957 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 111.298 0.11 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -128.96 173.11 10.71 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.51 142.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.365 1.466 . . . . 0.0 111.26 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.4 m -101.3 88.86 3.58 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.225 1.41 . . . . 0.0 110.295 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -79.96 147.9 31.42 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.26 -0.9 . . . . 0.0 110.788 164.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.444 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.7 OUTLIER -137.76 95.2 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.831 2.452 . . . . 0.0 108.743 175.244 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -139.35 169.49 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.556 1.142 . . . . 0.0 112.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 125.059 1.344 . . . . 0.0 110.127 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -127.5 154.76 44.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 113.308 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.43 158.6 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.295 1.838 . . . . 0.0 111.154 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.56 -37.52 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.157 1.783 . . . . 0.0 111.923 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.02 -22.87 66.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.366 1.066 . . . . 0.0 113.615 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -75.86 -59.16 2.88 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 169.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.16 -43.17 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.96 2.104 . . . . 0.0 112.588 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -60.38 -10.9 5.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.207 1.803 . . . . 0.0 114.695 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -114.25 -33.91 5.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.591 1.957 . . . . 0.0 112.244 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.0 mt -50.19 -42.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.843 0.857 . . . . 0.0 110.723 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.6 p -59.04 -42.65 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.389 -0.82 . . . . 0.0 112.736 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -52.73 37.11 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.222 0.919 . . . . 0.0 110.768 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -31.8 71.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.06 -42.41 38.43 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.613 0.765 . . . . 0.0 112.946 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 170' ' ' ILE . . . . . 0.413 ' HA ' HG21 ' B' ' 191' ' ' VAL . 65.1 mt -59.74 -57.02 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 119.4 1.0 . . . . 0.0 109.636 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.99 -28.53 70.16 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 t -62.64 -47.76 82.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.436 1.094 . . . . 0.0 112.281 168.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.37 -33.79 76.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -32.08 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.918 1.287 . . . . 0.0 111.392 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 62.08 17.3 55.18 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.665 1.126 . . . . 0.0 114.733 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 22.02 77.58 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.689 1.138 . . . . 0.0 115.314 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.29 157.25 3.73 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 119.386 1.593 . . . . 0.0 112.672 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.4 -179.69 1.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.384 1.474 . . . . 0.0 112.378 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -47.55 141.45 5.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.469 1.507 . . . . 0.0 113.256 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -132.33 171.75 13.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 112.444 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.57 -113.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 109.721 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 3.6 m -71.58 -1.03 12.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.242 1.817 . . . . 0.0 114.958 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -49.6 -40.92 40.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 113.626 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.9 -30.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.687 0.795 . . . . 0.0 112.868 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -62.57 -55.53 26.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.766 1.166 . . . . 0.0 111.87 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.3 -25.3 67.57 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.8 -0.562 . . . . 0.0 112.248 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -76.5 -56.17 4.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.342 1.057 . . . . 0.0 111.463 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.7 t -57.28 -26.62 61.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.936 0.789 . . . . 0.0 112.78 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.2 t -81.72 -57.78 3.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.171 0.896 . . . . 0.0 112.86 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.83 -34.78 73.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.279 1.4 . . . . 0.0 114.007 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' B' ' 170' ' ' ILE . 85.8 t -70.29 -64.12 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.105 0.962 . . . . 0.0 109.375 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -49.2 -30.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.135 1.374 . . . . 0.0 110.964 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -60.66 -32.63 71.81 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -113.59 -35.56 5.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.402 1.481 . . . . 0.0 112.797 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 48.3 m -61.63 -52.11 65.71 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.985 2.114 . . . . 0.0 111.919 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -42.48 99.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.008 0.367 . . . . 0.0 110.749 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 60.2 p -67.0 -27.17 67.21 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.84 -50.99 17.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.55 2.34 . . . . 0.0 113.247 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.96 -29.98 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.646 -1.284 . . . . 0.0 114.098 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 87.8 m -57.0 -28.31 62.33 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.154 0.982 . . . . 0.0 111.36 167.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -89.41 -28.11 19.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.95 -33.51 73.82 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.081 0.553 . . . . 0.0 109.897 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.96 -98.96 2.15 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.763 1.649 . . . . 0.0 112.398 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -134.12 121.07 15.41 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.729 1.212 . . . . 0.0 112.798 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.48 106.96 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.988 3.125 . . . . 0.0 112.709 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -146.97 172.17 14.11 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.369 1.868 . . . . 0.0 111.962 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -77.8 83.93 4.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.392 1.477 . . . . 0.0 111.854 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -74.53 142.12 44.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.306 1.443 . . . . 0.0 109.946 166.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.1 156.56 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.381 1.472 . . . . 0.0 110.129 170.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.34 159.3 28.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 110.379 165.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 19.1 p -136.93 151.23 48.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.111 157.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 18.3 p -141.12 150.4 42.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.92 1.288 . . . . 0.0 111.771 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.12 103.08 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.225 1.41 . . . . 0.0 108.341 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.491 HG23 ' HB3' ' B' ' 249' ' ' CYS . 1.4 mm -99.73 117.52 45.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.136 1.374 . . . . 0.0 107.989 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.0 tpt -142.2 147.74 37.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.654 0.781 . . . . 0.0 111.745 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -152.29 91.49 1.6 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.732 2.013 . . . . 0.0 109.646 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -59.44 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 175.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.99 -46.11 0.43 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.305 1.042 . . . . 0.0 113.665 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.51 -8.94 26.29 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.122 1.344 . . . . 0.0 115.412 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -140.01 79.02 1.69 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -171.67 21.1 0.07 OUTLIER Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 134.01 54.95 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.828 2.051 . . . . 0.0 111.572 -174.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -128.43 88.15 2.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.468 1.107 . . . . 0.0 109.3 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.571 ' HB ' HG13 ' B' ' 278' ' ' VAL . 55.5 m -107.09 142.32 36.94 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.699 -1.251 . . . . 0.0 109.579 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.25 138.03 39.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.27 0.628 . . . . 0.0 111.676 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 2.4 m -136.38 127.72 28.33 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -170.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 78.9 p -74.46 10.12 1.45 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 36.0 m -60.68 166.46 3.25 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 0.0 112.961 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -166.0 147.1 6.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.213 1.805 . . . . 0.0 110.42 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -86.44 151.53 23.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.718 0.807 . . . . 0.0 111.077 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.53 159.76 41.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.389 1.875 . . . . 0.0 112.916 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.6 t -125.18 -53.9 1.61 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.541 1.937 . . . . 0.0 112.223 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 79.2 p -104.22 -6.29 21.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.832 1.653 . . . . 0.0 113.635 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -42.74 9.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.675 1.59 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.16 -164.71 0.8 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.224 2.209 . . . . 0.0 110.611 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.82 142.5 13.96 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.373 1.463 . . . . 0.0 114.987 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 24.5 p -153.74 157.56 39.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.633 1.973 . . . . 0.0 111.997 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 19.3 t -145.22 160.27 41.73 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.786 1.634 . . . . 0.0 111.124 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 145.54 26.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.173 -1.579 . . . . 0.0 111.286 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.9 t -135.73 104.57 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.627 1.171 . . . . 0.0 109.333 -171.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.75 104.53 16.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.543 1.137 . . . . 0.0 112.126 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -98.64 140.09 33.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.227 1.013 . . . . 0.0 110.648 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.83 149.21 43.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.321 1.848 . . . . 0.0 111.018 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -143.24 -166.24 2.27 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.579 1.151 . . . . 0.0 111.398 -170.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -42.32 -61.05 1.28 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.778 2.431 . . . . 0.0 114.21 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.0 t -145.41 -6.13 0.64 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.135 1.374 . . . . 0.0 113.845 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 16.0 ptm -94.16 149.41 21.26 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.19 1.396 . . . . 0.0 110.118 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -131.83 134.49 45.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.67 1.588 . . . . 0.0 109.054 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.491 ' HB3' HG23 ' B' ' 214' ' ' ILE . 10.1 p -140.48 84.27 1.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.184 0.992 . . . . 0.0 112.07 -170.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.76 136.94 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.43 -0.793 . . . . 0.0 111.281 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.49 143.45 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.918 1.687 . . . . 0.0 110.508 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 t -131.39 127.16 36.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.694 1.198 . . . . 0.0 110.191 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -123.06 136.66 54.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.803 2.041 . . . . 0.0 112.548 -168.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.54 116.29 15.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.712 1.205 . . . . 0.0 109.146 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.98 60.8 0.34 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.68 1.61 . . . . 0.0 112.959 -166.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 256' ' ' LEU . . . . . 0.432 HD22 ' H ' ' B' ' 256' ' ' LEU . 1.8 mm? -61.73 126.95 29.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.932 1.293 . . . . 0.0 113.09 -166.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 126.153 1.781 . . . . 0.0 111.714 -169.354 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 111.297 0.11 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -129.28 173.37 10.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.697 1.599 . . . . 0.0 111.063 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 11.0 mm -56.79 144.13 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.429 1.492 . . . . 0.0 111.318 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 89.9 m -105.81 90.2 3.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.211 1.404 . . . . 0.0 110.255 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -82.76 149.82 27.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.451 -0.781 . . . . 0.0 111.021 164.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.571 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.5 p -141.29 94.69 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 127.819 2.448 . . . . 0.0 109.285 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.51 169.21 18.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.554 1.542 . . . . 0.0 112.144 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.741 1.217 . . . . 0.0 110.099 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.96 155.49 30.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.79 0.836 . . . . 0.0 110.482 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.96 156.69 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.793 1.237 . . . . 0.0 110.49 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 19' ' ' VAL . 87.1 t -57.88 -43.4 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.575 1.55 . . . . 0.0 110.824 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 7.11 0.32 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.11 1.764 . . . . 0.0 114.058 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -122.2 -54.41 1.9 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 16' ' ' VAL . 6.7 p -45.55 -44.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.706 0.802 . . . . 0.0 112.808 166.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -62.73 -11.01 14.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -106.77 -38.24 6.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.874 2.07 . . . . 0.0 112.352 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mt -49.6 -41.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.135 1.374 . . . . 0.0 110.901 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.65 -41.78 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.4 -0.812 . . . . 0.0 112.903 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -51.23 57.86 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.571 1.078 . . . . 0.0 111.087 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -30.12 71.31 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.38 -40.72 29.45 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.094 0.957 . . . . 0.0 113.39 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.04 -55.75 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.275 0.943 . . . . 0.0 109.65 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.08 -31.44 70.01 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -58.64 -50.39 74.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.892 1.277 . . . . 0.0 112.149 167.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.32 -31.7 72.16 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.57 -37.08 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.529 1.132 . . . . 0.0 110.777 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 16.98 78.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.023 0.821 . . . . 0.0 114.165 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.86 79.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.052 1.311 . . . . 0.0 115.48 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.34 168.74 5.32 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.005 1.402 . . . . 0.0 113.635 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.74 -167.61 0.49 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.732 1.613 . . . . 0.0 113.387 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -52.35 149.66 5.41 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.848 1.659 . . . . 0.0 112.864 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -144.42 172.8 12.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.828 1.251 . . . . 0.0 112.463 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.68 -92.84 0.12 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.788 1.635 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -98.17 4.02 48.99 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.961 2.504 . . . . 0.0 113.881 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -49.38 -43.89 44.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.249 1.02 . . . . 0.0 112.641 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -52.07 -36.83 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.63 1.172 . . . . 0.0 113.19 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.2 -52.96 42.99 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.467 1.107 . . . . 0.0 112.201 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.59 -23.56 67.31 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.082 -1.011 . . . . 0.0 112.904 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -77.06 -55.67 5.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.951 1.301 . . . . 0.0 111.525 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 t -57.12 -29.16 63.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.619 0.645 . . . . 0.0 112.628 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -78.34 -58.8 3.06 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.247 0.93 . . . . 0.0 112.241 170.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -59.1 -41.28 87.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 113.972 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.44 -63.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.0 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.4 -29.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.628 1.171 . . . . 0.0 110.591 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.87 -38.9 76.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -107.33 -39.87 5.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.676 1.59 . . . . 0.0 112.155 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -60.49 -50.66 72.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.271 2.228 . . . . 0.0 112.542 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.465 ' HG ' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -65.7 -35.84 81.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.232 0.539 . . . . 0.0 111.44 177.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.6 t -63.06 -40.56 98.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.469 -0.769 . . . . 0.0 112.215 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -66.22 -49.15 68.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.891 2.076 . . . . 0.0 113.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.427 HD21 HD22 ' A' ' 53' ' ' LEU . 3.9 pp -65.85 -25.8 67.36 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.717 -1.239 . . . . 0.0 114.089 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.0 m -62.87 -23.51 67.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.452 1.101 . . . . 0.0 111.469 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -91.92 -24.52 19.26 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.155 0.982 . . . . 0.0 113.257 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.92 -22.32 66.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.928 1.291 . . . . 0.0 114.381 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.67 -130.42 3.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.29 1.424 . . . . 0.0 112.444 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -64.61 120.2 63.74 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.616 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.21 120.72 5.44 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.954 3.103 . . . . 0.0 112.385 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -163.91 -171.03 2.32 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.118 1.767 . . . . 0.0 112.277 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.95 123.79 36.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.062 1.345 . . . . 0.0 111.525 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 126.9 55.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.394 1.878 . . . . 0.0 109.353 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.18 148.25 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.124 0.97 . . . . 0.0 110.203 174.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG11 ' HG ' ' A' ' 53' ' ' LEU . 34.7 m -138.36 155.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.233 1.013 . . . . 0.0 111.256 167.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -140.41 155.27 46.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.997 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 p -146.21 149.49 34.04 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.469 1.128 . . . . 0.0 112.32 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.22 123.55 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.17 1.388 . . . . 0.0 109.082 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.5 98.67 7.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.565 1.946 . . . . 0.0 107.387 -174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 ttt -110.27 157.13 19.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 0.0 110.474 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.53 133.56 53.98 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.86 1.264 . . . . 0.0 110.988 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -64.81 -9.2 18.87 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.53 -19.16 23.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.241 1.816 . . . . 0.0 114.422 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.86 42.69 0.56 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.908 1.242 . . . . 0.0 113.905 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.4 74.25 1.57 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.254 1.021 . . . . 0.0 112.27 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.66 161.58 20.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.089 1.328 . . . . 0.0 115.113 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.0 -177.78 5.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.119 1.367 . . . . 0.0 113.52 -165.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -104.99 111.91 24.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.902 0.881 . . . . 0.0 110.161 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.443 ' HB ' HG13 ' A' ' 135' ' ' VAL . 59.2 m -112.18 144.87 40.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.108 1.363 . . . . 0.0 109.425 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.02 33.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.185 0.993 . . . . 0.0 112.004 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.0 p -142.62 138.76 30.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.081 0.943 . . . . 0.0 112.347 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -81.88 17.73 1.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.797 0.839 . . . . 0.0 112.034 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.564 ' SG ' HD11 ' B' ' 209' ' ' ILE . 39.8 m -61.78 173.9 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.762 1.268 . . . . 0.0 111.676 165.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.03 149.86 14.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.854 2.062 . . . . 0.0 109.289 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -83.56 134.66 34.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.722 0.809 . . . . 0.0 109.193 170.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -138.14 119.26 14.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 109.646 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.93 -47.0 4.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.058 1.743 . . . . 0.0 113.826 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 t -106.39 -22.36 12.83 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.806 1.242 . . . . 0.0 112.979 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -30.52 30.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.007 1.723 . . . . 0.0 112.999 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.44 -165.99 1.15 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.124 2.17 . . . . 0.0 110.103 -178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.06 147.06 16.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.425 1.012 . . . . 0.0 113.073 170.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 p -162.79 150.98 14.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.923 1.289 . . . . 0.0 111.42 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 29.7 p -156.47 172.2 18.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.749 1.22 . . . . 0.0 112.246 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -154.4 150.75 28.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.358 1.063 . . . . 0.0 111.41 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.66 134.5 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.2 1.4 . . . . 0.0 109.562 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -123.61 125.74 45.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.06 1.344 . . . . 0.0 111.621 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -135.29 120.0 18.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.783 1.633 . . . . 0.0 109.938 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -82.16 153.28 26.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.335 -0.853 . . . . 0.0 111.803 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -120.74 -170.51 2.01 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 109.047 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -51.66 -54.14 31.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.0 t -138.14 -22.0 1.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.038 1.335 . . . . 0.0 114.319 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.1 ptp -92.29 177.63 6.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.807 1.243 . . . . 0.0 111.483 168.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -142.29 145.95 34.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 109.828 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 24.6 p -128.17 130.44 48.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.402 1.081 . . . . 0.0 110.869 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.05 133.39 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.157 0.983 . . . . 0.0 109.664 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.28 129.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 126.006 1.723 . . . . 0.0 109.665 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 p -126.49 148.79 49.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 67' ' ' VAL . . . -135.34 131.92 37.0 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.5 1.52 . . . . 0.0 110.973 -171.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -130.7 114.35 15.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.072 0.939 . . . . 0.0 110.031 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.05 84.05 0.49 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.638 1.59 . . . . 0.0 110.613 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.98 126.91 36.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.359 1.064 . . . . 0.0 112.737 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 125.032 1.333 . . . . 0.0 112.632 -174.569 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.446 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -118.96 170.78 8.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.541 0.736 . . . . 0.0 112.106 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.95 127.8 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.139 1.776 . . . . 0.0 111.493 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.3 m -97.62 101.54 13.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.914 1.686 . . . . 0.0 110.619 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -92.8 147.37 22.91 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.733 -1.229 . . . . 0.0 111.203 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -137.92 113.42 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.771 2.428 . . . . 0.0 109.505 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.08 141.77 42.37 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.317 -0.864 . . . . 0.0 112.15 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.099 178.567 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.34 0.591 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -65.56 164.81 13.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.311 0.577 . . . . 0.0 111.272 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.46 155.5 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.861 1.265 . . . . 0.0 110.633 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.02 -41.78 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.16 0.984 . . . . 0.0 111.61 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -25.57 68.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.92 1.288 . . . . 0.0 113.406 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -56.51 4.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.361 1.465 . . . . 0.0 110.635 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -50.81 -44.3 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.874 1.27 . . . . 0.0 112.198 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -62.06 -13.45 26.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.741 1.217 . . . . 0.0 113.621 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -100.64 -39.67 7.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.743 2.017 . . . . 0.0 112.353 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -50.85 -42.55 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.98 1.312 . . . . 0.0 110.905 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.24 -41.78 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.433 -0.792 . . . . 0.0 112.857 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -51.32 58.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.69 1.132 . . . . 0.0 111.249 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -30.29 71.44 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.54 -39.9 30.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.986 0.914 . . . . 0.0 113.448 175.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.57 -55.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.302 0.956 . . . . 0.0 109.572 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.0 -31.56 70.03 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 3.0 t -58.33 -50.45 73.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.779 1.232 . . . . 0.0 112.211 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.6 72.1 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.61 -37.22 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.504 1.121 . . . . 0.0 110.871 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.988 0.804 . . . . 0.0 114.303 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.48 17.48 77.65 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.063 1.316 . . . . 0.0 115.621 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -65.24 172.98 2.74 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 118.934 1.367 . . . . 0.0 113.625 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.25 -160.54 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.377 1.471 . . . . 0.0 112.511 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -48.26 151.42 1.03 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.851 1.66 . . . . 0.0 113.083 165.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -147.8 172.3 14.34 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.983 1.313 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.51 -92.78 0.12 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.81 1.644 . . . . 0.0 111.383 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 2.0 p -98.26 3.99 48.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.981 2.512 . . . . 0.0 113.948 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.64 -43.87 47.12 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.075 -1.015 . . . . 0.0 112.619 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.9 -37.02 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.68 1.192 . . . . 0.0 113.132 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.17 -53.29 39.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.491 1.116 . . . . 0.0 112.177 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -64.26 -23.66 67.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.072 -1.018 . . . . 0.0 112.985 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.86 -55.93 5.05 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.978 1.311 . . . . 0.0 111.541 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 8.5 t -57.14 -27.89 62.26 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.603 0.638 . . . . 0.0 112.719 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.9 t -79.45 -60.03 2.52 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.388 0.995 . . . . 0.0 112.3 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -58.13 -41.24 83.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.28 1.4 . . . . 0.0 113.975 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.81 -63.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 124.874 1.269 . . . . 0.0 109.734 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.06 -29.31 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.047 1.339 . . . . 0.0 110.907 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -59.23 -37.25 77.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -109.1 -39.03 5.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.793 1.637 . . . . 0.0 112.118 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 52.4 m -61.7 -51.73 67.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.655 2.382 . . . . 0.0 112.4 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 196' ' ' LEU . . . . . 0.491 HD13 HD11 ' B' ' 199' ' ' LEU . 0.0 OUTLIER -65.91 -36.51 83.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 117.953 0.342 . . . . 0.0 110.823 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.1 t -59.3 -43.67 92.6 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.546 -0.721 . . . . 0.0 112.203 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.46 -51.62 62.18 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.366 2.267 . . . . 0.0 113.292 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 199' ' ' LEU . . . . . 0.491 HD11 HD13 ' B' ' 196' ' ' LEU . 4.4 pp -66.07 -27.24 67.92 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 22.9 m -59.13 -37.01 76.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.132 0.573 . . . . 0.0 109.995 168.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -77.25 -25.18 51.24 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . 0.297 0.0 OUTLIER -56.01 -26.2 47.71 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.967 1.707 . . . . 0.0 114.112 178.536 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -139.69 -82.77 0.09 OUTLIER Glycine 0 CA--C 1.535 1.295 0 CA-C-N 119.62 1.1 . . . . 0.0 114.425 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.15 172.62 3.4 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 125.97 1.708 . . . . 0.0 113.64 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.0 170.85 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 166.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -56.75 112.39 1.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.329 1.452 . . . . 0.0 112.899 172.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -177.75 100.97 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.255 2.622 . . . . 0.0 111.057 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -151.67 169.26 22.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.614 1.566 . . . . 0.0 110.497 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 209' ' ' ILE . . . . . 0.564 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.2 tt -133.58 155.57 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 108.92 157.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 210' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' B' ' 253' ' ' ALA . 35.1 m -136.17 152.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 123.861 0.865 . . . . 0.0 111.105 165.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 39.7 p -133.69 158.83 42.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.84 1.256 . . . . 0.0 110.266 170.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.87 156.75 42.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.336 1.065 . . . . 0.0 112.656 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.66 127.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.408 -0.808 . . . . 0.0 110.752 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' B' ' 249' ' ' CYS . 2.4 mm -119.22 98.29 6.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 127.094 2.158 . . . . 0.0 107.356 -169.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.7 ttt -105.61 156.22 18.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.456 1.102 . . . . 0.0 110.401 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -122.42 132.04 54.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.801 1.24 . . . . 0.0 110.8 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -64.45 -9.11 16.31 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -57.31 -20.72 30.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.432 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 123.72 40.86 0.44 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.688 1.137 . . . . 0.0 114.232 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.45 70.33 1.25 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.317 1.047 . . . . 0.0 112.575 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.31 155.32 16.38 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.468 1.509 . . . . 0.0 115.597 -173.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 178.35 9.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.937 1.695 . . . . 0.0 112.624 -166.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -108.79 110.61 22.02 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.386 1.075 . . . . 0.0 111.216 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 224' ' ' THR . . . . . 0.44 ' HB ' HG13 ' B' ' 278' ' ' VAL . 55.7 m -105.67 145.2 31.37 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.266 1.026 . . . . 0.0 109.207 173.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.88 33.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 111.044 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 94.1 p -137.55 143.71 41.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.203 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.4 t -84.55 15.77 3.56 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.782 0.833 . . . . 0.0 111.885 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 31.8 m -61.23 167.7 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.169 0.988 . . . . 0.0 111.636 166.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.6 147.29 21.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.693 1.997 . . . . 0.0 109.779 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -82.64 128.55 34.44 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 0.0 108.7 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -133.04 116.42 16.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.794 1.638 . . . . 0.0 109.302 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 -47.11 5.16 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.9 1.68 . . . . 0.0 114.41 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 16.7 t -106.43 -21.02 13.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.74 1.216 . . . . 0.0 112.977 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -29.81 29.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.45 1.9 . . . . 0.0 113.356 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.1 -167.65 1.54 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.0 2.52 . . . . 0.0 109.294 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.58 146.35 16.92 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.419 1.009 . . . . 0.0 112.906 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 29.7 p -160.64 147.28 15.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.976 1.31 . . . . 0.0 111.783 170.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 11.6 p -152.35 169.28 22.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.789 1.236 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 9.6 t -155.65 151.74 27.83 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.693 -1.254 . . . . 0.0 111.645 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.67 138.86 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.24 1.416 . . . . 0.0 109.817 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -127.3 127.56 44.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.057 1.343 . . . . 0.0 111.782 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -136.5 119.63 16.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 110.04 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -81.95 153.11 26.43 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.936 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -120.93 -170.67 2.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.52 1.528 . . . . 0.0 109.079 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -51.67 -54.85 23.64 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t -137.46 -21.57 1.16 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.958 1.303 . . . . 0.0 114.245 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 20.1 ptp -93.03 178.06 5.87 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.386 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -142.43 145.97 34.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.075 1.35 . . . . 0.0 109.63 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' CYS . . . . . 0.405 ' HB3' HD12 ' B' ' 214' ' ' ILE . 25.0 p -128.22 132.8 48.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.314 1.046 . . . . 0.0 110.888 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.61 138.26 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.124 0.969 . . . . 0.0 109.925 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.3 p -127.53 128.88 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.119 1.768 . . . . 0.0 110.07 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.5 p -123.23 148.93 45.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.672 1.189 . . . . 0.0 111.453 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 253' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -136.55 139.22 42.05 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.327 1.451 . . . . 0.0 112.698 -175.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.2 121.72 15.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.631 1.172 . . . . 0.0 109.572 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -111.69 82.03 0.3 Allowed Glycine 0 N--CA 1.469 0.859 0 C-N-CA 126.316 1.913 . . . . 0.0 111.863 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.87 105.34 17.27 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.706 1.202 . . . . 0.0 113.575 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 125.092 1.357 . . . . 0.0 112.532 -169.71 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.415 0.15 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 274' ' ' LYS . . . . . 0.431 ' H ' ' HE2' ' B' ' 274' ' ' LYS 0.327 0.0 OUTLIER -127.34 177.04 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.209 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.17 129.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.176 0.99 . . . . 0.0 110.174 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 63.0 m -102.1 93.53 5.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.722 1.609 . . . . 0.0 109.953 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.89 149.59 24.7 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.329 -0.857 . . . . 0.0 111.081 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 278' ' ' VAL . . . . . 0.44 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.4 p -147.2 118.13 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.723 2.009 . . . . 0.0 109.974 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -138.64 143.97 39.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.561 1.144 . . . . 0.0 111.569 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 125.819 1.647 . . . . 0.0 108.799 178.348 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -97.23 46.37 1.03 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.121 1.369 . . . . 0.0 112.228 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -58.2 -25.49 61.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.932 -1.105 . . . . 0.0 113.505 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.25 -14.67 61.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.294 1.438 . . . . 0.0 114.302 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.86 -31.6 72.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.57 1.148 . . . . 0.0 112.912 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -115.85 178.29 4.37 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.099 1.76 . . . . 0.0 111.758 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.36 179.19 8.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.861 1.264 . . . . 0.0 110.692 174.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -127.12 150.89 49.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.706 1.602 . . . . 0.0 111.069 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.91 125.23 35.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.235 1.414 . . . . 0.0 111.807 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.43 -20.44 60.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.082 -1.011 . . . . 0.0 112.958 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.17 -25.62 63.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 t -93.98 -19.05 21.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.466 1.106 . . . . 0.0 112.771 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 132.02 48.35 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.0 -1.062 . . . . 0.0 111.824 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.25 178.57 5.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.83 1.252 . . . . 0.0 112.289 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.5 152.68 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.173 1.389 . . . . 0.0 110.916 171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.62 -43.42 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.731 1.212 . . . . 0.0 111.704 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.67 -29.85 68.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.101 1.36 . . . . 0.0 113.337 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.22 -57.34 4.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.101 0.96 . . . . 0.0 110.502 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.9 t -51.43 -40.45 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.74 1.216 . . . . 0.0 112.512 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -61.36 -19.76 62.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.76 1.624 . . . . 0.0 113.949 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.19 -35.55 10.34 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.731 1.612 . . . . 0.0 113.357 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mt -51.75 -38.88 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.277 1.031 . . . . 0.0 110.809 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 97' ' ' VAL . 9.9 p -64.1 -42.36 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.88 62.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.884 1.22 . . . . 0.0 111.299 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -32.47 71.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.3 -43.23 52.19 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.02 -55.41 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.616 1.098 . . . . 0.0 110.374 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.71 -29.77 70.96 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.422 -0.799 . . . . 0.0 113.138 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -61.24 -46.27 91.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.279 1.032 . . . . 0.0 112.236 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.34 93.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.144 0.977 . . . . 0.0 113.331 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.98 -48.0 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.254 1.021 . . . . 0.0 110.565 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.46 19.91 67.2 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.398 0.999 . . . . 0.0 115.01 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.14 20.46 77.4 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.918 1.247 . . . . 0.0 115.401 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.04 179.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 114.43 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.23 144.69 19.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.405 1.482 . . . . 0.0 113.32 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.65 121.04 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.819 1.248 . . . . 0.0 111.032 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.97 157.98 45.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.269 1.828 . . . . 0.0 111.112 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -106.44 -66.01 1.04 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.208 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -60.6 -18.51 53.42 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.943 1.297 . . . . 0.0 114.254 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.72 -38.96 79.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.036 -1.04 . . . . 0.0 113.191 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.08 -35.24 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.363 0.665 . . . . 0.0 111.943 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -62.12 -50.63 71.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.451 . . . . 0.0 111.341 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.95 -25.6 64.63 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -77.85 -54.26 6.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.01 0.823 . . . . 0.0 111.148 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -54.99 -36.08 65.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.678 0.672 . . . . 0.0 111.984 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -73.78 -56.86 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.345 0.975 . . . . 0.0 112.04 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -57.36 -40.27 77.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.98 1.312 . . . . 0.0 113.342 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.17 -63.64 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 C-N-CA 124.479 1.112 . . . . 0.0 110.524 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.76 -28.77 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.709 1.204 . . . . 0.0 110.788 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.87 -42.54 79.97 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.331 1.053 . . . . 0.0 112.667 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -103.41 -36.2 8.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.226 1.41 . . . . 0.0 112.592 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.9 m -62.89 -49.68 73.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.048 2.139 . . . . 0.0 112.355 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -36.7 83.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.709 0.404 . . . . 0.0 111.407 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 t -63.06 -42.86 99.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.486 0.714 . . . . 0.0 112.495 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -66.94 -49.38 65.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.045 1.738 . . . . 0.0 113.27 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.61 -28.03 68.83 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.68 -1.262 . . . . 0.0 113.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -57.59 -28.24 63.43 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.419 1.088 . . . . 0.0 111.151 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -89.75 -28.04 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.392 1.077 . . . . 0.0 113.285 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.85 -21.74 61.63 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.408 1.083 . . . . 0.0 112.463 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -134.72 8.61 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.373 1.94 . . . . 0.0 112.629 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -116.71 155.76 48.57 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 125.644 1.578 . . . . 0.0 112.578 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.38 114.16 3.15 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.856 3.037 . . . . 0.0 111.66 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.45 175.14 12.57 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.084 2.154 . . . . 0.0 110.808 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.74 100.42 7.08 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.231 1.413 . . . . 0.0 110.887 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.5 143.59 28.06 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.036 1.335 . . . . 0.0 109.949 168.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -133.44 153.4 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.464 1.505 . . . . 0.0 109.528 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.38 150.42 24.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.734 0.814 . . . . 0.0 111.084 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -133.78 136.67 44.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.331 1.453 . . . . 0.0 109.139 171.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 48.3 t -131.28 140.67 49.84 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.068 0.947 . . . . 0.0 111.159 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.49 101.31 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.543 1.537 . . . . 0.0 109.179 -168.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.22 95.88 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.288 1.435 . . . . 0.0 110.033 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.58 166.17 14.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.985 1.714 . . . . 0.0 112.815 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 119.47 22.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.683 1.193 . . . . 0.0 112.374 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -67.24 -11.29 57.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.084 1.354 . . . . 0.0 113.546 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -54.48 -28.61 46.0 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.996 1.719 . . . . 0.0 114.21 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.3 10.48 0.09 OUTLIER Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.05 97.82 4.57 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.107 1.454 . . . . 0.0 112.478 -165.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.31 169.08 25.96 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.197 1.856 . . . . 0.0 112.862 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.07 174.82 13.22 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.088 1.355 . . . . 0.0 113.319 -167.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.16 98.66 9.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.952 0.901 . . . . 0.0 112.08 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.481 ' HB ' HG13 ' A' ' 135' ' ' VAL . 48.3 m -95.29 139.82 31.07 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.212 -0.93 . . . . 0.0 109.637 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.06 111.77 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.949 1.7 . . . . 0.0 110.363 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 m -115.43 107.78 15.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 110.594 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -76.95 35.32 0.16 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.707 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.32 176.4 8.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.866 1.266 . . . . 0.0 111.412 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -141.17 137.63 32.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.278 1.431 . . . . 0.0 109.929 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -79.59 132.1 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.422 0.689 . . . . 0.0 109.803 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -142.68 149.0 38.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.372 1.469 . . . . 0.0 110.586 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -123.51 -60.47 1.47 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.176 1.39 . . . . 0.0 112.344 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -92.86 -26.79 17.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.017 0.927 . . . . 0.0 112.852 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -52.86 30.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.817 2.047 . . . . 0.0 113.317 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -146.87 173.87 12.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.769 2.427 . . . . 0.0 110.44 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.92 121.26 6.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.114 1.34 . . . . 0.0 113.359 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -146.85 144.84 29.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.456 1.502 . . . . 0.0 110.616 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.7 t -149.55 164.5 34.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.601 1.161 . . . . 0.0 111.184 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -162.96 150.48 13.35 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.178 -1.576 . . . . 0.0 111.143 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 23' ' ' VAL . 2.0 t -139.32 127.03 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.893 1.277 . . . . 0.0 110.113 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.76 111.74 17.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.04 1.336 . . . . 0.0 112.515 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -125.45 93.74 3.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.975 1.71 . . . . 0.0 110.678 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 151.83 29.4 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.685 1.194 . . . . 0.0 112.381 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -125.74 -175.22 3.28 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.915 1.686 . . . . 0.0 110.574 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -54.17 -50.22 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.032 1.333 . . . . 0.0 113.908 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -134.4 1.95 3.21 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.935 1.694 . . . . 0.0 113.895 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.26 156.97 32.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.292 2.237 . . . . 0.0 110.958 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -134.75 120.95 20.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.313 1.445 . . . . 0.0 110.815 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.2 m -126.16 98.31 5.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.218 1.007 . . . . 0.0 110.64 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 116.18 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.439 1.096 . . . . 0.0 111.882 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.12 137.38 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.471 1.908 . . . . 0.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -130.09 147.59 51.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.809 1.244 . . . . 0.0 111.349 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.99 140.01 39.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.796 1.639 . . . . 0.0 113.57 -170.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.55 113.61 13.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.549 1.14 . . . . 0.0 109.621 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.84 77.64 0.23 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.531 2.015 . . . . 0.0 110.734 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.06 108.92 2.8 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 111.232 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 m -135.52 111.47 9.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.736 2.014 . . . . 0.0 111.115 -171.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.76 1.35 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.947 1.299 . . . . 0.0 114.273 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.11 2.15 77.08 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.332 1.444 . . . . 0.0 116.177 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.61 16.11 60.65 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.996 1.398 . . . . 0.0 115.54 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.51 90.0 0.06 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.055 1.788 . . . . 0.0 113.398 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.1 p -139.03 -170.28 2.83 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.178 2.191 . . . . 0.0 111.685 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.08 23.13 7.53 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.444 1.021 . . . . 0.0 114.698 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.44 152.63 11.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.129 1.372 . . . . 0.0 114.62 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.8 t -72.29 -36.15 68.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.001 1.321 . . . . 0.0 113.161 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -74.16 165.17 54.79 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 123.975 0.797 . . . . 0.0 113.73 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 152.58 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.22 2.613 . . . . 0.0 111.94 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.55 146.39 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.319 1.048 . . . . 0.0 111.142 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 115.07 14.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.056 1.343 . . . . 0.0 110.779 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.1 tp -80.23 146.37 31.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.121 0.968 . . . . 0.0 110.523 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.17 -165.73 38.44 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.875 1.702 . . . . 0.0 111.443 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -127.16 164.14 22.29 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.612 1.165 . . . . 0.0 111.598 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.58 153.34 42.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.02 1.328 . . . . 0.0 111.328 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.75 176.77 8.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.44 1.896 . . . . 0.0 111.106 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.06 139.66 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.621 1.568 . . . . 0.0 111.142 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -115.7 92.88 4.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.363 1.465 . . . . 0.0 110.787 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -76.27 149.45 37.12 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.872 -1.143 . . . . 0.0 111.218 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -137.11 108.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.427 2.291 . . . . 0.0 109.636 174.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -131.89 119.8 21.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.074 1.75 . . . . 0.0 109.645 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.09 88.55 3.15 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.572 1.549 . . . . 0.0 109.902 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.5 117.69 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 110.867 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.29 -18.34 18.19 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.677 2.251 . . . . 0.0 113.279 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.01 171.28 16.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.618 2.367 . . . . 0.0 110.503 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -117.84 160.48 21.32 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.9 1.28 . . . . 0.0 111.44 166.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 mt -67.43 125.66 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.593 1.957 . . . . 0.0 110.416 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.713 1.605 . . . . 0.0 111.596 177.844 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -84.29 49.79 1.73 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.123 1.369 . . . . 0.0 113.496 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -60.01 -25.34 65.21 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.707 -1.246 . . . . 0.0 113.403 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.85 -14.43 61.43 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.275 1.43 . . . . 0.0 114.334 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.9 -31.71 72.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.556 1.142 . . . . 0.0 112.888 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -115.74 178.36 4.34 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.134 1.774 . . . . 0.0 111.871 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.2 179.18 8.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.707 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.98 151.2 48.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.72 1.608 . . . . 0.0 111.101 171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -90.34 125.07 35.41 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.272 1.429 . . . . 0.0 111.817 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.23 -20.59 60.12 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.104 -0.997 . . . . 0.0 112.994 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.11 -25.1 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.8 t -94.9 -18.97 20.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.547 1.139 . . . . 0.0 112.829 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.69 133.22 51.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.001 -1.062 . . . . 0.0 111.828 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -77.29 177.33 8.01 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.501 1.12 . . . . 0.0 112.361 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.0 152.59 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.26 1.424 . . . . 0.0 110.814 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.33 -43.2 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.0 -29.81 68.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.035 1.334 . . . . 0.0 113.357 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -73.71 -57.8 3.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 110.398 172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.6 -40.47 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.815 1.246 . . . . 0.0 112.505 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 29.3 t -61.22 -19.95 62.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.773 1.629 . . . . 0.0 113.963 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -97.96 -35.76 10.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.339 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.83 -38.69 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 110.866 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.418 HG21 HG21 ' B' ' 240' ' ' VAL . 10.0 p -64.15 -42.3 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -50.82 62.27 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.873 1.215 . . . . 0.0 111.263 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -32.47 71.14 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -43.27 52.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.95 -55.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.59 1.087 . . . . 0.0 110.336 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.64 -29.88 71.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.395 -0.816 . . . . 0.0 113.102 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.8 t -61.22 -46.3 90.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.231 1.013 . . . . 0.0 112.194 168.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.26 93.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.127 0.971 . . . . 0.0 113.319 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.97 -47.99 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.29 1.036 . . . . 0.0 110.529 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.43 19.96 67.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.391 0.996 . . . . 0.0 115.004 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.42 77.5 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.915 1.245 . . . . 0.0 115.407 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.02 179.45 0.91 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.98 1.312 . . . . 0.0 114.393 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.24 144.76 19.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.418 1.487 . . . . 0.0 113.334 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.71 120.98 15.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 110.982 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.92 157.88 45.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.321 1.848 . . . . 0.0 111.178 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -106.32 -65.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.476 1.111 . . . . 0.0 111.251 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -60.55 -18.51 52.89 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.923 1.289 . . . . 0.0 114.225 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.88 -38.86 79.78 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.981 -1.074 . . . . 0.0 113.207 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.12 -35.13 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.395 0.678 . . . . 0.0 111.982 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.16 -50.75 70.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.353 1.461 . . . . 0.0 111.277 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.89 -25.72 64.75 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -77.79 -54.29 6.52 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.012 0.824 . . . . 0.0 111.141 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -55.09 -35.71 64.89 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.64 0.655 . . . . 0.0 112.007 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -73.97 -57.34 4.04 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.372 0.987 . . . . 0.0 112.02 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.77 -40.13 75.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.037 1.335 . . . . 0.0 113.336 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.02 -63.87 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.489 1.116 . . . . 0.0 110.529 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.67 -28.9 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.741 1.217 . . . . 0.0 110.753 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.94 -41.82 78.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 0.0 112.725 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -104.12 -36.41 7.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.221 1.408 . . . . 0.0 112.514 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 35.2 m -62.59 -49.74 74.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.123 2.169 . . . . 0.0 112.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -37.15 84.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.858 0.463 . . . . 0.0 111.474 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.9 t -61.79 -46.43 89.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.438 0.695 . . . . 0.0 112.112 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -64.04 -49.36 72.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.063 1.745 . . . . 0.0 113.5 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.73 -28.21 68.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.734 -1.229 . . . . 0.0 113.595 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 82.1 m -58.3 -31.35 67.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.613 0.765 . . . . 0.0 110.85 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -84.95 -27.81 26.28 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.893 0.877 . . . . 0.0 113.088 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 27.7 mt -71.41 -20.75 62.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.502 1.121 . . . . 0.0 112.443 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.83 -136.26 9.27 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.702 2.096 . . . . 0.0 112.933 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -115.47 156.23 46.19 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.848 1.659 . . . . 0.0 112.427 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.75 110.85 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.879 3.053 . . . . 0.0 111.738 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.59 173.92 12.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.952 2.101 . . . . 0.0 110.892 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -74.31 96.2 2.79 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.074 1.35 . . . . 0.0 111.8 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -81.91 153.77 26.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.251 1.421 . . . . 0.0 111.413 164.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.26 153.72 10.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.939 2.096 . . . . 0.0 108.681 167.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.64 151.54 22.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.999 0.919 . . . . 0.0 110.912 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.5 p -132.82 137.56 46.79 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.232 1.413 . . . . 0.0 109.229 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 47.7 t -132.26 145.04 51.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.272 1.029 . . . . 0.0 111.124 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.16 106.73 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.625 1.57 . . . . 0.0 108.782 -167.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 mm -101.18 94.7 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.086 1.355 . . . . 0.0 109.688 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 166.27 14.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.014 1.725 . . . . 0.0 112.6 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.25 121.16 24.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.524 1.13 . . . . 0.0 112.571 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -67.95 -11.17 58.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.049 1.34 . . . . 0.0 113.582 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.25 -28.04 50.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 114.212 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.64 11.5 0.1 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.48 98.5 4.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 -166.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -143.27 169.26 25.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.27 1.89 . . . . 0.0 112.874 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.14 174.64 13.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.18 1.392 . . . . 0.0 113.252 -167.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.24 100.41 11.51 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.91 0.884 . . . . 0.0 112.093 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.566 ' HB ' HG13 ' B' ' 278' ' ' VAL . 79.6 m -96.8 139.61 32.59 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.085 -1.009 . . . . 0.0 109.803 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.53 110.18 12.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.848 1.659 . . . . 0.0 109.955 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 10.1 m -112.44 108.03 17.03 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.37 1.068 . . . . 0.0 110.292 -172.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.6 t -76.96 35.52 0.16 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.62 1.168 . . . . 0.0 112.673 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 2.5 m -84.88 175.91 8.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 0.0 111.622 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.2 137.21 32.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.326 1.45 . . . . 0.0 109.932 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -78.91 130.6 35.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.373 0.669 . . . . 0.0 109.704 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -139.85 145.44 38.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.61 1.564 . . . . 0.0 110.25 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 47.6 t -120.5 -61.74 1.54 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.097 1.359 . . . . 0.0 112.419 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 9.1 t -93.26 -25.0 17.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.093 0.957 . . . . 0.0 112.797 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -52.84 30.75 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.753 2.021 . . . . 0.0 112.968 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -148.7 174.49 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.744 2.418 . . . . 0.0 110.44 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.68 120.75 6.25 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.012 1.292 . . . . 0.0 113.514 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 52.6 m -146.39 144.51 29.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.418 1.487 . . . . 0.0 110.769 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 6.9 t -149.14 164.7 33.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.695 1.198 . . . . 0.0 111.179 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 2.9 t -163.12 150.61 13.16 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.166 -1.584 . . . . 0.0 111.11 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.418 HG21 HG21 ' B' ' 166' ' ' VAL . 2.0 t -139.38 127.27 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.919 1.288 . . . . 0.0 110.109 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.91 111.91 17.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.029 1.332 . . . . 0.0 112.536 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -125.51 94.13 4.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.958 1.703 . . . . 0.0 110.678 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.76 151.87 28.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 112.39 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -125.9 -175.18 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.86 1.664 . . . . 0.0 110.551 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -54.32 -50.02 68.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.112 1.365 . . . . 0.0 113.949 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -134.61 2.02 3.16 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.953 1.701 . . . . 0.0 113.895 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.27 156.97 32.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.232 2.213 . . . . 0.0 110.879 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.82 121.4 20.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.333 1.453 . . . . 0.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 15.9 m -126.28 98.57 5.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.258 1.023 . . . . 0.0 110.551 -175.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 117.74 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.255 1.022 . . . . 0.0 111.85 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.0 137.99 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.558 1.943 . . . . 0.0 111.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.2 t -131.32 147.4 52.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.861 1.264 . . . . 0.0 111.382 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.44 38.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.725 1.61 . . . . 0.0 113.543 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.91 110.08 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -105.29 77.94 0.26 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.237 1.875 . . . . 0.0 110.669 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.73 108.69 2.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.402 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 33.6 m -135.5 112.56 10.36 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.792 2.037 . . . . 0.0 111.137 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.4 pp -104.71 1.38 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.884 1.274 . . . . 0.0 114.193 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.83 2.31 74.81 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.325 1.441 . . . . 0.0 116.21 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.18 60.65 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 118.995 1.397 . . . . 0.0 115.466 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -62.61 90.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.022 1.772 . . . . 0.0 113.432 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 90.4 p -138.94 -170.2 2.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.211 2.204 . . . . 0.0 111.722 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.01 7.58 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.479 1.037 . . . . 0.0 114.712 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.52 152.64 11.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.087 1.355 . . . . 0.0 114.608 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 t -72.35 -36.12 68.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.971 1.309 . . . . 0.0 113.161 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -74.22 165.22 54.78 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 123.992 0.805 . . . . 0.0 113.683 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.49 152.74 65.72 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.949 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.8 146.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.33 1.052 . . . . 0.0 111.12 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 115.13 14.84 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.07 1.348 . . . . 0.0 110.824 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 57.9 tp -80.24 146.5 31.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.134 0.974 . . . . 0.0 110.546 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.02 -165.76 38.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.901 1.715 . . . . 0.0 111.431 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -127.48 164.48 21.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.608 1.163 . . . . 0.0 111.611 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -125.21 152.96 43.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.04 1.336 . . . . 0.0 111.315 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.73 177.31 7.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.546 1.939 . . . . 0.0 111.098 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.08 139.33 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.561 1.544 . . . . 0.0 111.259 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.1 m -114.84 90.76 3.42 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.343 1.457 . . . . 0.0 110.562 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.95 149.99 37.57 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.814 -1.178 . . . . 0.0 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.6 p -143.17 108.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.607 1.963 . . . . 0.0 110.407 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -130.02 120.02 24.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.896 2.078 . . . . 0.0 109.142 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -99.55 98.92 7.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.573 1.149 . . . . 0.0 108.536 167.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.45 116.51 4.74 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.82 2.347 . . . . 0.0 110.533 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.54 -18.5 19.92 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.512 2.141 . . . . 0.0 113.325 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 171.81 15.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.616 2.367 . . . . 0.0 110.658 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -118.27 160.54 21.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.92 1.288 . . . . 0.0 111.604 166.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.68 126.03 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.661 1.984 . . . . 0.0 110.437 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 125.706 1.602 . . . . 0.0 111.612 177.621 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -87.62 5.45 39.48 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -170.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.1 mmm -62.98 -53.75 49.03 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.676 -1.265 . . . . 0.0 112.419 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -69.02 -16.58 63.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.75 -20.95 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.853 0.861 . . . . 0.0 112.464 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -99.09 143.97 28.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.613 1.165 . . . . 0.0 111.492 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -153.02 -177.34 6.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.913 1.685 . . . . 0.0 109.916 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.05 164.51 27.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 0.0 112.867 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.06 124.33 21.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.201 1.401 . . . . 0.0 112.201 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.26 -16.99 44.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.834 1.654 . . . . 0.0 114.06 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -82.6 -37.9 24.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.853 -1.154 . . . . 0.0 112.342 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 t -73.12 -13.9 61.28 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.463 1.905 . . . . 0.0 112.829 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 139.63 58.79 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.769 -1.207 . . . . 0.0 111.217 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -101.55 172.02 7.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.147 0.979 . . . . 0.0 111.07 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.95 146.21 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.15 1.38 . . . . 0.0 109.763 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.9 t -60.48 -38.52 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.496 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.56 -29.15 68.98 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.86 1.264 . . . . 0.0 113.74 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.36 -58.23 3.45 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.933 0.893 . . . . 0.0 110.426 171.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.496 HG13 HD22 ' A' ' 56' ' ' LEU . 52.3 t -52.03 -44.01 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.319 1.447 . . . . 0.0 112.095 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.26 -12.8 44.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.127 1.771 . . . . 0.0 113.834 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -101.95 -31.98 10.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 113.133 171.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mt -51.59 -43.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.052 0.941 . . . . 0.0 110.451 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.65 -42.56 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -52.48 56.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.037 1.29 . . . . 0.0 110.805 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.18 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.55 -38.5 70.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.074 0.949 . . . . 0.0 113.089 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' A' ' 48' ' ' VAL . 50.2 mt -61.06 -57.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.329 0.968 . . . . 0.0 110.057 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.82 -28.75 70.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 t -59.73 -46.57 88.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.72 1.208 . . . . 0.0 112.386 168.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.16 79.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.92 0.888 . . . . 0.0 113.151 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.6 mt -67.72 -40.18 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.346 1.058 . . . . 0.0 111.728 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.96 12.85 58.43 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.837 1.208 . . . . 0.0 114.992 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.84 15.52 73.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.723 1.154 . . . . 0.0 114.766 -172.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.61 -175.79 0.71 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.203 1.401 . . . . 0.0 112.369 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.16 107.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.402 1.481 . . . . 0.0 112.616 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -70.52 100.01 1.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.534 1.534 . . . . 0.0 111.109 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.5 164.87 11.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.645 1.178 . . . . 0.0 111.738 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -73.42 -55.75 5.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -68.21 -21.05 64.88 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.623 -0.673 . . . . 0.0 112.559 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -58.61 -44.03 89.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 168.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -54.81 -34.61 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.393 0.997 . . . . 0.0 112.048 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.2 -49.92 65.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.086 0.954 . . . . 0.0 111.936 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.01 -26.0 66.57 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.565 -0.709 . . . . 0.0 112.813 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -76.71 -53.62 7.73 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.308 1.043 . . . . 0.0 111.247 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 t -58.27 -26.78 63.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -81.46 -57.38 3.5 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.597 1.09 . . . . 0.0 112.542 169.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -57.83 -38.36 75.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 113.74 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 27' ' ' ILE . 88.0 t -68.02 -62.55 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 123.841 0.856 . . . . 0.0 110.343 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.9 t -48.95 -29.67 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.983 1.313 . . . . 0.0 110.82 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.01 -42.99 86.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.534 0.733 . . . . 0.0 112.788 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -103.87 -34.75 8.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.216 1.406 . . . . 0.0 113.149 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -59.17 -53.96 52.43 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.323 1.849 . . . . 0.0 111.487 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -37.78 83.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.961 0.505 . . . . 0.0 111.979 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 p -70.92 -29.93 66.11 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.92 -51.89 19.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.484 2.314 . . . . 0.0 112.968 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.496 HD22 HG13 ' A' ' 19' ' ' VAL . 4.3 pp -64.78 -25.6 67.99 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.865 -1.147 . . . . 0.0 113.731 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 m -59.95 -33.58 72.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.143 0.977 . . . . 0.0 110.939 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -82.09 -28.42 32.33 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.39 -16.56 63.53 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.64 -120.67 4.55 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.247 1.88 . . . . 0.0 112.544 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -131.64 152.38 80.3 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 126.376 1.87 . . . . 0.0 111.631 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.31 109.42 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.953 3.102 . . . . 0.0 112.108 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -148.04 161.56 41.14 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.705 1.202 . . . . 0.0 112.57 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -69.17 92.6 0.56 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.193 1.397 . . . . 0.0 110.828 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -70.5 165.02 23.52 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.629 -0.67 . . . . 0.0 112.038 164.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' B' ' 228' ' ' CYS . 4.5 tt -144.43 159.88 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.696 1.598 . . . . 0.0 110.092 167.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 110' ' ' ALA . 34.9 m -139.67 148.11 23.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.3 1.44 . . . . 0.0 110.776 171.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 124.62 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.141 1.776 . . . . 0.0 108.642 175.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.09 151.0 49.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.77 100.0 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.028 1.731 . . . . 0.0 109.012 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 mm -97.27 109.69 23.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.456 ' HG3' HD21 ' A' ' 79' ' ' LEU . 8.3 ttm -124.11 154.78 39.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.747 1.219 . . . . 0.0 110.748 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.59 150.53 36.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.889 1.276 . . . . 0.0 111.833 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -90.66 3.45 54.17 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.11 1.364 . . . . 0.0 113.498 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -67.74 -18.53 64.92 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.162 1.785 . . . . 0.0 115.072 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.55 -1.75 2.14 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.201 1.24 . . . . 0.0 116.201 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.6 122.74 12.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.819 1.81 . . . . 0.0 111.79 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.59 112.82 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.023 1.297 . . . . 0.0 113.163 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.628 HD22 HD22 ' B' ' 222' ' ' LEU . 0.2 OUTLIER -140.38 151.73 45.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.13 2.572 . . . . 0.0 109.597 -172.207 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -118.4 104.94 11.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.692 1.597 . . . . 0.0 108.713 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 135' ' ' VAL . 1.8 m -123.75 117.94 26.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.425 0.69 . . . . 0.0 109.629 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.42 118.96 32.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.607 0.763 . . . . 0.0 110.768 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -122.56 111.95 17.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.105 1.362 . . . . 0.0 110.024 -173.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.0 m -73.91 22.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.081 -1.012 . . . . 0.0 113.698 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.5 m -66.19 166.5 11.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 112.117 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.2 159.78 36.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.787 2.035 . . . . 0.0 109.773 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -87.17 141.66 28.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.803 0.841 . . . . 0.0 110.374 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.37 158.49 43.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.086 1.354 . . . . 0.0 112.475 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.1 t -135.05 -56.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.03 1.332 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -86.43 -28.77 23.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.223 0.919 . . . . 0.0 112.637 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.4 -43.34 73.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.937 1.695 . . . . 0.0 112.684 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -161.42 -164.54 1.15 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.189 1.796 . . . . 0.0 111.552 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.57 124.92 7.77 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.097 1.808 . . . . 0.0 114.734 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -145.97 178.41 8.21 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.998 2.119 . . . . 0.0 111.764 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 32.7 t -166.59 135.39 2.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.399 1.48 . . . . 0.0 109.811 162.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -143.95 147.37 33.85 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.869 -1.769 . . . . 0.0 112.303 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.3 144.66 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 110.249 -169.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -138.6 113.14 8.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.312 1.445 . . . . 0.0 111.802 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -124.36 105.84 9.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.282 1.833 . . . . 0.0 110.472 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.75 165.75 16.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.107 0.963 . . . . 0.0 111.66 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.03 -178.77 5.61 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.772 1.229 . . . . 0.0 111.673 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -50.06 -56.56 10.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 113.776 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.0 t -133.71 -15.58 2.38 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.555 1.542 . . . . 0.0 113.744 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.1 ptp -104.68 178.74 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.989 1.716 . . . . 0.0 111.089 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.35 157.57 43.63 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.295 -0.878 . . . . 0.0 111.399 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.9 m -131.45 125.49 32.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.962 1.305 . . . . 0.0 110.462 -171.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -125.75 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.341 1.056 . . . . 0.0 110.633 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.39 109.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 126.146 1.778 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.7 t -108.77 126.95 53.58 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.185 1.394 . . . . 0.0 110.878 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -123.44 157.18 34.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.484 1.914 . . . . 0.0 112.705 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -143.06 158.84 43.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.967 1.307 . . . . 0.0 111.822 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.05 89.07 0.08 OUTLIER Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.311 1.434 . . . . 0.0 111.233 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.79 89.17 1.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.486 1.514 . . . . 0.0 111.404 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 t -75.58 98.89 4.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.07 1.348 . . . . 0.0 112.957 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.8 -4.66 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.025 1.33 . . . . 0.0 114.518 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.03 2.41 26.67 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.09 33.03 7.13 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.198 1.499 . . . . 0.0 114.211 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.5 97.01 0.16 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.491 1.52 . . . . 0.0 112.905 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -124.67 -163.91 1.22 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.616 1.966 . . . . 0.0 111.828 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.12 -0.2 33.46 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.716 1.627 . . . . 0.0 115.431 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -172.51 0.61 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.728 1.211 . . . . 0.0 112.511 169.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.6 t -56.4 -24.45 44.89 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 114.017 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.34 0.44 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.132 1.825 . . . . 0.0 112.257 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.91 159.45 52.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.359 2.706 . . . . 0.0 112.61 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.6 97.79 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 125.782 1.633 . . . . 0.0 112.376 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 107.23 9.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.803 1.641 . . . . 0.0 114.284 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -151.23 173.01 14.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.237 2.615 . . . . 0.0 111.883 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.45 73.05 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.779 1.181 . . . . 0.0 113.437 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.15 72.9 1.41 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.853 1.661 . . . . 0.0 111.962 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.75 159.46 24.22 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.045 1.338 . . . . 0.0 112.463 166.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -137.29 177.9 7.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.694 2.797 . . . . 0.0 111.083 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.66 130.89 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.021 1.728 . . . . 0.0 111.075 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.5 m -97.19 90.55 5.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.146 1.378 . . . . 0.0 110.153 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.49 146.6 34.3 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.817 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -129.71 140.72 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.97 1.708 . . . . 0.0 110.46 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -149.41 143.96 26.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.927 1.291 . . . . 0.0 112.07 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -134.42 96.57 15.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.377 1.471 . . . . 0.0 110.078 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.61 164.43 35.74 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.15 2.567 . . . . 0.0 112.006 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.5 -48.33 1.67 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.099 2.533 . . . . 0.0 113.162 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -160.98 -57.05 0.05 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.962 1.705 . . . . 0.0 111.373 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 172.61 13.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.58 1.952 . . . . 0.0 112.129 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.07 168.06 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.396 1.478 . . . . 0.0 112.172 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.408 1.883 . . . . 0.0 112.115 -179.206 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 49.7 m -89.64 5.69 44.61 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.233 1.413 . . . . 0.0 114.432 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 84.7 mmm -63.65 -53.53 50.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.851 -1.155 . . . . 0.0 112.313 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.78 -16.68 63.87 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.68 -21.13 62.62 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.853 0.861 . . . . 0.0 112.444 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -99.04 143.9 28.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.59 1.156 . . . . 0.0 111.496 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -153.03 -177.28 6.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.927 1.691 . . . . 0.0 109.94 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.15 164.69 27.11 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.928 1.291 . . . . 0.0 112.874 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.03 124.15 20.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.16 -17.04 44.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 113.937 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.34 -38.23 24.55 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.866 -1.146 . . . . 0.0 112.325 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.1 t -72.92 -14.33 61.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.391 1.877 . . . . 0.0 112.674 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.95 138.14 58.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.771 -1.206 . . . . 0.0 111.254 174.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -99.83 172.0 7.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.207 1.003 . . . . 0.0 111.143 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.19 146.36 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.142 1.377 . . . . 0.0 109.782 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.4 -38.69 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.261 -0.899 . . . . 0.0 111.501 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.5 -29.11 68.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.884 1.274 . . . . 0.0 113.814 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.38 -58.41 3.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.929 0.891 . . . . 0.0 110.376 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.498 HG13 HD22 ' B' ' 199' ' ' LEU . 53.3 t -52.08 -43.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.35 1.46 . . . . 0.0 112.122 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.1 t -64.14 -12.72 42.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 113.9 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -102.16 -31.96 10.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.782 1.633 . . . . 0.0 113.133 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 23.0 mt -51.41 -43.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 110.464 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.72 -42.51 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -52.32 57.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.037 1.289 . . . . 0.0 110.975 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -34.34 76.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.41 -38.47 71.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.159 0.984 . . . . 0.0 113.119 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' B' ' 191' ' ' VAL . 49.8 mt -61.0 -58.05 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.242 0.928 . . . . 0.0 109.975 172.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.68 -28.93 70.27 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.559 -0.713 . . . . 0.0 112.889 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -59.54 -46.67 88.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.769 1.227 . . . . 0.0 112.401 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.16 79.95 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.923 0.889 . . . . 0.0 113.146 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.71 -40.2 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.317 1.047 . . . . 0.0 111.774 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.02 12.73 58.26 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.865 1.221 . . . . 0.0 115.026 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.96 15.51 74.14 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.76 1.171 . . . . 0.0 114.762 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.72 -175.7 0.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.171 1.388 . . . . 0.0 112.34 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 107.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.316 1.446 . . . . 0.0 112.653 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -70.39 99.86 1.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.632 1.573 . . . . 0.0 111.14 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.53 164.85 11.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.623 1.169 . . . . 0.0 111.738 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -73.35 -55.9 5.78 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.4 m -67.92 -21.21 65.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.516 -0.74 . . . . 0.0 112.54 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -58.48 -44.04 89.22 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.91 -34.58 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.36 0.982 . . . . 0.0 112.039 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -65.97 -50.08 65.58 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.073 0.949 . . . . 0.0 111.943 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.04 -26.09 66.59 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.517 -0.739 . . . . 0.0 112.711 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -76.59 -53.51 7.95 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 111.314 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.5 t -58.42 -26.48 63.34 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.6 t -81.57 -57.94 3.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.625 1.102 . . . . 0.0 112.579 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -57.36 -38.19 73.8 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' B' ' 170' ' ' ILE . 87.8 t -68.08 -62.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 123.857 0.863 . . . . 0.0 110.276 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.95 -29.68 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.018 1.327 . . . . 0.0 110.852 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.06 -42.8 86.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.428 0.691 . . . . 0.0 112.826 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.02 -34.76 8.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 113.085 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 18.6 m -59.14 -53.88 53.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.38 1.872 . . . . 0.0 111.452 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -38.19 84.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.039 0.536 . . . . 0.0 111.94 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 37.2 p -70.78 -29.74 66.03 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -72.14 -51.91 19.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.475 2.31 . . . . 0.0 113.045 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.498 HD22 HG13 ' B' ' 162' ' ' VAL . 4.4 pp -65.03 -25.8 67.99 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.808 -1.183 . . . . 0.0 113.706 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 60.2 m -59.33 -34.79 72.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.051 0.94 . . . . 0.0 110.676 167.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -81.12 -28.38 35.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.2 -16.58 63.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.33 1.052 . . . . 0.0 113.074 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.9 -117.21 4.22 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.036 1.779 . . . . 0.0 112.558 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -132.96 158.92 74.61 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 126.716 2.006 . . . . 0.0 111.474 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.04 110.09 3.01 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.572 2.848 . . . . 0.0 112.286 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.84 165.18 29.64 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.687 1.595 . . . . 0.0 111.965 173.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -72.7 98.04 2.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.632 1.173 . . . . 0.0 110.425 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -74.39 164.56 26.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.268 0.556 . . . . 0.0 111.937 165.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 4.2 tt -145.09 159.31 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.851 1.66 . . . . 0.0 109.991 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' B' ' 253' ' ' ALA . 35.1 m -140.18 147.9 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 125.317 1.447 . . . . 0.0 110.695 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 123.26 14.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.054 1.742 . . . . 0.0 108.616 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.1 p -126.46 150.26 48.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.14 103.19 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.153 1.781 . . . . 0.0 109.002 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.45 108.97 24.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.8 ttm -123.91 162.79 22.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.765 1.226 . . . . 0.0 110.951 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.82 44.23 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 112.277 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -90.62 1.81 56.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -67.71 -18.8 65.03 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.012 1.725 . . . . 0.0 115.078 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.04 -1.41 2.22 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.19 125.26 19.89 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.767 1.783 . . . . 0.0 111.563 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -130.32 112.19 1.25 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.944 1.259 . . . . 0.0 112.999 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.628 HD22 HD22 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -139.17 153.37 47.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.148 2.579 . . . . 0.0 109.591 -172.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -119.55 102.18 8.46 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 108.79 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 1.4 m -121.4 123.59 42.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.015 0.926 . . . . 0.0 109.121 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.59 119.89 29.33 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.172 0.589 . . . . 0.0 111.011 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -122.47 112.38 17.98 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.022 1.329 . . . . 0.0 109.988 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 70.5 m -74.11 23.22 0.08 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' CYS . . . . . 0.426 ' SG ' HD11 ' A' ' 66' ' ' ILE . 20.6 m -67.18 167.03 12.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.639 1.176 . . . . 0.0 112.109 167.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.59 161.73 37.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.126 2.17 . . . . 0.0 109.73 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -88.66 141.64 28.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.92 0.888 . . . . 0.0 110.275 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -146.01 157.56 43.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.088 1.355 . . . . 0.0 112.544 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.0 t -127.14 -61.09 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.2 1.4 . . . . 0.0 112.133 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 82.7 p -95.34 -21.67 18.24 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -40.69 86.69 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.89 1.276 . . . . 0.0 111.608 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -162.04 -163.79 0.99 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 126.636 1.974 . . . . 0.0 111.026 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.27 9.04 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.061 1.791 . . . . 0.0 114.489 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 87.3 p -148.12 178.18 8.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 111.576 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 31.4 t -166.84 134.71 2.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 109.82 162.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -143.36 147.19 34.29 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.9 -1.75 . . . . 0.0 112.362 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.85 144.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.665 1.186 . . . . 0.0 110.175 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -138.73 113.1 8.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.145 1.378 . . . . 0.0 111.823 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -124.9 103.81 8.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.266 1.827 . . . . 0.0 110.346 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.17 165.99 6.61 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.83 0.852 . . . . 0.0 112.588 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -140.36 -177.73 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.301 1.44 . . . . 0.0 111.465 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -49.81 -56.73 9.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.584 . . . . 0.0 113.852 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.6 t -133.51 -16.71 2.34 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.69 1.596 . . . . 0.0 113.552 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.3 ptp -104.05 -179.32 3.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.196 1.798 . . . . 0.0 111.162 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -149.25 161.27 42.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.008 0.923 . . . . 0.0 111.578 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 32.2 m -132.77 124.95 29.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.425 1.49 . . . . 0.0 110.051 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.08 136.55 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.095 0.958 . . . . 0.0 110.539 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.95 108.03 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.972 1.709 . . . . 0.0 111.093 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.5 t -107.06 123.53 48.35 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.107 1.363 . . . . 0.0 110.775 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -118.33 158.14 25.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.41 1.884 . . . . 0.0 112.368 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -142.18 156.54 45.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.648 1.179 . . . . 0.0 112.034 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -171.3 88.91 0.08 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.722 0.677 . . . . 0.0 113.119 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.69 91.87 2.94 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.612 1.165 . . . . 0.0 110.777 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.3 t -84.96 98.72 10.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.187 1.395 . . . . 0.0 112.183 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -3.83 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -175.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -74.03 3.64 36.27 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.741 1.162 . . . . 0.0 115.898 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.64 33.45 7.09 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.377 1.589 . . . . 0.0 114.359 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -62.47 97.6 0.18 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.394 1.473 . . . . 0.0 112.985 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 9.6 t -125.62 -164.35 1.29 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.628 1.971 . . . . 0.0 111.95 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 109.55 -0.65 30.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.759 1.647 . . . . 0.0 115.309 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -171.32 0.65 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.767 1.227 . . . . 0.0 112.525 170.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 8.7 t -55.65 -27.21 48.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.501 1.52 . . . . 0.0 114.24 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 129.96 -72.31 0.48 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.798 1.666 . . . . 0.0 112.519 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 153.54 67.37 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.069 2.513 . . . . 0.0 112.053 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.72 158.58 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.34 1.056 . . . . 0.0 111.272 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 168.24 9.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.036 1.335 . . . . 0.0 112.048 167.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.3 mt -72.51 169.42 16.5 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.45 1.1 . . . . 0.0 112.17 170.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.78 165.62 20.75 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.548 1.547 . . . . 0.0 112.986 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.08 88.15 2.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.717 2.007 . . . . 0.0 109.76 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -151.78 157.3 41.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.096 1.358 . . . . 0.0 111.703 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -135.68 177.92 7.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.682 2.393 . . . . 0.0 111.111 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.8 mm -53.01 130.24 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.981 1.712 . . . . 0.0 111.106 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 32.0 m -96.26 86.48 4.23 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.098 1.359 . . . . 0.0 110.114 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.14 145.47 27.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.809 0.844 . . . . 0.0 110.883 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.0 136.86 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.121 1.768 . . . . 0.0 110.964 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -143.74 144.69 31.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.497 1.519 . . . . 0.0 112.109 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.5 97.43 15.99 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.23 1.412 . . . . 0.0 110.522 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.05 164.5 35.47 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.18 2.587 . . . . 0.0 112.076 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.93 -49.28 1.09 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.198 2.599 . . . . 0.0 113.252 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -160.49 -57.45 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.009 1.724 . . . . 0.0 111.495 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.36 172.61 13.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.599 1.96 . . . . 0.0 112.167 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.69 168.08 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 0.0 112.203 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.346 1.858 . . . . 0.0 112.031 -179.041 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.504 ' HG ' ' N ' ' B' ' 144' ' ' GLY . 3.3 p -152.61 103.38 2.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 112.3 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.01 -35.07 77.46 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.282 1.433 . . . . 0.0 113.132 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.45 -17.06 64.25 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.99 -16.97 57.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.946 . . . . 0.0 113.254 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.62 140.08 58.83 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.288 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.08 176.76 8.56 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.999 1.719 . . . . 0.0 110.706 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.28 30.23 7.45 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.813 1.645 . . . . 0.0 112.933 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.71 19.33 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.716 2.406 . . . . 0.0 116.048 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.45 -28.16 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.472 1.509 . . . . 0.0 113.014 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -73.66 -29.27 62.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -90.82 -23.75 20.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 147.21 46.06 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.33 -0.856 . . . . 0.0 112.009 170.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.92 166.3 11.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.266 1.026 . . . . 0.0 112.289 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.83 158.08 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.289 1.435 . . . . 0.0 110.584 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.3 -36.4 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.47 -32.59 58.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.687 0.795 . . . . 0.0 112.881 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.74 -54.79 5.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.096 0.558 . . . . 0.0 110.236 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 HD22 ' A' ' 56' ' ' LEU . 77.5 t -52.08 -43.8 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.952 1.301 . . . . 0.0 112.661 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -64.04 -9.45 16.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.628 1.971 . . . . 0.0 113.898 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -102.68 -38.06 7.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.551 1.54 . . . . 0.0 112.433 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.9 mt -50.08 -44.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.851 0.86 . . . . 0.0 110.474 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -59.24 -42.36 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -52.06 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.046 1.294 . . . . 0.0 111.086 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -33.41 74.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.87 59.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.192 0.997 . . . . 0.0 112.931 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' HA ' HG21 ' A' ' 48' ' ' VAL . 59.7 mt -59.75 -58.87 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.319 0.963 . . . . 0.0 109.626 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.7 -30.01 71.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -59.29 -50.66 73.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.429 1.091 . . . . 0.0 112.061 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.95 73.18 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.47 -35.76 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.478 1.111 . . . . 0.0 111.582 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.55 81.68 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.109 0.861 . . . . 0.0 114.739 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.37 3.04 56.61 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.158 1.361 . . . . 0.0 115.863 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -64.62 165.26 10.48 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 119.235 1.517 . . . . 0.0 111.694 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.77 -178.75 4.98 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.931 -1.106 . . . . 0.0 112.053 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -51.73 141.04 17.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.546 0.738 . . . . 0.0 111.285 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 165.19 24.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.361 1.065 . . . . 0.0 111.594 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -84.09 -88.3 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.824 0.849 . . . . 0.0 111.055 -171.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -78.47 -21.08 49.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.345 -1.472 . . . . 0.0 113.921 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -38.01 71.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.238 1.015 . . . . 0.0 112.445 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.17 -30.37 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -68.06 -45.29 74.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.827 0.851 . . . . 0.0 111.188 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.39 -26.4 66.43 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -76.73 -53.82 7.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.972 0.806 . . . . 0.0 111.322 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -56.0 -32.07 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.618 0.644 . . . . 0.0 112.452 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -77.65 -59.45 2.78 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.357 0.98 . . . . 0.0 112.581 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -57.08 -39.02 74.17 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.389 1.476 . . . . 0.0 113.63 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 27' ' ' ILE . 86.3 t -68.3 -63.5 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 C-N-CA 123.976 0.91 . . . . 0.0 109.97 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.88 -30.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.761 1.224 . . . . 0.0 110.621 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.44 -46.4 83.63 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.646 0.779 . . . . 0.0 112.671 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -98.23 -39.45 8.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 0.0 112.705 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -58.28 -53.09 62.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.265 2.226 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -38.07 85.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.64 0.376 . . . . 0.0 111.208 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 t -62.57 -44.58 95.98 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.329 -0.857 . . . . 0.0 112.252 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -61.38 -49.28 77.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.729 2.012 . . . . 0.0 113.048 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 19' ' ' VAL . 3.9 pp -68.77 -27.12 65.61 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.0 m -59.9 -30.68 69.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 110.918 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -82.16 -28.01 32.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.519 -0.738 . . . . 0.0 112.97 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.35 -28.87 66.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.637 0.775 . . . . 0.0 111.433 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.42 -104.61 2.3 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.771 1.653 . . . . 0.0 113.855 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HB3' HD13 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -137.31 154.44 75.5 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.114 1.766 . . . . 0.0 112.642 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.54 110.51 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.86 3.04 . . . . 0.0 111.673 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.442 ' CD1' HD11 ' A' ' 115' ' ' ILE . 1.8 t80 -148.37 170.25 18.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 112.587 173.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -71.37 116.01 11.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.644 0.778 . . . . 0.0 110.563 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -101.59 164.15 11.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.518 1.127 . . . . 0.0 110.74 165.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.429 HD11 ' SG ' ' B' ' 228' ' ' CYS . 1.0 OUTLIER -147.42 155.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.602 1.961 . . . . 0.0 108.518 171.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 110' ' ' ALA . 3.8 m -139.53 151.78 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 110.415 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.53 128.74 25.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.939 2.095 . . . . 0.0 108.862 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.4 p -131.81 145.3 51.49 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.253 -0.904 . . . . 0.0 112.66 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.64 110.25 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.468 1.507 . . . . 0.0 108.606 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' A' ' 106' ' ' CYS . 3.6 mm -109.8 95.67 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.31 1.844 . . . . 0.0 107.808 -174.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -134.5 154.15 51.58 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.654 0.782 . . . . 0.0 111.975 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.27 149.33 33.58 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.731 -0.606 . . . . 0.0 112.019 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -7.38 59.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -65.96 -36.88 84.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.473 1.909 . . . . 0.0 114.367 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.8 40.37 1.59 Allowed Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.6 1.095 . . . . 0.0 115.026 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.06 -169.94 0.67 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.173 1.389 . . . . 0.0 112.701 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.0 73.15 1.05 Allowed Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.545 -1.347 . . . . 0.0 113.939 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.12 90.85 2.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.891 2.076 . . . . 0.0 112.065 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -113.65 136.44 52.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.271 1.428 . . . . 0.0 110.181 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.441 ' HB ' HG13 ' A' ' 135' ' ' VAL . 27.9 m -145.27 147.31 32.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.902 1.281 . . . . 0.0 109.779 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.4 147.88 30.73 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.254 -0.904 . . . . 0.0 111.602 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.1 p -148.52 133.47 18.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.039 0.536 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.5 m -80.51 19.19 0.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.687 -0.633 . . . . 0.0 112.564 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.482 ' SG ' HD11 ' B' ' 209' ' ' ILE . 56.1 m -68.34 165.16 19.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.717 1.207 . . . . 0.0 112.204 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -163.02 140.11 7.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.653 1.581 . . . . 0.0 110.61 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.02 150.79 40.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.13 0.572 . . . . 0.0 110.498 171.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -140.32 152.75 46.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.62 1.568 . . . . 0.0 110.617 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.3 t -109.24 -66.31 1.07 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.197 0.999 . . . . 0.0 111.426 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.5 p -89.78 -26.68 20.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 113.027 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -77.82 -44.87 26.08 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.364 1.866 . . . . 0.0 112.92 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -148.85 -174.24 4.57 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.117 2.567 . . . . 0.0 110.686 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.98 123.24 3.97 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.618 1.58 . . . . 0.0 113.441 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.46 125.08 13.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.411 1.484 . . . . 0.0 111.337 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.43 112.24 18.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.601 1.56 . . . . 0.0 112.175 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 t -125.21 147.97 48.84 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.523 -1.361 . . . . 0.0 112.319 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.69 136.39 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.739 1.615 . . . . 0.0 109.723 -170.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.58 101.4 5.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.461 1.504 . . . . 0.0 112.022 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -110.04 129.2 55.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.23 159.37 16.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.973 0.909 . . . . 0.0 110.934 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.75 -178.4 4.48 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.599 1.56 . . . . 0.0 110.593 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -51.24 60.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.181 2.192 . . . . 0.0 113.025 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -138.48 -3.51 1.7 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.299 1.439 . . . . 0.0 114.115 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.3 ptp -126.18 -173.71 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.608 1.963 . . . . 0.0 110.746 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.29 156.41 43.8 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.341 -0.85 . . . . 0.0 111.033 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.424 ' CB ' HD12 ' A' ' 71' ' ' ILE . 4.9 p -131.33 96.15 3.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.333 1.453 . . . . 0.0 111.019 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.25 138.32 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.244 1.018 . . . . 0.0 111.413 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.41 137.03 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.309 1.844 . . . . 0.0 109.999 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.2 t -128.25 123.21 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.072 1.349 . . . . 0.0 109.853 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -110.21 150.96 27.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.606 1.162 . . . . 0.0 111.53 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.66 106.91 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.764 1.626 . . . . 0.0 107.915 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.23 88.24 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.962 1.744 . . . . 0.0 110.358 -169.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' H ' HD22 ' A' ' 113' ' ' LEU . 1.5 mm? -64.42 163.61 12.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.998 1.319 . . . . 0.0 112.218 -173.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.8 t -124.68 130.31 52.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.836 1.254 . . . . 0.0 112.381 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 61' ' ' LYS . 1.7 mp -77.56 -57.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.06 1.744 . . . . 0.0 109.549 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.97 -26.74 73.4 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.64 -0.533 . . . . 0.0 112.957 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.5 25.32 68.58 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.203 1.001 . . . . 0.0 114.16 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.0 149.16 31.05 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.898 1.237 . . . . 0.0 113.713 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -69.22 177.83 2.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.979 1.312 . . . . 0.0 113.419 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.85 20.58 5.65 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.91 1.243 . . . . 0.0 113.982 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -58.13 177.64 0.12 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.563 1.545 . . . . 0.0 112.352 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -18.95 14.74 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.93 -73.39 0.4 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.097 1.808 . . . . 0.0 111.97 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.23 157.06 62.84 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.109 2.539 . . . . 0.0 112.384 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.7 pt -110.77 148.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.861 1.664 . . . . 0.0 110.636 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 138.62 48.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.757 1.223 . . . . 0.0 110.791 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.7 mt -135.26 121.76 20.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.94 1.696 . . . . 0.0 109.49 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.75 -174.95 28.23 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.009 1.29 . . . . 0.0 113.639 -173.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.9 ttm -81.38 -178.08 6.77 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.049 1.34 . . . . 0.0 112.416 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -132.49 174.98 9.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.079 1.752 . . . . 0.0 112.421 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -121.7 168.21 12.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.925 1.69 . . . . 0.0 112.051 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mm -71.85 146.49 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.447 1.499 . . . . 0.0 110.704 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.1 m -112.79 92.7 4.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.39 1.476 . . . . 0.0 110.292 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.54 149.34 22.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.863 0.865 . . . . 0.0 111.036 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.441 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -135.9 106.75 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.522 2.329 . . . . 0.0 108.795 175.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.17 152.13 48.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.1 0.96 . . . . 0.0 111.833 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -75.47 152.23 85.48 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.794 0.837 . . . . 0.0 111.4 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.97 159.01 53.86 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.975 2.45 . . . . 0.0 112.26 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.51 -48.2 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.172 2.582 . . . . 0.0 113.232 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -159.1 -53.99 0.06 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.806 1.642 . . . . 0.0 111.938 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 170.86 11.31 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.132 1.373 . . . . 0.0 112.258 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.77 168.31 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.854 1.662 . . . . 0.0 111.884 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.054 1.742 . . . . 0.0 110.981 177.122 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLY . . . . . 0.504 ' N ' ' HG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.481 1.637 0 CA-C-O 119.503 -0.61 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.8 p -152.73 101.8 2.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.648 1.179 . . . . 0.0 112.398 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -61.36 -34.95 76.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.33 1.452 . . . . 0.0 113.074 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -65.65 -16.91 64.19 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.0 -17.01 57.62 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.046 0.938 . . . . 0.0 113.245 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.73 140.27 58.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.762 0.825 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.04 176.77 8.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.963 1.705 . . . . 0.0 110.702 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -114.32 30.2 7.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.779 1.631 . . . . 0.0 112.979 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.5 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 127.772 2.429 . . . . 0.0 116.068 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -63.48 -28.04 69.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.483 1.513 . . . . 0.0 113.059 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -73.64 -30.21 62.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.9 t -90.15 -23.84 21.22 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.92 147.78 41.98 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.403 -0.811 . . . . 0.0 112.1 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -93.67 174.38 7.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.06 0.944 . . . . 0.0 112.022 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.58 159.27 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.278 1.431 . . . . 0.0 110.766 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 89.3 t -61.95 -38.33 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.133 -0.979 . . . . 0.0 112.014 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.63 -30.31 60.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 112.877 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.87 -61.05 1.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.763 0.825 . . . . 0.0 110.75 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.537 HG13 HD22 ' B' ' 199' ' ' LEU . 77.9 t -54.06 -41.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.873 1.269 . . . . 0.0 113.124 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -62.3 -8.74 6.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.772 1.629 . . . . 0.0 113.715 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -106.17 -39.51 5.93 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.846 1.658 . . . . 0.0 112.588 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.7 -43.32 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.282 0.947 . . . . 0.0 110.533 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.34 -42.59 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -51.34 57.59 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.957 1.253 . . . . 0.0 110.98 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -33.57 74.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.0 61.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.974 0.91 . . . . 0.0 113.069 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.459 ' HA ' HG21 ' B' ' 191' ' ' VAL . 60.5 mt -59.83 -58.77 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.393 0.997 . . . . 0.0 109.645 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -63.04 -29.69 71.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 t -59.35 -50.57 73.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.466 1.106 . . . . 0.0 112.067 167.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.02 -31.79 72.89 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.68 -35.46 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.22 13.51 81.81 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.055 0.836 . . . . 0.0 114.777 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.17 3.3 56.75 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.873 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.49 164.93 10.72 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.23 1.515 . . . . 0.0 111.646 169.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.82 -178.56 4.32 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.925 -1.109 . . . . 0.0 111.995 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -51.63 139.07 21.55 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.677 -0.639 . . . . 0.0 110.908 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -179.81 4.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.714 1.206 . . . . 0.0 111.01 -175.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -96.47 -99.15 0.18 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.531 0.732 . . . . 0.0 109.998 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -66.62 -23.15 66.13 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.729 -1.232 . . . . 0.0 114.157 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -38.89 72.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.163 0.985 . . . . 0.0 112.552 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 45.2 t -54.82 -33.47 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.604 1.162 . . . . 0.0 112.512 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -66.74 -45.66 77.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.616 0.766 . . . . 0.0 111.553 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.06 -26.06 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.639 -0.663 . . . . 0.0 112.667 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -77.14 -53.14 8.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.797 0.726 . . . . 0.0 111.322 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.0 t -56.03 -31.95 63.59 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.479 0.581 . . . . 0.0 112.508 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 9.4 t -77.68 -59.81 2.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 119.361 0.982 . . . . 0.0 112.633 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -56.63 -38.59 72.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.305 1.442 . . . . 0.0 113.698 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.459 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.6 t -68.54 -63.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 123.854 0.861 . . . . 0.0 109.997 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.82 -30.57 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.741 1.217 . . . . 0.0 110.702 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -57.49 -45.72 84.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.685 0.794 . . . . 0.0 112.727 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -98.77 -39.47 8.62 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.194 1.397 . . . . 0.0 112.766 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 26.9 m -58.48 -52.17 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.294 2.238 . . . . 0.0 112.147 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -38.21 86.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.669 0.388 . . . . 0.0 111.179 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.7 t -63.12 -43.87 97.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.368 -0.832 . . . . 0.0 112.347 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.77 -48.92 78.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.826 2.05 . . . . 0.0 112.939 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.537 HD22 HG13 ' B' ' 162' ' ' VAL . 4.4 pp -69.45 -25.63 64.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.9 m -60.73 -30.6 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.934 -0.479 . . . . 0.0 110.599 166.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -81.56 -29.58 33.38 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.554 -0.716 . . . . 0.0 112.505 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.86 -17.73 63.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 112.953 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -109.92 -100.13 2.6 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.867 1.698 . . . . 0.0 113.767 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' LYS . . . . . 0.516 ' HB3' HD13 ' B' ' 258' ' ' ILE . 0.1 OUTLIER -142.65 155.23 63.53 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.837 1.655 . . . . 0.0 112.001 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.63 109.34 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 111.574 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 206' ' ' PHE . . . . . 0.451 ' CD1' HD11 ' B' ' 258' ' ' ILE . 1.7 t80 -147.37 169.92 18.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.181 0.993 . . . . 0.0 112.471 173.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -71.46 120.17 16.67 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.271 0.628 . . . . 0.0 110.388 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -106.67 163.63 12.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.821 1.249 . . . . 0.0 110.647 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' ILE . . . . . 0.482 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.2 tt -147.44 155.26 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.335 1.854 . . . . 0.0 108.708 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' B' ' 253' ' ' ALA . 4.2 m -140.05 151.13 21.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.984 0.914 . . . . 0.0 110.314 168.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.08 129.59 27.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.871 2.069 . . . . 0.0 108.921 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.44 148.41 52.4 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.165 -0.96 . . . . 0.0 112.532 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 15.6 t -136.15 115.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.071 1.349 . . . . 0.0 108.93 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' B' ' 249' ' ' CYS . 3.0 mm -112.7 94.58 3.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.595 1.958 . . . . 0.0 107.538 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 9.1 ptm -132.14 150.27 52.2 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.289 1.436 . . . . 0.0 111.757 -170.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -88.01 140.18 29.76 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.292 0.637 . . . . 0.0 112.312 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -9.23 58.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.98 -30.68 71.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.326 1.851 . . . . 0.0 114.485 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.65 29.97 5.4 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.229 0.918 . . . . 0.0 115.343 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.4 176.24 1.92 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 118.29 1.045 . . . . 0.0 111.941 163.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 59.24 1.28 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.233 1.873 . . . . 0.0 116.253 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.96 99.14 8.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.242 1.817 . . . . 0.0 110.457 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.48 132.01 55.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.262 1.425 . . . . 0.0 110.209 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.456 ' HB ' HG13 ' B' ' 278' ' ' VAL . 28.7 m -140.77 147.21 38.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.713 0.805 . . . . 0.0 110.172 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.67 147.9 33.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.476 0.655 . . . . 0.0 111.538 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 134.78 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.236 0.614 . . . . 0.0 111.529 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 29.8 m -80.9 19.15 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 173.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' A' ' 66' ' ' ILE . 56.6 m -68.24 165.13 19.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.557 1.143 . . . . 0.0 112.172 172.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -162.84 140.7 8.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.539 1.536 . . . . 0.0 110.568 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 150.22 40.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.329 0.652 . . . . 0.0 110.429 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.99 151.08 45.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.6 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.5 t -108.59 -66.42 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.148 0.979 . . . . 0.0 111.594 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 58.1 p -89.76 -26.46 20.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.815 0.846 . . . . 0.0 112.998 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.9 m -77.59 -45.14 26.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.366 1.866 . . . . 0.0 112.92 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -148.95 -174.17 4.56 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.112 2.565 . . . . 0.0 110.802 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.68 125.58 5.24 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.656 1.598 . . . . 0.0 113.358 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.72 125.82 12.91 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 111.235 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.8 p -122.06 112.26 18.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.409 1.484 . . . . 0.0 112.244 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.8 t -124.67 148.5 47.94 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.401 -1.437 . . . . 0.0 112.32 -173.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.59 136.46 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.682 1.593 . . . . 0.0 109.82 -170.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.8 99.22 4.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.381 1.472 . . . . 0.0 112.176 -169.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -108.24 124.44 50.3 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.88 1.272 . . . . 0.0 110.01 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.36 158.86 18.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -129.91 -176.71 4.01 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.744 1.618 . . . . 0.0 110.728 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -51.51 55.9 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.672 1.989 . . . . 0.0 113.394 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.6 t -138.77 -2.89 1.69 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.402 1.481 . . . . 0.0 113.855 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 13.8 ptp -127.87 -175.85 3.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.801 2.04 . . . . 0.0 110.726 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -141.41 158.33 44.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.093 0.957 . . . . 0.0 111.543 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.427 ' CB ' HD12 ' B' ' 214' ' ' ILE . 3.8 p -130.81 93.14 3.35 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.79 1.636 . . . . 0.0 110.452 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.64 136.35 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.224 1.01 . . . . 0.0 111.095 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.75 138.07 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.162 1.785 . . . . 0.0 110.249 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 t -128.68 123.07 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.082 1.353 . . . . 0.0 109.986 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -108.65 150.4 27.58 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.49 1.116 . . . . 0.0 111.423 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -128.19 105.55 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.876 1.67 . . . . 0.0 108.042 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -137.48 94.71 0.22 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.22 1.867 . . . . 0.0 109.838 -171.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.48 ' H ' HD22 ' B' ' 256' ' ' LEU . 1.6 mm? -68.57 163.88 22.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.088 0.955 . . . . 0.0 111.679 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t -125.86 129.81 50.11 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.853 1.261 . . . . 0.0 112.099 -174.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 258' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' B' ' 204' ' ' LYS . 1.7 mp -76.67 -57.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.134 1.774 . . . . 0.0 109.632 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.33 -25.82 74.67 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.976 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.34 25.46 68.49 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 118.284 1.042 . . . . 0.0 114.267 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -57.14 149.97 29.97 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.785 1.183 . . . . 0.0 113.754 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 88.2 p -69.31 177.51 2.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.877 1.271 . . . . 0.0 113.447 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 116.65 19.3 5.39 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.897 1.237 . . . . 0.0 114.147 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -58.56 177.74 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.53 1.532 . . . . 0.0 112.263 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.04 -18.72 15.27 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 139.62 -73.13 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.18 1.847 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.33 156.93 63.04 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.026 2.484 . . . . 0.0 112.416 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 24.8 pt -110.46 148.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.853 1.661 . . . . 0.0 110.657 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 138.82 48.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.757 1.223 . . . . 0.0 110.844 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 54.4 mt -135.24 121.62 20.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 109.497 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.93 -175.03 28.37 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.034 1.302 . . . . 0.0 113.581 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 8.0 ttm -81.53 -177.71 6.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.095 1.358 . . . . 0.0 112.437 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.94 175.21 9.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.1 1.76 . . . . 0.0 112.414 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -121.85 168.33 11.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.93 1.692 . . . . 0.0 112.091 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.61 147.95 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.389 1.475 . . . . 0.0 110.651 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 80.4 m -114.79 91.75 3.72 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.375 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.03 148.78 22.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.147 0.979 . . . . 0.0 110.792 168.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' B' ' 224' ' ' THR . 1.4 p -142.11 104.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.902 2.081 . . . . 0.0 109.653 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -135.7 153.87 51.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.401 1.48 . . . . 0.0 112.214 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -74.92 150.14 85.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.729 -0.607 . . . . 0.0 111.527 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 159.37 50.92 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.273 2.649 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.23 -49.22 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.195 2.597 . . . . 0.0 113.334 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -159.4 -53.97 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.743 1.617 . . . . 0.0 111.919 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.96 171.09 11.4 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.176 1.39 . . . . 0.0 112.27 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 168.54 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.835 1.654 . . . . 0.0 111.802 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.15 0 C-N-CA 126.033 1.733 . . . . 0.0 110.921 177.112 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -61.14 115.4 3.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.851 1.66 . . . . 0.0 112.445 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ttt -66.9 -40.8 87.83 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.513 -0.742 . . . . 0.0 112.093 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -15.82 63.82 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -23.29 67.22 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.471 1.109 . . . . 0.0 113.111 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -129.86 168.52 16.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.7 2.0 . . . . 0.0 111.39 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -155.87 166.9 32.09 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.245 -0.909 . . . . 0.0 112.72 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.81 51.07 1.05 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.847 1.659 . . . . 0.0 112.571 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.14 0.37 4.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.407 1.483 . . . . 0.0 114.969 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.31 -24.33 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.081 2.152 . . . . 0.0 115.124 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -18.02 18.32 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.72 1.608 . . . . 0.0 114.818 172.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 t -61.68 -32.85 73.06 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.632 1.173 . . . . 0.0 112.712 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.09 140.24 37.91 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.356 -0.84 . . . . 0.0 111.127 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -69.96 175.8 4.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.747 0.819 . . . . 0.0 111.899 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.17 146.68 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.8 1.24 . . . . 0.0 110.769 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.54 -39.31 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.154 0.982 . . . . 0.0 111.458 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.83 -28.82 69.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.767 1.227 . . . . 0.0 113.222 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.26 -58.49 3.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.558 1.143 . . . . 0.0 110.837 171.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.26 -41.16 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.485 1.114 . . . . 0.0 112.424 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -62.92 -17.4 61.72 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.255 1.422 . . . . 0.0 113.934 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -97.97 -35.16 10.55 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.767 1.627 . . . . 0.0 113.259 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 mt -50.41 -41.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.203 1.001 . . . . 0.0 110.684 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.59 -40.76 90.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -52.35 56.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.857 1.208 . . . . 0.0 111.058 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -33.01 73.51 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.89 -42.44 57.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.615 0.766 . . . . 0.0 112.984 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.57 -56.95 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.99 0.813 . . . . 0.0 109.828 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.12 -30.89 70.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.3 t -59.84 -49.65 76.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.56 1.144 . . . . 0.0 112.238 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.21 77.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.075 0.95 . . . . 0.0 113.507 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.9 -37.02 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.866 1.266 . . . . 0.0 111.613 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.37 17.59 74.46 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.145 0.878 . . . . 0.0 114.599 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.11 78.58 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.694 1.14 . . . . 0.0 115.576 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.62 156.55 8.22 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 113.138 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -175.63 1.03 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.413 1.485 . . . . 0.0 112.352 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -47.99 146.75 2.37 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -136.74 178.5 7.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.067 1.347 . . . . 0.0 112.24 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -95.37 -118.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.454 1.501 . . . . 0.0 110.45 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.8 p -66.75 0.47 2.36 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.885 2.074 . . . . 0.0 115.91 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -50.52 -44.36 56.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.844 1.202 . . . . 0.0 112.761 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.2 t -55.92 -34.05 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -67.03 -51.61 52.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.451 1.023 . . . . 0.0 112.411 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.73 -25.65 68.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.49 -0.756 . . . . 0.0 112.42 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.64 -56.08 4.93 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.713 1.205 . . . . 0.0 111.629 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -22.59 63.42 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.94 -60.19 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.375 0.989 . . . . 0.0 111.905 166.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.3 -39.26 72.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.01 1.277 . . . . 0.0 113.905 -173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.19 -64.56 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 110.022 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -47.77 -30.17 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.957 1.303 . . . . 0.0 110.993 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.86 -42.83 85.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.955 0.902 . . . . 0.0 112.87 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -101.78 -39.77 7.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.611 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -57.64 -53.17 61.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.425 2.29 . . . . 0.0 112.598 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -37.11 80.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.571 0.623 . . . . 0.0 111.333 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m -65.15 -37.06 86.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -69.21 -52.12 31.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.163 1.785 . . . . 0.0 112.965 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.06 -26.46 68.57 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.858 -1.151 . . . . 0.0 113.7 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.6 m -57.48 -31.96 66.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 167.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -88.81 -25.53 22.17 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.17 -16.79 63.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.065 0.946 . . . . 0.0 113.26 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.02 -112.61 3.36 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.658 1.599 . . . . 0.0 112.77 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -132.67 152.11 79.33 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 125.422 1.489 . . . . 0.0 113.492 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.06 104.14 1.48 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.44 3.426 . . . . 0.0 112.275 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -142.81 177.9 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.297 1.839 . . . . 0.0 112.216 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -100.19 75.91 1.86 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.625 1.57 . . . . 0.0 111.35 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -67.05 147.12 53.59 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 111.009 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.664 HD11 ' SG ' ' B' ' 228' ' ' CYS . 0.7 OUTLIER -130.89 156.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.384 1.474 . . . . 0.0 109.756 170.442 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.69 158.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.491 0.716 . . . . 0.0 109.976 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.53 131.97 32.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.744 1.617 . . . . 0.0 108.973 164.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.5 p -124.92 150.33 46.68 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 167.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.34 117.88 50.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.284 1.034 . . . . 0.0 108.247 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.417 HD12 ' CB ' ' A' ' 106' ' ' CYS . 3.6 mm -114.91 120.95 65.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 107.71 -177.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -144.45 139.74 28.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.61 0.719 . . . . 0.0 111.319 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -145.79 106.73 4.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.463 1.905 . . . . 0.0 109.424 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -146.72 -58.57 0.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.754 0.821 . . . . 0.0 112.567 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -122.52 -9.96 8.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.286 1.434 . . . . 0.0 113.767 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.0 -3.85 55.95 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.315 1.435 . . . . 0.0 114.908 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.38 165.99 21.27 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 156.06 52.33 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.53 0.586 . . . . 0.0 113.966 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.05 178.95 4.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.556 1.942 . . . . 0.0 111.354 169.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.15 92.73 3.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.141 1.377 . . . . 0.0 109.791 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.565 ' HB ' HG13 ' A' ' 135' ' ' VAL . 18.7 m -108.88 147.24 32.45 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.687 -1.258 . . . . 0.0 108.871 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.63 146.18 32.15 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.232 -0.918 . . . . 0.0 112.194 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -143.16 143.12 31.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 112.883 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t -78.39 12.13 2.1 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' B' ' 209' ' ' ILE . 12.5 m -62.71 173.03 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.093 0.957 . . . . 0.0 112.394 168.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -161.63 157.1 24.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.689 1.995 . . . . 0.0 110.082 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -78.11 146.95 34.87 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.626 172.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.15 158.54 43.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.666 1.586 . . . . 0.0 111.577 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t -134.47 -57.29 0.84 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.202 1.401 . . . . 0.0 112.479 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 m -84.24 -36.81 22.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.946 0.899 . . . . 0.0 112.09 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.4 -46.86 59.17 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.743 1.617 . . . . 0.0 112.719 -172.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.07 -167.97 2.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.768 2.427 . . . . 0.0 109.923 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.43 156.06 15.88 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 124.297 0.951 . . . . 0.0 113.835 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -145.75 169.62 18.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.983 1.713 . . . . 0.0 112.243 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.3 t -166.35 158.17 13.63 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.073 1.749 . . . . 0.0 110.292 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.6 t -150.32 146.78 26.96 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 119.534 -1.979 . . . . 0.0 111.261 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.7 95.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.266 1.426 . . . . 0.0 110.661 -166.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -86.79 116.08 24.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.099 1.76 . . . . 0.0 112.366 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -126.39 113.62 17.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.725 1.61 . . . . 0.0 110.231 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.3 170.56 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.58 1.552 . . . . 0.0 112.599 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.6 -170.92 3.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.888 1.275 . . . . 0.0 112.482 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -42.92 -58.57 2.34 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.301 2.24 . . . . 0.0 114.16 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t -136.05 -29.59 1.0 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 113.099 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.57 149.8 34.81 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.925 0.89 . . . . 0.0 111.586 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -136.36 141.16 43.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.533 1.533 . . . . 0.0 109.585 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' CB ' HD12 ' A' ' 71' ' ' ILE . 1.7 p -144.24 71.92 1.33 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.695 -169.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.94 142.04 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.319 -0.863 . . . . 0.0 111.588 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.1 t -121.61 142.91 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.639 1.975 . . . . 0.0 110.335 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -138.78 122.87 17.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.889 1.675 . . . . 0.0 109.553 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.3 142.67 51.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.07 1.748 . . . . 0.0 113.586 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -140.67 125.83 18.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.073 0.949 . . . . 0.0 111.263 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.85 70.33 0.22 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 127.378 2.418 . . . . 0.0 111.394 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.64 128.91 37.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.119 0.968 . . . . 0.0 111.287 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.7 m -141.52 92.63 2.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.141 1.776 . . . . 0.0 111.779 -161.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -87.95 1.62 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.887 1.675 . . . . 0.0 114.97 -174.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.47 -5.24 77.22 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.1 1.28 61.29 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 118.833 1.317 . . . . 0.0 116.254 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -147.99 91.06 0.14 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.267 1.413 . . . . 0.0 112.791 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.8 m -118.04 103.5 9.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 110.689 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.32 -15.77 0.76 Allowed Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.776 1.655 . . . . 0.0 115.861 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -133.98 169.15 17.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.103 2.561 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 t -116.41 -14.56 10.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.939 1.696 . . . . 0.0 113.637 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.57 -175.59 27.46 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.47 151.31 86.02 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.022 2.481 . . . . 0.0 111.893 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.7 pt -123.01 147.27 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.129 1.372 . . . . 0.0 110.993 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.5 164.57 37.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.676 1.59 . . . . 0.0 112.077 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.3 mt -76.59 118.63 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.589 1.556 . . . . 0.0 109.83 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.4 -159.18 29.99 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.108 1.813 . . . . 0.0 113.055 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.82 93.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.844 0.858 . . . . 0.0 111.062 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.93 98.14 5.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.606 1.963 . . . . 0.0 110.764 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -129.22 167.11 18.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.805 1.242 . . . . 0.0 111.687 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.4 mm -51.08 132.08 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.239 2.215 . . . . 0.0 111.243 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 m -99.82 95.85 7.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.345 1.458 . . . . 0.0 109.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.64 148.39 30.27 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.377 -0.827 . . . . 0.0 111.141 166.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 81' ' ' THR . 1.5 p -131.98 89.1 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.803 2.441 . . . . 0.0 109.049 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -134.63 166.16 23.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.25 1.42 . . . . 0.0 111.714 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.33 156.08 73.12 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.273 1.429 . . . . 0.0 111.048 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.13 161.88 44.04 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.257 2.638 . . . . 0.0 112.69 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.55 -53.18 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.357 2.704 . . . . 0.0 112.854 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -160.19 -61.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.399 1.48 . . . . 0.0 111.514 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -100.88 176.19 5.37 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.91 141.17 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.319 -0.863 . . . . 0.0 111.881 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.475 1.91 . . . . 0.0 112.306 -178.174 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 3.1 p -60.26 115.54 3.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.935 1.694 . . . . 0.0 112.488 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.7 ttt -66.98 -40.6 87.47 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.505 -0.747 . . . . 0.0 112.136 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -15.78 63.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -23.39 67.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.518 1.127 . . . . 0.0 113.118 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -129.78 168.52 16.42 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.596 1.958 . . . . 0.0 111.381 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -155.9 166.79 32.43 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.21 -0.931 . . . . 0.0 112.713 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.6 51.14 1.06 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 112.531 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.21 0.33 5.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.439 1.496 . . . . 0.0 114.945 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.44 -24.16 7.39 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.007 2.123 . . . . 0.0 115.201 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -17.77 16.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.722 1.609 . . . . 0.0 114.838 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 6.0 t -61.81 -32.34 72.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.722 1.209 . . . . 0.0 112.93 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.76 144.3 33.73 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.242 -0.911 . . . . 0.0 111.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.33 173.41 10.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.577 0.751 . . . . 0.0 112.116 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 94.5 t -123.97 142.49 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.63 1.572 . . . . 0.0 109.726 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.11 -41.79 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.86 0.864 . . . . 0.0 111.552 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.06 -35.29 66.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.7 1.6 . . . . 0.0 113.348 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -72.6 -58.92 3.0 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.788 1.235 . . . . 0.0 110.746 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 80.8 t -52.19 -40.77 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.502 1.121 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -63.63 -17.82 63.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 113.982 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.37 -35.24 11.26 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.491 1.517 . . . . 0.0 113.192 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.4 mt -50.66 -41.35 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.104 0.961 . . . . 0.0 110.712 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 121.322 -0.861 . . . . 0.0 113.322 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -52.33 57.29 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.831 1.196 . . . . 0.0 110.982 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -33.0 73.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.84 -42.23 58.38 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.402 ' HA ' HG21 ' B' ' 191' ' ' VAL . 66.1 mt -60.61 -56.89 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.106 0.866 . . . . 0.0 109.786 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.2 -30.89 70.69 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.0 t -59.75 -49.75 76.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.631 1.172 . . . . 0.0 112.24 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.25 77.49 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.88 -36.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.879 1.272 . . . . 0.0 111.55 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 70.43 17.57 74.57 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.111 0.862 . . . . 0.0 114.588 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.0 78.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.705 1.145 . . . . 0.0 115.595 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -57.63 156.66 8.07 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.914 1.357 . . . . 0.0 113.101 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.5 -175.52 1.05 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.43 1.492 . . . . 0.0 112.256 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -48.1 146.97 2.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.584 1.553 . . . . 0.0 113.395 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -136.95 178.39 7.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.084 1.353 . . . . 0.0 112.276 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -95.46 -117.66 0.11 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.403 1.481 . . . . 0.0 110.492 169.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 58.5 p -66.76 0.39 2.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.855 2.062 . . . . 0.0 115.957 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -50.86 -44.58 59.63 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.793 1.179 . . . . 0.0 112.779 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.35 -34.02 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -66.7 -51.55 54.71 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.453 1.024 . . . . 0.0 112.403 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.86 -25.63 67.98 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.517 -0.739 . . . . 0.0 112.507 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -76.88 -55.91 5.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.612 1.165 . . . . 0.0 111.547 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 t -60.26 -22.1 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -82.55 -60.41 2.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.233 0.924 . . . . 0.0 111.909 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -55.92 -39.09 71.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.974 1.261 . . . . 0.0 113.905 -173.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' B' ' 170' ' ' ILE . 97.2 t -68.33 -64.51 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.52 -30.49 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.999 1.319 . . . . 0.0 111.004 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.88 -42.22 84.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.072 0.949 . . . . 0.0 112.778 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -102.95 -38.68 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.215 1.406 . . . . 0.0 112.781 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.9 m -58.97 -52.85 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.33 2.252 . . . . 0.0 112.624 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -36.04 79.8 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.553 0.615 . . . . 0.0 111.561 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.1 m -60.34 -49.77 76.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 0.0 112.327 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -60.14 -51.73 68.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.91 1.684 . . . . 0.0 113.56 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.04 -26.08 68.11 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.1 m -58.89 -34.2 71.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.615 0.766 . . . . 0.0 110.952 167.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -84.75 -24.69 28.7 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.72 -15.45 63.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.657 1.183 . . . . 0.0 113.302 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -113.05 -113.17 3.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.666 1.603 . . . . 0.0 112.762 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -130.76 153.17 81.53 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 125.774 1.63 . . . . 0.0 112.959 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.89 98.79 0.92 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.198 3.266 . . . . 0.0 112.193 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -140.01 165.84 26.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.225 1.41 . . . . 0.0 112.91 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -84.75 78.54 9.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.912 1.685 . . . . 0.0 111.644 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -59.5 156.32 13.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 112.365 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' ILE . . . . . 0.576 HD11 ' SG ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -144.13 155.96 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.185 1.794 . . . . 0.0 108.949 165.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.91 160.16 29.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.596 162.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.3 141.5 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 109.766 164.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.74 148.71 47.43 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.103 0.961 . . . . 0.0 111.41 171.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.87 104.83 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.899 1.28 . . . . 0.0 108.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' B' ' 249' ' ' CYS . 3.7 mm -101.38 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.543 1.537 . . . . 0.0 108.266 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 4.5 tpt -134.57 136.79 43.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.926 0.87 . . . . 0.0 112.322 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -143.17 100.26 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.986 2.114 . . . . 0.0 109.347 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -143.03 -63.92 0.41 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.521 0.728 . . . . 0.0 111.981 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -109.5 -22.48 11.98 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 113.439 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.9 -9.59 76.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.651 1.596 . . . . 0.0 115.03 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -143.98 81.88 1.7 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.027 1.731 . . . . 0.0 110.762 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 176.9 88.61 0.07 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.016 0.817 . . . . 0.0 112.797 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.68 124.84 7.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.755 1.622 . . . . 0.0 109.489 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.44 88.21 2.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.755 1.622 . . . . 0.0 109.101 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.697 ' HB ' HG13 ' B' ' 278' ' ' VAL . 88.5 m -106.34 144.43 33.04 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.541 -1.35 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.33 133.42 27.78 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.37 -0.831 . . . . 0.0 112.177 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.0 p -134.03 144.58 48.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.021 0.928 . . . . 0.0 113.015 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 15.6 t -78.91 12.3 2.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' CYS . . . . . 0.664 ' SG ' HD11 ' A' ' 66' ' ' ILE . 19.1 m -63.22 172.74 1.74 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.952 . . . . 0.0 112.518 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -162.42 158.15 23.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.725 2.01 . . . . 0.0 110.128 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -76.36 139.8 41.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.5 -0.75 . . . . 0.0 110.506 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -145.22 153.36 41.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.391 1.476 . . . . 0.0 111.859 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 25.8 t -128.74 -59.75 1.12 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.745 1.618 . . . . 0.0 112.499 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.0 m -83.37 -37.24 23.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.872 0.869 . . . . 0.0 111.867 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -51.72 43.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.856 1.662 . . . . 0.0 112.023 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.01 -171.13 3.75 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.732 2.413 . . . . 0.0 109.791 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.54 154.4 16.53 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.308 0.956 . . . . 0.0 114.176 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 85.7 p -144.75 168.45 20.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.24 1.816 . . . . 0.0 112.068 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.6 t -166.23 157.62 13.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.043 1.737 . . . . 0.0 110.185 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.1 t -150.05 146.53 27.01 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.368 -2.082 . . . . 0.0 111.37 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.41 92.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.205 1.402 . . . . 0.0 110.611 -166.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -84.73 115.02 22.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.107 1.763 . . . . 0.0 112.32 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -124.63 117.26 23.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.474 1.51 . . . . 0.0 110.006 172.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -103.05 170.73 7.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.719 1.607 . . . . 0.0 112.425 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.75 -173.66 4.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.896 1.278 . . . . 0.0 112.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -40.16 -58.36 1.49 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 127.422 2.289 . . . . 0.0 114.031 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.2 t -136.39 -20.95 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.816 1.647 . . . . 0.0 113.341 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 21.9 ptm -90.18 132.93 35.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.871 1.268 . . . . 0.0 111.699 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.22 131.9 55.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.124 1.37 . . . . 0.0 109.873 172.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.458 ' HB3' HG23 ' B' ' 214' ' ' ILE . 1.6 p -137.95 68.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.593 1.557 . . . . 0.0 111.941 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pp -85.36 138.27 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.122 0.969 . . . . 0.0 111.949 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.95 144.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.822 2.049 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 t -139.32 122.61 17.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.001 1.72 . . . . 0.0 109.781 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -125.62 143.07 51.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.974 1.71 . . . . 0.0 113.625 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -140.48 126.3 19.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.993 0.917 . . . . 0.0 111.103 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.62 70.06 0.22 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.915 2.198 . . . . 0.0 110.881 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.45 130.46 43.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.104 0.962 . . . . 0.0 111.227 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.0 m -142.39 100.51 3.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.251 1.82 . . . . 0.0 111.512 -162.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 258' ' ' ILE . . . . . 0.506 ' H ' HD13 ' B' ' 258' ' ' ILE . 0.2 OUTLIER -96.25 2.18 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.881 1.672 . . . . 0.0 114.551 -174.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -76.0 -5.28 79.89 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.82 60.21 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.796 1.298 . . . . 0.0 116.293 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -148.35 91.86 0.15 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.215 1.388 . . . . 0.0 112.794 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.1 m -119.46 103.21 9.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.316 1.447 . . . . 0.0 110.804 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 69.49 -15.93 0.79 Allowed Glycine 0 CA--C 1.541 1.714 0 C-N-CA 125.726 1.631 . . . . 0.0 115.755 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -134.05 168.66 18.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.164 2.586 . . . . 0.0 110.981 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 10.1 t -114.24 -14.43 12.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.922 1.689 . . . . 0.0 113.563 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -74.6 -177.27 38.06 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 125.657 1.599 . . . . 0.0 114.26 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.04 139.85 52.37 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.535 2.823 . . . . 0.0 112.568 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 43.5 pt -108.05 147.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.794 1.238 . . . . 0.0 111.263 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.85 169.44 19.8 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.67 1.588 . . . . 0.0 111.97 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 33.5 mt -83.97 110.36 18.36 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.336 1.455 . . . . 0.0 109.909 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -89.62 -160.37 36.42 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.262 1.887 . . . . 0.0 113.152 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 97.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.962 0.905 . . . . 0.0 111.097 170.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.29 97.68 4.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.295 1.838 . . . . 0.0 111.126 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -130.26 167.26 18.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.831 1.252 . . . . 0.0 111.883 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -50.2 133.64 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.402 2.281 . . . . 0.0 111.354 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 55.3 m -101.74 91.0 4.21 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.395 1.478 . . . . 0.0 109.697 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.76 148.14 34.98 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.739 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' B' ' 224' ' ' THR . 4.0 p -137.68 92.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 108.816 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -134.55 165.54 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.441 1.896 . . . . 0.0 111.548 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.79 155.69 57.02 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.02 1.328 . . . . 0.0 111.509 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.0 162.13 42.98 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.399 2.733 . . . . 0.0 112.447 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.45 -52.56 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.254 2.636 . . . . 0.0 112.834 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -160.89 -60.41 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.378 1.471 . . . . 0.0 111.462 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -102.48 174.37 5.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.931 2.092 . . . . 0.0 111.19 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.03 134.33 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.073 1.349 . . . . 0.0 110.388 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.339 1.856 . . . . 0.0 112.492 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m -72.89 8.22 1.64 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.057 1.743 . . . . 0.0 115.327 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -0.74 2.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.441 1.897 . . . . 0.0 114.339 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.59 -33.92 56.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.774 2.029 . . . . 0.0 114.915 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -90.09 -18.91 25.01 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.566 1.146 . . . . 0.0 113.148 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -93.57 -172.36 2.88 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.631 1.972 . . . . 0.0 111.593 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 -172.19 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.475 1.91 . . . . 0.0 110.112 175.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.58 118.16 3.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.959 0.904 . . . . 0.0 111.605 167.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.67 55.53 0.85 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.798 1.639 . . . . 0.0 112.879 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -28.29 64.2 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.827 -1.171 . . . . 0.0 113.589 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.99 -25.77 67.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.934 1.694 . . . . 0.0 115.389 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -103.13 -25.39 13.41 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.008 0.923 . . . . 0.0 112.199 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.58 124.44 19.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.439 1.096 . . . . 0.0 112.808 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -66.89 171.56 5.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.662 1.585 . . . . 0.0 112.78 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.81 147.97 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.638 1.575 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.9 -40.2 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.26 1.024 . . . . 0.0 111.877 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.4 -32.54 70.27 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.855 1.262 . . . . 0.0 113.12 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.65 -55.92 6.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.411 1.084 . . . . 0.0 110.294 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.15 -43.85 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.834 1.254 . . . . 0.0 112.794 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -63.92 -6.32 5.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.305 1.442 . . . . 0.0 114.167 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -113.17 -34.28 5.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.152 2.181 . . . . 0.0 112.313 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -43.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.041 1.337 . . . . 0.0 110.586 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.82 -43.16 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.45 -0.781 . . . . 0.0 112.883 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -52.04 50.88 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.363 0.983 . . . . 0.0 111.675 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -31.85 72.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.43 63.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.45 ' HA ' HG21 ' A' ' 48' ' ' VAL . 58.2 mt -58.05 -55.44 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.244 0.929 . . . . 0.0 109.972 173.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.07 -30.84 70.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 t -61.21 -43.23 99.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.892 0.877 . . . . 0.0 112.396 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.34 -36.37 79.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.272 1.029 . . . . 0.0 113.479 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.61 -42.05 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.385 1.074 . . . . 0.0 110.996 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.11 57.96 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.837 1.208 . . . . 0.0 115.218 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.3 22.93 71.42 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.658 1.123 . . . . 0.0 114.656 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.24 -177.55 0.54 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.005 1.322 . . . . 0.0 112.434 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.25 141.43 8.54 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.836 1.254 . . . . 0.0 112.714 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -66.57 104.9 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.774 1.229 . . . . 0.0 110.929 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -124.15 114.94 20.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.019 1.727 . . . . 0.0 110.797 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -77.47 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.862 0.865 . . . . 0.0 112.603 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -57.57 -25.13 59.53 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.373 -1.455 . . . . 0.0 114.06 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -57.99 -30.57 66.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.6 t -52.85 -34.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.359 0.981 . . . . 0.0 111.851 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -64.34 -50.99 65.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.641 1.176 . . . . 0.0 112.641 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -66.81 -28.06 68.06 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.272 -0.893 . . . . 0.0 112.721 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.95 -54.56 6.69 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.673 0.789 . . . . 0.0 111.214 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -58.43 -26.1 62.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.579 0.751 . . . . 0.0 112.76 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 t -83.56 -54.23 5.09 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.217 0.917 . . . . 0.0 112.961 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -58.76 -38.73 79.1 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.916 1.235 . . . . 0.0 113.344 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 27' ' ' ILE . 71.8 t -68.66 -63.71 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 124.035 0.934 . . . . 0.0 109.833 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.39 -29.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.895 1.278 . . . . 0.0 111.175 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.42 -46.51 86.33 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -95.31 -41.15 9.17 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.835 1.254 . . . . 0.0 112.541 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 m -52.92 -55.97 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.552 2.341 . . . . 0.0 112.463 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' CG ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -62.23 -37.32 84.91 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.161 0.437 . . . . 0.0 110.984 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -60.82 -46.53 90.17 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 112.515 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.18 -49.92 75.73 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.653 1.981 . . . . 0.0 113.015 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.57 -28.33 66.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 m -58.95 -27.54 65.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.884 0.874 . . . . 0.0 111.72 165.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -87.87 -23.31 24.01 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.55 -15.19 63.22 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.07 -99.86 0.21 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.678 0.656 . . . . 0.0 113.795 172.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -94.31 109.47 42.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.663 1.185 . . . . 0.0 112.87 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.77 103.12 1.7 Allowed 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.968 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -141.78 163.41 32.97 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.796 1.638 . . . . 0.0 113.733 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -68.61 101.9 1.38 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.068 1.747 . . . . 0.0 112.204 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.461 ' CG ' HD12 ' A' ' 53' ' ' LEU . 54.4 p90 -81.43 173.52 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.689 1.596 . . . . 0.0 112.107 164.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.459 HD11 ' SG ' ' B' ' 228' ' ' CYS . 2.6 tt -142.39 154.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.375 1.87 . . . . 0.0 109.464 162.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 110' ' ' ALA . 10.4 m -143.49 145.31 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.997 1.719 . . . . 0.0 109.658 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -142.75 155.9 44.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.472 1.109 . . . . 0.0 110.192 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.4 p -148.29 156.43 42.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.041 0.937 . . . . 0.0 112.938 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.86 132.15 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.223 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.51 111.33 35.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 127.324 2.25 . . . . 0.0 107.532 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.1 ttt -117.05 154.12 31.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.13 0.972 . . . . 0.0 111.392 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.52 153.08 20.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.823 1.249 . . . . 0.0 111.964 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -60.77 -16.35 39.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.775 1.63 . . . . 0.0 114.546 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -58.37 -26.99 63.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.043 1.337 . . . . 0.0 112.788 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.52 27.1 72.95 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.146 0.879 . . . . 0.0 114.598 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.66 151.68 10.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.569 1.147 . . . . 0.0 113.527 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.8 102.95 1.04 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.522 1.058 . . . . 0.0 114.173 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 pp -143.6 147.61 34.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.11 2.564 . . . . 0.0 109.549 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -134.65 132.28 38.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.416 ' HB ' HG13 ' A' ' 135' ' ' VAL . 48.4 m -133.28 139.15 46.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.243 1.017 . . . . 0.0 109.886 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.75 124.05 12.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.537 0.735 . . . . 0.0 110.933 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.9 p -130.51 137.98 50.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.792 0.806 . . . . 0.0 111.649 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.4 m -81.41 13.64 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.454 -0.779 . . . . 0.0 112.69 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' B' ' 209' ' ' ILE . 8.2 m -60.07 161.46 6.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.006 0.908 . . . . 0.0 111.92 169.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -157.53 136.57 11.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.717 1.607 . . . . 0.0 109.539 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 163.87 27.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.718 0.407 . . . . 0.0 111.098 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -140.02 155.31 47.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.423 1.089 . . . . 0.0 111.508 168.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -118.28 -63.34 1.43 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.889 2.076 . . . . 0.0 111.753 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -109.63 -28.94 8.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.315 1.446 . . . . 0.0 112.173 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -42.73 85.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.708 2.403 . . . . 0.0 112.994 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.93 -175.59 5.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.864 1.665 . . . . 0.0 112.185 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.73 153.26 20.86 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.628 1.109 . . . . 0.0 114.185 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 t -163.27 163.17 25.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.424 1.89 . . . . 0.0 110.554 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 8.1 p -167.91 149.79 5.47 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.984 1.714 . . . . 0.0 111.327 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -145.33 144.46 30.73 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.116 -1.615 . . . . 0.0 111.679 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -143.29 126.31 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.112 1.365 . . . . 0.0 110.604 -161.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -127.83 122.44 32.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 -170.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -133.49 104.41 6.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.786 1.634 . . . . 0.0 110.293 -174.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.59 168.05 9.94 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.1 . . . . 0.0 112.394 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -145.29 -176.18 5.0 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.781 0.832 . . . . 0.0 112.548 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -49.84 -51.89 36.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.944 1.698 . . . . 0.0 113.874 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.4 t -132.95 -47.27 0.86 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.7 ptp -67.08 170.83 6.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.587 0.755 . . . . 0.0 112.411 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -146.11 147.46 31.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.5 1.52 . . . . 0.0 109.557 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 28.9 p -128.26 143.6 51.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.244 1.021 . . . . 0.0 112.606 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.37 119.85 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.584 1.554 . . . . 0.0 110.102 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 t -104.99 136.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.828 1.651 . . . . 0.0 109.571 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.9 t -131.26 123.58 28.69 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 110.601 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.55 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -109.68 149.56 29.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.858 1.663 . . . . 0.0 111.791 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -141.31 152.32 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.832 1.253 . . . . 0.0 110.657 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.09 85.41 0.23 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.837 1.208 . . . . 0.0 112.074 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.29 121.4 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.353 1.461 . . . . 0.0 111.675 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 m -148.73 117.84 6.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.546 1.138 . . . . 0.0 113.174 -169.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -22.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.945 2.098 . . . . 0.0 115.623 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.86 -16.47 78.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.334 0.968 . . . . 0.0 114.604 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.95 13.26 56.9 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.687 1.136 . . . . 0.0 115.262 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.57 66.58 3.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.756 1.646 . . . . 0.0 113.37 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -133.98 176.17 8.81 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.185 2.194 . . . . 0.0 111.733 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.57 28.75 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.891 1.234 . . . . 0.0 115.214 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -68.06 47.59 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.021 2.128 . . . . 0.0 113.62 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.2 p -149.48 -15.23 0.28 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.23 -167.04 23.1 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.33 1.443 . . . . 0.0 112.405 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.25 174.67 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.413 2.742 . . . . 0.0 112.159 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.79 96.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.76 1.624 . . . . 0.0 113.027 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 166.16 11.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.014 0.926 . . . . 0.0 112.723 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.8 mt -66.06 126.42 28.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.515 1.126 . . . . 0.0 110.96 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 157.44 92.77 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.022 0.82 . . . . 0.0 113.056 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.3 ttm -64.04 159.73 19.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.725 1.21 . . . . 0.0 112.48 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -117.29 91.83 3.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.501 1.52 . . . . 0.0 112.042 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -130.81 177.6 7.29 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.448 1.499 . . . . 0.0 112.007 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.4 mm -51.6 138.13 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.908 2.083 . . . . 0.0 111.313 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.6 m -107.42 91.93 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.579 1.552 . . . . 0.0 110.818 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -93.19 148.82 21.69 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.326 -0.859 . . . . 0.0 111.294 171.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.416 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -144.31 115.47 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.022 2.129 . . . . 0.0 109.833 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -140.86 133.72 29.04 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.48 1.512 . . . . 0.0 111.157 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.26 97.87 14.48 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.172 1.789 . . . . 0.0 109.698 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.12 162.69 38.31 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 123.123 2.548 . . . . 0.0 111.894 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -50.22 2.82 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.433 2.755 . . . . 0.0 113.111 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.56 -69.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.292 1.837 . . . . 0.0 109.766 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.54 167.8 8.35 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.85 2.06 . . . . 0.0 112.28 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -110.21 160.48 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.95 1.3 . . . . 0.0 112.247 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.252 1.231 0 C-N-CA 127.003 2.121 . . . . 0.0 110.65 -179.476 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 20.0 m -72.96 9.54 1.14 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.471 1.909 . . . . 0.0 115.521 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.15 -0.61 2.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.239 1.816 . . . . 0.0 114.39 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.61 -34.11 57.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.903 2.081 . . . . 0.0 114.763 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -89.88 -19.14 24.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.528 1.131 . . . . 0.0 113.144 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -93.12 -172.27 2.92 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.567 1.947 . . . . 0.0 111.628 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 -172.03 3.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 110.092 175.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -51.5 117.4 2.62 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.942 0.897 . . . . 0.0 111.53 167.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.79 55.35 0.87 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.757 1.623 . . . . 0.0 112.822 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -29.2 62.83 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.873 -1.142 . . . . 0.0 113.535 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.03 -21.66 63.82 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.086 1.754 . . . . 0.0 115.601 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.4 t -112.9 -20.62 11.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.872 1.269 . . . . 0.0 112.639 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.51 118.76 8.0 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.114 -0.991 . . . . 0.0 112.302 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.01 161.17 26.81 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.46 144.29 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.101 1.361 . . . . 0.0 112.897 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.32 -41.47 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.881 1.672 . . . . 0.0 112.232 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.37 -31.84 69.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.589 1.156 . . . . 0.0 113.178 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.87 -55.66 5.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.274 174.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 58.2 t -44.72 -46.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.158 1.783 . . . . 0.0 112.842 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -63.95 -7.03 7.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.732 1.613 . . . . 0.0 114.429 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -111.03 -33.66 6.43 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.569 2.348 . . . . 0.0 112.196 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 30.2 mt -50.14 -42.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.043 1.337 . . . . 0.0 110.644 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.45 -43.79 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.343 -0.848 . . . . 0.0 112.929 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -52.36 50.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.358 0.981 . . . . 0.0 111.519 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.76 72.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.71 62.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.124 0.97 . . . . 0.0 113.313 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.431 ' HA ' HG21 ' B' ' 191' ' ' VAL . 56.4 mt -57.49 -55.33 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.158 0.89 . . . . 0.0 109.88 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.08 -31.08 70.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 18.0 t -61.17 -42.95 99.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.858 0.863 . . . . 0.0 112.354 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.31 77.5 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.264 1.025 . . . . 0.0 113.586 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.25 -42.43 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.38 1.072 . . . . 0.0 110.88 173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.91 58.21 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.982 1.277 . . . . 0.0 115.173 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.74 23.39 70.71 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.585 1.088 . . . . 0.0 114.598 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.12 -177.18 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.043 1.337 . . . . 0.0 112.488 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -48.76 141.75 7.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.722 1.209 . . . . 0.0 112.571 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.93 101.47 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.566 1.146 . . . . 0.0 110.862 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -117.8 114.44 23.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.081 1.753 . . . . 0.0 110.542 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -74.15 -64.37 1.03 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.372 1.069 . . . . 0.0 112.546 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.9 m -56.63 -23.74 43.32 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -55.24 -28.79 55.75 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.7 -31.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.479 1.036 . . . . 0.0 112.89 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -65.34 -50.34 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.828 1.251 . . . . 0.0 112.207 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.91 -26.85 67.06 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.401 -0.812 . . . . 0.0 112.661 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.39 -53.95 7.04 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.818 0.847 . . . . 0.0 111.592 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.1 t -56.72 -28.49 61.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.588 0.631 . . . . 0.0 112.592 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.8 t -82.43 -55.81 4.27 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.341 0.973 . . . . 0.0 112.816 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -59.53 -39.27 83.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.078 1.308 . . . . 0.0 113.281 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' B' ' 170' ' ' ILE . 79.2 t -68.36 -63.91 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 C-N-CA 123.706 0.803 . . . . 0.0 109.625 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 96.2 t -49.9 -29.62 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -58.89 -46.94 86.67 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.599 0.636 . . . . 0.0 112.43 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -93.87 -40.2 10.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.756 1.222 . . . . 0.0 112.771 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 5.4 m -54.71 -56.03 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.746 2.418 . . . . 0.0 112.42 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -37.07 79.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.112 0.414 . . . . 0.0 110.602 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.6 t -62.41 -47.71 82.94 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.217 -0.927 . . . . 0.0 112.557 169.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -56.81 -47.35 80.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.871 1.668 . . . . 0.0 113.001 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.24 -18.93 59.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 89.1 m -61.69 -40.31 94.55 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.613 -0.679 . . . . 0.0 110.26 157.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -75.25 -19.58 59.65 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.874 -1.142 . . . . 0.0 113.896 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 10.5 mt -59.07 -20.23 51.43 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . 168.21 -54.07 0.22 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.724 1.147 . . . . 0.0 115.554 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -57.96 156.5 19.2 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 127.367 2.267 . . . . 0.0 113.735 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.18 160.17 42.9 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.985 2.457 . . . . 0.0 113.278 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.28 93.71 3.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.955 0.902 . . . . 0.0 113.003 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -165.41 85.26 0.37 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.024 1.33 . . . . 0.0 114.217 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.3 158.78 43.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.782 1.233 . . . . 0.0 112.194 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 85' ' ' CYS . 5.3 tt -138.57 156.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.112 2.165 . . . . 0.0 109.356 171.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' B' ' 253' ' ' ALA . 4.3 m -142.05 147.75 21.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.432 1.893 . . . . 0.0 110.054 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 14.6 t -143.02 154.55 44.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.72 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.73 157.46 43.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.35 1.06 . . . . 0.0 112.504 171.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 26.3 t -134.18 136.06 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.172 1.389 . . . . 0.0 109.141 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mm -108.95 108.82 26.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 127.365 2.266 . . . . 0.0 106.9 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 62.0 mtt -107.82 158.95 16.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.603 1.161 . . . . 0.0 110.848 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -119.14 150.87 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.882 1.273 . . . . 0.0 110.933 -174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -59.61 -17.11 30.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.694 1.598 . . . . 0.0 114.882 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -59.58 -30.0 68.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.376 1.471 . . . . 0.0 112.955 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.42 42.54 93.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.25 1.405 . . . . 0.0 114.405 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.33 175.63 0.42 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.528 1.531 . . . . 0.0 114.258 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.35 91.26 0.3 Allowed Glycine 0 CA--C 1.539 1.582 0 O-C-N 120.571 -1.331 . . . . 0.0 114.424 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.81 118.35 13.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.149 1.78 . . . . 0.0 113.122 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.12 133.04 55.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.694 0.798 . . . . 0.0 110.076 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.472 ' HB ' HG13 ' B' ' 278' ' ' VAL . 50.5 m -135.47 141.89 45.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.876 0.87 . . . . 0.0 110.283 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.13 128.62 18.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.5 p -132.6 139.43 47.78 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.669 0.747 . . . . 0.0 111.509 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -82.46 12.5 4.47 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.562 -0.711 . . . . 0.0 112.605 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' CYS . . . . . 0.459 ' SG ' HD11 ' A' ' 66' ' ' ILE . 4.3 m -60.7 161.65 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.988 0.899 . . . . 0.0 111.895 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -158.73 139.36 12.64 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.481 1.513 . . . . 0.0 109.582 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' TRP . . . . . 0.408 ' CZ2' ' HB2' ' B' ' 232' ' ' SER . 0.0 OUTLIER -72.41 161.63 30.57 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.834 171.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -137.98 149.74 46.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.722 1.209 . . . . 0.0 110.319 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' SER . . . . . 0.408 ' HB2' ' CZ2' ' B' ' 230' ' ' TRP . 1.8 t -112.05 -63.27 1.45 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.785 2.034 . . . . 0.0 112.125 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 8.5 t -109.82 -26.18 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.442 1.497 . . . . 0.0 112.237 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -41.41 75.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.627 2.771 . . . . 0.0 113.193 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.54 -173.89 4.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.912 2.085 . . . . 0.0 110.589 -172.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -98.86 158.57 20.2 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.437 1.017 . . . . 0.0 114.078 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.3 t -166.44 163.21 17.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.114 1.766 . . . . 0.0 110.621 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.57 141.45 2.38 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.2 1.8 . . . . 0.0 111.091 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -142.59 146.75 34.89 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 119.955 -1.716 . . . . 0.0 111.949 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -141.3 146.43 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.884 1.273 . . . . 0.0 110.353 -168.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -137.79 126.77 24.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 112.544 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -135.86 102.38 5.04 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.753 1.621 . . . . 0.0 109.984 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.51 164.84 13.23 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.983 -1.073 . . . . 0.0 112.242 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -141.71 -177.62 5.27 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.407 1.083 . . . . 0.0 111.691 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -47.81 -51.43 22.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.295 1.838 . . . . 0.0 114.088 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.1 t -132.05 -48.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.532 1.533 . . . . 0.0 111.996 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.74 173.96 3.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.076 0.95 . . . . 0.0 112.655 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.62 146.32 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.381 1.472 . . . . 0.0 109.829 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.5 p -127.49 143.04 51.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.055 0.931 . . . . 0.0 112.424 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.08 127.88 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.628 1.571 . . . . 0.0 109.56 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.24 123.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.378 1.471 . . . . 0.0 110.16 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.2 t -119.53 115.6 24.36 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.149 0.979 . . . . 0.0 110.116 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.561 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -97.38 153.78 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.795 1.238 . . . . 0.0 111.826 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -142.05 149.77 40.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.345 1.458 . . . . 0.0 110.091 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -135.08 80.55 0.31 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 124.972 1.272 . . . . 0.0 113.003 -171.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.21 108.09 20.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.635 1.174 . . . . 0.0 112.087 -167.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.46 120.38 21.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.56 1.944 . . . . 0.0 113.172 -170.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -21.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 115.517 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.98 81.13 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.273 0.94 . . . . 0.0 114.762 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.01 13.09 56.88 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.711 1.148 . . . . 0.0 115.324 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -80.4 61.33 4.44 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.77 1.653 . . . . 0.0 113.88 -171.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.75 -179.83 5.62 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.067 1.747 . . . . 0.0 112.475 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 110.07 5.16 29.01 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.037 1.303 . . . . 0.0 115.275 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.32 34.6 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.997 2.519 . . . . 0.0 114.932 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 18.7 p -139.0 -13.69 1.2 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 131.21 -167.09 22.57 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.077 1.322 . . . . 0.0 112.842 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.5 174.4 9.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.539 2.826 . . . . 0.0 112.312 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.15 96.35 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.718 1.607 . . . . 0.0 113.057 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 166.57 11.43 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.251 -0.906 . . . . 0.0 112.753 171.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 44.4 mt -66.06 126.68 29.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.641 1.176 . . . . 0.0 110.897 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.36 92.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.01 0.814 . . . . 0.0 113.199 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 4.5 ttm -63.43 160.89 15.3 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.763 1.225 . . . . 0.0 112.595 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -118.52 91.37 3.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.799 1.639 . . . . 0.0 112.092 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.14 177.94 7.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.427 1.491 . . . . 0.0 112.087 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.1 mm -51.69 140.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 126.991 2.116 . . . . 0.0 111.354 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 71.6 m -110.93 91.84 3.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.589 1.555 . . . . 0.0 110.702 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -94.77 149.38 21.31 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.428 -0.795 . . . . 0.0 111.323 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.472 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.9 p -149.32 118.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.04 1.736 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.87 138.14 30.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.764 1.625 . . . . 0.0 110.663 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -130.91 94.57 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.145 1.778 . . . . 0.0 109.373 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.16 160.01 48.37 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 122.574 2.182 . . . . 0.0 112.015 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.24 -51.43 3.55 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.786 2.991 . . . . 0.0 113.344 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -68.92 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.215 1.806 . . . . 0.0 109.46 174.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.53 168.19 7.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.879 2.072 . . . . 0.0 112.339 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 285' ' ' ILE . . . . . 0.428 ' H ' HD13 ' B' ' 285' ' ' ILE . 0.2 OUTLIER -110.51 160.46 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 C--O 1.253 1.285 0 C-N-CA 127.089 2.156 . . . . 0.0 110.745 -179.57 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 121.286 0.381 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m -81.51 37.23 0.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.726 2.01 . . . . 0.0 115.387 -165.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.7 mtt -59.1 -24.63 63.12 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.619 -1.301 . . . . 0.0 114.125 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.16 -13.73 30.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.08 -27.36 63.56 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.307 -0.871 . . . . 0.0 112.931 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -82.86 158.85 22.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.613 1.165 . . . . 0.0 112.05 168.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -148.27 161.73 40.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.966 1.306 . . . . 0.0 111.459 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.34 165.65 12.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.894 1.678 . . . . 0.0 112.141 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.74 79.61 2.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.714 1.205 . . . . 0.0 112.383 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.68 -22.04 64.97 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.734 -1.229 . . . . 0.0 113.496 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.02 -24.39 63.27 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -98.81 -24.04 15.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.334 1.054 . . . . 0.0 113.014 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.57 159.07 30.56 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.243 -0.91 . . . . 0.0 112.071 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -69.16 166.07 19.08 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.463 0.705 . . . . 0.0 112.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -135.53 159.57 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.714 1.206 . . . . 0.0 111.729 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.08 -38.33 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.439 1.096 . . . . 0.0 112.608 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.91 -27.97 68.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.859 1.264 . . . . 0.0 113.042 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -76.34 -56.41 4.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.711 0.804 . . . . 0.0 110.801 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.3 t -52.49 -39.59 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.157 1.383 . . . . 0.0 112.615 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.18 -15.06 12.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.612 1.565 . . . . 0.0 114.276 174.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -108.58 -35.49 6.44 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.327 1.851 . . . . 0.0 112.786 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.32 -42.9 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.459 1.027 . . . . 0.0 110.581 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.84 -43.41 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.598 -0.689 . . . . 0.0 112.53 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -54.02 31.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.605 1.093 . . . . 0.0 111.405 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.68 75.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.23 62.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.667 0.787 . . . . 0.0 112.811 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' HG21 ' A' ' 48' ' ' VAL . 60.0 mt -60.23 -57.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.113 0.869 . . . . 0.0 109.885 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.74 -31.75 71.06 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -58.84 -50.4 74.13 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.441 1.096 . . . . 0.0 112.182 168.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.63 -33.22 75.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.15 -37.72 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.836 1.254 . . . . 0.0 111.337 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.86 16.96 78.16 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.071 0.843 . . . . 0.0 114.54 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.9 8.49 72.67 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.172 1.368 . . . . 0.0 116.001 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.78 150.74 15.56 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 118.934 1.367 . . . . 0.0 113.747 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -175.77 3.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.168 1.787 . . . . 0.0 112.197 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -37.39 136.1 0.5 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 129.046 2.939 . . . . 0.0 114.995 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -134.94 174.5 10.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.519 1.528 . . . . 0.0 112.968 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.06 -93.06 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.4 1.48 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 p -98.99 4.9 47.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.332 2.253 . . . . 0.0 113.398 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -50.76 -43.76 58.45 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.019 -1.051 . . . . 0.0 112.689 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.21 -35.17 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.392 1.077 . . . . 0.0 112.687 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -67.81 -49.64 61.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 112.532 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.14 -26.78 67.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.092 -1.005 . . . . 0.0 112.576 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -75.23 -55.75 5.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.814 1.246 . . . . 0.0 111.182 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t -58.38 -23.5 57.2 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.549 -0.739 . . . . 0.0 112.99 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -85.1 -54.98 4.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.793 1.179 . . . . 0.0 112.368 169.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -57.78 -35.63 71.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.922 1.237 . . . . 0.0 113.782 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 27' ' ' ILE . 96.1 t -75.15 -67.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 124.318 1.047 . . . . 0.0 109.688 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.13 -28.42 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.695 1.198 . . . . 0.0 111.226 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -52.22 -57.86 8.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.698 0.799 . . . . 0.0 112.908 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -90.61 -39.81 12.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.545 1.138 . . . . 0.0 112.396 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.7 m -57.2 -53.93 52.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.122 2.169 . . . . 0.0 112.514 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.99 -37.99 84.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.71 0.686 . . . . 0.0 111.722 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -63.24 -40.28 96.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 0.0 112.379 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.95 -50.77 61.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.528 1.931 . . . . 0.0 113.189 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.46 -24.1 65.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 53.5 m -59.2 -30.42 68.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.218 1.007 . . . . 0.0 111.262 165.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -90.6 -22.71 21.1 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.51 -15.22 60.5 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.42 -126.51 1.57 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.713 1.149 . . . . 0.0 112.442 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 5.3 mmpt? -55.78 112.09 3.89 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.957 1.703 . . . . 0.0 112.957 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.53 108.98 2.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.441 2.761 . . . . 0.0 111.748 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -144.56 179.81 7.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.446 1.898 . . . . 0.0 111.005 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -90.88 128.14 36.64 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 166.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 112' ' ' GLY . 24.0 m-85 -113.88 145.43 41.48 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.907 1.683 . . . . 0.0 108.847 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 tt -122.75 153.65 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.232 1.013 . . . . 0.0 110.045 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.51 151.79 28.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.49 1.916 . . . . 0.0 109.032 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.63 138.69 47.44 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.051 1.74 . . . . 0.0 108.46 166.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.88 138.45 37.44 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.02 126.79 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.342 1.457 . . . . 0.0 108.911 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.0 mm -117.64 94.66 3.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 127.358 2.263 . . . . 0.0 107.442 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.61 107.84 12.44 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.728 1.611 . . . . 0.0 110.642 -168.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -66.65 135.2 53.73 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.318 -0.864 . . . . 0.0 112.198 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -8.4 2.94 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.093 1.757 . . . . 0.0 115.498 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -16.8 49.69 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.079 2.152 . . . . 0.0 113.773 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.68 -3.04 5.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.068 1.318 . . . . 0.0 115.761 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 45.71 0.28 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.824 1.65 . . . . 0.0 113.974 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 161.6 33.52 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.914 1.245 . . . . 0.0 113.394 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.732 HD13 HD11 ' B' ' 222' ' ' LEU . 1.6 pt? -151.82 -171.66 4.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.595 1.558 . . . . 0.0 112.085 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.96 138.11 41.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.401 0.546 . . . . 0.0 111.149 168.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.7 m -142.76 144.68 32.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.336 1.454 . . . . 0.0 110.12 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.34 144.19 31.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.8 p -145.88 140.7 27.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.015 0.912 . . . . 0.0 112.264 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 t -78.87 23.33 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.28 1.032 . . . . 0.0 112.584 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.9 m -67.07 171.19 5.82 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.304 -0.873 . . . . 0.0 111.648 165.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -163.44 149.74 11.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.741 2.416 . . . . 0.0 108.557 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -81.26 134.96 35.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.07 0.85 . . . . 0.0 109.594 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.38 127.23 5.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.229 . . . . 0.0 111.564 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -113.8 -31.96 6.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.597 1.559 . . . . 0.0 112.161 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -80.1 -38.46 31.6 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.803 1.641 . . . . 0.0 112.556 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -53.75 5.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.068 1.347 . . . . 0.0 112.405 -171.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -139.99 -161.27 1.17 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.927 2.491 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.82 153.5 16.93 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.831 -1.168 . . . . 0.0 113.754 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 p -155.62 154.83 32.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.729 1.612 . . . . 0.0 111.259 170.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 34.1 t -153.58 97.54 2.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.707 1.203 . . . . 0.0 111.797 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t -90.04 146.19 24.53 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.03 -1.044 . . . . 0.0 112.268 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.68 131.68 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.037 1.735 . . . . 0.0 109.265 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -119.79 128.7 53.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.525 1.53 . . . . 0.0 110.736 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -131.81 159.76 37.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.205 1.402 . . . . 0.0 110.089 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.5 144.68 42.32 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.201 -0.937 . . . . 0.0 111.0 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -117.31 -173.01 2.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.75 1.22 . . . . 0.0 109.318 -165.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -48.6 70.14 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 120.953 -1.092 . . . . 0.0 113.667 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 t -140.73 -17.82 0.86 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.908 2.083 . . . . 0.0 113.129 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.0 mtm -91.28 170.37 10.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.669 1.587 . . . . 0.0 111.09 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -138.02 161.17 37.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.874 0.869 . . . . 0.0 110.73 163.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.0 p -141.62 136.44 30.98 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.049 0.94 . . . . 0.0 111.301 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.2 119.45 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.869 1.268 . . . . 0.0 109.982 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.19 129.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.924 1.289 . . . . 0.0 110.661 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -121.47 106.86 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.274 0.63 . . . . 0.0 111.745 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.81 138.84 33.04 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -129.15 126.06 38.43 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.844 1.658 . . . . 0.0 110.335 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 65' ' ' TYR . . . -126.17 73.65 0.43 Allowed Glycine 0 CA--C 1.524 0.61 0 C-N-CA 126.782 2.134 . . . . 0.0 111.671 -171.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.42 123.11 17.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.964 1.306 . . . . 0.0 110.081 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t -146.81 83.58 1.59 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.894 1.677 . . . . 0.0 111.54 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -78.09 -2.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.23 2.73 88.04 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.397 1.475 . . . . 0.0 116.325 -174.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.11 20.39 72.88 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 119.173 1.486 . . . . 0.0 115.049 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.18 -176.88 35.86 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.342 1.449 . . . . 0.0 114.579 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.2 t -76.19 -172.65 2.13 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.554 1.142 . . . . 0.0 113.474 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.56 6.46 6.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.8 2.143 . . . . 0.0 113.89 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -123.28 172.08 8.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.456 1.902 . . . . 0.0 113.741 -168.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -118.78 2.28 11.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 113.872 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.27 -169.49 41.05 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.905 1.717 . . . . 0.0 112.285 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.62 169.66 13.97 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.442 2.761 . . . . 0.0 112.351 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -59.1 125.71 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.839 . . . . 0.0 111.631 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.39 155.92 39.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.719 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.24 149.57 37.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.32 1.048 . . . . 0.0 110.957 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.59 176.65 42.22 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.427 -0.796 . . . . 0.0 115.021 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mtt -86.8 145.7 26.52 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 112.928 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.7 93.78 1.71 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.021 1.728 . . . . 0.0 111.257 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -130.95 174.8 9.64 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.07 1.348 . . . . 0.0 111.833 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 136.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 111.418 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.0 m -94.74 96.42 9.37 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.288 1.435 . . . . 0.0 110.411 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -95.52 145.93 24.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.944 -1.097 . . . . 0.0 111.015 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.65 118.37 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.207 2.203 . . . . 0.0 109.349 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -137.75 150.37 47.2 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.306 -0.871 . . . . 0.0 112.053 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.81 154.43 77.89 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.203 1.401 . . . . 0.0 110.96 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.78 121.4 8.92 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.018 2.479 . . . . 0.0 111.164 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.67 176.23 9.13 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.9 2.4 . . . . 0.0 111.606 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.25 162.63 19.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.94 1.696 . . . . 0.0 110.764 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -144.75 176.64 9.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.065 1.346 . . . . 0.0 110.861 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 178.42 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 126.933 2.093 . . . . 0.0 110.801 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.848 1.659 . . . . 0.0 114.147 177.517 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 26.3 m -81.04 37.29 0.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.751 2.02 . . . . 0.0 115.38 -165.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 42.5 mtt -59.23 -24.67 63.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.68 -1.263 . . . . 0.0 114.116 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.29 -13.54 29.62 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.0 -27.19 63.51 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.222 -0.924 . . . . 0.0 112.91 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -82.87 159.44 22.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.533 1.133 . . . . 0.0 112.105 169.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -148.19 163.59 36.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.068 1.347 . . . . 0.0 111.464 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.57 165.49 13.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.887 1.675 . . . . 0.0 112.14 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.94 80.12 2.82 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.769 1.227 . . . . 0.0 112.372 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.15 -21.27 64.91 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.715 -1.241 . . . . 0.0 113.473 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.86 -23.57 63.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 14.2 t -99.43 -25.15 14.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.514 1.126 . . . . 0.0 113.038 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.65 153.55 43.27 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.277 -0.889 . . . . 0.0 111.976 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.05 155.73 40.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.3 p -131.07 158.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.174 1.39 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.22 -35.94 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.779 2.032 . . . . 0.0 111.784 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.29 -31.96 66.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.439 1.096 . . . . 0.0 113.122 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -82.52 -51.12 8.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.499 -0.751 . . . . 0.0 110.491 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 90.2 t -51.0 -39.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.733 1.213 . . . . 0.0 112.511 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -61.15 -16.4 44.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.236 1.814 . . . . 0.0 114.493 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -104.18 -34.63 8.31 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.224 1.809 . . . . 0.0 112.526 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 36.1 mt -51.51 -43.59 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.133 0.878 . . . . 0.0 110.804 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.96 -43.16 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.702 -0.624 . . . . 0.0 112.318 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -54.66 24.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.601 1.091 . . . . 0.0 111.453 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -34.38 75.29 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.75 60.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 112.899 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.416 ' HA ' HG21 ' B' ' 191' ' ' VAL . 58.1 mt -59.84 -56.81 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.113 0.87 . . . . 0.0 109.61 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.41 -32.35 71.25 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 40.5 t -58.56 -50.4 73.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.515 1.126 . . . . 0.0 112.17 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.29 75.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 92.7 mt -61.94 -37.95 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.873 1.269 . . . . 0.0 111.22 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.06 17.04 78.45 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.045 0.831 . . . . 0.0 114.448 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.89 8.6 72.5 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.132 1.349 . . . . 0.0 115.967 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.85 151.22 14.87 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.947 1.373 . . . . 0.0 113.652 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.34 -173.17 2.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 112.23 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -39.79 137.71 0.87 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.732 2.813 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -136.84 174.09 11.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.516 1.526 . . . . 0.0 112.831 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -87.77 -92.44 0.11 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.416 1.486 . . . . 0.0 112.224 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 19.1 p -99.84 5.15 45.49 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.345 2.258 . . . . 0.0 113.248 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -50.76 -43.7 58.44 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.05 -1.031 . . . . 0.0 112.674 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.02 -35.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.331 1.052 . . . . 0.0 112.711 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.71 -49.81 60.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.475 1.11 . . . . 0.0 112.489 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.91 -26.91 67.82 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.621 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -75.09 -55.74 5.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.807 1.243 . . . . 0.0 111.215 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.1 t -58.95 -21.63 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 4.8 t -86.51 -55.6 3.81 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.824 1.193 . . . . 0.0 112.412 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -57.48 -35.95 70.85 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.045 1.293 . . . . 0.0 113.82 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' B' ' 170' ' ' ILE . 94.9 t -74.79 -67.16 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.382 1.073 . . . . 0.0 109.543 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.63 -29.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.797 1.239 . . . . 0.0 111.049 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.59 -55.27 23.46 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.29 -37.89 11.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.772 1.229 . . . . 0.0 112.571 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -60.07 -53.04 62.51 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.006 2.122 . . . . 0.0 112.731 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.02 -35.8 81.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.696 0.68 . . . . 0.0 112.043 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t -60.65 -50.42 73.56 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.726 0.81 . . . . 0.0 111.308 169.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -58.37 -51.17 70.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.522 1.929 . . . . 0.0 113.586 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.2 -23.03 63.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -61.17 -41.01 96.02 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -74.57 -24.08 58.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.42 -11.33 9.98 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -159.81 -73.65 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.942 1.246 . . . . 0.0 114.807 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -65.99 168.45 9.1 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 126.756 2.022 . . . . 0.0 113.318 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.38 173.54 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.223 2.615 . . . . 0.0 112.05 171.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.82 94.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.404 1.482 . . . . 0.0 113.04 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -158.13 107.06 2.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.596 1.959 . . . . 0.0 111.916 168.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -154.68 165.34 36.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.977 1.711 . . . . 0.0 111.031 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.8 tt -147.72 156.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 126.174 1.79 . . . . 0.0 108.864 160.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.13 152.46 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.289 1.836 . . . . 0.0 109.657 162.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.6 p -132.85 138.94 47.21 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.104 1.762 . . . . 0.0 108.518 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.75 145.7 38.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.879 0.847 . . . . 0.0 112.745 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.35 131.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.983 1.313 . . . . 0.0 109.224 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -118.71 93.45 2.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 127.215 2.206 . . . . 0.0 107.358 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.6 90.85 3.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 109.888 -172.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.53 153.22 13.34 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.457 -1.402 . . . . 0.0 113.533 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -7.79 53.7 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -16.91 56.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.441 1.896 . . . . 0.0 114.108 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 -3.18 6.38 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.176 1.231 . . . . 0.0 116.176 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -74.1 51.99 0.43 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.427 1.491 . . . . 0.0 113.287 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.05 30.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.652 1.596 . . . . 0.0 112.842 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.732 HD11 HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -159.69 -173.8 4.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.32 1.848 . . . . 0.0 110.804 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.41 139.26 40.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.842 0.747 . . . . 0.0 111.002 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.45 ' HB ' HG13 ' B' ' 278' ' ' VAL . 53.4 m -142.74 145.12 33.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.803 1.241 . . . . 0.0 110.142 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.71 38.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.433 1.093 . . . . 0.0 110.729 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 69.4 p -145.88 142.2 28.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.892 0.853 . . . . 0.0 112.07 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 9.5 t -80.79 25.81 0.43 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.975 0.91 . . . . 0.0 112.496 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 58.9 m -67.51 171.35 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.334 -0.854 . . . . 0.0 111.599 164.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -166.44 154.33 10.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.921 2.489 . . . . 0.0 108.83 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -81.61 132.09 35.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.428 -0.795 . . . . 0.0 110.014 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -152.78 116.46 4.77 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.046 1.338 . . . . 0.0 112.512 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.3 t -107.02 -34.05 7.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.397 1.479 . . . . 0.0 112.393 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 12.2 p -80.01 -36.09 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.986 1.314 . . . . 0.0 112.32 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -56.6 3.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.242 1.417 . . . . 0.0 111.802 -174.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -155.57 0.65 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.581 2.352 . . . . 0.0 109.341 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.59 153.5 16.79 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 120.728 -1.233 . . . . 0.0 113.556 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 25.8 p -156.79 147.18 21.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.211 1.404 . . . . 0.0 112.315 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.981 1.312 . . . . 0.0 111.838 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 14.2 t -86.57 146.4 26.37 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.034 -1.041 . . . . 0.0 112.205 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 t -139.39 135.96 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 109.267 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.34 129.79 51.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.538 1.535 . . . . 0.0 110.848 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -132.63 159.03 40.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.225 1.41 . . . . 0.0 110.035 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -136.64 144.16 43.87 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.026 -1.046 . . . . 0.0 111.028 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.9 -173.5 2.4 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.61 1.164 . . . . 0.0 109.454 -165.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -50.97 65.44 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.996 -1.065 . . . . 0.0 113.654 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.6 t -140.17 -10.94 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.064 1.746 . . . . 0.0 113.43 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.0 mtm -94.25 169.27 10.36 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 110.542 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -139.56 157.87 45.08 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 111.262 165.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.1 p -141.27 138.57 33.31 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.933 . . . . 0.0 111.876 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.66 126.83 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.877 1.271 . . . . 0.0 109.937 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.54 129.3 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.443 1.497 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -121.8 106.55 11.38 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.401 0.68 . . . . 0.0 111.9 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.99 140.93 29.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -131.57 115.54 16.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.142 1.777 . . . . 0.0 109.701 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.85 76.23 0.22 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.573 2.035 . . . . 0.0 111.028 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.08 123.38 20.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.838 0.855 . . . . 0.0 112.263 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 10.4 t -142.66 119.6 11.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.112 1.765 . . . . 0.0 112.058 -165.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.29 -0.26 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 114.095 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.57 2.72 74.07 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.34 1.447 . . . . 0.0 115.721 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.32 24.73 62.79 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 118.784 1.292 . . . . 0.0 115.11 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.41 -175.59 45.65 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.102 1.334 . . . . 0.0 114.248 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t -74.63 -175.77 2.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.399 1.08 . . . . 0.0 113.546 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 124.26 9.17 5.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.703 2.097 . . . . 0.0 114.068 -170.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 170.66 11.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.237 1.815 . . . . 0.0 113.645 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.3 t -120.08 4.5 10.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.662 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 167.31 -168.03 40.23 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.94 1.733 . . . . 0.0 112.389 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.89 -179.33 2.05 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.993 3.129 . . . . 0.0 112.843 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.0 85.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.695 1.198 . . . . 0.0 113.793 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -70.3 159.92 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.437 1.095 . . . . 0.0 112.323 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.37 138.44 31.43 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.115 1.366 . . . . 0.0 110.101 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -171.38 171.71 44.13 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.758 0.694 . . . . 0.0 114.458 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.54 147.92 27.5 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.921 1.289 . . . . 0.0 112.547 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -154.08 93.1 1.6 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.614 1.565 . . . . 0.0 111.884 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -131.71 175.1 9.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 111.929 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 mm -52.86 140.5 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.662 1.985 . . . . 0.0 111.64 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 90.4 m -99.06 93.95 6.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.372 1.469 . . . . 0.0 110.332 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -94.26 146.82 23.75 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.036 -1.04 . . . . 0.0 110.778 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.45 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.9 p -148.6 120.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.384 1.874 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.09 152.15 48.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.033 0.933 . . . . 0.0 112.075 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -135.0 154.4 79.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.223 1.409 . . . . 0.0 111.114 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.51 122.12 9.92 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.11 2.54 . . . . 0.0 111.336 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.09 174.96 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.983 2.455 . . . . 0.0 111.908 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.95 162.01 19.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.866 1.666 . . . . 0.0 110.646 168.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -144.43 176.36 9.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.906 1.282 . . . . 0.0 110.854 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 177.88 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.859 2.063 . . . . 0.0 110.817 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.824 1.649 . . . . 0.0 114.212 177.51 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -66.8 1.69 1.73 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.4 mtt -52.95 -36.58 60.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.92 -15.25 29.01 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 -19.73 65.78 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -135.97 131.71 35.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.36 1.464 . . . . 0.0 111.436 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -143.12 131.3 21.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.482 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.456 ' HB3' ' HA3' ' A' ' 118' ' ' GLY . . . -72.1 177.15 4.56 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.71 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 101.05 0.12 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 112.219 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.11 -15.27 59.62 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.968 -1.082 . . . . 0.0 112.528 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.24 -27.4 69.32 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 t -82.43 -26.28 32.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.462 1.105 . . . . 0.0 112.57 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.67 118.22 17.39 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.626 -1.296 . . . . 0.0 111.63 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.49 158.66 31.36 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.399 -0.813 . . . . 0.0 112.534 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.55 141.49 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.774 0.83 . . . . 0.0 111.852 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.12 -42.89 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.858 1.663 . . . . 0.0 111.327 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.95 -31.48 60.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 113.311 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -86.64 -53.34 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.044 0.937 . . . . 0.0 111.701 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.696 HG13 HD22 ' A' ' 56' ' ' LEU . 54.3 t -44.14 -48.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.836 1.255 . . . . 0.0 112.605 169.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -65.31 -3.18 3.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.396 1.478 . . . . 0.0 113.919 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.54 -31.67 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.236 1.815 . . . . 0.0 112.274 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -50.87 -44.71 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.369 0.986 . . . . 0.0 110.437 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 97' ' ' VAL . 9.0 p -59.81 -41.85 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -51.93 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.747 1.158 . . . . 0.0 111.585 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -33.32 75.27 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.05 69.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.396 1.079 . . . . 0.0 113.091 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.5 mt -59.86 -56.64 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.258 0.936 . . . . 0.0 110.274 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -60.45 -31.59 70.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.1 t -59.19 -46.68 87.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.32 1.048 . . . . 0.0 112.499 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.94 81.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.401 1.08 . . . . 0.0 113.815 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.95 -43.43 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 110.713 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.35 14.02 61.29 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.59 1.091 . . . . 0.0 115.066 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.78 85.87 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.139 1.352 . . . . 0.0 115.105 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -63.84 168.15 5.35 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 118.735 1.267 . . . . 0.0 112.55 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.63 102.03 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.203 1.801 . . . . 0.0 111.657 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.84 139.07 46.93 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.64 1.976 . . . . 0.0 112.499 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.23 156.98 43.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -57.89 -53.49 57.66 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.7 m -69.92 -26.36 64.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -58.7 -45.7 88.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.042 0.537 . . . . 0.0 112.182 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -56.91 -35.13 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.842 0.746 . . . . 0.0 112.424 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.89 -47.52 80.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.989 0.915 . . . . 0.0 111.621 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -67.81 -24.06 65.25 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -78.93 -52.57 8.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.132 0.878 . . . . 0.0 111.555 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -55.01 -35.23 64.18 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.665 0.666 . . . . 0.0 112.135 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -75.89 -55.76 5.32 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.205 0.911 . . . . 0.0 112.593 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.92 -38.03 75.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.911 1.284 . . . . 0.0 113.532 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.22 -62.32 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 C-N-CA 123.92 0.888 . . . . 0.0 110.384 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.61 -29.84 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.632 1.173 . . . . 0.0 110.75 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.53 -30.61 69.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.753 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -112.53 -42.24 3.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.995 1.718 . . . . 0.0 112.257 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -51.85 -55.58 19.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.5 2.32 . . . . 0.0 112.577 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -37.99 87.38 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.412 0.625 . . . . 0.0 110.989 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.6 m -67.15 -28.36 68.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.22 -52.38 10.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.555 2.342 . . . . 0.0 112.249 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.696 HD22 HG13 ' A' ' 19' ' ' VAL . 3.7 pp -65.74 -25.53 67.32 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -55.38 -37.03 67.02 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.367 1.067 . . . . 0.0 110.913 166.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -81.79 -34.13 30.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.494 0.718 . . . . 0.0 112.712 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -69.74 -28.91 66.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.366 0.666 . . . . 0.0 111.013 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.67 -118.79 4.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.045 1.783 . . . . 0.0 113.256 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -133.89 151.98 77.82 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.696 1.598 . . . . 0.0 113.606 -171.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 113.77 3.86 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.929 3.086 . . . . 0.0 112.214 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -147.62 171.7 15.19 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.299 1.839 . . . . 0.0 110.663 171.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.9 135.86 48.24 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.741 0.781 . . . . 0.0 110.84 162.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -131.13 157.49 42.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 128.014 2.526 . . . . 0.0 108.208 170.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -138.56 155.18 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.178 1.391 . . . . 0.0 109.144 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 110' ' ' ALA . 13.0 m -139.23 148.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 124.751 1.221 . . . . 0.0 110.374 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -145.83 154.05 41.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.304 1.042 . . . . 0.0 110.53 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.5 p -146.07 149.51 34.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.275 1.03 . . . . 0.0 112.854 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.73 111.33 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.841 1.656 . . . . 0.0 109.402 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.564 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.3 mm -107.33 96.47 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.523 1.529 . . . . 0.0 107.481 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.64 89.4 2.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.885 1.274 . . . . 0.0 111.247 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -166.15 120.43 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.473 1.909 . . . . 0.0 107.966 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -152.59 -64.56 0.16 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.757 1.223 . . . . 0.0 111.304 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.2 -15.61 13.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.638 1.575 . . . . 0.0 113.507 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.44 -11.66 33.27 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.273 1.892 . . . . 0.0 114.533 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.52 117.44 9.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.219 1.408 . . . . 0.0 111.938 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.3 174.49 19.62 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.64 1.59 . . . . 0.0 114.095 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.92 -172.54 2.18 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.49 1.916 . . . . 0.0 111.599 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.78 108.56 20.41 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.527 -0.733 . . . . 0.0 110.241 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.3 m -120.41 137.72 54.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.831 0.852 . . . . 0.0 109.868 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.32 134.61 29.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.298 0.639 . . . . 0.0 111.683 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.3 p -132.28 134.99 45.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.972 0.892 . . . . 0.0 111.229 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -83.36 24.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.515 -0.74 . . . . 0.0 111.599 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.8 m -62.79 163.54 9.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.63 0.729 . . . . 0.0 111.288 164.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.05 136.84 5.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 108.986 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 149.79 48.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.412 0.685 . . . . 0.0 110.296 173.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -134.07 152.2 51.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.073 1.349 . . . . 0.0 110.794 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t -120.13 -65.42 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.4 1.08 . . . . 0.0 112.465 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.8 t -82.18 -35.75 28.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.043 0.838 . . . . 0.0 112.607 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -67.37 -36.5 81.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.227 1.411 . . . . 0.0 113.352 -171.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.17 179.14 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.36 2.264 . . . . 0.0 111.121 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 134.52 11.98 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.946 1.26 . . . . 0.0 113.14 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -150.5 139.53 21.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.768 1.627 . . . . 0.0 110.458 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.459 ' SG ' HG11 ' A' ' 19' ' ' VAL . 5.5 p -151.48 120.27 6.58 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.913 0.779 . . . . 0.0 111.902 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -132.29 151.71 51.71 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 112.078 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 23' ' ' VAL . 1.7 t -139.5 139.76 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.605 1.562 . . . . 0.0 109.943 -170.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.05 131.98 50.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.983 1.313 . . . . 0.0 112.13 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -139.46 106.54 5.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.802 1.241 . . . . 0.0 110.926 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -86.38 148.81 25.41 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.986 0.914 . . . . 0.0 112.066 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -123.66 -176.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.755 1.622 . . . . 0.0 110.694 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -67.71 0.24 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.597 1.559 . . . . 0.0 113.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.5 t -117.32 8.19 13.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.405 1.882 . . . . 0.0 112.488 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.0 mtt -134.58 173.98 11.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.43 1.892 . . . . 0.0 111.069 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -151.45 161.99 41.72 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 109.794 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.564 ' CB ' HD12 ' A' ' 71' ' ' ILE . 10.3 p -132.27 151.21 51.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 110.406 171.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.49 137.8 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 109.257 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.24 140.13 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.939 1.296 . . . . 0.0 109.678 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -131.9 145.13 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.998 0.919 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.53 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -130.24 145.1 51.71 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.262 1.425 . . . . 0.0 111.934 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.1 151.63 51.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.772 1.629 . . . . 0.0 111.08 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.81 86.72 0.15 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.175 1.369 . . . . 0.0 111.353 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -78.14 122.39 25.58 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.993 1.317 . . . . 0.0 111.568 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 m -142.18 121.59 13.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.654 1.581 . . . . 0.0 112.302 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.428 HD11 HD11 ' B' ' 258' ' ' ILE . 2.1 pp -112.39 8.23 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.15 -2.07 30.23 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.656 1.598 . . . . 0.0 117.053 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.87 1.5 73.26 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.208 1.504 . . . . 0.0 115.711 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 8' ' ' ALA . . . -161.39 73.34 0.2 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.325 1.917 . . . . 0.0 111.552 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.1 t -151.3 171.19 17.84 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.306 1.443 . . . . 0.0 111.439 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.92 2.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.178 1.847 . . . . 0.0 114.978 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.72 169.72 14.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.409 1.883 . . . . 0.0 112.11 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.5 t -122.43 -19.23 6.47 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.679 1.592 . . . . 0.0 114.333 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -175.1 -72.27 0.05 OUTLIER Glycine 0 CA--C 1.537 1.453 0 O-C-N 121.114 -0.991 . . . . 0.0 113.524 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.18 163.27 39.73 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.874 2.382 . . . . 0.0 111.8 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.2 pt -127.57 139.08 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 111.501 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.78 158.07 45.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.903 1.681 . . . . 0.0 113.02 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.7 170.03 17.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.184 0.994 . . . . 0.0 111.605 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.3 158.12 30.88 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.099 1.333 . . . . 0.0 112.743 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtt -77.03 157.08 31.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.899 0.879 . . . . 0.0 112.312 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -145.98 96.16 2.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.633 1.573 . . . . 0.0 111.404 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.13 169.08 15.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.911 1.284 . . . . 0.0 111.836 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.2 mm -60.34 151.06 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.373 1.869 . . . . 0.0 111.275 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.2 m -124.59 95.23 4.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.971 1.708 . . . . 0.0 110.885 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -97.64 149.96 21.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.933 -1.104 . . . . 0.0 111.434 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.98 102.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.488 2.315 . . . . 0.0 109.045 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -142.45 115.84 9.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.614 1.166 . . . . 0.0 111.724 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -134.71 82.84 43.43 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.102 1.361 . . . . 0.0 110.91 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.53 165.34 23.1 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.92 2.413 . . . . 0.0 112.802 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.95 -23.09 41.17 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.339 2.693 . . . . 0.0 114.337 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -118.09 -178.84 3.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.433 2.293 . . . . 0.0 110.858 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -61.3 171.56 1.35 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.039 1.336 . . . . 0.0 113.113 171.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.92 168.41 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 0.0 112.348 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.194 1.798 . . . . 0.0 111.032 177.438 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 17.0 m -66.79 1.46 1.83 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 51.5 mtt -52.17 -37.1 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.999 1.32 . . . . 0.0 113.331 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.76 -15.41 29.26 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.21 -19.81 65.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.052 -1.03 . . . . 0.0 113.65 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.08 130.71 33.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.345 1.458 . . . . 0.0 111.543 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -142.22 131.09 22.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.626 0.771 . . . . 0.0 111.503 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ALA . . . . . 0.49 ' HB3' ' HA3' ' B' ' 261' ' ' GLY . . . -71.28 177.55 3.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.494 1.117 . . . . 0.0 112.646 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.12 98.38 0.08 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.323 1.449 . . . . 0.0 112.259 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.72 -16.98 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.861 -1.149 . . . . 0.0 112.512 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.21 -27.14 69.15 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.8 t -83.76 -24.82 30.96 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.216 1.007 . . . . 0.0 112.675 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.34 127.27 32.18 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.361 -1.462 . . . . 0.0 111.051 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -65.75 167.02 9.92 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.275 -0.89 . . . . 0.0 111.575 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.39 145.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.411 1.084 . . . . 0.0 111.315 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.38 -39.65 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.618 1.167 . . . . 0.0 111.925 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.36 -31.12 68.92 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.667 1.587 . . . . 0.0 113.312 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -74.0 -60.05 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.939 0.895 . . . . 0.0 110.172 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.66 HG13 HD22 ' B' ' 199' ' ' LEU . 40.3 t -54.23 -42.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.752 1.221 . . . . 0.0 113.143 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -64.74 -3.31 3.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.058 1.343 . . . . 0.0 113.747 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.37 -33.35 5.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.438 1.895 . . . . 0.0 112.432 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 39.1 mt -51.8 -43.14 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.497 1.044 . . . . 0.0 110.352 169.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 240' ' ' VAL . 9.0 p -59.97 -41.93 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.74 56.93 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.772 1.169 . . . . 0.0 111.52 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -33.74 76.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.0 71.71 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.228 1.011 . . . . 0.0 113.036 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.88 -56.97 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.241 0.928 . . . . 0.0 110.312 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -60.28 -31.67 70.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -59.27 -46.7 87.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.34 1.056 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.11 81.62 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.402 1.081 . . . . 0.0 113.797 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.82 -43.43 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.277 1.031 . . . . 0.0 110.734 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.86 13.77 62.06 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.493 1.044 . . . . 0.0 115.0 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.78 10.82 85.85 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.188 1.375 . . . . 0.0 115.027 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -63.79 168.25 5.19 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.694 1.247 . . . . 0.0 112.501 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.62 102.55 0.07 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.076 1.75 . . . . 0.0 111.598 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.95 138.65 48.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.573 1.949 . . . . 0.0 112.526 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.8 156.63 43.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.697 1.199 . . . . 0.0 111.422 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -57.98 -53.53 57.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -69.42 -26.88 64.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -58.59 -45.47 89.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 0.0 112.22 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 4.2 t -56.49 -35.66 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.832 0.742 . . . . 0.0 112.444 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -63.8 -47.46 80.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.87 0.868 . . . . 0.0 111.585 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -67.92 -23.93 65.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -78.84 -52.9 7.68 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.172 0.896 . . . . 0.0 111.406 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.8 t -54.96 -34.79 63.6 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.736 0.698 . . . . 0.0 112.185 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.4 t -75.79 -56.75 4.38 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.178 0.899 . . . . 0.0 112.636 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -57.23 -38.44 73.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.952 1.301 . . . . 0.0 113.646 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.9 -64.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 83.1 t -51.65 -29.28 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 110.677 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.88 -34.48 73.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.171 0.988 . . . . 0.0 113.548 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -110.69 -38.6 5.11 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.693 1.597 . . . . 0.0 112.355 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 22.1 m -55.29 -53.52 55.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.419 2.288 . . . . 0.0 111.753 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 7.6 tp -60.12 -36.01 76.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.259 0.481 . . . . 0.0 112.054 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 68.4 m -70.6 -30.73 67.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.964 0.906 . . . . 0.0 113.355 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -71.34 -52.12 20.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.903 2.081 . . . . 0.0 112.453 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.66 HD22 HG13 ' B' ' 162' ' ' VAL . 2.8 pp -64.93 -26.43 68.31 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 53.9 m -58.32 -30.46 66.71 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.941 0.896 . . . . 0.0 110.984 168.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -85.88 -36.28 20.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.817 0.847 . . . . 0.0 112.717 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.82 -23.8 66.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.968 0.907 . . . . 0.0 112.699 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.55 -112.68 3.71 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.153 1.359 . . . . 0.0 112.734 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -137.63 154.53 75.03 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.711 1.604 . . . . 0.0 113.237 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.48 115.32 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.682 2.921 . . . . 0.0 112.2 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.35 172.68 15.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.413 1.885 . . . . 0.0 110.686 171.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -71.81 132.16 44.06 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.568 -0.708 . . . . 0.0 110.907 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -129.31 147.68 51.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.736 1.614 . . . . 0.0 109.198 168.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.2 tt -128.38 154.81 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.397 1.479 . . . . 0.0 109.253 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' B' ' 253' ' ' ALA . 3.5 m -136.69 150.76 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.134 1.374 . . . . 0.0 111.055 172.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 18.6 p -137.83 151.95 48.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.601 1.561 . . . . 0.0 110.279 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.3 p -146.43 152.33 38.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.162 0.982 . . . . 0.0 113.003 168.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.51 114.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 108.974 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' B' ' 249' ' ' CYS . 3.1 mm -107.28 91.26 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.446 1.898 . . . . 0.0 107.648 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 2.2 ttt -98.73 135.94 39.5 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.374 1.47 . . . . 0.0 109.506 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -81.72 145.65 30.39 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.492 -0.755 . . . . 0.0 112.37 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -76.1 -0.16 20.94 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.289 1.435 . . . . 0.0 114.045 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.18 -21.31 13.1 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.424 1.89 . . . . 0.0 113.996 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.03 -12.27 62.23 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.703 1.621 . . . . 0.0 114.36 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.75 89.71 1.37 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.272 1.429 . . . . 0.0 111.55 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.55 -169.01 27.73 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.97 1.272 . . . . 0.0 113.672 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.2 -176.03 4.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.665 2.386 . . . . 0.0 111.379 -173.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.01 104.24 13.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.216 1.007 . . . . 0.0 110.278 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 135.24 54.1 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.837 0.855 . . . . 0.0 110.56 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.78 12.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.286 0.234 . . . . 0.0 111.038 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -120.65 138.15 54.08 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.954 0.883 . . . . 0.0 110.966 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 69.8 m -84.2 21.36 1.4 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.41 -0.806 . . . . 0.0 111.899 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.2 m -64.82 162.6 15.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.509 0.724 . . . . 0.0 111.65 168.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.725 1.61 . . . . 0.0 110.388 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -69.78 151.8 45.35 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.426 -0.796 . . . . 0.0 110.483 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -137.03 151.04 48.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.396 1.478 . . . . 0.0 110.351 167.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 2.4 t -119.78 -64.76 1.23 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.425 1.09 . . . . 0.0 112.523 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 46.6 t -82.44 -35.74 27.27 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.258 -0.901 . . . . 0.0 112.647 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -36.7 80.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.3 1.44 . . . . 0.0 113.406 -170.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.27 178.7 7.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.478 2.311 . . . . 0.0 110.744 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -96.95 134.33 11.73 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.871 1.224 . . . . 0.0 112.955 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 56.0 m -150.52 148.63 28.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.924 1.689 . . . . 0.0 110.152 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 3.2 p -152.57 121.41 6.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.726 1.211 . . . . 0.0 111.331 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.0 t -132.71 151.02 52.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.239 1.416 . . . . 0.0 112.271 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 166' ' ' VAL . 1.7 t -140.6 139.98 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.517 1.527 . . . . 0.0 110.014 -169.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.81 130.88 49.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.861 1.264 . . . . 0.0 112.236 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -138.77 104.29 5.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.0 1.32 . . . . 0.0 110.639 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.58 149.87 27.22 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.217 -0.927 . . . . 0.0 111.679 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -124.38 -177.79 3.9 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.361 1.465 . . . . 0.0 110.868 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -67.91 0.23 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.513 1.525 . . . . 0.0 113.35 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -119.15 15.13 13.18 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.486 1.914 . . . . 0.0 112.952 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 43.0 mtt -142.47 175.11 10.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.493 1.917 . . . . 0.0 109.9 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -151.54 158.7 43.92 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.869 0.868 . . . . 0.0 109.972 161.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.424 ' CB ' HD12 ' B' ' 214' ' ' ILE . 12.6 p -134.09 144.06 48.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.437 1.113 . . . . 0.0 110.99 174.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.19 132.64 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.427 1.491 . . . . 0.0 109.299 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.1 142.01 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.205 1.402 . . . . 0.0 110.027 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.1 t -135.79 144.52 45.8 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.785 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.518 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -130.21 144.36 51.32 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.479 1.511 . . . . 0.0 111.728 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -132.63 148.45 52.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.181 1.792 . . . . 0.0 110.571 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -147.61 87.3 0.16 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.581 1.562 . . . . 0.0 112.32 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.01 118.46 21.76 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 111.604 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 75.6 m -141.36 119.11 11.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.753 1.621 . . . . 0.0 112.347 -168.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 258' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 115' ' ' ILE . 2.1 pp -111.13 8.19 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -68.88 -2.32 29.51 Favored Glycine 0 CA--C 1.542 1.746 0 N-CA-C 117.092 1.597 . . . . 0.0 117.092 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.96 71.35 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 119.275 1.537 . . . . 0.0 115.783 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 261' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' B' ' 151' ' ' ALA . . . -162.48 74.97 0.18 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.543 2.021 . . . . 0.0 111.206 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.3 t -152.82 171.0 18.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.474 1.51 . . . . 0.0 111.35 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 80.5 -28.64 2.68 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 126.261 1.886 . . . . 0.0 114.908 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.11 168.97 15.33 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.439 1.896 . . . . 0.0 112.208 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 37.2 t -121.33 -19.17 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.681 1.592 . . . . 0.0 114.363 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -175.33 -72.55 0.05 OUTLIER Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.224 -0.922 . . . . 0.0 113.522 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.87 162.75 41.57 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.789 2.326 . . . . 0.0 111.794 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.123 1.369 . . . . 0.0 111.452 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.24 158.15 45.07 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.867 1.667 . . . . 0.0 113.027 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.87 170.05 17.28 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.119 0.967 . . . . 0.0 111.615 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -167.24 158.13 30.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.137 1.351 . . . . 0.0 112.672 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 3.6 mtt -76.95 157.28 31.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.806 0.843 . . . . 0.0 112.254 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -145.88 96.32 2.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 111.348 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -129.86 169.53 15.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.16 150.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.443 1.897 . . . . 0.0 111.366 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.6 m -123.67 88.41 2.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.739 1.616 . . . . 0.0 110.878 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -93.61 150.74 20.18 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.378 -0.826 . . . . 0.0 111.369 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.15 108.51 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.624 1.97 . . . . 0.0 110.043 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -141.65 113.32 7.77 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.742 1.617 . . . . 0.0 111.294 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -130.12 83.54 62.95 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.043 1.337 . . . . 0.0 110.875 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.5 165.46 25.01 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.954 2.436 . . . . 0.0 112.57 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.24 -20.02 33.08 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.277 2.651 . . . . 0.0 114.339 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -118.8 -179.04 3.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.461 2.304 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -61.34 171.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.083 1.353 . . . . 0.0 113.145 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 168.73 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.693 1.597 . . . . 0.0 112.338 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.227 1.811 . . . . 0.0 111.036 177.78 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.1 p -65.14 67.15 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.837 2.055 . . . . 0.0 115.749 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.2 mmt -71.25 -75.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.134 1.774 . . . . 0.0 111.991 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -102.59 -65.06 1.02 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.164 0.986 . . . . 0.0 113.405 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -130.99 1.33 4.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.657 2.383 . . . . 0.0 111.367 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.07 170.88 9.11 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.175 1.39 . . . . 0.0 112.315 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -128.44 160.14 33.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.305 1.442 . . . . 0.0 111.749 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.0 83.14 1.78 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.266 1.826 . . . . 0.0 110.67 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 152.11 42.63 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.555 0.742 . . . . 0.0 112.01 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.38 -23.17 23.43 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.149 -0.969 . . . . 0.0 113.371 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.24 -24.07 62.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 t -91.41 -14.12 31.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.843 2.057 . . . . 0.0 112.761 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.72 160.26 28.47 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.933 -1.105 . . . . 0.0 111.368 169.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -140.16 167.96 20.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.628 1.571 . . . . 0.0 110.959 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.99 152.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.92 1.288 . . . . 0.0 110.148 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.75 -35.84 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.263 -0.898 . . . . 0.0 111.517 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.61 -25.02 67.08 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.142 0.977 . . . . 0.0 113.48 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -78.62 -57.67 3.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.246 1.018 . . . . 0.0 110.535 169.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.8 t -50.49 -44.92 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.475 1.51 . . . . 0.0 112.535 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -67.68 -9.06 40.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.266 1.827 . . . . 0.0 113.628 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -102.33 -31.37 10.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.581 1.552 . . . . 0.0 112.844 170.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mt -49.27 -44.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.359 1.064 . . . . 0.0 110.467 170.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.97 -43.68 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -49.96 65.35 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.257 1.39 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -33.35 75.38 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.113 0.965 . . . . 0.0 113.091 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 48' ' ' VAL . 44.9 mt -57.59 -56.17 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.225 0.92 . . . . 0.0 110.315 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.07 -32.01 70.54 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -60.86 -45.47 94.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.331 1.052 . . . . 0.0 112.449 170.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.95 71.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.24 -44.03 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.999 . . . . 0.0 110.938 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.03 71.92 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.61 26.84 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.348 1.451 . . . . 0.0 116.257 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.27 -179.17 1.52 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.024 1.412 . . . . 0.0 112.689 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -156.92 0.57 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.986 1.314 . . . . 0.0 111.803 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.9 158.04 0.74 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.028 1.331 . . . . 0.0 112.42 162.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.49 -176.4 5.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.715 1.206 . . . . 0.0 111.75 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.58 -100.76 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.882 1.273 . . . . 0.0 109.655 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -67.83 -24.33 65.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.96 1.304 . . . . 0.0 113.992 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -41.63 78.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.055 -1.028 . . . . 0.0 112.669 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.2 -29.18 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.615 0.766 . . . . 0.0 112.57 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.12 -48.43 78.53 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.695 1.198 . . . . 0.0 111.385 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.55 -26.36 67.09 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.349 -0.844 . . . . 0.0 112.986 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -77.13 -54.24 6.76 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.498 -0.752 . . . . 0.0 111.186 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 t -56.5 -29.83 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.783 0.719 . . . . 0.0 112.739 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -79.73 -52.68 7.63 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.477 1.035 . . . . 0.0 112.505 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -58.5 -38.0 76.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.578 1.151 . . . . 0.0 113.323 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 27' ' ' ILE . 75.8 t -67.02 -65.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 124.667 1.187 . . . . 0.0 109.807 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.7 -29.09 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.873 1.269 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.67 -47.19 80.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 0.0 112.705 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.57 -38.29 9.21 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.023 1.329 . . . . 0.0 112.885 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -56.39 -53.64 54.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.538 1.935 . . . . 0.0 112.135 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -40.16 91.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.688 0.676 . . . . 0.0 111.307 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 p -69.68 -27.96 65.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -75.2 -52.15 11.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.677 2.391 . . . . 0.0 113.04 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.65 -28.27 69.79 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.626 -1.296 . . . . 0.0 113.308 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.9 m -56.25 -32.99 65.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.754 1.222 . . . . 0.0 111.056 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -85.59 -28.34 24.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.211 1.004 . . . . 0.0 113.233 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.73 -25.34 62.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.95 0.9 . . . . 0.0 112.312 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.47 -141.14 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.253 1.883 . . . . 0.0 112.035 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -112.84 155.08 44.6 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.397 1.479 . . . . 0.0 112.813 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.44 111.91 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.882 3.054 . . . . 0.0 111.238 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.2 174.86 10.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 0.0 111.387 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HE3' ' CE2' ' B' ' 254' ' ' PHE . 0.5 OUTLIER -66.21 124.17 21.92 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.943 0.897 . . . . 0.0 110.072 163.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -124.56 165.36 17.97 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.999 2.12 . . . . 0.0 109.811 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.428 HG22 ' CD2' ' A' ' 111' ' ' PHE . 4.8 tp -152.06 154.24 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.63 1.572 . . . . 0.0 109.52 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 110' ' ' ALA . 33.9 m -136.84 148.18 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 111.359 167.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.96 127.31 13.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 110.191 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' B' ' 225' ' ' ALA . 7.9 p -127.58 155.53 43.7 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.897 0.879 . . . . 0.0 112.301 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.466 ' C ' HD13 ' A' ' 71' ' ' ILE . 10.0 p -140.19 122.72 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.948 1.299 . . . . 0.0 108.723 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 106' ' ' CYS . 1.9 mm -120.78 116.35 49.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 127.937 2.495 . . . . 0.0 107.474 -174.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.465 ' HG3' HD11 ' A' ' 79' ' ' LEU . 14.5 tmm? -135.92 151.93 50.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.184 0.992 . . . . 0.0 112.279 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -105.15 110.6 23.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.884 1.673 . . . . 0.0 112.263 -168.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.99 -6.17 11.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.186 2.194 . . . . 0.0 113.225 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -25.75 6.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.819 2.448 . . . . 0.0 114.336 162.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.31 7.05 0.59 Allowed Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 130.26 45.46 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.594 1.697 . . . . 0.0 112.338 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.6 112.9 2.16 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD11 ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -146.85 171.56 15.01 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.41 1.884 . . . . 0.0 112.324 -176.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -121.73 130.93 53.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 110.621 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 135' ' ' VAL . 51.5 m -142.23 147.42 36.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.268 1.427 . . . . 0.0 109.059 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 153.2 40.77 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.822 -1.174 . . . . 0.0 111.904 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -155.58 165.03 37.8 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.3 t -116.43 9.89 14.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 112.643 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.45 106.26 5.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.995 1.318 . . . . 0.0 113.189 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -127.03 151.4 48.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.74 1.216 . . . . 0.0 111.429 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 145.83 52.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.195 0.998 . . . . 0.0 110.218 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -140.84 151.85 44.66 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.612 1.565 . . . . 0.0 109.351 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 t -117.02 -63.75 1.4 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.365 1.466 . . . . 0.0 112.143 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t -87.9 -28.76 21.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.201 1.001 . . . . 0.0 112.885 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -52.79 8.64 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.327 1.451 . . . . 0.0 111.948 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -151.54 -174.21 4.76 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.129 2.972 . . . . 0.0 109.608 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.63 6.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.297 1.427 . . . . 0.0 113.342 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.47 165.75 30.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.195 1.398 . . . . 0.0 111.126 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.94 126.93 10.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.984 0.914 . . . . 0.0 110.789 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 t -134.64 144.68 47.99 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.497 -1.377 . . . . 0.0 111.901 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.24 139.36 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.837 1.255 . . . . 0.0 110.11 -168.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.01 123.98 20.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.781 1.633 . . . . 0.0 112.255 -170.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -135.03 103.07 5.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.259 1.824 . . . . 0.0 110.531 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.95 149.59 44.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.165 0.986 . . . . 0.0 112.552 171.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -127.46 -179.37 4.87 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.509 . . . . 0.0 110.469 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.23 -48.61 72.7 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 13.74 5.35 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.447 1.899 . . . . 0.0 112.388 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.0 mtt -143.17 176.87 8.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.815 2.046 . . . . 0.0 109.695 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.0 156.1 35.37 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.276 1.03 . . . . 0.0 110.105 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.59 ' HB2' HD12 ' A' ' 71' ' ' ILE . 24.0 p -133.94 136.21 44.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.927 . . . . 0.0 111.647 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.19 129.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.34 1.456 . . . . 0.0 110.168 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.76 111.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.2 1.8 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -107.38 121.39 44.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.189 0.996 . . . . 0.0 110.151 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -119.63 160.51 22.36 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.294 1.438 . . . . 0.0 112.467 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -135.93 156.52 48.63 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.996 1.318 . . . . 0.0 109.874 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -179.95 91.99 0.08 OUTLIER Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.14 174.02 2.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.094 0.95 . . . . 0.0 112.155 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -120.28 159.22 25.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.784 1.234 . . . . 0.0 111.96 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.2 pt -56.83 -50.75 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.652 2.381 . . . . 0.0 113.271 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -125.14 -26.69 1.31 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.683 1.135 . . . . 0.0 114.388 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.04 10.02 44.26 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 124.834 1.207 . . . . 0.0 115.652 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.94 33.01 2.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.12 1.819 . . . . 0.0 114.367 -170.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.0 p -126.96 83.82 2.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.557 1.943 . . . . 0.0 110.698 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.47 69.49 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.732 0.682 . . . . 0.0 113.848 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.59 166.46 1.8 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.961 1.304 . . . . 0.0 112.747 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.9 m -46.79 -39.45 11.84 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.361 1.864 . . . . 0.0 114.861 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.32 -83.21 0.35 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.274 2.368 . . . . 0.0 111.137 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.67 163.66 36.78 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.608 2.872 . . . . 0.0 112.827 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -82.21 156.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.875 169.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 173.18 1.84 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.797 1.639 . . . . 0.0 112.506 168.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.42 146.64 49.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.777 1.231 . . . . 0.0 111.791 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.26 159.15 27.22 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 126.073 1.797 . . . . 0.0 113.799 -171.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -73.33 167.95 20.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.713 1.205 . . . . 0.0 112.707 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.56 114.17 14.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.412 1.885 . . . . 0.0 111.071 172.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.08 -177.88 4.31 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.182 1.793 . . . . 0.0 111.152 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.26 140.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.006 0.922 . . . . 0.0 110.762 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.6 m -121.69 119.89 33.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.878 1.671 . . . . 0.0 110.606 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 117.27 33.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.59 1.156 . . . . 0.0 110.891 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.426 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -100.48 105.02 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 128.987 2.915 . . . . 0.0 109.31 178.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -133.33 156.52 47.46 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.164 -0.96 . . . . 0.0 112.262 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.56 94.31 47.76 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.03 1.332 . . . . 0.0 109.704 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.78 164.93 33.8 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.003 2.469 . . . . 0.0 111.952 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.43 -23.57 20.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.956 2.437 . . . . 0.0 113.819 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -67.98 141.15 56.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.702 0.801 . . . . 0.0 111.759 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.1 178.53 6.94 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.406 1.482 . . . . 0.0 112.304 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.8 160.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.188 1.795 . . . . 0.0 111.214 173.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.251 1.18 0 C-N-CA 127.024 2.13 . . . . 0.0 112.567 -177.225 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -65.43 67.09 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.545 2.338 . . . . 0.0 115.782 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 9.3 mmt -70.19 -74.78 0.13 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.829 1.652 . . . . 0.0 112.011 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -102.99 -64.96 1.03 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -131.02 1.36 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.599 2.359 . . . . 0.0 111.274 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.01 170.96 8.86 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.167 1.387 . . . . 0.0 112.341 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -128.51 160.25 32.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.347 1.459 . . . . 0.0 111.75 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.93 83.2 1.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.345 1.858 . . . . 0.0 110.688 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.72 151.38 45.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.554 0.741 . . . . 0.0 112.055 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -23.77 23.8 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.214 -0.929 . . . . 0.0 113.312 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -70.75 -24.31 62.59 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -92.47 -13.75 29.49 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.678 1.991 . . . . 0.0 112.826 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.37 160.51 27.15 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.944 -1.098 . . . . 0.0 111.291 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -139.63 167.4 22.19 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.573 1.549 . . . . 0.0 110.898 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.14 152.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.018 1.327 . . . . 0.0 110.172 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.41 -36.49 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.212 -0.93 . . . . 0.0 111.581 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.15 -24.2 66.11 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -79.19 -58.34 3.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.44 1.096 . . . . 0.0 110.62 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 24.7 t -50.38 -44.56 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 112.602 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -68.12 -8.76 41.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 113.651 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -102.8 -30.91 10.57 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.55 1.54 . . . . 0.0 112.787 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.1 mt -49.34 -44.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.408 1.083 . . . . 0.0 110.344 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.56 -43.65 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -50.01 65.04 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.157 1.344 . . . . 0.0 111.384 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -33.44 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.12 -40.47 71.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.207 1.003 . . . . 0.0 112.97 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' B' ' 191' ' ' VAL . 44.3 mt -57.56 -56.39 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.215 0.916 . . . . 0.0 110.277 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.88 -32.15 70.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -60.81 -45.5 94.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.344 1.057 . . . . 0.0 112.452 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.86 71.37 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.27 -44.16 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.161 0.984 . . . . 0.0 110.916 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.08 71.27 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.103 0.859 . . . . 0.0 115.071 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.33 -4.6 26.68 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.396 1.474 . . . . 0.0 116.229 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.35 -179.26 1.58 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.077 1.439 . . . . 0.0 112.558 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.48 -156.86 0.57 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.917 1.287 . . . . 0.0 111.759 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.92 158.03 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.105 1.362 . . . . 0.0 112.458 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.55 -176.23 5.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.718 1.207 . . . . 0.0 111.779 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.9 -100.92 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.87 1.268 . . . . 0.0 109.632 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 22.4 m -67.61 -24.31 65.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.937 1.295 . . . . 0.0 114.018 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -41.62 78.6 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.035 -1.041 . . . . 0.0 112.593 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.07 -29.23 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.545 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -63.17 -48.63 77.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.637 1.175 . . . . 0.0 111.391 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.41 -26.4 67.21 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.332 -0.855 . . . . 0.0 112.922 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -76.94 -54.44 6.57 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.505 -0.747 . . . . 0.0 111.23 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.3 t -56.56 -29.27 61.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.2 t -80.16 -53.08 7.01 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.497 1.044 . . . . 0.0 112.557 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -58.04 -37.86 75.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.649 1.18 . . . . 0.0 113.276 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' B' ' 170' ' ' ILE . 74.0 t -66.66 -66.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 124.844 1.257 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.66 -29.25 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.71 1.204 . . . . 0.0 111.06 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.45 -47.35 79.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.499 0.72 . . . . 0.0 112.752 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.73 -38.17 9.19 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.053 1.341 . . . . 0.0 113.004 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 20.6 m -56.45 -53.38 58.11 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.559 1.943 . . . . 0.0 112.116 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -40.66 93.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.786 0.721 . . . . 0.0 111.303 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 35.3 p -69.14 -29.09 67.05 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.325 -0.86 . . . . 0.0 113.257 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -73.93 -51.73 15.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.662 2.385 . . . . 0.0 113.073 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.4 -28.22 69.54 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.61 -1.306 . . . . 0.0 113.292 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 96.2 m -58.17 -27.49 63.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.611 1.164 . . . . 0.0 111.117 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -90.76 -28.43 18.26 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.443 1.097 . . . . 0.0 113.607 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.13 -27.06 63.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.689 0.796 . . . . 0.0 111.821 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -137.01 9.58 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.127 1.822 . . . . 0.0 111.949 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -119.76 160.55 41.97 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 125.463 1.505 . . . . 0.0 113.571 -173.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 115.93 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.629 2.886 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.8 175.55 11.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.317 1.447 . . . . 0.0 111.7 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.26 109.05 5.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.78 1.232 . . . . 0.0 109.719 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.83 159.47 15.77 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.86 1.264 . . . . 0.0 109.948 167.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.9 tt -146.8 157.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 109.863 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' B' ' 253' ' ' ALA . 33.7 m -138.87 147.27 25.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.894 1.678 . . . . 0.0 110.722 174.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.01 126.97 11.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.94 1.696 . . . . 0.0 109.628 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.41 158.42 42.04 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.635 0.774 . . . . 0.0 112.931 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' VAL . . . . . 0.501 ' C ' HD13 ' B' ' 214' ' ' ILE . 7.6 p -145.05 124.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.758 1.223 . . . . 0.0 109.703 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.2 mm -123.92 113.02 35.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.766 2.426 . . . . 0.0 107.845 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -134.64 153.12 52.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.255 1.026 . . . . 0.0 112.41 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -103.44 114.15 28.2 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.984 1.714 . . . . 0.0 112.512 -168.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -66.95 -5.51 12.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.002 2.121 . . . . 0.0 113.336 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.78 -24.8 6.44 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.627 2.371 . . . . 0.0 114.332 161.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 7.97 1.49 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.2 88.13 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.199 1.5 . . . . 0.0 113.529 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 142.21 33.27 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.157 -0.964 . . . . 0.0 113.918 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.97 172.02 17.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.209 2.204 . . . . 0.0 111.186 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -125.18 122.53 37.32 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.803 1.241 . . . . 0.0 109.981 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.49 ' HB ' HG13 ' B' ' 278' ' ' VAL . 93.8 m -132.51 145.92 51.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 108.427 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ALA . . . . . 0.42 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . . . -140.62 143.3 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.502 -0.749 . . . . 0.0 110.819 173.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 83.2 p -140.67 158.18 44.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.696 0.76 . . . . 0.0 111.546 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 34.5 t -103.83 5.4 35.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.087 0.955 . . . . 0.0 111.991 170.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 73.1 m -67.4 151.89 46.65 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.452 1.12 . . . . 0.0 113.73 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.97 162.07 23.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.672 2.389 . . . . 0.0 109.695 -171.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.9 144.63 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.382 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -136.37 151.15 49.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.317 1.847 . . . . 0.0 110.587 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 22.3 t -117.55 -68.19 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.695 1.198 . . . . 0.0 111.929 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 4.6 t -83.87 -32.0 25.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.436 0.694 . . . . 0.0 112.345 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.18 42.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.859 1.664 . . . . 0.0 112.522 -173.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -154.62 -172.9 4.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 128.804 2.842 . . . . 0.0 110.053 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -120.02 131.39 8.86 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.605 1.574 . . . . 0.0 113.776 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 p -155.08 159.91 40.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.174 2.19 . . . . 0.0 111.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.7 t -149.66 110.36 4.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.762 1.225 . . . . 0.0 110.698 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.3 t -118.71 146.46 44.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.637 1.175 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.91 141.31 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.717 1.207 . . . . 0.0 110.241 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.67 124.65 20.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.922 1.689 . . . . 0.0 112.355 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -135.29 105.65 6.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.213 1.805 . . . . 0.0 110.599 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 150.11 40.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.204 1.002 . . . . 0.0 112.395 172.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -127.87 -179.89 5.2 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.434 1.494 . . . . 0.0 110.529 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -48.45 75.09 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.0 t -131.6 14.68 4.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.492 1.917 . . . . 0.0 112.478 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 26.5 mtt -143.4 176.49 9.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.796 2.039 . . . . 0.0 109.82 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -154.11 155.91 36.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.325 1.05 . . . . 0.0 110.043 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.618 ' HB2' HD12 ' B' ' 214' ' ' ILE . 21.7 p -135.22 135.4 40.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.947 0.899 . . . . 0.0 111.734 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -134.56 131.36 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.319 1.448 . . . . 0.0 110.394 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.13 107.68 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.126 1.77 . . . . 0.0 110.75 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.7 t -96.31 129.39 43.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.547 0.739 . . . . 0.0 110.139 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -126.62 147.76 49.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 112.272 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.558 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 1.1 m-85 -117.22 149.47 40.35 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.966 1.706 . . . . 0.0 111.264 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -172.02 89.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.407 -170.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.428 ' H ' HD22 ' B' ' 256' ' ' LEU . 0.9 OUTLIER -66.47 165.22 14.81 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.883 0.849 . . . . 0.0 111.952 -178.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.4 t -102.21 160.11 14.81 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.568 1.147 . . . . 0.0 111.631 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -58.16 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.074 2.15 . . . . 0.0 112.63 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -113.82 -26.22 3.94 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.541 1.067 . . . . 0.0 114.591 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 60.25 23.75 60.3 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.42 1.11 . . . . 0.0 114.88 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.4 -164.57 25.66 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.171 1.843 . . . . 0.0 114.641 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 74.5 p -59.47 162.28 5.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.521 1.129 . . . . 0.0 113.031 174.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.78 81.61 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.432 1.015 . . . . 0.0 114.392 -170.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -67.82 -173.42 0.35 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.814 1.246 . . . . 0.0 111.923 165.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 18.3 m -47.58 -39.04 15.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.077 1.751 . . . . 0.0 114.785 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 124.16 -74.82 0.39 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.334 1.921 . . . . 0.0 112.27 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.07 173.67 14.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.654 2.903 . . . . 0.0 112.943 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 268' ' ' ILE . . . . . 0.529 HD13 ' H ' ' B' ' 268' ' ' ILE . 0.1 OUTLIER -85.1 154.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.65 1.98 . . . . 0.0 111.403 163.146 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 168.26 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.017 1.327 . . . . 0.0 112.543 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 92.6 mt -117.46 156.92 27.15 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.367 1.467 . . . . 0.0 111.997 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.97 159.83 10.43 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.842 1.687 . . . . 0.0 114.063 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.43 165.71 24.56 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.577 -0.955 . . . . 0.0 112.033 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -131.98 116.58 17.3 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.924 1.689 . . . . 0.0 110.701 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.78 -173.3 2.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.2 mm -57.8 141.89 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 110.649 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 88.7 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.561 1.944 . . . . 0.0 110.011 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.77 136.19 33.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.728 0.811 . . . . 0.0 110.81 171.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.49 HG13 ' HB ' ' B' ' 224' ' ' THR . 5.4 p -131.77 103.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 128.199 2.6 . . . . 0.0 109.656 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -129.78 157.95 40.78 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 0.0 111.562 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.44 94.54 48.81 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.836 1.254 . . . . 0.0 109.37 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.1 164.66 34.05 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.053 2.502 . . . . 0.0 111.979 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.5 -22.18 21.58 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.97 2.446 . . . . 0.0 113.765 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.65 140.59 55.48 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.777 0.831 . . . . 0.0 111.531 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.45 1.5 . . . . 0.0 112.794 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 159.31 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.412 1.885 . . . . 0.0 111.654 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.207 2.203 . . . . 0.0 112.741 -177.58 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -81.42 164.55 21.99 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.141 0.976 . . . . 0.0 113.433 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 mtm -69.97 -44.83 68.66 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.291 1.836 . . . . 0.0 112.206 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.67 -13.37 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.44 -27.73 60.74 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.396 1.078 . . . . 0.0 112.859 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -77.58 161.69 27.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.18 1.392 . . . . 0.0 111.354 172.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -135.48 154.08 51.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.506 1.122 . . . . 0.0 111.869 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 -9.7 44.99 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.07 -10.14 13.19 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.17 1.788 . . . . 0.0 115.002 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -53.03 -27.8 21.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.899 1.679 . . . . 0.0 113.831 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.59 -16.72 6.63 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 t -60.87 -27.61 68.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.321 1.448 . . . . 0.0 113.421 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 116.14 7.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 110.829 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -61.87 164.96 5.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.457 0.703 . . . . 0.0 111.935 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.51 156.83 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.804 0.842 . . . . 0.0 111.398 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 t -57.39 -34.76 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.097 1.759 . . . . 0.0 111.523 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.39 -27.6 67.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.645 1.178 . . . . 0.0 113.256 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -78.12 -59.23 2.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.991 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.527 HG13 HD22 ' A' ' 56' ' ' LEU . 34.1 t -49.74 -45.91 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.502 1.521 . . . . 0.0 112.87 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 t -60.73 -25.26 66.32 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.302 1.441 . . . . 0.0 112.894 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.52 -37.75 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.51 -1.369 . . . . 0.0 113.155 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mt -52.1 -43.6 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.515 1.126 . . . . 0.0 110.84 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.1 -42.15 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.47 -0.776 . . . . 0.0 113.032 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -52.9 54.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.174 1.352 . . . . 0.0 112.082 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.11 74.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.54 -45.68 65.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.004 0.922 . . . . 0.0 112.882 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mt -54.72 -57.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 119.204 0.911 . . . . 0.0 110.415 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.97 -29.92 68.76 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.8 p -66.68 -33.7 76.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.23 52.09 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.043 1.337 . . . . 0.0 112.438 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.69 -41.51 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.869 1.268 . . . . 0.0 110.926 171.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.15 81.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.251 0.929 . . . . 0.0 114.272 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 10.02 75.54 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.334 1.445 . . . . 0.0 115.903 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -61.22 155.58 20.56 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.072 1.436 . . . . 0.0 113.056 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.78 -171.53 1.62 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.167 1.787 . . . . 0.0 112.286 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -41.41 139.29 1.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.743 2.817 . . . . 0.0 114.737 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -135.88 174.75 10.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.485 1.514 . . . . 0.0 113.163 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -90.42 -97.45 0.11 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.541 1.537 . . . . 0.0 111.138 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.8 p -89.37 -1.65 58.13 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.681 1.992 . . . . 0.0 114.326 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.31 -42.77 61.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.433 1.493 . . . . 0.0 113.566 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.08 -32.15 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.55 -48.77 71.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 112.176 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -68.54 -25.99 65.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -76.63 -55.45 5.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.918 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -54.29 -35.3 62.44 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.953 0.797 . . . . 0.0 112.186 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -75.68 -54.55 6.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.129 0.877 . . . . 0.0 112.761 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.91 -36.85 73.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.668 1.187 . . . . 0.0 113.33 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.64 -63.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 C-N-CA 124.177 0.991 . . . . 0.0 110.015 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.8 t -49.15 -30.75 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.057 0.943 . . . . 0.0 110.715 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -59.91 -35.84 75.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -107.02 -42.54 4.87 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.36 1.464 . . . . 0.0 112.659 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 m -54.18 -54.84 34.25 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.339 2.256 . . . . 0.0 112.254 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -39.07 86.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.517 0.598 . . . . 0.0 111.218 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -57.48 -52.61 64.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.203 0.601 . . . . 0.0 111.425 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -59.77 -51.13 71.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.565 1.946 . . . . 0.0 114.489 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.527 HD22 HG13 ' A' ' 19' ' ' VAL . 3.7 pp -65.06 -28.64 69.61 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.574 -1.329 . . . . 0.0 113.734 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 m -59.46 -33.91 71.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.47 0.708 . . . . 0.0 111.071 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -80.66 -24.9 38.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.26 -16.01 62.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.2 -111.3 3.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 112.693 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -133.91 150.92 75.83 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.369 1.868 . . . . 0.0 112.222 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 102.58 1.42 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.98 3.12 . . . . 0.0 112.404 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -143.05 161.67 37.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.471 1.509 . . . . 0.0 112.109 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -65.5 100.07 0.47 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.96 1.704 . . . . 0.0 110.991 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -75.02 166.14 24.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.467 1.107 . . . . 0.0 111.9 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.99 156.07 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.443 2.297 . . . . 0.0 108.186 164.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.69 155.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.782 -0.574 . . . . 0.0 109.455 160.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -134.68 137.47 43.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.519 1.128 . . . . 0.0 109.991 165.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -128.88 144.76 51.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.795 0.838 . . . . 0.0 111.916 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -131.82 99.5 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.298 1.839 . . . . 0.0 108.841 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.501 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -95.75 99.96 10.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.89 96.18 2.76 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.124 1.369 . . . . 0.0 111.292 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -149.35 159.06 44.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.305 1.442 . . . . 0.0 110.458 154.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -153.48 -80.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.07 1.748 . . . . 0.0 110.059 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -84.0 -18.85 35.78 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.895 1.278 . . . . 0.0 113.775 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.68 -2.26 3.71 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.784 1.659 . . . . 0.0 115.093 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.05 179.08 2.45 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.967 1.707 . . . . 0.0 114.167 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.1 -172.29 28.23 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.812 2.149 . . . . 0.0 112.356 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 179.64 6.36 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 111.986 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -106.87 111.21 23.62 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.469 -0.77 . . . . 0.0 111.1 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.431 ' HB ' HG13 ' A' ' 135' ' ' VAL . 16.6 m -116.93 140.71 49.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.474 1.11 . . . . 0.0 109.972 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.02 138.95 34.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.733 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -139.56 120.81 14.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 110.429 -166.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 t -79.97 66.23 5.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.319 1.057 . . . . 0.0 110.093 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.443 ' SG ' HD11 ' B' ' 209' ' ' ILE . 3.9 m -114.04 171.18 7.76 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 0.0 110.787 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -144.07 129.58 19.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.986 1.314 . . . . 0.0 109.86 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -76.98 125.98 30.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.434 1.094 . . . . 0.0 109.846 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -146.01 90.06 1.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.488 1.115 . . . . 0.0 111.336 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -68.1 -60.57 2.39 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.173 1.389 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.7 t -88.08 -33.67 18.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.476 1.11 . . . . 0.0 112.304 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 m -74.75 -38.24 62.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -165.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.76 -134.47 0.14 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.335 1.854 . . . . 0.0 109.422 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.96 150.59 20.66 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.316 1.436 . . . . 0.0 113.464 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 p -162.63 157.3 21.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.6 t -165.25 157.99 15.95 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.302 1.841 . . . . 0.0 109.378 165.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 t -143.24 139.14 30.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.28 -1.512 . . . . 0.0 111.13 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.1 138.31 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 109.658 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.25 119.08 11.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.733 1.613 . . . . 0.0 111.023 -166.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -135.83 141.74 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.868 1.267 . . . . 0.0 112.149 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 165.7 24.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.49 -174.12 4.59 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.17 -62.41 0.95 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.294 1.837 . . . . 0.0 113.536 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -139.18 -6.59 1.39 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.987 1.715 . . . . 0.0 113.124 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.9 ptm -129.17 78.81 1.88 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.642 1.577 . . . . 0.0 112.111 -165.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -51.27 133.5 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.165 1.386 . . . . 0.0 111.306 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.501 ' CB ' HD12 ' A' ' 71' ' ' ILE . 14.3 p -113.63 136.33 52.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 111.767 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.1 126.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.81 1.644 . . . . 0.0 110.994 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.78 122.98 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.221 1.808 . . . . 0.0 110.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -115.64 118.42 33.05 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.788 1.235 . . . . 0.0 110.675 -178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.98 140.8 37.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.262 1.825 . . . . 0.0 112.15 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -133.41 148.51 51.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.339 1.456 . . . . 0.0 109.67 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.1 127.44 3.85 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 125.591 1.567 . . . . 0.0 109.344 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.95 133.43 49.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.63 0.772 . . . . 0.0 111.419 -168.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -134.65 132.83 39.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.959 1.304 . . . . 0.0 112.305 -169.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.3 -1.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.28 -2.19 64.11 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.936 1.255 . . . . 0.0 115.702 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.32 77.56 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 118.775 1.288 . . . . 0.0 115.139 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -54.16 114.8 4.49 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.877 1.703 . . . . 0.0 112.811 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.2 t -135.01 172.51 12.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.861 1.665 . . . . 0.0 111.993 -173.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 135.87 36.65 0.2 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.092 1.805 . . . . 0.0 114.907 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -54.35 166.53 0.41 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.088 1.755 . . . . 0.0 113.842 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.3 t -56.2 -43.78 78.84 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.711 1.605 . . . . 0.0 113.264 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.11 176.85 24.87 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.121 1.344 . . . . 0.0 113.393 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -66.05 145.75 80.18 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.826 2.35 . . . . 0.0 111.101 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.66 154.82 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.097 0.475 . . . . 0.0 111.463 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 166.66 25.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.56 1.144 . . . . 0.0 112.674 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.96 126.66 28.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.187 1.395 . . . . 0.0 109.786 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -157.07 162.78 31.99 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.909 1.242 . . . . 0.0 112.573 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.9 170.55 16.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.478 1.511 . . . . 0.0 110.961 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.1 164.4 29.22 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.36 1.464 . . . . 0.0 112.289 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -132.54 174.46 10.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.364 1.866 . . . . 0.0 111.083 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.15 134.34 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.17 1.788 . . . . 0.0 111.399 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 m -98.32 92.32 5.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.206 1.402 . . . . 0.0 110.242 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -92.55 149.83 21.12 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.701 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.431 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -143.39 97.79 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.569 2.347 . . . . 0.0 108.686 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -144.72 166.26 25.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.048 1.339 . . . . 0.0 112.539 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -120.34 89.09 43.21 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.367 1.467 . . . . 0.0 109.622 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.87 167.35 27.26 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.426 2.751 . . . . 0.0 112.196 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.97 -32.52 17.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.73 2.287 . . . . 0.0 113.881 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.96 -62.92 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.012 1.325 . . . . 0.0 112.467 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -97.04 178.01 5.41 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.575 1.95 . . . . 0.0 112.039 -172.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.79 172.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.41 1.484 . . . . 0.0 112.754 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.452 2.301 . . . . 0.0 112.244 179.851 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -87.31 162.84 17.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.807 0.843 . . . . 0.0 112.649 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 7.1 mtm -70.65 -44.64 66.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 112.32 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.94 -12.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -74.31 -27.58 60.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.433 1.093 . . . . 0.0 112.944 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -77.48 162.48 27.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 111.473 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -136.44 153.92 50.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.482 1.113 . . . . 0.0 111.965 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.82 47.34 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.36 -9.95 14.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.065 1.746 . . . . 0.0 114.998 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.37 -27.54 24.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 113.834 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -56.91 -16.68 7.29 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 3.4 t -60.17 -27.13 66.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.347 1.459 . . . . 0.0 113.274 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.32 114.67 6.98 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.006 0.922 . . . . 0.0 111.206 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.39 166.9 2.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.196 0.999 . . . . 0.0 112.788 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.52 156.99 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.415 1.086 . . . . 0.0 111.546 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.99 -38.91 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.618 1.167 . . . . 0.0 111.469 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.27 -26.47 67.79 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.565 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -76.86 -60.71 2.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.883 0.873 . . . . 0.0 110.421 171.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.617 HG13 HD22 ' B' ' 199' ' ' LEU . 51.1 t -49.23 -45.95 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.001 1.72 . . . . 0.0 112.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 21.7 t -59.74 -25.15 64.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.272 1.429 . . . . 0.0 112.98 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -86.93 -37.72 17.34 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.604 -1.31 . . . . 0.0 113.05 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.4 mt -51.95 -44.12 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.975 0.91 . . . . 0.0 110.979 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -52.53 49.96 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.917 1.235 . . . . 0.0 111.959 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.66 72.56 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -45.78 56.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 112.868 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.423 ' HA ' HG21 ' B' ' 191' ' ' VAL . 51.6 mt -54.43 -57.37 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.275 0.943 . . . . 0.0 110.327 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.75 -30.09 68.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 9.7 p -66.7 -33.51 75.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 172.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.15 -33.55 50.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.057 1.343 . . . . 0.0 112.535 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.77 -40.4 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.844 1.258 . . . . 0.0 110.969 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.27 15.04 80.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.208 0.908 . . . . 0.0 114.327 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.44 78.17 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.315 1.436 . . . . 0.0 115.797 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -61.19 155.34 21.04 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.119 1.46 . . . . 0.0 113.103 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.89 -171.44 1.63 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.198 1.799 . . . . 0.0 112.242 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -41.35 139.44 1.04 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.739 2.816 . . . . 0.0 114.808 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -135.93 174.3 10.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.495 1.518 . . . . 0.0 113.19 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.21 -96.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.658 1.583 . . . . 0.0 111.292 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.7 p -90.67 -1.71 57.86 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.803 2.041 . . . . 0.0 114.354 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.6 -42.48 61.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.422 1.489 . . . . 0.0 113.7 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.98 -31.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.05 -49.08 68.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.794 1.238 . . . . 0.0 112.139 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -68.33 -26.19 65.48 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -76.48 -55.57 5.41 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 110.941 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.6 t -55.36 -32.45 62.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.928 0.786 . . . . 0.0 112.399 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.3 t -77.54 -55.7 5.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.281 0.946 . . . . 0.0 112.756 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.65 -36.19 71.55 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.884 1.22 . . . . 0.0 113.405 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' B' ' 170' ' ' ILE . 69.6 t -67.74 -63.4 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 109.964 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.77 -31.14 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.302 1.041 . . . . 0.0 110.722 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.82 -35.36 74.56 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -107.62 -42.41 4.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.42 1.488 . . . . 0.0 112.663 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.8 m -54.62 -54.18 44.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.417 2.287 . . . . 0.0 112.379 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -38.94 87.63 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 0.0 111.187 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 23.8 t -58.05 -51.98 67.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.307 0.643 . . . . 0.0 111.522 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.58 -51.54 69.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.576 1.95 . . . . 0.0 114.273 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.617 HD22 HG13 ' B' ' 162' ' ' VAL . 4.0 pp -65.48 -28.59 69.32 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.622 -1.299 . . . . 0.0 113.881 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 4.6 m -58.99 -32.46 69.71 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.397 0.679 . . . . 0.0 111.059 168.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -81.09 -27.27 35.7 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.692 -0.63 . . . . 0.0 112.58 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.4 -21.21 62.87 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.32 -111.72 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.013 1.292 . . . . 0.0 112.364 171.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -133.51 152.22 78.74 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.926 1.69 . . . . 0.0 112.37 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.42 99.96 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.891 3.061 . . . . 0.0 112.107 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -142.4 162.96 34.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.544 1.537 . . . . 0.0 112.196 174.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -66.39 101.95 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.191 1.796 . . . . 0.0 111.085 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -80.04 165.07 22.92 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.86 1.264 . . . . 0.0 111.908 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' ILE . . . . . 0.443 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.7 tt -149.14 157.6 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 127.781 2.432 . . . . 0.0 108.236 164.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.72 155.67 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 161.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 134.25 40.0 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.672 1.189 . . . . 0.0 109.59 166.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 8.3 p -128.02 148.57 50.54 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.902 0.881 . . . . 0.0 112.505 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -133.27 104.24 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.195 1.798 . . . . 0.0 109.061 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -99.12 109.22 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 107.837 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 159.1 35.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.284 1.433 . . . . 0.0 111.445 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.23 130.06 41.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.525 1.53 . . . . 0.0 112.712 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -80.88 -4.13 53.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.171 2.189 . . . . 0.0 114.116 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -58.45 -20.38 44.58 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.436 1.894 . . . . 0.0 114.639 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.67 5.03 3.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.756 1.645 . . . . 0.0 114.614 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.4 6.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 113.114 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -175.1 -177.53 44.26 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.43 1.966 . . . . 0.0 111.76 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 179.85 7.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.487 1.515 . . . . 0.0 112.315 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -109.96 109.96 20.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.59 0.632 . . . . 0.0 111.411 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.5 ' HB ' HG13 ' B' ' 278' ' ' VAL . 35.7 m -113.85 138.49 50.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.829 0.852 . . . . 0.0 110.393 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.04 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.551 . . . . 0.0 111.293 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 3.2 m -136.07 119.6 17.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.793 0.837 . . . . 0.0 110.114 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.1 t -79.88 64.88 4.86 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.413 1.101 . . . . 0.0 109.975 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 170.83 7.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 110.641 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.79 132.07 21.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 109.899 -170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -76.83 124.6 27.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.459 1.104 . . . . 0.0 109.618 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -142.74 84.23 1.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.843 1.257 . . . . 0.0 110.976 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.5 t -65.11 -62.08 1.76 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.274 1.429 . . . . 0.0 112.474 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 35.8 t -88.48 -28.65 20.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.287 1.035 . . . . 0.0 112.535 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.1 m -77.08 -38.23 52.88 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.655 -0.653 . . . . 0.0 112.63 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 -134.75 0.14 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.211 1.804 . . . . 0.0 109.689 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.81 150.92 20.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.381 1.467 . . . . 0.0 113.272 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 31.3 p -162.6 156.74 21.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.159 1.384 . . . . 0.0 111.915 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.6 162.59 16.63 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.342 1.857 . . . . 0.0 109.644 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.2 t -146.49 141.14 26.77 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.392 -1.442 . . . . 0.0 110.78 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.5 136.52 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.973 1.309 . . . . 0.0 109.509 -171.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 121.81 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.45 1.5 . . . . 0.0 111.394 -171.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -130.43 169.89 14.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.621 1.569 . . . . 0.0 110.912 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.65 164.83 14.38 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.043 1.337 . . . . 0.0 111.89 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -177.15 5.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.382 1.473 . . . . 0.0 109.458 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.55 -71.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.212 2.205 . . . . 0.0 114.055 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.0 t -138.32 16.41 2.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.489 1.516 . . . . 0.0 113.167 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.78 121.83 13.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.598 1.559 . . . . 0.0 110.987 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -79.08 152.2 30.97 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.558 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 23.1 p -133.46 115.7 15.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.388 0.675 . . . . 0.0 112.501 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.91 129.62 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.432 1.493 . . . . 0.0 111.565 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.25 121.3 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.485 1.914 . . . . 0.0 111.044 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.5 t -112.95 121.9 46.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.774 1.23 . . . . 0.0 110.627 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -108.4 141.44 40.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.289 1.836 . . . . 0.0 112.392 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.44 147.95 50.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.404 1.482 . . . . 0.0 109.697 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -138.09 125.18 3.15 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 125.698 1.618 . . . . 0.0 109.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.66 132.14 48.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.626 0.77 . . . . 0.0 111.783 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 52.1 m -134.33 132.21 39.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.041 1.337 . . . . 0.0 112.483 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.3 pp -117.91 -1.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.18 -2.17 64.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.86 1.219 . . . . 0.0 115.717 -175.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.61 15.35 77.65 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 118.777 1.288 . . . . 0.0 115.214 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.48 113.58 3.56 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.91 1.719 . . . . 0.0 113.003 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -131.09 173.48 10.97 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.182 1.793 . . . . 0.0 112.025 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 135.62 34.81 0.24 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.225 1.869 . . . . 0.0 114.996 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.2 167.16 0.47 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.044 1.738 . . . . 0.0 113.856 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 23.0 t -58.6 -41.72 86.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.993 1.317 . . . . 0.0 113.281 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -105.28 177.83 23.22 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.327 1.441 . . . . 0.0 113.119 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.07 149.95 85.55 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.856 2.371 . . . . 0.0 111.669 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.05 157.7 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 122.897 0.479 . . . . 0.0 111.578 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.45 167.44 26.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.373 1.069 . . . . 0.0 112.868 174.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.21 120.49 13.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.145 1.378 . . . . 0.0 109.978 171.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -151.4 161.38 29.15 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.114 1.34 . . . . 0.0 112.746 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.59 170.41 16.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.618 1.567 . . . . 0.0 110.885 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.34 164.69 28.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.389 1.476 . . . . 0.0 112.296 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -132.29 175.12 9.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.421 1.888 . . . . 0.0 111.135 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.1 132.67 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.016 1.727 . . . . 0.0 111.385 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 57.1 m -95.72 88.62 5.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.086 1.354 . . . . 0.0 110.004 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -92.12 150.04 21.16 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.277 -0.89 . . . . 0.0 111.42 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.4 p -148.63 102.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.747 2.019 . . . . 0.0 109.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -143.89 167.12 23.07 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.839 1.655 . . . . 0.0 111.794 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -116.59 89.05 26.56 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.993 1.317 . . . . 0.0 109.755 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.55 167.19 27.68 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.357 2.705 . . . . 0.0 112.238 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.02 -32.87 16.69 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.837 2.358 . . . . 0.0 113.833 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -62.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.935 1.294 . . . . 0.0 112.468 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.43 178.02 5.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.61 1.964 . . . . 0.0 111.97 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.82 172.09 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.3 1.44 . . . . 0.0 112.802 -174.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.253 1.262 0 C-N-CA 127.462 2.305 . . . . 0.0 112.299 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -70.51 -171.19 0.46 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.344 1.858 . . . . 0.0 113.148 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt -46.14 -57.03 4.86 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.609 1.963 . . . . 0.0 113.814 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' HG3' ' H ' ' A' ' 5' ' ' ASP 0.286 11.0 pt-20 -112.27 -77.25 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.577 0.751 . . . . 0.0 112.959 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 20.3 t70 -125.37 -14.02 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.829 1.652 . . . . 0.0 111.645 166.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -163.57 175.09 11.01 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.863 2.065 . . . . 0.0 113.292 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.96 178.72 1.69 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.9 2.08 . . . . 0.0 112.853 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.29 46.3 1.92 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.258 1.823 . . . . 0.0 112.781 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.84 4.67 2.39 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.42 -26.25 12.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.036 1.735 . . . . 0.0 114.644 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.25 -17.58 20.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 t -61.53 -26.25 67.82 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.975 1.71 . . . . 0.0 113.812 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.87 155.6 17.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.658 1.183 . . . . 0.0 110.882 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -125.11 165.3 18.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.854 1.261 . . . . 0.0 110.496 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.87 142.51 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.762 1.225 . . . . 0.0 110.138 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.61 -41.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.808 1.643 . . . . 0.0 113.813 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.35 -29.8 67.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.291 1.036 . . . . 0.0 112.93 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -76.36 -56.11 4.94 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.41 1.084 . . . . 0.0 110.736 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 56' ' ' LEU . 9.5 t -48.25 -44.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.538 1.135 . . . . 0.0 112.277 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -68.23 -6.84 25.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.474 1.51 . . . . 0.0 114.12 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -107.11 -32.73 7.7 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.538 1.935 . . . . 0.0 112.662 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 mt -50.29 -42.76 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.277 0.944 . . . . 0.0 110.133 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -59.85 -43.85 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.463 -0.773 . . . . 0.0 113.085 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -51.77 56.15 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.923 1.238 . . . . 0.0 111.132 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -34.01 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.3 -37.46 63.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.706 0.803 . . . . 0.0 112.839 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 48' ' ' VAL . 57.2 mt -59.43 -59.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.337 0.971 . . . . 0.0 109.544 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.57 -31.6 70.72 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.0 t -58.71 -50.5 73.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 112.209 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.96 -31.98 72.08 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.43 -44.43 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.384 1.073 . . . . 0.0 110.973 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.19 12.0 74.56 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.11 -1.93 26.94 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 171.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.23 170.06 6.35 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 119.347 1.574 . . . . 0.0 112.004 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.75 -147.24 0.34 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -68.23 103.07 1.49 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.037 2.135 . . . . 0.0 111.28 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -92.95 173.06 7.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.291 1.437 . . . . 0.0 112.645 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -84.2 -112.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.469 1.108 . . . . 0.0 110.367 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.7 m -61.95 -20.32 63.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.576 1.55 . . . . 0.0 114.659 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.05 -41.84 75.66 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.138 -0.976 . . . . 0.0 112.501 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.0 t -54.77 -36.1 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.526 1.131 . . . . 0.0 112.675 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -66.11 -47.85 72.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.785 0.721 . . . . 0.0 112.42 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -65.17 -24.06 67.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.029 0.831 . . . . 0.0 112.466 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.66 -53.63 6.96 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -56.2 -30.55 62.44 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.816 0.734 . . . . 0.0 112.588 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -78.85 -58.43 3.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 170.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -58.21 -39.21 78.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.048 1.295 . . . . 0.0 113.538 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 27' ' ' ILE . 84.6 t -68.26 -62.42 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 123.89 0.876 . . . . 0.0 109.956 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -50.04 -29.55 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.46 1.104 . . . . 0.0 110.855 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.27 -52.01 66.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.609 0.763 . . . . 0.0 112.01 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -92.35 -38.62 11.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.5 m -61.27 -53.16 60.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.402 2.281 . . . . 0.0 112.431 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -37.86 84.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.28 0.562 . . . . 0.0 111.003 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m -65.96 -29.63 70.06 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.86 -50.28 12.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.421 2.289 . . . . 0.0 112.592 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.52 HD22 HG13 ' A' ' 19' ' ' VAL . 4.1 pp -65.18 -25.74 67.85 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.856 -1.152 . . . . 0.0 113.786 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -57.53 -32.82 67.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.564 1.146 . . . . 0.0 110.848 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -84.27 -30.55 25.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.56 -31.92 70.4 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.588 0.355 . . . . 0.0 111.105 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.04 -137.79 4.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.013 1.292 . . . . 0.0 111.976 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.75 158.76 39.61 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.154 1.382 . . . . 0.0 112.791 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.44 109.46 2.45 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.514 2.809 . . . . 0.0 111.161 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.96 173.81 12.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.763 1.225 . . . . 0.0 112.123 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.23 112.08 10.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.28 . . . . 0.0 110.537 168.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.88 134.85 54.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.967 1.307 . . . . 0.0 109.34 170.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -118.06 152.36 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.369 1.868 . . . . 0.0 109.158 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.98 154.53 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.331 1.052 . . . . 0.0 110.218 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 153.38 40.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.775 168.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -147.18 156.33 42.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.076 0.95 . . . . 0.0 112.737 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.28 121.27 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.442 1.497 . . . . 0.0 108.993 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.64 118.21 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 126.876 2.07 . . . . 0.0 107.507 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.95 161.78 35.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.52 1.528 . . . . 0.0 110.751 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -130.1 157.48 42.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.745 -1.222 . . . . 0.0 113.99 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -76.44 -7.92 56.07 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.286 1.435 . . . . 0.0 114.368 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.39 -16.29 45.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.536 1.934 . . . . 0.0 114.263 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.04 30.57 0.79 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.101 1.334 . . . . 0.0 115.301 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.26 73.69 0.49 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.977 1.311 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 95.24 0.23 Allowed Glycine 0 N--CA 1.468 0.776 0 C-N-CA 126.192 1.853 . . . . 0.0 115.049 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.55 162.32 25.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.773 1.629 . . . . 0.0 111.892 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -127.05 97.73 5.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.815 1.246 . . . . 0.0 108.622 170.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.2 m -105.69 136.39 45.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.821 0.848 . . . . 0.0 109.13 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 119.57 12.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.84 0.856 . . . . 0.0 110.542 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 p -125.08 139.7 53.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.929 0.871 . . . . 0.0 111.378 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.2 m -87.19 16.17 5.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.664 0.785 . . . . 0.0 112.277 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' B' ' 209' ' ' ILE . 24.7 m -70.7 166.22 21.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.345 1.058 . . . . 0.0 112.163 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.3 151.44 26.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.868 1.667 . . . . 0.0 110.769 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -78.92 127.98 32.71 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.474 -0.767 . . . . 0.0 110.005 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.78 139.4 38.26 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.245 1.018 . . . . 0.0 112.144 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -134.44 -38.13 0.84 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.607 1.563 . . . . 0.0 113.219 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 t -89.68 -43.22 10.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.35 1.46 . . . . 0.0 111.299 173.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -43.35 87.55 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.965 1.706 . . . . 0.0 112.416 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.68 -161.67 0.94 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.463 1.905 . . . . 0.0 111.377 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.41 114.66 4.49 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.873 1.702 . . . . 0.0 115.944 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 m -139.45 176.21 8.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.125 2.17 . . . . 0.0 111.602 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.84 131.49 6.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.002 2.121 . . . . 0.0 109.208 166.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.9 t -139.11 146.02 40.18 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.825 -1.797 . . . . 0.0 112.436 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 137.85 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.951 1.3 . . . . 0.0 110.259 -167.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 114.91 16.63 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.279 1.432 . . . . 0.0 111.695 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.403 ' CH2' HG21 ' A' ' 27' ' ' ILE . 8.4 m95 -121.5 97.7 5.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.741 1.616 . . . . 0.0 109.557 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -63.75 168.83 4.56 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.356 -0.84 . . . . 0.0 112.337 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.89 -177.83 5.16 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.857 1.663 . . . . 0.0 112.93 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.8 t -135.29 -30.12 1.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.251 1.42 . . . . 0.0 113.679 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptp -87.25 176.81 7.38 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.962 -1.086 . . . . 0.0 112.506 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.55 150.54 30.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.663 1.185 . . . . 0.0 111.639 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.2 p -136.59 142.86 43.35 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.262 1.029 . . . . 0.0 112.346 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.39 135.13 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.701 1.6 . . . . 0.0 109.978 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.65 131.5 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.903 1.681 . . . . 0.0 110.255 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.2 p -125.07 147.51 48.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.56 136.47 47.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.068 2.147 . . . . 0.0 110.967 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -135.42 157.99 45.5 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.792 1.637 . . . . 0.0 108.982 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.24 85.17 0.05 OUTLIER Glycine 0 N--CA 1.464 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 111.442 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -69.02 153.9 42.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.035 0.934 . . . . 0.0 110.085 -178.19 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 m -154.58 82.06 1.1 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.455 0.702 . . . . 0.0 111.608 -171.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -14.66 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -92.31 8.38 77.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.327 1.918 . . . . 0.0 115.733 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.66 30.4 0.33 Allowed Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.058 1.429 . . . . 0.0 115.771 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.93 -162.0 6.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.963 1.744 . . . . 0.0 115.149 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 t -57.55 159.35 5.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.796 0.838 . . . . 0.0 112.156 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.38 19.03 9.66 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.466 1.031 . . . . 0.0 113.987 -165.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -61.63 173.18 1.02 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.934 1.294 . . . . 0.0 112.383 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.3 m -67.52 23.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.145 2.178 . . . . 0.0 115.188 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.05 -172.51 33.74 Favored Glycine 0 CA--C 1.543 1.792 0 C-N-CA 126.84 2.162 . . . . 0.0 113.878 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.7 146.15 65.81 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.27 2.647 . . . . 0.0 112.172 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.6 pt -81.32 164.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.232 1.015 . . . . 0.0 111.7 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 162.76 34.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.125 2.17 . . . . 0.0 110.795 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.0 mt -135.07 120.39 19.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.961 1.304 . . . . 0.0 109.498 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -161.65 153.86 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.997 1.284 . . . . 0.0 112.32 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttm -75.83 160.72 29.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.536 0.734 . . . . 0.0 112.213 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.27 83.49 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.16 1.384 . . . . 0.0 112.016 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -130.6 -179.92 5.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.761 1.224 . . . . 0.0 111.559 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.3 134.2 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.105 1.362 . . . . 0.0 110.93 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.6 m -115.84 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 110.245 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -90.98 147.48 23.06 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.447 -0.783 . . . . 0.0 111.384 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.89 103.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 128.019 2.527 . . . . 0.0 108.708 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.58 130.6 21.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.059 1.344 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -144.0 91.44 6.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.453 1.501 . . . . 0.0 109.911 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.33 167.55 21.93 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.259 2.639 . . . . 0.0 112.8 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.41 -14.6 31.03 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.754 . . . . 0.0 113.442 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -56.95 129.99 44.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.376 1.07 . . . . 0.0 110.882 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.39 171.4 16.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.017 2.127 . . . . 0.0 110.316 -175.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.2 161.75 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.655 1.582 . . . . 0.0 111.659 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.61 1.964 . . . . 0.0 110.604 -177.648 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 23.0 m -138.7 -47.14 0.5 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.286 1.034 . . . . 0.0 113.724 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 14.6 tpt -66.38 -43.3 86.27 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.145 0.978 . . . . 0.0 113.031 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -109.47 -25.01 10.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 114.055 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.99 -20.33 29.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.558 1.143 . . . . 0.0 113.353 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.75 162.72 17.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.837 2.055 . . . . 0.0 110.618 168.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.19 165.49 22.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.524 1.53 . . . . 0.0 110.994 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.54 39.39 0.83 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.262 1.425 . . . . 0.0 113.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.88 -2.71 5.51 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.44 -25.61 16.73 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.252 1.821 . . . . 0.0 114.547 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -59.22 -19.16 43.15 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 3.8 t -58.86 -22.44 59.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.533 1.933 . . . . 0.0 114.555 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.26 139.98 46.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.226 1.41 . . . . 0.0 109.944 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.484 ' CZ ' HD11 ' B' ' 165' ' ' ILE . 0.0 OUTLIER -111.98 162.32 15.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 111.643 175.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.79 135.9 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.656 1.582 . . . . 0.0 109.968 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.62 -42.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.094 2.158 . . . . 0.0 113.451 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.29 -31.33 65.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.647 1.179 . . . . 0.0 112.92 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -87.61 -49.21 7.32 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.965 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 21.6 t -45.7 -41.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 120.114 1.325 . . . . 0.0 112.263 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -70.89 -8.28 51.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.113 1.765 . . . . 0.0 115.036 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -103.34 -31.44 10.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.762 2.425 . . . . 0.0 112.581 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' ILE . . . . . 0.484 HD11 ' CZ ' ' B' ' 157' ' ' PHE . 33.8 mt -50.56 -42.65 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.226 1.01 . . . . 0.0 110.296 171.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.39 -42.89 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -51.9 56.13 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.859 1.208 . . . . 0.0 111.058 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -33.64 76.33 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.17 -36.56 61.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.626 0.77 . . . . 0.0 112.976 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' B' ' 191' ' ' VAL . 55.1 mt -59.75 -59.43 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.291 0.95 . . . . 0.0 109.558 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.32 -31.72 70.56 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.0 t -58.57 -50.3 74.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.372 1.069 . . . . 0.0 112.16 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.15 72.16 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.72 -44.28 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.327 1.051 . . . . 0.0 110.867 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.17 75.08 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 -1.96 26.83 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -66.35 170.53 5.86 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 119.319 1.559 . . . . 0.0 112.025 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.57 -146.31 0.34 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.853 1.661 . . . . 0.0 112.09 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -70.03 97.76 1.21 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.022 2.129 . . . . 0.0 111.365 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.57 173.95 10.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.267 1.427 . . . . 0.0 112.8 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -85.77 -106.66 0.05 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.461 1.105 . . . . 0.0 110.557 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 30.0 m -66.1 -20.73 66.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -55.6 -38.75 69.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.054 0.942 . . . . 0.0 112.612 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -35.24 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.939 0.896 . . . . 0.0 113.304 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -69.08 -46.37 67.96 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.8 0.84 . . . . 0.0 111.992 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -65.68 -24.92 67.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.501 0.591 . . . . 0.0 112.496 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -78.14 -54.77 5.88 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.667 0.787 . . . . 0.0 111.656 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.9 t -56.05 -30.17 61.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.759 0.708 . . . . 0.0 112.617 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -78.78 -59.95 2.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.21 0.914 . . . . 0.0 112.627 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -57.2 -39.38 75.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.094 1.315 . . . . 0.0 113.594 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' B' ' 170' ' ' ILE . 91.4 t -67.8 -62.95 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 C-N-CA 123.895 0.878 . . . . 0.0 109.839 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.2 t -50.11 -29.81 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 110.76 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.55 -52.29 65.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.75 0.82 . . . . 0.0 111.839 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -91.62 -38.64 12.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.795 1.238 . . . . 0.0 112.694 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 42.1 m -62.74 -52.77 61.94 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.768 2.427 . . . . 0.0 112.532 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.75 86.74 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.54 0.686 . . . . 0.0 111.09 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 52.9 m -64.7 -31.42 72.63 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -77.08 -49.51 15.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.461 2.305 . . . . 0.0 112.652 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.65 -27.98 69.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.879 -1.138 . . . . 0.0 113.661 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -58.55 -32.48 68.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.833 0.853 . . . . 0.0 110.807 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -81.7 -31.46 32.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.01 -30.29 55.81 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.706 0.23 . . . . 0.0 110.964 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.83 -134.6 2.61 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.507 1.527 . . . . 0.0 111.682 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 153.18 49.86 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.535 1.134 . . . . 0.0 113.849 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 107.16 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.057 3.171 . . . . 0.0 111.687 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.1 171.08 17.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 111.759 175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.2 98.16 1.32 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.799 1.24 . . . . 0.0 111.366 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -83.3 155.64 23.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.845 0.858 . . . . 0.0 110.671 163.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' ILE . . . . . 0.404 HD11 ' SG ' ' A' ' 85' ' ' CYS . 2.1 tt -141.03 153.33 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.825 2.05 . . . . 0.0 108.759 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 253' ' ' ALA . 23.4 m -141.42 154.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.284 1.034 . . . . 0.0 110.297 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 15.0 t -146.65 153.79 40.72 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.892 0.877 . . . . 0.0 109.827 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 22.7 p -148.45 160.49 43.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.157 0.983 . . . . 0.0 112.667 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.49 136.37 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 110.467 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 5.4 mm -119.15 120.41 63.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 127.791 2.436 . . . . 0.0 107.164 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 22.3 ttt -140.27 156.6 46.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.193 1.397 . . . . 0.0 111.171 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.99 140.71 52.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.715 1.206 . . . . 0.0 112.286 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -62.22 -7.88 4.85 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.203 1.801 . . . . 0.0 115.071 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.62 -16.95 43.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.396 2.278 . . . . 0.0 114.212 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 126.91 29.12 0.89 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.961 1.267 . . . . 0.0 115.127 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.88 72.52 0.25 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.311 1.444 . . . . 0.0 112.846 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.25 96.69 0.24 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.353 1.93 . . . . 0.0 114.983 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 pp -126.92 161.18 28.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 111.651 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.78 97.91 4.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.868 1.267 . . . . 0.0 108.591 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 38.8 m -110.17 132.29 54.3 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.262 0.625 . . . . 0.0 109.506 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -135.33 118.02 16.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.202 1.001 . . . . 0.0 110.276 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 24.2 p -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.987 0.899 . . . . 0.0 111.075 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 72.4 m -86.08 16.11 4.53 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.369 -0.832 . . . . 0.0 112.147 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 20.7 m -70.26 165.82 21.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.121 0.968 . . . . 0.0 112.055 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -155.81 150.77 26.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -76.49 130.95 38.69 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.26 141.86 37.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.172 0.989 . . . . 0.0 111.385 166.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 11.0 t -134.01 -50.0 0.82 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.647 1.579 . . . . 0.0 112.033 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 34.2 t -78.48 -34.26 47.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.778 0.831 . . . . 0.0 111.618 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -47.58 28.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.474 1.509 . . . . 0.0 113.065 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.32 -162.74 1.25 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.884 1.673 . . . . 0.0 111.825 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -102.19 112.14 4.24 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.823 1.678 . . . . 0.0 116.138 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 68.7 m -140.03 175.76 9.31 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.071 2.148 . . . . 0.0 111.971 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 40.3 t -160.04 127.02 4.44 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.066 2.147 . . . . 0.0 109.398 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.7 t -136.04 146.1 46.75 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 119.755 -1.841 . . . . 0.0 112.536 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.25 139.43 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.003 1.321 . . . . 0.0 110.289 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 117.73 19.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.988 1.315 . . . . 0.0 111.948 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -124.63 96.15 4.79 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.69 1.596 . . . . 0.0 109.566 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.21 169.38 4.57 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.53 -0.731 . . . . 0.0 112.456 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -142.39 -177.2 5.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 111.981 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -44.43 81.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.263 1.825 . . . . 0.0 112.802 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.4 t -133.93 -34.92 0.98 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.623 1.569 . . . . 0.0 113.469 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 18.6 ptp -86.6 177.39 7.39 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.956 -1.09 . . . . 0.0 112.71 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -151.43 157.89 42.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.01 1.324 . . . . 0.0 111.22 165.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 25.8 p -137.0 141.65 42.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.079 0.952 . . . . 0.0 111.621 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.07 134.18 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.059 1.343 . . . . 0.0 110.108 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.62 130.74 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 126.007 1.723 . . . . 0.0 110.211 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 45.7 p -124.63 144.97 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.497 0.719 . . . . 0.0 111.181 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -128.41 137.55 51.91 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.865 2.066 . . . . 0.0 110.733 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -135.71 163.51 30.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.985 1.714 . . . . 0.0 108.834 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 153.65 86.54 0.06 OUTLIER Glycine 0 N--CA 1.464 0.504 0 O-C-N 121.382 -0.824 . . . . 0.0 111.183 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.478 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.5 OUTLIER -67.65 156.67 36.32 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.968 0.907 . . . . 0.0 110.231 -178.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.1 m -155.78 79.83 1.01 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.825 0.822 . . . . 0.0 111.248 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 258' ' ' ILE . . . . . 0.49 ' H ' HD12 ' B' ' 258' ' ' ILE . 2.0 mp -62.26 -24.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 0.0 111.913 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.67 6.55 57.99 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.725 1.631 . . . . 0.0 116.362 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 135.17 32.14 0.31 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 119.26 1.53 . . . . 0.0 115.656 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.41 -158.17 8.09 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.378 1.942 . . . . 0.0 115.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 6.1 t -58.01 160.75 4.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.083 0.953 . . . . 0.0 112.359 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.82 20.9 9.49 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.512 1.053 . . . . 0.0 113.901 -166.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -61.99 173.3 1.11 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.867 1.267 . . . . 0.0 112.037 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 20.9 m -67.91 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.098 2.159 . . . . 0.0 115.264 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.54 -170.48 42.25 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 127.223 2.344 . . . . 0.0 114.124 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.23 156.77 63.74 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.606 2.87 . . . . 0.0 113.334 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.85 96.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.672 1.589 . . . . 0.0 112.387 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -72.78 149.61 43.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.459 1.104 . . . . 0.0 111.676 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 29.7 mt -127.19 119.24 25.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.554 . . . . 0.0 109.839 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -160.12 159.16 30.49 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.901 1.239 . . . . 0.0 112.822 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 7.8 ttm -77.32 161.87 27.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.589 0.756 . . . . 0.0 111.927 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.98 84.65 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.017 1.327 . . . . 0.0 112.197 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -131.01 179.87 5.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.858 1.263 . . . . 0.0 111.524 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.28 134.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.044 1.338 . . . . 0.0 110.838 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 74.0 m -116.24 90.62 3.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.916 1.686 . . . . 0.0 110.091 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -91.16 148.72 22.17 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.615 0.722 . . . . 0.0 111.371 170.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.34 112.8 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 127.222 2.209 . . . . 0.0 109.932 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.12 130.6 18.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.976 1.31 . . . . 0.0 111.655 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -143.38 91.66 6.86 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.495 1.518 . . . . 0.0 109.91 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.0 167.67 21.02 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.097 2.532 . . . . 0.0 112.623 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.55 -14.47 33.63 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.375 2.717 . . . . 0.0 113.537 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.99 130.56 46.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.345 1.058 . . . . 0.0 110.989 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.6 171.38 16.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.106 2.162 . . . . 0.0 110.323 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.26 161.93 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.633 1.573 . . . . 0.0 111.756 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.605 1.962 . . . . 0.0 110.603 -177.835 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -64.5 -40.11 95.05 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -66.61 -38.99 88.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -78.5 2.14 20.03 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.359 1.463 . . . . 0.0 114.142 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -123.44 11.74 9.31 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.681 1.992 . . . . 0.0 112.637 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -23.73 124.52 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.55 2.74 . . . . 0.0 115.26 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -73.06 171.33 13.09 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.81 0.844 . . . . 0.0 111.966 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.24 51.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.84 1.656 . . . . 0.0 111.452 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.07 74.78 5.6 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.034 1.334 . . . . 0.0 112.434 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.79 -20.01 46.08 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.885 -1.134 . . . . 0.0 113.919 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.58 -28.08 65.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.67 . . . . 0.0 114.741 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 t -104.34 -17.51 14.79 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.352 1.061 . . . . 0.0 112.5 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.63 156.29 23.79 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.726 0.774 . . . . 0.0 111.316 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -110.3 168.18 9.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.355 1.462 . . . . 0.0 110.475 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.83 159.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.754 0.788 . . . . 0.0 111.146 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.03 -34.73 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.763 2.025 . . . . 0.0 111.702 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -59.69 -28.6 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.922 0.889 . . . . 0.0 113.099 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -82.27 -54.19 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.687 0.795 . . . . 0.0 110.706 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.431 HG13 HD22 ' A' ' 56' ' ' LEU . 97.4 t -49.97 -42.37 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.088 1.355 . . . . 0.0 112.422 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 t -59.58 -19.44 48.78 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.006 1.723 . . . . 0.0 113.747 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -97.48 -43.21 7.36 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.877 1.671 . . . . 0.0 112.111 172.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.0 mt -50.41 -41.97 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.02 -44.63 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.82 58.92 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.22 1.373 . . . . 0.0 111.518 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -34.56 76.2 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.35 -43.51 66.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.681 0.792 . . . . 0.0 112.972 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.61 -58.92 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 118.983 0.811 . . . . 0.0 109.773 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.53 -31.67 72.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.6 t -61.01 -48.15 83.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.998 0.919 . . . . 0.0 112.035 169.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.38 76.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.586 1.155 . . . . 0.0 114.002 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.39 -49.96 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 0.0 110.532 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.7 11.61 59.01 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.271 0.938 . . . . 0.0 115.289 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.66 -3.99 23.04 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.32 169.76 8.34 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 119.254 1.527 . . . . 0.0 111.8 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 -148.77 0.36 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.377 1.471 . . . . 0.0 111.676 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -60.5 131.33 50.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.178 1.791 . . . . 0.0 110.918 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.01 -177.31 3.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.293 1.437 . . . . 0.0 112.235 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -98.04 -96.6 0.22 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.913 1.285 . . . . 0.0 110.078 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -73.85 -22.62 59.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.965 1.306 . . . . 0.0 113.91 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.54 -44.03 84.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.207 -0.933 . . . . 0.0 112.393 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.57 -36.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.895 0.878 . . . . 0.0 113.009 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -61.12 -53.97 50.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.53 1.132 . . . . 0.0 111.176 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.68 -54.93 5.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 112.224 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -58.7 -22.72 58.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -85.53 -57.64 2.98 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.269 0.941 . . . . 0.0 112.25 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -59.75 -40.89 89.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.09 1.314 . . . . 0.0 113.752 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.62 -62.91 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 C-N-CA 124.075 0.95 . . . . 0.0 109.86 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -49.92 -28.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.682 1.193 . . . . 0.0 110.952 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -57.72 11.02 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.796 0.725 . . . . 0.0 111.858 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -86.28 -36.64 19.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.169 0.988 . . . . 0.0 113.217 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 m -60.91 -51.82 67.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.777 2.031 . . . . 0.0 112.172 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tp -61.48 -32.25 72.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.354 0.662 . . . . 0.0 112.287 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 t -61.98 -58.51 7.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.549 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.88 -49.55 49.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.431 HD22 HG13 ' A' ' 19' ' ' VAL . 2.5 pp -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -62.64 -44.44 96.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 119.028 -0.511 . . . . 0.0 109.768 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -64.88 -25.16 67.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.307 0.958 . . . . 0.0 113.356 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.21 -2.88 14.52 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 171.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.27 -98.7 0.18 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 124.865 1.221 . . . . 0.0 114.64 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -67.83 168.88 11.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 125.431 1.492 . . . . 0.0 114.392 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.11 167.74 21.02 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.541 2.161 . . . . 0.0 112.668 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -55.49 97.55 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.357 2.263 . . . . 0.0 114.45 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 96.06 0.65 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.921 2.088 . . . . 0.0 111.212 174.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -153.37 150.32 28.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.183 1.393 . . . . 0.0 110.012 170.386 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.42 146.61 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 171.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 110' ' ' ALA . 4.6 m -137.98 148.18 25.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.644 1.578 . . . . 0.0 110.392 165.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -135.74 155.96 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.671 1.188 . . . . 0.0 109.791 166.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.0 t -151.41 144.41 24.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.247 1.419 . . . . 0.0 110.834 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.85 140.54 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.067 1.347 . . . . 0.0 109.876 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 106' ' ' CYS . 1.4 mm -126.34 110.87 24.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 127.334 2.253 . . . . 0.0 108.374 -175.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.14 168.71 18.35 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.023 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -110.99 124.81 52.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.312 1.445 . . . . 0.0 111.261 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -84.26 -0.71 53.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.981 1.712 . . . . 0.0 114.033 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.38 -19.7 64.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.102 1.761 . . . . 0.0 114.166 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.09 34.75 0.36 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.306 1.432 . . . . 0.0 114.617 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.11 173.14 3.96 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 118.905 1.353 . . . . 0.0 112.794 171.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.2 103.98 0.33 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.186 1.374 . . . . 0.0 113.195 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 164.09 31.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.821 1.248 . . . . 0.0 113.609 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -127.53 131.66 50.04 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.308 1.043 . . . . 0.0 110.395 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.555 ' HB ' HG13 ' A' ' 135' ' ' VAL . 47.9 m -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.957 1.303 . . . . 0.0 109.039 176.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.09 121.27 12.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.436 1.094 . . . . 0.0 110.787 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.2 p -129.69 131.04 46.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.347 0.594 . . . . 0.0 111.447 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -90.67 18.34 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.268 -0.895 . . . . 0.0 111.978 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.8 m -61.2 162.93 6.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.286 1.435 . . . . 0.0 112.408 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -158.23 134.36 9.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.228 1.011 . . . . 0.0 111.602 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.72 148.0 30.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 110.913 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -134.68 149.57 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.841 1.656 . . . . 0.0 110.644 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.8 t -97.3 -66.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.831 1.252 . . . . 0.0 112.304 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 t -91.24 -26.47 18.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.974 . . . . 0.0 112.535 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -30.76 52.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.905 1.682 . . . . 0.0 113.091 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 -167.02 1.05 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.961 2.104 . . . . 0.0 111.135 -172.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.87 146.15 15.28 Favored Glycine 0 CA--C 1.539 1.571 0 O-C-N 120.909 -1.119 . . . . 0.0 114.641 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 134.99 13.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.193 1.397 . . . . 0.0 111.784 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 24.0 t -127.99 97.26 4.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.661 1.184 . . . . 0.0 113.077 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -88.14 150.02 23.58 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.028 -1.045 . . . . 0.0 112.715 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.27 138.68 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.332 1.853 . . . . 0.0 109.407 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -125.23 119.48 28.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.709 1.604 . . . . 0.0 111.956 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -128.52 102.54 6.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 110.127 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -77.52 151.3 34.62 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.177 -0.952 . . . . 0.0 112.039 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.15 -178.42 3.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.32 1.448 . . . . 0.0 109.952 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -60.46 -45.02 95.23 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -129.92 -21.12 3.06 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.818 1.647 . . . . 0.0 113.919 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.9 mtt -100.84 173.12 6.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 170.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -147.84 147.43 29.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.083 1.353 . . . . 0.0 109.936 167.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 71' ' ' ILE . 9.0 p -133.35 134.01 43.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.894 1.277 . . . . 0.0 110.641 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.97 110.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.041 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.36 138.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 110.8 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.5 p -134.16 114.74 13.43 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.282 -0.886 . . . . 0.0 112.576 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -100.08 136.12 40.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.84 1.256 . . . . 0.0 112.043 -176.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -134.34 112.86 11.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.426 1.491 . . . . 0.0 111.183 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -103.07 61.94 0.46 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.743 -1.223 . . . . 0.0 113.878 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -52.43 109.5 0.4 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 113.298 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 m -155.03 106.79 2.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.098 2.159 . . . . 0.0 111.934 -171.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -8.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.455 1.902 . . . . 0.0 115.852 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.45 -5.87 45.73 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.603 1.573 . . . . 0.0 116.158 -165.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.79 44.72 97.06 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 118.476 1.138 . . . . 0.0 112.912 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.21 61.99 1.79 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.876 1.703 . . . . 0.0 113.148 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -66.28 -178.14 0.62 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.402 2.281 . . . . 0.0 112.821 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.65 33.23 3.91 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.208 0.908 . . . . 0.0 114.069 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -59.69 165.81 2.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.235 1.017 . . . . 0.0 112.666 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.8 t -61.46 -24.49 66.59 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.103 1.361 . . . . 0.0 113.757 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.63 177.72 17.88 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.121 1.82 . . . . 0.0 113.18 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.31 174.1 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.672 2.914 . . . . 0.0 112.286 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.05 141.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.759 0.824 . . . . 0.0 111.568 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 163.22 22.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 112.219 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.72 112.7 25.8 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.216 1.406 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -124.59 115.08 2.39 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.179 1.847 . . . . 0.0 111.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.8 mtm -64.75 99.87 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.866 0.833 . . . . 0.0 111.022 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.58 109.83 4.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.435 1.494 . . . . 0.0 110.943 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -128.89 168.73 15.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.912 1.285 . . . . 0.0 111.375 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -62.5 135.78 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.317 1.447 . . . . 0.0 110.842 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.3 m -106.37 88.95 2.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.864 1.666 . . . . 0.0 110.147 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -89.96 149.83 22.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.154 172.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -145.27 104.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.988 2.115 . . . . 0.0 109.356 -177.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.8 119.96 18.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 110.826 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.45 95.44 43.04 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.429 1.491 . . . . 0.0 108.851 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.84 164.78 33.81 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.443 2.762 . . . . 0.0 111.74 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.68 -52.8 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.023 2.482 . . . . 0.0 112.754 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 -69.9 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.885 2.074 . . . . 0.0 109.836 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.48 173.73 3.9 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.267 1.827 . . . . 0.0 112.117 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.4 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 111.962 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.714 2.005 . . . . 0.0 110.544 179.406 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -60.45 -35.54 76.1 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.736 1.268 . . . . 0.0 113.749 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -70.0 -24.33 63.28 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.01 5.2 51.72 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.346 1.458 . . . . 0.0 113.199 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -124.47 10.72 8.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.589 1.956 . . . . 0.0 112.921 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -29.8 127.26 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.849 2.86 . . . . 0.0 113.245 164.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.64 172.31 12.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 111.673 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -124.98 144.63 50.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.756 1.622 . . . . 0.0 111.337 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.86 75.71 4.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.0 1.32 . . . . 0.0 112.348 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -58.7 -20.12 45.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.971 -1.081 . . . . 0.0 113.793 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.24 -27.24 65.28 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.838 1.655 . . . . 0.0 114.763 174.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 5.3 t -104.73 -17.96 14.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.256 1.023 . . . . 0.0 112.522 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.21 154.28 31.84 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.566 -0.709 . . . . 0.0 111.569 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -105.27 173.63 6.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.841 1.256 . . . . 0.0 111.195 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.32 161.44 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.585 1.154 . . . . 0.0 111.584 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.03 -40.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.513 1.125 . . . . 0.0 112.126 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.76 -25.15 67.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.592 1.157 . . . . 0.0 113.018 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -79.46 -58.29 3.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 110.986 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.528 HG22 HD13 ' B' ' 199' ' ' LEU . 85.9 t -52.38 -40.94 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.915 1.286 . . . . 0.0 112.607 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 19.5 t -58.94 -18.62 35.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.572 1.549 . . . . 0.0 113.408 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.3 -43.86 6.44 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.135 1.374 . . . . 0.0 112.031 171.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 38.7 mt -50.58 -42.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.201 1.0 . . . . 0.0 111.262 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.26 -43.54 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.487 -0.758 . . . . 0.0 112.887 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -51.76 53.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.943 1.247 . . . . 0.0 111.399 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.23 75.57 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.28 -43.43 64.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.801 0.84 . . . . 0.0 113.037 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.38 -58.76 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 119.124 0.874 . . . . 0.0 109.702 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -62.45 -31.74 72.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 37.5 t -60.9 -48.18 83.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.988 0.915 . . . . 0.0 112.108 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.19 76.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.29 -49.9 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.512 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 92.73 11.55 59.03 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.235 0.922 . . . . 0.0 115.266 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.5 -4.0 23.29 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -67.12 169.61 8.24 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.299 1.549 . . . . 0.0 111.862 170.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.13 -148.49 0.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.362 1.465 . . . . 0.0 111.615 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.44 132.31 53.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.155 1.782 . . . . 0.0 110.999 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -177.34 4.1 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.288 1.435 . . . . 0.0 112.157 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -98.06 -96.71 0.22 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 0.0 110.143 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.2 m -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.014 1.326 . . . . 0.0 113.929 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.9 -44.0 86.49 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.09 -1.006 . . . . 0.0 112.377 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.77 -36.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.943 0.897 . . . . 0.0 112.988 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.75 -54.44 45.16 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.626 1.17 . . . . 0.0 111.075 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -64.33 -22.83 67.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 113.049 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.35 -54.9 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.188 0.903 . . . . 0.0 112.301 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.3 t -58.86 -21.04 56.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.2 t -87.02 -58.75 2.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.212 0.915 . . . . 0.0 112.332 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -58.88 -40.7 85.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.142 1.337 . . . . 0.0 113.793 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.52 -63.27 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 124.182 0.993 . . . . 0.0 109.817 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 77.1 t -48.6 -29.74 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.234 1.413 . . . . 0.0 111.167 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -55.45 33.5 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.628 0.771 . . . . 0.0 111.711 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -88.87 -35.08 16.75 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.369 1.068 . . . . 0.0 113.367 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.2 m -63.43 -52.62 60.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.0 2.12 . . . . 0.0 112.605 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.607 HD13 HD11 ' B' ' 199' ' ' LEU . 0.1 OUTLIER -62.97 -32.57 73.92 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.609 0.364 . . . . 0.0 111.023 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t -60.52 -57.81 11.14 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.387 -0.821 . . . . 0.0 111.469 165.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -50.37 -49.14 55.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.711 1.604 . . . . 0.0 113.433 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.607 HD11 HD13 ' B' ' 196' ' ' LEU . 4.0 pp -70.74 -27.87 64.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 1.5 m -60.89 -44.96 96.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 163.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -64.58 -25.76 68.11 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.227 0.921 . . . . 0.0 113.415 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.16 -4.6 18.14 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.99 -101.89 0.26 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 119.984 1.265 . . . . 0.0 114.658 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.28 167.81 11.45 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.82 1.648 . . . . 0.0 114.008 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.08 166.03 24.42 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.178 1.919 . . . . 0.0 112.236 168.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -50.97 115.87 1.73 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.964 1.705 . . . . 0.0 112.269 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 171.08 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 130.222 3.409 . . . . 0.0 111.193 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' TYR . . . . . 0.405 ' CG ' HD12 ' B' ' 196' ' ' LEU . 54.9 p90 -145.6 171.06 15.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.572 1.949 . . . . 0.0 109.743 167.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.77 151.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.0 143.18 27.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.339 1.456 . . . . 0.0 109.092 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 155.04 51.34 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.876 0.87 . . . . 0.0 110.144 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.11 148.67 28.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.183 1.393 . . . . 0.0 111.288 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.75 141.06 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 110.445 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' B' ' 249' ' ' CYS . 1.2 mm -126.65 110.38 23.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 127.847 2.459 . . . . 0.0 108.171 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 167.51 20.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.919 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -111.55 126.96 55.54 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.253 1.421 . . . . 0.0 111.214 -168.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -85.69 0.35 52.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.913 1.685 . . . . 0.0 113.956 -168.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.1 -19.92 64.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.073 1.749 . . . . 0.0 114.152 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 37.41 0.39 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.329 1.442 . . . . 0.0 114.375 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.12 172.68 6.46 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 118.758 1.279 . . . . 0.0 112.285 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -142.27 78.88 0.27 Allowed Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.553 1.073 . . . . 0.0 114.396 -173.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.36 156.03 28.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 111.393 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.32 134.3 52.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 110.892 173.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.705 ' HB ' HG13 ' B' ' 278' ' ' VAL . 99.6 m -138.54 143.85 39.65 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 109.063 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.28 13.75 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.594 1.157 . . . . 0.0 110.84 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.4 p -128.46 136.59 51.04 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.813 -0.555 . . . . 0.0 111.761 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.5 m -94.22 18.79 10.29 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.662 -0.648 . . . . 0.0 111.776 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.3 m -61.68 162.59 8.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.065 1.346 . . . . 0.0 112.347 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -158.63 134.93 9.25 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.514 1.126 . . . . 0.0 111.466 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 147.16 27.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.167 0.987 . . . . 0.0 110.791 171.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -131.87 144.58 50.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.127 1.771 . . . . 0.0 110.14 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.0 t -89.45 -68.19 0.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 112.238 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 6.9 t -92.74 -25.49 18.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.265 1.026 . . . . 0.0 112.533 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -29.34 55.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.933 1.693 . . . . 0.0 112.911 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -164.38 0.9 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.04 1.736 . . . . 0.0 111.644 -171.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -151.19 144.51 11.82 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.935 -1.103 . . . . 0.0 114.455 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.45 151.28 33.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.734 1.614 . . . . 0.0 110.633 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 12.4 t -142.43 104.54 4.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.507 1.123 . . . . 0.0 112.565 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.3 t -97.36 147.58 24.03 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.43 1.092 . . . . 0.0 112.418 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.13 136.28 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.862 1.665 . . . . 0.0 109.626 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -125.1 119.06 27.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.491 1.516 . . . . 0.0 111.829 -173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -128.07 102.51 6.76 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.329 1.452 . . . . 0.0 109.956 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.59 151.0 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.15 -0.969 . . . . 0.0 111.881 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.82 -178.24 3.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.301 1.44 . . . . 0.0 109.937 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.62 -44.77 95.96 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -129.89 -21.61 3.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.744 1.617 . . . . 0.0 113.894 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.8 mtt -100.64 173.33 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.995 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -147.6 148.07 30.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.037 1.335 . . . . 0.0 110.002 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' B' ' 214' ' ' ILE . 9.8 p -132.73 135.41 45.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.821 1.248 . . . . 0.0 111.014 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.85 111.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.97 1.308 . . . . 0.0 111.172 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.7 143.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.046 1.339 . . . . 0.0 111.161 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 66.8 p -139.02 110.66 7.09 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.16 139.94 30.15 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.519 1.128 . . . . 0.0 113.05 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -137.29 102.65 4.87 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.769 1.627 . . . . 0.0 110.204 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -95.12 61.13 1.59 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 113.507 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.02 109.47 0.26 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 0.0 113.528 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.8 m -152.94 105.97 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.509 1.924 . . . . 0.0 112.419 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.93 -5.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.384 1.874 . . . . 0.0 115.955 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -67.69 -6.73 44.62 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.066 1.317 . . . . 0.0 115.865 -169.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.28 42.04 99.38 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.514 1.157 . . . . 0.0 112.929 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -73.72 63.7 1.9 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.01 1.767 . . . . 0.0 113.258 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -66.37 -177.89 0.6 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.333 2.253 . . . . 0.0 112.88 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 106.51 32.52 3.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.395 0.998 . . . . 0.0 114.188 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.01 165.17 3.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.321 1.061 . . . . 0.0 112.815 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 20.7 t -61.34 -24.91 66.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.303 1.441 . . . . 0.0 113.703 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -129.1 177.69 17.76 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 126.143 1.83 . . . . 0.0 113.049 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.33 174.1 10.5 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.646 2.897 . . . . 0.0 112.213 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.79 141.32 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.753 0.821 . . . . 0.0 111.579 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.86 22.74 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.177 1.391 . . . . 0.0 112.292 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 43.7 mt -106.54 112.51 25.54 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.197 1.399 . . . . 0.0 110.128 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -124.28 115.09 2.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.143 1.83 . . . . 0.0 111.161 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 18.3 mtm -65.09 99.1 0.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.884 0.842 . . . . 0.0 111.026 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -69.63 109.53 4.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.569 1.548 . . . . 0.0 110.922 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -128.85 169.9 14.03 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.965 1.306 . . . . 0.0 111.313 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.73 138.45 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.173 1.389 . . . . 0.0 110.944 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 66.7 m -109.59 86.0 2.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.874 1.669 . . . . 0.0 109.853 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.96 150.94 23.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.603 0.761 . . . . 0.0 111.133 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.3 p -149.94 105.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.364 1.866 . . . . 0.0 109.934 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.47 121.73 21.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.383 . . . . 0.0 110.687 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.7 95.21 39.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.236 1.415 . . . . 0.0 108.727 174.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.88 164.85 34.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.552 2.835 . . . . 0.0 111.776 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.7 -52.05 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.862 2.374 . . . . 0.0 112.576 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.12 -69.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.37 173.57 3.91 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.344 1.858 . . . . 0.0 112.17 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.85 157.34 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.541 1.536 . . . . 0.0 111.979 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.808 2.043 . . . . 0.0 110.596 179.439 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.97 97.56 5.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.015 1.326 . . . . 0.0 111.417 -174.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -60.86 -27.63 68.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.11 -17.17 60.97 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -77.03 -31.19 56.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.649 0.78 . . . . 0.0 112.571 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -72.66 147.75 45.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.782 0.833 . . . . 0.0 111.518 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 158.14 45.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.847 1.259 . . . . 0.0 111.538 -177.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.65 64.96 3.79 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.183 1.393 . . . . 0.0 113.081 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.53 -0.56 6.84 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.456 1.503 . . . . 0.0 114.622 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -59.67 -18.66 43.88 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.34 -29.94 47.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -90.58 -29.88 17.56 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.622 0.769 . . . . 0.0 111.431 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.65 131.12 45.56 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.207 -0.933 . . . . 0.0 111.423 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.27 171.82 2.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.782 1.633 . . . . 0.0 113.434 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.09 147.06 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.446 1.098 . . . . 0.0 112.173 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.24 -40.48 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.087 1.355 . . . . 0.0 112.075 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.1 -33.4 69.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.623 1.569 . . . . 0.0 112.631 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -77.2 -52.23 9.6 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.905 1.282 . . . . 0.0 111.177 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 56' ' ' LEU . 16.1 t -48.51 -42.34 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.485 1.114 . . . . 0.0 112.222 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -56.98 -24.75 55.65 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.194 1.398 . . . . 0.0 113.603 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.97 -35.58 11.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.329 1.452 . . . . 0.0 113.292 172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.89 -43.1 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 119.615 1.098 . . . . 0.0 110.445 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.29 -43.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -52.58 45.95 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.864 1.211 . . . . 0.0 111.45 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -30.71 70.57 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.45 -43.84 31.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 48' ' ' VAL . 58.6 mt -55.78 -56.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.564 1.075 . . . . 0.0 109.88 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -59.61 -28.25 67.02 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -67.37 -35.47 79.42 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.12 -29.89 43.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.972 1.309 . . . . 0.0 113.147 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.69 -37.03 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.58 1.152 . . . . 0.0 111.458 172.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.81 11.45 84.61 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.103 0.858 . . . . 0.0 114.832 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.06 -0.97 35.46 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.575 1.56 . . . . 0.0 116.382 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.85 168.82 4.68 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.128 1.464 . . . . 0.0 112.931 167.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.61 -154.55 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.771 1.628 . . . . 0.0 111.901 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.1 160.03 0.39 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.337 1.455 . . . . 0.0 112.992 163.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -151.1 175.07 12.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.342 1.057 . . . . 0.0 113.295 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -97.37 -101.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.541 1.537 . . . . 0.0 110.02 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -67.99 -22.09 65.02 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -58.82 -43.75 90.72 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.97 -1.081 . . . . 0.0 112.99 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.63 -38.57 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.209 1.003 . . . . 0.0 112.782 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -63.13 -54.72 33.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.932 1.293 . . . . 0.0 111.696 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.75 -26.23 68.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.254 -0.904 . . . . 0.0 112.634 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -75.48 -53.89 7.92 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.112 0.965 . . . . 0.0 111.182 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -59.2 -22.23 60.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -86.55 -56.74 3.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.681 1.128 . . . . 0.0 112.457 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -58.22 -37.11 74.21 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.786 1.234 . . . . 0.0 113.676 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 27' ' ' ILE . 94.3 t -69.49 -64.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 123.897 0.879 . . . . 0.0 109.559 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.01 -31.68 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.866 1.266 . . . . 0.0 111.103 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -43.56 90.6 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.635 0.652 . . . . 0.0 112.602 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -96.81 -44.26 7.15 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.985 1.314 . . . . 0.0 112.391 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.2 m -55.82 -51.88 65.95 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.522 2.329 . . . . 0.0 112.871 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.23 -38.98 88.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.166 0.439 . . . . 0.0 110.94 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 p -64.43 -30.67 71.7 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.22 -0.925 . . . . 0.0 113.334 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.03 -48.61 20.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.194 2.198 . . . . 0.0 113.075 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 HD22 HG13 ' A' ' 19' ' ' VAL . 3.5 pp -64.63 -27.8 69.18 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.728 -1.232 . . . . 0.0 114.135 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.7 m -58.16 -34.73 70.63 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.444 1.098 . . . . 0.0 110.925 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -78.94 -36.31 41.9 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.773 -0.579 . . . . 0.0 112.262 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.75 -24.56 66.23 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -105.39 2.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 113.257 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -138.28 152.58 71.79 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.577 1.551 . . . . 0.0 112.12 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.88 111.31 3.0 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.611 2.874 . . . . 0.0 111.375 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.12 179.86 7.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.331 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -93.57 95.37 9.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.472 1.509 . . . . 0.0 111.678 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -83.71 151.6 25.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.887 1.675 . . . . 0.0 109.933 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.483 HG22 ' CD2' ' A' ' 111' ' ' PHE . 1.3 tp -125.67 149.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.709 1.604 . . . . 0.0 108.667 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.9 146.29 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.529 0.732 . . . . 0.0 111.285 164.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.86 117.71 13.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.397 2.279 . . . . 0.0 109.732 174.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.3 p -123.79 136.6 54.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.404 0.682 . . . . 0.0 112.448 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.56 109.3 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.347 1.459 . . . . 0.0 109.29 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 mm -103.15 111.13 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.68 105.4 3.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.895 1.278 . . . . 0.0 109.905 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.09 10.64 1.74 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -69.83 -77.66 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.922 1.289 . . . . 0.0 112.998 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.63 -20.8 5.86 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.85 7.24 5.19 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.641 -1.089 . . . . 0.0 115.708 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.9 93.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.509 1.924 . . . . 0.0 114.812 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.39 78.1 1.0 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.694 1.616 . . . . 0.0 113.429 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 pp -54.48 150.92 8.41 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.629 1.572 . . . . 0.0 112.475 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -123.06 83.31 2.11 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.487 1.515 . . . . 0.0 109.363 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.536 ' HB ' HG13 ' A' ' 135' ' ' VAL . 54.5 m -97.17 139.09 33.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.673 -0.642 . . . . 0.0 109.465 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.54 128.03 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 110.422 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -127.76 117.41 21.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.921 0.889 . . . . 0.0 109.622 -170.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -79.9 41.56 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.425 1.107 . . . . 0.0 111.177 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.76 179.6 7.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.98 1.312 . . . . 0.0 110.577 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -145.55 154.05 41.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.724 1.609 . . . . 0.0 109.621 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -97.45 132.48 43.11 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.006 0.922 . . . . 0.0 109.89 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -144.05 141.53 30.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.228 1.411 . . . . 0.0 110.435 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -114.17 -56.52 2.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.426 1.491 . . . . 0.0 111.718 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.96 -40.25 10.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.172 0.989 . . . . 0.0 112.097 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -32.39 73.18 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.644 2.378 . . . . 0.0 114.223 -169.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.22 -177.5 6.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.591 1.957 . . . . 0.0 110.85 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.09 116.93 3.86 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.969 1.747 . . . . 0.0 114.027 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 t -140.93 172.55 12.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.398 1.879 . . . . 0.0 110.505 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -168.14 140.34 2.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.543 1.537 . . . . 0.0 110.639 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -148.98 144.64 26.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.959 -1.713 . . . . 0.0 111.602 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -139.02 120.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.472 1.109 . . . . 0.0 109.489 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 93.83 4.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.297 1.039 . . . . 0.0 113.024 -171.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -99.43 105.73 17.7 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.96 1.304 . . . . 0.0 110.362 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -109.49 165.77 11.39 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.558 1.543 . . . . 0.0 110.71 169.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -139.13 179.78 6.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.67 1.188 . . . . 0.0 110.031 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -45.1 -40.28 6.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.921 1.688 . . . . 0.0 115.011 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.7 t -133.7 22.9 3.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.302 1.841 . . . . 0.0 113.083 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 mtt -135.79 158.76 43.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -148.99 116.56 6.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.114 1.765 . . . . 0.0 110.704 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.09 68.16 1.3 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.162 1.785 . . . . 0.0 111.481 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pp -97.18 153.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.635 -1.291 . . . . 0.0 113.175 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -132.84 116.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.805 2.042 . . . . 0.0 111.889 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.5 t -97.91 136.17 38.59 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.558 1.143 . . . . 0.0 110.084 171.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.3 166.59 22.78 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.901 1.68 . . . . 0.0 112.262 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.483 ' CD2' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -150.21 161.07 43.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.009 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.32 83.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.447 HD11 ' CE1' ' A' ' 111' ' ' PHE . 1.3 pp -137.92 158.24 44.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.938 1.695 . . . . 0.0 112.682 -169.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 t -137.85 129.86 28.76 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.05 1.34 . . . . 0.0 112.505 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.6 -5.31 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.394 1.477 . . . . 0.0 114.019 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -98.15 18.37 57.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.634 1.588 . . . . 0.0 114.624 -172.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.44 19.73 5.32 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.433 1.492 . . . . 0.0 114.299 -172.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.69 102.95 0.08 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.51 2.005 . . . . 0.0 114.219 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -120.91 -165.51 1.22 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.903 2.081 . . . . 0.0 111.186 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.68 5.54 15.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.521 1.058 . . . . 0.0 115.153 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -53.04 157.05 1.88 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.973 1.387 . . . . 0.0 113.172 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -63.81 -17.45 63.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.93 -71.13 0.37 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.575 1.56 . . . . 0.0 112.26 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.51 170.48 18.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.46 2.773 . . . . 0.0 112.78 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.91 91.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.54 1.936 . . . . 0.0 111.625 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 167.4 21.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.035 0.934 . . . . 0.0 112.476 173.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.38 125.83 26.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.774 1.63 . . . . 0.0 111.206 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.24 83.69 0.51 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.67 1.605 . . . . 0.0 113.193 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.67 90.19 0.4 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.682 1.593 . . . . 0.0 112.992 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.46 99.39 12.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.509 1.524 . . . . 0.0 111.628 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -129.31 166.94 18.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.357 1.463 . . . . 0.0 111.447 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.4 149.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.768 1.627 . . . . 0.0 111.324 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.2 m -121.61 91.29 3.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 110.861 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -77.5 148.06 35.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.886 166.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.536 HG13 ' HB ' ' A' ' 81' ' ' THR . 1.4 p -133.67 97.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 127.864 2.466 . . . . 0.0 109.089 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.93 151.92 48.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.283 1.033 . . . . 0.0 111.631 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.39 155.84 80.4 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.794 1.238 . . . . 0.0 111.457 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.79 166.77 28.89 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 124.136 3.224 . . . . 0.0 112.786 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.38 -15.95 24.83 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.867 3.045 . . . . 0.0 115.066 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -160.63 -67.92 0.07 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.802 1.641 . . . . 0.0 111.559 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -75.51 115.79 15.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.296 -171.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.532 ' H ' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -93.94 169.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.253 1.821 . . . . 0.0 112.113 176.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 128.604 2.762 . . . . 0.0 113.277 177.87 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.37 96.59 4.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.458 -174.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -60.65 -27.41 67.78 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.33 -17.35 60.85 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.06 -31.61 56.27 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.609 0.763 . . . . 0.0 112.58 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -72.34 146.82 46.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.396 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.37 158.93 43.27 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.951 1.3 . . . . 0.0 111.394 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.13 64.06 3.21 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.178 1.391 . . . . 0.0 113.061 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.31 0.54 4.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.731 1.612 . . . . 0.0 114.669 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -59.64 -19.41 49.06 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.599 -1.313 . . . . 0.0 114.23 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.99 -26.79 43.3 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 12.3 t -91.32 -33.51 15.28 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.601 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.81 144.02 56.55 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.369 -0.832 . . . . 0.0 111.352 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.26 170.49 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.515 -0.741 . . . . 0.0 112.811 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.18 141.94 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.957 1.303 . . . . 0.0 112.006 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 159' ' ' VAL . . . . . 0.693 ' HA ' HG22 ' B' ' 162' ' ' VAL . 16.1 t -59.27 -34.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.561 1.144 . . . . 0.0 111.604 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -60.63 -15.38 27.82 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.167 1.387 . . . . 0.0 113.671 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -109.3 -47.56 3.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 110.13 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' B' ' 159' ' ' VAL . 4.3 m -51.31 -32.4 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t -60.75 -20.99 62.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.433 1.493 . . . . 0.0 114.267 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -103.45 -31.8 9.81 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.166 1.786 . . . . 0.0 112.971 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 41.0 mt -49.81 -41.15 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.413 1.006 . . . . 0.0 110.689 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.85 -43.43 97.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -51.99 48.27 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.724 1.147 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -31.46 71.03 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.53 -42.6 42.52 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.46 ' HA ' HG21 ' B' ' 191' ' ' VAL . 56.8 mt -55.77 -55.99 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.533 1.06 . . . . 0.0 109.886 174.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -59.15 -29.18 67.23 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 6.5 p -66.63 -34.37 77.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.1 -29.79 34.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.347 . . . . 0.0 113.199 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.25 -37.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 111.276 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.51 84.13 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.121 0.867 . . . . 0.0 114.817 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.13 35.45 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.471 1.51 . . . . 0.0 116.319 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -63.68 168.49 4.81 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.152 1.476 . . . . 0.0 112.958 167.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -85.16 -155.04 0.2 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.7 1.6 . . . . 0.0 111.718 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.14 159.39 0.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 0.0 113.06 164.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -151.15 172.06 16.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.351 1.46 . . . . 0.0 112.24 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -93.44 -100.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.4 1.08 . . . . 0.0 109.44 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 70.6 m -65.57 -22.22 66.67 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -59.64 -42.37 92.61 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.757 -1.214 . . . . 0.0 112.764 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.19 -38.08 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.292 1.037 . . . . 0.0 112.762 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -62.27 -55.68 25.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.452 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -63.62 -26.45 68.69 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.484 -0.76 . . . . 0.0 112.654 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -75.3 -54.21 7.46 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.172 0.989 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.5 t -58.02 -25.07 60.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 13.8 t -84.43 -56.81 3.43 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.668 1.122 . . . . 0.0 112.201 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -57.7 -37.01 72.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.893 1.224 . . . . 0.0 113.684 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' B' ' 170' ' ' ILE . 98.7 t -70.24 -65.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.165 0.986 . . . . 0.0 109.622 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.08 -31.99 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.668 1.187 . . . . 0.0 111.154 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -43.1 90.4 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.478 0.581 . . . . 0.0 112.566 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -96.5 -44.37 7.2 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.02 1.328 . . . . 0.0 112.511 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -59.43 -48.68 80.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.113 2.565 . . . . 0.0 113.495 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -40.62 97.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.959 0.345 . . . . 0.0 110.396 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 1.4 p -62.05 -30.87 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 112.996 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -76.2 -48.31 20.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.017 2.127 . . . . 0.0 112.918 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.37 -30.42 71.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.937 1.244 . . . . 0.0 113.463 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 31.0 m -58.34 -30.59 66.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.218 1.007 . . . . 0.0 111.05 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -81.47 -36.04 29.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.7 mt -78.36 -19.49 53.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -95.52 -101.7 1.87 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.709 1.623 . . . . 0.0 112.445 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -141.38 151.34 60.89 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 113.012 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.76 110.52 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.832 3.022 . . . . 0.0 111.446 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.88 178.85 8.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 0.0 112.152 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -88.05 93.47 9.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.308 1.443 . . . . 0.0 111.538 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.73 139.41 30.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.235 1.414 . . . . 0.0 109.952 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 3.0 tt -119.76 153.58 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.11 1.764 . . . . 0.0 109.644 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.451 HG12 ' CB ' ' B' ' 253' ' ' ALA . 22.1 m -142.02 146.63 22.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.36 1.064 . . . . 0.0 110.718 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.16 119.92 17.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.064 2.146 . . . . 0.0 109.1 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.3 p -123.03 144.35 49.34 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.543 -0.723 . . . . 0.0 112.215 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 64.9 t -124.31 101.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.038 1.735 . . . . 0.0 108.254 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.32 113.63 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.918 0.887 . . . . 0.0 108.837 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.8 ptp -134.98 146.51 49.15 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.848 0.859 . . . . 0.0 110.529 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -90.14 143.86 26.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.348 -0.845 . . . . 0.0 110.9 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -70.0 4.06 2.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.363 1.465 . . . . 0.0 114.347 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -50.45 -35.23 27.86 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.498 1.519 . . . . 0.0 112.416 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.69 20.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.902 1.239 . . . . 0.0 115.334 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.27 61.09 1.15 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.2 1.4 . . . . 0.0 113.849 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -74.91 63.72 2.37 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.647 1.594 . . . . 0.0 112.959 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.04 159.26 11.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.097 1.759 . . . . 0.0 111.826 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -125.97 89.32 3.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 110.178 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.722 ' HB ' HG13 ' B' ' 278' ' ' VAL . 53.3 m -97.09 139.04 33.68 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.438 177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.71 127.16 44.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.093 1.357 . . . . 0.0 110.122 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m -126.16 116.86 22.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.147 0.979 . . . . 0.0 109.605 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.9 t -80.04 44.61 0.67 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.504 1.145 . . . . 0.0 111.152 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 3.8 m -86.73 179.39 6.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.112 1.365 . . . . 0.0 110.507 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -147.03 148.13 31.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.45 1.5 . . . . 0.0 109.864 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -91.12 132.49 36.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -142.41 139.14 31.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 110.469 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 45.7 t -112.18 -58.64 2.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.465 1.506 . . . . 0.0 111.817 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.8 -38.68 12.22 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.172 0.989 . . . . 0.0 112.155 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -32.38 72.69 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.443 2.297 . . . . 0.0 114.088 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.77 -175.87 5.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.609 1.964 . . . . 0.0 110.803 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -113.62 123.59 6.19 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.563 1.554 . . . . 0.0 114.165 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 22.7 t -146.35 170.92 15.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.208 2.203 . . . . 0.0 110.575 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.2 p -168.78 126.07 1.01 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 0.0 111.896 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.7 t -141.47 141.84 33.64 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 119.597 -1.939 . . . . 0.0 112.575 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.61 123.46 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.652 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 99.02 6.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.308 1.043 . . . . 0.0 113.163 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.07 88.84 2.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.255 1.422 . . . . 0.0 110.884 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -83.48 163.69 20.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.829 0.852 . . . . 0.0 111.37 164.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -141.63 179.93 6.54 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -49.45 -41.23 39.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.451 1.5 . . . . 0.0 113.937 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 21.59 2.85 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 29.2 mtt -139.32 160.33 40.07 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.479 -1.388 . . . . 0.0 113.653 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -135.99 109.87 8.17 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.688 1.995 . . . . 0.0 110.956 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 70.9 m -130.6 78.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.355 1.462 . . . . 0.0 110.697 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.48 145.81 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.266 1.026 . . . . 0.0 112.339 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.55 129.58 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.199 1.8 . . . . 0.0 112.126 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.2 t -114.29 130.24 56.65 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.641 1.577 . . . . 0.0 109.606 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.451 ' CB ' HG12 ' B' ' 210' ' ' VAL . . . -128.42 151.98 48.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.037 1.735 . . . . 0.0 111.764 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -141.02 143.67 34.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.451 1.1 . . . . 0.0 110.94 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -168.47 82.15 0.1 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.257 0.932 . . . . 0.0 111.523 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.2 160.07 38.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.405 1.882 . . . . 0.0 112.121 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 18.3 t -139.46 132.35 29.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.852 1.261 . . . . 0.0 112.515 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.06 -9.65 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.679 1.592 . . . . 0.0 113.527 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.43 22.86 38.66 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.996 1.76 . . . . 0.0 114.545 -169.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.03 6.94 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.305 1.431 . . . . 0.0 114.162 -172.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -49.39 100.79 0.04 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.678 2.085 . . . . 0.0 114.343 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 81.0 p -120.4 -165.75 1.23 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.944 2.098 . . . . 0.0 111.098 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 116.21 6.77 15.43 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.391 0.996 . . . . 0.0 115.21 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -54.54 158.8 2.35 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.941 1.371 . . . . 0.0 113.275 174.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.6 m -64.44 -18.08 64.41 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 144.25 -71.07 0.38 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.551 1.548 . . . . 0.0 112.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.56 170.41 18.62 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.486 2.791 . . . . 0.0 112.801 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.98 91.01 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.568 1.947 . . . . 0.0 111.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 167.25 22.24 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.118 0.967 . . . . 0.0 112.498 173.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 125.66 25.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.785 1.634 . . . . 0.0 111.233 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -101.18 83.54 0.51 Allowed Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 113.185 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.85 90.33 0.42 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.719 1.607 . . . . 0.0 113.046 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -88.93 99.34 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.581 1.553 . . . . 0.0 111.75 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -129.62 166.68 19.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.347 1.459 . . . . 0.0 111.432 171.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.44 149.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 111.394 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 28.2 m -121.47 91.16 3.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.162 1.385 . . . . 0.0 110.876 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -78.36 149.33 33.42 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.904 -1.123 . . . . 0.0 110.862 166.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.722 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.8 p -138.7 97.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.742 2.417 . . . . 0.0 109.245 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -133.7 157.67 45.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.307 1.443 . . . . 0.0 110.87 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -134.42 155.87 79.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.308 1.043 . . . . 0.0 111.361 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -74.02 167.76 26.44 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.694 2.929 . . . . 0.0 112.734 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.55 -17.27 26.71 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.327 2.685 . . . . 0.0 114.741 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -161.36 -65.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.575 1.55 . . . . 0.0 112.051 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.13 120.34 22.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.559 1.544 . . . . 0.0 112.294 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 285' ' ' ILE . . . . . 0.432 ' H ' HD13 ' B' ' 285' ' ' ILE . 0.2 OUTLIER -104.73 169.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.566 1.946 . . . . 0.0 112.085 -178.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 128.334 2.654 . . . . 0.0 113.111 -179.674 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -140.21 -72.72 0.36 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.994 1.317 . . . . 0.0 111.199 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -75.55 -27.14 58.51 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.475 -0.766 . . . . 0.0 112.835 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -13.1 61.97 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.73 -19.04 65.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.574 1.15 . . . . 0.0 113.244 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -118.75 172.36 7.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.825 1.65 . . . . 0.0 111.736 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.01 -174.6 4.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 110.864 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.33 109.94 0.35 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.745 1.618 . . . . 0.0 112.885 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.8 15.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.803 1.241 . . . . 0.0 112.645 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -20.7 60.93 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.44 -26.84 66.6 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.7 t -114.62 -18.22 11.48 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.795 1.638 . . . . 0.0 112.629 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.47 172.53 9.36 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.144 -0.973 . . . . 0.0 111.228 166.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 14.7 p90 -139.18 165.86 26.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.163 1.385 . . . . 0.0 110.117 173.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.62 152.31 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.278 1.031 . . . . 0.0 110.929 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -57.25 -41.17 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.727 1.211 . . . . 0.0 111.323 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.16 66.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -62.54 1.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.766 0.827 . . . . 0.0 110.263 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 56' ' ' LEU . 96.6 t -45.44 -47.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.436 1.894 . . . . 0.0 112.565 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 t -65.87 -13.63 59.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.163 1.785 . . . . 0.0 113.745 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -31.86 11.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.945 1.698 . . . . 0.0 112.255 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.37 -42.33 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.509 0.724 . . . . 0.0 110.272 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.42 -42.12 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -52.24 54.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.175 1.352 . . . . 0.0 111.174 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -30.99 72.03 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.75 -38.7 58.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.432 1.093 . . . . 0.0 113.203 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.454 ' HA ' HG21 ' A' ' 48' ' ' VAL . 49.4 mt -56.89 -56.99 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.166 0.894 . . . . 0.0 109.691 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -59.64 -27.89 66.75 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -47.74 78.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.092 0.957 . . . . 0.0 112.024 169.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.5 -27.16 63.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.775 1.23 . . . . 0.0 114.047 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.58 -35.41 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.564 1.146 . . . . 0.0 111.153 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.48 15.91 70.06 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.1 0.857 . . . . 0.0 114.299 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.9 2.44 78.29 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.087 1.327 . . . . 0.0 115.631 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -65.73 174.34 2.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.841 1.321 . . . . 0.0 112.243 168.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -155.01 0.21 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.119 1.368 . . . . 0.0 111.78 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -51.18 159.45 0.64 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.176 0.991 . . . . 0.0 112.28 158.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -151.6 177.39 10.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.38 1.472 . . . . 0.0 110.631 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -92.14 -114.22 0.09 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.32 1.048 . . . . 0.0 110.931 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -57.47 -22.41 43.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.383 1.873 . . . . 0.0 114.655 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -51.35 -38.97 55.97 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.376 1.471 . . . . 0.0 112.901 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.51 -32.42 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 112.915 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -68.24 -45.15 74.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.227 0.922 . . . . 0.0 112.168 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -22.86 65.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.75 0.704 . . . . 0.0 112.724 174.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.5 -55.1 5.29 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.716 0.806 . . . . 0.0 111.501 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -56.19 -28.99 60.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.916 0.78 . . . . 0.0 113.045 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -79.98 -57.57 3.58 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.338 0.972 . . . . 0.0 112.179 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -57.42 -38.21 73.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.94 1.245 . . . . 0.0 113.484 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 27' ' ' ILE . 84.3 t -66.75 -65.55 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 123.874 0.869 . . . . 0.0 109.491 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.8 t -47.9 -32.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.355 1.062 . . . . 0.0 110.939 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -58.42 -40.54 82.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.8 -40.99 5.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.479 1.512 . . . . 0.0 112.681 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 m -57.68 -53.37 58.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.702 2.401 . . . . 0.0 112.404 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -40.52 92.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.798 0.727 . . . . 0.0 110.693 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -60.9 -40.92 94.91 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.663 -0.648 . . . . 0.0 112.72 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -66.07 -51.29 59.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.924 2.089 . . . . 0.0 113.382 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.52 HD22 HG13 ' A' ' 19' ' ' VAL . 4.1 pp -66.02 -26.24 67.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -58.93 -32.72 69.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.13 0.972 . . . . 0.0 111.466 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -85.58 -23.99 27.38 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -67.79 -26.28 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.12 0.968 . . . . 0.0 112.3 170.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA3' ' CD2' ' A' ' 14' ' ' PHE . . . -98.74 -119.4 4.14 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.965 1.745 . . . . 0.0 112.535 171.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -129.73 156.29 79.08 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.445 1.498 . . . . 0.0 113.156 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.77 113.39 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.93 3.087 . . . . 0.0 112.212 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.11 166.12 31.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.517 1.127 . . . . 0.0 112.196 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -73.3 98.78 2.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.657 0.783 . . . . 0.0 110.956 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -73.34 158.02 35.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.828 0.851 . . . . 0.0 111.179 161.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 tt -132.44 151.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.337 1.455 . . . . 0.0 108.955 164.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 110' ' ' ALA . 18.0 m -142.0 149.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.859 1.263 . . . . 0.0 110.309 169.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 p -135.8 139.37 43.45 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.654 1.582 . . . . 0.0 109.903 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -136.1 150.32 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.648 -0.657 . . . . 0.0 112.056 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.87 104.64 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.888 1.675 . . . . 0.0 108.661 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.469 HD12 ' HB2' ' A' ' 106' ' ' CYS . 2.6 mm -101.2 120.63 51.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.811 1.644 . . . . 0.0 108.926 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.81 166.17 26.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.883 0.849 . . . . 0.0 112.211 174.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -85.96 157.07 20.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.734 1.614 . . . . 0.0 111.245 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.33 11.07 1.04 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.604 1.962 . . . . 0.0 114.954 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -5.48 5.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 114.942 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.81 -3.38 45.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.965 1.745 . . . . 0.0 114.711 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.47 87.53 0.88 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.233 1.413 . . . . 0.0 111.652 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.31 89.3 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.002 1.763 . . . . 0.0 111.031 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.585 ' H ' HD22 ' A' ' 79' ' ' LEU . 1.3 mm? -64.58 160.16 20.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.738 1.215 . . . . 0.0 111.658 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -87.94 96.85 10.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.444 -0.785 . . . . 0.0 109.99 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -117.14 132.16 56.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.783 0.833 . . . . 0.0 109.862 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.57 32.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.323 0.649 . . . . 0.0 111.74 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.9 m -134.09 121.35 21.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.723 1.209 . . . . 0.0 110.569 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -74.35 17.62 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.071 -1.018 . . . . 0.0 113.02 175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.4 m -62.8 167.94 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.833 -1.167 . . . . 0.0 112.22 167.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.18 154.79 21.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.667 1.587 . . . . 0.0 110.636 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -84.22 150.54 25.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.585 1.154 . . . . 0.0 110.241 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -146.93 164.62 32.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.589 1.956 . . . . 0.0 110.303 171.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -128.87 -56.28 1.2 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.498 1.119 . . . . 0.0 113.216 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -78.32 -46.98 18.75 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.389 1.076 . . . . 0.0 112.197 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -48.34 61.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.571 1.949 . . . . 0.0 112.525 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -149.29 -159.71 1.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.411 3.084 . . . . 0.0 108.79 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.56 -173.7 18.02 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.975 1.274 . . . . 0.0 112.923 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.6 p -155.27 173.45 16.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.359 2.263 . . . . 0.0 109.635 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 36.1 t -147.0 122.01 10.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.171 -0.956 . . . . 0.0 109.658 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 t -133.18 149.27 52.05 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.663 -1.273 . . . . 0.0 112.204 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.7 116.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.655 1.582 . . . . 0.0 108.266 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -113.77 95.21 5.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.905 1.282 . . . . 0.0 110.285 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -104.57 118.42 36.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.527 1.131 . . . . 0.0 110.208 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -104.42 162.93 12.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.818 1.647 . . . . 0.0 111.302 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -151.29 -177.41 6.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.209 1.004 . . . . 0.0 111.506 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.73 -67.57 0.2 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.827 2.451 . . . . 0.0 113.847 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.5 t -133.97 24.72 3.93 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.184 1.394 . . . . 0.0 113.306 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.54 162.83 34.12 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.163 -1.586 . . . . 0.0 111.218 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -140.02 137.22 34.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.73 1.212 . . . . 0.0 110.34 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.469 ' HB2' HD12 ' A' ' 71' ' ' ILE . 11.2 p -139.97 85.88 2.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.874 1.321 . . . . 0.0 111.845 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.09 133.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.024 1.329 . . . . 0.0 111.104 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.81 126.44 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.605 1.562 . . . . 0.0 110.867 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 t -117.13 127.9 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.481 1.912 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.465 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -121.73 149.12 43.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.061 1.744 . . . . 0.0 112.582 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -142.2 94.0 2.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.358 1.463 . . . . 0.0 108.663 174.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 113' ' ' LEU . . . -150.01 95.06 0.16 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 120.571 -1.331 . . . . 0.0 110.743 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.428 HD13 ' C ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -148.68 75.27 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.468 1.907 . . . . 0.0 112.142 -174.256 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -145.33 91.26 2.11 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.466 -0.771 . . . . 0.0 112.075 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.36 -13.25 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.78 -8.91 1.37 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.555 1.074 . . . . 0.0 115.079 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.95 1.53 40.66 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.204 1.383 . . . . 0.0 115.405 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -163.43 175.73 39.65 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.329 1.918 . . . . 0.0 113.345 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 m -74.54 174.02 9.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.342 1.457 . . . . 0.0 112.654 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.41 24.13 9.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.572 1.082 . . . . 0.0 114.847 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -62.38 169.0 3.14 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.287 1.835 . . . . 0.0 112.529 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.0 t -65.43 -24.3 67.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.93 74.68 0.43 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.84 1.686 . . . . 0.0 111.975 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.12 142.61 34.53 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.364 2.709 . . . . 0.0 111.44 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.7 pt -134.48 141.03 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.678 1.591 . . . . 0.0 109.944 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.0 120.5 42.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.481 1.912 . . . . 0.0 110.328 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.1 mt -143.08 -174.41 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 128.884 2.874 . . . . 0.0 109.848 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -168.51 94.08 0.11 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.035 -1.041 . . . . 0.0 112.99 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.2 ttt -151.49 130.72 12.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.282 1.433 . . . . 0.0 110.45 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -168.84 112.16 0.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.456 1.502 . . . . 0.0 112.252 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.41 148.9 49.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.054 1.741 . . . . 0.0 112.308 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -60.21 150.71 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.47 1.908 . . . . 0.0 111.471 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 m -115.95 89.59 3.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.229 1.412 . . . . 0.0 110.886 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -98.57 146.45 25.8 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.022 -1.049 . . . . 0.0 111.139 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.52 94.08 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 128.032 2.533 . . . . 0.0 108.006 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.17 162.54 35.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.935 1.294 . . . . 0.0 111.559 176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -112.68 89.33 12.87 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.968 1.307 . . . . 0.0 108.392 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 114.63 3.39 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.123 2.549 . . . . 0.0 110.432 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -37.9 5.33 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.377 2.051 . . . . 0.0 112.21 -174.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -152.16 175.64 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.773 3.229 . . . . 0.0 110.039 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.07 135.87 56.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.071 1.348 . . . . 0.0 111.722 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.61 172.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.148 1.779 . . . . 0.0 111.449 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.555 1.542 . . . . 0.0 111.186 174.456 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -71.95 0.42 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.351 1.46 . . . . 0.0 111.415 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -74.86 -23.71 58.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.521 -0.737 . . . . 0.0 112.952 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -13.35 62.08 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.67 -33.58 71.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.907 1.283 . . . . 0.0 113.18 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -145.39 134.89 23.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.139 1.775 . . . . 0.0 111.934 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -147.51 6.49 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.97 69.4 1.37 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.457 -1.402 . . . . 0.0 112.348 -167.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.07 134.43 48.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.117 1.367 . . . . 0.0 111.546 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.05 -22.47 65.77 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.91 -28.45 67.51 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 14.0 t -108.51 -18.84 13.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.279 1.432 . . . . 0.0 112.694 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.6 171.6 8.69 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.987 0.899 . . . . 0.0 111.468 167.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 157' ' ' PHE . . . . . 0.436 ' CD2' ' HA3' ' B' ' 203' ' ' GLY . 13.6 p90 -139.76 166.62 24.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.286 1.435 . . . . 0.0 110.028 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.68 152.45 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.263 1.025 . . . . 0.0 110.992 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.15 -41.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.79 1.236 . . . . 0.0 111.347 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 113.564 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.65 -62.68 1.5 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.788 0.835 . . . . 0.0 110.172 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.501 HG13 HD22 ' B' ' 199' ' ' LEU . 96.1 t -45.15 -47.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 126.462 1.905 . . . . 0.0 112.607 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t -65.7 -13.8 59.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.111 1.764 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.16 -31.94 11.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.98 1.712 . . . . 0.0 112.203 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 8.6 mt -55.64 -42.18 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.449 0.7 . . . . 0.0 110.26 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.54 -41.71 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.35 53.36 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.145 1.339 . . . . 0.0 111.172 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -30.86 71.91 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.82 -38.88 57.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.421 1.088 . . . . 0.0 113.177 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' B' ' 191' ' ' VAL . 49.8 mt -56.78 -56.97 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.222 0.919 . . . . 0.0 109.663 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.57 -27.97 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -47.67 78.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.157 0.983 . . . . 0.0 111.968 170.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.57 -27.41 64.11 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 114.086 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 58.5 mt -61.5 -35.33 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.609 1.164 . . . . 0.0 111.141 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 82.91 16.18 70.75 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.136 0.874 . . . . 0.0 114.259 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.74 2.32 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.128 1.347 . . . . 0.0 115.58 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -65.16 170.99 4.01 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 118.766 1.283 . . . . 0.0 112.33 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.0 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.26 1.424 . . . . 0.0 112.293 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -53.06 154.18 3.12 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.453 -0.78 . . . . 0.0 111.632 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -145.17 171.02 15.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.142 1.377 . . . . 0.0 110.737 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -84.77 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.213 1.005 . . . . 0.0 110.755 175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 15.6 m -59.73 -20.5 56.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.499 1.52 . . . . 0.0 114.727 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.73 -38.42 55.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.501 1.52 . . . . 0.0 112.888 175.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -55.91 -30.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.73 -45.25 71.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.855 0.862 . . . . 0.0 111.693 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -24.08 65.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -78.19 -54.41 6.26 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.734 0.814 . . . . 0.0 111.54 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.9 t -57.02 -27.53 61.69 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.1 t -81.32 -58.22 3.14 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.434 1.015 . . . . 0.0 112.429 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -56.48 -38.21 71.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.988 1.267 . . . . 0.0 113.584 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.7 t -66.68 -65.72 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 123.822 0.849 . . . . 0.0 109.489 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.9 t -47.74 -32.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 110.968 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -58.55 -40.52 83.25 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -104.92 -40.95 5.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.494 1.518 . . . . 0.0 112.616 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 39.3 m -57.47 -53.67 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.705 2.402 . . . . 0.0 112.438 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -40.9 93.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.749 0.704 . . . . 0.0 110.568 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -60.66 -39.6 88.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -67.42 -51.21 54.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.894 2.078 . . . . 0.0 113.396 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.501 HD22 HG13 ' B' ' 162' ' ' VAL . 3.9 pp -66.27 -26.06 67.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -175.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.4 m -58.68 -32.54 69.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.094 0.958 . . . . 0.0 111.522 165.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -86.21 -23.89 26.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.78 -26.73 66.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.987 0.915 . . . . 0.0 112.194 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' B' ' 157' ' ' PHE . . . -97.56 -121.49 4.25 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.098 1.809 . . . . 0.0 112.562 171.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -128.0 156.34 76.34 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 125.448 1.499 . . . . 0.0 113.172 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.29 112.5 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.005 3.137 . . . . 0.0 112.21 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.15 166.0 32.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.564 1.146 . . . . 0.0 112.314 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -72.6 100.47 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.714 0.806 . . . . 0.0 110.998 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -75.31 157.26 34.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 111.053 160.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 tt -132.26 151.42 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.576 1.55 . . . . 0.0 108.95 164.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' B' ' 253' ' ' ALA . 19.3 m -142.74 149.75 18.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.882 1.273 . . . . 0.0 110.344 170.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 6.7 p -136.89 140.97 42.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.532 1.533 . . . . 0.0 110.145 170.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.8 p -138.48 155.34 48.53 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.617 -0.677 . . . . 0.0 112.176 169.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.96 114.66 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.76 1.624 . . . . 0.0 108.493 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.7 mm -106.93 116.56 50.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 125.863 1.665 . . . . 0.0 108.727 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 215' ' ' MET . . . . . 0.417 ' HG2' HD12 ' A' ' 79' ' ' LEU . 1.1 tmt? -134.86 119.57 18.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.401 1.48 . . . . 0.0 110.64 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 81.71 0.88 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.278 1.831 . . . . 0.0 111.0 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.11 -74.38 0.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.073 1.349 . . . . 0.0 110.968 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -19.55 2.12 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.94 -2.48 6.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.058 1.79 . . . . 0.0 115.98 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.99 101.17 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.527 1.531 . . . . 0.0 114.173 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.06 102.18 1.54 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.574 1.083 . . . . 0.0 112.218 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.515 HD23 HD23 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -44.17 151.81 0.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.363 1.465 . . . . 0.0 113.297 166.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.35 93.27 9.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.334 -0.853 . . . . 0.0 109.462 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.496 ' HB ' HG13 ' B' ' 278' ' ' VAL . 50.3 m -116.01 132.79 56.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.243 0.617 . . . . 0.0 110.428 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.56 129.11 38.6 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.218 0.607 . . . . 0.0 111.321 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -131.56 120.57 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.779 1.232 . . . . 0.0 110.211 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 5.0 t -74.02 16.58 0.22 Allowed 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.194 -0.942 . . . . 0.0 113.045 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.6 m -62.44 167.49 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.88 -1.138 . . . . 0.0 112.26 167.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.22 154.27 21.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.739 1.616 . . . . 0.0 110.523 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -81.38 151.42 27.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.251 1.021 . . . . 0.0 110.122 168.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -145.93 163.2 35.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.619 1.968 . . . . 0.0 109.979 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 14.6 t -126.07 -58.82 1.36 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.447 1.099 . . . . 0.0 112.864 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 17.3 p -79.0 -46.59 17.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.384 1.073 . . . . 0.0 112.333 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -48.41 66.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.434 1.893 . . . . 0.0 112.324 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -150.35 -159.13 0.99 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 129.327 3.051 . . . . 0.0 108.718 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.62 -174.03 18.38 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.951 1.263 . . . . 0.0 113.286 169.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 94.9 p -155.1 173.69 16.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.392 2.277 . . . . 0.0 109.634 170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.18 123.73 11.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 166.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 12.8 t -134.01 149.16 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.528 -1.358 . . . . 0.0 112.118 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.65 114.25 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.453 1.501 . . . . 0.0 108.066 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -111.34 96.97 6.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.9 1.28 . . . . 0.0 109.851 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -107.87 124.78 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 109.931 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 168.78 9.85 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 110.643 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -148.11 -158.04 0.87 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.992 0.917 . . . . 0.0 110.807 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.73 -65.97 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.267 2.227 . . . . 0.0 113.649 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 t -139.39 1.62 1.98 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.9 ptp -98.17 154.37 17.81 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.598 -1.314 . . . . 0.0 112.279 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.9 120.01 25.42 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.867 1.667 . . . . 0.0 108.979 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.496 ' HB2' HD12 ' B' ' 214' ' ' ILE . 20.3 p -126.98 79.01 1.85 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.801 1.286 . . . . 0.0 111.139 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.09 136.13 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.005 1.322 . . . . 0.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.05 126.55 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.547 1.539 . . . . 0.0 110.944 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 32.0 t -113.82 132.15 55.98 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.44 1.896 . . . . 0.0 110.407 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -125.38 149.2 48.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.089 1.756 . . . . 0.0 112.555 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -142.67 98.18 3.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.607 1.563 . . . . 0.0 108.346 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 255' ' ' GLY . . . . . 0.45 ' N ' HD13 ' B' ' 256' ' ' LEU . . . -155.24 94.15 0.14 Allowed Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.655 -1.278 . . . . 0.0 110.64 172.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.45 HD13 ' N ' ' B' ' 255' ' ' GLY . 0.0 OUTLIER -148.37 76.66 1.37 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.504 1.921 . . . . 0.0 112.256 -173.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -146.98 93.0 2.2 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.519 -0.738 . . . . 0.0 112.115 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.9 pp -107.41 -13.39 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -136.65 -5.64 1.93 Allowed Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.709 1.147 . . . . 0.0 115.074 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.87 2.2 28.92 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.342 1.448 . . . . 0.0 115.624 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.64 174.14 41.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.425 1.964 . . . . 0.0 113.232 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 38.2 m -72.61 174.22 7.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.519 1.528 . . . . 0.0 112.929 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 100.73 23.93 9.64 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.557 1.075 . . . . 0.0 114.857 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -62.31 169.09 3.04 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.212 1.805 . . . . 0.0 112.548 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 8.1 t -64.71 -23.37 67.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -128.77 74.8 0.43 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.965 1.745 . . . . 0.0 112.179 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.74 143.32 33.47 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.364 2.709 . . . . 0.0 111.545 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 33.8 pt -134.16 154.46 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.369 1.468 . . . . 0.0 111.298 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 113.14 18.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.647 1.579 . . . . 0.0 111.39 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 7.3 mt -140.91 -176.71 4.77 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.571 2.748 . . . . 0.0 110.313 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.39 94.02 0.11 Allowed Glycine 0 N--CA 1.471 0.996 0 O-C-N 121.234 -0.916 . . . . 0.0 112.779 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 6.4 ttt -151.09 129.26 11.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.289 1.436 . . . . 0.0 110.434 -173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -167.33 112.13 0.72 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.29 1.436 . . . . 0.0 112.321 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.28 148.76 49.64 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.987 1.715 . . . . 0.0 112.276 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.91 150.58 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.585 1.954 . . . . 0.0 111.438 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.8 m -116.6 88.55 2.92 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.256 1.422 . . . . 0.0 110.787 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -99.1 147.63 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.3 p -138.26 98.16 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 127.3 2.24 . . . . 0.0 108.794 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.84 159.52 42.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.587 1.555 . . . . 0.0 111.612 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.56 92.98 10.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.649 1.18 . . . . 0.0 108.527 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.8 115.26 3.86 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.049 2.499 . . . . 0.0 110.187 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.31 -35.87 7.83 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.405 2.07 . . . . 0.0 112.276 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -152.58 175.01 13.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.624 3.17 . . . . 0.0 109.988 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -65.55 135.16 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.009 1.324 . . . . 0.0 111.638 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.33 172.52 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 126.136 1.774 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.541 1.536 . . . . 0.0 111.199 174.636 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -127.87 -34.58 2.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.005 1.322 . . . . 0.0 114.034 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.2 mtm -60.11 -33.11 71.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.081 0.953 . . . . 0.0 112.494 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.29 -16.68 58.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.396 1.478 . . . . 0.0 114.526 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.36 -31.19 26.89 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.181 0.992 . . . . 0.0 112.518 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.27 147.63 49.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.016 0.926 . . . . 0.0 111.148 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.43 137.54 19.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 0.0 112.376 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.55 95.06 3.26 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.667 1.587 . . . . 0.0 111.549 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.14 87.45 0.58 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.169 1.388 . . . . 0.0 112.178 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.78 -26.05 56.74 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.992 1.317 . . . . 0.0 113.564 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.91 -23.58 63.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.949 1.7 . . . . 0.0 115.103 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.21 -16.44 14.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.912 1.285 . . . . 0.0 112.596 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.21 166.35 9.93 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.887 0.875 . . . . 0.0 112.029 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.17 171.49 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.76 1.624 . . . . 0.0 111.425 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.75 161.05 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.544 1.137 . . . . 0.0 111.274 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.39 -44.66 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.591 1.556 . . . . 0.0 111.872 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.61 -25.85 66.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 113.194 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.81 -57.89 3.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.84 0.856 . . . . 0.0 110.85 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.28 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.181 1.392 . . . . 0.0 112.768 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -63.16 -8.29 7.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.617 1.567 . . . . 0.0 114.293 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -109.92 -36.8 5.79 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.877 1.671 . . . . 0.0 112.453 169.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.6 mt -49.34 -44.46 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.086 0.857 . . . . 0.0 110.591 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 97' ' ' VAL . 6.6 p -59.41 -41.46 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.522 -0.736 . . . . 0.0 112.956 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -51.06 52.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.286 0.948 . . . . 0.0 111.01 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.13 72.2 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.9 -47.68 36.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.035 0.934 . . . . 0.0 112.179 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.404 HG13 HG11 ' A' ' 48' ' ' VAL . 65.2 mt -59.53 -58.43 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.183 0.901 . . . . 0.0 110.366 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.16 -27.87 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -65.15 -50.61 65.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.699 0.799 . . . . 0.0 111.795 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.84 -30.81 71.09 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 113.883 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -62.89 -31.6 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.81 1.644 . . . . 0.0 112.578 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.76 7.71 0.43 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 119.052 2.381 . . . . 0.0 119.052 -161.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.37 95.67 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 120.237 2.019 . . . . 0.0 114.731 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -146.85 -173.3 4.19 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.426 1.613 . . . . 0.0 114.098 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.62 -178.1 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.481 1.912 . . . . 0.0 112.537 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -48.94 154.63 0.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -134.84 171.56 14.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.914 1.286 . . . . 0.0 112.349 -170.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -91.49 -113.75 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.111 1.365 . . . . 0.0 110.865 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.7 p -74.57 4.62 5.82 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.179 1.792 . . . . 0.0 115.318 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -47.95 -33.44 7.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.321 1.848 . . . . 0.0 114.559 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 p -48.63 -32.17 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.544 1.137 . . . . 0.0 113.55 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.18 -52.02 57.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.155 1.382 . . . . 0.0 112.284 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.18 -26.33 67.36 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.106 -0.996 . . . . 0.0 112.775 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.81 -53.62 7.68 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.269 1.028 . . . . 0.0 111.557 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.54 -24.24 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.566 0.746 . . . . 0.0 112.72 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -80.67 -63.66 1.36 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.102 0.865 . . . . 0.0 112.197 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -55.15 -41.46 71.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.29 1.436 . . . . 0.0 114.289 -171.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG11 HG13 ' A' ' 27' ' ' ILE . 85.2 t -66.69 -62.55 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 124.219 1.008 . . . . 0.0 110.248 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.6 t -49.04 -31.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.991 1.317 . . . . 0.0 110.766 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -62.61 -31.19 71.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -108.68 -41.48 4.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.225 1.41 . . . . 0.0 112.165 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.9 m -59.15 -51.47 69.86 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.932 2.493 . . . . 0.0 112.583 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -38.41 91.07 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.287 0.565 . . . . 0.0 111.336 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -61.88 -46.0 91.32 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -60.0 -49.14 78.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.709 2.004 . . . . 0.0 112.809 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.75 -24.8 63.58 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.571 -1.331 . . . . 0.0 114.399 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.0 m -60.36 -28.16 67.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.928 0.491 . . . . 0.0 111.024 165.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -87.19 -29.35 21.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.951 0.901 . . . . 0.0 112.695 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.92 -20.82 62.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.626 1.17 . . . . 0.0 112.385 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.61 -110.56 3.51 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.434 1.969 . . . . 0.0 112.81 172.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -137.78 148.67 61.77 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.379 1.872 . . . . 0.0 111.13 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.34 120.32 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.048 3.165 . . . . 0.0 112.439 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.79 166.77 32.43 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 112.392 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.09 92.61 0.75 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.663 1.185 . . . . 0.0 110.36 166.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -68.6 162.63 25.46 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.664 0.745 . . . . 0.0 110.797 157.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.541 HD11 ' SG ' ' B' ' 228' ' ' CYS . 7.3 tt -141.84 153.62 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.742 1.617 . . . . 0.0 109.045 166.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 110' ' ' ALA . 21.7 m -144.67 152.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.956 1.302 . . . . 0.0 110.566 173.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -144.34 158.64 43.63 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.421 1.089 . . . . 0.0 110.256 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.2 p -151.62 152.72 33.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.078 1.351 . . . . 0.0 111.88 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -133.61 123.49 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.917 1.287 . . . . 0.0 109.317 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mm -111.16 108.36 25.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 127.431 2.293 . . . . 0.0 109.121 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -135.91 153.47 51.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.438 2.295 . . . . 0.0 110.733 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -143.98 147.81 34.43 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 112.495 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -80.04 -14.38 58.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.62 -7.75 55.87 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.12 25.51 0.02 OUTLIER Glycine 0 N--CA 1.477 1.375 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.644 ' HB1' HD11 ' B' ' 222' ' ' LEU . . . -139.25 126.77 21.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.893 1.277 . . . . 0.0 112.472 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.25 101.4 0.16 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.927 0.775 . . . . 0.0 114.111 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.721 HD13 HD13 ' B' ' 222' ' ' LEU . 8.8 mp -113.99 -174.56 2.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.688 2.395 . . . . 0.0 110.358 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.15 130.64 55.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.382 0.673 . . . . 0.0 110.317 170.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.2 m -137.78 142.85 40.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.284 1.433 . . . . 0.0 109.749 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.72 138.29 39.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.675 1.19 . . . . 0.0 110.551 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.2 p -141.43 120.05 12.5 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.583 1.153 . . . . 0.0 110.993 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.8 m -75.91 13.2 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.839 -1.163 . . . . 0.0 113.406 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.673 ' SG ' HD11 ' B' ' 209' ' ' ILE . 8.2 m -60.43 164.49 4.36 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.899 167.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.95 158.21 30.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.445 1.898 . . . . 0.0 110.053 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -80.72 139.42 36.13 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.247 0.546 . . . . 0.0 109.651 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -154.35 162.66 41.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.164 1.786 . . . . 0.0 111.178 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.6 t -132.98 -59.32 0.89 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.232 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 -39.09 51.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.369 1.068 . . . . 0.0 111.513 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -53.68 53.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.78 1.632 . . . . 0.0 111.641 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -150.09 -69.76 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.982 1.313 . . . . 0.0 112.404 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.29 151.95 6.36 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 127.238 2.352 . . . . 0.0 113.38 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 p -165.35 141.48 5.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.689 1.995 . . . . 0.0 110.557 173.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.72 63.85 1.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.869 1.268 . . . . 0.0 112.35 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -76.41 150.59 36.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.338 1.855 . . . . 0.0 113.591 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 23' ' ' VAL . 1.7 t -142.12 135.21 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.463 1.505 . . . . 0.0 110.457 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -115.19 120.15 38.77 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.48 1.112 . . . . 0.0 112.012 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -133.2 98.54 4.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.695 1.598 . . . . 0.0 110.261 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 173.48 8.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.79 1.236 . . . . 0.0 111.949 166.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -143.43 -176.39 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.764 1.626 . . . . 0.0 111.203 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -51.56 -43.31 62.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.172 1.389 . . . . 0.0 114.246 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 t -137.71 8.52 2.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.271 1.428 . . . . 0.0 114.101 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.14 165.38 16.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.184 1.393 . . . . 0.0 112.819 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -145.28 118.76 9.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.161 1.784 . . . . 0.0 109.941 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.9 p -143.62 74.44 1.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 111.938 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.0 pt -74.71 158.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.457 -0.777 . . . . 0.0 111.421 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.07 141.15 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.486 1.914 . . . . 0.0 109.949 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -135.38 125.18 25.51 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.257 -0.902 . . . . 0.0 111.54 -174.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -121.62 144.17 48.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.299 1.44 . . . . 0.0 112.823 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -146.18 -176.67 5.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 126.607 1.963 . . . . 0.0 110.125 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.53 84.41 1.11 Allowed Glycine 0 CA--C 1.539 1.552 0 O-C-N 120.87 -1.144 . . . . 0.0 112.892 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 46.22 1.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.174 2.19 . . . . 0.0 113.031 -167.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 t -124.86 77.58 1.62 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.193 0.997 . . . . 0.0 112.268 -170.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -10.49 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -168.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.12 -3.93 29.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.127 1.346 . . . . 0.0 115.133 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.4 3.37 57.6 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.962 1.267 . . . . 0.0 115.849 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.29 174.0 34.8 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.548 2.023 . . . . 0.0 113.345 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.0 p -69.78 174.69 4.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.653 1.581 . . . . 0.0 113.477 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.59 8.98 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.528 1.061 . . . . 0.0 114.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.84 165.22 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.409 1.484 . . . . 0.0 113.559 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 t -76.39 12.34 1.26 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.353 1.861 . . . . 0.0 114.635 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.17 162.39 40.37 Favored Glycine 0 CA--C 1.543 1.842 0 O-C-N 120.728 -1.233 . . . . 0.0 114.207 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.97 171.92 15.68 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.007 3.138 . . . . 0.0 113.143 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.57 132.38 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.964 1.706 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.72 161.18 41.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.761 1.624 . . . . 0.0 112.788 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.9 155.99 22.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.389 1.476 . . . . 0.0 112.599 176.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.23 -171.76 32.16 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.889 1.233 . . . . 0.0 113.617 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.6 mtt -136.99 170.64 15.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.307 1.843 . . . . 0.0 112.225 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.57 143.45 47.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.578 1.951 . . . . 0.0 111.455 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -136.23 169.44 17.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.85 2.06 . . . . 0.0 111.443 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 mm -63.71 146.02 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 110.588 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.6 m -106.07 111.74 24.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.279 1.432 . . . . 0.0 110.067 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.99 145.37 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.782 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.86 104.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -139.63 150.36 44.86 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.737 0.815 . . . . 0.0 112.465 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -133.84 157.77 77.03 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.574 1.55 . . . . 0.0 111.557 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 160.53 48.43 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.524 2.816 . . . . 0.0 112.94 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.92 -38.86 15.63 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.317 2.678 . . . . 0.0 113.473 -175.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.34 -177.96 6.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.843 2.057 . . . . 0.0 110.93 174.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -105.92 136.59 45.3 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.203 1.001 . . . . 0.0 111.783 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.56 165.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.708 2.003 . . . . 0.0 111.326 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.254 1.327 0 C-N-CA 125.881 1.672 . . . . 0.0 111.318 173.87 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 CA-C-O 119.669 -0.517 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -132.86 -37.65 1.01 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.501 1.12 . . . . 0.0 113.67 175.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 18.4 mtm -59.16 -33.56 71.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.299 1.04 . . . . 0.0 112.649 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.32 -16.79 58.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 114.592 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.57 -30.96 26.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.14 0.976 . . . . 0.0 112.548 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.79 147.89 49.84 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.976 0.91 . . . . 0.0 111.23 168.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.1 138.05 20.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.778 0.831 . . . . 0.0 112.447 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.22 96.08 4.46 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.594 1.558 . . . . 0.0 111.576 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.33 86.21 0.59 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.008 1.323 . . . . 0.0 112.226 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.43 -25.91 51.94 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.04 1.336 . . . . 0.0 113.522 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.01 -24.34 62.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.711 1.604 . . . . 0.0 115.018 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.81 -19.75 13.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.376 1.07 . . . . 0.0 112.502 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.26 159.69 20.27 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.23 -0.919 . . . . 0.0 111.56 170.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.59 162.63 27.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.402 1.081 . . . . 0.0 110.721 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 p -138.61 158.96 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.736 1.215 . . . . 0.0 111.166 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.83 -38.55 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.74 2.416 . . . . 0.0 112.67 -174.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.86 -28.34 68.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 113.072 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.49 -47.8 7.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.47 0.708 . . . . 0.0 110.708 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 70.2 t -48.58 -42.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.338 1.455 . . . . 0.0 112.187 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t -64.25 -8.23 11.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.622 1.569 . . . . 0.0 114.874 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.54 -35.09 6.84 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.308 1.843 . . . . 0.0 112.446 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.9 mt -49.79 -42.13 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.143 0.977 . . . . 0.0 110.583 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.29 -43.57 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.52 63.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.455 1.025 . . . . 0.0 111.053 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -33.73 76.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.57 63.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.647 0.779 . . . . 0.0 112.206 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.4 HG13 HG11 ' B' ' 191' ' ' VAL . 66.5 mt -59.5 -59.18 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.109 0.868 . . . . 0.0 109.986 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -61.86 -29.48 70.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 32.9 t -63.6 -51.93 63.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.983 0.913 . . . . 0.0 111.912 167.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.29 -30.71 71.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.071 1.348 . . . . 0.0 113.989 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.78 -34.81 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.249 1.419 . . . . 0.0 111.005 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.33 80.81 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.897 1.237 . . . . 0.0 114.916 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.48 68.82 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.104 1.335 . . . . 0.0 115.487 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -70.57 -176.14 1.2 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.811 1.306 . . . . 0.0 112.301 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.89 154.25 5.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.721 -1.237 . . . . 0.0 111.424 170.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -48.92 150.0 1.66 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.021 1.328 . . . . 0.0 113.1 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -127.85 166.64 17.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.577 1.151 . . . . 0.0 111.483 -173.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -89.0 -113.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.519 1.128 . . . . 0.0 110.553 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 61.0 p -74.37 5.91 4.16 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -48.59 -33.97 10.72 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.085 1.754 . . . . 0.0 114.475 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 65.6 t -50.11 -33.02 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.567 1.147 . . . . 0.0 112.665 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.94 -52.99 57.23 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.309 1.443 . . . . 0.0 112.367 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.79 -26.3 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.045 -1.035 . . . . 0.0 112.742 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.96 -53.19 8.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.264 1.026 . . . . 0.0 111.519 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.59 -24.38 63.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.385 0.674 . . . . 0.0 112.79 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.6 t -80.51 -64.01 1.28 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.121 0.873 . . . . 0.0 112.138 165.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -55.25 -39.74 70.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.312 1.445 . . . . 0.0 114.345 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.4 HG11 HG13 ' B' ' 170' ' ' ILE . 88.8 t -68.21 -62.37 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 C-N-CA 124.139 0.976 . . . . 0.0 110.208 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.18 -31.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.922 1.289 . . . . 0.0 110.721 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -62.03 -31.78 72.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.932 0.893 . . . . 0.0 113.376 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -108.22 -41.61 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.162 1.385 . . . . 0.0 112.163 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 46.2 m -59.71 -51.36 70.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.074 2.55 . . . . 0.0 112.617 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -38.32 90.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 111.262 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.5 t -61.32 -46.64 89.44 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.624 -0.673 . . . . 0.0 111.626 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.69 -50.5 73.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.789 2.035 . . . . 0.0 112.941 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.99 -27.65 67.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.081 1.309 . . . . 0.0 114.027 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 93.7 m -59.57 -29.09 67.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.116 0.566 . . . . 0.0 111.283 167.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.72 -28.83 22.84 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 89.8 mt -78.92 -19.4 51.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.181 0.992 . . . . 0.0 111.895 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -102.19 -104.25 2.79 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.429 1.966 . . . . 0.0 112.087 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -141.43 145.81 39.49 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.084 1.754 . . . . 0.0 111.505 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 122.23 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.053 3.168 . . . . 0.0 112.522 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -158.51 167.58 29.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.25 1.42 . . . . 0.0 112.106 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.15 92.13 0.54 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.651 1.18 . . . . 0.0 110.305 166.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -68.06 161.85 25.85 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.603 0.716 . . . . 0.0 110.582 157.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 209' ' ' ILE . . . . . 0.673 HD11 ' SG ' ' A' ' 85' ' ' CYS . 7.1 tt -141.16 153.54 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.774 1.629 . . . . 0.0 108.94 166.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' B' ' 253' ' ' ALA . 25.7 m -144.15 151.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.808 1.243 . . . . 0.0 110.44 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.2 t -142.67 157.46 44.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.473 1.109 . . . . 0.0 110.06 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 46.4 t -152.85 147.8 26.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.39 1.476 . . . . 0.0 111.313 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.37 127.57 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.4 mm -113.34 111.17 34.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 127.429 2.292 . . . . 0.0 109.462 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -135.76 153.65 51.48 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.652 2.381 . . . . 0.0 110.945 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -144.32 144.15 31.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.378 1.471 . . . . 0.0 112.636 -172.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -75.97 -15.64 60.13 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -75.8 -7.88 55.52 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.48 23.75 0.02 OUTLIER Glycine 0 CA--C 1.536 1.363 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -138.61 123.33 18.67 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.745 1.272 . . . . 0.0 112.591 -168.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.63 103.06 0.19 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.048 0.832 . . . . 0.0 114.292 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.721 HD13 HD13 ' A' ' 79' ' ' LEU . 8.5 mp -114.64 -174.31 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.895 2.478 . . . . 0.0 110.444 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.56 129.96 55.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.58 0.752 . . . . 0.0 110.587 170.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.578 ' HB ' HG13 ' B' ' 278' ' ' VAL . 22.9 m -135.66 145.36 46.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.102 1.361 . . . . 0.0 109.964 172.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.55 41.74 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 110.997 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.8 p -142.88 122.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.462 1.105 . . . . 0.0 110.755 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.7 m -77.03 13.25 1.12 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.946 -1.096 . . . . 0.0 113.168 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' CYS . . . . . 0.541 ' SG ' HD11 ' A' ' 66' ' ' ILE . 5.2 m -59.83 164.52 3.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.836 167.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.44 159.57 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.832 . . . . 0.0 110.247 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -80.42 135.72 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.222 0.535 . . . . 0.0 109.567 169.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -152.11 162.84 40.49 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.753 1.621 . . . . 0.0 111.47 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 32.1 t -137.1 -58.98 0.71 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.872 1.269 . . . . 0.0 112.173 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -74.48 -40.78 61.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.102 0.961 . . . . 0.0 111.368 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -54.26 46.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.947 1.699 . . . . 0.0 111.621 -174.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.14 -70.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.876 1.27 . . . . 0.0 112.703 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 137.11 152.69 6.22 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 127.509 2.48 . . . . 0.0 113.484 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 44.9 p -171.49 127.29 0.65 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.558 1.543 . . . . 0.0 112.459 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.56 65.04 0.67 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.972 1.709 . . . . 0.0 112.431 -171.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.9 t -76.94 146.75 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.16 1.384 . . . . 0.0 113.637 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.32 114.94 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.694 1.198 . . . . 0.0 110.906 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -94.14 119.02 32.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.72 1.208 . . . . 0.0 111.859 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -130.08 106.81 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.437 1.495 . . . . 0.0 110.323 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 169.91 9.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.365 1.466 . . . . 0.0 111.667 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -140.83 -177.33 5.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.637 1.575 . . . . 0.0 110.968 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -51.75 -42.25 62.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.888 1.275 . . . . 0.0 114.406 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 7.6 t -138.1 8.21 2.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.252 1.421 . . . . 0.0 114.324 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.35 159.4 27.55 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.45 119.04 15.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.647 1.979 . . . . 0.0 110.33 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.68 73.88 1.43 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.887 1.275 . . . . 0.0 112.031 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.32 125.57 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.37 1.468 . . . . 0.0 111.765 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.22 147.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.412 1.485 . . . . 0.0 110.614 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -139.75 129.76 24.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.93 0.892 . . . . 0.0 111.981 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -123.6 145.2 49.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.367 1.467 . . . . 0.0 113.05 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -147.5 -176.5 5.27 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.709 2.004 . . . . 0.0 109.972 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 86.47 84.89 1.09 Allowed Glycine 0 CA--C 1.538 1.523 0 O-C-N 120.794 -1.191 . . . . 0.0 112.922 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.93 1.03 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.066 2.146 . . . . 0.0 113.038 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 t -125.76 78.24 1.73 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.096 0.951 . . . . 0.0 112.111 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.67 -10.75 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -168.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -110.72 -3.82 28.43 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.084 1.326 . . . . 0.0 115.14 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.33 58.61 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.943 1.259 . . . . 0.0 115.776 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.11 35.05 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.48 1.99 . . . . 0.0 113.391 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 71.3 p -69.7 174.84 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.666 1.586 . . . . 0.0 113.553 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.63 26.28 9.3 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.58 1.086 . . . . 0.0 114.877 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -60.06 164.77 3.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.366 1.466 . . . . 0.0 113.595 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 7.7 t -76.24 17.76 0.34 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.688 1.995 . . . . 0.0 114.523 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -90.31 161.52 28.91 Favored Glycine 0 CA--C 1.54 1.65 0 O-C-N 120.649 -1.282 . . . . 0.0 114.296 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.36 167.7 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.924 3.083 . . . . 0.0 113.199 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.51 121.33 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 111.582 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 269' ' ' LYS . . . . . 0.528 ' HE3' ' H ' ' B' ' 269' ' ' LYS . 0.0 OUTLIER -144.07 155.55 44.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.6 1.56 . . . . 0.0 113.909 176.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.85 163.1 28.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.339 1.056 . . . . 0.0 112.073 173.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.82 -174.11 28.55 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.986 1.279 . . . . 0.0 113.557 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 6.7 mtt -137.8 169.88 17.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.411 1.885 . . . . 0.0 111.881 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -134.17 142.7 47.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.323 1.849 . . . . 0.0 111.46 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -136.24 169.61 17.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.807 2.043 . . . . 0.0 111.418 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.79 146.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.084 1.354 . . . . 0.0 110.607 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 85.1 m -107.79 103.7 13.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.455 1.502 . . . . 0.0 110.26 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -104.45 147.41 27.6 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.876 -1.14 . . . . 0.0 110.74 171.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.4 p -145.15 107.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.736 2.014 . . . . 0.0 109.916 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -139.0 151.68 47.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.728 0.811 . . . . 0.0 112.564 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -133.37 157.5 77.96 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.559 1.544 . . . . 0.0 111.499 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.55 160.87 47.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.56 2.84 . . . . 0.0 112.886 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.96 -38.53 16.32 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.223 2.615 . . . . 0.0 113.503 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.56 -177.87 6.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.907 2.083 . . . . 0.0 110.919 174.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.26 137.07 44.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.254 1.022 . . . . 0.0 111.828 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.6 165.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 0.0 111.383 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 35.0 t . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.926 1.69 . . . . 0.0 111.361 173.945 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.271 1.428 . . . . 0.0 112.616 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -56.92 -39.83 75.2 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.64 1.176 . . . . 0.0 114.018 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.75 -12.97 59.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.72 -22.04 37.61 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.322 1.049 . . . . 0.0 112.876 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -66.67 137.69 56.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.463 1.505 . . . . 0.0 110.348 168.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -142.9 157.93 44.11 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.434 1.094 . . . . 0.0 111.861 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.12 68.69 2.6 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.492 1.517 . . . . 0.0 113.091 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.22 -0.16 7.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.311 1.445 . . . . 0.0 114.731 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.77 -30.64 70.15 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.658 -1.276 . . . . 0.0 114.159 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.7 -25.25 16.18 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -75.93 -19.72 58.56 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.075 0.55 . . . . 0.0 111.832 170.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.17 146.79 42.13 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.771 -1.206 . . . . 0.0 112.219 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -123.39 164.76 18.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.433 1.493 . . . . 0.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.66 161.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 110.939 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.33 -36.92 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.767 1.627 . . . . 0.0 112.047 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.83 -26.14 67.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.64 1.176 . . . . 0.0 112.274 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.96 -58.96 2.75 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.297 0.639 . . . . 0.0 110.099 171.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 56' ' ' LEU . 96.7 t -47.59 -43.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.763 1.625 . . . . 0.0 113.325 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 t -59.3 -21.39 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.605 1.562 . . . . 0.0 113.574 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -99.63 -34.23 10.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.384 1.474 . . . . 0.0 113.114 172.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 mt -51.42 -42.96 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.251 1.02 . . . . 0.0 110.633 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.55 -44.1 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 121.408 -0.807 . . . . 0.0 113.102 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -51.36 65.43 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.945 1.248 . . . . 0.0 111.697 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -35.44 79.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.15 64.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.4 ' HA ' HG21 ' A' ' 48' ' ' VAL . 61.4 mt -60.28 -56.58 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.155 0.889 . . . . 0.0 109.001 173.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.25 -32.31 73.68 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.7 p -69.81 -36.99 76.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.18 -0.95 . . . . 0.0 112.699 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -28.04 62.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.669 1.188 . . . . 0.0 113.899 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.59 -34.22 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.975 1.31 . . . . 0.0 110.809 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.19 81.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.797 1.189 . . . . 0.0 114.729 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.98 17.69 65.77 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.287 1.422 . . . . 0.0 115.543 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.28 -173.29 1.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.696 1.248 . . . . 0.0 111.733 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 115.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 111.297 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -64.77 126.08 26.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.384 1.074 . . . . 0.0 111.394 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -127.41 127.67 44.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.253 1.021 . . . . 0.0 112.583 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -64.15 -42.49 96.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.265 1.026 . . . . 0.0 112.954 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 t -62.64 -28.78 70.15 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.994 -1.066 . . . . 0.0 112.712 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -72.8 -26.56 61.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.58 -34.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.078 1.308 . . . . 0.0 112.401 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.3 -49.2 72.72 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.953 1.301 . . . . 0.0 112.593 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.88 -25.89 66.61 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.152 -0.967 . . . . 0.0 112.909 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -78.08 -53.07 7.8 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.717 0.807 . . . . 0.0 111.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.61 -22.81 62.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -82.83 -60.22 2.24 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.508 1.049 . . . . 0.0 112.189 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -57.66 -38.98 76.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.113 1.324 . . . . 0.0 114.32 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 27' ' ' ILE . 88.2 t -68.52 -64.53 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 C-N-CA 124.644 1.177 . . . . 0.0 109.895 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.6 t -47.53 -30.99 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 110.863 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.61 -38.5 72.14 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.136 0.975 . . . . 0.0 113.314 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -112.21 -34.6 5.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.998 1.719 . . . . 0.0 112.648 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -62.21 -52.67 62.83 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.031 2.132 . . . . 0.0 112.572 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -33.85 75.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.371 0.532 . . . . 0.0 111.123 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 m -60.69 -54.76 41.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.548 0.739 . . . . 0.0 111.853 166.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -53.47 -50.82 64.52 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.435 1.894 . . . . 0.0 112.751 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.471 HD22 HG13 ' A' ' 19' ' ' VAL . 3.6 pp -68.95 -27.19 65.51 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.2 m -59.65 -43.4 93.93 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -71.44 -23.11 61.79 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.0 5.77 3.97 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.215 1.406 . . . . 0.0 113.386 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.11 -97.86 0.14 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.594 1.088 . . . . 0.0 114.981 164.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -66.87 170.66 5.67 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 125.163 1.385 . . . . 0.0 114.598 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.12 168.27 14.39 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.166 1.911 . . . . 0.0 112.131 166.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -56.8 113.82 1.82 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.571 1.548 . . . . 0.0 112.651 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.33 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.377 3.071 . . . . 0.0 110.273 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.93 172.28 13.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.833 2.453 . . . . 0.0 108.915 169.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 tt -134.74 153.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.519 1.527 . . . . 0.0 108.403 162.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.08 141.61 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.858 0.863 . . . . 0.0 110.255 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.06 141.55 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.511 1.525 . . . . 0.0 108.932 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 146.93 41.27 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.496 -0.752 . . . . 0.0 112.964 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.24 125.38 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.465 1.506 . . . . 0.0 109.144 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mm -124.63 104.68 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.026 2.13 . . . . 0.0 108.076 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.57 166.96 20.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 112.286 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.09 109.49 12.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.639 1.175 . . . . 0.0 111.861 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -61.38 -20.09 62.63 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.89 -16.69 61.1 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.28 18.09 0.02 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.895 1.918 . . . . 0.0 117.895 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.5 65.84 1.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.367 1.583 . . . . 0.0 111.971 -171.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.33 159.42 40.98 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.623 1.106 . . . . 0.0 113.145 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.436 ' HB3' HD12 ' B' ' 222' ' ' LEU . 0.0 OUTLIER -160.97 174.88 13.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.43 1.892 . . . . 0.0 112.06 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -120.86 133.24 55.31 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.553 1.141 . . . . 0.0 111.112 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.451 ' HB ' HG13 ' A' ' 135' ' ' VAL . 13.3 m -141.0 144.61 35.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.587 1.555 . . . . 0.0 109.77 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.8 126.29 20.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.663 1.185 . . . . 0.0 109.991 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.4 p -128.57 113.3 15.27 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.849 0.86 . . . . 0.0 110.755 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -77.45 11.26 2.07 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.557 1.143 . . . . 0.0 112.844 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.6 m -58.76 163.01 3.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.931 1.692 . . . . 0.0 112.714 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -159.16 137.82 10.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.918 1.287 . . . . 0.0 110.353 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -73.7 148.91 42.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.478 0.711 . . . . 0.0 110.195 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -136.16 151.69 50.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 110.913 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.0 t -106.35 -63.24 1.29 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.492 1.117 . . . . 0.0 112.158 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.5 p -84.87 -32.01 23.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.804 0.842 . . . . 0.0 113.159 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -49.86 47.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.24 1.416 . . . . 0.0 111.943 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -149.82 -174.43 4.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.668 2.387 . . . . 0.0 110.3 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.73 149.06 18.65 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.709 1.147 . . . . 0.0 112.256 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -155.56 131.9 10.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.692 1.197 . . . . 0.0 110.418 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 11.0 t -123.31 136.49 54.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -128.19 141.35 51.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.383 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.4 113.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 126.468 1.907 . . . . 0.0 108.949 -168.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.0 114.26 24.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.729 1.612 . . . . 0.0 111.378 -174.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -124.82 105.35 9.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.158 1.783 . . . . 0.0 109.569 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 167.1 7.48 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.475 -0.766 . . . . 0.0 112.253 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -144.83 -179.21 6.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.976 0.911 . . . . 0.0 111.518 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -52.11 55.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.793 1.637 . . . . 0.0 113.74 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.3 t -127.67 -30.11 2.57 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.89 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.2 ptp -96.59 179.44 4.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.49 1.516 . . . . 0.0 111.835 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.1 152.51 37.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.643 1.577 . . . . 0.0 109.38 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.0 p -129.66 137.38 50.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.108 0.963 . . . . 0.0 110.995 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.1 125.38 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.921 1.289 . . . . 0.0 110.271 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.12 128.03 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.895 2.078 . . . . 0.0 108.994 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -126.74 110.14 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.154 1.381 . . . . 0.0 111.291 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.27 143.38 27.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.449 1.9 . . . . 0.0 112.383 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -134.02 126.27 29.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.983 1.313 . . . . 0.0 110.001 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.59 73.99 0.3 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.554 2.026 . . . . 0.0 111.206 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.97 123.22 16.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.006 1.322 . . . . 0.0 110.92 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -151.51 80.34 1.29 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.49 1.516 . . . . 0.0 112.62 -169.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -113.27 0.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.282 1.433 . . . . 0.0 114.814 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.34 -0.88 55.66 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.321 1.289 . . . . 0.0 116.321 -175.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 2.05 75.11 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.16 1.362 . . . . 0.0 115.664 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.49 -163.56 33.33 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.559 1.552 . . . . 0.0 114.262 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -64.83 -172.69 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.719 1.607 . . . . 0.0 112.705 170.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.16 21.02 14.18 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 125.328 1.442 . . . . 0.0 115.121 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -137.49 159.73 41.13 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.895 1.678 . . . . 0.0 112.065 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.98 -25.56 64.59 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.58 -74.58 0.39 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.1 1.81 . . . . 0.0 112.663 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.26 166.24 30.31 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.559 2.84 . . . . 0.0 112.774 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.3 pt -102.33 133.86 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.962 1.305 . . . . 0.0 111.232 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.41 167.46 21.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.533 1.533 . . . . 0.0 111.19 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.5 mt -86.17 172.23 10.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.371 1.868 . . . . 0.0 112.517 173.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.45 158.31 31.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.409 1.481 . . . . 0.0 112.643 171.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -74.82 132.8 41.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 111.404 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.05 85.06 2.14 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.366 1.466 . . . . 0.0 111.277 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -127.06 165.43 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.309 1.044 . . . . 0.0 112.373 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.2 mm -64.56 148.38 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.503 1.521 . . . . 0.0 110.872 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.5 m -126.04 100.43 6.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.89 1.276 . . . . 0.0 110.595 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -92.04 149.46 21.51 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.95 168.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -146.34 103.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.082 2.153 . . . . 0.0 109.22 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -139.1 157.73 45.44 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.095 -1.003 . . . . 0.0 112.507 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.03 157.2 72.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 165.09 31.31 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.628 2.885 . . . . 0.0 113.189 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.89 168.93 17.39 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.534 2.823 . . . . 0.0 112.439 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.58 169.37 11.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.922 1.689 . . . . 0.0 111.52 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.06 135.67 56.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.892 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.34 161.04 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.947 1.699 . . . . 0.0 110.76 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.806 1.643 . . . . 0.0 112.464 -179.328 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.28 157.96 18.6 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.938 1.695 . . . . 0.0 112.485 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -57.08 -39.55 75.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.526 1.13 . . . . 0.0 113.984 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.15 -12.77 59.62 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.95 -21.95 36.94 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.254 1.021 . . . . 0.0 112.917 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -66.59 137.81 57.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.405 1.482 . . . . 0.0 110.334 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -143.02 157.83 44.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.454 1.102 . . . . 0.0 111.907 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.29 68.9 2.74 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.431 1.492 . . . . 0.0 113.084 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.33 -0.51 8.27 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.51 -30.29 69.63 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.663 -1.273 . . . . 0.0 114.215 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.31 -25.36 15.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.1 t -75.28 -21.17 58.7 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.872 -0.518 . . . . 0.0 111.746 170.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 142.81 50.48 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.822 -1.173 . . . . 0.0 112.061 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -118.75 167.81 11.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.277 1.431 . . . . 0.0 110.663 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.44 160.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.494 1.118 . . . . 0.0 111.066 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.94 -37.34 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.631 1.173 . . . . 0.0 111.946 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -28.06 66.19 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.093 0.957 . . . . 0.0 112.882 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -77.3 -59.6 2.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.975 1.31 . . . . 0.0 110.767 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.496 HG13 HD22 ' B' ' 199' ' ' LEU . 84.0 t -48.67 -42.5 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 125.055 1.342 . . . . 0.0 113.292 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.8 t -58.95 -19.33 41.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.281 1.432 . . . . 0.0 113.454 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -101.92 -34.26 9.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.803 1.241 . . . . 0.0 113.161 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 24.1 mt -51.04 -44.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.496 1.044 . . . . 0.0 110.608 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.29 -43.31 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.453 -0.779 . . . . 0.0 112.874 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -51.02 62.88 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.733 1.151 . . . . 0.0 111.592 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -34.48 76.69 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.11 59.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.946 0.898 . . . . 0.0 113.34 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.18 -57.22 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.206 0.912 . . . . 0.0 109.064 174.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.29 -31.29 72.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.5 p -69.98 -37.57 75.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.19 -0.944 . . . . 0.0 112.681 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.16 -31.22 68.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.388 1.075 . . . . 0.0 113.462 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.8 -35.75 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.364 1.465 . . . . 0.0 112.636 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -58.74 -1.05 0.73 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -159.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.41 -32.68 81.91 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.904 1.852 . . . . 0.0 115.285 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -166.67 2.31 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.848 1.324 . . . . 0.0 112.511 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.07 161.92 3.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.383 1.473 . . . . 0.0 112.703 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.65 130.19 39.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.314 1.446 . . . . 0.0 111.132 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -132.89 133.97 43.97 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.776 1.23 . . . . 0.0 112.156 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -73.57 -43.17 60.47 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.25 1.02 . . . . 0.0 113.101 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 7.2 t -62.23 -27.68 69.16 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.066 -1.021 . . . . 0.0 112.502 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -73.25 -26.19 61.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -53.81 -34.03 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.261 1.391 . . . . 0.0 112.571 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.58 -49.62 72.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.1 1.36 . . . . 0.0 112.567 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.06 -25.42 66.24 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.198 -0.939 . . . . 0.0 112.932 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -78.39 -52.72 8.17 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.611 0.764 . . . . 0.0 111.756 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.75 -22.73 62.5 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.8 t -82.83 -60.6 2.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.492 1.042 . . . . 0.0 112.205 165.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -56.83 -41.31 77.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.302 1.41 . . . . 0.0 114.294 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.35 -64.67 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 110.036 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 87.6 t -47.7 -30.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.958 1.303 . . . . 0.0 110.973 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.08 -38.15 72.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.009 0.924 . . . . 0.0 113.162 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.6 -35.41 5.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 112.596 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 44.7 m -61.48 -52.66 63.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.157 2.183 . . . . 0.0 112.634 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -34.23 76.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.487 0.585 . . . . 0.0 111.192 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 66.5 m -61.06 -53.6 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.511 0.725 . . . . 0.0 111.887 167.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -54.42 -50.88 66.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.594 1.958 . . . . 0.0 112.648 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.496 HD22 HG13 ' B' ' 162' ' ' VAL . 3.9 pp -69.38 -26.55 64.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 66.7 m -59.27 -43.48 92.49 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -71.87 -23.25 61.48 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.38 4.96 4.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.28 1.432 . . . . 0.0 113.464 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -155.93 -97.28 0.13 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.517 1.053 . . . . 0.0 114.941 164.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -67.67 171.22 5.52 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 125.156 1.382 . . . . 0.0 114.666 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.62 169.7 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.019 1.812 . . . . 0.0 111.889 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -56.26 114.19 1.87 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.591 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.8 97.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 129.342 3.057 . . . . 0.0 110.169 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -149.8 171.88 16.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.687 2.395 . . . . 0.0 109.044 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -135.24 153.53 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.903 1.681 . . . . 0.0 108.217 162.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 253' ' ' ALA . 27.3 m -139.02 141.88 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.863 0.865 . . . . 0.0 110.124 166.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.257 1.423 . . . . 0.0 108.895 169.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.2 p -135.79 150.21 49.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.12 0.962 . . . . 0.0 113.078 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 12.9 t -132.27 125.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.894 1.677 . . . . 0.0 108.184 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.6 mm -122.49 104.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.997 2.119 . . . . 0.0 107.418 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 162.97 29.28 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 112.753 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.1 137.34 52.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.265 1.426 . . . . 0.0 111.134 -174.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -89.1 -14.18 36.88 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -77.85 -17.06 57.8 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 173.59 21.37 0.02 OUTLIER Glycine 0 CA--C 1.538 1.517 0 N-CA-C 117.703 1.841 . . . . 0.0 117.703 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.73 73.25 1.42 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.773 1.786 . . . . 0.0 112.767 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.5 160.16 32.73 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.682 1.134 . . . . 0.0 113.518 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -162.02 176.68 10.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.797 2.039 . . . . 0.0 111.941 -177.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.19 131.2 53.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.677 1.591 . . . . 0.0 110.957 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.59 ' HB ' HG13 ' B' ' 278' ' ' VAL . 90.6 m -139.05 143.38 38.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.449 1.1 . . . . 0.0 109.916 174.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.8 128.73 27.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 110.23 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.9 p -130.81 114.69 15.63 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.845 0.858 . . . . 0.0 110.912 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 t -78.16 11.21 2.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.447 1.099 . . . . 0.0 112.712 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.2 m -58.42 162.51 3.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.803 1.641 . . . . 0.0 112.774 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -158.96 138.55 11.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.846 1.258 . . . . 0.0 110.537 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.73 145.0 47.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.391 0.677 . . . . 0.0 109.927 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -130.13 151.81 50.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.614 1.566 . . . . 0.0 110.23 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 29.7 t -106.75 -64.28 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.927 1.291 . . . . 0.0 112.211 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 70.8 p -83.65 -31.64 26.06 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.868 0.867 . . . . 0.0 113.262 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -48.81 58.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 111.928 -173.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.07 -175.12 5.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.881 2.472 . . . . 0.0 110.754 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.99 146.74 16.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.784 1.183 . . . . 0.0 112.252 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 1.4 m -152.73 126.69 9.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.098 1.359 . . . . 0.0 110.679 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 16.8 t -121.33 130.08 53.43 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.59 1.156 . . . . 0.0 111.416 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.5 t -125.53 143.73 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.166 0.986 . . . . 0.0 111.338 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.42 131.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.506 1.523 . . . . 0.0 109.183 -172.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 114.47 17.8 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.434 1.493 . . . . 0.0 111.346 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.77 102.67 7.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.456 1.903 . . . . 0.0 109.408 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 165.95 7.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.492 -0.755 . . . . 0.0 112.093 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -144.1 -178.74 6.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.998 0.919 . . . . 0.0 111.581 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -51.08 59.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.858 1.663 . . . . 0.0 113.751 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -129.4 -29.28 2.23 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.519 1.528 . . . . 0.0 113.992 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -97.14 179.17 5.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.529 1.532 . . . . 0.0 111.828 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.57 151.72 36.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.369 1.468 . . . . 0.0 109.539 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.402 ' HB2' HD12 ' B' ' 214' ' ' ILE . 29.9 p -129.53 137.52 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.072 0.949 . . . . 0.0 111.148 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.0 130.02 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.992 1.317 . . . . 0.0 109.975 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.5 125.72 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.695 1.598 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.8 m -121.87 109.05 14.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.876 1.671 . . . . 0.0 110.916 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -94.52 143.83 26.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 112.579 176.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -134.76 122.46 22.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.347 1.459 . . . . 0.0 109.737 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.43 74.08 0.27 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.419 1.961 . . . . 0.0 111.331 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.92 121.82 13.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.016 1.326 . . . . 0.0 110.919 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.9 m -149.77 76.55 1.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.994 1.718 . . . . 0.0 112.406 -169.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.15 -2.1 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.221 1.408 . . . . 0.0 114.698 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.86 0.81 60.9 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.96 1.83 75.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 118.951 1.376 . . . . 0.0 115.732 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.53 -163.94 34.08 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.607 1.575 . . . . 0.0 114.187 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.5 t -65.03 -172.36 0.09 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.732 1.613 . . . . 0.0 112.805 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 99.67 20.78 15.96 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 125.289 1.423 . . . . 0.0 114.953 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -137.37 159.17 42.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.9 1.68 . . . . 0.0 112.226 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.3 t -69.14 -25.85 64.59 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 123.82 -74.06 0.4 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 126.089 1.804 . . . . 0.0 112.844 -177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.18 166.55 29.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.663 2.909 . . . . 0.0 112.845 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 30.3 pt -103.25 134.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.895 1.278 . . . . 0.0 111.241 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.71 167.44 21.42 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.622 1.569 . . . . 0.0 111.236 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 8.3 mt -86.44 172.93 9.99 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.413 1.885 . . . . 0.0 112.616 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.62 159.03 32.02 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.126 1.345 . . . . 0.0 113.177 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -76.63 129.17 36.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.018 0.927 . . . . 0.0 111.456 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.86 83.41 2.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.711 1.604 . . . . 0.0 111.682 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -127.92 166.51 18.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.031 0.933 . . . . 0.0 111.993 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.38 149.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.53 1.532 . . . . 0.0 111.274 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 86.4 m -126.96 99.89 5.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.005 1.322 . . . . 0.0 110.725 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -93.94 150.03 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.163 -0.961 . . . . 0.0 110.858 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.59 HG13 ' HB ' ' B' ' 224' ' ' THR . 4.0 p -150.28 104.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.534 1.934 . . . . 0.0 110.062 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.61 159.18 42.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.031 1.332 . . . . 0.0 112.373 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.3 156.61 72.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.844 1.658 . . . . 0.0 111.94 -178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.04 165.23 30.87 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.612 2.875 . . . . 0.0 113.18 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.61 168.85 17.17 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.546 2.831 . . . . 0.0 112.475 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.74 169.26 12.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.034 1.734 . . . . 0.0 111.486 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.84 134.6 55.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.135 0.974 . . . . 0.0 110.918 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.18 152.95 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 110.95 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.696 1.998 . . . . 0.0 110.455 -178.572 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -68.51 84.28 0.28 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.918 2.087 . . . . 0.0 114.074 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -15.24 0.58 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.641 1.976 . . . . 0.0 115.882 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.94 -38.73 79.65 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.5 -3.07 2.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.49 1.516 . . . . 0.0 112.446 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.23 172.68 12.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.492 1.917 . . . . 0.0 111.631 -173.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -150.9 177.44 10.13 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.178 1.391 . . . . 0.0 111.562 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.53 120.51 39.77 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.38 1.472 . . . . 0.0 110.59 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.85 100.9 9.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.468 1.507 . . . . 0.0 111.982 -174.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.81 -18.01 40.46 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -59.38 -12.45 5.93 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 169.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 t -61.21 -18.59 59.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.195 1.398 . . . . 0.0 113.681 168.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.58 148.96 49.75 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.819 -1.175 . . . . 0.0 111.508 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.27 170.16 8.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.262 1.425 . . . . 0.0 111.764 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -149.57 157.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.72 1.208 . . . . 0.0 111.366 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -53.45 -41.27 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.834 1.653 . . . . 0.0 112.063 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.91 -25.85 67.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.74 1.216 . . . . 0.0 113.544 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -79.96 -56.22 4.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.022 0.929 . . . . 0.0 110.632 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.0 t -47.34 -43.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.432 1.893 . . . . 0.0 112.381 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -63.79 -9.66 15.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.292 1.837 . . . . 0.0 114.362 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -111.17 -32.67 6.69 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.524 1.93 . . . . 0.0 112.475 172.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.3 mt -50.74 -43.37 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.014 0.825 . . . . 0.0 110.317 168.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.15 -44.04 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.495 -0.753 . . . . 0.0 112.957 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -52.36 51.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.756 1.162 . . . . 0.0 111.318 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -34.75 77.26 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.41 -41.42 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.78 0.832 . . . . 0.0 112.984 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.463 ' HA ' HG21 ' A' ' 48' ' ' VAL . 56.2 mt -58.25 -59.56 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.297 0.953 . . . . 0.0 109.522 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -62.97 -29.95 71.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.29 -49.93 75.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.27 1.028 . . . . 0.0 112.104 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.46 72.04 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.48 -40.67 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.799 1.24 . . . . 0.0 111.506 173.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.11 74.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.163 0.887 . . . . 0.0 115.139 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.71 -0.31 36.56 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.392 1.472 . . . . 0.0 116.256 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.47 162.03 8.64 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 118.879 1.34 . . . . 0.0 112.008 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.31 -166.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.599 1.56 . . . . 0.0 111.57 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -43.92 121.67 2.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.392 2.277 . . . . 0.0 112.425 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -115.81 170.17 8.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.631 1.172 . . . . 0.0 113.085 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 -95.86 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.703 1.201 . . . . 0.0 109.317 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -76.81 -21.01 55.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.637 1.175 . . . . 0.0 113.988 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -41.81 76.9 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.998 0.919 . . . . 0.0 112.367 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.16 -33.42 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.02 -46.73 80.1 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.362 0.983 . . . . 0.0 112.204 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -65.79 -24.84 67.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.692 0.678 . . . . 0.0 112.532 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.75 -51.86 9.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.034 0.833 . . . . 0.0 111.887 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -56.52 -29.59 62.06 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.847 0.749 . . . . 0.0 112.521 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -79.35 -60.77 2.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.389 0.995 . . . . 0.0 112.409 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.84 -38.6 75.96 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.334 1.453 . . . . 0.0 114.284 -172.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' A' ' 27' ' ' ILE . 81.7 t -68.21 -64.44 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 123.9 0.88 . . . . 0.0 109.469 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.9 t -50.42 -28.44 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.469 1.507 . . . . 0.0 110.835 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.11 28.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.579 1.151 . . . . 0.0 112.115 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -93.27 -35.56 13.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.041 1.336 . . . . 0.0 112.734 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -59.75 -54.38 47.03 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.944 2.097 . . . . 0.0 112.285 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -37.44 83.15 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.122 0.487 . . . . 0.0 111.236 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.0 t -62.18 -40.45 96.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.151 -0.968 . . . . 0.0 113.102 170.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.1 -49.85 63.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.721 1.608 . . . . 0.0 112.422 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.74 -24.8 65.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.9 m -55.89 -34.76 65.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.674 0.789 . . . . 0.0 110.919 163.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -84.88 -31.46 23.72 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.13 -30.47 70.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.472 0.709 . . . . 0.0 111.578 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.38 -100.81 2.61 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.147 1.832 . . . . 0.0 112.724 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -136.63 141.76 36.6 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.867 1.267 . . . . 0.0 113.677 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.44 104.18 1.66 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.448 3.432 . . . . 0.0 112.605 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -142.84 179.89 6.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.078 1.751 . . . . 0.0 112.166 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.5 89.25 3.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.464 1.506 . . . . 0.0 111.706 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.13 147.42 25.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.033 1.333 . . . . 0.0 110.747 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.3 152.96 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 126.117 1.767 . . . . 0.0 109.292 174.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 110' ' ' ALA . 9.5 m -138.39 146.68 26.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.604 1.161 . . . . 0.0 110.823 172.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 126.98 20.02 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.422 1.889 . . . . 0.0 108.921 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 p -129.7 138.09 50.95 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 112.552 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.1 98.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.139 1.376 . . . . 0.0 109.5 -167.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -106.7 91.32 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.359 1.864 . . . . 0.0 107.928 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -147.37 93.83 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.057 1.743 . . . . 0.0 110.763 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.54 133.37 8.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 109.649 170.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -52.05 0.14 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.274 1.43 . . . . 0.0 112.123 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.68 -23.95 8.98 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.875 1.27 . . . . 0.0 113.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.0 -1.34 38.35 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.538 1.542 . . . . 0.0 115.056 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.29 68.58 1.43 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.402 1.881 . . . . 0.0 111.237 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.9 15.93 0.09 OUTLIER Glycine 0 CA--C 1.537 1.429 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 -170.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.41 104.46 4.59 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.656 1.983 . . . . 0.0 110.005 -159.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 132.7 51.66 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.836 -1.165 . . . . 0.0 108.835 173.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 m -154.15 140.63 18.79 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.257 -1.527 . . . . 0.0 109.603 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.06 24.36 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.544 -0.722 . . . . 0.0 112.811 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -142.03 129.63 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.619 0.768 . . . . 0.0 110.51 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -79.75 8.83 5.96 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.292 -0.88 . . . . 0.0 112.482 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.65 162.94 17.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.636 1.174 . . . . 0.0 112.675 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.17 151.84 28.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.423 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 169.07 18.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.942 0.497 . . . . 0.0 111.484 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -139.41 148.61 43.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.213 1.005 . . . . 0.0 111.427 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -112.49 -68.94 0.9 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.461 1.504 . . . . 0.0 111.634 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.3 t -84.3 -38.82 19.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.698 0.799 . . . . 0.0 112.108 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -67.51 -45.96 74.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.672 1.189 . . . . 0.0 112.689 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.6 -169.8 3.47 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.56 2.344 . . . . 0.0 110.408 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.43 174.13 15.14 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.266 1.412 . . . . 0.0 114.518 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.7 t -154.88 163.1 40.78 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.385 1.874 . . . . 0.0 111.151 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 20.9 t -164.88 115.13 1.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.002 1.321 . . . . 0.0 112.164 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.694 -1.254 . . . . 0.0 112.01 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.62 151.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 110.184 -172.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -138.94 121.68 16.43 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.501 1.52 . . . . 0.0 111.02 -168.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -135.52 103.1 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.9 1.68 . . . . 0.0 111.018 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.47 142.49 58.37 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.027 -1.046 . . . . 0.0 112.254 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.35 -167.8 1.79 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.842 1.257 . . . . 0.0 109.932 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.03 -52.01 9.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.842 2.057 . . . . 0.0 114.585 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -140.59 -35.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.162 1.785 . . . . 0.0 111.402 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.4 ptp -79.03 112.95 16.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.478 1.511 . . . . 0.0 111.795 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.78 116.48 19.97 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.269 -1.519 . . . . 0.0 109.889 170.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.469 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -81.38 134.42 35.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.114 173.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.26 132.26 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.778 1.631 . . . . 0.0 109.846 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.77 127.88 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.615 1.566 . . . . 0.0 110.728 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 t -119.14 111.89 18.83 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.124 0.97 . . . . 0.0 110.802 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -87.47 139.62 30.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.913 0.885 . . . . 0.0 111.193 167.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -124.12 126.71 46.65 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 109.313 168.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.56 78.35 0.24 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 125.531 1.538 . . . . 0.0 112.35 -170.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.66 123.26 24.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.654 1.581 . . . . 0.0 111.764 -173.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.4 m -137.64 93.61 2.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.174 2.19 . . . . 0.0 112.807 -164.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.71 -2.2 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.92 63.53 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.441 1.496 . . . . 0.0 115.698 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.88 45.3 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.552 1.176 . . . . 0.0 115.46 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.06 138.9 48.15 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 118.705 1.252 . . . . 0.0 113.048 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.8 m -134.04 -173.75 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.053 1.741 . . . . 0.0 111.849 -175.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.91 12.66 6.39 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 124.816 1.198 . . . . 0.0 115.476 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -56.25 162.67 1.93 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.07 1.748 . . . . 0.0 115.635 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.5 t -103.13 -45.89 4.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.168 1.787 . . . . 0.0 113.061 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.92 -178.3 50.54 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.08 1.324 . . . . 0.0 114.417 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 140.78 56.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.31 2.673 . . . . 0.0 111.256 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 pp -77.32 128.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.784 0.833 . . . . 0.0 111.855 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.81 154.77 49.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.927 1.691 . . . . 0.0 112.059 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -146.14 152.59 39.52 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.251 2.621 . . . . 0.0 109.155 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.1 -149.49 20.27 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.033 1.301 . . . . 0.0 112.533 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.74 175.72 1.06 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.075 0.95 . . . . 0.0 112.466 170.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.05 177.14 8.04 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 112.751 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -117.39 178.24 4.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 111.417 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -109.31 145.31 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.802 1.641 . . . . 0.0 109.926 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -117.4 90.71 3.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.047 1.339 . . . . 0.0 110.078 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -104.52 138.53 40.76 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.427 1.091 . . . . 0.0 110.816 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.45 98.98 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.214 2.606 . . . . 0.0 108.586 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.0 p30 -135.31 168.19 19.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.06 0.944 . . . . 0.0 111.82 168.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -98.84 154.03 37.58 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.437 1.095 . . . . 0.0 109.386 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 115.44 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.267 2.645 . . . . 0.0 111.272 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -53.93 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.656 2.237 . . . . 0.0 112.332 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.67 -176.28 4.21 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.554 2.741 . . . . 0.0 109.944 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -107.81 140.67 40.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.602 1.161 . . . . 0.0 111.328 165.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.51 177.45 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 127.25 2.22 . . . . 0.0 111.405 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.257 9.6 p . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.275 1.83 . . . . 0.0 111.647 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.1 p -69.39 70.32 0.26 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.513 1.925 . . . . 0.0 114.612 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -80.85 0.09 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.241 1.416 . . . . 0.0 111.896 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -92.48 -64.58 1.09 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.24 1.68 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.226 2.211 . . . . 0.0 111.455 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -69.32 162.56 26.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.519 1.128 . . . . 0.0 112.722 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -146.8 173.87 11.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.423 1.489 . . . . 0.0 112.041 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.61 102.92 10.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.421 1.888 . . . . 0.0 110.677 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.78 100.9 12.72 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.45 1.5 . . . . 0.0 112.594 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.29 -19.31 54.46 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.01 -13.02 5.37 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 170.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 4.7 t -57.71 -27.57 63.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.092 1.357 . . . . 0.0 113.423 171.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.59 134.24 49.69 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.739 -1.226 . . . . 0.0 111.634 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.72 159.11 15.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.085 0.954 . . . . 0.0 112.255 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.49 156.35 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.149 1.78 . . . . 0.0 110.767 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 44.3 t -51.21 -40.09 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.294 2.638 . . . . 0.0 112.415 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.97 -28.32 62.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 113.175 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.47 -46.96 7.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.045 0.938 . . . . 0.0 110.854 175.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -48.65 -42.27 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.502 1.121 . . . . 0.0 112.067 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 12.1 t -63.55 -9.13 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.545 1.938 . . . . 0.0 114.692 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -109.98 -32.09 7.16 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.688 1.995 . . . . 0.0 112.552 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.9 mt -51.46 -41.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.822 0.849 . . . . 0.0 110.517 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.22 -44.17 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 121.447 -0.783 . . . . 0.0 112.939 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.63 53.8 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.736 1.153 . . . . 0.0 111.345 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.6 77.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.64 65.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.529 0.731 . . . . 0.0 112.924 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.462 ' HA ' HG21 ' B' ' 191' ' ' VAL . 58.0 mt -58.37 -59.9 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 119.127 0.876 . . . . 0.0 109.388 174.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.51 -30.15 71.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.1 t -61.3 -50.04 74.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 112.105 168.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.35 71.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.4 -40.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.822 1.249 . . . . 0.0 111.523 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.05 12.13 74.69 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.192 0.901 . . . . 0.0 115.036 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.56 -0.39 36.96 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.339 1.447 . . . . 0.0 116.266 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.61 162.49 8.3 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 118.852 1.326 . . . . 0.0 111.972 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -93.38 -166.16 1.47 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 111.505 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -43.82 125.58 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.482 2.313 . . . . 0.0 112.597 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -120.4 163.87 17.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.44 1.096 . . . . 0.0 113.749 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -71.91 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.055 1.342 . . . . 0.0 110.982 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m -107.31 -18.81 13.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.258 1.423 . . . . 0.0 113.694 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.42 -42.22 66.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.504 1.122 . . . . 0.0 111.991 174.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.43 -32.38 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.442 1.497 . . . . 0.0 114.5 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.94 -46.4 71.57 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.313 0.96 . . . . 0.0 112.11 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -65.58 -25.36 67.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.664 0.665 . . . . 0.0 112.327 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -77.64 -53.42 7.59 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.973 0.909 . . . . 0.0 111.823 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 15.1 t -56.35 -28.92 60.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.994 0.815 . . . . 0.0 112.671 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . 0.25 10.6 t -79.87 -61.91 1.85 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.425 1.011 . . . . 0.0 112.284 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.76 -38.45 72.48 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.592 1.557 . . . . 0.0 114.037 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.2 t -67.91 -64.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 192' ' ' VAL . . . . . 0.47 HG12 HG21 ' B' ' 210' ' ' VAL . 99.5 t -50.55 -28.37 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.46 1.504 . . . . 0.0 110.939 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -55.4 28.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.762 1.225 . . . . 0.0 112.037 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.73 -34.91 13.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.088 1.355 . . . . 0.0 112.817 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 38.2 m -60.7 -55.21 35.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.997 2.119 . . . . 0.0 112.343 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -36.45 82.19 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.515 0.598 . . . . 0.0 111.556 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 25.2 t -58.17 -51.08 71.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.635 0.774 . . . . 0.0 112.036 167.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.96 -50.91 71.89 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.808 1.643 . . . . 0.0 112.806 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.34 -27.73 67.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 63.9 m -57.33 -36.23 70.89 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.099 0.56 . . . . 0.0 110.598 165.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -79.15 -31.48 44.02 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.071 -1.018 . . . . 0.0 113.192 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.19 -28.95 61.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.178 0.591 . . . . 0.0 110.888 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.27 -94.95 1.99 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.355 1.931 . . . . 0.0 112.791 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -140.17 143.16 32.69 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.401 1.481 . . . . 0.0 113.061 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 114.12 3.75 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.732 2.955 . . . . 0.0 112.081 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.76 175.11 12.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.687 1.595 . . . . 0.0 112.673 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -94.54 87.65 5.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.744 1.218 . . . . 0.0 111.566 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -72.85 153.14 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.288 1.035 . . . . 0.0 112.253 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.5 tt -143.24 153.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.694 1.998 . . . . 0.0 108.72 166.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.47 HG21 HG12 ' B' ' 192' ' ' VAL . 15.5 m -139.75 144.79 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.296 1.038 . . . . 0.0 110.171 172.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.17 123.51 19.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.798 1.639 . . . . 0.0 108.681 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 11.8 p -124.5 142.13 51.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.186 0.994 . . . . 0.0 112.096 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 t -133.78 111.65 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.122 1.369 . . . . 0.0 107.622 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.2 mm -111.83 90.38 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.788 1.635 . . . . 0.0 107.73 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 162.69 13.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.478 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -75.23 137.98 41.61 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.405 0.622 . . . . 0.0 112.209 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -2.63 20.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.869 2.067 . . . . 0.0 114.185 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -55.06 -29.55 57.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.244 1.818 . . . . 0.0 113.901 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.47 75.89 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.797 1.189 . . . . 0.0 115.438 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.58 60.84 1.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.882 1.673 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.25 62.25 0.07 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-O 121.805 0.669 . . . . 0.0 114.225 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.85 96.25 1.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.698 1.999 . . . . 0.0 109.205 -171.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.18 101.39 6.74 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.199 -1.563 . . . . 0.0 108.63 173.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.485 ' HB ' HG13 ' B' ' 278' ' ' VAL . 22.8 m -130.98 139.09 49.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.398 -1.439 . . . . 0.0 109.765 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.97 138.36 31.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 m -141.46 135.73 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.79 0.836 . . . . 0.0 110.759 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 8.3 t -82.76 9.62 9.35 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.362 -0.836 . . . . 0.0 112.368 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.66 162.57 18.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.177 0.991 . . . . 0.0 112.685 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -154.97 149.9 26.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.207 1.803 . . . . 0.0 110.25 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.15 167.87 21.03 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.176 0.512 . . . . 0.0 111.225 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -139.38 148.65 43.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.451 1.1 . . . . 0.0 110.981 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -109.94 -68.31 0.93 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.536 1.535 . . . . 0.0 111.645 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 11.8 t -84.09 -39.46 19.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.871 0.868 . . . . 0.0 112.036 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -66.6 -46.48 75.75 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.026 1.331 . . . . 0.0 113.038 -172.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.68 -170.51 3.68 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 127.798 2.439 . . . . 0.0 110.19 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -116.08 173.75 14.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.21 1.386 . . . . 0.0 114.571 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 21.3 t -153.41 163.59 39.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.573 1.949 . . . . 0.0 111.062 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 23.1 t -164.85 111.66 1.0 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.023 1.329 . . . . 0.0 112.235 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.8 t -113.93 147.33 38.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.545 -1.347 . . . . 0.0 112.373 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.3 t -139.79 153.27 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.326 1.85 . . . . 0.0 110.394 -173.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -135.13 130.32 35.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.922 1.689 . . . . 0.0 111.621 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -138.68 101.94 4.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.414 1.886 . . . . 0.0 110.368 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.1 146.2 53.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.802 -1.186 . . . . 0.0 112.073 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.32 -175.34 3.84 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.011 1.325 . . . . 0.0 110.226 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.63 -66.74 0.33 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.111 1.764 . . . . 0.0 114.527 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -133.51 17.37 3.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.089 1.756 . . . . 0.0 111.88 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 12.8 ptp -137.92 158.45 44.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.741 2.016 . . . . 0.0 109.095 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -126.1 123.9 39.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.917 0.887 . . . . 0.0 109.894 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.36 130.72 39.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.828 0.851 . . . . 0.0 110.965 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.3 pt -128.72 129.68 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 109.188 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.79 126.03 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.634 1.574 . . . . 0.0 110.45 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 13.6 t -118.64 110.47 17.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.185 0.994 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -85.91 141.22 29.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.987 0.915 . . . . 0.0 111.316 167.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -125.07 125.6 44.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.258 1.423 . . . . 0.0 109.164 167.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.31 77.26 0.23 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.897 1.713 . . . . 0.0 111.67 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 123.53 25.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.276 1.431 . . . . 0.0 111.95 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m -137.53 99.49 3.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.321 2.248 . . . . 0.0 112.479 -165.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.65 -3.97 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -90.63 2.5 80.41 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.318 1.437 . . . . 0.0 115.724 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 91.83 17.65 47.28 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.738 1.269 . . . . 0.0 115.548 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -57.03 140.37 44.84 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 118.708 1.254 . . . . 0.0 113.352 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.4 m -134.6 -173.59 3.33 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.146 1.779 . . . . 0.0 111.907 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 120.17 11.41 6.87 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.767 1.175 . . . . 0.0 115.389 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -54.78 162.25 1.29 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.163 1.785 . . . . 0.0 115.809 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 32.5 t -102.27 -46.35 4.84 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.211 1.805 . . . . 0.0 113.087 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -78.64 -178.43 50.16 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.069 1.318 . . . . 0.0 114.436 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.68 141.44 60.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.236 2.624 . . . . 0.0 111.261 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.75 128.61 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.803 0.841 . . . . 0.0 111.87 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.81 154.72 49.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.999 1.72 . . . . 0.0 112.113 173.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 45.7 tp -146.38 152.59 39.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.165 2.586 . . . . 0.0 109.123 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 137.59 -149.77 20.5 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.968 1.271 . . . . 0.0 112.548 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 175.22 1.12 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.998 0.919 . . . . 0.0 112.328 169.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -135.31 178.02 7.36 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.07 1.348 . . . . 0.0 112.646 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -118.29 176.53 5.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.041 1.737 . . . . 0.0 111.51 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.51 146.42 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.753 1.621 . . . . 0.0 109.859 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 27.1 m -119.73 90.8 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.867 1.267 . . . . 0.0 110.027 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -109.11 140.4 42.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 0.0 110.958 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.485 HG13 ' HB ' ' B' ' 224' ' ' THR . 3.0 p -136.14 94.23 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 127.906 2.482 . . . . 0.0 109.68 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.3 167.69 18.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.683 1.193 . . . . 0.0 113.032 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -94.23 152.3 40.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.07 0.948 . . . . 0.0 110.303 166.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.28 113.87 3.24 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.377 2.718 . . . . 0.0 110.887 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.74 -52.47 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.506 2.138 . . . . 0.0 112.333 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.17 -176.02 3.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.631 2.772 . . . . 0.0 109.865 177.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.12 140.26 41.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.62 1.168 . . . . 0.0 111.269 165.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.37 177.31 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.227 2.211 . . . . 0.0 111.411 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . 0.26 10.2 p . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.363 1.865 . . . . 0.0 111.713 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.481 0 CA-C-O 119.594 -0.559 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m -123.37 -15.72 7.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.486 1.115 . . . . 0.0 113.928 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.81 -20.51 66.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 112.824 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -63.93 -20.88 66.18 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.802 1.241 . . . . 0.0 114.244 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.56 -23.27 37.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.872 0.869 . . . . 0.0 112.955 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.61 151.77 42.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.114 0.966 . . . . 0.0 111.97 170.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -152.16 168.34 25.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.716 1.606 . . . . 0.0 111.083 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.69 174.28 8.41 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.071 1.748 . . . . 0.0 112.543 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.76 151.95 46.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.902 0.881 . . . . 0.0 113.218 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.56 -23.89 67.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.836 0.855 . . . . 0.0 112.725 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.19 -26.15 42.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -93.79 -21.05 19.54 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.175 0.99 . . . . 0.0 112.424 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.0 128.11 35.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.685 1.194 . . . . 0.0 111.752 168.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -104.75 176.0 5.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.9 1.28 . . . . 0.0 111.313 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG13 ' H ' ' A' ' 18' ' ' GLU . 14.7 p -140.89 154.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.516 1.127 . . . . 0.0 112.065 176.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -57.98 -44.52 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.579 1.552 . . . . 0.0 112.214 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.31 -26.39 68.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.921 0.888 . . . . 0.0 113.045 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.47 ' H ' HG13 ' A' ' 15' ' ' VAL . 12.1 tt0 -77.23 -60.41 2.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.146 1.379 . . . . 0.0 109.837 172.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.5 t -48.97 -42.6 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.789 1.636 . . . . 0.0 112.518 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -66.91 -9.55 39.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.703 1.601 . . . . 0.0 114.247 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -107.56 -32.46 7.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.275 1.83 . . . . 0.0 112.613 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -50.24 -44.52 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.248 1.019 . . . . 0.0 110.09 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.51 -45.41 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -50.34 62.53 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.458 1.027 . . . . 0.0 111.575 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -33.53 75.83 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.37 68.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.788 0.835 . . . . 0.0 112.406 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 HG11 ' A' ' 48' ' ' VAL . 61.7 mt -58.86 -57.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.889 0.768 . . . . 0.0 110.179 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -63.94 -25.14 68.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -66.71 -50.21 63.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.571 -0.706 . . . . 0.0 111.611 166.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.01 65.66 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.567 1.547 . . . . 0.0 114.217 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.13 -30.28 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 127.389 2.276 . . . . 0.0 112.059 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.69 -14.69 0.01 OUTLIER Glycine 0 C--O 1.279 2.967 0 N-CA-C 120.662 3.025 . . . . 0.0 120.662 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.24 -42.3 49.01 Favored Glycine 0 N--CA 1.482 1.702 0 C-N-CA 127.761 2.6 . . . . 0.0 115.772 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.47 -168.76 3.14 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.224 2.012 . . . . 0.0 111.896 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.79 -170.46 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.955 2.502 . . . . 0.0 112.798 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -74.28 103.82 4.82 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 119.978 -1.701 . . . . 0.0 111.192 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -122.99 88.52 2.94 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.021 1.328 . . . . 0.0 113.514 -174.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -64.96 -16.06 62.92 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.7 p -79.4 -31.56 42.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.988 1.715 . . . . 0.0 115.408 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -61.89 -15.39 42.32 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.159 1.784 . . . . 0.0 114.366 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.1 t -49.62 -31.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.754 1.622 . . . . 0.0 113.262 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -60.51 -53.36 58.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.947 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -67.94 -26.56 66.02 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.362 -0.837 . . . . 0.0 112.317 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -76.86 -52.66 9.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 111.223 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 t -59.0 -28.62 66.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 112.692 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -79.06 -59.36 2.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.156 0.889 . . . . 0.0 112.337 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.07 -38.02 78.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.781 1.173 . . . . 0.0 114.016 -172.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG11 HG13 ' A' ' 27' ' ' ILE . 89.2 t -70.82 -59.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 C-N-CA 123.691 0.796 . . . . 0.0 110.574 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.61 -30.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.12 0.968 . . . . 0.0 110.835 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.22 -28.41 70.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.01 -42.86 3.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.063 1.745 . . . . 0.0 112.385 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 m -54.97 -54.18 46.11 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.552 2.341 . . . . 0.0 113.016 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -39.06 93.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.125 0.42 . . . . 0.0 110.675 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -58.22 -52.02 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.308 0.643 . . . . 0.0 111.456 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.47 -47.62 83.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.391 2.276 . . . . 0.0 113.598 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.3 -25.51 63.36 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.667 -1.271 . . . . 0.0 114.403 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.1 m -61.76 -24.44 66.82 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.645 -0.659 . . . . 0.0 111.299 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -91.03 -19.89 22.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.76 -22.2 59.94 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.598 0.759 . . . . 0.0 112.729 162.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.89 -154.65 28.8 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.227 1.87 . . . . 0.0 112.143 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -90.8 161.57 35.59 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.847 1.659 . . . . 0.0 112.317 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.35 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.813 3.009 . . . . 0.0 112.384 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.45 165.26 32.65 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.543 1.537 . . . . 0.0 112.123 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -75.36 93.61 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.584 1.554 . . . . 0.0 111.241 170.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -68.52 162.77 24.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.619 -0.676 . . . . 0.0 111.378 163.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.3 150.72 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.618 1.567 . . . . 0.0 108.905 163.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.8 148.13 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.219 1.008 . . . . 0.0 111.117 164.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -140.24 156.3 46.54 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.13 1.372 . . . . 0.0 110.161 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.6 p -143.88 146.38 32.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.759 1.623 . . . . 0.0 111.968 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 124.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.997 1.319 . . . . 0.0 108.006 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.2 112.31 37.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 127.937 2.495 . . . . 0.0 107.332 -169.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.2 tpt -140.53 146.96 38.81 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.35 1.46 . . . . 0.0 111.169 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -95.3 130.11 42.18 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.628 1.171 . . . . 0.0 112.727 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -69.45 -10.11 56.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.324 1.85 . . . . 0.0 114.454 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.74 -20.61 35.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.744 2.017 . . . . 0.0 114.294 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.3 -1.5 3.03 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.124 1.345 . . . . 0.0 114.913 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 155.55 27.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.902 1.351 . . . . 0.0 111.626 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.82 160.32 31.83 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.084 0.85 . . . . 0.0 113.289 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 168.68 22.0 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.082 1.753 . . . . 0.0 112.586 -173.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -121.76 132.46 54.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 110.695 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 m -139.08 146.08 40.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.361 1.464 . . . . 0.0 109.729 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.95 146.38 30.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.39 0.676 . . . . 0.0 111.377 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.4 p -148.18 151.14 35.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 t -79.24 11.08 3.07 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' B' ' 209' ' ' ILE . 3.8 m -63.86 173.2 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.384 -0.823 . . . . 0.0 112.648 173.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -162.94 154.88 18.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.876 2.071 . . . . 0.0 109.931 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -76.83 147.62 37.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.207 1.003 . . . . 0.0 110.474 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.2 81.29 0.69 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -62.56 1.54 Allowed 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.522 -1.361 . . . . 0.0 113.315 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 p -97.07 -11.04 24.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.918 1.687 . . . . 0.0 113.117 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -47.8 21.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.251 1.42 . . . . 0.0 112.726 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -154.46 -47.63 0.09 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.02 111.36 1.4 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-N 120.35 1.432 . . . . 0.0 115.145 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -146.37 163.85 34.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.49 1.516 . . . . 0.0 112.352 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.1 t -156.46 149.37 23.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.203 1.801 . . . . 0.0 110.608 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 t -142.67 142.79 32.11 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.73 -1.856 . . . . 0.0 111.138 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.4 107.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.137 0.975 . . . . 0.0 109.995 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -92.17 124.01 35.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.106 0.962 . . . . 0.0 112.437 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -131.21 136.95 48.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.101 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.98 164.36 12.56 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 111.795 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -138.23 -178.73 5.41 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.871 1.668 . . . . 0.0 110.018 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.25 -49.59 60.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.061 2.545 . . . . 0.0 114.193 -175.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.5 t -136.45 0.77 2.55 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.173 1.389 . . . . 0.0 113.282 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.4 ptp -132.84 176.88 8.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.86 1.664 . . . . 0.0 111.958 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -136.09 147.47 47.84 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.98 1.312 . . . . 0.0 110.694 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.21 69.66 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.964 1.306 . . . . 0.0 110.786 -163.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.53 138.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.323 1.049 . . . . 0.0 111.325 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.09 145.15 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.688 1.595 . . . . 0.0 111.613 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.26 120.98 16.35 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.912 1.285 . . . . 0.0 110.469 -166.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.93 136.74 52.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.132 1.773 . . . . 0.0 112.711 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.23 117.27 17.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.165 1.386 . . . . 0.0 108.372 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.04 73.15 0.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.113 1.34 . . . . 0.0 112.945 -163.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.02 119.76 18.68 Favored 'General case' 0 C--O 1.273 2.331 0 C-N-CA 125.243 1.417 . . . . 0.0 111.544 -165.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.3 t -141.13 79.38 1.69 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.372 1.558 . . . . 0.0 114.042 -165.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.3 -12.77 3.41 Favored 'Isoleucine or valine' 0 C--O 1.267 2.025 0 C-N-CA 125.27 1.428 . . . . 0.0 113.993 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.13 0.69 89.61 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 126.882 2.182 . . . . 0.0 115.421 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.66 9.0 2.36 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.95 18.99 10.64 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.754 1.777 . . . . 0.0 115.942 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -117.39 71.73 0.82 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 125.829 1.651 . . . . 0.0 112.105 -163.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' HA2' HG23 ' A' ' 15' ' ' VAL . . . 78.72 1.08 82.8 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.016 1.166 . . . . 0.0 116.016 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -78.93 64.85 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -165.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.2 p -161.44 -11.53 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.46 -169.83 18.94 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.256 2.36 . . . . 0.0 111.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.12 138.05 38.87 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.715 2.277 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.07 166.95 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.652 1.181 . . . . 0.0 111.454 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 172.54 12.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.896 1.678 . . . . 0.0 112.526 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 166.88 9.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.453 1.101 . . . . 0.0 112.449 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.36 -175.62 37.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.734 1.159 . . . . 0.0 112.973 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -138.35 164.0 30.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.453 1.901 . . . . 0.0 111.041 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.13 77.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.342 1.057 . . . . 0.0 112.328 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -129.36 164.2 24.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.277 1.031 . . . . 0.0 112.334 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.5 mm -49.02 137.49 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 128.408 2.683 . . . . 0.0 112.053 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 93.7 m -100.49 92.01 4.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.981 1.312 . . . . 0.0 110.598 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -89.12 150.54 22.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.213 167.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.29 103.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.46 2.304 . . . . 0.0 109.007 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.51 130.2 40.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 111.153 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.76 90.58 47.65 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.548 1.539 . . . . 0.0 108.487 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 166.22 28.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.052 2.501 . . . . 0.0 111.886 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.71 -56.15 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.781 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -165.39 170.2 14.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 129.317 3.047 . . . . 0.0 109.333 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.89 136.22 43.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.098 0.559 . . . . 0.0 110.757 164.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 164.64 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.08 1.752 . . . . 0.0 111.499 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 125.979 1.712 . . . . 0.0 110.907 174.532 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.457 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -121.55 -14.89 8.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.277 1.431 . . . . 0.0 113.69 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.53 -20.69 66.37 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 112.847 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.15 -20.81 66.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.802 1.241 . . . . 0.0 114.26 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.74 -23.33 36.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 112.916 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.52 152.47 42.97 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.127 0.971 . . . . 0.0 111.873 169.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -151.58 169.34 22.35 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.701 1.6 . . . . 0.0 111.074 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.49 174.65 8.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.095 1.758 . . . . 0.0 112.498 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.69 153.16 43.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.01 0.924 . . . . 0.0 112.942 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.99 -27.79 68.4 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.413 -0.804 . . . . 0.0 112.411 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.06 -26.64 59.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 6.0 t -92.17 -19.45 22.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.997 0.919 . . . . 0.0 112.605 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.69 115.47 15.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.796 1.238 . . . . 0.0 112.242 173.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -84.96 179.23 7.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.517 1.127 . . . . 0.0 112.024 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.443 HG13 ' H ' ' B' ' 161' ' ' GLU . 8.1 p -144.25 156.7 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.343 -0.848 . . . . 0.0 113.049 169.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.9 -44.49 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.559 1.944 . . . . 0.0 111.969 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.08 -25.83 68.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.595 0.758 . . . . 0.0 113.035 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' GLU . . . . . 0.443 ' H ' HG13 ' B' ' 158' ' ' VAL . 11.4 tt0 -78.57 -59.5 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.259 1.423 . . . . 0.0 110.048 172.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -49.29 -43.58 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 126.359 1.864 . . . . 0.0 112.173 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -66.95 -9.29 36.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.469 1.508 . . . . 0.0 114.152 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -106.88 -32.44 7.91 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.21 1.804 . . . . 0.0 112.715 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 28.6 mt -50.37 -44.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.341 1.056 . . . . 0.0 110.057 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.44 -45.29 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -50.44 61.42 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.469 1.031 . . . . 0.0 111.574 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.12 74.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.32 66.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.745 0.818 . . . . 0.0 112.411 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.423 HG13 HG11 ' B' ' 191' ' ' VAL . 61.6 mt -58.99 -57.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.932 0.787 . . . . 0.0 110.101 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.75 -25.32 68.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -66.79 -50.05 63.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.693 -0.629 . . . . 0.0 111.553 166.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.71 -24.87 65.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.544 1.538 . . . . 0.0 114.235 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 mt -56.12 -30.3 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 127.415 2.286 . . . . 0.0 111.916 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -41.31 -13.61 0.01 OUTLIER Glycine 0 C--O 1.28 3.012 0 N-CA-C 120.656 3.023 . . . . 0.0 120.656 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.14 -42.01 54.46 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 127.724 2.583 . . . . 0.0 115.574 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.34 -168.82 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.35 2.075 . . . . 0.0 111.966 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.57 -170.63 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.929 2.492 . . . . 0.0 112.832 165.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.2 102.59 4.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.032 -1.668 . . . . 0.0 111.245 -172.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -122.94 88.36 2.92 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.098 1.359 . . . . 0.0 113.202 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.32 -21.24 65.11 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.0 p -77.67 -27.81 50.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.375 1.87 . . . . 0.0 115.175 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -64.34 -15.64 60.74 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.389 1.475 . . . . 0.0 114.111 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.55 -29.45 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.742 1.617 . . . . 0.0 114.538 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -60.64 -52.69 64.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.522 1.055 . . . . 0.0 112.434 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -68.12 -26.56 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.499 -0.751 . . . . 0.0 112.248 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -77.04 -52.93 8.48 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.866 0.866 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -58.92 -28.26 66.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.997 0.919 . . . . 0.0 112.755 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 5.9 t -79.22 -60.19 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.148 0.885 . . . . 0.0 112.355 167.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -58.55 -37.47 75.77 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.89 1.223 . . . . 0.0 114.033 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.423 HG11 HG13 ' B' ' 170' ' ' ILE . 89.0 t -71.01 -59.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 123.682 0.793 . . . . 0.0 110.42 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 92.4 t -48.65 -31.1 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.095 0.958 . . . . 0.0 110.819 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.18 -27.73 69.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.72 -43.02 3.51 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.043 1.737 . . . . 0.0 112.331 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.2 m -55.01 -54.18 46.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.64 2.376 . . . . 0.0 113.064 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.94 93.19 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.204 0.456 . . . . 0.0 110.66 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 11.3 t -58.49 -51.71 68.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.31 0.644 . . . . 0.0 111.52 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.57 -48.15 81.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.441 2.297 . . . . 0.0 113.505 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.66 -25.31 63.85 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.662 -1.273 . . . . 0.0 114.37 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.9 m -62.19 -24.82 67.43 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.708 -0.62 . . . . 0.0 111.278 166.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -89.99 -21.33 22.46 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.74 -22.19 60.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.841 0.856 . . . . 0.0 113.011 162.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -153.53 26.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.274 1.892 . . . . 0.0 112.212 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -93.66 157.21 38.7 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.532 1.533 . . . . 0.0 112.281 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 112.75 3.3 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.934 3.089 . . . . 0.0 112.104 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -147.4 159.33 43.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.712 1.205 . . . . 0.0 112.217 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -68.8 79.67 0.3 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.326 2.251 . . . . 0.0 111.661 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -60.95 159.02 12.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.979 0.895 . . . . 0.0 111.087 163.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 209' ' ' ILE . . . . . 0.409 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.0 tt -137.25 153.22 28.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 125.952 1.701 . . . . 0.0 108.831 166.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 19.2 m -141.49 147.12 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.703 1.201 . . . . 0.0 109.869 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -138.42 157.71 45.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.792 1.237 . . . . 0.0 109.405 168.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 32.0 p -145.82 152.66 39.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 112.124 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.7 128.75 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.961 1.304 . . . . 0.0 108.247 -176.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.9 mm -119.87 114.08 42.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 128.093 2.557 . . . . 0.0 106.809 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 36.2 tpp -140.19 148.37 41.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.499 1.52 . . . . 0.0 111.161 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -97.65 128.15 44.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.014 1.326 . . . . 0.0 112.36 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.78 -9.07 48.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.449 1.9 . . . . 0.0 114.452 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -57.27 -21.36 33.89 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.104 2.161 . . . . 0.0 114.412 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 -2.76 3.35 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.963 1.268 . . . . 0.0 115.102 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.9 164.46 14.94 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.81 1.305 . . . . 0.0 111.93 169.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -173.81 162.65 33.49 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.025 0.821 . . . . 0.0 113.425 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.21 171.84 16.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.998 1.719 . . . . 0.0 113.063 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -120.69 133.4 55.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.403 0.681 . . . . 0.0 111.055 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 19.2 m -138.22 147.01 43.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.426 1.09 . . . . 0.0 110.296 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -143.98 146.5 32.95 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.719 -0.613 . . . . 0.0 111.359 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 95.6 p -147.98 151.21 35.4 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 11.53 2.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.7 m -63.72 173.5 1.72 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.869 0.843 . . . . 0.0 112.342 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.08 156.78 22.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.835 2.054 . . . . 0.0 109.793 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.21 138.15 45.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 0.0 109.617 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -145.6 104.82 3.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.895 1.278 . . . . 0.0 111.472 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 39.2 t -78.5 -75.7 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.019 -1.051 . . . . 0.0 111.033 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 64.8 p -85.81 -19.17 31.07 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.209 1.403 . . . . 0.0 113.068 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -41.99 80.3 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.096 1.759 . . . . 0.0 112.94 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -153.07 -77.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.62 1.168 . . . . 0.0 113.124 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 161.07 105.46 0.2 Allowed Glycine 0 CA--C 1.538 1.527 0 O-C-N 120.659 -1.276 . . . . 0.0 114.566 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 77.3 p -137.72 162.15 34.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.8 1.24 . . . . 0.0 112.775 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.3 t -157.12 155.17 30.59 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.987 1.715 . . . . 0.0 110.221 171.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.0 t -148.36 145.07 27.93 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 119.803 -1.811 . . . . 0.0 111.003 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.62 118.9 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -106.17 123.29 47.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.565 1.146 . . . . 0.0 112.256 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -130.63 140.01 50.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.603 1.561 . . . . 0.0 110.974 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.5 159.74 15.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.77 . . . . 0.0 111.624 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -133.68 178.42 6.95 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.437 1.895 . . . . 0.0 110.251 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -48.57 57.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.466 2.706 . . . . 0.0 113.837 -176.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.8 t -137.28 0.67 2.34 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.11 1.364 . . . . 0.0 113.288 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.6 ptp -131.62 178.94 6.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.807 1.643 . . . . 0.0 111.994 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.106 1.362 . . . . 0.0 110.458 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 8.3 p -141.02 71.77 1.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 0.0 111.014 -164.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.99 140.59 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.112 0.965 . . . . 0.0 111.683 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.88 139.25 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.271 1.829 . . . . 0.0 110.935 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 36.1 p -130.93 139.09 50.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.43 1.092 . . . . 0.0 112.173 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -127.19 138.86 53.22 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.044 1.738 . . . . 0.0 112.783 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -132.96 109.01 9.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.094 1.357 . . . . 0.0 109.042 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.06 66.24 0.58 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.579 2.038 . . . . 0.0 110.438 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.453 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.6 OUTLIER -62.37 142.52 57.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 111.184 -169.299 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.08 130.17 11.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 258' ' ' ILE . . . . . 0.402 HD13 ' H ' ' B' ' 258' ' ' ILE . 0.2 OUTLIER -112.7 -7.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.46 1.904 . . . . 0.0 113.538 179.118 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.93 43.73 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.309 1.909 . . . . 0.0 114.369 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.41 58.29 0.44 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.139 1.352 . . . . 0.0 112.715 -175.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.55 -160.01 29.25 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.405 1.002 . . . . 0.0 112.308 170.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 53.0 m -51.48 148.4 5.16 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.102 0.961 . . . . 0.0 113.321 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.94 3.56 63.86 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.896 1.236 . . . . 0.0 115.149 -172.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -122.8 56.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.107 1.453 . . . . 0.0 113.235 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 57.3 p -161.83 -27.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -144.6 -172.6 15.27 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.486 2.47 . . . . 0.0 111.898 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.3 137.87 44.88 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.936 2.424 . . . . 0.0 112.509 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 48.9 pt -78.2 166.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 111.659 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 172.69 12.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.104 1.762 . . . . 0.0 112.348 173.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.46 166.63 10.01 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.34 1.056 . . . . 0.0 112.443 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -167.83 -175.38 37.57 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.713 1.149 . . . . 0.0 113.124 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 1.4 mtt -138.76 165.35 27.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.471 1.908 . . . . 0.0 111.107 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.9 78.01 1.65 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 0.0 112.095 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -128.94 163.71 24.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 112.24 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.3 mm -49.49 135.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 128.053 2.541 . . . . 0.0 111.921 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.5 m -97.55 88.02 4.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.921 1.288 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -85.58 150.46 24.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.626 -0.671 . . . . 0.0 110.777 164.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.95 107.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.578 1.951 . . . . 0.0 109.687 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.69 133.48 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.506 1.123 . . . . 0.0 111.027 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -127.86 90.31 48.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.448 1.499 . . . . 0.0 108.361 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.04 166.08 29.13 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.238 2.625 . . . . 0.0 111.869 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.85 -55.76 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.244 2.629 . . . . 0.0 112.811 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -165.64 170.25 14.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.261 3.025 . . . . 0.0 109.332 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.7 136.15 43.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.982 0.513 . . . . 0.0 110.829 164.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.66 164.17 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.149 1.78 . . . . 0.0 111.479 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 125.78 1.632 . . . . 0.0 110.944 174.314 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -68.4 162.02 26.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.679 1.191 . . . . 0.0 112.167 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.98 -49.58 62.99 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.937 0.895 . . . . 0.0 112.824 176.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -76.27 -12.01 60.01 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -80.96 -24.73 37.88 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.287 -0.883 . . . . 0.0 112.379 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -63.12 143.15 58.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.488 0.661 . . . . 0.0 111.259 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -135.11 -177.44 4.64 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.905 1.682 . . . . 0.0 110.64 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.24 9.96 21.75 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.623 1.569 . . . . 0.0 113.759 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.31 -1.81 7.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -172.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -59.28 -15.81 17.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.557 1.543 . . . . 0.0 114.355 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -21.94 26.22 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -73.29 -24.55 60.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.601 1.161 . . . . 0.0 113.893 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.04 157.19 31.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.719 0.808 . . . . 0.0 111.466 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.42 164.37 12.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.784 0.833 . . . . 0.0 112.122 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.14 158.07 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.809 0.844 . . . . 0.0 112.358 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.76 -39.86 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.835 2.054 . . . . 0.0 112.92 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.22 -22.99 63.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.003 0.921 . . . . 0.0 113.097 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -96.86 -51.17 4.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.038 0.935 . . . . 0.0 111.972 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.1 t -48.59 -38.06 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.008 1.323 . . . . 0.0 112.464 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 t -63.9 -13.68 47.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.045 1.738 . . . . 0.0 114.298 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -101.8 -38.14 7.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.899 2.08 . . . . 0.0 111.976 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -51.71 -42.44 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.067 0.849 . . . . 0.0 110.866 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.92 -42.41 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.6 -0.688 . . . . 0.0 112.804 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.86 49.52 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 111.121 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -30.71 70.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.04 -44.66 38.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.541 0.736 . . . . 0.0 112.966 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 -58.01 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.061 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.27 -29.56 70.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.64 -46.81 86.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.834 0.854 . . . . 0.0 112.181 168.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.01 -35.57 80.91 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.32 -48.23 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.918 1.287 . . . . 0.0 109.907 172.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.43 12.79 74.93 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.389 0.995 . . . . 0.0 114.662 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 3.39 38.61 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.684 1.434 . . . . 0.0 116.684 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.98 146.25 43.22 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.696 1.748 . . . . 0.0 111.085 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.62 -160.39 0.15 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.914 1.286 . . . . 0.0 111.876 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -47.73 136.64 10.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.297 1.039 . . . . 0.0 111.617 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -136.7 179.16 6.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.775 1.63 . . . . 0.0 111.375 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.97 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.335 1.054 . . . . 0.0 112.226 165.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.9 p -47.31 -0.54 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.179 2.591 . . . . 0.0 117.821 168.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.22 -39.5 2.98 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.666 2.386 . . . . 0.0 113.31 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.77 -29.52 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.368 1.467 . . . . 0.0 113.193 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.95 -49.36 75.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.668 1.187 . . . . 0.0 112.312 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.56 -25.41 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.471 -0.768 . . . . 0.0 112.638 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.09 -54.1 7.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.893 0.769 . . . . 0.0 111.393 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.06 -24.27 62.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.771 0.829 . . . . 0.0 112.651 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.3 t -83.32 -59.71 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.407 1.003 . . . . 0.0 113.033 166.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -58.44 -38.78 78.18 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.987 1.315 . . . . 0.0 113.896 -172.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.65 -62.87 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 C-N-CA 124.309 1.044 . . . . 0.0 109.623 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -48.92 -30.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.414 1.486 . . . . 0.0 111.051 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -59.33 -34.35 72.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -112.71 -36.34 5.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.632 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.8 m -59.92 -51.74 68.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.757 2.023 . . . . 0.0 111.816 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -43.38 98.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 111.057 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -66.79 -26.2 66.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -75.31 -51.98 11.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.262 2.225 . . . . 0.0 113.271 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.59 -25.89 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -59.61 -33.93 72.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.144 0.577 . . . . 0.0 110.493 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -79.59 -28.6 41.05 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mt -61.95 -32.3 72.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.58 -99.62 2.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.711 1.148 . . . . 0.0 113.269 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -135.95 146.31 56.24 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.86 1.664 . . . . 0.0 113.092 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.53 99.11 1.01 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.296 3.33 . . . . 0.0 112.32 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -140.62 167.89 21.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.615 1.566 . . . . 0.0 111.823 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -61.52 129.27 40.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.77 1.228 . . . . 0.0 110.543 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -115.09 152.16 33.02 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.09 1.756 . . . . 0.0 110.167 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -151.98 157.3 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.514 1.526 . . . . 0.0 109.283 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.28 152.14 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.236 1.814 . . . . 0.0 109.055 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -128.86 144.41 51.17 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.079 1.352 . . . . 0.0 108.315 161.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.2 p -137.57 154.22 49.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.724 0.773 . . . . 0.0 111.688 167.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.41 114.47 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.779 1.231 . . . . 0.0 109.605 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -107.26 97.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 126.165 1.786 . . . . 0.0 106.596 -177.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -154.63 90.07 1.29 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 112.592 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -151.6 142.57 23.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.832 2.053 . . . . 0.0 108.698 160.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -158.03 -62.61 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.38 1.472 . . . . 0.0 111.242 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -115.04 -9.51 12.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.764 1.626 . . . . 0.0 114.303 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.67 2.31 57.46 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.28 1.419 . . . . 0.0 115.254 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -177.34 2.24 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.118 1.459 . . . . 0.0 112.261 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.16 -173.12 41.54 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.444 1.021 . . . . 0.0 114.13 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.87 174.02 10.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.079 2.552 . . . . 0.0 110.543 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -98.42 100.82 12.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.281 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -111.94 142.65 44.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 108.744 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 145.44 32.49 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 111.193 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.7 p -139.96 143.69 36.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 122.086 0.946 . . . . 0.0 112.097 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -81.72 16.2 1.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.102 0.961 . . . . 0.0 112.056 170.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 25.0 m -64.3 161.5 16.61 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.198 -0.939 . . . . 0.0 112.044 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -160.01 138.25 10.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.149 1.38 . . . . 0.0 111.995 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -70.12 146.69 50.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.16 0.584 . . . . 0.0 110.503 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -140.45 160.3 40.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.183 1.393 . . . . 0.0 110.925 168.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -117.52 -64.4 1.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.055 1.342 . . . . 0.0 112.223 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 t -86.5 -39.77 15.94 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.788 0.835 . . . . 0.0 112.163 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -53.87 52.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.134 1.774 . . . . 0.0 111.589 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -142.44 176.3 9.12 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.503 2.721 . . . . 0.0 109.542 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.33 140.57 15.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.989 0.804 . . . . 0.0 112.117 172.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -143.42 149.44 37.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.42 . . . . 0.0 110.282 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.26 108.97 4.02 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.09 0.956 . . . . 0.0 111.48 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 t -100.97 143.25 31.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.895 0.878 . . . . 0.0 111.729 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.39 128.87 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.441 1.896 . . . . 0.0 109.245 -168.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -121.64 122.18 39.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.937 1.695 . . . . 0.0 112.063 -170.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -133.49 117.49 17.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.688 1.595 . . . . 0.0 110.767 -175.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.77 167.5 21.28 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.348 -0.845 . . . . 0.0 112.946 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -151.39 -175.16 5.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.079 1.352 . . . . 0.0 111.375 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.83 -59.21 2.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.601 1.96 . . . . 0.0 113.347 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.2 t -138.13 -35.58 0.62 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.807 1.643 . . . . 0.0 112.846 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.9 ptp -100.33 89.85 4.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.932 1.293 . . . . 0.0 112.797 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.29 155.87 8.35 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.53 -0.731 . . . . 0.0 111.661 173.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.587 ' CB ' HD12 ' A' ' 71' ' ' ILE . 2.8 p -127.51 135.76 50.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.936 1.294 . . . . 0.0 111.066 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.65 122.43 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.491 1.517 . . . . 0.0 110.258 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.92 138.13 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.292 1.837 . . . . 0.0 108.756 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -127.52 107.48 9.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.416 1.086 . . . . 0.0 110.431 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.56 147.74 25.19 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.242 1.017 . . . . 0.0 112.388 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 8.0 m-85 -136.78 118.58 15.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.217 2.207 . . . . 0.0 108.959 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.42 100.74 0.93 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.719 2.104 . . . . 0.0 110.423 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.04 145.41 36.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.646 1.178 . . . . 0.0 111.882 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 t -151.86 120.63 6.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.8 -47.21 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.466 1.106 . . . . 0.0 109.148 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.89 -23.93 77.31 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.318 0.961 . . . . 0.0 115.219 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.08 92.01 Favored Glycine 0 CA--C 1.539 1.593 0 CA-C-N 118.732 1.266 . . . . 0.0 114.201 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.99 88.02 0.38 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.139 1.828 . . . . 0.0 113.888 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -122.86 177.99 5.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.204 2.602 . . . . 0.0 112.364 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.87 21.3 2.94 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.691 1.139 . . . . 0.0 114.733 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -55.74 -176.76 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 128.783 2.833 . . . . 0.0 114.416 171.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -57.1 -37.64 72.22 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.25 162.04 47.61 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.666 0.65 . . . . 0.0 112.984 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.1 169.76 18.59 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.349 2.699 . . . . 0.0 112.544 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.81 144.76 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.517 1.527 . . . . 0.0 111.386 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 157.07 47.53 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 167.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -139.47 161.81 36.59 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.529 2.732 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.56 -171.21 31.09 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.239 0.924 . . . . 0.0 114.234 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.6 ptp -66.56 176.57 1.86 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.225 1.01 . . . . 0.0 112.908 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.3 170.84 15.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.488 1.515 . . . . 0.0 112.813 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.94 161.33 29.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.277 1.831 . . . . 0.0 111.7 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.98 153.04 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.939 1.695 . . . . 0.0 110.259 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 100.0 m -121.86 94.32 4.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.313 1.445 . . . . 0.0 110.844 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -88.15 149.79 23.69 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.241 -0.912 . . . . 0.0 111.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.26 94.44 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 127.69 2.396 . . . . 0.0 108.521 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.98 165.56 27.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.11 1.364 . . . . 0.0 112.378 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.16 90.23 41.27 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.214 1.405 . . . . 0.0 109.944 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.78 115.94 4.5 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.309 2.673 . . . . 0.0 110.707 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.48 -33.46 6.84 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.5 2.133 . . . . 0.0 112.829 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -155.84 173.3 16.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.301 3.04 . . . . 0.0 109.821 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -70.46 141.93 51.99 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.999 0.52 . . . . 0.0 111.269 166.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.59 172.33 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.412 1.885 . . . . 0.0 111.081 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.617 1.967 . . . . 0.0 110.697 177.341 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 19.6 m -67.22 161.46 24.76 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.486 1.114 . . . . 0.0 112.24 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -52.2 -49.36 64.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.777 0.831 . . . . 0.0 112.879 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -76.28 -11.85 59.98 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -80.99 -24.43 37.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.31 -0.869 . . . . 0.0 112.472 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -63.28 143.52 57.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.579 0.704 . . . . 0.0 111.121 168.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -135.04 -176.73 4.35 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.93 1.692 . . . . 0.0 110.614 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.68 9.84 19.29 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.659 1.584 . . . . 0.0 113.739 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.34 -2.3 8.12 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -58.99 -16.42 18.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.808 1.643 . . . . 0.0 114.228 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -21.72 25.06 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 167.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -72.44 -25.14 61.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.569 1.148 . . . . 0.0 113.74 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.8 155.36 31.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.436 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.75 159.07 15.23 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 0.0 111.935 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.66 158.9 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.551 1.141 . . . . 0.0 111.267 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.81 -35.54 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.82 2.048 . . . . 0.0 113.383 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.33 -23.05 66.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.864 0.866 . . . . 0.0 113.039 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -86.49 -54.52 4.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.901 1.28 . . . . 0.0 110.643 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 162' ' ' VAL . . . . . 0.451 HG22 HD23 ' B' ' 199' ' ' LEU . 39.8 t -53.91 -38.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.087 1.355 . . . . 0.0 112.577 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.1 t -61.19 -11.36 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.286 1.834 . . . . 0.0 114.258 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -107.4 -36.9 6.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.879 1.671 . . . . 0.0 112.317 168.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.8 mt -51.11 -40.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.508 1.049 . . . . 0.0 111.25 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.81 -41.18 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.462 -0.774 . . . . 0.0 113.058 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -49.28 51.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.901 1.228 . . . . 0.0 111.646 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -29.62 70.11 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.29 -44.67 28.88 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.407 ' HA ' HG21 ' B' ' 191' ' ' VAL . 71.6 mt -58.06 -58.73 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.221 0.918 . . . . 0.0 110.052 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.14 -29.49 70.38 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -62.89 -46.38 88.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.789 0.836 . . . . 0.0 112.059 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.24 79.8 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.3 -47.96 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.936 1.294 . . . . 0.0 109.946 172.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.14 12.89 75.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.395 0.998 . . . . 0.0 114.685 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.48 40.3 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -60.12 146.43 43.22 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 119.671 1.735 . . . . 0.0 111.115 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.68 -160.29 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.982 1.313 . . . . 0.0 111.789 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -47.93 137.48 9.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.269 1.028 . . . . 0.0 111.748 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -137.09 179.44 6.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.732 1.613 . . . . 0.0 111.426 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -63.48 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.508 1.123 . . . . 0.0 112.185 164.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 42.0 p -47.16 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.284 2.634 . . . . 0.0 117.925 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.76 -39.56 3.81 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.815 2.446 . . . . 0.0 113.442 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.18 -28.79 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.199 1.4 . . . . 0.0 113.169 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.63 -49.55 74.73 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.71 1.204 . . . . 0.0 112.354 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.58 -25.76 65.94 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.516 -0.74 . . . . 0.0 112.666 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -75.63 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.887 0.767 . . . . 0.0 111.452 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.0 t -59.65 -22.95 62.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.769 0.828 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -84.24 -59.64 2.33 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.477 1.035 . . . . 0.0 113.19 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -58.32 -38.62 77.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.99 1.316 . . . . 0.0 114.03 -172.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' B' ' 170' ' ' ILE . 88.0 t -66.45 -62.65 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 124.393 1.077 . . . . 0.0 109.591 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.96 -30.4 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.473 1.509 . . . . 0.0 110.953 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.21 -33.07 70.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -114.62 -35.48 4.86 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.654 1.581 . . . . 0.0 112.824 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 54.2 m -61.58 -48.3 81.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.984 2.114 . . . . 0.0 112.079 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' B' ' 199' ' ' LEU . 0.2 OUTLIER -62.79 -45.16 93.95 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.455 0.645 . . . . 0.0 110.642 176.027 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 83.0 p -66.18 -25.26 66.86 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.137 -0.977 . . . . 0.0 113.375 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -75.79 -54.53 6.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.438 2.295 . . . . 0.0 113.155 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -64.8 -26.28 68.28 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.744 1.156 . . . . 0.0 113.433 -172.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -56.99 -40.57 76.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.325 0.65 . . . . 0.0 110.835 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -73.87 -29.07 61.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.784 0.834 . . . . 0.0 112.637 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 5.2 mt -62.49 -31.98 72.81 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -97.9 2.1 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.767 1.175 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -136.78 146.74 56.48 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.776 1.631 . . . . 0.0 112.98 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.23 97.27 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.202 3.268 . . . . 0.0 112.203 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.15 167.67 21.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.506 1.522 . . . . 0.0 111.838 172.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -61.77 131.35 49.6 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.887 1.275 . . . . 0.0 110.754 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -116.96 152.33 34.79 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.259 1.824 . . . . 0.0 110.296 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.7 tt -152.81 157.41 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.38 152.56 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.451 1.9 . . . . 0.0 109.225 165.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 2.1 p -127.27 144.05 51.12 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.025 1.33 . . . . 0.0 108.353 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 20.1 p -138.12 155.83 48.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.959 0.885 . . . . 0.0 112.01 168.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.46 125.21 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.374 1.07 . . . . 0.0 109.877 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' B' ' 249' ' ' CYS . 2.2 mm -115.82 98.32 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.027 2.131 . . . . 0.0 107.18 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -116.26 152.66 33.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.444 1.497 . . . . 0.0 110.48 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.97 147.6 32.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.813 0.816 . . . . 0.0 112.483 -175.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -75.9 1.23 15.68 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.937 1.695 . . . . 0.0 114.292 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -64.97 -13.17 56.78 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.52 5.26 61.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.965 1.269 . . . . 0.0 115.348 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.2 -169.89 0.69 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.566 1.183 . . . . 0.0 112.185 169.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.85 -170.54 42.86 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.071 -1.018 . . . . 0.0 114.152 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.69 -171.44 2.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.341 2.256 . . . . 0.0 111.449 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -114.36 94.79 4.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.462 0.705 . . . . 0.0 110.232 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.475 ' HB ' HG13 ' B' ' 278' ' ' VAL . 23.3 m -106.67 142.35 36.46 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.891 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.88 141.21 38.58 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.425 0.69 . . . . 0.0 110.638 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 25.0 p -135.98 140.27 43.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.119 0.962 . . . . 0.0 111.714 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.9 t -80.44 14.99 1.77 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.828 0.851 . . . . 0.0 111.993 171.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 228' ' ' CYS . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 254' ' ' PHE . 13.2 m -64.66 161.77 17.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.214 -0.929 . . . . 0.0 112.017 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.09 139.02 10.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.85 146.59 51.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.725 -0.61 . . . . 0.0 110.343 174.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -139.88 159.32 42.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.247 1.419 . . . . 0.0 110.726 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 43.3 t -117.1 -64.58 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.09 1.356 . . . . 0.0 112.228 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.5 t -86.78 -39.64 15.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.796 0.839 . . . . 0.0 112.095 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -54.29 47.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 111.614 -174.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -142.11 176.55 8.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.465 2.706 . . . . 0.0 109.631 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.03 140.57 15.2 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.046 0.831 . . . . 0.0 112.229 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 150.05 39.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.289 1.436 . . . . 0.0 110.276 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.4 t -148.44 107.59 3.89 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.143 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.7 t -98.8 142.69 30.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.861 0.864 . . . . 0.0 111.527 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 123.41 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 109.075 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -115.14 119.16 35.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.853 1.661 . . . . 0.0 111.339 -172.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.7 148.55 49.0 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.14 1.376 . . . . 0.0 110.514 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.12 165.49 11.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.816 1.246 . . . . 0.0 111.355 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.72 -176.06 5.46 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.78 1.232 . . . . 0.0 110.521 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.27 -67.09 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.127 1.771 . . . . 0.0 113.017 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -139.53 4.97 2.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.072 1.749 . . . . 0.0 113.405 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 23.9 ptp -133.99 82.01 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 111.992 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -58.15 147.23 30.76 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.361 -0.837 . . . . 0.0 111.379 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' B' ' 214' ' ' ILE . 4.4 p -134.47 116.54 15.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.275 1.03 . . . . 0.0 111.991 -171.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.8 pt -117.14 130.16 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.615 1.166 . . . . 0.0 111.188 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.59 139.05 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.721 2.008 . . . . 0.0 108.691 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.3 t -129.83 109.82 11.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.344 1.058 . . . . 0.0 110.655 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.11 148.0 23.91 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.185 0.994 . . . . 0.0 112.243 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 254' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' B' ' 228' ' ' CYS . 8.7 m-85 -136.3 119.13 16.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.122 2.169 . . . . 0.0 108.952 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.03 100.09 0.91 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.662 2.077 . . . . 0.0 110.304 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.24 145.69 36.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.624 1.17 . . . . 0.0 111.734 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -151.93 122.06 7.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.02 -47.04 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.631 1.172 . . . . 0.0 109.149 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.69 -23.67 77.72 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.3 0.952 . . . . 0.0 115.185 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 58.02 39.57 92.15 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.762 1.281 . . . . 0.0 114.148 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -71.14 87.35 0.39 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.07 1.795 . . . . 0.0 113.882 -175.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 97.8 p -121.98 178.36 4.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.02 2.528 . . . . 0.0 112.358 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 121.56 21.44 3.0 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.724 1.154 . . . . 0.0 114.523 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -55.09 -178.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.849 2.86 . . . . 0.0 114.418 171.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -57.51 -36.61 71.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -79.92 162.75 46.96 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 123.734 0.683 . . . . 0.0 112.99 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.19 169.85 18.49 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.297 2.665 . . . . 0.0 112.512 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.9 pt -119.5 145.07 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.591 1.556 . . . . 0.0 111.352 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 157.31 46.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.606 1.162 . . . . 0.0 112.961 167.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 72.1 mt -139.65 162.01 36.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.589 2.755 . . . . 0.0 109.444 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -171.44 31.03 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.269 0.938 . . . . 0.0 114.23 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 12.7 ptp -66.51 176.52 1.85 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.195 0.998 . . . . 0.0 112.906 171.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.89 15.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.443 1.497 . . . . 0.0 112.711 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.69 161.24 29.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.342 1.857 . . . . 0.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.19 152.34 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.833 1.653 . . . . 0.0 110.269 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 98.3 m -120.92 91.57 3.56 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.475 1.51 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -86.47 150.74 24.06 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.475 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.2 p -141.08 100.11 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.754 2.022 . . . . 0.0 109.344 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.38 166.97 23.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.724 1.61 . . . . 0.0 111.69 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 88.79 27.24 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.901 1.28 . . . . 0.0 109.588 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 115.52 4.26 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.129 2.552 . . . . 0.0 110.777 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 -34.26 5.99 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.562 2.175 . . . . 0.0 112.739 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -156.58 173.9 16.24 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.554 3.141 . . . . 0.0 109.738 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.94 141.93 52.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.992 0.517 . . . . 0.0 111.197 166.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 172.07 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.456 1.902 . . . . 0.0 111.137 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.575 1.95 . . . . 0.0 110.688 177.294 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -85.26 1.74 46.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.85 1.26 . . . . 0.0 113.814 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -3.43 6.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -16.48 2.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.374 2.27 . . . . 0.0 116.12 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.92 -21.77 66.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.465 1.106 . . . . 0.0 113.628 170.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -137.49 -171.14 2.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.285 2.234 . . . . 0.0 111.157 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -142.71 142.56 32.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.956 0.903 . . . . 0.0 112.144 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.77 -177.99 3.96 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.691 1.996 . . . . 0.0 112.198 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.65 46.37 0.12 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.797 1.639 . . . . 0.0 114.001 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -61.22 -20.09 62.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 119.988 -1.695 . . . . 0.0 112.738 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.3 -24.94 61.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.4 t -103.7 -21.56 13.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.572 1.149 . . . . 0.0 112.962 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 164.75 5.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.191 0.996 . . . . 0.0 113.665 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.0 152.45 48.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.318 1.047 . . . . 0.0 113.419 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.46 161.56 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.423 1.889 . . . . 0.0 111.421 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.478 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 63.7 t -61.03 -35.55 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.642 1.977 . . . . 0.0 111.56 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.35 4.83 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.98 1.312 . . . . 0.0 114.008 172.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -109.23 -59.79 1.85 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.8 -1.187 . . . . 0.0 107.888 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 16' ' ' VAL . 2.1 p -44.39 -42.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.192 1.797 . . . . 0.0 112.971 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 t -60.04 -11.65 6.38 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -115.57 -33.93 5.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.654 1.982 . . . . 0.0 112.308 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -41.84 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.144 0.977 . . . . 0.0 110.731 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.5 p -59.05 -42.85 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.413 -0.804 . . . . 0.0 112.7 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -53.14 33.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.158 0.89 . . . . 0.0 110.728 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -31.86 71.99 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.14 -42.3 38.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.535 0.734 . . . . 0.0 112.964 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 48' ' ' VAL . 65.0 mt -59.47 -56.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.284 0.947 . . . . 0.0 109.522 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.03 -28.88 70.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.5 t -62.52 -47.52 83.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.365 1.066 . . . . 0.0 112.299 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.78 76.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -32.1 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.887 1.275 . . . . 0.0 111.3 170.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.19 17.37 55.73 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.657 1.122 . . . . 0.0 114.709 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.22 21.53 77.76 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.659 1.123 . . . . 0.0 115.265 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -55.36 156.86 4.05 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 119.485 1.643 . . . . 0.0 112.569 171.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 -179.45 1.07 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.468 1.507 . . . . 0.0 112.391 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -47.56 141.71 4.95 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.606 1.562 . . . . 0.0 113.251 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -132.71 171.83 13.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.811 1.244 . . . . 0.0 112.586 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -91.65 -114.63 0.08 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 109.843 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -70.64 -1.01 9.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 114.985 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.4 -41.27 39.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.152 1.381 . . . . 0.0 113.629 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.5 -30.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 118.402 -0.809 . . . . 0.0 113.001 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.29 -55.03 32.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.787 1.176 . . . . 0.0 111.632 170.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.93 -25.35 67.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.86 -0.525 . . . . 0.0 112.405 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.39 -56.35 4.71 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.2 1.0 . . . . 0.0 111.45 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 t -57.41 -26.66 61.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.823 0.738 . . . . 0.0 112.76 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -81.29 -57.38 3.52 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.304 0.956 . . . . 0.0 112.811 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -60.24 -34.79 74.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.466 -1.397 . . . . 0.0 114.073 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 27' ' ' ILE . 83.6 t -70.33 -64.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.214 1.005 . . . . 0.0 109.368 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.17 -30.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.055 1.342 . . . . 0.0 111.002 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.5 -32.56 71.55 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -114.0 -35.46 5.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.496 1.519 . . . . 0.0 112.75 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.7 m -62.03 -51.36 68.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.073 2.149 . . . . 0.0 112.108 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -42.93 98.67 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.91 0.323 . . . . 0.0 110.691 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 p -66.51 -27.01 67.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -74.29 -50.49 18.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.532 2.333 . . . . 0.0 113.309 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.41 -29.81 70.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.2 1.364 . . . . 0.0 114.045 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.2 m -57.12 -27.96 62.27 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.162 0.985 . . . . 0.0 111.444 167.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.78 -28.17 19.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.78 -33.62 74.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.062 0.545 . . . . 0.0 109.852 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.1 -98.67 2.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.635 1.588 . . . . 0.0 112.403 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -134.27 121.06 15.23 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.661 1.185 . . . . 0.0 112.788 -173.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.72 107.1 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.006 3.138 . . . . 0.0 112.977 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -146.17 170.94 15.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.351 1.861 . . . . 0.0 112.13 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -76.5 81.16 3.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.521 1.529 . . . . 0.0 111.957 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.71 138.17 46.42 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.622 1.569 . . . . 0.0 110.162 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 154.46 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.405 1.482 . . . . 0.0 109.879 171.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.84 159.19 33.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 124.613 1.165 . . . . 0.0 110.826 162.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 p -136.04 146.76 47.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.249 1.019 . . . . 0.0 110.793 157.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.4 p -136.63 143.43 43.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.313 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.05 95.78 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.877 1.271 . . . . 0.0 108.345 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mm -91.34 114.13 28.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 tpt -137.61 161.54 36.19 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.34 1.456 . . . . 0.0 110.736 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -67.47 151.98 46.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.494 -0.754 . . . . 0.0 111.37 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 1.87 1.35 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.152 2.181 . . . . 0.0 115.002 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -56.24 -21.86 26.14 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.773 1.629 . . . . 0.0 114.299 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.99 34.15 70.6 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.955 0.788 . . . . 0.0 113.897 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -177.38 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.069 1.748 . . . . 0.0 113.779 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.83 47.47 3.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.086 1.327 . . . . 0.0 114.327 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.38 125.55 24.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.909 1.354 . . . . 0.0 109.463 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -120.22 92.58 3.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.199 1.0 . . . . 0.0 109.537 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' HG13 ' A' ' 135' ' ' VAL . 31.1 m -109.98 142.89 40.73 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.028 -1.045 . . . . 0.0 109.329 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.8 140.39 34.7 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.637 -0.665 . . . . 0.0 111.945 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -139.38 127.56 22.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 p -75.07 13.09 0.74 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.899 -1.126 . . . . 0.0 113.967 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 57.4 m -58.29 164.48 2.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.585 1.554 . . . . 0.0 112.694 170.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -167.14 138.52 3.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.954 1.702 . . . . 0.0 110.331 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -83.03 149.19 27.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.752 0.821 . . . . 0.0 110.872 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -142.09 159.0 43.11 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.364 1.865 . . . . 0.0 111.123 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.9 t -114.66 -64.12 1.36 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.716 1.206 . . . . 0.0 111.201 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -87.26 -18.04 31.16 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -41.46 12.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.753 1.621 . . . . 0.0 112.738 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -164.27 -171.68 2.48 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.458 1.903 . . . . 0.0 111.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.83 140.42 14.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.883 1.706 . . . . 0.0 114.83 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.9 p -155.87 158.04 37.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.462 1.905 . . . . 0.0 111.912 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 17.8 t -146.39 160.4 42.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.506 1.522 . . . . 0.0 111.026 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -148.83 144.82 27.2 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.145 -1.597 . . . . 0.0 111.24 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -134.89 102.64 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.809 1.244 . . . . 0.0 109.427 -170.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.28 104.52 16.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.823 1.249 . . . . 0.0 112.356 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -103.86 143.82 32.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.333 1.063 . . . . 0.0 110.725 170.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.03 147.8 33.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.365 1.866 . . . . 0.0 110.996 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -141.4 -172.3 3.48 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 112.195 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -58.51 2.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.865 2.466 . . . . 0.0 114.576 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.9 t -141.45 21.71 2.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.967 1.307 . . . . 0.0 113.438 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.1 150.21 45.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.384 1.474 . . . . 0.0 111.32 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.16 128.92 49.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.298 1.839 . . . . 0.0 109.645 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.8 p -137.72 82.55 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.208 1.004 . . . . 0.0 112.773 -172.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -109.8 133.45 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.027 0.931 . . . . 0.0 112.077 -173.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.54 146.33 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.226 1.81 . . . . 0.0 111.408 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -133.9 129.2 36.02 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.139 1.376 . . . . 0.0 110.067 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.82 135.92 53.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.67 1.988 . . . . 0.0 112.434 -169.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 90.7 m-85 -132.29 115.22 15.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.5 58.52 0.39 Allowed Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.862 1.696 . . . . 0.0 112.801 -167.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 113' ' ' LEU . 2.4 mm? -58.72 124.27 19.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 112.888 -168.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m -133.28 89.4 2.6 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.03 1.732 . . . . 0.0 111.739 -169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.62 -15.85 64.71 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.996 1.284 . . . . 0.0 115.651 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.77 12.73 65.04 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 118.713 1.256 . . . . 0.0 116.122 171.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.17 104.78 0.31 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.316 1.913 . . . . 0.0 114.5 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.8 p -52.06 138.62 24.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.037 2.135 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.15 31.3 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.156 1.36 . . . . 0.0 115.044 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -99.99 23.09 10.31 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.933 1.693 . . . . 0.0 113.555 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.1 t -130.25 -59.38 1.04 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.922 1.689 . . . . 0.0 112.27 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.69 -113.04 3.65 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.242 -1.31 . . . . 0.0 111.244 -173.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.92 138.99 38.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.572 2.181 . . . . 0.0 111.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.9 pp -92.9 131.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.108 1.363 . . . . 0.0 110.617 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.86 129.64 38.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.74 122.46 20.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.595 0.758 . . . . 0.0 110.16 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -160.57 163.89 34.28 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.245 1.402 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 56.9 ttm -119.05 115.78 25.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.789 1.236 . . . . 0.0 110.802 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 120.64 18.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.348 1.459 . . . . 0.0 111.298 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -128.96 173.11 10.71 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.51 142.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.365 1.466 . . . . 0.0 111.26 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.4 m -101.3 88.86 3.58 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.225 1.41 . . . . 0.0 110.295 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -79.96 147.9 31.42 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.26 -0.9 . . . . 0.0 110.788 164.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.444 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.7 OUTLIER -137.76 95.2 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.831 2.452 . . . . 0.0 108.743 175.244 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -139.35 169.49 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.556 1.142 . . . . 0.0 112.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.45 89.79 32.93 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.059 1.344 . . . . 0.0 110.127 174.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.33 165.95 30.63 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.17 2.58 . . . . 0.0 112.47 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.03 -38.32 7.36 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.986 2.457 . . . . 0.0 113.527 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -156.22 -65.98 0.11 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.997 1.319 . . . . 0.0 112.242 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.03 -179.0 6.4 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.161 1.784 . . . . 0.0 112.041 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 163.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.802 1.641 . . . . 0.0 112.097 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.5 t . . . . . 0 C--O 1.252 1.196 0 C-N-CA 127.186 2.194 . . . . 0.0 110.329 -179.724 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -84.31 2.01 42.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.37 1.468 . . . . 0.0 113.946 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -2.04 5.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.765 1.626 . . . . 0.0 115.245 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -54.99 -16.43 2.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.435 2.294 . . . . 0.0 115.939 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.41 -21.66 66.71 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.543 1.137 . . . . 0.0 113.598 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -137.78 -172.31 3.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.136 2.175 . . . . 0.0 111.531 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -140.14 142.55 35.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.598 1.159 . . . . 0.0 111.97 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.8 -179.74 4.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.93 2.092 . . . . 0.0 111.947 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.94 48.77 0.17 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.766 1.627 . . . . 0.0 113.967 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -61.86 -20.93 64.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.012 -1.68 . . . . 0.0 112.817 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -57.43 -21.93 39.92 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -106.7 -21.59 13.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 113.288 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 163.09 7.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.154 0.982 . . . . 0.0 113.509 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -127.5 154.76 44.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 113.308 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.43 158.6 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.295 1.838 . . . . 0.0 111.154 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.56 -37.52 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.157 1.783 . . . . 0.0 111.923 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.02 -22.87 66.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.366 1.066 . . . . 0.0 113.615 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -75.86 -59.16 2.88 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 169.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.16 -43.17 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.96 2.104 . . . . 0.0 112.588 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -60.38 -10.9 5.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.207 1.803 . . . . 0.0 114.695 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -114.25 -33.91 5.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.591 1.957 . . . . 0.0 112.244 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.0 mt -50.19 -42.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.843 0.857 . . . . 0.0 110.723 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.6 p -59.04 -42.65 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.389 -0.82 . . . . 0.0 112.736 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -52.73 37.11 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.222 0.919 . . . . 0.0 110.768 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -31.8 71.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.06 -42.41 38.43 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.613 0.765 . . . . 0.0 112.946 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 170' ' ' ILE . . . . . 0.413 ' HA ' HG21 ' B' ' 191' ' ' VAL . 65.1 mt -59.74 -57.02 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 119.4 1.0 . . . . 0.0 109.636 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.99 -28.53 70.16 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 t -62.64 -47.76 82.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.436 1.094 . . . . 0.0 112.281 168.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.37 -33.79 76.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -32.08 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.918 1.287 . . . . 0.0 111.392 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 62.08 17.3 55.18 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.665 1.126 . . . . 0.0 114.733 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 22.02 77.58 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.689 1.138 . . . . 0.0 115.314 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.29 157.25 3.73 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 119.386 1.593 . . . . 0.0 112.672 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.4 -179.69 1.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.384 1.474 . . . . 0.0 112.378 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -47.55 141.45 5.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.469 1.507 . . . . 0.0 113.256 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -132.33 171.75 13.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 112.444 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.57 -113.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 109.721 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 3.6 m -71.58 -1.03 12.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.242 1.817 . . . . 0.0 114.958 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -49.6 -40.92 40.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 113.626 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.9 -30.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.687 0.795 . . . . 0.0 112.868 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -62.57 -55.53 26.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.766 1.166 . . . . 0.0 111.87 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.3 -25.3 67.57 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.8 -0.562 . . . . 0.0 112.248 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -76.5 -56.17 4.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.342 1.057 . . . . 0.0 111.463 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.7 t -57.28 -26.62 61.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.936 0.789 . . . . 0.0 112.78 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.2 t -81.72 -57.78 3.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.171 0.896 . . . . 0.0 112.86 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.83 -34.78 73.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.279 1.4 . . . . 0.0 114.007 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' B' ' 170' ' ' ILE . 85.8 t -70.29 -64.12 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.105 0.962 . . . . 0.0 109.375 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -49.2 -30.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.135 1.374 . . . . 0.0 110.964 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -60.66 -32.63 71.81 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -113.59 -35.56 5.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.402 1.481 . . . . 0.0 112.797 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 48.3 m -61.63 -52.11 65.71 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.985 2.114 . . . . 0.0 111.919 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -42.48 99.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.008 0.367 . . . . 0.0 110.749 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 60.2 p -67.0 -27.17 67.21 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.84 -50.99 17.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.55 2.34 . . . . 0.0 113.247 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.96 -29.98 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.646 -1.284 . . . . 0.0 114.098 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 87.8 m -57.0 -28.31 62.33 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.154 0.982 . . . . 0.0 111.36 167.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -89.41 -28.11 19.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.95 -33.51 73.82 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.081 0.553 . . . . 0.0 109.897 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.96 -98.96 2.15 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.763 1.649 . . . . 0.0 112.398 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -134.12 121.07 15.41 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.729 1.212 . . . . 0.0 112.798 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.48 106.96 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.988 3.125 . . . . 0.0 112.709 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -146.97 172.17 14.11 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.369 1.868 . . . . 0.0 111.962 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -77.8 83.93 4.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.392 1.477 . . . . 0.0 111.854 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -74.53 142.12 44.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.306 1.443 . . . . 0.0 109.946 166.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.1 156.56 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.381 1.472 . . . . 0.0 110.129 170.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.34 159.3 28.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 110.379 165.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 19.1 p -136.93 151.23 48.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.111 157.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 18.3 p -141.12 150.4 42.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.92 1.288 . . . . 0.0 111.771 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.12 103.08 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.225 1.41 . . . . 0.0 108.341 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.491 HG23 ' HB3' ' B' ' 249' ' ' CYS . 1.4 mm -99.73 117.52 45.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.136 1.374 . . . . 0.0 107.989 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.0 tpt -142.2 147.74 37.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.654 0.781 . . . . 0.0 111.745 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -152.29 91.49 1.6 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.732 2.013 . . . . 0.0 109.646 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -59.44 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 175.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.99 -46.11 0.43 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.305 1.042 . . . . 0.0 113.665 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.51 -8.94 26.29 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.122 1.344 . . . . 0.0 115.412 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -140.01 79.02 1.69 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -171.67 21.1 0.07 OUTLIER Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 134.01 54.95 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.828 2.051 . . . . 0.0 111.572 -174.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -128.43 88.15 2.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.468 1.107 . . . . 0.0 109.3 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.571 ' HB ' HG13 ' B' ' 278' ' ' VAL . 55.5 m -107.09 142.32 36.94 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.699 -1.251 . . . . 0.0 109.579 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.25 138.03 39.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.27 0.628 . . . . 0.0 111.676 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 2.4 m -136.38 127.72 28.33 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -170.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 78.9 p -74.46 10.12 1.45 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 36.0 m -60.68 166.46 3.25 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 0.0 112.961 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -166.0 147.1 6.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.213 1.805 . . . . 0.0 110.42 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -86.44 151.53 23.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.718 0.807 . . . . 0.0 111.077 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.53 159.76 41.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.389 1.875 . . . . 0.0 112.916 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.6 t -125.18 -53.9 1.61 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.541 1.937 . . . . 0.0 112.223 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 79.2 p -104.22 -6.29 21.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.832 1.653 . . . . 0.0 113.635 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -42.74 9.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.675 1.59 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.16 -164.71 0.8 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.224 2.209 . . . . 0.0 110.611 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.82 142.5 13.96 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.373 1.463 . . . . 0.0 114.987 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 24.5 p -153.74 157.56 39.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.633 1.973 . . . . 0.0 111.997 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 19.3 t -145.22 160.27 41.73 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.786 1.634 . . . . 0.0 111.124 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 145.54 26.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.173 -1.579 . . . . 0.0 111.286 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.9 t -135.73 104.57 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.627 1.171 . . . . 0.0 109.333 -171.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.75 104.53 16.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.543 1.137 . . . . 0.0 112.126 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -98.64 140.09 33.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.227 1.013 . . . . 0.0 110.648 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.83 149.21 43.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.321 1.848 . . . . 0.0 111.018 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -143.24 -166.24 2.27 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.579 1.151 . . . . 0.0 111.398 -170.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -42.32 -61.05 1.28 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.778 2.431 . . . . 0.0 114.21 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.0 t -145.41 -6.13 0.64 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.135 1.374 . . . . 0.0 113.845 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 16.0 ptm -94.16 149.41 21.26 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.19 1.396 . . . . 0.0 110.118 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -131.83 134.49 45.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.67 1.588 . . . . 0.0 109.054 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.491 ' HB3' HG23 ' B' ' 214' ' ' ILE . 10.1 p -140.48 84.27 1.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.184 0.992 . . . . 0.0 112.07 -170.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.76 136.94 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.43 -0.793 . . . . 0.0 111.281 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.49 143.45 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.918 1.687 . . . . 0.0 110.508 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 t -131.39 127.16 36.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.694 1.198 . . . . 0.0 110.191 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -123.06 136.66 54.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.803 2.041 . . . . 0.0 112.548 -168.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.54 116.29 15.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.712 1.205 . . . . 0.0 109.146 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.98 60.8 0.34 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.68 1.61 . . . . 0.0 112.959 -166.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 256' ' ' LEU . . . . . 0.432 HD22 ' H ' ' B' ' 256' ' ' LEU . 1.8 mm? -61.73 126.95 29.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.932 1.293 . . . . 0.0 113.09 -166.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 66.6 m -135.32 86.6 2.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.153 1.781 . . . . 0.0 111.714 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -10.11 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -63.45 -17.72 60.15 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.002 1.286 . . . . 0.0 115.316 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.81 9.58 62.83 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -52.16 144.58 18.56 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.062 1.315 . . . . 0.0 114.506 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 82.4 p -61.63 173.42 0.98 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.216 1.406 . . . . 0.0 112.699 171.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 64.47 43.76 96.21 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.501 -0.749 . . . . 0.0 113.154 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -71.06 -149.6 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 126.712 2.005 . . . . 0.0 111.49 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 26.9 t -50.43 -39.86 48.75 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.478 -1.389 . . . . 0.0 112.924 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 121.83 -78.53 0.34 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.833 1.682 . . . . 0.0 112.319 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.73 144.28 59.1 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.04 2.493 . . . . 0.0 111.324 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.9 pp -95.09 128.46 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.837 1.255 . . . . 0.0 110.612 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.69 122.94 28.24 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.321 1.449 . . . . 0.0 110.415 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.96 123.14 19.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.494 0.717 . . . . 0.0 110.174 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.17 160.26 32.38 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.17 1.367 . . . . 0.0 112.157 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 57.0 ttm -116.8 114.95 24.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.9 1.28 . . . . 0.0 110.741 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.71 120.05 17.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.327 1.451 . . . . 0.0 111.297 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -129.28 173.37 10.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.697 1.599 . . . . 0.0 111.063 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 11.0 mm -56.79 144.13 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.429 1.492 . . . . 0.0 111.318 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 89.9 m -105.81 90.2 3.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.211 1.404 . . . . 0.0 110.255 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -82.76 149.82 27.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.451 -0.781 . . . . 0.0 111.021 164.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.571 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.5 p -141.29 94.69 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 127.819 2.448 . . . . 0.0 109.285 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.51 169.21 18.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.554 1.542 . . . . 0.0 112.144 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.87 91.74 31.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.741 1.217 . . . . 0.0 110.099 172.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.82 166.32 29.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.123 2.548 . . . . 0.0 112.474 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -38.62 6.46 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.969 2.446 . . . . 0.0 113.491 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -155.98 -65.99 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.062 1.345 . . . . 0.0 112.158 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.76 -179.33 6.54 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.134 1.774 . . . . 0.0 112.125 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.92 168.39 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.981 1.712 . . . . 0.0 111.971 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.683 1.993 . . . . 0.0 112.225 179.329 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.498 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 156.23 19.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.214 1.406 . . . . 0.0 112.407 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -82.51 -48.81 10.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.949 0.899 . . . . 0.0 112.34 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.23 -12.32 59.75 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -22.3 63.92 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.367 1.467 . . . . 0.0 113.306 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -69.57 132.21 45.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.15 0.886 . . . . 0.0 111.398 171.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -147.57 150.03 33.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.808 1.243 . . . . 0.0 111.597 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 9.01 38.67 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.971 1.708 . . . . 0.0 114.561 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.63 -10.45 8.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.893 1.677 . . . . 0.0 115.519 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -52.11 -22.09 3.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.661 1.984 . . . . 0.0 113.558 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -55.63 -22.7 23.85 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -73.36 -20.32 60.79 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.153 0.981 . . . . 0.0 113.524 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.28 146.43 54.95 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.187 -0.946 . . . . 0.0 111.191 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.96 155.49 30.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.79 0.836 . . . . 0.0 110.482 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.96 156.69 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.793 1.237 . . . . 0.0 110.49 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 19' ' ' VAL . 87.1 t -57.88 -43.4 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.575 1.55 . . . . 0.0 110.824 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 7.11 0.32 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.11 1.764 . . . . 0.0 114.058 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -122.2 -54.41 1.9 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 16' ' ' VAL . 6.7 p -45.55 -44.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.706 0.802 . . . . 0.0 112.808 166.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -62.73 -11.01 14.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -106.77 -38.24 6.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.874 2.07 . . . . 0.0 112.352 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mt -49.6 -41.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.135 1.374 . . . . 0.0 110.901 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.65 -41.78 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.4 -0.812 . . . . 0.0 112.903 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -51.23 57.86 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.571 1.078 . . . . 0.0 111.087 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -30.12 71.31 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.38 -40.72 29.45 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.094 0.957 . . . . 0.0 113.39 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.04 -55.75 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.275 0.943 . . . . 0.0 109.65 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.08 -31.44 70.01 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -58.64 -50.39 74.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.892 1.277 . . . . 0.0 112.149 167.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.32 -31.7 72.16 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.57 -37.08 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.529 1.132 . . . . 0.0 110.777 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 16.98 78.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.023 0.821 . . . . 0.0 114.165 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.86 79.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.052 1.311 . . . . 0.0 115.48 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.34 168.74 5.32 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.005 1.402 . . . . 0.0 113.635 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.74 -167.61 0.49 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.732 1.613 . . . . 0.0 113.387 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -52.35 149.66 5.41 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.848 1.659 . . . . 0.0 112.864 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -144.42 172.8 12.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.828 1.251 . . . . 0.0 112.463 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.68 -92.84 0.12 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.788 1.635 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -98.17 4.02 48.99 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.961 2.504 . . . . 0.0 113.881 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -49.38 -43.89 44.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.249 1.02 . . . . 0.0 112.641 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -52.07 -36.83 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.63 1.172 . . . . 0.0 113.19 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.2 -52.96 42.99 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.467 1.107 . . . . 0.0 112.201 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.59 -23.56 67.31 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.082 -1.011 . . . . 0.0 112.904 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -77.06 -55.67 5.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.951 1.301 . . . . 0.0 111.525 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 t -57.12 -29.16 63.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.619 0.645 . . . . 0.0 112.628 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -78.34 -58.8 3.06 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.247 0.93 . . . . 0.0 112.241 170.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -59.1 -41.28 87.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 113.972 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.44 -63.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.0 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.4 -29.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.628 1.171 . . . . 0.0 110.591 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.87 -38.9 76.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -107.33 -39.87 5.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.676 1.59 . . . . 0.0 112.155 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -60.49 -50.66 72.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.271 2.228 . . . . 0.0 112.542 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.465 ' HG ' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -65.7 -35.84 81.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.232 0.539 . . . . 0.0 111.44 177.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.6 t -63.06 -40.56 98.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.469 -0.769 . . . . 0.0 112.215 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -66.22 -49.15 68.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.891 2.076 . . . . 0.0 113.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.427 HD21 HD22 ' A' ' 53' ' ' LEU . 3.9 pp -65.85 -25.8 67.36 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.717 -1.239 . . . . 0.0 114.089 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.0 m -62.87 -23.51 67.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.452 1.101 . . . . 0.0 111.469 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -91.92 -24.52 19.26 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.155 0.982 . . . . 0.0 113.257 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.92 -22.32 66.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.928 1.291 . . . . 0.0 114.381 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.67 -130.42 3.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.29 1.424 . . . . 0.0 112.444 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -64.61 120.2 63.74 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.616 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.21 120.72 5.44 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.954 3.103 . . . . 0.0 112.385 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -163.91 -171.03 2.32 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.118 1.767 . . . . 0.0 112.277 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.95 123.79 36.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.062 1.345 . . . . 0.0 111.525 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 126.9 55.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.394 1.878 . . . . 0.0 109.353 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.18 148.25 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.124 0.97 . . . . 0.0 110.203 174.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG11 ' HG ' ' A' ' 53' ' ' LEU . 34.7 m -138.36 155.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.233 1.013 . . . . 0.0 111.256 167.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -140.41 155.27 46.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.997 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 p -146.21 149.49 34.04 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.469 1.128 . . . . 0.0 112.32 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.22 123.55 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.17 1.388 . . . . 0.0 109.082 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.5 98.67 7.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.565 1.946 . . . . 0.0 107.387 -174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 ttt -110.27 157.13 19.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 0.0 110.474 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.53 133.56 53.98 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.86 1.264 . . . . 0.0 110.988 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -64.81 -9.2 18.87 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.53 -19.16 23.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.241 1.816 . . . . 0.0 114.422 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.86 42.69 0.56 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.908 1.242 . . . . 0.0 113.905 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.4 74.25 1.57 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.254 1.021 . . . . 0.0 112.27 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.66 161.58 20.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.089 1.328 . . . . 0.0 115.113 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.0 -177.78 5.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.119 1.367 . . . . 0.0 113.52 -165.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -104.99 111.91 24.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.902 0.881 . . . . 0.0 110.161 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.443 ' HB ' HG13 ' A' ' 135' ' ' VAL . 59.2 m -112.18 144.87 40.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.108 1.363 . . . . 0.0 109.425 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.02 33.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.185 0.993 . . . . 0.0 112.004 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.0 p -142.62 138.76 30.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.081 0.943 . . . . 0.0 112.347 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -81.88 17.73 1.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.797 0.839 . . . . 0.0 112.034 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.564 ' SG ' HD11 ' B' ' 209' ' ' ILE . 39.8 m -61.78 173.9 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.762 1.268 . . . . 0.0 111.676 165.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.03 149.86 14.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.854 2.062 . . . . 0.0 109.289 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -83.56 134.66 34.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.722 0.809 . . . . 0.0 109.193 170.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -138.14 119.26 14.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 109.646 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.93 -47.0 4.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.058 1.743 . . . . 0.0 113.826 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 t -106.39 -22.36 12.83 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.806 1.242 . . . . 0.0 112.979 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -30.52 30.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.007 1.723 . . . . 0.0 112.999 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.44 -165.99 1.15 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.124 2.17 . . . . 0.0 110.103 -178.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.06 147.06 16.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.425 1.012 . . . . 0.0 113.073 170.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 p -162.79 150.98 14.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.923 1.289 . . . . 0.0 111.42 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 29.7 p -156.47 172.2 18.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.749 1.22 . . . . 0.0 112.246 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -154.4 150.75 28.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.358 1.063 . . . . 0.0 111.41 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.66 134.5 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.2 1.4 . . . . 0.0 109.562 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -123.61 125.74 45.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.06 1.344 . . . . 0.0 111.621 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -135.29 120.0 18.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.783 1.633 . . . . 0.0 109.938 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -82.16 153.28 26.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.335 -0.853 . . . . 0.0 111.803 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -120.74 -170.51 2.01 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 109.047 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -51.66 -54.14 31.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.0 t -138.14 -22.0 1.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.038 1.335 . . . . 0.0 114.319 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.1 ptp -92.29 177.63 6.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.807 1.243 . . . . 0.0 111.483 168.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -142.29 145.95 34.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 109.828 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 24.6 p -128.17 130.44 48.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.402 1.081 . . . . 0.0 110.869 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.05 133.39 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.157 0.983 . . . . 0.0 109.664 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.28 129.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 126.006 1.723 . . . . 0.0 109.665 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 p -126.49 148.79 49.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 67' ' ' VAL . . . -135.34 131.92 37.0 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.5 1.52 . . . . 0.0 110.973 -171.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -130.7 114.35 15.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.072 0.939 . . . . 0.0 110.031 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.05 84.05 0.49 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.638 1.59 . . . . 0.0 110.613 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.98 126.91 36.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.359 1.064 . . . . 0.0 112.737 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 t -147.26 116.3 6.87 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.032 1.333 . . . . 0.0 112.632 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -16.96 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.89 -15.54 69.31 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.814 1.197 . . . . 0.0 114.759 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.26 20.32 67.21 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 118.638 1.219 . . . . 0.0 115.245 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.61 51.22 3.35 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.135 1.826 . . . . 0.0 114.817 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.5 m -136.97 167.21 21.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.882 2.073 . . . . 0.0 111.899 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.04 18.14 6.96 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.694 1.14 . . . . 0.0 115.713 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -73.03 49.25 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.167 2.187 . . . . 0.0 113.781 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.9 p -144.6 7.18 1.27 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.817 1.647 . . . . 0.0 113.36 -172.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.66 -109.0 2.68 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.756 2.122 . . . . 0.0 111.636 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.85 141.17 64.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.609 2.206 . . . . 0.0 111.895 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.74 124.37 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.361 1.064 . . . . 0.0 111.201 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.32 147.52 40.16 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.705 -1.247 . . . . 0.0 111.55 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.9 mt -84.85 131.79 34.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.622 1.569 . . . . 0.0 110.182 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 158.23 105.87 0.22 Allowed Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.094 0.854 . . . . 0.0 113.188 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 68.8 mtm -67.89 156.73 36.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.372 1.069 . . . . 0.0 112.698 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.87 83.93 1.87 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.93 1.692 . . . . 0.0 111.712 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -118.96 170.78 8.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.541 0.736 . . . . 0.0 112.106 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.95 127.8 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.139 1.776 . . . . 0.0 111.493 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.3 m -97.62 101.54 13.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.914 1.686 . . . . 0.0 110.619 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -92.8 147.37 22.91 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.733 -1.229 . . . . 0.0 111.203 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -137.92 113.42 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.771 2.428 . . . . 0.0 109.505 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.08 141.77 42.37 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.317 -0.864 . . . . 0.0 112.15 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -140.04 94.62 8.81 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.099 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 164.74 33.87 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.6 -59.43 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.652 2.901 . . . . 0.0 112.865 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -158.58 -60.51 0.08 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.205 1.802 . . . . 0.0 110.305 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -89.2 -176.41 5.1 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.2 1.8 . . . . 0.0 111.952 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.57 161.74 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.636 1.974 . . . . 0.0 111.354 173.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 126.513 1.925 . . . . 0.0 110.641 179.315 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.18 157.38 17.17 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 0.0 112.453 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -83.18 -48.87 10.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.144 0.978 . . . . 0.0 112.38 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.17 -12.22 59.45 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 -22.26 64.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.438 1.495 . . . . 0.0 113.34 173.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -69.49 132.33 46.13 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.118 0.872 . . . . 0.0 111.38 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -147.26 151.1 36.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.895 1.278 . . . . 0.0 111.611 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.48 9.36 40.34 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.009 1.724 . . . . 0.0 114.53 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.75 -10.34 8.61 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -52.0 -22.51 4.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.674 1.99 . . . . 0.0 113.587 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -55.2 -22.4 17.45 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -74.65 -20.39 59.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.409 1.084 . . . . 0.0 113.757 174.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.25 150.08 48.84 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.97 -1.082 . . . . 0.0 111.186 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -65.56 164.81 13.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.311 0.577 . . . . 0.0 111.272 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.46 155.5 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.861 1.265 . . . . 0.0 110.633 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.02 -41.78 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.16 0.984 . . . . 0.0 111.61 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -25.57 68.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.92 1.288 . . . . 0.0 113.406 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -56.51 4.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.361 1.465 . . . . 0.0 110.635 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -50.81 -44.3 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.874 1.27 . . . . 0.0 112.198 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -62.06 -13.45 26.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.741 1.217 . . . . 0.0 113.621 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -100.64 -39.67 7.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.743 2.017 . . . . 0.0 112.353 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -50.85 -42.55 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.98 1.312 . . . . 0.0 110.905 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.24 -41.78 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.433 -0.792 . . . . 0.0 112.857 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -51.32 58.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.69 1.132 . . . . 0.0 111.249 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -30.29 71.44 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.54 -39.9 30.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.986 0.914 . . . . 0.0 113.448 175.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.57 -55.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.302 0.956 . . . . 0.0 109.572 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.0 -31.56 70.03 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 3.0 t -58.33 -50.45 73.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.779 1.232 . . . . 0.0 112.211 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.6 72.1 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.61 -37.22 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.504 1.121 . . . . 0.0 110.871 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.988 0.804 . . . . 0.0 114.303 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.48 17.48 77.65 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.063 1.316 . . . . 0.0 115.621 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -65.24 172.98 2.74 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 118.934 1.367 . . . . 0.0 113.625 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.25 -160.54 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.377 1.471 . . . . 0.0 112.511 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -48.26 151.42 1.03 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.851 1.66 . . . . 0.0 113.083 165.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -147.8 172.3 14.34 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.983 1.313 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.51 -92.78 0.12 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.81 1.644 . . . . 0.0 111.383 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 2.0 p -98.26 3.99 48.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.981 2.512 . . . . 0.0 113.948 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.64 -43.87 47.12 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.075 -1.015 . . . . 0.0 112.619 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.9 -37.02 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.68 1.192 . . . . 0.0 113.132 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.17 -53.29 39.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.491 1.116 . . . . 0.0 112.177 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -64.26 -23.66 67.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.072 -1.018 . . . . 0.0 112.985 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.86 -55.93 5.05 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.978 1.311 . . . . 0.0 111.541 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 8.5 t -57.14 -27.89 62.26 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.603 0.638 . . . . 0.0 112.719 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.9 t -79.45 -60.03 2.52 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.388 0.995 . . . . 0.0 112.3 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -58.13 -41.24 83.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.28 1.4 . . . . 0.0 113.975 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.81 -63.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 124.874 1.269 . . . . 0.0 109.734 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.06 -29.31 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.047 1.339 . . . . 0.0 110.907 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -59.23 -37.25 77.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -109.1 -39.03 5.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.793 1.637 . . . . 0.0 112.118 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 52.4 m -61.7 -51.73 67.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.655 2.382 . . . . 0.0 112.4 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 196' ' ' LEU . . . . . 0.491 HD13 HD11 ' B' ' 199' ' ' LEU . 0.0 OUTLIER -65.91 -36.51 83.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 117.953 0.342 . . . . 0.0 110.823 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.1 t -59.3 -43.67 92.6 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.546 -0.721 . . . . 0.0 112.203 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.46 -51.62 62.18 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.366 2.267 . . . . 0.0 113.292 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 199' ' ' LEU . . . . . 0.491 HD11 HD13 ' B' ' 196' ' ' LEU . 4.4 pp -66.07 -27.24 67.92 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 22.9 m -59.13 -37.01 76.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.132 0.573 . . . . 0.0 109.995 168.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -77.25 -25.18 51.24 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . 0.297 0.0 OUTLIER -56.01 -26.2 47.71 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.967 1.707 . . . . 0.0 114.112 178.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -139.69 -82.77 0.09 OUTLIER Glycine 0 CA--C 1.535 1.295 0 CA-C-N 119.62 1.1 . . . . 0.0 114.425 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.15 172.62 3.4 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 125.97 1.708 . . . . 0.0 113.64 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.0 170.85 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 166.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -56.75 112.39 1.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.329 1.452 . . . . 0.0 112.899 172.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -177.75 100.97 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.255 2.622 . . . . 0.0 111.057 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -151.67 169.26 22.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.614 1.566 . . . . 0.0 110.497 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 209' ' ' ILE . . . . . 0.564 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.2 tt -133.58 155.57 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 108.92 157.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 210' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' B' ' 253' ' ' ALA . 35.1 m -136.17 152.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 123.861 0.865 . . . . 0.0 111.105 165.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 39.7 p -133.69 158.83 42.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.84 1.256 . . . . 0.0 110.266 170.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.87 156.75 42.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.336 1.065 . . . . 0.0 112.656 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.66 127.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.408 -0.808 . . . . 0.0 110.752 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' B' ' 249' ' ' CYS . 2.4 mm -119.22 98.29 6.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 127.094 2.158 . . . . 0.0 107.356 -169.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.7 ttt -105.61 156.22 18.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.456 1.102 . . . . 0.0 110.401 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -122.42 132.04 54.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.801 1.24 . . . . 0.0 110.8 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -64.45 -9.11 16.31 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -57.31 -20.72 30.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.432 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 123.72 40.86 0.44 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.688 1.137 . . . . 0.0 114.232 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.45 70.33 1.25 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.317 1.047 . . . . 0.0 112.575 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.31 155.32 16.38 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.468 1.509 . . . . 0.0 115.597 -173.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 178.35 9.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.937 1.695 . . . . 0.0 112.624 -166.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -108.79 110.61 22.02 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.386 1.075 . . . . 0.0 111.216 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 224' ' ' THR . . . . . 0.44 ' HB ' HG13 ' B' ' 278' ' ' VAL . 55.7 m -105.67 145.2 31.37 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.266 1.026 . . . . 0.0 109.207 173.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.88 33.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 111.044 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 94.1 p -137.55 143.71 41.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.203 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.4 t -84.55 15.77 3.56 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.782 0.833 . . . . 0.0 111.885 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 31.8 m -61.23 167.7 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.169 0.988 . . . . 0.0 111.636 166.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.6 147.29 21.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.693 1.997 . . . . 0.0 109.779 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -82.64 128.55 34.44 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 0.0 108.7 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -133.04 116.42 16.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.794 1.638 . . . . 0.0 109.302 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 -47.11 5.16 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.9 1.68 . . . . 0.0 114.41 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 16.7 t -106.43 -21.02 13.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.74 1.216 . . . . 0.0 112.977 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -29.81 29.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.45 1.9 . . . . 0.0 113.356 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.1 -167.65 1.54 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.0 2.52 . . . . 0.0 109.294 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.58 146.35 16.92 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.419 1.009 . . . . 0.0 112.906 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 29.7 p -160.64 147.28 15.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.976 1.31 . . . . 0.0 111.783 170.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 11.6 p -152.35 169.28 22.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.789 1.236 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 9.6 t -155.65 151.74 27.83 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.693 -1.254 . . . . 0.0 111.645 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.67 138.86 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.24 1.416 . . . . 0.0 109.817 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -127.3 127.56 44.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.057 1.343 . . . . 0.0 111.782 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -136.5 119.63 16.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 110.04 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -81.95 153.11 26.43 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.936 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -120.93 -170.67 2.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.52 1.528 . . . . 0.0 109.079 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -51.67 -54.85 23.64 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t -137.46 -21.57 1.16 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.958 1.303 . . . . 0.0 114.245 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 20.1 ptp -93.03 178.06 5.87 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.386 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -142.43 145.97 34.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.075 1.35 . . . . 0.0 109.63 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' CYS . . . . . 0.405 ' HB3' HD12 ' B' ' 214' ' ' ILE . 25.0 p -128.22 132.8 48.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.314 1.046 . . . . 0.0 110.888 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.61 138.26 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.124 0.969 . . . . 0.0 109.925 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.3 p -127.53 128.88 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.119 1.768 . . . . 0.0 110.07 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.5 p -123.23 148.93 45.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.672 1.189 . . . . 0.0 111.453 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 253' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -136.55 139.22 42.05 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.327 1.451 . . . . 0.0 112.698 -175.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.2 121.72 15.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.631 1.172 . . . . 0.0 109.572 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -111.69 82.03 0.3 Allowed Glycine 0 N--CA 1.469 0.859 0 C-N-CA 126.316 1.913 . . . . 0.0 111.863 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.87 105.34 17.27 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.706 1.202 . . . . 0.0 113.575 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.5 t -128.53 112.18 14.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.092 1.357 . . . . 0.0 112.532 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -17.99 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 114.681 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -67.35 -16.25 66.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.866 1.222 . . . . 0.0 114.798 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.43 15.86 66.52 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 118.694 1.247 . . . . 0.0 115.499 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.53 59.72 3.7 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.94 1.733 . . . . 0.0 114.153 -174.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 71.3 m -140.59 167.43 22.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.451 2.301 . . . . 0.0 111.325 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.7 19.43 6.52 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 115.761 1.064 . . . . 0.0 115.761 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -73.2 51.26 0.31 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.053 2.141 . . . . 0.0 113.734 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 80.1 p -147.96 6.79 0.8 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.537 1.535 . . . . 0.0 113.504 -170.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 77.13 -109.3 2.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.593 2.044 . . . . 0.0 111.675 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.56 141.81 68.56 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.658 2.239 . . . . 0.0 112.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.34 125.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.363 1.065 . . . . 0.0 111.26 173.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 148.92 43.76 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.246 -0.909 . . . . 0.0 111.826 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 29.4 mt -84.23 130.25 34.83 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.818 1.647 . . . . 0.0 110.028 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 159.6 100.75 0.16 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.969 0.795 . . . . 0.0 113.036 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 69.6 mtm -67.67 157.07 35.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.821 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -107.04 99.01 8.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.191 1.796 . . . . 0.0 111.045 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 274' ' ' LYS . . . . . 0.431 ' H ' ' HE2' ' B' ' 274' ' ' LYS 0.327 0.0 OUTLIER -127.34 177.04 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.209 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.17 129.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.176 0.99 . . . . 0.0 110.174 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 63.0 m -102.1 93.53 5.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.722 1.609 . . . . 0.0 109.953 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.89 149.59 24.7 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.329 -0.857 . . . . 0.0 111.081 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 278' ' ' VAL . . . . . 0.44 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.4 p -147.2 118.13 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.723 2.009 . . . . 0.0 109.974 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -138.64 143.97 39.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.561 1.144 . . . . 0.0 111.569 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.05 95.42 9.48 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.819 1.647 . . . . 0.0 108.799 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.23 164.73 33.95 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.818 2.345 . . . . 0.0 112.14 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.52 -59.15 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.514 2.809 . . . . 0.0 112.877 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -158.51 -60.6 0.08 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.16 1.784 . . . . 0.0 110.414 170.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.36 -176.61 5.13 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.237 1.815 . . . . 0.0 111.887 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.0 161.66 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.588 1.955 . . . . 0.0 111.363 173.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.677 1.991 . . . . 0.0 110.57 179.553 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.829 0 CA-C-O 121.291 0.567 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.25 178.57 5.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.83 1.252 . . . . 0.0 112.289 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.5 152.68 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.173 1.389 . . . . 0.0 110.916 171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.62 -43.42 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.731 1.212 . . . . 0.0 111.704 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.67 -29.85 68.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.101 1.36 . . . . 0.0 113.337 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.22 -57.34 4.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.101 0.96 . . . . 0.0 110.502 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.9 t -51.43 -40.45 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.74 1.216 . . . . 0.0 112.512 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -61.36 -19.76 62.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.76 1.624 . . . . 0.0 113.949 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.19 -35.55 10.34 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.731 1.612 . . . . 0.0 113.357 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mt -51.75 -38.88 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.277 1.031 . . . . 0.0 110.809 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 97' ' ' VAL . 9.9 p -64.1 -42.36 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.88 62.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.884 1.22 . . . . 0.0 111.299 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -32.47 71.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.3 -43.23 52.19 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.02 -55.41 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.616 1.098 . . . . 0.0 110.374 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.71 -29.77 70.96 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.422 -0.799 . . . . 0.0 113.138 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -61.24 -46.27 91.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.279 1.032 . . . . 0.0 112.236 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.34 93.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.144 0.977 . . . . 0.0 113.331 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.98 -48.0 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.254 1.021 . . . . 0.0 110.565 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.46 19.91 67.2 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.398 0.999 . . . . 0.0 115.01 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.14 20.46 77.4 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.918 1.247 . . . . 0.0 115.401 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.04 179.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 114.43 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.23 144.69 19.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.405 1.482 . . . . 0.0 113.32 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.65 121.04 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.819 1.248 . . . . 0.0 111.032 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.97 157.98 45.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.269 1.828 . . . . 0.0 111.112 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -106.44 -66.01 1.04 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.208 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -60.6 -18.51 53.42 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.943 1.297 . . . . 0.0 114.254 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.72 -38.96 79.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.036 -1.04 . . . . 0.0 113.191 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.08 -35.24 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.363 0.665 . . . . 0.0 111.943 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -62.12 -50.63 71.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.451 . . . . 0.0 111.341 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.95 -25.6 64.63 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -77.85 -54.26 6.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.01 0.823 . . . . 0.0 111.148 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -54.99 -36.08 65.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.678 0.672 . . . . 0.0 111.984 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -73.78 -56.86 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.345 0.975 . . . . 0.0 112.04 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -57.36 -40.27 77.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.98 1.312 . . . . 0.0 113.342 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.17 -63.64 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 C-N-CA 124.479 1.112 . . . . 0.0 110.524 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.76 -28.77 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.709 1.204 . . . . 0.0 110.788 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.87 -42.54 79.97 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.331 1.053 . . . . 0.0 112.667 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -103.41 -36.2 8.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.226 1.41 . . . . 0.0 112.592 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.9 m -62.89 -49.68 73.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.048 2.139 . . . . 0.0 112.355 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -36.7 83.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.709 0.404 . . . . 0.0 111.407 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 t -63.06 -42.86 99.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.486 0.714 . . . . 0.0 112.495 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -66.94 -49.38 65.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.045 1.738 . . . . 0.0 113.27 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.61 -28.03 68.83 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.68 -1.262 . . . . 0.0 113.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -57.59 -28.24 63.43 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.419 1.088 . . . . 0.0 111.151 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -89.75 -28.04 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.392 1.077 . . . . 0.0 113.285 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.85 -21.74 61.63 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.408 1.083 . . . . 0.0 112.463 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -134.72 8.61 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.373 1.94 . . . . 0.0 112.629 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -116.71 155.76 48.57 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 125.644 1.578 . . . . 0.0 112.578 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.38 114.16 3.15 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.856 3.037 . . . . 0.0 111.66 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.45 175.14 12.57 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.084 2.154 . . . . 0.0 110.808 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.74 100.42 7.08 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.231 1.413 . . . . 0.0 110.887 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.5 143.59 28.06 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.036 1.335 . . . . 0.0 109.949 168.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -133.44 153.4 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.464 1.505 . . . . 0.0 109.528 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.38 150.42 24.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.734 0.814 . . . . 0.0 111.084 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -133.78 136.67 44.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.331 1.453 . . . . 0.0 109.139 171.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 48.3 t -131.28 140.67 49.84 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.068 0.947 . . . . 0.0 111.159 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.49 101.31 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.543 1.537 . . . . 0.0 109.179 -168.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.22 95.88 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.288 1.435 . . . . 0.0 110.033 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.58 166.17 14.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.985 1.714 . . . . 0.0 112.815 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 119.47 22.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.683 1.193 . . . . 0.0 112.374 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -67.24 -11.29 57.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.084 1.354 . . . . 0.0 113.546 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -54.48 -28.61 46.0 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.996 1.719 . . . . 0.0 114.21 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.3 10.48 0.09 OUTLIER Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.05 97.82 4.57 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.107 1.454 . . . . 0.0 112.478 -165.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.31 169.08 25.96 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.197 1.856 . . . . 0.0 112.862 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.07 174.82 13.22 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.088 1.355 . . . . 0.0 113.319 -167.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.16 98.66 9.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.952 0.901 . . . . 0.0 112.08 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.481 ' HB ' HG13 ' A' ' 135' ' ' VAL . 48.3 m -95.29 139.82 31.07 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.212 -0.93 . . . . 0.0 109.637 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.06 111.77 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.949 1.7 . . . . 0.0 110.363 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 m -115.43 107.78 15.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 110.594 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -76.95 35.32 0.16 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.707 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.32 176.4 8.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.866 1.266 . . . . 0.0 111.412 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -141.17 137.63 32.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.278 1.431 . . . . 0.0 109.929 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -79.59 132.1 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.422 0.689 . . . . 0.0 109.803 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -142.68 149.0 38.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.372 1.469 . . . . 0.0 110.586 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -123.51 -60.47 1.47 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.176 1.39 . . . . 0.0 112.344 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -92.86 -26.79 17.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.017 0.927 . . . . 0.0 112.852 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -52.86 30.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.817 2.047 . . . . 0.0 113.317 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -146.87 173.87 12.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.769 2.427 . . . . 0.0 110.44 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.92 121.26 6.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.114 1.34 . . . . 0.0 113.359 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -146.85 144.84 29.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.456 1.502 . . . . 0.0 110.616 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.7 t -149.55 164.5 34.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.601 1.161 . . . . 0.0 111.184 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -162.96 150.48 13.35 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.178 -1.576 . . . . 0.0 111.143 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 23' ' ' VAL . 2.0 t -139.32 127.03 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.893 1.277 . . . . 0.0 110.113 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.76 111.74 17.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.04 1.336 . . . . 0.0 112.515 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -125.45 93.74 3.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.975 1.71 . . . . 0.0 110.678 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 151.83 29.4 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.685 1.194 . . . . 0.0 112.381 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -125.74 -175.22 3.28 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.915 1.686 . . . . 0.0 110.574 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -54.17 -50.22 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.032 1.333 . . . . 0.0 113.908 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -134.4 1.95 3.21 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.935 1.694 . . . . 0.0 113.895 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.26 156.97 32.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.292 2.237 . . . . 0.0 110.958 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -134.75 120.95 20.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.313 1.445 . . . . 0.0 110.815 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.2 m -126.16 98.31 5.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.218 1.007 . . . . 0.0 110.64 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 116.18 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.439 1.096 . . . . 0.0 111.882 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.12 137.38 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.471 1.908 . . . . 0.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -130.09 147.59 51.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.809 1.244 . . . . 0.0 111.349 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.99 140.01 39.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.796 1.639 . . . . 0.0 113.57 -170.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.55 113.61 13.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.549 1.14 . . . . 0.0 109.621 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.84 77.64 0.23 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.531 2.015 . . . . 0.0 110.734 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.06 108.92 2.8 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 111.232 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.47 0.542 0 C-N-CA 126.736 2.014 . . . . 0.0 111.115 -171.003 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 121.169 0.509 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.75 176.77 8.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.44 1.896 . . . . 0.0 111.106 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.06 139.66 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.621 1.568 . . . . 0.0 111.142 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -115.7 92.88 4.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.363 1.465 . . . . 0.0 110.787 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -76.27 149.45 37.12 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.872 -1.143 . . . . 0.0 111.218 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -137.11 108.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.427 2.291 . . . . 0.0 109.636 174.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -131.89 119.8 21.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.074 1.75 . . . . 0.0 109.645 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.78 0 C-N-CA 125.572 1.549 . . . . 0.0 109.902 173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 CA-C-O 121.22 0.533 . . . . 0.0 111.828 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -77.29 177.33 8.01 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.501 1.12 . . . . 0.0 112.361 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.0 152.59 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.26 1.424 . . . . 0.0 110.814 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.33 -43.2 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.0 -29.81 68.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.035 1.334 . . . . 0.0 113.357 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -73.71 -57.8 3.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 110.398 172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.6 -40.47 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.815 1.246 . . . . 0.0 112.505 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 29.3 t -61.22 -19.95 62.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.773 1.629 . . . . 0.0 113.963 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -97.96 -35.76 10.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.339 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.83 -38.69 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 110.866 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.418 HG21 HG21 ' B' ' 240' ' ' VAL . 10.0 p -64.15 -42.3 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -50.82 62.27 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.873 1.215 . . . . 0.0 111.263 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -32.47 71.14 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -43.27 52.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.95 -55.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.59 1.087 . . . . 0.0 110.336 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.64 -29.88 71.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.395 -0.816 . . . . 0.0 113.102 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.8 t -61.22 -46.3 90.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.231 1.013 . . . . 0.0 112.194 168.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.26 93.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.127 0.971 . . . . 0.0 113.319 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.97 -47.99 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.29 1.036 . . . . 0.0 110.529 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.43 19.96 67.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.391 0.996 . . . . 0.0 115.004 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.42 77.5 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.915 1.245 . . . . 0.0 115.407 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.02 179.45 0.91 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.98 1.312 . . . . 0.0 114.393 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.24 144.76 19.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.418 1.487 . . . . 0.0 113.334 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.71 120.98 15.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 110.982 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.92 157.88 45.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.321 1.848 . . . . 0.0 111.178 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -106.32 -65.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.476 1.111 . . . . 0.0 111.251 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -60.55 -18.51 52.89 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.923 1.289 . . . . 0.0 114.225 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.88 -38.86 79.78 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.981 -1.074 . . . . 0.0 113.207 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.12 -35.13 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.395 0.678 . . . . 0.0 111.982 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.16 -50.75 70.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.353 1.461 . . . . 0.0 111.277 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.89 -25.72 64.75 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -77.79 -54.29 6.52 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.012 0.824 . . . . 0.0 111.141 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -55.09 -35.71 64.89 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.64 0.655 . . . . 0.0 112.007 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -73.97 -57.34 4.04 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.372 0.987 . . . . 0.0 112.02 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.77 -40.13 75.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.037 1.335 . . . . 0.0 113.336 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.02 -63.87 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.489 1.116 . . . . 0.0 110.529 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.67 -28.9 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.741 1.217 . . . . 0.0 110.753 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.94 -41.82 78.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 0.0 112.725 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -104.12 -36.41 7.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.221 1.408 . . . . 0.0 112.514 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 35.2 m -62.59 -49.74 74.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.123 2.169 . . . . 0.0 112.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -37.15 84.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.858 0.463 . . . . 0.0 111.474 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.9 t -61.79 -46.43 89.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.438 0.695 . . . . 0.0 112.112 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -64.04 -49.36 72.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.063 1.745 . . . . 0.0 113.5 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.73 -28.21 68.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.734 -1.229 . . . . 0.0 113.595 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 82.1 m -58.3 -31.35 67.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.613 0.765 . . . . 0.0 110.85 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -84.95 -27.81 26.28 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.893 0.877 . . . . 0.0 113.088 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 27.7 mt -71.41 -20.75 62.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.502 1.121 . . . . 0.0 112.443 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.83 -136.26 9.27 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.702 2.096 . . . . 0.0 112.933 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -115.47 156.23 46.19 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.848 1.659 . . . . 0.0 112.427 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.75 110.85 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.879 3.053 . . . . 0.0 111.738 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.59 173.92 12.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.952 2.101 . . . . 0.0 110.892 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -74.31 96.2 2.79 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.074 1.35 . . . . 0.0 111.8 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -81.91 153.77 26.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.251 1.421 . . . . 0.0 111.413 164.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.26 153.72 10.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.939 2.096 . . . . 0.0 108.681 167.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.64 151.54 22.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.999 0.919 . . . . 0.0 110.912 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.5 p -132.82 137.56 46.79 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.232 1.413 . . . . 0.0 109.229 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 47.7 t -132.26 145.04 51.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.272 1.029 . . . . 0.0 111.124 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.16 106.73 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.625 1.57 . . . . 0.0 108.782 -167.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 mm -101.18 94.7 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.086 1.355 . . . . 0.0 109.688 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 166.27 14.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.014 1.725 . . . . 0.0 112.6 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.25 121.16 24.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.524 1.13 . . . . 0.0 112.571 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -67.95 -11.17 58.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.049 1.34 . . . . 0.0 113.582 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.25 -28.04 50.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 114.212 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.64 11.5 0.1 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.48 98.5 4.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 -166.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -143.27 169.26 25.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.27 1.89 . . . . 0.0 112.874 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.14 174.64 13.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.18 1.392 . . . . 0.0 113.252 -167.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.24 100.41 11.51 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.91 0.884 . . . . 0.0 112.093 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.566 ' HB ' HG13 ' B' ' 278' ' ' VAL . 79.6 m -96.8 139.61 32.59 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.085 -1.009 . . . . 0.0 109.803 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.53 110.18 12.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.848 1.659 . . . . 0.0 109.955 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 10.1 m -112.44 108.03 17.03 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.37 1.068 . . . . 0.0 110.292 -172.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.6 t -76.96 35.52 0.16 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.62 1.168 . . . . 0.0 112.673 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 2.5 m -84.88 175.91 8.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 0.0 111.622 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.2 137.21 32.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.326 1.45 . . . . 0.0 109.932 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -78.91 130.6 35.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.373 0.669 . . . . 0.0 109.704 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -139.85 145.44 38.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.61 1.564 . . . . 0.0 110.25 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 47.6 t -120.5 -61.74 1.54 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.097 1.359 . . . . 0.0 112.419 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 9.1 t -93.26 -25.0 17.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.093 0.957 . . . . 0.0 112.797 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -52.84 30.75 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.753 2.021 . . . . 0.0 112.968 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -148.7 174.49 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.744 2.418 . . . . 0.0 110.44 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.68 120.75 6.25 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.012 1.292 . . . . 0.0 113.514 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 52.6 m -146.39 144.51 29.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.418 1.487 . . . . 0.0 110.769 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 6.9 t -149.14 164.7 33.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.695 1.198 . . . . 0.0 111.179 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 2.9 t -163.12 150.61 13.16 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.166 -1.584 . . . . 0.0 111.11 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.418 HG21 HG21 ' B' ' 166' ' ' VAL . 2.0 t -139.38 127.27 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.919 1.288 . . . . 0.0 110.109 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.91 111.91 17.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.029 1.332 . . . . 0.0 112.536 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -125.51 94.13 4.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.958 1.703 . . . . 0.0 110.678 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.76 151.87 28.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 112.39 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -125.9 -175.18 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.86 1.664 . . . . 0.0 110.551 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -54.32 -50.02 68.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.112 1.365 . . . . 0.0 113.949 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -134.61 2.02 3.16 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.953 1.701 . . . . 0.0 113.895 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.27 156.97 32.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.232 2.213 . . . . 0.0 110.879 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.82 121.4 20.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.333 1.453 . . . . 0.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 15.9 m -126.28 98.57 5.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.258 1.023 . . . . 0.0 110.551 -175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 117.74 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.255 1.022 . . . . 0.0 111.85 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.0 137.99 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.558 1.943 . . . . 0.0 111.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.2 t -131.32 147.4 52.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.861 1.264 . . . . 0.0 111.382 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.44 38.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.725 1.61 . . . . 0.0 113.543 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.91 110.08 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -105.29 77.94 0.26 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.237 1.875 . . . . 0.0 110.669 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.73 108.69 2.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.402 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 126.792 2.037 . . . . 0.0 111.137 -171.013 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.352 0 CA-C-O 121.198 0.523 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.73 177.31 7.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.546 1.939 . . . . 0.0 111.098 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.08 139.33 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.561 1.544 . . . . 0.0 111.259 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.1 m -114.84 90.76 3.42 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.343 1.457 . . . . 0.0 110.562 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.95 149.99 37.57 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.814 -1.178 . . . . 0.0 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.6 p -143.17 108.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.607 1.963 . . . . 0.0 110.407 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -130.02 120.02 24.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.896 2.078 . . . . 0.0 109.142 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 63.6 t80 . . . . . 0 CA--C 1.545 0.76 0 C-N-CA 124.573 1.149 . . . . 0.0 108.536 167.381 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 121.027 0.442 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -101.55 172.02 7.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.147 0.979 . . . . 0.0 111.07 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.95 146.21 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.15 1.38 . . . . 0.0 109.763 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.9 t -60.48 -38.52 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.496 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.56 -29.15 68.98 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.86 1.264 . . . . 0.0 113.74 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.36 -58.23 3.45 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.933 0.893 . . . . 0.0 110.426 171.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.496 HG13 HD22 ' A' ' 56' ' ' LEU . 52.3 t -52.03 -44.01 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.319 1.447 . . . . 0.0 112.095 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.26 -12.8 44.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.127 1.771 . . . . 0.0 113.834 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -101.95 -31.98 10.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 113.133 171.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mt -51.59 -43.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.052 0.941 . . . . 0.0 110.451 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.65 -42.56 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -52.48 56.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.037 1.29 . . . . 0.0 110.805 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.18 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.55 -38.5 70.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.074 0.949 . . . . 0.0 113.089 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' A' ' 48' ' ' VAL . 50.2 mt -61.06 -57.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.329 0.968 . . . . 0.0 110.057 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.82 -28.75 70.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 t -59.73 -46.57 88.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.72 1.208 . . . . 0.0 112.386 168.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.16 79.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.92 0.888 . . . . 0.0 113.151 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.6 mt -67.72 -40.18 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.346 1.058 . . . . 0.0 111.728 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.96 12.85 58.43 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.837 1.208 . . . . 0.0 114.992 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.84 15.52 73.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.723 1.154 . . . . 0.0 114.766 -172.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.61 -175.79 0.71 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.203 1.401 . . . . 0.0 112.369 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.16 107.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.402 1.481 . . . . 0.0 112.616 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -70.52 100.01 1.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.534 1.534 . . . . 0.0 111.109 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.5 164.87 11.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.645 1.178 . . . . 0.0 111.738 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -73.42 -55.75 5.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -68.21 -21.05 64.88 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.623 -0.673 . . . . 0.0 112.559 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -58.61 -44.03 89.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 168.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -54.81 -34.61 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.393 0.997 . . . . 0.0 112.048 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.2 -49.92 65.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.086 0.954 . . . . 0.0 111.936 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.01 -26.0 66.57 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.565 -0.709 . . . . 0.0 112.813 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -76.71 -53.62 7.73 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.308 1.043 . . . . 0.0 111.247 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 t -58.27 -26.78 63.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -81.46 -57.38 3.5 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.597 1.09 . . . . 0.0 112.542 169.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -57.83 -38.36 75.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 113.74 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 27' ' ' ILE . 88.0 t -68.02 -62.55 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 123.841 0.856 . . . . 0.0 110.343 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.9 t -48.95 -29.67 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.983 1.313 . . . . 0.0 110.82 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.01 -42.99 86.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.534 0.733 . . . . 0.0 112.788 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -103.87 -34.75 8.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.216 1.406 . . . . 0.0 113.149 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -59.17 -53.96 52.43 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.323 1.849 . . . . 0.0 111.487 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -37.78 83.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.961 0.505 . . . . 0.0 111.979 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 p -70.92 -29.93 66.11 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.92 -51.89 19.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.484 2.314 . . . . 0.0 112.968 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.496 HD22 HG13 ' A' ' 19' ' ' VAL . 4.3 pp -64.78 -25.6 67.99 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.865 -1.147 . . . . 0.0 113.731 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 m -59.95 -33.58 72.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.143 0.977 . . . . 0.0 110.939 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -82.09 -28.42 32.33 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.39 -16.56 63.53 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.64 -120.67 4.55 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.247 1.88 . . . . 0.0 112.544 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -131.64 152.38 80.3 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 126.376 1.87 . . . . 0.0 111.631 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.31 109.42 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.953 3.102 . . . . 0.0 112.108 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -148.04 161.56 41.14 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.705 1.202 . . . . 0.0 112.57 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -69.17 92.6 0.56 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.193 1.397 . . . . 0.0 110.828 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -70.5 165.02 23.52 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.629 -0.67 . . . . 0.0 112.038 164.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' B' ' 228' ' ' CYS . 4.5 tt -144.43 159.88 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.696 1.598 . . . . 0.0 110.092 167.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 110' ' ' ALA . 34.9 m -139.67 148.11 23.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.3 1.44 . . . . 0.0 110.776 171.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 124.62 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.141 1.776 . . . . 0.0 108.642 175.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.09 151.0 49.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.77 100.0 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.028 1.731 . . . . 0.0 109.012 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 mm -97.27 109.69 23.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.456 ' HG3' HD21 ' A' ' 79' ' ' LEU . 8.3 ttm -124.11 154.78 39.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.747 1.219 . . . . 0.0 110.748 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.59 150.53 36.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.889 1.276 . . . . 0.0 111.833 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -90.66 3.45 54.17 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.11 1.364 . . . . 0.0 113.498 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -67.74 -18.53 64.92 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.162 1.785 . . . . 0.0 115.072 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.55 -1.75 2.14 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.201 1.24 . . . . 0.0 116.201 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.6 122.74 12.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.819 1.81 . . . . 0.0 111.79 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.59 112.82 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.023 1.297 . . . . 0.0 113.163 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.628 HD22 HD22 ' B' ' 222' ' ' LEU . 0.2 OUTLIER -140.38 151.73 45.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.13 2.572 . . . . 0.0 109.597 -172.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -118.4 104.94 11.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.692 1.597 . . . . 0.0 108.713 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 135' ' ' VAL . 1.8 m -123.75 117.94 26.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.425 0.69 . . . . 0.0 109.629 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.42 118.96 32.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.607 0.763 . . . . 0.0 110.768 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -122.56 111.95 17.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.105 1.362 . . . . 0.0 110.024 -173.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.0 m -73.91 22.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.081 -1.012 . . . . 0.0 113.698 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.5 m -66.19 166.5 11.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 112.117 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.2 159.78 36.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.787 2.035 . . . . 0.0 109.773 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -87.17 141.66 28.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.803 0.841 . . . . 0.0 110.374 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.37 158.49 43.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.086 1.354 . . . . 0.0 112.475 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.1 t -135.05 -56.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.03 1.332 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -86.43 -28.77 23.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.223 0.919 . . . . 0.0 112.637 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.4 -43.34 73.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.937 1.695 . . . . 0.0 112.684 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -161.42 -164.54 1.15 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.189 1.796 . . . . 0.0 111.552 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.57 124.92 7.77 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.097 1.808 . . . . 0.0 114.734 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -145.97 178.41 8.21 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.998 2.119 . . . . 0.0 111.764 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 32.7 t -166.59 135.39 2.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.399 1.48 . . . . 0.0 109.811 162.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -143.95 147.37 33.85 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.869 -1.769 . . . . 0.0 112.303 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.3 144.66 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 110.249 -169.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -138.6 113.14 8.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.312 1.445 . . . . 0.0 111.802 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -124.36 105.84 9.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.282 1.833 . . . . 0.0 110.472 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.75 165.75 16.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.107 0.963 . . . . 0.0 111.66 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.03 -178.77 5.61 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.772 1.229 . . . . 0.0 111.673 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -50.06 -56.56 10.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 113.776 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.0 t -133.71 -15.58 2.38 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.555 1.542 . . . . 0.0 113.744 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.1 ptp -104.68 178.74 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.989 1.716 . . . . 0.0 111.089 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.35 157.57 43.63 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.295 -0.878 . . . . 0.0 111.399 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.9 m -131.45 125.49 32.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.962 1.305 . . . . 0.0 110.462 -171.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -125.75 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.341 1.056 . . . . 0.0 110.633 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.39 109.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 126.146 1.778 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.7 t -108.77 126.95 53.58 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.185 1.394 . . . . 0.0 110.878 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -123.44 157.18 34.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.484 1.914 . . . . 0.0 112.705 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -143.06 158.84 43.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.967 1.307 . . . . 0.0 111.822 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.05 89.07 0.08 OUTLIER Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.311 1.434 . . . . 0.0 111.233 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.79 89.17 1.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.486 1.514 . . . . 0.0 111.404 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.543 0.697 0 C-N-CA 125.07 1.348 . . . . 0.0 112.957 -172.646 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.811 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -137.29 177.9 7.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.694 2.797 . . . . 0.0 111.083 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.66 130.89 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.021 1.728 . . . . 0.0 111.075 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.5 m -97.19 90.55 5.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.146 1.378 . . . . 0.0 110.153 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.49 146.6 34.3 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.817 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -129.71 140.72 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.97 1.708 . . . . 0.0 110.46 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -149.41 143.96 26.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.927 1.291 . . . . 0.0 112.07 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 125.377 1.471 . . . . 0.0 110.078 173.951 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.995 0.426 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -99.83 172.0 7.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.207 1.003 . . . . 0.0 111.143 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.19 146.36 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.142 1.377 . . . . 0.0 109.782 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.4 -38.69 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.261 -0.899 . . . . 0.0 111.501 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.5 -29.11 68.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.884 1.274 . . . . 0.0 113.814 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.38 -58.41 3.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.929 0.891 . . . . 0.0 110.376 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.498 HG13 HD22 ' B' ' 199' ' ' LEU . 53.3 t -52.08 -43.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.35 1.46 . . . . 0.0 112.122 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.1 t -64.14 -12.72 42.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 113.9 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -102.16 -31.96 10.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.782 1.633 . . . . 0.0 113.133 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 23.0 mt -51.41 -43.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 110.464 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.72 -42.51 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -52.32 57.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.037 1.289 . . . . 0.0 110.975 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -34.34 76.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.41 -38.47 71.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.159 0.984 . . . . 0.0 113.119 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' B' ' 191' ' ' VAL . 49.8 mt -61.0 -58.05 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.242 0.928 . . . . 0.0 109.975 172.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.68 -28.93 70.27 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.559 -0.713 . . . . 0.0 112.889 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -59.54 -46.67 88.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.769 1.227 . . . . 0.0 112.401 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.16 79.95 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.923 0.889 . . . . 0.0 113.146 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.71 -40.2 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.317 1.047 . . . . 0.0 111.774 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.02 12.73 58.26 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.865 1.221 . . . . 0.0 115.026 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.96 15.51 74.14 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.76 1.171 . . . . 0.0 114.762 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.72 -175.7 0.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.171 1.388 . . . . 0.0 112.34 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 107.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.316 1.446 . . . . 0.0 112.653 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -70.39 99.86 1.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.632 1.573 . . . . 0.0 111.14 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.53 164.85 11.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.623 1.169 . . . . 0.0 111.738 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -73.35 -55.9 5.78 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.4 m -67.92 -21.21 65.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.516 -0.74 . . . . 0.0 112.54 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -58.48 -44.04 89.22 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.91 -34.58 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.36 0.982 . . . . 0.0 112.039 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -65.97 -50.08 65.58 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.073 0.949 . . . . 0.0 111.943 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.04 -26.09 66.59 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.517 -0.739 . . . . 0.0 112.711 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -76.59 -53.51 7.95 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 111.314 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.5 t -58.42 -26.48 63.34 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.6 t -81.57 -57.94 3.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.625 1.102 . . . . 0.0 112.579 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -57.36 -38.19 73.8 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' B' ' 170' ' ' ILE . 87.8 t -68.08 -62.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 123.857 0.863 . . . . 0.0 110.276 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.95 -29.68 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.018 1.327 . . . . 0.0 110.852 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.06 -42.8 86.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.428 0.691 . . . . 0.0 112.826 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.02 -34.76 8.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 113.085 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 18.6 m -59.14 -53.88 53.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.38 1.872 . . . . 0.0 111.452 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -38.19 84.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.039 0.536 . . . . 0.0 111.94 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 37.2 p -70.78 -29.74 66.03 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -72.14 -51.91 19.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.475 2.31 . . . . 0.0 113.045 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.498 HD22 HG13 ' B' ' 162' ' ' VAL . 4.4 pp -65.03 -25.8 67.99 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.808 -1.183 . . . . 0.0 113.706 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 60.2 m -59.33 -34.79 72.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.051 0.94 . . . . 0.0 110.676 167.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -81.12 -28.38 35.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.2 -16.58 63.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.33 1.052 . . . . 0.0 113.074 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.9 -117.21 4.22 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.036 1.779 . . . . 0.0 112.558 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -132.96 158.92 74.61 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 126.716 2.006 . . . . 0.0 111.474 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.04 110.09 3.01 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.572 2.848 . . . . 0.0 112.286 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.84 165.18 29.64 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.687 1.595 . . . . 0.0 111.965 173.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -72.7 98.04 2.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.632 1.173 . . . . 0.0 110.425 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -74.39 164.56 26.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.268 0.556 . . . . 0.0 111.937 165.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 4.2 tt -145.09 159.31 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.851 1.66 . . . . 0.0 109.991 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' B' ' 253' ' ' ALA . 35.1 m -140.18 147.9 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 125.317 1.447 . . . . 0.0 110.695 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 123.26 14.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.054 1.742 . . . . 0.0 108.616 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.1 p -126.46 150.26 48.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.14 103.19 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.153 1.781 . . . . 0.0 109.002 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.45 108.97 24.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.8 ttm -123.91 162.79 22.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.765 1.226 . . . . 0.0 110.951 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.82 44.23 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 112.277 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -90.62 1.81 56.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -67.71 -18.8 65.03 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.012 1.725 . . . . 0.0 115.078 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.04 -1.41 2.22 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.19 125.26 19.89 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.767 1.783 . . . . 0.0 111.563 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -130.32 112.19 1.25 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.944 1.259 . . . . 0.0 112.999 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.628 HD22 HD22 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -139.17 153.37 47.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.148 2.579 . . . . 0.0 109.591 -172.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -119.55 102.18 8.46 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 108.79 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 1.4 m -121.4 123.59 42.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.015 0.926 . . . . 0.0 109.121 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.59 119.89 29.33 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.172 0.589 . . . . 0.0 111.011 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -122.47 112.38 17.98 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.022 1.329 . . . . 0.0 109.988 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 70.5 m -74.11 23.22 0.08 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . 0.426 ' SG ' HD11 ' A' ' 66' ' ' ILE . 20.6 m -67.18 167.03 12.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.639 1.176 . . . . 0.0 112.109 167.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.59 161.73 37.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.126 2.17 . . . . 0.0 109.73 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -88.66 141.64 28.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.92 0.888 . . . . 0.0 110.275 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -146.01 157.56 43.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.088 1.355 . . . . 0.0 112.544 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.0 t -127.14 -61.09 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.2 1.4 . . . . 0.0 112.133 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 82.7 p -95.34 -21.67 18.24 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -40.69 86.69 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.89 1.276 . . . . 0.0 111.608 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -162.04 -163.79 0.99 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 126.636 1.974 . . . . 0.0 111.026 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.27 9.04 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.061 1.791 . . . . 0.0 114.489 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 87.3 p -148.12 178.18 8.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 111.576 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 31.4 t -166.84 134.71 2.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 109.82 162.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -143.36 147.19 34.29 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.9 -1.75 . . . . 0.0 112.362 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.85 144.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.665 1.186 . . . . 0.0 110.175 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -138.73 113.1 8.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.145 1.378 . . . . 0.0 111.823 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -124.9 103.81 8.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.266 1.827 . . . . 0.0 110.346 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.17 165.99 6.61 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.83 0.852 . . . . 0.0 112.588 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -140.36 -177.73 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.301 1.44 . . . . 0.0 111.465 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -49.81 -56.73 9.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.584 . . . . 0.0 113.852 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.6 t -133.51 -16.71 2.34 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.69 1.596 . . . . 0.0 113.552 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.3 ptp -104.05 -179.32 3.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.196 1.798 . . . . 0.0 111.162 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -149.25 161.27 42.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.008 0.923 . . . . 0.0 111.578 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 32.2 m -132.77 124.95 29.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.425 1.49 . . . . 0.0 110.051 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.08 136.55 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.095 0.958 . . . . 0.0 110.539 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.95 108.03 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.972 1.709 . . . . 0.0 111.093 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.5 t -107.06 123.53 48.35 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.107 1.363 . . . . 0.0 110.775 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -118.33 158.14 25.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.41 1.884 . . . . 0.0 112.368 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -142.18 156.54 45.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.648 1.179 . . . . 0.0 112.034 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -171.3 88.91 0.08 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.722 0.677 . . . . 0.0 113.119 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.69 91.87 2.94 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.612 1.165 . . . . 0.0 110.777 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.3 t . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 125.187 1.395 . . . . 0.0 112.183 -173.526 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.59 0 CA-C-O 121.138 0.494 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -135.68 177.92 7.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.682 2.393 . . . . 0.0 111.111 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.8 mm -53.01 130.24 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.981 1.712 . . . . 0.0 111.106 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 32.0 m -96.26 86.48 4.23 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.098 1.359 . . . . 0.0 110.114 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.14 145.47 27.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.809 0.844 . . . . 0.0 110.883 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.0 136.86 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.121 1.768 . . . . 0.0 110.964 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -143.74 144.69 31.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.497 1.519 . . . . 0.0 112.109 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 125.23 1.412 . . . . 0.0 110.522 174.963 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 121.011 0.434 . . . . 0.0 112.009 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.92 166.3 11.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.266 1.026 . . . . 0.0 112.289 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.83 158.08 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.289 1.435 . . . . 0.0 110.584 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.3 -36.4 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.47 -32.59 58.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.687 0.795 . . . . 0.0 112.881 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.74 -54.79 5.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.096 0.558 . . . . 0.0 110.236 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 HD22 ' A' ' 56' ' ' LEU . 77.5 t -52.08 -43.8 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.952 1.301 . . . . 0.0 112.661 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -64.04 -9.45 16.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.628 1.971 . . . . 0.0 113.898 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -102.68 -38.06 7.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.551 1.54 . . . . 0.0 112.433 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.9 mt -50.08 -44.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.851 0.86 . . . . 0.0 110.474 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -59.24 -42.36 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -52.06 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.046 1.294 . . . . 0.0 111.086 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -33.41 74.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.87 59.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.192 0.997 . . . . 0.0 112.931 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.451 ' HA ' HG21 ' A' ' 48' ' ' VAL . 59.7 mt -59.75 -58.87 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.319 0.963 . . . . 0.0 109.626 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.7 -30.01 71.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -59.29 -50.66 73.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.429 1.091 . . . . 0.0 112.061 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.95 73.18 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.47 -35.76 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.478 1.111 . . . . 0.0 111.582 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.55 81.68 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.109 0.861 . . . . 0.0 114.739 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.37 3.04 56.61 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.158 1.361 . . . . 0.0 115.863 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -64.62 165.26 10.48 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 119.235 1.517 . . . . 0.0 111.694 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.77 -178.75 4.98 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.931 -1.106 . . . . 0.0 112.053 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -51.73 141.04 17.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.546 0.738 . . . . 0.0 111.285 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 165.19 24.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.361 1.065 . . . . 0.0 111.594 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -84.09 -88.3 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.824 0.849 . . . . 0.0 111.055 -171.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -78.47 -21.08 49.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.345 -1.472 . . . . 0.0 113.921 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -38.01 71.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.238 1.015 . . . . 0.0 112.445 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.17 -30.37 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -68.06 -45.29 74.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.827 0.851 . . . . 0.0 111.188 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.39 -26.4 66.43 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -76.73 -53.82 7.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.972 0.806 . . . . 0.0 111.322 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -56.0 -32.07 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.618 0.644 . . . . 0.0 112.452 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -77.65 -59.45 2.78 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.357 0.98 . . . . 0.0 112.581 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -57.08 -39.02 74.17 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.389 1.476 . . . . 0.0 113.63 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 27' ' ' ILE . 86.3 t -68.3 -63.5 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 C-N-CA 123.976 0.91 . . . . 0.0 109.97 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.88 -30.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.761 1.224 . . . . 0.0 110.621 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.44 -46.4 83.63 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.646 0.779 . . . . 0.0 112.671 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -98.23 -39.45 8.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 0.0 112.705 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -58.28 -53.09 62.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.265 2.226 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -38.07 85.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.64 0.376 . . . . 0.0 111.208 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 t -62.57 -44.58 95.98 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.329 -0.857 . . . . 0.0 112.252 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -61.38 -49.28 77.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.729 2.012 . . . . 0.0 113.048 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 19' ' ' VAL . 3.9 pp -68.77 -27.12 65.61 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.0 m -59.9 -30.68 69.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 110.918 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -82.16 -28.01 32.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.519 -0.738 . . . . 0.0 112.97 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.35 -28.87 66.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.637 0.775 . . . . 0.0 111.433 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.42 -104.61 2.3 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.771 1.653 . . . . 0.0 113.855 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.31 154.44 75.5 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.114 1.766 . . . . 0.0 112.642 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.54 110.51 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.86 3.04 . . . . 0.0 111.673 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -148.37 170.25 18.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 112.587 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -71.37 116.01 11.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.644 0.778 . . . . 0.0 110.563 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -101.59 164.15 11.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.518 1.127 . . . . 0.0 110.74 165.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.429 HD11 ' SG ' ' B' ' 228' ' ' CYS . 1.0 OUTLIER -147.42 155.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.602 1.961 . . . . 0.0 108.518 171.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 110' ' ' ALA . 3.8 m -139.53 151.78 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 110.415 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.53 128.74 25.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.939 2.095 . . . . 0.0 108.862 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.4 p -131.81 145.3 51.49 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.253 -0.904 . . . . 0.0 112.66 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.64 110.25 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.468 1.507 . . . . 0.0 108.606 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' A' ' 106' ' ' CYS . 3.6 mm -109.8 95.67 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.31 1.844 . . . . 0.0 107.808 -174.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -134.5 154.15 51.58 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.654 0.782 . . . . 0.0 111.975 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.27 149.33 33.58 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.731 -0.606 . . . . 0.0 112.019 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -7.38 59.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -65.96 -36.88 84.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.473 1.909 . . . . 0.0 114.367 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.8 40.37 1.59 Allowed Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.6 1.095 . . . . 0.0 115.026 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.06 -169.94 0.67 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.173 1.389 . . . . 0.0 112.701 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.0 73.15 1.05 Allowed Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.545 -1.347 . . . . 0.0 113.939 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.12 90.85 2.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.891 2.076 . . . . 0.0 112.065 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -113.65 136.44 52.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.271 1.428 . . . . 0.0 110.181 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.441 ' HB ' HG13 ' A' ' 135' ' ' VAL . 27.9 m -145.27 147.31 32.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.902 1.281 . . . . 0.0 109.779 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.4 147.88 30.73 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.254 -0.904 . . . . 0.0 111.602 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.1 p -148.52 133.47 18.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.039 0.536 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.5 m -80.51 19.19 0.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.687 -0.633 . . . . 0.0 112.564 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.482 ' SG ' HD11 ' B' ' 209' ' ' ILE . 56.1 m -68.34 165.16 19.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.717 1.207 . . . . 0.0 112.204 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -163.02 140.11 7.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.653 1.581 . . . . 0.0 110.61 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.02 150.79 40.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.13 0.572 . . . . 0.0 110.498 171.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -140.32 152.75 46.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.62 1.568 . . . . 0.0 110.617 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.3 t -109.24 -66.31 1.07 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.197 0.999 . . . . 0.0 111.426 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.5 p -89.78 -26.68 20.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 113.027 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -77.82 -44.87 26.08 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.364 1.866 . . . . 0.0 112.92 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -148.85 -174.24 4.57 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.117 2.567 . . . . 0.0 110.686 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.98 123.24 3.97 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.618 1.58 . . . . 0.0 113.441 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.46 125.08 13.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.411 1.484 . . . . 0.0 111.337 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.43 112.24 18.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.601 1.56 . . . . 0.0 112.175 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 t -125.21 147.97 48.84 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.523 -1.361 . . . . 0.0 112.319 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.69 136.39 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.739 1.615 . . . . 0.0 109.723 -170.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.58 101.4 5.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.461 1.504 . . . . 0.0 112.022 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -110.04 129.2 55.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.23 159.37 16.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.973 0.909 . . . . 0.0 110.934 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.75 -178.4 4.48 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.599 1.56 . . . . 0.0 110.593 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -51.24 60.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.181 2.192 . . . . 0.0 113.025 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -138.48 -3.51 1.7 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.299 1.439 . . . . 0.0 114.115 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.3 ptp -126.18 -173.71 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.608 1.963 . . . . 0.0 110.746 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.29 156.41 43.8 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.341 -0.85 . . . . 0.0 111.033 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.424 ' CB ' HD12 ' A' ' 71' ' ' ILE . 4.9 p -131.33 96.15 3.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.333 1.453 . . . . 0.0 111.019 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.25 138.32 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.244 1.018 . . . . 0.0 111.413 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.41 137.03 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.309 1.844 . . . . 0.0 109.999 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.2 t -128.25 123.21 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.072 1.349 . . . . 0.0 109.853 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -110.21 150.96 27.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.606 1.162 . . . . 0.0 111.53 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.66 106.91 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.764 1.626 . . . . 0.0 107.915 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.23 88.24 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.962 1.744 . . . . 0.0 110.358 -169.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.532 HD22 ' H ' ' A' ' 113' ' ' LEU . 1.5 mm? -64.42 163.61 12.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.998 1.319 . . . . 0.0 112.218 -173.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.471 0.6 0 C-N-CA 124.836 1.254 . . . . 0.0 112.381 -174.06 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -121.7 168.21 12.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.925 1.69 . . . . 0.0 112.051 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mm -71.85 146.49 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.447 1.499 . . . . 0.0 110.704 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.1 m -112.79 92.7 4.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.39 1.476 . . . . 0.0 110.292 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.54 149.34 22.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.863 0.865 . . . . 0.0 111.036 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.441 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -135.9 106.75 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.522 2.329 . . . . 0.0 108.795 175.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.17 152.13 48.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.1 0.96 . . . . 0.0 111.833 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.4 p90 . . . . . 0 CA--C 1.548 0.869 0 C-N-CA 123.794 0.837 . . . . 0.0 111.4 174.305 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.795 0 CA-C-O 121.4 0.619 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -93.67 174.38 7.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.06 0.944 . . . . 0.0 112.022 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.58 159.27 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.278 1.431 . . . . 0.0 110.766 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 89.3 t -61.95 -38.33 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.133 -0.979 . . . . 0.0 112.014 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.63 -30.31 60.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 112.877 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.87 -61.05 1.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.763 0.825 . . . . 0.0 110.75 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.537 HG13 HD22 ' B' ' 199' ' ' LEU . 77.9 t -54.06 -41.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.873 1.269 . . . . 0.0 113.124 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -62.3 -8.74 6.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.772 1.629 . . . . 0.0 113.715 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -106.17 -39.51 5.93 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.846 1.658 . . . . 0.0 112.588 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.7 -43.32 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.282 0.947 . . . . 0.0 110.533 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.34 -42.59 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -51.34 57.59 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.957 1.253 . . . . 0.0 110.98 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -33.57 74.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.0 61.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.974 0.91 . . . . 0.0 113.069 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.459 ' HA ' HG21 ' B' ' 191' ' ' VAL . 60.5 mt -59.83 -58.77 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.393 0.997 . . . . 0.0 109.645 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -63.04 -29.69 71.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 t -59.35 -50.57 73.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.466 1.106 . . . . 0.0 112.067 167.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.02 -31.79 72.89 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.68 -35.46 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.22 13.51 81.81 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.055 0.836 . . . . 0.0 114.777 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.17 3.3 56.75 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.873 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.49 164.93 10.72 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.23 1.515 . . . . 0.0 111.646 169.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.82 -178.56 4.32 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.925 -1.109 . . . . 0.0 111.995 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -51.63 139.07 21.55 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.677 -0.639 . . . . 0.0 110.908 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -179.81 4.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.714 1.206 . . . . 0.0 111.01 -175.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -96.47 -99.15 0.18 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.531 0.732 . . . . 0.0 109.998 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -66.62 -23.15 66.13 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.729 -1.232 . . . . 0.0 114.157 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -38.89 72.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.163 0.985 . . . . 0.0 112.552 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 45.2 t -54.82 -33.47 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.604 1.162 . . . . 0.0 112.512 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -66.74 -45.66 77.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.616 0.766 . . . . 0.0 111.553 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.06 -26.06 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.639 -0.663 . . . . 0.0 112.667 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -77.14 -53.14 8.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.797 0.726 . . . . 0.0 111.322 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.0 t -56.03 -31.95 63.59 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.479 0.581 . . . . 0.0 112.508 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 9.4 t -77.68 -59.81 2.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 119.361 0.982 . . . . 0.0 112.633 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -56.63 -38.59 72.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.305 1.442 . . . . 0.0 113.698 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.459 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.6 t -68.54 -63.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 123.854 0.861 . . . . 0.0 109.997 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.82 -30.57 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.741 1.217 . . . . 0.0 110.702 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -57.49 -45.72 84.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.685 0.794 . . . . 0.0 112.727 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -98.77 -39.47 8.62 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.194 1.397 . . . . 0.0 112.766 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 26.9 m -58.48 -52.17 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.294 2.238 . . . . 0.0 112.147 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -38.21 86.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.669 0.388 . . . . 0.0 111.179 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.7 t -63.12 -43.87 97.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.368 -0.832 . . . . 0.0 112.347 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.77 -48.92 78.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.826 2.05 . . . . 0.0 112.939 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.537 HD22 HG13 ' B' ' 162' ' ' VAL . 4.4 pp -69.45 -25.63 64.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.9 m -60.73 -30.6 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.934 -0.479 . . . . 0.0 110.599 166.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -81.56 -29.58 33.38 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.554 -0.716 . . . . 0.0 112.505 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.86 -17.73 63.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 112.953 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -109.92 -100.13 2.6 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.867 1.698 . . . . 0.0 113.767 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.65 155.23 63.53 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.837 1.655 . . . . 0.0 112.001 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.63 109.34 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 111.574 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -147.37 169.92 18.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.181 0.993 . . . . 0.0 112.471 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -71.46 120.17 16.67 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.271 0.628 . . . . 0.0 110.388 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -106.67 163.63 12.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.821 1.249 . . . . 0.0 110.647 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . 0.482 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.2 tt -147.44 155.26 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.335 1.854 . . . . 0.0 108.708 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' B' ' 253' ' ' ALA . 4.2 m -140.05 151.13 21.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.984 0.914 . . . . 0.0 110.314 168.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.08 129.59 27.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.871 2.069 . . . . 0.0 108.921 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.44 148.41 52.4 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.165 -0.96 . . . . 0.0 112.532 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 15.6 t -136.15 115.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.071 1.349 . . . . 0.0 108.93 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' B' ' 249' ' ' CYS . 3.0 mm -112.7 94.58 3.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.595 1.958 . . . . 0.0 107.538 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 9.1 ptm -132.14 150.27 52.2 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.289 1.436 . . . . 0.0 111.757 -170.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -88.01 140.18 29.76 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.292 0.637 . . . . 0.0 112.312 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -9.23 58.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.98 -30.68 71.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.326 1.851 . . . . 0.0 114.485 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.65 29.97 5.4 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.229 0.918 . . . . 0.0 115.343 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.4 176.24 1.92 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 118.29 1.045 . . . . 0.0 111.941 163.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 59.24 1.28 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.233 1.873 . . . . 0.0 116.253 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.96 99.14 8.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.242 1.817 . . . . 0.0 110.457 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.48 132.01 55.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.262 1.425 . . . . 0.0 110.209 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.456 ' HB ' HG13 ' B' ' 278' ' ' VAL . 28.7 m -140.77 147.21 38.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.713 0.805 . . . . 0.0 110.172 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.67 147.9 33.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.476 0.655 . . . . 0.0 111.538 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 134.78 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.236 0.614 . . . . 0.0 111.529 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 29.8 m -80.9 19.15 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 173.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' A' ' 66' ' ' ILE . 56.6 m -68.24 165.13 19.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.557 1.143 . . . . 0.0 112.172 172.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -162.84 140.7 8.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.539 1.536 . . . . 0.0 110.568 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 150.22 40.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.329 0.652 . . . . 0.0 110.429 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.99 151.08 45.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.6 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.5 t -108.59 -66.42 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.148 0.979 . . . . 0.0 111.594 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 58.1 p -89.76 -26.46 20.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.815 0.846 . . . . 0.0 112.998 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.9 m -77.59 -45.14 26.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.366 1.866 . . . . 0.0 112.92 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -148.95 -174.17 4.56 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.112 2.565 . . . . 0.0 110.802 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.68 125.58 5.24 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.656 1.598 . . . . 0.0 113.358 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.72 125.82 12.91 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 111.235 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.8 p -122.06 112.26 18.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.409 1.484 . . . . 0.0 112.244 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.8 t -124.67 148.5 47.94 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.401 -1.437 . . . . 0.0 112.32 -173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.59 136.46 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.682 1.593 . . . . 0.0 109.82 -170.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.8 99.22 4.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.381 1.472 . . . . 0.0 112.176 -169.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -108.24 124.44 50.3 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.88 1.272 . . . . 0.0 110.01 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.36 158.86 18.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -129.91 -176.71 4.01 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.744 1.618 . . . . 0.0 110.728 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -51.51 55.9 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.672 1.989 . . . . 0.0 113.394 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.6 t -138.77 -2.89 1.69 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.402 1.481 . . . . 0.0 113.855 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 13.8 ptp -127.87 -175.85 3.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.801 2.04 . . . . 0.0 110.726 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -141.41 158.33 44.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.093 0.957 . . . . 0.0 111.543 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.427 ' CB ' HD12 ' B' ' 214' ' ' ILE . 3.8 p -130.81 93.14 3.35 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.79 1.636 . . . . 0.0 110.452 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.64 136.35 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.224 1.01 . . . . 0.0 111.095 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.75 138.07 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.162 1.785 . . . . 0.0 110.249 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 t -128.68 123.07 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.082 1.353 . . . . 0.0 109.986 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -108.65 150.4 27.58 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.49 1.116 . . . . 0.0 111.423 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -128.19 105.55 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.876 1.67 . . . . 0.0 108.042 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -137.48 94.71 0.22 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.22 1.867 . . . . 0.0 109.838 -171.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.48 HD22 ' H ' ' B' ' 256' ' ' LEU . 1.6 mm? -68.57 163.88 22.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.088 0.955 . . . . 0.0 111.679 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 124.853 1.261 . . . . 0.0 112.099 -174.597 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -121.85 168.33 11.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.93 1.692 . . . . 0.0 112.091 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.61 147.95 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.389 1.475 . . . . 0.0 110.651 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 80.4 m -114.79 91.75 3.72 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.375 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.03 148.78 22.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.147 0.979 . . . . 0.0 110.792 168.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' B' ' 224' ' ' THR . 1.4 p -142.11 104.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.902 2.081 . . . . 0.0 109.653 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -135.7 153.87 51.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.401 1.48 . . . . 0.0 112.214 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 30.7 p90 . . . . . 0 CA--C 1.551 1.011 0 O-C-N 121.729 -0.607 . . . . 0.0 111.527 175.351 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.687 0 CA-C-O 121.238 0.542 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -69.96 175.8 4.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.747 0.819 . . . . 0.0 111.899 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.17 146.68 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.8 1.24 . . . . 0.0 110.769 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.54 -39.31 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.154 0.982 . . . . 0.0 111.458 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.83 -28.82 69.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.767 1.227 . . . . 0.0 113.222 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.26 -58.49 3.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.558 1.143 . . . . 0.0 110.837 171.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.26 -41.16 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.485 1.114 . . . . 0.0 112.424 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -62.92 -17.4 61.72 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.255 1.422 . . . . 0.0 113.934 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -97.97 -35.16 10.55 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.767 1.627 . . . . 0.0 113.259 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 mt -50.41 -41.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.203 1.001 . . . . 0.0 110.684 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.59 -40.76 90.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -52.35 56.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.857 1.208 . . . . 0.0 111.058 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -33.01 73.51 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.89 -42.44 57.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.615 0.766 . . . . 0.0 112.984 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.57 -56.95 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.99 0.813 . . . . 0.0 109.828 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.12 -30.89 70.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.3 t -59.84 -49.65 76.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.56 1.144 . . . . 0.0 112.238 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.21 77.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.075 0.95 . . . . 0.0 113.507 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.9 -37.02 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.866 1.266 . . . . 0.0 111.613 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.37 17.59 74.46 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.145 0.878 . . . . 0.0 114.599 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.11 78.58 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.694 1.14 . . . . 0.0 115.576 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.62 156.55 8.22 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 113.138 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -175.63 1.03 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.413 1.485 . . . . 0.0 112.352 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -47.99 146.75 2.37 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -136.74 178.5 7.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.067 1.347 . . . . 0.0 112.24 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -95.37 -118.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.454 1.501 . . . . 0.0 110.45 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.8 p -66.75 0.47 2.36 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.885 2.074 . . . . 0.0 115.91 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -50.52 -44.36 56.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.844 1.202 . . . . 0.0 112.761 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.2 t -55.92 -34.05 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -67.03 -51.61 52.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.451 1.023 . . . . 0.0 112.411 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.73 -25.65 68.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.49 -0.756 . . . . 0.0 112.42 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.64 -56.08 4.93 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.713 1.205 . . . . 0.0 111.629 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -22.59 63.42 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.94 -60.19 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.375 0.989 . . . . 0.0 111.905 166.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.3 -39.26 72.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.01 1.277 . . . . 0.0 113.905 -173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.19 -64.56 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 110.022 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -47.77 -30.17 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.957 1.303 . . . . 0.0 110.993 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.86 -42.83 85.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.955 0.902 . . . . 0.0 112.87 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -101.78 -39.77 7.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.611 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -57.64 -53.17 61.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.425 2.29 . . . . 0.0 112.598 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -37.11 80.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.571 0.623 . . . . 0.0 111.333 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m -65.15 -37.06 86.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -69.21 -52.12 31.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.163 1.785 . . . . 0.0 112.965 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.06 -26.46 68.57 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.858 -1.151 . . . . 0.0 113.7 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.6 m -57.48 -31.96 66.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 167.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -88.81 -25.53 22.17 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.17 -16.79 63.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.065 0.946 . . . . 0.0 113.26 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.02 -112.61 3.36 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.658 1.599 . . . . 0.0 112.77 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -132.67 152.11 79.33 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 125.422 1.489 . . . . 0.0 113.492 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.06 104.14 1.48 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.44 3.426 . . . . 0.0 112.275 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -142.81 177.9 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.297 1.839 . . . . 0.0 112.216 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -100.19 75.91 1.86 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.625 1.57 . . . . 0.0 111.35 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -67.05 147.12 53.59 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 111.009 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.664 HD11 ' SG ' ' B' ' 228' ' ' CYS . 0.7 OUTLIER -130.89 156.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.384 1.474 . . . . 0.0 109.756 170.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.69 158.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.491 0.716 . . . . 0.0 109.976 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.53 131.97 32.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.744 1.617 . . . . 0.0 108.973 164.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.5 p -124.92 150.33 46.68 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 167.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.34 117.88 50.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.284 1.034 . . . . 0.0 108.247 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.417 HD12 ' CB ' ' A' ' 106' ' ' CYS . 3.6 mm -114.91 120.95 65.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 107.71 -177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -144.45 139.74 28.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.61 0.719 . . . . 0.0 111.319 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -145.79 106.73 4.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.463 1.905 . . . . 0.0 109.424 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -146.72 -58.57 0.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.754 0.821 . . . . 0.0 112.567 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -122.52 -9.96 8.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.286 1.434 . . . . 0.0 113.767 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.0 -3.85 55.95 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.315 1.435 . . . . 0.0 114.908 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.38 165.99 21.27 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 156.06 52.33 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.53 0.586 . . . . 0.0 113.966 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.05 178.95 4.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.556 1.942 . . . . 0.0 111.354 169.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.15 92.73 3.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.141 1.377 . . . . 0.0 109.791 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.565 ' HB ' HG13 ' A' ' 135' ' ' VAL . 18.7 m -108.88 147.24 32.45 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.687 -1.258 . . . . 0.0 108.871 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.63 146.18 32.15 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.232 -0.918 . . . . 0.0 112.194 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -143.16 143.12 31.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 112.883 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t -78.39 12.13 2.1 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' B' ' 209' ' ' ILE . 12.5 m -62.71 173.03 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.093 0.957 . . . . 0.0 112.394 168.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -161.63 157.1 24.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.689 1.995 . . . . 0.0 110.082 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -78.11 146.95 34.87 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.626 172.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.15 158.54 43.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.666 1.586 . . . . 0.0 111.577 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t -134.47 -57.29 0.84 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.202 1.401 . . . . 0.0 112.479 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 m -84.24 -36.81 22.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.946 0.899 . . . . 0.0 112.09 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.4 -46.86 59.17 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.743 1.617 . . . . 0.0 112.719 -172.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.07 -167.97 2.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.768 2.427 . . . . 0.0 109.923 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.43 156.06 15.88 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 124.297 0.951 . . . . 0.0 113.835 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -145.75 169.62 18.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.983 1.713 . . . . 0.0 112.243 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.3 t -166.35 158.17 13.63 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.073 1.749 . . . . 0.0 110.292 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.6 t -150.32 146.78 26.96 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 119.534 -1.979 . . . . 0.0 111.261 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.7 95.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.266 1.426 . . . . 0.0 110.661 -166.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -86.79 116.08 24.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.099 1.76 . . . . 0.0 112.366 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -126.39 113.62 17.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.725 1.61 . . . . 0.0 110.231 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.3 170.56 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.58 1.552 . . . . 0.0 112.599 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.6 -170.92 3.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.888 1.275 . . . . 0.0 112.482 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -42.92 -58.57 2.34 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.301 2.24 . . . . 0.0 114.16 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t -136.05 -29.59 1.0 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 113.099 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.57 149.8 34.81 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.925 0.89 . . . . 0.0 111.586 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -136.36 141.16 43.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.533 1.533 . . . . 0.0 109.585 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.417 ' CB ' HD12 ' A' ' 71' ' ' ILE . 1.7 p -144.24 71.92 1.33 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.695 -169.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.94 142.04 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.319 -0.863 . . . . 0.0 111.588 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.1 t -121.61 142.91 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.639 1.975 . . . . 0.0 110.335 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -138.78 122.87 17.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.889 1.675 . . . . 0.0 109.553 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.3 142.67 51.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.07 1.748 . . . . 0.0 113.586 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -140.67 125.83 18.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.073 0.949 . . . . 0.0 111.263 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.85 70.33 0.22 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 127.378 2.418 . . . . 0.0 111.394 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.64 128.91 37.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.119 0.968 . . . . 0.0 111.287 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.7 m . . . . . 0 CA--C 1.538 0.501 0 C-N-CA 126.141 1.776 . . . . 0.0 111.779 -161.119 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.336 0 CA-C-O 120.637 0.256 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -129.22 167.11 18.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.805 1.242 . . . . 0.0 111.687 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.4 mm -51.08 132.08 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.239 2.215 . . . . 0.0 111.243 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 m -99.82 95.85 7.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.345 1.458 . . . . 0.0 109.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.64 148.39 30.27 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.377 -0.827 . . . . 0.0 111.141 166.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 81' ' ' THR . 1.5 p -131.98 89.1 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.803 2.441 . . . . 0.0 109.049 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -134.63 166.16 23.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.25 1.42 . . . . 0.0 111.714 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.547 0.864 0 C-N-CA 125.273 1.429 . . . . 0.0 111.048 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.749 0 CA-C-O 121.175 0.512 . . . . 0.0 111.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.33 173.41 10.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.577 0.751 . . . . 0.0 112.116 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 94.5 t -123.97 142.49 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.63 1.572 . . . . 0.0 109.726 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.11 -41.79 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.86 0.864 . . . . 0.0 111.552 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.06 -35.29 66.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.7 1.6 . . . . 0.0 113.348 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -72.6 -58.92 3.0 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.788 1.235 . . . . 0.0 110.746 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 80.8 t -52.19 -40.77 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.502 1.121 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -63.63 -17.82 63.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 113.982 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.37 -35.24 11.26 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.491 1.517 . . . . 0.0 113.192 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.4 mt -50.66 -41.35 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.104 0.961 . . . . 0.0 110.712 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 121.322 -0.861 . . . . 0.0 113.322 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -52.33 57.29 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.831 1.196 . . . . 0.0 110.982 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -33.0 73.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.84 -42.23 58.38 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.402 ' HA ' HG21 ' B' ' 191' ' ' VAL . 66.1 mt -60.61 -56.89 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.106 0.866 . . . . 0.0 109.786 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.2 -30.89 70.69 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.0 t -59.75 -49.75 76.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.631 1.172 . . . . 0.0 112.24 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.25 77.49 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.88 -36.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.879 1.272 . . . . 0.0 111.55 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 70.43 17.57 74.57 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.111 0.862 . . . . 0.0 114.588 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.0 78.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.705 1.145 . . . . 0.0 115.595 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -57.63 156.66 8.07 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.914 1.357 . . . . 0.0 113.101 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.5 -175.52 1.05 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.43 1.492 . . . . 0.0 112.256 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -48.1 146.97 2.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.584 1.553 . . . . 0.0 113.395 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -136.95 178.39 7.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.084 1.353 . . . . 0.0 112.276 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -95.46 -117.66 0.11 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.403 1.481 . . . . 0.0 110.492 169.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 58.5 p -66.76 0.39 2.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.855 2.062 . . . . 0.0 115.957 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -50.86 -44.58 59.63 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.793 1.179 . . . . 0.0 112.779 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.35 -34.02 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -66.7 -51.55 54.71 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.453 1.024 . . . . 0.0 112.403 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.86 -25.63 67.98 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.517 -0.739 . . . . 0.0 112.507 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -76.88 -55.91 5.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.612 1.165 . . . . 0.0 111.547 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 t -60.26 -22.1 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -82.55 -60.41 2.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.233 0.924 . . . . 0.0 111.909 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -55.92 -39.09 71.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.974 1.261 . . . . 0.0 113.905 -173.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' B' ' 170' ' ' ILE . 97.2 t -68.33 -64.51 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.52 -30.49 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.999 1.319 . . . . 0.0 111.004 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.88 -42.22 84.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.072 0.949 . . . . 0.0 112.778 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -102.95 -38.68 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.215 1.406 . . . . 0.0 112.781 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.9 m -58.97 -52.85 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.33 2.252 . . . . 0.0 112.624 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -36.04 79.8 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.553 0.615 . . . . 0.0 111.561 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.1 m -60.34 -49.77 76.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 0.0 112.327 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -60.14 -51.73 68.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.91 1.684 . . . . 0.0 113.56 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.04 -26.08 68.11 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.1 m -58.89 -34.2 71.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.615 0.766 . . . . 0.0 110.952 167.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -84.75 -24.69 28.7 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.72 -15.45 63.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.657 1.183 . . . . 0.0 113.302 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -113.05 -113.17 3.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.666 1.603 . . . . 0.0 112.762 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -130.76 153.17 81.53 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 125.774 1.63 . . . . 0.0 112.959 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.89 98.79 0.92 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.198 3.266 . . . . 0.0 112.193 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -140.01 165.84 26.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.225 1.41 . . . . 0.0 112.91 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -84.75 78.54 9.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.912 1.685 . . . . 0.0 111.644 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -59.5 156.32 13.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 112.365 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . 0.576 HD11 ' SG ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -144.13 155.96 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.185 1.794 . . . . 0.0 108.949 165.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.91 160.16 29.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.596 162.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.3 141.5 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 109.766 164.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.74 148.71 47.43 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.103 0.961 . . . . 0.0 111.41 171.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.87 104.83 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.899 1.28 . . . . 0.0 108.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' B' ' 249' ' ' CYS . 3.7 mm -101.38 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.543 1.537 . . . . 0.0 108.266 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 4.5 tpt -134.57 136.79 43.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.926 0.87 . . . . 0.0 112.322 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -143.17 100.26 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.986 2.114 . . . . 0.0 109.347 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -143.03 -63.92 0.41 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.521 0.728 . . . . 0.0 111.981 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -109.5 -22.48 11.98 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 113.439 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.9 -9.59 76.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.651 1.596 . . . . 0.0 115.03 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -143.98 81.88 1.7 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.027 1.731 . . . . 0.0 110.762 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 176.9 88.61 0.07 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.016 0.817 . . . . 0.0 112.797 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.68 124.84 7.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.755 1.622 . . . . 0.0 109.489 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.44 88.21 2.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.755 1.622 . . . . 0.0 109.101 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.697 ' HB ' HG13 ' B' ' 278' ' ' VAL . 88.5 m -106.34 144.43 33.04 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.541 -1.35 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.33 133.42 27.78 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.37 -0.831 . . . . 0.0 112.177 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.0 p -134.03 144.58 48.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.021 0.928 . . . . 0.0 113.015 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 15.6 t -78.91 12.3 2.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . 0.664 ' SG ' HD11 ' A' ' 66' ' ' ILE . 19.1 m -63.22 172.74 1.74 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.952 . . . . 0.0 112.518 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -162.42 158.15 23.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.725 2.01 . . . . 0.0 110.128 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -76.36 139.8 41.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.5 -0.75 . . . . 0.0 110.506 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -145.22 153.36 41.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.391 1.476 . . . . 0.0 111.859 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 25.8 t -128.74 -59.75 1.12 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.745 1.618 . . . . 0.0 112.499 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.0 m -83.37 -37.24 23.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.872 0.869 . . . . 0.0 111.867 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -51.72 43.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.856 1.662 . . . . 0.0 112.023 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.01 -171.13 3.75 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.732 2.413 . . . . 0.0 109.791 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.54 154.4 16.53 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.308 0.956 . . . . 0.0 114.176 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 85.7 p -144.75 168.45 20.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.24 1.816 . . . . 0.0 112.068 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.6 t -166.23 157.62 13.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.043 1.737 . . . . 0.0 110.185 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.1 t -150.05 146.53 27.01 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.368 -2.082 . . . . 0.0 111.37 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.41 92.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.205 1.402 . . . . 0.0 110.611 -166.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -84.73 115.02 22.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.107 1.763 . . . . 0.0 112.32 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -124.63 117.26 23.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.474 1.51 . . . . 0.0 110.006 172.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -103.05 170.73 7.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.719 1.607 . . . . 0.0 112.425 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.75 -173.66 4.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.896 1.278 . . . . 0.0 112.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -40.16 -58.36 1.49 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 127.422 2.289 . . . . 0.0 114.031 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.2 t -136.39 -20.95 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.816 1.647 . . . . 0.0 113.341 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 21.9 ptm -90.18 132.93 35.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.871 1.268 . . . . 0.0 111.699 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.22 131.9 55.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.124 1.37 . . . . 0.0 109.873 172.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.458 ' HB3' HG23 ' B' ' 214' ' ' ILE . 1.6 p -137.95 68.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.593 1.557 . . . . 0.0 111.941 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pp -85.36 138.27 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.122 0.969 . . . . 0.0 111.949 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.95 144.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.822 2.049 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 t -139.32 122.61 17.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.001 1.72 . . . . 0.0 109.781 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -125.62 143.07 51.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.974 1.71 . . . . 0.0 113.625 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -140.48 126.3 19.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.993 0.917 . . . . 0.0 111.103 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.62 70.06 0.22 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.915 2.198 . . . . 0.0 110.881 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.45 130.46 43.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.104 0.962 . . . . 0.0 111.227 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 CA--C 1.538 0.496 0 C-N-CA 126.251 1.82 . . . . 0.0 111.512 -162.056 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-O 120.675 0.274 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -130.26 167.26 18.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.831 1.252 . . . . 0.0 111.883 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -50.2 133.64 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.402 2.281 . . . . 0.0 111.354 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 55.3 m -101.74 91.0 4.21 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.395 1.478 . . . . 0.0 109.697 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.76 148.14 34.98 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.739 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' B' ' 224' ' ' THR . 4.0 p -137.68 92.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 108.816 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -134.55 165.54 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.441 1.896 . . . . 0.0 111.548 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 125.02 1.328 . . . . 0.0 111.509 177.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.895 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -66.89 171.56 5.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.662 1.585 . . . . 0.0 112.78 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.81 147.97 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.638 1.575 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.9 -40.2 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.26 1.024 . . . . 0.0 111.877 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.4 -32.54 70.27 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.855 1.262 . . . . 0.0 113.12 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.65 -55.92 6.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.411 1.084 . . . . 0.0 110.294 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.15 -43.85 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.834 1.254 . . . . 0.0 112.794 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -63.92 -6.32 5.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.305 1.442 . . . . 0.0 114.167 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -113.17 -34.28 5.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.152 2.181 . . . . 0.0 112.313 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -43.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.041 1.337 . . . . 0.0 110.586 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.82 -43.16 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.45 -0.781 . . . . 0.0 112.883 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -52.04 50.88 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.363 0.983 . . . . 0.0 111.675 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -31.85 72.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.43 63.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.45 ' HA ' HG21 ' A' ' 48' ' ' VAL . 58.2 mt -58.05 -55.44 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.244 0.929 . . . . 0.0 109.972 173.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.07 -30.84 70.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 t -61.21 -43.23 99.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.892 0.877 . . . . 0.0 112.396 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.34 -36.37 79.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.272 1.029 . . . . 0.0 113.479 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.61 -42.05 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.385 1.074 . . . . 0.0 110.996 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.11 57.96 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.837 1.208 . . . . 0.0 115.218 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.3 22.93 71.42 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.658 1.123 . . . . 0.0 114.656 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.24 -177.55 0.54 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.005 1.322 . . . . 0.0 112.434 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.25 141.43 8.54 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.836 1.254 . . . . 0.0 112.714 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -66.57 104.9 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.774 1.229 . . . . 0.0 110.929 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -124.15 114.94 20.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.019 1.727 . . . . 0.0 110.797 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -77.47 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.862 0.865 . . . . 0.0 112.603 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -57.57 -25.13 59.53 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.373 -1.455 . . . . 0.0 114.06 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -57.99 -30.57 66.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.6 t -52.85 -34.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.359 0.981 . . . . 0.0 111.851 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -64.34 -50.99 65.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.641 1.176 . . . . 0.0 112.641 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -66.81 -28.06 68.06 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.272 -0.893 . . . . 0.0 112.721 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.95 -54.56 6.69 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.673 0.789 . . . . 0.0 111.214 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -58.43 -26.1 62.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.579 0.751 . . . . 0.0 112.76 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 t -83.56 -54.23 5.09 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.217 0.917 . . . . 0.0 112.961 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -58.76 -38.73 79.1 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.916 1.235 . . . . 0.0 113.344 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 27' ' ' ILE . 71.8 t -68.66 -63.71 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 124.035 0.934 . . . . 0.0 109.833 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.39 -29.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.895 1.278 . . . . 0.0 111.175 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.42 -46.51 86.33 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -95.31 -41.15 9.17 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.835 1.254 . . . . 0.0 112.541 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 m -52.92 -55.97 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.552 2.341 . . . . 0.0 112.463 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' CG ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -62.23 -37.32 84.91 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.161 0.437 . . . . 0.0 110.984 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -60.82 -46.53 90.17 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 112.515 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.18 -49.92 75.73 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.653 1.981 . . . . 0.0 113.015 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.57 -28.33 66.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 m -58.95 -27.54 65.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.884 0.874 . . . . 0.0 111.72 165.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -87.87 -23.31 24.01 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.55 -15.19 63.22 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.07 -99.86 0.21 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.678 0.656 . . . . 0.0 113.795 172.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -94.31 109.47 42.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.663 1.185 . . . . 0.0 112.87 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.77 103.12 1.7 Allowed 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.968 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -141.78 163.41 32.97 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.796 1.638 . . . . 0.0 113.733 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -68.61 101.9 1.38 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.068 1.747 . . . . 0.0 112.204 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.461 ' CG ' HD12 ' A' ' 53' ' ' LEU . 54.4 p90 -81.43 173.52 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.689 1.596 . . . . 0.0 112.107 164.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.459 HD11 ' SG ' ' B' ' 228' ' ' CYS . 2.6 tt -142.39 154.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.375 1.87 . . . . 0.0 109.464 162.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 110' ' ' ALA . 10.4 m -143.49 145.31 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.997 1.719 . . . . 0.0 109.658 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -142.75 155.9 44.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.472 1.109 . . . . 0.0 110.192 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.4 p -148.29 156.43 42.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.041 0.937 . . . . 0.0 112.938 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.86 132.15 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.223 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.51 111.33 35.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 127.324 2.25 . . . . 0.0 107.532 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.1 ttt -117.05 154.12 31.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.13 0.972 . . . . 0.0 111.392 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.52 153.08 20.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.823 1.249 . . . . 0.0 111.964 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -60.77 -16.35 39.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.775 1.63 . . . . 0.0 114.546 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -58.37 -26.99 63.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.043 1.337 . . . . 0.0 112.788 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.52 27.1 72.95 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.146 0.879 . . . . 0.0 114.598 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.66 151.68 10.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.569 1.147 . . . . 0.0 113.527 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.8 102.95 1.04 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.522 1.058 . . . . 0.0 114.173 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 pp -143.6 147.61 34.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.11 2.564 . . . . 0.0 109.549 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -134.65 132.28 38.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.416 ' HB ' HG13 ' A' ' 135' ' ' VAL . 48.4 m -133.28 139.15 46.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.243 1.017 . . . . 0.0 109.886 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.75 124.05 12.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.537 0.735 . . . . 0.0 110.933 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.9 p -130.51 137.98 50.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.792 0.806 . . . . 0.0 111.649 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.4 m -81.41 13.64 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.454 -0.779 . . . . 0.0 112.69 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' B' ' 209' ' ' ILE . 8.2 m -60.07 161.46 6.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.006 0.908 . . . . 0.0 111.92 169.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -157.53 136.57 11.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.717 1.607 . . . . 0.0 109.539 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 163.87 27.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.718 0.407 . . . . 0.0 111.098 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -140.02 155.31 47.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.423 1.089 . . . . 0.0 111.508 168.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -118.28 -63.34 1.43 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.889 2.076 . . . . 0.0 111.753 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -109.63 -28.94 8.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.315 1.446 . . . . 0.0 112.173 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -42.73 85.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.708 2.403 . . . . 0.0 112.994 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.93 -175.59 5.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.864 1.665 . . . . 0.0 112.185 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.73 153.26 20.86 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.628 1.109 . . . . 0.0 114.185 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 t -163.27 163.17 25.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.424 1.89 . . . . 0.0 110.554 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 8.1 p -167.91 149.79 5.47 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.984 1.714 . . . . 0.0 111.327 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -145.33 144.46 30.73 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.116 -1.615 . . . . 0.0 111.679 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -143.29 126.31 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.112 1.365 . . . . 0.0 110.604 -161.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -127.83 122.44 32.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 -170.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -133.49 104.41 6.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.786 1.634 . . . . 0.0 110.293 -174.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.59 168.05 9.94 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.1 . . . . 0.0 112.394 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -145.29 -176.18 5.0 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.781 0.832 . . . . 0.0 112.548 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -49.84 -51.89 36.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.944 1.698 . . . . 0.0 113.874 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.4 t -132.95 -47.27 0.86 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.7 ptp -67.08 170.83 6.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.587 0.755 . . . . 0.0 112.411 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -146.11 147.46 31.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.5 1.52 . . . . 0.0 109.557 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 28.9 p -128.26 143.6 51.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.244 1.021 . . . . 0.0 112.606 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.37 119.85 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.584 1.554 . . . . 0.0 110.102 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 t -104.99 136.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.828 1.651 . . . . 0.0 109.571 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.9 t -131.26 123.58 28.69 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 110.601 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.55 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -109.68 149.56 29.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.858 1.663 . . . . 0.0 111.791 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -141.31 152.32 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.832 1.253 . . . . 0.0 110.657 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.09 85.41 0.23 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.837 1.208 . . . . 0.0 112.074 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.29 121.4 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.353 1.461 . . . . 0.0 111.675 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.472 0.673 0 C-N-CA 124.546 1.138 . . . . 0.0 113.174 -169.148 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -130.81 177.6 7.29 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.448 1.499 . . . . 0.0 112.007 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.4 mm -51.6 138.13 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.908 2.083 . . . . 0.0 111.313 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.6 m -107.42 91.93 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.579 1.552 . . . . 0.0 110.818 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -93.19 148.82 21.69 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.326 -0.859 . . . . 0.0 111.294 171.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.416 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -144.31 115.47 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.022 2.129 . . . . 0.0 109.833 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -140.86 133.72 29.04 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.48 1.512 . . . . 0.0 111.157 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 . . . . . 0 CA--C 1.546 0.795 0 C-N-CA 126.172 1.789 . . . . 0.0 109.698 175.089 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 121.252 0.548 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.01 161.17 26.81 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.46 144.29 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.101 1.361 . . . . 0.0 112.897 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.32 -41.47 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.881 1.672 . . . . 0.0 112.232 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.37 -31.84 69.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.589 1.156 . . . . 0.0 113.178 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.87 -55.66 5.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.274 174.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 58.2 t -44.72 -46.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.158 1.783 . . . . 0.0 112.842 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -63.95 -7.03 7.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.732 1.613 . . . . 0.0 114.429 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -111.03 -33.66 6.43 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.569 2.348 . . . . 0.0 112.196 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 30.2 mt -50.14 -42.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.043 1.337 . . . . 0.0 110.644 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.45 -43.79 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.343 -0.848 . . . . 0.0 112.929 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -52.36 50.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.358 0.981 . . . . 0.0 111.519 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.76 72.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.71 62.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.124 0.97 . . . . 0.0 113.313 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.431 ' HA ' HG21 ' B' ' 191' ' ' VAL . 56.4 mt -57.49 -55.33 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.158 0.89 . . . . 0.0 109.88 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.08 -31.08 70.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 18.0 t -61.17 -42.95 99.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.858 0.863 . . . . 0.0 112.354 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.31 77.5 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.264 1.025 . . . . 0.0 113.586 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.25 -42.43 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.38 1.072 . . . . 0.0 110.88 173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.91 58.21 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.982 1.277 . . . . 0.0 115.173 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.74 23.39 70.71 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.585 1.088 . . . . 0.0 114.598 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.12 -177.18 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.043 1.337 . . . . 0.0 112.488 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -48.76 141.75 7.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.722 1.209 . . . . 0.0 112.571 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.93 101.47 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.566 1.146 . . . . 0.0 110.862 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -117.8 114.44 23.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.081 1.753 . . . . 0.0 110.542 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -74.15 -64.37 1.03 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.372 1.069 . . . . 0.0 112.546 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.9 m -56.63 -23.74 43.32 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -55.24 -28.79 55.75 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.7 -31.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.479 1.036 . . . . 0.0 112.89 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -65.34 -50.34 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.828 1.251 . . . . 0.0 112.207 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.91 -26.85 67.06 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.401 -0.812 . . . . 0.0 112.661 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.39 -53.95 7.04 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.818 0.847 . . . . 0.0 111.592 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.1 t -56.72 -28.49 61.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.588 0.631 . . . . 0.0 112.592 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.8 t -82.43 -55.81 4.27 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.341 0.973 . . . . 0.0 112.816 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -59.53 -39.27 83.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.078 1.308 . . . . 0.0 113.281 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' B' ' 170' ' ' ILE . 79.2 t -68.36 -63.91 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 C-N-CA 123.706 0.803 . . . . 0.0 109.625 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 96.2 t -49.9 -29.62 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -58.89 -46.94 86.67 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.599 0.636 . . . . 0.0 112.43 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -93.87 -40.2 10.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.756 1.222 . . . . 0.0 112.771 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 5.4 m -54.71 -56.03 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.746 2.418 . . . . 0.0 112.42 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -37.07 79.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.112 0.414 . . . . 0.0 110.602 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.6 t -62.41 -47.71 82.94 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.217 -0.927 . . . . 0.0 112.557 169.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -56.81 -47.35 80.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.871 1.668 . . . . 0.0 113.001 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.24 -18.93 59.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 89.1 m -61.69 -40.31 94.55 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.613 -0.679 . . . . 0.0 110.26 157.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -75.25 -19.58 59.65 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.874 -1.142 . . . . 0.0 113.896 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 10.5 mt -59.07 -20.23 51.43 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . 168.21 -54.07 0.22 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.724 1.147 . . . . 0.0 115.554 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -57.96 156.5 19.2 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 127.367 2.267 . . . . 0.0 113.735 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.18 160.17 42.9 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.985 2.457 . . . . 0.0 113.278 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.28 93.71 3.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.955 0.902 . . . . 0.0 113.003 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -165.41 85.26 0.37 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.024 1.33 . . . . 0.0 114.217 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.3 158.78 43.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.782 1.233 . . . . 0.0 112.194 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 85' ' ' CYS . 5.3 tt -138.57 156.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.112 2.165 . . . . 0.0 109.356 171.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' B' ' 253' ' ' ALA . 4.3 m -142.05 147.75 21.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.432 1.893 . . . . 0.0 110.054 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 14.6 t -143.02 154.55 44.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.72 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.73 157.46 43.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.35 1.06 . . . . 0.0 112.504 171.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 26.3 t -134.18 136.06 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.172 1.389 . . . . 0.0 109.141 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mm -108.95 108.82 26.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 127.365 2.266 . . . . 0.0 106.9 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 62.0 mtt -107.82 158.95 16.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.603 1.161 . . . . 0.0 110.848 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -119.14 150.87 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.882 1.273 . . . . 0.0 110.933 -174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -59.61 -17.11 30.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.694 1.598 . . . . 0.0 114.882 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -59.58 -30.0 68.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.376 1.471 . . . . 0.0 112.955 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.42 42.54 93.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.25 1.405 . . . . 0.0 114.405 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.33 175.63 0.42 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.528 1.531 . . . . 0.0 114.258 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.35 91.26 0.3 Allowed Glycine 0 CA--C 1.539 1.582 0 O-C-N 120.571 -1.331 . . . . 0.0 114.424 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.81 118.35 13.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.149 1.78 . . . . 0.0 113.122 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.12 133.04 55.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.694 0.798 . . . . 0.0 110.076 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.472 ' HB ' HG13 ' B' ' 278' ' ' VAL . 50.5 m -135.47 141.89 45.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.876 0.87 . . . . 0.0 110.283 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.13 128.62 18.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.5 p -132.6 139.43 47.78 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.669 0.747 . . . . 0.0 111.509 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -82.46 12.5 4.47 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.562 -0.711 . . . . 0.0 112.605 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . 0.459 ' SG ' HD11 ' A' ' 66' ' ' ILE . 4.3 m -60.7 161.65 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.988 0.899 . . . . 0.0 111.895 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -158.73 139.36 12.64 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.481 1.513 . . . . 0.0 109.582 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . 0.408 ' CZ2' ' HB2' ' B' ' 232' ' ' SER . 0.0 OUTLIER -72.41 161.63 30.57 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.834 171.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -137.98 149.74 46.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.722 1.209 . . . . 0.0 110.319 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . 0.408 ' HB2' ' CZ2' ' B' ' 230' ' ' TRP . 1.8 t -112.05 -63.27 1.45 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.785 2.034 . . . . 0.0 112.125 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 8.5 t -109.82 -26.18 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.442 1.497 . . . . 0.0 112.237 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -41.41 75.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.627 2.771 . . . . 0.0 113.193 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.54 -173.89 4.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.912 2.085 . . . . 0.0 110.589 -172.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -98.86 158.57 20.2 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.437 1.017 . . . . 0.0 114.078 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.3 t -166.44 163.21 17.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.114 1.766 . . . . 0.0 110.621 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.57 141.45 2.38 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.2 1.8 . . . . 0.0 111.091 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -142.59 146.75 34.89 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 119.955 -1.716 . . . . 0.0 111.949 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -141.3 146.43 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.884 1.273 . . . . 0.0 110.353 -168.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -137.79 126.77 24.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 112.544 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -135.86 102.38 5.04 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.753 1.621 . . . . 0.0 109.984 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.51 164.84 13.23 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.983 -1.073 . . . . 0.0 112.242 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -141.71 -177.62 5.27 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.407 1.083 . . . . 0.0 111.691 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -47.81 -51.43 22.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.295 1.838 . . . . 0.0 114.088 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.1 t -132.05 -48.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.532 1.533 . . . . 0.0 111.996 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.74 173.96 3.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.076 0.95 . . . . 0.0 112.655 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.62 146.32 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.381 1.472 . . . . 0.0 109.829 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.5 p -127.49 143.04 51.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.055 0.931 . . . . 0.0 112.424 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.08 127.88 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.628 1.571 . . . . 0.0 109.56 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.24 123.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.378 1.471 . . . . 0.0 110.16 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.2 t -119.53 115.6 24.36 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.149 0.979 . . . . 0.0 110.116 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.561 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -97.38 153.78 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.795 1.238 . . . . 0.0 111.826 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -142.05 149.77 40.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.345 1.458 . . . . 0.0 110.091 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -135.08 80.55 0.31 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 124.972 1.272 . . . . 0.0 113.003 -171.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.21 108.09 20.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.635 1.174 . . . . 0.0 112.087 -167.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.67 0 C-N-CA 126.56 1.944 . . . . 0.0 113.172 -170.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.14 177.94 7.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.427 1.491 . . . . 0.0 112.087 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.1 mm -51.69 140.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 126.991 2.116 . . . . 0.0 111.354 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 71.6 m -110.93 91.84 3.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.589 1.555 . . . . 0.0 110.702 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -94.77 149.38 21.31 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.428 -0.795 . . . . 0.0 111.323 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.472 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.9 p -149.32 118.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.04 1.736 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.87 138.14 30.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.764 1.625 . . . . 0.0 110.663 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 126.145 1.778 . . . . 0.0 109.373 175.502 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 121.342 0.592 . . . . 0.0 112.071 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -69.16 166.07 19.08 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.463 0.705 . . . . 0.0 112.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -135.53 159.57 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.714 1.206 . . . . 0.0 111.729 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.08 -38.33 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.439 1.096 . . . . 0.0 112.608 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.91 -27.97 68.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.859 1.264 . . . . 0.0 113.042 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -76.34 -56.41 4.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.711 0.804 . . . . 0.0 110.801 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.3 t -52.49 -39.59 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.157 1.383 . . . . 0.0 112.615 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.18 -15.06 12.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.612 1.565 . . . . 0.0 114.276 174.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -108.58 -35.49 6.44 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.327 1.851 . . . . 0.0 112.786 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.32 -42.9 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.459 1.027 . . . . 0.0 110.581 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.84 -43.41 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.598 -0.689 . . . . 0.0 112.53 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -54.02 31.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.605 1.093 . . . . 0.0 111.405 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.68 75.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.23 62.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.667 0.787 . . . . 0.0 112.811 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' HG21 ' A' ' 48' ' ' VAL . 60.0 mt -60.23 -57.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.113 0.869 . . . . 0.0 109.885 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.74 -31.75 71.06 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -58.84 -50.4 74.13 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.441 1.096 . . . . 0.0 112.182 168.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.63 -33.22 75.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.15 -37.72 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.836 1.254 . . . . 0.0 111.337 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.86 16.96 78.16 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.071 0.843 . . . . 0.0 114.54 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.9 8.49 72.67 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.172 1.368 . . . . 0.0 116.001 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.78 150.74 15.56 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 118.934 1.367 . . . . 0.0 113.747 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -175.77 3.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.168 1.787 . . . . 0.0 112.197 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -37.39 136.1 0.5 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 129.046 2.939 . . . . 0.0 114.995 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -134.94 174.5 10.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.519 1.528 . . . . 0.0 112.968 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.06 -93.06 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.4 1.48 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 p -98.99 4.9 47.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.332 2.253 . . . . 0.0 113.398 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -50.76 -43.76 58.45 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.019 -1.051 . . . . 0.0 112.689 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.21 -35.17 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.392 1.077 . . . . 0.0 112.687 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -67.81 -49.64 61.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 112.532 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.14 -26.78 67.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.092 -1.005 . . . . 0.0 112.576 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -75.23 -55.75 5.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.814 1.246 . . . . 0.0 111.182 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t -58.38 -23.5 57.2 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.549 -0.739 . . . . 0.0 112.99 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -85.1 -54.98 4.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.793 1.179 . . . . 0.0 112.368 169.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -57.78 -35.63 71.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.922 1.237 . . . . 0.0 113.782 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 27' ' ' ILE . 96.1 t -75.15 -67.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 124.318 1.047 . . . . 0.0 109.688 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.13 -28.42 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.695 1.198 . . . . 0.0 111.226 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -52.22 -57.86 8.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.698 0.799 . . . . 0.0 112.908 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -90.61 -39.81 12.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.545 1.138 . . . . 0.0 112.396 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.7 m -57.2 -53.93 52.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.122 2.169 . . . . 0.0 112.514 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.99 -37.99 84.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.71 0.686 . . . . 0.0 111.722 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -63.24 -40.28 96.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 0.0 112.379 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.95 -50.77 61.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.528 1.931 . . . . 0.0 113.189 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.46 -24.1 65.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 53.5 m -59.2 -30.42 68.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.218 1.007 . . . . 0.0 111.262 165.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -90.6 -22.71 21.1 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.51 -15.22 60.5 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.42 -126.51 1.57 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.713 1.149 . . . . 0.0 112.442 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 5.3 mmpt? -55.78 112.09 3.89 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.957 1.703 . . . . 0.0 112.957 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.53 108.98 2.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.441 2.761 . . . . 0.0 111.748 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -144.56 179.81 7.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.446 1.898 . . . . 0.0 111.005 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -90.88 128.14 36.64 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 166.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 112' ' ' GLY . 24.0 m-85 -113.88 145.43 41.48 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.907 1.683 . . . . 0.0 108.847 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 tt -122.75 153.65 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.232 1.013 . . . . 0.0 110.045 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.51 151.79 28.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.49 1.916 . . . . 0.0 109.032 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.63 138.69 47.44 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.051 1.74 . . . . 0.0 108.46 166.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.88 138.45 37.44 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.02 126.79 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.342 1.457 . . . . 0.0 108.911 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.0 mm -117.64 94.66 3.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 127.358 2.263 . . . . 0.0 107.442 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.61 107.84 12.44 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.728 1.611 . . . . 0.0 110.642 -168.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -66.65 135.2 53.73 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.318 -0.864 . . . . 0.0 112.198 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -8.4 2.94 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.093 1.757 . . . . 0.0 115.498 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -16.8 49.69 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.079 2.152 . . . . 0.0 113.773 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.68 -3.04 5.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.068 1.318 . . . . 0.0 115.761 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 45.71 0.28 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.824 1.65 . . . . 0.0 113.974 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 161.6 33.52 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.914 1.245 . . . . 0.0 113.394 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.732 HD13 HD11 ' B' ' 222' ' ' LEU . 1.6 pt? -151.82 -171.66 4.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.595 1.558 . . . . 0.0 112.085 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.96 138.11 41.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.401 0.546 . . . . 0.0 111.149 168.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.7 m -142.76 144.68 32.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.336 1.454 . . . . 0.0 110.12 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.34 144.19 31.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.8 p -145.88 140.7 27.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.015 0.912 . . . . 0.0 112.264 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 t -78.87 23.33 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.28 1.032 . . . . 0.0 112.584 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.9 m -67.07 171.19 5.82 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.304 -0.873 . . . . 0.0 111.648 165.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -163.44 149.74 11.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.741 2.416 . . . . 0.0 108.557 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -81.26 134.96 35.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.07 0.85 . . . . 0.0 109.594 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.38 127.23 5.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.229 . . . . 0.0 111.564 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -113.8 -31.96 6.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.597 1.559 . . . . 0.0 112.161 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -80.1 -38.46 31.6 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.803 1.641 . . . . 0.0 112.556 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -53.75 5.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.068 1.347 . . . . 0.0 112.405 -171.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -139.99 -161.27 1.17 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.927 2.491 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.82 153.5 16.93 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.831 -1.168 . . . . 0.0 113.754 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 p -155.62 154.83 32.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.729 1.612 . . . . 0.0 111.259 170.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 34.1 t -153.58 97.54 2.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.707 1.203 . . . . 0.0 111.797 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t -90.04 146.19 24.53 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.03 -1.044 . . . . 0.0 112.268 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.68 131.68 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.037 1.735 . . . . 0.0 109.265 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -119.79 128.7 53.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.525 1.53 . . . . 0.0 110.736 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -131.81 159.76 37.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.205 1.402 . . . . 0.0 110.089 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.5 144.68 42.32 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.201 -0.937 . . . . 0.0 111.0 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -117.31 -173.01 2.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.75 1.22 . . . . 0.0 109.318 -165.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -48.6 70.14 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 120.953 -1.092 . . . . 0.0 113.667 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 t -140.73 -17.82 0.86 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.908 2.083 . . . . 0.0 113.129 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.0 mtm -91.28 170.37 10.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.669 1.587 . . . . 0.0 111.09 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -138.02 161.17 37.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.874 0.869 . . . . 0.0 110.73 163.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.0 p -141.62 136.44 30.98 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.049 0.94 . . . . 0.0 111.301 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.2 119.45 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.869 1.268 . . . . 0.0 109.982 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.19 129.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.924 1.289 . . . . 0.0 110.661 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -121.47 106.86 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.274 0.63 . . . . 0.0 111.745 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.81 138.84 33.04 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -129.15 126.06 38.43 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.844 1.658 . . . . 0.0 110.335 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 65' ' ' TYR . . . -126.17 73.65 0.43 Allowed Glycine 0 CA--C 1.524 0.61 0 C-N-CA 126.782 2.134 . . . . 0.0 111.671 -171.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.42 123.11 17.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.964 1.306 . . . . 0.0 110.081 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.894 1.677 . . . . 0.0 111.54 -162.805 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.544 0 N-CA-C 111.257 0.095 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -130.95 174.8 9.64 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.07 1.348 . . . . 0.0 111.833 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 136.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 111.418 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.0 m -94.74 96.42 9.37 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.288 1.435 . . . . 0.0 110.411 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -95.52 145.93 24.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.944 -1.097 . . . . 0.0 111.015 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.65 118.37 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.207 2.203 . . . . 0.0 109.349 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -137.75 150.37 47.2 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.306 -0.871 . . . . 0.0 112.053 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.539 0.541 0 C-N-CA 125.203 1.401 . . . . 0.0 110.96 -178.732 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 121.205 0.526 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.05 155.73 40.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.3 p -131.07 158.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.174 1.39 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.22 -35.94 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.779 2.032 . . . . 0.0 111.784 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.29 -31.96 66.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.439 1.096 . . . . 0.0 113.122 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -82.52 -51.12 8.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.499 -0.751 . . . . 0.0 110.491 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 90.2 t -51.0 -39.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.733 1.213 . . . . 0.0 112.511 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -61.15 -16.4 44.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.236 1.814 . . . . 0.0 114.493 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -104.18 -34.63 8.31 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.224 1.809 . . . . 0.0 112.526 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 36.1 mt -51.51 -43.59 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.133 0.878 . . . . 0.0 110.804 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.96 -43.16 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.702 -0.624 . . . . 0.0 112.318 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -54.66 24.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.601 1.091 . . . . 0.0 111.453 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -34.38 75.29 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.75 60.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 112.899 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.416 ' HA ' HG21 ' B' ' 191' ' ' VAL . 58.1 mt -59.84 -56.81 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.113 0.87 . . . . 0.0 109.61 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.41 -32.35 71.25 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 40.5 t -58.56 -50.4 73.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.515 1.126 . . . . 0.0 112.17 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.29 75.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 92.7 mt -61.94 -37.95 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.873 1.269 . . . . 0.0 111.22 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.06 17.04 78.45 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.045 0.831 . . . . 0.0 114.448 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.89 8.6 72.5 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.132 1.349 . . . . 0.0 115.967 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.85 151.22 14.87 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.947 1.373 . . . . 0.0 113.652 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.34 -173.17 2.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 112.23 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -39.79 137.71 0.87 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.732 2.813 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -136.84 174.09 11.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.516 1.526 . . . . 0.0 112.831 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -87.77 -92.44 0.11 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.416 1.486 . . . . 0.0 112.224 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 19.1 p -99.84 5.15 45.49 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.345 2.258 . . . . 0.0 113.248 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -50.76 -43.7 58.44 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.05 -1.031 . . . . 0.0 112.674 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.02 -35.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.331 1.052 . . . . 0.0 112.711 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.71 -49.81 60.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.475 1.11 . . . . 0.0 112.489 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.91 -26.91 67.82 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.621 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -75.09 -55.74 5.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.807 1.243 . . . . 0.0 111.215 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.1 t -58.95 -21.63 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 4.8 t -86.51 -55.6 3.81 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.824 1.193 . . . . 0.0 112.412 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -57.48 -35.95 70.85 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.045 1.293 . . . . 0.0 113.82 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' B' ' 170' ' ' ILE . 94.9 t -74.79 -67.16 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.382 1.073 . . . . 0.0 109.543 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.63 -29.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.797 1.239 . . . . 0.0 111.049 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.59 -55.27 23.46 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.29 -37.89 11.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.772 1.229 . . . . 0.0 112.571 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -60.07 -53.04 62.51 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.006 2.122 . . . . 0.0 112.731 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.02 -35.8 81.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.696 0.68 . . . . 0.0 112.043 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t -60.65 -50.42 73.56 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.726 0.81 . . . . 0.0 111.308 169.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -58.37 -51.17 70.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.522 1.929 . . . . 0.0 113.586 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.2 -23.03 63.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -61.17 -41.01 96.02 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -74.57 -24.08 58.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.42 -11.33 9.98 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -159.81 -73.65 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.942 1.246 . . . . 0.0 114.807 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -65.99 168.45 9.1 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 126.756 2.022 . . . . 0.0 113.318 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.38 173.54 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.223 2.615 . . . . 0.0 112.05 171.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.82 94.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.404 1.482 . . . . 0.0 113.04 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -158.13 107.06 2.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.596 1.959 . . . . 0.0 111.916 168.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -154.68 165.34 36.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.977 1.711 . . . . 0.0 111.031 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.8 tt -147.72 156.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 126.174 1.79 . . . . 0.0 108.864 160.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.13 152.46 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.289 1.836 . . . . 0.0 109.657 162.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.6 p -132.85 138.94 47.21 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.104 1.762 . . . . 0.0 108.518 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.75 145.7 38.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.879 0.847 . . . . 0.0 112.745 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.35 131.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.983 1.313 . . . . 0.0 109.224 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -118.71 93.45 2.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 127.215 2.206 . . . . 0.0 107.358 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.6 90.85 3.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 109.888 -172.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.53 153.22 13.34 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.457 -1.402 . . . . 0.0 113.533 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -7.79 53.7 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -16.91 56.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.441 1.896 . . . . 0.0 114.108 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 -3.18 6.38 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.176 1.231 . . . . 0.0 116.176 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -74.1 51.99 0.43 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.427 1.491 . . . . 0.0 113.287 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.05 30.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.652 1.596 . . . . 0.0 112.842 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.732 HD11 HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -159.69 -173.8 4.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.32 1.848 . . . . 0.0 110.804 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.41 139.26 40.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.842 0.747 . . . . 0.0 111.002 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.45 ' HB ' HG13 ' B' ' 278' ' ' VAL . 53.4 m -142.74 145.12 33.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.803 1.241 . . . . 0.0 110.142 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.71 38.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.433 1.093 . . . . 0.0 110.729 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 69.4 p -145.88 142.2 28.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.892 0.853 . . . . 0.0 112.07 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 9.5 t -80.79 25.81 0.43 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.975 0.91 . . . . 0.0 112.496 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 58.9 m -67.51 171.35 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.334 -0.854 . . . . 0.0 111.599 164.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -166.44 154.33 10.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.921 2.489 . . . . 0.0 108.83 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -81.61 132.09 35.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.428 -0.795 . . . . 0.0 110.014 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -152.78 116.46 4.77 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.046 1.338 . . . . 0.0 112.512 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.3 t -107.02 -34.05 7.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.397 1.479 . . . . 0.0 112.393 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 12.2 p -80.01 -36.09 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.986 1.314 . . . . 0.0 112.32 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -56.6 3.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.242 1.417 . . . . 0.0 111.802 -174.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -155.57 0.65 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.581 2.352 . . . . 0.0 109.341 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.59 153.5 16.79 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 120.728 -1.233 . . . . 0.0 113.556 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 25.8 p -156.79 147.18 21.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.211 1.404 . . . . 0.0 112.315 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.981 1.312 . . . . 0.0 111.838 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 14.2 t -86.57 146.4 26.37 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.034 -1.041 . . . . 0.0 112.205 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 t -139.39 135.96 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 109.267 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.34 129.79 51.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.538 1.535 . . . . 0.0 110.848 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -132.63 159.03 40.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.225 1.41 . . . . 0.0 110.035 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -136.64 144.16 43.87 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.026 -1.046 . . . . 0.0 111.028 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.9 -173.5 2.4 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.61 1.164 . . . . 0.0 109.454 -165.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -50.97 65.44 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.996 -1.065 . . . . 0.0 113.654 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.6 t -140.17 -10.94 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.064 1.746 . . . . 0.0 113.43 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.0 mtm -94.25 169.27 10.36 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 110.542 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -139.56 157.87 45.08 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 111.262 165.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.1 p -141.27 138.57 33.31 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.933 . . . . 0.0 111.876 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.66 126.83 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.877 1.271 . . . . 0.0 109.937 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.54 129.3 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.443 1.497 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -121.8 106.55 11.38 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.401 0.68 . . . . 0.0 111.9 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.99 140.93 29.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -131.57 115.54 16.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.142 1.777 . . . . 0.0 109.701 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.85 76.23 0.22 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.573 2.035 . . . . 0.0 111.028 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.08 123.38 20.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.838 0.855 . . . . 0.0 112.263 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.468 0.441 0 C-N-CA 126.112 1.765 . . . . 0.0 112.058 -165.529 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -131.71 175.1 9.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 111.929 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 mm -52.86 140.5 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.662 1.985 . . . . 0.0 111.64 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 90.4 m -99.06 93.95 6.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.372 1.469 . . . . 0.0 110.332 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -94.26 146.82 23.75 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.036 -1.04 . . . . 0.0 110.778 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.45 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.9 p -148.6 120.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.384 1.874 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.09 152.15 48.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.033 0.933 . . . . 0.0 112.075 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 125.223 1.409 . . . . 0.0 111.114 -179.624 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 121.151 0.5 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.49 158.66 31.36 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.399 -0.813 . . . . 0.0 112.534 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.55 141.49 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.774 0.83 . . . . 0.0 111.852 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.12 -42.89 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.858 1.663 . . . . 0.0 111.327 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.95 -31.48 60.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 113.311 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -86.64 -53.34 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.044 0.937 . . . . 0.0 111.701 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.696 HG13 HD22 ' A' ' 56' ' ' LEU . 54.3 t -44.14 -48.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.836 1.255 . . . . 0.0 112.605 169.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -65.31 -3.18 3.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.396 1.478 . . . . 0.0 113.919 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.54 -31.67 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.236 1.815 . . . . 0.0 112.274 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -50.87 -44.71 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.369 0.986 . . . . 0.0 110.437 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 97' ' ' VAL . 9.0 p -59.81 -41.85 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -51.93 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.747 1.158 . . . . 0.0 111.585 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -33.32 75.27 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.05 69.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.396 1.079 . . . . 0.0 113.091 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.5 mt -59.86 -56.64 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.258 0.936 . . . . 0.0 110.274 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -60.45 -31.59 70.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.1 t -59.19 -46.68 87.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.32 1.048 . . . . 0.0 112.499 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.94 81.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.401 1.08 . . . . 0.0 113.815 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.95 -43.43 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 110.713 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.35 14.02 61.29 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.59 1.091 . . . . 0.0 115.066 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.78 85.87 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.139 1.352 . . . . 0.0 115.105 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -63.84 168.15 5.35 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 118.735 1.267 . . . . 0.0 112.55 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.63 102.03 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.203 1.801 . . . . 0.0 111.657 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.84 139.07 46.93 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.64 1.976 . . . . 0.0 112.499 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.23 156.98 43.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -57.89 -53.49 57.66 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.7 m -69.92 -26.36 64.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -58.7 -45.7 88.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.042 0.537 . . . . 0.0 112.182 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -56.91 -35.13 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.842 0.746 . . . . 0.0 112.424 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.89 -47.52 80.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.989 0.915 . . . . 0.0 111.621 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -67.81 -24.06 65.25 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -78.93 -52.57 8.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.132 0.878 . . . . 0.0 111.555 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -55.01 -35.23 64.18 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.665 0.666 . . . . 0.0 112.135 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -75.89 -55.76 5.32 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.205 0.911 . . . . 0.0 112.593 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.92 -38.03 75.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.911 1.284 . . . . 0.0 113.532 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.22 -62.32 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 C-N-CA 123.92 0.888 . . . . 0.0 110.384 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.61 -29.84 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.632 1.173 . . . . 0.0 110.75 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.53 -30.61 69.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.753 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -112.53 -42.24 3.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.995 1.718 . . . . 0.0 112.257 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -51.85 -55.58 19.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.5 2.32 . . . . 0.0 112.577 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -37.99 87.38 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.412 0.625 . . . . 0.0 110.989 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.6 m -67.15 -28.36 68.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.22 -52.38 10.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.555 2.342 . . . . 0.0 112.249 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.696 HD22 HG13 ' A' ' 19' ' ' VAL . 3.7 pp -65.74 -25.53 67.32 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -55.38 -37.03 67.02 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.367 1.067 . . . . 0.0 110.913 166.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -81.79 -34.13 30.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.494 0.718 . . . . 0.0 112.712 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -69.74 -28.91 66.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.366 0.666 . . . . 0.0 111.013 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.67 -118.79 4.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.045 1.783 . . . . 0.0 113.256 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -133.89 151.98 77.82 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.696 1.598 . . . . 0.0 113.606 -171.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 113.77 3.86 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.929 3.086 . . . . 0.0 112.214 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -147.62 171.7 15.19 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.299 1.839 . . . . 0.0 110.663 171.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.9 135.86 48.24 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.741 0.781 . . . . 0.0 110.84 162.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -131.13 157.49 42.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 128.014 2.526 . . . . 0.0 108.208 170.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -138.56 155.18 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.178 1.391 . . . . 0.0 109.144 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 110' ' ' ALA . 13.0 m -139.23 148.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 124.751 1.221 . . . . 0.0 110.374 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -145.83 154.05 41.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.304 1.042 . . . . 0.0 110.53 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.5 p -146.07 149.51 34.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.275 1.03 . . . . 0.0 112.854 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.73 111.33 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.841 1.656 . . . . 0.0 109.402 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.564 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.3 mm -107.33 96.47 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.523 1.529 . . . . 0.0 107.481 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.64 89.4 2.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.885 1.274 . . . . 0.0 111.247 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -166.15 120.43 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.473 1.909 . . . . 0.0 107.966 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -152.59 -64.56 0.16 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.757 1.223 . . . . 0.0 111.304 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.2 -15.61 13.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.638 1.575 . . . . 0.0 113.507 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.44 -11.66 33.27 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.273 1.892 . . . . 0.0 114.533 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.52 117.44 9.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.219 1.408 . . . . 0.0 111.938 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.3 174.49 19.62 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.64 1.59 . . . . 0.0 114.095 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.92 -172.54 2.18 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.49 1.916 . . . . 0.0 111.599 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.78 108.56 20.41 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.527 -0.733 . . . . 0.0 110.241 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.3 m -120.41 137.72 54.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.831 0.852 . . . . 0.0 109.868 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.32 134.61 29.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.298 0.639 . . . . 0.0 111.683 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.3 p -132.28 134.99 45.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.972 0.892 . . . . 0.0 111.229 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -83.36 24.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.515 -0.74 . . . . 0.0 111.599 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.8 m -62.79 163.54 9.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.63 0.729 . . . . 0.0 111.288 164.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.05 136.84 5.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 108.986 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 149.79 48.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.412 0.685 . . . . 0.0 110.296 173.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -134.07 152.2 51.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.073 1.349 . . . . 0.0 110.794 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t -120.13 -65.42 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.4 1.08 . . . . 0.0 112.465 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.8 t -82.18 -35.75 28.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.043 0.838 . . . . 0.0 112.607 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -67.37 -36.5 81.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.227 1.411 . . . . 0.0 113.352 -171.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.17 179.14 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.36 2.264 . . . . 0.0 111.121 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 134.52 11.98 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.946 1.26 . . . . 0.0 113.14 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -150.5 139.53 21.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.768 1.627 . . . . 0.0 110.458 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . 0.459 ' SG ' HG11 ' A' ' 19' ' ' VAL . 5.5 p -151.48 120.27 6.58 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.913 0.779 . . . . 0.0 111.902 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -132.29 151.71 51.71 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 112.078 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 23' ' ' VAL . 1.7 t -139.5 139.76 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.605 1.562 . . . . 0.0 109.943 -170.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.05 131.98 50.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.983 1.313 . . . . 0.0 112.13 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -139.46 106.54 5.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.802 1.241 . . . . 0.0 110.926 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -86.38 148.81 25.41 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.986 0.914 . . . . 0.0 112.066 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -123.66 -176.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.755 1.622 . . . . 0.0 110.694 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -67.71 0.24 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.597 1.559 . . . . 0.0 113.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.5 t -117.32 8.19 13.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.405 1.882 . . . . 0.0 112.488 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.0 mtt -134.58 173.98 11.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.43 1.892 . . . . 0.0 111.069 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -151.45 161.99 41.72 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 109.794 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.564 ' CB ' HD12 ' A' ' 71' ' ' ILE . 10.3 p -132.27 151.21 51.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 110.406 171.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.49 137.8 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 109.257 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.24 140.13 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.939 1.296 . . . . 0.0 109.678 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -131.9 145.13 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.998 0.919 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.53 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -130.24 145.1 51.71 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.262 1.425 . . . . 0.0 111.934 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.1 151.63 51.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.772 1.629 . . . . 0.0 111.08 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.81 86.72 0.15 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.175 1.369 . . . . 0.0 111.353 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -78.14 122.39 25.58 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.993 1.317 . . . . 0.0 111.568 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 CA--C 1.537 0.472 0 C-N-CA 125.654 1.581 . . . . 0.0 112.302 -168.198 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.13 169.08 15.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.911 1.284 . . . . 0.0 111.836 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.2 mm -60.34 151.06 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.373 1.869 . . . . 0.0 111.275 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.2 m -124.59 95.23 4.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.971 1.708 . . . . 0.0 110.885 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -97.64 149.96 21.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.933 -1.104 . . . . 0.0 111.434 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.98 102.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.488 2.315 . . . . 0.0 109.045 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -142.45 115.84 9.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.614 1.166 . . . . 0.0 111.724 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 125.102 1.361 . . . . 0.0 110.91 -179.377 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 121.027 0.441 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -65.75 167.02 9.92 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.275 -0.89 . . . . 0.0 111.575 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.39 145.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.411 1.084 . . . . 0.0 111.315 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.38 -39.65 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.618 1.167 . . . . 0.0 111.925 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.36 -31.12 68.92 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.667 1.587 . . . . 0.0 113.312 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -74.0 -60.05 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.939 0.895 . . . . 0.0 110.172 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.66 HG13 HD22 ' B' ' 199' ' ' LEU . 40.3 t -54.23 -42.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.752 1.221 . . . . 0.0 113.143 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -64.74 -3.31 3.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.058 1.343 . . . . 0.0 113.747 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.37 -33.35 5.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.438 1.895 . . . . 0.0 112.432 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 39.1 mt -51.8 -43.14 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.497 1.044 . . . . 0.0 110.352 169.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 240' ' ' VAL . 9.0 p -59.97 -41.93 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.74 56.93 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.772 1.169 . . . . 0.0 111.52 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -33.74 76.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.0 71.71 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.228 1.011 . . . . 0.0 113.036 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.88 -56.97 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.241 0.928 . . . . 0.0 110.312 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -60.28 -31.67 70.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -59.27 -46.7 87.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.34 1.056 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.11 81.62 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.402 1.081 . . . . 0.0 113.797 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.82 -43.43 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.277 1.031 . . . . 0.0 110.734 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.86 13.77 62.06 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.493 1.044 . . . . 0.0 115.0 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.78 10.82 85.85 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.188 1.375 . . . . 0.0 115.027 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -63.79 168.25 5.19 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.694 1.247 . . . . 0.0 112.501 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.62 102.55 0.07 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.076 1.75 . . . . 0.0 111.598 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.95 138.65 48.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.573 1.949 . . . . 0.0 112.526 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.8 156.63 43.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.697 1.199 . . . . 0.0 111.422 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -57.98 -53.53 57.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -69.42 -26.88 64.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -58.59 -45.47 89.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 0.0 112.22 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 4.2 t -56.49 -35.66 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.832 0.742 . . . . 0.0 112.444 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -63.8 -47.46 80.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.87 0.868 . . . . 0.0 111.585 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -67.92 -23.93 65.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -78.84 -52.9 7.68 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.172 0.896 . . . . 0.0 111.406 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.8 t -54.96 -34.79 63.6 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.736 0.698 . . . . 0.0 112.185 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.4 t -75.79 -56.75 4.38 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.178 0.899 . . . . 0.0 112.636 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -57.23 -38.44 73.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.952 1.301 . . . . 0.0 113.646 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.9 -64.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 83.1 t -51.65 -29.28 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 110.677 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.88 -34.48 73.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.171 0.988 . . . . 0.0 113.548 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -110.69 -38.6 5.11 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.693 1.597 . . . . 0.0 112.355 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 22.1 m -55.29 -53.52 55.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.419 2.288 . . . . 0.0 111.753 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 7.6 tp -60.12 -36.01 76.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.259 0.481 . . . . 0.0 112.054 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 68.4 m -70.6 -30.73 67.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.964 0.906 . . . . 0.0 113.355 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -71.34 -52.12 20.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.903 2.081 . . . . 0.0 112.453 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.66 HD22 HG13 ' B' ' 162' ' ' VAL . 2.8 pp -64.93 -26.43 68.31 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 53.9 m -58.32 -30.46 66.71 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.941 0.896 . . . . 0.0 110.984 168.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -85.88 -36.28 20.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.817 0.847 . . . . 0.0 112.717 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.82 -23.8 66.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.968 0.907 . . . . 0.0 112.699 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.55 -112.68 3.71 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.153 1.359 . . . . 0.0 112.734 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -137.63 154.53 75.03 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.711 1.604 . . . . 0.0 113.237 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.48 115.32 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.682 2.921 . . . . 0.0 112.2 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.35 172.68 15.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.413 1.885 . . . . 0.0 110.686 171.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -71.81 132.16 44.06 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.568 -0.708 . . . . 0.0 110.907 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -129.31 147.68 51.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.736 1.614 . . . . 0.0 109.198 168.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.2 tt -128.38 154.81 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.397 1.479 . . . . 0.0 109.253 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' B' ' 253' ' ' ALA . 3.5 m -136.69 150.76 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.134 1.374 . . . . 0.0 111.055 172.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 18.6 p -137.83 151.95 48.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.601 1.561 . . . . 0.0 110.279 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.3 p -146.43 152.33 38.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.162 0.982 . . . . 0.0 113.003 168.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.51 114.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 108.974 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' B' ' 249' ' ' CYS . 3.1 mm -107.28 91.26 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.446 1.898 . . . . 0.0 107.648 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 2.2 ttt -98.73 135.94 39.5 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.374 1.47 . . . . 0.0 109.506 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -81.72 145.65 30.39 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.492 -0.755 . . . . 0.0 112.37 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -76.1 -0.16 20.94 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.289 1.435 . . . . 0.0 114.045 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.18 -21.31 13.1 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.424 1.89 . . . . 0.0 113.996 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.03 -12.27 62.23 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.703 1.621 . . . . 0.0 114.36 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.75 89.71 1.37 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.272 1.429 . . . . 0.0 111.55 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.55 -169.01 27.73 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.97 1.272 . . . . 0.0 113.672 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.2 -176.03 4.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.665 2.386 . . . . 0.0 111.379 -173.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.01 104.24 13.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.216 1.007 . . . . 0.0 110.278 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 135.24 54.1 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.837 0.855 . . . . 0.0 110.56 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.78 12.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.286 0.234 . . . . 0.0 111.038 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -120.65 138.15 54.08 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.954 0.883 . . . . 0.0 110.966 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 69.8 m -84.2 21.36 1.4 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.41 -0.806 . . . . 0.0 111.899 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.2 m -64.82 162.6 15.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.509 0.724 . . . . 0.0 111.65 168.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.725 1.61 . . . . 0.0 110.388 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -69.78 151.8 45.35 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.426 -0.796 . . . . 0.0 110.483 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -137.03 151.04 48.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.396 1.478 . . . . 0.0 110.351 167.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 2.4 t -119.78 -64.76 1.23 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.425 1.09 . . . . 0.0 112.523 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 46.6 t -82.44 -35.74 27.27 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.258 -0.901 . . . . 0.0 112.647 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -36.7 80.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.3 1.44 . . . . 0.0 113.406 -170.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.27 178.7 7.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.478 2.311 . . . . 0.0 110.744 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -96.95 134.33 11.73 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.871 1.224 . . . . 0.0 112.955 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 56.0 m -150.52 148.63 28.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.924 1.689 . . . . 0.0 110.152 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 3.2 p -152.57 121.41 6.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.726 1.211 . . . . 0.0 111.331 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.0 t -132.71 151.02 52.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.239 1.416 . . . . 0.0 112.271 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 166' ' ' VAL . 1.7 t -140.6 139.98 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.517 1.527 . . . . 0.0 110.014 -169.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.81 130.88 49.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.861 1.264 . . . . 0.0 112.236 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -138.77 104.29 5.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.0 1.32 . . . . 0.0 110.639 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.58 149.87 27.22 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.217 -0.927 . . . . 0.0 111.679 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -124.38 -177.79 3.9 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.361 1.465 . . . . 0.0 110.868 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -67.91 0.23 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.513 1.525 . . . . 0.0 113.35 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -119.15 15.13 13.18 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.486 1.914 . . . . 0.0 112.952 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 43.0 mtt -142.47 175.11 10.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.493 1.917 . . . . 0.0 109.9 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -151.54 158.7 43.92 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.869 0.868 . . . . 0.0 109.972 161.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.424 ' CB ' HD12 ' B' ' 214' ' ' ILE . 12.6 p -134.09 144.06 48.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.437 1.113 . . . . 0.0 110.99 174.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.19 132.64 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.427 1.491 . . . . 0.0 109.299 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.1 142.01 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.205 1.402 . . . . 0.0 110.027 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.1 t -135.79 144.52 45.8 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.785 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.518 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -130.21 144.36 51.32 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.479 1.511 . . . . 0.0 111.728 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -132.63 148.45 52.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.181 1.792 . . . . 0.0 110.571 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -147.61 87.3 0.16 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.581 1.562 . . . . 0.0 112.32 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.01 118.46 21.76 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 111.604 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 CA--C 1.538 0.506 0 C-N-CA 125.753 1.621 . . . . 0.0 112.347 -168.153 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 111.348 0.129 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -129.86 169.53 15.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.16 150.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.443 1.897 . . . . 0.0 111.366 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.6 m -123.67 88.41 2.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.739 1.616 . . . . 0.0 110.878 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -93.61 150.74 20.18 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.378 -0.826 . . . . 0.0 111.369 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.15 108.51 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.624 1.97 . . . . 0.0 110.043 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -141.65 113.32 7.77 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.742 1.617 . . . . 0.0 111.294 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 125.043 1.337 . . . . 0.0 110.875 -178.894 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 121.781 0.8 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -140.16 167.96 20.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.628 1.571 . . . . 0.0 110.959 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.99 152.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.92 1.288 . . . . 0.0 110.148 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.75 -35.84 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.263 -0.898 . . . . 0.0 111.517 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.61 -25.02 67.08 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.142 0.977 . . . . 0.0 113.48 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -78.62 -57.67 3.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.246 1.018 . . . . 0.0 110.535 169.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.8 t -50.49 -44.92 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.475 1.51 . . . . 0.0 112.535 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -67.68 -9.06 40.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.266 1.827 . . . . 0.0 113.628 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -102.33 -31.37 10.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.581 1.552 . . . . 0.0 112.844 170.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mt -49.27 -44.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.359 1.064 . . . . 0.0 110.467 170.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.97 -43.68 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -49.96 65.35 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.257 1.39 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -33.35 75.38 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.113 0.965 . . . . 0.0 113.091 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 48' ' ' VAL . 44.9 mt -57.59 -56.17 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.225 0.92 . . . . 0.0 110.315 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.07 -32.01 70.54 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -60.86 -45.47 94.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.331 1.052 . . . . 0.0 112.449 170.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.95 71.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.24 -44.03 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.999 . . . . 0.0 110.938 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.03 71.92 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.61 26.84 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.348 1.451 . . . . 0.0 116.257 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.27 -179.17 1.52 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.024 1.412 . . . . 0.0 112.689 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -156.92 0.57 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.986 1.314 . . . . 0.0 111.803 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.9 158.04 0.74 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.028 1.331 . . . . 0.0 112.42 162.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.49 -176.4 5.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.715 1.206 . . . . 0.0 111.75 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.58 -100.76 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.882 1.273 . . . . 0.0 109.655 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -67.83 -24.33 65.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.96 1.304 . . . . 0.0 113.992 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -41.63 78.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.055 -1.028 . . . . 0.0 112.669 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.2 -29.18 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.615 0.766 . . . . 0.0 112.57 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.12 -48.43 78.53 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.695 1.198 . . . . 0.0 111.385 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.55 -26.36 67.09 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.349 -0.844 . . . . 0.0 112.986 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -77.13 -54.24 6.76 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.498 -0.752 . . . . 0.0 111.186 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 t -56.5 -29.83 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.783 0.719 . . . . 0.0 112.739 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -79.73 -52.68 7.63 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.477 1.035 . . . . 0.0 112.505 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -58.5 -38.0 76.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.578 1.151 . . . . 0.0 113.323 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 27' ' ' ILE . 75.8 t -67.02 -65.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 124.667 1.187 . . . . 0.0 109.807 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.7 -29.09 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.873 1.269 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.67 -47.19 80.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 0.0 112.705 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.57 -38.29 9.21 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.023 1.329 . . . . 0.0 112.885 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -56.39 -53.64 54.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.538 1.935 . . . . 0.0 112.135 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -40.16 91.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.688 0.676 . . . . 0.0 111.307 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 p -69.68 -27.96 65.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -75.2 -52.15 11.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.677 2.391 . . . . 0.0 113.04 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.65 -28.27 69.79 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.626 -1.296 . . . . 0.0 113.308 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.9 m -56.25 -32.99 65.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.754 1.222 . . . . 0.0 111.056 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -85.59 -28.34 24.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.211 1.004 . . . . 0.0 113.233 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.73 -25.34 62.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.95 0.9 . . . . 0.0 112.312 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.47 -141.14 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.253 1.883 . . . . 0.0 112.035 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -112.84 155.08 44.6 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.397 1.479 . . . . 0.0 112.813 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.44 111.91 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.882 3.054 . . . . 0.0 111.238 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.2 174.86 10.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 0.0 111.387 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HE3' ' CE2' ' B' ' 254' ' ' PHE . 0.5 OUTLIER -66.21 124.17 21.92 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.943 0.897 . . . . 0.0 110.072 163.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -124.56 165.36 17.97 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.999 2.12 . . . . 0.0 109.811 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.428 HG22 ' CD2' ' A' ' 111' ' ' PHE . 4.8 tp -152.06 154.24 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.63 1.572 . . . . 0.0 109.52 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 110' ' ' ALA . 33.9 m -136.84 148.18 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 111.359 167.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.96 127.31 13.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 110.191 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' B' ' 225' ' ' ALA . 7.9 p -127.58 155.53 43.7 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.897 0.879 . . . . 0.0 112.301 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.466 ' C ' HD13 ' A' ' 71' ' ' ILE . 10.0 p -140.19 122.72 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.948 1.299 . . . . 0.0 108.723 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 106' ' ' CYS . 1.9 mm -120.78 116.35 49.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 127.937 2.495 . . . . 0.0 107.474 -174.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.465 ' HG3' HD11 ' A' ' 79' ' ' LEU . 14.5 tmm? -135.92 151.93 50.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.184 0.992 . . . . 0.0 112.279 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -105.15 110.6 23.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.884 1.673 . . . . 0.0 112.263 -168.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.99 -6.17 11.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.186 2.194 . . . . 0.0 113.225 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -25.75 6.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.819 2.448 . . . . 0.0 114.336 162.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.31 7.05 0.59 Allowed Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 130.26 45.46 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.594 1.697 . . . . 0.0 112.338 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.6 112.9 2.16 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD11 ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -146.85 171.56 15.01 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.41 1.884 . . . . 0.0 112.324 -176.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -121.73 130.93 53.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 110.621 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 135' ' ' VAL . 51.5 m -142.23 147.42 36.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.268 1.427 . . . . 0.0 109.059 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 153.2 40.77 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.822 -1.174 . . . . 0.0 111.904 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -155.58 165.03 37.8 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.3 t -116.43 9.89 14.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 112.643 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.45 106.26 5.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.995 1.318 . . . . 0.0 113.189 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -127.03 151.4 48.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.74 1.216 . . . . 0.0 111.429 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 145.83 52.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.195 0.998 . . . . 0.0 110.218 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -140.84 151.85 44.66 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.612 1.565 . . . . 0.0 109.351 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 t -117.02 -63.75 1.4 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.365 1.466 . . . . 0.0 112.143 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t -87.9 -28.76 21.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.201 1.001 . . . . 0.0 112.885 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -52.79 8.64 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.327 1.451 . . . . 0.0 111.948 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -151.54 -174.21 4.76 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.129 2.972 . . . . 0.0 109.608 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.63 6.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.297 1.427 . . . . 0.0 113.342 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.47 165.75 30.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.195 1.398 . . . . 0.0 111.126 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.94 126.93 10.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.984 0.914 . . . . 0.0 110.789 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 t -134.64 144.68 47.99 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.497 -1.377 . . . . 0.0 111.901 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.24 139.36 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.837 1.255 . . . . 0.0 110.11 -168.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.01 123.98 20.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.781 1.633 . . . . 0.0 112.255 -170.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -135.03 103.07 5.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.259 1.824 . . . . 0.0 110.531 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.95 149.59 44.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.165 0.986 . . . . 0.0 112.552 171.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -127.46 -179.37 4.87 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.509 . . . . 0.0 110.469 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.23 -48.61 72.7 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 13.74 5.35 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.447 1.899 . . . . 0.0 112.388 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.0 mtt -143.17 176.87 8.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.815 2.046 . . . . 0.0 109.695 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.0 156.1 35.37 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.276 1.03 . . . . 0.0 110.105 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.59 ' HB2' HD12 ' A' ' 71' ' ' ILE . 24.0 p -133.94 136.21 44.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.927 . . . . 0.0 111.647 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.19 129.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.34 1.456 . . . . 0.0 110.168 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.76 111.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.2 1.8 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -107.38 121.39 44.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.189 0.996 . . . . 0.0 110.151 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -119.63 160.51 22.36 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.294 1.438 . . . . 0.0 112.467 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -135.93 156.52 48.63 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.996 1.318 . . . . 0.0 109.874 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -179.95 91.99 0.08 OUTLIER Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.14 174.02 2.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.094 0.95 . . . . 0.0 112.155 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 124.784 1.234 . . . . 0.0 111.96 -179.565 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.176 0.036 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.08 -177.88 4.31 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.182 1.793 . . . . 0.0 111.152 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.26 140.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.006 0.922 . . . . 0.0 110.762 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.6 m -121.69 119.89 33.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.878 1.671 . . . . 0.0 110.606 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 117.27 33.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.59 1.156 . . . . 0.0 110.891 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.426 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -100.48 105.02 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 128.987 2.915 . . . . 0.0 109.31 178.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -133.33 156.52 47.46 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.164 -0.96 . . . . 0.0 112.262 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 125.03 1.332 . . . . 0.0 109.704 177.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.805 0 CA-C-O 121.736 0.779 . . . . 0.0 111.291 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -139.63 167.4 22.19 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.573 1.549 . . . . 0.0 110.898 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.14 152.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.018 1.327 . . . . 0.0 110.172 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.41 -36.49 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.212 -0.93 . . . . 0.0 111.581 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.15 -24.2 66.11 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -79.19 -58.34 3.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.44 1.096 . . . . 0.0 110.62 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 24.7 t -50.38 -44.56 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 112.602 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -68.12 -8.76 41.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 113.651 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -102.8 -30.91 10.57 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.55 1.54 . . . . 0.0 112.787 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.1 mt -49.34 -44.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.408 1.083 . . . . 0.0 110.344 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.56 -43.65 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -50.01 65.04 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.157 1.344 . . . . 0.0 111.384 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -33.44 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.12 -40.47 71.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.207 1.003 . . . . 0.0 112.97 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' B' ' 191' ' ' VAL . 44.3 mt -57.56 -56.39 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.215 0.916 . . . . 0.0 110.277 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.88 -32.15 70.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -60.81 -45.5 94.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.344 1.057 . . . . 0.0 112.452 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.86 71.37 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.27 -44.16 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.161 0.984 . . . . 0.0 110.916 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.08 71.27 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.103 0.859 . . . . 0.0 115.071 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.33 -4.6 26.68 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.396 1.474 . . . . 0.0 116.229 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.35 -179.26 1.58 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.077 1.439 . . . . 0.0 112.558 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.48 -156.86 0.57 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.917 1.287 . . . . 0.0 111.759 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.92 158.03 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.105 1.362 . . . . 0.0 112.458 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.55 -176.23 5.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.718 1.207 . . . . 0.0 111.779 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.9 -100.92 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.87 1.268 . . . . 0.0 109.632 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 22.4 m -67.61 -24.31 65.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.937 1.295 . . . . 0.0 114.018 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -41.62 78.6 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.035 -1.041 . . . . 0.0 112.593 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.07 -29.23 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.545 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -63.17 -48.63 77.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.637 1.175 . . . . 0.0 111.391 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.41 -26.4 67.21 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.332 -0.855 . . . . 0.0 112.922 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -76.94 -54.44 6.57 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.505 -0.747 . . . . 0.0 111.23 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.3 t -56.56 -29.27 61.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.2 t -80.16 -53.08 7.01 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.497 1.044 . . . . 0.0 112.557 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -58.04 -37.86 75.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.649 1.18 . . . . 0.0 113.276 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' B' ' 170' ' ' ILE . 74.0 t -66.66 -66.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 124.844 1.257 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.66 -29.25 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.71 1.204 . . . . 0.0 111.06 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.45 -47.35 79.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.499 0.72 . . . . 0.0 112.752 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.73 -38.17 9.19 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.053 1.341 . . . . 0.0 113.004 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 20.6 m -56.45 -53.38 58.11 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.559 1.943 . . . . 0.0 112.116 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -40.66 93.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.786 0.721 . . . . 0.0 111.303 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 35.3 p -69.14 -29.09 67.05 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.325 -0.86 . . . . 0.0 113.257 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -73.93 -51.73 15.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.662 2.385 . . . . 0.0 113.073 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.4 -28.22 69.54 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.61 -1.306 . . . . 0.0 113.292 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 96.2 m -58.17 -27.49 63.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.611 1.164 . . . . 0.0 111.117 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -90.76 -28.43 18.26 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.443 1.097 . . . . 0.0 113.607 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.13 -27.06 63.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.689 0.796 . . . . 0.0 111.821 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -137.01 9.58 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.127 1.822 . . . . 0.0 111.949 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -119.76 160.55 41.97 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 125.463 1.505 . . . . 0.0 113.571 -173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 115.93 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.629 2.886 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.8 175.55 11.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.317 1.447 . . . . 0.0 111.7 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.26 109.05 5.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.78 1.232 . . . . 0.0 109.719 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.83 159.47 15.77 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.86 1.264 . . . . 0.0 109.948 167.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.9 tt -146.8 157.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 109.863 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' B' ' 253' ' ' ALA . 33.7 m -138.87 147.27 25.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.894 1.678 . . . . 0.0 110.722 174.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.01 126.97 11.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.94 1.696 . . . . 0.0 109.628 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.41 158.42 42.04 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.635 0.774 . . . . 0.0 112.931 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . 0.501 ' C ' HD13 ' B' ' 214' ' ' ILE . 7.6 p -145.05 124.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.758 1.223 . . . . 0.0 109.703 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.2 mm -123.92 113.02 35.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.766 2.426 . . . . 0.0 107.845 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -134.64 153.12 52.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.255 1.026 . . . . 0.0 112.41 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -103.44 114.15 28.2 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.984 1.714 . . . . 0.0 112.512 -168.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -66.95 -5.51 12.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.002 2.121 . . . . 0.0 113.336 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.78 -24.8 6.44 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.627 2.371 . . . . 0.0 114.332 161.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 7.97 1.49 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.2 88.13 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.199 1.5 . . . . 0.0 113.529 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 142.21 33.27 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.157 -0.964 . . . . 0.0 113.918 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.97 172.02 17.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.209 2.204 . . . . 0.0 111.186 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -125.18 122.53 37.32 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.803 1.241 . . . . 0.0 109.981 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.49 ' HB ' HG13 ' B' ' 278' ' ' VAL . 93.8 m -132.51 145.92 51.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 108.427 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . 0.42 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . . . -140.62 143.3 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.502 -0.749 . . . . 0.0 110.819 173.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 83.2 p -140.67 158.18 44.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.696 0.76 . . . . 0.0 111.546 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 34.5 t -103.83 5.4 35.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.087 0.955 . . . . 0.0 111.991 170.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 73.1 m -67.4 151.89 46.65 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.452 1.12 . . . . 0.0 113.73 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.97 162.07 23.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.672 2.389 . . . . 0.0 109.695 -171.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.9 144.63 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.382 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -136.37 151.15 49.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.317 1.847 . . . . 0.0 110.587 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 22.3 t -117.55 -68.19 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.695 1.198 . . . . 0.0 111.929 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 4.6 t -83.87 -32.0 25.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.436 0.694 . . . . 0.0 112.345 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.18 42.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.859 1.664 . . . . 0.0 112.522 -173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -154.62 -172.9 4.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 128.804 2.842 . . . . 0.0 110.053 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -120.02 131.39 8.86 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.605 1.574 . . . . 0.0 113.776 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 p -155.08 159.91 40.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.174 2.19 . . . . 0.0 111.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.7 t -149.66 110.36 4.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.762 1.225 . . . . 0.0 110.698 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.3 t -118.71 146.46 44.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.637 1.175 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.91 141.31 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.717 1.207 . . . . 0.0 110.241 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.67 124.65 20.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.922 1.689 . . . . 0.0 112.355 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -135.29 105.65 6.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.213 1.805 . . . . 0.0 110.599 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 150.11 40.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.204 1.002 . . . . 0.0 112.395 172.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -127.87 -179.89 5.2 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.434 1.494 . . . . 0.0 110.529 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -48.45 75.09 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.0 t -131.6 14.68 4.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.492 1.917 . . . . 0.0 112.478 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 26.5 mtt -143.4 176.49 9.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.796 2.039 . . . . 0.0 109.82 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -154.11 155.91 36.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.325 1.05 . . . . 0.0 110.043 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.618 ' HB2' HD12 ' B' ' 214' ' ' ILE . 21.7 p -135.22 135.4 40.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.947 0.899 . . . . 0.0 111.734 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -134.56 131.36 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.319 1.448 . . . . 0.0 110.394 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.13 107.68 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.126 1.77 . . . . 0.0 110.75 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.7 t -96.31 129.39 43.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.547 0.739 . . . . 0.0 110.139 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -126.62 147.76 49.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 112.272 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.558 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 1.1 m-85 -117.22 149.47 40.35 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.966 1.706 . . . . 0.0 111.264 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -172.02 89.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.407 -170.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.428 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.9 OUTLIER -66.47 165.22 14.81 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.883 0.849 . . . . 0.0 111.952 -178.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.4 t . . . . . 0 CA--C 1.536 0.409 0 C-N-CA 124.568 1.147 . . . . 0.0 111.631 175.434 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 120.466 0.174 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.78 -173.3 2.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.2 mm -57.8 141.89 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 110.649 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 88.7 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.561 1.944 . . . . 0.0 110.011 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.77 136.19 33.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.728 0.811 . . . . 0.0 110.81 171.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.49 HG13 ' HB ' ' B' ' 224' ' ' THR . 5.4 p -131.77 103.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 128.199 2.6 . . . . 0.0 109.656 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -129.78 157.95 40.78 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 0.0 111.562 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 124.836 1.254 . . . . 0.0 109.37 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -61.87 164.96 5.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.457 0.703 . . . . 0.0 111.935 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.51 156.83 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.804 0.842 . . . . 0.0 111.398 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 t -57.39 -34.76 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.097 1.759 . . . . 0.0 111.523 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.39 -27.6 67.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.645 1.178 . . . . 0.0 113.256 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -78.12 -59.23 2.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.991 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.527 HG13 HD22 ' A' ' 56' ' ' LEU . 34.1 t -49.74 -45.91 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.502 1.521 . . . . 0.0 112.87 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 t -60.73 -25.26 66.32 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.302 1.441 . . . . 0.0 112.894 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.52 -37.75 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.51 -1.369 . . . . 0.0 113.155 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mt -52.1 -43.6 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.515 1.126 . . . . 0.0 110.84 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.1 -42.15 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.47 -0.776 . . . . 0.0 113.032 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -52.9 54.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.174 1.352 . . . . 0.0 112.082 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.11 74.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.54 -45.68 65.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.004 0.922 . . . . 0.0 112.882 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mt -54.72 -57.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 119.204 0.911 . . . . 0.0 110.415 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.97 -29.92 68.76 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.8 p -66.68 -33.7 76.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.23 52.09 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.043 1.337 . . . . 0.0 112.438 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.69 -41.51 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.869 1.268 . . . . 0.0 110.926 171.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.15 81.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.251 0.929 . . . . 0.0 114.272 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 10.02 75.54 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.334 1.445 . . . . 0.0 115.903 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -61.22 155.58 20.56 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.072 1.436 . . . . 0.0 113.056 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.78 -171.53 1.62 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.167 1.787 . . . . 0.0 112.286 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -41.41 139.29 1.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.743 2.817 . . . . 0.0 114.737 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -135.88 174.75 10.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.485 1.514 . . . . 0.0 113.163 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -90.42 -97.45 0.11 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.541 1.537 . . . . 0.0 111.138 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.8 p -89.37 -1.65 58.13 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.681 1.992 . . . . 0.0 114.326 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.31 -42.77 61.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.433 1.493 . . . . 0.0 113.566 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.08 -32.15 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.55 -48.77 71.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 112.176 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -68.54 -25.99 65.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -76.63 -55.45 5.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.918 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -54.29 -35.3 62.44 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.953 0.797 . . . . 0.0 112.186 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -75.68 -54.55 6.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.129 0.877 . . . . 0.0 112.761 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.91 -36.85 73.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.668 1.187 . . . . 0.0 113.33 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.64 -63.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 C-N-CA 124.177 0.991 . . . . 0.0 110.015 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.8 t -49.15 -30.75 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.057 0.943 . . . . 0.0 110.715 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -59.91 -35.84 75.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -107.02 -42.54 4.87 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.36 1.464 . . . . 0.0 112.659 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 m -54.18 -54.84 34.25 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.339 2.256 . . . . 0.0 112.254 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -39.07 86.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.517 0.598 . . . . 0.0 111.218 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -57.48 -52.61 64.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.203 0.601 . . . . 0.0 111.425 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -59.77 -51.13 71.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.565 1.946 . . . . 0.0 114.489 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.527 HD22 HG13 ' A' ' 19' ' ' VAL . 3.7 pp -65.06 -28.64 69.61 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.574 -1.329 . . . . 0.0 113.734 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 m -59.46 -33.91 71.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.47 0.708 . . . . 0.0 111.071 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -80.66 -24.9 38.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.26 -16.01 62.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.2 -111.3 3.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 112.693 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -133.91 150.92 75.83 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.369 1.868 . . . . 0.0 112.222 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 102.58 1.42 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.98 3.12 . . . . 0.0 112.404 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -143.05 161.67 37.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.471 1.509 . . . . 0.0 112.109 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -65.5 100.07 0.47 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.96 1.704 . . . . 0.0 110.991 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -75.02 166.14 24.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.467 1.107 . . . . 0.0 111.9 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.99 156.07 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.443 2.297 . . . . 0.0 108.186 164.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.69 155.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.782 -0.574 . . . . 0.0 109.455 160.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -134.68 137.47 43.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.519 1.128 . . . . 0.0 109.991 165.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -128.88 144.76 51.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.795 0.838 . . . . 0.0 111.916 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -131.82 99.5 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.298 1.839 . . . . 0.0 108.841 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.501 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -95.75 99.96 10.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.89 96.18 2.76 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.124 1.369 . . . . 0.0 111.292 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -149.35 159.06 44.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.305 1.442 . . . . 0.0 110.458 154.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -153.48 -80.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.07 1.748 . . . . 0.0 110.059 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -84.0 -18.85 35.78 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.895 1.278 . . . . 0.0 113.775 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.68 -2.26 3.71 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.784 1.659 . . . . 0.0 115.093 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.05 179.08 2.45 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.967 1.707 . . . . 0.0 114.167 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.1 -172.29 28.23 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.812 2.149 . . . . 0.0 112.356 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 179.64 6.36 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 111.986 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -106.87 111.21 23.62 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.469 -0.77 . . . . 0.0 111.1 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.431 ' HB ' HG13 ' A' ' 135' ' ' VAL . 16.6 m -116.93 140.71 49.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.474 1.11 . . . . 0.0 109.972 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.02 138.95 34.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.733 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -139.56 120.81 14.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 110.429 -166.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 t -79.97 66.23 5.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.319 1.057 . . . . 0.0 110.093 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.443 ' SG ' HD11 ' B' ' 209' ' ' ILE . 3.9 m -114.04 171.18 7.76 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 0.0 110.787 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -144.07 129.58 19.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.986 1.314 . . . . 0.0 109.86 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -76.98 125.98 30.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.434 1.094 . . . . 0.0 109.846 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -146.01 90.06 1.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.488 1.115 . . . . 0.0 111.336 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -68.1 -60.57 2.39 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.173 1.389 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.7 t -88.08 -33.67 18.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.476 1.11 . . . . 0.0 112.304 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 m -74.75 -38.24 62.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -165.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.76 -134.47 0.14 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.335 1.854 . . . . 0.0 109.422 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.96 150.59 20.66 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.316 1.436 . . . . 0.0 113.464 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 p -162.63 157.3 21.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.6 t -165.25 157.99 15.95 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.302 1.841 . . . . 0.0 109.378 165.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 t -143.24 139.14 30.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.28 -1.512 . . . . 0.0 111.13 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.1 138.31 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 109.658 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.25 119.08 11.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.733 1.613 . . . . 0.0 111.023 -166.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -135.83 141.74 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.868 1.267 . . . . 0.0 112.149 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 165.7 24.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.49 -174.12 4.59 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.17 -62.41 0.95 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.294 1.837 . . . . 0.0 113.536 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -139.18 -6.59 1.39 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.987 1.715 . . . . 0.0 113.124 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.9 ptm -129.17 78.81 1.88 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.642 1.577 . . . . 0.0 112.111 -165.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -51.27 133.5 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.165 1.386 . . . . 0.0 111.306 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.501 ' CB ' HD12 ' A' ' 71' ' ' ILE . 14.3 p -113.63 136.33 52.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 111.767 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.1 126.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.81 1.644 . . . . 0.0 110.994 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.78 122.98 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.221 1.808 . . . . 0.0 110.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -115.64 118.42 33.05 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.788 1.235 . . . . 0.0 110.675 -178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.98 140.8 37.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.262 1.825 . . . . 0.0 112.15 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -133.41 148.51 51.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.339 1.456 . . . . 0.0 109.67 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.1 127.44 3.85 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 125.591 1.567 . . . . 0.0 109.344 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.95 133.43 49.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.63 0.772 . . . . 0.0 111.419 -168.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 124.959 1.304 . . . . 0.0 112.305 -169.623 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.354 0.597 . . . . 0.0 112.289 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -132.54 174.46 10.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.364 1.866 . . . . 0.0 111.083 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.15 134.34 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.17 1.788 . . . . 0.0 111.399 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 m -98.32 92.32 5.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.206 1.402 . . . . 0.0 110.242 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -92.55 149.83 21.12 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.701 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.431 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -143.39 97.79 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.569 2.347 . . . . 0.0 108.686 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -144.72 166.26 25.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.048 1.339 . . . . 0.0 112.539 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 CA--C 1.542 0.649 0 C-N-CA 125.367 1.467 . . . . 0.0 109.622 174.643 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 121.172 0.51 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.39 166.9 2.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.196 0.999 . . . . 0.0 112.788 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.52 156.99 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.415 1.086 . . . . 0.0 111.546 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.99 -38.91 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.618 1.167 . . . . 0.0 111.469 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.27 -26.47 67.79 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.565 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -76.86 -60.71 2.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.883 0.873 . . . . 0.0 110.421 171.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.617 HG13 HD22 ' B' ' 199' ' ' LEU . 51.1 t -49.23 -45.95 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.001 1.72 . . . . 0.0 112.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 21.7 t -59.74 -25.15 64.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.272 1.429 . . . . 0.0 112.98 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -86.93 -37.72 17.34 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.604 -1.31 . . . . 0.0 113.05 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.4 mt -51.95 -44.12 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.975 0.91 . . . . 0.0 110.979 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -52.53 49.96 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.917 1.235 . . . . 0.0 111.959 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.66 72.56 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -45.78 56.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 112.868 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.423 ' HA ' HG21 ' B' ' 191' ' ' VAL . 51.6 mt -54.43 -57.37 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.275 0.943 . . . . 0.0 110.327 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.75 -30.09 68.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 9.7 p -66.7 -33.51 75.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 172.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.15 -33.55 50.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.057 1.343 . . . . 0.0 112.535 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.77 -40.4 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.844 1.258 . . . . 0.0 110.969 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.27 15.04 80.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.208 0.908 . . . . 0.0 114.327 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.44 78.17 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.315 1.436 . . . . 0.0 115.797 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -61.19 155.34 21.04 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.119 1.46 . . . . 0.0 113.103 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.89 -171.44 1.63 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.198 1.799 . . . . 0.0 112.242 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -41.35 139.44 1.04 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.739 2.816 . . . . 0.0 114.808 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -135.93 174.3 10.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.495 1.518 . . . . 0.0 113.19 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.21 -96.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.658 1.583 . . . . 0.0 111.292 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.7 p -90.67 -1.71 57.86 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.803 2.041 . . . . 0.0 114.354 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.6 -42.48 61.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.422 1.489 . . . . 0.0 113.7 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.98 -31.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.05 -49.08 68.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.794 1.238 . . . . 0.0 112.139 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -68.33 -26.19 65.48 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -76.48 -55.57 5.41 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 110.941 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.6 t -55.36 -32.45 62.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.928 0.786 . . . . 0.0 112.399 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.3 t -77.54 -55.7 5.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.281 0.946 . . . . 0.0 112.756 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.65 -36.19 71.55 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.884 1.22 . . . . 0.0 113.405 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' B' ' 170' ' ' ILE . 69.6 t -67.74 -63.4 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 109.964 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.77 -31.14 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.302 1.041 . . . . 0.0 110.722 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.82 -35.36 74.56 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -107.62 -42.41 4.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.42 1.488 . . . . 0.0 112.663 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.8 m -54.62 -54.18 44.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.417 2.287 . . . . 0.0 112.379 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -38.94 87.63 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 0.0 111.187 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 23.8 t -58.05 -51.98 67.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.307 0.643 . . . . 0.0 111.522 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.58 -51.54 69.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.576 1.95 . . . . 0.0 114.273 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.617 HD22 HG13 ' B' ' 162' ' ' VAL . 4.0 pp -65.48 -28.59 69.32 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.622 -1.299 . . . . 0.0 113.881 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 4.6 m -58.99 -32.46 69.71 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.397 0.679 . . . . 0.0 111.059 168.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -81.09 -27.27 35.7 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.692 -0.63 . . . . 0.0 112.58 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.4 -21.21 62.87 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.32 -111.72 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.013 1.292 . . . . 0.0 112.364 171.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -133.51 152.22 78.74 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.926 1.69 . . . . 0.0 112.37 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.42 99.96 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.891 3.061 . . . . 0.0 112.107 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -142.4 162.96 34.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.544 1.537 . . . . 0.0 112.196 174.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -66.39 101.95 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.191 1.796 . . . . 0.0 111.085 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -80.04 165.07 22.92 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.86 1.264 . . . . 0.0 111.908 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . 0.443 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.7 tt -149.14 157.6 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 127.781 2.432 . . . . 0.0 108.236 164.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.72 155.67 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 161.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 134.25 40.0 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.672 1.189 . . . . 0.0 109.59 166.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 8.3 p -128.02 148.57 50.54 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.902 0.881 . . . . 0.0 112.505 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -133.27 104.24 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.195 1.798 . . . . 0.0 109.061 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -99.12 109.22 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 107.837 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 159.1 35.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.284 1.433 . . . . 0.0 111.445 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.23 130.06 41.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.525 1.53 . . . . 0.0 112.712 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -80.88 -4.13 53.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.171 2.189 . . . . 0.0 114.116 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -58.45 -20.38 44.58 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.436 1.894 . . . . 0.0 114.639 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.67 5.03 3.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.756 1.645 . . . . 0.0 114.614 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.4 6.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 113.114 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -175.1 -177.53 44.26 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.43 1.966 . . . . 0.0 111.76 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 179.85 7.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.487 1.515 . . . . 0.0 112.315 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -109.96 109.96 20.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.59 0.632 . . . . 0.0 111.411 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.5 ' HB ' HG13 ' B' ' 278' ' ' VAL . 35.7 m -113.85 138.49 50.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.829 0.852 . . . . 0.0 110.393 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.04 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.551 . . . . 0.0 111.293 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 3.2 m -136.07 119.6 17.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.793 0.837 . . . . 0.0 110.114 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.1 t -79.88 64.88 4.86 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.413 1.101 . . . . 0.0 109.975 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 170.83 7.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 110.641 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.79 132.07 21.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 109.899 -170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -76.83 124.6 27.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.459 1.104 . . . . 0.0 109.618 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -142.74 84.23 1.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.843 1.257 . . . . 0.0 110.976 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.5 t -65.11 -62.08 1.76 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.274 1.429 . . . . 0.0 112.474 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 35.8 t -88.48 -28.65 20.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.287 1.035 . . . . 0.0 112.535 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.1 m -77.08 -38.23 52.88 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.655 -0.653 . . . . 0.0 112.63 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 -134.75 0.14 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.211 1.804 . . . . 0.0 109.689 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.81 150.92 20.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.381 1.467 . . . . 0.0 113.272 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 31.3 p -162.6 156.74 21.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.159 1.384 . . . . 0.0 111.915 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.6 162.59 16.63 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.342 1.857 . . . . 0.0 109.644 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.2 t -146.49 141.14 26.77 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.392 -1.442 . . . . 0.0 110.78 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.5 136.52 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.973 1.309 . . . . 0.0 109.509 -171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 121.81 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.45 1.5 . . . . 0.0 111.394 -171.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -130.43 169.89 14.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.621 1.569 . . . . 0.0 110.912 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.65 164.83 14.38 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.043 1.337 . . . . 0.0 111.89 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -177.15 5.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.382 1.473 . . . . 0.0 109.458 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.55 -71.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.212 2.205 . . . . 0.0 114.055 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.0 t -138.32 16.41 2.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.489 1.516 . . . . 0.0 113.167 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.78 121.83 13.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.598 1.559 . . . . 0.0 110.987 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -79.08 152.2 30.97 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.558 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 23.1 p -133.46 115.7 15.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.388 0.675 . . . . 0.0 112.501 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.91 129.62 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.432 1.493 . . . . 0.0 111.565 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.25 121.3 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.485 1.914 . . . . 0.0 111.044 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.5 t -112.95 121.9 46.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.774 1.23 . . . . 0.0 110.627 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -108.4 141.44 40.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.289 1.836 . . . . 0.0 112.392 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.44 147.95 50.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.404 1.482 . . . . 0.0 109.697 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -138.09 125.18 3.15 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 125.698 1.618 . . . . 0.0 109.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.66 132.14 48.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.626 0.77 . . . . 0.0 111.783 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 52.1 m . . . . . 0 N--CA 1.471 0.587 0 C-N-CA 125.041 1.337 . . . . 0.0 112.483 -169.409 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.277 0.56 . . . . 0.0 112.296 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -132.29 175.12 9.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.421 1.888 . . . . 0.0 111.135 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.1 132.67 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.016 1.727 . . . . 0.0 111.385 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 57.1 m -95.72 88.62 5.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.086 1.354 . . . . 0.0 110.004 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -92.12 150.04 21.16 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.277 -0.89 . . . . 0.0 111.42 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.4 p -148.63 102.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.747 2.019 . . . . 0.0 109.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -143.89 167.12 23.07 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.839 1.655 . . . . 0.0 111.794 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 CA--C 1.542 0.654 0 C-N-CA 124.993 1.317 . . . . 0.0 109.755 174.202 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 121.464 0.65 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -125.11 165.3 18.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.854 1.261 . . . . 0.0 110.496 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.87 142.51 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.762 1.225 . . . . 0.0 110.138 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.61 -41.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.808 1.643 . . . . 0.0 113.813 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.35 -29.8 67.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.291 1.036 . . . . 0.0 112.93 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -76.36 -56.11 4.94 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.41 1.084 . . . . 0.0 110.736 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 56' ' ' LEU . 9.5 t -48.25 -44.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.538 1.135 . . . . 0.0 112.277 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -68.23 -6.84 25.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.474 1.51 . . . . 0.0 114.12 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -107.11 -32.73 7.7 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.538 1.935 . . . . 0.0 112.662 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 mt -50.29 -42.76 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.277 0.944 . . . . 0.0 110.133 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -59.85 -43.85 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.463 -0.773 . . . . 0.0 113.085 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -51.77 56.15 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.923 1.238 . . . . 0.0 111.132 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -34.01 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.3 -37.46 63.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.706 0.803 . . . . 0.0 112.839 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 48' ' ' VAL . 57.2 mt -59.43 -59.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.337 0.971 . . . . 0.0 109.544 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.57 -31.6 70.72 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.0 t -58.71 -50.5 73.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 112.209 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.96 -31.98 72.08 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.43 -44.43 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.384 1.073 . . . . 0.0 110.973 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.19 12.0 74.56 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.11 -1.93 26.94 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 171.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.23 170.06 6.35 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 119.347 1.574 . . . . 0.0 112.004 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.75 -147.24 0.34 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -68.23 103.07 1.49 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.037 2.135 . . . . 0.0 111.28 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -92.95 173.06 7.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.291 1.437 . . . . 0.0 112.645 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -84.2 -112.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.469 1.108 . . . . 0.0 110.367 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.7 m -61.95 -20.32 63.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.576 1.55 . . . . 0.0 114.659 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.05 -41.84 75.66 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.138 -0.976 . . . . 0.0 112.501 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.0 t -54.77 -36.1 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.526 1.131 . . . . 0.0 112.675 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -66.11 -47.85 72.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.785 0.721 . . . . 0.0 112.42 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -65.17 -24.06 67.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.029 0.831 . . . . 0.0 112.466 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.66 -53.63 6.96 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -56.2 -30.55 62.44 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.816 0.734 . . . . 0.0 112.588 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -78.85 -58.43 3.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 170.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -58.21 -39.21 78.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.048 1.295 . . . . 0.0 113.538 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 27' ' ' ILE . 84.6 t -68.26 -62.42 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 123.89 0.876 . . . . 0.0 109.956 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -50.04 -29.55 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.46 1.104 . . . . 0.0 110.855 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.27 -52.01 66.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.609 0.763 . . . . 0.0 112.01 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -92.35 -38.62 11.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.5 m -61.27 -53.16 60.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.402 2.281 . . . . 0.0 112.431 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -37.86 84.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.28 0.562 . . . . 0.0 111.003 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m -65.96 -29.63 70.06 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.86 -50.28 12.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.421 2.289 . . . . 0.0 112.592 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.52 HD22 HG13 ' A' ' 19' ' ' VAL . 4.1 pp -65.18 -25.74 67.85 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.856 -1.152 . . . . 0.0 113.786 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -57.53 -32.82 67.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.564 1.146 . . . . 0.0 110.848 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -84.27 -30.55 25.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.56 -31.92 70.4 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.588 0.355 . . . . 0.0 111.105 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.04 -137.79 4.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.013 1.292 . . . . 0.0 111.976 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.75 158.76 39.61 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.154 1.382 . . . . 0.0 112.791 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.44 109.46 2.45 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.514 2.809 . . . . 0.0 111.161 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.96 173.81 12.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.763 1.225 . . . . 0.0 112.123 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.23 112.08 10.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.28 . . . . 0.0 110.537 168.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.88 134.85 54.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.967 1.307 . . . . 0.0 109.34 170.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -118.06 152.36 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.369 1.868 . . . . 0.0 109.158 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.98 154.53 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.331 1.052 . . . . 0.0 110.218 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 153.38 40.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.775 168.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -147.18 156.33 42.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.076 0.95 . . . . 0.0 112.737 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.28 121.27 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.442 1.497 . . . . 0.0 108.993 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.64 118.21 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 126.876 2.07 . . . . 0.0 107.507 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.95 161.78 35.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.52 1.528 . . . . 0.0 110.751 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -130.1 157.48 42.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.745 -1.222 . . . . 0.0 113.99 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -76.44 -7.92 56.07 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.286 1.435 . . . . 0.0 114.368 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.39 -16.29 45.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.536 1.934 . . . . 0.0 114.263 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.04 30.57 0.79 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.101 1.334 . . . . 0.0 115.301 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.26 73.69 0.49 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.977 1.311 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 95.24 0.23 Allowed Glycine 0 N--CA 1.468 0.776 0 C-N-CA 126.192 1.853 . . . . 0.0 115.049 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.55 162.32 25.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.773 1.629 . . . . 0.0 111.892 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.05 97.73 5.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.815 1.246 . . . . 0.0 108.622 170.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.2 m -105.69 136.39 45.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.821 0.848 . . . . 0.0 109.13 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 119.57 12.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.84 0.856 . . . . 0.0 110.542 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 p -125.08 139.7 53.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.929 0.871 . . . . 0.0 111.378 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.2 m -87.19 16.17 5.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.664 0.785 . . . . 0.0 112.277 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' B' ' 209' ' ' ILE . 24.7 m -70.7 166.22 21.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.345 1.058 . . . . 0.0 112.163 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.3 151.44 26.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.868 1.667 . . . . 0.0 110.769 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -78.92 127.98 32.71 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.474 -0.767 . . . . 0.0 110.005 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.78 139.4 38.26 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.245 1.018 . . . . 0.0 112.144 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -134.44 -38.13 0.84 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.607 1.563 . . . . 0.0 113.219 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 t -89.68 -43.22 10.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.35 1.46 . . . . 0.0 111.299 173.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -43.35 87.55 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.965 1.706 . . . . 0.0 112.416 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.68 -161.67 0.94 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.463 1.905 . . . . 0.0 111.377 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.41 114.66 4.49 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.873 1.702 . . . . 0.0 115.944 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 m -139.45 176.21 8.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.125 2.17 . . . . 0.0 111.602 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.84 131.49 6.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.002 2.121 . . . . 0.0 109.208 166.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.9 t -139.11 146.02 40.18 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.825 -1.797 . . . . 0.0 112.436 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 137.85 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.951 1.3 . . . . 0.0 110.259 -167.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 114.91 16.63 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.279 1.432 . . . . 0.0 111.695 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.403 ' CH2' HG21 ' A' ' 27' ' ' ILE . 8.4 m95 -121.5 97.7 5.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.741 1.616 . . . . 0.0 109.557 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -63.75 168.83 4.56 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.356 -0.84 . . . . 0.0 112.337 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.89 -177.83 5.16 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.857 1.663 . . . . 0.0 112.93 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.8 t -135.29 -30.12 1.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.251 1.42 . . . . 0.0 113.679 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptp -87.25 176.81 7.38 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.962 -1.086 . . . . 0.0 112.506 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.55 150.54 30.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.663 1.185 . . . . 0.0 111.639 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.2 p -136.59 142.86 43.35 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.262 1.029 . . . . 0.0 112.346 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.39 135.13 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.701 1.6 . . . . 0.0 109.978 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.65 131.5 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.903 1.681 . . . . 0.0 110.255 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.2 p -125.07 147.51 48.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.56 136.47 47.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.068 2.147 . . . . 0.0 110.967 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -135.42 157.99 45.5 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.792 1.637 . . . . 0.0 108.982 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.24 85.17 0.05 OUTLIER Glycine 0 N--CA 1.464 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 111.442 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -69.02 153.9 42.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.035 0.934 . . . . 0.0 110.085 -178.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 N--CA 1.474 0.764 0 C-N-CA 123.455 0.702 . . . . 0.0 111.608 -171.21 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.371 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -130.6 -179.92 5.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.761 1.224 . . . . 0.0 111.559 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.3 134.2 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.105 1.362 . . . . 0.0 110.93 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.6 m -115.84 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 110.245 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -90.98 147.48 23.06 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.447 -0.783 . . . . 0.0 111.384 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.89 103.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 128.019 2.527 . . . . 0.0 108.708 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.58 130.6 21.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.059 1.344 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 125.453 1.501 . . . . 0.0 109.911 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.482 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.484 ' CZ ' HD11 ' B' ' 165' ' ' ILE . 0.0 OUTLIER -111.98 162.32 15.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 111.643 175.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.79 135.9 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.656 1.582 . . . . 0.0 109.968 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.62 -42.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.094 2.158 . . . . 0.0 113.451 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.29 -31.33 65.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.647 1.179 . . . . 0.0 112.92 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -87.61 -49.21 7.32 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.965 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 21.6 t -45.7 -41.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 120.114 1.325 . . . . 0.0 112.263 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -70.89 -8.28 51.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.113 1.765 . . . . 0.0 115.036 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -103.34 -31.44 10.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.762 2.425 . . . . 0.0 112.581 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . 0.484 HD11 ' CZ ' ' B' ' 157' ' ' PHE . 33.8 mt -50.56 -42.65 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.226 1.01 . . . . 0.0 110.296 171.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.39 -42.89 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -51.9 56.13 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.859 1.208 . . . . 0.0 111.058 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -33.64 76.33 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.17 -36.56 61.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.626 0.77 . . . . 0.0 112.976 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' B' ' 191' ' ' VAL . 55.1 mt -59.75 -59.43 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.291 0.95 . . . . 0.0 109.558 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.32 -31.72 70.56 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.0 t -58.57 -50.3 74.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.372 1.069 . . . . 0.0 112.16 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.15 72.16 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.72 -44.28 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.327 1.051 . . . . 0.0 110.867 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.17 75.08 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 -1.96 26.83 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -66.35 170.53 5.86 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 119.319 1.559 . . . . 0.0 112.025 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.57 -146.31 0.34 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.853 1.661 . . . . 0.0 112.09 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -70.03 97.76 1.21 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.022 2.129 . . . . 0.0 111.365 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.57 173.95 10.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.267 1.427 . . . . 0.0 112.8 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -85.77 -106.66 0.05 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.461 1.105 . . . . 0.0 110.557 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 30.0 m -66.1 -20.73 66.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -55.6 -38.75 69.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.054 0.942 . . . . 0.0 112.612 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -35.24 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.939 0.896 . . . . 0.0 113.304 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -69.08 -46.37 67.96 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.8 0.84 . . . . 0.0 111.992 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -65.68 -24.92 67.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.501 0.591 . . . . 0.0 112.496 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -78.14 -54.77 5.88 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.667 0.787 . . . . 0.0 111.656 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.9 t -56.05 -30.17 61.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.759 0.708 . . . . 0.0 112.617 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -78.78 -59.95 2.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.21 0.914 . . . . 0.0 112.627 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -57.2 -39.38 75.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.094 1.315 . . . . 0.0 113.594 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' B' ' 170' ' ' ILE . 91.4 t -67.8 -62.95 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 C-N-CA 123.895 0.878 . . . . 0.0 109.839 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.2 t -50.11 -29.81 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 110.76 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.55 -52.29 65.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.75 0.82 . . . . 0.0 111.839 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -91.62 -38.64 12.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.795 1.238 . . . . 0.0 112.694 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 42.1 m -62.74 -52.77 61.94 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.768 2.427 . . . . 0.0 112.532 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.75 86.74 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.54 0.686 . . . . 0.0 111.09 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 52.9 m -64.7 -31.42 72.63 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -77.08 -49.51 15.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.461 2.305 . . . . 0.0 112.652 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.65 -27.98 69.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.879 -1.138 . . . . 0.0 113.661 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -58.55 -32.48 68.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.833 0.853 . . . . 0.0 110.807 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -81.7 -31.46 32.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.01 -30.29 55.81 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.706 0.23 . . . . 0.0 110.964 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.83 -134.6 2.61 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.507 1.527 . . . . 0.0 111.682 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 153.18 49.86 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.535 1.134 . . . . 0.0 113.849 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 107.16 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.057 3.171 . . . . 0.0 111.687 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.1 171.08 17.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 111.759 175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.2 98.16 1.32 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.799 1.24 . . . . 0.0 111.366 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -83.3 155.64 23.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.845 0.858 . . . . 0.0 110.671 163.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . 0.404 HD11 ' SG ' ' A' ' 85' ' ' CYS . 2.1 tt -141.03 153.33 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.825 2.05 . . . . 0.0 108.759 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 253' ' ' ALA . 23.4 m -141.42 154.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.284 1.034 . . . . 0.0 110.297 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 15.0 t -146.65 153.79 40.72 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.892 0.877 . . . . 0.0 109.827 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 22.7 p -148.45 160.49 43.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.157 0.983 . . . . 0.0 112.667 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.49 136.37 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 110.467 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 5.4 mm -119.15 120.41 63.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 127.791 2.436 . . . . 0.0 107.164 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 22.3 ttt -140.27 156.6 46.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.193 1.397 . . . . 0.0 111.171 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.99 140.71 52.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.715 1.206 . . . . 0.0 112.286 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -62.22 -7.88 4.85 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.203 1.801 . . . . 0.0 115.071 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.62 -16.95 43.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.396 2.278 . . . . 0.0 114.212 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 126.91 29.12 0.89 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.961 1.267 . . . . 0.0 115.127 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.88 72.52 0.25 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.311 1.444 . . . . 0.0 112.846 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.25 96.69 0.24 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.353 1.93 . . . . 0.0 114.983 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 pp -126.92 161.18 28.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 111.651 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.78 97.91 4.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.868 1.267 . . . . 0.0 108.591 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 38.8 m -110.17 132.29 54.3 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.262 0.625 . . . . 0.0 109.506 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -135.33 118.02 16.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.202 1.001 . . . . 0.0 110.276 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 24.2 p -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.987 0.899 . . . . 0.0 111.075 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 72.4 m -86.08 16.11 4.53 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.369 -0.832 . . . . 0.0 112.147 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 20.7 m -70.26 165.82 21.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.121 0.968 . . . . 0.0 112.055 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -155.81 150.77 26.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -76.49 130.95 38.69 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.26 141.86 37.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.172 0.989 . . . . 0.0 111.385 166.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 11.0 t -134.01 -50.0 0.82 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.647 1.579 . . . . 0.0 112.033 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 34.2 t -78.48 -34.26 47.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.778 0.831 . . . . 0.0 111.618 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -47.58 28.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.474 1.509 . . . . 0.0 113.065 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.32 -162.74 1.25 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.884 1.673 . . . . 0.0 111.825 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -102.19 112.14 4.24 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.823 1.678 . . . . 0.0 116.138 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 68.7 m -140.03 175.76 9.31 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.071 2.148 . . . . 0.0 111.971 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 40.3 t -160.04 127.02 4.44 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.066 2.147 . . . . 0.0 109.398 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.7 t -136.04 146.1 46.75 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 119.755 -1.841 . . . . 0.0 112.536 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.25 139.43 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.003 1.321 . . . . 0.0 110.289 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 117.73 19.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.988 1.315 . . . . 0.0 111.948 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -124.63 96.15 4.79 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.69 1.596 . . . . 0.0 109.566 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.21 169.38 4.57 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.53 -0.731 . . . . 0.0 112.456 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -142.39 -177.2 5.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 111.981 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -44.43 81.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.263 1.825 . . . . 0.0 112.802 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.4 t -133.93 -34.92 0.98 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.623 1.569 . . . . 0.0 113.469 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 18.6 ptp -86.6 177.39 7.39 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.956 -1.09 . . . . 0.0 112.71 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -151.43 157.89 42.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.01 1.324 . . . . 0.0 111.22 165.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 25.8 p -137.0 141.65 42.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.079 0.952 . . . . 0.0 111.621 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.07 134.18 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.059 1.343 . . . . 0.0 110.108 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.62 130.74 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 126.007 1.723 . . . . 0.0 110.211 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 45.7 p -124.63 144.97 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.497 0.719 . . . . 0.0 111.181 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -128.41 137.55 51.91 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.865 2.066 . . . . 0.0 110.733 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -135.71 163.51 30.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.985 1.714 . . . . 0.0 108.834 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 153.65 86.54 0.06 OUTLIER Glycine 0 N--CA 1.464 0.504 0 O-C-N 121.382 -0.824 . . . . 0.0 111.183 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.478 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.5 OUTLIER -67.65 156.67 36.32 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.968 0.907 . . . . 0.0 110.231 -178.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 121.825 0.822 . . . . 0.0 111.248 -172.115 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.407 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -131.01 179.87 5.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.858 1.263 . . . . 0.0 111.524 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.28 134.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.044 1.338 . . . . 0.0 110.838 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 74.0 m -116.24 90.62 3.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.916 1.686 . . . . 0.0 110.091 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -91.16 148.72 22.17 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.615 0.722 . . . . 0.0 111.371 170.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.34 112.8 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 127.222 2.209 . . . . 0.0 109.932 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.12 130.6 18.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.976 1.31 . . . . 0.0 111.655 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 125.495 1.518 . . . . 0.0 109.91 -179.944 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.744 0 CA-C-O 121.726 0.774 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -110.3 168.18 9.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.355 1.462 . . . . 0.0 110.475 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.83 159.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.754 0.788 . . . . 0.0 111.146 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.03 -34.73 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.763 2.025 . . . . 0.0 111.702 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -59.69 -28.6 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.922 0.889 . . . . 0.0 113.099 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -82.27 -54.19 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.687 0.795 . . . . 0.0 110.706 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.431 HG13 HD22 ' A' ' 56' ' ' LEU . 97.4 t -49.97 -42.37 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.088 1.355 . . . . 0.0 112.422 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 t -59.58 -19.44 48.78 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.006 1.723 . . . . 0.0 113.747 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -97.48 -43.21 7.36 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.877 1.671 . . . . 0.0 112.111 172.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.0 mt -50.41 -41.97 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.02 -44.63 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.82 58.92 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.22 1.373 . . . . 0.0 111.518 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -34.56 76.2 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.35 -43.51 66.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.681 0.792 . . . . 0.0 112.972 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.61 -58.92 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 118.983 0.811 . . . . 0.0 109.773 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.53 -31.67 72.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.6 t -61.01 -48.15 83.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.998 0.919 . . . . 0.0 112.035 169.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.38 76.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.586 1.155 . . . . 0.0 114.002 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.39 -49.96 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 0.0 110.532 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.7 11.61 59.01 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.271 0.938 . . . . 0.0 115.289 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.66 -3.99 23.04 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.32 169.76 8.34 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 119.254 1.527 . . . . 0.0 111.8 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 -148.77 0.36 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.377 1.471 . . . . 0.0 111.676 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -60.5 131.33 50.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.178 1.791 . . . . 0.0 110.918 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.01 -177.31 3.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.293 1.437 . . . . 0.0 112.235 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -98.04 -96.6 0.22 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.913 1.285 . . . . 0.0 110.078 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -73.85 -22.62 59.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.965 1.306 . . . . 0.0 113.91 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.54 -44.03 84.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.207 -0.933 . . . . 0.0 112.393 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.57 -36.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.895 0.878 . . . . 0.0 113.009 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -61.12 -53.97 50.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.53 1.132 . . . . 0.0 111.176 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.68 -54.93 5.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 112.224 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -58.7 -22.72 58.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -85.53 -57.64 2.98 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.269 0.941 . . . . 0.0 112.25 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -59.75 -40.89 89.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.09 1.314 . . . . 0.0 113.752 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.62 -62.91 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 C-N-CA 124.075 0.95 . . . . 0.0 109.86 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -49.92 -28.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.682 1.193 . . . . 0.0 110.952 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -57.72 11.02 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.796 0.725 . . . . 0.0 111.858 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -86.28 -36.64 19.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.169 0.988 . . . . 0.0 113.217 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 m -60.91 -51.82 67.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.777 2.031 . . . . 0.0 112.172 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tp -61.48 -32.25 72.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.354 0.662 . . . . 0.0 112.287 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 t -61.98 -58.51 7.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.549 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.88 -49.55 49.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.431 HD22 HG13 ' A' ' 19' ' ' VAL . 2.5 pp -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -62.64 -44.44 96.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 119.028 -0.511 . . . . 0.0 109.768 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -64.88 -25.16 67.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.307 0.958 . . . . 0.0 113.356 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.21 -2.88 14.52 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 171.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.27 -98.7 0.18 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 124.865 1.221 . . . . 0.0 114.64 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -67.83 168.88 11.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 125.431 1.492 . . . . 0.0 114.392 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.11 167.74 21.02 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.541 2.161 . . . . 0.0 112.668 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -55.49 97.55 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.357 2.263 . . . . 0.0 114.45 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 96.06 0.65 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.921 2.088 . . . . 0.0 111.212 174.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -153.37 150.32 28.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.183 1.393 . . . . 0.0 110.012 170.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.42 146.61 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 171.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 110' ' ' ALA . 4.6 m -137.98 148.18 25.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.644 1.578 . . . . 0.0 110.392 165.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -135.74 155.96 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.671 1.188 . . . . 0.0 109.791 166.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.0 t -151.41 144.41 24.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.247 1.419 . . . . 0.0 110.834 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.85 140.54 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.067 1.347 . . . . 0.0 109.876 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 106' ' ' CYS . 1.4 mm -126.34 110.87 24.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 127.334 2.253 . . . . 0.0 108.374 -175.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.14 168.71 18.35 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.023 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -110.99 124.81 52.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.312 1.445 . . . . 0.0 111.261 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -84.26 -0.71 53.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.981 1.712 . . . . 0.0 114.033 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.38 -19.7 64.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.102 1.761 . . . . 0.0 114.166 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.09 34.75 0.36 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.306 1.432 . . . . 0.0 114.617 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.11 173.14 3.96 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 118.905 1.353 . . . . 0.0 112.794 171.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.2 103.98 0.33 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.186 1.374 . . . . 0.0 113.195 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 164.09 31.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.821 1.248 . . . . 0.0 113.609 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -127.53 131.66 50.04 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.308 1.043 . . . . 0.0 110.395 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.555 ' HB ' HG13 ' A' ' 135' ' ' VAL . 47.9 m -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.957 1.303 . . . . 0.0 109.039 176.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.09 121.27 12.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.436 1.094 . . . . 0.0 110.787 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.2 p -129.69 131.04 46.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.347 0.594 . . . . 0.0 111.447 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -90.67 18.34 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.268 -0.895 . . . . 0.0 111.978 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.8 m -61.2 162.93 6.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.286 1.435 . . . . 0.0 112.408 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -158.23 134.36 9.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.228 1.011 . . . . 0.0 111.602 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.72 148.0 30.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 110.913 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -134.68 149.57 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.841 1.656 . . . . 0.0 110.644 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.8 t -97.3 -66.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.831 1.252 . . . . 0.0 112.304 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 t -91.24 -26.47 18.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.974 . . . . 0.0 112.535 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -30.76 52.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.905 1.682 . . . . 0.0 113.091 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 -167.02 1.05 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.961 2.104 . . . . 0.0 111.135 -172.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.87 146.15 15.28 Favored Glycine 0 CA--C 1.539 1.571 0 O-C-N 120.909 -1.119 . . . . 0.0 114.641 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 134.99 13.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.193 1.397 . . . . 0.0 111.784 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 24.0 t -127.99 97.26 4.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.661 1.184 . . . . 0.0 113.077 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -88.14 150.02 23.58 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.028 -1.045 . . . . 0.0 112.715 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.27 138.68 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.332 1.853 . . . . 0.0 109.407 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -125.23 119.48 28.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.709 1.604 . . . . 0.0 111.956 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -128.52 102.54 6.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 110.127 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -77.52 151.3 34.62 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.177 -0.952 . . . . 0.0 112.039 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.15 -178.42 3.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.32 1.448 . . . . 0.0 109.952 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -60.46 -45.02 95.23 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -129.92 -21.12 3.06 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.818 1.647 . . . . 0.0 113.919 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.9 mtt -100.84 173.12 6.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 170.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -147.84 147.43 29.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.083 1.353 . . . . 0.0 109.936 167.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 71' ' ' ILE . 9.0 p -133.35 134.01 43.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.894 1.277 . . . . 0.0 110.641 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.97 110.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.041 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.36 138.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 110.8 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.5 p -134.16 114.74 13.43 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.282 -0.886 . . . . 0.0 112.576 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -100.08 136.12 40.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.84 1.256 . . . . 0.0 112.043 -176.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -134.34 112.86 11.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.426 1.491 . . . . 0.0 111.183 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -103.07 61.94 0.46 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.743 -1.223 . . . . 0.0 113.878 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -52.43 109.5 0.4 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 113.298 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 m . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 127.098 2.159 . . . . 0.0 111.934 -171.316 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 120.331 0.11 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -128.89 168.73 15.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.912 1.285 . . . . 0.0 111.375 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -62.5 135.78 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.317 1.447 . . . . 0.0 110.842 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.3 m -106.37 88.95 2.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.864 1.666 . . . . 0.0 110.147 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -89.96 149.83 22.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.154 172.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -145.27 104.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.988 2.115 . . . . 0.0 109.356 -177.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.8 119.96 18.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 110.826 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 125.429 1.491 . . . . 0.0 108.851 174.442 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 121.416 0.627 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -105.27 173.63 6.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.841 1.256 . . . . 0.0 111.195 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.32 161.44 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.585 1.154 . . . . 0.0 111.584 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.03 -40.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.513 1.125 . . . . 0.0 112.126 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.76 -25.15 67.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.592 1.157 . . . . 0.0 113.018 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -79.46 -58.29 3.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 110.986 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.528 HG22 HD13 ' B' ' 199' ' ' LEU . 85.9 t -52.38 -40.94 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.915 1.286 . . . . 0.0 112.607 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 19.5 t -58.94 -18.62 35.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.572 1.549 . . . . 0.0 113.408 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.3 -43.86 6.44 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.135 1.374 . . . . 0.0 112.031 171.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 38.7 mt -50.58 -42.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.201 1.0 . . . . 0.0 111.262 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.26 -43.54 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.487 -0.758 . . . . 0.0 112.887 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -51.76 53.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.943 1.247 . . . . 0.0 111.399 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.23 75.57 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.28 -43.43 64.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.801 0.84 . . . . 0.0 113.037 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.38 -58.76 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 119.124 0.874 . . . . 0.0 109.702 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -62.45 -31.74 72.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 37.5 t -60.9 -48.18 83.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.988 0.915 . . . . 0.0 112.108 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.19 76.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.29 -49.9 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.512 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 92.73 11.55 59.03 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.235 0.922 . . . . 0.0 115.266 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.5 -4.0 23.29 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -67.12 169.61 8.24 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.299 1.549 . . . . 0.0 111.862 170.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.13 -148.49 0.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.362 1.465 . . . . 0.0 111.615 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.44 132.31 53.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.155 1.782 . . . . 0.0 110.999 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -177.34 4.1 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.288 1.435 . . . . 0.0 112.157 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -98.06 -96.71 0.22 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 0.0 110.143 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.2 m -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.014 1.326 . . . . 0.0 113.929 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.9 -44.0 86.49 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.09 -1.006 . . . . 0.0 112.377 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.77 -36.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.943 0.897 . . . . 0.0 112.988 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.75 -54.44 45.16 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.626 1.17 . . . . 0.0 111.075 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -64.33 -22.83 67.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 113.049 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.35 -54.9 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.188 0.903 . . . . 0.0 112.301 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.3 t -58.86 -21.04 56.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.2 t -87.02 -58.75 2.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.212 0.915 . . . . 0.0 112.332 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -58.88 -40.7 85.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.142 1.337 . . . . 0.0 113.793 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.52 -63.27 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 124.182 0.993 . . . . 0.0 109.817 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 77.1 t -48.6 -29.74 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.234 1.413 . . . . 0.0 111.167 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -55.45 33.5 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.628 0.771 . . . . 0.0 111.711 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -88.87 -35.08 16.75 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.369 1.068 . . . . 0.0 113.367 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.2 m -63.43 -52.62 60.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.0 2.12 . . . . 0.0 112.605 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.607 HD13 HD11 ' B' ' 199' ' ' LEU . 0.1 OUTLIER -62.97 -32.57 73.92 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.609 0.364 . . . . 0.0 111.023 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t -60.52 -57.81 11.14 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.387 -0.821 . . . . 0.0 111.469 165.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -50.37 -49.14 55.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.711 1.604 . . . . 0.0 113.433 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.607 HD11 HD13 ' B' ' 196' ' ' LEU . 4.0 pp -70.74 -27.87 64.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 1.5 m -60.89 -44.96 96.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 163.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -64.58 -25.76 68.11 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.227 0.921 . . . . 0.0 113.415 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.16 -4.6 18.14 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.99 -101.89 0.26 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 119.984 1.265 . . . . 0.0 114.658 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.28 167.81 11.45 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.82 1.648 . . . . 0.0 114.008 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.08 166.03 24.42 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.178 1.919 . . . . 0.0 112.236 168.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -50.97 115.87 1.73 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.964 1.705 . . . . 0.0 112.269 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 171.08 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 130.222 3.409 . . . . 0.0 111.193 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . 0.405 ' CG ' HD12 ' B' ' 196' ' ' LEU . 54.9 p90 -145.6 171.06 15.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.572 1.949 . . . . 0.0 109.743 167.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.77 151.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.0 143.18 27.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.339 1.456 . . . . 0.0 109.092 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 155.04 51.34 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.876 0.87 . . . . 0.0 110.144 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.11 148.67 28.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.183 1.393 . . . . 0.0 111.288 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.75 141.06 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 110.445 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' B' ' 249' ' ' CYS . 1.2 mm -126.65 110.38 23.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 127.847 2.459 . . . . 0.0 108.171 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 167.51 20.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.919 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -111.55 126.96 55.54 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.253 1.421 . . . . 0.0 111.214 -168.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -85.69 0.35 52.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.913 1.685 . . . . 0.0 113.956 -168.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.1 -19.92 64.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.073 1.749 . . . . 0.0 114.152 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 37.41 0.39 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.329 1.442 . . . . 0.0 114.375 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.12 172.68 6.46 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 118.758 1.279 . . . . 0.0 112.285 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -142.27 78.88 0.27 Allowed Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.553 1.073 . . . . 0.0 114.396 -173.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.36 156.03 28.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 111.393 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.32 134.3 52.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 110.892 173.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.705 ' HB ' HG13 ' B' ' 278' ' ' VAL . 99.6 m -138.54 143.85 39.65 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 109.063 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.28 13.75 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.594 1.157 . . . . 0.0 110.84 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.4 p -128.46 136.59 51.04 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.813 -0.555 . . . . 0.0 111.761 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.5 m -94.22 18.79 10.29 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.662 -0.648 . . . . 0.0 111.776 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.3 m -61.68 162.59 8.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.065 1.346 . . . . 0.0 112.347 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -158.63 134.93 9.25 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.514 1.126 . . . . 0.0 111.466 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 147.16 27.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.167 0.987 . . . . 0.0 110.791 171.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -131.87 144.58 50.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.127 1.771 . . . . 0.0 110.14 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.0 t -89.45 -68.19 0.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 112.238 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 6.9 t -92.74 -25.49 18.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.265 1.026 . . . . 0.0 112.533 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -29.34 55.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.933 1.693 . . . . 0.0 112.911 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -164.38 0.9 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.04 1.736 . . . . 0.0 111.644 -171.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -151.19 144.51 11.82 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.935 -1.103 . . . . 0.0 114.455 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.45 151.28 33.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.734 1.614 . . . . 0.0 110.633 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 12.4 t -142.43 104.54 4.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.507 1.123 . . . . 0.0 112.565 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.3 t -97.36 147.58 24.03 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.43 1.092 . . . . 0.0 112.418 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.13 136.28 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.862 1.665 . . . . 0.0 109.626 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -125.1 119.06 27.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.491 1.516 . . . . 0.0 111.829 -173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -128.07 102.51 6.76 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.329 1.452 . . . . 0.0 109.956 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.59 151.0 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.15 -0.969 . . . . 0.0 111.881 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.82 -178.24 3.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.301 1.44 . . . . 0.0 109.937 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.62 -44.77 95.96 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -129.89 -21.61 3.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.744 1.617 . . . . 0.0 113.894 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.8 mtt -100.64 173.33 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.995 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -147.6 148.07 30.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.037 1.335 . . . . 0.0 110.002 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' B' ' 214' ' ' ILE . 9.8 p -132.73 135.41 45.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.821 1.248 . . . . 0.0 111.014 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.85 111.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.97 1.308 . . . . 0.0 111.172 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.7 143.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.046 1.339 . . . . 0.0 111.161 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 66.8 p -139.02 110.66 7.09 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.16 139.94 30.15 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.519 1.128 . . . . 0.0 113.05 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -137.29 102.65 4.87 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.769 1.627 . . . . 0.0 110.204 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -95.12 61.13 1.59 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 113.507 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.02 109.47 0.26 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 0.0 113.528 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.8 m . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 126.509 1.924 . . . . 0.0 112.419 -171.3 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.3 0.095 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -128.85 169.9 14.03 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.965 1.306 . . . . 0.0 111.313 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.73 138.45 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.173 1.389 . . . . 0.0 110.944 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 66.7 m -109.59 86.0 2.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.874 1.669 . . . . 0.0 109.853 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.96 150.94 23.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.603 0.761 . . . . 0.0 111.133 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.3 p -149.94 105.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.364 1.866 . . . . 0.0 109.934 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.47 121.73 21.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.383 . . . . 0.0 110.687 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 125.236 1.415 . . . . 0.0 108.727 174.443 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.858 0 CA-C-O 121.436 0.636 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.27 171.82 2.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.782 1.633 . . . . 0.0 113.434 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.09 147.06 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.446 1.098 . . . . 0.0 112.173 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.24 -40.48 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.087 1.355 . . . . 0.0 112.075 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.1 -33.4 69.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.623 1.569 . . . . 0.0 112.631 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -77.2 -52.23 9.6 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.905 1.282 . . . . 0.0 111.177 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 56' ' ' LEU . 16.1 t -48.51 -42.34 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.485 1.114 . . . . 0.0 112.222 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -56.98 -24.75 55.65 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.194 1.398 . . . . 0.0 113.603 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.97 -35.58 11.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.329 1.452 . . . . 0.0 113.292 172.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.89 -43.1 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 119.615 1.098 . . . . 0.0 110.445 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.29 -43.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -52.58 45.95 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.864 1.211 . . . . 0.0 111.45 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -30.71 70.57 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.45 -43.84 31.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 48' ' ' VAL . 58.6 mt -55.78 -56.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.564 1.075 . . . . 0.0 109.88 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -59.61 -28.25 67.02 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -67.37 -35.47 79.42 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.12 -29.89 43.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.972 1.309 . . . . 0.0 113.147 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.69 -37.03 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.58 1.152 . . . . 0.0 111.458 172.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.81 11.45 84.61 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.103 0.858 . . . . 0.0 114.832 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.06 -0.97 35.46 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.575 1.56 . . . . 0.0 116.382 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.85 168.82 4.68 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.128 1.464 . . . . 0.0 112.931 167.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.61 -154.55 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.771 1.628 . . . . 0.0 111.901 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.1 160.03 0.39 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.337 1.455 . . . . 0.0 112.992 163.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -151.1 175.07 12.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.342 1.057 . . . . 0.0 113.295 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -97.37 -101.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.541 1.537 . . . . 0.0 110.02 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -67.99 -22.09 65.02 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -58.82 -43.75 90.72 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.97 -1.081 . . . . 0.0 112.99 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.63 -38.57 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.209 1.003 . . . . 0.0 112.782 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -63.13 -54.72 33.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.932 1.293 . . . . 0.0 111.696 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.75 -26.23 68.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.254 -0.904 . . . . 0.0 112.634 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -75.48 -53.89 7.92 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.112 0.965 . . . . 0.0 111.182 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -59.2 -22.23 60.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -86.55 -56.74 3.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.681 1.128 . . . . 0.0 112.457 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -58.22 -37.11 74.21 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.786 1.234 . . . . 0.0 113.676 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 27' ' ' ILE . 94.3 t -69.49 -64.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 123.897 0.879 . . . . 0.0 109.559 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.01 -31.68 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.866 1.266 . . . . 0.0 111.103 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -43.56 90.6 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.635 0.652 . . . . 0.0 112.602 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -96.81 -44.26 7.15 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.985 1.314 . . . . 0.0 112.391 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.2 m -55.82 -51.88 65.95 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.522 2.329 . . . . 0.0 112.871 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.23 -38.98 88.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.166 0.439 . . . . 0.0 110.94 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 p -64.43 -30.67 71.7 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.22 -0.925 . . . . 0.0 113.334 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.03 -48.61 20.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.194 2.198 . . . . 0.0 113.075 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.42 HD22 HG13 ' A' ' 19' ' ' VAL . 3.5 pp -64.63 -27.8 69.18 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.728 -1.232 . . . . 0.0 114.135 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.7 m -58.16 -34.73 70.63 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.444 1.098 . . . . 0.0 110.925 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -78.94 -36.31 41.9 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.773 -0.579 . . . . 0.0 112.262 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.75 -24.56 66.23 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -105.39 2.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 113.257 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -138.28 152.58 71.79 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.577 1.551 . . . . 0.0 112.12 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.88 111.31 3.0 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.611 2.874 . . . . 0.0 111.375 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.12 179.86 7.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.331 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -93.57 95.37 9.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.472 1.509 . . . . 0.0 111.678 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -83.71 151.6 25.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.887 1.675 . . . . 0.0 109.933 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.483 HG22 ' CD2' ' A' ' 111' ' ' PHE . 1.3 tp -125.67 149.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.709 1.604 . . . . 0.0 108.667 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.9 146.29 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.529 0.732 . . . . 0.0 111.285 164.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.86 117.71 13.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.397 2.279 . . . . 0.0 109.732 174.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.3 p -123.79 136.6 54.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.404 0.682 . . . . 0.0 112.448 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.56 109.3 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.347 1.459 . . . . 0.0 109.29 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 mm -103.15 111.13 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.68 105.4 3.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.895 1.278 . . . . 0.0 109.905 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.09 10.64 1.74 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -69.83 -77.66 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.922 1.289 . . . . 0.0 112.998 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.63 -20.8 5.86 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.85 7.24 5.19 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.641 -1.089 . . . . 0.0 115.708 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.9 93.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.509 1.924 . . . . 0.0 114.812 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.39 78.1 1.0 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.694 1.616 . . . . 0.0 113.429 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 pp -54.48 150.92 8.41 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.629 1.572 . . . . 0.0 112.475 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -123.06 83.31 2.11 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.487 1.515 . . . . 0.0 109.363 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.536 ' HB ' HG13 ' A' ' 135' ' ' VAL . 54.5 m -97.17 139.09 33.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.673 -0.642 . . . . 0.0 109.465 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.54 128.03 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 110.422 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -127.76 117.41 21.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.921 0.889 . . . . 0.0 109.622 -170.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -79.9 41.56 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.425 1.107 . . . . 0.0 111.177 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.76 179.6 7.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.98 1.312 . . . . 0.0 110.577 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -145.55 154.05 41.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.724 1.609 . . . . 0.0 109.621 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -97.45 132.48 43.11 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.006 0.922 . . . . 0.0 109.89 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -144.05 141.53 30.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.228 1.411 . . . . 0.0 110.435 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -114.17 -56.52 2.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.426 1.491 . . . . 0.0 111.718 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.96 -40.25 10.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.172 0.989 . . . . 0.0 112.097 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -32.39 73.18 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.644 2.378 . . . . 0.0 114.223 -169.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.22 -177.5 6.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.591 1.957 . . . . 0.0 110.85 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.09 116.93 3.86 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.969 1.747 . . . . 0.0 114.027 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 t -140.93 172.55 12.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.398 1.879 . . . . 0.0 110.505 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -168.14 140.34 2.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.543 1.537 . . . . 0.0 110.639 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -148.98 144.64 26.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.959 -1.713 . . . . 0.0 111.602 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -139.02 120.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.472 1.109 . . . . 0.0 109.489 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 93.83 4.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.297 1.039 . . . . 0.0 113.024 -171.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -99.43 105.73 17.7 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.96 1.304 . . . . 0.0 110.362 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -109.49 165.77 11.39 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.558 1.543 . . . . 0.0 110.71 169.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -139.13 179.78 6.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.67 1.188 . . . . 0.0 110.031 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -45.1 -40.28 6.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.921 1.688 . . . . 0.0 115.011 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.7 t -133.7 22.9 3.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.302 1.841 . . . . 0.0 113.083 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 mtt -135.79 158.76 43.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -148.99 116.56 6.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.114 1.765 . . . . 0.0 110.704 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.09 68.16 1.3 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.162 1.785 . . . . 0.0 111.481 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pp -97.18 153.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.635 -1.291 . . . . 0.0 113.175 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -132.84 116.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.805 2.042 . . . . 0.0 111.889 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.5 t -97.91 136.17 38.59 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.558 1.143 . . . . 0.0 110.084 171.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.3 166.59 22.78 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.901 1.68 . . . . 0.0 112.262 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.483 ' CD2' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -150.21 161.07 43.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.009 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.32 83.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.447 HD11 ' CE1' ' A' ' 111' ' ' PHE . 1.3 pp -137.92 158.24 44.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.938 1.695 . . . . 0.0 112.682 -169.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 t . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 125.05 1.34 . . . . 0.0 112.505 -175.239 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 111.628 0.232 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -129.31 166.94 18.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.357 1.463 . . . . 0.0 111.447 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.4 149.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.768 1.627 . . . . 0.0 111.324 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.2 m -121.61 91.29 3.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 110.861 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -77.5 148.06 35.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.886 166.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.536 HG13 ' HB ' ' A' ' 81' ' ' THR . 1.4 p -133.67 97.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 127.864 2.466 . . . . 0.0 109.089 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.93 151.92 48.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.283 1.033 . . . . 0.0 111.631 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 CA--C 1.546 0.798 0 C-N-CA 124.794 1.238 . . . . 0.0 111.457 -179.248 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 120.56 0.219 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.26 170.49 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.515 -0.741 . . . . 0.0 112.811 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.18 141.94 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.957 1.303 . . . . 0.0 112.006 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . 0.693 ' HA ' HG22 ' B' ' 162' ' ' VAL . 16.1 t -59.27 -34.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.561 1.144 . . . . 0.0 111.604 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -60.63 -15.38 27.82 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.167 1.387 . . . . 0.0 113.671 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -109.3 -47.56 3.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 110.13 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' B' ' 159' ' ' VAL . 4.3 m -51.31 -32.4 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t -60.75 -20.99 62.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.433 1.493 . . . . 0.0 114.267 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -103.45 -31.8 9.81 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.166 1.786 . . . . 0.0 112.971 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 41.0 mt -49.81 -41.15 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.413 1.006 . . . . 0.0 110.689 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.85 -43.43 97.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -51.99 48.27 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.724 1.147 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -31.46 71.03 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.53 -42.6 42.52 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.46 ' HA ' HG21 ' B' ' 191' ' ' VAL . 56.8 mt -55.77 -55.99 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.533 1.06 . . . . 0.0 109.886 174.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -59.15 -29.18 67.23 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 6.5 p -66.63 -34.37 77.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.1 -29.79 34.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.347 . . . . 0.0 113.199 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.25 -37.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 111.276 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.51 84.13 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.121 0.867 . . . . 0.0 114.817 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.13 35.45 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.471 1.51 . . . . 0.0 116.319 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -63.68 168.49 4.81 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.152 1.476 . . . . 0.0 112.958 167.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -85.16 -155.04 0.2 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.7 1.6 . . . . 0.0 111.718 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.14 159.39 0.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 0.0 113.06 164.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -151.15 172.06 16.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.351 1.46 . . . . 0.0 112.24 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -93.44 -100.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.4 1.08 . . . . 0.0 109.44 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 70.6 m -65.57 -22.22 66.67 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -59.64 -42.37 92.61 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.757 -1.214 . . . . 0.0 112.764 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.19 -38.08 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.292 1.037 . . . . 0.0 112.762 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -62.27 -55.68 25.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.452 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -63.62 -26.45 68.69 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.484 -0.76 . . . . 0.0 112.654 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -75.3 -54.21 7.46 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.172 0.989 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.5 t -58.02 -25.07 60.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 13.8 t -84.43 -56.81 3.43 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.668 1.122 . . . . 0.0 112.201 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -57.7 -37.01 72.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.893 1.224 . . . . 0.0 113.684 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' B' ' 170' ' ' ILE . 98.7 t -70.24 -65.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.165 0.986 . . . . 0.0 109.622 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.08 -31.99 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.668 1.187 . . . . 0.0 111.154 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -43.1 90.4 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.478 0.581 . . . . 0.0 112.566 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -96.5 -44.37 7.2 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.02 1.328 . . . . 0.0 112.511 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -59.43 -48.68 80.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.113 2.565 . . . . 0.0 113.495 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -40.62 97.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.959 0.345 . . . . 0.0 110.396 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 1.4 p -62.05 -30.87 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 112.996 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -76.2 -48.31 20.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.017 2.127 . . . . 0.0 112.918 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.37 -30.42 71.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.937 1.244 . . . . 0.0 113.463 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 31.0 m -58.34 -30.59 66.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.218 1.007 . . . . 0.0 111.05 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -81.47 -36.04 29.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.7 mt -78.36 -19.49 53.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -95.52 -101.7 1.87 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.709 1.623 . . . . 0.0 112.445 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -141.38 151.34 60.89 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 113.012 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.76 110.52 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.832 3.022 . . . . 0.0 111.446 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.88 178.85 8.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 0.0 112.152 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -88.05 93.47 9.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.308 1.443 . . . . 0.0 111.538 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.73 139.41 30.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.235 1.414 . . . . 0.0 109.952 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 3.0 tt -119.76 153.58 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.11 1.764 . . . . 0.0 109.644 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.451 HG12 ' CB ' ' B' ' 253' ' ' ALA . 22.1 m -142.02 146.63 22.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.36 1.064 . . . . 0.0 110.718 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.16 119.92 17.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.064 2.146 . . . . 0.0 109.1 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.3 p -123.03 144.35 49.34 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.543 -0.723 . . . . 0.0 112.215 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 64.9 t -124.31 101.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.038 1.735 . . . . 0.0 108.254 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.32 113.63 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.918 0.887 . . . . 0.0 108.837 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.8 ptp -134.98 146.51 49.15 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.848 0.859 . . . . 0.0 110.529 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -90.14 143.86 26.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.348 -0.845 . . . . 0.0 110.9 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -70.0 4.06 2.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.363 1.465 . . . . 0.0 114.347 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -50.45 -35.23 27.86 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.498 1.519 . . . . 0.0 112.416 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.69 20.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.902 1.239 . . . . 0.0 115.334 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.27 61.09 1.15 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.2 1.4 . . . . 0.0 113.849 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -74.91 63.72 2.37 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.647 1.594 . . . . 0.0 112.959 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.04 159.26 11.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.097 1.759 . . . . 0.0 111.826 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -125.97 89.32 3.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 110.178 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.722 ' HB ' HG13 ' B' ' 278' ' ' VAL . 53.3 m -97.09 139.04 33.68 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.438 177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.71 127.16 44.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.093 1.357 . . . . 0.0 110.122 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m -126.16 116.86 22.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.147 0.979 . . . . 0.0 109.605 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.9 t -80.04 44.61 0.67 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.504 1.145 . . . . 0.0 111.152 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 3.8 m -86.73 179.39 6.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.112 1.365 . . . . 0.0 110.507 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -147.03 148.13 31.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.45 1.5 . . . . 0.0 109.864 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -91.12 132.49 36.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -142.41 139.14 31.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 110.469 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 45.7 t -112.18 -58.64 2.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.465 1.506 . . . . 0.0 111.817 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.8 -38.68 12.22 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.172 0.989 . . . . 0.0 112.155 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -32.38 72.69 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.443 2.297 . . . . 0.0 114.088 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.77 -175.87 5.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.609 1.964 . . . . 0.0 110.803 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -113.62 123.59 6.19 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.563 1.554 . . . . 0.0 114.165 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 22.7 t -146.35 170.92 15.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.208 2.203 . . . . 0.0 110.575 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.2 p -168.78 126.07 1.01 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 0.0 111.896 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.7 t -141.47 141.84 33.64 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 119.597 -1.939 . . . . 0.0 112.575 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.61 123.46 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.652 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 99.02 6.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.308 1.043 . . . . 0.0 113.163 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.07 88.84 2.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.255 1.422 . . . . 0.0 110.884 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -83.48 163.69 20.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.829 0.852 . . . . 0.0 111.37 164.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -141.63 179.93 6.54 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -49.45 -41.23 39.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.451 1.5 . . . . 0.0 113.937 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 21.59 2.85 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 29.2 mtt -139.32 160.33 40.07 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.479 -1.388 . . . . 0.0 113.653 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -135.99 109.87 8.17 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.688 1.995 . . . . 0.0 110.956 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 70.9 m -130.6 78.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.355 1.462 . . . . 0.0 110.697 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.48 145.81 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.266 1.026 . . . . 0.0 112.339 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.55 129.58 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.199 1.8 . . . . 0.0 112.126 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.2 t -114.29 130.24 56.65 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.641 1.577 . . . . 0.0 109.606 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.451 ' CB ' HG12 ' B' ' 210' ' ' VAL . . . -128.42 151.98 48.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.037 1.735 . . . . 0.0 111.764 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -141.02 143.67 34.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.451 1.1 . . . . 0.0 110.94 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -168.47 82.15 0.1 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.257 0.932 . . . . 0.0 111.523 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.2 160.07 38.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.405 1.882 . . . . 0.0 112.121 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 18.3 t . . . . . 0 N--CA 1.473 0.678 0 C-N-CA 124.852 1.261 . . . . 0.0 112.515 -175.723 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -129.62 166.68 19.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.347 1.459 . . . . 0.0 111.432 171.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.44 149.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 111.394 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 28.2 m -121.47 91.16 3.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.162 1.385 . . . . 0.0 110.876 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -78.36 149.33 33.42 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.904 -1.123 . . . . 0.0 110.862 166.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.722 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.8 p -138.7 97.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.742 2.417 . . . . 0.0 109.245 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -133.7 157.67 45.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.307 1.443 . . . . 0.0 110.87 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 CA--C 1.543 0.695 0 C-N-CA 124.308 1.043 . . . . 0.0 111.361 177.769 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 121.893 0.854 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 14.7 p90 -139.18 165.86 26.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.163 1.385 . . . . 0.0 110.117 173.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.62 152.31 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.278 1.031 . . . . 0.0 110.929 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -57.25 -41.17 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.727 1.211 . . . . 0.0 111.323 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.16 66.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -62.54 1.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.766 0.827 . . . . 0.0 110.263 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 56' ' ' LEU . 96.6 t -45.44 -47.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.436 1.894 . . . . 0.0 112.565 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 t -65.87 -13.63 59.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.163 1.785 . . . . 0.0 113.745 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -31.86 11.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.945 1.698 . . . . 0.0 112.255 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.37 -42.33 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.509 0.724 . . . . 0.0 110.272 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.42 -42.12 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -52.24 54.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.175 1.352 . . . . 0.0 111.174 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -30.99 72.03 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.75 -38.7 58.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.432 1.093 . . . . 0.0 113.203 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.454 ' HA ' HG21 ' A' ' 48' ' ' VAL . 49.4 mt -56.89 -56.99 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.166 0.894 . . . . 0.0 109.691 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -59.64 -27.89 66.75 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -47.74 78.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.092 0.957 . . . . 0.0 112.024 169.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.5 -27.16 63.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.775 1.23 . . . . 0.0 114.047 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.58 -35.41 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.564 1.146 . . . . 0.0 111.153 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.48 15.91 70.06 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.1 0.857 . . . . 0.0 114.299 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.9 2.44 78.29 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.087 1.327 . . . . 0.0 115.631 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -65.73 174.34 2.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.841 1.321 . . . . 0.0 112.243 168.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -155.01 0.21 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.119 1.368 . . . . 0.0 111.78 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -51.18 159.45 0.64 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.176 0.991 . . . . 0.0 112.28 158.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -151.6 177.39 10.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.38 1.472 . . . . 0.0 110.631 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -92.14 -114.22 0.09 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.32 1.048 . . . . 0.0 110.931 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -57.47 -22.41 43.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.383 1.873 . . . . 0.0 114.655 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -51.35 -38.97 55.97 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.376 1.471 . . . . 0.0 112.901 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.51 -32.42 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 112.915 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -68.24 -45.15 74.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.227 0.922 . . . . 0.0 112.168 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -22.86 65.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.75 0.704 . . . . 0.0 112.724 174.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.5 -55.1 5.29 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.716 0.806 . . . . 0.0 111.501 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -56.19 -28.99 60.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.916 0.78 . . . . 0.0 113.045 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -79.98 -57.57 3.58 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.338 0.972 . . . . 0.0 112.179 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -57.42 -38.21 73.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.94 1.245 . . . . 0.0 113.484 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 27' ' ' ILE . 84.3 t -66.75 -65.55 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 123.874 0.869 . . . . 0.0 109.491 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.8 t -47.9 -32.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.355 1.062 . . . . 0.0 110.939 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -58.42 -40.54 82.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.8 -40.99 5.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.479 1.512 . . . . 0.0 112.681 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 m -57.68 -53.37 58.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.702 2.401 . . . . 0.0 112.404 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -40.52 92.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.798 0.727 . . . . 0.0 110.693 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -60.9 -40.92 94.91 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.663 -0.648 . . . . 0.0 112.72 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -66.07 -51.29 59.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.924 2.089 . . . . 0.0 113.382 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.52 HD22 HG13 ' A' ' 19' ' ' VAL . 4.1 pp -66.02 -26.24 67.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -58.93 -32.72 69.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.13 0.972 . . . . 0.0 111.466 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -85.58 -23.99 27.38 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -67.79 -26.28 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.12 0.968 . . . . 0.0 112.3 170.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA3' ' CD2' ' A' ' 14' ' ' PHE . . . -98.74 -119.4 4.14 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.965 1.745 . . . . 0.0 112.535 171.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -129.73 156.29 79.08 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.445 1.498 . . . . 0.0 113.156 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.77 113.39 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.93 3.087 . . . . 0.0 112.212 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.11 166.12 31.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.517 1.127 . . . . 0.0 112.196 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -73.3 98.78 2.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.657 0.783 . . . . 0.0 110.956 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -73.34 158.02 35.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.828 0.851 . . . . 0.0 111.179 161.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 tt -132.44 151.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.337 1.455 . . . . 0.0 108.955 164.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 110' ' ' ALA . 18.0 m -142.0 149.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.859 1.263 . . . . 0.0 110.309 169.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 p -135.8 139.37 43.45 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.654 1.582 . . . . 0.0 109.903 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -136.1 150.32 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.648 -0.657 . . . . 0.0 112.056 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.87 104.64 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.888 1.675 . . . . 0.0 108.661 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.469 HD12 ' HB2' ' A' ' 106' ' ' CYS . 2.6 mm -101.2 120.63 51.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.811 1.644 . . . . 0.0 108.926 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.81 166.17 26.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.883 0.849 . . . . 0.0 112.211 174.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -85.96 157.07 20.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.734 1.614 . . . . 0.0 111.245 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.33 11.07 1.04 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.604 1.962 . . . . 0.0 114.954 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -5.48 5.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 114.942 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.81 -3.38 45.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.965 1.745 . . . . 0.0 114.711 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.47 87.53 0.88 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.233 1.413 . . . . 0.0 111.652 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.31 89.3 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.002 1.763 . . . . 0.0 111.031 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.585 ' H ' HD22 ' A' ' 79' ' ' LEU . 1.3 mm? -64.58 160.16 20.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.738 1.215 . . . . 0.0 111.658 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -87.94 96.85 10.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.444 -0.785 . . . . 0.0 109.99 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -117.14 132.16 56.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.783 0.833 . . . . 0.0 109.862 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.57 32.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.323 0.649 . . . . 0.0 111.74 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.9 m -134.09 121.35 21.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.723 1.209 . . . . 0.0 110.569 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -74.35 17.62 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.071 -1.018 . . . . 0.0 113.02 175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.4 m -62.8 167.94 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.833 -1.167 . . . . 0.0 112.22 167.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.18 154.79 21.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.667 1.587 . . . . 0.0 110.636 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -84.22 150.54 25.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.585 1.154 . . . . 0.0 110.241 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -146.93 164.62 32.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.589 1.956 . . . . 0.0 110.303 171.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -128.87 -56.28 1.2 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.498 1.119 . . . . 0.0 113.216 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -78.32 -46.98 18.75 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.389 1.076 . . . . 0.0 112.197 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -48.34 61.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.571 1.949 . . . . 0.0 112.525 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -149.29 -159.71 1.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.411 3.084 . . . . 0.0 108.79 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.56 -173.7 18.02 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.975 1.274 . . . . 0.0 112.923 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.6 p -155.27 173.45 16.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.359 2.263 . . . . 0.0 109.635 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 36.1 t -147.0 122.01 10.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.171 -0.956 . . . . 0.0 109.658 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 t -133.18 149.27 52.05 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.663 -1.273 . . . . 0.0 112.204 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.7 116.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.655 1.582 . . . . 0.0 108.266 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -113.77 95.21 5.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.905 1.282 . . . . 0.0 110.285 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -104.57 118.42 36.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.527 1.131 . . . . 0.0 110.208 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -104.42 162.93 12.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.818 1.647 . . . . 0.0 111.302 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -151.29 -177.41 6.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.209 1.004 . . . . 0.0 111.506 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.73 -67.57 0.2 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.827 2.451 . . . . 0.0 113.847 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.5 t -133.97 24.72 3.93 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.184 1.394 . . . . 0.0 113.306 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.54 162.83 34.12 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.163 -1.586 . . . . 0.0 111.218 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -140.02 137.22 34.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.73 1.212 . . . . 0.0 110.34 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.469 ' HB2' HD12 ' A' ' 71' ' ' ILE . 11.2 p -139.97 85.88 2.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.874 1.321 . . . . 0.0 111.845 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.09 133.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.024 1.329 . . . . 0.0 111.104 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.81 126.44 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.605 1.562 . . . . 0.0 110.867 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 t -117.13 127.9 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.481 1.912 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.465 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -121.73 149.12 43.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.061 1.744 . . . . 0.0 112.582 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -142.2 94.0 2.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.358 1.463 . . . . 0.0 108.663 174.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 113' ' ' LEU . . . -150.01 95.06 0.16 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 120.571 -1.331 . . . . 0.0 110.743 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.428 HD13 ' C ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -148.68 75.27 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.468 1.907 . . . . 0.0 112.142 -174.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.47 0.571 0 O-C-N 121.466 -0.771 . . . . 0.0 112.075 -178.472 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.41 148.9 49.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.054 1.741 . . . . 0.0 112.308 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -60.21 150.71 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.47 1.908 . . . . 0.0 111.471 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 m -115.95 89.59 3.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.229 1.412 . . . . 0.0 110.886 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -98.57 146.45 25.8 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.022 -1.049 . . . . 0.0 111.139 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.52 94.08 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 128.032 2.533 . . . . 0.0 108.006 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.17 162.54 35.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.935 1.294 . . . . 0.0 111.559 176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 124.968 1.307 . . . . 0.0 108.392 174.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 CA-C-O 121.987 0.899 . . . . 0.0 111.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . 0.436 ' CD2' ' HA3' ' B' ' 203' ' ' GLY . 13.6 p90 -139.76 166.62 24.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.286 1.435 . . . . 0.0 110.028 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.68 152.45 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.263 1.025 . . . . 0.0 110.992 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.15 -41.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.79 1.236 . . . . 0.0 111.347 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 113.564 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.65 -62.68 1.5 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.788 0.835 . . . . 0.0 110.172 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.501 HG13 HD22 ' B' ' 199' ' ' LEU . 96.1 t -45.15 -47.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 126.462 1.905 . . . . 0.0 112.607 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t -65.7 -13.8 59.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.111 1.764 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.16 -31.94 11.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.98 1.712 . . . . 0.0 112.203 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 8.6 mt -55.64 -42.18 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.449 0.7 . . . . 0.0 110.26 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.54 -41.71 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.35 53.36 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.145 1.339 . . . . 0.0 111.172 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -30.86 71.91 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.82 -38.88 57.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.421 1.088 . . . . 0.0 113.177 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' B' ' 191' ' ' VAL . 49.8 mt -56.78 -56.97 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.222 0.919 . . . . 0.0 109.663 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.57 -27.97 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -47.67 78.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.157 0.983 . . . . 0.0 111.968 170.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.57 -27.41 64.11 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 114.086 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 58.5 mt -61.5 -35.33 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.609 1.164 . . . . 0.0 111.141 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 82.91 16.18 70.75 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.136 0.874 . . . . 0.0 114.259 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.74 2.32 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.128 1.347 . . . . 0.0 115.58 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -65.16 170.99 4.01 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 118.766 1.283 . . . . 0.0 112.33 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.0 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.26 1.424 . . . . 0.0 112.293 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -53.06 154.18 3.12 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.453 -0.78 . . . . 0.0 111.632 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -145.17 171.02 15.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.142 1.377 . . . . 0.0 110.737 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -84.77 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.213 1.005 . . . . 0.0 110.755 175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 15.6 m -59.73 -20.5 56.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.499 1.52 . . . . 0.0 114.727 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.73 -38.42 55.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.501 1.52 . . . . 0.0 112.888 175.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -55.91 -30.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.73 -45.25 71.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.855 0.862 . . . . 0.0 111.693 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -24.08 65.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -78.19 -54.41 6.26 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.734 0.814 . . . . 0.0 111.54 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.9 t -57.02 -27.53 61.69 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.1 t -81.32 -58.22 3.14 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.434 1.015 . . . . 0.0 112.429 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -56.48 -38.21 71.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.988 1.267 . . . . 0.0 113.584 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.7 t -66.68 -65.72 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 123.822 0.849 . . . . 0.0 109.489 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.9 t -47.74 -32.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 110.968 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -58.55 -40.52 83.25 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -104.92 -40.95 5.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.494 1.518 . . . . 0.0 112.616 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 39.3 m -57.47 -53.67 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.705 2.402 . . . . 0.0 112.438 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -40.9 93.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.749 0.704 . . . . 0.0 110.568 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -60.66 -39.6 88.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -67.42 -51.21 54.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.894 2.078 . . . . 0.0 113.396 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.501 HD22 HG13 ' B' ' 162' ' ' VAL . 3.9 pp -66.27 -26.06 67.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -175.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.4 m -58.68 -32.54 69.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.094 0.958 . . . . 0.0 111.522 165.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -86.21 -23.89 26.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.78 -26.73 66.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.987 0.915 . . . . 0.0 112.194 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' B' ' 157' ' ' PHE . . . -97.56 -121.49 4.25 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.098 1.809 . . . . 0.0 112.562 171.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -128.0 156.34 76.34 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 125.448 1.499 . . . . 0.0 113.172 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.29 112.5 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.005 3.137 . . . . 0.0 112.21 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.15 166.0 32.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.564 1.146 . . . . 0.0 112.314 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -72.6 100.47 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.714 0.806 . . . . 0.0 110.998 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -75.31 157.26 34.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 111.053 160.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 tt -132.26 151.42 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.576 1.55 . . . . 0.0 108.95 164.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' B' ' 253' ' ' ALA . 19.3 m -142.74 149.75 18.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.882 1.273 . . . . 0.0 110.344 170.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 6.7 p -136.89 140.97 42.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.532 1.533 . . . . 0.0 110.145 170.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.8 p -138.48 155.34 48.53 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.617 -0.677 . . . . 0.0 112.176 169.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.96 114.66 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.76 1.624 . . . . 0.0 108.493 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.7 mm -106.93 116.56 50.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 125.863 1.665 . . . . 0.0 108.727 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . 0.417 ' HG2' HD12 ' A' ' 79' ' ' LEU . 1.1 tmt? -134.86 119.57 18.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.401 1.48 . . . . 0.0 110.64 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 81.71 0.88 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.278 1.831 . . . . 0.0 111.0 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.11 -74.38 0.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.073 1.349 . . . . 0.0 110.968 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -19.55 2.12 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.94 -2.48 6.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.058 1.79 . . . . 0.0 115.98 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.99 101.17 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.527 1.531 . . . . 0.0 114.173 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.06 102.18 1.54 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.574 1.083 . . . . 0.0 112.218 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.515 HD23 HD23 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -44.17 151.81 0.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.363 1.465 . . . . 0.0 113.297 166.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.35 93.27 9.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.334 -0.853 . . . . 0.0 109.462 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.496 ' HB ' HG13 ' B' ' 278' ' ' VAL . 50.3 m -116.01 132.79 56.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.243 0.617 . . . . 0.0 110.428 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.56 129.11 38.6 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.218 0.607 . . . . 0.0 111.321 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -131.56 120.57 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.779 1.232 . . . . 0.0 110.211 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 5.0 t -74.02 16.58 0.22 Allowed 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.194 -0.942 . . . . 0.0 113.045 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.6 m -62.44 167.49 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.88 -1.138 . . . . 0.0 112.26 167.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.22 154.27 21.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.739 1.616 . . . . 0.0 110.523 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -81.38 151.42 27.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.251 1.021 . . . . 0.0 110.122 168.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -145.93 163.2 35.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.619 1.968 . . . . 0.0 109.979 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 14.6 t -126.07 -58.82 1.36 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.447 1.099 . . . . 0.0 112.864 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 17.3 p -79.0 -46.59 17.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.384 1.073 . . . . 0.0 112.333 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -48.41 66.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.434 1.893 . . . . 0.0 112.324 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -150.35 -159.13 0.99 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 129.327 3.051 . . . . 0.0 108.718 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.62 -174.03 18.38 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.951 1.263 . . . . 0.0 113.286 169.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 94.9 p -155.1 173.69 16.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.392 2.277 . . . . 0.0 109.634 170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.18 123.73 11.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 166.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 12.8 t -134.01 149.16 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.528 -1.358 . . . . 0.0 112.118 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.65 114.25 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.453 1.501 . . . . 0.0 108.066 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -111.34 96.97 6.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.9 1.28 . . . . 0.0 109.851 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -107.87 124.78 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 109.931 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 168.78 9.85 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 110.643 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -148.11 -158.04 0.87 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.992 0.917 . . . . 0.0 110.807 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.73 -65.97 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.267 2.227 . . . . 0.0 113.649 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 t -139.39 1.62 1.98 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.9 ptp -98.17 154.37 17.81 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.598 -1.314 . . . . 0.0 112.279 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.9 120.01 25.42 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.867 1.667 . . . . 0.0 108.979 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.496 ' HB2' HD12 ' B' ' 214' ' ' ILE . 20.3 p -126.98 79.01 1.85 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.801 1.286 . . . . 0.0 111.139 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.09 136.13 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.005 1.322 . . . . 0.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.05 126.55 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.547 1.539 . . . . 0.0 110.944 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 32.0 t -113.82 132.15 55.98 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.44 1.896 . . . . 0.0 110.407 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -125.38 149.2 48.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.089 1.756 . . . . 0.0 112.555 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -142.67 98.18 3.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.607 1.563 . . . . 0.0 108.346 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . 0.45 ' N ' HD13 ' B' ' 256' ' ' LEU . . . -155.24 94.15 0.14 Allowed Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.655 -1.278 . . . . 0.0 110.64 172.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.45 HD13 ' N ' ' B' ' 255' ' ' GLY . 0.0 OUTLIER -148.37 76.66 1.37 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.504 1.921 . . . . 0.0 112.256 -173.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.471 0.584 0 O-C-N 121.519 -0.738 . . . . 0.0 112.115 -177.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.28 148.76 49.64 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.987 1.715 . . . . 0.0 112.276 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.91 150.58 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.585 1.954 . . . . 0.0 111.438 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.8 m -116.6 88.55 2.92 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.256 1.422 . . . . 0.0 110.787 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -99.1 147.63 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.3 p -138.26 98.16 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 127.3 2.24 . . . . 0.0 108.794 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.84 159.52 42.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.587 1.555 . . . . 0.0 111.612 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 CA--C 1.542 0.658 0 C-N-CA 124.649 1.18 . . . . 0.0 108.527 171.415 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.926 0 CA-C-O 121.661 0.743 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.17 171.49 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.76 1.624 . . . . 0.0 111.425 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.75 161.05 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.544 1.137 . . . . 0.0 111.274 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.39 -44.66 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.591 1.556 . . . . 0.0 111.872 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.61 -25.85 66.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 113.194 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.81 -57.89 3.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.84 0.856 . . . . 0.0 110.85 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.28 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.181 1.392 . . . . 0.0 112.768 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -63.16 -8.29 7.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.617 1.567 . . . . 0.0 114.293 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -109.92 -36.8 5.79 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.877 1.671 . . . . 0.0 112.453 169.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.6 mt -49.34 -44.46 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.086 0.857 . . . . 0.0 110.591 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 97' ' ' VAL . 6.6 p -59.41 -41.46 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.522 -0.736 . . . . 0.0 112.956 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -51.06 52.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.286 0.948 . . . . 0.0 111.01 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.13 72.2 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.9 -47.68 36.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.035 0.934 . . . . 0.0 112.179 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.404 HG13 HG11 ' A' ' 48' ' ' VAL . 65.2 mt -59.53 -58.43 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.183 0.901 . . . . 0.0 110.366 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.16 -27.87 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -65.15 -50.61 65.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.699 0.799 . . . . 0.0 111.795 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.84 -30.81 71.09 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 113.883 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -62.89 -31.6 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.81 1.644 . . . . 0.0 112.578 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.76 7.71 0.43 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 119.052 2.381 . . . . 0.0 119.052 -161.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.37 95.67 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 120.237 2.019 . . . . 0.0 114.731 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -146.85 -173.3 4.19 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.426 1.613 . . . . 0.0 114.098 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.62 -178.1 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.481 1.912 . . . . 0.0 112.537 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -48.94 154.63 0.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -134.84 171.56 14.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.914 1.286 . . . . 0.0 112.349 -170.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -91.49 -113.75 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.111 1.365 . . . . 0.0 110.865 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.7 p -74.57 4.62 5.82 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.179 1.792 . . . . 0.0 115.318 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -47.95 -33.44 7.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.321 1.848 . . . . 0.0 114.559 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 p -48.63 -32.17 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.544 1.137 . . . . 0.0 113.55 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.18 -52.02 57.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.155 1.382 . . . . 0.0 112.284 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.18 -26.33 67.36 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.106 -0.996 . . . . 0.0 112.775 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.81 -53.62 7.68 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.269 1.028 . . . . 0.0 111.557 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.54 -24.24 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.566 0.746 . . . . 0.0 112.72 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -80.67 -63.66 1.36 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.102 0.865 . . . . 0.0 112.197 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -55.15 -41.46 71.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.29 1.436 . . . . 0.0 114.289 -171.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.404 HG11 HG13 ' A' ' 27' ' ' ILE . 85.2 t -66.69 -62.55 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 124.219 1.008 . . . . 0.0 110.248 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.6 t -49.04 -31.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.991 1.317 . . . . 0.0 110.766 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -62.61 -31.19 71.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -108.68 -41.48 4.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.225 1.41 . . . . 0.0 112.165 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.9 m -59.15 -51.47 69.86 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.932 2.493 . . . . 0.0 112.583 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -38.41 91.07 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.287 0.565 . . . . 0.0 111.336 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -61.88 -46.0 91.32 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -60.0 -49.14 78.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.709 2.004 . . . . 0.0 112.809 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.75 -24.8 63.58 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.571 -1.331 . . . . 0.0 114.399 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.0 m -60.36 -28.16 67.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.928 0.491 . . . . 0.0 111.024 165.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -87.19 -29.35 21.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.951 0.901 . . . . 0.0 112.695 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.92 -20.82 62.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.626 1.17 . . . . 0.0 112.385 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.61 -110.56 3.51 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.434 1.969 . . . . 0.0 112.81 172.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -137.78 148.67 61.77 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.379 1.872 . . . . 0.0 111.13 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.34 120.32 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.048 3.165 . . . . 0.0 112.439 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.79 166.77 32.43 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 112.392 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.09 92.61 0.75 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.663 1.185 . . . . 0.0 110.36 166.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -68.6 162.63 25.46 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.664 0.745 . . . . 0.0 110.797 157.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.541 HD11 ' SG ' ' B' ' 228' ' ' CYS . 7.3 tt -141.84 153.62 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.742 1.617 . . . . 0.0 109.045 166.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 110' ' ' ALA . 21.7 m -144.67 152.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.956 1.302 . . . . 0.0 110.566 173.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -144.34 158.64 43.63 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.421 1.089 . . . . 0.0 110.256 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.2 p -151.62 152.72 33.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.078 1.351 . . . . 0.0 111.88 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -133.61 123.49 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.917 1.287 . . . . 0.0 109.317 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mm -111.16 108.36 25.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 127.431 2.293 . . . . 0.0 109.121 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -135.91 153.47 51.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.438 2.295 . . . . 0.0 110.733 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -143.98 147.81 34.43 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 112.495 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -80.04 -14.38 58.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.62 -7.75 55.87 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.12 25.51 0.02 OUTLIER Glycine 0 N--CA 1.477 1.375 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.644 ' HB1' HD11 ' B' ' 222' ' ' LEU . . . -139.25 126.77 21.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.893 1.277 . . . . 0.0 112.472 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.25 101.4 0.16 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.927 0.775 . . . . 0.0 114.111 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.721 HD13 HD13 ' B' ' 222' ' ' LEU . 8.8 mp -113.99 -174.56 2.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.688 2.395 . . . . 0.0 110.358 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.15 130.64 55.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.382 0.673 . . . . 0.0 110.317 170.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.2 m -137.78 142.85 40.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.284 1.433 . . . . 0.0 109.749 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.72 138.29 39.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.675 1.19 . . . . 0.0 110.551 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.2 p -141.43 120.05 12.5 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.583 1.153 . . . . 0.0 110.993 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.8 m -75.91 13.2 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.839 -1.163 . . . . 0.0 113.406 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.673 ' SG ' HD11 ' B' ' 209' ' ' ILE . 8.2 m -60.43 164.49 4.36 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.899 167.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.95 158.21 30.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.445 1.898 . . . . 0.0 110.053 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -80.72 139.42 36.13 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.247 0.546 . . . . 0.0 109.651 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -154.35 162.66 41.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.164 1.786 . . . . 0.0 111.178 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.6 t -132.98 -59.32 0.89 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.232 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 -39.09 51.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.369 1.068 . . . . 0.0 111.513 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -53.68 53.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.78 1.632 . . . . 0.0 111.641 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -150.09 -69.76 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.982 1.313 . . . . 0.0 112.404 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.29 151.95 6.36 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 127.238 2.352 . . . . 0.0 113.38 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 p -165.35 141.48 5.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.689 1.995 . . . . 0.0 110.557 173.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.72 63.85 1.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.869 1.268 . . . . 0.0 112.35 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -76.41 150.59 36.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.338 1.855 . . . . 0.0 113.591 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 23' ' ' VAL . 1.7 t -142.12 135.21 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.463 1.505 . . . . 0.0 110.457 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -115.19 120.15 38.77 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.48 1.112 . . . . 0.0 112.012 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -133.2 98.54 4.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.695 1.598 . . . . 0.0 110.261 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 173.48 8.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.79 1.236 . . . . 0.0 111.949 166.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -143.43 -176.39 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.764 1.626 . . . . 0.0 111.203 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -51.56 -43.31 62.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.172 1.389 . . . . 0.0 114.246 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 t -137.71 8.52 2.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.271 1.428 . . . . 0.0 114.101 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.14 165.38 16.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.184 1.393 . . . . 0.0 112.819 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -145.28 118.76 9.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.161 1.784 . . . . 0.0 109.941 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.9 p -143.62 74.44 1.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 111.938 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.0 pt -74.71 158.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.457 -0.777 . . . . 0.0 111.421 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.07 141.15 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.486 1.914 . . . . 0.0 109.949 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -135.38 125.18 25.51 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.257 -0.902 . . . . 0.0 111.54 -174.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -121.62 144.17 48.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.299 1.44 . . . . 0.0 112.823 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -146.18 -176.67 5.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 126.607 1.963 . . . . 0.0 110.125 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.53 84.41 1.11 Allowed Glycine 0 CA--C 1.539 1.552 0 O-C-N 120.87 -1.144 . . . . 0.0 112.892 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 46.22 1.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.174 2.19 . . . . 0.0 113.031 -167.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 122.193 0.997 . . . . 0.0 112.268 -170.669 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 111.455 0.168 . . . . 0.0 111.455 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -136.23 169.44 17.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.85 2.06 . . . . 0.0 111.443 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 mm -63.71 146.02 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 110.588 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.6 m -106.07 111.74 24.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.279 1.432 . . . . 0.0 110.067 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.99 145.37 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.782 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.86 104.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -139.63 150.36 44.86 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.737 0.815 . . . . 0.0 112.465 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.548 0.901 0 C-N-CA 125.574 1.55 . . . . 0.0 111.557 -175.367 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.845 0 CA-C-O 121.239 0.542 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.59 162.63 27.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.402 1.081 . . . . 0.0 110.721 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 p -138.61 158.96 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.736 1.215 . . . . 0.0 111.166 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.83 -38.55 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.74 2.416 . . . . 0.0 112.67 -174.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.86 -28.34 68.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 113.072 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.49 -47.8 7.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.47 0.708 . . . . 0.0 110.708 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 70.2 t -48.58 -42.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.338 1.455 . . . . 0.0 112.187 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t -64.25 -8.23 11.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.622 1.569 . . . . 0.0 114.874 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.54 -35.09 6.84 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.308 1.843 . . . . 0.0 112.446 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.9 mt -49.79 -42.13 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.143 0.977 . . . . 0.0 110.583 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.29 -43.57 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.52 63.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.455 1.025 . . . . 0.0 111.053 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -33.73 76.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.57 63.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.647 0.779 . . . . 0.0 112.206 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.4 HG13 HG11 ' B' ' 191' ' ' VAL . 66.5 mt -59.5 -59.18 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.109 0.868 . . . . 0.0 109.986 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -61.86 -29.48 70.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 32.9 t -63.6 -51.93 63.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.983 0.913 . . . . 0.0 111.912 167.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.29 -30.71 71.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.071 1.348 . . . . 0.0 113.989 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.78 -34.81 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.249 1.419 . . . . 0.0 111.005 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.33 80.81 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.897 1.237 . . . . 0.0 114.916 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.48 68.82 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.104 1.335 . . . . 0.0 115.487 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -70.57 -176.14 1.2 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.811 1.306 . . . . 0.0 112.301 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.89 154.25 5.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.721 -1.237 . . . . 0.0 111.424 170.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -48.92 150.0 1.66 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.021 1.328 . . . . 0.0 113.1 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -127.85 166.64 17.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.577 1.151 . . . . 0.0 111.483 -173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -89.0 -113.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.519 1.128 . . . . 0.0 110.553 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 61.0 p -74.37 5.91 4.16 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -48.59 -33.97 10.72 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.085 1.754 . . . . 0.0 114.475 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 65.6 t -50.11 -33.02 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.567 1.147 . . . . 0.0 112.665 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.94 -52.99 57.23 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.309 1.443 . . . . 0.0 112.367 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.79 -26.3 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.045 -1.035 . . . . 0.0 112.742 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.96 -53.19 8.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.264 1.026 . . . . 0.0 111.519 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.59 -24.38 63.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.385 0.674 . . . . 0.0 112.79 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.6 t -80.51 -64.01 1.28 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.121 0.873 . . . . 0.0 112.138 165.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -55.25 -39.74 70.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.312 1.445 . . . . 0.0 114.345 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.4 HG11 HG13 ' B' ' 170' ' ' ILE . 88.8 t -68.21 -62.37 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 C-N-CA 124.139 0.976 . . . . 0.0 110.208 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.18 -31.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.922 1.289 . . . . 0.0 110.721 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -62.03 -31.78 72.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.932 0.893 . . . . 0.0 113.376 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -108.22 -41.61 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.162 1.385 . . . . 0.0 112.163 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 46.2 m -59.71 -51.36 70.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.074 2.55 . . . . 0.0 112.617 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -38.32 90.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 111.262 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.5 t -61.32 -46.64 89.44 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.624 -0.673 . . . . 0.0 111.626 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.69 -50.5 73.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.789 2.035 . . . . 0.0 112.941 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.99 -27.65 67.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.081 1.309 . . . . 0.0 114.027 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 93.7 m -59.57 -29.09 67.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.116 0.566 . . . . 0.0 111.283 167.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.72 -28.83 22.84 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 89.8 mt -78.92 -19.4 51.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.181 0.992 . . . . 0.0 111.895 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -102.19 -104.25 2.79 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.429 1.966 . . . . 0.0 112.087 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -141.43 145.81 39.49 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.084 1.754 . . . . 0.0 111.505 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 122.23 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.053 3.168 . . . . 0.0 112.522 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -158.51 167.58 29.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.25 1.42 . . . . 0.0 112.106 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.15 92.13 0.54 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.651 1.18 . . . . 0.0 110.305 166.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -68.06 161.85 25.85 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.603 0.716 . . . . 0.0 110.582 157.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . 0.673 HD11 ' SG ' ' A' ' 85' ' ' CYS . 7.1 tt -141.16 153.54 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.774 1.629 . . . . 0.0 108.94 166.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' B' ' 253' ' ' ALA . 25.7 m -144.15 151.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.808 1.243 . . . . 0.0 110.44 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.2 t -142.67 157.46 44.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.473 1.109 . . . . 0.0 110.06 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 46.4 t -152.85 147.8 26.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.39 1.476 . . . . 0.0 111.313 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.37 127.57 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.4 mm -113.34 111.17 34.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 127.429 2.292 . . . . 0.0 109.462 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -135.76 153.65 51.48 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.652 2.381 . . . . 0.0 110.945 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -144.32 144.15 31.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.378 1.471 . . . . 0.0 112.636 -172.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -75.97 -15.64 60.13 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -75.8 -7.88 55.52 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.48 23.75 0.02 OUTLIER Glycine 0 CA--C 1.536 1.363 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -138.61 123.33 18.67 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.745 1.272 . . . . 0.0 112.591 -168.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.63 103.06 0.19 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.048 0.832 . . . . 0.0 114.292 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.721 HD13 HD13 ' A' ' 79' ' ' LEU . 8.5 mp -114.64 -174.31 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.895 2.478 . . . . 0.0 110.444 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.56 129.96 55.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.58 0.752 . . . . 0.0 110.587 170.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.578 ' HB ' HG13 ' B' ' 278' ' ' VAL . 22.9 m -135.66 145.36 46.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.102 1.361 . . . . 0.0 109.964 172.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.55 41.74 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 110.997 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.8 p -142.88 122.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.462 1.105 . . . . 0.0 110.755 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.7 m -77.03 13.25 1.12 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.946 -1.096 . . . . 0.0 113.168 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . 0.541 ' SG ' HD11 ' A' ' 66' ' ' ILE . 5.2 m -59.83 164.52 3.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.836 167.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.44 159.57 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.832 . . . . 0.0 110.247 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -80.42 135.72 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.222 0.535 . . . . 0.0 109.567 169.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -152.11 162.84 40.49 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.753 1.621 . . . . 0.0 111.47 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 32.1 t -137.1 -58.98 0.71 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.872 1.269 . . . . 0.0 112.173 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -74.48 -40.78 61.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.102 0.961 . . . . 0.0 111.368 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -54.26 46.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.947 1.699 . . . . 0.0 111.621 -174.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.14 -70.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.876 1.27 . . . . 0.0 112.703 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 137.11 152.69 6.22 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 127.509 2.48 . . . . 0.0 113.484 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 44.9 p -171.49 127.29 0.65 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.558 1.543 . . . . 0.0 112.459 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.56 65.04 0.67 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.972 1.709 . . . . 0.0 112.431 -171.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.9 t -76.94 146.75 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.16 1.384 . . . . 0.0 113.637 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.32 114.94 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.694 1.198 . . . . 0.0 110.906 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -94.14 119.02 32.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.72 1.208 . . . . 0.0 111.859 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -130.08 106.81 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.437 1.495 . . . . 0.0 110.323 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 169.91 9.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.365 1.466 . . . . 0.0 111.667 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -140.83 -177.33 5.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.637 1.575 . . . . 0.0 110.968 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -51.75 -42.25 62.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.888 1.275 . . . . 0.0 114.406 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 7.6 t -138.1 8.21 2.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.252 1.421 . . . . 0.0 114.324 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.35 159.4 27.55 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.45 119.04 15.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.647 1.979 . . . . 0.0 110.33 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.68 73.88 1.43 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.887 1.275 . . . . 0.0 112.031 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.32 125.57 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.37 1.468 . . . . 0.0 111.765 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.22 147.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.412 1.485 . . . . 0.0 110.614 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -139.75 129.76 24.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.93 0.892 . . . . 0.0 111.981 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -123.6 145.2 49.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.367 1.467 . . . . 0.0 113.05 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -147.5 -176.5 5.27 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.709 2.004 . . . . 0.0 109.972 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 86.47 84.89 1.09 Allowed Glycine 0 CA--C 1.538 1.523 0 O-C-N 120.794 -1.191 . . . . 0.0 112.922 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.93 1.03 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.066 2.146 . . . . 0.0 113.038 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.473 0.686 0 CA-C-O 122.096 0.951 . . . . 0.0 112.111 -171.104 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.518 0 N-CA-C 111.46 0.171 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -136.24 169.61 17.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.807 2.043 . . . . 0.0 111.418 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.79 146.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.084 1.354 . . . . 0.0 110.607 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 85.1 m -107.79 103.7 13.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.455 1.502 . . . . 0.0 110.26 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -104.45 147.41 27.6 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.876 -1.14 . . . . 0.0 110.74 171.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.4 p -145.15 107.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.736 2.014 . . . . 0.0 109.916 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -139.0 151.68 47.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.728 0.811 . . . . 0.0 112.564 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 CA--C 1.547 0.865 0 C-N-CA 125.559 1.544 . . . . 0.0 111.499 -176.3 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.188 0.518 . . . . 0.0 112.219 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -123.39 164.76 18.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.433 1.493 . . . . 0.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.66 161.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 110.939 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.33 -36.92 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.767 1.627 . . . . 0.0 112.047 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.83 -26.14 67.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.64 1.176 . . . . 0.0 112.274 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.96 -58.96 2.75 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.297 0.639 . . . . 0.0 110.099 171.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 56' ' ' LEU . 96.7 t -47.59 -43.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.763 1.625 . . . . 0.0 113.325 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 t -59.3 -21.39 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.605 1.562 . . . . 0.0 113.574 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -99.63 -34.23 10.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.384 1.474 . . . . 0.0 113.114 172.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 mt -51.42 -42.96 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.251 1.02 . . . . 0.0 110.633 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.55 -44.1 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 121.408 -0.807 . . . . 0.0 113.102 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -51.36 65.43 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.945 1.248 . . . . 0.0 111.697 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -35.44 79.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.15 64.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.4 ' HA ' HG21 ' A' ' 48' ' ' VAL . 61.4 mt -60.28 -56.58 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.155 0.889 . . . . 0.0 109.001 173.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.25 -32.31 73.68 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.7 p -69.81 -36.99 76.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.18 -0.95 . . . . 0.0 112.699 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -28.04 62.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.669 1.188 . . . . 0.0 113.899 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.59 -34.22 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.975 1.31 . . . . 0.0 110.809 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.19 81.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.797 1.189 . . . . 0.0 114.729 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.98 17.69 65.77 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.287 1.422 . . . . 0.0 115.543 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.28 -173.29 1.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.696 1.248 . . . . 0.0 111.733 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 115.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 111.297 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -64.77 126.08 26.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.384 1.074 . . . . 0.0 111.394 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -127.41 127.67 44.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.253 1.021 . . . . 0.0 112.583 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -64.15 -42.49 96.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.265 1.026 . . . . 0.0 112.954 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 t -62.64 -28.78 70.15 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.994 -1.066 . . . . 0.0 112.712 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -72.8 -26.56 61.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.58 -34.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.078 1.308 . . . . 0.0 112.401 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.3 -49.2 72.72 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.953 1.301 . . . . 0.0 112.593 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.88 -25.89 66.61 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.152 -0.967 . . . . 0.0 112.909 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -78.08 -53.07 7.8 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.717 0.807 . . . . 0.0 111.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.61 -22.81 62.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -82.83 -60.22 2.24 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.508 1.049 . . . . 0.0 112.189 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -57.66 -38.98 76.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.113 1.324 . . . . 0.0 114.32 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 27' ' ' ILE . 88.2 t -68.52 -64.53 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 C-N-CA 124.644 1.177 . . . . 0.0 109.895 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.6 t -47.53 -30.99 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 110.863 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.61 -38.5 72.14 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.136 0.975 . . . . 0.0 113.314 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -112.21 -34.6 5.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.998 1.719 . . . . 0.0 112.648 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -62.21 -52.67 62.83 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.031 2.132 . . . . 0.0 112.572 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -33.85 75.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.371 0.532 . . . . 0.0 111.123 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 m -60.69 -54.76 41.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.548 0.739 . . . . 0.0 111.853 166.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -53.47 -50.82 64.52 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.435 1.894 . . . . 0.0 112.751 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.471 HD22 HG13 ' A' ' 19' ' ' VAL . 3.6 pp -68.95 -27.19 65.51 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.2 m -59.65 -43.4 93.93 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -71.44 -23.11 61.79 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.0 5.77 3.97 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.215 1.406 . . . . 0.0 113.386 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.11 -97.86 0.14 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.594 1.088 . . . . 0.0 114.981 164.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -66.87 170.66 5.67 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 125.163 1.385 . . . . 0.0 114.598 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.12 168.27 14.39 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.166 1.911 . . . . 0.0 112.131 166.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -56.8 113.82 1.82 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.571 1.548 . . . . 0.0 112.651 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.33 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.377 3.071 . . . . 0.0 110.273 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.93 172.28 13.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.833 2.453 . . . . 0.0 108.915 169.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 tt -134.74 153.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.519 1.527 . . . . 0.0 108.403 162.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.08 141.61 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.858 0.863 . . . . 0.0 110.255 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.06 141.55 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.511 1.525 . . . . 0.0 108.932 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 146.93 41.27 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.496 -0.752 . . . . 0.0 112.964 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.24 125.38 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.465 1.506 . . . . 0.0 109.144 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mm -124.63 104.68 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.026 2.13 . . . . 0.0 108.076 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.57 166.96 20.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 112.286 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.09 109.49 12.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.639 1.175 . . . . 0.0 111.861 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -61.38 -20.09 62.63 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.89 -16.69 61.1 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.28 18.09 0.02 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.895 1.918 . . . . 0.0 117.895 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.5 65.84 1.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.367 1.583 . . . . 0.0 111.971 -171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.33 159.42 40.98 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.623 1.106 . . . . 0.0 113.145 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.436 ' HB3' HD12 ' B' ' 222' ' ' LEU . 0.0 OUTLIER -160.97 174.88 13.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.43 1.892 . . . . 0.0 112.06 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -120.86 133.24 55.31 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.553 1.141 . . . . 0.0 111.112 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.451 ' HB ' HG13 ' A' ' 135' ' ' VAL . 13.3 m -141.0 144.61 35.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.587 1.555 . . . . 0.0 109.77 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.8 126.29 20.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.663 1.185 . . . . 0.0 109.991 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.4 p -128.57 113.3 15.27 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.849 0.86 . . . . 0.0 110.755 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -77.45 11.26 2.07 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.557 1.143 . . . . 0.0 112.844 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.6 m -58.76 163.01 3.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.931 1.692 . . . . 0.0 112.714 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -159.16 137.82 10.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.918 1.287 . . . . 0.0 110.353 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -73.7 148.91 42.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.478 0.711 . . . . 0.0 110.195 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -136.16 151.69 50.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 110.913 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.0 t -106.35 -63.24 1.29 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.492 1.117 . . . . 0.0 112.158 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.5 p -84.87 -32.01 23.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.804 0.842 . . . . 0.0 113.159 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -49.86 47.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.24 1.416 . . . . 0.0 111.943 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -149.82 -174.43 4.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.668 2.387 . . . . 0.0 110.3 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.73 149.06 18.65 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.709 1.147 . . . . 0.0 112.256 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -155.56 131.9 10.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.692 1.197 . . . . 0.0 110.418 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 11.0 t -123.31 136.49 54.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -128.19 141.35 51.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.383 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.4 113.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 126.468 1.907 . . . . 0.0 108.949 -168.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.0 114.26 24.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.729 1.612 . . . . 0.0 111.378 -174.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -124.82 105.35 9.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.158 1.783 . . . . 0.0 109.569 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 167.1 7.48 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.475 -0.766 . . . . 0.0 112.253 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -144.83 -179.21 6.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.976 0.911 . . . . 0.0 111.518 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -52.11 55.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.793 1.637 . . . . 0.0 113.74 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.3 t -127.67 -30.11 2.57 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.89 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.2 ptp -96.59 179.44 4.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.49 1.516 . . . . 0.0 111.835 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.1 152.51 37.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.643 1.577 . . . . 0.0 109.38 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.0 p -129.66 137.38 50.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.108 0.963 . . . . 0.0 110.995 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.1 125.38 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.921 1.289 . . . . 0.0 110.271 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.12 128.03 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.895 2.078 . . . . 0.0 108.994 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -126.74 110.14 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.154 1.381 . . . . 0.0 111.291 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.27 143.38 27.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.449 1.9 . . . . 0.0 112.383 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -134.02 126.27 29.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.983 1.313 . . . . 0.0 110.001 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.59 73.99 0.3 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.554 2.026 . . . . 0.0 111.206 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.97 123.22 16.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.006 1.322 . . . . 0.0 110.92 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.471 0.606 0 C-N-CA 125.49 1.516 . . . . 0.0 112.62 -169.142 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.405 0 CA-C-O 120.637 0.256 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -127.06 165.43 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.309 1.044 . . . . 0.0 112.373 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.2 mm -64.56 148.38 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.503 1.521 . . . . 0.0 110.872 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.5 m -126.04 100.43 6.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.89 1.276 . . . . 0.0 110.595 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -92.04 149.46 21.51 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.95 168.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -146.34 103.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.082 2.153 . . . . 0.0 109.22 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -139.1 157.73 45.44 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.095 -1.003 . . . . 0.0 112.507 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.545 0.788 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.778 0 CA-C-O 121.047 0.451 . . . . 0.0 112.061 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -118.75 167.81 11.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.277 1.431 . . . . 0.0 110.663 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.44 160.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.494 1.118 . . . . 0.0 111.066 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.94 -37.34 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.631 1.173 . . . . 0.0 111.946 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -28.06 66.19 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.093 0.957 . . . . 0.0 112.882 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -77.3 -59.6 2.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.975 1.31 . . . . 0.0 110.767 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.496 HG13 HD22 ' B' ' 199' ' ' LEU . 84.0 t -48.67 -42.5 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 125.055 1.342 . . . . 0.0 113.292 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.8 t -58.95 -19.33 41.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.281 1.432 . . . . 0.0 113.454 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -101.92 -34.26 9.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.803 1.241 . . . . 0.0 113.161 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 24.1 mt -51.04 -44.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.496 1.044 . . . . 0.0 110.608 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.29 -43.31 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.453 -0.779 . . . . 0.0 112.874 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -51.02 62.88 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.733 1.151 . . . . 0.0 111.592 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -34.48 76.69 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.11 59.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.946 0.898 . . . . 0.0 113.34 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.18 -57.22 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.206 0.912 . . . . 0.0 109.064 174.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.29 -31.29 72.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.5 p -69.98 -37.57 75.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.19 -0.944 . . . . 0.0 112.681 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.16 -31.22 68.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.388 1.075 . . . . 0.0 113.462 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.8 -35.75 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.364 1.465 . . . . 0.0 112.636 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -58.74 -1.05 0.73 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -159.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.41 -32.68 81.91 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.904 1.852 . . . . 0.0 115.285 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -166.67 2.31 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.848 1.324 . . . . 0.0 112.511 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.07 161.92 3.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.383 1.473 . . . . 0.0 112.703 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.65 130.19 39.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.314 1.446 . . . . 0.0 111.132 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -132.89 133.97 43.97 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.776 1.23 . . . . 0.0 112.156 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -73.57 -43.17 60.47 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.25 1.02 . . . . 0.0 113.101 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 7.2 t -62.23 -27.68 69.16 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.066 -1.021 . . . . 0.0 112.502 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -73.25 -26.19 61.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -53.81 -34.03 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.261 1.391 . . . . 0.0 112.571 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.58 -49.62 72.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.1 1.36 . . . . 0.0 112.567 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.06 -25.42 66.24 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.198 -0.939 . . . . 0.0 112.932 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -78.39 -52.72 8.17 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.611 0.764 . . . . 0.0 111.756 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.75 -22.73 62.5 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.8 t -82.83 -60.6 2.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.492 1.042 . . . . 0.0 112.205 165.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -56.83 -41.31 77.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.302 1.41 . . . . 0.0 114.294 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.35 -64.67 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 110.036 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 87.6 t -47.7 -30.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.958 1.303 . . . . 0.0 110.973 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.08 -38.15 72.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.009 0.924 . . . . 0.0 113.162 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.6 -35.41 5.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 112.596 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 44.7 m -61.48 -52.66 63.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.157 2.183 . . . . 0.0 112.634 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -34.23 76.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.487 0.585 . . . . 0.0 111.192 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 66.5 m -61.06 -53.6 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.511 0.725 . . . . 0.0 111.887 167.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -54.42 -50.88 66.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.594 1.958 . . . . 0.0 112.648 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.496 HD22 HG13 ' B' ' 162' ' ' VAL . 3.9 pp -69.38 -26.55 64.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 66.7 m -59.27 -43.48 92.49 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -71.87 -23.25 61.48 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.38 4.96 4.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.28 1.432 . . . . 0.0 113.464 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -155.93 -97.28 0.13 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.517 1.053 . . . . 0.0 114.941 164.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -67.67 171.22 5.52 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 125.156 1.382 . . . . 0.0 114.666 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.62 169.7 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.019 1.812 . . . . 0.0 111.889 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -56.26 114.19 1.87 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.591 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.8 97.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 129.342 3.057 . . . . 0.0 110.169 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -149.8 171.88 16.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.687 2.395 . . . . 0.0 109.044 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -135.24 153.53 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.903 1.681 . . . . 0.0 108.217 162.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 253' ' ' ALA . 27.3 m -139.02 141.88 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.863 0.865 . . . . 0.0 110.124 166.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.257 1.423 . . . . 0.0 108.895 169.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.2 p -135.79 150.21 49.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.12 0.962 . . . . 0.0 113.078 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 12.9 t -132.27 125.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.894 1.677 . . . . 0.0 108.184 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.6 mm -122.49 104.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.997 2.119 . . . . 0.0 107.418 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 162.97 29.28 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 112.753 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.1 137.34 52.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.265 1.426 . . . . 0.0 111.134 -174.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -89.1 -14.18 36.88 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -77.85 -17.06 57.8 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 173.59 21.37 0.02 OUTLIER Glycine 0 CA--C 1.538 1.517 0 N-CA-C 117.703 1.841 . . . . 0.0 117.703 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.73 73.25 1.42 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.773 1.786 . . . . 0.0 112.767 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.5 160.16 32.73 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.682 1.134 . . . . 0.0 113.518 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -162.02 176.68 10.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.797 2.039 . . . . 0.0 111.941 -177.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.19 131.2 53.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.677 1.591 . . . . 0.0 110.957 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.59 ' HB ' HG13 ' B' ' 278' ' ' VAL . 90.6 m -139.05 143.38 38.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.449 1.1 . . . . 0.0 109.916 174.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.8 128.73 27.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 110.23 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.9 p -130.81 114.69 15.63 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.845 0.858 . . . . 0.0 110.912 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 t -78.16 11.21 2.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.447 1.099 . . . . 0.0 112.712 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.2 m -58.42 162.51 3.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.803 1.641 . . . . 0.0 112.774 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -158.96 138.55 11.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.846 1.258 . . . . 0.0 110.537 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.73 145.0 47.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.391 0.677 . . . . 0.0 109.927 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -130.13 151.81 50.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.614 1.566 . . . . 0.0 110.23 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 29.7 t -106.75 -64.28 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.927 1.291 . . . . 0.0 112.211 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 70.8 p -83.65 -31.64 26.06 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.868 0.867 . . . . 0.0 113.262 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -48.81 58.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 111.928 -173.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.07 -175.12 5.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.881 2.472 . . . . 0.0 110.754 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.99 146.74 16.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.784 1.183 . . . . 0.0 112.252 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 1.4 m -152.73 126.69 9.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.098 1.359 . . . . 0.0 110.679 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 16.8 t -121.33 130.08 53.43 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.59 1.156 . . . . 0.0 111.416 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.5 t -125.53 143.73 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.166 0.986 . . . . 0.0 111.338 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.42 131.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.506 1.523 . . . . 0.0 109.183 -172.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 114.47 17.8 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.434 1.493 . . . . 0.0 111.346 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.77 102.67 7.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.456 1.903 . . . . 0.0 109.408 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 165.95 7.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.492 -0.755 . . . . 0.0 112.093 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -144.1 -178.74 6.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.998 0.919 . . . . 0.0 111.581 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -51.08 59.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.858 1.663 . . . . 0.0 113.751 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -129.4 -29.28 2.23 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.519 1.528 . . . . 0.0 113.992 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -97.14 179.17 5.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.529 1.532 . . . . 0.0 111.828 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.57 151.72 36.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.369 1.468 . . . . 0.0 109.539 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.402 ' HB2' HD12 ' B' ' 214' ' ' ILE . 29.9 p -129.53 137.52 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.072 0.949 . . . . 0.0 111.148 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.0 130.02 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.992 1.317 . . . . 0.0 109.975 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.5 125.72 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.695 1.598 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.8 m -121.87 109.05 14.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.876 1.671 . . . . 0.0 110.916 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -94.52 143.83 26.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 112.579 176.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -134.76 122.46 22.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.347 1.459 . . . . 0.0 109.737 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.43 74.08 0.27 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.419 1.961 . . . . 0.0 111.331 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.92 121.82 13.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.016 1.326 . . . . 0.0 110.919 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.9 m . . . . . 0 CA--C 1.539 0.531 0 C-N-CA 125.994 1.718 . . . . 0.0 112.406 -169.043 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -127.92 166.51 18.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.031 0.933 . . . . 0.0 111.993 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.38 149.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.53 1.532 . . . . 0.0 111.274 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 86.4 m -126.96 99.89 5.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.005 1.322 . . . . 0.0 110.725 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -93.94 150.03 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.163 -0.961 . . . . 0.0 110.858 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.59 HG13 ' HB ' ' B' ' 224' ' ' THR . 4.0 p -150.28 104.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.534 1.934 . . . . 0.0 110.062 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.61 159.18 42.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.031 1.332 . . . . 0.0 112.373 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.546 0.791 0 C-N-CA 125.844 1.658 . . . . 0.0 111.94 -178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 CA-C-O 121.176 0.512 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.27 170.16 8.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.262 1.425 . . . . 0.0 111.764 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -149.57 157.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.72 1.208 . . . . 0.0 111.366 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -53.45 -41.27 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.834 1.653 . . . . 0.0 112.063 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.91 -25.85 67.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.74 1.216 . . . . 0.0 113.544 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -79.96 -56.22 4.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.022 0.929 . . . . 0.0 110.632 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.0 t -47.34 -43.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.432 1.893 . . . . 0.0 112.381 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -63.79 -9.66 15.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.292 1.837 . . . . 0.0 114.362 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -111.17 -32.67 6.69 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.524 1.93 . . . . 0.0 112.475 172.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.3 mt -50.74 -43.37 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.014 0.825 . . . . 0.0 110.317 168.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.15 -44.04 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.495 -0.753 . . . . 0.0 112.957 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -52.36 51.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.756 1.162 . . . . 0.0 111.318 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -34.75 77.26 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.41 -41.42 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.78 0.832 . . . . 0.0 112.984 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.463 ' HA ' HG21 ' A' ' 48' ' ' VAL . 56.2 mt -58.25 -59.56 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.297 0.953 . . . . 0.0 109.522 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -62.97 -29.95 71.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.29 -49.93 75.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.27 1.028 . . . . 0.0 112.104 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.46 72.04 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.48 -40.67 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.799 1.24 . . . . 0.0 111.506 173.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.11 74.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.163 0.887 . . . . 0.0 115.139 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.71 -0.31 36.56 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.392 1.472 . . . . 0.0 116.256 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.47 162.03 8.64 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 118.879 1.34 . . . . 0.0 112.008 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.31 -166.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.599 1.56 . . . . 0.0 111.57 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -43.92 121.67 2.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.392 2.277 . . . . 0.0 112.425 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -115.81 170.17 8.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.631 1.172 . . . . 0.0 113.085 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 -95.86 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.703 1.201 . . . . 0.0 109.317 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -76.81 -21.01 55.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.637 1.175 . . . . 0.0 113.988 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -41.81 76.9 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.998 0.919 . . . . 0.0 112.367 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.16 -33.42 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.02 -46.73 80.1 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.362 0.983 . . . . 0.0 112.204 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -65.79 -24.84 67.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.692 0.678 . . . . 0.0 112.532 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.75 -51.86 9.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.034 0.833 . . . . 0.0 111.887 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -56.52 -29.59 62.06 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.847 0.749 . . . . 0.0 112.521 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -79.35 -60.77 2.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.389 0.995 . . . . 0.0 112.409 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.84 -38.6 75.96 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.334 1.453 . . . . 0.0 114.284 -172.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' A' ' 27' ' ' ILE . 81.7 t -68.21 -64.44 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 123.9 0.88 . . . . 0.0 109.469 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.9 t -50.42 -28.44 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.469 1.507 . . . . 0.0 110.835 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.11 28.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.579 1.151 . . . . 0.0 112.115 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -93.27 -35.56 13.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.041 1.336 . . . . 0.0 112.734 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -59.75 -54.38 47.03 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.944 2.097 . . . . 0.0 112.285 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -37.44 83.15 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.122 0.487 . . . . 0.0 111.236 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.0 t -62.18 -40.45 96.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.151 -0.968 . . . . 0.0 113.102 170.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.1 -49.85 63.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.721 1.608 . . . . 0.0 112.422 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.74 -24.8 65.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.9 m -55.89 -34.76 65.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.674 0.789 . . . . 0.0 110.919 163.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -84.88 -31.46 23.72 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.13 -30.47 70.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.472 0.709 . . . . 0.0 111.578 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.38 -100.81 2.61 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.147 1.832 . . . . 0.0 112.724 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -136.63 141.76 36.6 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.867 1.267 . . . . 0.0 113.677 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.44 104.18 1.66 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.448 3.432 . . . . 0.0 112.605 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -142.84 179.89 6.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.078 1.751 . . . . 0.0 112.166 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.5 89.25 3.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.464 1.506 . . . . 0.0 111.706 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.13 147.42 25.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.033 1.333 . . . . 0.0 110.747 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.3 152.96 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 126.117 1.767 . . . . 0.0 109.292 174.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 110' ' ' ALA . 9.5 m -138.39 146.68 26.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.604 1.161 . . . . 0.0 110.823 172.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 126.98 20.02 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.422 1.889 . . . . 0.0 108.921 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 p -129.7 138.09 50.95 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 112.552 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.1 98.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.139 1.376 . . . . 0.0 109.5 -167.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -106.7 91.32 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.359 1.864 . . . . 0.0 107.928 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -147.37 93.83 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.057 1.743 . . . . 0.0 110.763 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.54 133.37 8.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 109.649 170.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -52.05 0.14 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.274 1.43 . . . . 0.0 112.123 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.68 -23.95 8.98 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.875 1.27 . . . . 0.0 113.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.0 -1.34 38.35 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.538 1.542 . . . . 0.0 115.056 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.29 68.58 1.43 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.402 1.881 . . . . 0.0 111.237 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.9 15.93 0.09 OUTLIER Glycine 0 CA--C 1.537 1.429 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 -170.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.41 104.46 4.59 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.656 1.983 . . . . 0.0 110.005 -159.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 132.7 51.66 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.836 -1.165 . . . . 0.0 108.835 173.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 m -154.15 140.63 18.79 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.257 -1.527 . . . . 0.0 109.603 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.06 24.36 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.544 -0.722 . . . . 0.0 112.811 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -142.03 129.63 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.619 0.768 . . . . 0.0 110.51 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -79.75 8.83 5.96 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.292 -0.88 . . . . 0.0 112.482 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.65 162.94 17.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.636 1.174 . . . . 0.0 112.675 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.17 151.84 28.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.423 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 169.07 18.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.942 0.497 . . . . 0.0 111.484 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -139.41 148.61 43.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.213 1.005 . . . . 0.0 111.427 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -112.49 -68.94 0.9 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.461 1.504 . . . . 0.0 111.634 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.3 t -84.3 -38.82 19.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.698 0.799 . . . . 0.0 112.108 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -67.51 -45.96 74.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.672 1.189 . . . . 0.0 112.689 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.6 -169.8 3.47 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.56 2.344 . . . . 0.0 110.408 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.43 174.13 15.14 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.266 1.412 . . . . 0.0 114.518 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.7 t -154.88 163.1 40.78 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.385 1.874 . . . . 0.0 111.151 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 20.9 t -164.88 115.13 1.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.002 1.321 . . . . 0.0 112.164 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.694 -1.254 . . . . 0.0 112.01 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.62 151.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 110.184 -172.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -138.94 121.68 16.43 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.501 1.52 . . . . 0.0 111.02 -168.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -135.52 103.1 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.9 1.68 . . . . 0.0 111.018 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.47 142.49 58.37 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.027 -1.046 . . . . 0.0 112.254 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.35 -167.8 1.79 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.842 1.257 . . . . 0.0 109.932 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.03 -52.01 9.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.842 2.057 . . . . 0.0 114.585 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -140.59 -35.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.162 1.785 . . . . 0.0 111.402 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.4 ptp -79.03 112.95 16.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.478 1.511 . . . . 0.0 111.795 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.78 116.48 19.97 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.269 -1.519 . . . . 0.0 109.889 170.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.469 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -81.38 134.42 35.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.114 173.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.26 132.26 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.778 1.631 . . . . 0.0 109.846 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.77 127.88 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.615 1.566 . . . . 0.0 110.728 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 t -119.14 111.89 18.83 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.124 0.97 . . . . 0.0 110.802 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -87.47 139.62 30.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.913 0.885 . . . . 0.0 111.193 167.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -124.12 126.71 46.65 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 109.313 168.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.56 78.35 0.24 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 125.531 1.538 . . . . 0.0 112.35 -170.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.66 123.26 24.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.654 1.581 . . . . 0.0 111.764 -173.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.4 m . . . . . 0 N--CA 1.473 0.689 0 C-N-CA 127.174 2.19 . . . . 0.0 112.807 -164.187 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.446 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -117.39 178.24 4.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 111.417 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -109.31 145.31 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.802 1.641 . . . . 0.0 109.926 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -117.4 90.71 3.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.047 1.339 . . . . 0.0 110.078 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -104.52 138.53 40.76 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.427 1.091 . . . . 0.0 110.816 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.45 98.98 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.214 2.606 . . . . 0.0 108.586 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.0 p30 -135.31 168.19 19.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.06 0.944 . . . . 0.0 111.82 168.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 CA--C 1.544 0.747 0 C-N-CA 124.437 1.095 . . . . 0.0 109.386 166.585 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.72 159.11 15.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.085 0.954 . . . . 0.0 112.255 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.49 156.35 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.149 1.78 . . . . 0.0 110.767 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 44.3 t -51.21 -40.09 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.294 2.638 . . . . 0.0 112.415 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.97 -28.32 62.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 113.175 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.47 -46.96 7.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.045 0.938 . . . . 0.0 110.854 175.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -48.65 -42.27 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.502 1.121 . . . . 0.0 112.067 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 12.1 t -63.55 -9.13 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.545 1.938 . . . . 0.0 114.692 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -109.98 -32.09 7.16 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.688 1.995 . . . . 0.0 112.552 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.9 mt -51.46 -41.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.822 0.849 . . . . 0.0 110.517 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.22 -44.17 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 121.447 -0.783 . . . . 0.0 112.939 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.63 53.8 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.736 1.153 . . . . 0.0 111.345 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.6 77.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.64 65.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.529 0.731 . . . . 0.0 112.924 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.462 ' HA ' HG21 ' B' ' 191' ' ' VAL . 58.0 mt -58.37 -59.9 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 119.127 0.876 . . . . 0.0 109.388 174.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.51 -30.15 71.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.1 t -61.3 -50.04 74.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 112.105 168.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.35 71.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.4 -40.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.822 1.249 . . . . 0.0 111.523 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.05 12.13 74.69 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.192 0.901 . . . . 0.0 115.036 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.56 -0.39 36.96 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.339 1.447 . . . . 0.0 116.266 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.61 162.49 8.3 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 118.852 1.326 . . . . 0.0 111.972 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -93.38 -166.16 1.47 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 111.505 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -43.82 125.58 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.482 2.313 . . . . 0.0 112.597 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -120.4 163.87 17.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.44 1.096 . . . . 0.0 113.749 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -71.91 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.055 1.342 . . . . 0.0 110.982 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m -107.31 -18.81 13.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.258 1.423 . . . . 0.0 113.694 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.42 -42.22 66.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.504 1.122 . . . . 0.0 111.991 174.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.43 -32.38 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.442 1.497 . . . . 0.0 114.5 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.94 -46.4 71.57 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.313 0.96 . . . . 0.0 112.11 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -65.58 -25.36 67.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.664 0.665 . . . . 0.0 112.327 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -77.64 -53.42 7.59 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.973 0.909 . . . . 0.0 111.823 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 15.1 t -56.35 -28.92 60.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.994 0.815 . . . . 0.0 112.671 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . 0.25 10.6 t -79.87 -61.91 1.85 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.425 1.011 . . . . 0.0 112.284 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.76 -38.45 72.48 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.592 1.557 . . . . 0.0 114.037 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.2 t -67.91 -64.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . 0.47 HG12 HG21 ' B' ' 210' ' ' VAL . 99.5 t -50.55 -28.37 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.46 1.504 . . . . 0.0 110.939 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -55.4 28.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.762 1.225 . . . . 0.0 112.037 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.73 -34.91 13.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.088 1.355 . . . . 0.0 112.817 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 38.2 m -60.7 -55.21 35.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.997 2.119 . . . . 0.0 112.343 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -36.45 82.19 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.515 0.598 . . . . 0.0 111.556 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 25.2 t -58.17 -51.08 71.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.635 0.774 . . . . 0.0 112.036 167.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.96 -50.91 71.89 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.808 1.643 . . . . 0.0 112.806 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.34 -27.73 67.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 63.9 m -57.33 -36.23 70.89 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.099 0.56 . . . . 0.0 110.598 165.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -79.15 -31.48 44.02 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.071 -1.018 . . . . 0.0 113.192 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.19 -28.95 61.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.178 0.591 . . . . 0.0 110.888 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.27 -94.95 1.99 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.355 1.931 . . . . 0.0 112.791 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -140.17 143.16 32.69 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.401 1.481 . . . . 0.0 113.061 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 114.12 3.75 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.732 2.955 . . . . 0.0 112.081 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.76 175.11 12.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.687 1.595 . . . . 0.0 112.673 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -94.54 87.65 5.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.744 1.218 . . . . 0.0 111.566 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -72.85 153.14 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.288 1.035 . . . . 0.0 112.253 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.5 tt -143.24 153.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.694 1.998 . . . . 0.0 108.72 166.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.47 HG21 HG12 ' B' ' 192' ' ' VAL . 15.5 m -139.75 144.79 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.296 1.038 . . . . 0.0 110.171 172.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.17 123.51 19.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.798 1.639 . . . . 0.0 108.681 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 11.8 p -124.5 142.13 51.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.186 0.994 . . . . 0.0 112.096 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 t -133.78 111.65 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.122 1.369 . . . . 0.0 107.622 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.2 mm -111.83 90.38 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.788 1.635 . . . . 0.0 107.73 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 162.69 13.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.478 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -75.23 137.98 41.61 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.405 0.622 . . . . 0.0 112.209 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -2.63 20.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.869 2.067 . . . . 0.0 114.185 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -55.06 -29.55 57.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.244 1.818 . . . . 0.0 113.901 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.47 75.89 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.797 1.189 . . . . 0.0 115.438 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.58 60.84 1.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.882 1.673 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.25 62.25 0.07 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-O 121.805 0.669 . . . . 0.0 114.225 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.85 96.25 1.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.698 1.999 . . . . 0.0 109.205 -171.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.18 101.39 6.74 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.199 -1.563 . . . . 0.0 108.63 173.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.485 ' HB ' HG13 ' B' ' 278' ' ' VAL . 22.8 m -130.98 139.09 49.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.398 -1.439 . . . . 0.0 109.765 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.97 138.36 31.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 m -141.46 135.73 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.79 0.836 . . . . 0.0 110.759 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 8.3 t -82.76 9.62 9.35 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.362 -0.836 . . . . 0.0 112.368 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.66 162.57 18.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.177 0.991 . . . . 0.0 112.685 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -154.97 149.9 26.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.207 1.803 . . . . 0.0 110.25 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.15 167.87 21.03 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.176 0.512 . . . . 0.0 111.225 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -139.38 148.65 43.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.451 1.1 . . . . 0.0 110.981 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -109.94 -68.31 0.93 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.536 1.535 . . . . 0.0 111.645 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 11.8 t -84.09 -39.46 19.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.871 0.868 . . . . 0.0 112.036 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -66.6 -46.48 75.75 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.026 1.331 . . . . 0.0 113.038 -172.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.68 -170.51 3.68 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 127.798 2.439 . . . . 0.0 110.19 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -116.08 173.75 14.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.21 1.386 . . . . 0.0 114.571 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 21.3 t -153.41 163.59 39.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.573 1.949 . . . . 0.0 111.062 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 23.1 t -164.85 111.66 1.0 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.023 1.329 . . . . 0.0 112.235 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.8 t -113.93 147.33 38.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.545 -1.347 . . . . 0.0 112.373 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.3 t -139.79 153.27 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.326 1.85 . . . . 0.0 110.394 -173.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -135.13 130.32 35.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.922 1.689 . . . . 0.0 111.621 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -138.68 101.94 4.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.414 1.886 . . . . 0.0 110.368 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.1 146.2 53.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.802 -1.186 . . . . 0.0 112.073 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.32 -175.34 3.84 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.011 1.325 . . . . 0.0 110.226 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.63 -66.74 0.33 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.111 1.764 . . . . 0.0 114.527 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -133.51 17.37 3.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.089 1.756 . . . . 0.0 111.88 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 12.8 ptp -137.92 158.45 44.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.741 2.016 . . . . 0.0 109.095 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -126.1 123.9 39.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.917 0.887 . . . . 0.0 109.894 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.36 130.72 39.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.828 0.851 . . . . 0.0 110.965 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.3 pt -128.72 129.68 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 109.188 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.79 126.03 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.634 1.574 . . . . 0.0 110.45 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 13.6 t -118.64 110.47 17.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.185 0.994 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -85.91 141.22 29.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.987 0.915 . . . . 0.0 111.316 167.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -125.07 125.6 44.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.258 1.423 . . . . 0.0 109.164 167.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.31 77.26 0.23 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.897 1.713 . . . . 0.0 111.67 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 123.53 25.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.276 1.431 . . . . 0.0 111.95 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 127.321 2.248 . . . . 0.0 112.479 -165.046 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.425 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -118.29 176.53 5.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.041 1.737 . . . . 0.0 111.51 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.51 146.42 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.753 1.621 . . . . 0.0 109.859 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 27.1 m -119.73 90.8 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.867 1.267 . . . . 0.0 110.027 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -109.11 140.4 42.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 0.0 110.958 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.485 HG13 ' HB ' ' B' ' 224' ' ' THR . 3.0 p -136.14 94.23 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 127.906 2.482 . . . . 0.0 109.68 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.3 167.69 18.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.683 1.193 . . . . 0.0 113.032 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 28.5 p90 . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 124.07 0.948 . . . . 0.0 110.303 166.895 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.938 0 CA-C-O 120.883 0.373 . . . . 0.0 111.752 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -104.75 176.0 5.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.9 1.28 . . . . 0.0 111.313 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG13 ' H ' ' A' ' 18' ' ' GLU . 14.7 p -140.89 154.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.516 1.127 . . . . 0.0 112.065 176.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -57.98 -44.52 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.579 1.552 . . . . 0.0 112.214 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.31 -26.39 68.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.921 0.888 . . . . 0.0 113.045 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.47 ' H ' HG13 ' A' ' 15' ' ' VAL . 12.1 tt0 -77.23 -60.41 2.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.146 1.379 . . . . 0.0 109.837 172.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.5 t -48.97 -42.6 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.789 1.636 . . . . 0.0 112.518 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -66.91 -9.55 39.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.703 1.601 . . . . 0.0 114.247 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -107.56 -32.46 7.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.275 1.83 . . . . 0.0 112.613 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -50.24 -44.52 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.248 1.019 . . . . 0.0 110.09 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.51 -45.41 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -50.34 62.53 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.458 1.027 . . . . 0.0 111.575 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -33.53 75.83 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.37 68.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.788 0.835 . . . . 0.0 112.406 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 HG11 ' A' ' 48' ' ' VAL . 61.7 mt -58.86 -57.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.889 0.768 . . . . 0.0 110.179 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -63.94 -25.14 68.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -66.71 -50.21 63.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.571 -0.706 . . . . 0.0 111.611 166.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.01 65.66 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.567 1.547 . . . . 0.0 114.217 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.13 -30.28 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 127.389 2.276 . . . . 0.0 112.059 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.69 -14.69 0.01 OUTLIER Glycine 0 C--O 1.279 2.967 0 N-CA-C 120.662 3.025 . . . . 0.0 120.662 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.24 -42.3 49.01 Favored Glycine 0 N--CA 1.482 1.702 0 C-N-CA 127.761 2.6 . . . . 0.0 115.772 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.47 -168.76 3.14 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.224 2.012 . . . . 0.0 111.896 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.79 -170.46 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.955 2.502 . . . . 0.0 112.798 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -74.28 103.82 4.82 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 119.978 -1.701 . . . . 0.0 111.192 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -122.99 88.52 2.94 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.021 1.328 . . . . 0.0 113.514 -174.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -64.96 -16.06 62.92 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.7 p -79.4 -31.56 42.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.988 1.715 . . . . 0.0 115.408 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -61.89 -15.39 42.32 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.159 1.784 . . . . 0.0 114.366 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.1 t -49.62 -31.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.754 1.622 . . . . 0.0 113.262 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -60.51 -53.36 58.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.947 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -67.94 -26.56 66.02 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.362 -0.837 . . . . 0.0 112.317 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -76.86 -52.66 9.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 111.223 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 t -59.0 -28.62 66.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 112.692 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -79.06 -59.36 2.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.156 0.889 . . . . 0.0 112.337 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.07 -38.02 78.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.781 1.173 . . . . 0.0 114.016 -172.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.431 HG11 HG13 ' A' ' 27' ' ' ILE . 89.2 t -70.82 -59.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 C-N-CA 123.691 0.796 . . . . 0.0 110.574 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.61 -30.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.12 0.968 . . . . 0.0 110.835 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.22 -28.41 70.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.01 -42.86 3.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.063 1.745 . . . . 0.0 112.385 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 m -54.97 -54.18 46.11 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.552 2.341 . . . . 0.0 113.016 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -39.06 93.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.125 0.42 . . . . 0.0 110.675 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -58.22 -52.02 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.308 0.643 . . . . 0.0 111.456 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.47 -47.62 83.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.391 2.276 . . . . 0.0 113.598 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.3 -25.51 63.36 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.667 -1.271 . . . . 0.0 114.403 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.1 m -61.76 -24.44 66.82 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.645 -0.659 . . . . 0.0 111.299 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -91.03 -19.89 22.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.76 -22.2 59.94 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.598 0.759 . . . . 0.0 112.729 162.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.89 -154.65 28.8 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.227 1.87 . . . . 0.0 112.143 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -90.8 161.57 35.59 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.847 1.659 . . . . 0.0 112.317 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.35 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.813 3.009 . . . . 0.0 112.384 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.45 165.26 32.65 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.543 1.537 . . . . 0.0 112.123 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -75.36 93.61 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.584 1.554 . . . . 0.0 111.241 170.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -68.52 162.77 24.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.619 -0.676 . . . . 0.0 111.378 163.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.3 150.72 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.618 1.567 . . . . 0.0 108.905 163.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.8 148.13 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.219 1.008 . . . . 0.0 111.117 164.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -140.24 156.3 46.54 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.13 1.372 . . . . 0.0 110.161 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.6 p -143.88 146.38 32.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.759 1.623 . . . . 0.0 111.968 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 124.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.997 1.319 . . . . 0.0 108.006 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.2 112.31 37.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 127.937 2.495 . . . . 0.0 107.332 -169.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.2 tpt -140.53 146.96 38.81 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.35 1.46 . . . . 0.0 111.169 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -95.3 130.11 42.18 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.628 1.171 . . . . 0.0 112.727 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -69.45 -10.11 56.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.324 1.85 . . . . 0.0 114.454 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.74 -20.61 35.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.744 2.017 . . . . 0.0 114.294 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.3 -1.5 3.03 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.124 1.345 . . . . 0.0 114.913 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 155.55 27.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.902 1.351 . . . . 0.0 111.626 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.82 160.32 31.83 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.084 0.85 . . . . 0.0 113.289 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 168.68 22.0 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.082 1.753 . . . . 0.0 112.586 -173.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -121.76 132.46 54.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 110.695 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 m -139.08 146.08 40.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.361 1.464 . . . . 0.0 109.729 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.95 146.38 30.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.39 0.676 . . . . 0.0 111.377 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.4 p -148.18 151.14 35.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 t -79.24 11.08 3.07 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' B' ' 209' ' ' ILE . 3.8 m -63.86 173.2 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.384 -0.823 . . . . 0.0 112.648 173.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -162.94 154.88 18.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.876 2.071 . . . . 0.0 109.931 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -76.83 147.62 37.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.207 1.003 . . . . 0.0 110.474 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.2 81.29 0.69 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -62.56 1.54 Allowed 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.522 -1.361 . . . . 0.0 113.315 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 p -97.07 -11.04 24.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.918 1.687 . . . . 0.0 113.117 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -47.8 21.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.251 1.42 . . . . 0.0 112.726 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -154.46 -47.63 0.09 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.02 111.36 1.4 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-N 120.35 1.432 . . . . 0.0 115.145 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -146.37 163.85 34.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.49 1.516 . . . . 0.0 112.352 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.1 t -156.46 149.37 23.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.203 1.801 . . . . 0.0 110.608 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 t -142.67 142.79 32.11 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.73 -1.856 . . . . 0.0 111.138 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.4 107.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.137 0.975 . . . . 0.0 109.995 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -92.17 124.01 35.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.106 0.962 . . . . 0.0 112.437 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -131.21 136.95 48.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.101 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.98 164.36 12.56 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 111.795 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -138.23 -178.73 5.41 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.871 1.668 . . . . 0.0 110.018 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.25 -49.59 60.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.061 2.545 . . . . 0.0 114.193 -175.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.5 t -136.45 0.77 2.55 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.173 1.389 . . . . 0.0 113.282 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.4 ptp -132.84 176.88 8.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.86 1.664 . . . . 0.0 111.958 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -136.09 147.47 47.84 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.98 1.312 . . . . 0.0 110.694 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.21 69.66 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.964 1.306 . . . . 0.0 110.786 -163.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.53 138.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.323 1.049 . . . . 0.0 111.325 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.09 145.15 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.688 1.595 . . . . 0.0 111.613 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.26 120.98 16.35 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.912 1.285 . . . . 0.0 110.469 -166.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.93 136.74 52.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.132 1.773 . . . . 0.0 112.711 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.23 117.27 17.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.165 1.386 . . . . 0.0 108.372 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.04 73.15 0.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.113 1.34 . . . . 0.0 112.945 -163.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.02 119.76 18.68 Favored 'General case' 0 C--O 1.273 2.331 0 C-N-CA 125.243 1.417 . . . . 0.0 111.544 -165.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--N 1.301 -1.536 0 CA-C-O 123.372 1.558 . . . . 0.0 114.042 -165.097 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -129.36 164.2 24.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.277 1.031 . . . . 0.0 112.334 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.5 mm -49.02 137.49 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 128.408 2.683 . . . . 0.0 112.053 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 93.7 m -100.49 92.01 4.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.981 1.312 . . . . 0.0 110.598 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -89.12 150.54 22.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.213 167.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.29 103.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.46 2.304 . . . . 0.0 109.007 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.51 130.2 40.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 111.153 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 . . . . . 0 CA--C 1.538 0.513 0 C-N-CA 125.548 1.539 . . . . 0.0 108.487 176.966 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.996 0 CA-C-O 121.624 0.726 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -84.96 179.23 7.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.517 1.127 . . . . 0.0 112.024 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.443 HG13 ' H ' ' B' ' 161' ' ' GLU . 8.1 p -144.25 156.7 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.343 -0.848 . . . . 0.0 113.049 169.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.9 -44.49 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.559 1.944 . . . . 0.0 111.969 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.08 -25.83 68.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.595 0.758 . . . . 0.0 113.035 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . 0.443 ' H ' HG13 ' B' ' 158' ' ' VAL . 11.4 tt0 -78.57 -59.5 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.259 1.423 . . . . 0.0 110.048 172.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -49.29 -43.58 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 126.359 1.864 . . . . 0.0 112.173 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -66.95 -9.29 36.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.469 1.508 . . . . 0.0 114.152 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -106.88 -32.44 7.91 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.21 1.804 . . . . 0.0 112.715 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 28.6 mt -50.37 -44.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.341 1.056 . . . . 0.0 110.057 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.44 -45.29 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -50.44 61.42 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.469 1.031 . . . . 0.0 111.574 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.12 74.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.32 66.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.745 0.818 . . . . 0.0 112.411 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.423 HG13 HG11 ' B' ' 191' ' ' VAL . 61.6 mt -58.99 -57.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.932 0.787 . . . . 0.0 110.101 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.75 -25.32 68.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -66.79 -50.05 63.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.693 -0.629 . . . . 0.0 111.553 166.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.71 -24.87 65.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.544 1.538 . . . . 0.0 114.235 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 mt -56.12 -30.3 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 127.415 2.286 . . . . 0.0 111.916 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -41.31 -13.61 0.01 OUTLIER Glycine 0 C--O 1.28 3.012 0 N-CA-C 120.656 3.023 . . . . 0.0 120.656 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.14 -42.01 54.46 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 127.724 2.583 . . . . 0.0 115.574 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.34 -168.82 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.35 2.075 . . . . 0.0 111.966 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.57 -170.63 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.929 2.492 . . . . 0.0 112.832 165.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.2 102.59 4.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.032 -1.668 . . . . 0.0 111.245 -172.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -122.94 88.36 2.92 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.098 1.359 . . . . 0.0 113.202 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.32 -21.24 65.11 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.0 p -77.67 -27.81 50.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.375 1.87 . . . . 0.0 115.175 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -64.34 -15.64 60.74 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.389 1.475 . . . . 0.0 114.111 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.55 -29.45 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.742 1.617 . . . . 0.0 114.538 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -60.64 -52.69 64.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.522 1.055 . . . . 0.0 112.434 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -68.12 -26.56 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.499 -0.751 . . . . 0.0 112.248 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -77.04 -52.93 8.48 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.866 0.866 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -58.92 -28.26 66.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.997 0.919 . . . . 0.0 112.755 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 5.9 t -79.22 -60.19 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.148 0.885 . . . . 0.0 112.355 167.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -58.55 -37.47 75.77 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.89 1.223 . . . . 0.0 114.033 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.423 HG11 HG13 ' B' ' 170' ' ' ILE . 89.0 t -71.01 -59.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 123.682 0.793 . . . . 0.0 110.42 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 92.4 t -48.65 -31.1 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.095 0.958 . . . . 0.0 110.819 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.18 -27.73 69.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.72 -43.02 3.51 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.043 1.737 . . . . 0.0 112.331 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.2 m -55.01 -54.18 46.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.64 2.376 . . . . 0.0 113.064 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.94 93.19 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.204 0.456 . . . . 0.0 110.66 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 11.3 t -58.49 -51.71 68.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.31 0.644 . . . . 0.0 111.52 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.57 -48.15 81.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.441 2.297 . . . . 0.0 113.505 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.66 -25.31 63.85 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.662 -1.273 . . . . 0.0 114.37 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.9 m -62.19 -24.82 67.43 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.708 -0.62 . . . . 0.0 111.278 166.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -89.99 -21.33 22.46 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.74 -22.19 60.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.841 0.856 . . . . 0.0 113.011 162.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -153.53 26.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.274 1.892 . . . . 0.0 112.212 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -93.66 157.21 38.7 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.532 1.533 . . . . 0.0 112.281 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 112.75 3.3 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.934 3.089 . . . . 0.0 112.104 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -147.4 159.33 43.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.712 1.205 . . . . 0.0 112.217 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -68.8 79.67 0.3 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.326 2.251 . . . . 0.0 111.661 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -60.95 159.02 12.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.979 0.895 . . . . 0.0 111.087 163.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . 0.409 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.0 tt -137.25 153.22 28.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 125.952 1.701 . . . . 0.0 108.831 166.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 19.2 m -141.49 147.12 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.703 1.201 . . . . 0.0 109.869 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -138.42 157.71 45.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.792 1.237 . . . . 0.0 109.405 168.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 32.0 p -145.82 152.66 39.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 112.124 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.7 128.75 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.961 1.304 . . . . 0.0 108.247 -176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.9 mm -119.87 114.08 42.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 128.093 2.557 . . . . 0.0 106.809 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 36.2 tpp -140.19 148.37 41.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.499 1.52 . . . . 0.0 111.161 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -97.65 128.15 44.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.014 1.326 . . . . 0.0 112.36 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.78 -9.07 48.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.449 1.9 . . . . 0.0 114.452 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -57.27 -21.36 33.89 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.104 2.161 . . . . 0.0 114.412 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 -2.76 3.35 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.963 1.268 . . . . 0.0 115.102 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.9 164.46 14.94 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.81 1.305 . . . . 0.0 111.93 169.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -173.81 162.65 33.49 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.025 0.821 . . . . 0.0 113.425 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.21 171.84 16.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.998 1.719 . . . . 0.0 113.063 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -120.69 133.4 55.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.403 0.681 . . . . 0.0 111.055 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 19.2 m -138.22 147.01 43.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.426 1.09 . . . . 0.0 110.296 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -143.98 146.5 32.95 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.719 -0.613 . . . . 0.0 111.359 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 95.6 p -147.98 151.21 35.4 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 11.53 2.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.7 m -63.72 173.5 1.72 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.869 0.843 . . . . 0.0 112.342 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.08 156.78 22.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.835 2.054 . . . . 0.0 109.793 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.21 138.15 45.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 0.0 109.617 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -145.6 104.82 3.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.895 1.278 . . . . 0.0 111.472 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 39.2 t -78.5 -75.7 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.019 -1.051 . . . . 0.0 111.033 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 64.8 p -85.81 -19.17 31.07 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.209 1.403 . . . . 0.0 113.068 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -41.99 80.3 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.096 1.759 . . . . 0.0 112.94 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -153.07 -77.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.62 1.168 . . . . 0.0 113.124 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 161.07 105.46 0.2 Allowed Glycine 0 CA--C 1.538 1.527 0 O-C-N 120.659 -1.276 . . . . 0.0 114.566 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 77.3 p -137.72 162.15 34.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.8 1.24 . . . . 0.0 112.775 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.3 t -157.12 155.17 30.59 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.987 1.715 . . . . 0.0 110.221 171.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.0 t -148.36 145.07 27.93 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 119.803 -1.811 . . . . 0.0 111.003 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.62 118.9 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -106.17 123.29 47.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.565 1.146 . . . . 0.0 112.256 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -130.63 140.01 50.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.603 1.561 . . . . 0.0 110.974 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.5 159.74 15.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.77 . . . . 0.0 111.624 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -133.68 178.42 6.95 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.437 1.895 . . . . 0.0 110.251 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -48.57 57.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.466 2.706 . . . . 0.0 113.837 -176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.8 t -137.28 0.67 2.34 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.11 1.364 . . . . 0.0 113.288 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.6 ptp -131.62 178.94 6.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.807 1.643 . . . . 0.0 111.994 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.106 1.362 . . . . 0.0 110.458 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 8.3 p -141.02 71.77 1.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 0.0 111.014 -164.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.99 140.59 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.112 0.965 . . . . 0.0 111.683 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.88 139.25 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.271 1.829 . . . . 0.0 110.935 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 36.1 p -130.93 139.09 50.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.43 1.092 . . . . 0.0 112.173 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -127.19 138.86 53.22 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.044 1.738 . . . . 0.0 112.783 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -132.96 109.01 9.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.094 1.357 . . . . 0.0 109.042 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.06 66.24 0.58 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.579 2.038 . . . . 0.0 110.438 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.453 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.6 OUTLIER -62.37 142.52 57.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 111.184 -169.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -128.94 163.71 24.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 112.24 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.3 mm -49.49 135.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 128.053 2.541 . . . . 0.0 111.921 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.5 m -97.55 88.02 4.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.921 1.288 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -85.58 150.46 24.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.626 -0.671 . . . . 0.0 110.777 164.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.95 107.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.578 1.951 . . . . 0.0 109.687 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.69 133.48 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.506 1.123 . . . . 0.0 111.027 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 125.448 1.499 . . . . 0.0 108.361 176.614 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.434 0.635 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.42 164.37 12.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.784 0.833 . . . . 0.0 112.122 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.14 158.07 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.809 0.844 . . . . 0.0 112.358 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.76 -39.86 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.835 2.054 . . . . 0.0 112.92 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.22 -22.99 63.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.003 0.921 . . . . 0.0 113.097 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -96.86 -51.17 4.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.038 0.935 . . . . 0.0 111.972 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.1 t -48.59 -38.06 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.008 1.323 . . . . 0.0 112.464 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 t -63.9 -13.68 47.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.045 1.738 . . . . 0.0 114.298 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -101.8 -38.14 7.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.899 2.08 . . . . 0.0 111.976 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -51.71 -42.44 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.067 0.849 . . . . 0.0 110.866 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.92 -42.41 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.6 -0.688 . . . . 0.0 112.804 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.86 49.52 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 111.121 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -30.71 70.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.04 -44.66 38.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.541 0.736 . . . . 0.0 112.966 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 -58.01 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.061 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.27 -29.56 70.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.64 -46.81 86.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.834 0.854 . . . . 0.0 112.181 168.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.01 -35.57 80.91 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.32 -48.23 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.918 1.287 . . . . 0.0 109.907 172.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.43 12.79 74.93 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.389 0.995 . . . . 0.0 114.662 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 3.39 38.61 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.684 1.434 . . . . 0.0 116.684 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.98 146.25 43.22 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.696 1.748 . . . . 0.0 111.085 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.62 -160.39 0.15 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.914 1.286 . . . . 0.0 111.876 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -47.73 136.64 10.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.297 1.039 . . . . 0.0 111.617 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -136.7 179.16 6.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.775 1.63 . . . . 0.0 111.375 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.97 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.335 1.054 . . . . 0.0 112.226 165.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.9 p -47.31 -0.54 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.179 2.591 . . . . 0.0 117.821 168.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.22 -39.5 2.98 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.666 2.386 . . . . 0.0 113.31 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.77 -29.52 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.368 1.467 . . . . 0.0 113.193 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.95 -49.36 75.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.668 1.187 . . . . 0.0 112.312 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.56 -25.41 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.471 -0.768 . . . . 0.0 112.638 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.09 -54.1 7.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.893 0.769 . . . . 0.0 111.393 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.06 -24.27 62.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.771 0.829 . . . . 0.0 112.651 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.3 t -83.32 -59.71 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.407 1.003 . . . . 0.0 113.033 166.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -58.44 -38.78 78.18 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.987 1.315 . . . . 0.0 113.896 -172.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.65 -62.87 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 C-N-CA 124.309 1.044 . . . . 0.0 109.623 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -48.92 -30.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.414 1.486 . . . . 0.0 111.051 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -59.33 -34.35 72.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -112.71 -36.34 5.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.632 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.8 m -59.92 -51.74 68.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.757 2.023 . . . . 0.0 111.816 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -43.38 98.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 111.057 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -66.79 -26.2 66.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -75.31 -51.98 11.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.262 2.225 . . . . 0.0 113.271 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.59 -25.89 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -59.61 -33.93 72.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.144 0.577 . . . . 0.0 110.493 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -79.59 -28.6 41.05 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mt -61.95 -32.3 72.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.58 -99.62 2.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.711 1.148 . . . . 0.0 113.269 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -135.95 146.31 56.24 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.86 1.664 . . . . 0.0 113.092 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.53 99.11 1.01 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.296 3.33 . . . . 0.0 112.32 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -140.62 167.89 21.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.615 1.566 . . . . 0.0 111.823 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -61.52 129.27 40.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.77 1.228 . . . . 0.0 110.543 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -115.09 152.16 33.02 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.09 1.756 . . . . 0.0 110.167 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -151.98 157.3 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.514 1.526 . . . . 0.0 109.283 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.28 152.14 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.236 1.814 . . . . 0.0 109.055 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -128.86 144.41 51.17 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.079 1.352 . . . . 0.0 108.315 161.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.2 p -137.57 154.22 49.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.724 0.773 . . . . 0.0 111.688 167.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.41 114.47 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.779 1.231 . . . . 0.0 109.605 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -107.26 97.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 126.165 1.786 . . . . 0.0 106.596 -177.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -154.63 90.07 1.29 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 112.592 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -151.6 142.57 23.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.832 2.053 . . . . 0.0 108.698 160.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -158.03 -62.61 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.38 1.472 . . . . 0.0 111.242 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -115.04 -9.51 12.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.764 1.626 . . . . 0.0 114.303 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.67 2.31 57.46 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.28 1.419 . . . . 0.0 115.254 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -177.34 2.24 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.118 1.459 . . . . 0.0 112.261 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.16 -173.12 41.54 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.444 1.021 . . . . 0.0 114.13 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.87 174.02 10.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.079 2.552 . . . . 0.0 110.543 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -98.42 100.82 12.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.281 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -111.94 142.65 44.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 108.744 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 145.44 32.49 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 111.193 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.7 p -139.96 143.69 36.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 122.086 0.946 . . . . 0.0 112.097 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -81.72 16.2 1.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.102 0.961 . . . . 0.0 112.056 170.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 25.0 m -64.3 161.5 16.61 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.198 -0.939 . . . . 0.0 112.044 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -160.01 138.25 10.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.149 1.38 . . . . 0.0 111.995 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -70.12 146.69 50.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.16 0.584 . . . . 0.0 110.503 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -140.45 160.3 40.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.183 1.393 . . . . 0.0 110.925 168.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -117.52 -64.4 1.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.055 1.342 . . . . 0.0 112.223 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 t -86.5 -39.77 15.94 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.788 0.835 . . . . 0.0 112.163 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -53.87 52.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.134 1.774 . . . . 0.0 111.589 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -142.44 176.3 9.12 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.503 2.721 . . . . 0.0 109.542 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.33 140.57 15.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.989 0.804 . . . . 0.0 112.117 172.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -143.42 149.44 37.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.42 . . . . 0.0 110.282 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.26 108.97 4.02 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.09 0.956 . . . . 0.0 111.48 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 t -100.97 143.25 31.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.895 0.878 . . . . 0.0 111.729 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.39 128.87 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.441 1.896 . . . . 0.0 109.245 -168.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -121.64 122.18 39.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.937 1.695 . . . . 0.0 112.063 -170.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -133.49 117.49 17.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.688 1.595 . . . . 0.0 110.767 -175.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.77 167.5 21.28 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.348 -0.845 . . . . 0.0 112.946 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -151.39 -175.16 5.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.079 1.352 . . . . 0.0 111.375 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.83 -59.21 2.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.601 1.96 . . . . 0.0 113.347 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.2 t -138.13 -35.58 0.62 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.807 1.643 . . . . 0.0 112.846 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.9 ptp -100.33 89.85 4.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.932 1.293 . . . . 0.0 112.797 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.29 155.87 8.35 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.53 -0.731 . . . . 0.0 111.661 173.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.587 ' CB ' HD12 ' A' ' 71' ' ' ILE . 2.8 p -127.51 135.76 50.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.936 1.294 . . . . 0.0 111.066 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.65 122.43 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.491 1.517 . . . . 0.0 110.258 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.92 138.13 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.292 1.837 . . . . 0.0 108.756 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -127.52 107.48 9.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.416 1.086 . . . . 0.0 110.431 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.56 147.74 25.19 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.242 1.017 . . . . 0.0 112.388 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 8.0 m-85 -136.78 118.58 15.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.217 2.207 . . . . 0.0 108.959 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.42 100.74 0.93 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.719 2.104 . . . . 0.0 110.423 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.04 145.41 36.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.646 1.178 . . . . 0.0 111.882 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.851 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.94 161.33 29.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.277 1.831 . . . . 0.0 111.7 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.98 153.04 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.939 1.695 . . . . 0.0 110.259 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 100.0 m -121.86 94.32 4.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.313 1.445 . . . . 0.0 110.844 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -88.15 149.79 23.69 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.241 -0.912 . . . . 0.0 111.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.26 94.44 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 127.69 2.396 . . . . 0.0 108.521 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.98 165.56 27.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.11 1.364 . . . . 0.0 112.378 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 125.214 1.405 . . . . 0.0 109.944 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.346 0.594 . . . . 0.0 111.436 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.75 159.07 15.23 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 0.0 111.935 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.66 158.9 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.551 1.141 . . . . 0.0 111.267 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.81 -35.54 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.82 2.048 . . . . 0.0 113.383 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.33 -23.05 66.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.864 0.866 . . . . 0.0 113.039 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -86.49 -54.52 4.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.901 1.28 . . . . 0.0 110.643 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . 0.451 HG22 HD23 ' B' ' 199' ' ' LEU . 39.8 t -53.91 -38.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.087 1.355 . . . . 0.0 112.577 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.1 t -61.19 -11.36 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.286 1.834 . . . . 0.0 114.258 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -107.4 -36.9 6.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.879 1.671 . . . . 0.0 112.317 168.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.8 mt -51.11 -40.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.508 1.049 . . . . 0.0 111.25 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.81 -41.18 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.462 -0.774 . . . . 0.0 113.058 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -49.28 51.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.901 1.228 . . . . 0.0 111.646 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -29.62 70.11 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.29 -44.67 28.88 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.407 ' HA ' HG21 ' B' ' 191' ' ' VAL . 71.6 mt -58.06 -58.73 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.221 0.918 . . . . 0.0 110.052 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.14 -29.49 70.38 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -62.89 -46.38 88.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.789 0.836 . . . . 0.0 112.059 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.24 79.8 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.3 -47.96 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.936 1.294 . . . . 0.0 109.946 172.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.14 12.89 75.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.395 0.998 . . . . 0.0 114.685 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.48 40.3 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -60.12 146.43 43.22 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 119.671 1.735 . . . . 0.0 111.115 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.68 -160.29 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.982 1.313 . . . . 0.0 111.789 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -47.93 137.48 9.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.269 1.028 . . . . 0.0 111.748 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -137.09 179.44 6.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.732 1.613 . . . . 0.0 111.426 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -63.48 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.508 1.123 . . . . 0.0 112.185 164.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 42.0 p -47.16 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.284 2.634 . . . . 0.0 117.925 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.76 -39.56 3.81 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.815 2.446 . . . . 0.0 113.442 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.18 -28.79 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.199 1.4 . . . . 0.0 113.169 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.63 -49.55 74.73 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.71 1.204 . . . . 0.0 112.354 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.58 -25.76 65.94 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.516 -0.74 . . . . 0.0 112.666 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -75.63 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.887 0.767 . . . . 0.0 111.452 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.0 t -59.65 -22.95 62.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.769 0.828 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -84.24 -59.64 2.33 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.477 1.035 . . . . 0.0 113.19 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -58.32 -38.62 77.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.99 1.316 . . . . 0.0 114.03 -172.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' B' ' 170' ' ' ILE . 88.0 t -66.45 -62.65 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 124.393 1.077 . . . . 0.0 109.591 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.96 -30.4 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.473 1.509 . . . . 0.0 110.953 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.21 -33.07 70.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -114.62 -35.48 4.86 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.654 1.581 . . . . 0.0 112.824 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 54.2 m -61.58 -48.3 81.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.984 2.114 . . . . 0.0 112.079 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' B' ' 199' ' ' LEU . 0.2 OUTLIER -62.79 -45.16 93.95 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.455 0.645 . . . . 0.0 110.642 176.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 83.0 p -66.18 -25.26 66.86 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.137 -0.977 . . . . 0.0 113.375 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -75.79 -54.53 6.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.438 2.295 . . . . 0.0 113.155 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -64.8 -26.28 68.28 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.744 1.156 . . . . 0.0 113.433 -172.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -56.99 -40.57 76.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.325 0.65 . . . . 0.0 110.835 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -73.87 -29.07 61.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.784 0.834 . . . . 0.0 112.637 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 5.2 mt -62.49 -31.98 72.81 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -97.9 2.1 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.767 1.175 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -136.78 146.74 56.48 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.776 1.631 . . . . 0.0 112.98 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.23 97.27 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.202 3.268 . . . . 0.0 112.203 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.15 167.67 21.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.506 1.522 . . . . 0.0 111.838 172.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -61.77 131.35 49.6 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.887 1.275 . . . . 0.0 110.754 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -116.96 152.33 34.79 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.259 1.824 . . . . 0.0 110.296 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.7 tt -152.81 157.41 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.38 152.56 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.451 1.9 . . . . 0.0 109.225 165.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 2.1 p -127.27 144.05 51.12 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.025 1.33 . . . . 0.0 108.353 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 20.1 p -138.12 155.83 48.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.959 0.885 . . . . 0.0 112.01 168.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.46 125.21 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.374 1.07 . . . . 0.0 109.877 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' B' ' 249' ' ' CYS . 2.2 mm -115.82 98.32 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.027 2.131 . . . . 0.0 107.18 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -116.26 152.66 33.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.444 1.497 . . . . 0.0 110.48 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.97 147.6 32.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.813 0.816 . . . . 0.0 112.483 -175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -75.9 1.23 15.68 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.937 1.695 . . . . 0.0 114.292 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -64.97 -13.17 56.78 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.52 5.26 61.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.965 1.269 . . . . 0.0 115.348 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.2 -169.89 0.69 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.566 1.183 . . . . 0.0 112.185 169.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.85 -170.54 42.86 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.071 -1.018 . . . . 0.0 114.152 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.69 -171.44 2.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.341 2.256 . . . . 0.0 111.449 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -114.36 94.79 4.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.462 0.705 . . . . 0.0 110.232 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.475 ' HB ' HG13 ' B' ' 278' ' ' VAL . 23.3 m -106.67 142.35 36.46 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.891 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.88 141.21 38.58 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.425 0.69 . . . . 0.0 110.638 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 25.0 p -135.98 140.27 43.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.119 0.962 . . . . 0.0 111.714 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.9 t -80.44 14.99 1.77 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.828 0.851 . . . . 0.0 111.993 171.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 254' ' ' PHE . 13.2 m -64.66 161.77 17.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.214 -0.929 . . . . 0.0 112.017 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.09 139.02 10.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.85 146.59 51.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.725 -0.61 . . . . 0.0 110.343 174.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -139.88 159.32 42.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.247 1.419 . . . . 0.0 110.726 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 43.3 t -117.1 -64.58 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.09 1.356 . . . . 0.0 112.228 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.5 t -86.78 -39.64 15.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.796 0.839 . . . . 0.0 112.095 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -54.29 47.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 111.614 -174.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -142.11 176.55 8.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.465 2.706 . . . . 0.0 109.631 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.03 140.57 15.2 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.046 0.831 . . . . 0.0 112.229 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 150.05 39.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.289 1.436 . . . . 0.0 110.276 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.4 t -148.44 107.59 3.89 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.143 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.7 t -98.8 142.69 30.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.861 0.864 . . . . 0.0 111.527 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 123.41 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 109.075 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -115.14 119.16 35.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.853 1.661 . . . . 0.0 111.339 -172.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.7 148.55 49.0 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.14 1.376 . . . . 0.0 110.514 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.12 165.49 11.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.816 1.246 . . . . 0.0 111.355 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.72 -176.06 5.46 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.78 1.232 . . . . 0.0 110.521 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.27 -67.09 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.127 1.771 . . . . 0.0 113.017 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -139.53 4.97 2.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.072 1.749 . . . . 0.0 113.405 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 23.9 ptp -133.99 82.01 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 111.992 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -58.15 147.23 30.76 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.361 -0.837 . . . . 0.0 111.379 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' B' ' 214' ' ' ILE . 4.4 p -134.47 116.54 15.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.275 1.03 . . . . 0.0 111.991 -171.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.8 pt -117.14 130.16 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.615 1.166 . . . . 0.0 111.188 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.59 139.05 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.721 2.008 . . . . 0.0 108.691 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.3 t -129.83 109.82 11.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.344 1.058 . . . . 0.0 110.655 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.11 148.0 23.91 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.185 0.994 . . . . 0.0 112.243 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' B' ' 228' ' ' CYS . 8.7 m-85 -136.3 119.13 16.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.122 2.169 . . . . 0.0 108.952 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.03 100.09 0.91 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.662 2.077 . . . . 0.0 110.304 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.24 145.69 36.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.624 1.17 . . . . 0.0 111.734 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 178.315 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.69 161.24 29.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.342 1.857 . . . . 0.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.19 152.34 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.833 1.653 . . . . 0.0 110.269 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 98.3 m -120.92 91.57 3.56 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.475 1.51 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -86.47 150.74 24.06 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.475 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.2 p -141.08 100.11 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.754 2.022 . . . . 0.0 109.344 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.38 166.97 23.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.724 1.61 . . . . 0.0 111.69 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 124.901 1.28 . . . . 0.0 109.588 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.0 152.45 48.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.318 1.047 . . . . 0.0 113.419 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.46 161.56 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.423 1.889 . . . . 0.0 111.421 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.478 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 63.7 t -61.03 -35.55 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.642 1.977 . . . . 0.0 111.56 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.35 4.83 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.98 1.312 . . . . 0.0 114.008 172.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -109.23 -59.79 1.85 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.8 -1.187 . . . . 0.0 107.888 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 16' ' ' VAL . 2.1 p -44.39 -42.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.192 1.797 . . . . 0.0 112.971 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 t -60.04 -11.65 6.38 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -115.57 -33.93 5.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.654 1.982 . . . . 0.0 112.308 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -41.84 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.144 0.977 . . . . 0.0 110.731 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.5 p -59.05 -42.85 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.413 -0.804 . . . . 0.0 112.7 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -53.14 33.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.158 0.89 . . . . 0.0 110.728 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -31.86 71.99 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.14 -42.3 38.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.535 0.734 . . . . 0.0 112.964 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 48' ' ' VAL . 65.0 mt -59.47 -56.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.284 0.947 . . . . 0.0 109.522 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.03 -28.88 70.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.5 t -62.52 -47.52 83.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.365 1.066 . . . . 0.0 112.299 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.78 76.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -32.1 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.887 1.275 . . . . 0.0 111.3 170.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.19 17.37 55.73 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.657 1.122 . . . . 0.0 114.709 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.22 21.53 77.76 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.659 1.123 . . . . 0.0 115.265 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -55.36 156.86 4.05 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 119.485 1.643 . . . . 0.0 112.569 171.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 -179.45 1.07 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.468 1.507 . . . . 0.0 112.391 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -47.56 141.71 4.95 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.606 1.562 . . . . 0.0 113.251 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -132.71 171.83 13.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.811 1.244 . . . . 0.0 112.586 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -91.65 -114.63 0.08 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 109.843 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -70.64 -1.01 9.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 114.985 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.4 -41.27 39.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.152 1.381 . . . . 0.0 113.629 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.5 -30.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 118.402 -0.809 . . . . 0.0 113.001 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.29 -55.03 32.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.787 1.176 . . . . 0.0 111.632 170.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.93 -25.35 67.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.86 -0.525 . . . . 0.0 112.405 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.39 -56.35 4.71 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.2 1.0 . . . . 0.0 111.45 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 t -57.41 -26.66 61.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.823 0.738 . . . . 0.0 112.76 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -81.29 -57.38 3.52 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.304 0.956 . . . . 0.0 112.811 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -60.24 -34.79 74.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.466 -1.397 . . . . 0.0 114.073 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 27' ' ' ILE . 83.6 t -70.33 -64.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.214 1.005 . . . . 0.0 109.368 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.17 -30.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.055 1.342 . . . . 0.0 111.002 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.5 -32.56 71.55 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -114.0 -35.46 5.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.496 1.519 . . . . 0.0 112.75 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.7 m -62.03 -51.36 68.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.073 2.149 . . . . 0.0 112.108 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -42.93 98.67 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.91 0.323 . . . . 0.0 110.691 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 p -66.51 -27.01 67.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -74.29 -50.49 18.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.532 2.333 . . . . 0.0 113.309 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.41 -29.81 70.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.2 1.364 . . . . 0.0 114.045 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.2 m -57.12 -27.96 62.27 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.162 0.985 . . . . 0.0 111.444 167.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.78 -28.17 19.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.78 -33.62 74.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.062 0.545 . . . . 0.0 109.852 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.1 -98.67 2.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.635 1.588 . . . . 0.0 112.403 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -134.27 121.06 15.23 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.661 1.185 . . . . 0.0 112.788 -173.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.72 107.1 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.006 3.138 . . . . 0.0 112.977 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -146.17 170.94 15.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.351 1.861 . . . . 0.0 112.13 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -76.5 81.16 3.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.521 1.529 . . . . 0.0 111.957 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.71 138.17 46.42 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.622 1.569 . . . . 0.0 110.162 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 154.46 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.405 1.482 . . . . 0.0 109.879 171.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.84 159.19 33.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 124.613 1.165 . . . . 0.0 110.826 162.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 p -136.04 146.76 47.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.249 1.019 . . . . 0.0 110.793 157.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.4 p -136.63 143.43 43.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.313 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.05 95.78 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.877 1.271 . . . . 0.0 108.345 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mm -91.34 114.13 28.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 tpt -137.61 161.54 36.19 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.34 1.456 . . . . 0.0 110.736 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -67.47 151.98 46.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.494 -0.754 . . . . 0.0 111.37 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 1.87 1.35 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.152 2.181 . . . . 0.0 115.002 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -56.24 -21.86 26.14 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.773 1.629 . . . . 0.0 114.299 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.99 34.15 70.6 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.955 0.788 . . . . 0.0 113.897 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -177.38 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.069 1.748 . . . . 0.0 113.779 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.83 47.47 3.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.086 1.327 . . . . 0.0 114.327 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.38 125.55 24.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.909 1.354 . . . . 0.0 109.463 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -120.22 92.58 3.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.199 1.0 . . . . 0.0 109.537 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' HG13 ' A' ' 135' ' ' VAL . 31.1 m -109.98 142.89 40.73 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.028 -1.045 . . . . 0.0 109.329 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.8 140.39 34.7 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.637 -0.665 . . . . 0.0 111.945 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -139.38 127.56 22.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 p -75.07 13.09 0.74 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.899 -1.126 . . . . 0.0 113.967 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 57.4 m -58.29 164.48 2.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.585 1.554 . . . . 0.0 112.694 170.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -167.14 138.52 3.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.954 1.702 . . . . 0.0 110.331 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -83.03 149.19 27.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.752 0.821 . . . . 0.0 110.872 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -142.09 159.0 43.11 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.364 1.865 . . . . 0.0 111.123 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.9 t -114.66 -64.12 1.36 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.716 1.206 . . . . 0.0 111.201 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -87.26 -18.04 31.16 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -41.46 12.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.753 1.621 . . . . 0.0 112.738 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -164.27 -171.68 2.48 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.458 1.903 . . . . 0.0 111.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.83 140.42 14.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.883 1.706 . . . . 0.0 114.83 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.9 p -155.87 158.04 37.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.462 1.905 . . . . 0.0 111.912 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 17.8 t -146.39 160.4 42.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.506 1.522 . . . . 0.0 111.026 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -148.83 144.82 27.2 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.145 -1.597 . . . . 0.0 111.24 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -134.89 102.64 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.809 1.244 . . . . 0.0 109.427 -170.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.28 104.52 16.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.823 1.249 . . . . 0.0 112.356 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -103.86 143.82 32.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.333 1.063 . . . . 0.0 110.725 170.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.03 147.8 33.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.365 1.866 . . . . 0.0 110.996 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -141.4 -172.3 3.48 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 112.195 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -58.51 2.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.865 2.466 . . . . 0.0 114.576 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.9 t -141.45 21.71 2.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.967 1.307 . . . . 0.0 113.438 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.1 150.21 45.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.384 1.474 . . . . 0.0 111.32 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.16 128.92 49.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.298 1.839 . . . . 0.0 109.645 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.8 p -137.72 82.55 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.208 1.004 . . . . 0.0 112.773 -172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -109.8 133.45 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.027 0.931 . . . . 0.0 112.077 -173.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.54 146.33 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.226 1.81 . . . . 0.0 111.408 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -133.9 129.2 36.02 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.139 1.376 . . . . 0.0 110.067 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.82 135.92 53.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.67 1.988 . . . . 0.0 112.434 -169.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 90.7 m-85 -132.29 115.22 15.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.5 58.52 0.39 Allowed Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.862 1.696 . . . . 0.0 112.801 -167.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 113' ' ' LEU . 2.4 mm? -58.72 124.27 19.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 112.888 -168.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.47 0.553 0 C-N-CA 126.03 1.732 . . . . 0.0 111.739 -169.957 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.437 0 N-CA-C 111.298 0.11 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -128.96 173.11 10.71 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.51 142.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.365 1.466 . . . . 0.0 111.26 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.4 m -101.3 88.86 3.58 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.225 1.41 . . . . 0.0 110.295 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -79.96 147.9 31.42 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.26 -0.9 . . . . 0.0 110.788 164.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.444 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.7 OUTLIER -137.76 95.2 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.831 2.452 . . . . 0.0 108.743 175.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -139.35 169.49 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.556 1.142 . . . . 0.0 112.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 125.059 1.344 . . . . 0.0 110.127 174.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -127.5 154.76 44.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 113.308 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.43 158.6 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.295 1.838 . . . . 0.0 111.154 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.56 -37.52 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.157 1.783 . . . . 0.0 111.923 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.02 -22.87 66.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.366 1.066 . . . . 0.0 113.615 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -75.86 -59.16 2.88 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 169.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.16 -43.17 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.96 2.104 . . . . 0.0 112.588 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -60.38 -10.9 5.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.207 1.803 . . . . 0.0 114.695 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -114.25 -33.91 5.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.591 1.957 . . . . 0.0 112.244 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.0 mt -50.19 -42.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.843 0.857 . . . . 0.0 110.723 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.6 p -59.04 -42.65 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.389 -0.82 . . . . 0.0 112.736 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -52.73 37.11 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.222 0.919 . . . . 0.0 110.768 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -31.8 71.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.06 -42.41 38.43 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.613 0.765 . . . . 0.0 112.946 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . 0.413 ' HA ' HG21 ' B' ' 191' ' ' VAL . 65.1 mt -59.74 -57.02 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 119.4 1.0 . . . . 0.0 109.636 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.99 -28.53 70.16 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 t -62.64 -47.76 82.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.436 1.094 . . . . 0.0 112.281 168.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.37 -33.79 76.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -32.08 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.918 1.287 . . . . 0.0 111.392 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 62.08 17.3 55.18 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.665 1.126 . . . . 0.0 114.733 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 22.02 77.58 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.689 1.138 . . . . 0.0 115.314 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.29 157.25 3.73 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 119.386 1.593 . . . . 0.0 112.672 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.4 -179.69 1.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.384 1.474 . . . . 0.0 112.378 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -47.55 141.45 5.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.469 1.507 . . . . 0.0 113.256 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -132.33 171.75 13.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 112.444 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.57 -113.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 109.721 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 3.6 m -71.58 -1.03 12.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.242 1.817 . . . . 0.0 114.958 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -49.6 -40.92 40.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 113.626 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.9 -30.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.687 0.795 . . . . 0.0 112.868 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -62.57 -55.53 26.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.766 1.166 . . . . 0.0 111.87 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.3 -25.3 67.57 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.8 -0.562 . . . . 0.0 112.248 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -76.5 -56.17 4.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.342 1.057 . . . . 0.0 111.463 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.7 t -57.28 -26.62 61.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.936 0.789 . . . . 0.0 112.78 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.2 t -81.72 -57.78 3.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.171 0.896 . . . . 0.0 112.86 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.83 -34.78 73.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.279 1.4 . . . . 0.0 114.007 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' B' ' 170' ' ' ILE . 85.8 t -70.29 -64.12 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.105 0.962 . . . . 0.0 109.375 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -49.2 -30.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.135 1.374 . . . . 0.0 110.964 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -60.66 -32.63 71.81 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -113.59 -35.56 5.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.402 1.481 . . . . 0.0 112.797 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 48.3 m -61.63 -52.11 65.71 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.985 2.114 . . . . 0.0 111.919 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -42.48 99.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.008 0.367 . . . . 0.0 110.749 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 60.2 p -67.0 -27.17 67.21 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.84 -50.99 17.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.55 2.34 . . . . 0.0 113.247 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.96 -29.98 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.646 -1.284 . . . . 0.0 114.098 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 87.8 m -57.0 -28.31 62.33 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.154 0.982 . . . . 0.0 111.36 167.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -89.41 -28.11 19.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.95 -33.51 73.82 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.081 0.553 . . . . 0.0 109.897 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.96 -98.96 2.15 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.763 1.649 . . . . 0.0 112.398 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -134.12 121.07 15.41 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.729 1.212 . . . . 0.0 112.798 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.48 106.96 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.988 3.125 . . . . 0.0 112.709 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -146.97 172.17 14.11 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.369 1.868 . . . . 0.0 111.962 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -77.8 83.93 4.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.392 1.477 . . . . 0.0 111.854 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -74.53 142.12 44.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.306 1.443 . . . . 0.0 109.946 166.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.1 156.56 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.381 1.472 . . . . 0.0 110.129 170.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.34 159.3 28.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 110.379 165.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 19.1 p -136.93 151.23 48.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.111 157.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 18.3 p -141.12 150.4 42.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.92 1.288 . . . . 0.0 111.771 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.12 103.08 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.225 1.41 . . . . 0.0 108.341 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.491 HG23 ' HB3' ' B' ' 249' ' ' CYS . 1.4 mm -99.73 117.52 45.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.136 1.374 . . . . 0.0 107.989 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.0 tpt -142.2 147.74 37.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.654 0.781 . . . . 0.0 111.745 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -152.29 91.49 1.6 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.732 2.013 . . . . 0.0 109.646 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -59.44 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 175.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.99 -46.11 0.43 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.305 1.042 . . . . 0.0 113.665 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.51 -8.94 26.29 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.122 1.344 . . . . 0.0 115.412 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -140.01 79.02 1.69 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -171.67 21.1 0.07 OUTLIER Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 134.01 54.95 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.828 2.051 . . . . 0.0 111.572 -174.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -128.43 88.15 2.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.468 1.107 . . . . 0.0 109.3 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.571 ' HB ' HG13 ' B' ' 278' ' ' VAL . 55.5 m -107.09 142.32 36.94 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.699 -1.251 . . . . 0.0 109.579 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.25 138.03 39.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.27 0.628 . . . . 0.0 111.676 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 2.4 m -136.38 127.72 28.33 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -170.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 78.9 p -74.46 10.12 1.45 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 36.0 m -60.68 166.46 3.25 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 0.0 112.961 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -166.0 147.1 6.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.213 1.805 . . . . 0.0 110.42 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -86.44 151.53 23.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.718 0.807 . . . . 0.0 111.077 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.53 159.76 41.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.389 1.875 . . . . 0.0 112.916 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.6 t -125.18 -53.9 1.61 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.541 1.937 . . . . 0.0 112.223 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 79.2 p -104.22 -6.29 21.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.832 1.653 . . . . 0.0 113.635 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -42.74 9.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.675 1.59 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.16 -164.71 0.8 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.224 2.209 . . . . 0.0 110.611 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.82 142.5 13.96 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.373 1.463 . . . . 0.0 114.987 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 24.5 p -153.74 157.56 39.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.633 1.973 . . . . 0.0 111.997 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 19.3 t -145.22 160.27 41.73 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.786 1.634 . . . . 0.0 111.124 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 145.54 26.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.173 -1.579 . . . . 0.0 111.286 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.9 t -135.73 104.57 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.627 1.171 . . . . 0.0 109.333 -171.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.75 104.53 16.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.543 1.137 . . . . 0.0 112.126 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -98.64 140.09 33.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.227 1.013 . . . . 0.0 110.648 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.83 149.21 43.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.321 1.848 . . . . 0.0 111.018 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -143.24 -166.24 2.27 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.579 1.151 . . . . 0.0 111.398 -170.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -42.32 -61.05 1.28 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.778 2.431 . . . . 0.0 114.21 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.0 t -145.41 -6.13 0.64 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.135 1.374 . . . . 0.0 113.845 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 16.0 ptm -94.16 149.41 21.26 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.19 1.396 . . . . 0.0 110.118 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -131.83 134.49 45.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.67 1.588 . . . . 0.0 109.054 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.491 ' HB3' HG23 ' B' ' 214' ' ' ILE . 10.1 p -140.48 84.27 1.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.184 0.992 . . . . 0.0 112.07 -170.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.76 136.94 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.43 -0.793 . . . . 0.0 111.281 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.49 143.45 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.918 1.687 . . . . 0.0 110.508 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 t -131.39 127.16 36.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.694 1.198 . . . . 0.0 110.191 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -123.06 136.66 54.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.803 2.041 . . . . 0.0 112.548 -168.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.54 116.29 15.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.712 1.205 . . . . 0.0 109.146 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.98 60.8 0.34 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.68 1.61 . . . . 0.0 112.959 -166.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . 0.432 HD22 ' H ' ' B' ' 256' ' ' LEU . 1.8 mm? -61.73 126.95 29.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.932 1.293 . . . . 0.0 113.09 -166.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 66.6 m . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 126.153 1.781 . . . . 0.0 111.714 -169.354 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 111.297 0.11 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -129.28 173.37 10.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.697 1.599 . . . . 0.0 111.063 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 11.0 mm -56.79 144.13 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.429 1.492 . . . . 0.0 111.318 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 89.9 m -105.81 90.2 3.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.211 1.404 . . . . 0.0 110.255 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -82.76 149.82 27.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.451 -0.781 . . . . 0.0 111.021 164.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.571 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.5 p -141.29 94.69 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 127.819 2.448 . . . . 0.0 109.285 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.51 169.21 18.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.554 1.542 . . . . 0.0 112.144 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.741 1.217 . . . . 0.0 110.099 172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.561 0.696 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.96 155.49 30.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.79 0.836 . . . . 0.0 110.482 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.96 156.69 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.793 1.237 . . . . 0.0 110.49 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 19' ' ' VAL . 87.1 t -57.88 -43.4 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.575 1.55 . . . . 0.0 110.824 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 7.11 0.32 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.11 1.764 . . . . 0.0 114.058 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -122.2 -54.41 1.9 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 16' ' ' VAL . 6.7 p -45.55 -44.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.706 0.802 . . . . 0.0 112.808 166.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -62.73 -11.01 14.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -106.77 -38.24 6.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.874 2.07 . . . . 0.0 112.352 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mt -49.6 -41.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.135 1.374 . . . . 0.0 110.901 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.65 -41.78 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.4 -0.812 . . . . 0.0 112.903 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -51.23 57.86 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.571 1.078 . . . . 0.0 111.087 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -30.12 71.31 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.38 -40.72 29.45 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.094 0.957 . . . . 0.0 113.39 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.04 -55.75 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.275 0.943 . . . . 0.0 109.65 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.08 -31.44 70.01 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -58.64 -50.39 74.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.892 1.277 . . . . 0.0 112.149 167.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.32 -31.7 72.16 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.57 -37.08 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.529 1.132 . . . . 0.0 110.777 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 16.98 78.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.023 0.821 . . . . 0.0 114.165 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.86 79.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.052 1.311 . . . . 0.0 115.48 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.34 168.74 5.32 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.005 1.402 . . . . 0.0 113.635 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.74 -167.61 0.49 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.732 1.613 . . . . 0.0 113.387 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -52.35 149.66 5.41 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.848 1.659 . . . . 0.0 112.864 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -144.42 172.8 12.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.828 1.251 . . . . 0.0 112.463 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.68 -92.84 0.12 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.788 1.635 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -98.17 4.02 48.99 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.961 2.504 . . . . 0.0 113.881 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -49.38 -43.89 44.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.249 1.02 . . . . 0.0 112.641 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -52.07 -36.83 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.63 1.172 . . . . 0.0 113.19 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.2 -52.96 42.99 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.467 1.107 . . . . 0.0 112.201 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.59 -23.56 67.31 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.082 -1.011 . . . . 0.0 112.904 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -77.06 -55.67 5.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.951 1.301 . . . . 0.0 111.525 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 t -57.12 -29.16 63.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.619 0.645 . . . . 0.0 112.628 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -78.34 -58.8 3.06 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.247 0.93 . . . . 0.0 112.241 170.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -59.1 -41.28 87.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 113.972 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.44 -63.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.0 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.4 -29.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.628 1.171 . . . . 0.0 110.591 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.87 -38.9 76.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -107.33 -39.87 5.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.676 1.59 . . . . 0.0 112.155 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -60.49 -50.66 72.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.271 2.228 . . . . 0.0 112.542 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.465 ' HG ' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -65.7 -35.84 81.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.232 0.539 . . . . 0.0 111.44 177.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.6 t -63.06 -40.56 98.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.469 -0.769 . . . . 0.0 112.215 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -66.22 -49.15 68.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.891 2.076 . . . . 0.0 113.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.427 HD21 HD22 ' A' ' 53' ' ' LEU . 3.9 pp -65.85 -25.8 67.36 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.717 -1.239 . . . . 0.0 114.089 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.0 m -62.87 -23.51 67.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.452 1.101 . . . . 0.0 111.469 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -91.92 -24.52 19.26 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.155 0.982 . . . . 0.0 113.257 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.92 -22.32 66.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.928 1.291 . . . . 0.0 114.381 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.67 -130.42 3.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.29 1.424 . . . . 0.0 112.444 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -64.61 120.2 63.74 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.616 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.21 120.72 5.44 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.954 3.103 . . . . 0.0 112.385 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -163.91 -171.03 2.32 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.118 1.767 . . . . 0.0 112.277 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.95 123.79 36.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.062 1.345 . . . . 0.0 111.525 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 126.9 55.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.394 1.878 . . . . 0.0 109.353 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.18 148.25 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.124 0.97 . . . . 0.0 110.203 174.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.465 HG11 ' HG ' ' A' ' 53' ' ' LEU . 34.7 m -138.36 155.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.233 1.013 . . . . 0.0 111.256 167.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -140.41 155.27 46.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.997 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 p -146.21 149.49 34.04 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.469 1.128 . . . . 0.0 112.32 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.22 123.55 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.17 1.388 . . . . 0.0 109.082 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.5 98.67 7.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.565 1.946 . . . . 0.0 107.387 -174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 ttt -110.27 157.13 19.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 0.0 110.474 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.53 133.56 53.98 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.86 1.264 . . . . 0.0 110.988 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -64.81 -9.2 18.87 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.53 -19.16 23.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.241 1.816 . . . . 0.0 114.422 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.86 42.69 0.56 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.908 1.242 . . . . 0.0 113.905 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.4 74.25 1.57 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.254 1.021 . . . . 0.0 112.27 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.66 161.58 20.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.089 1.328 . . . . 0.0 115.113 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.0 -177.78 5.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.119 1.367 . . . . 0.0 113.52 -165.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -104.99 111.91 24.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.902 0.881 . . . . 0.0 110.161 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.443 ' HB ' HG13 ' A' ' 135' ' ' VAL . 59.2 m -112.18 144.87 40.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.108 1.363 . . . . 0.0 109.425 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.02 33.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.185 0.993 . . . . 0.0 112.004 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.0 p -142.62 138.76 30.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.081 0.943 . . . . 0.0 112.347 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -81.88 17.73 1.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.797 0.839 . . . . 0.0 112.034 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.564 ' SG ' HD11 ' B' ' 209' ' ' ILE . 39.8 m -61.78 173.9 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.762 1.268 . . . . 0.0 111.676 165.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.03 149.86 14.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.854 2.062 . . . . 0.0 109.289 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -83.56 134.66 34.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.722 0.809 . . . . 0.0 109.193 170.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -138.14 119.26 14.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 109.646 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.93 -47.0 4.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.058 1.743 . . . . 0.0 113.826 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 t -106.39 -22.36 12.83 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.806 1.242 . . . . 0.0 112.979 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -30.52 30.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.007 1.723 . . . . 0.0 112.999 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.44 -165.99 1.15 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.124 2.17 . . . . 0.0 110.103 -178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.06 147.06 16.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.425 1.012 . . . . 0.0 113.073 170.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 p -162.79 150.98 14.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.923 1.289 . . . . 0.0 111.42 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 29.7 p -156.47 172.2 18.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.749 1.22 . . . . 0.0 112.246 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -154.4 150.75 28.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.358 1.063 . . . . 0.0 111.41 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.66 134.5 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.2 1.4 . . . . 0.0 109.562 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -123.61 125.74 45.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.06 1.344 . . . . 0.0 111.621 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -135.29 120.0 18.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.783 1.633 . . . . 0.0 109.938 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -82.16 153.28 26.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.335 -0.853 . . . . 0.0 111.803 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -120.74 -170.51 2.01 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 109.047 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -51.66 -54.14 31.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.0 t -138.14 -22.0 1.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.038 1.335 . . . . 0.0 114.319 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.1 ptp -92.29 177.63 6.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.807 1.243 . . . . 0.0 111.483 168.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -142.29 145.95 34.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 109.828 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 24.6 p -128.17 130.44 48.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.402 1.081 . . . . 0.0 110.869 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.05 133.39 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.157 0.983 . . . . 0.0 109.664 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.28 129.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 126.006 1.723 . . . . 0.0 109.665 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 p -126.49 148.79 49.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 67' ' ' VAL . . . -135.34 131.92 37.0 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.5 1.52 . . . . 0.0 110.973 -171.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -130.7 114.35 15.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.072 0.939 . . . . 0.0 110.031 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.05 84.05 0.49 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.638 1.59 . . . . 0.0 110.613 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.98 126.91 36.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.359 1.064 . . . . 0.0 112.737 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.467 0.408 0 C-N-CA 125.032 1.333 . . . . 0.0 112.632 -174.569 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.446 0 N-CA-C 111.712 0.264 . . . . 0.0 111.712 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -118.96 170.78 8.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.541 0.736 . . . . 0.0 112.106 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.95 127.8 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.139 1.776 . . . . 0.0 111.493 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.3 m -97.62 101.54 13.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.914 1.686 . . . . 0.0 110.619 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -92.8 147.37 22.91 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.733 -1.229 . . . . 0.0 111.203 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -137.92 113.42 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.771 2.428 . . . . 0.0 109.505 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.08 141.77 42.37 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.317 -0.864 . . . . 0.0 112.15 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 . . . . . 0 CA--C 1.541 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.099 178.567 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.34 0.591 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -65.56 164.81 13.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.311 0.577 . . . . 0.0 111.272 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.46 155.5 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.861 1.265 . . . . 0.0 110.633 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.02 -41.78 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.16 0.984 . . . . 0.0 111.61 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -25.57 68.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.92 1.288 . . . . 0.0 113.406 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -56.51 4.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.361 1.465 . . . . 0.0 110.635 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -50.81 -44.3 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.874 1.27 . . . . 0.0 112.198 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -62.06 -13.45 26.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.741 1.217 . . . . 0.0 113.621 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -100.64 -39.67 7.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.743 2.017 . . . . 0.0 112.353 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -50.85 -42.55 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.98 1.312 . . . . 0.0 110.905 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.24 -41.78 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.433 -0.792 . . . . 0.0 112.857 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -51.32 58.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.69 1.132 . . . . 0.0 111.249 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -30.29 71.44 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.54 -39.9 30.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.986 0.914 . . . . 0.0 113.448 175.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.57 -55.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.302 0.956 . . . . 0.0 109.572 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.0 -31.56 70.03 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 3.0 t -58.33 -50.45 73.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.779 1.232 . . . . 0.0 112.211 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.6 72.1 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.61 -37.22 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.504 1.121 . . . . 0.0 110.871 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.988 0.804 . . . . 0.0 114.303 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.48 17.48 77.65 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.063 1.316 . . . . 0.0 115.621 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -65.24 172.98 2.74 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 118.934 1.367 . . . . 0.0 113.625 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.25 -160.54 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.377 1.471 . . . . 0.0 112.511 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -48.26 151.42 1.03 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.851 1.66 . . . . 0.0 113.083 165.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -147.8 172.3 14.34 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.983 1.313 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.51 -92.78 0.12 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.81 1.644 . . . . 0.0 111.383 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 2.0 p -98.26 3.99 48.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.981 2.512 . . . . 0.0 113.948 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.64 -43.87 47.12 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.075 -1.015 . . . . 0.0 112.619 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.9 -37.02 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.68 1.192 . . . . 0.0 113.132 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.17 -53.29 39.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.491 1.116 . . . . 0.0 112.177 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -64.26 -23.66 67.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.072 -1.018 . . . . 0.0 112.985 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.86 -55.93 5.05 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.978 1.311 . . . . 0.0 111.541 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 8.5 t -57.14 -27.89 62.26 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.603 0.638 . . . . 0.0 112.719 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.9 t -79.45 -60.03 2.52 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.388 0.995 . . . . 0.0 112.3 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -58.13 -41.24 83.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.28 1.4 . . . . 0.0 113.975 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.81 -63.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 124.874 1.269 . . . . 0.0 109.734 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.06 -29.31 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.047 1.339 . . . . 0.0 110.907 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -59.23 -37.25 77.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -109.1 -39.03 5.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.793 1.637 . . . . 0.0 112.118 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 52.4 m -61.7 -51.73 67.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.655 2.382 . . . . 0.0 112.4 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 196' ' ' LEU . . . . . 0.491 HD13 HD11 ' B' ' 199' ' ' LEU . 0.0 OUTLIER -65.91 -36.51 83.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 117.953 0.342 . . . . 0.0 110.823 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.1 t -59.3 -43.67 92.6 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.546 -0.721 . . . . 0.0 112.203 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.46 -51.62 62.18 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.366 2.267 . . . . 0.0 113.292 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 199' ' ' LEU . . . . . 0.491 HD11 HD13 ' B' ' 196' ' ' LEU . 4.4 pp -66.07 -27.24 67.92 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 22.9 m -59.13 -37.01 76.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.132 0.573 . . . . 0.0 109.995 168.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -77.25 -25.18 51.24 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' LEU . . . . . . . . . . . . 0.297 0.0 OUTLIER -56.01 -26.2 47.71 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.967 1.707 . . . . 0.0 114.112 178.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -139.69 -82.77 0.09 OUTLIER Glycine 0 CA--C 1.535 1.295 0 CA-C-N 119.62 1.1 . . . . 0.0 114.425 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.15 172.62 3.4 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 125.97 1.708 . . . . 0.0 113.64 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.0 170.85 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 166.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -56.75 112.39 1.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.329 1.452 . . . . 0.0 112.899 172.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -177.75 100.97 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.255 2.622 . . . . 0.0 111.057 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -151.67 169.26 22.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.614 1.566 . . . . 0.0 110.497 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' ILE . . . . . 0.564 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.2 tt -133.58 155.57 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 108.92 157.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' B' ' 253' ' ' ALA . 35.1 m -136.17 152.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 123.861 0.865 . . . . 0.0 111.105 165.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 39.7 p -133.69 158.83 42.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.84 1.256 . . . . 0.0 110.266 170.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.87 156.75 42.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.336 1.065 . . . . 0.0 112.656 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.66 127.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.408 -0.808 . . . . 0.0 110.752 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' B' ' 249' ' ' CYS . 2.4 mm -119.22 98.29 6.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 127.094 2.158 . . . . 0.0 107.356 -169.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.7 ttt -105.61 156.22 18.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.456 1.102 . . . . 0.0 110.401 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -122.42 132.04 54.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.801 1.24 . . . . 0.0 110.8 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -64.45 -9.11 16.31 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -57.31 -20.72 30.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.432 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 123.72 40.86 0.44 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.688 1.137 . . . . 0.0 114.232 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.45 70.33 1.25 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.317 1.047 . . . . 0.0 112.575 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.31 155.32 16.38 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.468 1.509 . . . . 0.0 115.597 -173.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 178.35 9.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.937 1.695 . . . . 0.0 112.624 -166.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -108.79 110.61 22.02 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.386 1.075 . . . . 0.0 111.216 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' THR . . . . . 0.44 ' HB ' HG13 ' B' ' 278' ' ' VAL . 55.7 m -105.67 145.2 31.37 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.266 1.026 . . . . 0.0 109.207 173.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.88 33.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 111.044 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 94.1 p -137.55 143.71 41.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.203 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.4 t -84.55 15.77 3.56 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.782 0.833 . . . . 0.0 111.885 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 31.8 m -61.23 167.7 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.169 0.988 . . . . 0.0 111.636 166.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.6 147.29 21.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.693 1.997 . . . . 0.0 109.779 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -82.64 128.55 34.44 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 0.0 108.7 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -133.04 116.42 16.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.794 1.638 . . . . 0.0 109.302 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 -47.11 5.16 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.9 1.68 . . . . 0.0 114.41 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 16.7 t -106.43 -21.02 13.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.74 1.216 . . . . 0.0 112.977 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -29.81 29.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.45 1.9 . . . . 0.0 113.356 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.1 -167.65 1.54 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.0 2.52 . . . . 0.0 109.294 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.58 146.35 16.92 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.419 1.009 . . . . 0.0 112.906 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 29.7 p -160.64 147.28 15.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.976 1.31 . . . . 0.0 111.783 170.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 11.6 p -152.35 169.28 22.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.789 1.236 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 9.6 t -155.65 151.74 27.83 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.693 -1.254 . . . . 0.0 111.645 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.67 138.86 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.24 1.416 . . . . 0.0 109.817 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -127.3 127.56 44.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.057 1.343 . . . . 0.0 111.782 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -136.5 119.63 16.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 110.04 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -81.95 153.11 26.43 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.936 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -120.93 -170.67 2.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.52 1.528 . . . . 0.0 109.079 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -51.67 -54.85 23.64 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t -137.46 -21.57 1.16 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.958 1.303 . . . . 0.0 114.245 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 20.1 ptp -93.03 178.06 5.87 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.386 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -142.43 145.97 34.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.075 1.35 . . . . 0.0 109.63 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' CYS . . . . . 0.405 ' HB3' HD12 ' B' ' 214' ' ' ILE . 25.0 p -128.22 132.8 48.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.314 1.046 . . . . 0.0 110.888 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.61 138.26 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.124 0.969 . . . . 0.0 109.925 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.3 p -127.53 128.88 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.119 1.768 . . . . 0.0 110.07 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.5 p -123.23 148.93 45.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.672 1.189 . . . . 0.0 111.453 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 253' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -136.55 139.22 42.05 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.327 1.451 . . . . 0.0 112.698 -175.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.2 121.72 15.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.631 1.172 . . . . 0.0 109.572 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -111.69 82.03 0.3 Allowed Glycine 0 N--CA 1.469 0.859 0 C-N-CA 126.316 1.913 . . . . 0.0 111.863 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.87 105.34 17.27 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.706 1.202 . . . . 0.0 113.575 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 CA--C 1.534 0.356 0 C-N-CA 125.092 1.357 . . . . 0.0 112.532 -169.71 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.43 0 CA-C-O 120.415 0.15 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 274' ' ' LYS . . . . . 0.431 ' H ' ' HE2' ' B' ' 274' ' ' LYS 0.327 0.0 OUTLIER -127.34 177.04 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.209 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.17 129.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.176 0.99 . . . . 0.0 110.174 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 63.0 m -102.1 93.53 5.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.722 1.609 . . . . 0.0 109.953 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.89 149.59 24.7 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.329 -0.857 . . . . 0.0 111.081 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 278' ' ' VAL . . . . . 0.44 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.4 p -147.2 118.13 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.723 2.009 . . . . 0.0 109.974 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -138.64 143.97 39.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.561 1.144 . . . . 0.0 111.569 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 125.819 1.647 . . . . 0.0 108.799 178.348 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.741 0 N-CA-C 112.251 -0.34 . . . . 0.0 112.251 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -97.23 46.37 1.03 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.121 1.369 . . . . 0.0 112.228 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.1 ptt? -58.2 -25.49 61.66 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 120.932 -1.105 . . . . 0.0 113.505 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.25 -14.67 61.25 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.294 1.438 . . . . 0.0 114.302 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -65.86 -31.6 72.64 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.57 1.148 . . . . 0.0 112.912 175.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -115.85 178.29 4.37 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.099 1.76 . . . . 0.0 111.758 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.36 179.19 8.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.861 1.264 . . . . 0.0 110.692 174.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -127.12 150.89 49.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.706 1.602 . . . . 0.0 111.069 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.91 125.23 35.28 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.235 1.414 . . . . 0.0 111.807 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.43 -20.44 60.03 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 121.082 -1.011 . . . . 0.0 112.958 175.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.17 -25.62 63.53 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 t -93.98 -19.05 21.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.466 1.106 . . . . 0.0 112.771 175.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.82 132.02 48.35 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 121.0 -1.062 . . . . 0.0 111.824 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.25 178.57 5.04 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.83 1.252 . . . . 0.0 112.289 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -138.5 152.68 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.173 1.389 . . . . 0.0 110.916 171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.8 t -58.62 -43.42 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.731 1.212 . . . . 0.0 111.704 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -59.67 -29.85 68.35 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.101 1.36 . . . . 0.0 113.337 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.22 -57.34 4.02 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.101 0.96 . . . . 0.0 110.502 173.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.9 t -51.43 -40.45 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.74 1.216 . . . . 0.0 112.512 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 t -61.36 -19.76 62.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.76 1.624 . . . . 0.0 113.949 174.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -98.19 -35.55 10.34 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.731 1.612 . . . . 0.0 113.357 173.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 mt -51.75 -38.88 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.277 1.031 . . . . 0.0 110.809 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 97' ' ' VAL . 9.9 p -64.1 -42.36 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.88 62.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.884 1.22 . . . . 0.0 111.299 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.19 -32.47 71.12 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.3 -43.23 52.19 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.02 -55.41 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 119.616 1.098 . . . . 0.0 110.374 174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -63.71 -29.77 70.96 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.422 -0.799 . . . . 0.0 113.138 -176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.7 t -61.24 -46.27 91.09 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.279 1.032 . . . . 0.0 112.236 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.34 93.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.144 0.977 . . . . 0.0 113.331 175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.98 -48.0 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.254 1.021 . . . . 0.0 110.565 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.46 19.91 67.2 Favored Glycine 0 CA--C 1.539 1.583 0 C-N-CA 124.398 0.999 . . . . 0.0 115.01 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 76.14 20.46 77.4 Favored Glycine 0 CA--C 1.539 1.588 0 C-N-CA 124.918 1.247 . . . . 0.0 115.401 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.04 179.47 0.91 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.9 1.28 . . . . 0.0 114.43 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.23 144.69 19.41 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.405 1.482 . . . . 0.0 113.32 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.65 121.04 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.819 1.248 . . . . 0.0 111.032 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.97 157.98 45.49 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.269 1.828 . . . . 0.0 111.112 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -106.44 -66.01 1.04 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.507 1.123 . . . . 0.0 111.208 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 49.1 m -60.6 -18.51 53.42 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.943 1.297 . . . . 0.0 114.254 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.72 -38.96 79.5 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.036 -1.04 . . . . 0.0 113.191 171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -54.08 -35.24 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.363 0.665 . . . . 0.0 111.943 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -62.12 -50.63 71.12 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.329 1.451 . . . . 0.0 111.341 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -68.95 -25.6 64.63 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -77.85 -54.26 6.54 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 119.01 0.823 . . . . 0.0 111.148 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.8 t -54.99 -36.08 65.03 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.678 0.672 . . . . 0.0 111.984 175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -73.78 -56.86 4.46 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.345 0.975 . . . . 0.0 112.04 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -57.36 -40.27 77.71 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.98 1.312 . . . . 0.0 113.342 -176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.4 t -67.17 -63.64 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 C-N-CA 124.479 1.112 . . . . 0.0 110.524 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.6 t -50.76 -28.77 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.709 1.204 . . . . 0.0 110.788 178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.87 -42.54 79.97 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.331 1.053 . . . . 0.0 112.667 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -103.41 -36.2 8.09 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.226 1.41 . . . . 0.0 112.592 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.9 m -62.89 -49.68 73.86 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.048 2.139 . . . . 0.0 112.355 -178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -36.7 83.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.709 0.404 . . . . 0.0 111.407 177.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.2 t -63.06 -42.86 99.77 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.486 0.714 . . . . 0.0 112.495 170.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -66.94 -49.38 65.68 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.045 1.738 . . . . 0.0 113.27 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.61 -28.03 68.83 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.68 -1.262 . . . . 0.0 113.529 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 54.9 m -57.59 -28.24 63.43 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.419 1.088 . . . . 0.0 111.151 168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -89.75 -28.04 19.64 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.392 1.077 . . . . 0.0 113.285 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.8 mt -71.85 -21.74 61.63 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.408 1.083 . . . . 0.0 112.463 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -134.72 8.61 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 126.373 1.94 . . . . 0.0 112.629 170.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -116.71 155.76 48.57 Favored Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 125.644 1.578 . . . . 0.0 112.578 177.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.38 114.16 3.15 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 123.856 3.037 . . . . 0.0 111.66 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -151.45 175.14 12.57 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 127.084 2.154 . . . . 0.0 110.808 176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -78.74 100.42 7.08 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.231 1.413 . . . . 0.0 110.887 170.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -97.5 143.59 28.06 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.036 1.335 . . . . 0.0 109.949 168.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -133.44 153.4 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.464 1.505 . . . . 0.0 109.528 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.4 m -138.38 150.42 24.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 C-N-CA 123.734 0.814 . . . . 0.0 111.084 167.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 p -133.78 136.67 44.67 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.331 1.453 . . . . 0.0 109.139 171.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 48.3 t -131.28 140.67 49.84 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.068 0.947 . . . . 0.0 111.159 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.1 t -129.49 101.31 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.543 1.537 . . . . 0.0 109.179 -168.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -95.22 95.88 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.288 1.435 . . . . 0.0 110.033 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.58 166.17 14.33 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 125.985 1.714 . . . . 0.0 112.815 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 119.47 22.33 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.683 1.193 . . . . 0.0 112.374 174.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.5 ttmt -67.24 -11.29 57.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.084 1.354 . . . . 0.0 113.546 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -54.48 -28.61 46.0 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.996 1.719 . . . . 0.0 114.21 174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.3 10.48 0.09 OUTLIER Glycine 0 CA--C 1.536 1.367 0 N-CA-C 116.15 1.22 . . . . 0.0 116.15 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.05 97.82 4.57 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 119.107 1.454 . . . . 0.0 112.478 -165.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.31 169.08 25.96 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.197 1.856 . . . . 0.0 112.862 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.07 174.82 13.22 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.088 1.355 . . . . 0.0 113.319 -167.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.16 98.66 9.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.952 0.901 . . . . 0.0 112.08 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.481 ' HB ' HG13 ' A' ' 135' ' ' VAL . 48.3 m -95.29 139.82 31.07 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.212 -0.93 . . . . 0.0 109.637 172.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.06 111.77 11.78 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.949 1.7 . . . . 0.0 110.363 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.5 m -115.43 107.78 15.64 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.234 1.014 . . . . 0.0 110.594 -170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 t -76.95 35.32 0.16 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.799 1.24 . . . . 0.0 112.707 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 2.1 m -85.32 176.4 8.33 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.866 1.266 . . . . 0.0 111.412 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -141.17 137.63 32.83 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.278 1.431 . . . . 0.0 109.929 -175.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.3 t-105 -79.59 132.1 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.422 0.689 . . . . 0.0 109.803 172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -142.68 149.0 38.28 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.372 1.469 . . . . 0.0 110.586 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 47.7 t -123.51 -60.47 1.47 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.176 1.39 . . . . 0.0 112.344 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -92.86 -26.79 17.49 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.017 0.927 . . . . 0.0 112.852 176.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.13 -52.86 30.02 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.817 2.047 . . . . 0.0 113.317 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -146.87 173.87 12.02 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.769 2.427 . . . . 0.0 110.44 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -91.92 121.26 6.33 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.114 1.34 . . . . 0.0 113.359 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 56.6 m -146.85 144.84 29.6 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.456 1.502 . . . . 0.0 110.616 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 6.7 t -149.55 164.5 34.92 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.601 1.161 . . . . 0.0 111.184 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -162.96 150.48 13.35 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.178 -1.576 . . . . 0.0 111.143 -176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 23' ' ' VAL . 2.0 t -139.32 127.03 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.893 1.277 . . . . 0.0 110.113 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.76 111.74 17.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.04 1.336 . . . . 0.0 112.515 -171.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -125.45 93.74 3.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.975 1.71 . . . . 0.0 110.678 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.25 151.83 29.4 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.685 1.194 . . . . 0.0 112.381 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.7 m-20 -125.74 -175.22 3.28 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.915 1.686 . . . . 0.0 110.574 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -54.17 -50.22 67.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.032 1.333 . . . . 0.0 113.908 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.8 t -134.4 1.95 3.21 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.935 1.694 . . . . 0.0 113.895 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.26 156.97 32.69 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.292 2.237 . . . . 0.0 110.958 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -134.75 120.95 20.06 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.313 1.445 . . . . 0.0 110.815 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 16.2 m -126.16 98.31 5.43 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.218 1.007 . . . . 0.0 110.64 -175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 116.18 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.439 1.096 . . . . 0.0 111.882 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -108.12 137.38 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 126.471 1.908 . . . . 0.0 111.135 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -130.09 147.59 51.85 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.809 1.244 . . . . 0.0 111.349 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -137.99 140.01 39.96 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.796 1.639 . . . . 0.0 113.57 -170.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -132.55 113.61 13.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.549 1.14 . . . . 0.0 109.621 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -109.84 77.64 0.23 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 126.531 2.015 . . . . 0.0 110.734 -175.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.06 108.92 2.8 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 111.232 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 m -135.52 111.47 9.5 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.736 2.014 . . . . 0.0 111.115 -171.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.76 1.35 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.947 1.299 . . . . 0.0 114.273 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -80.11 2.15 77.08 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 125.332 1.444 . . . . 0.0 116.177 -175.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.61 16.11 60.65 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.996 1.398 . . . . 0.0 115.54 176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.51 90.0 0.06 OUTLIER Glycine 0 CA--C 1.536 1.352 0 C-N-CA 126.055 1.788 . . . . 0.0 113.398 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.1 p -139.03 -170.28 2.83 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.178 2.191 . . . . 0.0 111.685 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.08 23.13 7.53 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.444 1.021 . . . . 0.0 114.698 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.44 152.63 11.18 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.129 1.372 . . . . 0.0 114.62 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 21.8 t -72.29 -36.15 68.88 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.001 1.321 . . . . 0.0 113.161 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -74.16 165.17 54.79 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 123.975 0.797 . . . . 0.0 113.73 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 152.58 65.9 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 123.22 2.613 . . . . 0.0 111.94 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.55 146.39 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.319 1.048 . . . . 0.0 111.142 174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.89 115.07 14.8 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.056 1.343 . . . . 0.0 110.779 -178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 58.1 tp -80.23 146.37 31.75 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.121 0.968 . . . . 0.0 110.523 173.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 172.17 -165.73 38.44 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.875 1.702 . . . . 0.0 111.443 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -127.16 164.14 22.29 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.612 1.165 . . . . 0.0 111.598 171.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -124.58 153.34 42.3 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.02 1.328 . . . . 0.0 111.328 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.75 176.77 8.38 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.44 1.896 . . . . 0.0 111.106 -176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.06 139.66 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.621 1.568 . . . . 0.0 111.142 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.7 m -115.7 92.88 4.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.363 1.465 . . . . 0.0 110.787 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -76.27 149.45 37.12 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 120.872 -1.143 . . . . 0.0 111.218 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.481 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -137.11 108.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 127.427 2.291 . . . . 0.0 109.636 174.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -131.89 119.8 21.68 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.074 1.75 . . . . 0.0 109.645 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.09 88.55 3.15 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 125.572 1.549 . . . . 0.0 109.902 173.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.5 117.69 5.14 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.969 2.446 . . . . 0.0 110.867 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.29 -18.34 18.19 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.677 2.251 . . . . 0.0 113.279 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.01 171.28 16.63 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.618 2.367 . . . . 0.0 110.503 177.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -117.84 160.48 21.32 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.9 1.28 . . . . 0.0 111.44 166.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 5.2 mt -67.43 125.66 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.593 1.957 . . . . 0.0 110.416 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 C--O 1.251 1.172 0 C-N-CA 125.713 1.605 . . . . 0.0 111.596 177.844 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 112.304 -0.318 . . . . 0.0 112.304 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 3.7 t -84.29 49.79 1.73 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.123 1.369 . . . . 0.0 113.496 -171.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 24.0 ptt? -60.01 -25.34 65.21 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.707 -1.246 . . . . 0.0 113.403 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.85 -14.43 61.43 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.275 1.43 . . . . 0.0 114.334 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.9 -31.71 72.79 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.556 1.142 . . . . 0.0 112.888 175.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -115.74 178.36 4.34 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.134 1.774 . . . . 0.0 111.871 175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -149.2 179.18 8.1 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.927 1.291 . . . . 0.0 110.707 174.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.98 151.2 48.86 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.72 1.608 . . . . 0.0 111.101 171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -90.34 125.07 35.41 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.272 1.429 . . . . 0.0 111.817 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -74.23 -20.59 60.12 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.104 -0.997 . . . . 0.0 112.994 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.11 -25.1 63.34 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.8 t -94.9 -18.97 20.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 124.547 1.139 . . . . 0.0 112.829 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.69 133.22 51.68 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.001 -1.062 . . . . 0.0 111.828 174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 27.0 p90 -77.29 177.33 8.01 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.501 1.12 . . . . 0.0 112.361 175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.0 152.59 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.26 1.424 . . . . 0.0 110.814 173.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.33 -43.2 89.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.616 1.166 . . . . 0.0 111.749 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -60.0 -29.81 68.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.035 1.334 . . . . 0.0 113.357 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -73.71 -57.8 3.74 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.142 0.977 . . . . 0.0 110.398 172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.1 t -51.6 -40.47 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.815 1.246 . . . . 0.0 112.505 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 29.3 t -61.22 -19.95 62.23 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.773 1.629 . . . . 0.0 113.963 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -97.96 -35.76 10.36 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.339 173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 42.3 mt -51.83 -38.69 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.242 1.017 . . . . 0.0 110.866 174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.418 HG21 HG21 ' B' ' 240' ' ' VAL . 10.0 p -64.15 -42.3 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -50.82 62.27 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 119.873 1.215 . . . . 0.0 111.263 178.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -32.47 71.14 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.24 -43.27 52.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.0 mt -59.95 -55.52 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.59 1.087 . . . . 0.0 110.336 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -63.64 -29.88 71.06 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.395 -0.816 . . . . 0.0 113.102 -176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.8 t -61.22 -46.3 90.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.231 1.013 . . . . 0.0 112.194 168.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.26 93.41 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.127 0.971 . . . . 0.0 113.319 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 85.8 mt -63.97 -47.99 88.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.29 1.036 . . . . 0.0 110.529 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.43 19.96 67.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 124.391 0.996 . . . . 0.0 115.004 -177.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 76.11 20.42 77.5 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.915 1.245 . . . . 0.0 115.407 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.02 179.45 0.91 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.98 1.312 . . . . 0.0 114.393 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.24 144.76 19.23 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.418 1.487 . . . . 0.0 113.334 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -68.71 120.98 15.54 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.871 1.268 . . . . 0.0 110.982 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -136.92 157.88 45.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.321 1.848 . . . . 0.0 111.178 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -106.32 -65.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.476 1.111 . . . . 0.0 111.251 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.8 m -60.55 -18.51 52.89 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.923 1.289 . . . . 0.0 114.225 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 mmtp -58.88 -38.86 79.78 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 120.981 -1.074 . . . . 0.0 113.207 171.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 62.4 t -54.12 -35.13 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.395 0.678 . . . . 0.0 111.982 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -62.16 -50.75 70.62 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.353 1.461 . . . . 0.0 111.277 176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -68.89 -25.72 64.75 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.8 m0 -77.79 -54.29 6.52 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.012 0.824 . . . . 0.0 111.141 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.6 t -55.09 -35.71 64.89 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 118.64 0.655 . . . . 0.0 112.007 175.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -73.97 -57.34 4.04 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.372 0.987 . . . . 0.0 112.02 173.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -56.77 -40.13 75.29 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.037 1.335 . . . . 0.0 113.336 -176.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.02 -63.87 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 C-N-CA 124.489 1.116 . . . . 0.0 110.529 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.5 t -50.67 -28.9 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.741 1.217 . . . . 0.0 110.753 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.94 -41.82 78.93 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.427 1.091 . . . . 0.0 112.725 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -104.12 -36.41 7.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.221 1.408 . . . . 0.0 112.514 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 35.2 m -62.59 -49.74 74.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.123 2.169 . . . . 0.0 112.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.44 -37.15 84.78 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.858 0.463 . . . . 0.0 111.474 177.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 42.9 t -61.79 -46.43 89.57 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.438 0.695 . . . . 0.0 112.112 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -64.04 -49.36 72.67 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.063 1.745 . . . . 0.0 113.5 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -65.73 -28.21 68.88 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.734 -1.229 . . . . 0.0 113.595 -179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 82.1 m -58.3 -31.35 67.42 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.613 0.765 . . . . 0.0 110.85 169.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -84.95 -27.81 26.28 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.893 0.877 . . . . 0.0 113.088 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 27.7 mt -71.41 -20.75 62.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.502 1.121 . . . . 0.0 112.443 170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.83 -136.26 9.27 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.702 2.096 . . . . 0.0 112.933 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -115.47 156.23 46.19 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.848 1.659 . . . . 0.0 112.427 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.75 110.85 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.879 3.053 . . . . 0.0 111.738 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -148.59 173.92 12.66 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.952 2.101 . . . . 0.0 110.892 175.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -74.31 96.2 2.79 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.074 1.35 . . . . 0.0 111.8 174.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -81.91 153.77 26.15 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.251 1.421 . . . . 0.0 111.413 164.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.26 153.72 10.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 C-N-CA 126.939 2.096 . . . . 0.0 108.681 167.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.64 151.54 22.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 123.999 0.919 . . . . 0.0 110.912 166.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.5 p -132.82 137.56 46.79 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.232 1.413 . . . . 0.0 109.229 170.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 47.7 t -132.26 145.04 51.03 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.272 1.029 . . . . 0.0 111.124 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 55.7 t -134.16 106.73 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 125.625 1.57 . . . . 0.0 108.782 -167.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 18.8 mm -101.18 94.7 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 125.086 1.355 . . . . 0.0 109.688 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 166.27 14.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.014 1.725 . . . . 0.0 112.6 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.25 121.16 24.29 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.524 1.13 . . . . 0.0 112.571 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 6.8 ttmt -67.95 -11.17 58.27 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.049 1.34 . . . . 0.0 113.582 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -55.25 -28.04 50.59 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 114.212 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 150.64 11.5 0.1 Allowed Glycine 0 CA--C 1.536 1.405 0 N-CA-C 116.086 1.195 . . . . 0.0 116.086 178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -129.48 98.5 4.87 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 119.128 1.464 . . . . 0.0 112.457 -166.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -143.27 169.26 25.88 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.27 1.89 . . . . 0.0 112.874 177.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.14 174.64 13.47 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.18 1.392 . . . . 0.0 113.252 -167.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.24 100.41 11.51 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.91 0.884 . . . . 0.0 112.093 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.566 ' HB ' HG13 ' B' ' 278' ' ' VAL . 79.6 m -96.8 139.61 32.59 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.085 -1.009 . . . . 0.0 109.803 172.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.53 110.18 12.04 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.848 1.659 . . . . 0.0 109.955 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 10.1 m -112.44 108.03 17.03 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.37 1.068 . . . . 0.0 110.292 -172.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.6 t -76.96 35.52 0.16 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.62 1.168 . . . . 0.0 112.673 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 2.5 m -84.88 175.91 8.81 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.757 1.223 . . . . 0.0 111.622 175.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -141.2 137.21 32.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.326 1.45 . . . . 0.0 109.932 -175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -78.91 130.6 35.79 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.373 0.669 . . . . 0.0 109.704 172.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -139.85 145.44 38.09 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.61 1.564 . . . . 0.0 110.25 171.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 47.6 t -120.5 -61.74 1.54 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.097 1.359 . . . . 0.0 112.419 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 9.1 t -93.26 -25.0 17.97 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.093 0.957 . . . . 0.0 112.797 175.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -52.84 30.75 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.753 2.021 . . . . 0.0 112.968 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -148.7 174.49 12.12 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.744 2.418 . . . . 0.0 110.44 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -92.68 120.75 6.25 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.012 1.292 . . . . 0.0 113.514 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 52.6 m -146.39 144.51 29.78 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.418 1.487 . . . . 0.0 110.769 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 6.9 t -149.14 164.7 33.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.695 1.198 . . . . 0.0 111.179 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 2.9 t -163.12 150.61 13.16 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 120.166 -1.584 . . . . 0.0 111.11 -177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.418 HG21 HG21 ' B' ' 166' ' ' VAL . 2.0 t -139.38 127.27 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.919 1.288 . . . . 0.0 110.109 -173.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -122.91 111.91 17.21 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.029 1.332 . . . . 0.0 112.536 -171.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -125.51 94.13 4.05 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.958 1.703 . . . . 0.0 110.678 -176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.76 151.87 28.59 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 112.39 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -125.9 -175.18 3.28 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.86 1.664 . . . . 0.0 110.551 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -54.32 -50.02 68.33 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.112 1.365 . . . . 0.0 113.949 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -134.61 2.02 3.16 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 125.953 1.701 . . . . 0.0 113.895 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 1.3 mmt -122.27 156.97 32.72 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 127.232 2.213 . . . . 0.0 110.879 -178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -134.82 121.4 20.6 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.333 1.453 . . . . 0.0 110.758 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 15.9 m -126.28 98.57 5.51 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.258 1.023 . . . . 0.0 110.551 -175.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.94 117.74 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.255 1.022 . . . . 0.0 111.85 -176.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.8 p -110.0 137.99 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.558 1.943 . . . . 0.0 111.135 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.2 t -131.32 147.4 52.57 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.861 1.264 . . . . 0.0 111.382 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -138.81 140.44 38.55 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.725 1.61 . . . . 0.0 113.543 -169.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.91 110.08 9.48 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.497 1.119 . . . . 0.0 109.772 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -105.29 77.94 0.26 Allowed Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.237 1.875 . . . . 0.0 110.669 -176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.73 108.69 2.59 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.68 1.192 . . . . 0.0 111.402 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 33.6 m -135.5 112.56 10.36 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 126.792 2.037 . . . . 0.0 111.137 -171.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.4 pp -104.71 1.38 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 124.884 1.274 . . . . 0.0 114.193 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.83 2.31 74.81 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.325 1.441 . . . . 0.0 116.21 -175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.54 16.18 60.65 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 118.995 1.397 . . . . 0.0 115.466 176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -62.61 90.02 0.06 OUTLIER Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.022 1.772 . . . . 0.0 113.432 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 90.4 p -138.94 -170.2 2.81 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 127.211 2.204 . . . . 0.0 111.722 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 106.09 23.01 7.58 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.479 1.037 . . . . 0.0 114.712 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.52 152.64 11.39 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.087 1.355 . . . . 0.0 114.608 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 22.0 t -72.35 -36.12 68.72 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.971 1.309 . . . . 0.0 113.161 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -74.22 165.22 54.78 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 123.992 0.805 . . . . 0.0 113.683 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.49 152.74 65.72 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.949 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.6 pp -87.8 146.4 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.33 1.052 . . . . 0.0 111.12 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.93 115.13 14.84 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.07 1.348 . . . . 0.0 110.824 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 57.9 tp -80.24 146.5 31.66 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.134 0.974 . . . . 0.0 110.546 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 172.02 -165.76 38.53 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.901 1.715 . . . . 0.0 111.431 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 24.9 ptt? -127.48 164.48 21.82 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.608 1.163 . . . . 0.0 111.611 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -125.21 152.96 43.84 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.04 1.336 . . . . 0.0 111.315 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 25.5 mmmt -135.73 177.31 7.92 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.546 1.939 . . . . 0.0 111.098 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 23.1 mm -54.08 139.33 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.561 1.544 . . . . 0.0 111.259 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.1 m -114.84 90.76 3.42 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.343 1.457 . . . . 0.0 110.562 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -75.95 149.99 37.57 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 120.814 -1.178 . . . . 0.0 111.04 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.566 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.6 p -143.17 108.57 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 126.607 1.963 . . . . 0.0 110.407 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -130.02 120.02 24.08 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.896 2.078 . . . . 0.0 109.142 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -99.55 98.92 7.62 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 124.573 1.149 . . . . 0.0 108.536 167.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.45 116.51 4.74 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.82 2.347 . . . . 0.0 110.533 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -74.54 -18.5 19.92 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 122.512 2.141 . . . . 0.0 113.325 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.43 171.81 15.96 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 127.616 2.367 . . . . 0.0 110.658 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -118.27 160.54 21.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.92 1.288 . . . . 0.0 111.604 166.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 5.1 mt -67.68 126.03 26.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.661 1.984 . . . . 0.0 110.437 177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 43.3 t . . . . . 0 N--CA 1.482 1.165 0 C-N-CA 125.706 1.602 . . . . 0.0 111.612 177.621 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -87.62 5.45 39.48 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 114.622 1.342 . . . . 0.0 114.622 -170.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.1 mmm -62.98 -53.75 49.03 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 120.676 -1.265 . . . . 0.0 112.419 -174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -69.02 -16.58 63.75 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -70.75 -20.95 62.57 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.853 0.861 . . . . 0.0 112.464 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -99.09 143.97 28.76 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.613 1.165 . . . . 0.0 111.492 170.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -153.02 -177.34 6.23 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.913 1.685 . . . . 0.0 109.916 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.05 164.51 27.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.967 1.307 . . . . 0.0 112.867 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.06 124.33 21.33 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.201 1.401 . . . . 0.0 112.201 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.26 -16.99 44.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.834 1.654 . . . . 0.0 114.06 177.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -82.6 -37.9 24.36 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.853 -1.154 . . . . 0.0 112.342 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 t -73.12 -13.9 61.28 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.463 1.905 . . . . 0.0 112.829 172.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.15 139.63 58.79 Favored 'General case' 0 CA--C 1.541 0.627 0 O-C-N 120.769 -1.207 . . . . 0.0 111.217 174.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -101.55 172.02 7.21 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.147 0.979 . . . . 0.0 111.07 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.5 p -134.95 146.21 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.15 1.38 . . . . 0.0 109.763 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.9 t -60.48 -38.52 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 O-C-N 121.321 -0.862 . . . . 0.0 111.496 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -60.56 -29.15 68.98 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.86 1.264 . . . . 0.0 113.74 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -73.36 -58.23 3.45 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.933 0.893 . . . . 0.0 110.426 171.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.496 HG13 HD22 ' A' ' 56' ' ' LEU . 52.3 t -52.03 -44.01 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.319 1.447 . . . . 0.0 112.095 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 t -64.26 -12.8 44.75 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.127 1.771 . . . . 0.0 113.834 175.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -101.95 -31.98 10.42 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.793 1.637 . . . . 0.0 113.133 171.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.1 mt -51.59 -43.4 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.052 0.941 . . . . 0.0 110.451 171.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.65 -42.56 92.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.78 -52.48 56.69 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 120.037 1.29 . . . . 0.0 110.805 177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -34.18 76.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.55 -38.5 70.99 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.074 0.949 . . . . 0.0 113.089 174.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' A' ' 48' ' ' VAL . 50.2 mt -61.06 -57.86 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.329 0.968 . . . . 0.0 110.057 172.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.82 -28.75 70.22 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.7 t -59.73 -46.57 88.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.72 1.208 . . . . 0.0 112.386 168.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.16 79.95 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.92 0.888 . . . . 0.0 113.151 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 71.6 mt -67.72 -40.18 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.346 1.058 . . . . 0.0 111.728 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.96 12.85 58.43 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.837 1.208 . . . . 0.0 114.992 -177.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 70.84 15.52 73.88 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.723 1.154 . . . . 0.0 114.766 -172.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.61 -175.79 0.71 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.203 1.401 . . . . 0.0 112.369 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -52.16 107.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.402 1.481 . . . . 0.0 112.616 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -70.52 100.01 1.72 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.534 1.534 . . . . 0.0 111.109 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.5 164.87 11.54 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.645 1.178 . . . . 0.0 111.738 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.6 p80 -73.42 -55.75 5.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.5 m -68.21 -21.05 64.88 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 121.623 -0.673 . . . . 0.0 112.559 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -58.61 -44.03 89.81 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 168.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.9 t -54.81 -34.61 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.393 0.997 . . . . 0.0 112.048 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -66.2 -49.92 65.66 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.086 0.954 . . . . 0.0 111.936 177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.01 -26.0 66.57 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.565 -0.709 . . . . 0.0 112.813 174.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -76.71 -53.62 7.73 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.308 1.043 . . . . 0.0 111.247 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.5 t -58.27 -26.78 63.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.9 t -81.46 -57.38 3.5 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 119.597 1.09 . . . . 0.0 112.542 169.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -57.83 -38.36 75.48 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.908 1.283 . . . . 0.0 113.74 -175.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 27' ' ' ILE . 88.0 t -68.02 -62.55 1.21 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 C-N-CA 123.841 0.856 . . . . 0.0 110.343 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.9 t -48.95 -29.67 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 124.983 1.313 . . . . 0.0 110.82 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.01 -42.99 86.39 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.534 0.733 . . . . 0.0 112.788 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -103.87 -34.75 8.41 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 125.216 1.406 . . . . 0.0 113.149 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.5 m -59.17 -53.96 52.43 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.323 1.849 . . . . 0.0 111.487 177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.89 -37.78 83.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.961 0.505 . . . . 0.0 111.979 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 p -70.92 -29.93 66.11 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -71.92 -51.89 19.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 127.484 2.314 . . . . 0.0 112.968 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.496 HD22 HG13 ' A' ' 19' ' ' VAL . 4.3 pp -64.78 -25.6 67.99 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.865 -1.147 . . . . 0.0 113.731 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 m -59.95 -33.58 72.1 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.143 0.977 . . . . 0.0 110.939 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -82.09 -28.42 32.33 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -69.39 -16.56 63.53 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.342 1.057 . . . . 0.0 113.073 170.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.64 -120.67 4.55 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 126.247 1.88 . . . . 0.0 112.544 172.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mttp -131.64 152.38 80.3 Favored Pre-proline 0 N--CA 1.476 0.829 0 C-N-CA 126.376 1.87 . . . . 0.0 111.631 -176.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -70.31 109.42 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.953 3.102 . . . . 0.0 112.108 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -148.04 161.56 41.14 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.705 1.202 . . . . 0.0 112.57 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.9 ttmt -69.17 92.6 0.56 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.193 1.397 . . . . 0.0 110.828 169.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -70.5 165.02 23.52 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.629 -0.67 . . . . 0.0 112.038 164.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.426 HD11 ' SG ' ' B' ' 228' ' ' CYS . 4.5 tt -144.43 159.88 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.696 1.598 . . . . 0.0 110.092 167.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' A' ' 110' ' ' ALA . 34.9 m -139.67 148.11 23.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.3 1.44 . . . . 0.0 110.776 171.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.09 124.62 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.141 1.776 . . . . 0.0 108.642 175.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.2 p -127.09 151.0 49.22 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 175.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -132.77 100.0 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.028 1.731 . . . . 0.0 109.012 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.3 mm -97.27 109.69 23.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.456 ' HG3' HD21 ' A' ' 79' ' ' LEU . 8.3 ttm -124.11 154.78 39.49 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.747 1.219 . . . . 0.0 110.748 -177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.59 150.53 36.51 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.889 1.276 . . . . 0.0 111.833 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -90.66 3.45 54.17 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.11 1.364 . . . . 0.0 113.498 -177.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -67.74 -18.53 64.92 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.162 1.785 . . . . 0.0 115.072 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.55 -1.75 2.14 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 116.201 1.24 . . . . 0.0 116.201 -175.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.6 122.74 12.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.819 1.81 . . . . 0.0 111.79 174.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -126.59 112.82 1.66 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.023 1.297 . . . . 0.0 113.163 -174.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.628 HD22 HD22 ' B' ' 222' ' ' LEU . 0.2 OUTLIER -140.38 151.73 45.19 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 128.13 2.572 . . . . 0.0 109.597 -172.207 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -118.4 104.94 11.21 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.692 1.597 . . . . 0.0 108.713 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.459 ' HB ' HG22 ' A' ' 135' ' ' VAL . 1.8 m -123.75 117.94 26.07 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.425 0.69 . . . . 0.0 109.629 -174.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.42 118.96 32.52 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.607 0.763 . . . . 0.0 110.768 -172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 10.3 m -122.56 111.95 17.42 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.105 1.362 . . . . 0.0 110.024 -173.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.0 m -73.91 22.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.081 -1.012 . . . . 0.0 113.698 176.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 11.5 m -66.19 166.5 11.8 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.495 1.118 . . . . 0.0 112.117 167.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -158.2 159.78 36.46 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.787 2.035 . . . . 0.0 109.773 176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -87.17 141.66 28.49 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 123.803 0.841 . . . . 0.0 110.374 173.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -147.37 158.49 43.99 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.086 1.354 . . . . 0.0 112.475 169.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.1 t -135.05 -56.57 0.81 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.03 1.332 . . . . 0.0 112.465 174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -86.43 -28.77 23.33 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.223 0.919 . . . . 0.0 112.637 174.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.4 -43.34 73.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.937 1.695 . . . . 0.0 112.684 -175.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -161.42 -164.54 1.15 Allowed 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 126.189 1.796 . . . . 0.0 111.552 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.57 124.92 7.77 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 126.097 1.808 . . . . 0.0 114.734 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.4 p -145.97 178.41 8.21 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.998 2.119 . . . . 0.0 111.764 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 32.7 t -166.59 135.39 2.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.399 1.48 . . . . 0.0 109.811 162.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -143.95 147.37 33.85 Favored 'General case' 0 N--CA 1.482 1.132 0 O-C-N 119.869 -1.769 . . . . 0.0 112.303 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -138.3 144.66 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.665 1.186 . . . . 0.0 110.249 -169.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -138.6 113.14 8.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.312 1.445 . . . . 0.0 111.802 -172.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.7 m95 -124.36 105.84 9.76 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.282 1.833 . . . . 0.0 110.472 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -67.75 165.75 16.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.107 0.963 . . . . 0.0 111.66 174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -140.03 -178.77 5.61 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.772 1.229 . . . . 0.0 111.673 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -50.06 -56.56 10.31 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.79 1.636 . . . . 0.0 113.776 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.0 t -133.71 -15.58 2.38 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 125.555 1.542 . . . . 0.0 113.744 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.1 ptp -104.68 178.74 4.47 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.989 1.716 . . . . 0.0 111.089 171.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -147.35 157.57 43.63 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.295 -0.878 . . . . 0.0 111.399 170.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 36.9 m -131.45 125.49 32.65 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.962 1.305 . . . . 0.0 110.462 -171.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.5 pt -125.75 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.341 1.056 . . . . 0.0 110.633 173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.39 109.44 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 126.146 1.778 . . . . 0.0 111.115 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.7 t -108.77 126.95 53.58 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.185 1.394 . . . . 0.0 110.878 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -123.44 157.18 34.05 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.484 1.914 . . . . 0.0 112.705 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -143.06 158.84 43.23 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.967 1.307 . . . . 0.0 111.822 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -177.05 89.07 0.08 OUTLIER Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.311 1.434 . . . . 0.0 111.233 -176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -73.79 89.17 1.81 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.486 1.514 . . . . 0.0 111.404 -173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.1 t -75.58 98.89 4.11 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.07 1.348 . . . . 0.0 112.957 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.8 -4.66 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 125.025 1.33 . . . . 0.0 114.518 -178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.03 2.41 26.67 Favored Glycine 0 CA--C 1.537 1.433 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -174.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 94.09 33.03 7.13 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.198 1.499 . . . . 0.0 114.211 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.5 97.01 0.16 Allowed Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.491 1.52 . . . . 0.0 112.905 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -124.67 -163.91 1.22 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.616 1.966 . . . . 0.0 111.828 -174.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 108.12 -0.2 33.46 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.716 1.627 . . . . 0.0 115.431 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.45 -172.51 0.61 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.728 1.211 . . . . 0.0 112.511 169.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.6 t -56.4 -24.45 44.89 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.166 1.386 . . . . 0.0 114.017 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 129.85 -74.34 0.44 Allowed Glycine 0 CA--C 1.535 1.306 0 C-N-CA 126.132 1.825 . . . . 0.0 112.257 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.91 159.45 52.52 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.359 2.706 . . . . 0.0 112.61 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.6 97.79 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 125.782 1.633 . . . . 0.0 112.376 -172.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 107.23 9.61 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.803 1.641 . . . . 0.0 114.284 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mt -151.23 173.01 14.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.237 2.615 . . . . 0.0 111.883 173.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 163.45 73.05 0.02 OUTLIER Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.779 1.181 . . . . 0.0 113.437 175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.15 72.9 1.41 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.853 1.661 . . . . 0.0 111.962 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -162.75 159.46 24.22 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.045 1.338 . . . . 0.0 112.463 166.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.2 mmmt -137.29 177.9 7.51 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 128.694 2.797 . . . . 0.0 111.083 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 34.2 mm -53.66 130.89 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.021 1.728 . . . . 0.0 111.075 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 35.5 m -97.19 90.55 5.17 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.146 1.378 . . . . 0.0 110.153 -177.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -109.49 146.6 34.3 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.673 0.789 . . . . 0.0 111.817 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.459 HG22 ' HB ' ' A' ' 81' ' ' THR . 0.8 OUTLIER -129.71 140.72 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.97 1.708 . . . . 0.0 110.46 -178.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -149.41 143.96 26.06 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.927 1.291 . . . . 0.0 112.07 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -134.42 96.57 15.29 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.377 1.471 . . . . 0.0 110.078 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.61 164.43 35.74 Favored 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 123.15 2.567 . . . . 0.0 112.006 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -67.5 -48.33 1.67 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 123.099 2.533 . . . . 0.0 113.162 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -160.98 -57.05 0.05 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.962 1.705 . . . . 0.0 111.373 176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.28 172.61 13.0 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.58 1.952 . . . . 0.0 112.129 -175.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.07 168.06 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.396 1.478 . . . . 0.0 112.172 -177.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.408 1.883 . . . . 0.0 112.115 -179.206 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 49.7 m -89.64 5.69 44.61 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.233 1.413 . . . . 0.0 114.432 -169.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 84.7 mmm -63.65 -53.53 50.02 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.851 -1.155 . . . . 0.0 112.313 -174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.78 -16.68 63.87 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.68 -21.13 62.62 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.853 0.861 . . . . 0.0 112.444 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -99.04 143.9 28.8 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.59 1.156 . . . . 0.0 111.496 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -153.03 -177.28 6.19 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.927 1.691 . . . . 0.0 109.94 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -135.15 164.69 27.11 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.928 1.291 . . . . 0.0 112.874 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.03 124.15 20.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.271 1.428 . . . . 0.0 112.284 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.16 -17.04 44.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.753 1.621 . . . . 0.0 113.937 176.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -82.34 -38.23 24.55 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 120.866 -1.146 . . . . 0.0 112.325 -174.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.1 t -72.92 -14.33 61.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.391 1.877 . . . . 0.0 112.674 172.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.95 138.14 58.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.771 -1.206 . . . . 0.0 111.254 174.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -99.83 172.0 7.52 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.207 1.003 . . . . 0.0 111.143 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 12.3 p -135.19 146.36 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.142 1.377 . . . . 0.0 109.782 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.5 t -60.4 -38.69 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 O-C-N 121.261 -0.899 . . . . 0.0 111.501 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.5 -29.11 68.89 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.884 1.274 . . . . 0.0 113.814 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -73.38 -58.41 3.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.929 0.891 . . . . 0.0 110.376 171.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.498 HG13 HD22 ' B' ' 199' ' ' LEU . 53.3 t -52.08 -43.93 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.35 1.46 . . . . 0.0 112.122 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.1 t -64.14 -12.72 42.56 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.0 1.72 . . . . 0.0 113.9 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -102.16 -31.96 10.33 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.782 1.633 . . . . 0.0 113.133 172.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 23.0 mt -51.41 -43.52 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.1 0.96 . . . . 0.0 110.464 171.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.72 -42.51 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -52.32 57.58 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 120.037 1.289 . . . . 0.0 110.975 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -34.34 76.32 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.41 -38.47 71.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.159 0.984 . . . . 0.0 113.119 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.461 ' HA ' HG21 ' B' ' 191' ' ' VAL . 49.8 mt -61.0 -58.05 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.242 0.928 . . . . 0.0 109.975 172.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.68 -28.93 70.27 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.559 -0.713 . . . . 0.0 112.889 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -59.54 -46.67 88.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.769 1.227 . . . . 0.0 112.401 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.73 -35.16 79.95 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.923 0.889 . . . . 0.0 113.146 174.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 72.0 mt -67.71 -40.2 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.317 1.047 . . . . 0.0 111.774 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.02 12.73 58.26 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.865 1.221 . . . . 0.0 115.026 -177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 70.96 15.51 74.14 Favored Glycine 0 CA--C 1.54 1.623 0 C-N-CA 124.76 1.171 . . . . 0.0 114.762 -172.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -68.72 -175.7 0.72 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.171 1.388 . . . . 0.0 112.34 175.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -52.21 107.83 0.24 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.316 1.446 . . . . 0.0 112.653 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -70.39 99.86 1.65 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.632 1.573 . . . . 0.0 111.14 176.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.53 164.85 11.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.623 1.169 . . . . 0.0 111.738 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 26.8 p80 -73.35 -55.9 5.78 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.4 m -67.92 -21.21 65.13 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 121.516 -0.74 . . . . 0.0 112.54 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp -58.48 -44.04 89.22 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 168.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 48.0 t -54.91 -34.58 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 119.36 0.982 . . . . 0.0 112.039 176.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -65.97 -50.08 65.58 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.073 0.949 . . . . 0.0 111.943 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.04 -26.09 66.59 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.517 -0.739 . . . . 0.0 112.711 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.5 m0 -76.59 -53.51 7.95 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.251 1.021 . . . . 0.0 111.314 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.5 t -58.42 -26.48 63.34 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 11.6 t -81.57 -57.94 3.24 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 119.625 1.102 . . . . 0.0 112.579 169.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -57.36 -38.19 73.8 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.998 1.319 . . . . 0.0 113.682 -174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' B' ' 170' ' ' ILE . 87.8 t -68.08 -62.8 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 123.857 0.863 . . . . 0.0 110.276 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.95 -29.68 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.018 1.327 . . . . 0.0 110.852 176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -58.06 -42.8 86.24 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.428 0.691 . . . . 0.0 112.826 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -104.02 -34.76 8.34 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.26 1.424 . . . . 0.0 113.085 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 18.6 m -59.14 -53.88 53.28 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.38 1.872 . . . . 0.0 111.452 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -38.19 84.27 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.039 0.536 . . . . 0.0 111.94 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 37.2 p -70.78 -29.74 66.03 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -72.14 -51.91 19.17 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.475 2.31 . . . . 0.0 113.045 173.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.498 HD22 HG13 ' B' ' 162' ' ' VAL . 4.4 pp -65.03 -25.8 67.99 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 120.808 -1.183 . . . . 0.0 113.706 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 60.2 m -59.33 -34.79 72.76 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.051 0.94 . . . . 0.0 110.676 167.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -81.12 -28.38 35.16 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 7.4 mt -69.2 -16.58 63.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.33 1.052 . . . . 0.0 113.074 170.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.9 -117.21 4.22 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.036 1.779 . . . . 0.0 112.558 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -132.96 158.92 74.61 Favored Pre-proline 0 N--CA 1.476 0.832 0 C-N-CA 126.716 2.006 . . . . 0.0 111.474 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.04 110.09 3.01 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.572 2.848 . . . . 0.0 112.286 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -145.84 165.18 29.64 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.687 1.595 . . . . 0.0 111.965 173.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 ttmt -72.7 98.04 2.3 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.632 1.173 . . . . 0.0 110.425 169.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -74.39 164.56 26.46 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.268 0.556 . . . . 0.0 111.937 165.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 4.2 tt -145.09 159.31 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 125.851 1.66 . . . . 0.0 109.991 166.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.421 HG12 ' HB2' ' B' ' 253' ' ' ALA . 35.1 m -140.18 147.9 23.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 125.317 1.447 . . . . 0.0 110.695 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.14 123.26 14.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.054 1.742 . . . . 0.0 108.616 176.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.1 p -126.46 150.26 48.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 176.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 3.5 t -132.14 103.19 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 126.153 1.781 . . . . 0.0 109.002 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 6.6 mm -100.45 108.97 24.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.8 ttm -123.91 162.79 22.61 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.765 1.226 . . . . 0.0 110.951 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.34 152.82 44.23 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.784 1.234 . . . . 0.0 112.277 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -90.62 1.81 56.44 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.378 1.471 . . . . 0.0 113.548 -177.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -67.71 -18.8 65.03 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.012 1.725 . . . . 0.0 115.078 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 140.04 -1.41 2.22 Favored Glycine 0 CA--C 1.538 1.508 0 N-CA-C 116.214 1.246 . . . . 0.0 116.214 -175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -55.19 125.26 19.89 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 119.767 1.783 . . . . 0.0 111.563 173.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -130.32 112.19 1.25 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.944 1.259 . . . . 0.0 112.999 -174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.628 HD22 HD22 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -139.17 153.37 47.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.148 2.579 . . . . 0.0 109.591 -172.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -119.55 102.18 8.46 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.943 1.697 . . . . 0.0 108.79 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 1.4 m -121.4 123.59 42.47 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.015 0.926 . . . . 0.0 109.121 -174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -125.59 119.89 29.33 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.172 0.589 . . . . 0.0 111.011 -173.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 11.1 m -122.47 112.38 17.98 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.022 1.329 . . . . 0.0 109.988 -173.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 70.5 m -74.11 23.22 0.08 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . 0.426 ' SG ' HD11 ' A' ' 66' ' ' ILE . 20.6 m -67.18 167.03 12.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.639 1.176 . . . . 0.0 112.109 167.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -158.59 161.73 37.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.126 2.17 . . . . 0.0 109.73 176.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -88.66 141.64 28.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.92 0.888 . . . . 0.0 110.275 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -146.01 157.56 43.87 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 125.088 1.355 . . . . 0.0 112.544 169.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.0 t -127.14 -61.09 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.2 1.4 . . . . 0.0 112.133 177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 82.7 p -95.34 -21.67 18.24 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 173.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.16 -40.69 86.69 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.89 1.276 . . . . 0.0 111.608 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -162.04 -163.79 0.99 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 126.636 1.974 . . . . 0.0 111.026 175.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -108.22 128.27 9.04 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 126.061 1.791 . . . . 0.0 114.489 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 87.3 p -148.12 178.18 8.76 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.112 2.165 . . . . 0.0 111.576 173.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 31.4 t -166.84 134.71 2.62 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.372 1.469 . . . . 0.0 109.82 162.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -143.36 147.19 34.29 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 119.9 -1.75 . . . . 0.0 112.362 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.85 144.5 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.665 1.186 . . . . 0.0 110.175 -169.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -138.73 113.1 8.8 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.145 1.378 . . . . 0.0 111.823 -171.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -124.9 103.81 8.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.266 1.827 . . . . 0.0 110.346 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -63.17 165.99 6.61 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.83 0.852 . . . . 0.0 112.588 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -140.36 -177.73 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.301 1.44 . . . . 0.0 111.465 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -49.81 -56.73 9.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.659 1.584 . . . . 0.0 113.852 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 12.6 t -133.51 -16.71 2.34 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 125.69 1.596 . . . . 0.0 113.552 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.3 ptp -104.05 -179.32 3.91 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.196 1.798 . . . . 0.0 111.162 172.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -149.25 161.27 42.35 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.008 0.923 . . . . 0.0 111.578 169.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 32.2 m -132.77 124.95 29.05 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.425 1.49 . . . . 0.0 110.051 -173.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 5.5 pt -124.08 136.55 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.095 0.958 . . . . 0.0 110.539 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.4 p -133.95 108.03 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 C-N-CA 125.972 1.709 . . . . 0.0 111.093 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.5 t -107.06 123.53 48.35 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.107 1.363 . . . . 0.0 110.775 -176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.421 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -118.33 158.14 25.78 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.41 1.884 . . . . 0.0 112.368 -177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -142.18 156.54 45.34 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.648 1.179 . . . . 0.0 112.034 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -171.3 88.91 0.08 OUTLIER Glycine 0 CA--C 1.528 0.849 0 C-N-CA 123.722 0.677 . . . . 0.0 113.119 -171.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -75.69 91.87 2.94 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.612 1.165 . . . . 0.0 110.777 -176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 3.3 t -84.96 98.72 10.53 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.187 1.395 . . . . 0.0 112.183 -173.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -101.17 -3.83 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -175.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -74.03 3.64 36.27 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.741 1.162 . . . . 0.0 115.898 -174.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 93.64 33.45 7.09 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 119.377 1.589 . . . . 0.0 114.359 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -62.47 97.6 0.18 Allowed Glycine 0 CA--C 1.536 1.401 0 C-N-CA 125.394 1.473 . . . . 0.0 112.985 176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 9.6 t -125.62 -164.35 1.29 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.628 1.971 . . . . 0.0 111.95 -174.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 109.55 -0.65 30.75 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.759 1.647 . . . . 0.0 115.309 175.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -171.32 0.65 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.767 1.227 . . . . 0.0 112.525 170.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 8.7 t -55.65 -27.21 48.65 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.501 1.52 . . . . 0.0 114.24 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 129.96 -72.31 0.48 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.798 1.666 . . . . 0.0 112.519 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 153.54 67.37 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.069 2.513 . . . . 0.0 112.053 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 6.3 pt -83.72 158.58 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.34 1.056 . . . . 0.0 111.272 169.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 168.24 9.44 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.036 1.335 . . . . 0.0 112.048 167.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.3 mt -72.51 169.42 16.5 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.45 1.1 . . . . 0.0 112.17 170.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -127.78 165.62 20.75 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 125.548 1.547 . . . . 0.0 112.986 174.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -138.08 88.15 2.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.717 2.007 . . . . 0.0 109.76 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -151.78 157.3 41.79 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.096 1.358 . . . . 0.0 111.703 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -135.68 177.92 7.45 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.682 2.393 . . . . 0.0 111.111 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.8 mm -53.01 130.24 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.981 1.712 . . . . 0.0 111.106 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 32.0 m -96.26 86.48 4.23 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.098 1.359 . . . . 0.0 110.114 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -99.14 145.47 27.15 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.809 0.844 . . . . 0.0 110.883 172.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.2 p -131.0 136.86 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 126.121 1.768 . . . . 0.0 110.964 173.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -143.74 144.69 31.94 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.497 1.519 . . . . 0.0 112.109 178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.5 97.43 15.99 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 125.23 1.412 . . . . 0.0 110.522 174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.05 164.5 35.47 Favored 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.18 2.587 . . . . 0.0 112.076 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.93 -49.28 1.09 Allowed 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.198 2.599 . . . . 0.0 113.252 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 15.5 tpp180 -160.49 -57.45 0.06 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 126.009 1.724 . . . . 0.0 111.495 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.36 172.61 13.03 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.599 1.96 . . . . 0.0 112.167 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.69 168.08 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.294 1.438 . . . . 0.0 112.203 -177.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.253 1.261 0 C-N-CA 126.346 1.858 . . . . 0.0 112.031 -179.041 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 CA-C-O 119.538 -0.59 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.504 ' HG ' ' N ' ' B' ' 144' ' ' GLY . 3.3 p -152.61 103.38 2.8 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.766 1.226 . . . . 0.0 112.3 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -62.01 -35.07 77.46 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.282 1.433 . . . . 0.0 113.132 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -65.45 -17.06 64.25 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -77.99 -16.97 57.68 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.066 0.946 . . . . 0.0 113.254 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -64.62 140.08 58.83 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.288 169.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.08 176.76 8.56 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.999 1.719 . . . . 0.0 110.706 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -114.28 30.23 7.45 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.813 1.645 . . . . 0.0 112.933 -178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.71 19.33 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 127.716 2.406 . . . . 0.0 116.048 -175.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -63.45 -28.16 69.78 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.472 1.509 . . . . 0.0 113.014 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -73.66 -29.27 62.22 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.9 t -90.82 -23.75 20.49 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.278 1.031 . . . . 0.0 112.351 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 147.21 46.06 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 121.33 -0.856 . . . . 0.0 112.009 170.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.92 166.3 11.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.266 1.026 . . . . 0.0 112.289 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.7 p -136.83 158.08 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.289 1.435 . . . . 0.0 110.584 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -60.3 -36.4 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.459 1.503 . . . . 0.0 111.85 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -54.47 -32.59 58.08 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.687 0.795 . . . . 0.0 112.881 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -79.74 -54.79 5.51 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.096 0.558 . . . . 0.0 110.236 175.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.565 HG13 HD22 ' A' ' 56' ' ' LEU . 77.5 t -52.08 -43.8 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.952 1.301 . . . . 0.0 112.661 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.7 t -64.04 -9.45 16.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.628 1.971 . . . . 0.0 113.898 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -102.68 -38.06 7.65 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.551 1.54 . . . . 0.0 112.433 168.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.9 mt -50.08 -44.17 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 123.851 0.86 . . . . 0.0 110.474 173.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -59.24 -42.36 86.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -52.06 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 120.046 1.294 . . . . 0.0 111.086 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.44 -33.41 74.75 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.27 -39.87 59.31 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.192 0.997 . . . . 0.0 112.931 176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.451 ' HA ' HG21 ' A' ' 48' ' ' VAL . 59.7 mt -59.75 -58.87 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 119.319 0.963 . . . . 0.0 109.626 173.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -62.7 -30.01 71.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.3 t -59.29 -50.66 73.16 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.429 1.091 . . . . 0.0 112.061 167.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.88 -31.95 73.18 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.7 mt -62.47 -35.76 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.478 1.111 . . . . 0.0 111.582 173.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.3 13.55 81.68 Favored Glycine 0 CA--C 1.539 1.532 0 C-N-CA 124.109 0.861 . . . . 0.0 114.739 -178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.37 3.04 56.61 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.158 1.361 . . . . 0.0 115.863 175.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -64.62 165.26 10.48 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 119.235 1.517 . . . . 0.0 111.694 169.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.77 -178.75 4.98 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.931 -1.106 . . . . 0.0 112.053 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -51.73 141.04 17.68 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.546 0.738 . . . . 0.0 111.285 168.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.36 165.19 24.79 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.361 1.065 . . . . 0.0 111.594 -173.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 m170 -84.09 -88.3 0.1 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.824 0.849 . . . . 0.0 111.055 -171.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.5 m -78.47 -21.08 49.58 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.345 -1.472 . . . . 0.0 113.921 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.78 -38.01 71.9 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.238 1.015 . . . . 0.0 112.445 177.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.17 -30.37 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.7 m-20 -68.06 -45.29 74.26 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.827 0.851 . . . . 0.0 111.188 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -67.39 -26.4 66.43 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 172.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -76.73 -53.82 7.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 118.972 0.806 . . . . 0.0 111.322 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -56.0 -32.07 63.61 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 118.618 0.644 . . . . 0.0 112.452 176.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.1 t -77.65 -59.45 2.78 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.357 0.98 . . . . 0.0 112.581 171.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -57.08 -39.02 74.17 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.389 1.476 . . . . 0.0 113.63 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 27' ' ' ILE . 86.3 t -68.3 -63.5 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.812 0 C-N-CA 123.976 0.91 . . . . 0.0 109.97 -177.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.88 -30.41 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.761 1.224 . . . . 0.0 110.621 176.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -57.44 -46.4 83.63 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.646 0.779 . . . . 0.0 112.671 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -98.23 -39.45 8.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 0.0 112.705 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 25.4 m -58.28 -53.09 62.19 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.265 2.226 . . . . 0.0 112.123 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -38.07 85.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 122.64 0.376 . . . . 0.0 111.208 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.4 t -62.57 -44.58 95.98 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 121.329 -0.857 . . . . 0.0 112.252 172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -61.38 -49.28 77.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.729 2.012 . . . . 0.0 113.048 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 19' ' ' VAL . 3.9 pp -68.77 -27.12 65.61 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 35.0 m -59.9 -30.68 69.19 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 121.812 -0.555 . . . . 0.0 110.918 165.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -82.16 -28.01 32.38 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.519 -0.738 . . . . 0.0 112.97 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -69.35 -28.87 66.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.637 0.775 . . . . 0.0 111.433 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.42 -104.61 2.3 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.771 1.653 . . . . 0.0 113.855 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HB3' HD13 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -137.31 154.44 75.5 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.114 1.766 . . . . 0.0 112.642 179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -71.54 110.51 2.89 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.86 3.04 . . . . 0.0 111.673 177.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.442 ' CD1' HD11 ' A' ' 115' ' ' ILE . 1.8 t80 -148.37 170.25 18.38 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.265 1.026 . . . . 0.0 112.587 173.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -71.37 116.01 11.19 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.644 0.778 . . . . 0.0 110.563 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -101.59 164.15 11.9 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.518 1.127 . . . . 0.0 110.74 165.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.429 HD11 ' SG ' ' B' ' 228' ' ' CYS . 1.0 OUTLIER -147.42 155.31 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.602 1.961 . . . . 0.0 108.518 171.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 110' ' ' ALA . 3.8 m -139.53 151.78 22.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 123.83 0.852 . . . . 0.0 110.415 167.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -138.53 128.74 25.73 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.939 2.095 . . . . 0.0 108.862 173.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.4 p -131.81 145.3 51.49 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.253 -0.904 . . . . 0.0 112.66 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.2 t -132.64 110.25 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 125.468 1.507 . . . . 0.0 108.606 -172.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' A' ' 106' ' ' CYS . 3.6 mm -109.8 95.67 4.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.31 1.844 . . . . 0.0 107.808 -174.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.3 ptt? -134.5 154.15 51.58 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.654 0.782 . . . . 0.0 111.975 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -78.27 149.33 33.58 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.731 -0.606 . . . . 0.0 112.019 -174.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.22 -7.38 59.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 -177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -65.96 -36.88 84.53 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.473 1.909 . . . . 0.0 114.367 -173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 108.8 40.37 1.59 Allowed Glycine 0 CA--C 1.539 1.574 0 C-N-CA 124.6 1.095 . . . . 0.0 115.026 -178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.06 -169.94 0.67 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 125.173 1.389 . . . . 0.0 112.701 170.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.0 73.15 1.05 Allowed Glycine 0 CA--C 1.538 1.515 0 O-C-N 120.545 -1.347 . . . . 0.0 113.939 176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.12 90.85 2.94 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.891 2.076 . . . . 0.0 112.065 -175.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -113.65 136.44 52.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.271 1.428 . . . . 0.0 110.181 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.441 ' HB ' HG13 ' A' ' 135' ' ' VAL . 27.9 m -145.27 147.31 32.23 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.902 1.281 . . . . 0.0 109.779 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.4 147.88 30.73 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.254 -0.904 . . . . 0.0 111.602 173.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 95.1 p -148.52 133.47 18.11 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.039 0.536 . . . . 0.0 111.61 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 27.5 m -80.51 19.19 0.82 Allowed 'General case' 0 N--CA 1.48 1.048 0 O-C-N 121.687 -0.633 . . . . 0.0 112.564 173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.482 ' SG ' HD11 ' B' ' 209' ' ' ILE . 56.1 m -68.34 165.16 19.23 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.717 1.207 . . . . 0.0 112.204 172.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -163.02 140.11 7.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.653 1.581 . . . . 0.0 110.61 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.02 150.79 40.46 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.13 0.572 . . . . 0.0 110.498 171.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -140.32 152.75 46.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.62 1.568 . . . . 0.0 110.617 170.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.3 t -109.24 -66.31 1.07 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.197 0.999 . . . . 0.0 111.426 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 57.5 p -89.78 -26.68 20.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 113.027 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.9 m -77.82 -44.87 26.08 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 126.364 1.866 . . . . 0.0 112.92 -174.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -148.85 -174.24 4.57 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 128.117 2.567 . . . . 0.0 110.686 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.98 123.24 3.97 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.618 1.58 . . . . 0.0 113.441 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.46 125.08 13.25 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.411 1.484 . . . . 0.0 111.337 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.8 p -120.43 112.24 18.73 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.601 1.56 . . . . 0.0 112.175 -169.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.0 t -125.21 147.97 48.84 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 120.523 -1.361 . . . . 0.0 112.319 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.69 136.39 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.739 1.615 . . . . 0.0 109.723 -170.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -131.58 101.4 5.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.461 1.504 . . . . 0.0 112.022 -169.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -110.04 129.2 55.72 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.821 1.248 . . . . 0.0 109.768 177.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -91.23 159.37 16.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.973 0.909 . . . . 0.0 110.934 174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -127.75 -178.4 4.48 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.599 1.56 . . . . 0.0 110.593 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.39 -51.24 60.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 127.181 2.192 . . . . 0.0 113.025 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -138.48 -3.51 1.7 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.299 1.439 . . . . 0.0 114.115 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.3 ptp -126.18 -173.71 2.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.608 1.963 . . . . 0.0 110.746 173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -145.29 156.41 43.8 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.341 -0.85 . . . . 0.0 111.033 173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.424 ' CB ' HD12 ' A' ' 71' ' ' ILE . 4.9 p -131.33 96.15 3.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.333 1.453 . . . . 0.0 111.019 -175.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.6 pt -97.25 138.32 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.244 1.018 . . . . 0.0 111.413 174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.2 p -130.41 137.03 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 126.309 1.844 . . . . 0.0 109.999 175.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.2 t -128.25 123.21 33.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 125.072 1.349 . . . . 0.0 109.853 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.435 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -110.21 150.96 27.92 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.606 1.162 . . . . 0.0 111.53 174.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.66 106.91 9.27 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 125.764 1.626 . . . . 0.0 107.915 177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.23 88.24 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 125.962 1.744 . . . . 0.0 110.358 -169.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.532 ' H ' HD22 ' A' ' 113' ' ' LEU . 1.5 mm? -64.42 163.61 12.93 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.998 1.319 . . . . 0.0 112.218 -173.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.8 t -124.68 130.31 52.18 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.836 1.254 . . . . 0.0 112.381 -174.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.507 HD13 ' HB3' ' A' ' 61' ' ' LYS . 1.7 mp -77.56 -57.56 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.06 1.744 . . . . 0.0 109.549 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.97 -26.74 73.4 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-O 119.64 -0.533 . . . . 0.0 112.957 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.5 25.32 68.58 Favored Glycine 0 CA--C 1.537 1.412 0 CA-C-N 118.203 1.001 . . . . 0.0 114.16 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.0 149.16 31.05 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.898 1.237 . . . . 0.0 113.713 -175.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -69.22 177.83 2.6 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.979 1.312 . . . . 0.0 113.419 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.85 20.58 5.65 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.91 1.243 . . . . 0.0 113.982 -171.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -58.13 177.64 0.12 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.563 1.545 . . . . 0.0 112.352 171.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.81 -18.95 14.74 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 139.93 -73.39 0.4 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.097 1.808 . . . . 0.0 111.97 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.23 157.06 62.84 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.109 2.539 . . . . 0.0 112.384 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 24.7 pt -110.77 148.93 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.861 1.664 . . . . 0.0 110.636 174.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.94 138.62 48.41 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.757 1.223 . . . . 0.0 110.791 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.7 mt -135.26 121.76 20.61 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.94 1.696 . . . . 0.0 109.49 -172.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 148.75 -174.95 28.23 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.009 1.29 . . . . 0.0 113.639 -173.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.9 ttm -81.38 -178.08 6.77 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.049 1.34 . . . . 0.0 112.416 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -132.49 174.98 9.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.079 1.752 . . . . 0.0 112.421 175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -121.7 168.21 12.06 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.925 1.69 . . . . 0.0 112.051 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 27.2 mm -71.85 146.49 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.447 1.499 . . . . 0.0 110.704 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.1 m -112.79 92.7 4.11 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.39 1.476 . . . . 0.0 110.292 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -90.54 149.34 22.2 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.863 0.865 . . . . 0.0 111.036 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.441 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -135.9 106.75 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 127.522 2.329 . . . . 0.0 108.795 175.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -138.17 152.13 48.38 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.1 0.96 . . . . 0.0 111.833 174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 25.4 p90 -75.47 152.23 85.48 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.794 0.837 . . . . 0.0 111.4 174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.97 159.01 53.86 Favored 'Trans proline' 0 CA--C 1.546 1.11 0 C-N-CA 122.975 2.45 . . . . 0.0 112.26 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.51 -48.2 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.172 2.582 . . . . 0.0 113.232 -174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -159.1 -53.99 0.06 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.806 1.642 . . . . 0.0 111.938 170.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.58 170.86 11.31 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.132 1.373 . . . . 0.0 112.258 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.77 168.31 20.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 125.854 1.662 . . . . 0.0 111.884 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.251 1.166 0 C-N-CA 126.054 1.742 . . . . 0.0 110.981 177.122 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . 0.504 ' N ' ' HG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.481 1.637 0 CA-C-O 119.503 -0.61 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 2.8 p -152.73 101.8 2.65 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.648 1.179 . . . . 0.0 112.398 -177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -61.36 -34.95 76.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.33 1.452 . . . . 0.0 113.074 -178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -65.65 -16.91 64.19 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -78.0 -17.01 57.62 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.046 0.938 . . . . 0.0 113.245 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -64.73 140.27 58.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.762 0.825 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.04 176.77 8.55 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.963 1.705 . . . . 0.0 110.702 178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -114.32 30.2 7.47 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.779 1.631 . . . . 0.0 112.979 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.5 19.17 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 127.772 2.429 . . . . 0.0 116.068 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -63.48 -28.04 69.69 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.483 1.513 . . . . 0.0 113.059 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -73.64 -30.21 62.81 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.9 t -90.15 -23.84 21.22 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.305 1.042 . . . . 0.0 112.275 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -60.92 147.78 41.98 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.403 -0.811 . . . . 0.0 112.1 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -93.67 174.38 7.22 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.06 0.944 . . . . 0.0 112.022 178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.6 p -140.58 159.27 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.278 1.431 . . . . 0.0 110.766 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 89.3 t -61.95 -38.33 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.133 -0.979 . . . . 0.0 112.014 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -55.63 -30.31 60.72 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.203 1.001 . . . . 0.0 112.877 175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -71.87 -61.05 1.92 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.763 0.825 . . . . 0.0 110.75 172.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.537 HG13 HD22 ' B' ' 199' ' ' LEU . 77.9 t -54.06 -41.63 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 124.873 1.269 . . . . 0.0 113.124 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -62.3 -8.74 6.31 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.772 1.629 . . . . 0.0 113.715 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -106.17 -39.51 5.93 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.846 1.658 . . . . 0.0 112.588 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.7 -43.32 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 119.282 0.947 . . . . 0.0 110.533 173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.34 -42.59 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.56 -51.34 57.59 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.957 1.253 . . . . 0.0 110.98 178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -33.57 74.87 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.0 61.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.974 0.91 . . . . 0.0 113.069 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.459 ' HA ' HG21 ' B' ' 191' ' ' VAL . 60.5 mt -59.83 -58.77 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 119.393 0.997 . . . . 0.0 109.645 173.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -63.04 -29.69 71.01 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -175.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.5 t -59.35 -50.57 73.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.466 1.106 . . . . 0.0 112.067 167.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.02 -31.79 72.89 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 91.5 mt -62.68 -35.46 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 124.41 1.084 . . . . 0.0 111.628 173.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.22 13.51 81.81 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 124.055 0.836 . . . . 0.0 114.777 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 99.17 3.3 56.75 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.14 1.353 . . . . 0.0 115.873 175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -64.49 164.93 10.72 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.23 1.515 . . . . 0.0 111.646 169.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.82 -178.56 4.32 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.925 -1.109 . . . . 0.0 111.995 175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -51.63 139.07 21.55 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.677 -0.639 . . . . 0.0 110.908 166.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -123.87 -179.81 4.53 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.714 1.206 . . . . 0.0 111.01 -175.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 23.6 m170 -96.47 -99.15 0.18 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.531 0.732 . . . . 0.0 109.998 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 49.1 m -66.62 -23.15 66.13 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.729 -1.232 . . . . 0.0 114.157 177.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.7 -38.89 72.92 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.163 0.985 . . . . 0.0 112.552 176.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 45.2 t -54.82 -33.47 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.604 1.162 . . . . 0.0 112.512 174.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 57.9 m-20 -66.74 -45.66 77.92 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.616 0.766 . . . . 0.0 111.553 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -67.06 -26.06 66.56 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.639 -0.663 . . . . 0.0 112.667 173.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -77.14 -53.14 8.13 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.797 0.726 . . . . 0.0 111.322 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.0 t -56.03 -31.95 63.59 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.479 0.581 . . . . 0.0 112.508 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 9.4 t -77.68 -59.81 2.63 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 119.361 0.982 . . . . 0.0 112.633 170.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -56.63 -38.59 72.31 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.305 1.442 . . . . 0.0 113.698 -174.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.459 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.6 t -68.54 -63.45 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 123.854 0.861 . . . . 0.0 109.997 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.82 -30.57 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.741 1.217 . . . . 0.0 110.702 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -57.49 -45.72 84.56 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.685 0.794 . . . . 0.0 112.727 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 27.4 mm100 -98.77 -39.47 8.62 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.194 1.397 . . . . 0.0 112.766 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 26.9 m -58.48 -52.17 66.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.294 2.238 . . . . 0.0 112.147 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -38.21 86.64 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 122.669 0.388 . . . . 0.0 111.179 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.7 t -63.12 -43.87 97.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.368 -0.832 . . . . 0.0 112.347 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -61.77 -48.92 78.47 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.826 2.05 . . . . 0.0 112.939 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.537 HD22 HG13 ' B' ' 162' ' ' VAL . 4.4 pp -69.45 -25.63 64.19 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.9 m -60.73 -30.6 70.08 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.934 -0.479 . . . . 0.0 110.599 166.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -81.56 -29.58 33.38 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.554 -0.716 . . . . 0.0 112.505 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.86 -17.73 63.38 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.602 1.161 . . . . 0.0 112.953 174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -109.92 -100.13 2.6 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.867 1.698 . . . . 0.0 113.767 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . 0.516 ' HB3' HD13 ' B' ' 258' ' ' ILE . 0.1 OUTLIER -142.65 155.23 63.53 Favored Pre-proline 0 N--CA 1.476 0.848 0 C-N-CA 125.837 1.655 . . . . 0.0 112.001 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -71.63 109.34 2.61 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 111.574 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . 0.451 ' CD1' HD11 ' B' ' 258' ' ' ILE . 1.7 t80 -147.37 169.92 18.44 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.181 0.993 . . . . 0.0 112.471 173.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -71.46 120.17 16.67 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.271 0.628 . . . . 0.0 110.388 169.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -106.67 163.63 12.75 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.821 1.249 . . . . 0.0 110.647 166.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . 0.482 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.2 tt -147.44 155.26 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 C-N-CA 126.335 1.854 . . . . 0.0 108.708 172.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' B' ' 253' ' ' ALA . 4.2 m -140.05 151.13 21.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.984 0.914 . . . . 0.0 110.314 168.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.08 129.59 27.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.871 2.069 . . . . 0.0 108.921 173.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.2 p -132.44 148.41 52.4 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.165 -0.96 . . . . 0.0 112.532 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 15.6 t -136.15 115.08 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 125.071 1.349 . . . . 0.0 108.93 -172.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.427 HD12 ' CB ' ' B' ' 249' ' ' CYS . 3.0 mm -112.7 94.58 3.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.595 1.958 . . . . 0.0 107.538 -172.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 9.1 ptm -132.14 150.27 52.2 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.289 1.436 . . . . 0.0 111.757 -170.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -88.01 140.18 29.76 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.292 0.637 . . . . 0.0 112.312 -172.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.94 -9.23 58.43 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -64.98 -30.68 71.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.326 1.851 . . . . 0.0 114.485 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.65 29.97 5.4 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 124.229 0.918 . . . . 0.0 115.343 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -66.4 176.24 1.92 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 118.29 1.045 . . . . 0.0 111.941 163.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 59.24 1.28 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.233 1.873 . . . . 0.0 116.253 -173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.96 99.14 8.3 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.242 1.817 . . . . 0.0 110.457 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -113.48 132.01 55.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.262 1.425 . . . . 0.0 110.209 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.456 ' HB ' HG13 ' B' ' 278' ' ' VAL . 28.7 m -140.77 147.21 38.74 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.713 0.805 . . . . 0.0 110.172 176.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.67 147.9 33.6 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.476 0.655 . . . . 0.0 111.538 174.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 97.3 p -148.15 134.78 19.84 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 123.236 0.614 . . . . 0.0 111.529 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 29.8 m -80.9 19.15 0.89 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 173.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' A' ' 66' ' ' ILE . 56.6 m -68.24 165.13 19.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.557 1.143 . . . . 0.0 112.172 172.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -162.84 140.7 8.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.539 1.536 . . . . 0.0 110.568 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 150.22 40.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.329 0.652 . . . . 0.0 110.429 171.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -139.99 151.08 45.2 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.697 1.599 . . . . 0.0 110.6 171.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.5 t -108.59 -66.42 1.05 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.148 0.979 . . . . 0.0 111.594 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 58.1 p -89.76 -26.46 20.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.815 0.846 . . . . 0.0 112.998 -178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.9 m -77.59 -45.14 26.12 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.366 1.866 . . . . 0.0 112.92 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -148.95 -174.17 4.56 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 128.112 2.565 . . . . 0.0 110.802 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -127.68 125.58 5.24 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.656 1.598 . . . . 0.0 113.358 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.72 125.82 12.91 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.375 1.47 . . . . 0.0 111.235 -175.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.8 p -122.06 112.26 18.02 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.409 1.484 . . . . 0.0 112.244 -170.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.8 t -124.67 148.5 47.94 Favored 'General case' 0 N--CA 1.482 1.129 0 O-C-N 120.401 -1.437 . . . . 0.0 112.32 -173.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.59 136.46 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.682 1.593 . . . . 0.0 109.82 -170.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -130.8 99.22 4.86 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.381 1.472 . . . . 0.0 112.176 -169.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.1 m95 -108.24 124.44 50.3 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.88 1.272 . . . . 0.0 110.01 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -87.36 158.86 18.93 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.062 0.945 . . . . 0.0 110.836 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -129.91 -176.71 4.01 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.744 1.618 . . . . 0.0 110.728 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.8 -51.51 55.9 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.672 1.989 . . . . 0.0 113.394 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.6 t -138.77 -2.89 1.69 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 125.402 1.481 . . . . 0.0 113.855 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 13.8 ptp -127.87 -175.85 3.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.801 2.04 . . . . 0.0 110.726 174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -141.41 158.33 44.0 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.093 0.957 . . . . 0.0 111.543 172.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.427 ' CB ' HD12 ' B' ' 214' ' ' ILE . 3.8 p -130.81 93.14 3.35 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.79 1.636 . . . . 0.0 110.452 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.64 136.35 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.224 1.01 . . . . 0.0 111.095 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 4.4 p -129.75 138.07 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.162 1.785 . . . . 0.0 110.249 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 14.1 t -128.68 123.07 32.2 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.082 1.353 . . . . 0.0 109.986 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -108.65 150.4 27.58 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.49 1.116 . . . . 0.0 111.423 173.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -128.19 105.55 8.44 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 125.876 1.67 . . . . 0.0 108.042 176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -137.48 94.71 0.22 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 126.22 1.867 . . . . 0.0 109.838 -171.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.48 ' H ' HD22 ' B' ' 256' ' ' LEU . 1.6 mm? -68.57 163.88 22.61 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.088 0.955 . . . . 0.0 111.679 -175.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 15.3 t -125.86 129.81 50.11 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.853 1.261 . . . . 0.0 112.099 -174.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . 0.516 HD13 ' HB3' ' B' ' 204' ' ' LYS . 1.7 mp -76.67 -57.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.134 1.774 . . . . 0.0 109.632 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.33 -25.82 74.67 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-O 119.693 -0.504 . . . . 0.0 112.976 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.34 25.46 68.49 Favored Glycine 0 CA--C 1.537 1.427 0 CA-C-N 118.284 1.042 . . . . 0.0 114.267 175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -57.14 149.97 29.97 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.785 1.183 . . . . 0.0 113.754 -175.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 88.2 p -69.31 177.51 2.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.877 1.271 . . . . 0.0 113.447 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 116.65 19.3 5.39 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.897 1.237 . . . . 0.0 114.147 -172.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 26.3 mm100 -58.56 177.74 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.53 1.532 . . . . 0.0 112.263 172.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.04 -18.72 15.27 Favored 'General case' 0 N--CA 1.481 1.075 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 177.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 139.62 -73.13 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 126.18 1.847 . . . . 0.0 112.082 175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.33 156.93 63.04 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.026 2.484 . . . . 0.0 112.416 177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 24.8 pt -110.46 148.76 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.853 1.661 . . . . 0.0 110.657 174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 138.82 48.74 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.757 1.223 . . . . 0.0 110.844 -177.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 54.4 mt -135.24 121.62 20.43 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.956 1.702 . . . . 0.0 109.497 -172.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.93 -175.03 28.37 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.034 1.302 . . . . 0.0 113.581 -173.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 8.0 ttm -81.53 -177.71 6.64 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.095 1.358 . . . . 0.0 112.437 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.94 175.21 9.57 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.1 1.76 . . . . 0.0 112.414 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 23.3 mmmt -121.85 168.33 11.98 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.93 1.692 . . . . 0.0 112.091 -177.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 26.7 mm -71.61 147.95 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 125.389 1.475 . . . . 0.0 110.651 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 80.4 m -114.79 91.75 3.72 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.35 1.46 . . . . 0.0 110.375 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -91.03 148.78 22.15 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.147 0.979 . . . . 0.0 110.792 168.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.456 HG13 ' HB ' ' B' ' 224' ' ' THR . 1.4 p -142.11 104.37 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 126.902 2.081 . . . . 0.0 109.653 178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -135.7 153.87 51.45 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.401 1.48 . . . . 0.0 112.214 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -74.92 150.14 85.84 Favored Pre-proline 0 CA--C 1.551 1.011 0 O-C-N 121.729 -0.607 . . . . 0.0 111.527 175.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.76 159.37 50.92 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.273 2.649 . . . . 0.0 112.564 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.23 -49.22 2.78 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.195 2.597 . . . . 0.0 113.334 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -159.4 -53.97 0.06 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.743 1.617 . . . . 0.0 111.919 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.96 171.09 11.4 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 125.176 1.39 . . . . 0.0 112.27 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.68 168.54 19.51 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 C-N-CA 125.835 1.654 . . . . 0.0 111.802 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.15 0 C-N-CA 126.033 1.733 . . . . 0.0 110.921 177.112 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.626 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -61.14 115.4 3.75 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.851 1.66 . . . . 0.0 112.445 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ttt -66.9 -40.8 87.83 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.513 -0.742 . . . . 0.0 112.093 179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -15.82 63.82 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.55 -23.29 67.22 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.471 1.109 . . . . 0.0 113.111 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -129.86 168.52 16.48 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.7 2.0 . . . . 0.0 111.39 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -155.87 166.9 32.09 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.245 -0.909 . . . . 0.0 112.72 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.81 51.07 1.05 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.847 1.659 . . . . 0.0 112.571 -176.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.14 0.37 4.82 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.407 1.483 . . . . 0.0 114.969 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.31 -24.33 7.31 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.081 2.152 . . . . 0.0 115.124 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -18.02 18.32 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.72 1.608 . . . . 0.0 114.818 172.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 t -61.68 -32.85 73.06 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.632 1.173 . . . . 0.0 112.712 172.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.09 140.24 37.91 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.356 -0.84 . . . . 0.0 111.127 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -69.96 175.8 4.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.747 0.819 . . . . 0.0 111.899 170.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.17 146.68 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.8 1.24 . . . . 0.0 110.769 171.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.54 -39.31 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.154 0.982 . . . . 0.0 111.458 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -60.83 -28.82 69.09 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.767 1.227 . . . . 0.0 113.222 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -75.26 -58.49 3.25 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.558 1.143 . . . . 0.0 110.837 171.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 84.9 t -52.26 -41.16 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 124.485 1.114 . . . . 0.0 112.424 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.3 t -62.92 -17.4 61.72 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.255 1.422 . . . . 0.0 113.934 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -97.97 -35.16 10.55 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.767 1.627 . . . . 0.0 113.259 172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.8 mt -50.41 -41.63 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.203 1.001 . . . . 0.0 110.684 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.59 -40.76 90.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -52.35 56.42 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.857 1.208 . . . . 0.0 111.058 176.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -33.01 73.51 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.89 -42.44 57.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.615 0.766 . . . . 0.0 112.984 176.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.5 mt -60.57 -56.95 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 118.99 0.813 . . . . 0.0 109.828 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.12 -30.89 70.64 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -176.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.3 t -59.84 -49.65 76.86 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.56 1.144 . . . . 0.0 112.238 168.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.21 77.42 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.075 0.95 . . . . 0.0 113.507 174.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 89.6 mt -64.9 -37.02 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 124.866 1.266 . . . . 0.0 111.613 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.37 17.59 74.46 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.145 0.878 . . . . 0.0 114.599 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.46 16.11 78.58 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 124.694 1.14 . . . . 0.0 115.576 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -57.62 156.55 8.22 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 118.927 1.364 . . . . 0.0 113.138 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -175.63 1.03 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.413 1.485 . . . . 0.0 112.352 172.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -47.99 146.75 2.37 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.64 1.576 . . . . 0.0 113.424 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -136.74 178.5 7.02 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.067 1.347 . . . . 0.0 112.24 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -95.37 -118.12 0.11 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.454 1.501 . . . . 0.0 110.45 169.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.8 p -66.75 0.47 2.36 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.885 2.074 . . . . 0.0 115.91 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -50.52 -44.36 56.15 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 119.844 1.202 . . . . 0.0 112.761 174.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.2 t -55.92 -34.05 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.6 t30 -67.03 -51.61 52.62 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.451 1.023 . . . . 0.0 112.411 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.73 -25.65 68.02 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.49 -0.756 . . . . 0.0 112.42 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.64 -56.08 4.93 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.713 1.205 . . . . 0.0 111.629 176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.5 t -60.34 -22.59 63.42 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -81.94 -60.19 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.375 0.989 . . . . 0.0 111.905 166.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -56.3 -39.26 72.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 120.01 1.277 . . . . 0.0 113.905 -173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.5 t -68.19 -64.56 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.695 0 C-N-CA 124.147 0.979 . . . . 0.0 110.022 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 85.7 t -47.77 -30.17 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.957 1.303 . . . . 0.0 110.993 176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.86 -42.83 85.33 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.955 0.902 . . . . 0.0 112.87 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -101.78 -39.77 7.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.002 1.321 . . . . 0.0 112.611 177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.7 m -57.64 -53.17 61.24 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 127.425 2.29 . . . . 0.0 112.598 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -37.11 80.3 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.571 0.623 . . . . 0.0 111.333 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.6 m -65.15 -37.06 86.2 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 170.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -69.21 -52.12 31.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 126.163 1.785 . . . . 0.0 112.965 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.06 -26.46 68.57 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 120.858 -1.151 . . . . 0.0 113.7 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.6 m -57.48 -31.96 66.49 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.629 1.171 . . . . 0.0 111.387 167.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 mmmm -88.81 -25.53 22.17 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.17 -16.79 63.71 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.065 0.946 . . . . 0.0 113.26 173.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.02 -112.61 3.36 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.658 1.599 . . . . 0.0 112.77 171.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -132.67 152.11 79.33 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 125.422 1.489 . . . . 0.0 113.492 -174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.06 104.14 1.48 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 124.44 3.426 . . . . 0.0 112.275 -178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -142.81 177.9 8.02 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.297 1.839 . . . . 0.0 112.216 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.1 tttt -100.19 75.91 1.86 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.625 1.57 . . . . 0.0 111.35 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -67.05 147.12 53.59 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 126.142 1.777 . . . . 0.0 111.009 175.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.664 HD11 ' SG ' ' B' ' 228' ' ' CYS . 0.7 OUTLIER -130.89 156.04 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 125.384 1.474 . . . . 0.0 109.756 170.442 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 m -135.69 158.58 39.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 C-N-CA 123.491 0.716 . . . . 0.0 109.976 161.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.53 131.97 32.52 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 125.744 1.617 . . . . 0.0 108.973 164.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 28.5 p -124.92 150.33 46.68 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.743 0.817 . . . . 0.0 110.834 167.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.0 p -125.34 117.88 50.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 C-N-CA 124.284 1.034 . . . . 0.0 108.247 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.417 HD12 ' CB ' ' A' ' 106' ' ' CYS . 3.6 mm -114.91 120.95 65.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 125.528 1.531 . . . . 0.0 107.71 -177.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -144.45 139.74 28.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.61 0.719 . . . . 0.0 111.319 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -145.79 106.73 4.14 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.463 1.905 . . . . 0.0 109.424 177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tptt -146.72 -58.57 0.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.754 0.821 . . . . 0.0 112.567 172.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -122.52 -9.96 8.44 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.286 1.434 . . . . 0.0 113.767 -176.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.0 -3.85 55.95 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.315 1.435 . . . . 0.0 114.908 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.38 165.99 21.27 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 171.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.84 156.06 52.33 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 123.53 0.586 . . . . 0.0 113.966 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -106.05 178.95 4.41 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.556 1.942 . . . . 0.0 111.354 169.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.15 92.73 3.79 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.141 1.377 . . . . 0.0 109.791 175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.565 ' HB ' HG13 ' A' ' 135' ' ' VAL . 18.7 m -108.88 147.24 32.45 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 120.687 -1.258 . . . . 0.0 108.871 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.63 146.18 32.15 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.232 -0.918 . . . . 0.0 112.194 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.8 p -143.16 143.12 31.67 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.971 0.908 . . . . 0.0 112.883 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 16.0 t -78.39 12.13 2.1 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 172.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.576 ' SG ' HD11 ' B' ' 209' ' ' ILE . 12.5 m -62.71 173.03 1.4 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.093 0.957 . . . . 0.0 112.394 168.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -161.63 157.1 24.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.689 1.995 . . . . 0.0 110.082 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -78.11 146.95 34.87 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.42 -0.8 . . . . 0.0 110.626 172.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.15 158.54 43.06 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.666 1.586 . . . . 0.0 111.577 173.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.8 t -134.47 -57.29 0.84 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.202 1.401 . . . . 0.0 112.479 178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.1 m -84.24 -36.81 22.45 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.946 0.899 . . . . 0.0 112.09 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.4 -46.86 59.17 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.743 1.617 . . . . 0.0 112.719 -172.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -148.07 -167.97 2.95 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 127.768 2.427 . . . . 0.0 109.923 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.43 156.06 15.88 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 124.297 0.951 . . . . 0.0 113.835 167.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -145.75 169.62 18.15 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.983 1.713 . . . . 0.0 112.243 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.3 t -166.35 158.17 13.63 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.073 1.749 . . . . 0.0 110.292 167.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.6 t -150.32 146.78 26.96 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 119.534 -1.979 . . . . 0.0 111.261 174.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -138.7 95.14 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 125.266 1.426 . . . . 0.0 110.661 -166.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -86.79 116.08 24.64 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.099 1.76 . . . . 0.0 112.366 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -126.39 113.62 17.12 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.725 1.61 . . . . 0.0 110.231 173.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -100.3 170.56 8.35 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.58 1.552 . . . . 0.0 112.599 170.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -155.6 -170.92 3.59 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.888 1.275 . . . . 0.0 112.482 175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -42.92 -58.57 2.34 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.301 2.24 . . . . 0.0 114.16 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t -136.05 -29.59 1.0 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.817 1.647 . . . . 0.0 113.099 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.5 ptm -77.57 149.8 34.81 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.925 0.89 . . . . 0.0 111.586 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -136.36 141.16 43.7 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.533 1.533 . . . . 0.0 109.585 170.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.417 ' CB ' HD12 ' A' ' 71' ' ' ILE . 1.7 p -144.24 71.92 1.33 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.835 1.254 . . . . 0.0 111.695 -169.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.94 142.04 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 O-C-N 121.319 -0.863 . . . . 0.0 111.588 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 15.1 t -121.61 142.91 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 126.639 1.975 . . . . 0.0 110.335 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -138.78 122.87 17.97 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.889 1.675 . . . . 0.0 109.553 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -126.3 142.67 51.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.07 1.748 . . . . 0.0 113.586 -172.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -140.67 125.83 18.55 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.073 0.949 . . . . 0.0 111.263 -178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -112.85 70.33 0.22 Allowed Glycine 0 CA--C 1.525 0.671 0 C-N-CA 127.378 2.418 . . . . 0.0 111.394 -175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -64.64 128.91 37.78 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.119 0.968 . . . . 0.0 111.287 -175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 73.7 m -141.52 92.63 2.48 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.141 1.776 . . . . 0.0 111.779 -161.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.573 ' H ' HD13 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -87.95 1.62 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.887 1.675 . . . . 0.0 114.97 -174.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.47 -5.24 77.22 Favored Glycine 0 CA--C 1.539 1.59 0 N-CA-C 116.295 1.278 . . . . 0.0 116.295 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.1 1.28 61.29 Favored Glycine 0 CA--C 1.539 1.573 0 CA-C-N 118.833 1.317 . . . . 0.0 116.254 172.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -147.99 91.06 0.14 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.267 1.413 . . . . 0.0 112.791 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.8 m -118.04 103.5 9.96 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.323 1.449 . . . . 0.0 110.689 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 69.32 -15.77 0.76 Allowed Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.776 1.655 . . . . 0.0 115.861 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -133.98 169.15 17.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 128.103 2.561 . . . . 0.0 111.022 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.6 t -116.41 -14.56 10.97 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.939 1.696 . . . . 0.0 113.637 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -72.57 -175.59 27.46 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 175.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -64.47 151.31 86.02 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.022 2.481 . . . . 0.0 111.893 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 41.7 pt -123.01 147.27 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.129 1.372 . . . . 0.0 110.993 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.5 164.57 37.33 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.676 1.59 . . . . 0.0 112.077 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 33.3 mt -76.59 118.63 19.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.589 1.556 . . . . 0.0 109.83 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -98.4 -159.18 29.99 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.108 1.813 . . . . 0.0 113.055 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.82 93.13 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.844 0.858 . . . . 0.0 111.062 169.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -126.93 98.14 5.23 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.606 1.963 . . . . 0.0 110.764 -174.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -129.22 167.11 18.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.805 1.242 . . . . 0.0 111.687 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.4 mm -51.08 132.08 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 127.239 2.215 . . . . 0.0 111.243 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 51.6 m -99.82 95.85 7.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.345 1.458 . . . . 0.0 109.928 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.64 148.39 30.27 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.377 -0.827 . . . . 0.0 111.141 166.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 81' ' ' THR . 1.5 p -131.98 89.1 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 127.803 2.441 . . . . 0.0 109.049 173.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -134.63 166.16 23.55 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.25 1.42 . . . . 0.0 111.714 176.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -126.33 156.08 73.12 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.273 1.429 . . . . 0.0 111.048 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.13 161.88 44.04 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 123.257 2.638 . . . . 0.0 112.69 -177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -66.55 -53.18 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 123.357 2.704 . . . . 0.0 112.854 -176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.7 tpt85 -160.19 -61.04 0.06 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.399 1.48 . . . . 0.0 111.514 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -100.88 176.19 5.37 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.797 2.039 . . . . 0.0 111.602 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.91 141.17 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 121.319 -0.863 . . . . 0.0 111.881 170.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.475 1.91 . . . . 0.0 112.306 -178.174 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 3.1 p -60.26 115.54 3.58 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.935 1.694 . . . . 0.0 112.488 174.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.7 ttt -66.98 -40.6 87.47 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 121.505 -0.747 . . . . 0.0 112.136 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -15.78 63.8 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -176.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -23.39 67.27 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.518 1.127 . . . . 0.0 113.118 176.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -129.78 168.52 16.42 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.596 1.958 . . . . 0.0 111.381 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -155.9 166.79 32.43 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.21 -0.931 . . . . 0.0 112.713 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -97.6 51.14 1.06 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.763 1.625 . . . . 0.0 112.531 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.21 0.33 5.0 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.439 1.496 . . . . 0.0 114.945 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -52.44 -24.16 7.39 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 127.007 2.123 . . . . 0.0 115.201 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -17.77 16.55 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.722 1.609 . . . . 0.0 114.838 172.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 6.0 t -61.81 -32.34 72.63 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.722 1.209 . . . . 0.0 112.93 172.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -79.76 144.3 33.73 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.242 -0.911 . . . . 0.0 111.473 174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.33 173.41 10.27 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.577 0.751 . . . . 0.0 112.116 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 94.5 t -123.97 142.49 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.63 1.572 . . . . 0.0 109.726 174.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.11 -41.79 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.86 0.864 . . . . 0.0 111.552 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.06 -35.29 66.77 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.7 1.6 . . . . 0.0 113.348 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -72.6 -58.92 3.0 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.788 1.235 . . . . 0.0 110.746 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 80.8 t -52.19 -40.77 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.502 1.121 . . . . 0.0 112.383 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 13.8 t -63.63 -17.82 63.29 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 113.982 175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.37 -35.24 11.26 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.491 1.517 . . . . 0.0 113.192 172.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.4 mt -50.66 -41.35 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.104 0.961 . . . . 0.0 110.712 174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -63.86 -40.68 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 O-C-N 121.322 -0.861 . . . . 0.0 113.322 178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -52.33 57.29 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.831 1.196 . . . . 0.0 110.982 176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -33.0 73.6 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.84 -42.23 58.38 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.402 ' HA ' HG21 ' B' ' 191' ' ' VAL . 66.1 mt -60.61 -56.89 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 119.106 0.866 . . . . 0.0 109.786 173.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.2 -30.89 70.69 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -175.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 45.0 t -59.75 -49.75 76.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.631 1.172 . . . . 0.0 112.24 168.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.25 77.49 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.88 -36.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.879 1.272 . . . . 0.0 111.55 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 70.43 17.57 74.57 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.111 0.862 . . . . 0.0 114.588 -177.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 79.53 16.0 78.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.705 1.145 . . . . 0.0 115.595 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -57.63 156.66 8.07 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.914 1.357 . . . . 0.0 113.101 173.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.5 -175.52 1.05 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.43 1.492 . . . . 0.0 112.256 172.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -48.1 146.97 2.34 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.584 1.553 . . . . 0.0 113.395 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -136.95 178.39 7.12 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.084 1.353 . . . . 0.0 112.276 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 22.5 m-70 -95.46 -117.66 0.11 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.403 1.481 . . . . 0.0 110.492 169.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 58.5 p -66.76 0.39 2.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.855 2.062 . . . . 0.0 115.957 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 16.1 mmtt -50.86 -44.58 59.63 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 119.793 1.179 . . . . 0.0 112.779 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 14.2 t -56.35 -34.02 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 112.991 0.738 . . . . 0.0 112.991 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -66.7 -51.55 54.71 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.453 1.024 . . . . 0.0 112.403 173.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -64.86 -25.63 67.98 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.517 -0.739 . . . . 0.0 112.507 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -76.88 -55.91 5.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.612 1.165 . . . . 0.0 111.547 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 5.3 t -60.26 -22.1 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.7 t -82.55 -60.41 2.2 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 119.233 0.924 . . . . 0.0 111.909 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -55.92 -39.09 71.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.974 1.261 . . . . 0.0 113.905 -173.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' B' ' 170' ' ' ILE . 97.2 t -68.33 -64.51 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.702 0 C-N-CA 124.198 0.999 . . . . 0.0 110.04 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 95.4 t -47.52 -30.49 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.999 1.319 . . . . 0.0 111.004 176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.88 -42.22 84.14 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.072 0.949 . . . . 0.0 112.778 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -102.95 -38.68 7.26 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.215 1.406 . . . . 0.0 112.781 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.9 m -58.97 -52.85 64.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.33 2.252 . . . . 0.0 112.624 178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -36.04 79.8 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 118.553 0.615 . . . . 0.0 111.561 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 10.1 m -60.34 -49.77 76.29 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.478 0.711 . . . . 0.0 112.327 167.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -60.14 -51.73 68.34 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.91 1.684 . . . . 0.0 113.56 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -65.04 -26.08 68.11 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 37.1 m -58.89 -34.2 71.39 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.615 0.766 . . . . 0.0 110.952 167.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -84.75 -24.69 28.7 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 8.5 mt -69.72 -15.45 63.16 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.657 1.183 . . . . 0.0 113.302 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -113.05 -113.17 3.16 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.666 1.603 . . . . 0.0 112.762 172.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -130.76 153.17 81.53 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 125.774 1.63 . . . . 0.0 112.959 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.89 98.79 0.92 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.198 3.266 . . . . 0.0 112.193 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -140.01 165.84 26.25 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.225 1.41 . . . . 0.0 112.91 175.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -84.75 78.54 9.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.912 1.685 . . . . 0.0 111.644 -171.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -59.5 156.32 13.43 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.88 1.272 . . . . 0.0 112.365 172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . 0.576 HD11 ' SG ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -144.13 155.96 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.185 1.794 . . . . 0.0 108.949 165.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 4.9 m -138.91 160.16 29.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 123.842 0.857 . . . . 0.0 109.596 162.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.3 141.5 39.8 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 109.766 164.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 28.7 p -136.74 148.71 47.43 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.103 0.961 . . . . 0.0 111.41 171.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.87 104.83 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.899 1.28 . . . . 0.0 108.12 -176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.458 HG23 ' HB3' ' B' ' 249' ' ' CYS . 3.7 mm -101.38 109.48 25.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 C-N-CA 125.543 1.537 . . . . 0.0 108.266 -178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 4.5 tpt -134.57 136.79 43.25 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.926 0.87 . . . . 0.0 112.322 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -143.17 100.26 3.6 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.986 2.114 . . . . 0.0 109.347 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 9.5 tptt -143.03 -63.92 0.41 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.521 0.728 . . . . 0.0 111.981 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -109.5 -22.48 11.98 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.991 1.316 . . . . 0.0 113.439 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.9 -9.59 76.36 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 125.651 1.596 . . . . 0.0 115.03 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -143.98 81.88 1.7 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.027 1.731 . . . . 0.0 110.762 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 176.9 88.61 0.07 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.016 0.817 . . . . 0.0 112.797 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.68 124.84 7.42 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.755 1.622 . . . . 0.0 109.489 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -122.44 88.21 2.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.755 1.622 . . . . 0.0 109.101 175.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.697 ' HB ' HG13 ' B' ' 278' ' ' VAL . 88.5 m -106.34 144.43 33.04 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 120.541 -1.35 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.33 133.42 27.78 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.37 -0.831 . . . . 0.0 112.177 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.0 p -134.03 144.58 48.77 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.021 0.928 . . . . 0.0 113.015 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 15.6 t -78.91 12.3 2.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.87 0.692 . . . . 0.0 112.87 172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . 0.664 ' SG ' HD11 ' A' ' 66' ' ' ILE . 19.1 m -63.22 172.74 1.74 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.176 -0.952 . . . . 0.0 112.518 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -162.42 158.15 23.47 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.725 2.01 . . . . 0.0 110.128 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.1 t-105 -76.36 139.8 41.14 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.5 -0.75 . . . . 0.0 110.506 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -145.22 153.36 41.25 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.391 1.476 . . . . 0.0 111.859 169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 25.8 t -128.74 -59.75 1.12 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.745 1.618 . . . . 0.0 112.499 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 31.0 m -83.37 -37.24 23.59 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.872 0.869 . . . . 0.0 111.867 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -51.72 43.64 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.856 1.662 . . . . 0.0 112.023 -174.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -148.01 -171.13 3.75 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 127.732 2.413 . . . . 0.0 109.791 177.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.54 154.4 16.53 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.308 0.956 . . . . 0.0 114.176 171.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 85.7 p -144.75 168.45 20.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 126.24 1.816 . . . . 0.0 112.068 177.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.6 t -166.23 157.62 13.4 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.043 1.737 . . . . 0.0 110.185 168.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.1 t -150.05 146.53 27.01 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 119.368 -2.082 . . . . 0.0 111.37 174.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.41 92.82 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 125.205 1.402 . . . . 0.0 110.611 -166.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -84.73 115.02 22.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.107 1.763 . . . . 0.0 112.32 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -124.63 117.26 23.87 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.474 1.51 . . . . 0.0 110.006 172.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -103.05 170.73 7.79 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.719 1.607 . . . . 0.0 112.425 171.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.75 -173.66 4.58 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.896 1.278 . . . . 0.0 112.191 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.2 mmtp -40.16 -58.36 1.49 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 127.422 2.289 . . . . 0.0 114.031 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.2 t -136.39 -20.95 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.816 1.647 . . . . 0.0 113.341 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 21.9 ptm -90.18 132.93 35.21 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.871 1.268 . . . . 0.0 111.699 175.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -113.22 131.9 55.71 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.124 1.37 . . . . 0.0 109.873 172.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.458 ' HB3' HG23 ' B' ' 214' ' ' ILE . 1.6 p -137.95 68.13 1.41 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.593 1.557 . . . . 0.0 111.941 -172.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pp -85.36 138.27 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.122 0.969 . . . . 0.0 111.949 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.95 144.57 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.822 2.049 . . . . 0.0 110.421 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.0 t -139.32 122.61 17.05 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.001 1.72 . . . . 0.0 109.781 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -125.62 143.07 51.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.974 1.71 . . . . 0.0 113.625 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -140.48 126.3 19.35 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.993 0.917 . . . . 0.0 111.103 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.62 70.06 0.22 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.915 2.198 . . . . 0.0 110.881 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -64.45 130.46 43.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.104 0.962 . . . . 0.0 111.227 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 71.0 m -142.39 100.51 3.71 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.251 1.82 . . . . 0.0 111.512 -162.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . 0.506 ' H ' HD13 ' B' ' 258' ' ' ILE . 0.2 OUTLIER -96.25 2.18 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.881 1.672 . . . . 0.0 114.551 -174.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -76.0 -5.28 79.89 Favored Glycine 0 CA--C 1.539 1.549 0 N-CA-C 116.242 1.257 . . . . 0.0 116.242 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.82 60.21 Favored Glycine 0 CA--C 1.539 1.585 0 CA-C-N 118.796 1.298 . . . . 0.0 116.293 172.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -148.35 91.86 0.15 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.215 1.388 . . . . 0.0 112.794 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 20.1 m -119.46 103.21 9.25 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.316 1.447 . . . . 0.0 110.804 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 69.49 -15.93 0.79 Allowed Glycine 0 CA--C 1.541 1.714 0 C-N-CA 125.726 1.631 . . . . 0.0 115.755 -177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -134.05 168.66 18.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 128.164 2.586 . . . . 0.0 110.981 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 10.1 t -114.24 -14.43 12.28 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.922 1.689 . . . . 0.0 113.563 177.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -74.6 -177.27 38.06 Favored Glycine 0 CA--C 1.542 1.78 0 C-N-CA 125.657 1.599 . . . . 0.0 114.26 176.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -67.04 139.85 52.37 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.535 2.823 . . . . 0.0 112.568 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 43.5 pt -108.05 147.23 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.794 1.238 . . . . 0.0 111.263 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.85 169.44 19.8 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.67 1.588 . . . . 0.0 111.97 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 33.5 mt -83.97 110.36 18.36 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.336 1.455 . . . . 0.0 109.909 172.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -89.62 -160.37 36.42 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 126.262 1.887 . . . . 0.0 113.152 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.79 97.91 0.11 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.962 0.905 . . . . 0.0 111.097 170.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.29 97.68 4.19 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.295 1.838 . . . . 0.0 111.126 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -130.26 167.26 18.75 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.831 1.252 . . . . 0.0 111.883 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -50.2 133.64 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 127.402 2.281 . . . . 0.0 111.354 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 55.3 m -101.74 91.0 4.21 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.395 1.478 . . . . 0.0 109.697 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -77.76 148.14 34.98 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.439 -0.788 . . . . 0.0 110.739 162.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' B' ' 224' ' ' THR . 4.0 p -137.68 92.54 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 127.187 2.195 . . . . 0.0 108.816 174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -134.55 165.54 24.97 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.441 1.896 . . . . 0.0 111.548 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.79 155.69 57.02 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.02 1.328 . . . . 0.0 111.509 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -69.0 162.13 42.98 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.399 2.733 . . . . 0.0 112.447 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.45 -52.56 0.77 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.254 2.636 . . . . 0.0 112.834 -176.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.2 tpt85 -160.89 -60.41 0.06 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.378 1.471 . . . . 0.0 111.462 175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -102.48 174.37 5.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.931 2.092 . . . . 0.0 111.19 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.03 134.33 29.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 125.073 1.349 . . . . 0.0 110.388 175.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.253 1.281 0 C-N-CA 126.339 1.856 . . . . 0.0 112.492 -177.587 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.518 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.4 m -72.89 8.22 1.64 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 126.057 1.743 . . . . 0.0 115.327 -177.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.97 -0.74 2.5 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.441 1.897 . . . . 0.0 114.339 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.59 -33.92 56.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.774 2.029 . . . . 0.0 114.915 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -90.09 -18.91 25.01 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.566 1.146 . . . . 0.0 113.148 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -93.57 -172.36 2.88 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.631 1.972 . . . . 0.0 111.593 175.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.91 -172.19 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.475 1.91 . . . . 0.0 110.112 175.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -51.58 118.16 3.15 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.959 0.904 . . . . 0.0 111.605 167.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.67 55.53 0.85 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.798 1.639 . . . . 0.0 112.879 -176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -28.29 64.2 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.827 -1.171 . . . . 0.0 113.589 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.99 -25.77 67.82 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.934 1.694 . . . . 0.0 115.389 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -103.13 -25.39 13.41 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.008 0.923 . . . . 0.0 112.199 173.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.58 124.44 19.04 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.439 1.096 . . . . 0.0 112.808 -178.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -66.89 171.56 5.25 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.662 1.585 . . . . 0.0 112.78 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -110.81 147.97 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.638 1.575 . . . . 0.0 111.362 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 84.8 t -60.9 -40.2 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.26 1.024 . . . . 0.0 111.877 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -59.4 -32.54 70.27 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.855 1.262 . . . . 0.0 113.12 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -71.65 -55.92 6.81 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.411 1.084 . . . . 0.0 110.294 173.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -49.15 -43.85 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.834 1.254 . . . . 0.0 112.794 176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -63.92 -6.32 5.87 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.305 1.442 . . . . 0.0 114.167 176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -113.17 -34.28 5.73 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.152 2.181 . . . . 0.0 112.313 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -43.06 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.041 1.337 . . . . 0.0 110.586 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.0 p -59.82 -43.16 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 O-C-N 121.45 -0.781 . . . . 0.0 112.883 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.39 -52.04 50.88 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.363 0.983 . . . . 0.0 111.675 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -31.85 72.3 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.95 -40.43 63.06 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.014 0.926 . . . . 0.0 113.193 174.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.45 ' HA ' HG21 ' A' ' 48' ' ' VAL . 58.2 mt -58.05 -55.44 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.244 0.929 . . . . 0.0 109.972 173.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.07 -30.84 70.57 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 t -61.21 -43.23 99.21 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.892 0.877 . . . . 0.0 112.396 170.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.34 -36.37 79.16 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.272 1.029 . . . . 0.0 113.479 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.0 mt -64.61 -42.05 94.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.385 1.074 . . . . 0.0 110.996 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.87 14.11 57.96 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.837 1.208 . . . . 0.0 115.218 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 66.3 22.93 71.42 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.658 1.123 . . . . 0.0 114.656 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -66.24 -177.55 0.54 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 125.005 1.322 . . . . 0.0 112.434 175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -49.25 141.43 8.54 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.836 1.254 . . . . 0.0 112.714 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -66.57 104.9 1.37 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.774 1.229 . . . . 0.0 110.929 -177.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.2 mm-40 -124.15 114.94 20.33 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 126.019 1.727 . . . . 0.0 110.797 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -77.47 -57.52 3.78 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.862 0.865 . . . . 0.0 112.603 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.1 m -57.57 -25.13 59.53 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.373 -1.455 . . . . 0.0 114.06 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -57.99 -30.57 66.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 170.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.6 t -52.85 -34.06 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.359 0.981 . . . . 0.0 111.851 177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -64.34 -50.99 65.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.641 1.176 . . . . 0.0 112.641 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -66.81 -28.06 68.06 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.272 -0.893 . . . . 0.0 112.721 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.0 m0 -75.95 -54.56 6.69 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.673 0.789 . . . . 0.0 111.214 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 t -58.43 -26.1 62.93 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.579 0.751 . . . . 0.0 112.76 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.4 t -83.56 -54.23 5.09 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 119.217 0.917 . . . . 0.0 112.961 169.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -58.76 -38.73 79.1 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.916 1.235 . . . . 0.0 113.344 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.45 HG21 ' HA ' ' A' ' 27' ' ' ILE . 71.8 t -68.66 -63.71 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.945 0 C-N-CA 124.035 0.934 . . . . 0.0 109.833 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 97.2 t -49.39 -29.86 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 124.895 1.278 . . . . 0.0 111.175 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -58.42 -46.51 86.33 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -95.31 -41.15 9.17 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.835 1.254 . . . . 0.0 112.541 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.8 m -52.92 -55.97 19.37 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 127.552 2.341 . . . . 0.0 112.463 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD12 ' CG ' ' A' ' 65' ' ' TYR . 0.0 OUTLIER -62.23 -37.32 84.91 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 118.161 0.437 . . . . 0.0 110.984 -178.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 t -60.82 -46.53 90.17 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 112.515 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -60.18 -49.92 75.73 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.653 1.981 . . . . 0.0 113.015 178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.57 -28.33 66.86 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.9 m -58.95 -27.54 65.44 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.884 0.874 . . . . 0.0 111.72 165.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.9 mmtm -87.87 -23.31 24.01 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.55 -15.19 63.22 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.07 -99.86 0.21 Allowed Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.678 0.656 . . . . 0.0 113.795 172.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.4 pttt -94.31 109.47 42.88 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.663 1.185 . . . . 0.0 112.87 -172.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.77 103.12 1.7 Allowed 'Trans proline' 0 CA--C 1.546 1.112 0 C-N-CA 123.322 2.681 . . . . 0.0 112.968 -175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -141.78 163.41 32.97 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.796 1.638 . . . . 0.0 113.733 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -68.61 101.9 1.38 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 126.068 1.747 . . . . 0.0 112.204 174.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.461 ' CG ' HD12 ' A' ' 53' ' ' LEU . 54.4 p90 -81.43 173.52 12.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.689 1.596 . . . . 0.0 112.107 164.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.459 HD11 ' SG ' ' B' ' 228' ' ' CYS . 2.6 tt -142.39 154.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 126.375 1.87 . . . . 0.0 109.464 162.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.55 HG12 ' HB2' ' A' ' 110' ' ' ALA . 10.4 m -143.49 145.31 22.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 C-N-CA 125.997 1.719 . . . . 0.0 109.658 175.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 t -142.75 155.9 44.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.472 1.109 . . . . 0.0 110.192 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.4 p -148.29 156.43 42.52 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.041 0.937 . . . . 0.0 112.938 170.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -130.86 132.15 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.506 1.522 . . . . 0.0 109.223 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.4 mm -110.51 111.33 35.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 127.324 2.25 . . . . 0.0 107.532 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 12.1 ttt -117.05 154.12 31.52 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.13 0.972 . . . . 0.0 111.392 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.52 153.08 20.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.823 1.249 . . . . 0.0 111.964 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.4 ttmm -60.77 -16.35 39.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.775 1.63 . . . . 0.0 114.546 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -58.37 -26.99 63.8 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.043 1.337 . . . . 0.0 112.788 169.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.52 27.1 72.95 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 124.146 0.879 . . . . 0.0 114.598 175.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.66 151.68 10.5 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.569 1.147 . . . . 0.0 113.527 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.8 102.95 1.04 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 124.522 1.058 . . . . 0.0 114.173 -172.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 pp -143.6 147.61 34.63 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 128.11 2.564 . . . . 0.0 109.549 179.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -134.65 132.28 38.76 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.416 ' HB ' HG13 ' A' ' 135' ' ' VAL . 48.4 m -133.28 139.15 46.75 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.243 1.017 . . . . 0.0 109.886 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.75 124.05 12.28 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.537 0.735 . . . . 0.0 110.933 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.9 p -130.51 137.98 50.0 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.792 0.806 . . . . 0.0 111.649 177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.4 m -81.41 13.64 2.88 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.454 -0.779 . . . . 0.0 112.69 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.591 ' SG ' HD11 ' B' ' 209' ' ' ILE . 8.2 m -60.07 161.46 6.79 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 122.006 0.908 . . . . 0.0 111.92 169.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -157.53 136.57 11.69 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.717 1.607 . . . . 0.0 109.539 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 163.87 27.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 122.718 0.407 . . . . 0.0 111.098 172.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -140.02 155.31 47.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.423 1.089 . . . . 0.0 111.508 168.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -118.28 -63.34 1.43 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.889 2.076 . . . . 0.0 111.753 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -109.63 -28.94 8.6 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.315 1.446 . . . . 0.0 112.173 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.72 -42.73 85.84 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.708 2.403 . . . . 0.0 112.994 174.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -158.93 -175.59 5.38 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.864 1.665 . . . . 0.0 112.185 -175.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.73 153.26 20.86 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.628 1.109 . . . . 0.0 114.185 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.8 t -163.27 163.17 25.45 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.424 1.89 . . . . 0.0 110.554 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 8.1 p -167.91 149.79 5.47 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.984 1.714 . . . . 0.0 111.327 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.7 t -145.33 144.46 30.73 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.116 -1.615 . . . . 0.0 111.679 -175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.7 t -143.29 126.31 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.112 1.365 . . . . 0.0 110.604 -161.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 2.8 ptt85 -127.83 122.44 32.65 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.857 1.263 . . . . 0.0 112.861 -170.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -133.49 104.41 6.38 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.786 1.634 . . . . 0.0 110.293 -174.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.59 168.05 9.94 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.941 -1.1 . . . . 0.0 112.394 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -145.29 -176.18 5.0 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.781 0.832 . . . . 0.0 112.548 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp -49.84 -51.89 36.67 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 125.944 1.698 . . . . 0.0 113.874 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.4 t -132.95 -47.27 0.86 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.552 1.541 . . . . 0.0 112.056 174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.7 ptp -67.08 170.83 6.3 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.587 0.755 . . . . 0.0 112.411 169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -146.11 147.46 31.58 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.5 1.52 . . . . 0.0 109.557 171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 28.9 p -128.26 143.6 51.04 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.244 1.021 . . . . 0.0 112.606 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.37 119.85 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 125.584 1.554 . . . . 0.0 110.102 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.5 t -104.99 136.52 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 125.828 1.651 . . . . 0.0 109.571 177.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.9 t -131.26 123.58 28.69 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.87 0.868 . . . . 0.0 110.601 174.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.55 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -109.68 149.56 29.56 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.858 1.663 . . . . 0.0 111.791 178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -141.31 152.32 44.36 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.832 1.253 . . . . 0.0 110.657 177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.09 85.41 0.23 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.837 1.208 . . . . 0.0 112.074 -175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.29 121.4 33.76 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.353 1.461 . . . . 0.0 111.675 -172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.7 m -148.73 117.84 6.79 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.546 1.138 . . . . 0.0 113.174 -169.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -22.4 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.945 2.098 . . . . 0.0 115.623 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.86 -16.47 78.17 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.334 0.968 . . . . 0.0 114.604 -177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.95 13.26 56.9 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 124.687 1.136 . . . . 0.0 115.262 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -78.57 66.58 3.26 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.756 1.646 . . . . 0.0 113.37 -174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.4 m -133.98 176.17 8.81 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 127.185 2.194 . . . . 0.0 111.733 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.76 2.57 28.75 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.891 1.234 . . . . 0.0 115.214 -176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 -68.06 47.59 0.05 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 127.021 2.128 . . . . 0.0 113.62 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.2 p -149.48 -15.23 0.28 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 175.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 132.23 -167.04 23.1 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.33 1.443 . . . . 0.0 112.405 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -69.25 174.67 8.73 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.413 2.742 . . . . 0.0 112.159 174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.79 96.13 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.76 1.624 . . . . 0.0 113.027 176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 166.16 11.68 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.014 0.926 . . . . 0.0 112.723 171.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.8 mt -66.06 126.42 28.57 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.515 1.126 . . . . 0.0 110.96 176.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 157.44 92.77 0.09 OUTLIER Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.022 0.82 . . . . 0.0 113.056 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.3 ttm -64.04 159.73 19.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.725 1.21 . . . . 0.0 112.48 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -117.29 91.83 3.68 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.501 1.52 . . . . 0.0 112.042 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -130.81 177.6 7.29 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.448 1.499 . . . . 0.0 112.007 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 37.4 mm -51.6 138.13 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 126.908 2.083 . . . . 0.0 111.313 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.6 m -107.42 91.93 3.86 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.579 1.552 . . . . 0.0 110.818 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -93.19 148.82 21.69 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.326 -0.859 . . . . 0.0 111.294 171.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.416 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -144.31 115.47 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 127.022 2.129 . . . . 0.0 109.833 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -140.86 133.72 29.04 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.48 1.512 . . . . 0.0 111.157 -176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -134.26 97.87 14.48 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.172 1.789 . . . . 0.0 109.698 175.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -74.12 162.69 38.31 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 123.123 2.548 . . . . 0.0 111.894 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.42 -50.22 2.82 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.433 2.755 . . . . 0.0 113.111 -176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.56 -69.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.292 1.837 . . . . 0.0 109.766 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.54 167.8 8.35 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.85 2.06 . . . . 0.0 112.28 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.423 ' H ' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -110.21 160.48 9.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 124.95 1.3 . . . . 0.0 112.247 -179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 C--O 1.252 1.231 0 C-N-CA 127.003 2.121 . . . . 0.0 110.65 -179.476 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 20.0 m -72.96 9.54 1.14 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.471 1.909 . . . . 0.0 115.521 -175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.15 -0.61 2.57 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.239 1.816 . . . . 0.0 114.39 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -53.61 -34.11 57.32 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.903 2.081 . . . . 0.0 114.763 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -89.88 -19.14 24.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.528 1.131 . . . . 0.0 113.144 176.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -93.12 -172.27 2.92 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.567 1.947 . . . . 0.0 111.628 175.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.04 -172.03 3.68 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.388 1.875 . . . . 0.0 110.092 175.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -51.5 117.4 2.62 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.942 0.897 . . . . 0.0 111.53 167.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.79 55.35 0.87 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.757 1.623 . . . . 0.0 112.822 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.91 -29.2 62.83 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.873 -1.142 . . . . 0.0 113.535 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -61.03 -21.66 63.82 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.086 1.754 . . . . 0.0 115.601 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.4 t -112.9 -20.62 11.51 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.872 1.269 . . . . 0.0 112.639 174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.51 118.76 8.0 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 121.114 -0.991 . . . . 0.0 112.302 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -79.01 161.17 26.81 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 114.004 1.112 . . . . 0.0 114.004 -174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.7 p -99.46 144.29 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.101 1.361 . . . . 0.0 112.897 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 95.6 t -59.32 -41.47 84.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.881 1.672 . . . . 0.0 112.232 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -59.37 -31.84 69.59 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.589 1.156 . . . . 0.0 113.178 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.87 -55.66 5.42 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.798 0.839 . . . . 0.0 110.274 174.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 58.2 t -44.72 -46.03 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 126.158 1.783 . . . . 0.0 112.842 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -63.95 -7.03 7.1 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.732 1.613 . . . . 0.0 114.429 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -111.03 -33.66 6.43 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.569 2.348 . . . . 0.0 112.196 175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 30.2 mt -50.14 -42.65 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.043 1.337 . . . . 0.0 110.644 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 7.0 p -59.45 -43.79 91.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.343 -0.848 . . . . 0.0 112.929 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -52.36 50.01 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.358 0.981 . . . . 0.0 111.519 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.79 -31.76 72.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.98 -40.71 62.78 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.124 0.97 . . . . 0.0 113.313 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.431 ' HA ' HG21 ' B' ' 191' ' ' VAL . 56.4 mt -57.49 -55.33 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 119.158 0.89 . . . . 0.0 109.88 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -61.08 -31.08 70.75 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 18.0 t -61.17 -42.95 99.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.858 0.863 . . . . 0.0 112.354 170.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.07 -36.31 77.5 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.264 1.025 . . . . 0.0 113.586 174.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 90.1 mt -64.25 -42.43 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 124.38 1.072 . . . . 0.0 110.88 173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.91 58.21 Favored Glycine 0 CA--C 1.537 1.46 0 C-N-CA 124.982 1.277 . . . . 0.0 115.173 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 65.74 23.39 70.71 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.585 1.088 . . . . 0.0 114.598 -173.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -66.12 -177.18 0.48 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.043 1.337 . . . . 0.0 112.488 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -48.76 141.75 7.01 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.722 1.209 . . . . 0.0 112.571 177.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -66.93 101.47 0.85 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.566 1.146 . . . . 0.0 110.862 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -117.8 114.44 23.29 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 126.081 1.753 . . . . 0.0 110.542 -171.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 24.9 m80 -74.15 -64.37 1.03 Allowed 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.372 1.069 . . . . 0.0 112.546 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 50.9 m -56.63 -23.74 43.32 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 114.946 1.461 . . . . 0.0 114.946 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -55.24 -28.79 55.75 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 170.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -54.7 -31.09 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 119.479 1.036 . . . . 0.0 112.89 178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -65.34 -50.34 66.0 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.828 1.251 . . . . 0.0 112.207 175.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -66.91 -26.85 67.06 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.401 -0.812 . . . . 0.0 112.661 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -77.39 -53.95 7.04 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 123.818 0.847 . . . . 0.0 111.592 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.1 t -56.72 -28.49 61.1 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 118.588 0.631 . . . . 0.0 112.592 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 3.8 t -82.43 -55.81 4.27 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.341 0.973 . . . . 0.0 112.816 171.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -59.53 -39.27 83.37 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 120.078 1.308 . . . . 0.0 113.281 -175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' B' ' 170' ' ' ILE . 79.2 t -68.36 -63.91 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 C-N-CA 123.706 0.803 . . . . 0.0 109.625 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 96.2 t -49.9 -29.62 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -58.89 -46.94 86.67 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 118.599 0.636 . . . . 0.0 112.43 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -93.87 -40.2 10.29 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.756 1.222 . . . . 0.0 112.771 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 5.4 m -54.71 -56.03 23.51 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 127.746 2.418 . . . . 0.0 112.42 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.37 -37.07 79.57 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.112 0.414 . . . . 0.0 110.602 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.6 t -62.41 -47.71 82.94 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 121.217 -0.927 . . . . 0.0 112.557 169.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.0 tt0 -56.81 -47.35 80.45 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.871 1.668 . . . . 0.0 113.001 177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.2 pp -75.24 -18.93 59.99 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.506 1.299 . . . . 0.0 114.506 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 89.1 m -61.69 -40.31 94.55 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 121.613 -0.679 . . . . 0.0 110.26 157.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.4 mmtm -75.25 -19.58 59.65 Favored 'General case' 0 N--CA 1.484 1.26 0 O-C-N 120.874 -1.142 . . . . 0.0 113.896 -176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 10.5 mt -59.07 -20.23 51.43 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . 168.21 -54.07 0.22 Allowed Glycine 0 CA--C 1.53 1.017 0 CA-C-N 119.724 1.147 . . . . 0.0 115.554 175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -57.96 156.5 19.2 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 127.367 2.267 . . . . 0.0 113.735 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -74.18 160.17 42.9 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.985 2.457 . . . . 0.0 113.278 -174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.28 93.71 3.46 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.955 0.902 . . . . 0.0 113.003 -178.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -165.41 85.26 0.37 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.024 1.33 . . . . 0.0 114.217 172.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -139.3 158.78 43.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.782 1.233 . . . . 0.0 112.194 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . 0.591 HD11 ' SG ' ' A' ' 85' ' ' CYS . 5.3 tt -138.57 156.39 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 127.112 2.165 . . . . 0.0 109.356 171.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' B' ' 253' ' ' ALA . 4.3 m -142.05 147.75 21.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.432 1.893 . . . . 0.0 110.054 173.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 14.6 t -143.02 154.55 44.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.72 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.1 p -145.73 157.46 43.94 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.35 1.06 . . . . 0.0 112.504 171.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 26.3 t -134.18 136.06 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.172 1.389 . . . . 0.0 109.141 176.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.6 mm -108.95 108.82 26.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 C-N-CA 127.365 2.266 . . . . 0.0 106.9 175.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 62.0 mtt -107.82 158.95 16.89 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.603 1.161 . . . . 0.0 110.848 175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -119.14 150.87 39.31 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.882 1.273 . . . . 0.0 110.933 -174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -59.61 -17.11 30.54 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.694 1.598 . . . . 0.0 114.882 -172.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -59.58 -30.0 68.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.376 1.471 . . . . 0.0 112.955 169.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 57.42 42.54 93.83 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.25 1.405 . . . . 0.0 114.405 176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -60.33 175.63 0.42 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.528 1.531 . . . . 0.0 114.258 -176.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -69.35 91.26 0.3 Allowed Glycine 0 CA--C 1.539 1.582 0 O-C-N 120.571 -1.331 . . . . 0.0 114.424 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.81 118.35 13.89 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.149 1.78 . . . . 0.0 113.122 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -114.12 133.04 55.83 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.694 0.798 . . . . 0.0 110.076 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.472 ' HB ' HG13 ' B' ' 278' ' ' VAL . 50.5 m -135.47 141.89 45.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.876 0.87 . . . . 0.0 110.283 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -144.13 128.62 18.0 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.352 0.661 . . . . 0.0 110.855 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.5 p -132.6 139.43 47.78 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.669 0.747 . . . . 0.0 111.509 175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 49.0 m -82.46 12.5 4.47 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.562 -0.711 . . . . 0.0 112.605 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . 0.459 ' SG ' HD11 ' A' ' 66' ' ' ILE . 4.3 m -60.7 161.65 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.988 0.899 . . . . 0.0 111.895 170.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -158.73 139.36 12.64 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.481 1.513 . . . . 0.0 109.582 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . 0.408 ' CZ2' ' HB2' ' B' ' 232' ' ' SER . 0.0 OUTLIER -72.41 161.63 30.57 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.834 171.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -137.98 149.74 46.37 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.722 1.209 . . . . 0.0 110.319 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . 0.408 ' HB2' ' CZ2' ' B' ' 230' ' ' TRP . 1.8 t -112.05 -63.27 1.45 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.785 2.034 . . . . 0.0 112.125 -176.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 8.5 t -109.82 -26.18 9.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.442 1.497 . . . . 0.0 112.237 -175.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -41.41 75.07 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 128.627 2.771 . . . . 0.0 113.193 175.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -159.54 -173.89 4.37 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.912 2.085 . . . . 0.0 110.589 -172.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -98.86 158.57 20.2 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.437 1.017 . . . . 0.0 114.078 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 8.3 t -166.44 163.21 17.28 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.114 1.766 . . . . 0.0 110.621 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 8.2 p -169.57 141.45 2.38 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 126.2 1.8 . . . . 0.0 111.091 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 10.1 t -142.59 146.75 34.89 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 119.955 -1.716 . . . . 0.0 111.949 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -141.3 146.43 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 124.884 1.273 . . . . 0.0 110.353 -168.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -137.79 126.77 24.18 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.524 1.13 . . . . 0.0 112.544 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 16.1 m95 -135.86 102.38 5.04 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.753 1.621 . . . . 0.0 109.984 -174.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.51 164.84 13.23 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 120.983 -1.073 . . . . 0.0 112.242 170.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -141.71 -177.62 5.27 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.407 1.083 . . . . 0.0 111.691 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -47.81 -51.43 22.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 126.295 1.838 . . . . 0.0 114.088 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 11.1 t -132.05 -48.33 0.93 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.532 1.533 . . . . 0.0 111.996 175.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -66.74 173.96 3.19 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.076 0.95 . . . . 0.0 112.655 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -147.62 146.32 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.381 1.472 . . . . 0.0 109.829 172.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.5 p -127.49 143.04 51.24 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 122.055 0.931 . . . . 0.0 112.424 178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -135.08 127.88 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.628 1.571 . . . . 0.0 109.56 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.24 123.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 125.378 1.471 . . . . 0.0 110.16 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 10.2 t -119.53 115.6 24.36 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.149 0.979 . . . . 0.0 110.116 -177.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.561 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -97.38 153.78 17.87 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.795 1.238 . . . . 0.0 111.826 173.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -142.05 149.77 40.37 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.345 1.458 . . . . 0.0 110.091 177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -135.08 80.55 0.31 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 124.972 1.272 . . . . 0.0 113.003 -171.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.21 108.09 20.74 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.635 1.174 . . . . 0.0 112.087 -167.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.46 120.38 21.86 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.56 1.944 . . . . 0.0 113.172 -170.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -21.66 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 125.947 1.699 . . . . 0.0 115.517 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -74.87 -14.98 81.13 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.273 0.94 . . . . 0.0 114.762 -176.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 65.01 13.09 56.88 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 124.711 1.148 . . . . 0.0 115.324 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -80.4 61.33 4.44 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.77 1.653 . . . . 0.0 113.88 -171.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.75 -179.83 5.62 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.067 1.747 . . . . 0.0 112.475 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 110.07 5.16 29.01 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.037 1.303 . . . . 0.0 115.275 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 61.6 mm-40 -66.32 34.6 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 127.997 2.519 . . . . 0.0 114.932 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 18.7 p -139.0 -13.69 1.2 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 131.21 -167.09 22.57 Favored Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.077 1.322 . . . . 0.0 112.842 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -69.5 174.4 9.33 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.539 2.826 . . . . 0.0 112.312 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.15 96.35 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 125.718 1.607 . . . . 0.0 113.057 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.08 166.57 11.43 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.251 -0.906 . . . . 0.0 112.753 171.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 44.4 mt -66.06 126.68 29.39 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.641 1.176 . . . . 0.0 110.897 176.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 157.36 92.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.01 0.814 . . . . 0.0 113.199 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 4.5 ttm -63.43 160.89 15.3 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 124.763 1.225 . . . . 0.0 112.595 177.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -118.52 91.37 3.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.799 1.639 . . . . 0.0 112.092 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -131.14 177.94 7.07 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.427 1.491 . . . . 0.0 112.087 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.1 mm -51.69 140.62 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 126.991 2.116 . . . . 0.0 111.354 174.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 71.6 m -110.93 91.84 3.82 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.589 1.555 . . . . 0.0 110.702 -177.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -94.77 149.38 21.31 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.428 -0.795 . . . . 0.0 111.323 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.472 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.9 p -149.32 118.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.04 1.736 . . . . 0.0 110.907 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -142.87 138.14 30.06 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.764 1.625 . . . . 0.0 110.663 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -130.91 94.57 28.01 Favored Pre-proline 0 CA--C 1.542 0.643 0 C-N-CA 126.145 1.778 . . . . 0.0 109.373 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.16 160.01 48.37 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 122.574 2.182 . . . . 0.0 112.015 178.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -62.24 -51.43 3.55 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.786 2.991 . . . . 0.0 113.344 -176.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 -68.92 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.215 1.806 . . . . 0.0 109.46 174.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -65.53 168.19 7.77 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.879 2.072 . . . . 0.0 112.339 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . 0.428 ' H ' HD13 ' B' ' 285' ' ' ILE . 0.2 OUTLIER -110.51 160.46 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.981 1.312 . . . . 0.0 112.141 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 C--O 1.253 1.285 0 C-N-CA 127.089 2.156 . . . . 0.0 110.745 -179.57 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 CA-C-O 121.286 0.381 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.1 m -81.51 37.23 0.45 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.726 2.01 . . . . 0.0 115.387 -165.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.7 mtt -59.1 -24.63 63.12 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 120.619 -1.301 . . . . 0.0 114.125 -178.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -62.16 -13.73 30.22 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 174.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -71.08 -27.36 63.56 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.307 -0.871 . . . . 0.0 112.931 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -82.86 158.85 22.54 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.613 1.165 . . . . 0.0 112.05 168.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -148.27 161.73 40.92 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.966 1.306 . . . . 0.0 111.459 176.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -115.34 165.65 12.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.894 1.678 . . . . 0.0 112.141 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.74 79.61 2.69 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.714 1.205 . . . . 0.0 112.383 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.68 -22.04 64.97 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 120.734 -1.229 . . . . 0.0 113.496 175.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -70.02 -24.39 63.27 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 t -98.81 -24.04 15.15 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.334 1.054 . . . . 0.0 113.014 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.57 159.07 30.56 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 121.243 -0.91 . . . . 0.0 112.071 172.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -69.16 166.07 19.08 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.463 0.705 . . . . 0.0 112.239 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -135.53 159.57 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 124.714 1.206 . . . . 0.0 111.729 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.08 -38.33 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.439 1.096 . . . . 0.0 112.608 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.91 -27.97 68.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.859 1.264 . . . . 0.0 113.042 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -76.34 -56.41 4.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.711 0.804 . . . . 0.0 110.801 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.3 t -52.49 -39.59 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 125.157 1.383 . . . . 0.0 112.615 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.5 m -59.18 -15.06 12.73 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 125.612 1.565 . . . . 0.0 114.276 174.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -108.58 -35.49 6.44 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.327 1.851 . . . . 0.0 112.786 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mt -51.32 -42.9 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.459 1.027 . . . . 0.0 110.581 171.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.2 p -58.84 -43.41 88.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 O-C-N 121.598 -0.689 . . . . 0.0 112.53 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.98 -54.02 31.43 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.605 1.093 . . . . 0.0 111.405 177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.33 -34.68 75.66 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.0 -41.23 62.19 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.667 0.787 . . . . 0.0 112.811 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.423 ' HA ' HG21 ' A' ' 48' ' ' VAL . 60.0 mt -60.23 -57.03 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 119.113 0.869 . . . . 0.0 109.885 173.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.74 -31.75 71.06 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 t -58.84 -50.4 74.13 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.441 1.096 . . . . 0.0 112.182 168.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.63 -33.22 75.39 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.7 mt -62.15 -37.72 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.836 1.254 . . . . 0.0 111.337 172.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.86 16.96 78.16 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.071 0.843 . . . . 0.0 114.54 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.9 8.49 72.67 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.172 1.368 . . . . 0.0 116.001 178.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -56.78 150.74 15.56 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 118.934 1.367 . . . . 0.0 113.747 174.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.69 -175.77 3.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.168 1.787 . . . . 0.0 112.197 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -37.39 136.1 0.5 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 129.046 2.939 . . . . 0.0 114.995 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -134.94 174.5 10.53 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.519 1.528 . . . . 0.0 112.968 -177.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -88.06 -93.06 0.1 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.4 1.48 . . . . 0.0 112.201 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.1 p -98.99 4.9 47.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 127.332 2.253 . . . . 0.0 113.398 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -50.76 -43.76 58.45 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.019 -1.051 . . . . 0.0 112.689 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 47.4 t -52.21 -35.17 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.392 1.077 . . . . 0.0 112.687 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -67.81 -49.64 61.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 0.0 112.532 175.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -66.14 -26.78 67.6 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.092 -1.005 . . . . 0.0 112.576 174.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 48.4 m0 -75.23 -55.75 5.4 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.814 1.246 . . . . 0.0 111.182 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.2 t -58.38 -23.5 57.2 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 118.549 -0.739 . . . . 0.0 112.99 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 t -85.1 -54.98 4.28 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 119.793 1.179 . . . . 0.0 112.368 169.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 26.3 t30 -57.78 -35.63 71.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 119.922 1.237 . . . . 0.0 113.782 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 27' ' ' ILE . 96.1 t -75.15 -67.33 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.751 0 C-N-CA 124.318 1.047 . . . . 0.0 109.688 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.13 -28.42 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.695 1.198 . . . . 0.0 111.226 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -52.22 -57.86 8.38 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.698 0.799 . . . . 0.0 112.908 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -90.61 -39.81 12.29 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.545 1.138 . . . . 0.0 112.396 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.7 m -57.2 -53.93 52.53 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.122 2.169 . . . . 0.0 112.514 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -60.99 -37.99 84.44 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 118.71 0.686 . . . . 0.0 111.722 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -63.24 -40.28 96.98 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.389 0.676 . . . . 0.0 112.379 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -66.95 -50.77 61.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.528 1.931 . . . . 0.0 113.189 177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.3 pp -67.46 -24.1 65.57 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 53.5 m -59.2 -30.42 68.2 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.218 1.007 . . . . 0.0 111.262 165.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -90.6 -22.71 21.1 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.7 mt -64.51 -15.22 60.5 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.42 -126.51 1.57 Allowed Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.713 1.149 . . . . 0.0 112.442 169.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 61' ' ' LYS . 5.3 mmpt? -55.78 112.09 3.89 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.957 1.703 . . . . 0.0 112.957 -176.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.53 108.98 2.75 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.441 2.761 . . . . 0.0 111.748 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -144.56 179.81 7.04 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.446 1.898 . . . . 0.0 111.005 175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -90.88 128.14 36.64 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.225 -0.922 . . . . 0.0 110.264 166.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.424 ' CE2' ' HA3' ' A' ' 112' ' ' GLY . 24.0 m-85 -113.88 145.43 41.48 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.907 1.683 . . . . 0.0 108.847 176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.6 tt -122.75 153.65 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 C-N-CA 124.232 1.013 . . . . 0.0 110.045 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.51 151.79 28.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.49 1.916 . . . . 0.0 109.032 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -132.63 138.69 47.44 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.051 1.74 . . . . 0.0 108.46 166.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 31.1 p -138.88 138.45 37.44 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 171.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.3 t -120.02 126.79 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.342 1.457 . . . . 0.0 108.911 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.0 mm -117.64 94.66 3.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 C-N-CA 127.358 2.263 . . . . 0.0 107.442 -170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.61 107.84 12.44 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.728 1.611 . . . . 0.0 110.642 -168.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -66.65 135.2 53.73 Favored 'General case' 0 CA--C 1.543 0.695 0 O-C-N 121.318 -0.864 . . . . 0.0 112.198 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 -8.4 2.94 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.093 1.757 . . . . 0.0 115.498 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.33 -16.8 49.69 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.079 2.152 . . . . 0.0 113.773 177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 130.68 -3.04 5.72 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.068 1.318 . . . . 0.0 115.761 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 45.71 0.28 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.824 1.65 . . . . 0.0 113.974 -176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.82 161.6 33.52 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.914 1.245 . . . . 0.0 113.394 177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.732 HD13 HD11 ' B' ' 222' ' ' LEU . 1.6 pt? -151.82 -171.66 4.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.595 1.558 . . . . 0.0 112.085 -172.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.96 138.11 41.68 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.401 0.546 . . . . 0.0 111.149 168.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.7 m -142.76 144.68 32.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.336 1.454 . . . . 0.0 110.12 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.34 144.19 31.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.294 1.038 . . . . 0.0 111.172 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.8 p -145.88 140.7 27.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.015 0.912 . . . . 0.0 112.264 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.2 t -78.87 23.33 0.34 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.28 1.032 . . . . 0.0 112.584 176.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.9 m -67.07 171.19 5.82 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.304 -0.873 . . . . 0.0 111.648 165.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -163.44 149.74 11.92 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.741 2.416 . . . . 0.0 108.557 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.2 t-105 -81.26 134.96 35.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 119.07 0.85 . . . . 0.0 109.594 171.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -158.38 127.23 5.53 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.771 1.229 . . . . 0.0 111.564 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -113.8 -31.96 6.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.597 1.559 . . . . 0.0 112.161 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 5.0 p -80.1 -38.46 31.6 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 125.803 1.641 . . . . 0.0 112.556 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -82.92 -53.75 5.61 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.068 1.347 . . . . 0.0 112.405 -171.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -139.99 -161.27 1.17 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.927 2.491 . . . . 0.0 109.567 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.82 153.5 16.93 Favored Glycine 0 CA--C 1.536 1.4 0 O-C-N 120.831 -1.168 . . . . 0.0 113.754 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 p -155.62 154.83 32.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.729 1.612 . . . . 0.0 111.259 170.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 34.1 t -153.58 97.54 2.13 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.707 1.203 . . . . 0.0 111.797 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.7 t -90.04 146.19 24.53 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.03 -1.044 . . . . 0.0 112.268 175.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 19.6 t -139.68 131.68 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.037 1.735 . . . . 0.0 109.265 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 ppt_? -119.79 128.7 53.96 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.525 1.53 . . . . 0.0 110.736 -177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -131.81 159.76 37.57 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.205 1.402 . . . . 0.0 110.089 175.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -137.5 144.68 42.32 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 121.201 -0.937 . . . . 0.0 111.0 -175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -117.31 -173.01 2.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.75 1.22 . . . . 0.0 109.318 -165.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -48.6 70.14 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 120.953 -1.092 . . . . 0.0 113.667 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 t -140.73 -17.82 0.86 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.908 2.083 . . . . 0.0 113.129 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 12.0 mtm -91.28 170.37 10.05 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.669 1.587 . . . . 0.0 111.09 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -138.02 161.17 37.41 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.874 0.869 . . . . 0.0 110.73 163.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.0 p -141.62 136.44 30.98 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.049 0.94 . . . . 0.0 111.301 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.2 119.45 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.869 1.268 . . . . 0.0 109.982 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.19 129.6 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.924 1.289 . . . . 0.0 110.661 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -121.47 106.86 11.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.274 0.63 . . . . 0.0 111.745 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.81 138.84 33.04 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -129.15 126.06 38.43 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.844 1.658 . . . . 0.0 110.335 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' A' ' 65' ' ' TYR . . . -126.17 73.65 0.43 Allowed Glycine 0 CA--C 1.524 0.61 0 C-N-CA 126.782 2.134 . . . . 0.0 111.671 -171.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -63.42 123.11 17.9 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.964 1.306 . . . . 0.0 110.081 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.4 t -146.81 83.58 1.59 Allowed 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.894 1.677 . . . . 0.0 111.54 -162.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -78.09 -2.9 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -172.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.23 2.73 88.04 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.397 1.475 . . . . 0.0 116.325 -174.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 78.11 20.39 72.88 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-N 119.173 1.486 . . . . 0.0 115.049 178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -74.18 -176.88 35.86 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.342 1.449 . . . . 0.0 114.579 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.2 t -76.19 -172.65 2.13 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.554 1.142 . . . . 0.0 113.474 176.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 125.56 6.46 6.11 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 126.8 2.143 . . . . 0.0 113.89 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -123.28 172.08 8.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.456 1.902 . . . . 0.0 113.741 -168.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.3 t -118.78 2.28 11.62 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.439 1.496 . . . . 0.0 113.872 -172.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.27 -169.49 41.05 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.905 1.717 . . . . 0.0 112.285 -174.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.62 169.66 13.97 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.442 2.761 . . . . 0.0 112.351 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.5 pp -59.1 125.71 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.796 0.839 . . . . 0.0 111.631 176.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.39 155.92 39.6 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.712 2.005 . . . . 0.0 111.719 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.6 mt -76.24 149.57 37.16 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.32 1.048 . . . . 0.0 110.957 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 173.59 176.65 42.22 Favored Glycine 0 CA--C 1.534 1.262 0 O-C-N 121.427 -0.796 . . . . 0.0 115.021 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.4 mtt -86.8 145.7 26.52 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.378 1.471 . . . . 0.0 112.928 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -153.7 93.78 1.71 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.021 1.728 . . . . 0.0 111.257 173.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -130.95 174.8 9.64 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.07 1.348 . . . . 0.0 111.833 176.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 36.2 mm -52.52 136.56 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 126.476 1.91 . . . . 0.0 111.418 176.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 85.0 m -94.74 96.42 9.37 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.288 1.435 . . . . 0.0 110.411 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -95.52 145.93 24.83 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.944 -1.097 . . . . 0.0 111.015 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.65 118.37 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 127.207 2.203 . . . . 0.0 109.349 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -137.75 150.37 47.2 Favored 'General case' 0 CA--C 1.535 0.378 0 O-C-N 121.306 -0.871 . . . . 0.0 112.053 175.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.81 154.43 77.89 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.203 1.401 . . . . 0.0 110.96 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.78 121.4 8.92 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.018 2.479 . . . . 0.0 111.164 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -72.67 176.23 9.13 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.9 2.4 . . . . 0.0 111.606 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.25 162.63 19.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.94 1.696 . . . . 0.0 110.764 169.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -144.75 176.64 9.29 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.065 1.346 . . . . 0.0 110.861 170.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.81 178.42 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 126.933 2.093 . . . . 0.0 110.801 177.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.252 1.236 0 C-N-CA 125.848 1.659 . . . . 0.0 114.147 177.517 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 112.119 -0.392 . . . . 0.0 112.119 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 26.3 m -81.04 37.29 0.43 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.751 2.02 . . . . 0.0 115.38 -165.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 42.5 mtt -59.23 -24.67 63.36 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.68 -1.263 . . . . 0.0 114.116 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.29 -13.54 29.62 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.0 -27.19 63.51 Favored 'General case' 0 CA--C 1.547 0.836 0 O-C-N 121.222 -0.924 . . . . 0.0 112.91 175.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -82.87 159.44 22.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.533 1.133 . . . . 0.0 112.105 169.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -148.19 163.59 36.52 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.068 1.347 . . . . 0.0 111.464 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -118.57 165.49 13.88 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.887 1.675 . . . . 0.0 112.14 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.94 80.12 2.82 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.769 1.227 . . . . 0.0 112.372 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.15 -21.27 64.91 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.715 -1.241 . . . . 0.0 113.473 174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.86 -23.57 63.3 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 115.13 1.529 . . . . 0.0 115.13 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 14.2 t -99.43 -25.15 14.55 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.514 1.126 . . . . 0.0 113.038 176.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.65 153.55 43.27 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.277 -0.889 . . . . 0.0 111.976 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -71.05 155.73 40.45 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.3 p -131.07 158.35 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.174 1.39 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 84.3 t -57.22 -35.94 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.779 2.032 . . . . 0.0 111.784 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -57.29 -31.96 66.16 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.439 1.096 . . . . 0.0 113.122 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -82.52 -51.12 8.1 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.499 -0.751 . . . . 0.0 110.491 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 90.2 t -51.0 -39.99 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.733 1.213 . . . . 0.0 112.511 177.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 70.1 m -61.15 -16.4 44.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.236 1.814 . . . . 0.0 114.493 173.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 20.4 t30 -104.18 -34.63 8.31 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.224 1.809 . . . . 0.0 112.526 175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 36.1 mt -51.51 -43.59 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 CA-C-N 119.133 0.878 . . . . 0.0 110.804 172.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.96 -43.16 84.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 O-C-N 121.702 -0.624 . . . . 0.0 112.318 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.7 -54.66 24.3 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.601 1.091 . . . . 0.0 111.453 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.42 -34.38 75.29 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 -177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.85 -40.75 60.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.642 0.777 . . . . 0.0 112.899 176.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.416 ' HA ' HG21 ' B' ' 191' ' ' VAL . 58.1 mt -59.84 -56.81 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 119.113 0.87 . . . . 0.0 109.61 173.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -60.41 -32.35 71.25 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 40.5 t -58.56 -50.4 73.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.515 1.126 . . . . 0.0 112.17 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.29 75.48 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 176.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 92.7 mt -61.94 -37.95 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.873 1.269 . . . . 0.0 111.22 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 73.06 17.04 78.45 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 124.045 0.831 . . . . 0.0 114.448 -178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.89 8.6 72.5 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 125.132 1.349 . . . . 0.0 115.967 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -56.85 151.22 14.87 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 118.947 1.373 . . . . 0.0 113.652 174.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.34 -173.17 2.36 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.297 1.839 . . . . 0.0 112.23 171.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -39.79 137.71 0.87 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 128.732 2.813 . . . . 0.0 114.623 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -136.84 174.09 11.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.516 1.526 . . . . 0.0 112.831 -177.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -87.77 -92.44 0.11 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.416 1.486 . . . . 0.0 112.224 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 19.1 p -99.84 5.15 45.49 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 127.345 2.258 . . . . 0.0 113.248 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -50.76 -43.7 58.44 Favored 'General case' 0 N--CA 1.477 0.925 0 O-C-N 121.05 -1.031 . . . . 0.0 112.674 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 47.9 t -52.02 -35.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.331 1.052 . . . . 0.0 112.711 176.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -67.71 -49.81 60.73 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.475 1.11 . . . . 0.0 112.489 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -65.91 -26.91 67.82 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.062 -1.024 . . . . 0.0 112.621 174.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 48.5 m0 -75.09 -55.74 5.43 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.807 1.243 . . . . 0.0 111.215 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.1 t -58.95 -21.63 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 4.8 t -86.51 -55.6 3.81 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.824 1.193 . . . . 0.0 112.412 168.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -57.48 -35.95 70.85 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.045 1.293 . . . . 0.0 113.82 -177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' B' ' 170' ' ' ILE . 94.9 t -74.79 -67.16 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 C-N-CA 124.382 1.073 . . . . 0.0 109.543 -178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.3 t -48.63 -29.21 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.797 1.239 . . . . 0.0 111.049 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -52.59 -55.27 23.46 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 174.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 29.9 mm100 -94.29 -37.89 11.28 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.772 1.229 . . . . 0.0 112.571 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -60.07 -53.04 62.51 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.006 2.122 . . . . 0.0 112.731 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 9.4 tp -63.02 -35.8 81.45 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.696 0.68 . . . . 0.0 112.043 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.9 t -60.65 -50.42 73.56 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.726 0.81 . . . . 0.0 111.308 169.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -58.37 -51.17 70.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.522 1.929 . . . . 0.0 113.586 177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.9 pp -69.2 -23.03 63.85 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -61.17 -41.01 96.02 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 164.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -74.57 -24.08 58.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.42 -11.33 9.98 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -159.81 -73.65 0.02 OUTLIER Glycine 0 CA--C 1.535 1.314 0 CA-C-N 119.942 1.246 . . . . 0.0 114.807 173.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -65.99 168.45 9.1 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 126.756 2.022 . . . . 0.0 113.318 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.38 173.54 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.223 2.615 . . . . 0.0 112.05 171.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.82 94.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.404 1.482 . . . . 0.0 113.04 -177.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -158.13 107.06 2.02 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.596 1.959 . . . . 0.0 111.916 168.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -154.68 165.34 36.87 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.977 1.711 . . . . 0.0 111.031 173.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.8 tt -147.72 156.61 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 126.174 1.79 . . . . 0.0 108.864 160.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -135.13 152.46 32.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 126.289 1.836 . . . . 0.0 109.657 162.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.6 p -132.85 138.94 47.21 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 126.104 1.762 . . . . 0.0 108.518 166.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.4 p -139.75 145.7 38.6 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.879 0.847 . . . . 0.0 112.745 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 53.2 t -131.35 131.17 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.983 1.313 . . . . 0.0 109.224 -174.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -118.71 93.45 2.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 127.215 2.206 . . . . 0.0 107.358 -173.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -119.6 90.85 3.41 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.847 2.059 . . . . 0.0 109.888 -172.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -57.53 153.22 13.34 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 120.457 -1.402 . . . . 0.0 113.533 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -7.79 53.7 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.17 -16.91 56.15 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.441 1.896 . . . . 0.0 114.108 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 -3.18 6.38 Favored Glycine 0 N--CA 1.473 1.107 0 N-CA-C 116.176 1.231 . . . . 0.0 116.176 174.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -74.1 51.99 0.43 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.427 1.491 . . . . 0.0 113.287 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.32 157.05 30.03 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.652 1.596 . . . . 0.0 112.842 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.732 HD11 HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -159.69 -173.8 4.3 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.32 1.848 . . . . 0.0 110.804 -174.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.41 139.26 40.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.842 0.747 . . . . 0.0 111.002 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.45 ' HB ' HG13 ' B' ' 278' ' ' VAL . 53.4 m -142.74 145.12 33.01 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.803 1.241 . . . . 0.0 110.142 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -139.53 144.71 38.0 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.433 1.093 . . . . 0.0 110.729 175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 69.4 p -145.88 142.2 28.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 121.892 0.853 . . . . 0.0 112.07 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 9.5 t -80.79 25.81 0.43 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.975 0.91 . . . . 0.0 112.496 175.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 58.9 m -67.51 171.35 6.25 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.334 -0.854 . . . . 0.0 111.599 164.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -166.44 154.33 10.08 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.921 2.489 . . . . 0.0 108.83 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -81.61 132.09 35.29 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.428 -0.795 . . . . 0.0 110.014 173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -152.78 116.46 4.77 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.046 1.338 . . . . 0.0 112.512 177.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 37.3 t -107.02 -34.05 7.29 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.397 1.479 . . . . 0.0 112.393 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 12.2 p -80.01 -36.09 36.42 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.986 1.314 . . . . 0.0 112.32 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 -56.6 3.93 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.242 1.417 . . . . 0.0 111.802 -174.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -135.47 -155.57 0.65 Allowed 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 127.581 2.352 . . . . 0.0 109.341 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -119.59 153.5 16.79 Favored Glycine 0 CA--C 1.536 1.374 0 O-C-N 120.728 -1.233 . . . . 0.0 113.556 171.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 25.8 p -156.79 147.18 21.34 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.211 1.404 . . . . 0.0 112.315 173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.5 t -146.9 93.82 2.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.981 1.312 . . . . 0.0 111.838 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 14.2 t -86.57 146.4 26.37 Favored 'General case' 0 N--CA 1.475 0.798 0 O-C-N 121.034 -1.041 . . . . 0.0 112.205 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 12.2 t -139.39 135.96 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.991 1.716 . . . . 0.0 109.267 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -123.34 129.79 51.81 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.538 1.535 . . . . 0.0 110.848 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 13.5 m95 -132.63 159.03 40.75 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.225 1.41 . . . . 0.0 110.035 175.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -136.64 144.16 43.87 Favored 'General case' 0 N--CA 1.467 0.409 0 O-C-N 121.026 -1.046 . . . . 0.0 111.028 -175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -116.9 -173.5 2.4 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.61 1.164 . . . . 0.0 109.454 -165.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.02 -50.97 65.44 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 120.996 -1.065 . . . . 0.0 113.654 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.6 t -140.17 -10.94 1.11 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.064 1.746 . . . . 0.0 113.43 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 10.0 mtm -94.25 169.27 10.36 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.54 1.536 . . . . 0.0 110.542 172.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -139.56 157.87 45.08 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 121.338 -0.851 . . . . 0.0 111.262 165.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 27.1 p -141.27 138.57 33.31 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.034 0.933 . . . . 0.0 111.876 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -133.66 126.83 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.877 1.271 . . . . 0.0 109.937 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.54 129.3 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.443 1.497 . . . . 0.0 110.639 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -121.8 106.55 11.38 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.401 0.68 . . . . 0.0 111.9 -175.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -85.99 140.93 29.87 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -131.57 115.54 16.25 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.142 1.777 . . . . 0.0 109.701 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.85 76.23 0.22 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 126.573 2.035 . . . . 0.0 111.028 -177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -67.08 123.38 20.07 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.838 0.855 . . . . 0.0 112.263 -173.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 10.4 t -142.66 119.6 11.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.112 1.765 . . . . 0.0 112.058 -165.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.5 pp -112.29 -0.26 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.563 1.545 . . . . 0.0 114.095 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -92.57 2.72 74.07 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.34 1.447 . . . . 0.0 115.721 -175.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 78.32 24.73 62.79 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 118.784 1.292 . . . . 0.0 115.11 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.41 -175.59 45.65 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.102 1.334 . . . . 0.0 114.248 177.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 5.0 t -74.63 -175.77 2.55 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.399 1.08 . . . . 0.0 113.546 176.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 124.26 9.17 5.66 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 126.703 2.097 . . . . 0.0 114.068 -170.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -125.58 170.66 11.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.237 1.815 . . . . 0.0 113.645 -171.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.3 t -120.08 4.5 10.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.531 1.532 . . . . 0.0 113.662 -173.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 167.31 -168.03 40.23 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.94 1.733 . . . . 0.0 112.389 -173.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.89 -179.33 2.05 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 123.993 3.129 . . . . 0.0 112.843 176.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.0 85.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 124.695 1.198 . . . . 0.0 113.793 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 16.7 mmmt -70.3 159.92 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.437 1.095 . . . . 0.0 112.323 175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 53.0 mt -88.37 138.44 31.43 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.115 1.366 . . . . 0.0 110.101 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -171.38 171.71 44.13 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 123.758 0.694 . . . . 0.0 114.458 -178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -83.54 147.92 27.5 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.921 1.289 . . . . 0.0 112.547 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -154.08 93.1 1.6 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.614 1.565 . . . . 0.0 111.884 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -131.71 175.1 9.47 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.058 1.343 . . . . 0.0 111.929 176.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 37.9 mm -52.86 140.5 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 126.662 1.985 . . . . 0.0 111.64 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 90.4 m -99.06 93.95 6.26 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.372 1.469 . . . . 0.0 110.332 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -94.26 146.82 23.75 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.036 -1.04 . . . . 0.0 110.778 167.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.45 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.9 p -148.6 120.07 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 126.384 1.874 . . . . 0.0 110.015 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.09 152.15 48.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.033 0.933 . . . . 0.0 112.075 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -135.0 154.4 79.14 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 125.223 1.409 . . . . 0.0 111.114 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -64.51 122.12 9.92 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.11 2.54 . . . . 0.0 111.336 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.09 174.96 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.983 2.455 . . . . 0.0 111.908 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.95 162.01 19.23 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.866 1.666 . . . . 0.0 110.646 168.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -144.43 176.36 9.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.906 1.282 . . . . 0.0 110.854 170.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.01 177.88 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 126.859 2.063 . . . . 0.0 110.817 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.824 1.649 . . . . 0.0 114.212 177.51 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.619 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -66.8 1.69 1.73 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.4 mtt -52.95 -36.58 60.13 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.727 1.211 . . . . 0.0 113.333 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.92 -15.25 29.01 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.9 -19.73 65.78 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -135.97 131.71 35.42 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.36 1.464 . . . . 0.0 111.436 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -143.12 131.3 21.93 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.482 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.456 ' HB3' ' HA3' ' A' ' 118' ' ' GLY . . . -72.1 177.15 4.56 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.465 1.106 . . . . 0.0 112.71 178.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.81 101.05 0.12 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.301 1.44 . . . . 0.0 112.219 174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -77.11 -15.27 59.62 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 120.968 -1.082 . . . . 0.0 112.528 172.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -63.24 -27.4 69.32 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 t -82.43 -26.28 32.89 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.462 1.105 . . . . 0.0 112.57 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.67 118.22 17.39 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 120.626 -1.296 . . . . 0.0 111.63 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.49 158.66 31.36 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.399 -0.813 . . . . 0.0 112.534 176.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.7 p -106.55 141.49 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 123.774 0.83 . . . . 0.0 111.852 -175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 68.9 t -57.12 -42.89 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.858 1.663 . . . . 0.0 111.327 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -54.95 -31.48 60.51 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.205 1.402 . . . . 0.0 113.311 175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -86.64 -53.34 5.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.044 0.937 . . . . 0.0 111.701 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.696 HG13 HD22 ' A' ' 56' ' ' LEU . 54.3 t -44.14 -48.34 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.836 1.255 . . . . 0.0 112.605 169.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.9 t -65.31 -3.18 3.75 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.396 1.478 . . . . 0.0 113.919 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -111.54 -31.67 6.93 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.236 1.815 . . . . 0.0 112.274 170.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.5 mt -50.87 -44.71 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.369 0.986 . . . . 0.0 110.437 168.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 97' ' ' VAL . 9.0 p -59.81 -41.85 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.64 -51.93 55.76 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.747 1.158 . . . . 0.0 111.585 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -33.32 75.27 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.01 -38.05 69.68 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.396 1.079 . . . . 0.0 113.091 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.5 mt -59.86 -56.64 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 CA-C-N 119.258 0.936 . . . . 0.0 110.274 172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -60.45 -31.59 70.58 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.1 t -59.19 -46.68 87.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.32 1.048 . . . . 0.0 112.499 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.79 -35.94 81.23 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.401 1.08 . . . . 0.0 113.815 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.6 mt -63.95 -43.43 97.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.327 1.051 . . . . 0.0 110.713 174.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.35 14.02 61.29 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.59 1.091 . . . . 0.0 115.066 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.9 10.78 85.87 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.139 1.352 . . . . 0.0 115.105 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -63.84 168.15 5.35 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 118.735 1.267 . . . . 0.0 112.55 176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -55.63 102.03 0.06 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.203 1.801 . . . . 0.0 111.657 170.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.84 139.07 46.93 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.64 1.976 . . . . 0.0 112.499 173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -146.23 156.98 43.77 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.734 1.214 . . . . 0.0 111.296 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -57.89 -53.49 57.66 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.7 m -69.92 -26.36 64.11 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.1 mmtt -58.7 -45.7 88.92 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.042 0.537 . . . . 0.0 112.182 170.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 t -56.91 -35.13 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 118.842 0.746 . . . . 0.0 112.424 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 61.6 m-20 -63.89 -47.52 80.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.989 0.915 . . . . 0.0 111.621 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -67.81 -24.06 65.25 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -78.93 -52.57 8.1 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.132 0.878 . . . . 0.0 111.555 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.9 t -55.01 -35.23 64.18 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.665 0.666 . . . . 0.0 112.135 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -75.89 -55.76 5.32 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.205 0.911 . . . . 0.0 112.593 173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.92 -38.03 75.15 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.911 1.284 . . . . 0.0 113.532 -176.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.0 t -67.22 -62.32 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.85 0 C-N-CA 123.92 0.888 . . . . 0.0 110.384 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -50.61 -29.84 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.632 1.173 . . . . 0.0 110.75 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.53 -30.61 69.86 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.282 1.033 . . . . 0.0 113.753 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -112.53 -42.24 3.69 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.995 1.718 . . . . 0.0 112.257 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 m -51.85 -55.58 19.16 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.5 2.32 . . . . 0.0 112.577 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.19 -37.99 87.38 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.412 0.625 . . . . 0.0 110.989 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.6 m -67.15 -28.36 68.06 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 173.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.22 -52.38 10.16 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 127.555 2.342 . . . . 0.0 112.249 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.696 HD22 HG13 ' A' ' 19' ' ' VAL . 3.7 pp -65.74 -25.53 67.32 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.2 m -55.38 -37.03 67.02 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.367 1.067 . . . . 0.0 110.913 166.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -81.79 -34.13 30.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.494 0.718 . . . . 0.0 112.712 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -69.74 -28.91 66.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.366 0.666 . . . . 0.0 111.013 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.67 -118.79 4.19 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.045 1.783 . . . . 0.0 113.256 171.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -133.89 151.98 77.82 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.696 1.598 . . . . 0.0 113.606 -171.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.35 113.77 3.86 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.929 3.086 . . . . 0.0 112.214 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -147.62 171.7 15.19 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.299 1.839 . . . . 0.0 110.663 171.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 73.7 mttt -70.9 135.86 48.24 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.741 0.781 . . . . 0.0 110.84 162.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -131.13 157.49 42.98 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 128.014 2.526 . . . . 0.0 108.208 170.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.5 tt -138.56 155.18 27.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.178 1.391 . . . . 0.0 109.144 173.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG12 ' HB2' ' A' ' 110' ' ' ALA . 13.0 m -139.23 148.89 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 124.751 1.221 . . . . 0.0 110.374 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -145.83 154.05 41.57 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.304 1.042 . . . . 0.0 110.53 175.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.5 p -146.07 149.51 34.2 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.275 1.03 . . . . 0.0 112.854 172.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.5 t -129.73 111.33 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.841 1.656 . . . . 0.0 109.402 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.564 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.3 mm -107.33 96.47 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 125.523 1.529 . . . . 0.0 107.481 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.64 89.4 2.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.885 1.274 . . . . 0.0 111.247 -177.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -166.15 120.43 1.15 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.473 1.909 . . . . 0.0 107.966 169.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -152.59 -64.56 0.16 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.757 1.223 . . . . 0.0 111.304 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -110.2 -15.61 13.95 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.638 1.575 . . . . 0.0 113.507 168.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 109.44 -11.66 33.27 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 126.273 1.892 . . . . 0.0 114.533 -177.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.52 117.44 9.48 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.219 1.408 . . . . 0.0 111.938 173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -130.3 174.49 19.62 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 125.64 1.59 . . . . 0.0 114.095 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -115.92 -172.54 2.18 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.49 1.916 . . . . 0.0 111.599 -170.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.78 108.56 20.41 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.527 -0.733 . . . . 0.0 110.241 176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.3 m -120.41 137.72 54.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.831 0.852 . . . . 0.0 109.868 177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.32 134.61 29.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.298 0.639 . . . . 0.0 111.683 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 56.3 p -132.28 134.99 45.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.972 0.892 . . . . 0.0 111.229 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.6 m -83.36 24.47 0.82 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.515 -0.74 . . . . 0.0 111.599 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 64.8 m -62.79 163.54 9.23 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.63 0.729 . . . . 0.0 111.288 164.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -163.05 136.84 5.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 108.986 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -69.17 149.79 48.23 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.412 0.685 . . . . 0.0 110.296 173.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -134.07 152.2 51.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.073 1.349 . . . . 0.0 110.794 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.3 t -120.13 -65.42 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.4 1.08 . . . . 0.0 112.465 176.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 46.8 t -82.18 -35.75 28.03 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.043 0.838 . . . . 0.0 112.607 171.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.2 m -67.37 -36.5 81.48 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.227 1.411 . . . . 0.0 113.352 -171.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.17 179.14 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.36 2.264 . . . . 0.0 111.121 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.06 134.52 11.98 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.946 1.26 . . . . 0.0 113.14 176.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.7 m -150.5 139.53 21.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.768 1.627 . . . . 0.0 110.458 176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.459 ' SG ' HG11 ' A' ' 19' ' ' VAL . 5.5 p -151.48 120.27 6.58 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 118.913 0.779 . . . . 0.0 111.902 -178.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -132.29 151.71 51.71 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.37 1.468 . . . . 0.0 112.078 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.457 HG21 HG21 ' A' ' 23' ' ' VAL . 1.7 t -139.5 139.76 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.605 1.562 . . . . 0.0 109.943 -170.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.05 131.98 50.8 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.983 1.313 . . . . 0.0 112.13 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.9 m95 -139.46 106.54 5.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.802 1.241 . . . . 0.0 110.926 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -86.38 148.81 25.41 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.986 0.914 . . . . 0.0 112.066 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -123.66 -176.25 3.42 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.755 1.622 . . . . 0.0 110.694 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -67.71 0.24 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.597 1.559 . . . . 0.0 113.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.5 t -117.32 8.19 13.05 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.405 1.882 . . . . 0.0 112.488 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 35.0 mtt -134.58 173.98 11.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.43 1.892 . . . . 0.0 111.069 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -151.45 161.99 41.72 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.598 1.159 . . . . 0.0 109.794 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.564 ' CB ' HD12 ' A' ' 71' ' ' ILE . 10.3 p -132.27 151.21 51.94 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 110.406 171.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 pt -135.49 137.8 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 109.257 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.24 140.13 49.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.939 1.296 . . . . 0.0 109.678 173.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -131.9 145.13 51.34 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.998 0.919 . . . . 0.0 110.658 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.53 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -130.24 145.1 51.71 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.262 1.425 . . . . 0.0 111.934 177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -132.1 151.63 51.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.772 1.629 . . . . 0.0 111.08 175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -148.81 86.72 0.15 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.175 1.369 . . . . 0.0 111.353 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -78.14 122.39 25.58 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.993 1.317 . . . . 0.0 111.568 -177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.2 m -142.18 121.59 13.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.654 1.581 . . . . 0.0 112.302 -168.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.428 HD11 HD11 ' B' ' 258' ' ' ILE . 2.1 pp -112.39 8.23 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -69.15 -2.07 30.23 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.656 1.598 . . . . 0.0 117.053 -174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.87 1.5 73.26 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-N 119.208 1.504 . . . . 0.0 115.711 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.456 ' HA3' ' HB3' ' A' ' 8' ' ' ALA . . . -161.39 73.34 0.2 Allowed Glycine 0 CA--C 1.527 0.815 0 C-N-CA 126.325 1.917 . . . . 0.0 111.552 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 12.1 t -151.3 171.19 17.84 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.306 1.443 . . . . 0.0 111.439 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 80.52 -28.92 2.65 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 126.178 1.847 . . . . 0.0 114.978 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -128.72 169.72 14.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.409 1.883 . . . . 0.0 112.11 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.5 t -122.43 -19.23 6.47 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.679 1.592 . . . . 0.0 114.333 -174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -175.1 -72.27 0.05 OUTLIER Glycine 0 CA--C 1.537 1.453 0 O-C-N 121.114 -0.991 . . . . 0.0 113.524 -178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.18 163.27 39.73 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.874 2.382 . . . . 0.0 111.8 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.2 pt -127.57 139.08 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 111.501 175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.78 158.07 45.13 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.903 1.681 . . . . 0.0 113.02 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.7 170.03 17.3 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.184 0.994 . . . . 0.0 111.605 173.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.3 158.12 30.88 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.099 1.333 . . . . 0.0 112.743 169.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 3.5 mtt -77.03 157.08 31.36 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.899 0.879 . . . . 0.0 112.312 172.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -145.98 96.16 2.75 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.633 1.573 . . . . 0.0 111.404 174.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -130.13 169.08 15.8 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.911 1.284 . . . . 0.0 111.836 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 30.2 mm -60.34 151.06 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 126.373 1.869 . . . . 0.0 111.275 175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 88.2 m -124.59 95.23 4.45 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.971 1.708 . . . . 0.0 110.885 -176.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -97.64 149.96 21.68 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.933 -1.104 . . . . 0.0 111.434 173.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.98 102.06 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 127.488 2.315 . . . . 0.0 109.045 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -142.45 115.84 9.01 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.614 1.166 . . . . 0.0 111.724 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -134.71 82.84 43.43 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.102 1.361 . . . . 0.0 110.91 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -65.53 165.34 23.1 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.92 2.413 . . . . 0.0 112.802 178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.95 -23.09 41.17 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.339 2.693 . . . . 0.0 114.337 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -118.09 -178.84 3.6 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 127.433 2.293 . . . . 0.0 110.858 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -61.3 171.56 1.35 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.039 1.336 . . . . 0.0 113.113 171.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.92 168.41 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 125.64 1.576 . . . . 0.0 112.348 -179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.2 t . . . . . 0 C--O 1.252 1.226 0 C-N-CA 126.194 1.798 . . . . 0.0 111.032 177.438 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.58 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 17.0 m -66.79 1.46 1.83 Allowed 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 51.5 mtt -52.17 -37.1 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.999 1.32 . . . . 0.0 113.331 178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.76 -15.41 29.26 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -67.21 -19.81 65.6 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.052 -1.03 . . . . 0.0 113.65 172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -136.08 130.71 33.83 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.345 1.458 . . . . 0.0 111.543 -178.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -142.22 131.09 22.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.626 0.771 . . . . 0.0 111.503 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . 0.49 ' HB3' ' HA3' ' B' ' 261' ' ' GLY . . . -71.28 177.55 3.83 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.494 1.117 . . . . 0.0 112.646 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.12 98.38 0.08 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.323 1.449 . . . . 0.0 112.259 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -73.72 -16.98 61.17 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 120.861 -1.149 . . . . 0.0 112.512 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -63.21 -27.14 69.15 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 8.8 t -83.76 -24.82 30.96 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.216 1.007 . . . . 0.0 112.675 174.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -73.34 127.27 32.18 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.361 -1.462 . . . . 0.0 111.051 169.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -65.75 167.02 9.92 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.275 -0.89 . . . . 0.0 111.575 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -111.39 145.11 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.411 1.084 . . . . 0.0 111.315 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 8.3 p -57.38 -39.65 69.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.618 1.167 . . . . 0.0 111.925 179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -59.36 -31.12 68.92 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.667 1.587 . . . . 0.0 113.312 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -74.0 -60.05 2.44 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.939 0.895 . . . . 0.0 110.172 174.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.66 HG13 HD22 ' B' ' 199' ' ' LEU . 40.3 t -54.23 -42.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.752 1.221 . . . . 0.0 113.143 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.5 t -64.74 -3.31 3.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.058 1.343 . . . . 0.0 113.747 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.37 -33.35 5.96 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.438 1.895 . . . . 0.0 112.432 170.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 39.1 mt -51.8 -43.14 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.497 1.044 . . . . 0.0 110.352 169.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 240' ' ' VAL . 9.0 p -59.97 -41.93 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -51.74 56.93 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.772 1.169 . . . . 0.0 111.52 177.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -33.74 76.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.33 -38.0 71.71 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.228 1.011 . . . . 0.0 113.036 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 46.4 mt -59.88 -56.97 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-N 119.241 0.928 . . . . 0.0 110.312 172.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -60.28 -31.67 70.45 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -59.27 -46.7 87.83 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.34 1.056 . . . . 0.0 112.513 168.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.8 -36.11 81.62 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.402 1.081 . . . . 0.0 113.797 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.82 -43.43 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.277 1.031 . . . . 0.0 110.734 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 66.86 13.77 62.06 Favored Glycine 0 CA--C 1.54 1.603 0 C-N-CA 124.493 1.044 . . . . 0.0 115.0 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.78 10.82 85.85 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.188 1.375 . . . . 0.0 115.027 -173.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -63.79 168.25 5.19 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.694 1.247 . . . . 0.0 112.501 176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -55.62 102.55 0.07 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.076 1.75 . . . . 0.0 111.598 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -55.95 138.65 48.42 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.573 1.949 . . . . 0.0 112.526 173.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -145.8 156.63 43.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.697 1.199 . . . . 0.0 111.422 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -57.98 -53.53 57.16 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 177.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 74.4 m -69.42 -26.88 64.83 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.9 mmtt -58.59 -45.47 89.05 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.138 0.575 . . . . 0.0 112.22 170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 4.2 t -56.49 -35.66 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 118.832 0.742 . . . . 0.0 112.444 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -63.8 -47.46 80.8 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.87 0.868 . . . . 0.0 111.585 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -67.92 -23.93 65.14 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.3 m0 -78.84 -52.9 7.68 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 119.172 0.896 . . . . 0.0 111.406 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 14.8 t -54.96 -34.79 63.6 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.736 0.698 . . . . 0.0 112.185 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.4 t -75.79 -56.75 4.38 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 119.178 0.899 . . . . 0.0 112.636 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -57.23 -38.44 73.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.952 1.301 . . . . 0.0 113.646 -175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 53.6 t -64.9 -64.07 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 110.117 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 83.1 t -51.65 -29.28 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 124.777 1.231 . . . . 0.0 110.677 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -59.88 -34.48 73.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.171 0.988 . . . . 0.0 113.548 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -110.69 -38.6 5.11 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.693 1.597 . . . . 0.0 112.355 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 22.1 m -55.29 -53.52 55.12 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.419 2.288 . . . . 0.0 111.753 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 7.6 tp -60.12 -36.01 76.52 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.259 0.481 . . . . 0.0 112.054 178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 68.4 m -70.6 -30.73 67.48 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.964 0.906 . . . . 0.0 113.355 173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -71.34 -52.12 20.48 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.903 2.081 . . . . 0.0 112.453 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.66 HD22 HG13 ' B' ' 162' ' ' VAL . 2.8 pp -64.93 -26.43 68.31 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 53.9 m -58.32 -30.46 66.71 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.941 0.896 . . . . 0.0 110.984 168.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.1 mmtm -85.88 -36.28 20.05 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.817 0.847 . . . . 0.0 112.717 177.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 71.0 mt -66.82 -23.8 66.09 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.968 0.907 . . . . 0.0 112.699 178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -106.55 -112.68 3.71 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.153 1.359 . . . . 0.0 112.734 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -137.63 154.53 75.03 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.711 1.604 . . . . 0.0 113.237 -169.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.48 115.32 4.27 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.682 2.921 . . . . 0.0 112.2 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -150.35 172.68 15.0 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.413 1.885 . . . . 0.0 110.686 171.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -71.81 132.16 44.06 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.568 -0.708 . . . . 0.0 110.907 165.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -129.31 147.68 51.16 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.736 1.614 . . . . 0.0 109.198 168.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.2 tt -128.38 154.81 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.397 1.479 . . . . 0.0 109.253 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' B' ' 253' ' ' ALA . 3.5 m -136.69 150.76 27.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 125.134 1.374 . . . . 0.0 111.055 172.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 18.6 p -137.83 151.95 48.6 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.601 1.561 . . . . 0.0 110.279 172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 30.3 p -146.43 152.33 38.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 122.162 0.982 . . . . 0.0 113.003 168.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 22.9 t -134.51 114.26 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.233 1.413 . . . . 0.0 108.974 -176.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.424 HD12 ' CB ' ' B' ' 249' ' ' CYS . 3.1 mm -107.28 91.26 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 126.446 1.898 . . . . 0.0 107.648 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 2.2 ttt -98.73 135.94 39.5 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.374 1.47 . . . . 0.0 109.506 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -81.72 145.65 30.39 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.492 -0.755 . . . . 0.0 112.37 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -76.1 -0.16 20.94 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.289 1.435 . . . . 0.0 114.045 -176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -55.18 -21.31 13.1 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 126.424 1.89 . . . . 0.0 113.996 169.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.03 -12.27 62.23 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.703 1.621 . . . . 0.0 114.36 178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.75 89.71 1.37 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.272 1.429 . . . . 0.0 111.55 174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.55 -169.01 27.73 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 124.97 1.272 . . . . 0.0 113.672 174.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.2 -176.03 4.46 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 127.665 2.386 . . . . 0.0 111.379 -173.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.01 104.24 13.86 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.216 1.007 . . . . 0.0 110.278 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.47 135.24 54.1 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.837 0.855 . . . . 0.0 110.56 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -140.52 118.78 12.06 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.286 0.234 . . . . 0.0 111.038 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 15.0 p -120.65 138.15 54.08 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.954 0.883 . . . . 0.0 110.966 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 69.8 m -84.2 21.36 1.4 Allowed 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.41 -0.806 . . . . 0.0 111.899 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.2 m -64.82 162.6 15.86 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.509 0.724 . . . . 0.0 111.65 168.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -162.21 139.83 8.53 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.725 1.61 . . . . 0.0 110.388 -175.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -69.78 151.8 45.35 Favored 'General case' 0 CA--C 1.543 0.682 0 O-C-N 121.426 -0.796 . . . . 0.0 110.483 174.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -137.03 151.04 48.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.396 1.478 . . . . 0.0 110.351 167.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 2.4 t -119.78 -64.76 1.23 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.425 1.09 . . . . 0.0 112.523 176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 46.6 t -82.44 -35.74 27.27 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.258 -0.901 . . . . 0.0 112.647 171.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -67.9 -36.7 80.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.3 1.44 . . . . 0.0 113.406 -170.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -163.27 178.7 7.95 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.478 2.311 . . . . 0.0 110.744 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -96.95 134.33 11.73 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.871 1.224 . . . . 0.0 112.955 175.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 56.0 m -150.52 148.63 28.93 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.924 1.689 . . . . 0.0 110.152 169.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 3.2 p -152.57 121.41 6.53 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.726 1.211 . . . . 0.0 111.331 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.0 t -132.71 151.02 52.08 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.239 1.416 . . . . 0.0 112.271 -172.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 166' ' ' VAL . 1.7 t -140.6 139.98 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.517 1.527 . . . . 0.0 110.014 -169.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.81 130.88 49.4 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.861 1.264 . . . . 0.0 112.236 -176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 20.9 m95 -138.77 104.29 5.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.0 1.32 . . . . 0.0 110.639 -176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -82.58 149.87 27.22 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.217 -0.927 . . . . 0.0 111.679 177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 10.5 m-20 -124.38 -177.79 3.9 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.361 1.465 . . . . 0.0 110.868 -178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.91 -67.91 0.23 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.513 1.525 . . . . 0.0 113.35 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.7 t -119.15 15.13 13.18 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.486 1.914 . . . . 0.0 112.952 -177.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 43.0 mtt -142.47 175.11 10.04 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.493 1.917 . . . . 0.0 109.9 178.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -151.54 158.7 43.92 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.869 0.868 . . . . 0.0 109.972 161.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.424 ' CB ' HD12 ' B' ' 214' ' ' ILE . 12.6 p -134.09 144.06 48.38 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 122.437 1.113 . . . . 0.0 110.99 174.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pt -134.19 132.64 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 125.427 1.491 . . . . 0.0 109.299 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 13.8 p -124.1 142.01 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 C-N-CA 125.205 1.402 . . . . 0.0 110.027 176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.1 t -135.79 144.52 45.8 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.05 0.94 . . . . 0.0 110.785 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.518 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -130.21 144.36 51.32 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.479 1.511 . . . . 0.0 111.728 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -132.63 148.45 52.36 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.181 1.792 . . . . 0.0 110.571 -177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -147.61 87.3 0.16 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.581 1.562 . . . . 0.0 112.32 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -80.01 118.46 21.76 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.075 1.35 . . . . 0.0 111.604 -178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 75.6 m -141.36 119.11 11.74 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.753 1.621 . . . . 0.0 112.347 -168.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 115' ' ' ILE . 2.1 pp -111.13 8.19 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -68.88 -2.32 29.51 Favored Glycine 0 CA--C 1.542 1.746 0 N-CA-C 117.092 1.597 . . . . 0.0 117.092 -175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 91.31 1.96 71.35 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-N 119.275 1.537 . . . . 0.0 115.783 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' B' ' 151' ' ' ALA . . . -162.48 74.97 0.18 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.543 2.021 . . . . 0.0 111.206 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 12.3 t -152.82 171.0 18.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.474 1.51 . . . . 0.0 111.35 176.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 80.5 -28.64 2.68 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 126.261 1.886 . . . . 0.0 114.908 -176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.11 168.97 15.33 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.439 1.896 . . . . 0.0 112.208 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 37.2 t -121.33 -19.17 7.11 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.681 1.592 . . . . 0.0 114.363 -174.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -175.33 -72.55 0.05 OUTLIER Glycine 0 CA--C 1.537 1.454 0 O-C-N 121.224 -0.922 . . . . 0.0 113.522 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.87 162.75 41.57 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 122.789 2.326 . . . . 0.0 111.794 174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 35.6 pt -127.32 138.53 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.123 1.369 . . . . 0.0 111.452 175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.24 158.15 45.07 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.867 1.667 . . . . 0.0 113.027 176.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 6.3 mp -78.87 170.05 17.28 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.119 0.967 . . . . 0.0 111.615 173.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -167.24 158.13 30.91 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.137 1.351 . . . . 0.0 112.672 169.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 3.6 mtt -76.95 157.28 31.39 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.806 0.843 . . . . 0.0 112.254 172.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -145.88 96.32 2.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.542 1.537 . . . . 0.0 111.348 174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -129.86 169.53 15.07 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.83 1.252 . . . . 0.0 111.702 175.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.16 150.24 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 126.443 1.897 . . . . 0.0 111.366 176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.6 m -123.67 88.41 2.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.739 1.616 . . . . 0.0 110.878 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -93.61 150.74 20.18 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.378 -0.826 . . . . 0.0 111.369 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 3.2 p -148.15 108.51 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 126.624 1.97 . . . . 0.0 110.043 176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -141.65 113.32 7.77 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.742 1.617 . . . . 0.0 111.294 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -130.12 83.54 62.95 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.043 1.337 . . . . 0.0 110.875 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -66.5 165.46 25.01 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 122.954 2.436 . . . . 0.0 112.57 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -70.24 -20.02 33.08 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.277 2.651 . . . . 0.0 114.339 -176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -118.8 -179.04 3.69 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 127.461 2.304 . . . . 0.0 110.841 176.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 3.4 pm0 -61.34 171.57 1.36 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.083 1.353 . . . . 0.0 113.145 171.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.39 168.73 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.693 1.597 . . . . 0.0 112.338 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.227 1.811 . . . . 0.0 111.036 177.78 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 CA-C-O 119.302 -0.721 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.1 p -65.14 67.15 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.837 2.055 . . . . 0.0 115.749 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 9.2 mmt -71.25 -75.06 0.13 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.134 1.774 . . . . 0.0 111.991 173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -102.59 -65.06 1.02 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.164 0.986 . . . . 0.0 113.405 -172.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -130.99 1.33 4.28 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.657 2.383 . . . . 0.0 111.367 178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.07 170.88 9.11 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.175 1.39 . . . . 0.0 112.315 177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -128.44 160.14 33.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.305 1.442 . . . . 0.0 111.749 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -113.0 83.14 1.78 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.266 1.826 . . . . 0.0 110.67 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.5 152.11 42.63 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.555 0.742 . . . . 0.0 112.01 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.38 -23.17 23.43 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 121.149 -0.969 . . . . 0.0 113.371 -176.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -71.24 -24.07 62.12 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.3 t -91.41 -14.12 31.16 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.843 2.057 . . . . 0.0 112.761 174.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.72 160.26 28.47 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.933 -1.105 . . . . 0.0 111.368 169.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -140.16 167.96 20.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.628 1.571 . . . . 0.0 110.959 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.0 p -145.99 152.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.92 1.288 . . . . 0.0 110.148 -179.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -59.75 -35.84 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.263 -0.898 . . . . 0.0 111.517 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -61.61 -25.02 67.08 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.142 0.977 . . . . 0.0 113.48 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -78.62 -57.67 3.65 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.246 1.018 . . . . 0.0 110.535 169.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 38.8 t -50.49 -44.92 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.475 1.51 . . . . 0.0 112.535 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.3 t -67.68 -9.06 40.08 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.266 1.827 . . . . 0.0 113.628 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -102.33 -31.37 10.55 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.581 1.552 . . . . 0.0 112.844 170.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mt -49.27 -44.23 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.359 1.064 . . . . 0.0 110.467 170.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.97 -43.68 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.26 -49.96 65.35 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 120.257 1.39 . . . . 0.0 111.415 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.44 -33.35 75.38 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.26 -40.49 70.94 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.113 0.965 . . . . 0.0 113.091 173.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 48' ' ' VAL . 44.9 mt -57.59 -56.17 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 119.225 0.92 . . . . 0.0 110.315 173.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -60.07 -32.01 70.54 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.4 t -60.86 -45.47 94.4 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.331 1.052 . . . . 0.0 112.449 170.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.97 -32.95 71.44 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.24 -44.03 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.196 0.999 . . . . 0.0 110.938 173.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.29 13.03 71.92 Favored Glycine 0 CA--C 1.539 1.537 0 N-CA-C 115.189 0.836 . . . . 0.0 115.189 -177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.23 -4.61 26.84 Favored Glycine 0 CA--C 1.538 1.52 0 C-N-CA 125.348 1.451 . . . . 0.0 116.257 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.27 -179.17 1.52 Allowed 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 119.024 1.412 . . . . 0.0 112.689 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.61 -156.92 0.57 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.986 1.314 . . . . 0.0 111.803 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.9 158.04 0.74 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.028 1.331 . . . . 0.0 112.42 162.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.49 -176.4 5.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.715 1.206 . . . . 0.0 111.75 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.58 -100.76 0.15 Allowed 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.882 1.273 . . . . 0.0 109.655 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.4 m -67.83 -24.33 65.26 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.96 1.304 . . . . 0.0 113.992 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.86 -41.63 78.31 Favored 'General case' 0 N--CA 1.478 0.94 0 O-C-N 121.055 -1.028 . . . . 0.0 112.669 178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.2 -29.18 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.615 0.766 . . . . 0.0 112.57 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -63.12 -48.43 78.53 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.695 1.198 . . . . 0.0 111.385 173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.55 -26.36 67.09 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.349 -0.844 . . . . 0.0 112.986 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -77.13 -54.24 6.76 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.498 -0.752 . . . . 0.0 111.186 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.8 t -56.5 -29.83 62.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 118.783 0.719 . . . . 0.0 112.739 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -79.73 -52.68 7.63 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 119.477 1.035 . . . . 0.0 112.505 172.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.9 t30 -58.5 -38.0 76.75 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.578 1.151 . . . . 0.0 113.323 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 27' ' ' ILE . 75.8 t -67.02 -65.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.799 0 C-N-CA 124.667 1.187 . . . . 0.0 109.807 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.8 t -49.7 -29.09 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.873 1.269 . . . . 0.0 111.027 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -56.67 -47.19 80.37 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.536 0.734 . . . . 0.0 112.705 177.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.57 -38.29 9.21 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.023 1.329 . . . . 0.0 112.885 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.8 m -56.39 -53.64 54.97 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.538 1.935 . . . . 0.0 112.135 176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.76 -40.16 91.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 118.688 0.676 . . . . 0.0 111.307 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.4 p -69.68 -27.96 65.45 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -75.2 -52.15 11.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.677 2.391 . . . . 0.0 113.04 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.0 pp -63.65 -28.27 69.79 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 120.626 -1.296 . . . . 0.0 113.308 -178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.9 m -56.25 -32.99 65.01 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.754 1.222 . . . . 0.0 111.056 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -85.59 -28.34 24.89 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.211 1.004 . . . . 0.0 113.233 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -71.73 -25.34 62.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.95 0.9 . . . . 0.0 112.312 174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -102.47 -141.14 11.4 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 126.253 1.883 . . . . 0.0 112.035 169.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -112.84 155.08 44.6 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 125.397 1.479 . . . . 0.0 112.813 -176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.44 111.91 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 123.882 3.054 . . . . 0.0 111.238 177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.2 174.86 10.71 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.351 1.46 . . . . 0.0 111.387 176.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.558 ' HE3' ' CE2' ' B' ' 254' ' ' PHE . 0.5 OUTLIER -66.21 124.17 21.92 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.943 0.897 . . . . 0.0 110.072 163.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -124.56 165.36 17.97 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.999 2.12 . . . . 0.0 109.811 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.428 HG22 ' CD2' ' A' ' 111' ' ' PHE . 4.8 tp -152.06 154.24 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.63 1.572 . . . . 0.0 109.52 178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 110' ' ' ALA . 33.9 m -136.84 148.18 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.237 1.015 . . . . 0.0 111.359 167.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -146.96 127.31 13.95 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.585 1.554 . . . . 0.0 110.191 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' B' ' 225' ' ' ALA . 7.9 p -127.58 155.53 43.7 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.897 0.879 . . . . 0.0 112.301 173.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.466 ' C ' HD13 ' A' ' 71' ' ' ILE . 10.0 p -140.19 122.72 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.948 1.299 . . . . 0.0 108.723 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 106' ' ' CYS . 1.9 mm -120.78 116.35 49.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 127.937 2.495 . . . . 0.0 107.474 -174.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.465 ' HG3' HD11 ' A' ' 79' ' ' LEU . 14.5 tmm? -135.92 151.93 50.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 122.184 0.992 . . . . 0.0 112.279 -171.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -105.15 110.6 23.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.884 1.673 . . . . 0.0 112.263 -168.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -65.99 -6.17 11.85 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.186 2.194 . . . . 0.0 113.225 -178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -51.23 -25.75 6.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.819 2.448 . . . . 0.0 114.336 162.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.31 7.05 0.59 Allowed Glycine 0 CA--C 1.537 1.414 0 N-CA-C 116.828 1.491 . . . . 0.0 116.828 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.1 130.26 45.46 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 119.594 1.697 . . . . 0.0 112.338 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.6 112.9 2.16 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.77 1.652 . . . . 0.0 112.646 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD11 ' HG3' ' A' ' 72' ' ' MET . 0.0 OUTLIER -146.85 171.56 15.01 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.41 1.884 . . . . 0.0 112.324 -176.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -121.73 130.93 53.79 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.992 1.717 . . . . 0.0 110.621 176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.426 ' HB ' HG13 ' A' ' 135' ' ' VAL . 51.5 m -142.23 147.42 36.46 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.268 1.427 . . . . 0.0 109.059 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -145.63 153.2 40.77 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.822 -1.174 . . . . 0.0 111.904 176.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.6 p -155.58 165.03 37.8 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.3 t -116.43 9.89 14.48 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 125.387 1.475 . . . . 0.0 112.643 171.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.45 106.26 5.98 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.995 1.318 . . . . 0.0 113.189 -175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -127.03 151.4 48.65 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.74 1.216 . . . . 0.0 111.429 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -69.48 145.83 52.42 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.195 0.998 . . . . 0.0 110.218 171.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -140.84 151.85 44.66 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.612 1.565 . . . . 0.0 109.351 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.7 t -117.02 -63.75 1.4 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.365 1.466 . . . . 0.0 112.143 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 7.3 t -87.9 -28.76 21.34 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.201 1.001 . . . . 0.0 112.885 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.19 -52.79 8.64 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.327 1.451 . . . . 0.0 111.948 -173.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -151.54 -174.21 4.76 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 129.129 2.972 . . . . 0.0 109.608 -175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -122.84 126.63 6.4 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.297 1.427 . . . . 0.0 113.342 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -148.47 165.75 30.23 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.195 1.398 . . . . 0.0 111.126 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 45.2 t -150.94 126.93 10.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.984 0.914 . . . . 0.0 110.789 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.6 t -134.64 144.68 47.99 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 120.497 -1.377 . . . . 0.0 111.901 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -135.24 139.36 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.837 1.255 . . . . 0.0 110.11 -168.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.01 123.98 20.15 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.781 1.633 . . . . 0.0 112.255 -170.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -135.03 103.07 5.42 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 126.259 1.824 . . . . 0.0 110.531 -176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.95 149.59 44.9 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.165 0.986 . . . . 0.0 112.552 171.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -127.46 -179.37 4.87 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.474 1.509 . . . . 0.0 110.469 176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.23 -48.61 72.7 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 t -130.75 13.74 5.35 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 126.447 1.899 . . . . 0.0 112.388 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 26.0 mtt -143.17 176.87 8.79 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.815 2.046 . . . . 0.0 109.695 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -155.0 156.1 35.37 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.276 1.03 . . . . 0.0 110.105 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.59 ' HB2' HD12 ' A' ' 71' ' ' ILE . 24.0 p -133.94 136.21 44.06 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.019 0.927 . . . . 0.0 111.647 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pt -134.19 129.35 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.34 1.456 . . . . 0.0 110.168 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.76 111.62 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 C-N-CA 126.2 1.8 . . . . 0.0 110.816 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.4 t -107.38 121.39 44.48 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.189 0.996 . . . . 0.0 110.151 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.499 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -119.63 160.51 22.36 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.294 1.438 . . . . 0.0 112.467 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.428 ' CD2' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -135.93 156.52 48.63 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.996 1.318 . . . . 0.0 109.874 175.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -179.95 91.99 0.08 OUTLIER Glycine 0 N--CA 1.462 0.425 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -171.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.14 174.02 2.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 122.094 0.95 . . . . 0.0 112.155 -176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -120.28 159.22 25.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.784 1.234 . . . . 0.0 111.96 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.2 pt -56.83 -50.75 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.652 2.381 . . . . 0.0 113.271 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -125.14 -26.69 1.31 Allowed Glycine 0 CA--C 1.535 1.301 0 C-N-CA 124.683 1.135 . . . . 0.0 114.388 175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.04 10.02 44.26 Favored Glycine 0 CA--C 1.541 1.716 0 C-N-CA 124.834 1.207 . . . . 0.0 115.652 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.94 33.01 2.07 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 126.12 1.819 . . . . 0.0 114.367 -170.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 38.0 p -126.96 83.82 2.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.557 1.943 . . . . 0.0 110.698 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 70.04 32.47 69.49 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 123.732 0.682 . . . . 0.0 113.848 -174.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -58.59 166.46 1.8 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.961 1.304 . . . . 0.0 112.747 175.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 26.9 m -46.79 -39.45 11.84 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.361 1.864 . . . . 0.0 114.861 -173.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.32 -83.21 0.35 Allowed Glycine 0 CA--C 1.533 1.179 0 C-N-CA 127.274 2.368 . . . . 0.0 111.137 177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -73.67 163.66 36.78 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.608 2.872 . . . . 0.0 112.827 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 125' ' ' ILE . 0.1 OUTLIER -82.21 156.58 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 125.347 1.459 . . . . 0.0 111.875 169.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 173.18 1.84 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.797 1.639 . . . . 0.0 112.506 168.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -125.42 146.64 49.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.777 1.231 . . . . 0.0 111.791 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.26 159.15 27.22 Favored Glycine 0 CA--C 1.541 1.66 0 C-N-CA 126.073 1.797 . . . . 0.0 113.799 -171.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -73.33 167.95 20.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.713 1.205 . . . . 0.0 112.707 173.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -131.56 114.17 14.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.412 1.885 . . . . 0.0 111.071 172.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -128.08 -177.88 4.31 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.182 1.793 . . . . 0.0 111.152 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 28.7 mm -59.26 140.19 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 124.006 0.922 . . . . 0.0 110.762 174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 13.6 m -121.69 119.89 33.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.878 1.671 . . . . 0.0 110.606 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.41 117.27 33.16 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.59 1.156 . . . . 0.0 110.891 175.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.426 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.4 OUTLIER -100.48 105.02 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 128.987 2.915 . . . . 0.0 109.31 178.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -133.33 156.52 47.46 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.164 -0.96 . . . . 0.0 112.262 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.56 94.31 47.76 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.03 1.332 . . . . 0.0 109.704 177.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.78 164.93 33.8 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 123.003 2.469 . . . . 0.0 111.952 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.43 -23.57 20.21 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.956 2.437 . . . . 0.0 113.819 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -67.98 141.15 56.35 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.702 0.801 . . . . 0.0 111.759 172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -77.1 178.53 6.94 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.406 1.482 . . . . 0.0 112.304 173.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.8 160.85 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.188 1.795 . . . . 0.0 111.214 173.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.251 1.18 0 C-N-CA 127.024 2.13 . . . . 0.0 112.567 -177.225 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 73.3 p -65.43 67.09 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 127.545 2.338 . . . . 0.0 115.782 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 9.3 mmt -70.19 -74.78 0.13 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.829 1.652 . . . . 0.0 112.011 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -102.99 -64.96 1.03 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.134 0.974 . . . . 0.0 113.426 -172.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -131.02 1.36 4.27 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.599 2.359 . . . . 0.0 111.274 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -69.01 170.96 8.86 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.167 1.387 . . . . 0.0 112.341 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -128.51 160.25 32.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.347 1.459 . . . . 0.0 111.75 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.93 83.2 1.78 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.345 1.858 . . . . 0.0 110.688 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.72 151.38 45.23 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.554 0.741 . . . . 0.0 112.055 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -23.77 23.8 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.214 -0.929 . . . . 0.0 113.312 -176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -70.75 -24.31 62.59 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 10.0 t -92.47 -13.75 29.49 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.678 1.991 . . . . 0.0 112.826 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.37 160.51 27.15 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.944 -1.098 . . . . 0.0 111.291 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -139.63 167.4 22.19 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.573 1.549 . . . . 0.0 110.898 -176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.14 152.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.018 1.327 . . . . 0.0 110.172 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.41 -36.49 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 121.212 -0.93 . . . . 0.0 111.581 -177.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -61.15 -24.2 66.11 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -79.19 -58.34 3.27 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.44 1.096 . . . . 0.0 110.62 168.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 24.7 t -50.38 -44.56 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.41 1.484 . . . . 0.0 112.602 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.1 t -68.12 -8.76 41.09 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.392 1.877 . . . . 0.0 113.651 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -102.8 -30.91 10.57 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.55 1.54 . . . . 0.0 112.787 170.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.1 mt -49.34 -44.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 124.408 1.083 . . . . 0.0 110.344 170.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.56 -43.65 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.33 -50.01 65.04 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 120.157 1.344 . . . . 0.0 111.384 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -33.44 75.6 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.12 -40.47 71.42 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.207 1.003 . . . . 0.0 112.97 173.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' B' ' 191' ' ' VAL . 44.3 mt -57.56 -56.39 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.215 0.916 . . . . 0.0 110.277 173.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -59.88 -32.15 70.46 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -60.81 -45.5 94.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.344 1.057 . . . . 0.0 112.452 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.92 -32.86 71.37 Favored 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 95.9 mt -62.27 -44.16 98.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.161 0.984 . . . . 0.0 110.916 173.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.49 13.08 71.27 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.103 0.859 . . . . 0.0 115.071 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.33 -4.6 26.68 Favored Glycine 0 CA--C 1.539 1.544 0 C-N-CA 125.396 1.474 . . . . 0.0 116.229 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -69.35 -179.26 1.58 Allowed 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 119.077 1.439 . . . . 0.0 112.558 170.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -99.48 -156.86 0.57 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.917 1.287 . . . . 0.0 111.759 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -50.92 158.03 0.74 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.105 1.362 . . . . 0.0 112.458 162.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -150.55 -176.23 5.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.718 1.207 . . . . 0.0 111.779 -178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.9 -100.92 0.15 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.87 1.268 . . . . 0.0 109.632 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 22.4 m -67.61 -24.31 65.46 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.937 1.295 . . . . 0.0 114.018 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.95 -41.62 78.6 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 121.035 -1.041 . . . . 0.0 112.593 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.07 -29.23 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.646 0.778 . . . . 0.0 112.545 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -63.17 -48.63 77.61 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.637 1.175 . . . . 0.0 111.391 173.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -66.41 -26.4 67.21 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 121.332 -0.855 . . . . 0.0 112.922 174.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -76.94 -54.44 6.57 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.505 -0.747 . . . . 0.0 111.23 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.3 t -56.56 -29.27 61.81 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.2 t -80.16 -53.08 7.01 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 119.497 1.044 . . . . 0.0 112.557 171.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 25.1 t30 -58.04 -37.86 75.17 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.649 1.18 . . . . 0.0 113.276 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' B' ' 170' ' ' ILE . 74.0 t -66.66 -66.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 124.844 1.257 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 93.6 t -49.66 -29.25 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.71 1.204 . . . . 0.0 111.06 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -56.45 -47.35 79.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.499 0.72 . . . . 0.0 112.752 177.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -98.73 -38.17 9.19 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.053 1.341 . . . . 0.0 113.004 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 20.6 m -56.45 -53.38 58.11 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.559 1.943 . . . . 0.0 112.116 176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -40.66 93.0 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.786 0.721 . . . . 0.0 111.303 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 35.3 p -69.14 -29.09 67.05 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.325 -0.86 . . . . 0.0 113.257 176.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -73.93 -51.73 15.16 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.662 2.385 . . . . 0.0 113.073 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.4 -28.22 69.54 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 120.61 -1.306 . . . . 0.0 113.292 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 96.2 m -58.17 -27.49 63.88 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.611 1.164 . . . . 0.0 111.117 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -90.76 -28.43 18.26 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.443 1.097 . . . . 0.0 113.607 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.8 mt -71.13 -27.06 63.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.689 0.796 . . . . 0.0 111.821 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -137.01 9.58 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 126.127 1.822 . . . . 0.0 111.949 166.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -119.76 160.55 41.97 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 125.463 1.505 . . . . 0.0 113.571 -173.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.53 115.93 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.629 2.886 . . . . 0.0 111.586 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -150.8 175.55 11.9 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.317 1.447 . . . . 0.0 111.7 175.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.26 109.05 5.05 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.78 1.232 . . . . 0.0 109.719 165.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -104.83 159.47 15.77 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.86 1.264 . . . . 0.0 109.948 167.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.9 tt -146.8 157.09 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.505 1.522 . . . . 0.0 109.863 172.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.449 HG12 ' HB2' ' B' ' 253' ' ' ALA . 33.7 m -138.87 147.27 25.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.894 1.678 . . . . 0.0 110.722 174.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -149.01 126.97 11.9 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.94 1.696 . . . . 0.0 109.628 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 7.3 p -132.41 158.42 42.04 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.635 0.774 . . . . 0.0 112.931 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . 0.501 ' C ' HD13 ' B' ' 214' ' ' ILE . 7.6 p -145.05 124.83 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 124.758 1.223 . . . . 0.0 109.703 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.2 mm -123.92 113.02 35.16 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 127.766 2.426 . . . . 0.0 107.845 -172.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 15.9 tmm? -134.64 153.12 52.13 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 122.255 1.026 . . . . 0.0 112.41 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -103.44 114.15 28.2 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.984 1.714 . . . . 0.0 112.512 -168.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -66.95 -5.51 12.98 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 127.002 2.121 . . . . 0.0 113.336 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -51.78 -24.8 6.44 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.627 2.371 . . . . 0.0 114.332 161.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 7.97 1.49 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.534 1.374 . . . . 0.0 116.534 175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -72.2 88.13 1.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.199 1.5 . . . . 0.0 113.529 -174.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.67 142.21 33.27 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.157 -0.964 . . . . 0.0 113.918 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.97 172.02 17.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.209 2.204 . . . . 0.0 111.186 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -125.18 122.53 37.32 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.803 1.241 . . . . 0.0 109.981 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.49 ' HB ' HG13 ' B' ' 278' ' ' VAL . 93.8 m -132.51 145.92 51.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.177 0.991 . . . . 0.0 108.427 174.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . 0.42 ' HB3' ' SG ' ' A' ' 69' ' ' CYS . . . -140.62 143.3 35.15 Favored 'General case' 0 C--N 1.329 -0.305 0 O-C-N 121.502 -0.749 . . . . 0.0 110.819 173.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 83.2 p -140.67 158.18 44.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.696 0.76 . . . . 0.0 111.546 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 34.5 t -103.83 5.4 35.88 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.087 0.955 . . . . 0.0 111.991 170.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 73.1 m -67.4 151.89 46.65 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 122.452 1.12 . . . . 0.0 113.73 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -163.97 162.07 23.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.672 2.389 . . . . 0.0 109.695 -171.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -95.9 144.63 26.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.642 0.777 . . . . 0.0 110.382 171.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -136.37 151.15 49.25 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.317 1.847 . . . . 0.0 110.587 173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 22.3 t -117.55 -68.19 0.94 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.695 1.198 . . . . 0.0 111.929 176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 4.6 t -83.87 -32.0 25.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.436 0.694 . . . . 0.0 112.345 177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.99 -51.18 42.09 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.859 1.664 . . . . 0.0 112.522 -173.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -154.62 -172.9 4.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 128.804 2.842 . . . . 0.0 110.053 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -120.02 131.39 8.86 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.605 1.574 . . . . 0.0 113.776 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 2.3 p -155.08 159.91 40.6 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.174 2.19 . . . . 0.0 111.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.7 t -149.66 110.36 4.28 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.762 1.225 . . . . 0.0 110.698 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.3 t -118.71 146.46 44.72 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.637 1.175 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -134.91 141.31 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.717 1.207 . . . . 0.0 110.241 -170.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.67 124.65 20.0 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.922 1.689 . . . . 0.0 112.355 -171.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -135.29 105.65 6.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.213 1.805 . . . . 0.0 110.599 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.15 150.11 40.61 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.204 1.002 . . . . 0.0 112.395 172.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 -127.87 -179.89 5.2 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.434 1.494 . . . . 0.0 110.529 176.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -48.45 75.09 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -174.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.0 t -131.6 14.68 4.94 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.492 1.917 . . . . 0.0 112.478 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 26.5 mtt -143.4 176.49 9.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.796 2.039 . . . . 0.0 109.82 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -154.11 155.91 36.28 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.325 1.05 . . . . 0.0 110.043 168.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.618 ' HB2' HD12 ' B' ' 214' ' ' ILE . 21.7 p -135.22 135.4 40.95 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.947 0.899 . . . . 0.0 111.734 175.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.7 pt -134.56 131.36 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.319 1.448 . . . . 0.0 110.394 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.13 107.68 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 126.126 1.77 . . . . 0.0 110.75 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 9.7 t -96.31 129.39 43.66 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.547 0.739 . . . . 0.0 110.139 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.449 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -126.62 147.76 49.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.977 0.911 . . . . 0.0 112.272 174.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.558 ' CE2' ' HE3' ' A' ' 64' ' ' LYS . 1.1 m-85 -117.22 149.47 40.35 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 125.966 1.706 . . . . 0.0 111.264 174.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -172.02 89.68 0.09 OUTLIER Glycine 0 C--N 1.333 0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.407 -170.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.428 ' H ' HD22 ' B' ' 256' ' ' LEU . 0.9 OUTLIER -66.47 165.22 14.81 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.883 0.849 . . . . 0.0 111.952 -178.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.4 t -102.21 160.11 14.81 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.568 1.147 . . . . 0.0 111.631 175.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.35 -58.16 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 127.074 2.15 . . . . 0.0 112.63 175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -113.82 -26.22 3.94 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.541 1.067 . . . . 0.0 114.591 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 60.25 23.75 60.3 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 118.42 1.11 . . . . 0.0 114.88 -178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -78.4 -164.57 25.66 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.171 1.843 . . . . 0.0 114.641 -174.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 74.5 p -59.47 162.28 5.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.521 1.129 . . . . 0.0 113.031 174.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.78 81.61 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 124.432 1.015 . . . . 0.0 114.392 -170.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -67.82 -173.42 0.35 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.814 1.246 . . . . 0.0 111.923 165.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 18.3 m -47.58 -39.04 15.62 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.077 1.751 . . . . 0.0 114.785 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 124.16 -74.82 0.39 Allowed Glycine 0 CA--C 1.536 1.402 0 C-N-CA 126.334 1.921 . . . . 0.0 112.27 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.07 173.67 14.1 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.654 2.903 . . . . 0.0 112.943 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . 0.529 HD13 ' H ' ' B' ' 268' ' ' ILE . 0.1 OUTLIER -85.1 154.61 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 126.65 1.98 . . . . 0.0 111.403 163.146 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.64 168.26 6.26 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.017 1.327 . . . . 0.0 112.543 166.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 92.6 mt -117.46 156.92 27.15 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.367 1.467 . . . . 0.0 111.997 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 76.97 159.83 10.43 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 125.842 1.687 . . . . 0.0 114.063 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.43 165.71 24.56 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.577 -0.955 . . . . 0.0 112.033 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -131.98 116.58 17.3 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.924 1.689 . . . . 0.0 110.701 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -126.78 -173.3 2.84 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 28.2 mm -57.8 141.89 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.661 1.184 . . . . 0.0 110.649 172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 88.7 m -125.99 96.59 4.8 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.561 1.944 . . . . 0.0 110.011 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.77 136.19 33.19 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.728 0.811 . . . . 0.0 110.81 171.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.49 HG13 ' HB ' ' B' ' 224' ' ' THR . 5.4 p -131.77 103.29 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 128.199 2.6 . . . . 0.0 109.656 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -129.78 157.95 40.78 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.487 1.515 . . . . 0.0 111.562 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -120.44 94.54 48.81 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.836 1.254 . . . . 0.0 109.37 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.1 164.66 34.05 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.053 2.502 . . . . 0.0 111.979 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.5 -22.18 21.58 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.97 2.446 . . . . 0.0 113.765 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -68.65 140.59 55.48 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.777 0.831 . . . . 0.0 111.531 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 176.04 10.13 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.45 1.5 . . . . 0.0 112.794 170.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.16 159.31 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 126.412 1.885 . . . . 0.0 111.654 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.207 2.203 . . . . 0.0 112.741 -177.58 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -81.42 164.55 21.99 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.141 0.976 . . . . 0.0 113.433 -177.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 mtm -69.97 -44.83 68.66 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.291 1.836 . . . . 0.0 112.206 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.67 -13.37 62.27 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.44 -27.73 60.74 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.396 1.078 . . . . 0.0 112.859 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -77.58 161.69 27.65 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.18 1.392 . . . . 0.0 111.354 172.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -135.48 154.08 51.53 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.506 1.122 . . . . 0.0 111.869 -176.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.55 -9.7 44.99 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.07 -10.14 13.19 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.17 1.788 . . . . 0.0 115.002 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -53.03 -27.8 21.37 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.899 1.679 . . . . 0.0 113.831 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.59 -16.72 6.63 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.154 1.538 . . . . 0.0 115.154 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 t -60.87 -27.61 68.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.321 1.448 . . . . 0.0 113.421 171.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.42 116.14 7.84 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.99 0.916 . . . . 0.0 110.829 173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -61.87 164.96 5.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.457 0.703 . . . . 0.0 111.935 174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.51 156.83 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.804 0.842 . . . . 0.0 111.398 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.3 t -57.39 -34.76 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.097 1.759 . . . . 0.0 111.523 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -60.39 -27.6 67.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.645 1.178 . . . . 0.0 113.256 175.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -78.12 -59.23 2.87 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.584 -0.698 . . . . 0.0 109.991 170.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.527 HG13 HD22 ' A' ' 56' ' ' LEU . 34.1 t -49.74 -45.91 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.502 1.521 . . . . 0.0 112.87 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.6 t -60.73 -25.26 66.32 Favored 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 125.302 1.441 . . . . 0.0 112.894 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -85.52 -37.75 19.31 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 120.51 -1.369 . . . . 0.0 113.155 171.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.0 mt -52.1 -43.6 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.515 1.126 . . . . 0.0 110.84 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -64.1 -42.15 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 118.47 -0.776 . . . . 0.0 113.032 178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.63 -52.9 54.99 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.174 1.352 . . . . 0.0 112.082 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.39 -34.11 74.8 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.54 -45.68 65.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.004 0.922 . . . . 0.0 112.882 173.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 47.2 mt -54.72 -57.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 CA-C-N 119.204 0.911 . . . . 0.0 110.415 174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -59.97 -29.92 68.76 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.8 p -66.68 -33.7 76.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.82 -34.23 52.09 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.043 1.337 . . . . 0.0 112.438 173.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 81.8 mt -61.69 -41.51 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.869 1.268 . . . . 0.0 110.926 171.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.19 15.15 81.29 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.251 0.929 . . . . 0.0 114.272 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 10.02 75.54 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.334 1.445 . . . . 0.0 115.903 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.4 m-20 -61.22 155.58 20.56 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.072 1.436 . . . . 0.0 113.056 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.78 -171.53 1.62 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 126.167 1.787 . . . . 0.0 112.286 172.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -41.41 139.29 1.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 128.743 2.817 . . . . 0.0 114.737 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -135.88 174.75 10.27 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.485 1.514 . . . . 0.0 113.163 -176.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -90.42 -97.45 0.11 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.541 1.537 . . . . 0.0 111.138 176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.8 p -89.37 -1.65 58.13 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.681 1.992 . . . . 0.0 114.326 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.31 -42.77 61.41 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.433 1.493 . . . . 0.0 113.566 -176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 25.1 t -55.08 -32.15 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -65.55 -48.77 71.28 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.655 1.182 . . . . 0.0 112.176 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -68.54 -25.99 65.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.0 m0 -76.63 -55.45 5.5 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.391 1.076 . . . . 0.0 110.918 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -54.29 -35.3 62.44 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.953 0.797 . . . . 0.0 112.186 176.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -75.68 -54.55 6.79 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 119.129 0.877 . . . . 0.0 112.761 173.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.91 -36.85 73.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.668 1.187 . . . . 0.0 113.33 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.64 -63.25 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 C-N-CA 124.177 0.991 . . . . 0.0 110.015 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 76.8 t -49.15 -30.75 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.057 0.943 . . . . 0.0 110.715 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -59.91 -35.84 75.73 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -107.02 -42.54 4.87 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.36 1.464 . . . . 0.0 112.659 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 15.5 m -54.18 -54.84 34.25 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 127.339 2.256 . . . . 0.0 112.254 175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.49 -39.07 86.37 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 118.517 0.598 . . . . 0.0 111.218 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -57.48 -52.61 64.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.203 0.601 . . . . 0.0 111.425 169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -59.77 -51.13 71.06 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.565 1.946 . . . . 0.0 114.489 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.527 HD22 HG13 ' A' ' 19' ' ' VAL . 3.7 pp -65.06 -28.64 69.61 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 120.574 -1.329 . . . . 0.0 113.734 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.1 m -59.46 -33.91 71.89 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.47 0.708 . . . . 0.0 111.071 167.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -80.66 -24.9 38.63 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.8 mt -71.26 -16.01 62.46 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 170.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.2 -111.3 3.48 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.648 1.594 . . . . 0.0 112.693 174.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -133.91 150.92 75.83 Favored Pre-proline 0 N--CA 1.477 0.876 0 C-N-CA 126.369 1.868 . . . . 0.0 112.222 -177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.6 102.58 1.42 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.98 3.12 . . . . 0.0 112.404 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -143.05 161.67 37.54 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.471 1.509 . . . . 0.0 112.109 172.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -65.5 100.07 0.47 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.96 1.704 . . . . 0.0 110.991 170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -75.02 166.14 24.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.467 1.107 . . . . 0.0 111.9 162.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -146.99 156.07 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 127.443 2.297 . . . . 0.0 108.186 164.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.69 155.21 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 121.782 -0.574 . . . . 0.0 109.455 160.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 p -134.68 137.47 43.6 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.519 1.128 . . . . 0.0 109.991 165.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -128.88 144.76 51.27 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 123.795 0.838 . . . . 0.0 111.916 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.5 t -131.82 99.5 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 126.298 1.839 . . . . 0.0 108.841 -171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.501 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -95.75 99.96 10.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.621 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.89 96.18 2.76 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.124 1.369 . . . . 0.0 111.292 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -149.35 159.06 44.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.305 1.442 . . . . 0.0 110.458 154.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -153.48 -80.53 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.07 1.748 . . . . 0.0 110.059 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -84.0 -18.85 35.78 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.895 1.278 . . . . 0.0 113.775 175.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.68 -2.26 3.71 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.784 1.659 . . . . 0.0 115.093 -174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.05 179.08 2.45 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.967 1.707 . . . . 0.0 114.167 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -161.1 -172.29 28.23 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 126.812 2.149 . . . . 0.0 112.356 177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.61 179.64 6.36 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.255 1.822 . . . . 0.0 111.986 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -106.87 111.21 23.62 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 121.469 -0.77 . . . . 0.0 111.1 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.431 ' HB ' HG13 ' A' ' 135' ' ' VAL . 16.6 m -116.93 140.71 49.15 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.474 1.11 . . . . 0.0 109.972 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.02 138.95 34.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.223 0.535 . . . . 0.0 111.733 177.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.5 m -139.56 120.81 14.85 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.641 0.776 . . . . 0.0 110.429 -166.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 t -79.97 66.23 5.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 122.319 1.057 . . . . 0.0 110.093 174.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.443 ' SG ' HD11 ' B' ' 209' ' ' ILE . 3.9 m -114.04 171.18 7.76 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.513 1.925 . . . . 0.0 110.787 176.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -144.07 129.58 19.03 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.986 1.314 . . . . 0.0 109.86 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.8 t-105 -76.98 125.98 30.22 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.434 1.094 . . . . 0.0 109.846 174.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -146.01 90.06 1.94 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.488 1.115 . . . . 0.0 111.336 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.6 t -68.1 -60.57 2.39 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 125.173 1.389 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.7 t -88.08 -33.67 18.21 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.476 1.11 . . . . 0.0 112.304 175.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 m -74.75 -38.24 62.27 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -165.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.76 -134.47 0.14 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 126.335 1.854 . . . . 0.0 109.422 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -136.96 150.59 20.66 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 125.316 1.436 . . . . 0.0 113.464 171.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 28.8 p -162.63 157.3 21.74 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.967 1.307 . . . . 0.0 112.074 174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 43.6 t -165.25 157.99 15.95 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.302 1.841 . . . . 0.0 109.378 165.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.5 t -143.24 139.14 30.09 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.28 -1.512 . . . . 0.0 111.13 175.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.1 138.31 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.16 1.384 . . . . 0.0 109.658 -170.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.25 119.08 11.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.733 1.613 . . . . 0.0 111.023 -166.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -135.83 141.74 44.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.868 1.267 . . . . 0.0 112.149 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.65 165.7 24.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 174.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.49 -174.12 4.59 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.738 1.215 . . . . 0.0 110.161 178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.17 -62.41 0.95 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 126.294 1.837 . . . . 0.0 113.536 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 4.8 t -139.18 -6.59 1.39 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.987 1.715 . . . . 0.0 113.124 177.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 6.9 ptm -129.17 78.81 1.88 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.642 1.577 . . . . 0.0 112.111 -165.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -51.27 133.5 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.165 1.386 . . . . 0.0 111.306 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.501 ' CB ' HD12 ' A' ' 71' ' ' ILE . 14.3 p -113.63 136.33 52.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.951 1.3 . . . . 0.0 111.767 -176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 pt -129.1 126.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.81 1.644 . . . . 0.0 110.994 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.78 122.98 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.221 1.808 . . . . 0.0 110.931 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.2 t -115.64 118.42 33.05 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.788 1.235 . . . . 0.0 110.675 -178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -103.98 140.8 37.22 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.262 1.825 . . . . 0.0 112.15 -178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -133.41 148.51 51.8 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.339 1.456 . . . . 0.0 109.67 174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -138.1 127.44 3.85 Favored Glycine 0 N--CA 1.465 0.569 0 C-N-CA 125.591 1.567 . . . . 0.0 109.344 175.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -104.95 133.43 49.76 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.63 0.772 . . . . 0.0 111.419 -168.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.5 m -134.65 132.83 39.41 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.959 1.304 . . . . 0.0 112.305 -169.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.3 pp -118.3 -1.86 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.28 -2.19 64.11 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.936 1.255 . . . . 0.0 115.702 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.57 15.32 77.56 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 118.775 1.288 . . . . 0.0 115.139 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -54.16 114.8 4.49 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.877 1.703 . . . . 0.0 112.811 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.2 t -135.01 172.51 12.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.861 1.665 . . . . 0.0 111.993 -173.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 135.87 36.65 0.2 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.092 1.805 . . . . 0.0 114.907 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -54.35 166.53 0.41 Allowed 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 126.088 1.755 . . . . 0.0 113.842 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.3 t -56.2 -43.78 78.84 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.711 1.605 . . . . 0.0 113.264 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -103.11 176.85 24.87 Favored Glycine 0 CA--C 1.54 1.633 0 C-N-CA 125.121 1.344 . . . . 0.0 113.393 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -66.05 145.75 80.18 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.826 2.35 . . . . 0.0 111.101 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pt -66.66 154.82 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 121.097 0.475 . . . . 0.0 111.463 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.75 166.66 25.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.56 1.144 . . . . 0.0 112.674 172.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -64.96 126.66 28.71 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.187 1.395 . . . . 0.0 109.786 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -157.07 162.78 31.99 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 124.909 1.242 . . . . 0.0 112.573 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.9 170.55 16.83 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.478 1.511 . . . . 0.0 110.961 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -138.1 164.4 29.22 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.36 1.464 . . . . 0.0 112.289 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -132.54 174.46 10.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.364 1.866 . . . . 0.0 111.083 -177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.8 mm -50.15 134.34 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 126.17 1.788 . . . . 0.0 111.399 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 60.9 m -98.32 92.32 5.64 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.206 1.402 . . . . 0.0 110.242 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -92.55 149.83 21.12 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 121.355 -0.841 . . . . 0.0 111.701 171.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.431 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.5 OUTLIER -143.39 97.79 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 127.569 2.347 . . . . 0.0 108.686 179.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -144.72 166.26 25.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.048 1.339 . . . . 0.0 112.539 -177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -120.34 89.09 43.21 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.367 1.467 . . . . 0.0 109.622 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -74.87 167.35 27.26 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.426 2.751 . . . . 0.0 112.196 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.97 -32.52 17.55 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.73 2.287 . . . . 0.0 113.881 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.96 -62.92 0.09 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.012 1.325 . . . . 0.0 112.467 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -97.04 178.01 5.41 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.575 1.95 . . . . 0.0 112.039 -172.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.79 172.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.41 1.484 . . . . 0.0 112.754 -175.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.254 1.299 0 C-N-CA 127.452 2.301 . . . . 0.0 112.244 179.851 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.9 t -87.31 162.84 17.17 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.807 0.843 . . . . 0.0 112.649 176.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 7.1 mtm -70.65 -44.64 66.7 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.829 1.652 . . . . 0.0 112.32 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.94 -12.69 61.8 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -74.31 -27.58 60.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.433 1.093 . . . . 0.0 112.944 176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -77.48 162.48 27.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.202 1.401 . . . . 0.0 111.473 172.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -136.44 153.92 50.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.482 1.113 . . . . 0.0 111.965 -176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.82 47.34 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 -176.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.36 -9.95 14.47 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.065 1.746 . . . . 0.0 114.998 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -53.37 -27.54 24.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 113.834 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -56.91 -16.68 7.29 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 115.146 1.536 . . . . 0.0 115.146 175.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 3.4 t -60.17 -27.13 66.86 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.347 1.459 . . . . 0.0 113.274 171.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.32 114.67 6.98 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.006 0.922 . . . . 0.0 111.206 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.39 166.9 2.78 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.196 0.999 . . . . 0.0 112.788 171.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.52 156.99 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.415 1.086 . . . . 0.0 111.546 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.8 t -57.99 -38.91 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.618 1.167 . . . . 0.0 111.469 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.27 -26.47 67.79 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.749 1.22 . . . . 0.0 113.565 176.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -76.86 -60.71 2.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.883 0.873 . . . . 0.0 110.421 171.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.617 HG13 HD22 ' B' ' 199' ' ' LEU . 51.1 t -49.23 -45.95 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 126.001 1.72 . . . . 0.0 112.194 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 21.7 t -59.74 -25.15 64.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.272 1.429 . . . . 0.0 112.98 177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -86.93 -37.72 17.34 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.604 -1.31 . . . . 0.0 113.05 171.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.4 mt -51.95 -44.12 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.975 0.91 . . . . 0.0 110.979 175.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 -41.58 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -52.53 49.96 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.917 1.235 . . . . 0.0 111.959 177.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -32.66 72.56 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -45.78 56.94 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 112.868 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.423 ' HA ' HG21 ' B' ' 191' ' ' VAL . 51.6 mt -54.43 -57.37 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.275 0.943 . . . . 0.0 110.327 174.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -59.75 -30.09 68.62 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 9.7 p -66.7 -33.51 75.8 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 172.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -78.15 -33.55 50.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.057 1.343 . . . . 0.0 112.535 173.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 81.9 mt -61.77 -40.4 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.844 1.258 . . . . 0.0 110.969 171.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 74.27 15.04 80.28 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.208 0.908 . . . . 0.0 114.327 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 85.72 9.44 78.17 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 125.315 1.436 . . . . 0.0 115.797 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -61.19 155.34 21.04 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.119 1.46 . . . . 0.0 113.103 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -75.89 -171.44 1.63 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.198 1.799 . . . . 0.0 112.242 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -41.35 139.44 1.04 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 128.739 2.816 . . . . 0.0 114.808 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -135.93 174.3 10.76 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.495 1.518 . . . . 0.0 113.19 -176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -89.21 -96.23 0.1 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.658 1.583 . . . . 0.0 111.292 176.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 40.7 p -90.67 -1.71 57.86 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.803 2.041 . . . . 0.0 114.354 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.1 mmpp? -51.6 -42.48 61.99 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.422 1.489 . . . . 0.0 113.7 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.3 t -54.98 -31.46 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -66.05 -49.08 68.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.794 1.238 . . . . 0.0 112.139 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -68.33 -26.19 65.48 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 173.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -76.48 -55.57 5.41 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.205 1.002 . . . . 0.0 110.941 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 10.6 t -55.36 -32.45 62.59 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.928 0.786 . . . . 0.0 112.399 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.3 t -77.54 -55.7 5.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.281 0.946 . . . . 0.0 112.756 172.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -57.65 -36.19 71.55 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.884 1.22 . . . . 0.0 113.405 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' B' ' 170' ' ' ILE . 69.6 t -67.74 -63.4 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.77 0 C-N-CA 124.13 0.972 . . . . 0.0 109.964 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.77 -31.14 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.302 1.041 . . . . 0.0 110.722 176.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.82 -35.36 74.56 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -107.62 -42.41 4.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.42 1.488 . . . . 0.0 112.663 177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.8 m -54.62 -54.18 44.91 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 127.417 2.287 . . . . 0.0 112.379 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.95 -38.94 87.63 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.374 0.534 . . . . 0.0 111.187 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 23.8 t -58.05 -51.98 67.42 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.307 0.643 . . . . 0.0 111.522 169.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -59.58 -51.54 69.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.576 1.95 . . . . 0.0 114.273 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.617 HD22 HG13 ' B' ' 162' ' ' VAL . 4.0 pp -65.48 -28.59 69.32 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.622 -1.299 . . . . 0.0 113.881 -177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 4.6 m -58.99 -32.46 69.71 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.397 0.679 . . . . 0.0 111.059 168.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -81.09 -27.27 35.7 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 121.692 -0.63 . . . . 0.0 112.58 178.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 9.8 mt -70.4 -21.21 62.87 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.32 -111.72 3.36 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.013 1.292 . . . . 0.0 112.364 171.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 1.4 mmmt -133.51 152.22 78.74 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 125.926 1.69 . . . . 0.0 112.37 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.42 99.96 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.891 3.061 . . . . 0.0 112.107 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -142.4 162.96 34.14 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.544 1.537 . . . . 0.0 112.196 174.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -66.39 101.95 0.81 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.191 1.796 . . . . 0.0 111.085 173.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -80.04 165.07 22.92 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.86 1.264 . . . . 0.0 111.908 164.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . 0.443 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.7 tt -149.14 157.6 6.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 127.781 2.432 . . . . 0.0 108.236 164.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.9 m -137.72 155.67 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 161.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 1.2 p -135.15 134.25 40.0 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 124.672 1.189 . . . . 0.0 109.59 166.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 8.3 p -128.02 148.57 50.54 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.902 0.881 . . . . 0.0 112.505 175.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 83.9 t -133.27 104.24 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.195 1.798 . . . . 0.0 109.061 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 2.5 mm -99.12 109.22 23.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 107.837 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.77 159.1 35.83 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.284 1.433 . . . . 0.0 111.445 -176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -69.23 130.06 41.59 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.525 1.53 . . . . 0.0 112.712 -173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -80.88 -4.13 53.73 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.171 2.189 . . . . 0.0 114.116 -176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 35.7 t30 -58.45 -20.38 44.58 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 126.436 1.894 . . . . 0.0 114.639 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 131.67 5.03 3.72 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.756 1.645 . . . . 0.0 114.614 -177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -90.69 178.4 6.08 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 113.114 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -175.1 -177.53 44.26 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 126.43 1.966 . . . . 0.0 111.76 178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.35 179.85 7.24 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.487 1.515 . . . . 0.0 112.315 -177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -109.96 109.96 20.74 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 118.59 0.632 . . . . 0.0 111.411 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.5 ' HB ' HG13 ' B' ' 278' ' ' VAL . 35.7 m -113.85 138.49 50.22 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.829 0.852 . . . . 0.0 110.393 174.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -136.67 134.04 36.84 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.076 0.551 . . . . 0.0 111.293 175.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 3.2 m -136.07 119.6 17.01 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.793 0.837 . . . . 0.0 110.114 -166.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.1 t -79.88 64.88 4.86 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.413 1.101 . . . . 0.0 109.975 174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.0 m -113.01 170.83 7.93 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.605 1.962 . . . . 0.0 110.641 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -143.79 132.07 21.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.915 1.286 . . . . 0.0 109.899 -170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -76.83 124.6 27.95 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.459 1.104 . . . . 0.0 109.618 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -142.74 84.23 1.84 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.843 1.257 . . . . 0.0 110.976 -175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.5 t -65.11 -62.08 1.76 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.274 1.429 . . . . 0.0 112.474 -175.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 35.8 t -88.48 -28.65 20.69 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.287 1.035 . . . . 0.0 112.535 175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 2.1 m -77.08 -38.23 52.88 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 121.655 -0.653 . . . . 0.0 112.63 -166.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -137.18 -134.75 0.14 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.211 1.804 . . . . 0.0 109.689 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -135.81 150.92 20.49 Favored Glycine 0 CA--C 1.537 1.463 0 C-N-CA 125.381 1.467 . . . . 0.0 113.272 169.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 31.3 p -162.6 156.74 21.1 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.159 1.384 . . . . 0.0 111.915 175.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.6 162.59 16.63 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 126.342 1.857 . . . . 0.0 109.644 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 6.2 t -146.49 141.14 26.77 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 120.392 -1.442 . . . . 0.0 110.78 174.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 4.8 t -132.5 136.52 55.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 124.973 1.309 . . . . 0.0 109.509 -171.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.38 121.81 19.4 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.45 1.5 . . . . 0.0 111.394 -171.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.8 m95 -130.43 169.89 14.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.621 1.569 . . . . 0.0 110.912 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.65 164.83 14.38 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.043 1.337 . . . . 0.0 111.89 178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -150.18 -177.15 5.77 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.382 1.473 . . . . 0.0 109.458 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.55 -71.15 0.08 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 127.212 2.205 . . . . 0.0 114.055 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.0 t -138.32 16.41 2.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.489 1.516 . . . . 0.0 113.167 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.78 121.83 13.74 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.598 1.559 . . . . 0.0 110.987 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -79.08 152.2 30.97 Favored 'General case' 0 CA--C 1.542 0.673 0 O-C-N 121.215 -0.928 . . . . 0.0 110.558 174.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 23.1 p -133.46 115.7 15.11 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.388 0.675 . . . . 0.0 112.501 -173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.6 pt -122.91 129.62 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.432 1.493 . . . . 0.0 111.565 -177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.25 121.3 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 126.485 1.914 . . . . 0.0 111.044 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.5 t -112.95 121.9 46.03 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.774 1.23 . . . . 0.0 110.627 -178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -108.4 141.44 40.24 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.289 1.836 . . . . 0.0 112.392 -176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -134.44 147.95 50.52 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.404 1.482 . . . . 0.0 109.697 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -138.09 125.18 3.15 Favored Glycine 0 N--CA 1.464 0.515 0 C-N-CA 125.698 1.618 . . . . 0.0 109.493 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -102.66 132.14 48.97 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.626 0.77 . . . . 0.0 111.783 -167.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 52.1 m -134.33 132.21 39.25 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.041 1.337 . . . . 0.0 112.483 -169.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.3 pp -117.91 -1.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -94.18 -2.17 64.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.86 1.219 . . . . 0.0 115.717 -175.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.61 15.35 77.65 Favored Glycine 0 CA--C 1.54 1.617 0 CA-C-N 118.777 1.288 . . . . 0.0 115.214 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -54.48 113.58 3.56 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 125.91 1.719 . . . . 0.0 113.003 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 23.1 t -131.09 173.48 10.97 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.182 1.793 . . . . 0.0 112.025 -173.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 135.62 34.81 0.24 Allowed Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.225 1.869 . . . . 0.0 114.996 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -55.2 167.16 0.47 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 126.044 1.738 . . . . 0.0 113.856 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 23.0 t -58.6 -41.72 86.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.993 1.317 . . . . 0.0 113.281 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -105.28 177.83 23.22 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 125.327 1.441 . . . . 0.0 113.119 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -66.07 149.95 85.55 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.856 2.371 . . . . 0.0 111.669 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -69.05 157.7 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 122.897 0.479 . . . . 0.0 111.578 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.45 167.44 26.21 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.373 1.069 . . . . 0.0 112.868 174.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 18.9 mt -67.21 120.49 13.85 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.145 1.378 . . . . 0.0 109.978 171.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -151.4 161.38 29.15 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.114 1.34 . . . . 0.0 112.746 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.59 170.41 16.97 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.618 1.567 . . . . 0.0 110.885 177.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.34 164.69 28.65 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.389 1.476 . . . . 0.0 112.296 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -132.29 175.12 9.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 126.421 1.888 . . . . 0.0 111.135 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.9 mm -50.1 132.67 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 126.016 1.727 . . . . 0.0 111.385 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 57.1 m -95.72 88.62 5.04 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.086 1.354 . . . . 0.0 110.004 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -92.12 150.04 21.16 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.277 -0.89 . . . . 0.0 111.42 170.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.4 p -148.63 102.07 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.747 2.019 . . . . 0.0 109.444 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -143.89 167.12 23.07 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.839 1.655 . . . . 0.0 111.794 -177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -116.59 89.05 26.56 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 124.993 1.317 . . . . 0.0 109.755 174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -74.55 167.19 27.68 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.357 2.705 . . . . 0.0 112.238 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.02 -32.87 16.69 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.837 2.358 . . . . 0.0 113.833 -178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -62.54 0.08 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.935 1.294 . . . . 0.0 112.468 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -98.43 178.02 5.16 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.61 1.964 . . . . 0.0 111.97 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -124.82 172.09 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.3 1.44 . . . . 0.0 112.802 -174.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.253 1.262 0 C-N-CA 127.462 2.305 . . . . 0.0 112.299 -179.918 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.493 -0.643 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -70.51 -171.19 0.46 Allowed 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 126.344 1.858 . . . . 0.0 113.148 173.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.7 tpt -46.14 -57.03 4.86 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.609 1.963 . . . . 0.0 113.814 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.498 ' HG3' ' H ' ' A' ' 5' ' ' ASP 0.286 11.0 pt-20 -112.27 -77.25 0.58 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.577 0.751 . . . . 0.0 112.959 -179.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.498 ' H ' ' HG3' ' A' ' 4' ' ' GLU . 20.3 t70 -125.37 -14.02 6.51 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.829 1.652 . . . . 0.0 111.645 166.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -163.57 175.09 11.01 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.863 2.065 . . . . 0.0 113.292 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -67.96 178.72 1.69 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.9 2.08 . . . . 0.0 112.853 172.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -119.29 46.3 1.92 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 126.258 1.823 . . . . 0.0 112.781 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.84 4.67 2.39 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -52.42 -26.25 12.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.036 1.735 . . . . 0.0 114.644 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -58.25 -17.58 20.38 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 172.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.0 t -61.53 -26.25 67.82 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.975 1.71 . . . . 0.0 113.812 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.87 155.6 17.85 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.658 1.183 . . . . 0.0 110.882 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -125.11 165.3 18.47 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.854 1.261 . . . . 0.0 110.496 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -135.87 142.51 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.762 1.225 . . . . 0.0 110.138 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 p -50.61 -41.81 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.808 1.643 . . . . 0.0 113.813 178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -59.35 -29.8 67.92 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.291 1.036 . . . . 0.0 112.93 174.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.5 tp10 -76.36 -56.11 4.94 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.41 1.084 . . . . 0.0 110.736 171.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 56' ' ' LEU . 9.5 t -48.25 -44.34 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 124.538 1.135 . . . . 0.0 112.277 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -68.23 -6.84 25.8 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.474 1.51 . . . . 0.0 114.12 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -107.11 -32.73 7.7 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.538 1.935 . . . . 0.0 112.662 170.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.9 mt -50.29 -42.76 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 119.277 0.944 . . . . 0.0 110.133 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.7 p -59.85 -43.85 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 121.463 -0.773 . . . . 0.0 113.085 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -51.77 56.15 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.923 1.238 . . . . 0.0 111.132 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 -34.01 77.04 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.3 -37.46 63.63 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.706 0.803 . . . . 0.0 112.839 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 48' ' ' VAL . 57.2 mt -59.43 -59.54 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 119.337 0.971 . . . . 0.0 109.544 173.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.57 -31.6 70.72 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.0 t -58.71 -50.5 73.68 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.263 1.025 . . . . 0.0 112.209 169.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.96 -31.98 72.08 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 87.9 mt -59.43 -44.43 92.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.384 1.073 . . . . 0.0 110.973 174.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.19 12.0 74.56 Favored Glycine 0 CA--C 1.54 1.656 0 N-CA-C 115.186 0.834 . . . . 0.0 115.186 -177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.11 -1.93 26.94 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.733 1.453 . . . . 0.0 116.733 171.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -66.23 170.06 6.35 Favored 'General case' 0 CA--C 1.555 1.17 0 CA-C-N 119.347 1.574 . . . . 0.0 112.004 169.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -99.75 -147.24 0.34 Allowed 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.742 1.617 . . . . 0.0 111.993 -177.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -68.23 103.07 1.49 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.037 2.135 . . . . 0.0 111.28 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -92.95 173.06 7.93 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.291 1.437 . . . . 0.0 112.645 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -84.2 -112.18 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.469 1.108 . . . . 0.0 110.367 169.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 19.7 m -61.95 -20.32 63.7 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.576 1.55 . . . . 0.0 114.659 -175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mmtm -56.05 -41.84 75.66 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.138 -0.976 . . . . 0.0 112.501 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.0 t -54.77 -36.1 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.526 1.131 . . . . 0.0 112.675 175.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -66.11 -47.85 72.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.785 0.721 . . . . 0.0 112.42 176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -65.17 -24.06 67.28 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.029 0.831 . . . . 0.0 112.466 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.66 -53.63 6.96 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.568 0.747 . . . . 0.0 111.61 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.8 t -56.2 -30.55 62.44 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 118.816 0.734 . . . . 0.0 112.588 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -78.85 -58.43 3.25 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.189 0.904 . . . . 0.0 112.671 170.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -58.21 -39.21 78.42 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.048 1.295 . . . . 0.0 113.538 -174.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 27' ' ' ILE . 84.6 t -68.26 -62.42 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 123.89 0.876 . . . . 0.0 109.956 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.5 t -50.04 -29.55 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.46 1.104 . . . . 0.0 110.855 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -56.27 -52.01 66.07 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.609 0.763 . . . . 0.0 112.01 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -92.35 -38.62 11.93 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.91 1.284 . . . . 0.0 112.634 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 34.5 m -61.27 -53.16 60.35 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 127.402 2.281 . . . . 0.0 112.431 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.04 -37.86 84.1 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.28 0.562 . . . . 0.0 111.003 176.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.7 m -65.96 -29.63 70.06 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 172.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -77.86 -50.28 12.59 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 127.421 2.289 . . . . 0.0 112.592 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.52 HD22 HG13 ' A' ' 19' ' ' VAL . 4.1 pp -65.18 -25.74 67.85 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 120.856 -1.152 . . . . 0.0 113.786 178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 55.3 m -57.53 -32.82 67.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.564 1.146 . . . . 0.0 110.848 167.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -84.27 -30.55 25.55 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 33.5 mt -69.56 -31.92 70.4 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.588 0.355 . . . . 0.0 111.105 170.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.04 -137.79 4.07 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.013 1.292 . . . . 0.0 111.976 171.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.75 158.76 39.61 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 125.154 1.382 . . . . 0.0 112.791 179.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.44 109.46 2.45 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.514 2.809 . . . . 0.0 111.161 175.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.96 173.81 12.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.763 1.225 . . . . 0.0 112.123 176.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -74.23 112.08 10.04 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.901 1.28 . . . . 0.0 110.537 168.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -112.88 134.85 54.2 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.967 1.307 . . . . 0.0 109.34 170.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.6 tt -118.06 152.36 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 126.369 1.868 . . . . 0.0 109.158 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.98 154.53 21.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.331 1.052 . . . . 0.0 110.218 169.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 t -146.84 153.38 40.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.775 168.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 22.3 p -147.18 156.33 42.88 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.076 0.95 . . . . 0.0 112.737 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 56.0 t -133.28 121.27 42.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 125.442 1.497 . . . . 0.0 108.993 177.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.64 118.21 53.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 126.876 2.07 . . . . 0.0 107.507 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.95 161.78 35.78 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.52 1.528 . . . . 0.0 110.751 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -130.1 157.48 42.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 120.745 -1.222 . . . . 0.0 113.99 172.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -76.44 -7.92 56.07 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.286 1.435 . . . . 0.0 114.368 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -61.39 -16.29 45.02 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.536 1.934 . . . . 0.0 114.263 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 127.04 30.57 0.79 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.101 1.334 . . . . 0.0 115.301 174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.26 73.69 0.49 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.977 1.311 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.9 95.24 0.23 Allowed Glycine 0 N--CA 1.468 0.776 0 C-N-CA 126.192 1.853 . . . . 0.0 115.049 -173.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.6 pp -125.55 162.32 25.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.773 1.629 . . . . 0.0 111.892 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.05 97.73 5.06 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.815 1.246 . . . . 0.0 108.622 170.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.2 m -105.69 136.39 45.38 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.821 0.848 . . . . 0.0 109.13 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -141.21 119.57 12.23 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 123.84 0.856 . . . . 0.0 110.542 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.4 p -125.08 139.7 53.55 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.929 0.871 . . . . 0.0 111.378 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.2 m -87.19 16.17 5.45 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.664 0.785 . . . . 0.0 112.277 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.404 ' SG ' HD11 ' B' ' 209' ' ' ILE . 24.7 m -70.7 166.22 21.3 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.345 1.058 . . . . 0.0 112.163 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -156.3 151.44 26.45 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.868 1.667 . . . . 0.0 110.769 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -78.92 127.98 32.71 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 121.474 -0.767 . . . . 0.0 110.005 174.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -138.78 139.4 38.26 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.245 1.018 . . . . 0.0 112.144 169.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.4 t -134.44 -38.13 0.84 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.607 1.563 . . . . 0.0 113.219 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.4 t -89.68 -43.22 10.87 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.35 1.46 . . . . 0.0 111.299 173.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.09 -43.35 87.55 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.965 1.706 . . . . 0.0 112.416 -176.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.68 -161.67 0.94 Allowed 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 126.463 1.905 . . . . 0.0 111.377 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.41 114.66 4.49 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.873 1.702 . . . . 0.0 115.944 -176.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 60.8 m -139.45 176.21 8.91 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 127.125 2.17 . . . . 0.0 111.602 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 44.4 t -158.84 131.49 6.95 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 127.002 2.121 . . . . 0.0 109.208 166.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.9 t -139.11 146.02 40.18 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 119.825 -1.797 . . . . 0.0 112.436 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.0 t -139.19 137.85 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.951 1.3 . . . . 0.0 110.259 -167.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.61 114.91 16.63 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.279 1.432 . . . . 0.0 111.695 -177.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.403 ' CH2' HG21 ' A' ' 27' ' ' ILE . 8.4 m95 -121.5 97.7 5.62 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.741 1.616 . . . . 0.0 109.557 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -63.75 168.83 4.56 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.356 -0.84 . . . . 0.0 112.337 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -139.89 -177.83 5.16 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.598 1.159 . . . . 0.0 111.41 176.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.34 -44.39 88.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.857 1.663 . . . . 0.0 112.93 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 10.8 t -135.29 -30.12 1.05 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.251 1.42 . . . . 0.0 113.679 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.6 ptp -87.25 176.81 7.38 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.962 -1.086 . . . . 0.0 112.506 171.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.55 150.54 30.45 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.663 1.185 . . . . 0.0 111.639 169.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.2 p -136.59 142.86 43.35 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.262 1.029 . . . . 0.0 112.346 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.39 135.13 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 125.701 1.6 . . . . 0.0 109.978 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.65 131.5 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 C-N-CA 125.903 1.681 . . . . 0.0 110.255 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 45.2 p -125.07 147.51 48.95 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.582 0.753 . . . . 0.0 111.295 177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.56 136.47 47.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 127.068 2.147 . . . . 0.0 110.967 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -135.42 157.99 45.5 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.792 1.637 . . . . 0.0 108.982 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 161.24 85.17 0.05 OUTLIER Glycine 0 N--CA 1.464 0.554 0 O-C-N 121.231 -0.918 . . . . 0.0 111.442 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.449 HD22 ' H ' ' A' ' 113' ' ' LEU . 0.4 OUTLIER -69.02 153.9 42.99 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.035 0.934 . . . . 0.0 110.085 -178.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.1 m -154.58 82.06 1.1 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.455 0.702 . . . . 0.0 111.608 -171.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.01 -14.66 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -92.31 8.38 77.44 Favored Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.327 1.918 . . . . 0.0 115.733 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 135.66 30.4 0.33 Allowed Glycine 0 CA--C 1.537 1.444 0 CA-C-N 119.058 1.429 . . . . 0.0 115.771 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -72.93 -162.0 6.49 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.963 1.744 . . . . 0.0 115.149 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 5.8 t -57.55 159.35 5.07 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.796 0.838 . . . . 0.0 112.156 172.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.38 19.03 9.66 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 124.466 1.031 . . . . 0.0 113.987 -165.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -61.63 173.18 1.02 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.934 1.294 . . . . 0.0 112.383 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.3 m -67.52 23.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.145 2.178 . . . . 0.0 115.188 176.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.05 -172.51 33.74 Favored Glycine 0 CA--C 1.543 1.792 0 C-N-CA 126.84 2.162 . . . . 0.0 113.878 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.7 146.15 65.81 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 123.27 2.647 . . . . 0.0 112.172 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.6 pt -81.32 164.9 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.232 1.015 . . . . 0.0 111.7 168.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.23 162.76 34.66 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.125 2.17 . . . . 0.0 110.795 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.0 mt -135.07 120.39 19.03 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.961 1.304 . . . . 0.0 109.498 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -161.65 153.86 24.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.997 1.284 . . . . 0.0 112.32 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.8 ttm -75.83 160.72 29.66 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.536 0.734 . . . . 0.0 112.213 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -140.27 83.49 1.91 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.16 1.384 . . . . 0.0 112.016 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -130.6 -179.92 5.57 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.761 1.224 . . . . 0.0 111.559 177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 33.4 mm -54.3 134.2 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.105 1.362 . . . . 0.0 110.93 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 77.6 m -115.84 91.44 3.6 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.968 1.707 . . . . 0.0 110.245 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -90.98 147.48 23.06 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.447 -0.783 . . . . 0.0 111.384 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.89 103.51 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 128.019 2.527 . . . . 0.0 108.708 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.58 130.6 21.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.059 1.344 . . . . 0.0 111.826 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -144.0 91.44 6.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.453 1.501 . . . . 0.0 109.911 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.33 167.55 21.93 Favored 'Trans proline' 0 CA--C 1.547 1.167 0 C-N-CA 123.259 2.639 . . . . 0.0 112.8 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.41 -14.6 31.03 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.43 2.754 . . . . 0.0 113.442 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -56.95 129.99 44.04 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.376 1.07 . . . . 0.0 110.882 171.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.39 171.4 16.09 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.017 2.127 . . . . 0.0 110.316 -175.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.2 161.75 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.655 1.582 . . . . 0.0 111.659 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 38.2 t . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.61 1.964 . . . . 0.0 110.604 -177.648 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.725 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 23.0 m -138.7 -47.14 0.5 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.286 1.034 . . . . 0.0 113.724 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 14.6 tpt -66.38 -43.3 86.27 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.145 0.978 . . . . 0.0 113.031 -177.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -109.47 -25.01 10.72 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 114.055 -176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -85.99 -20.33 29.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.558 1.143 . . . . 0.0 113.353 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -118.75 162.72 17.97 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.837 2.055 . . . . 0.0 110.618 168.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -130.19 165.49 22.26 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.524 1.53 . . . . 0.0 110.994 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.54 39.39 0.83 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.262 1.425 . . . . 0.0 113.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.88 -2.71 5.51 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -53.44 -25.61 16.73 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.252 1.821 . . . . 0.0 114.547 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -59.22 -19.16 43.15 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 173.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 3.8 t -58.86 -22.44 59.09 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.533 1.933 . . . . 0.0 114.555 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -111.26 139.98 46.21 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.226 1.41 . . . . 0.0 109.944 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.484 ' CZ ' HD11 ' B' ' 165' ' ' ILE . 0.0 OUTLIER -111.98 162.32 15.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.938 0.895 . . . . 0.0 111.643 175.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.79 135.9 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.656 1.582 . . . . 0.0 109.968 -175.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 2.7 p -48.62 -42.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 127.094 2.158 . . . . 0.0 113.451 -178.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.29 -31.33 65.51 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.647 1.179 . . . . 0.0 112.92 175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -87.61 -49.21 7.32 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-O 118.376 -0.821 . . . . 0.0 111.965 172.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 21.6 t -45.7 -41.54 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 120.114 1.325 . . . . 0.0 112.263 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.1 t -70.89 -8.28 51.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.113 1.765 . . . . 0.0 115.036 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 19.0 t30 -103.34 -31.44 10.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.762 2.425 . . . . 0.0 112.581 171.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . 0.484 HD11 ' CZ ' ' B' ' 157' ' ' PHE . 33.8 mt -50.56 -42.65 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.226 1.01 . . . . 0.0 110.296 171.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.6 p -60.39 -42.89 92.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -51.9 56.13 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 119.859 1.208 . . . . 0.0 111.058 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.37 -33.64 76.33 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.17 -36.56 61.49 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.626 0.77 . . . . 0.0 112.976 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' B' ' 191' ' ' VAL . 55.1 mt -59.75 -59.43 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 119.291 0.95 . . . . 0.0 109.558 173.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.32 -31.72 70.56 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.0 t -58.57 -50.3 74.31 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.372 1.069 . . . . 0.0 112.16 169.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -68.23 -32.15 72.16 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 88.7 mt -59.72 -44.28 93.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.327 1.051 . . . . 0.0 110.867 174.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.87 12.17 75.08 Favored Glycine 0 CA--C 1.539 1.584 0 N-CA-C 115.13 0.812 . . . . 0.0 115.13 -177.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 112.18 -1.96 26.83 Favored Glycine 0 CA--C 1.538 1.53 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 171.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -66.35 170.53 5.86 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-N 119.319 1.559 . . . . 0.0 112.025 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.57 -146.31 0.34 Allowed 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.853 1.661 . . . . 0.0 112.09 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -70.03 97.76 1.21 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.022 2.129 . . . . 0.0 111.365 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -84.57 173.95 10.39 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.267 1.427 . . . . 0.0 112.8 177.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -85.77 -106.66 0.05 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.461 1.105 . . . . 0.0 110.557 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 30.0 m -66.1 -20.73 66.25 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 mmtm -55.6 -38.75 69.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.054 0.942 . . . . 0.0 112.612 176.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -53.46 -35.24 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.939 0.896 . . . . 0.0 113.304 175.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -69.08 -46.37 67.96 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.8 0.84 . . . . 0.0 111.992 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -65.68 -24.92 67.11 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.501 0.591 . . . . 0.0 112.496 173.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 41.9 m0 -78.14 -54.77 5.88 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.667 0.787 . . . . 0.0 111.656 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 13.9 t -56.05 -30.17 61.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.759 0.708 . . . . 0.0 112.617 176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -78.78 -59.95 2.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 119.21 0.914 . . . . 0.0 112.627 170.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 27.3 t30 -57.2 -39.38 75.29 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.094 1.315 . . . . 0.0 113.594 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' B' ' 170' ' ' ILE . 91.4 t -67.8 -62.95 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 C-N-CA 123.895 0.878 . . . . 0.0 109.839 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.2 t -50.11 -29.81 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.351 1.06 . . . . 0.0 110.76 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.55 -52.29 65.33 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.75 0.82 . . . . 0.0 111.839 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -91.62 -38.64 12.34 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.795 1.238 . . . . 0.0 112.694 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 42.1 m -62.74 -52.77 61.94 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.768 2.427 . . . . 0.0 112.532 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.29 -37.75 86.74 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.54 0.686 . . . . 0.0 111.09 176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 52.9 m -64.7 -31.42 72.63 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -77.08 -49.51 15.14 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.461 2.305 . . . . 0.0 112.652 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -64.65 -27.98 69.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 120.879 -1.138 . . . . 0.0 113.661 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 54.5 m -58.55 -32.48 68.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.833 0.853 . . . . 0.0 110.807 168.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -81.7 -31.46 32.14 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.01 -30.29 55.81 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 117.706 0.23 . . . . 0.0 110.964 175.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -83.83 -134.6 2.61 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.507 1.527 . . . . 0.0 111.682 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.25 153.18 49.86 Favored Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 124.535 1.134 . . . . 0.0 113.849 -176.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 107.16 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.057 3.171 . . . . 0.0 111.687 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.1 171.08 17.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.038 1.335 . . . . 0.0 111.759 175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -70.2 98.16 1.32 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.799 1.24 . . . . 0.0 111.366 172.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -83.3 155.64 23.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.845 0.858 . . . . 0.0 110.671 163.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . 0.404 HD11 ' SG ' ' A' ' 85' ' ' CYS . 2.1 tt -141.03 153.33 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.825 2.05 . . . . 0.0 108.759 169.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 253' ' ' ALA . 23.4 m -141.42 154.8 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.284 1.034 . . . . 0.0 110.297 169.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 15.0 t -146.65 153.79 40.72 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 123.892 0.877 . . . . 0.0 109.827 169.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 22.7 p -148.45 160.49 43.0 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.157 0.983 . . . . 0.0 112.667 172.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.49 136.37 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 124.712 1.205 . . . . 0.0 110.467 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 5.4 mm -119.15 120.41 63.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 127.791 2.436 . . . . 0.0 107.164 -176.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 22.3 ttt -140.27 156.6 46.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.193 1.397 . . . . 0.0 111.171 -173.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -125.99 140.71 52.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.715 1.206 . . . . 0.0 112.286 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -62.22 -7.88 4.85 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.203 1.801 . . . . 0.0 115.071 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.62 -16.95 43.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.396 2.278 . . . . 0.0 114.212 176.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 126.91 29.12 0.89 Allowed Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.961 1.267 . . . . 0.0 115.127 174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -68.88 72.52 0.25 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.311 1.444 . . . . 0.0 112.846 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -65.25 96.69 0.24 Allowed Glycine 0 N--CA 1.467 0.751 0 C-N-CA 126.353 1.93 . . . . 0.0 114.983 -173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.7 pp -126.92 161.18 28.91 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.107 1.763 . . . . 0.0 111.651 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.78 97.91 4.81 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.868 1.267 . . . . 0.0 108.591 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 38.8 m -110.17 132.29 54.3 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.262 0.625 . . . . 0.0 109.506 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -135.33 118.02 16.05 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.202 1.001 . . . . 0.0 110.276 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 24.2 p -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.987 0.899 . . . . 0.0 111.075 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 72.4 m -86.08 16.11 4.53 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.369 -0.832 . . . . 0.0 112.147 174.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 20.7 m -70.26 165.82 21.42 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.121 0.968 . . . . 0.0 112.055 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -155.81 150.77 26.44 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.862 1.665 . . . . 0.0 110.616 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -76.49 130.95 38.69 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.588 -0.695 . . . . 0.0 109.648 172.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -139.26 141.86 37.81 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.172 0.989 . . . . 0.0 111.385 166.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 11.0 t -134.01 -50.0 0.82 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.647 1.579 . . . . 0.0 112.033 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 34.2 t -78.48 -34.26 47.7 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.778 0.831 . . . . 0.0 111.618 174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.95 -47.58 28.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.474 1.509 . . . . 0.0 113.065 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -157.32 -162.74 1.25 Allowed 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 125.884 1.673 . . . . 0.0 111.825 -179.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -102.19 112.14 4.24 Favored Glycine 0 CA--C 1.542 1.775 0 C-N-CA 125.823 1.678 . . . . 0.0 116.138 -176.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 68.7 m -140.03 175.76 9.31 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 127.071 2.148 . . . . 0.0 111.971 170.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 40.3 t -160.04 127.02 4.44 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.066 2.147 . . . . 0.0 109.398 167.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.7 t -136.04 146.1 46.75 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 119.755 -1.841 . . . . 0.0 112.536 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.25 139.43 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 125.003 1.321 . . . . 0.0 110.289 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.51 117.73 19.18 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.988 1.315 . . . . 0.0 111.948 -177.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -124.63 96.15 4.79 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.69 1.596 . . . . 0.0 109.566 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -64.21 169.38 4.57 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 121.53 -0.731 . . . . 0.0 112.456 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -142.39 -177.2 5.15 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.332 1.053 . . . . 0.0 111.981 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -44.43 81.47 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.263 1.825 . . . . 0.0 112.802 -178.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 9.4 t -133.93 -34.92 0.98 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.623 1.569 . . . . 0.0 113.469 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 18.6 ptp -86.6 177.39 7.39 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.956 -1.09 . . . . 0.0 112.71 172.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -151.43 157.89 42.97 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.01 1.324 . . . . 0.0 111.22 165.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 25.8 p -137.0 141.65 42.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.079 0.952 . . . . 0.0 111.621 174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.5 pt -131.07 134.18 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.059 1.343 . . . . 0.0 110.108 175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.62 130.74 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 126.007 1.723 . . . . 0.0 110.211 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 45.7 p -124.63 144.97 49.89 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 123.497 0.719 . . . . 0.0 111.181 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -128.41 137.55 51.91 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 126.865 2.066 . . . . 0.0 110.733 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -135.71 163.51 30.02 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.985 1.714 . . . . 0.0 108.834 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 153.65 86.54 0.06 OUTLIER Glycine 0 N--CA 1.464 0.504 0 O-C-N 121.382 -0.824 . . . . 0.0 111.183 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.478 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.5 OUTLIER -67.65 156.67 36.32 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.968 0.907 . . . . 0.0 110.231 -178.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.1 m -155.78 79.83 1.01 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.825 0.822 . . . . 0.0 111.248 -172.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . 0.49 ' H ' HD12 ' B' ' 258' ' ' ILE . 2.0 mp -62.26 -24.67 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.395 1.078 . . . . 0.0 111.913 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -79.67 6.55 57.99 Favored Glycine 0 CA--C 1.54 1.632 0 C-N-CA 125.725 1.631 . . . . 0.0 116.362 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 135.17 32.14 0.31 Allowed Glycine 0 CA--C 1.538 1.511 0 CA-C-N 119.26 1.53 . . . . 0.0 115.656 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -76.41 -158.17 8.09 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 126.378 1.942 . . . . 0.0 115.196 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 6.1 t -58.01 160.75 4.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.083 0.953 . . . . 0.0 112.359 173.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 104.82 20.9 9.49 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.512 1.053 . . . . 0.0 113.901 -166.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -61.99 173.3 1.11 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.867 1.267 . . . . 0.0 112.037 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 20.9 m -67.91 25.74 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.098 2.159 . . . . 0.0 115.264 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -80.54 -170.48 42.25 Favored Glycine 0 CA--C 1.545 1.907 0 C-N-CA 127.223 2.344 . . . . 0.0 114.124 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.23 156.77 63.74 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.606 2.87 . . . . 0.0 113.334 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pt -100.85 96.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.672 1.589 . . . . 0.0 112.387 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 17.7 mmmt -72.78 149.61 43.51 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.459 1.104 . . . . 0.0 111.676 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 29.7 mt -127.19 119.24 25.97 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.586 1.554 . . . . 0.0 109.839 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -160.12 159.16 30.49 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.901 1.239 . . . . 0.0 112.822 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 7.8 ttm -77.32 161.87 27.73 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.589 0.756 . . . . 0.0 111.927 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -140.98 84.65 1.94 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.017 1.327 . . . . 0.0 112.197 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -131.01 179.87 5.74 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.858 1.263 . . . . 0.0 111.524 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 33.5 mm -54.28 134.14 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.044 1.338 . . . . 0.0 110.838 173.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 74.0 m -116.24 90.62 3.38 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.916 1.686 . . . . 0.0 110.091 -177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -91.16 148.72 22.17 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.615 0.722 . . . . 0.0 111.371 170.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 7.6 p -139.34 112.8 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 127.222 2.209 . . . . 0.0 109.932 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -145.12 130.6 18.79 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.976 1.31 . . . . 0.0 111.655 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -143.38 91.66 6.86 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.495 1.518 . . . . 0.0 109.91 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -68.0 167.67 21.02 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.097 2.532 . . . . 0.0 112.623 178.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.55 -14.47 33.63 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.375 2.717 . . . . 0.0 113.537 175.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -56.99 130.56 46.6 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.345 1.058 . . . . 0.0 110.989 170.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.6 171.38 16.24 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.106 2.162 . . . . 0.0 110.323 -176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.26 161.93 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.633 1.573 . . . . 0.0 111.756 178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 38.7 t . . . . . 0 C--O 1.253 1.257 0 C-N-CA 126.605 1.962 . . . . 0.0 110.603 -177.835 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 111.737 -0.545 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -64.5 -40.11 95.05 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -175.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 mpp? -66.61 -38.99 88.11 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -174.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -78.5 2.14 20.03 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.359 1.463 . . . . 0.0 114.142 174.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -123.44 11.74 9.31 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.681 1.992 . . . . 0.0 112.637 -174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -23.73 124.52 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.55 2.74 . . . . 0.0 115.26 161.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -73.06 171.33 13.09 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.81 0.844 . . . . 0.0 111.966 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -126.85 144.24 51.03 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.84 1.656 . . . . 0.0 111.452 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.07 74.78 5.6 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.034 1.334 . . . . 0.0 112.434 -176.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -58.79 -20.01 46.08 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 120.885 -1.134 . . . . 0.0 113.919 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.58 -28.08 65.66 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.876 1.67 . . . . 0.0 114.741 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.6 t -104.34 -17.51 14.79 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.352 1.061 . . . . 0.0 112.5 175.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.63 156.29 23.79 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-O 121.726 0.774 . . . . 0.0 111.316 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -110.3 168.18 9.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.355 1.462 . . . . 0.0 110.475 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.83 159.13 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-O 121.754 0.788 . . . . 0.0 111.146 176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.7 t -56.03 -34.73 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.763 2.025 . . . . 0.0 111.702 179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -59.69 -28.6 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.922 0.889 . . . . 0.0 113.099 174.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -82.27 -54.19 5.44 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.687 0.795 . . . . 0.0 110.706 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.431 HG13 HD22 ' A' ' 56' ' ' LEU . 97.4 t -49.97 -42.37 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 125.088 1.355 . . . . 0.0 112.422 -179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 t -59.58 -19.44 48.78 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.006 1.723 . . . . 0.0 113.747 175.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -97.48 -43.21 7.36 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.877 1.671 . . . . 0.0 112.111 172.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.0 mt -50.41 -41.97 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.791 1.236 . . . . 0.0 111.061 174.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.02 -44.63 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 175.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 -51.82 58.92 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.22 1.373 . . . . 0.0 111.518 177.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -34.56 76.2 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.35 -43.51 66.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.681 0.792 . . . . 0.0 112.972 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 61.9 mt -57.61 -58.92 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 118.983 0.811 . . . . 0.0 109.773 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -62.53 -31.67 72.48 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.6 t -61.01 -48.15 83.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.998 0.919 . . . . 0.0 112.035 169.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.38 76.7 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.586 1.155 . . . . 0.0 114.002 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 83.2 mt -57.39 -49.96 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.638 1.175 . . . . 0.0 110.532 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.7 11.61 59.01 Favored Glycine 0 CA--C 1.54 1.656 0 C-N-CA 124.271 0.938 . . . . 0.0 115.289 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.66 -3.99 23.04 Favored Glycine 0 CA--C 1.537 1.443 0 N-CA-C 116.805 1.482 . . . . 0.0 116.805 170.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -67.32 169.76 8.34 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 119.254 1.527 . . . . 0.0 111.8 170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -100.51 -148.77 0.36 Allowed 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.377 1.471 . . . . 0.0 111.676 -178.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -60.5 131.33 50.42 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.178 1.791 . . . . 0.0 110.918 173.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.01 -177.31 3.99 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.293 1.437 . . . . 0.0 112.235 -174.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.1 m80 -98.04 -96.6 0.22 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.913 1.285 . . . . 0.0 110.078 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -73.85 -22.62 59.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.965 1.306 . . . . 0.0 113.91 175.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.54 -44.03 84.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.207 -0.933 . . . . 0.0 112.393 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.1 t -57.57 -36.88 55.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.895 0.878 . . . . 0.0 113.009 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -61.12 -53.97 50.36 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.53 1.132 . . . . 0.0 111.176 175.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.41 -22.5 66.98 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 176.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.68 -54.93 5.8 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 119.162 0.892 . . . . 0.0 112.224 174.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.9 t -58.7 -22.72 58.01 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.6 t -85.53 -57.64 2.98 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 119.269 0.941 . . . . 0.0 112.25 169.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 20.3 t30 -59.75 -40.89 89.63 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 120.09 1.314 . . . . 0.0 113.752 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.62 -62.91 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.947 0 C-N-CA 124.075 0.95 . . . . 0.0 109.86 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 87.2 t -49.92 -28.55 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.682 1.193 . . . . 0.0 110.952 177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -57.72 11.02 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 118.796 0.725 . . . . 0.0 111.858 176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -86.28 -36.64 19.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.169 0.988 . . . . 0.0 113.217 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 m -60.91 -51.82 67.68 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.777 2.031 . . . . 0.0 112.172 -179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.7 tp -61.48 -32.25 72.25 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.354 0.662 . . . . 0.0 112.287 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.9 t -61.98 -58.51 7.61 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.281 -0.39 . . . . 0.0 110.549 165.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -49.88 -49.55 49.08 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 113.654 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.431 HD22 HG13 ' A' ' 19' ' ' VAL . 2.5 pp -67.47 -29.97 69.56 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 1.6 m -62.64 -44.44 96.27 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 119.028 -0.511 . . . . 0.0 109.768 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.0 mmmm -64.88 -25.16 67.77 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.307 0.958 . . . . 0.0 113.356 -177.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -70.21 -2.88 14.52 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 171.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.27 -98.7 0.18 Allowed Glycine 0 CA--C 1.542 1.724 0 C-N-CA 124.865 1.221 . . . . 0.0 114.64 171.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -67.83 168.88 11.03 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 125.431 1.492 . . . . 0.0 114.392 -175.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.11 167.74 21.02 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.541 2.161 . . . . 0.0 112.668 167.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -55.49 97.55 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 127.357 2.263 . . . . 0.0 114.45 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.57 96.06 0.65 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.921 2.088 . . . . 0.0 111.212 174.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -153.37 150.32 28.74 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.183 1.393 . . . . 0.0 110.012 170.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.42 146.61 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.442 1.097 . . . . 0.0 109.781 171.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 110' ' ' ALA . 4.6 m -137.98 148.18 25.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 125.644 1.578 . . . . 0.0 110.392 165.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -135.74 155.96 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.671 1.188 . . . . 0.0 109.791 166.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 43.0 t -151.41 144.41 24.55 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.247 1.419 . . . . 0.0 110.834 178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.85 140.54 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.067 1.347 . . . . 0.0 109.876 174.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.403 HD12 ' HB3' ' A' ' 106' ' ' CYS . 1.4 mm -126.34 110.87 24.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.759 0 C-N-CA 127.334 2.253 . . . . 0.0 108.374 -175.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.14 168.71 18.35 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.374 -0.83 . . . . 0.0 113.023 177.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -110.99 124.81 52.89 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.312 1.445 . . . . 0.0 111.261 -169.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -84.26 -0.71 53.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.981 1.712 . . . . 0.0 114.033 -169.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.38 -19.7 64.89 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 126.102 1.761 . . . . 0.0 114.166 173.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.09 34.75 0.36 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 125.306 1.432 . . . . 0.0 114.617 -177.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.11 173.14 3.96 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 118.905 1.353 . . . . 0.0 112.794 171.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -143.2 103.98 0.33 Allowed Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.186 1.374 . . . . 0.0 113.195 -175.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 164.09 31.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.821 1.248 . . . . 0.0 113.609 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -127.53 131.66 50.04 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.308 1.043 . . . . 0.0 110.395 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.555 ' HB ' HG13 ' A' ' 135' ' ' VAL . 47.9 m -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.957 1.303 . . . . 0.0 109.039 176.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.09 121.27 12.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.436 1.094 . . . . 0.0 110.787 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.2 p -129.69 131.04 46.23 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.347 0.594 . . . . 0.0 111.447 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.3 m -90.67 18.34 6.52 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 121.268 -0.895 . . . . 0.0 111.978 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 7.8 m -61.2 162.93 6.81 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.286 1.435 . . . . 0.0 112.408 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -158.23 134.36 9.29 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.228 1.011 . . . . 0.0 111.602 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -80.72 148.0 30.33 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.406 1.082 . . . . 0.0 110.913 172.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -134.68 149.57 50.52 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.841 1.656 . . . . 0.0 110.644 169.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.8 t -97.3 -66.97 0.87 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.831 1.252 . . . . 0.0 112.304 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.5 t -91.24 -26.47 18.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.134 0.974 . . . . 0.0 112.535 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -30.76 52.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.905 1.682 . . . . 0.0 113.091 -177.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.48 -167.02 1.05 Allowed 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.961 2.104 . . . . 0.0 111.135 -172.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -148.87 146.15 15.28 Favored Glycine 0 CA--C 1.539 1.571 0 O-C-N 120.909 -1.119 . . . . 0.0 114.641 175.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -154.3 134.99 13.59 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.193 1.397 . . . . 0.0 111.784 -172.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 24.0 t -127.99 97.26 4.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.661 1.184 . . . . 0.0 113.077 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -88.14 150.02 23.58 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 121.028 -1.045 . . . . 0.0 112.715 173.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -140.27 138.68 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.332 1.853 . . . . 0.0 109.407 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -125.23 119.48 28.59 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.709 1.604 . . . . 0.0 111.956 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -128.52 102.54 6.66 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.242 1.417 . . . . 0.0 110.127 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -77.52 151.3 34.62 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 121.177 -0.952 . . . . 0.0 112.039 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.15 -178.42 3.86 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.32 1.448 . . . . 0.0 109.952 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -60.46 -45.02 95.23 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -129.92 -21.12 3.06 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.818 1.647 . . . . 0.0 113.919 177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 7.9 mtt -100.84 173.12 6.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.148 1.379 . . . . 0.0 112.068 170.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -147.84 147.43 29.79 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.083 1.353 . . . . 0.0 109.936 167.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HB3' HD12 ' A' ' 71' ' ' ILE . 9.0 p -133.35 134.01 43.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.894 1.277 . . . . 0.0 110.641 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pp -132.97 110.3 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.784 1.234 . . . . 0.0 111.041 -175.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.36 138.79 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.97 1.308 . . . . 0.0 110.8 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.5 p -134.16 114.74 13.43 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.282 -0.886 . . . . 0.0 112.576 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -100.08 136.12 40.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.84 1.256 . . . . 0.0 112.043 -176.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -134.34 112.86 11.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.426 1.491 . . . . 0.0 111.183 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -103.07 61.94 0.46 Allowed Glycine 0 CA--C 1.529 0.92 0 O-C-N 120.743 -1.223 . . . . 0.0 113.878 -171.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -52.43 109.5 0.4 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.456 1.502 . . . . 0.0 113.298 -176.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 m -155.03 106.79 2.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.098 2.159 . . . . 0.0 111.934 -171.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -8.76 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 126.455 1.902 . . . . 0.0 115.852 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.45 -5.87 45.73 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.603 1.573 . . . . 0.0 116.158 -165.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 62.79 44.72 97.06 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-N 118.476 1.138 . . . . 0.0 112.912 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -73.21 61.99 1.79 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.876 1.703 . . . . 0.0 113.148 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 19.6 m -66.28 -178.14 0.62 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.402 2.281 . . . . 0.0 112.821 175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 104.65 33.23 3.91 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.208 0.908 . . . . 0.0 114.069 -178.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -59.69 165.81 2.85 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.235 1.017 . . . . 0.0 112.666 172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 20.8 t -61.46 -24.49 66.59 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.103 1.361 . . . . 0.0 113.757 177.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -129.63 177.72 17.88 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.121 1.82 . . . . 0.0 113.18 174.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.31 174.1 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.672 2.914 . . . . 0.0 112.286 176.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pp -58.05 141.81 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.759 0.824 . . . . 0.0 111.568 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.67 163.22 22.48 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.158 1.383 . . . . 0.0 112.219 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 43.8 mt -106.72 112.7 25.8 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.216 1.406 . . . . 0.0 110.193 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -124.59 115.08 2.39 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 126.179 1.847 . . . . 0.0 111.182 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.8 mtm -64.75 99.87 0.36 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.866 0.833 . . . . 0.0 111.022 172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -69.58 109.83 4.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.435 1.494 . . . . 0.0 110.943 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 14.2 mmmt -128.89 168.73 15.53 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.912 1.285 . . . . 0.0 111.375 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.1 mm -62.5 135.78 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.317 1.447 . . . . 0.0 110.842 177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 87.3 m -106.37 88.95 2.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.864 1.666 . . . . 0.0 110.147 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -89.96 149.83 22.41 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.729 0.812 . . . . 0.0 111.154 172.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.555 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -145.27 104.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.988 2.115 . . . . 0.0 109.356 -177.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -134.8 119.96 18.8 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.483 1.113 . . . . 0.0 110.826 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -115.45 95.44 43.04 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 125.429 1.491 . . . . 0.0 108.851 174.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.84 164.78 33.81 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.443 2.762 . . . . 0.0 111.74 174.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.68 -52.8 0.39 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.023 2.482 . . . . 0.0 112.754 -176.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.07 -69.9 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.885 2.074 . . . . 0.0 109.836 176.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -67.48 173.73 3.9 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.267 1.827 . . . . 0.0 112.117 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.33 157.4 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.43 1.492 . . . . 0.0 111.962 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.714 2.005 . . . . 0.0 110.544 179.406 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 50.2 m -60.45 -35.54 76.1 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 118.736 1.268 . . . . 0.0 113.749 -176.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -70.0 -24.33 63.28 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -96.01 5.2 51.72 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.346 1.458 . . . . 0.0 113.199 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -124.47 10.72 8.56 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.589 1.956 . . . . 0.0 112.921 -172.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -29.8 127.26 0.12 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 128.849 2.86 . . . . 0.0 113.245 164.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -75.64 172.31 12.82 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.612 0.765 . . . . 0.0 111.673 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -124.98 144.63 50.27 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.756 1.622 . . . . 0.0 111.337 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.86 75.71 4.39 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.0 1.32 . . . . 0.0 112.348 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -58.7 -20.12 45.83 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.971 -1.081 . . . . 0.0 113.793 177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -69.24 -27.24 65.28 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.838 1.655 . . . . 0.0 114.763 174.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 5.3 t -104.73 -17.96 14.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.256 1.023 . . . . 0.0 112.522 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.21 154.28 31.84 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.566 -0.709 . . . . 0.0 111.569 172.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -105.27 173.63 6.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.841 1.256 . . . . 0.0 111.195 178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 11.2 p -142.32 161.44 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.585 1.154 . . . . 0.0 111.584 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 11.7 p -55.03 -40.33 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.513 1.125 . . . . 0.0 112.126 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -61.76 -25.15 67.28 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.592 1.157 . . . . 0.0 113.018 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 48.9 tt0 -79.46 -58.29 3.27 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.045 1.338 . . . . 0.0 110.986 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.528 HG22 HD13 ' B' ' 199' ' ' LEU . 85.9 t -52.38 -40.94 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 124.915 1.286 . . . . 0.0 112.607 178.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 19.5 t -58.94 -18.62 35.27 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.572 1.549 . . . . 0.0 113.408 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.3 -43.86 6.44 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.135 1.374 . . . . 0.0 112.031 171.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 38.7 mt -50.58 -42.11 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.201 1.0 . . . . 0.0 111.262 175.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.0 p -59.26 -43.54 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 O-C-N 121.487 -0.758 . . . . 0.0 112.887 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -51.76 53.99 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 119.943 1.247 . . . . 0.0 111.399 177.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.23 75.57 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.28 -43.43 64.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.801 0.84 . . . . 0.0 113.037 174.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 61.4 mt -57.38 -58.76 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 119.124 0.874 . . . . 0.0 109.702 174.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -62.45 -31.74 72.5 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 37.5 t -60.9 -48.18 83.0 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.988 0.915 . . . . 0.0 112.108 169.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.19 76.16 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 83.0 mt -57.29 -49.9 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.635 1.174 . . . . 0.0 110.512 174.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 92.73 11.55 59.03 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.235 0.922 . . . . 0.0 115.266 -175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 114.5 -4.0 23.29 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 170.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -67.12 169.61 8.24 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 119.299 1.549 . . . . 0.0 111.862 170.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -100.13 -148.49 0.36 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.362 1.465 . . . . 0.0 111.615 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -60.44 132.31 53.49 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 126.155 1.782 . . . . 0.0 110.999 172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -177.34 4.1 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.288 1.435 . . . . 0.0 112.157 -174.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -98.06 -96.71 0.22 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.878 1.271 . . . . 0.0 110.143 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 69.2 m -73.9 -22.09 59.83 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.014 1.326 . . . . 0.0 113.929 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 2.2 mmtm -57.9 -44.0 86.49 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.09 -1.006 . . . . 0.0 112.377 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 26.1 t -57.77 -36.65 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.943 0.897 . . . . 0.0 112.988 177.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -60.75 -54.44 45.16 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.626 1.17 . . . . 0.0 111.075 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -64.33 -22.83 67.08 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.404 -0.81 . . . . 0.0 113.049 176.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -77.35 -54.9 5.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.188 0.903 . . . . 0.0 112.301 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.3 t -58.86 -21.04 56.25 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 10.2 t -87.02 -58.75 2.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.212 0.915 . . . . 0.0 112.332 168.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -58.88 -40.7 85.2 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 120.142 1.337 . . . . 0.0 113.793 -174.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.52 -63.27 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 124.182 0.993 . . . . 0.0 109.817 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 77.1 t -48.6 -29.74 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.234 1.413 . . . . 0.0 111.167 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.48 -55.45 33.5 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.628 0.771 . . . . 0.0 111.711 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -88.87 -35.08 16.75 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.369 1.068 . . . . 0.0 113.367 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 28.2 m -63.43 -52.62 60.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.0 2.12 . . . . 0.0 112.605 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.607 HD13 HD11 ' B' ' 199' ' ' LEU . 0.1 OUTLIER -62.97 -32.57 73.92 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.609 0.364 . . . . 0.0 111.023 179.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t -60.52 -57.81 11.14 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.387 -0.821 . . . . 0.0 111.469 165.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -50.37 -49.14 55.16 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.711 1.604 . . . . 0.0 113.433 -176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.607 HD11 HD13 ' B' ' 196' ' ' LEU . 4.0 pp -70.74 -27.87 64.27 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 1.5 m -60.89 -44.96 96.4 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 163.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -64.58 -25.76 68.11 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.227 0.921 . . . . 0.0 113.415 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.16 -4.6 18.14 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 170.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -148.99 -101.89 0.26 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 119.984 1.265 . . . . 0.0 114.658 173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 3.4 mtpm? -66.28 167.81 11.45 Favored Pre-proline 0 N--CA 1.483 1.192 0 C-N-CA 125.82 1.648 . . . . 0.0 114.008 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -67.08 166.03 24.42 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.178 1.919 . . . . 0.0 112.236 168.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -50.97 115.87 1.73 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.964 1.705 . . . . 0.0 112.269 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 171.08 92.49 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 130.222 3.409 . . . . 0.0 111.193 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . 0.405 ' CG ' HD12 ' B' ' 196' ' ' LEU . 54.9 p90 -145.6 171.06 15.25 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.572 1.949 . . . . 0.0 109.743 167.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.4 tt -134.77 151.82 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.388 1.075 . . . . 0.0 108.99 161.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 27.7 m -142.0 143.18 27.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 C-N-CA 125.339 1.456 . . . . 0.0 109.092 169.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 11.7 t -135.2 155.04 51.34 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.876 0.87 . . . . 0.0 110.144 169.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 41.9 t -151.11 148.67 28.57 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.183 1.393 . . . . 0.0 111.288 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 8.3 p -129.75 141.06 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.178 1.391 . . . . 0.0 110.445 174.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' B' ' 249' ' ' CYS . 1.2 mm -126.65 110.38 23.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 C-N-CA 127.847 2.459 . . . . 0.0 108.171 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.86 167.51 20.43 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.002 -0.999 . . . . 0.0 112.919 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -111.55 126.96 55.54 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.253 1.421 . . . . 0.0 111.214 -168.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 17.6 tttm -85.69 0.35 52.98 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.913 1.685 . . . . 0.0 113.956 -168.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -63.1 -19.92 64.88 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.073 1.749 . . . . 0.0 114.152 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 128.97 37.41 0.39 Allowed Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.329 1.442 . . . . 0.0 114.375 -177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -69.12 172.68 6.46 Favored 'General case' 0 CA--C 1.552 1.043 0 CA-C-N 118.758 1.279 . . . . 0.0 112.285 169.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -142.27 78.88 0.27 Allowed Glycine 0 N--CA 1.475 1.247 0 C-N-CA 124.553 1.073 . . . . 0.0 114.396 -173.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.36 156.03 28.57 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.192 1.397 . . . . 0.0 111.393 -176.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.32 134.3 52.29 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 110.892 173.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.705 ' HB ' HG13 ' B' ' 278' ' ' VAL . 99.6 m -138.54 143.85 39.65 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 109.063 175.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -142.19 122.28 13.75 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.594 1.157 . . . . 0.0 110.84 -177.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.4 p -128.46 136.59 51.04 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.813 -0.555 . . . . 0.0 111.761 176.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 6.5 m -94.22 18.79 10.29 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 121.662 -0.648 . . . . 0.0 111.776 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 39.3 m -61.68 162.59 8.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.065 1.346 . . . . 0.0 112.347 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -158.63 134.93 9.25 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.514 1.126 . . . . 0.0 111.466 -175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -83.51 147.16 27.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.167 0.987 . . . . 0.0 110.791 171.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -131.87 144.58 50.98 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.127 1.771 . . . . 0.0 110.14 170.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 21.0 t -89.45 -68.19 0.79 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.637 1.175 . . . . 0.0 112.238 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 6.9 t -92.74 -25.49 18.18 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.265 1.026 . . . . 0.0 112.533 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.02 -29.34 55.32 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.933 1.693 . . . . 0.0 112.911 -178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.7 -164.38 0.9 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 126.04 1.736 . . . . 0.0 111.644 -171.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -151.19 144.51 11.82 Favored Glycine 0 CA--C 1.537 1.463 0 O-C-N 120.935 -1.103 . . . . 0.0 114.455 173.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.45 151.28 33.72 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.734 1.614 . . . . 0.0 110.633 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 12.4 t -142.43 104.54 4.43 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.507 1.123 . . . . 0.0 112.565 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.3 t -97.36 147.58 24.03 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.43 1.092 . . . . 0.0 112.418 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 10.5 t -140.13 136.28 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 125.862 1.665 . . . . 0.0 109.626 -175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -125.1 119.06 27.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.491 1.516 . . . . 0.0 111.829 -173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -128.07 102.51 6.76 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.329 1.452 . . . . 0.0 109.956 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -77.59 151.0 34.64 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.15 -0.969 . . . . 0.0 111.881 172.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -121.82 -178.24 3.78 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.301 1.44 . . . . 0.0 109.937 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -60.62 -44.77 95.96 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.8 t -129.89 -21.61 3.01 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.744 1.617 . . . . 0.0 113.894 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.8 mtt -100.64 173.33 6.59 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.272 1.429 . . . . 0.0 111.995 170.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -147.6 148.07 30.73 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.037 1.335 . . . . 0.0 110.002 166.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' B' ' 214' ' ' ILE . 9.8 p -132.73 135.41 45.74 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.821 1.248 . . . . 0.0 111.014 179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.85 111.94 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.97 1.308 . . . . 0.0 111.172 -175.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 14.7 p -105.7 143.28 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 125.046 1.339 . . . . 0.0 111.161 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 66.8 p -139.02 110.66 7.09 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -90.16 139.94 30.15 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.519 1.128 . . . . 0.0 113.05 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -137.29 102.65 4.87 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.769 1.627 . . . . 0.0 110.204 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -95.12 61.13 1.59 Allowed Glycine 0 CA--C 1.533 1.174 0 O-C-N 120.688 -1.257 . . . . 0.0 113.507 -172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -49.02 109.47 0.26 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.966 1.706 . . . . 0.0 113.528 -175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 9.8 m -152.94 105.97 2.99 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.509 1.924 . . . . 0.0 112.419 -171.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.93 -5.87 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 126.384 1.874 . . . . 0.0 115.955 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -67.69 -6.73 44.62 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.066 1.317 . . . . 0.0 115.865 -169.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 63.28 42.04 99.38 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 118.514 1.157 . . . . 0.0 112.929 178.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -73.72 63.7 1.9 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.01 1.767 . . . . 0.0 113.258 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 19.8 m -66.37 -177.89 0.6 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.333 2.253 . . . . 0.0 112.88 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 106.51 32.52 3.64 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.395 0.998 . . . . 0.0 114.188 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -60.01 165.17 3.45 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 118.321 1.061 . . . . 0.0 112.815 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 20.7 t -61.34 -24.91 66.79 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.303 1.441 . . . . 0.0 113.703 177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -129.1 177.69 17.76 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 126.143 1.83 . . . . 0.0 113.049 174.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.33 174.1 10.5 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.646 2.897 . . . . 0.0 112.213 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.1 pp -57.79 141.32 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 C-N-CA 123.753 0.821 . . . . 0.0 111.579 174.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 162.86 22.74 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.177 1.391 . . . . 0.0 112.292 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 43.7 mt -106.54 112.51 25.54 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.197 1.399 . . . . 0.0 110.128 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -124.28 115.09 2.43 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 126.143 1.83 . . . . 0.0 111.161 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 18.3 mtm -65.09 99.1 0.34 Allowed 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 117.884 0.842 . . . . 0.0 111.026 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -69.63 109.53 4.37 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.569 1.548 . . . . 0.0 110.922 173.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 15.3 mmmt -128.85 169.9 14.03 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.965 1.306 . . . . 0.0 111.313 177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.1 mm -61.73 138.45 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.173 1.389 . . . . 0.0 110.944 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 66.7 m -109.59 86.0 2.21 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.874 1.669 . . . . 0.0 109.853 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -87.96 150.94 23.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.603 0.761 . . . . 0.0 111.133 170.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.705 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.3 p -149.94 105.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 126.364 1.866 . . . . 0.0 109.934 -177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -134.47 121.73 21.47 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.156 1.383 . . . . 0.0 110.687 177.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -114.7 95.21 39.97 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 125.236 1.415 . . . . 0.0 108.727 174.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.88 164.85 34.41 Favored 'Trans proline' 0 CA--C 1.547 1.173 0 C-N-CA 123.552 2.835 . . . . 0.0 111.776 175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -69.7 -52.05 0.35 Allowed 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.862 2.374 . . . . 0.0 112.576 -174.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.12 -69.42 0.06 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 127.318 2.247 . . . . 0.0 109.459 175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -67.37 173.57 3.91 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.344 1.858 . . . . 0.0 112.17 -178.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.85 157.34 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.541 1.536 . . . . 0.0 111.979 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.808 2.043 . . . . 0.0 110.596 179.439 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.97 97.56 5.0 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.015 1.326 . . . . 0.0 111.417 -174.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 19.4 ptt? -60.86 -27.63 68.25 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.11 -17.17 60.97 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -77.03 -31.19 56.1 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.649 0.78 . . . . 0.0 112.571 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -72.66 147.75 45.45 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.782 0.833 . . . . 0.0 111.518 173.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.61 158.14 45.02 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.847 1.259 . . . . 0.0 111.538 -177.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -78.65 64.96 3.79 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.183 1.393 . . . . 0.0 113.081 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.53 -0.56 6.84 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 125.456 1.503 . . . . 0.0 114.622 176.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -59.67 -18.66 43.88 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -78.34 -29.94 47.85 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 t -90.58 -29.88 17.56 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.622 0.769 . . . . 0.0 111.431 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.65 131.12 45.56 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 121.207 -0.933 . . . . 0.0 111.423 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.27 171.82 2.21 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.782 1.633 . . . . 0.0 113.434 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.8 p -140.09 147.06 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.446 1.098 . . . . 0.0 112.173 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.24 -40.48 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.087 1.355 . . . . 0.0 112.075 -175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -58.1 -33.4 69.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.623 1.569 . . . . 0.0 112.631 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 tp10 -77.2 -52.23 9.6 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.905 1.282 . . . . 0.0 111.177 173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.42 HG13 HD22 ' A' ' 56' ' ' LEU . 16.1 t -48.51 -42.34 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 124.485 1.114 . . . . 0.0 112.222 178.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.6 t -56.98 -24.75 55.65 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.194 1.398 . . . . 0.0 113.603 176.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -95.97 -35.58 11.37 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.329 1.452 . . . . 0.0 113.292 172.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.9 mt -50.89 -43.1 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 119.615 1.098 . . . . 0.0 110.445 174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.2 p -63.29 -43.33 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.3 -52.58 45.95 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.864 1.211 . . . . 0.0 111.45 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -30.71 70.57 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.45 -43.84 31.05 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.458 ' HA ' HG21 ' A' ' 48' ' ' VAL . 58.6 mt -55.78 -56.22 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 119.564 1.075 . . . . 0.0 109.88 175.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -59.61 -28.25 67.02 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.7 p -67.37 -35.47 79.42 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.12 -29.89 43.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.972 1.309 . . . . 0.0 113.147 174.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 77.7 mt -61.69 -37.03 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.58 1.152 . . . . 0.0 111.458 172.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.81 11.45 84.61 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 124.103 0.858 . . . . 0.0 114.832 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 107.06 -0.97 35.46 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.575 1.56 . . . . 0.0 116.382 174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.2 m-80 -63.85 168.82 4.68 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 119.128 1.464 . . . . 0.0 112.931 167.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.61 -154.55 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.771 1.628 . . . . 0.0 111.901 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.1 160.03 0.39 Allowed 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.337 1.455 . . . . 0.0 112.992 163.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -151.1 175.07 12.48 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.342 1.057 . . . . 0.0 113.295 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -97.37 -101.02 0.19 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.541 1.537 . . . . 0.0 110.02 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.8 m -67.99 -22.09 65.02 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -58.82 -43.75 90.72 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 120.97 -1.081 . . . . 0.0 112.99 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -51.63 -38.57 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.209 1.003 . . . . 0.0 112.782 176.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -63.13 -54.72 33.42 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.932 1.293 . . . . 0.0 111.696 174.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.75 -26.23 68.55 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.254 -0.904 . . . . 0.0 112.634 177.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -75.48 -53.89 7.92 Favored 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 124.112 0.965 . . . . 0.0 111.182 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -59.2 -22.23 60.7 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.3 t -86.55 -56.74 3.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 119.681 1.128 . . . . 0.0 112.457 169.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -58.22 -37.11 74.21 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.786 1.234 . . . . 0.0 113.676 -175.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.458 HG21 ' HA ' ' A' ' 27' ' ' ILE . 94.3 t -69.49 -64.89 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 C-N-CA 123.897 0.879 . . . . 0.0 109.559 -178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.4 t -47.01 -31.68 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.866 1.266 . . . . 0.0 111.103 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -58.81 -43.56 90.6 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.635 0.652 . . . . 0.0 112.602 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -96.81 -44.26 7.15 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.985 1.314 . . . . 0.0 112.391 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.2 m -55.82 -51.88 65.95 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 127.522 2.329 . . . . 0.0 112.871 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.23 -38.98 88.59 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.166 0.439 . . . . 0.0 110.94 175.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 p -64.43 -30.67 71.7 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.22 -0.925 . . . . 0.0 113.334 173.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -76.03 -48.61 20.28 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.194 2.198 . . . . 0.0 113.075 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 HD22 HG13 ' A' ' 19' ' ' VAL . 3.5 pp -64.63 -27.8 69.18 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.728 -1.232 . . . . 0.0 114.135 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.7 m -58.16 -34.73 70.63 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.444 1.098 . . . . 0.0 110.925 167.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -78.94 -36.31 41.9 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.773 -0.579 . . . . 0.0 112.262 177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.9 mt -66.75 -24.56 66.23 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.22 -105.39 2.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.33 1.443 . . . . 0.0 113.257 176.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -138.28 152.58 71.79 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.577 1.551 . . . . 0.0 112.12 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.88 111.31 3.0 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.611 2.874 . . . . 0.0 111.375 175.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -150.12 179.86 7.75 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.887 1.275 . . . . 0.0 112.331 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -93.57 95.37 9.18 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.472 1.509 . . . . 0.0 111.678 175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -83.71 151.6 25.17 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.887 1.675 . . . . 0.0 109.933 175.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.483 HG22 ' CD2' ' A' ' 111' ' ' PHE . 1.3 tp -125.67 149.03 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.709 1.604 . . . . 0.0 108.667 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.8 m -138.9 146.29 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 123.529 0.732 . . . . 0.0 111.285 164.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -137.86 117.71 13.24 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 127.397 2.279 . . . . 0.0 109.732 174.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 30.3 p -123.79 136.6 54.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.404 0.682 . . . . 0.0 112.448 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -115.56 109.3 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.347 1.459 . . . . 0.0 109.29 -174.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 10.6 mm -103.15 111.13 31.78 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 C-N-CA 125.43 1.492 . . . . 0.0 109.116 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.68 105.4 3.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.895 1.278 . . . . 0.0 109.905 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.09 10.64 1.74 Allowed 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -172.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -69.83 -77.66 0.08 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.922 1.289 . . . . 0.0 112.998 -177.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -122.63 -20.8 5.86 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -171.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 126.85 7.24 5.19 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-O 118.641 -1.089 . . . . 0.0 115.708 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -47.9 93.29 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 126.509 1.924 . . . . 0.0 114.812 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.39 78.1 1.0 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 125.694 1.616 . . . . 0.0 113.429 -174.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 2.8 pp -54.48 150.92 8.41 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.629 1.572 . . . . 0.0 112.475 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -123.06 83.31 2.11 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.487 1.515 . . . . 0.0 109.363 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.536 ' HB ' HG13 ' A' ' 135' ' ' VAL . 54.5 m -97.17 139.09 33.67 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 121.673 -0.642 . . . . 0.0 109.465 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -131.54 128.03 38.45 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 110.422 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.8 m -127.76 117.41 21.85 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.921 0.889 . . . . 0.0 109.622 -170.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -79.9 41.56 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.425 1.107 . . . . 0.0 111.177 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.9 m -81.76 179.6 7.76 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.98 1.312 . . . . 0.0 110.577 167.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -145.55 154.05 41.75 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.724 1.609 . . . . 0.0 109.621 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.6 t-105 -97.45 132.48 43.11 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.006 0.922 . . . . 0.0 109.89 173.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -144.05 141.53 30.14 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.228 1.411 . . . . 0.0 110.435 174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 t -114.17 -56.52 2.38 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.426 1.491 . . . . 0.0 111.718 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.96 -40.25 10.67 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.172 0.989 . . . . 0.0 112.097 174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -32.39 73.18 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.644 2.378 . . . . 0.0 114.223 -169.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.22 -177.5 6.51 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.591 1.957 . . . . 0.0 110.85 -177.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.09 116.93 3.86 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 125.969 1.747 . . . . 0.0 114.027 -174.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 t -140.93 172.55 12.53 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.398 1.879 . . . . 0.0 110.505 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -168.14 140.34 2.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.543 1.537 . . . . 0.0 110.639 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.7 t -148.98 144.64 26.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 119.959 -1.713 . . . . 0.0 111.602 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.3 t -139.02 120.24 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 124.472 1.109 . . . . 0.0 109.489 -169.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 93.83 4.4 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.297 1.039 . . . . 0.0 113.024 -171.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -99.43 105.73 17.7 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.96 1.304 . . . . 0.0 110.362 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -109.49 165.77 11.39 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.558 1.543 . . . . 0.0 110.71 169.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -139.13 179.78 6.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.67 1.188 . . . . 0.0 110.031 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -45.1 -40.28 6.74 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.921 1.688 . . . . 0.0 115.011 -172.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.7 t -133.7 22.9 3.95 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 126.302 1.841 . . . . 0.0 113.083 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 30.2 mtt -135.79 158.76 43.59 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -169.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -148.99 116.56 6.2 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.114 1.765 . . . . 0.0 110.704 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 78.9 m -143.09 68.16 1.3 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.162 1.785 . . . . 0.0 111.481 -171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.4 pp -97.18 153.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.635 -1.291 . . . . 0.0 113.175 -173.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.4 p -132.84 116.26 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.805 2.042 . . . . 0.0 111.889 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.5 t -97.91 136.17 38.59 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.558 1.143 . . . . 0.0 110.084 171.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.3 166.59 22.78 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.901 1.68 . . . . 0.0 112.262 179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.483 ' CD2' HG22 ' A' ' 66' ' ' ILE . 0.0 OUTLIER -150.21 161.07 43.13 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.009 179.018 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.32 83.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.693 0 N-CA-C 112.212 -0.355 . . . . 0.0 112.212 -173.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.447 HD11 ' CE1' ' A' ' 111' ' ' PHE . 1.3 pp -137.92 158.24 44.74 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.938 1.695 . . . . 0.0 112.682 -169.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.7 t -137.85 129.86 28.76 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.05 1.34 . . . . 0.0 112.505 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.6 -5.31 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 125.394 1.477 . . . . 0.0 114.019 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -98.15 18.37 57.22 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.634 1.588 . . . . 0.0 114.624 -172.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 116.44 19.73 5.32 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.433 1.492 . . . . 0.0 114.299 -172.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -50.69 102.95 0.08 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.51 2.005 . . . . 0.0 114.219 178.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -120.91 -165.51 1.22 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.903 2.081 . . . . 0.0 111.186 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.68 5.54 15.85 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.521 1.058 . . . . 0.0 115.153 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -53.04 157.05 1.88 Allowed 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.973 1.387 . . . . 0.0 113.172 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -63.81 -17.45 63.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 144.93 -71.13 0.37 Allowed Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.575 1.56 . . . . 0.0 112.26 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.51 170.48 18.4 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 123.46 2.773 . . . . 0.0 112.78 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.91 91.27 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 126.54 1.936 . . . . 0.0 111.625 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.9 167.4 21.94 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.035 0.934 . . . . 0.0 112.476 173.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.7 mt -65.38 125.83 26.33 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.774 1.63 . . . . 0.0 111.206 178.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -101.24 83.69 0.51 Allowed Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.67 1.605 . . . . 0.0 113.193 -174.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.67 90.19 0.4 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.682 1.593 . . . . 0.0 112.992 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -88.46 99.39 12.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.509 1.524 . . . . 0.0 111.628 174.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -129.31 166.94 18.48 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.357 1.463 . . . . 0.0 111.447 171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.4 149.73 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 125.768 1.627 . . . . 0.0 111.324 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 29.2 m -121.61 91.29 3.48 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 110.861 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -77.5 148.06 35.52 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.884 -1.135 . . . . 0.0 110.886 166.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.536 HG13 ' HB ' ' A' ' 81' ' ' THR . 1.4 p -133.67 97.37 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 127.864 2.466 . . . . 0.0 109.089 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -137.93 151.92 48.46 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.283 1.033 . . . . 0.0 111.631 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -130.39 155.84 80.4 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.794 1.238 . . . . 0.0 111.457 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.79 166.77 28.89 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 124.136 3.224 . . . . 0.0 112.786 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.38 -15.95 24.83 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 123.867 3.045 . . . . 0.0 115.066 -177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.9 tpt180 -160.63 -67.92 0.07 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.802 1.641 . . . . 0.0 111.559 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -75.51 115.79 15.54 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.296 -171.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.532 ' H ' HD13 ' A' ' 142' ' ' ILE . 0.2 OUTLIER -93.94 169.68 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 126.253 1.821 . . . . 0.0 112.113 176.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 128.604 2.762 . . . . 0.0 113.277 177.87 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.37 96.59 4.88 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.374 1.47 . . . . 0.0 111.458 -174.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 19.7 ptt? -60.65 -27.41 67.78 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.33 -17.35 60.85 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -77.06 -31.61 56.27 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.609 0.763 . . . . 0.0 112.58 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -72.34 146.82 46.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.729 0.812 . . . . 0.0 111.396 173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.37 158.93 43.27 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.951 1.3 . . . . 0.0 111.394 -177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.13 64.06 3.21 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.178 1.391 . . . . 0.0 113.061 -178.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -69.31 0.54 4.84 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.731 1.612 . . . . 0.0 114.669 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -59.64 -19.41 49.06 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.599 -1.313 . . . . 0.0 114.23 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -78.99 -26.79 43.3 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 176.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 12.3 t -91.32 -33.51 15.28 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.433 0.693 . . . . 0.0 111.601 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -66.81 144.02 56.55 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.369 -0.832 . . . . 0.0 111.352 173.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -84.26 170.49 13.65 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.515 -0.741 . . . . 0.0 112.811 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.3 p -131.18 141.94 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.957 1.303 . . . . 0.0 112.006 -176.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . 0.693 ' HA ' HG22 ' B' ' 162' ' ' VAL . 16.1 t -59.27 -34.69 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.561 1.144 . . . . 0.0 111.604 -176.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -60.63 -15.38 27.82 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.167 1.387 . . . . 0.0 113.671 174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -109.3 -47.56 3.38 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 125.265 1.426 . . . . 0.0 110.13 178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.693 HG22 ' HA ' ' B' ' 159' ' ' VAL . 4.3 m -51.31 -32.4 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 172.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 22.1 t -60.75 -20.99 62.52 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.433 1.493 . . . . 0.0 114.267 171.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -103.45 -31.8 9.81 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.166 1.786 . . . . 0.0 112.971 174.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 41.0 mt -49.81 -41.15 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 119.413 1.006 . . . . 0.0 110.689 171.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.85 -43.43 97.84 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.97 -51.99 48.27 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.724 1.147 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -31.46 71.03 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.53 -42.6 42.52 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 174.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.46 ' HA ' HG21 ' B' ' 191' ' ' VAL . 56.8 mt -55.77 -55.99 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-N 119.533 1.06 . . . . 0.0 109.886 174.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -59.15 -29.18 67.23 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 6.5 p -66.63 -34.37 77.72 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 172.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.1 -29.79 34.8 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.347 . . . . 0.0 113.199 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 79.9 mt -61.25 -37.29 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.479 1.112 . . . . 0.0 111.276 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.51 84.13 Favored Glycine 0 CA--C 1.539 1.547 0 C-N-CA 124.121 0.867 . . . . 0.0 114.817 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 107.06 -1.13 35.45 Favored Glycine 0 CA--C 1.538 1.513 0 C-N-CA 125.471 1.51 . . . . 0.0 116.319 174.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 -63.68 168.49 4.81 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 119.152 1.476 . . . . 0.0 112.958 167.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -85.16 -155.04 0.2 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.7 1.6 . . . . 0.0 111.718 176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -50.14 159.39 0.45 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.408 1.483 . . . . 0.0 113.06 164.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -151.15 172.06 16.39 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.351 1.46 . . . . 0.0 112.24 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 14.5 m170 -93.44 -100.6 0.14 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.4 1.08 . . . . 0.0 109.44 173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 70.6 m -65.57 -22.22 66.67 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 -177.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -59.64 -42.37 92.61 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 120.757 -1.214 . . . . 0.0 112.764 174.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 49.7 t -52.19 -38.08 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.292 1.037 . . . . 0.0 112.762 175.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -62.27 -55.68 25.93 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.885 1.274 . . . . 0.0 111.452 174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -63.62 -26.45 68.69 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 121.484 -0.76 . . . . 0.0 112.654 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -75.3 -54.21 7.46 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 124.172 0.989 . . . . 0.0 111.152 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.5 t -58.02 -25.07 60.65 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 177.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 13.8 t -84.43 -56.81 3.43 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.668 1.122 . . . . 0.0 112.201 171.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -57.7 -37.01 72.75 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.893 1.224 . . . . 0.0 113.684 -176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' B' ' 170' ' ' ILE . 98.7 t -70.24 -65.36 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.746 0 C-N-CA 124.165 0.986 . . . . 0.0 109.622 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 90.9 t -47.08 -31.99 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.668 1.187 . . . . 0.0 111.154 176.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.79 -43.1 90.4 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 118.478 0.581 . . . . 0.0 112.566 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -96.5 -44.37 7.2 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.02 1.328 . . . . 0.0 112.511 176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 51.8 m -59.43 -48.68 80.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.113 2.565 . . . . 0.0 113.495 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.46 -40.62 97.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 117.959 0.345 . . . . 0.0 110.396 174.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 1.4 p -62.05 -30.87 71.28 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.454 -0.779 . . . . 0.0 112.996 173.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -76.2 -48.31 20.9 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.017 2.127 . . . . 0.0 112.918 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -63.37 -30.42 71.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 119.937 1.244 . . . . 0.0 113.463 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 31.0 m -58.34 -30.59 66.84 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.218 1.007 . . . . 0.0 111.05 169.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -81.47 -36.04 29.79 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 17.7 mt -78.36 -19.49 53.3 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -95.52 -101.7 1.87 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.709 1.623 . . . . 0.0 112.445 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.6 mtpt -141.38 151.34 60.89 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.019 1.328 . . . . 0.0 113.012 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.76 110.52 2.92 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.832 3.022 . . . . 0.0 111.446 175.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -150.88 178.85 8.75 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.58 1.152 . . . . 0.0 112.152 175.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -88.05 93.47 9.5 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.308 1.443 . . . . 0.0 111.538 174.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -86.73 139.41 30.76 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.235 1.414 . . . . 0.0 109.952 173.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 3.0 tt -119.76 153.58 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.11 1.764 . . . . 0.0 109.644 175.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.451 HG12 ' CB ' ' B' ' 253' ' ' ALA . 22.1 m -142.02 146.63 22.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.36 1.064 . . . . 0.0 110.718 170.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.16 119.92 17.29 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 127.064 2.146 . . . . 0.0 109.1 173.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.3 p -123.03 144.35 49.34 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.543 -0.723 . . . . 0.0 112.215 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 64.9 t -124.31 101.86 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.038 1.735 . . . . 0.0 108.254 -169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 11.5 mm -100.32 113.63 36.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 123.918 0.887 . . . . 0.0 108.837 179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.8 ptp -134.98 146.51 49.15 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.848 0.859 . . . . 0.0 110.529 178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -90.14 143.86 26.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.348 -0.845 . . . . 0.0 110.9 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -70.0 4.06 2.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.363 1.465 . . . . 0.0 114.347 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -50.45 -35.23 27.86 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.498 1.519 . . . . 0.0 112.416 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 157.69 20.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.902 1.239 . . . . 0.0 115.334 169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -75.27 61.09 1.15 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.2 1.4 . . . . 0.0 113.849 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -74.91 63.72 2.37 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.647 1.594 . . . . 0.0 112.959 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.04 159.26 11.94 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.097 1.759 . . . . 0.0 111.826 171.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -125.97 89.32 3.0 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.496 1.118 . . . . 0.0 110.178 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.722 ' HB ' HG13 ' B' ' 278' ' ' VAL . 53.3 m -97.09 139.04 33.68 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.649 -0.657 . . . . 0.0 110.438 177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -126.71 127.16 44.68 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.093 1.357 . . . . 0.0 110.122 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 1.7 m -126.16 116.86 22.0 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.147 0.979 . . . . 0.0 109.605 -172.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 1.9 t -80.04 44.61 0.67 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 122.504 1.145 . . . . 0.0 111.152 175.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 3.8 m -86.73 179.39 6.78 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.112 1.365 . . . . 0.0 110.507 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -147.03 148.13 31.36 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.45 1.5 . . . . 0.0 109.864 -175.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -91.12 132.49 36.02 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.431 -0.793 . . . . 0.0 110.25 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -142.41 139.14 31.55 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.346 1.458 . . . . 0.0 110.469 173.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 45.7 t -112.18 -58.64 2.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.465 1.506 . . . . 0.0 111.817 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.8 -38.68 12.22 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.172 0.989 . . . . 0.0 112.155 174.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.06 -32.38 72.69 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 127.443 2.297 . . . . 0.0 114.088 -169.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -160.77 -175.87 5.21 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.609 1.964 . . . . 0.0 110.803 -176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -113.62 123.59 6.19 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.563 1.554 . . . . 0.0 114.165 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 22.7 t -146.35 170.92 15.82 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.208 2.203 . . . . 0.0 110.575 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 1.2 p -168.78 126.07 1.01 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.315 1.446 . . . . 0.0 111.896 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.7 t -141.47 141.84 33.64 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 119.597 -1.939 . . . . 0.0 112.575 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -140.61 123.46 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 124.935 1.294 . . . . 0.0 109.652 -168.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.54 99.02 6.23 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.308 1.043 . . . . 0.0 113.163 -171.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.6 m95 -105.07 88.84 2.97 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.255 1.422 . . . . 0.0 110.884 178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -83.48 163.69 20.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.829 0.852 . . . . 0.0 111.37 164.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -141.63 179.93 6.54 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.461 1.504 . . . . 0.0 110.522 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 3.4 tmtt? -49.45 -41.23 39.53 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.451 1.5 . . . . 0.0 113.937 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.2 t -137.89 21.59 2.85 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 29.2 mtt -139.32 160.33 40.07 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.479 -1.388 . . . . 0.0 113.653 174.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -135.99 109.87 8.17 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.688 1.995 . . . . 0.0 110.956 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 70.9 m -130.6 78.39 1.84 Allowed 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.355 1.462 . . . . 0.0 110.697 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -108.48 145.81 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.266 1.026 . . . . 0.0 112.339 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.55 129.58 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.199 1.8 . . . . 0.0 112.126 -178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.2 t -114.29 130.24 56.65 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.641 1.577 . . . . 0.0 109.606 173.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.451 ' CB ' HG12 ' B' ' 210' ' ' VAL . . . -128.42 151.98 48.75 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.037 1.735 . . . . 0.0 111.764 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -141.02 143.67 34.55 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 124.451 1.1 . . . . 0.0 110.94 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -168.47 82.15 0.1 OUTLIER Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.257 0.932 . . . . 0.0 111.523 -167.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.2 160.07 38.98 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.405 1.882 . . . . 0.0 112.121 -170.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 18.3 t -139.46 132.35 29.29 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.852 1.261 . . . . 0.0 112.515 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -85.06 -9.65 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 125.679 1.592 . . . . 0.0 113.527 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -99.43 22.86 38.66 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.996 1.76 . . . . 0.0 114.545 -169.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.05 20.03 6.94 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.305 1.431 . . . . 0.0 114.162 -172.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -49.39 100.79 0.04 OUTLIER Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.678 2.085 . . . . 0.0 114.343 177.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 81.0 p -120.4 -165.75 1.23 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.944 2.098 . . . . 0.0 111.098 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 116.21 6.77 15.43 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.391 0.996 . . . . 0.0 115.21 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -54.54 158.8 2.35 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 118.941 1.371 . . . . 0.0 113.275 174.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 4.6 m -64.44 -18.08 64.41 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 144.25 -71.07 0.38 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.551 1.548 . . . . 0.0 112.237 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.56 170.41 18.62 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.486 2.791 . . . . 0.0 112.801 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.98 91.01 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.568 1.947 . . . . 0.0 111.625 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.68 167.25 22.24 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.118 0.967 . . . . 0.0 112.498 173.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 19.3 mt -65.42 125.66 25.83 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.785 1.634 . . . . 0.0 111.233 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -101.18 83.54 0.51 Allowed Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.706 1.622 . . . . 0.0 113.185 -174.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -68.85 90.33 0.42 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.719 1.607 . . . . 0.0 113.046 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -88.93 99.34 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.581 1.553 . . . . 0.0 111.75 174.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -129.62 166.68 19.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.347 1.459 . . . . 0.0 111.432 171.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.44 149.63 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.906 1.682 . . . . 0.0 111.394 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 28.2 m -121.47 91.16 3.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.162 1.385 . . . . 0.0 110.876 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -78.36 149.33 33.42 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.904 -1.123 . . . . 0.0 110.862 166.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.722 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.8 p -138.7 97.09 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 127.742 2.417 . . . . 0.0 109.245 175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -133.7 157.67 45.21 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 125.307 1.443 . . . . 0.0 110.87 177.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -134.42 155.87 79.37 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 124.308 1.043 . . . . 0.0 111.361 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -74.02 167.76 26.44 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.694 2.929 . . . . 0.0 112.734 -178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.55 -17.27 26.71 Favored 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 123.327 2.685 . . . . 0.0 114.741 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -161.36 -65.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.575 1.55 . . . . 0.0 112.051 173.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -77.13 120.34 22.08 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 125.559 1.544 . . . . 0.0 112.294 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . 0.432 ' H ' HD13 ' B' ' 285' ' ' ILE . 0.2 OUTLIER -104.73 169.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 126.566 1.946 . . . . 0.0 112.085 -178.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 N--CA 1.486 1.357 0 C-N-CA 128.334 2.654 . . . . 0.0 113.111 -179.674 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.613 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.3 m -140.21 -72.72 0.36 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.994 1.317 . . . . 0.0 111.199 176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -75.55 -27.14 58.51 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.475 -0.766 . . . . 0.0 112.835 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.16 -13.1 61.97 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.73 -19.04 65.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.574 1.15 . . . . 0.0 113.244 175.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -118.75 172.36 7.57 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.825 1.65 . . . . 0.0 111.736 170.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.01 -174.6 4.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.9 1.28 . . . . 0.0 110.864 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.33 109.94 0.35 Allowed 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.745 1.618 . . . . 0.0 112.885 178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.78 163.8 15.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.803 1.241 . . . . 0.0 112.645 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.49 -20.7 60.93 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.44 -26.84 66.6 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 175.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.7 t -114.62 -18.22 11.48 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.795 1.638 . . . . 0.0 112.629 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.47 172.53 9.36 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.144 -0.973 . . . . 0.0 111.228 166.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' CD2' ' HA3' ' A' ' 60' ' ' GLY . 14.7 p90 -139.18 165.86 26.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.163 1.385 . . . . 0.0 110.117 173.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.1 p -135.62 152.31 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.278 1.031 . . . . 0.0 110.929 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.9 t -57.25 -41.17 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.727 1.211 . . . . 0.0 111.323 -178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.16 66.88 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.683 1.193 . . . . 0.0 113.558 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -75.59 -62.54 1.54 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.766 0.827 . . . . 0.0 110.263 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG13 HD22 ' A' ' 56' ' ' LEU . 96.6 t -45.44 -47.83 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 126.436 1.894 . . . . 0.0 112.565 178.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 t -65.87 -13.63 59.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.163 1.785 . . . . 0.0 113.745 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -31.86 11.21 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.945 1.698 . . . . 0.0 112.255 170.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.0 mt -55.37 -42.33 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 123.509 0.724 . . . . 0.0 110.272 174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.42 -42.12 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -52.24 54.91 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.175 1.352 . . . . 0.0 111.174 177.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -30.99 72.03 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -178.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.75 -38.7 58.17 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.432 1.093 . . . . 0.0 113.203 174.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.454 ' HA ' HG21 ' A' ' 48' ' ' VAL . 49.4 mt -56.89 -56.99 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 119.166 0.894 . . . . 0.0 109.691 172.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -59.64 -27.89 66.75 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.33 -47.74 78.24 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.092 0.957 . . . . 0.0 112.024 169.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.5 -27.16 63.98 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.775 1.23 . . . . 0.0 114.047 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 58.2 mt -61.58 -35.41 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.564 1.146 . . . . 0.0 111.153 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.48 15.91 70.06 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.1 0.857 . . . . 0.0 114.299 -176.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.9 2.44 78.29 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 125.087 1.327 . . . . 0.0 115.631 178.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -65.73 174.34 2.39 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-N 118.841 1.321 . . . . 0.0 112.243 168.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.53 -155.01 0.21 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.119 1.368 . . . . 0.0 111.78 179.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -51.18 159.45 0.64 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.176 0.991 . . . . 0.0 112.28 158.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -151.6 177.39 10.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.38 1.472 . . . . 0.0 110.631 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 64.5 m80 -92.14 -114.22 0.09 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.32 1.048 . . . . 0.0 110.931 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.3 m -57.47 -22.41 43.51 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.383 1.873 . . . . 0.0 114.655 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mmtm -51.35 -38.97 55.97 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.376 1.471 . . . . 0.0 112.901 174.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.5 t -55.51 -32.42 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.118 0.967 . . . . 0.0 112.915 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -68.24 -45.15 74.04 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 119.227 0.922 . . . . 0.0 112.168 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -22.86 65.2 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 118.75 0.704 . . . . 0.0 112.724 174.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.5 -55.1 5.29 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 123.716 0.806 . . . . 0.0 111.501 179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.3 t -56.19 -28.99 60.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.916 0.78 . . . . 0.0 113.045 176.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -79.98 -57.57 3.58 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 119.338 0.972 . . . . 0.0 112.179 171.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -57.42 -38.21 73.98 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.94 1.245 . . . . 0.0 113.484 -176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 27' ' ' ILE . 84.3 t -66.75 -65.55 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 C-N-CA 123.874 0.869 . . . . 0.0 109.491 -178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 93.8 t -47.9 -32.07 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 124.355 1.062 . . . . 0.0 110.939 177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -58.42 -40.54 82.77 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -104.8 -40.99 5.77 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.479 1.512 . . . . 0.0 112.681 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 37.5 m -57.68 -53.37 58.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.702 2.401 . . . . 0.0 112.404 177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.8 -40.52 92.96 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.798 0.727 . . . . 0.0 110.693 179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.8 m -60.9 -40.92 94.91 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.663 -0.648 . . . . 0.0 112.72 172.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -66.07 -51.29 59.52 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.924 2.089 . . . . 0.0 113.382 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.52 HD22 HG13 ' A' ' 19' ' ' VAL . 4.1 pp -66.02 -26.24 67.44 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 20.1 m -58.93 -32.72 69.83 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.13 0.972 . . . . 0.0 111.466 166.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -85.58 -23.99 27.38 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.0 mt -67.79 -26.28 66.02 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.12 0.968 . . . . 0.0 112.3 170.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.439 ' HA3' ' CD2' ' A' ' 14' ' ' PHE . . . -98.74 -119.4 4.14 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 125.965 1.745 . . . . 0.0 112.535 171.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.8 mtpp -129.73 156.29 79.08 Favored Pre-proline 0 N--CA 1.482 1.144 0 C-N-CA 125.445 1.498 . . . . 0.0 113.156 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.77 113.39 2.96 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.93 3.087 . . . . 0.0 112.212 179.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.11 166.12 31.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.517 1.127 . . . . 0.0 112.196 174.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -73.3 98.78 2.75 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.657 0.783 . . . . 0.0 110.956 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -73.34 158.02 35.88 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.828 0.851 . . . . 0.0 111.179 161.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.7 tt -132.44 151.45 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 125.337 1.455 . . . . 0.0 108.955 164.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 110' ' ' ALA . 18.0 m -142.0 149.0 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.859 1.263 . . . . 0.0 110.309 169.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.3 p -135.8 139.37 43.45 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 125.654 1.582 . . . . 0.0 109.903 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -136.1 150.32 49.07 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 121.648 -0.657 . . . . 0.0 112.056 169.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.7 t -128.87 104.64 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.888 1.675 . . . . 0.0 108.661 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.469 HD12 ' HB2' ' A' ' 106' ' ' CYS . 2.6 mm -101.2 120.63 51.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.811 1.644 . . . . 0.0 108.926 177.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.81 166.17 26.7 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.883 0.849 . . . . 0.0 112.211 174.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -85.96 157.07 20.22 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.734 1.614 . . . . 0.0 111.245 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.33 11.07 1.04 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.604 1.962 . . . . 0.0 114.954 172.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -5.48 5.14 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.543 1.537 . . . . 0.0 114.942 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 103.81 -3.38 45.4 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.965 1.745 . . . . 0.0 114.711 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.47 87.53 0.88 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.233 1.413 . . . . 0.0 111.652 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -103.31 89.3 0.69 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 126.002 1.763 . . . . 0.0 111.031 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.585 ' H ' HD22 ' A' ' 79' ' ' LEU . 1.3 mm? -64.58 160.16 20.24 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.738 1.215 . . . . 0.0 111.658 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -87.94 96.85 10.64 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.444 -0.785 . . . . 0.0 109.99 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 75.9 m -117.14 132.16 56.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.783 0.833 . . . . 0.0 109.862 -177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -136.58 130.57 32.56 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.323 0.649 . . . . 0.0 111.74 -175.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 4.9 m -134.09 121.35 21.38 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.723 1.209 . . . . 0.0 110.569 -173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.0 t -74.35 17.62 0.19 Allowed 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.071 -1.018 . . . . 0.0 113.02 175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.4 m -62.8 167.94 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.833 -1.167 . . . . 0.0 112.22 167.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.18 154.79 21.94 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.667 1.587 . . . . 0.0 110.636 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -84.22 150.54 25.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.585 1.154 . . . . 0.0 110.241 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -146.93 164.62 32.34 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.589 1.956 . . . . 0.0 110.303 171.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 13.0 t -128.87 -56.28 1.2 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.498 1.119 . . . . 0.0 113.216 171.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.3 p -78.32 -46.98 18.75 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.389 1.076 . . . . 0.0 112.197 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.47 -48.34 61.06 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.571 1.949 . . . . 0.0 112.525 -170.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -149.29 -159.71 1.07 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.411 3.084 . . . . 0.0 108.79 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -146.56 -173.7 18.02 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.975 1.274 . . . . 0.0 112.923 168.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 98.6 p -155.27 173.45 16.62 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.359 2.263 . . . . 0.0 109.635 170.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 36.1 t -147.0 122.01 10.06 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.171 -0.956 . . . . 0.0 109.658 166.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.0 t -133.18 149.27 52.05 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.663 -1.273 . . . . 0.0 112.204 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -130.7 116.98 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 125.655 1.582 . . . . 0.0 108.266 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -113.77 95.21 5.21 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.905 1.282 . . . . 0.0 110.285 -170.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -104.57 118.42 36.53 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.527 1.131 . . . . 0.0 110.208 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -104.42 162.93 12.81 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.818 1.647 . . . . 0.0 111.302 173.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -151.29 -177.41 6.04 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.209 1.004 . . . . 0.0 111.506 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.73 -67.57 0.2 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.827 2.451 . . . . 0.0 113.847 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.5 t -133.97 24.72 3.93 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.184 1.394 . . . . 0.0 113.306 -176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.5 ptp -139.54 162.83 34.12 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.163 -1.586 . . . . 0.0 111.218 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -140.02 137.22 34.46 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.73 1.212 . . . . 0.0 110.34 172.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.469 ' HB2' HD12 ' A' ' 71' ' ' ILE . 11.2 p -139.97 85.88 2.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 122.874 1.321 . . . . 0.0 111.845 -175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -93.09 133.35 34.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.024 1.329 . . . . 0.0 111.104 178.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.81 126.44 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.605 1.562 . . . . 0.0 110.867 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.1 t -117.13 127.9 54.59 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 126.481 1.912 . . . . 0.0 110.498 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.465 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -121.73 149.12 43.72 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.061 1.744 . . . . 0.0 112.582 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -142.2 94.0 2.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.358 1.463 . . . . 0.0 108.663 174.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 113' ' ' LEU . . . -150.01 95.06 0.16 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 120.571 -1.331 . . . . 0.0 110.743 172.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.428 HD13 ' C ' ' A' ' 112' ' ' GLY . 0.0 OUTLIER -148.68 75.27 1.3 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.468 1.907 . . . . 0.0 112.142 -174.256 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 t -145.33 91.26 2.11 Favored 'General case' 0 N--CA 1.47 0.571 0 O-C-N 121.466 -0.771 . . . . 0.0 112.075 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.9 pp -105.36 -13.25 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -136.78 -8.91 1.37 Allowed Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.555 1.074 . . . . 0.0 115.079 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.95 1.53 40.66 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 125.204 1.383 . . . . 0.0 115.405 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -163.43 175.73 39.65 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 126.329 1.918 . . . . 0.0 113.345 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.5 m -74.54 174.02 9.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.342 1.457 . . . . 0.0 112.654 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 101.41 24.13 9.07 Favored Glycine 0 CA--C 1.537 1.447 0 C-N-CA 124.572 1.082 . . . . 0.0 114.847 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -62.38 169.0 3.14 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 126.287 1.835 . . . . 0.0 112.529 175.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.0 t -65.43 -24.3 67.16 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -128.93 74.68 0.43 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.84 1.686 . . . . 0.0 111.975 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -73.12 142.61 34.53 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.364 2.709 . . . . 0.0 111.44 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.7 pt -134.48 141.03 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.678 1.591 . . . . 0.0 109.944 178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.0 120.5 42.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.481 1.912 . . . . 0.0 110.328 175.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.1 mt -143.08 -174.41 4.18 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 128.884 2.874 . . . . 0.0 109.848 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -168.51 94.08 0.11 Allowed Glycine 0 CA--C 1.53 0.971 0 O-C-N 121.035 -1.041 . . . . 0.0 112.99 -176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 5.2 ttt -151.49 130.72 12.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.282 1.433 . . . . 0.0 110.45 -174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -168.84 112.16 0.55 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.456 1.502 . . . . 0.0 112.252 175.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.41 148.9 49.48 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.054 1.741 . . . . 0.0 112.308 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 45.5 mm -60.21 150.71 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 126.47 1.908 . . . . 0.0 111.471 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 61.1 m -115.95 89.59 3.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.229 1.412 . . . . 0.0 110.886 -177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -98.57 146.45 25.8 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.022 -1.049 . . . . 0.0 111.139 170.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.52 94.08 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 128.032 2.533 . . . . 0.0 108.006 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -142.17 162.54 35.22 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.935 1.294 . . . . 0.0 111.559 176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -112.68 89.33 12.87 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.968 1.307 . . . . 0.0 108.392 174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.69 114.63 3.39 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.123 2.549 . . . . 0.0 110.432 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.29 -37.9 5.33 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.377 2.051 . . . . 0.0 112.21 -174.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -152.16 175.64 12.39 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 129.773 3.229 . . . . 0.0 110.039 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -65.07 135.87 56.08 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.071 1.348 . . . . 0.0 111.722 168.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.61 172.76 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 126.148 1.779 . . . . 0.0 111.449 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 21.2 t . . . . . 0 C--O 1.253 1.257 0 C-N-CA 125.555 1.542 . . . . 0.0 111.186 174.456 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 111.584 -0.607 . . . . 0.0 111.584 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 69.4 m -137.8 -71.95 0.42 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.351 1.46 . . . . 0.0 111.415 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -74.86 -23.71 58.46 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.521 -0.737 . . . . 0.0 112.952 177.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.9 -13.35 62.08 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -178.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -59.67 -33.58 71.75 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.907 1.283 . . . . 0.0 113.18 178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -145.39 134.89 23.21 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.139 1.775 . . . . 0.0 111.934 176.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -147.51 6.49 0.84 Allowed 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -138.97 69.4 1.37 Allowed 'General case' 0 CA--C 1.543 0.68 0 O-C-N 120.457 -1.402 . . . . 0.0 112.348 -167.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.07 134.43 48.21 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.117 1.367 . . . . 0.0 111.546 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.05 -22.47 65.77 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 113.391 0.885 . . . . 0.0 113.391 -177.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.91 -28.45 67.51 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.521 1.304 . . . . 0.0 114.521 178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 14.0 t -108.51 -18.84 13.64 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.279 1.432 . . . . 0.0 112.694 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -69.6 171.6 8.69 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.987 0.899 . . . . 0.0 111.468 167.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . 0.436 ' CD2' ' HA3' ' B' ' 203' ' ' GLY . 13.6 p90 -139.76 166.62 24.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.286 1.435 . . . . 0.0 110.028 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.7 p -136.68 152.45 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.263 1.025 . . . . 0.0 110.992 -176.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 97.5 t -57.15 -41.55 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.79 1.236 . . . . 0.0 111.347 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 113.564 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -75.65 -62.68 1.5 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.788 0.835 . . . . 0.0 110.172 171.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.501 HG13 HD22 ' B' ' 199' ' ' LEU . 96.1 t -45.15 -47.89 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 126.462 1.905 . . . . 0.0 112.607 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.3 t -65.7 -13.8 59.99 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.111 1.764 . . . . 0.0 113.744 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.16 -31.94 11.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.98 1.712 . . . . 0.0 112.203 171.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 8.6 mt -55.64 -42.18 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.449 0.7 . . . . 0.0 110.26 174.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 9.9 p -59.54 -41.71 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.51 -52.35 53.36 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.145 1.339 . . . . 0.0 111.172 177.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -30.86 71.91 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.82 -38.88 57.7 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.421 1.088 . . . . 0.0 113.177 174.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.444 ' HA ' HG21 ' B' ' 191' ' ' VAL . 49.8 mt -56.78 -56.97 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 119.222 0.919 . . . . 0.0 109.663 172.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -59.57 -27.97 66.72 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -177.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.27 -47.67 78.65 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.157 0.983 . . . . 0.0 111.968 170.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.57 -27.41 64.11 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 114.086 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 58.5 mt -61.5 -35.33 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.609 1.164 . . . . 0.0 111.141 170.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 82.91 16.18 70.75 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.136 0.874 . . . . 0.0 114.259 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 87.74 2.32 81.82 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.128 1.347 . . . . 0.0 115.58 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -65.16 170.99 4.01 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 118.766 1.283 . . . . 0.0 112.33 169.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.85 -162.0 0.44 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.26 1.424 . . . . 0.0 112.293 176.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -53.06 154.18 3.12 Favored 'General case' 0 CA--C 1.545 0.759 0 O-C-N 121.453 -0.78 . . . . 0.0 111.632 162.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -145.17 171.02 15.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.142 1.377 . . . . 0.0 110.737 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -84.77 -114.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.213 1.005 . . . . 0.0 110.755 175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 15.6 m -59.73 -20.5 56.85 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.499 1.52 . . . . 0.0 114.727 -176.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -51.73 -38.42 55.23 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.501 1.52 . . . . 0.0 112.888 175.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 3.5 p -55.91 -30.28 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -68.73 -45.25 71.99 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.855 0.862 . . . . 0.0 111.693 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.47 -24.08 65.56 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 173.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -78.19 -54.41 6.26 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.734 0.814 . . . . 0.0 111.54 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 11.9 t -57.02 -27.53 61.69 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 7.1 t -81.32 -58.22 3.14 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 119.434 1.015 . . . . 0.0 112.429 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -56.48 -38.21 71.42 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 119.988 1.267 . . . . 0.0 113.584 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.444 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.7 t -66.68 -65.72 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 123.822 0.849 . . . . 0.0 109.489 -179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.9 t -47.74 -32.0 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.489 1.116 . . . . 0.0 110.968 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -58.55 -40.52 83.25 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -104.92 -40.95 5.75 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.494 1.518 . . . . 0.0 112.616 179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 39.3 m -57.47 -53.67 55.56 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 127.705 2.402 . . . . 0.0 112.438 177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.58 -40.9 93.41 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.749 0.704 . . . . 0.0 110.568 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 70.2 m -60.66 -39.6 88.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 172.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -67.42 -51.21 54.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 126.894 2.078 . . . . 0.0 113.396 177.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.501 HD22 HG13 ' B' ' 162' ' ' VAL . 3.9 pp -66.27 -26.06 67.16 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -175.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.4 m -58.68 -32.54 69.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.094 0.958 . . . . 0.0 111.522 165.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -86.21 -23.89 26.29 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.78 -26.73 66.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.987 0.915 . . . . 0.0 112.194 169.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . 0.436 ' HA3' ' CD2' ' B' ' 157' ' ' PHE . . . -97.56 -121.49 4.25 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 126.098 1.809 . . . . 0.0 112.562 171.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 12.8 mtpp -128.0 156.34 76.34 Favored Pre-proline 0 N--CA 1.48 1.068 0 C-N-CA 125.448 1.499 . . . . 0.0 113.172 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.29 112.5 2.57 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 124.005 3.137 . . . . 0.0 112.21 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -151.15 166.0 32.17 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.564 1.146 . . . . 0.0 112.314 174.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -72.6 100.47 2.78 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.714 0.806 . . . . 0.0 110.998 171.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -75.31 157.26 34.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.907 0.883 . . . . 0.0 111.053 160.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 5.4 tt -132.26 151.42 34.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 125.576 1.55 . . . . 0.0 108.95 164.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.46 HG12 ' HB2' ' B' ' 253' ' ' ALA . 19.3 m -142.74 149.75 18.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.882 1.273 . . . . 0.0 110.344 170.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 6.7 p -136.89 140.97 42.72 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 125.532 1.533 . . . . 0.0 110.145 170.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 15.8 p -138.48 155.34 48.53 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.617 -0.677 . . . . 0.0 112.176 169.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 41.5 t -135.96 114.66 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.76 1.624 . . . . 0.0 108.493 178.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.496 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.7 mm -106.93 116.56 50.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 125.863 1.665 . . . . 0.0 108.727 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . 0.417 ' HG2' HD12 ' A' ' 79' ' ' LEU . 1.1 tmt? -134.86 119.57 18.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.401 1.48 . . . . 0.0 110.64 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.74 81.71 0.88 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 126.278 1.831 . . . . 0.0 111.0 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.11 -74.38 0.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.073 1.349 . . . . 0.0 110.968 178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 -19.55 2.12 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 127.94 -2.48 6.85 Favored Glycine 0 CA--C 1.542 1.723 0 C-N-CA 126.058 1.79 . . . . 0.0 115.98 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -63.99 101.17 0.36 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.527 1.531 . . . . 0.0 114.173 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -76.06 102.18 1.54 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.574 1.083 . . . . 0.0 112.218 170.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.515 HD23 HD23 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -44.17 151.81 0.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.363 1.465 . . . . 0.0 113.297 166.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -87.35 93.27 9.35 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 121.334 -0.853 . . . . 0.0 109.462 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.496 ' HB ' HG13 ' B' ' 278' ' ' VAL . 50.3 m -116.01 132.79 56.55 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.243 0.617 . . . . 0.0 110.428 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -132.56 129.11 38.6 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.218 0.607 . . . . 0.0 111.321 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 4.1 m -131.56 120.57 23.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.779 1.232 . . . . 0.0 110.211 -174.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 5.0 t -74.02 16.58 0.22 Allowed 'General case' 0 N--CA 1.48 1.025 0 O-C-N 121.194 -0.942 . . . . 0.0 113.045 175.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.6 m -62.44 167.49 4.24 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 120.88 -1.138 . . . . 0.0 112.26 167.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -161.22 154.27 21.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.739 1.616 . . . . 0.0 110.523 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.4 t-105 -81.38 151.42 27.95 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.251 1.021 . . . . 0.0 110.122 168.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -145.93 163.2 35.89 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.619 1.968 . . . . 0.0 109.979 169.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 14.6 t -126.07 -58.82 1.36 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.447 1.099 . . . . 0.0 112.864 172.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 17.3 p -79.0 -46.59 17.89 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.384 1.073 . . . . 0.0 112.333 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.57 -48.41 66.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.434 1.893 . . . . 0.0 112.324 -170.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -150.35 -159.13 0.99 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 129.327 3.051 . . . . 0.0 108.718 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -146.62 -174.03 18.38 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 124.951 1.263 . . . . 0.0 113.286 169.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 94.9 p -155.1 173.69 16.24 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 127.392 2.277 . . . . 0.0 109.634 170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 36.6 t -147.18 123.73 11.08 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.264 -0.897 . . . . 0.0 109.444 166.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 12.8 t -134.01 149.16 51.18 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 120.528 -1.358 . . . . 0.0 112.118 178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.65 114.25 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 125.453 1.501 . . . . 0.0 108.066 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -111.34 96.97 6.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.9 1.28 . . . . 0.0 109.851 -170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 12.7 m95 -107.87 124.78 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.415 1.086 . . . . 0.0 109.931 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.41 168.78 9.85 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.616 1.966 . . . . 0.0 110.643 173.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -148.11 -158.04 0.87 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.992 0.917 . . . . 0.0 110.807 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -35.73 -65.97 0.22 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 127.267 2.227 . . . . 0.0 113.649 172.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 3.9 t -139.39 1.62 1.98 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 7.9 ptp -98.17 154.37 17.81 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 120.598 -1.314 . . . . 0.0 112.279 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -128.9 120.01 25.42 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.867 1.667 . . . . 0.0 108.979 168.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.496 ' HB2' HD12 ' B' ' 214' ' ' ILE . 20.3 p -126.98 79.01 1.85 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 122.801 1.286 . . . . 0.0 111.139 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.8 pp -92.09 136.13 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.005 1.322 . . . . 0.0 111.265 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.05 126.55 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.547 1.539 . . . . 0.0 110.944 177.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 32.0 t -113.82 132.15 55.98 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.44 1.896 . . . . 0.0 110.407 -178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.46 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -125.38 149.2 48.36 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.089 1.756 . . . . 0.0 112.555 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -142.67 98.18 3.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.607 1.563 . . . . 0.0 108.346 174.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . 0.45 ' N ' HD13 ' B' ' 256' ' ' LEU . . . -155.24 94.15 0.14 Allowed Glycine 0 CA--C 1.528 0.895 0 O-C-N 120.655 -1.278 . . . . 0.0 110.64 172.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.45 HD13 ' N ' ' B' ' 255' ' ' GLY . 0.0 OUTLIER -148.37 76.66 1.37 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.504 1.921 . . . . 0.0 112.256 -173.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 1.8 t -146.98 93.0 2.2 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.519 -0.738 . . . . 0.0 112.115 -177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.9 pp -107.41 -13.39 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -136.65 -5.64 1.93 Allowed Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.709 1.147 . . . . 0.0 115.074 178.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 68.87 2.2 28.92 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 125.342 1.448 . . . . 0.0 115.624 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -165.64 174.14 41.36 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 126.425 1.964 . . . . 0.0 113.232 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 38.2 m -72.61 174.22 7.84 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.519 1.528 . . . . 0.0 112.929 176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 100.73 23.93 9.64 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 124.557 1.075 . . . . 0.0 114.857 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -62.31 169.09 3.04 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.212 1.805 . . . . 0.0 112.548 174.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 8.1 t -64.71 -23.37 67.23 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -128.77 74.8 0.43 Allowed Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.965 1.745 . . . . 0.0 112.179 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.74 143.32 33.47 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 123.364 2.709 . . . . 0.0 111.545 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 33.8 pt -134.16 154.46 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.369 1.468 . . . . 0.0 111.298 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 113.14 18.34 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.647 1.579 . . . . 0.0 111.39 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 7.3 mt -140.91 -176.71 4.77 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.571 2.748 . . . . 0.0 110.313 178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.39 94.02 0.11 Allowed Glycine 0 N--CA 1.471 0.996 0 O-C-N 121.234 -0.916 . . . . 0.0 112.779 -176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 6.4 ttt -151.09 129.26 11.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.289 1.436 . . . . 0.0 110.434 -173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -167.33 112.13 0.72 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.29 1.436 . . . . 0.0 112.321 175.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.4 mmmt -135.28 148.76 49.64 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.987 1.715 . . . . 0.0 112.276 173.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 45.4 mm -59.91 150.58 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 126.585 1.954 . . . . 0.0 111.438 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 59.8 m -116.6 88.55 2.92 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.256 1.422 . . . . 0.0 110.787 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -99.1 147.63 24.87 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.104 -0.997 . . . . 0.0 110.877 169.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.3 p -138.26 98.16 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 127.3 2.24 . . . . 0.0 108.794 175.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -142.84 159.52 42.09 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.587 1.555 . . . . 0.0 111.612 177.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -108.56 92.98 10.94 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.649 1.18 . . . . 0.0 108.527 171.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.8 115.26 3.86 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 123.049 2.499 . . . . 0.0 110.187 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.31 -35.87 7.83 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.405 2.07 . . . . 0.0 112.276 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -152.58 175.01 13.23 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 129.624 3.17 . . . . 0.0 109.988 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -65.55 135.16 54.76 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.009 1.324 . . . . 0.0 111.638 168.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.33 172.52 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 126.136 1.774 . . . . 0.0 111.39 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 21.1 t . . . . . 0 C--O 1.252 1.229 0 C-N-CA 125.541 1.536 . . . . 0.0 111.199 174.636 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.049 -0.42 . . . . 0.0 112.049 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -127.87 -34.58 2.15 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.005 1.322 . . . . 0.0 114.034 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.2 mtm -60.11 -33.11 71.67 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.081 0.953 . . . . 0.0 112.494 177.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -77.29 -16.68 58.86 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.396 1.478 . . . . 0.0 114.526 174.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.36 -31.19 26.89 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.181 0.992 . . . . 0.0 112.518 -179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.27 147.63 49.48 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.016 0.926 . . . . 0.0 111.148 169.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.43 137.54 19.38 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.798 . . . . 0.0 112.376 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.55 95.06 3.26 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.667 1.587 . . . . 0.0 111.549 175.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.14 87.45 0.58 Allowed 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.169 1.388 . . . . 0.0 112.178 177.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -56.78 -26.05 56.74 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.992 1.317 . . . . 0.0 113.564 -177.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -69.91 -23.58 63.25 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.949 1.7 . . . . 0.0 115.103 175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.21 -16.44 14.26 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.912 1.285 . . . . 0.0 112.596 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.21 166.35 9.93 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.887 0.875 . . . . 0.0 112.029 169.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -134.17 171.49 14.16 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.76 1.624 . . . . 0.0 111.425 176.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.9 p -147.75 161.05 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.544 1.137 . . . . 0.0 111.274 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.8 t -55.39 -44.66 76.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.591 1.556 . . . . 0.0 111.872 177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -60.61 -25.85 66.57 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 113.194 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -76.81 -57.89 3.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.84 0.856 . . . . 0.0 110.85 171.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.4 t -49.28 -42.88 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 C-N-CA 125.181 1.392 . . . . 0.0 112.768 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -63.16 -8.29 7.64 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.617 1.567 . . . . 0.0 114.293 177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -109.92 -36.8 5.79 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.877 1.671 . . . . 0.0 112.453 169.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.6 mt -49.34 -44.46 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.086 0.857 . . . . 0.0 110.591 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 97' ' ' VAL . 6.6 p -59.41 -41.46 84.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.522 -0.736 . . . . 0.0 112.956 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.93 -51.06 52.14 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.286 0.948 . . . . 0.0 111.01 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -31.13 72.2 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.9 -47.68 36.27 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.035 0.934 . . . . 0.0 112.179 173.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.404 HG13 HG11 ' A' ' 48' ' ' VAL . 65.2 mt -59.53 -58.43 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.183 0.901 . . . . 0.0 110.366 177.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.16 -27.87 69.67 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.5 t -65.15 -50.61 65.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.699 0.799 . . . . 0.0 111.795 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.84 -30.81 71.09 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.65 1.18 . . . . 0.0 113.883 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 49.8 mt -62.89 -31.6 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.81 1.644 . . . . 0.0 112.578 175.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.76 7.71 0.43 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 119.052 2.381 . . . . 0.0 119.052 -161.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.48 -38.37 95.67 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 120.237 2.019 . . . . 0.0 114.731 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -146.85 -173.3 4.19 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 119.426 1.613 . . . . 0.0 114.098 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.62 -178.1 0.13 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.481 1.912 . . . . 0.0 112.537 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -48.94 154.63 0.71 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.457 1.503 . . . . 0.0 113.914 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -134.84 171.56 14.22 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.914 1.286 . . . . 0.0 112.349 -170.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -91.49 -113.75 0.09 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.111 1.365 . . . . 0.0 110.865 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 61.7 p -74.57 4.62 5.82 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 126.179 1.792 . . . . 0.0 115.318 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.9 mmtp -47.95 -33.44 7.73 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 126.321 1.848 . . . . 0.0 114.559 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.4 p -48.63 -32.17 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.544 1.137 . . . . 0.0 113.55 174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -65.18 -52.02 57.45 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.155 1.382 . . . . 0.0 112.284 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -66.18 -26.33 67.36 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.106 -0.996 . . . . 0.0 112.775 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.81 -53.62 7.68 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.269 1.028 . . . . 0.0 111.557 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.54 -24.24 63.52 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.566 0.746 . . . . 0.0 112.72 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 t -80.67 -63.66 1.36 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.102 0.865 . . . . 0.0 112.197 165.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -55.15 -41.46 71.84 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.29 1.436 . . . . 0.0 114.289 -171.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG11 HG13 ' A' ' 27' ' ' ILE . 85.2 t -66.69 -62.55 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 C-N-CA 124.219 1.008 . . . . 0.0 110.248 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.6 t -49.04 -31.38 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.991 1.317 . . . . 0.0 110.766 175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -62.61 -31.19 71.98 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -108.68 -41.48 4.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.225 1.41 . . . . 0.0 112.165 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.9 m -59.15 -51.47 69.86 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.932 2.493 . . . . 0.0 112.583 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.22 -38.41 91.07 Favored 'General case' 0 CA--C 1.546 0.802 0 CA-C-O 121.287 0.565 . . . . 0.0 111.336 178.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 t -61.88 -46.0 91.32 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 171.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -60.0 -49.14 78.84 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.709 2.004 . . . . 0.0 112.809 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.75 -24.8 63.58 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 120.571 -1.331 . . . . 0.0 114.399 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 98.0 m -60.36 -28.16 67.97 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.928 0.491 . . . . 0.0 111.024 165.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.4 mmtm -87.19 -29.35 21.82 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.951 0.901 . . . . 0.0 112.695 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.8 mt -70.92 -20.82 62.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.626 1.17 . . . . 0.0 112.385 174.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -105.61 -110.56 3.51 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.434 1.969 . . . . 0.0 112.81 172.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -137.78 148.67 61.77 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 126.379 1.872 . . . . 0.0 111.13 -175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -71.34 120.32 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.048 3.165 . . . . 0.0 112.439 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -156.79 166.77 32.43 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.881 1.272 . . . . 0.0 112.392 175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -70.09 92.61 0.75 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.663 1.185 . . . . 0.0 110.36 166.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -68.6 162.63 25.46 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.664 0.745 . . . . 0.0 110.797 157.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.541 HD11 ' SG ' ' B' ' 228' ' ' CYS . 7.3 tt -141.84 153.62 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.742 1.617 . . . . 0.0 109.045 166.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.437 HG12 ' HB2' ' A' ' 110' ' ' ALA . 21.7 m -144.67 152.13 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 124.956 1.302 . . . . 0.0 110.566 173.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.3 t -144.34 158.64 43.63 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.421 1.089 . . . . 0.0 110.256 170.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.2 p -151.62 152.72 33.23 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.078 1.351 . . . . 0.0 111.88 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.2 t -133.61 123.49 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.917 1.287 . . . . 0.0 109.317 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.0 mm -111.16 108.36 25.28 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 127.431 2.293 . . . . 0.0 109.121 -176.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 17.0 tmm? -135.91 153.47 51.43 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.438 2.295 . . . . 0.0 110.733 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -143.98 147.81 34.43 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.182 1.393 . . . . 0.0 112.495 -171.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -80.04 -14.38 58.59 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -76.62 -7.75 55.87 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 -175.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 170.12 25.51 0.02 OUTLIER Glycine 0 N--CA 1.477 1.375 0 N-CA-C 116.385 1.314 . . . . 0.0 116.385 178.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.644 ' HB1' HD11 ' B' ' 222' ' ' LEU . . . -139.25 126.77 21.7 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.893 1.277 . . . . 0.0 112.472 -168.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -173.25 101.4 0.16 Allowed Glycine 0 CA--C 1.534 1.24 0 C-N-CA 123.927 0.775 . . . . 0.0 114.111 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.721 HD13 HD13 ' B' ' 222' ' ' LEU . 8.8 mp -113.99 -174.56 2.5 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.688 2.395 . . . . 0.0 110.358 -176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -110.15 130.64 55.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.382 0.673 . . . . 0.0 110.317 170.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.2 m -137.78 142.85 40.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.284 1.433 . . . . 0.0 109.749 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -137.72 138.29 39.19 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.675 1.19 . . . . 0.0 110.551 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.2 p -141.43 120.05 12.5 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.583 1.153 . . . . 0.0 110.993 177.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.8 m -75.91 13.2 0.9 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 120.839 -1.163 . . . . 0.0 113.406 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.673 ' SG ' HD11 ' B' ' 209' ' ' ILE . 8.2 m -60.43 164.49 4.36 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.46 1.104 . . . . 0.0 112.899 167.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 3.1 p90 -159.95 158.21 30.29 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.445 1.898 . . . . 0.0 110.053 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.5 t-105 -80.72 139.42 36.13 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.247 0.546 . . . . 0.0 109.651 168.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.8 p30 -154.35 162.66 41.03 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.164 1.786 . . . . 0.0 111.178 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 10.6 t -132.98 -59.32 0.89 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.86 1.264 . . . . 0.0 112.232 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.3 t -77.01 -39.09 51.59 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.369 1.068 . . . . 0.0 111.513 174.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.57 -53.68 53.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.78 1.632 . . . . 0.0 111.641 -173.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -150.09 -69.76 0.19 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.982 1.313 . . . . 0.0 112.404 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 135.29 151.95 6.36 Favored Glycine 0 CA--C 1.542 1.734 0 C-N-CA 127.238 2.352 . . . . 0.0 113.38 178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.7 p -165.35 141.48 5.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.689 1.995 . . . . 0.0 110.557 173.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 1.7 p -126.72 63.85 1.29 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.869 1.268 . . . . 0.0 112.35 -174.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -76.41 150.59 36.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.338 1.855 . . . . 0.0 113.591 177.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.435 HG21 HG21 ' A' ' 23' ' ' VAL . 1.7 t -142.12 135.21 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.463 1.505 . . . . 0.0 110.457 -176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -115.19 120.15 38.77 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.48 1.112 . . . . 0.0 112.012 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -133.2 98.54 4.29 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.695 1.598 . . . . 0.0 110.261 -177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.82 173.48 8.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.79 1.236 . . . . 0.0 111.949 166.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -143.43 -176.39 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.764 1.626 . . . . 0.0 111.203 175.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -51.56 -43.31 62.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.172 1.389 . . . . 0.0 114.246 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 t -137.71 8.52 2.82 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.271 1.428 . . . . 0.0 114.101 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -123.14 165.38 16.96 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.184 1.393 . . . . 0.0 112.819 -176.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -145.28 118.76 9.06 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.161 1.784 . . . . 0.0 109.941 -176.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 3.9 p -143.62 74.44 1.43 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.0 1.32 . . . . 0.0 111.938 -175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.0 pt -74.71 158.9 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.457 -0.777 . . . . 0.0 111.421 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.4 p -136.07 141.15 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.486 1.914 . . . . 0.0 109.949 174.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.5 t -135.38 125.18 25.51 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.257 -0.902 . . . . 0.0 111.54 -174.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -121.62 144.17 48.9 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.299 1.44 . . . . 0.0 112.823 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -146.18 -176.67 5.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 126.607 1.963 . . . . 0.0 110.125 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.53 84.41 1.11 Allowed Glycine 0 CA--C 1.539 1.552 0 O-C-N 120.87 -1.144 . . . . 0.0 112.892 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 46.22 1.1 Allowed 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 127.174 2.19 . . . . 0.0 113.031 -167.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.5 t -124.86 77.58 1.62 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.193 0.997 . . . . 0.0 112.268 -170.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.6 pp -96.62 -10.49 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 -168.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -110.12 -3.93 29.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.127 1.346 . . . . 0.0 115.133 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.4 3.37 57.6 Favored Glycine 0 CA--C 1.54 1.627 0 C-N-CA 124.962 1.267 . . . . 0.0 115.849 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -157.29 174.0 34.8 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.548 2.023 . . . . 0.0 113.345 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.0 p -69.78 174.69 4.9 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.653 1.581 . . . . 0.0 113.477 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 98.75 26.59 8.98 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.528 1.061 . . . . 0.0 114.79 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -59.84 165.22 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.409 1.484 . . . . 0.0 113.559 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.2 t -76.39 12.34 1.26 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.353 1.861 . . . . 0.0 114.635 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -83.17 162.39 40.37 Favored Glycine 0 CA--C 1.543 1.842 0 O-C-N 120.728 -1.233 . . . . 0.0 114.207 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -71.97 171.92 15.68 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.007 3.138 . . . . 0.0 113.143 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.1 pp -128.57 132.38 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.964 1.706 . . . . 0.0 111.605 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.72 161.18 41.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.761 1.624 . . . . 0.0 112.788 178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.9 155.99 22.61 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.389 1.476 . . . . 0.0 112.599 176.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 153.23 -171.76 32.16 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.889 1.233 . . . . 0.0 113.617 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 7.6 mtt -136.99 170.64 15.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 126.307 1.843 . . . . 0.0 112.225 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -134.57 143.45 47.39 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.578 1.951 . . . . 0.0 111.455 178.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -136.23 169.44 17.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.85 2.06 . . . . 0.0 111.443 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 20.4 mm -63.71 146.02 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.101 1.36 . . . . 0.0 110.588 173.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 89.6 m -106.07 111.74 24.48 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.279 1.432 . . . . 0.0 110.067 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -112.99 145.37 40.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.004 -1.06 . . . . 0.0 110.782 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -142.86 104.88 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 127.087 2.155 . . . . 0.0 109.171 -175.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -139.63 150.36 44.86 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.737 0.815 . . . . 0.0 112.465 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -133.84 157.77 77.03 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.574 1.55 . . . . 0.0 111.557 -175.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.36 160.53 48.43 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 123.524 2.816 . . . . 0.0 112.94 -177.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.92 -38.86 15.63 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.317 2.678 . . . . 0.0 113.473 -175.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.34 -177.96 6.52 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.843 2.057 . . . . 0.0 110.93 174.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -105.92 136.59 45.3 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.203 1.001 . . . . 0.0 111.783 169.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.56 165.29 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 126.708 2.003 . . . . 0.0 111.326 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 35.6 t . . . . . 0 C--O 1.254 1.327 0 C-N-CA 125.881 1.672 . . . . 0.0 111.318 173.87 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 CA-C-O 119.669 -0.517 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 70.5 m -132.86 -37.65 1.01 Allowed 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.501 1.12 . . . . 0.0 113.67 175.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 18.4 mtm -59.16 -33.56 71.06 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.299 1.04 . . . . 0.0 112.649 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -77.32 -16.79 58.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.403 1.481 . . . . 0.0 114.592 174.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -83.57 -30.96 26.6 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.14 0.976 . . . . 0.0 112.548 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -69.79 147.89 49.84 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.976 0.91 . . . . 0.0 111.23 168.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -150.1 138.05 20.19 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.778 0.831 . . . . 0.0 112.447 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.22 96.08 4.46 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.594 1.558 . . . . 0.0 111.576 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.33 86.21 0.59 Allowed 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.008 1.323 . . . . 0.0 112.226 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -56.43 -25.91 51.94 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.04 1.336 . . . . 0.0 113.522 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.01 -24.34 62.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.711 1.604 . . . . 0.0 115.018 176.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.81 -19.75 13.81 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.376 1.07 . . . . 0.0 112.502 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.26 159.69 20.27 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 121.23 -0.919 . . . . 0.0 111.56 170.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.59 162.63 27.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.402 1.081 . . . . 0.0 110.721 169.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 14.0 p -138.61 158.96 31.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.736 1.215 . . . . 0.0 111.166 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.83 -38.55 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.74 2.416 . . . . 0.0 112.67 -174.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.86 -28.34 68.77 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.173 1.389 . . . . 0.0 113.072 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -90.49 -47.8 7.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.47 0.708 . . . . 0.0 110.708 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 70.2 t -48.58 -42.55 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.197 0 C-N-CA 125.338 1.455 . . . . 0.0 112.187 174.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.4 t -64.25 -8.23 11.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.622 1.569 . . . . 0.0 114.874 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -107.54 -35.09 6.84 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.308 1.843 . . . . 0.0 112.446 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 33.9 mt -49.79 -42.13 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.143 0.977 . . . . 0.0 110.583 170.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.29 -43.57 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -50.52 63.35 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.455 1.025 . . . . 0.0 111.053 179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -33.73 76.32 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.57 63.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.647 0.779 . . . . 0.0 112.206 174.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.4 HG13 HG11 ' B' ' 191' ' ' VAL . 66.5 mt -59.5 -59.18 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 119.109 0.868 . . . . 0.0 109.986 176.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -61.86 -29.48 70.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 32.9 t -63.6 -51.93 63.15 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.983 0.913 . . . . 0.0 111.912 167.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.29 -30.71 71.8 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.071 1.348 . . . . 0.0 113.989 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.3 mt -58.78 -34.81 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.249 1.419 . . . . 0.0 111.005 171.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 76.17 5.33 80.81 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 124.897 1.237 . . . . 0.0 114.916 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 64.14 24.48 68.82 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.104 1.335 . . . . 0.0 115.487 178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -70.57 -176.14 1.2 Allowed 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 118.811 1.306 . . . . 0.0 112.301 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -54.89 154.25 5.42 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 120.721 -1.237 . . . . 0.0 111.424 170.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -48.92 150.0 1.66 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.021 1.328 . . . . 0.0 113.1 176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -127.85 166.64 17.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.577 1.151 . . . . 0.0 111.483 -173.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -89.0 -113.83 0.06 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.519 1.128 . . . . 0.0 110.553 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 61.0 p -74.37 5.91 4.16 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -48.59 -33.97 10.72 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.085 1.754 . . . . 0.0 114.475 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 65.6 t -50.11 -33.02 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.567 1.147 . . . . 0.0 112.665 175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -63.94 -52.99 57.23 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.309 1.443 . . . . 0.0 112.367 173.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -65.79 -26.3 67.64 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.045 -1.035 . . . . 0.0 112.742 175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -76.96 -53.19 8.16 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.264 1.026 . . . . 0.0 111.519 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.59 -24.38 63.73 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.385 0.674 . . . . 0.0 112.79 177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.6 t -80.51 -64.01 1.28 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 119.121 0.873 . . . . 0.0 112.138 165.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -55.25 -39.74 70.11 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.312 1.445 . . . . 0.0 114.345 -171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.4 HG11 HG13 ' B' ' 170' ' ' ILE . 88.8 t -68.21 -62.37 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 C-N-CA 124.139 0.976 . . . . 0.0 110.208 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 91.4 t -49.18 -31.39 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.922 1.289 . . . . 0.0 110.721 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -62.03 -31.78 72.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.932 0.893 . . . . 0.0 113.376 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -108.22 -41.61 4.85 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.162 1.385 . . . . 0.0 112.163 174.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 46.2 m -59.71 -51.36 70.1 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.074 2.55 . . . . 0.0 112.617 -178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.8 -38.32 90.65 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.228 0.537 . . . . 0.0 111.262 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.5 t -61.32 -46.64 89.44 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.624 -0.673 . . . . 0.0 111.626 171.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -59.69 -50.5 73.6 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 126.789 2.035 . . . . 0.0 112.941 178.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.99 -27.65 67.61 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 120.081 1.309 . . . . 0.0 114.027 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 93.7 m -59.57 -29.09 67.7 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.116 0.566 . . . . 0.0 111.283 167.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 15.5 mmtm -86.72 -28.83 22.84 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 89.8 mt -78.92 -19.4 51.89 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.181 0.992 . . . . 0.0 111.895 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -102.19 -104.25 2.79 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 126.429 1.966 . . . . 0.0 112.087 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -141.43 145.81 39.49 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 126.084 1.754 . . . . 0.0 111.505 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 122.23 8.21 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 124.053 3.168 . . . . 0.0 112.522 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -158.51 167.58 29.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.25 1.42 . . . . 0.0 112.106 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -69.15 92.13 0.54 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.651 1.18 . . . . 0.0 110.305 166.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -68.06 161.85 25.85 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.603 0.716 . . . . 0.0 110.582 157.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . 0.673 HD11 ' SG ' ' A' ' 85' ' ' CYS . 7.1 tt -141.16 153.54 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.774 1.629 . . . . 0.0 108.94 166.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.429 HG12 ' HB2' ' B' ' 253' ' ' ALA . 25.7 m -144.15 151.69 16.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 124.808 1.243 . . . . 0.0 110.44 173.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 9.2 t -142.67 157.46 44.64 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.473 1.109 . . . . 0.0 110.06 169.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 46.4 t -152.85 147.8 26.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.39 1.476 . . . . 0.0 111.313 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 79.0 t -132.37 127.57 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.373 1.469 . . . . 0.0 109.249 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.4 mm -113.34 111.17 34.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.673 0 C-N-CA 127.429 2.292 . . . . 0.0 109.462 -177.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 16.8 tmm? -135.76 153.65 51.48 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.652 2.381 . . . . 0.0 110.945 -171.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -144.32 144.15 31.33 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.378 1.471 . . . . 0.0 112.636 -172.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -75.97 -15.64 60.13 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -75.8 -7.88 55.52 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 -175.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 170.48 23.75 0.02 OUTLIER Glycine 0 CA--C 1.536 1.363 0 N-CA-C 116.641 1.416 . . . . 0.0 116.641 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . 0.638 ' HB1' HD11 ' A' ' 79' ' ' LEU . . . -138.61 123.33 18.67 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 118.745 1.272 . . . . 0.0 112.591 -168.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -169.63 103.06 0.19 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 124.048 0.832 . . . . 0.0 114.292 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.721 HD13 HD13 ' A' ' 79' ' ' LEU . 8.5 mp -114.64 -174.31 2.46 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 127.895 2.478 . . . . 0.0 110.444 -176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.56 129.96 55.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.58 0.752 . . . . 0.0 110.587 170.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.578 ' HB ' HG13 ' B' ' 278' ' ' VAL . 22.9 m -135.66 145.36 46.7 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.102 1.361 . . . . 0.0 109.964 172.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.55 41.74 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.789 0.804 . . . . 0.0 110.997 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 77.8 p -142.88 122.15 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 124.462 1.105 . . . . 0.0 110.755 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.7 m -77.03 13.25 1.12 Allowed 'General case' 0 N--CA 1.473 0.684 0 O-C-N 120.946 -1.096 . . . . 0.0 113.168 177.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . 0.541 ' SG ' HD11 ' A' ' 66' ' ' ILE . 5.2 m -59.83 164.52 3.73 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.673 1.189 . . . . 0.0 112.836 167.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -160.44 159.57 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.281 1.832 . . . . 0.0 110.247 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.1 t-105 -80.42 135.72 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.222 0.535 . . . . 0.0 109.567 169.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 7.5 p30 -152.11 162.84 40.49 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.753 1.621 . . . . 0.0 111.47 168.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 32.1 t -137.1 -58.98 0.71 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.872 1.269 . . . . 0.0 112.173 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -74.48 -40.78 61.63 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.102 0.961 . . . . 0.0 111.368 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.13 -54.26 46.71 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.947 1.699 . . . . 0.0 111.621 -174.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -149.14 -70.74 0.2 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.876 1.27 . . . . 0.0 112.703 177.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 137.11 152.69 6.22 Favored Glycine 0 CA--C 1.544 1.857 0 C-N-CA 127.509 2.48 . . . . 0.0 113.484 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 44.9 p -171.49 127.29 0.65 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.558 1.543 . . . . 0.0 112.459 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -114.56 65.04 0.67 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.972 1.709 . . . . 0.0 112.431 -171.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 8.9 t -76.94 146.75 37.35 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.16 1.384 . . . . 0.0 113.637 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.7 t -140.32 114.94 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.694 1.198 . . . . 0.0 110.906 -175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -94.14 119.02 32.39 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.72 1.208 . . . . 0.0 111.859 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -130.08 106.81 8.87 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.437 1.495 . . . . 0.0 110.323 177.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 169.91 9.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.365 1.466 . . . . 0.0 111.667 169.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -140.83 -177.33 5.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.637 1.575 . . . . 0.0 110.968 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -51.75 -42.25 62.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.888 1.275 . . . . 0.0 114.406 -175.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 7.6 t -138.1 8.21 2.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.252 1.421 . . . . 0.0 114.324 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -122.35 159.4 27.55 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.118 1.367 . . . . 0.0 112.687 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.45 119.04 15.94 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.647 1.979 . . . . 0.0 110.33 -177.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.8 p -141.68 73.88 1.43 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.887 1.275 . . . . 0.0 112.031 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -86.32 125.57 40.7 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 125.37 1.468 . . . . 0.0 111.765 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 12.5 p -104.22 147.74 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.412 1.485 . . . . 0.0 110.614 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.4 t -139.75 129.76 24.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.93 0.892 . . . . 0.0 111.981 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.429 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -123.6 145.2 49.09 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.367 1.467 . . . . 0.0 113.05 -174.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -147.5 -176.5 5.27 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.709 2.004 . . . . 0.0 109.972 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 86.47 84.89 1.09 Allowed Glycine 0 CA--C 1.538 1.523 0 O-C-N 120.794 -1.191 . . . . 0.0 112.922 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 47.93 1.03 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.066 2.146 . . . . 0.0 113.038 -167.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.6 t -125.76 78.24 1.73 Allowed 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 122.096 0.951 . . . . 0.0 112.111 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.67 -10.75 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 115.148 1.536 . . . . 0.0 115.148 -168.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -110.72 -3.82 28.43 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 125.084 1.326 . . . . 0.0 115.14 -179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 72.66 3.33 58.61 Favored Glycine 0 CA--C 1.542 1.739 0 C-N-CA 124.943 1.259 . . . . 0.0 115.776 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -157.66 174.11 35.05 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 126.48 1.99 . . . . 0.0 113.391 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 71.3 p -69.7 174.84 4.68 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.666 1.586 . . . . 0.0 113.553 175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 98.63 26.28 9.3 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.58 1.086 . . . . 0.0 114.877 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -60.06 164.77 3.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.366 1.466 . . . . 0.0 113.595 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 7.7 t -76.24 17.76 0.34 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.688 1.995 . . . . 0.0 114.523 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -90.31 161.52 28.91 Favored Glycine 0 CA--C 1.54 1.65 0 O-C-N 120.649 -1.282 . . . . 0.0 114.296 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.36 167.7 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.924 3.083 . . . . 0.0 113.199 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.51 121.33 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.731 1.612 . . . . 0.0 111.582 -177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . 0.528 ' HE3' ' H ' ' B' ' 269' ' ' LYS . 0.0 OUTLIER -144.07 155.55 44.02 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.6 1.56 . . . . 0.0 113.909 176.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.85 163.1 28.38 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.339 1.056 . . . . 0.0 112.073 173.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 148.82 -174.11 28.55 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.986 1.279 . . . . 0.0 113.557 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 6.7 mtt -137.8 169.88 17.02 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.411 1.885 . . . . 0.0 111.881 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -134.17 142.7 47.53 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.323 1.849 . . . . 0.0 111.46 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -136.24 169.61 17.37 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.807 2.043 . . . . 0.0 111.418 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 18.9 mm -63.79 146.3 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.084 1.354 . . . . 0.0 110.607 173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 85.1 m -107.79 103.7 13.02 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.455 1.502 . . . . 0.0 110.26 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -104.45 147.41 27.6 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 120.876 -1.14 . . . . 0.0 110.74 171.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' B' ' 224' ' ' THR . 2.4 p -145.15 107.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 126.736 2.014 . . . . 0.0 109.916 -178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -139.0 151.68 47.03 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.728 0.811 . . . . 0.0 112.564 175.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -133.37 157.5 77.96 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 125.559 1.544 . . . . 0.0 111.499 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.55 160.87 47.15 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.56 2.84 . . . . 0.0 112.886 -176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.96 -38.53 16.32 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.223 2.615 . . . . 0.0 113.503 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.56 -177.87 6.5 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.907 2.083 . . . . 0.0 110.919 174.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -106.26 137.07 44.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.254 1.022 . . . . 0.0 111.828 169.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.6 165.54 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.864 2.066 . . . . 0.0 111.383 178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 35.0 t . . . . . 0 C--O 1.254 1.299 0 C-N-CA 125.926 1.69 . . . . 0.0 111.361 173.945 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.55 157.98 19.63 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.271 1.428 . . . . 0.0 112.616 -177.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -56.92 -39.83 75.2 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.64 1.176 . . . . 0.0 114.018 175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.75 -12.97 59.76 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 177.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -81.72 -22.04 37.61 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.322 1.049 . . . . 0.0 112.876 -174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -66.67 137.69 56.88 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.463 1.505 . . . . 0.0 110.348 168.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -142.9 157.93 44.11 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.434 1.094 . . . . 0.0 111.861 -174.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.12 68.69 2.6 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.492 1.517 . . . . 0.0 113.091 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.22 -0.16 7.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.311 1.445 . . . . 0.0 114.731 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -60.77 -30.64 70.15 Favored 'General case' 0 CA--C 1.544 0.727 0 O-C-N 120.658 -1.276 . . . . 0.0 114.159 178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.7 -25.25 16.18 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.1 t -75.93 -19.72 58.56 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.075 0.55 . . . . 0.0 111.832 170.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.17 146.79 42.13 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.771 -1.206 . . . . 0.0 112.219 175.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -123.39 164.76 18.23 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.433 1.493 . . . . 0.0 110.781 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.2 p -144.66 161.23 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.561 1.144 . . . . 0.0 110.939 177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.4 p -54.33 -36.92 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.767 1.627 . . . . 0.0 112.047 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.83 -26.14 67.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.64 1.176 . . . . 0.0 112.274 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.96 -58.96 2.75 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.297 0.639 . . . . 0.0 110.099 171.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.471 HG13 HD22 ' A' ' 56' ' ' LEU . 96.7 t -47.59 -43.5 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 125.763 1.625 . . . . 0.0 113.325 -178.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 t -59.3 -21.39 59.64 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 125.605 1.562 . . . . 0.0 113.574 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -99.63 -34.23 10.29 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.384 1.474 . . . . 0.0 113.114 172.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 mt -51.42 -42.96 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.251 1.02 . . . . 0.0 110.633 172.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.3 p -62.55 -44.1 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 121.408 -0.807 . . . . 0.0 113.102 177.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -51.36 65.43 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.945 1.248 . . . . 0.0 111.697 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -35.44 79.63 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.15 64.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.4 ' HA ' HG21 ' A' ' 48' ' ' VAL . 61.4 mt -60.28 -56.58 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 119.155 0.889 . . . . 0.0 109.001 173.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -63.25 -32.31 73.68 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.7 p -69.81 -36.99 76.1 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.18 -0.95 . . . . 0.0 112.699 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.01 -28.04 62.13 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.669 1.188 . . . . 0.0 113.899 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.59 -34.22 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.975 1.31 . . . . 0.0 110.809 169.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.31 5.19 81.19 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.797 1.189 . . . . 0.0 114.729 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.98 17.69 65.77 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.287 1.422 . . . . 0.0 115.543 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.28 -173.29 1.06 Allowed 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 118.696 1.248 . . . . 0.0 111.733 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.18 115.41 1.54 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.968 1.307 . . . . 0.0 111.297 175.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -64.77 126.08 26.81 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.384 1.074 . . . . 0.0 111.394 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -127.41 127.67 44.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.253 1.021 . . . . 0.0 112.583 -176.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -64.15 -42.49 96.75 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.265 1.026 . . . . 0.0 112.954 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.2 t -62.64 -28.78 70.15 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 120.994 -1.066 . . . . 0.0 112.712 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -72.8 -26.56 61.56 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.58 -34.7 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-N 120.078 1.308 . . . . 0.0 112.401 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.3 -49.2 72.72 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.953 1.301 . . . . 0.0 112.593 175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -66.88 -25.89 66.61 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.152 -0.967 . . . . 0.0 112.909 174.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 43.9 m0 -78.08 -53.07 7.8 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.717 0.807 . . . . 0.0 111.472 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.61 -22.81 62.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.3 t -82.83 -60.22 2.24 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 119.508 1.049 . . . . 0.0 112.189 166.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -57.66 -38.98 76.01 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 120.113 1.324 . . . . 0.0 114.32 -172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' A' ' 27' ' ' ILE . 88.2 t -68.52 -64.53 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.729 0 C-N-CA 124.644 1.177 . . . . 0.0 109.895 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 90.6 t -47.53 -30.99 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.057 1.343 . . . . 0.0 110.863 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.61 -38.5 72.14 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.136 0.975 . . . . 0.0 113.314 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -112.21 -34.6 5.87 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.998 1.719 . . . . 0.0 112.648 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 m -62.21 -52.67 62.83 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 127.031 2.132 . . . . 0.0 112.572 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.64 -33.85 75.87 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.371 0.532 . . . . 0.0 111.123 177.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.2 m -60.69 -54.76 41.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.548 0.739 . . . . 0.0 111.853 166.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -53.47 -50.82 64.52 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.435 1.894 . . . . 0.0 112.751 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.471 HD22 HG13 ' A' ' 19' ' ' VAL . 3.6 pp -68.95 -27.19 65.51 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 63.2 m -59.65 -43.4 93.93 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -71.44 -23.11 61.79 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.7 mt -74.0 5.77 3.97 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.215 1.406 . . . . 0.0 113.386 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.11 -97.86 0.14 Allowed Glycine 0 CA--C 1.535 1.286 0 CA-C-N 119.594 1.088 . . . . 0.0 114.981 164.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -66.87 170.66 5.67 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 125.163 1.385 . . . . 0.0 114.598 -175.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.12 168.27 14.39 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.166 1.911 . . . . 0.0 112.131 166.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -56.8 113.82 1.82 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.571 1.548 . . . . 0.0 112.651 175.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.33 96.46 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 129.377 3.071 . . . . 0.0 110.273 178.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.93 172.28 13.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 127.833 2.453 . . . . 0.0 108.915 169.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 1.7 tt -134.74 153.23 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.519 1.527 . . . . 0.0 108.403 162.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.08 141.61 35.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.858 0.863 . . . . 0.0 110.255 166.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -126.06 141.55 51.9 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.511 1.525 . . . . 0.0 108.932 168.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 27.3 p -139.12 146.93 41.27 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.496 -0.752 . . . . 0.0 112.964 170.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 t -128.24 125.38 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.465 1.506 . . . . 0.0 109.144 -174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 2.3 mm -124.63 104.68 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 127.026 2.13 . . . . 0.0 108.076 -172.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.57 166.96 20.24 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 112.286 -175.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.09 109.49 12.44 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.639 1.175 . . . . 0.0 111.861 -169.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -61.38 -20.09 62.63 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.511 1.301 . . . . 0.0 114.511 175.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -73.89 -16.69 61.1 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 172.28 18.09 0.02 OUTLIER Glycine 0 CA--C 1.538 1.492 0 N-CA-C 117.895 1.918 . . . . 0.0 117.895 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.5 65.84 1.5 Allowed 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 119.367 1.583 . . . . 0.0 111.971 -171.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.33 159.42 40.98 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.623 1.106 . . . . 0.0 113.145 177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.436 ' HB3' HD12 ' B' ' 222' ' ' LEU . 0.0 OUTLIER -160.97 174.88 13.14 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.43 1.892 . . . . 0.0 112.06 -174.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -120.86 133.24 55.31 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.553 1.141 . . . . 0.0 111.112 170.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.451 ' HB ' HG13 ' A' ' 135' ' ' VAL . 13.3 m -141.0 144.61 35.13 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.587 1.555 . . . . 0.0 109.77 174.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -139.8 126.29 20.31 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.663 1.185 . . . . 0.0 109.991 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 83.4 p -128.57 113.3 15.27 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.849 0.86 . . . . 0.0 110.755 -176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.4 t -77.45 11.26 2.07 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.557 1.143 . . . . 0.0 112.844 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 4.6 m -58.76 163.01 3.58 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.931 1.692 . . . . 0.0 112.714 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -159.16 137.82 10.9 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.918 1.287 . . . . 0.0 110.353 -176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -73.7 148.91 42.25 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.478 0.711 . . . . 0.0 110.195 173.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -136.16 151.69 50.02 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.474 1.51 . . . . 0.0 110.913 171.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.0 t -106.35 -63.24 1.29 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.492 1.117 . . . . 0.0 112.158 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 70.5 p -84.87 -32.01 23.45 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.804 0.842 . . . . 0.0 113.159 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -49.86 47.54 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.24 1.416 . . . . 0.0 111.943 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -149.82 -174.43 4.7 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 127.668 2.387 . . . . 0.0 110.3 -176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -129.73 149.06 18.65 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.709 1.147 . . . . 0.0 112.256 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 m -155.56 131.9 10.26 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.692 1.197 . . . . 0.0 110.418 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 11.0 t -123.31 136.49 54.71 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 111.487 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.0 t -128.19 141.35 51.5 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.205 -0.934 . . . . 0.0 111.383 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.6 t -134.4 113.63 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 126.468 1.907 . . . . 0.0 108.949 -168.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.0 114.26 24.35 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.729 1.612 . . . . 0.0 111.378 -174.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -124.82 105.35 9.2 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.158 1.783 . . . . 0.0 109.569 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.51 167.1 7.48 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.475 -0.766 . . . . 0.0 112.253 169.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -144.83 -179.21 6.45 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.976 0.911 . . . . 0.0 111.518 174.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -52.11 55.65 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.793 1.637 . . . . 0.0 113.74 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.3 t -127.67 -30.11 2.57 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.581 1.552 . . . . 0.0 113.89 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.2 ptp -96.59 179.44 4.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.49 1.516 . . . . 0.0 111.835 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.1 152.51 37.46 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.643 1.577 . . . . 0.0 109.38 168.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 30.0 p -129.66 137.38 50.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.108 0.963 . . . . 0.0 110.995 178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.1 125.38 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.921 1.289 . . . . 0.0 110.271 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 48.9 t -117.12 128.03 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 126.895 2.078 . . . . 0.0 108.994 -177.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 28.4 m -126.74 110.14 12.81 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.154 1.381 . . . . 0.0 111.291 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -96.27 143.38 27.4 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.449 1.9 . . . . 0.0 112.383 175.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -134.02 126.27 29.84 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.983 1.313 . . . . 0.0 110.001 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.59 73.99 0.3 Allowed Glycine 0 CA--C 1.529 0.935 0 C-N-CA 126.554 2.026 . . . . 0.0 111.206 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.97 123.22 16.96 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.006 1.322 . . . . 0.0 110.92 -178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 m -151.51 80.34 1.29 Allowed 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.49 1.516 . . . . 0.0 112.62 -169.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -113.27 0.56 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 125.282 1.433 . . . . 0.0 114.814 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.34 -0.88 55.66 Favored Glycine 0 CA--C 1.541 1.673 0 N-CA-C 116.321 1.289 . . . . 0.0 116.321 -175.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 90.07 2.05 75.11 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 125.16 1.362 . . . . 0.0 115.664 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.49 -163.56 33.33 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 125.559 1.552 . . . . 0.0 114.262 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -64.83 -172.69 0.09 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.719 1.607 . . . . 0.0 112.705 170.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.16 21.02 14.18 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 125.328 1.442 . . . . 0.0 115.121 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -137.49 159.73 41.13 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.895 1.678 . . . . 0.0 112.065 -177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.98 -25.56 64.59 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 123.58 -74.58 0.39 Allowed Glycine 0 CA--C 1.538 1.516 0 C-N-CA 126.1 1.81 . . . . 0.0 112.663 -176.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -72.26 166.24 30.31 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.559 2.84 . . . . 0.0 112.774 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.3 pt -102.33 133.86 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.962 1.305 . . . . 0.0 111.232 177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.41 167.46 21.29 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.533 1.533 . . . . 0.0 111.19 172.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 8.5 mt -86.17 172.23 10.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.371 1.868 . . . . 0.0 112.517 173.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.45 158.31 31.14 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.409 1.481 . . . . 0.0 112.643 171.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -74.82 132.8 41.83 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.848 0.859 . . . . 0.0 111.404 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.05 85.06 2.14 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 125.366 1.466 . . . . 0.0 111.277 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 28.2 mmtt -127.06 165.43 19.51 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.309 1.044 . . . . 0.0 112.373 176.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.2 mm -64.56 148.38 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.503 1.521 . . . . 0.0 110.872 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 91.5 m -126.04 100.43 6.35 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.89 1.276 . . . . 0.0 110.595 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -92.04 149.46 21.51 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.95 168.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.451 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.3 OUTLIER -146.34 103.78 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 127.082 2.153 . . . . 0.0 109.22 -179.2 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -139.1 157.73 45.44 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 121.095 -1.003 . . . . 0.0 112.507 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -127.03 157.2 72.82 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.577 1.551 . . . . 0.0 112.066 -176.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.01 165.09 31.31 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 123.628 2.885 . . . . 0.0 113.189 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.89 168.93 17.39 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.534 2.823 . . . . 0.0 112.439 175.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.58 169.37 11.98 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.922 1.689 . . . . 0.0 111.52 -178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -64.06 135.67 56.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.109 0.964 . . . . 0.0 110.892 169.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.34 161.04 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.947 1.699 . . . . 0.0 110.76 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 C--O 1.254 1.319 0 C-N-CA 125.806 1.643 . . . . 0.0 112.464 -179.328 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.465 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.28 157.96 18.6 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.938 1.695 . . . . 0.0 112.485 -175.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 16.6 ptt? -57.08 -39.55 75.18 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.526 1.13 . . . . 0.0 113.984 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -80.15 -12.77 59.62 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -81.95 -21.95 36.94 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.254 1.021 . . . . 0.0 112.917 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -66.59 137.81 57.02 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.405 1.482 . . . . 0.0 110.334 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -143.02 157.83 44.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.454 1.102 . . . . 0.0 111.907 -174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.29 68.9 2.74 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.431 1.492 . . . . 0.0 113.084 -177.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.33 -0.51 8.27 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.51 -30.29 69.63 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 120.663 -1.273 . . . . 0.0 114.215 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -96.31 -25.36 15.79 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.1 t -75.28 -21.17 58.7 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 121.872 -0.518 . . . . 0.0 111.746 170.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -59.1 142.81 50.48 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 120.822 -1.173 . . . . 0.0 112.061 174.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -118.75 167.81 11.33 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.277 1.431 . . . . 0.0 110.663 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.44 160.69 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.494 1.118 . . . . 0.0 111.066 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 78.2 t -59.94 -37.34 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.631 1.173 . . . . 0.0 111.946 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -28.06 66.19 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.093 0.957 . . . . 0.0 112.882 175.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -77.3 -59.6 2.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.975 1.31 . . . . 0.0 110.767 171.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.496 HG13 HD22 ' B' ' 199' ' ' LEU . 84.0 t -48.67 -42.5 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 125.055 1.342 . . . . 0.0 113.292 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.8 t -58.95 -19.33 41.98 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.281 1.432 . . . . 0.0 113.454 176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 23.4 t30 -101.92 -34.26 9.44 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.803 1.241 . . . . 0.0 113.161 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 24.1 mt -51.04 -44.69 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 119.496 1.044 . . . . 0.0 110.608 171.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.5 p -61.29 -43.31 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.453 -0.779 . . . . 0.0 112.874 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.58 -51.02 62.88 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.733 1.151 . . . . 0.0 111.592 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -34.48 76.69 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.07 -41.11 59.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.946 0.898 . . . . 0.0 113.34 176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 60.7 mt -61.18 -57.22 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 119.206 0.912 . . . . 0.0 109.064 174.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -63.29 -31.29 72.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 59.5 p -69.98 -37.57 75.8 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.19 -0.944 . . . . 0.0 112.681 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.16 -31.22 68.62 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.388 1.075 . . . . 0.0 113.462 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.8 -35.75 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.364 1.465 . . . . 0.0 112.636 174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -58.74 -1.05 0.73 Allowed Glycine 0 CA--C 1.541 1.706 0 N-CA-C 118.807 2.283 . . . . 0.0 118.807 -159.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -61.41 -32.68 81.91 Favored Glycine 0 CA--C 1.538 1.52 0 CA-C-N 119.904 1.852 . . . . 0.0 115.285 177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -155.48 -166.67 2.31 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 118.848 1.324 . . . . 0.0 112.511 177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.07 161.92 3.77 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.383 1.473 . . . . 0.0 112.703 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.65 130.19 39.98 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.314 1.446 . . . . 0.0 111.132 -174.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -132.89 133.97 43.97 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.776 1.23 . . . . 0.0 112.156 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -73.57 -43.17 60.47 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.25 1.02 . . . . 0.0 113.101 174.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 7.2 t -62.23 -27.68 69.16 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 121.066 -1.021 . . . . 0.0 112.502 -178.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -73.25 -26.19 61.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 60.6 t -53.81 -34.03 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.261 1.391 . . . . 0.0 112.571 -175.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -63.58 -49.62 72.67 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.1 1.36 . . . . 0.0 112.567 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -67.06 -25.42 66.24 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.198 -0.939 . . . . 0.0 112.932 174.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.8 m0 -78.39 -52.72 8.17 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.611 0.764 . . . . 0.0 111.756 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -59.75 -22.73 62.5 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.8 t -82.83 -60.6 2.12 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 119.492 1.042 . . . . 0.0 112.205 165.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -56.83 -41.31 77.63 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 120.302 1.41 . . . . 0.0 114.294 -172.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 88.3 t -66.35 -64.67 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 C-N-CA 124.743 1.217 . . . . 0.0 110.036 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 87.6 t -47.7 -30.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.958 1.303 . . . . 0.0 110.973 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -57.08 -38.15 72.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.009 0.924 . . . . 0.0 113.162 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -111.6 -35.41 5.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.04 1.736 . . . . 0.0 112.596 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 44.7 m -61.48 -52.66 63.61 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.157 2.183 . . . . 0.0 112.634 175.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.71 -34.23 76.73 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.487 0.585 . . . . 0.0 111.192 177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 66.5 m -61.06 -53.6 55.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.511 0.725 . . . . 0.0 111.887 167.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -54.42 -50.88 66.57 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.594 1.958 . . . . 0.0 112.648 -178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.496 HD22 HG13 ' B' ' 162' ' ' VAL . 3.9 pp -69.38 -26.55 64.71 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 66.7 m -59.27 -43.48 92.49 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 165.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -71.87 -23.25 61.48 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 80.8 mt -73.38 4.96 4.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.28 1.432 . . . . 0.0 113.464 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -155.93 -97.28 0.13 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-N 119.517 1.053 . . . . 0.0 114.941 164.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -67.67 171.22 5.52 Favored Pre-proline 0 N--CA 1.482 1.138 0 C-N-CA 125.156 1.382 . . . . 0.0 114.666 -174.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -66.62 169.7 13.89 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 122.019 1.812 . . . . 0.0 111.889 167.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 20.9 p90 -56.26 114.19 1.87 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.37 1.468 . . . . 0.0 112.591 175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.8 97.42 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 129.342 3.057 . . . . 0.0 110.169 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -149.8 171.88 16.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.687 2.395 . . . . 0.0 109.044 169.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 2.7 tt -135.24 153.53 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 125.903 1.681 . . . . 0.0 108.217 162.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' B' ' 253' ' ' ALA . 27.3 m -139.02 141.88 35.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 123.863 0.865 . . . . 0.0 110.124 166.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.257 1.423 . . . . 0.0 108.895 169.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 31.2 p -135.79 150.21 49.39 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 122.12 0.962 . . . . 0.0 113.078 169.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 12.9 t -132.27 125.24 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 125.894 1.677 . . . . 0.0 108.184 -175.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.402 HD12 ' HB2' ' B' ' 249' ' ' CYS . 2.6 mm -122.49 104.64 14.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 126.997 2.119 . . . . 0.0 107.418 -174.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.81 162.97 29.28 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.625 0.726 . . . . 0.0 112.753 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -117.1 137.34 52.35 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.265 1.426 . . . . 0.0 111.134 -174.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -89.1 -14.18 36.88 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -77.85 -17.06 57.8 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 173.59 21.37 0.02 OUTLIER Glycine 0 CA--C 1.538 1.517 0 N-CA-C 117.703 1.841 . . . . 0.0 117.703 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.73 73.25 1.42 Allowed 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 119.773 1.786 . . . . 0.0 112.767 -173.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.5 160.16 32.73 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.682 1.134 . . . . 0.0 113.518 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -162.02 176.68 10.49 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 126.797 2.039 . . . . 0.0 111.941 -177.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -122.19 131.2 53.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.677 1.591 . . . . 0.0 110.957 172.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.59 ' HB ' HG13 ' B' ' 278' ' ' VAL . 90.6 m -139.05 143.38 38.36 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.449 1.1 . . . . 0.0 109.916 174.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.8 128.73 27.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.159 0.984 . . . . 0.0 110.23 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 84.9 p -130.81 114.69 15.63 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.845 0.858 . . . . 0.0 110.912 -177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 2.2 t -78.16 11.21 2.43 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.447 1.099 . . . . 0.0 112.712 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 8.2 m -58.42 162.51 3.67 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.803 1.641 . . . . 0.0 112.774 175.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -158.96 138.55 11.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.846 1.258 . . . . 0.0 110.537 -175.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -72.73 145.0 47.44 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.391 0.677 . . . . 0.0 109.927 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -130.13 151.81 50.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.614 1.566 . . . . 0.0 110.23 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 29.7 t -106.75 -64.28 1.19 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.927 1.291 . . . . 0.0 112.211 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 70.8 p -83.65 -31.64 26.06 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.868 0.867 . . . . 0.0 113.262 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.73 -48.81 58.12 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.295 1.438 . . . . 0.0 111.928 -173.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -151.07 -175.12 5.02 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 127.881 2.472 . . . . 0.0 110.754 -176.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -126.99 146.74 16.54 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.784 1.183 . . . . 0.0 112.252 168.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 1.4 m -152.73 126.69 9.02 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.098 1.359 . . . . 0.0 110.679 -179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 16.8 t -121.33 130.08 53.43 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.59 1.156 . . . . 0.0 111.416 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 4.5 t -125.53 143.73 50.87 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.166 0.986 . . . . 0.0 111.338 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.42 131.1 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 125.506 1.523 . . . . 0.0 109.183 -172.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.09 114.47 17.8 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.434 1.493 . . . . 0.0 111.346 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 14.0 m95 -123.77 102.67 7.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.456 1.903 . . . . 0.0 109.408 -176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.74 165.95 7.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.492 -0.755 . . . . 0.0 112.093 169.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -144.1 -178.74 6.09 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.998 0.919 . . . . 0.0 111.581 174.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -51.08 59.89 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.858 1.663 . . . . 0.0 113.751 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 14.5 t -129.4 -29.28 2.23 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.519 1.528 . . . . 0.0 113.992 179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.3 ptp -97.14 179.17 5.01 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.529 1.532 . . . . 0.0 111.828 173.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 15.5 p90 -147.57 151.72 36.76 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.369 1.468 . . . . 0.0 109.539 169.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.402 ' HB2' HD12 ' B' ' 214' ' ' ILE . 29.9 p -129.53 137.52 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.072 0.949 . . . . 0.0 111.148 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.0 130.02 60.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.992 1.317 . . . . 0.0 109.975 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 7.5 p -126.5 125.72 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.695 1.598 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 20.8 m -121.87 109.05 14.18 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 125.876 1.671 . . . . 0.0 110.916 -173.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -94.52 143.83 26.09 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.919 1.688 . . . . 0.0 112.579 176.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -134.76 122.46 22.17 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.347 1.459 . . . . 0.0 109.737 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.43 74.08 0.27 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.419 1.961 . . . . 0.0 111.331 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.92 121.82 13.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.016 1.326 . . . . 0.0 110.919 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 7.9 m -149.77 76.55 1.3 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.994 1.718 . . . . 0.0 112.406 -169.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.15 -2.1 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 125.221 1.408 . . . . 0.0 114.698 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -75.86 0.81 60.9 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 116.668 1.427 . . . . 0.0 116.668 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 89.96 1.83 75.8 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 118.951 1.376 . . . . 0.0 115.732 175.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -82.53 -163.94 34.08 Favored Glycine 0 CA--C 1.539 1.587 0 C-N-CA 125.607 1.575 . . . . 0.0 114.187 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.5 t -65.03 -172.36 0.09 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.732 1.613 . . . . 0.0 112.805 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 99.67 20.78 15.96 Favored Glycine 0 N--CA 1.476 1.301 0 C-N-CA 125.289 1.423 . . . . 0.0 114.953 178.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -137.37 159.17 42.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.9 1.68 . . . . 0.0 112.226 -177.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 1.3 t -69.14 -25.85 64.59 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 123.82 -74.06 0.4 Allowed Glycine 0 CA--C 1.539 1.542 0 C-N-CA 126.089 1.804 . . . . 0.0 112.844 -177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -72.18 166.55 29.34 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.663 2.909 . . . . 0.0 112.845 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 30.3 pt -103.25 134.43 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.895 1.278 . . . . 0.0 111.241 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -136.71 167.44 21.42 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.622 1.569 . . . . 0.0 111.236 172.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 8.3 mt -86.44 172.93 9.99 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 126.413 1.885 . . . . 0.0 112.616 173.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -168.62 159.03 32.02 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.126 1.345 . . . . 0.0 113.177 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -76.63 129.17 36.02 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.018 0.927 . . . . 0.0 111.456 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -132.86 83.41 2.06 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.711 1.604 . . . . 0.0 111.682 -175.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -127.92 166.51 18.17 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.031 0.933 . . . . 0.0 111.993 177.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 15.3 mm -64.38 149.03 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.53 1.532 . . . . 0.0 111.274 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 86.4 m -126.96 99.89 5.91 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.005 1.322 . . . . 0.0 110.725 179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -93.94 150.03 20.72 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.163 -0.961 . . . . 0.0 110.858 167.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.59 HG13 ' HB ' ' B' ' 224' ' ' THR . 4.0 p -150.28 104.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.534 1.934 . . . . 0.0 110.062 -178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -136.61 159.18 42.58 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.031 1.332 . . . . 0.0 112.373 -179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -126.3 156.61 72.24 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 125.844 1.658 . . . . 0.0 111.94 -178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.04 165.23 30.87 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.612 2.875 . . . . 0.0 113.18 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.61 168.85 17.17 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.546 2.831 . . . . 0.0 112.475 175.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -124.74 169.26 12.17 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.034 1.734 . . . . 0.0 111.486 -177.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -63.84 134.6 55.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.135 0.974 . . . . 0.0 110.918 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.18 152.95 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.547 1.539 . . . . 0.0 110.95 177.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 C--O 1.252 1.221 0 C-N-CA 126.696 1.998 . . . . 0.0 110.455 -178.572 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.49 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -68.51 84.28 0.28 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.918 2.087 . . . . 0.0 114.074 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -15.24 0.58 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 126.641 1.976 . . . . 0.0 115.882 178.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.94 -38.73 79.65 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 115.486 1.661 . . . . 0.0 115.486 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -135.5 -3.07 2.4 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.49 1.516 . . . . 0.0 112.446 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -135.23 172.68 12.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.492 1.917 . . . . 0.0 111.631 -173.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -150.9 177.44 10.13 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.178 1.391 . . . . 0.0 111.562 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -99.53 120.51 39.77 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.38 1.472 . . . . 0.0 110.59 171.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -109.85 100.9 9.81 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.468 1.507 . . . . 0.0 111.982 -174.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -59.81 -18.01 40.46 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -59.38 -12.45 5.93 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 169.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.9 t -61.21 -18.59 59.01 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.195 1.398 . . . . 0.0 113.681 168.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.58 148.96 49.75 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 120.819 -1.175 . . . . 0.0 111.508 171.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.27 170.16 8.59 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.262 1.425 . . . . 0.0 111.764 177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -149.57 157.43 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.72 1.208 . . . . 0.0 111.366 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.7 t -53.45 -41.27 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.834 1.653 . . . . 0.0 112.063 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -61.91 -25.85 67.82 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.74 1.216 . . . . 0.0 113.544 176.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -79.96 -56.22 4.41 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.022 0.929 . . . . 0.0 110.632 169.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 53.0 t -47.34 -43.26 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 126.432 1.893 . . . . 0.0 112.381 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -63.79 -9.66 15.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.292 1.837 . . . . 0.0 114.362 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -111.17 -32.67 6.69 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.524 1.93 . . . . 0.0 112.475 172.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.3 mt -50.74 -43.37 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 119.014 0.825 . . . . 0.0 110.317 168.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 p -59.15 -44.04 90.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 121.495 -0.753 . . . . 0.0 112.957 177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -52.36 51.0 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 119.756 1.162 . . . . 0.0 111.318 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.35 -34.75 77.26 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.41 -41.42 66.28 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.78 0.832 . . . . 0.0 112.984 175.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.463 ' HA ' HG21 ' A' ' 48' ' ' VAL . 56.2 mt -58.25 -59.56 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-N 119.297 0.953 . . . . 0.0 109.522 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -62.97 -29.95 71.2 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.6 t -61.29 -49.93 75.03 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.27 1.028 . . . . 0.0 112.104 168.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.46 72.04 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 64.7 mt -59.48 -40.67 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.799 1.24 . . . . 0.0 111.506 173.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.09 12.11 74.63 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.163 0.887 . . . . 0.0 115.139 -178.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.71 -0.31 36.56 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.392 1.472 . . . . 0.0 116.256 174.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.47 162.03 8.64 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 118.879 1.34 . . . . 0.0 112.008 170.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.31 -166.34 1.5 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.599 1.56 . . . . 0.0 111.57 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -43.92 121.67 2.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.392 2.277 . . . . 0.0 112.425 173.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 mm-40 -115.81 170.17 8.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.631 1.172 . . . . 0.0 113.085 -177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -91.63 -95.86 0.13 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.703 1.201 . . . . 0.0 109.317 -178.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 50.8 m -76.81 -21.01 55.71 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.637 1.175 . . . . 0.0 113.988 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.39 -41.81 76.9 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.998 0.919 . . . . 0.0 112.367 177.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.16 -33.42 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 176.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -65.02 -46.73 80.1 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.362 0.983 . . . . 0.0 112.204 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -65.79 -24.84 67.01 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 118.692 0.678 . . . . 0.0 112.532 173.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -78.75 -51.86 9.2 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.034 0.833 . . . . 0.0 111.887 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.2 t -56.52 -29.59 62.06 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.847 0.749 . . . . 0.0 112.521 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -79.35 -60.77 2.24 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.389 0.995 . . . . 0.0 112.409 169.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.84 -38.6 75.96 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.334 1.453 . . . . 0.0 114.284 -172.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.463 HG21 ' HA ' ' A' ' 27' ' ' ILE . 81.7 t -68.21 -64.44 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.978 0 C-N-CA 123.9 0.88 . . . . 0.0 109.469 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 66.9 t -50.42 -28.44 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.469 1.507 . . . . 0.0 110.835 178.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.49 -55.11 28.07 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.579 1.151 . . . . 0.0 112.115 176.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.2 mt-30 -93.27 -35.56 13.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.041 1.336 . . . . 0.0 112.734 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 m -59.75 -54.38 47.03 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.944 2.097 . . . . 0.0 112.285 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.27 -37.44 83.15 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 121.122 0.487 . . . . 0.0 111.236 177.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.0 t -62.18 -40.45 96.07 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.151 -0.968 . . . . 0.0 113.102 170.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -67.1 -49.85 63.54 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.721 1.608 . . . . 0.0 112.422 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.74 -24.8 65.4 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 94.9 m -55.89 -34.76 65.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.674 0.789 . . . . 0.0 110.919 163.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 mmtm -84.88 -31.46 23.72 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.13 -30.47 70.48 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.472 0.709 . . . . 0.0 111.578 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -103.38 -100.81 2.61 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 126.147 1.832 . . . . 0.0 112.724 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.8 mttt -136.63 141.76 36.6 Favored Pre-proline 0 N--CA 1.479 0.983 0 C-N-CA 124.867 1.267 . . . . 0.0 113.677 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.44 104.18 1.66 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.448 3.432 . . . . 0.0 112.605 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -142.84 179.89 6.74 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.078 1.751 . . . . 0.0 112.166 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.5 89.25 3.87 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.464 1.506 . . . . 0.0 111.706 -174.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -87.13 147.42 25.64 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.033 1.333 . . . . 0.0 110.747 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -132.3 152.96 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 126.117 1.767 . . . . 0.0 109.292 174.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG12 ' HB2' ' A' ' 110' ' ' ALA . 9.5 m -138.39 146.68 26.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 124.604 1.161 . . . . 0.0 110.823 172.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.54 126.98 20.02 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.422 1.889 . . . . 0.0 108.921 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 9.3 p -129.7 138.09 50.95 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.807 0.843 . . . . 0.0 112.552 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.8 t -131.1 98.18 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.139 1.376 . . . . 0.0 109.5 -167.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -106.7 91.32 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 126.359 1.864 . . . . 0.0 107.928 -171.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -147.37 93.83 2.29 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.057 1.743 . . . . 0.0 110.763 -175.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -158.54 133.37 8.3 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 109.649 170.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.52 -52.05 0.14 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.274 1.43 . . . . 0.0 112.123 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -114.68 -23.95 8.98 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 124.875 1.27 . . . . 0.0 113.62 172.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.0 -1.34 38.35 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.538 1.542 . . . . 0.0 115.056 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.29 68.58 1.43 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.402 1.881 . . . . 0.0 111.237 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.9 15.93 0.09 OUTLIER Glycine 0 CA--C 1.537 1.429 0 N-CA-C 117.197 1.639 . . . . 0.0 117.197 -170.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -141.41 104.46 4.59 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.656 1.983 . . . . 0.0 110.005 -159.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.24 132.7 51.66 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.836 -1.165 . . . . 0.0 108.835 173.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.6 m -154.15 140.63 18.79 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 120.257 -1.527 . . . . 0.0 109.603 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.67 138.06 24.36 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.544 -0.722 . . . . 0.0 112.811 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.5 m -142.03 129.63 21.47 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 123.619 0.768 . . . . 0.0 110.51 -169.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -79.75 8.83 5.96 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.292 -0.88 . . . . 0.0 112.482 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 m -65.65 162.94 17.35 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.636 1.174 . . . . 0.0 112.675 176.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.17 151.84 28.69 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.154 1.782 . . . . 0.0 110.423 -179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.42 169.07 18.97 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 122.942 0.497 . . . . 0.0 111.484 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -139.41 148.61 43.04 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.213 1.005 . . . . 0.0 111.427 173.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 45.8 t -112.49 -68.94 0.9 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.461 1.504 . . . . 0.0 111.634 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.3 t -84.3 -38.82 19.94 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.698 0.799 . . . . 0.0 112.108 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 m -67.51 -45.96 74.26 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.672 1.189 . . . . 0.0 112.689 -172.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -151.6 -169.8 3.47 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 127.56 2.344 . . . . 0.0 110.408 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.43 174.13 15.14 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.266 1.412 . . . . 0.0 114.518 173.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.7 t -154.88 163.1 40.78 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.385 1.874 . . . . 0.0 111.151 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 20.9 t -164.88 115.13 1.14 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.002 1.321 . . . . 0.0 112.164 169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -114.37 146.41 40.59 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 120.694 -1.254 . . . . 0.0 112.01 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.5 t -138.62 151.21 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 126.149 1.78 . . . . 0.0 110.184 -172.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 30.7 ptt180 -138.94 121.68 16.43 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.501 1.52 . . . . 0.0 111.02 -168.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 7.5 m95 -135.52 103.1 5.34 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.9 1.68 . . . . 0.0 111.018 -172.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -63.47 142.49 58.37 Favored 'General case' 0 CA--C 1.546 0.827 0 O-C-N 121.027 -1.046 . . . . 0.0 112.254 172.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.35 -167.8 1.79 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.842 1.257 . . . . 0.0 109.932 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.03 -52.01 9.39 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 126.842 2.057 . . . . 0.0 114.585 -176.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.6 t -140.59 -35.57 0.49 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.162 1.785 . . . . 0.0 111.402 175.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 18.4 ptp -79.03 112.95 16.74 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.478 1.511 . . . . 0.0 111.795 175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -79.78 116.48 19.97 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 120.269 -1.519 . . . . 0.0 109.889 170.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.469 ' HA ' HD12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -81.38 134.42 35.56 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.016 0.926 . . . . 0.0 111.114 173.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.4 pt -129.26 132.26 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.778 1.631 . . . . 0.0 109.846 170.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.6 p -127.77 127.88 68.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.615 1.566 . . . . 0.0 110.728 176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.6 t -119.14 111.89 18.83 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.124 0.97 . . . . 0.0 110.802 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 67' ' ' VAL . . . -87.47 139.62 30.36 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.913 0.885 . . . . 0.0 111.193 167.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -124.12 126.71 46.65 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 109.313 168.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.56 78.35 0.24 Allowed Glycine 0 N--CA 1.465 0.614 0 C-N-CA 125.531 1.538 . . . . 0.0 112.35 -170.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.66 123.26 24.55 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.654 1.581 . . . . 0.0 111.764 -173.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.4 m -137.64 93.61 2.81 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.174 2.19 . . . . 0.0 112.807 -164.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.5 pp -84.71 -2.2 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.87 4.92 63.53 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.441 1.496 . . . . 0.0 115.698 -174.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 92.12 17.88 45.3 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 118.552 1.176 . . . . 0.0 115.46 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.06 138.9 48.15 Favored Glycine 0 CA--C 1.54 1.61 0 CA-C-N 118.705 1.252 . . . . 0.0 113.048 174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.8 m -134.04 -173.75 3.34 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.053 1.741 . . . . 0.0 111.849 -175.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 119.91 12.66 6.39 Favored Glycine 0 N--CA 1.477 1.382 0 C-N-CA 124.816 1.198 . . . . 0.0 115.476 176.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -56.25 162.67 1.93 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.07 1.748 . . . . 0.0 115.635 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.5 t -103.13 -45.89 4.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.168 1.787 . . . . 0.0 113.061 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.92 -178.3 50.54 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.08 1.324 . . . . 0.0 114.417 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.94 140.78 56.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.31 2.673 . . . . 0.0 111.256 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.2 pp -77.32 128.61 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.784 0.833 . . . . 0.0 111.855 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.81 154.77 49.51 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.927 1.691 . . . . 0.0 112.059 172.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 45.4 tp -146.14 152.59 39.52 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.251 2.621 . . . . 0.0 109.155 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 137.1 -149.49 20.27 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.033 1.301 . . . . 0.0 112.533 178.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.74 175.72 1.06 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.075 0.95 . . . . 0.0 112.466 170.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -135.05 177.14 8.04 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 112.751 -177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -117.39 178.24 4.45 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.211 1.804 . . . . 0.0 111.417 -178.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 35.6 mm -109.31 145.31 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.802 1.641 . . . . 0.0 109.926 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.1 m -117.4 90.71 3.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.047 1.339 . . . . 0.0 110.078 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -104.52 138.53 40.76 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.427 1.091 . . . . 0.0 110.816 175.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.45 98.98 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 128.214 2.606 . . . . 0.0 108.586 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 34.0 p30 -135.31 168.19 19.65 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.06 0.944 . . . . 0.0 111.82 168.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -98.84 154.03 37.58 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.437 1.095 . . . . 0.0 109.386 166.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.05 115.44 3.99 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.267 2.645 . . . . 0.0 111.272 178.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -53.93 0.23 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.656 2.237 . . . . 0.0 112.332 -176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -164.67 -176.28 4.21 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.554 2.741 . . . . 0.0 109.944 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -107.81 140.67 40.55 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.602 1.161 . . . . 0.0 111.328 165.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.51 177.45 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 127.25 2.22 . . . . 0.0 111.405 -178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.257 9.6 p . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.275 1.83 . . . . 0.0 111.647 175.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.583 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.1 p -69.39 70.32 0.26 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.513 1.925 . . . . 0.0 114.612 -175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.93 -80.85 0.09 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.241 1.416 . . . . 0.0 111.896 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -92.48 -64.58 1.09 Allowed 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -171.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -132.24 1.68 3.85 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.226 2.211 . . . . 0.0 111.455 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -69.32 162.56 26.98 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.519 1.128 . . . . 0.0 112.722 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -146.8 173.87 11.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.423 1.489 . . . . 0.0 112.041 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -113.61 102.92 10.73 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.421 1.888 . . . . 0.0 110.677 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -94.78 100.9 12.72 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.45 1.5 . . . . 0.0 112.594 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -60.29 -19.31 54.46 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.01 -13.02 5.37 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 170.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 4.7 t -57.71 -27.57 63.08 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.092 1.357 . . . . 0.0 113.423 171.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -68.59 134.24 49.69 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.739 -1.226 . . . . 0.0 111.634 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.72 159.11 15.76 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.085 0.954 . . . . 0.0 112.255 175.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.49 156.35 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.149 1.78 . . . . 0.0 110.767 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 44.3 t -51.21 -40.09 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 128.294 2.638 . . . . 0.0 112.415 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -56.97 -28.32 62.18 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.843 1.257 . . . . 0.0 113.175 175.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -91.47 -46.96 7.7 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.045 0.938 . . . . 0.0 110.854 175.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 56.6 t -48.65 -42.27 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 124.502 1.121 . . . . 0.0 112.067 175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 12.1 t -63.55 -9.13 11.76 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.545 1.938 . . . . 0.0 114.692 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -109.98 -32.09 7.16 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 126.688 1.995 . . . . 0.0 112.552 173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.9 mt -51.46 -41.48 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.822 0.849 . . . . 0.0 110.517 169.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.22 -44.17 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 O-C-N 121.447 -0.783 . . . . 0.0 112.939 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 -52.63 53.8 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.736 1.153 . . . . 0.0 111.345 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -34.6 77.28 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.73 -40.64 65.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.529 0.731 . . . . 0.0 112.924 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.462 ' HA ' HG21 ' B' ' 191' ' ' VAL . 58.0 mt -58.37 -59.9 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-N 119.127 0.876 . . . . 0.0 109.388 174.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -62.51 -30.15 71.07 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 -175.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 38.1 t -61.3 -50.04 74.59 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.17 0.988 . . . . 0.0 112.105 168.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.01 -31.35 71.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.6 mt -59.4 -40.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.822 1.249 . . . . 0.0 111.523 173.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 85.05 12.13 74.69 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 124.192 0.901 . . . . 0.0 115.036 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 106.56 -0.39 36.96 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.339 1.447 . . . . 0.0 116.266 174.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -61.61 162.49 8.3 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 118.852 1.326 . . . . 0.0 111.972 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -93.38 -166.16 1.47 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.448 1.499 . . . . 0.0 111.505 175.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -43.82 125.58 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.482 2.313 . . . . 0.0 112.597 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -120.4 163.87 17.23 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.44 1.096 . . . . 0.0 113.749 -176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -86.3 -71.91 0.52 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.055 1.342 . . . . 0.0 110.982 -172.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 48.7 m -107.31 -18.81 13.77 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.258 1.423 . . . . 0.0 113.694 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.42 -42.22 66.82 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.504 1.122 . . . . 0.0 111.991 174.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 10.0 p -53.43 -32.38 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.442 1.497 . . . . 0.0 114.5 175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -67.94 -46.4 71.57 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.313 0.96 . . . . 0.0 112.11 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -65.58 -25.36 67.38 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.664 0.665 . . . . 0.0 112.327 173.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -77.64 -53.42 7.59 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.973 0.909 . . . . 0.0 111.823 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 15.1 t -56.35 -28.92 60.58 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.994 0.815 . . . . 0.0 112.671 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . 0.25 10.6 t -79.87 -61.91 1.85 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 119.425 1.011 . . . . 0.0 112.284 169.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -56.76 -38.45 72.48 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.592 1.557 . . . . 0.0 114.037 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.462 HG21 ' HA ' ' B' ' 170' ' ' ILE . 86.2 t -67.91 -64.86 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -0.999 0 C-N-CA 123.842 0.857 . . . . 0.0 109.479 -179.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . 0.47 HG12 HG21 ' B' ' 210' ' ' VAL . 99.5 t -50.55 -28.37 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 125.46 1.504 . . . . 0.0 110.939 178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -55.4 28.44 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.762 1.225 . . . . 0.0 112.037 176.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -92.73 -34.91 13.73 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.088 1.355 . . . . 0.0 112.817 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 38.2 m -60.7 -55.21 35.94 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.997 2.119 . . . . 0.0 112.343 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -36.45 82.19 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 118.515 0.598 . . . . 0.0 111.556 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 25.2 t -58.17 -51.08 71.21 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.635 0.774 . . . . 0.0 112.036 167.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -59.96 -50.91 71.89 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.808 1.643 . . . . 0.0 112.806 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 2.9 pp -67.34 -27.73 67.38 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 63.9 m -57.33 -36.23 70.89 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.099 0.56 . . . . 0.0 110.598 165.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -79.15 -31.48 44.02 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.071 -1.018 . . . . 0.0 113.192 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 85.9 mt -74.19 -28.95 61.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.178 0.591 . . . . 0.0 110.888 -178.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.27 -94.95 1.99 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 126.355 1.931 . . . . 0.0 112.791 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 33.7 mttt -140.17 143.16 32.69 Favored Pre-proline 0 N--CA 1.48 1.029 0 C-N-CA 125.401 1.481 . . . . 0.0 113.061 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.74 114.12 3.75 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.732 2.955 . . . . 0.0 112.081 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -150.76 175.11 12.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.687 1.595 . . . . 0.0 112.673 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 52.3 tttt -94.54 87.65 5.19 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.744 1.218 . . . . 0.0 111.566 -177.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -72.85 153.14 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.288 1.035 . . . . 0.0 112.253 171.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 1.5 tt -143.24 153.19 16.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 126.694 1.998 . . . . 0.0 108.72 166.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.47 HG21 HG12 ' B' ' 192' ' ' VAL . 15.5 m -139.75 144.79 27.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.296 1.038 . . . . 0.0 110.171 172.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.17 123.51 19.42 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.798 1.639 . . . . 0.0 108.681 176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 11.8 p -124.5 142.13 51.56 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.186 0.994 . . . . 0.0 112.096 172.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 5.0 t -133.78 111.65 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.122 1.369 . . . . 0.0 107.622 -169.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.2 mm -111.83 90.38 1.47 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.659 0 C-N-CA 125.788 1.635 . . . . 0.0 107.73 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.27 162.69 13.58 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.478 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -75.23 137.98 41.61 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 121.405 0.622 . . . . 0.0 112.209 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -2.63 20.95 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.869 2.067 . . . . 0.0 114.185 -177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -55.06 -29.55 57.73 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.244 1.818 . . . . 0.0 113.901 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.54 -1.47 75.89 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.797 1.189 . . . . 0.0 115.438 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -139.58 60.84 1.56 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.882 1.673 . . . . 0.0 111.573 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.25 62.25 0.07 OUTLIER Glycine 0 N--CA 1.47 0.935 0 CA-C-O 121.805 0.669 . . . . 0.0 114.225 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -159.85 96.25 1.23 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.698 1.999 . . . . 0.0 109.205 -171.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.18 101.39 6.74 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 120.199 -1.563 . . . . 0.0 108.63 173.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.485 ' HB ' HG13 ' B' ' 278' ' ' VAL . 22.8 m -130.98 139.09 49.97 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 120.398 -1.439 . . . . 0.0 109.765 -179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.97 138.36 31.87 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.682 0.793 . . . . 0.0 112.506 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 6.8 m -141.46 135.73 30.58 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.79 0.836 . . . . 0.0 110.759 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 8.3 t -82.76 9.62 9.35 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 121.362 -0.836 . . . . 0.0 112.368 172.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 6.1 m -65.66 162.57 18.15 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.177 0.991 . . . . 0.0 112.685 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -154.97 149.9 26.78 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.207 1.803 . . . . 0.0 110.25 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.15 167.87 21.03 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.176 0.512 . . . . 0.0 111.225 171.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -139.38 148.65 43.13 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.451 1.1 . . . . 0.0 110.981 171.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 42.8 t -109.94 -68.31 0.93 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.536 1.535 . . . . 0.0 111.645 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 11.8 t -84.09 -39.46 19.5 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.871 0.868 . . . . 0.0 112.036 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 1.3 m -66.6 -46.48 75.75 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.026 1.331 . . . . 0.0 113.038 -172.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -150.68 -170.51 3.68 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 127.798 2.439 . . . . 0.0 110.19 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -116.08 173.75 14.89 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.21 1.386 . . . . 0.0 114.571 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 21.3 t -153.41 163.59 39.67 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.573 1.949 . . . . 0.0 111.062 179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 23.1 t -164.85 111.66 1.0 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.023 1.329 . . . . 0.0 112.235 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 7.8 t -113.93 147.33 38.72 Favored 'General case' 0 N--CA 1.481 1.085 0 O-C-N 120.545 -1.347 . . . . 0.0 112.373 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.3 t -139.79 153.27 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 126.326 1.85 . . . . 0.0 110.394 -173.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -135.13 130.32 35.26 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.922 1.689 . . . . 0.0 111.621 -175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.7 m95 -138.68 101.94 4.46 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.414 1.886 . . . . 0.0 110.368 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -68.1 146.2 53.69 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 120.802 -1.186 . . . . 0.0 112.073 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.32 -175.34 3.84 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 125.011 1.325 . . . . 0.0 110.226 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.63 -66.74 0.33 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.111 1.764 . . . . 0.0 114.527 -175.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 5.8 t -133.51 17.37 3.98 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 126.089 1.756 . . . . 0.0 111.88 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 12.8 ptp -137.92 158.45 44.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.741 2.016 . . . . 0.0 109.095 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -126.1 123.9 39.39 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.917 0.887 . . . . 0.0 109.894 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.36 130.72 39.03 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.828 0.851 . . . . 0.0 110.965 177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.3 pt -128.72 129.68 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 125.876 1.67 . . . . 0.0 109.188 167.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 6.9 p -124.79 126.03 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.634 1.574 . . . . 0.0 110.45 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 13.6 t -118.64 110.47 17.35 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.185 0.994 . . . . 0.0 110.826 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.419 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -85.91 141.22 29.72 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.987 0.915 . . . . 0.0 111.316 167.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -125.07 125.6 44.05 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.258 1.423 . . . . 0.0 109.164 167.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -108.31 77.26 0.23 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.897 1.713 . . . . 0.0 111.67 -172.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -74.62 123.53 25.01 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.276 1.431 . . . . 0.0 111.95 -173.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 70.8 m -137.53 99.49 3.96 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 127.321 2.248 . . . . 0.0 112.479 -165.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.65 -3.97 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -90.63 2.5 80.41 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 125.318 1.437 . . . . 0.0 115.724 -177.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 91.83 17.65 47.28 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-N 118.738 1.269 . . . . 0.0 115.548 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -57.03 140.37 44.84 Favored Glycine 0 CA--C 1.54 1.639 0 CA-C-N 118.708 1.254 . . . . 0.0 113.352 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 8.4 m -134.6 -173.59 3.33 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.146 1.779 . . . . 0.0 111.907 -175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 120.17 11.41 6.87 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.767 1.175 . . . . 0.0 115.389 175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -54.78 162.25 1.29 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.163 1.785 . . . . 0.0 115.809 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 32.5 t -102.27 -46.35 4.84 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.211 1.805 . . . . 0.0 113.087 179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -78.64 -178.43 50.16 Favored Glycine 0 CA--C 1.54 1.641 0 C-N-CA 125.069 1.318 . . . . 0.0 114.436 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -66.68 141.44 60.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.236 2.624 . . . . 0.0 111.261 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.75 128.61 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 123.803 0.841 . . . . 0.0 111.87 178.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.81 154.72 49.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.999 1.72 . . . . 0.0 112.113 173.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 45.7 tp -146.38 152.59 39.33 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.165 2.586 . . . . 0.0 109.123 176.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 137.59 -149.77 20.5 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.968 1.271 . . . . 0.0 112.548 178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.61 175.22 1.12 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.998 0.919 . . . . 0.0 112.328 169.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -135.31 178.02 7.36 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.07 1.348 . . . . 0.0 112.646 -178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -118.29 176.53 5.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.041 1.737 . . . . 0.0 111.51 -177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 34.7 mm -105.51 146.42 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 125.753 1.621 . . . . 0.0 109.859 -176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 27.1 m -119.73 90.8 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.867 1.267 . . . . 0.0 110.027 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -109.11 140.4 42.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 0.0 110.958 175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.485 HG13 ' HB ' ' B' ' 224' ' ' THR . 3.0 p -136.14 94.23 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 127.906 2.482 . . . . 0.0 109.68 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -131.3 167.69 18.8 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.683 1.193 . . . . 0.0 113.032 172.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -94.23 152.3 40.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.07 0.948 . . . . 0.0 110.303 166.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.28 113.87 3.24 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.377 2.718 . . . . 0.0 110.887 175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.74 -52.47 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 122.506 2.138 . . . . 0.0 112.333 -175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -165.17 -176.02 3.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.631 2.772 . . . . 0.0 109.865 177.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.12 140.26 41.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.62 1.168 . . . . 0.0 111.269 165.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.37 177.31 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 127.227 2.211 . . . . 0.0 111.411 -178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . 0.26 10.2 p . . . . . 0 C--O 1.252 1.188 0 C-N-CA 126.363 1.865 . . . . 0.0 111.713 175.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.481 0 CA-C-O 119.594 -0.559 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 m -123.37 -15.72 7.07 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.486 1.115 . . . . 0.0 113.928 -178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.3 mtt -64.81 -20.51 66.43 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.461 1.104 . . . . 0.0 112.824 175.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -63.93 -20.88 66.18 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.802 1.241 . . . . 0.0 114.244 170.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -81.56 -23.27 37.29 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.872 0.869 . . . . 0.0 112.955 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -72.61 151.77 42.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.114 0.966 . . . . 0.0 111.97 170.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -152.16 168.34 25.65 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.716 1.606 . . . . 0.0 111.083 178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -125.69 174.28 8.41 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.071 1.748 . . . . 0.0 112.543 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.76 151.95 46.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.902 0.881 . . . . 0.0 113.218 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -64.56 -23.89 67.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.836 0.855 . . . . 0.0 112.725 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -79.19 -26.15 42.66 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.9 t -93.79 -21.05 19.54 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.175 0.99 . . . . 0.0 112.424 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.0 128.11 35.12 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.685 1.194 . . . . 0.0 111.752 168.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -104.75 176.0 5.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.9 1.28 . . . . 0.0 111.313 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG13 ' H ' ' A' ' 18' ' ' GLU . 14.7 p -140.89 154.38 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.516 1.127 . . . . 0.0 112.065 176.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.0 p -57.98 -44.52 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.579 1.552 . . . . 0.0 112.214 175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -63.31 -26.39 68.75 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.921 0.888 . . . . 0.0 113.045 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.47 ' H ' HG13 ' A' ' 15' ' ' VAL . 12.1 tt0 -77.23 -60.41 2.37 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.146 1.379 . . . . 0.0 109.837 172.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.5 t -48.97 -42.6 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 125.789 1.636 . . . . 0.0 112.518 177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.6 t -66.91 -9.55 39.3 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.703 1.601 . . . . 0.0 114.247 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -107.56 -32.46 7.68 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 126.275 1.83 . . . . 0.0 112.613 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -50.24 -44.52 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.248 1.019 . . . . 0.0 110.09 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.51 -45.41 93.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.0 -50.34 62.53 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.458 1.027 . . . . 0.0 111.575 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -33.53 75.83 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.19 -44.37 68.85 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.788 0.835 . . . . 0.0 112.406 174.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 HG11 ' A' ' 48' ' ' VAL . 61.7 mt -58.86 -57.32 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.889 0.768 . . . . 0.0 110.179 175.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -63.94 -25.14 68.0 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -66.71 -50.21 63.55 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.571 -0.706 . . . . 0.0 111.611 166.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.01 65.66 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.567 1.547 . . . . 0.0 114.217 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 16.2 mt -56.13 -30.28 29.07 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 127.389 2.276 . . . . 0.0 112.059 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -40.69 -14.69 0.01 OUTLIER Glycine 0 C--O 1.279 2.967 0 N-CA-C 120.662 3.025 . . . . 0.0 120.662 -175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -51.24 -42.3 49.01 Favored Glycine 0 N--CA 1.482 1.702 0 C-N-CA 127.761 2.6 . . . . 0.0 115.772 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.47 -168.76 3.14 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.224 2.012 . . . . 0.0 111.896 -173.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -58.79 -170.46 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 127.955 2.502 . . . . 0.0 112.798 165.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -74.28 103.82 4.82 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 119.978 -1.701 . . . . 0.0 111.192 -172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -122.99 88.52 2.94 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.021 1.328 . . . . 0.0 113.514 -174.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -64.96 -16.06 62.92 Favored 'General case' 0 CA--C 1.581 2.155 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.7 p -79.4 -31.56 42.8 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.988 1.715 . . . . 0.0 115.408 174.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.3 mmtt -61.89 -15.39 42.32 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 126.159 1.784 . . . . 0.0 114.366 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 88.1 t -49.62 -31.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.754 1.622 . . . . 0.0 113.262 -175.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -60.51 -53.36 58.51 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.534 1.061 . . . . 0.0 112.947 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -67.94 -26.56 66.02 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.362 -0.837 . . . . 0.0 112.317 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -76.86 -52.66 9.08 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.031 0.932 . . . . 0.0 111.223 -178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.6 t -59.0 -28.62 66.55 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.934 0.893 . . . . 0.0 112.692 177.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.9 t -79.06 -59.36 2.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.156 0.889 . . . . 0.0 112.337 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -59.07 -38.02 78.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.781 1.173 . . . . 0.0 114.016 -172.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.431 HG11 HG13 ' A' ' 27' ' ' ILE . 89.2 t -70.82 -59.28 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.689 0 C-N-CA 123.691 0.796 . . . . 0.0 110.574 -177.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 92.5 t -48.61 -30.89 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.12 0.968 . . . . 0.0 110.835 174.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -63.22 -28.41 70.01 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -112.01 -42.86 3.67 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.063 1.745 . . . . 0.0 112.385 177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 m -54.97 -54.18 46.11 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.552 2.341 . . . . 0.0 113.016 175.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.83 -39.06 93.18 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 118.125 0.42 . . . . 0.0 110.675 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.2 t -58.22 -52.02 67.33 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.308 0.643 . . . . 0.0 111.456 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.47 -47.62 83.45 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.391 2.276 . . . . 0.0 113.598 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.3 -25.51 63.36 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 120.667 -1.271 . . . . 0.0 114.403 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 24.1 m -61.76 -24.44 66.82 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.645 -0.659 . . . . 0.0 111.299 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm -91.03 -19.89 22.69 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.3 mt -73.76 -22.2 59.94 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.598 0.759 . . . . 0.0 112.729 162.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.89 -154.65 28.8 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.227 1.87 . . . . 0.0 112.143 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 42.0 mttm -90.8 161.57 35.59 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.847 1.659 . . . . 0.0 112.317 172.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.35 114.22 3.98 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.813 3.009 . . . . 0.0 112.384 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -149.45 165.26 32.65 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.543 1.537 . . . . 0.0 112.123 172.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 15.9 mmtt -75.36 93.61 2.93 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 125.584 1.554 . . . . 0.0 111.241 170.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -68.52 162.77 24.95 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.619 -0.676 . . . . 0.0 111.378 163.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -134.3 150.72 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.618 1.567 . . . . 0.0 108.905 163.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.8 148.13 25.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.219 1.008 . . . . 0.0 111.117 164.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -140.24 156.3 46.54 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.13 1.372 . . . . 0.0 110.161 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.6 p -143.88 146.38 32.97 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.759 1.623 . . . . 0.0 111.968 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 91.3 t -123.72 124.59 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 124.997 1.319 . . . . 0.0 108.006 -176.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.5 mm -118.2 112.31 37.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 C-N-CA 127.937 2.495 . . . . 0.0 107.332 -169.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.2 tpt -140.53 146.96 38.81 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.35 1.46 . . . . 0.0 111.169 -174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -95.3 130.11 42.18 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.628 1.171 . . . . 0.0 112.727 -172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -69.45 -10.11 56.61 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.324 1.85 . . . . 0.0 114.454 -173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -57.74 -20.61 35.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.744 2.017 . . . . 0.0 114.294 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 137.3 -1.5 3.03 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.124 1.345 . . . . 0.0 114.913 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.06 155.55 27.42 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.902 1.351 . . . . 0.0 111.626 170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.82 160.32 31.83 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.084 0.85 . . . . 0.0 113.289 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.39 168.68 22.0 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.082 1.753 . . . . 0.0 112.586 -173.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -121.76 132.46 54.62 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 110.695 169.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 m -139.08 146.08 40.3 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.361 1.464 . . . . 0.0 109.729 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.95 146.38 30.09 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.39 0.676 . . . . 0.0 111.377 177.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 90.4 p -148.18 151.14 35.03 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.7 t -79.24 11.08 3.07 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' B' ' 209' ' ' ILE . 3.8 m -63.86 173.2 1.89 Allowed 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.384 -0.823 . . . . 0.0 112.648 173.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -162.94 154.88 18.13 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.876 2.071 . . . . 0.0 109.931 172.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -76.83 147.62 37.05 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.207 1.003 . . . . 0.0 110.474 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.2 81.29 0.69 Allowed 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.7 t -64.25 -62.56 1.54 Allowed 'General case' 0 N--CA 1.479 0.983 0 O-C-N 120.522 -1.361 . . . . 0.0 113.315 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 65.2 p -97.07 -11.04 24.91 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.918 1.687 . . . . 0.0 113.117 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -47.8 21.46 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.251 1.42 . . . . 0.0 112.726 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -154.46 -47.63 0.09 Allowed 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 131.02 111.36 1.4 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-N 120.35 1.432 . . . . 0.0 115.145 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.5 p -146.37 163.85 34.27 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.49 1.516 . . . . 0.0 112.352 174.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 50.1 t -156.46 149.37 23.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 126.203 1.801 . . . . 0.0 110.608 174.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.7 t -142.67 142.79 32.11 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 119.73 -1.856 . . . . 0.0 111.138 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.4 107.83 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.137 0.975 . . . . 0.0 109.995 -167.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 -92.17 124.01 35.94 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.106 0.962 . . . . 0.0 112.437 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 32.1 m95 -131.21 136.95 48.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.101 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -96.98 164.36 12.56 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.883 1.673 . . . . 0.0 111.795 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -138.23 -178.73 5.41 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.871 1.668 . . . . 0.0 110.018 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -51.25 -49.59 60.85 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 128.061 2.545 . . . . 0.0 114.193 -175.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.5 t -136.45 0.77 2.55 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.173 1.389 . . . . 0.0 113.282 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.4 ptp -132.84 176.88 8.08 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.86 1.664 . . . . 0.0 111.958 -177.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -136.09 147.47 47.84 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.98 1.312 . . . . 0.0 110.694 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 6.3 p -143.21 69.66 1.3 Allowed 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.964 1.306 . . . . 0.0 110.786 -163.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -79.53 138.58 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.323 1.049 . . . . 0.0 111.325 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 14.7 p -123.09 145.15 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.688 1.595 . . . . 0.0 111.613 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.26 120.98 16.35 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.912 1.285 . . . . 0.0 110.469 -166.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -113.93 136.74 52.56 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 126.132 1.773 . . . . 0.0 112.711 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.23 117.27 17.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.165 1.386 . . . . 0.0 108.372 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -144.04 73.15 0.34 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.113 1.34 . . . . 0.0 112.945 -163.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.02 119.76 18.68 Favored 'General case' 0 C--O 1.273 2.331 0 C-N-CA 125.243 1.417 . . . . 0.0 111.544 -165.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.3 t -141.13 79.38 1.69 Allowed 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 123.372 1.558 . . . . 0.0 114.042 -165.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 2.1 pp -59.3 -12.77 3.41 Favored 'Isoleucine or valine' 0 C--O 1.267 2.025 0 C-N-CA 125.27 1.428 . . . . 0.0 113.993 176.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -83.13 0.69 89.61 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 126.882 2.182 . . . . 0.0 115.421 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 132.66 9.0 2.36 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 175.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -81.95 18.99 10.64 Favored Glycine 0 CA--C 1.538 1.472 0 CA-C-N 119.754 1.777 . . . . 0.0 115.942 -177.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 m -117.39 71.73 0.82 Allowed 'General case' 0 C--O 1.243 0.731 0 C-N-CA 125.829 1.651 . . . . 0.0 112.105 -163.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.42 ' HA2' HG23 ' A' ' 15' ' ' VAL . . . 78.72 1.08 82.8 Favored Glycine 0 CA--C 1.539 1.556 0 N-CA-C 116.016 1.166 . . . . 0.0 116.016 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -78.93 64.85 3.97 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -165.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.2 p -161.44 -11.53 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 168.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -153.46 -169.83 18.94 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 127.256 2.36 . . . . 0.0 111.744 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -69.12 138.05 38.87 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.715 2.277 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.3 pt -79.07 166.95 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.652 1.181 . . . . 0.0 111.454 171.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 172.54 12.86 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.896 1.678 . . . . 0.0 112.526 173.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.25 166.88 9.12 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.453 1.101 . . . . 0.0 112.449 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.36 -175.62 37.48 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.734 1.159 . . . . 0.0 112.973 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -138.35 164.0 30.42 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.453 1.901 . . . . 0.0 111.041 176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.13 77.73 1.66 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.342 1.057 . . . . 0.0 112.328 177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -129.36 164.2 24.12 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.277 1.031 . . . . 0.0 112.334 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 43.5 mm -49.02 137.49 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 128.408 2.683 . . . . 0.0 112.053 -178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 93.7 m -100.49 92.01 4.95 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.981 1.312 . . . . 0.0 110.598 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -89.12 150.54 22.67 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.79 0.836 . . . . 0.0 111.213 167.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.29 103.53 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 127.46 2.304 . . . . 0.0 109.007 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -132.51 130.2 40.12 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 111.153 174.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -127.76 90.58 47.65 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 125.548 1.539 . . . . 0.0 108.487 176.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.3 166.22 28.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.052 2.501 . . . . 0.0 111.886 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.71 -56.15 0.55 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 123.36 2.707 . . . . 0.0 112.781 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 -165.39 170.2 14.84 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 129.317 3.047 . . . . 0.0 109.333 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -73.89 136.22 43.37 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.098 0.559 . . . . 0.0 110.757 164.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.72 164.64 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.08 1.752 . . . . 0.0 111.499 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 125.979 1.712 . . . . 0.0 110.907 174.532 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.457 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -121.55 -14.89 8.12 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.277 1.431 . . . . 0.0 113.69 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 66.4 mtt -64.53 -20.69 66.37 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.602 1.161 . . . . 0.0 112.847 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -64.15 -20.81 66.25 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.802 1.241 . . . . 0.0 114.26 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -81.74 -23.33 36.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.895 0.878 . . . . 0.0 112.916 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -71.52 152.47 42.97 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.127 0.971 . . . . 0.0 111.873 169.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -151.58 169.34 22.35 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.701 1.6 . . . . 0.0 111.074 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -126.49 174.65 8.48 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.095 1.758 . . . . 0.0 112.498 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.69 153.16 43.89 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.01 0.924 . . . . 0.0 112.942 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -65.99 -27.79 68.4 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.413 -0.804 . . . . 0.0 112.411 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.06 -26.64 59.54 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 6.0 t -92.17 -19.45 22.25 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.997 0.919 . . . . 0.0 112.605 175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -75.69 115.47 15.4 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.796 1.238 . . . . 0.0 112.242 173.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 22.6 p90 -84.96 179.23 7.34 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.517 1.127 . . . . 0.0 112.024 172.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.443 HG13 ' H ' ' B' ' 161' ' ' GLU . 8.1 p -144.25 156.7 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.343 -0.848 . . . . 0.0 113.049 169.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 4.3 p -56.9 -44.49 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.559 1.944 . . . . 0.0 111.969 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.08 -25.83 68.28 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.595 0.758 . . . . 0.0 113.035 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . 0.443 ' H ' HG13 ' B' ' 158' ' ' VAL . 11.4 tt0 -78.57 -59.5 2.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.259 1.423 . . . . 0.0 110.048 172.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -49.29 -43.58 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 126.359 1.864 . . . . 0.0 112.173 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.9 t -66.95 -9.29 36.83 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.469 1.508 . . . . 0.0 114.152 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -106.88 -32.44 7.91 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.21 1.804 . . . . 0.0 112.715 173.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 28.6 mt -50.37 -44.61 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.341 1.056 . . . . 0.0 110.057 169.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.44 -45.29 93.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.12 -50.44 61.42 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.469 1.031 . . . . 0.0 111.574 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -33.12 74.9 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.8 -44.32 66.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.745 0.818 . . . . 0.0 112.411 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.423 HG13 HG11 ' B' ' 191' ' ' VAL . 61.6 mt -58.99 -57.08 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-N 118.932 0.787 . . . . 0.0 110.101 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -63.75 -25.32 68.14 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 30.5 t -66.79 -50.05 63.91 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.693 -0.629 . . . . 0.0 111.553 166.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.71 -24.87 65.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.544 1.538 . . . . 0.0 114.235 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 17.4 mt -56.12 -30.3 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.283 0 C-N-CA 127.415 2.286 . . . . 0.0 111.916 176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . -41.31 -13.61 0.01 OUTLIER Glycine 0 C--O 1.28 3.012 0 N-CA-C 120.656 3.023 . . . . 0.0 120.656 -175.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . -52.14 -42.01 54.46 Favored Glycine 0 N--CA 1.483 1.828 0 C-N-CA 127.724 2.583 . . . . 0.0 115.574 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -147.34 -168.82 3.16 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 120.35 2.075 . . . . 0.0 111.966 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.57 -170.63 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 127.929 2.492 . . . . 0.0 112.832 165.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -74.2 102.59 4.34 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 120.032 -1.668 . . . . 0.0 111.245 -172.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -122.94 88.36 2.92 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.098 1.359 . . . . 0.0 113.202 -175.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -62.32 -21.24 65.11 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 175.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 13.0 p -77.67 -27.81 50.98 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.375 1.87 . . . . 0.0 115.175 177.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 26.5 mmtt -64.34 -15.64 60.74 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.389 1.475 . . . . 0.0 114.111 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.55 -29.45 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 125.742 1.617 . . . . 0.0 114.538 -175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -60.64 -52.69 64.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 119.522 1.055 . . . . 0.0 112.434 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -68.12 -26.56 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 121.499 -0.751 . . . . 0.0 112.248 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -77.04 -52.93 8.48 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.866 0.866 . . . . 0.0 111.237 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.4 t -58.92 -28.26 66.05 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.997 0.919 . . . . 0.0 112.755 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 5.9 t -79.22 -60.19 2.47 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.148 0.885 . . . . 0.0 112.355 167.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -58.55 -37.47 75.77 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 119.89 1.223 . . . . 0.0 114.033 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.423 HG11 HG13 ' B' ' 170' ' ' ILE . 89.0 t -71.01 -59.67 3.21 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 123.682 0.793 . . . . 0.0 110.42 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 92.4 t -48.65 -31.1 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.095 0.958 . . . . 0.0 110.819 174.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -63.18 -27.73 69.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.72 -43.02 3.51 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 126.043 1.737 . . . . 0.0 112.331 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 15.2 m -55.01 -54.18 46.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.64 2.376 . . . . 0.0 113.064 175.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.99 -38.94 93.19 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.204 0.456 . . . . 0.0 110.66 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 11.3 t -58.49 -51.71 68.73 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.31 0.644 . . . . 0.0 111.52 171.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -58.57 -48.15 81.88 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.441 2.297 . . . . 0.0 113.505 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.66 -25.31 63.85 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.662 -1.273 . . . . 0.0 114.37 -177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 21.9 m -62.19 -24.82 67.43 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.708 -0.62 . . . . 0.0 111.278 166.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 5.8 mmmm -89.99 -21.33 22.46 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.74 -22.19 60.9 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.841 0.856 . . . . 0.0 113.011 162.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -100.51 -153.53 26.85 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.274 1.892 . . . . 0.0 112.212 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -93.66 157.21 38.7 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 125.532 1.533 . . . . 0.0 112.281 172.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -70.57 112.75 3.3 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.934 3.089 . . . . 0.0 112.104 178.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -147.4 159.33 43.83 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.712 1.205 . . . . 0.0 112.217 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -68.8 79.67 0.3 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 127.326 2.251 . . . . 0.0 111.661 170.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -60.95 159.02 12.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.979 0.895 . . . . 0.0 111.087 163.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . 0.409 HD11 ' SG ' ' A' ' 85' ' ' CYS . 3.0 tt -137.25 153.22 28.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 125.952 1.701 . . . . 0.0 108.831 166.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 19.2 m -141.49 147.12 22.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.703 1.201 . . . . 0.0 109.869 170.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 8.9 t -138.42 157.71 45.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 124.792 1.237 . . . . 0.0 109.405 168.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 32.0 p -145.82 152.66 39.87 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.383 1.473 . . . . 0.0 112.124 175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 47.1 t -129.7 128.75 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.961 1.304 . . . . 0.0 108.247 -176.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 4.9 mm -119.87 114.08 42.94 Favored 'Isoleucine or valine' 0 C--O 1.245 0.839 0 C-N-CA 128.093 2.557 . . . . 0.0 106.809 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 36.2 tpp -140.19 148.37 41.47 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.499 1.52 . . . . 0.0 111.161 -176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -97.65 128.15 44.14 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.014 1.326 . . . . 0.0 112.36 -171.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.8 tttp -68.78 -9.07 48.8 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.449 1.9 . . . . 0.0 114.452 -173.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -57.27 -21.36 33.89 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.104 2.161 . . . . 0.0 114.412 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 136.9 -2.76 3.35 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.963 1.268 . . . . 0.0 115.102 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -65.9 164.46 14.94 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.81 1.305 . . . . 0.0 111.93 169.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -173.81 162.65 33.49 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.025 0.821 . . . . 0.0 113.425 -177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.21 171.84 16.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.998 1.719 . . . . 0.0 113.063 -171.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 12.2 m80 -120.69 133.4 55.35 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.403 0.681 . . . . 0.0 111.055 173.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . . . . . . . . . 19.2 m -138.22 147.01 43.3 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.426 1.09 . . . . 0.0 110.296 174.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -143.98 146.5 32.95 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.719 -0.613 . . . . 0.0 111.359 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 95.6 p -147.98 151.21 35.4 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 7.9 t -79.45 11.53 2.96 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 4.7 m -63.72 173.5 1.72 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.869 0.843 . . . . 0.0 112.342 171.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.08 156.78 22.49 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.835 2.054 . . . . 0.0 109.793 171.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.5 t-105 -73.21 138.15 45.44 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.552 0.741 . . . . 0.0 109.617 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -145.6 104.82 3.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.895 1.278 . . . . 0.0 111.472 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 39.2 t -78.5 -75.7 0.22 Allowed 'General case' 0 N--CA 1.473 0.699 0 O-C-N 121.019 -1.051 . . . . 0.0 111.033 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 64.8 p -85.81 -19.17 31.07 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.209 1.403 . . . . 0.0 113.068 -179.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.26 -41.99 80.3 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.096 1.759 . . . . 0.0 112.94 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -153.07 -77.7 0.11 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.62 1.168 . . . . 0.0 113.124 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . 161.07 105.46 0.2 Allowed Glycine 0 CA--C 1.538 1.527 0 O-C-N 120.659 -1.276 . . . . 0.0 114.566 -175.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 77.3 p -137.72 162.15 34.63 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.8 1.24 . . . . 0.0 112.775 177.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 44.3 t -157.12 155.17 30.59 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.987 1.715 . . . . 0.0 110.221 171.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 11.0 t -148.36 145.07 27.93 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 119.803 -1.811 . . . . 0.0 111.003 176.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.2 t -136.62 118.9 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 -168.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -106.17 123.29 47.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.565 1.146 . . . . 0.0 112.256 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -130.63 140.01 50.4 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.603 1.561 . . . . 0.0 110.974 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -102.5 159.74 15.17 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.124 1.77 . . . . 0.0 111.624 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -133.68 178.42 6.95 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 126.437 1.895 . . . . 0.0 110.251 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.53 -48.57 57.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 128.466 2.706 . . . . 0.0 113.837 -176.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.8 t -137.28 0.67 2.34 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.11 1.364 . . . . 0.0 113.288 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 19.6 ptp -131.62 178.94 6.36 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.807 1.643 . . . . 0.0 111.994 -177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -137.74 146.99 44.35 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.106 1.362 . . . . 0.0 110.458 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . . . . . . . . . 8.3 p -141.02 71.77 1.37 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.867 1.267 . . . . 0.0 111.014 -164.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.99 140.59 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.112 0.965 . . . . 0.0 111.683 -178.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.88 139.25 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 126.271 1.829 . . . . 0.0 110.935 179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 36.1 p -130.93 139.09 50.02 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.43 1.092 . . . . 0.0 112.173 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -127.19 138.86 53.22 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.044 1.738 . . . . 0.0 112.783 -171.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -132.96 109.01 9.27 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.094 1.357 . . . . 0.0 109.042 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -131.06 66.24 0.58 Allowed Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.579 2.038 . . . . 0.0 110.438 -172.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.453 HD22 ' H ' ' B' ' 256' ' ' LEU . 0.6 OUTLIER -62.37 142.52 57.78 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.269 1.428 . . . . 0.0 111.184 -169.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -153.08 130.17 11.12 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . 0.402 HD13 ' H ' ' B' ' 258' ' ' ILE . 0.2 OUTLIER -112.7 -7.4 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 126.46 1.904 . . . . 0.0 113.538 179.118 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -101.99 20.93 43.73 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.309 1.909 . . . . 0.0 114.369 179.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 112.41 58.29 0.44 Allowed Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.139 1.352 . . . . 0.0 112.715 -175.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -83.55 -160.01 29.25 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.405 1.002 . . . . 0.0 112.308 170.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 53.0 m -51.48 148.4 5.16 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.102 0.961 . . . . 0.0 113.321 173.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.94 3.56 63.86 Favored Glycine 0 CA--C 1.54 1.616 0 C-N-CA 124.896 1.236 . . . . 0.0 115.149 -172.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -122.8 56.52 1.14 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 119.107 1.453 . . . . 0.0 113.235 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 57.3 p -161.83 -27.47 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 170.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -144.6 -172.6 15.27 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 127.486 2.47 . . . . 0.0 111.898 177.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.3 137.87 44.88 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.936 2.424 . . . . 0.0 112.509 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 48.9 pt -78.2 166.77 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.77 1.228 . . . . 0.0 111.659 172.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.58 172.69 12.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.104 1.762 . . . . 0.0 112.348 173.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.46 166.63 10.01 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.34 1.056 . . . . 0.0 112.443 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -167.83 -175.38 37.57 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.713 1.149 . . . . 0.0 113.124 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 1.4 mtt -138.76 165.35 27.22 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.471 1.908 . . . . 0.0 111.107 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -138.9 78.01 1.65 Allowed 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 0.0 112.095 175.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -128.94 163.71 24.72 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.313 1.045 . . . . 0.0 112.24 176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 44.3 mm -49.49 135.96 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 128.053 2.541 . . . . 0.0 111.921 -178.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 94.5 m -97.55 88.02 4.25 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.921 1.288 . . . . 0.0 110.177 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -85.58 150.46 24.64 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.626 -0.671 . . . . 0.0 110.777 164.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.95 107.79 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.456 0 C-N-CA 126.578 1.951 . . . . 0.0 109.687 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -133.69 133.48 41.92 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.506 1.123 . . . . 0.0 111.027 176.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -127.86 90.31 48.17 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.448 1.499 . . . . 0.0 108.361 176.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.04 166.08 29.13 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.238 2.625 . . . . 0.0 111.869 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.85 -55.76 0.61 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.244 2.629 . . . . 0.0 112.811 -178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -165.64 170.25 14.37 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 129.261 3.025 . . . . 0.0 109.332 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -73.7 136.15 43.72 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.982 0.513 . . . . 0.0 110.829 164.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.66 164.17 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.149 1.78 . . . . 0.0 111.479 179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 125.78 1.632 . . . . 0.0 110.944 174.314 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 m -68.4 162.02 26.31 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.679 1.191 . . . . 0.0 112.167 175.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.98 -49.58 62.99 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.937 0.895 . . . . 0.0 112.824 176.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -76.27 -12.01 60.01 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -80.96 -24.73 37.88 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.287 -0.883 . . . . 0.0 112.379 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -63.12 143.15 58.04 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.488 0.661 . . . . 0.0 111.259 168.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -135.11 -177.44 4.64 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.905 1.682 . . . . 0.0 110.64 -177.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -111.24 9.96 21.75 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.623 1.569 . . . . 0.0 113.759 -178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.31 -1.81 7.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -172.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -59.28 -15.81 17.95 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.557 1.543 . . . . 0.0 114.355 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -21.94 26.22 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 167.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -73.29 -24.55 60.43 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.601 1.161 . . . . 0.0 113.893 173.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.04 157.19 31.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.719 0.808 . . . . 0.0 111.466 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -96.42 164.37 12.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.784 0.833 . . . . 0.0 112.122 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.14 158.07 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 123.809 0.844 . . . . 0.0 112.358 -176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.3 p -52.76 -39.86 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 126.835 2.054 . . . . 0.0 112.92 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -60.22 -22.99 63.69 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.003 0.921 . . . . 0.0 113.097 177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -96.86 -51.17 4.37 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.038 0.935 . . . . 0.0 111.972 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.1 t -48.59 -38.06 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.008 1.323 . . . . 0.0 112.464 175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 t -63.9 -13.68 47.37 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.045 1.738 . . . . 0.0 114.298 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -101.8 -38.14 7.98 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.899 2.08 . . . . 0.0 111.976 171.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.7 mt -51.71 -42.44 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.067 0.849 . . . . 0.0 110.866 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.92 -42.41 89.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.6 -0.688 . . . . 0.0 112.804 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.45 -50.86 49.52 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 119.723 1.147 . . . . 0.0 111.121 178.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -30.71 70.84 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.04 -44.66 38.15 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.541 0.736 . . . . 0.0 112.966 173.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -58.67 -58.01 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.303 0.956 . . . . 0.0 110.061 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -62.27 -29.56 70.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.618 0.97 . . . . 0.0 113.618 -176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -62.64 -46.81 86.53 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.834 0.854 . . . . 0.0 112.181 168.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.01 -35.57 80.91 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 175.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 86.0 mt -61.32 -48.23 89.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.918 1.287 . . . . 0.0 109.907 172.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.43 12.79 74.93 Favored Glycine 0 CA--C 1.537 1.464 0 C-N-CA 124.389 0.995 . . . . 0.0 114.662 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.2 3.39 38.61 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 116.684 1.434 . . . . 0.0 116.684 171.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -59.98 146.25 43.22 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 119.696 1.748 . . . . 0.0 111.085 171.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.62 -160.39 0.15 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.914 1.286 . . . . 0.0 111.876 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -47.73 136.64 10.4 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.297 1.039 . . . . 0.0 111.617 169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -136.7 179.16 6.54 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.775 1.63 . . . . 0.0 111.375 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.97 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.335 1.054 . . . . 0.0 112.226 165.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.9 p -47.31 -0.54 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 128.179 2.591 . . . . 0.0 117.821 168.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.22 -39.5 2.98 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.666 2.386 . . . . 0.0 113.31 172.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -52.77 -29.52 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 125.368 1.467 . . . . 0.0 113.193 176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -62.95 -49.36 75.05 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.668 1.187 . . . . 0.0 112.312 176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.56 -25.41 65.79 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.471 -0.768 . . . . 0.0 112.638 174.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -76.09 -54.1 7.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.893 0.769 . . . . 0.0 111.393 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.1 t -59.06 -24.27 62.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.771 0.829 . . . . 0.0 112.651 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.3 t -83.32 -59.71 2.37 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.407 1.003 . . . . 0.0 113.033 166.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -58.44 -38.78 78.18 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.987 1.315 . . . . 0.0 113.896 -172.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.0 t -66.65 -62.87 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.773 0 C-N-CA 124.309 1.044 . . . . 0.0 109.623 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -48.92 -30.1 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 125.414 1.486 . . . . 0.0 111.051 176.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -59.33 -34.35 72.24 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -112.71 -36.34 5.22 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.603 1.561 . . . . 0.0 112.632 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.8 m -59.92 -51.74 68.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.757 2.023 . . . . 0.0 111.816 177.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.95 -43.38 98.96 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.905 0.383 . . . . 0.0 111.057 178.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 83.4 p -66.79 -26.2 66.84 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -75.31 -51.98 11.91 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.262 2.225 . . . . 0.0 113.271 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.59 -25.89 66.84 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 36.5 m -59.61 -33.93 72.12 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.144 0.577 . . . . 0.0 110.493 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -79.59 -28.6 41.05 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.7 mt -61.95 -32.3 72.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -97.58 -99.62 2.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.711 1.148 . . . . 0.0 113.269 178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -135.95 146.31 56.24 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.86 1.664 . . . . 0.0 113.092 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.53 99.11 1.01 Allowed 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 124.296 3.33 . . . . 0.0 112.32 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -140.62 167.89 21.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.615 1.566 . . . . 0.0 111.823 172.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -61.52 129.27 40.31 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.77 1.228 . . . . 0.0 110.543 172.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -115.09 152.16 33.02 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 126.09 1.756 . . . . 0.0 110.167 172.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 5.5 tt -151.98 157.3 5.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.514 1.526 . . . . 0.0 109.283 171.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 m -137.28 152.14 27.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.236 1.814 . . . . 0.0 109.055 167.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -128.86 144.41 51.17 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 125.079 1.352 . . . . 0.0 108.315 161.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.2 p -137.57 154.22 49.83 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.724 0.773 . . . . 0.0 111.688 167.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.41 114.47 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 124.779 1.231 . . . . 0.0 109.605 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.587 HD12 ' CB ' ' A' ' 106' ' ' CYS . 1.0 OUTLIER -107.26 97.45 5.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 126.165 1.786 . . . . 0.0 106.596 -177.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -154.63 90.07 1.29 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.492 1.117 . . . . 0.0 112.592 -170.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -151.6 142.57 23.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.832 2.053 . . . . 0.0 108.698 160.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -158.03 -62.61 0.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 125.38 1.472 . . . . 0.0 111.242 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -115.04 -9.51 12.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.764 1.626 . . . . 0.0 114.303 178.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 98.67 2.31 57.46 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 125.28 1.419 . . . . 0.0 115.254 -177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -177.34 2.24 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 119.118 1.459 . . . . 0.0 112.261 167.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -176.16 -173.12 41.54 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.444 1.021 . . . . 0.0 114.13 176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.87 174.02 10.13 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 128.079 2.552 . . . . 0.0 110.543 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -98.42 100.82 12.12 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.488 -0.757 . . . . 0.0 110.281 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 53.8 m -111.94 142.65 44.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.942 0.897 . . . . 0.0 108.744 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.62 145.44 32.49 Favored 'General case' 0 C--O 1.236 0.355 0 O-C-N 121.319 -0.863 . . . . 0.0 111.193 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 30.7 p -139.96 143.69 36.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 122.086 0.946 . . . . 0.0 112.097 175.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.4 t -81.72 16.2 1.88 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.102 0.961 . . . . 0.0 112.056 170.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 25.0 m -64.3 161.5 16.61 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.198 -0.939 . . . . 0.0 112.044 172.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -160.01 138.25 10.21 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.149 1.38 . . . . 0.0 111.995 -177.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -70.12 146.69 50.69 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.16 0.584 . . . . 0.0 110.503 174.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -140.45 160.3 40.29 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.183 1.393 . . . . 0.0 110.925 168.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.5 t -117.52 -64.4 1.31 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.055 1.342 . . . . 0.0 112.223 174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 t -86.5 -39.77 15.94 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.788 0.835 . . . . 0.0 112.163 177.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -53.87 52.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.134 1.774 . . . . 0.0 111.589 -174.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -142.44 176.3 9.12 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.503 2.721 . . . . 0.0 109.542 177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -105.33 140.57 15.11 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 123.989 0.804 . . . . 0.0 112.117 172.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 49.5 m -143.42 149.44 37.65 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.249 1.42 . . . . 0.0 110.282 171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.26 108.97 4.02 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.09 0.956 . . . . 0.0 111.48 177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.3 t -100.97 143.25 31.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.895 0.878 . . . . 0.0 111.729 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.39 128.87 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 126.441 1.896 . . . . 0.0 109.245 -168.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 19.1 ptt-85 -121.64 122.18 39.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.937 1.695 . . . . 0.0 112.063 -170.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -133.49 117.49 17.22 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.688 1.595 . . . . 0.0 110.767 -175.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -73.77 167.5 21.28 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.348 -0.845 . . . . 0.0 112.946 171.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -151.39 -175.16 5.07 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.079 1.352 . . . . 0.0 111.375 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.83 -59.21 2.65 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.601 1.96 . . . . 0.0 113.347 172.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.2 t -138.13 -35.58 0.62 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.807 1.643 . . . . 0.0 112.846 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.9 ptp -100.33 89.85 4.12 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.932 1.293 . . . . 0.0 112.797 -174.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.29 155.87 8.35 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.53 -0.731 . . . . 0.0 111.661 173.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.587 ' CB ' HD12 ' A' ' 71' ' ' ILE . 2.8 p -127.51 135.76 50.82 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.936 1.294 . . . . 0.0 111.066 177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.5 pt -129.65 122.43 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 125.491 1.517 . . . . 0.0 110.258 175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.1 t -107.92 138.13 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.292 1.837 . . . . 0.0 108.756 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -127.52 107.48 9.97 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.416 1.086 . . . . 0.0 110.431 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.56 147.74 25.19 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.242 1.017 . . . . 0.0 112.388 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 8.0 m-85 -136.78 118.58 15.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.217 2.207 . . . . 0.0 108.959 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -116.42 100.74 0.93 Allowed Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.719 2.104 . . . . 0.0 110.423 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.04 145.41 36.41 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.646 1.178 . . . . 0.0 111.882 -176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.4 t -151.86 120.63 6.55 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.8 -47.21 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.466 1.106 . . . . 0.0 109.148 174.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.89 -23.93 77.31 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.318 0.961 . . . . 0.0 115.219 -174.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.26 39.08 92.01 Favored Glycine 0 CA--C 1.539 1.593 0 CA-C-N 118.732 1.266 . . . . 0.0 114.201 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -70.99 88.02 0.38 Allowed Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.139 1.828 . . . . 0.0 113.888 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 97.2 p -122.86 177.99 5.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.204 2.602 . . . . 0.0 112.364 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.87 21.3 2.94 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.691 1.139 . . . . 0.0 114.733 -178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -55.74 -176.76 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 128.783 2.833 . . . . 0.0 114.416 171.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -57.1 -37.64 72.22 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.25 162.04 47.61 Favored Glycine 0 CA--C 1.541 1.706 0 C-N-CA 123.666 0.65 . . . . 0.0 112.984 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -70.1 169.76 18.59 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 123.349 2.699 . . . . 0.0 112.544 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 pt -119.81 144.76 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 125.517 1.527 . . . . 0.0 111.386 176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.1 157.07 47.53 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.657 1.183 . . . . 0.0 112.983 167.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 71.7 mt -139.47 161.81 36.59 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 128.529 2.732 . . . . 0.0 109.424 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 151.56 -171.21 31.09 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.239 0.924 . . . . 0.0 114.234 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 12.6 ptp -66.56 176.57 1.86 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.225 1.01 . . . . 0.0 112.908 171.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.3 170.84 15.41 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.488 1.515 . . . . 0.0 112.813 178.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.94 161.33 29.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.277 1.831 . . . . 0.0 111.7 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.5 mm -75.98 153.04 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.939 1.695 . . . . 0.0 110.259 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 100.0 m -121.86 94.32 4.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.313 1.445 . . . . 0.0 110.844 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -88.15 149.79 23.69 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.241 -0.912 . . . . 0.0 111.647 170.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.26 94.44 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 127.69 2.396 . . . . 0.0 108.521 176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.98 165.56 27.21 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.11 1.364 . . . . 0.0 112.378 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -119.16 90.23 41.27 Favored Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 125.214 1.405 . . . . 0.0 109.944 175.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -71.78 115.94 4.5 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.309 2.673 . . . . 0.0 110.707 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -73.48 -33.46 6.84 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.5 2.133 . . . . 0.0 112.829 -175.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -155.84 173.3 16.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 129.301 3.04 . . . . 0.0 109.821 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -70.46 141.93 51.99 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 122.999 0.52 . . . . 0.0 111.269 166.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.59 172.33 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 126.412 1.885 . . . . 0.0 111.081 178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.617 1.967 . . . . 0.0 110.697 177.341 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.341 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 19.6 m -67.22 161.46 24.76 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.486 1.114 . . . . 0.0 112.24 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -52.2 -49.36 64.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.777 0.831 . . . . 0.0 112.879 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -76.28 -11.85 59.98 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -80.99 -24.43 37.99 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 121.31 -0.869 . . . . 0.0 112.472 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -63.28 143.52 57.73 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.579 0.704 . . . . 0.0 111.121 168.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -135.04 -176.73 4.35 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.93 1.692 . . . . 0.0 110.614 -177.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -112.68 9.84 19.29 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 125.659 1.584 . . . . 0.0 113.739 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -68.34 -2.3 8.12 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 23.1 mp0 -58.99 -16.42 18.0 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.808 1.643 . . . . 0.0 114.228 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -21.72 25.06 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 167.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -72.44 -25.14 61.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.569 1.148 . . . . 0.0 113.74 173.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -77.8 155.36 31.15 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.788 0.835 . . . . 0.0 111.436 177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.75 159.07 15.23 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.683 0.793 . . . . 0.0 111.935 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 13.0 p -141.66 158.9 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.551 1.141 . . . . 0.0 111.267 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 7.1 p -53.81 -35.54 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.82 2.048 . . . . 0.0 113.383 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -62.33 -23.05 66.54 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.864 0.866 . . . . 0.0 113.039 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -86.49 -54.52 4.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.901 1.28 . . . . 0.0 110.643 169.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . 0.451 HG22 HD23 ' B' ' 199' ' ' LEU . 39.8 t -53.91 -38.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.087 1.355 . . . . 0.0 112.577 -175.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 16.1 t -61.19 -11.36 8.9 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.286 1.834 . . . . 0.0 114.258 173.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -107.4 -36.9 6.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.879 1.671 . . . . 0.0 112.317 168.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 35.8 mt -51.11 -40.26 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.508 1.049 . . . . 0.0 111.25 173.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.81 -41.18 91.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 O-C-N 121.462 -0.774 . . . . 0.0 113.058 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.33 -49.28 51.06 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.901 1.228 . . . . 0.0 111.646 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -29.62 70.11 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 111.987 0.366 . . . . 0.0 111.987 -179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.29 -44.67 28.88 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.407 ' HA ' HG21 ' B' ' 191' ' ' VAL . 71.6 mt -58.06 -58.73 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.221 0.918 . . . . 0.0 110.052 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -62.14 -29.49 70.38 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.2 t -62.89 -46.38 88.11 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.789 0.836 . . . . 0.0 112.059 169.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -66.42 -35.24 79.8 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.3 -47.96 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.936 1.294 . . . . 0.0 109.946 172.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 84.14 12.89 75.51 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.395 0.998 . . . . 0.0 114.685 -177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 105.62 3.48 40.3 Favored Glycine 0 CA--C 1.536 1.388 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -60.12 146.43 43.22 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 119.671 1.735 . . . . 0.0 111.115 171.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -76.68 -160.29 0.15 Allowed 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.982 1.313 . . . . 0.0 111.789 175.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -47.93 137.48 9.99 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.269 1.028 . . . . 0.0 111.748 169.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -137.09 179.44 6.38 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.732 1.613 . . . . 0.0 111.426 -172.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -63.48 -164.34 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.508 1.123 . . . . 0.0 112.185 164.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 42.0 p -47.16 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.284 2.634 . . . . 0.0 117.925 168.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -43.76 -39.56 3.81 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.815 2.446 . . . . 0.0 113.442 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 24.1 t -53.18 -28.79 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.199 1.4 . . . . 0.0 113.169 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -62.63 -49.55 74.73 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.71 1.204 . . . . 0.0 112.354 176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -67.58 -25.76 65.94 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.516 -0.74 . . . . 0.0 112.666 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -75.63 -54.01 7.66 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.887 0.767 . . . . 0.0 111.452 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 6.0 t -59.65 -22.95 62.62 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.769 0.828 . . . . 0.0 112.788 178.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.5 t -84.24 -59.64 2.33 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 119.477 1.035 . . . . 0.0 113.19 165.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -58.32 -38.62 77.46 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.99 1.316 . . . . 0.0 114.03 -172.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.407 HG21 ' HA ' ' B' ' 170' ' ' ILE . 88.0 t -66.45 -62.65 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 C-N-CA 124.393 1.077 . . . . 0.0 109.591 -179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 98.4 t -48.96 -30.4 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.473 1.509 . . . . 0.0 110.953 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -59.21 -33.07 70.53 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -114.62 -35.48 4.86 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.654 1.581 . . . . 0.0 112.824 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 54.2 m -61.58 -48.3 81.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.984 2.114 . . . . 0.0 112.079 177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.566 ' HA ' HD12 ' B' ' 199' ' ' LEU . 0.2 OUTLIER -62.79 -45.16 93.95 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.455 0.645 . . . . 0.0 110.642 176.027 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 83.0 p -66.18 -25.26 66.86 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.137 -0.977 . . . . 0.0 113.375 177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -75.79 -54.53 6.79 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.438 2.295 . . . . 0.0 113.155 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' B' ' 196' ' ' LEU . 0.0 OUTLIER -64.8 -26.28 68.28 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 119.744 1.156 . . . . 0.0 113.433 -172.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 42.3 m -56.99 -40.57 76.8 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.325 0.65 . . . . 0.0 110.835 169.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -73.87 -29.07 61.9 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.784 0.834 . . . . 0.0 112.637 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 5.2 mt -62.49 -31.98 72.81 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.84 -97.9 2.1 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.767 1.175 . . . . 0.0 113.281 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 11.9 mttm -136.78 146.74 56.48 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 125.776 1.631 . . . . 0.0 112.98 -175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.23 97.27 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 124.202 3.268 . . . . 0.0 112.203 -178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -140.15 167.67 21.6 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.506 1.522 . . . . 0.0 111.838 172.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -61.77 131.35 49.6 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.887 1.275 . . . . 0.0 110.754 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -116.96 152.33 34.79 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.259 1.824 . . . . 0.0 110.296 173.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 6.7 tt -152.81 157.41 4.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 125.858 1.663 . . . . 0.0 109.147 172.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 3.5 m -136.38 152.56 29.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 126.451 1.9 . . . . 0.0 109.225 165.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 2.1 p -127.27 144.05 51.12 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 125.025 1.33 . . . . 0.0 108.353 160.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 20.1 p -138.12 155.83 48.35 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.959 0.885 . . . . 0.0 112.01 168.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 7.5 p -139.46 125.21 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 124.374 1.07 . . . . 0.0 109.877 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.53 HD12 ' CB ' ' B' ' 249' ' ' CYS . 2.2 mm -115.82 98.32 6.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 C-N-CA 127.027 2.131 . . . . 0.0 107.18 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.1 tmm? -116.26 152.66 33.36 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.444 1.497 . . . . 0.0 110.48 -174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -78.97 147.6 32.89 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.813 0.816 . . . . 0.0 112.483 -175.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -75.9 1.23 15.68 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.937 1.695 . . . . 0.0 114.292 176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -64.97 -13.17 56.78 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 94.52 5.26 61.8 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.965 1.269 . . . . 0.0 115.348 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -73.2 -169.89 0.69 Allowed 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 118.566 1.183 . . . . 0.0 112.185 169.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . 169.85 -170.54 42.86 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 121.071 -1.018 . . . . 0.0 114.152 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.69 -171.44 2.99 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.341 2.256 . . . . 0.0 111.449 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -114.36 94.79 4.95 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.462 0.705 . . . . 0.0 110.232 166.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.475 ' HB ' HG13 ' B' ' 278' ' ' VAL . 23.3 m -106.67 142.35 36.46 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.307 -0.871 . . . . 0.0 108.891 173.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.88 141.21 38.58 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.425 0.69 . . . . 0.0 110.638 176.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 25.0 p -135.98 140.27 43.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.119 0.962 . . . . 0.0 111.714 175.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 10.9 t -80.44 14.99 1.77 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.828 0.851 . . . . 0.0 111.993 171.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 254' ' ' PHE . 13.2 m -64.66 161.77 17.08 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.214 -0.929 . . . . 0.0 112.017 173.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -160.09 139.02 10.68 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.093 1.357 . . . . 0.0 111.875 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -69.85 146.59 51.2 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.725 -0.61 . . . . 0.0 110.343 174.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -139.88 159.32 42.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.247 1.419 . . . . 0.0 110.726 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 43.3 t -117.1 -64.58 1.29 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.09 1.356 . . . . 0.0 112.228 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 22.5 t -86.78 -39.64 15.74 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.796 0.839 . . . . 0.0 112.095 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 -54.29 47.44 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 111.614 -174.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -142.11 176.55 8.88 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 128.465 2.706 . . . . 0.0 109.631 177.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -106.03 140.57 15.2 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.046 0.831 . . . . 0.0 112.229 172.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 48.9 m -142.62 150.05 39.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.289 1.436 . . . . 0.0 110.276 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 48.4 t -148.44 107.59 3.89 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.053 0.941 . . . . 0.0 111.143 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 3.7 t -98.8 142.69 30.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.861 0.864 . . . . 0.0 111.527 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 3.0 t -137.11 123.41 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.375 0 C-N-CA 126.187 1.795 . . . . 0.0 109.075 -169.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 18.8 ptt-85 -115.14 119.16 35.47 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.853 1.661 . . . . 0.0 111.339 -172.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 17.8 m95 -125.7 148.55 49.0 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.14 1.376 . . . . 0.0 110.514 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -109.12 165.49 11.56 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.816 1.246 . . . . 0.0 111.355 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -151.72 -176.06 5.46 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.78 1.232 . . . . 0.0 110.521 -170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.27 -67.09 0.31 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.127 1.771 . . . . 0.0 113.017 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 8.8 t -139.53 4.97 2.2 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.072 1.749 . . . . 0.0 113.405 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 23.9 ptp -133.99 82.01 1.95 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.956 1.302 . . . . 0.0 111.992 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -58.15 147.23 30.76 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.361 -0.837 . . . . 0.0 111.379 177.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.53 ' CB ' HD12 ' B' ' 214' ' ' ILE . 4.4 p -134.47 116.54 15.24 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.275 1.03 . . . . 0.0 111.991 -171.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 2.8 pt -117.14 130.16 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.615 1.166 . . . . 0.0 111.188 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 15.5 t -114.59 139.05 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 126.721 2.008 . . . . 0.0 108.691 176.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 8.3 t -129.83 109.82 11.23 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.344 1.058 . . . . 0.0 110.655 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -89.11 148.0 23.91 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.185 0.994 . . . . 0.0 112.243 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' B' ' 228' ' ' CYS . 8.7 m-85 -136.3 119.13 16.21 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.122 2.169 . . . . 0.0 108.952 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -116.03 100.09 0.91 Allowed Glycine 0 CA--C 1.529 0.939 0 C-N-CA 126.662 2.077 . . . . 0.0 110.304 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.24 145.69 36.6 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.624 1.17 . . . . 0.0 111.734 -175.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.3 t -151.93 122.06 7.17 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 178.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.02 -47.04 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.631 1.172 . . . . 0.0 109.149 174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -71.69 -23.67 77.72 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.3 0.952 . . . . 0.0 115.185 -174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 58.02 39.57 92.15 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.762 1.281 . . . . 0.0 114.148 177.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -71.14 87.35 0.39 Allowed Glycine 0 CA--C 1.537 1.422 0 C-N-CA 126.07 1.795 . . . . 0.0 113.882 -175.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 97.8 p -121.98 178.36 4.93 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 128.02 2.528 . . . . 0.0 112.358 -176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 121.56 21.44 3.0 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 124.724 1.154 . . . . 0.0 114.523 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 9.0 pm0 -55.09 -178.06 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 128.849 2.86 . . . . 0.0 114.418 171.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 3.2 m -57.51 -36.61 71.77 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . -79.92 162.75 46.96 Favored Glycine 0 CA--C 1.541 1.718 0 C-N-CA 123.734 0.683 . . . . 0.0 112.99 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -70.19 169.85 18.49 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.297 2.665 . . . . 0.0 112.512 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.9 pt -119.5 145.07 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 125.591 1.556 . . . . 0.0 111.352 176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.21 157.31 46.93 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.606 1.162 . . . . 0.0 112.961 167.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 72.1 mt -139.65 162.01 36.15 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 128.589 2.755 . . . . 0.0 109.444 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 151.49 -171.44 31.03 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.269 0.938 . . . . 0.0 114.23 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 12.7 ptp -66.51 176.52 1.85 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.195 0.998 . . . . 0.0 112.906 171.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -137.29 170.89 15.32 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.443 1.497 . . . . 0.0 112.711 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -127.69 161.24 29.37 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.342 1.857 . . . . 0.0 111.71 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 43.2 mm -75.19 152.34 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 125.833 1.653 . . . . 0.0 110.269 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 98.3 m -120.92 91.57 3.56 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.475 1.51 . . . . 0.0 110.454 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -86.47 150.74 24.06 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.123 -0.986 . . . . 0.0 111.349 168.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.475 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.2 p -141.08 100.11 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 126.754 2.022 . . . . 0.0 109.344 174.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -140.38 166.97 23.26 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.724 1.61 . . . . 0.0 111.69 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.9 88.79 27.24 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.901 1.28 . . . . 0.0 109.588 175.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.73 115.52 4.26 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.129 2.552 . . . . 0.0 110.777 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.47 -34.26 5.99 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.562 2.175 . . . . 0.0 112.739 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 6.6 mmt180 -156.58 173.9 16.24 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 129.554 3.141 . . . . 0.0 109.738 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -69.94 141.93 52.99 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.992 0.517 . . . . 0.0 111.197 166.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.51 172.07 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 126.456 1.902 . . . . 0.0 111.137 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.575 1.95 . . . . 0.0 110.688 177.294 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.663 0 N-CA-C 111.751 -0.539 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.9 t -85.26 1.74 46.96 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.85 1.26 . . . . 0.0 113.814 -177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -66.68 -3.43 6.55 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 -177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -55.04 -16.48 2.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 127.374 2.27 . . . . 0.0 116.12 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -64.92 -21.77 66.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.465 1.106 . . . . 0.0 113.628 170.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -137.49 -171.14 2.91 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.285 2.234 . . . . 0.0 111.157 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -142.71 142.56 32.01 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.956 0.903 . . . . 0.0 112.144 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.77 -177.99 3.96 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.691 1.996 . . . . 0.0 112.198 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -71.65 46.37 0.12 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 125.797 1.639 . . . . 0.0 114.001 175.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.3 tm-20 -61.22 -20.09 62.4 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 119.988 -1.695 . . . . 0.0 112.738 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -58.3 -24.94 61.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.4 t -103.7 -21.56 13.69 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.572 1.149 . . . . 0.0 112.962 173.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.64 164.75 5.68 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.191 0.996 . . . . 0.0 113.665 177.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -129.0 152.45 48.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.318 1.047 . . . . 0.0 113.419 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.5 p -91.46 161.56 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 126.423 1.889 . . . . 0.0 111.421 178.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.478 ' HA ' ' CG1' ' A' ' 19' ' ' VAL . 63.7 t -61.03 -35.55 66.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.642 1.977 . . . . 0.0 111.56 177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.35 4.83 0.46 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.98 1.312 . . . . 0.0 114.008 172.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -109.23 -59.79 1.85 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 120.8 -1.187 . . . . 0.0 107.888 175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.478 ' CG1' ' HA ' ' A' ' 16' ' ' VAL . 2.1 p -44.39 -42.32 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.192 1.797 . . . . 0.0 112.971 170.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.3 t -60.04 -11.65 6.38 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 39.0 t-20 -115.57 -33.93 5.05 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.654 1.982 . . . . 0.0 112.308 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 mt -49.98 -41.84 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.144 0.977 . . . . 0.0 110.731 167.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 6.5 p -59.05 -42.85 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.413 -0.804 . . . . 0.0 112.7 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -53.14 33.79 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.158 0.89 . . . . 0.0 110.728 178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.66 -31.86 71.99 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.14 -42.3 38.41 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.535 0.734 . . . . 0.0 112.964 176.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.42 ' HA ' HG21 ' A' ' 48' ' ' VAL . 65.0 mt -59.47 -56.76 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 119.284 0.947 . . . . 0.0 109.522 173.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -63.03 -28.88 70.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.5 t -62.52 -47.52 83.56 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.365 1.066 . . . . 0.0 112.299 168.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.65 -33.78 76.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.5 mt -64.84 -32.1 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.887 1.275 . . . . 0.0 111.3 170.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.19 17.37 55.73 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 124.657 1.122 . . . . 0.0 114.709 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.22 21.53 77.76 Favored Glycine 0 CA--C 1.539 1.539 0 C-N-CA 124.659 1.123 . . . . 0.0 115.265 -175.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -55.36 156.86 4.05 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 119.485 1.643 . . . . 0.0 112.569 171.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.49 -179.45 1.07 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.468 1.507 . . . . 0.0 112.391 173.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -47.56 141.71 4.95 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.606 1.562 . . . . 0.0 113.251 175.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -132.71 171.83 13.34 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.811 1.244 . . . . 0.0 112.586 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -91.65 -114.63 0.08 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.687 1.595 . . . . 0.0 109.843 172.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.1 m -70.64 -1.01 9.87 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 126.395 1.878 . . . . 0.0 114.985 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.4 -41.27 39.02 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 125.152 1.381 . . . . 0.0 113.629 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.5 -30.1 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 118.402 -0.809 . . . . 0.0 113.001 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.29 -55.03 32.18 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 119.787 1.176 . . . . 0.0 111.632 170.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.93 -25.35 67.1 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.86 -0.525 . . . . 0.0 112.405 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.7 m0 -76.39 -56.35 4.71 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.2 1.0 . . . . 0.0 111.45 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 t -57.41 -26.66 61.47 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 118.823 0.738 . . . . 0.0 112.76 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 t -81.29 -57.38 3.52 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 119.304 0.956 . . . . 0.0 112.811 169.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -60.24 -34.79 74.19 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 120.466 -1.397 . . . . 0.0 114.073 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG21 ' HA ' ' A' ' 27' ' ' ILE . 83.6 t -70.33 -64.01 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.214 1.005 . . . . 0.0 109.368 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 98.9 t -49.17 -30.18 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.055 1.342 . . . . 0.0 111.002 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -60.5 -32.56 71.55 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -114.0 -35.46 5.08 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.496 1.519 . . . . 0.0 112.75 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.7 m -62.03 -51.36 68.29 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.073 2.149 . . . . 0.0 112.108 176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.44 -42.93 98.67 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 117.91 0.323 . . . . 0.0 110.691 178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.7 p -66.51 -27.01 67.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -74.29 -50.49 18.65 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.532 2.333 . . . . 0.0 113.309 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 pp -65.41 -29.81 70.55 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 120.2 1.364 . . . . 0.0 114.045 -178.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 91.2 m -57.12 -27.96 62.27 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.162 0.985 . . . . 0.0 111.444 167.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.78 -28.17 19.52 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 176.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.78 -33.62 74.18 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.062 0.545 . . . . 0.0 109.852 176.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -99.1 -98.67 2.15 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 125.635 1.588 . . . . 0.0 112.403 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 34.8 tptt -134.27 121.06 15.23 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.661 1.185 . . . . 0.0 112.788 -173.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.72 107.1 1.4 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 124.006 3.138 . . . . 0.0 112.977 -175.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -146.17 170.94 15.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.351 1.861 . . . . 0.0 112.13 176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -76.5 81.16 3.2 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.521 1.529 . . . . 0.0 111.957 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -72.71 138.17 46.42 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.622 1.569 . . . . 0.0 110.162 168.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -119.55 154.46 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 125.405 1.482 . . . . 0.0 109.879 171.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.84 159.19 33.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 C-N-CA 124.613 1.165 . . . . 0.0 110.826 162.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.4 p -136.04 146.76 47.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.249 1.019 . . . . 0.0 110.793 157.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 17.4 p -136.63 143.43 43.5 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.748 1.219 . . . . 0.0 111.313 171.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.4 t -122.05 95.78 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.877 1.271 . . . . 0.0 108.345 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 1.2 mm -91.34 114.13 28.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 2.8 tpt -137.61 161.54 36.19 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.34 1.456 . . . . 0.0 110.736 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -67.47 151.98 46.46 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.494 -0.754 . . . . 0.0 111.37 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.13 1.87 1.35 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 127.152 2.181 . . . . 0.0 115.002 174.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -56.24 -21.86 26.14 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.773 1.629 . . . . 0.0 114.299 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 69.99 34.15 70.6 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 123.955 0.788 . . . . 0.0 113.897 171.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -177.38 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.069 1.748 . . . . 0.0 113.779 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.83 47.47 3.09 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.086 1.327 . . . . 0.0 114.327 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.38 125.55 24.18 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.909 1.354 . . . . 0.0 109.463 173.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -120.22 92.58 3.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.199 1.0 . . . . 0.0 109.537 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' HG13 ' A' ' 135' ' ' VAL . 31.1 m -109.98 142.89 40.73 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.028 -1.045 . . . . 0.0 109.329 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.8 140.39 34.7 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 121.637 -0.665 . . . . 0.0 111.945 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 5.3 m -139.38 127.56 22.54 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -171.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.7 p -75.07 13.09 0.74 Allowed 'General case' 0 N--CA 1.484 1.246 0 O-C-N 120.899 -1.126 . . . . 0.0 113.967 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 111' ' ' PHE . 57.4 m -58.29 164.48 2.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.585 1.554 . . . . 0.0 112.694 170.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -167.14 138.52 3.2 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.954 1.702 . . . . 0.0 110.331 -176.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 1.7 t-105 -83.03 149.19 27.1 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.752 0.821 . . . . 0.0 110.872 174.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -142.09 159.0 43.11 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.364 1.865 . . . . 0.0 111.123 171.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.9 t -114.66 -64.12 1.36 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.716 1.206 . . . . 0.0 111.201 166.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 60.1 p -87.26 -18.04 31.16 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.27 -41.46 12.9 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.753 1.621 . . . . 0.0 112.738 -176.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -164.27 -171.68 2.48 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 126.458 1.903 . . . . 0.0 111.562 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.83 140.42 14.19 Favored Glycine 0 CA--C 1.54 1.624 0 C-N-CA 125.883 1.706 . . . . 0.0 114.83 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 34.9 p -155.87 158.04 37.37 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.462 1.905 . . . . 0.0 111.912 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 17.8 t -146.39 160.4 42.11 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.506 1.522 . . . . 0.0 111.026 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -148.83 144.82 27.2 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 120.145 -1.597 . . . . 0.0 111.24 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.5 t -134.89 102.64 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.809 1.244 . . . . 0.0 109.427 -170.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.28 104.52 16.49 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.823 1.249 . . . . 0.0 112.356 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -103.86 143.82 32.33 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.333 1.063 . . . . 0.0 110.725 170.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.03 147.8 33.01 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.365 1.866 . . . . 0.0 110.996 -174.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -141.4 -172.3 3.48 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.252 1.021 . . . . 0.0 112.195 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -44.03 -58.51 2.77 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.865 2.466 . . . . 0.0 114.576 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 14.9 t -141.45 21.71 2.2 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.967 1.307 . . . . 0.0 113.438 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 9.4 ptm -139.1 150.21 45.44 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.384 1.474 . . . . 0.0 111.32 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -125.16 128.92 49.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.298 1.839 . . . . 0.0 109.645 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 13.8 p -137.72 82.55 1.93 Allowed 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 122.208 1.004 . . . . 0.0 112.773 -172.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.0 pp -109.8 133.45 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.027 0.931 . . . . 0.0 112.077 -173.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.54 146.33 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.226 1.81 . . . . 0.0 111.408 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -133.9 129.2 36.02 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 125.139 1.376 . . . . 0.0 110.067 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -124.82 135.92 53.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.67 1.988 . . . . 0.0 112.434 -169.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 85' ' ' CYS . 90.7 m-85 -132.29 115.22 15.36 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.571 1.149 . . . . 0.0 109.373 -175.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -111.5 58.52 0.39 Allowed Glycine 0 N--CA 1.468 0.82 0 C-N-CA 125.862 1.696 . . . . 0.0 112.801 -167.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.436 HD22 ' H ' ' A' ' 113' ' ' LEU . 2.4 mm? -58.72 124.27 19.17 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 112.888 -168.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 69.5 m -133.28 89.4 2.6 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.03 1.732 . . . . 0.0 111.739 -169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.98 -10.1 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.62 -15.85 64.71 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.996 1.284 . . . . 0.0 115.651 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 68.77 12.73 65.04 Favored Glycine 0 CA--C 1.539 1.543 0 CA-C-N 118.713 1.256 . . . . 0.0 116.122 171.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.17 104.78 0.31 Allowed Glycine 0 CA--C 1.533 1.192 0 C-N-CA 126.316 1.913 . . . . 0.0 114.5 -174.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 52.8 p -52.06 138.62 24.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 127.037 2.135 . . . . 0.0 113.215 177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.22 -3.15 31.3 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 125.156 1.36 . . . . 0.0 115.044 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -99.99 23.09 10.31 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.933 1.693 . . . . 0.0 113.555 -176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.1 t -130.25 -59.38 1.04 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.922 1.689 . . . . 0.0 112.27 -176.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 83.69 -113.04 3.65 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.242 -1.31 . . . . 0.0 111.244 -173.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.92 138.99 38.59 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.572 2.181 . . . . 0.0 111.909 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.9 pp -92.9 131.65 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.108 1.363 . . . . 0.0 110.617 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -132.86 129.64 38.7 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.978 1.311 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 61.6 mt -71.74 122.46 20.68 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.595 0.758 . . . . 0.0 110.16 173.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -160.57 163.89 34.28 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.245 1.402 . . . . 0.0 112.178 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 56.9 ttm -119.05 115.78 25.02 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.789 1.236 . . . . 0.0 110.802 -177.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.32 120.64 18.21 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.348 1.459 . . . . 0.0 111.298 177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -128.96 173.11 10.71 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.675 1.59 . . . . 0.0 111.039 175.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 12.5 mm -57.51 142.26 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.365 1.466 . . . . 0.0 111.26 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 97.4 m -101.3 88.86 3.58 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.225 1.41 . . . . 0.0 110.295 176.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -79.96 147.9 31.42 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.26 -0.9 . . . . 0.0 110.788 164.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.444 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.7 OUTLIER -137.76 95.2 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 127.831 2.452 . . . . 0.0 108.743 175.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -139.35 169.49 17.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.556 1.142 . . . . 0.0 112.523 178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.45 89.79 32.93 Favored Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 125.059 1.344 . . . . 0.0 110.127 174.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -74.33 165.95 30.63 Favored 'Trans proline' 0 CA--C 1.547 1.164 0 C-N-CA 123.17 2.58 . . . . 0.0 112.47 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.03 -38.32 7.36 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.986 2.457 . . . . 0.0 113.527 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -156.22 -65.98 0.11 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.997 1.319 . . . . 0.0 112.242 175.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -87.03 -179.0 6.4 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.161 1.784 . . . . 0.0 112.041 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 163.14 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.802 1.641 . . . . 0.0 112.097 178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 56.5 t . . . . . 0 C--O 1.252 1.196 0 C-N-CA 127.186 2.194 . . . . 0.0 110.329 -179.724 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 4.0 t -84.31 2.01 42.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.37 1.468 . . . . 0.0 113.946 -177.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -67.27 -2.04 5.4 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.765 1.626 . . . . 0.0 115.245 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -54.99 -16.43 2.76 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 127.435 2.294 . . . . 0.0 115.939 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -64.41 -21.66 66.71 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.543 1.137 . . . . 0.0 113.598 169.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -137.78 -172.31 3.21 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.136 2.175 . . . . 0.0 111.531 -175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -140.14 142.55 35.99 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.598 1.159 . . . . 0.0 111.97 173.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -100.8 -179.74 4.16 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.93 2.092 . . . . 0.0 111.947 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -71.94 48.77 0.17 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.766 1.627 . . . . 0.0 113.967 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 12.6 tm-20 -61.86 -20.93 64.23 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.012 -1.68 . . . . 0.0 112.817 172.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -57.43 -21.93 39.92 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 13.3 t -106.7 -21.59 13.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 113.288 172.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.52 163.09 7.28 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.154 0.982 . . . . 0.0 113.509 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -127.5 154.76 44.74 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.374 1.07 . . . . 0.0 113.308 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -95.43 158.6 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.295 1.838 . . . . 0.0 111.154 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.56 -37.52 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.157 1.783 . . . . 0.0 111.923 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.02 -22.87 66.06 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.366 1.066 . . . . 0.0 113.615 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -75.86 -59.16 2.88 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.416 -0.803 . . . . 0.0 110.396 169.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 73.3 t -48.16 -43.17 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 126.96 2.104 . . . . 0.0 112.588 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 9.9 t -60.38 -10.9 5.39 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.207 1.803 . . . . 0.0 114.695 175.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -114.25 -33.91 5.49 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.591 1.957 . . . . 0.0 112.244 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 27.0 mt -50.19 -42.47 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.843 0.857 . . . . 0.0 110.723 167.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 6.6 p -59.04 -42.65 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 O-C-N 121.389 -0.82 . . . . 0.0 112.736 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -52.73 37.11 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.222 0.919 . . . . 0.0 110.768 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -31.8 71.99 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 -178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -77.06 -42.41 38.43 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.613 0.765 . . . . 0.0 112.946 175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . 0.413 ' HA ' HG21 ' B' ' 191' ' ' VAL . 65.1 mt -59.74 -57.02 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 119.4 1.0 . . . . 0.0 109.636 174.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -62.99 -28.53 70.16 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -175.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 47.7 t -62.64 -47.76 82.33 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.436 1.094 . . . . 0.0 112.281 168.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.37 -33.79 76.67 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 174.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 87.0 mt -64.92 -32.08 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.918 1.287 . . . . 0.0 111.392 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 62.08 17.3 55.18 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.665 1.126 . . . . 0.0 114.733 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 74.87 22.02 77.58 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 124.689 1.138 . . . . 0.0 115.314 -175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -55.29 157.25 3.73 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 119.386 1.593 . . . . 0.0 112.672 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.4 -179.69 1.09 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.384 1.474 . . . . 0.0 112.378 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -47.55 141.45 5.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.469 1.507 . . . . 0.0 113.256 175.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -132.33 171.75 13.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.798 1.239 . . . . 0.0 112.444 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -91.57 -113.73 0.09 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.497 1.519 . . . . 0.0 109.721 172.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 3.6 m -71.58 -1.03 12.1 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 126.242 1.817 . . . . 0.0 114.958 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -49.6 -40.92 40.62 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.139 1.376 . . . . 0.0 113.626 -175.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.9 -30.08 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 123.687 0.795 . . . . 0.0 112.868 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -62.57 -55.53 26.36 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 119.766 1.166 . . . . 0.0 111.87 170.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -65.3 -25.3 67.57 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.8 -0.562 . . . . 0.0 112.248 178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -76.5 -56.17 4.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.342 1.057 . . . . 0.0 111.463 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 7.7 t -57.28 -26.62 61.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 118.936 0.789 . . . . 0.0 112.78 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 6.2 t -81.72 -57.78 3.29 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 119.171 0.896 . . . . 0.0 112.86 168.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -59.83 -34.78 73.53 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 120.279 1.4 . . . . 0.0 114.007 -175.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.413 HG21 ' HA ' ' B' ' 170' ' ' ILE . 85.8 t -70.29 -64.12 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 C-N-CA 124.105 0.962 . . . . 0.0 109.375 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -49.2 -30.17 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 125.135 1.374 . . . . 0.0 110.964 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -60.66 -32.63 71.81 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -113.59 -35.56 5.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.402 1.481 . . . . 0.0 112.797 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 48.3 m -61.63 -52.11 65.71 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.985 2.114 . . . . 0.0 111.919 176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.03 -42.48 99.79 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.008 0.367 . . . . 0.0 110.749 178.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 60.2 p -67.0 -27.17 67.21 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 175.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -73.84 -50.99 17.75 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 127.55 2.34 . . . . 0.0 113.247 173.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . . . . . . . . . 3.8 pp -64.96 -29.98 70.95 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.646 -1.284 . . . . 0.0 114.098 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 87.8 m -57.0 -28.31 62.33 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.154 0.982 . . . . 0.0 111.36 167.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -89.41 -28.11 19.97 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . . 33.4 mt -68.95 -33.51 73.82 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.081 0.553 . . . . 0.0 109.897 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -98.96 -98.96 2.15 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.763 1.649 . . . . 0.0 112.398 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -134.12 121.07 15.41 Favored Pre-proline 0 N--CA 1.478 0.953 0 C-N-CA 124.729 1.212 . . . . 0.0 112.798 -173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -67.48 106.96 1.33 Allowed 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.988 3.125 . . . . 0.0 112.709 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -146.97 172.17 14.11 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.369 1.868 . . . . 0.0 111.962 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -77.8 83.93 4.13 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.392 1.477 . . . . 0.0 111.854 173.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -74.53 142.12 44.78 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.306 1.443 . . . . 0.0 109.946 166.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.1 156.56 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.381 1.472 . . . . 0.0 110.129 170.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 2.7 m -139.34 159.3 28.65 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 124.742 1.217 . . . . 0.0 110.379 165.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 19.1 p -136.93 151.23 48.8 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.111 157.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 18.3 p -141.12 150.4 42.79 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.92 1.288 . . . . 0.0 111.771 171.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.12 103.08 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.225 1.41 . . . . 0.0 108.341 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.491 HG23 ' HB3' ' B' ' 249' ' ' CYS . 1.4 mm -99.73 117.52 45.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 125.136 1.374 . . . . 0.0 107.989 -178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 7.0 tpt -142.2 147.74 37.05 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.654 0.781 . . . . 0.0 111.745 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -152.29 91.49 1.6 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.732 2.013 . . . . 0.0 109.646 -178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.73 -59.44 0.2 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 175.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -139.99 -46.11 0.43 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.305 1.042 . . . . 0.0 113.665 -177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 112.51 -8.94 26.29 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 125.122 1.344 . . . . 0.0 115.412 177.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -140.01 79.02 1.69 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -177.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -171.67 21.1 0.07 OUTLIER Glycine 0 CA--C 1.536 1.397 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.71 134.01 54.95 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.828 2.051 . . . . 0.0 111.572 -174.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -128.43 88.15 2.7 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.468 1.107 . . . . 0.0 109.3 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.571 ' HB ' HG13 ' B' ' 278' ' ' VAL . 55.5 m -107.09 142.32 36.94 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 120.699 -1.251 . . . . 0.0 109.579 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -137.25 138.03 39.67 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.27 0.628 . . . . 0.0 111.676 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 2.4 m -136.38 127.72 28.33 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.736 1.214 . . . . 0.0 109.677 -170.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 78.9 p -74.46 10.12 1.45 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 36.0 m -60.68 166.46 3.25 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.497 1.519 . . . . 0.0 112.961 172.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -166.0 147.1 6.76 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.213 1.805 . . . . 0.0 110.42 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -86.44 151.53 23.45 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.718 0.807 . . . . 0.0 111.077 173.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -154.53 159.76 41.13 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.389 1.875 . . . . 0.0 112.916 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 30.6 t -125.18 -53.9 1.61 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.541 1.937 . . . . 0.0 112.223 -171.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 79.2 p -104.22 -6.29 21.1 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.832 1.653 . . . . 0.0 113.635 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.97 -42.74 9.29 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.675 1.59 . . . . 0.0 112.169 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -165.16 -164.71 0.8 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.224 2.209 . . . . 0.0 110.611 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -124.82 142.5 13.96 Favored Glycine 0 CA--C 1.541 1.708 0 C-N-CA 125.373 1.463 . . . . 0.0 114.987 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 24.5 p -153.74 157.56 39.65 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 126.633 1.973 . . . . 0.0 111.997 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 19.3 t -145.22 160.27 41.73 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.786 1.634 . . . . 0.0 111.124 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -150.06 145.54 26.43 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.173 -1.579 . . . . 0.0 111.286 176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 2.9 t -135.73 104.57 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.627 1.171 . . . . 0.0 109.333 -171.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.75 104.53 16.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.543 1.137 . . . . 0.0 112.126 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -98.64 140.09 33.38 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.227 1.013 . . . . 0.0 110.648 169.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -139.83 149.21 43.2 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.321 1.848 . . . . 0.0 111.018 -175.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -143.24 -166.24 2.27 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.579 1.151 . . . . 0.0 111.398 -170.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 8.4 mmtt -42.32 -61.05 1.28 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 127.778 2.431 . . . . 0.0 114.21 177.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 13.0 t -145.41 -6.13 0.64 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.135 1.374 . . . . 0.0 113.845 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 16.0 ptm -94.16 149.41 21.26 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.19 1.396 . . . . 0.0 110.118 169.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -131.83 134.49 45.82 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.67 1.588 . . . . 0.0 109.054 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.491 ' HB3' HG23 ' B' ' 214' ' ' ILE . 10.1 p -140.48 84.27 1.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 122.184 0.992 . . . . 0.0 112.07 -170.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -103.76 136.94 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 121.43 -0.793 . . . . 0.0 111.281 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.49 143.45 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.918 1.687 . . . . 0.0 110.508 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 1.9 t -131.39 127.16 36.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.694 1.198 . . . . 0.0 110.191 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . . . . . . . . . . . -123.06 136.66 54.91 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.803 2.041 . . . . 0.0 112.548 -168.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -133.54 116.29 15.75 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.712 1.205 . . . . 0.0 109.146 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -112.98 60.8 0.34 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.68 1.61 . . . . 0.0 112.959 -166.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . 0.432 HD22 ' H ' ' B' ' 256' ' ' LEU . 1.8 mm? -61.73 126.95 29.17 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.932 1.293 . . . . 0.0 113.09 -166.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 66.6 m -135.32 86.6 2.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.153 1.781 . . . . 0.0 111.714 -169.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -67.4 -10.11 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -63.45 -17.72 60.15 Favored Glycine 0 CA--C 1.537 1.451 0 C-N-CA 125.002 1.286 . . . . 0.0 115.316 -178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 69.81 9.58 62.83 Favored Glycine 0 CA--C 1.536 1.378 0 N-CA-C 116.364 1.306 . . . . 0.0 116.364 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -52.16 144.58 18.56 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.062 1.315 . . . . 0.0 114.506 -173.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 82.4 p -61.63 173.42 0.98 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.216 1.406 . . . . 0.0 112.699 171.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 64.47 43.76 96.21 Favored Glycine 0 CA--C 1.537 1.467 0 O-C-N 121.501 -0.749 . . . . 0.0 113.154 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -71.06 -149.6 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 126.712 2.005 . . . . 0.0 111.49 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 26.9 t -50.43 -39.86 48.75 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 120.478 -1.389 . . . . 0.0 112.924 177.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 121.83 -78.53 0.34 Allowed Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.833 1.682 . . . . 0.0 112.319 173.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.73 144.28 59.1 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 123.04 2.493 . . . . 0.0 111.324 177.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.9 pp -95.09 128.46 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 124.837 1.255 . . . . 0.0 110.612 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -130.69 122.94 28.24 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.321 1.449 . . . . 0.0 110.415 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 69.6 mt -66.96 123.14 19.36 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.494 0.717 . . . . 0.0 110.174 173.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . -162.17 160.26 32.38 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.17 1.367 . . . . 0.0 112.157 177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 57.0 ttm -116.8 114.95 24.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.9 1.28 . . . . 0.0 110.741 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -72.71 120.05 17.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.327 1.451 . . . . 0.0 111.297 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -129.28 173.37 10.57 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.697 1.599 . . . . 0.0 111.063 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 11.0 mm -56.79 144.13 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.429 1.492 . . . . 0.0 111.318 177.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 89.9 m -105.81 90.2 3.32 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.211 1.404 . . . . 0.0 110.255 177.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -82.76 149.82 27.03 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.451 -0.781 . . . . 0.0 111.021 164.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.571 HG13 ' HB ' ' B' ' 224' ' ' THR . 6.5 p -141.29 94.69 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 127.819 2.448 . . . . 0.0 109.285 175.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -136.51 169.21 18.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.554 1.542 . . . . 0.0 112.144 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.87 91.74 31.9 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.741 1.217 . . . . 0.0 110.099 172.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.82 166.32 29.53 Favored 'Trans proline' 0 CA--C 1.547 1.16 0 C-N-CA 123.123 2.548 . . . . 0.0 112.474 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.27 -38.62 6.46 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.969 2.446 . . . . 0.0 113.491 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -155.98 -65.99 0.11 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.062 1.345 . . . . 0.0 112.158 175.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -86.76 -179.33 6.54 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.134 1.774 . . . . 0.0 112.125 -177.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -119.92 168.39 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.981 1.712 . . . . 0.0 111.971 178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.683 1.993 . . . . 0.0 112.225 179.329 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.498 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.76 156.23 19.85 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.214 1.406 . . . . 0.0 112.407 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -82.51 -48.81 10.6 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.949 0.899 . . . . 0.0 112.34 -178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.23 -12.32 59.75 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.18 -22.3 63.92 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.367 1.467 . . . . 0.0 113.306 173.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -69.57 132.21 45.88 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 119.15 0.886 . . . . 0.0 111.398 171.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -147.57 150.03 33.7 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.808 1.243 . . . . 0.0 111.597 -177.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -93.66 9.01 38.67 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.971 1.708 . . . . 0.0 114.561 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.63 -10.45 8.38 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.893 1.677 . . . . 0.0 115.519 -175.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -52.11 -22.09 3.86 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.661 1.984 . . . . 0.0 113.558 173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -55.63 -22.7 23.85 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 172.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -73.36 -20.32 60.79 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.153 0.981 . . . . 0.0 113.524 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.28 146.43 54.95 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.187 -0.946 . . . . 0.0 111.191 177.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -63.96 155.49 30.79 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.79 0.836 . . . . 0.0 110.482 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.96 156.69 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.793 1.237 . . . . 0.0 110.49 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 19' ' ' VAL . 87.1 t -57.88 -43.4 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 125.575 1.55 . . . . 0.0 110.824 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 7.11 0.32 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.11 1.764 . . . . 0.0 114.058 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -122.2 -54.41 1.9 Allowed 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 16' ' ' VAL . 6.7 p -45.55 -44.24 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.706 0.802 . . . . 0.0 112.808 166.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.0 t -62.73 -11.01 14.74 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -106.77 -38.24 6.16 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.874 2.07 . . . . 0.0 112.352 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.5 mt -49.6 -41.69 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.135 1.374 . . . . 0.0 110.901 170.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.6 p -60.65 -41.78 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 O-C-N 121.4 -0.812 . . . . 0.0 112.903 177.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -51.23 57.86 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 119.571 1.078 . . . . 0.0 111.087 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -30.12 71.31 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.38 -40.72 29.45 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.094 0.957 . . . . 0.0 113.39 175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.04 -55.75 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 119.275 0.943 . . . . 0.0 109.65 174.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.08 -31.44 70.01 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 t -58.64 -50.39 74.04 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.892 1.277 . . . . 0.0 112.149 167.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.32 -31.7 72.16 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.279 1.215 . . . . 0.0 114.279 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.57 -37.08 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.529 1.132 . . . . 0.0 110.777 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.96 16.98 78.31 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 124.023 0.821 . . . . 0.0 114.165 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.51 16.86 79.84 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.052 1.311 . . . . 0.0 115.48 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.34 168.74 5.32 Favored 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 119.005 1.402 . . . . 0.0 113.635 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.74 -167.61 0.49 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.732 1.613 . . . . 0.0 113.387 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -52.35 149.66 5.41 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.848 1.659 . . . . 0.0 112.864 170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -144.42 172.8 12.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.828 1.251 . . . . 0.0 112.463 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.68 -92.84 0.12 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.788 1.635 . . . . 0.0 111.407 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.5 p -98.17 4.02 48.99 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.961 2.504 . . . . 0.0 113.881 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.8 mmtm -49.38 -43.89 44.51 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.249 1.02 . . . . 0.0 112.641 174.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.9 t -52.07 -36.83 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.63 1.172 . . . . 0.0 113.19 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -66.2 -52.96 42.99 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.467 1.107 . . . . 0.0 112.201 174.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -64.59 -23.56 67.31 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 121.082 -1.011 . . . . 0.0 112.904 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -77.06 -55.67 5.25 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 124.951 1.301 . . . . 0.0 111.525 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.5 t -57.12 -29.16 63.32 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 118.619 0.645 . . . . 0.0 112.628 178.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 t -78.34 -58.8 3.06 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 119.247 0.93 . . . . 0.0 112.241 170.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -59.1 -41.28 87.7 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 120.154 1.343 . . . . 0.0 113.972 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.44 -63.09 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 C-N-CA 124.73 1.212 . . . . 0.0 110.0 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.2 t -50.4 -29.56 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 124.628 1.171 . . . . 0.0 110.591 176.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -57.87 -38.9 76.56 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -107.33 -39.87 5.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.676 1.59 . . . . 0.0 112.155 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.8 m -60.49 -50.66 72.66 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 127.271 2.228 . . . . 0.0 112.542 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.465 ' HG ' HG11 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -65.7 -35.84 81.9 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.232 0.539 . . . . 0.0 111.44 177.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.6 t -63.06 -40.56 98.05 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.469 -0.769 . . . . 0.0 112.215 170.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -66.22 -49.15 68.23 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.891 2.076 . . . . 0.0 113.151 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.427 HD21 HD22 ' A' ' 53' ' ' LEU . 3.9 pp -65.85 -25.8 67.36 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.717 -1.239 . . . . 0.0 114.089 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.0 m -62.87 -23.51 67.35 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.452 1.101 . . . . 0.0 111.469 168.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 mmtm -91.92 -24.52 19.26 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.155 0.982 . . . . 0.0 113.257 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 mt -64.92 -22.32 66.97 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.928 1.291 . . . . 0.0 114.381 176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -131.67 -130.42 3.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 125.29 1.424 . . . . 0.0 112.444 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -64.61 120.2 63.74 Favored Pre-proline 0 N--CA 1.481 1.119 0 CA-C-O 117.626 -1.178 . . . . 0.0 111.616 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.21 120.72 5.44 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.954 3.103 . . . . 0.0 112.385 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -163.91 -171.03 2.32 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.118 1.767 . . . . 0.0 112.277 -177.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.95 123.79 36.46 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.062 1.345 . . . . 0.0 111.525 174.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.2 126.9 55.58 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.394 1.878 . . . . 0.0 109.353 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.18 148.25 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.124 0.97 . . . . 0.0 110.203 174.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.465 HG11 ' HG ' ' A' ' 53' ' ' LEU . 34.7 m -138.36 155.9 29.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 124.233 1.013 . . . . 0.0 111.256 167.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.3 t -140.41 155.27 46.79 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 124.73 1.212 . . . . 0.0 109.997 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.4 p -146.21 149.49 34.04 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.469 1.128 . . . . 0.0 112.32 173.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 p -130.22 123.55 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 125.17 1.388 . . . . 0.0 109.082 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 3.1 mm -114.5 98.67 7.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 126.565 1.946 . . . . 0.0 107.387 -174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 ttt -110.27 157.13 19.8 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.573 1.149 . . . . 0.0 110.474 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -123.53 133.56 53.98 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.86 1.264 . . . . 0.0 110.988 -173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttt -64.81 -9.2 18.87 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.308 1.595 . . . . 0.0 115.308 -175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -57.53 -19.16 23.22 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.241 1.816 . . . . 0.0 114.422 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 118.86 42.69 0.56 Allowed Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.908 1.242 . . . . 0.0 113.905 172.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -132.4 74.25 1.57 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.254 1.021 . . . . 0.0 112.27 -172.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -125.66 161.58 20.07 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.089 1.328 . . . . 0.0 115.113 -174.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -146.0 -177.78 5.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.119 1.367 . . . . 0.0 113.52 -165.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -104.99 111.91 24.86 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.902 0.881 . . . . 0.0 110.161 173.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.443 ' HB ' HG13 ' A' ' 135' ' ' VAL . 59.2 m -112.18 144.87 40.85 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.108 1.363 . . . . 0.0 109.425 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -144.69 148.02 33.71 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.185 0.993 . . . . 0.0 112.004 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 94.0 p -142.62 138.76 30.96 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.081 0.943 . . . . 0.0 112.347 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 4.6 t -81.88 17.73 1.47 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.797 0.839 . . . . 0.0 112.034 174.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.564 ' SG ' HD11 ' B' ' 209' ' ' ILE . 39.8 m -61.78 173.9 0.93 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 122.762 1.268 . . . . 0.0 111.676 165.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.03 149.86 14.57 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.854 2.062 . . . . 0.0 109.289 -177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TRP . . . . . . . . . . . . . 3.2 t-105 -83.56 134.66 34.81 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.722 0.809 . . . . 0.0 109.193 170.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -138.14 119.26 14.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 109.646 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.93 -47.0 4.51 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.058 1.743 . . . . 0.0 113.826 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 t -106.39 -22.36 12.83 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.806 1.242 . . . . 0.0 112.979 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.41 -30.52 30.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.007 1.723 . . . . 0.0 112.999 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.44 -165.99 1.15 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.124 2.17 . . . . 0.0 110.103 -178.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -107.06 147.06 16.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.425 1.012 . . . . 0.0 113.073 170.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 35.9 p -162.79 150.98 14.07 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.923 1.289 . . . . 0.0 111.42 170.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . . . . . . . . . 29.7 p -156.47 172.2 18.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.749 1.22 . . . . 0.0 112.246 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -154.4 150.75 28.23 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.358 1.063 . . . . 0.0 111.41 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.66 134.5 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.2 1.4 . . . . 0.0 109.562 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -123.61 125.74 45.38 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.06 1.344 . . . . 0.0 111.621 -175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 22.5 m95 -135.29 120.0 18.32 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.783 1.633 . . . . 0.0 109.938 -175.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -82.16 153.28 26.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.335 -0.853 . . . . 0.0 111.803 172.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -120.74 -170.51 2.01 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.532 1.533 . . . . 0.0 109.047 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -51.66 -54.14 31.3 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 114.101 1.148 . . . . 0.0 114.101 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.0 t -138.14 -22.0 1.06 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 125.038 1.335 . . . . 0.0 114.319 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 20.1 ptp -92.29 177.63 6.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.807 1.243 . . . . 0.0 111.483 168.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -142.29 145.95 34.54 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.013 1.325 . . . . 0.0 109.828 172.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 24.6 p -128.17 130.44 48.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.402 1.081 . . . . 0.0 110.869 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.05 133.39 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 124.157 0.983 . . . . 0.0 109.664 174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.8 p -122.28 129.58 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 126.006 1.723 . . . . 0.0 109.665 -178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.4 p -126.49 148.79 49.63 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.915 0.886 . . . . 0.0 111.399 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.456 ' CB ' HG12 ' A' ' 67' ' ' VAL . . . -135.34 131.92 37.0 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.5 1.52 . . . . 0.0 110.973 -171.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -130.7 114.35 15.27 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 122.072 0.939 . . . . 0.0 110.031 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -102.05 84.05 0.49 Allowed Glycine 0 CA--C 1.524 0.599 0 C-N-CA 125.638 1.59 . . . . 0.0 110.613 -176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.98 126.91 36.22 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.359 1.064 . . . . 0.0 112.737 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.4 t -147.26 116.3 6.87 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.032 1.333 . . . . 0.0 112.632 -174.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -16.96 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.89 -15.54 69.31 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.814 1.197 . . . . 0.0 114.759 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 65.26 20.32 67.21 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 118.638 1.219 . . . . 0.0 115.245 174.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.61 51.22 3.35 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 126.135 1.826 . . . . 0.0 114.817 -172.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 66.5 m -136.97 167.21 21.94 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.882 2.073 . . . . 0.0 111.899 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.04 18.14 6.96 Favored Glycine 0 N--CA 1.475 1.263 0 C-N-CA 124.694 1.14 . . . . 0.0 115.713 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -73.03 49.25 0.24 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 127.167 2.187 . . . . 0.0 113.781 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 89.9 p -144.6 7.18 1.27 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.817 1.647 . . . . 0.0 113.36 -172.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.66 -109.0 2.68 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 126.756 2.122 . . . . 0.0 111.636 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.85 141.17 64.04 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.609 2.206 . . . . 0.0 111.895 173.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 pt -60.74 124.37 15.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 124.361 1.064 . . . . 0.0 111.201 174.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.32 147.52 40.16 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.705 -1.247 . . . . 0.0 111.55 171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.9 mt -84.85 131.79 34.48 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.622 1.569 . . . . 0.0 110.182 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 158.23 105.87 0.22 Allowed Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.094 0.854 . . . . 0.0 113.188 -175.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 68.8 mtm -67.89 156.73 36.53 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.372 1.069 . . . . 0.0 112.698 175.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -107.87 83.93 1.87 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.93 1.692 . . . . 0.0 111.712 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -118.96 170.78 8.74 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.541 0.736 . . . . 0.0 112.106 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.95 127.8 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 126.139 1.776 . . . . 0.0 111.493 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.3 m -97.62 101.54 13.08 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.914 1.686 . . . . 0.0 110.619 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -92.8 147.37 22.91 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.733 -1.229 . . . . 0.0 111.203 171.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 81' ' ' THR . 0.6 OUTLIER -137.92 113.42 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 127.771 2.428 . . . . 0.0 109.505 179.468 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -137.08 141.77 42.37 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 121.317 -0.864 . . . . 0.0 112.15 173.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -140.04 94.62 8.81 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.977 1.711 . . . . 0.0 109.099 178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.2 164.74 33.87 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.756 2.304 . . . . 0.0 112.113 177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -64.6 -59.43 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.652 2.901 . . . . 0.0 112.865 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -158.58 -60.51 0.08 Allowed 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.205 1.802 . . . . 0.0 110.305 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -89.2 -176.41 5.1 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.2 1.8 . . . . 0.0 111.952 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.57 161.74 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 126.636 1.974 . . . . 0.0 111.354 173.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.255 1.376 0 C-N-CA 126.513 1.925 . . . . 0.0 110.641 179.315 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.514 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.18 157.38 17.17 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.638 1.575 . . . . 0.0 112.453 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -83.18 -48.87 10.05 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.144 0.978 . . . . 0.0 112.38 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.17 -12.22 59.45 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.07 -22.26 64.02 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.438 1.495 . . . . 0.0 113.34 173.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -69.49 132.33 46.13 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.118 0.872 . . . . 0.0 111.38 171.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -147.26 151.1 36.1 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.895 1.278 . . . . 0.0 111.611 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -95.48 9.36 40.34 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.009 1.724 . . . . 0.0 114.53 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.75 -10.34 8.61 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 115.615 1.709 . . . . 0.0 115.615 -175.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -52.0 -22.51 4.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.674 1.99 . . . . 0.0 113.587 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -55.2 -22.4 17.45 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 172.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 1.4 t -74.65 -20.39 59.9 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.409 1.084 . . . . 0.0 113.757 174.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.25 150.08 48.84 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 120.97 -1.082 . . . . 0.0 111.186 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -65.56 164.81 13.41 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.311 0.577 . . . . 0.0 111.272 172.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.46 155.5 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.861 1.265 . . . . 0.0 110.633 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' VAL . . . . . . . . . . . . . 88.9 t -57.02 -41.78 78.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.16 0.984 . . . . 0.0 111.61 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.32 -25.57 68.1 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.92 1.288 . . . . 0.0 113.406 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.26 -56.51 4.4 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.361 1.465 . . . . 0.0 110.635 171.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' VAL . . . . . . . . . . . . . 93.8 t -50.81 -44.3 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.874 1.27 . . . . 0.0 112.198 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' SER . . . . . . . . . . . . . 8.7 t -62.06 -13.45 26.48 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.741 1.217 . . . . 0.0 113.621 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -100.64 -39.67 7.76 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.743 2.017 . . . . 0.0 112.353 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' ILE . . . . . . . . . . . . . 37.7 mt -50.85 -42.55 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.98 1.312 . . . . 0.0 110.905 172.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.24 -41.78 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 O-C-N 121.433 -0.792 . . . . 0.0 112.857 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -51.32 58.61 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.69 1.132 . . . . 0.0 111.249 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -30.29 71.44 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.54 -39.9 30.82 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.986 0.914 . . . . 0.0 113.448 175.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' ILE . . . . . . . . . . . . . 58.1 mt -58.57 -55.83 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.302 0.956 . . . . 0.0 109.572 174.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -60.0 -31.56 70.03 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' SER . . . . . . . . . . . . . 3.0 t -58.33 -50.45 73.6 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.779 1.232 . . . . 0.0 112.211 167.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.6 72.1 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 94.8 mt -62.61 -37.22 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.504 1.121 . . . . 0.0 110.871 173.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' GLY . . . . . . . . . . . . . . . 72.77 16.44 78.01 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 123.988 0.804 . . . . 0.0 114.303 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.48 17.48 77.65 Favored Glycine 0 CA--C 1.54 1.607 0 C-N-CA 125.063 1.316 . . . . 0.0 115.621 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -65.24 172.98 2.74 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 118.934 1.367 . . . . 0.0 113.625 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -80.25 -160.54 0.3 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.377 1.471 . . . . 0.0 112.511 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -48.26 151.42 1.03 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.851 1.66 . . . . 0.0 113.083 165.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -147.8 172.3 14.34 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.983 1.313 . . . . 0.0 112.105 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -89.51 -92.78 0.12 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.81 1.644 . . . . 0.0 111.383 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' SER . . . . . . . . . . . . . 2.0 p -98.26 3.99 48.79 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.981 2.512 . . . . 0.0 113.948 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' LYS . . . . . . . . . . . . . 27.0 mmtm -49.64 -43.87 47.12 Favored 'General case' 0 N--CA 1.48 1.043 0 O-C-N 121.075 -1.015 . . . . 0.0 112.619 175.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.9 -37.02 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.68 1.192 . . . . 0.0 113.132 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -66.17 -53.29 39.32 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.491 1.116 . . . . 0.0 112.177 173.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -64.26 -23.66 67.38 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.072 -1.018 . . . . 0.0 112.985 176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -76.86 -55.93 5.05 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 124.978 1.311 . . . . 0.0 111.541 175.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' THR . . . . . . . . . . . . . 8.5 t -57.14 -27.89 62.26 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.603 0.638 . . . . 0.0 112.719 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . . . . . . . . . 8.9 t -79.45 -60.03 2.52 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.388 0.995 . . . . 0.0 112.3 169.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 190' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -58.13 -41.24 83.22 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 120.28 1.4 . . . . 0.0 113.975 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.81 -63.67 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 C-N-CA 124.874 1.269 . . . . 0.0 109.734 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 192' ' ' VAL . . . . . . . . . . . . . 97.3 t -50.06 -29.31 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 125.047 1.339 . . . . 0.0 110.907 176.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 193' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -59.23 -37.25 77.07 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 194' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -109.1 -39.03 5.4 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.793 1.637 . . . . 0.0 112.118 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 195' ' ' THR . . . . . . . . . . . . . 52.4 m -61.7 -51.73 67.21 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 127.655 2.382 . . . . 0.0 112.4 178.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 196' ' ' LEU . . . . . 0.491 HD13 HD11 ' B' ' 199' ' ' LEU . 0.0 OUTLIER -65.91 -36.51 83.57 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 117.953 0.342 . . . . 0.0 110.823 177.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . . . . . . . . . 8.1 t -59.3 -43.67 92.6 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.546 -0.721 . . . . 0.0 112.203 171.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 198' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.46 -51.62 62.18 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.366 2.267 . . . . 0.0 113.292 178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 199' ' ' LEU . . . . . 0.491 HD11 HD13 ' B' ' 196' ' ' LEU . 4.4 pp -66.07 -27.24 67.92 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' THR . . . . . . . . . . . . . 22.9 m -59.13 -37.01 76.21 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 123.132 0.573 . . . . 0.0 109.995 168.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -77.25 -25.18 51.24 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' LEU . . . . . . . . . . . . 0.297 0.0 OUTLIER -56.01 -26.2 47.71 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 125.967 1.707 . . . . 0.0 114.112 178.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' GLY . . . . . . . . . . . . . . . -139.69 -82.77 0.09 OUTLIER Glycine 0 CA--C 1.535 1.295 0 CA-C-N 119.62 1.1 . . . . 0.0 114.425 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -67.15 172.62 3.4 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 125.97 1.708 . . . . 0.0 113.64 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.0 170.85 15.89 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.527 2.151 . . . . 0.0 112.297 166.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -56.75 112.39 1.29 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.329 1.452 . . . . 0.0 112.899 172.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -177.75 100.97 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 128.255 2.622 . . . . 0.0 111.057 170.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -151.67 169.26 22.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.614 1.566 . . . . 0.0 110.497 164.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' ILE . . . . . 0.564 HD11 ' SG ' ' A' ' 85' ' ' CYS . 1.2 tt -133.58 155.57 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 124.967 1.307 . . . . 0.0 108.92 157.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' B' ' 253' ' ' ALA . 35.1 m -136.17 152.75 30.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 123.861 0.865 . . . . 0.0 111.105 165.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' THR . . . . . . . . . . . . . 39.7 p -133.69 158.83 42.29 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.84 1.256 . . . . 0.0 110.266 170.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' CYS . . . . . . . . . . . . . 24.5 p -148.87 156.75 42.76 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 122.336 1.065 . . . . 0.0 112.656 170.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' VAL . . . . . . . . . . . . . 10.3 p -145.66 127.3 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 O-C-N 121.408 -0.808 . . . . 0.0 110.752 -174.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.405 HD12 ' HB3' ' B' ' 249' ' ' CYS . 2.4 mm -119.22 98.29 6.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 C-N-CA 127.094 2.158 . . . . 0.0 107.356 -169.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' MET . . . . . . . . . . . . . 1.7 ttt -105.61 156.22 18.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.456 1.102 . . . . 0.0 110.401 176.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -122.42 132.04 54.17 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.801 1.24 . . . . 0.0 110.8 -175.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' LYS . . . . . . . . . . . . . 10.5 pttt -64.45 -9.11 16.31 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 -175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -57.31 -20.72 30.21 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.252 1.821 . . . . 0.0 114.432 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 123.72 40.86 0.44 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.688 1.137 . . . . 0.0 114.232 172.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' ALA . . . . . . . . . . . . . . . -126.45 70.33 1.25 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.317 1.047 . . . . 0.0 112.575 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.31 155.32 16.38 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.468 1.509 . . . . 0.0 115.597 -173.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.09 178.35 9.28 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.937 1.695 . . . . 0.0 112.624 -166.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -108.79 110.61 22.02 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.386 1.075 . . . . 0.0 111.216 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' THR . . . . . 0.44 ' HB ' HG13 ' B' ' 278' ' ' VAL . 55.7 m -105.67 145.2 31.37 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.266 1.026 . . . . 0.0 109.207 173.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' ALA . . . . . . . . . . . . . . . -141.48 140.88 33.63 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.147 0.979 . . . . 0.0 111.044 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' SER . . . . . . . . . . . . . 94.1 p -137.55 143.71 41.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.203 176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 4.4 t -84.55 15.77 3.56 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.782 0.833 . . . . 0.0 111.885 175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' CYS . . . . . . . . . . . . . 31.8 m -61.23 167.7 2.99 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.169 0.988 . . . . 0.0 111.636 166.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.6 147.29 21.71 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.693 1.997 . . . . 0.0 109.779 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' TRP . . . . . . . . . . . . . 3.9 t-105 -82.64 128.55 34.44 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.847 0.859 . . . . 0.0 108.7 170.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -133.04 116.42 16.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.794 1.638 . . . . 0.0 109.302 176.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.82 -47.11 5.16 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.9 1.68 . . . . 0.0 114.41 -177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' SER . . . . . . . . . . . . . 16.7 t -106.43 -21.02 13.2 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.74 1.216 . . . . 0.0 112.977 177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 -29.81 29.68 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.45 1.9 . . . . 0.0 113.356 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -163.1 -167.65 1.54 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.0 2.52 . . . . 0.0 109.294 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' GLY . . . . . . . . . . . . . . . -109.58 146.35 16.92 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.419 1.009 . . . . 0.0 112.906 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' SER . . . . . . . . . . . . . 29.7 p -160.64 147.28 15.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.976 1.31 . . . . 0.0 111.783 170.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' CYS . . . . . . . . . . . . . 11.6 p -152.35 169.28 22.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.789 1.236 . . . . 0.0 111.6 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' THR . . . . . . . . . . . . . 9.6 t -155.65 151.74 27.83 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 120.693 -1.254 . . . . 0.0 111.645 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.67 138.86 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.24 1.416 . . . . 0.0 109.817 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -127.3 127.56 44.53 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.057 1.343 . . . . 0.0 111.782 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' TRP . . . . . . . . . . . . . 23.2 m95 -136.5 119.63 16.58 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.834 1.654 . . . . 0.0 110.04 -175.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -81.95 153.11 26.43 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.25 -0.906 . . . . 0.0 111.936 172.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -120.93 -170.67 2.05 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.52 1.528 . . . . 0.0 109.079 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' LYS . . . . . . . . . . . . . 5.3 mttt -51.67 -54.85 23.64 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.127 1.158 . . . . 0.0 114.127 177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' THR . . . . . . . . . . . . . 6.1 t -137.46 -21.57 1.16 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.958 1.303 . . . . 0.0 114.245 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' MET . . . . . . . . . . . . . 20.1 ptp -93.03 178.06 5.87 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.386 168.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -142.43 145.97 34.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.075 1.35 . . . . 0.0 109.63 172.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' CYS . . . . . 0.405 ' HB3' HD12 ' B' ' 214' ' ' ILE . 25.0 p -128.22 132.8 48.78 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.314 1.046 . . . . 0.0 110.888 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.61 138.26 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.124 0.969 . . . . 0.0 109.925 175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 11.3 p -127.53 128.88 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 126.119 1.768 . . . . 0.0 110.07 -176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 252' ' ' SER . . . . . . . . . . . . . 3.5 p -123.23 148.93 45.34 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.672 1.189 . . . . 0.0 111.453 -178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 253' ' ' ALA . . . . . 0.462 ' HB2' HG12 ' B' ' 210' ' ' VAL . . . -136.55 139.22 42.05 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.327 1.451 . . . . 0.0 112.698 -175.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 254' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -140.2 121.72 15.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.631 1.172 . . . . 0.0 109.572 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . -111.69 82.03 0.3 Allowed Glycine 0 N--CA 1.469 0.859 0 C-N-CA 126.316 1.913 . . . . 0.0 111.863 -175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.87 105.34 17.27 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.706 1.202 . . . . 0.0 113.575 -169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 257' ' ' SER . . . . . . . . . . . . . 6.5 t -128.53 112.18 14.04 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.092 1.357 . . . . 0.0 112.532 -169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 258' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -17.99 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.522 1.529 . . . . 0.0 114.681 -175.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 259' ' ' GLY . . . . . . . . . . . . . . . -67.35 -16.25 66.88 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.866 1.222 . . . . 0.0 114.798 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 260' ' ' GLY . . . . . . . . . . . . . . . 67.43 15.86 66.52 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 118.694 1.247 . . . . 0.0 115.499 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 261' ' ' GLY . . . . . . . . . . . . . . . -77.53 59.72 3.7 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 125.94 1.733 . . . . 0.0 114.153 -174.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 262' ' ' SER . . . . . . . . . . . . . 71.3 m -140.59 167.43 22.19 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.451 2.301 . . . . 0.0 111.325 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 263' ' ' GLY . . . . . . . . . . . . . . . 113.7 19.43 6.52 Favored Glycine 0 N--CA 1.477 1.377 0 N-CA-C 115.761 1.064 . . . . 0.0 115.761 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 264' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -73.2 51.26 0.31 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.053 2.141 . . . . 0.0 113.734 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 265' ' ' SER . . . . . . . . . . . . . 80.1 p -147.96 6.79 0.8 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.537 1.535 . . . . 0.0 113.504 -170.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 266' ' ' GLY . . . . . . . . . . . . . . . 77.13 -109.3 2.76 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 126.593 2.044 . . . . 0.0 111.675 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 267' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.56 141.81 68.56 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.658 2.239 . . . . 0.0 112.024 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -62.34 125.08 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.363 1.065 . . . . 0.0 111.26 173.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 269' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.36 148.92 43.76 Favored 'General case' 0 N--CA 1.476 0.838 0 O-C-N 121.246 -0.909 . . . . 0.0 111.826 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 270' ' ' LEU . . . . . . . . . . . . . 29.4 mt -84.23 130.25 34.83 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.818 1.647 . . . . 0.0 110.028 178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 271' ' ' GLY . . . . . . . . . . . . . . . 159.6 100.75 0.16 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.969 0.795 . . . . 0.0 113.036 -175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 272' ' ' MET . . . . . . . . . . . . . 69.6 mtm -67.67 157.07 35.41 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.821 176.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 273' ' ' ALA . . . . . . . . . . . . . . . -107.04 99.01 8.6 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.191 1.796 . . . . 0.0 111.045 -176.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 274' ' ' LYS . . . . . 0.431 ' H ' ' HE2' ' B' ' 274' ' ' LYS 0.327 0.0 OUTLIER -127.34 177.04 6.98 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 177.209 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 275' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.17 129.53 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.176 0.99 . . . . 0.0 110.174 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 276' ' ' THR . . . . . . . . . . . . . 63.0 m -102.1 93.53 5.28 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.722 1.609 . . . . 0.0 109.953 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 277' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.89 149.59 24.7 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 121.329 -0.857 . . . . 0.0 111.081 171.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 278' ' ' VAL . . . . . 0.44 HG13 ' HB ' ' B' ' 224' ' ' THR . 7.4 p -147.2 118.13 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 126.723 2.009 . . . . 0.0 109.974 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 279' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -138.64 143.97 39.49 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.561 1.144 . . . . 0.0 111.569 176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 280' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -139.05 95.42 9.48 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 125.819 1.647 . . . . 0.0 108.799 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 281' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.23 164.73 33.95 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 122.818 2.345 . . . . 0.0 112.14 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 282' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.52 -59.15 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.514 2.809 . . . . 0.0 112.877 -178.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 283' ' ' ARG . . . . . . . . . . . . . 12.0 tpp180 -158.51 -60.6 0.08 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.16 1.784 . . . . 0.0 110.414 170.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 284' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -89.36 -176.61 5.13 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 126.237 1.815 . . . . 0.0 111.887 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 285' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.0 161.66 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.588 1.955 . . . . 0.0 111.363 173.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 286' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.677 1.991 . . . . 0.0 110.57 179.553 . . . . . . . . 0 0 . 1 stop_ save_